en Chris mungall Erica Marcos Ningxian Fan Paul Fabry Randi Vita Ryan R. Brinkman Shunzhou Deng Alan Ruttenburg Alexander D. Diehl Amogh Madireddi Anna Maria Masci Anthony Huffman Barry Smith Bjoern Peters Edison Ong Ellen Zhang Hong Yu Jason Hu Jie Zheng Kallan Roan Khadeejah Khan Lindsay Cowell Melanie Courtot Ningxian Fan Omar Tibi Philip Huang Randi Vita Rebecca Racz Richard H. Scheuermann Rohit Goru Ronak Sutariya Samantha G. Sayers (SGS) Taiyu Lin Thomas Todd Xingxian Li Yongqun "Oliver" He (YH) Yu Lin (YL) Yuanyi (Penny) Pan Yuping Zheng Zuoshuang "Allen" Xiang The Vaccine Ontology (VO) is a community-based biomedical ontology in the domain of vaccine and vaccination. VO aims to standardize vaccine types and annotations, integrate various vaccine data, and support computer-assisted reasoning. The VO supports basic vaccine R&D and clinical vaccine usage. VO is being developed as a community-based ontology with support and collaborations from the vaccine and bio-ontology communities. OWL-DL An ontology in the domain of vaccine and vaccination Vaccine Ontology 2025-05-24 Relates an entity in the ontology to the name of the variable that is used to represent it in the code that generates the BFO OWL file from the lispy specification. Really of interest to developers only BFO OWL specification label Relates an entity in the ontology to the term that is used to represent it in the the CLIF specification of BFO2 Person:Alan Ruttenberg Really of interest to developers only BFO CLIF specification label editor preferred term The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English) PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> editor preferred term example of usage A phrase describing how a term should be used and/or a citation to a work which uses it. May also include other kinds of examples that facilitate immediate understanding, such as widely know prototypes or instances of a class, or cases where a relation is said to hold. PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> example of usage in branch An annotation property indicating which module the terms belong to. This is currently experimental and not implemented yet. GROUP:OBI OBI_0000277 in branch has curation status PERSON:Alan Ruttenberg PERSON:Bill Bug PERSON:Melanie Courtot has curation status definition The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions. 2012-04-05: Barry Smith The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible. Can you fix to something like: A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property. Alan Ruttenberg Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria. On the specifics of the proposed definition: We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with. 2012-04-05: Barry Smith The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible. Can you fix to something like: A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property. Alan Ruttenberg Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria. On the specifics of the proposed definition: We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with. PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> definition editor note An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology. PERSON:Daniel Schober GROUP:OBI:<http://purl.obofoundry.org/obo/obi> editor note term editor Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people 20110707, MC: label update to term editor and definition modified accordingly. See https://github.com/information-artifact-ontology/IAO/issues/115. PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> term editor alternative label A label for a class or property that can be used to refer to the class or property instead of the preferred rdfs:label. Alternative labels should be used to indicate community- or context-specific labels, abbreviations, shorthand forms and the like. OBO Operations committee PERSON:Daniel Schober GROUP:OBI:<http://purl.obolibrary.org/obo/obi> Consider re-defing to: An alternative name for a class or property which can mean the same thing as the preferred name (semantically equivalent, narrow, broad or related). alternative label definition source Formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007 PERSON:Daniel Schober Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w GROUP:OBI:<http://purl.obolibrary.org/obo/obi> definition source has obsolescence reason Relates an annotation property to an obsolescence reason. The values of obsolescence reasons come from a list of predefined terms, instances of the class obsolescence reason specification. PERSON:Alan Ruttenberg PERSON:Melanie Courtot has obsolescence reason curator note An administrative note of use for a curator but of no use for a user PERSON:Alan Ruttenberg curator note term tracker item the URI for an OBI Terms ticket at sourceforge, such as https://sourceforge.net/p/obi/obi-terms/772/ An IRI or similar locator for a request or discussion of an ontology term. Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg The 'tracker item' can associate a tracker with a specific ontology term. term tracker item ontology term requester The name of the person, project, or organization that motivated inclusion of an ontology term by requesting its addition. Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg Person: Jie Zheng, Chris Stoeckert, Alan Ruttenberg The 'term requester' can credit the person, organization or project who request the ontology term. ontology term requester is denotator type Relates an class defined in an ontology, to the type of it's denotator In OWL 2 add AnnotationPropertyRange('is denotator type' 'denotator type') Alan Ruttenberg is denotator type imported from For external terms/classes, the ontology from which the term was imported PERSON:Alan Ruttenberg PERSON:Melanie Courtot GROUP:OBI:<http://purl.obolibrary.org/obo/obi> imported from expand expression to ObjectProperty: RO_0002104 Label: has plasma membrane part Annotations: IAO_0000424 "http://purl.obolibrary.org/obo/BFO_0000051 some (http://purl.org/obo/owl/GO#GO_0005886 and http://purl.obolibrary.org/obo/BFO_0000051 some ?Y)" A macro expansion tag applied to an object property (or possibly a data property) which can be used by a macro-expansion engine to generate more complex expressions from simpler ones Chris Mungall expand expression to expand assertion to ObjectProperty: RO??? Label: spatially disjoint from Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary.org/obo/BFO_0000051 some ?X) (http://purl.obolibrary.org/obo/BFO_0000051 some ?Y)" A macro expansion tag applied to an annotation property which can be expanded into a more detailed axiom. Chris Mungall expand assertion to first order logic expression PERSON:Alan Ruttenberg first order logic expression antisymmetric property part_of antisymmetric property xsd:true Use boolean value xsd:true to indicate that the property is an antisymmetric property Alan Ruttenberg antisymmetric property OBO foundry unique label An alternative name for a class or property which is unique across the OBO Foundry. The intended usage of that property is as follow: OBO foundry unique labels are automatically generated based on regular expressions provided by each ontology, so that SO could specify unique label = 'sequence ' + [label], etc. , MA could specify 'mouse + [label]' etc. Upon importing terms, ontology developers can choose to use the 'OBO foundry unique label' for an imported term or not. The same applies to tools . PERSON:Alan Ruttenberg PERSON:Bjoern Peters PERSON:Chris Mungall PERSON:Melanie Courtot GROUP:OBO Foundry <http://obofoundry.org/> OBO foundry unique label has ID digit count Ontology: <http://purl.obolibrary.org/obo/ro/idrange/> Annotations: 'has ID prefix': "http://purl.obolibrary.org/obo/RO_" 'has ID digit count' : 7, rdfs:label "RO id policy" 'has ID policy for': "RO" Relates an ontology used to record id policy to the number of digits in the URI. The URI is: the 'has ID prefix" annotation property value concatenated with an integer in the id range (left padded with "0"s to make this many digits) Person:Alan Ruttenberg has ID digit count has ID range allocated Datatype: idrange:1 Annotations: 'has ID range allocated to': "Chris Mungall" EquivalentTo: xsd:integer[> 2151 , <= 2300] Relates a datatype that encodes a range of integers to the name of the person or organization who can use those ids constructed in that range to define new terms Person:Alan Ruttenberg has ID range allocated to has ID policy for Ontology: <http://purl.obolibrary.org/obo/ro/idrange/> Annotations: 'has ID prefix': "http://purl.obolibrary.org/obo/RO_" 'has ID digit count' : 7, rdfs:label "RO id policy" 'has ID policy for': "RO" Relating an ontology used to record id policy to the ontology namespace whose policy it manages Person:Alan Ruttenberg has ID policy for has ID prefix Ontology: <http://purl.obolibrary.org/obo/ro/idrange/> Annotations: 'has ID prefix': "http://purl.obolibrary.org/obo/RO_" 'has ID digit count' : 7, rdfs:label "RO id policy" 'has ID policy for': "RO" Relates an ontology used to record id policy to a prefix concatenated with an integer in the id range (left padded with "0"s to make this many digits) to construct an ID for a term being created. Person:Alan Ruttenberg has ID prefix elucidation person:Alan Ruttenberg Person:Barry Smith Primitive terms in a highest-level ontology such as BFO are terms which are so basic to our understanding of reality that there is no way of defining them in a non-circular fashion. For these, therefore, we can provide only elucidations, supplemented by examples and by axioms elucidation has associated axiom(nl) Person:Alan Ruttenberg Person:Alan Ruttenberg An axiom associated with a term expressed using natural language has associated axiom(nl) has associated axiom(fol) Person:Alan Ruttenberg Person:Alan Ruttenberg An axiom expressed in first order logic using CLIF syntax has associated axiom(fol) is allocated id range Relates an ontology IRI to an (inclusive) range of IRIs in an OBO name space. The range is give as, e.g. "IAO_0020000-IAO_0020999" PERSON:Alan Ruttenberg Add as annotation triples in the granting ontology is allocated id range has ontology root term Ontology annotation property. Relates an ontology to a term that is a designated root term of the ontology. Display tools like OLS can use terms annotated with this property as the starting point for rendering the ontology class hierarchy. There can be more than one root. Nicolas Matentzoglu has ontology root term may be identical to A annotation relationship between two terms in an ontology that may refer to the same (natural) type but where more evidence is required before terms are merged. David Osumi-Sutherland #40 VFB Edges asserting this should be annotated with to record evidence supporting the assertion and its provenance. may be identical to scheduled for obsoletion on or after Used when the class or object is scheduled for obsoletion/deprecation on or after a particular date. Chris Mungall, Jie Zheng https://github.com/geneontology/go-ontology/issues/15532 https://github.com/information-artifact-ontology/ontology-metadata/issues/32 GO ontology scheduled for obsoletion on or after has axiom id Person:Alan Ruttenberg Person:Alan Ruttenberg A URI that is intended to be unique label for an axiom used for tracking change to the ontology. For an axiom expressed in different languages, each expression is given the same URI has axiom label term replaced by Use on obsolete terms, relating the term to another term that can be used as a substitute Person:Alan Ruttenberg Person:Alan Ruttenberg Add as annotation triples in the granting ontology term replaced by ISA alternative term An alternative term used by the ISA tools project (http://isa-tools.org). Requested by Alejandra Gonzalez-Beltran https://sourceforge.net/tracker/?func=detail&aid=3603413&group_id=177891&atid=886178 Person: Alejandra Gonzalez-Beltran Person: Philippe Rocca-Serra ISA tools project (http://isa-tools.org) ISA alternative term IEDB alternative term An alternative term used by the IEDB. PERSON:Randi Vita, Jason Greenbaum, Bjoern Peters IEDB IEDB alternative term A GeneID in the NCBI Gene database Oliver He, Yue Liu NCBI GeneID the NCBI LocusTag name of a gene Oliver He, Yue Liu NCBI LocusTag a date of content modification Oliver He, Yue Liu modification date The NCBITaxon ontology ID of an organism. Oliver He, Yue Liu organism NCBITaxon ID A chromosome ID where a gene is located. Oliver He chromosome ID of gene an annotation property that specifies the type of a gene Oliver He type of gene an annotation property that specifies a nomenclature status Oliver He nomenclature status An annotation property that represents a gene's association with PubMed publication(s). Yongqun He has PubMed association This is an annotation used on an object property to indicate a logical characterstic beyond what is possible in OWL. OBO Operations call logical characteristic of object property 'part disjoint with' 'defined by construct' """ PREFIX owl: <http://www.w3.org/2002/07/owl#> PREFIX : <http://example.org/ CONSTRUCT { [ a owl:Restriction ; owl:onProperty :part_of ; owl:someValuesFrom ?a ; owl:disjointWith [ a owl:Restriction ; owl:onProperty :part_of ; owl:someValuesFrom ?b ] ] } WHERE { ?a :part_disjoint_with ?b . } Links an annotation property to a SPARQL CONSTRUCT query which is meant to provide semantics for a shortcut relation. defined by construct CHEBI:26523 (reactive oxygen species) has an exact synonym (ROS), which is of type OMO:0003000 (abbreviation) A synonym type for describing abbreviations or initalisms 2023-03-03 abbreviation A synonym type for describing ambiguous synonyms 2023-03-03 ambiguous synonym A synonym type for describing dubious synonyms 2023-03-03 dubious synonym EFO:0006346 (severe cutaneous adverse reaction) has an exact synonym (scar), which is of the type OMO:0003003 (layperson synonym) A synonym type for describing layperson or colloquial synonyms 2023-03-03 layperson synonym CHEBI:23367 (molecular entity) has an exact synonym (molecular entities), which is of the type OMO:0003004 (plural form) A synonym type for describing pluralization synonyms 2023-03-03 plural form CHEBI:16189 (sulfate) has an exact synonym (sulphate), which is of the type OMO:0003005 (UK spelling synonym) A synonym type for describing UK spelling variants 2023-03-03 UK spelling synonym A synonym type for common misspellings 2023-03-03 misspelling A synonym type for misnomers, i.e., a synonym that is not technically correct but is commonly used anyway 2023-03-03 misnomer MAPT, the gene that encodes the Tau protein, has a previous name DDPAC. Note: in this case, the name type is more specifically the gene symbol. A synonym type for names that have been used as primary labels in the past. 2023-07-25 previous name The legal name for Harvard University (https://ror.org/03vek6s52) is President and Fellows of Harvard College A synonym type for the legal entity name 2023-07-27 legal name CHEBI:46195 has been assigned the english International Nonproproprietary Name (INN) "paracetamol". In some cases such as this one, the INN might be the same as the ontology's primary label The International Nonproprietary Name (INN) is a standardize name for a pharmaceutical drug or active ingredient issued by the World Health Organization (WHO) meant to address the issues with country- or language-specific brand names. These are issued in several languages, including English, Latin, French, Russian, Spanish, Arabic, and Chinese. 2023-09-30 INN International Nonproprietary Name nasopharynx (UBERON:0001728) has the latin name "pars nasalis pharyngis A synonym type for describing Latin term synonyms. 2023-10-12 latin term NASA is an word acronym for the US National Aeronautics and Space Administration because the acronym is pronounced. FBI is an initialism (also known as alphabetism) for the US Federal Bureau of Investigation since the letters are pronounced one at a time. JPEG is an acronym for Joint Photographic Experts Group but does not count as a word acronym nor an initialism since it is mixed how it is pronounced. A synonym type for describing abbreviations that are a part of the full name's words, such as initialisms or alphabetisms. 2023-11-01 acronym A serial number such as "12324X"; a stop sign; a written proper name such as "OBI An information content entity that is a mark(s) or character(s) used as a conventional representation of another entity. 2024-03-25 has symbol An assertion that holds between an OWL Object Property and a temporal interpretation that elucidates how OWL Class Axioms that use this property are to be interpreted in a temporal context. temporal interpretation tooth SubClassOf 'never in taxon' value 'Aves' x never in taxon T if and only if T is a class, and x does not instantiate the class expression "in taxon some T". Note that this is a shortcut relation, and should be used as a hasValue restriction in OWL. Class: ?X DisjointWith: RO_0002162 some ?Y PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> PREFIX owl: <http://www.w3.org/2002/07/owl#> PREFIX in_taxon: <http://purl.obolibrary.org/obo/RO_0002162> PREFIX never_in_taxon: <http://purl.obolibrary.org/obo/RO_0002161> CONSTRUCT { in_taxon: a owl:ObjectProperty . a owl:Restriction ; owl:onProperty in_taxon: ; owl:someValuesFrom ?taxon ] . ?x rdfs:subClassOf [ a owl:Restriction ; owl:onProperty in_taxon: ; owl:someValuesFrom [ a owl:Class ; owl:complementOf ?taxon ] ] . } WHERE { ?x never_in_taxon: ?taxon . } never in taxon A is mutually_spatially_disjoint_with B if both A and B are classes, and there exists no p such that p is part_of some A and p is part_of some B. non-overlapping with shares no parts with Class: <http://www.w3.org/2002/07/owl#Nothing> EquivalentTo: (BFO_0000050 some ?X) and (BFO_0000050 some ?Y) PREFIX owl: <http://www.w3.org/2002/07/owl#> PREFIX part_of: <http://purl.obolibrary.org/obo/BFO_0000050> PREFIX mutually_spatially_disjoint_with: <http://purl.obolibrary.org/obo/RO_0002171> CONSTRUCT { part_of: a owl:ObjectProperty . [ a owl:Restriction ; owl:onProperty part_of: ; owl:someValuesFrom ?x ; a owl:Restriction ; owl:onProperty part_of: ; owl:someValuesFrom ?y ] ] } WHERE { ?x mutually_spatially_disjoint_with: ?y . } mutually spatially disjoint with https://github.com/obophenotype/uberon/wiki/Part-disjointness-Design-Pattern An assertion that holds between an ontology class and an organism taxon class, which is intepreted to yield some relationship between instances of the ontology class and the taxon. taxonomic class assertion S present_in_taxon T if some instance of T has some S. This does not means that all instances of T have an S - it may only be certain life stages or sexes that have S PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> PREFIX owl: <http://www.w3.org/2002/07/owl#> PREFIX in_taxon: <http://purl.obolibrary.org/obo/RO_0002162> PREFIX present_in_taxon: <http://purl.obolibrary.org/obo/RO_0002175> CONSTRUCT { in_taxon: a owl:ObjectProperty . ?witness rdfs:label ?label . ?witness rdfs:subClassOf ?x . ?witness rdfs:subClassOf [ a owl:Restriction ; owl:onProperty in_taxon: ; owl:someValuesFrom ?taxon ] . } WHERE { ?x present_in_taxon: ?taxon . BIND(IRI(CONCAT( "http://purl.obolibrary.org/obo/RO_0002175#", MD5(STR(?x)), "-", MD5(STR(?taxon)) )) as ?witness) BIND(CONCAT(STR(?x), " in taxon ", STR(?taxon)) AS ?label) } The SPARQL expansion for this relation introduces new named classes into the ontology. For this reason it is likely that the expansion should only be performed during a QC pipeline; the expanded output should usually not be included in a published version of the ontology. present in taxon An assertion that involves at least one OWL object that is intended to be expanded into one or more logical axioms. The logical expansion can yield axioms expressed using any formal logical system, including, but not limited to OWL2-DL. logical macro assertion http://purl.obolibrary.org/obo/ro/docs/shortcut-relations/ A logical macro assertion whose domain is an IRI for a class The domain for this class can be considered to be owl:Class, but we cannot assert this in OWL2-DL logical macro assertion on a class A logical macro assertion whose domain is an IRI for a property logical macro assertion on a property Used to annotate object properties to describe a logical meta-property or characteristic of the object property. logical macro assertion on an object property A shortcut relationship that holds between two entities based on their identity criteria logical macro assertion involving identity A shortcut relationship between two entities x and y1, such that the intent is that the relationship is functional and inverse function, but there is no guarantee that this property holds. in approximate one to one relationship with 'anterior end of organism' is-opposite-of 'posterior end of organism' 'increase in temperature' is-opposite-of 'decrease in temperature' x is the opposite of y if there exists some distance metric M, and there exists no z such as M(x,z) <= M(x,y) or M(y,z) <= M(y,x). is opposite of external_definition axiom_lost_from_external_ontology homology_notes has_relational_adjective taxon_notes development_notes external_ontology_notes fma_set_term An annotation property that represents a matched vaccine identifier used in the VIOLIN database. Oliver He Omar Tibi VIOLIN vaccine ID An annotation property that represents the trade name of a product. Oliver He trade name An annotation property that represents the active ingredient of a vaccine. Oliver He has vaccine active ingredient An annotation property that represents the vaccine ingredient of a vaccine. Such an ingredient may not be active. Oliver He has vaccine ingredient An annotation property that describes the dose information of a vaccine Oliver He vaccine dose annotation The vaccine Prevnar (trade name) has a FDA-defined proper name: Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein). Reference: https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm180017.htm An annotation property that represents the proper name of a vaccine, which is defined in an official way such as one defined by FDA. Kallan Roan Oliver He obsolete vaccine proper name true The vaccine Prevnar has the manufacturer: Wyeth Pharmaceuticals Inc. Reference: https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm180017.htm An annotation property that represents the manufacturer of a vaccine Kallan Roan Oliver He obsolete vaccine manufacturer true The vaccine Prevnar has the indications: - Immunization of infants 2, 4, 6 and 12-15 months of age to prevent invasive pneumococcal disease. - Immunization of infants and toddlers against otitis media caused by vaccine serotypes. Reference: https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm180017.htm An annotation property that represents the indications of a vaccine defined by the USA FDA. Kallan Roan Oliver He FDA vaccine indications Prevnar has the package insert PDF URL: https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM137038.pdf . Recorded on 11/26/2018. An annotation property that represents a URL of the package insert PDF document of a licensed vaccine Kallan Roan Oliver He vaccine package insert PDF URL An annotation property that indicate the number that is generated by FDA based on a request from an applicant of a product licensing. Kallan Roan Oliver He https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ProceduresSOPPs/UCM461225.pdf vaccine STN RxNorm ID obsolete has Protegen id true obsolete has Protegen annotation true As seen: http://purl.bioontology.org/ontology/RXNORM/901644, the RxNORM vaccine term "Prevnar 13 vaccine 0.5 ML Prefilled Syringe" has Preferred Name of: 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe [Prevnar 13]". In this case, the whole preferred name is annotated under the annotation property "RxNORM Preferred Name". RxNorm Preferred Name RxNorm Synonym An identifier assigned by the Vaccine Adjuvant Compendium (VAC: https://vac.niaid.nih.gov/) https://vac.niaid.nih.gov/ VAC adjuvant ID An annotation property that represents the annotated information about the antigens used for a specific vaccine. Oliver He Penny Pan https://en.wikipedia.org/wiki/Antigen vaccine antigen annotation obsolete vaccine preparation annotation true vaccine response annotation An annotation property that refers to a specific CVX ID. Oliver He Penny Pan https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx CVX code An annotation property that shows the status of vaccine developmeint including: clinical trial, research, licensed, or Emergency Use Authorization (EUA). Anthony Huffman Jie Zheng Oliver He Penny Pan obsolete status of vaccine development true An annotation property that represents an identifier of RxNorm or RxNorm extension concept assigned by OMOP. OMOP concept ID An annotation property that represents an identifier of RxNorm extension term assigned by OMOP. RxNorm OMOP extension ID An annotation property that refers to full vaccine name in CVX code set. CVX full vaccine name An annotation property that refers to short description in CVX code set. CVX short description has_rank An alternative label for a class or property which has a more general meaning than the preferred name/primary label. https://github.com/information-artifact-ontology/ontology-metadata/issues/18 has broad synonym https://github.com/information-artifact-ontology/ontology-metadata/issues/18 disease characteristic (MONDO:0021125) has cross-reference (http://www.geneontology.org/formats/oboInOwl#hasDbXref) "NCIT:C41009"^^xsd:string An annotation property that links an ontology entity or a statement to a prefixed identifier or URI. 2024-03-18 has cross-reference An alternative label for a class or property which has the exact same meaning than the preferred name/primary label. https://github.com/information-artifact-ontology/ontology-metadata/issues/20 has exact synonym https://github.com/information-artifact-ontology/ontology-metadata/issues/20 An alternative label for a class or property which has a more specific meaning than the preferred name/primary label. https://github.com/information-artifact-ontology/ontology-metadata/issues/19 has narrow synonym https://github.com/information-artifact-ontology/ontology-metadata/issues/19 An alternative label for a class or property that has been used synonymously with the primary term name, but the usage is not strictly correct. https://github.com/information-artifact-ontology/ontology-metadata/issues/21 has related synonym https://github.com/information-artifact-ontology/ontology-metadata/issues/21 is part of my brain is part of my body (continuant parthood, two material entities) my stomach cavity is part of my stomach (continuant parthood, immaterial entity is part of material entity) this day is part of this year (occurrent parthood) a core relation that holds between a part and its whole Everything is part of itself. Any part of any part of a thing is itself part of that thing. Two distinct things cannot be part of each other. Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See http://purl.obolibrary.org/obo/ro/docs/temporal-semantics/ Parthood requires the part and the whole to have compatible classes: only an occurrent can be part of an occurrent; only a process can be part of a process; only a continuant can be part of a continuant; only an independent continuant can be part of an independent continuant; only an immaterial entity can be part of an immaterial entity; only a specifically dependent continuant can be part of a specifically dependent continuant; only a generically dependent continuant can be part of a generically dependent continuant. (This list is not exhaustive.) A continuant cannot be part of an occurrent: use 'participates in'. An occurrent cannot be part of a continuant: use 'has participant'. A material entity cannot be part of an immaterial entity: use 'has location'. A specifically dependent continuant cannot be part of an independent continuant: use 'inheres in'. An independent continuant cannot be part of a specifically dependent continuant: use 'bearer of'. part_of part of http://www.obofoundry.org/ro/#OBO_REL:part_of precedes x precedes y if and only if the time point at which x ends is before or equivalent to the time point at which y starts. Formally: x precedes y iff ω(x) <= α(y), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point. precedes site of [copied from inverse property 'occurs in'] b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t Paraphrase of definition: a relation between an independent continuant and a process, in which the process takes place entirely within the independent continuant contains process process profile of is_manufactured_by http://www.affymetrix.com/products/arrays/specific/hgu133.affx is_manufactered_by http://www.affymetrix.com/ (if we decide to use these URIs for the actual entities) c is_manufactured_by o means that there was a process p in which c was built in which a person, or set of people or machines did the work(bore the "Manufacturer Role", and those people/and or machines were members or of directed by the organization to do this. Alan Ruttenberg Liju Fan has_make has_manufacturer is_manufactured_by objective_achieved_by This relation obtains between an objective specification and a planned process when the criteria specified in the objective specification are met at the end of the planned process. OBI OBI objective_achieved_by bearer of this apple is bearer of this red color this vase is bearer of this fragility Inverse of characteristic_of A bearer can have many dependents, and its dependents can exist for different periods of time, but none of its dependents can exist when the bearer does not exist. bearer_of is bearer of has characteristic A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The journal article (a generically dependent continuant) is concretized as the quality (a specifically dependent continuant), and both depend on that copy of the printed journal (an independent continuant). An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process). A relationship between a generically dependent continuant and a specifically dependent continuant or process, in which the generically dependent continuant depends on some independent continuant or process in virtue of the fact that the specifically dependent continuant or process also depends on that same independent continuant. A generically dependent continuant may be concretized as multiple specifically dependent continuants or processes. is concretized as A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The quality (a specifically dependent continuant) concretizes the journal article (a generically dependent continuant), and both depend on that copy of the printed journal (an independent continuant). An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process). A relationship between a specifically dependent continuant or process and a generically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant or process also depends on that same independent continuant. Multiple specifically dependent continuants or processes can concretize the same generically dependent continuant. concretizes this catalysis function is a function of this enzyme a relation between a function and an independent continuant (the bearer), in which the function specifically depends on the bearer for its existence A function inheres in its bearer at all times for which the function exists, however the function need not be realized at all the times that the function exists. function_of is function of This relation is modeled after the BFO relation of the same name which was in BFO2, but is used in a more restricted sense - specifically, we model this relation as functional (inherited from characteristic-of). Note that this relation is now removed from BFO2020. function of this red color is a quality of this apple a relation between a quality and an independent continuant (the bearer), in which the quality specifically depends on the bearer for its existence A quality inheres in its bearer at all times for which the quality exists. is quality of quality_of This relation is modeled after the BFO relation of the same name which was in BFO2, but is used in a more restricted sense - specifically, we model this relation as functional (inherited from characteristic-of). Note that this relation is now removed from BFO2020. quality of this investigator role is a role of this person a relation between a role and an independent continuant (the bearer), in which the role specifically depends on the bearer for its existence A role inheres in its bearer at all times for which the role exists, however the role need not be realized at all the times that the role exists. is role of role_of This relation is modeled after the BFO relation of the same name which was in BFO2, but is used in a more restricted sense - specifically, we model this relation as functional (inherited from characteristic-of). Note that this relation is now removed from BFO2020. role of inverse of has disposition This relation is modeled after the BFO relation of the same name which was in BFO2, but is used in a more restricted sense - specifically, we model this relation as functional (inherited from characteristic-of). Note that this relation is now removed from BFO2020. disposition of this parent cell derives into this cell (cell division) this parent nucleus derives into this nucleus (nuclear division) a relation between two distinct material entities, the old entity and the new entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops into'. To avoid making statements about a future that may not come to pass, it is often better to use the backward-looking 'derives from' rather than the forward-looking 'derives into'. derives_into derives into is location of my head is the location of my brain this cage is the location of this rat a relation between two independent continuants, the location and the target, in which the target is entirely within the location Most location relations will only hold at certain times, but this is difficult to specify in OWL. See http://purl.obolibrary.org/obo/ro/docs/temporal-semantics/ location_of location of This is redundant with the more specific 'independent and not spatial region' constraint. We leave in the redundant axiom for use with reasoners that do not use negation. This is redundant with the more specific 'independent and not spatial region' constraint. We leave in the redundant axiom for use with reasoners that do not use negation. the surface of my skin is a 2D boundary of my body a relation between a 2D immaterial entity (the boundary) and a material entity, in which the boundary delimits the material entity A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts. Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape. 2D_boundary_of boundary of is 2D boundary of is boundary of 2D boundary of my body has 2D boundary the surface of my skin a relation between a material entity and a 2D immaterial entity (the boundary), in which the boundary delimits the material entity A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts. Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape. has boundary has_2D_boundary has 2D boundary A relation that applies between a cell(c) and a gene(g) , where the process of 'transcription, DNA templated (GO_0006351)' is occuring in in cell c and that process has input gene g. x 'cell expresses' y iff: cell(x) AND gene(y) AND exists some 'transcription, DNA templated (GO_0006351)'(t) AND t occurs_in x AND t has_input y cell expresses David Osumi-Sutherland X ends_after Y iff: end(Y) before_or_simultaneous_with end(X) ends after David Osumi-Sutherland io X starts_during Y iff: (start(Y) before_or_simultaneous_with start(X)) AND (start(X) before_or_simultaneous_with end(Y)) starts during David Osumi-Sutherland d during X happens_during Y iff: (start(Y) before_or_simultaneous_with start(X)) AND (end(X) before_or_simultaneous_with end(Y)) happens during https://wiki.geneontology.org/Happens_during David Osumi-Sutherland o overlaps X ends_during Y iff: ((start(Y) before_or_simultaneous_with end(X)) AND end(X) before_or_simultaneous_with end(Y). ends during definition "x has gene product of y if and only if y is a gene (SO:0000704) that participates in some gene expression process (GO:0010467) where the output of that process is either y or something that is ribosomally translated from x" We would like to be able to express the rule: if t transcribed from g, and t is a noncoding RNA and has an evolved function, then t has gene product g. gene product of every HOTAIR lncRNA is the gene product of some HOXC gene every sonic hedgehog protein (PR:000014841) is the gene product of some sonic hedgehog gene x has gene product y if and only if x is a gene (SO:0000704) that participates in some gene expression process (GO:0010467) where the output of that process is either y or something that is ribosomally translated from y has gene product 'neural crest cell' SubClassOf expresses some 'Wnt1 gene' x expressed in y if and only if there is a gene expression process (GO:0010467) that occurs in y, and one of the following holds: (i) x is a gene, and x is transcribed into a transcript as part of the gene expression process (ii) x is a transcript, and the transcription of x is part of the gene expression process (iii) x is a mature gene product such as a protein, and x was translated or otherwise processes from a transcript that was transcribed as part of this gene expression process expressed in Do not use this relation directly. It is ended as a grouping for relations between occurrents involving the relative timing of their starts and ends. https://docs.google.com/document/d/1kBv1ep_9g3sTR-SD3jqzFqhuwo9TPNF-l-9fUDbO6rM/edit?pli=1 A relation that holds between two occurrents. This is a grouping relation that collects together all the Allen relations. temporally related to g is over-expressed in t iff g is expressed in t, and the expression level of g is increased relative to some background. over-expressed in g is under-expressed in t iff g is expressed in t, and the expression level of g is decreased relative to some background. under-expressed in c has-biological-role r iff c has-role r and r is a biological role (CHEBI:24432) has biological role c has-application-role r iff c has-role r and r is an application role (CHEBI:33232) has application role c has-chemical-role r iff c has-role r and r is a chemical role (CHEBI:51086) has chemical role x is ubiquitously expressed in y if and only if x is expressed in y, and the majority of cells in y express x Revisit this term after coordinating with SO/SOM. The domain of this relation should be a sequence, as an instance of a DNA molecule is only expressed in the cell of which it is a part. ubiquitously expressed in inverse of ubiquiotously expressed in ubiquitously expresses q characteristic of part of w if and only if there exists some p such that q inheres in p and p part of w. Because part_of is transitive, inheres in is a sub-relation of characteristic of part of inheres in part of characteristic of part of A relationship that holds via some environmental process Do not use this relation directly. It is ended as a grouping for a diverse set of relations, all involving the process of evolution. evolutionarily related to holds between two entities when some genome-level process such as gene expression is involved. This includes transcriptional, spliceosomal events. These relations can be used between either macromolecule entities (such as regions of nucleic acid) or between their abstract informational counterparts. Do not use this relation directly. It is intended as a grouping for a diverse set of relations, all involving the genome of an organism genomically related to An organism that is a member of a population of organisms is member of is a mereological relation between a item and a collection. is member of member part of SIO member of relation that links two events, processes, states, or objects such that one event, process, state, or object (a cause) contributes to the production of another event, process, state, or object (an effect) where the cause is partly or wholly responsible for the effect, and the effect is partly or wholly dependent on the cause. This branch of the ontology deals with causal relations between entities. It is divided into two branches: causal relations between occurrents/processes, and causal relations between material entities. We take an 'activity flow-centric approach', with the former as primary, and define causal relations between material entities in terms of causal relations between occurrents. To define causal relations in an activity-flow type network, we make use of 3 primitives: * Temporal: how do the intervals of the two occurrents relate? * Is the causal relation regulatory? * Is the influence positive or negative? The first of these can be formalized in terms of the Allen Interval Algebra. Informally, the 3 bins we care about are 'direct', 'indirect' or overlapping. Note that all causal relations should be classified under a RO temporal relation (see the branch under 'temporally related to'). Note that all causal relations are temporal, but not all temporal relations are causal. Two occurrents can be related in time without being causally connected. We take causal influence to be primitive, elucidated as being such that has the upstream changed, some qualities of the donwstream would necessarily be modified. For the second, we consider a relationship to be regulatory if the system in which the activities occur is capable of altering the relationship to achieve some objective. This could include changing the rate of production of a molecule. For the third, we consider the effect of the upstream process on the output(s) of the downstream process. If the level of output is increased, or the rate of production of the output is increased, then the direction is increased. Direction can be positive, negative or neutral or capable of either direction. Two positives in succession yield a positive, two negatives in succession yield a positive, otherwise the default assumption is that the net effect is canceled and the influence is neutral. Each of these 3 primitives can be composed to yield a cross-product of different relation types. Do not use this relation directly. It is intended as a grouping for a diverse set of relations, all involving cause and effect. causally related to depends on q towards e2 if and only if q is a relational quality such that q inheres-in some e, and e != e2 and q is dependent on e2 This relation is provided in order to support the use of relational qualities such as 'concentration of'; for example, the concentration of C in V is a quality that inheres in V, but pertains to C. towards x is transcribed from y if and only if x is synthesized from template y http://www.ncbi.nlm.nih.gov/pubmed/20226267 transcribed from inverse of transcribed from http://www.ncbi.nlm.nih.gov/pubmed/20226267 transcribed to x is the ribosomal translation of y if and only if a ribosome reads x through a series of triplet codon-amino acid adaptor activities (GO:0030533) and produces y http://www.ncbi.nlm.nih.gov/pubmed/20226267 ribosomal translation of inverse of ribosomal translation of http://www.ncbi.nlm.nih.gov/pubmed/20226267 ribosomally translates to 2017-11-05T03:20:01Z realizable has basis in Do not use this relation directly. It is intended as a grouping for a diverse set of relations, all of which have a disease as the subject. 2017-11-05T03:50:54Z causal relationship with disease as subject DEPRECATED This relation is similar to but different in important respects to the characteristic-of relation. See comments on that relation for more information. DEPRECATED inheres in true DEPRECATED bearer of true This relation groups relations between diseases and any other kind of entity. Do not use this relation directly. It is intended as a grouping for a diverse set of relations, in which the subject or object is a disease. 2018-09-26T00:00:32Z disease relationship A type of 'has vaccine component' relation that specifies a vaccine conjugate protein for a specific vaccine has vaccine conjugate protein A type of 'has vaccine vector' relation that specifies a bacterial vaccine vector Oliver He has bacterial vaccine vector A relation that specifies contraindication of a vaccine. This relation may be replaced by has_vaccine_allergen. We need to determine if any vaccine contraindicator is not a vaccine allergen. Oliver He has vaccine contraindication A type of 'has vaccine vector' that is specifically for viral vaccine vector has viral vaccine vector A 'has vaccine component' relation that specifies the plasmid used for development of a particular DNA vaccine. Oliver He has DNA vaccine plasmid A relation between a disorder and an infectious pathogen. The relation 'infection_of' is introduced to represent an infection caused by an infectious pathogen. A pathogen infection is a disorder. Since the number of pathogens is large, there are numerous infections. To make the description of a specific infection simple, the shortcut term 'infection_of' is defined: infection_of X = infection and has_part some (organism X and has_disposition some infectious disposition) Alan Ruttenburg Allen Xiang Bjoern Peters Melanie Courtot Oliver He infection_of An object property that specifies a process that is induced by vaccination of a vaccine Oliver He induced by vaccination of A 'has vaccine component' relation that specifies a gene inserted to DNA vaccine plasmid for development of a particular DNA vaccine, and this gene encodes for a protein antigen. Oliver He has DNA vaccine antigen gene An object property that defines a relation between a vaccine and its component Asiyah Yu Lin Oliver He has vaccine component An object property that specifies a vaccine antigen This relation only works for those vaccine antigen that is physically part of a vaccine preparation. It does not include those antigens that are not part of vaccine. For example, a protein antigen expressed in a DNA vaccine is not a part of vaccine pe ser. In this case, the vaccine expresses the protein, but the gene is part of the vaccine, not the protein. For the case, we can use the relation 'DNA vaccine expresses protein antigen' under the relation 'expresses'. Asiyah Yu Lin Oliver He has vaccine antigen A type of 'has vaccine antigen' relation that is specifically for vaccine protective protein antigen used in subunit vaccine development Asiyah Yu Lin Oliver He has subunit vaccine antigen A type of 'has vaccine antigen' relation that is specifically for vaccine protective antigen component Asiyah Yu Lin Oliver He has vaccine protective antigen A type of 'has vaccine component' relation that is specifically for vaccine adjuvant component Asiyah Yu Lin Oliver He has vaccine adjuvant A type of 'has vaccine component' relation that is specifically for vaccine vector component Asiyah Yu Lin Oliver He has vaccine vector An object property that indicates a secretion of a material (e.g., protein) from a vaccine organism. Oliver He vaccine organism secretes A 'has vaccine component' relation that is specifically used for vaccine preservative Asiyah Yu Lin Oliver He has vaccine preservative An object property that specifies a relation between a vaccine and its vaccinee has vaccinee An 'expresses' relation that specifies a relation between a DNA vaccine and a protein antigen to be expressed by the DNA vaccine. Oliver He DNA vaccine expresses protein antigen "A vaccinates B" means that the vaccine A is used for vaccinating the host B (e.g., human). A relation between a vaccine instance and an organism type such that if the vaccine instance is given to an instance of the organism by the process vaccination, then it changes the organism's disposition to have an immune response against a disease. Alan Ruttenburg Allen Xiang Melanie Courtot Oliver He obsolete vaccinates true has_vaccine_allegen is a relation that specifies an allegen to a vaccine. Oliver He obsolete has_vaccine_allergen true An object property that represents a mutational relation between a vaccine organism and another material (e.g., gene or protein). the mutated material initially exists in the original wildtype organism. Oliver He vaccine organism has mutation An object property that specifies a relation between a vaccine and a vaccine virmugen. This is a shortcut relation. Domain: vaccine Range: a gene Shortcut: is_specified_output_of some ('preparation of gene mutant vaccine' and (has_specified_input some gene)) Oliver He has vaccine virmugen A 'has subunit vaccine antigen' relation that indicates the antigen is protective. Oliver He has subunit vaccine protective antigen A relation that specifies a company that distributes a product (e.g., vaccine). The company is very likely not the manufacturer of the product. Allen Xiang Oliver He is_distributed_by An object property that represents a relation between a vaccine with a prime-boost schedule and a vaccine used for priming. Oliver He has prime vaccine An object property that represents a relation between a vaccine with a prime-boost schedule and a vaccine used for boost. Oliver He has boost vaccine A shortcut object property that represents a relation between a vaccine and a disease process where the vaccine immunizes a host against a disease process. Oliver He obsolete immunizes against disease process true An object property that represents a relation between a material entity and biological process Anthony Huffman Oliver He up-expressed as immune signature of A relation between a material entity and a parasite where the material entity causes some process against some parasite such that transmitting to additional hosts or vectors. capable of blocking transmission (of life cycle) Ellen Zhang Jie Zheng Xingxian Li flu season has flu season Jie Zheng brand name has drug brand name Jie Zheng drug package has drug package Jie Zheng organization has drug supplier BFO:0000001 entity Entity Julius Caesar Verdi’s Requiem the Second World War your body mass index BFO 2 Reference: In all areas of empirical inquiry we encounter general terms of two sorts. First are general terms which refer to universals or types:animaltuberculosissurgical procedurediseaseSecond, are general terms used to refer to groups of entities which instantiate a given universal but do not correspond to the extension of any subuniversal of that universal because there is nothing intrinsic to the entities in question by virtue of which they – and only they – are counted as belonging to the given group. Examples are: animal purchased by the Emperortuberculosis diagnosed on a Wednesdaysurgical procedure performed on a patient from Stockholmperson identified as candidate for clinical trial #2056-555person who is signatory of Form 656-PPVpainting by Leonardo da VinciSuch terms, which represent what are called ‘specializations’ in [81 Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001]) entity Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf per discussion with Barry Smith An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001]) BFO:0000002 continuant Continuant An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts. BFO 2 Reference: Continuant entities are entities which can be sliced to yield parts only along the spatial dimension, yielding for example the parts of your table which we call its legs, its top, its nails. ‘My desk stretches from the window to the door. It has spatial parts, and can be sliced (in space) in two. With respect to time, however, a thing is a continuant.’ [60, p. 240 Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002]) if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001]) if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002]) if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002]) (forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002] (forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001] (forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002] (forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002] continuant Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002]) if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001]) if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002]) if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002]) (forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002] (forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001] (forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002] (forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002] BFO:0000003 occurrent Occurrent An entity that has temporal parts and that happens, unfolds or develops through time. BFO 2 Reference: every occurrent that is not a temporal or spatiotemporal region is s-dependent on some independent continuant that is not a spatial region BFO 2 Reference: s-dependence obtains between every process and its participants in the sense that, as a matter of necessity, this process could not have existed unless these or those participants existed also. A process may have a succession of participants at different phases of its unfolding. Thus there may be different players on the field at different times during the course of a football game; but the process which is the entire game s-depends_on all of these players nonetheless. Some temporal parts of this process will s-depend_on on only some of the players. Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process. Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame. An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002]) Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001]) b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001]) (forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001] (forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001] occurrent Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process. per discussion with Barry Smith Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame. An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002]) Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001]) b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001]) (forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001] (forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001] BFO:0000004 ic IndependentContinuant a chair a heart a leg a molecule a spatial region an atom an orchestra. an organism the bottom right portion of a human torso the interior of your mouth b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002]) For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001]) For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002]) (forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001] (forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002] (iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002] A continuant that is a bearer of quality and realizable entity entities, in which other entities inhere and which itself cannot inhere in anything. independent continuant b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002]) For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001]) For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002]) (forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001] (forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002] (iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002] BFO:0000006 s-region SpatialRegion BFO 2 Reference: Spatial regions do not participate in processes. Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional. A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001]) All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001]) (forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001] (forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001] spatial region Spatial region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the union of a spatial point and a spatial line that doesn't overlap the point, or two spatial lines that intersect at a single point. In both cases the resultant spatial region is neither 0-dimensional, 1-dimensional, 2-dimensional, or 3-dimensional. per discussion with Barry Smith A spatial region is a continuant entity that is a continuant_part_of spaceR as defined relative to some frame R. (axiom label in BFO2 Reference: [035-001]) All continuant parts of spatial regions are spatial regions. (axiom label in BFO2 Reference: [036-001]) (forall (x y t) (if (and (SpatialRegion x) (continuantPartOfAt y x t)) (SpatialRegion y))) // axiom label in BFO2 CLIF: [036-001] (forall (x) (if (SpatialRegion x) (Continuant x))) // axiom label in BFO2 CLIF: [035-001] BFO:0000008 t-region TemporalRegion Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001]) All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001]) Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002]) (forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002] (forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001] (forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001] temporal region Temporal region doesn't have a closure axiom because the subclasses don't exhaust all possibilites. An example would be the mereological sum of a temporal instant and a temporal interval that doesn't overlap the instant. In this case the resultant temporal region is neither 0-dimensional nor 1-dimensional per discussion with Barry Smith A temporal region is an occurrent entity that is part of time as defined relative to some reference frame. (axiom label in BFO2 Reference: [100-001]) All parts of temporal regions are temporal regions. (axiom label in BFO2 Reference: [101-001]) Every temporal region t is such that t occupies_temporal_region t. (axiom label in BFO2 Reference: [119-002]) (forall (r) (if (TemporalRegion r) (occupiesTemporalRegion r r))) // axiom label in BFO2 CLIF: [119-002] (forall (x y) (if (and (TemporalRegion x) (occurrentPartOf y x)) (TemporalRegion y))) // axiom label in BFO2 CLIF: [101-001] (forall (x) (if (TemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [100-001] BFO:0000009 2d-s-region TwoDimensionalSpatialRegion an infinitely thin plane in space. the surface of a sphere-shaped part of space A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001]) (forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001] two-dimensional spatial region A two-dimensional spatial region is a spatial region that is of two dimensions. (axiom label in BFO2 Reference: [039-001]) (forall (x) (if (TwoDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [039-001] BFO:0000011 st-region SpatiotemporalRegion the spatiotemporal region occupied by a human life the spatiotemporal region occupied by a process of cellular meiosis. the spatiotemporal region occupied by the development of a cancer tumor A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001]) All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001]) Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001]) Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001]) Every spatiotemporal region occupies_spatiotemporal_region itself. Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002]) (forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002] (forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001] (forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001] (forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001] (forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001] spatiotemporal region A spatiotemporal region is an occurrent entity that is part of spacetime. (axiom label in BFO2 Reference: [095-001]) All parts of spatiotemporal regions are spatiotemporal regions. (axiom label in BFO2 Reference: [096-001]) Each spatiotemporal region at any time t projects_onto some spatial region at t. (axiom label in BFO2 Reference: [099-001]) Each spatiotemporal region projects_onto some temporal region. (axiom label in BFO2 Reference: [098-001]) Every spatiotemporal region s is such that s occupies_spatiotemporal_region s. (axiom label in BFO2 Reference: [107-002]) (forall (r) (if (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion r r))) // axiom label in BFO2 CLIF: [107-002] (forall (x t) (if (SpatioTemporalRegion x) (exists (y) (and (SpatialRegion y) (spatiallyProjectsOntoAt x y t))))) // axiom label in BFO2 CLIF: [099-001] (forall (x y) (if (and (SpatioTemporalRegion x) (occurrentPartOf y x)) (SpatioTemporalRegion y))) // axiom label in BFO2 CLIF: [096-001] (forall (x) (if (SpatioTemporalRegion x) (Occurrent x))) // axiom label in BFO2 CLIF: [095-001] (forall (x) (if (SpatioTemporalRegion x) (exists (y) (and (TemporalRegion y) (temporallyProjectsOnto x y))))) // axiom label in BFO2 CLIF: [098-001] BFO:0000015 process Process a process of cell-division, \ a beating of the heart a process of meiosis a process of sleeping the course of a disease the flight of a bird the life of an organism your process of aging. p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003]) BFO 2 Reference: The realm of occurrents is less pervasively marked by the presence of natural units than is the case in the realm of independent continuants. Thus there is here no counterpart of ‘object’. In BFO 1.0 ‘process’ served as such a counterpart. In BFO 2.0 ‘process’ is, rather, the occurrent counterpart of ‘material entity’. Those natural – as contrasted with engineered, which here means: deliberately executed – units which do exist in the realm of occurrents are typically either parasitic on the existence of natural units on the continuant side, or they are fiat in nature. Thus we can count lives; we can count football games; we can count chemical reactions performed in experiments or in chemical manufacturing. We cannot count the processes taking place, for instance, in an episode of insect mating behavior.Even where natural units are identifiable, for example cycles in a cyclical process such as the beating of a heart or an organism’s sleep/wake cycle, the processes in question form a sequence with no discontinuities (temporal gaps) of the sort that we find for instance where billiard balls or zebrafish or planets are separated by clear spatial gaps. Lives of organisms are process units, but they too unfold in a continuous series from other, prior processes such as fertilization, and they unfold in turn in continuous series of post-life processes such as post-mortem decay. Clear examples of boundaries of processes are almost always of the fiat sort (midnight, a time of death as declared in an operating theater or on a death certificate, the initiation of a state of war) (iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003] An occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. process p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003]) (iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003] BFO:0000016 disposition Disposition an atom of element X has the disposition to decay to an atom of element Y certain people have a predisposition to colon cancer children are innately disposed to categorize objects in certain ways. the cell wall is disposed to filter chemicals in endocytosis and exocytosis BFO 2 Reference: Dispositions exist along a strength continuum. Weaker forms of disposition are realized in only a fraction of triggering cases. These forms occur in a significant number of cases of a similar type. b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002]) If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002]) (forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002] (forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002] disposition b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002]) If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002]) (forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002] (forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002] BFO:0000017 realizable RealizableEntity the disposition of this piece of metal to conduct electricity. the disposition of your blood to coagulate the function of your reproductive organs the role of being a doctor the role of this boundary to delineate where Utah and Colorado meet A specifically dependent continuant that inheres in continuant entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances. To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002]) All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002]) (forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002] (forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002] realizable entity To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002]) All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002]) (forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002] (forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002] BFO:0000018 0d-s-region ZeroDimensionalSpatialRegion A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001]) (forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001] zero-dimensional spatial region (forall (x) (if (ZeroDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [037-001] A zero-dimensional spatial region is a point in space. (axiom label in BFO2 Reference: [037-001]) BFO:0000019 quality Quality the ambient temperature of this portion of air the color of a tomato the length of the circumference of your waist the mass of this piece of gold. the shape of your nose the shape of your nostril a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001]) If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001]) (forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001] (forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001] quality a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001]) If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001]) (forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001] (forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001] BFO:0000020 sdc SpecificallyDependentContinuant Reciprocal specifically dependent continuants: the function of this key to open this lock and the mutually dependent disposition of this lock: to be opened by this key of one-sided specifically dependent continuants: the mass of this tomato of relational dependent continuants (multiple bearers): John’s love for Mary, the ownership relation between John and this statue, the relation of authority between John and his subordinates. the disposition of this fish to decay the function of this heart: to pump blood the mutual dependence of proton donors and acceptors in chemical reactions [79 the mutual dependence of the role predator and the role prey as played by two organisms in a given interaction the pink color of a medium rare piece of grilled filet mignon at its center the role of being a doctor the shape of this hole. the smell of this portion of mozzarella b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003]) Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc. (iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003] A continuant that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same. specifically dependent continuant b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003]) Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc. per discussion with Barry Smith (iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003] BFO:0000023 role Role John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married. the priest role the role of a boundary to demarcate two neighboring administrative territories the role of a building in serving as a military target the role of a stone in marking a property boundary the role of subject in a clinical trial the student role A realizable entity the manifestation of which brings about some result or end that is not essential to a continuant in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant in some kinds of natural, social or institutional contexts. BFO 2 Reference: One major family of examples of non-rigid universals involves roles, and ontologies developed for corresponding administrative purposes may consist entirely of representatives of entities of this sort. Thus ‘professor’, defined as follows,b instance_of professor at t =Def. there is some c, c instance_of professor role & c inheres_in b at t.denotes a non-rigid universal and so also do ‘nurse’, ‘student’, ‘colonel’, ‘taxpayer’, and so forth. (These terms are all, in the jargon of philosophy, phase sortals.) By using role terms in definitions, we can create a BFO conformant treatment of such entities drawing on the fact that, while an instance of professor may be simultaneously an instance of trade union member, no instance of the type professor role is also (at any time) an instance of the type trade union member role (any more than any instance of the type color is at any time an instance of the type length).If an ontology of employment positions should be defined in terms of roles following the above pattern, this enables the ontology to do justice to the fact that individuals instantiate the corresponding universals – professor, sergeant, nurse – only during certain phases in their lives. b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001]) (forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001] role b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001]) (forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001] BFO:0000024 fiat-object-part FiatObjectPart or with divisions drawn by cognitive subjects for practical reasons, such as the division of a cake (before slicing) into (what will become) slices (and thus member parts of an object aggregate). However, this does not mean that fiat object parts are dependent for their existence on divisions or delineations effected by cognitive subjects. If, for example, it is correct to conceive geological layers of the Earth as fiat object parts of the Earth, then even though these layers were first delineated in recent times, still existed long before such delineation and what holds of these layers (for example that the oldest layers are also the lowest layers) did not begin to hold because of our acts of delineation.Treatment of material entity in BFOExamples viewed by some as problematic cases for the trichotomy of fiat object part, object, and object aggregate include: a mussel on (and attached to) a rock, a slime mold, a pizza, a cloud, a galaxy, a railway train with engine and multiple carriages, a clonal stand of quaking aspen, a bacterial community (biofilm), a broken femur. Note that, as Aristotle already clearly recognized, such problematic cases – which lie at or near the penumbra of instances defined by the categories in question – need not invalidate these categories. The existence of grey objects does not prove that there are not objects which are black and objects which are white; the existence of mules does not prove that there are not objects which are donkeys and objects which are horses. It does, however, show that the examples in question need to be addressed carefully in order to show how they can be fitted into the proposed scheme, for example by recognizing additional subdivisions [29 the FMA:regional parts of an intact human body. the Western hemisphere of the Earth the division of the brain into regions the division of the planet into hemispheres the dorsal and ventral surfaces of the body the upper and lower lobes of the left lung BFO 2 Reference: Most examples of fiat object parts are associated with theoretically drawn divisions b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004]) (forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004] fiat object part b is a fiat object part = Def. b is a material entity which is such that for all times t, if b exists at t then there is some object c such that b proper continuant_part of c at t and c is demarcated from the remainder of c by a two-dimensional continuant fiat boundary. (axiom label in BFO2 Reference: [027-004]) (forall (x) (if (FiatObjectPart x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y) (and (Object y) (properContinuantPartOfAt x y t)))))))) // axiom label in BFO2 CLIF: [027-004] BFO:0000026 1d-s-region OneDimensionalSpatialRegion an edge of a cube-shaped portion of space. A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001]) (forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001] one-dimensional spatial region A one-dimensional spatial region is a line or aggregate of lines stretching from one point in space to another. (axiom label in BFO2 Reference: [038-001]) (forall (x) (if (OneDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [038-001] BFO:0000027 object-aggregate ObjectAggregate a collection of cells in a blood biobank. a swarm of bees is an aggregate of members who are linked together through natural bonds a symphony orchestra an organization is an aggregate whose member parts have roles of specific types (for example in a jazz band, a chess club, a football team) defined by fiat: the aggregate of members of an organization defined through physical attachment: the aggregate of atoms in a lump of granite defined through physical containment: the aggregate of molecules of carbon dioxide in a sealed container defined via attributive delimitations such as: the patients in this hospital the aggregate of bearings in a constant velocity axle joint the aggregate of blood cells in your body the nitrogen atoms in the atmosphere the restaurants in Palo Alto your collection of Meissen ceramic plates. An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects BFO 2 Reference: object aggregates may gain and lose parts while remaining numerically identical (one and the same individual) over time. This holds both for aggregates whose membership is determined naturally (the aggregate of cells in your body) and aggregates determined by fiat (a baseball team, a congressional committee). ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158. b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004]) (forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004] object aggregate An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects An entity a is an object aggregate if and only if there is a mutually exhaustive and pairwise disjoint partition of a into objects ISBN:978-3-938793-98-5pp124-158#Thomas Bittner and Barry Smith, 'A Theory of Granular Partitions', in K. Munn and B. Smith (eds.), Applied Ontology: An Introduction, Frankfurt/Lancaster: ontos, 2008, 125-158. b is an object aggregate means: b is a material entity consisting exactly of a plurality of objects as member_parts at all times at which b exists. (axiom label in BFO2 Reference: [025-004]) (forall (x) (if (ObjectAggregate x) (and (MaterialEntity x) (forall (t) (if (existsAt x t) (exists (y z) (and (Object y) (Object z) (memberPartOfAt y x t) (memberPartOfAt z x t) (not (= y z)))))) (not (exists (w t_1) (and (memberPartOfAt w x t_1) (not (Object w)))))))) // axiom label in BFO2 CLIF: [025-004] BFO:0000028 3d-s-region ThreeDimensionalSpatialRegion a cube-shaped region of space a sphere-shaped region of space, A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001]) (forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001] three-dimensional spatial region A three-dimensional spatial region is a spatial region that is of three dimensions. (axiom label in BFO2 Reference: [040-001]) (forall (x) (if (ThreeDimensionalSpatialRegion x) (SpatialRegion x))) // axiom label in BFO2 CLIF: [040-001] BFO:0000029 site Site Manhattan Canyon) a hole in the interior of a portion of cheese a rabbit hole an air traffic control region defined in the airspace above an airport the Grand Canyon the Piazza San Marco the cockpit of an aircraft the hold of a ship the interior of a kangaroo pouch the interior of the trunk of your car the interior of your bedroom the interior of your office the interior of your refrigerator the lumen of your gut your left nostril (a fiat part – the opening – of your left nasal cavity) b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002]) (forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002] site b is a site means: b is a three-dimensional immaterial entity that is (partially or wholly) bounded by a material entity or it is a three-dimensional immaterial part thereof. (axiom label in BFO2 Reference: [034-002]) (forall (x) (if (Site x) (ImmaterialEntity x))) // axiom label in BFO2 CLIF: [034-002] BFO:0000030 object Object atom cell cells and organisms engineered artifacts grain of sand molecule organelle organism planet solid portions of matter star BFO 2 Reference: BFO rests on the presupposition that at multiple micro-, meso- and macroscopic scales reality exhibits certain stable, spatially separated or separable material units, combined or combinable into aggregates of various sorts (for example organisms into what are called ‘populations’). Such units play a central role in almost all domains of natural science from particle physics to cosmology. Many scientific laws govern the units in question, employing general terms (such as ‘molecule’ or ‘planet’) referring to the types and subtypes of units, and also to the types and subtypes of the processes through which such units develop and interact. The division of reality into such natural units is at the heart of biological science, as also is the fact that these units may form higher-level units (as cells form multicellular organisms) and that they may also form aggregates of units, for example as cells form portions of tissue and organs form families, herds, breeds, species, and so on. At the same time, the division of certain portions of reality into engineered units (manufactured artifacts) is the basis of modern industrial technology, which rests on the distributed mass production of engineered parts through division of labor and on their assembly into larger, compound units such as cars and laptops. The division of portions of reality into units is one starting point for the phenomenon of counting. BFO 2 Reference: Each object is such that there are entities of which we can assert unproblematically that they lie in its interior, and other entities of which we can assert unproblematically that they lie in its exterior. This may not be so for entities lying at or near the boundary between the interior and exterior. This means that two objects – for example the two cells depicted in Figure 3 – may be such that there are material entities crossing their boundaries which belong determinately to neither cell. Something similar obtains in certain cases of conjoined twins (see below). BFO 2 Reference: To say that b is causally unified means: b is a material entity which is such that its material parts are tied together in such a way that, in environments typical for entities of the type in question,if c, a continuant part of b that is in the interior of b at t, is larger than a certain threshold size (which will be determined differently from case to case, depending on factors such as porosity of external cover) and is moved in space to be at t at a location on the exterior of the spatial region that had been occupied by b at t, then either b’s other parts will be moved in coordinated fashion or b will be damaged (be affected, for example, by breakage or tearing) in the interval between t and t.causal changes in one part of b can have consequences for other parts of b without the mediation of any entity that lies on the exterior of b. Material entities with no proper material parts would satisfy these conditions trivially. Candidate examples of types of causal unity for material entities of more complex sorts are as follows (this is not intended to be an exhaustive list):CU1: Causal unity via physical coveringHere the parts in the interior of the unified entity are combined together causally through a common membrane or other physical covering\. The latter points outwards toward and may serve a protective function in relation to what lies on the exterior of the entity [13, 47 BFO 2 Reference: an object is a maximal causally unified material entity BFO 2 Reference: ‘objects’ are sometimes referred to as ‘grains’ [74 b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001]) object b is an object means: b is a material entity which manifests causal unity of one or other of the types CUn listed above & is of a type (a material universal) instances of which are maximal relative to this criterion of causal unity. (axiom label in BFO2 Reference: [024-001]) BFO:0000031 gdc GenericallyDependentContinuant The entries in your database are patterns instantiated as quality instances in your hard drive. The database itself is an aggregate of such patterns. When you create the database you create a particular instance of the generically dependent continuant type database. Each entry in the database is an instance of the generically dependent continuant type IAO: information content entity. the pdf file on your laptop, the pdf file that is a copy thereof on my laptop the sequence of this protein molecule; the sequence that is a copy thereof in that protein molecule. b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001]) (iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001] A continuant that is dependent on one or other independent continuant bearers. For every instance of A requires some instance of (an independent continuant type) B but which instance of B serves can change from time to time. generically dependent continuant b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001]) (iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001] BFO:0000034 function Function the function of a hammer to drive in nails the function of a heart pacemaker to regulate the beating of a heart through electricity the function of amylase in saliva to break down starch into sugar BFO 2 Reference: In the past, we have distinguished two varieties of function, artifactual function and biological function. These are not asserted subtypes of BFO:function however, since the same function – for example: to pump, to transport – can exist both in artifacts and in biological entities. The asserted subtypes of function that would be needed in order to yield a separate monoheirarchy are not artifactual function, biological function, etc., but rather transporting function, pumping function, etc. A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001]) (forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001] function A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001]) (forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001] BFO:0000035 p-boundary ProcessBoundary the boundary between the 2nd and 3rd year of your life. p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001]) Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002]) (forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002] (iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001] process boundary p is a process boundary =Def. p is a temporal part of a process & p has no proper temporal parts. (axiom label in BFO2 Reference: [084-001]) Every process boundary occupies_temporal_region a zero-dimensional temporal region. (axiom label in BFO2 Reference: [085-002]) (forall (x) (if (ProcessBoundary x) (exists (y) (and (ZeroDimensionalTemporalRegion y) (occupiesTemporalRegion x y))))) // axiom label in BFO2 CLIF: [085-002] (iff (ProcessBoundary a) (exists (p) (and (Process p) (temporalPartOf a p) (not (exists (b) (properTemporalPartOf b a)))))) // axiom label in BFO2 CLIF: [084-001] BFO:0000038 1d-t-region OneDimensionalTemporalRegion the temporal region during which a process occurs. BFO 2 Reference: A temporal interval is a special kind of one-dimensional temporal region, namely one that is self-connected (is without gaps or breaks). A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001]) (forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001] one-dimensional temporal region A one-dimensional temporal region is a temporal region that is extended. (axiom label in BFO2 Reference: [103-001]) (forall (x) (if (OneDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [103-001] BFO:0000040 material MaterialEntity a flame a forest fire a human being a hurricane a photon a puff of smoke a sea wave a tornado an aggregate of human beings. an energy wave an epidemic the undetached arm of a human being An independent continuant that is spatially extended whose identity is independent of that of other entities and can be maintained through time. BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60 BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity. BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here. A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002]) Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002]) every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002]) (forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002] (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002] (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002] material entity A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002]) Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002]) every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002]) (forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002] (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002] (forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002] BFO:0000140 cf-boundary ContinuantFiatBoundary b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001]) BFO 2 Reference: In BFO 1.1 the assumption was made that the external surface of a material entity such as a cell could be treated as if it were a boundary in the mathematical sense. The new document propounds the view that when we talk about external surfaces of material objects in this way then we are talking about something fiat. To be dealt with in a future version: fiat boundaries at different levels of granularity.More generally, the focus in discussion of boundaries in BFO 2.0 is now on fiat boundaries, which means: boundaries for which there is no assumption that they coincide with physical discontinuities. The ontology of boundaries becomes more closely allied with the ontology of regions. BFO 2 Reference: a continuant fiat boundary is a boundary of some material entity (for example: the plane separating the Northern and Southern hemispheres; the North Pole), or it is a boundary of some immaterial entity (for example of some portion of airspace). Three basic kinds of continuant fiat boundary can be distinguished (together with various combination kinds [29 Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions. Every continuant fiat boundary is located at some spatial region at every time at which it exists (iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001] continuant fiat boundary b is a continuant fiat boundary = Def. b is an immaterial entity that is of zero, one or two dimensions and does not include a spatial region as part. (axiom label in BFO2 Reference: [029-001]) Continuant fiat boundary doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the mereological sum of two-dimensional continuant fiat boundary and a one dimensional continuant fiat boundary that doesn't overlap it. The situation is analogous to temporal and spatial regions. (iff (ContinuantFiatBoundary a) (and (ImmaterialEntity a) (exists (b) (and (or (ZeroDimensionalSpatialRegion b) (OneDimensionalSpatialRegion b) (TwoDimensionalSpatialRegion b)) (forall (t) (locatedInAt a b t)))) (not (exists (c t) (and (SpatialRegion c) (continuantPartOfAt c a t)))))) // axiom label in BFO2 CLIF: [029-001] BFO:0000141 immaterial ImmaterialEntity BFO 2 Reference: Immaterial entities are divided into two subgroups:boundaries and sites, which bound, or are demarcated in relation, to material entities, and which can thus change location, shape and size and as their material hosts move or change shape or size (for example: your nasal passage; the hold of a ship; the boundary of Wales (which moves with the rotation of the Earth) [38, 7, 10 immaterial entity BFO:0000142 1d-cf-boundary OneDimensionalContinuantFiatBoundary The Equator all geopolitical boundaries all lines of latitude and longitude the line separating the outer surface of the mucosa of the lower lip from the outer surface of the skin of the chin. the median sulcus of your tongue a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001]) (iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001] one-dimensional continuant fiat boundary a one-dimensional continuant fiat boundary is a continuous fiat line whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [032-001]) (iff (OneDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (OneDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [032-001] BFO:0000144 process-profile ProcessProfile On a somewhat higher level of complexity are what we shall call rate process profiles, which are the targets of selective abstraction focused not on determinate quality magnitudes plotted over time, but rather on certain ratios between these magnitudes and elapsed times. A speed process profile, for example, is represented by a graph plotting against time the ratio of distance covered per unit of time. Since rates may change, and since such changes, too, may have rates of change, we have to deal here with a hierarchy of process profile universals at successive levels One important sub-family of rate process profiles is illustrated by the beat or frequency profiles of cyclical processes, illustrated by the 60 beats per minute beating process of John’s heart, or the 120 beats per minute drumming process involved in one of John’s performances in a rock band, and so on. Each such process includes what we shall call a beat process profile instance as part, a subtype of rate process profile in which the salient ratio is not distance covered but rather number of beat cycles per unit of time. Each beat process profile instance instantiates the determinable universal beat process profile. But it also instantiates multiple more specialized universals at lower levels of generality, selected from rate process profilebeat process profileregular beat process profile3 bpm beat process profile4 bpm beat process profileirregular beat process profileincreasing beat process profileand so on.In the case of a regular beat process profile, a rate can be assigned in the simplest possible fashion by dividing the number of cycles by the length of the temporal region occupied by the beating process profile as a whole. Irregular process profiles of this sort, for example as identified in the clinic, or in the readings on an aircraft instrument panel, are often of diagnostic significance. The simplest type of process profiles are what we shall call ‘quality process profiles’, which are the process profiles which serve as the foci of the sort of selective abstraction that is involved when measurements are made of changes in single qualities, as illustrated, for example, by process profiles of mass, temperature, aortic pressure, and so on. b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002]) b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005]) (forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005] (iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002] process profile b is a process_profile =Def. there is some process c such that b process_profile_of c (axiom label in BFO2 Reference: [093-002]) b process_profile_of c holds when b proper_occurrent_part_of c& there is some proper_occurrent_part d of c which has no parts in common with b & is mutually dependent on b& is such that b, c and d occupy the same temporal region (axiom label in BFO2 Reference: [094-005]) (forall (x y) (if (processProfileOf x y) (and (properContinuantPartOf x y) (exists (z t) (and (properOccurrentPartOf z y) (TemporalRegion t) (occupiesSpatioTemporalRegion x t) (occupiesSpatioTemporalRegion y t) (occupiesSpatioTemporalRegion z t) (not (exists (w) (and (occurrentPartOf w x) (occurrentPartOf w z))))))))) // axiom label in BFO2 CLIF: [094-005] (iff (ProcessProfile a) (exists (b) (and (Process b) (processProfileOf a b)))) // axiom label in BFO2 CLIF: [093-002] BFO:0000145 r-quality RelationalQuality John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married. a marriage bond, an instance of requited love, an obligation between one person and another. b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001]) (iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001] relational quality b is a relational quality = Def. for some independent continuants c, d and for some time t: b quality_of c at t & b quality_of d at t. (axiom label in BFO2 Reference: [057-001]) (iff (RelationalQuality a) (exists (b c t) (and (IndependentContinuant b) (IndependentContinuant c) (qualityOfAt a b t) (qualityOfAt a c t)))) // axiom label in BFO2 CLIF: [057-001] BFO:0000146 2d-cf-boundary TwoDimensionalContinuantFiatBoundary a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001]) (iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001] two-dimensional continuant fiat boundary a two-dimensional continuant fiat boundary (surface) is a self-connected fiat surface whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [033-001]) (iff (TwoDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (TwoDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [033-001] BFO:0000147 0d-cf-boundary ZeroDimensionalContinuantFiatBoundary the geographic North Pole the point of origin of some spatial coordinate system. the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona. a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001]) (iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001] zero-dimensional continuant fiat boundary zero dimension continuant fiat boundaries are not spatial points. Considering the example 'the quadripoint where the boundaries of Colorado, Utah, New Mexico, and Arizona meet' : There are many frames in which that point is zooming through many points in space. Whereas, no matter what the frame, the quadripoint is always in the same relation to the boundaries of Colorado, Utah, New Mexico, and Arizona. requested by Melanie Courtot a zero-dimensional continuant fiat boundary is a fiat point whose location is defined in relation to some material entity. (axiom label in BFO2 Reference: [031-001]) (iff (ZeroDimensionalContinuantFiatBoundary a) (and (ContinuantFiatBoundary a) (exists (b) (and (ZeroDimensionalSpatialRegion b) (forall (t) (locatedInAt a b t)))))) // axiom label in BFO2 CLIF: [031-001] BFO:0000148 0d-t-region ZeroDimensionalTemporalRegion a temporal region that is occupied by a process boundary right now the moment at which a child is born the moment at which a finger is detached in an industrial accident the moment of death. temporal instant. A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001]) (forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001] zero-dimensional temporal region A zero-dimensional temporal region is a temporal region that is without extent. (axiom label in BFO2 Reference: [102-001]) (forall (x) (if (ZeroDimensionalTemporalRegion x) (TemporalRegion x))) // axiom label in BFO2 CLIF: [102-001] BFO:0000182 history History A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001]) history A history is a process that is the sum of the totality of processes taking place in the spatiotemporal region occupied by a material entity or site, including processes on the surface of the entity or within the cavities to which it serves as host. (axiom label in BFO2 Reference: [138-001]) An organic hydroxy compound that consists of benzene bearing a single hydroxy substituent. The parent of the class of phenols. 0 C6H6O InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H ISWSIDIOOBJBQZ-UHFFFAOYSA-N 94.11120 94.04186 Oc1ccccc1 CHEBI:14777 CHEBI:25966 CHEBI:43543 CHEBI:8071 CAS:108-95-2 DrugBank:DB03255 Drug_Central:4266 Gmelin:2794 HMDB:HMDB0000228 KEGG:C00146 KEGG:C15584 KEGG:D00033 KEGG:D06536 KNApSAcK:C00002664 PDBeChem:IPH PMID:12058733 PMID:16953321 PMID:17852157 PMID:19029204 PMID:20886261 PMID:21492257 PMID:21689881 PMID:21809019 PMID:21822930 Reaxys:969616 UM-BBD_compID:c0128 Wikipedia:Phenol PHENOL Phenol phenol chebi_ontology Benzenol Carbolsaeure Hydroxybenzene Karbolsaeure Oxybenzene PhOH Phenic acid Phenylic acid Phenylic alcohol acide carbolique acide phenique carbolic acid CHEBI:15882 phenol CHEBI:15882 A carbonyl group with two C-bound amine groups. The commercially available fertilizer has an analysis of 46-0-0 (N-P2O5-K2O). 0 CH4N2O InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4) XSQUKJJJFZCRTK-UHFFFAOYSA-N 60.05534 60.03236 NC(N)=O CHEBI:15292 CHEBI:27218 CHEBI:46379 CHEBI:9888 CAS:57-13-6 DrugBank:DB03904 Drug_Central:4264 ECMDB:ECMDB04172 Gmelin:1378 HMDB:HMDB0000294 KEGG:C00086 KEGG:D00023 KNApSAcK:C00007314 MetaCyc:UREA PDBeChem:URE PMID:18037357 PMID:22770225 PPDB:1728 Reaxys:635724 UM-BBD_compID:c0165 Wikipedia:Urea YMDB:YMDB00003 UREA Urea urea chebi_ontology 1728 Carbamide E927b H2NC(O)NH2 Harnstoff Karbamid carbamide carbonyldiamide ur uree CHEBI:16199 urea CHEBI:16199 Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria). CHEBI:14520 CHEBI:25062 CHEBI:6494 KEGG:C00338 PMID:15589368 PMID:24186868 PMID:24506665 PMID:24642373 PMID:24659348 Lipopolysaccharide chebi_ontology LPS lipopolysaccharides CHEBI:16412 lipopolysaccharide CHEBI:16412 Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc. 0 (C2H2NOR)nC2H3NOR CHEBI:14753 CHEBI:25906 CHEBI:7990 KEGG:C00012 Peptide peptides chebi_ontology Peptid peptido peptidos CHEBI:16670 peptide CHEBI:16670 An aldehyde resulting from the formal oxidation of methanol. 0 CH2O InChI=1S/CH2O/c1-2/h1H2 WSFSSNUMVMOOMR-UHFFFAOYSA-N 30.02598 30.01056 [H]C([H])=O CHEBI:14274 CHEBI:24077 CHEBI:337763 CHEBI:5142 CAS:50-00-0 DrugBank:DB03843 Drug_Central:3244 Gmelin:445 HMDB:HMDB0001426 KEGG:C00067 KEGG:D00017 MetaCyc:FORMALDEHYDE PDBeChem:FOR PMID:110589 PMID:12686735 PMID:15091529 PMID:16423181 PMID:17618393 PMID:18837732 PMID:25042713 PMID:7381846 PMID:7548723 PMID:7689168 PMID:7896413 PMID:9686972 PPDB:359 Reaxys:1209228 UM-BBD_compID:c0122 Wikipedia:Formaldehyde FORMALDEHYDE Formaldehyde formaldehyde chebi_ontology FORMALIN Formaldehyd Formalin Methanal Methylene oxide Oxomethane Oxomethylene CHEBI:16842 formaldehyde CHEBI:16842 A amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class 0 C21H39N7O12 InChI=1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1 UCSJYZPVAKXKNQ-HZYVHMACSA-N 581.57434 581.26567 CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@@H](O[C@@H](C)[C@]1(O)C=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]1NC(N)=N CHEBI:15119 CHEBI:26784 CHEBI:45745 CHEBI:9284 CAS:57-92-1 DrugBank:DB01082 Drug_Central:2481 HMDB:HMDB0015214 KEGG:C00413 KEGG:D08531 MetaCyc:STREPTOMYCIN PDBeChem:SRY PMID:11228320 PMID:11905029 PMID:12118520 PMID:13030054 PMID:13116094 PMID:13136149 PMID:13596285 PMID:13691614 PMID:13985260 PMID:13990247 PMID:14623118 PMID:14828344 PMID:14852338 PMID:14939639 PMID:15081082 PMID:15137533 PMID:15207172 PMID:15686853 PMID:15736038 PMID:16904706 PMID:17105735 PMID:17238915 PMID:17429930 PMID:18173084 PMID:18916143 PMID:19052412 PMID:19335957 PMID:21350946 PMID:21362244 PMID:21593257 PMID:21937264 PMID:22101040 Pesticides:streptomycin Reaxys:74498 Wikipedia:Streptomycin N,N'''-[(1R,2R,3S,4R,5R,6S)-4-{5-deoxy-2-O-[2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl]-3-C-formyl-alpha-L-lyxofuranosyloxy}-2,5,6-trihydroxycyclohexane-1,3-diyl]diguanidine STREPTOMYCIN chebi_ontology 2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside Kantrex SM [2-deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{N',N'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine} streomycin streptomycin CHEBI:17076 streptomycin CHEBI:17076 A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. 0 C12H22O11 InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11?,12+/m1/s1 GUBGYTABKSRVRQ-QKKXKWKRSA-N 342.297 342.11621 OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O CHEBI:10296 CHEBI:10380 CHEBI:14497 CHEBI:22460 CHEBI:22760 CHEBI:25005 CHEBI:27755 CHEBI:613009 CAS:63-42-3 GlyGen:G74621DY GlyTouCan:G74621DY Gmelin:882872 KEGG:C00243 KEGG:D00046 KEGG:G10504 KNApSAcK:C00001136 PMID:1292745 PMID:17329833 PMID:18300214 PMID:19053747 PMID:19846069 PMID:19913595 PMID:20094999 PMID:20503067 PMID:20699559 PMID:20873837 PMID:20961532 PMID:21403918 PMID:2432147 PMID:2456994 PMID:28690131 PMID:28807538 PMID:6194884 PMID:7574700 Reaxys:1292745 beta-D-galactopyranosyl-(1->4)-D-glucopyranose lactose chebi_ontology (+)-lactose (Gal)1 (Glc)1 1-beta-D-Galactopyranosyl-4-D-glucopyranose 4-(beta-D-galactosido)-D-glucose 4-O-beta-D-galactopyranosyl-D-glucose D-lactose Galbeta1-4Glc Lac Laktobiose Laktose Milchzucker Milk sugar WURCS=2.0/2,2,1/[a2122h-1x_1-5][a2112h-1b_1-5]/1-2/a4-b1 beta-D-Gal-(1->4)-D-Glc beta-D-Galp-(1->4)-D-Glcp beta-Gal1,4-Glc lactobiose milk sugar CHEBI:17716 lactose CHEBI:17716 Any of a group of aminoglycoside antibiotics produced by fermentation of some Micromonospora spp. CHEBI:14293 CHEBI:24206 CHEBI:24212 CHEBI:5306 CAS:1403-66-3 DrugBank:DB00798 KEGG:C00505 4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)pentopyranosyloxy]-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside chebi_ontology Gentamicin gentamycins CHEBI:17833 gentamycin CHEBI:17833 A glycosyl glycoside formed by glucose and fructose units joined by an acetal oxygen bridge from hemiacetal of glucose to the hemiketal of the fructose. 0 C12H22O11 InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1 CZMRCDWAGMRECN-UGDNZRGBSA-N 342.29650 342.11621 OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O CHEBI:15128 CHEBI:26812 CHEBI:45795 CHEBI:9314 CAS:57-50-1 DrugBank:DB02772 Drug_Central:4610 Gmelin:97695 HMDB:HMDB0000258 KEGG:C00089 KEGG:D00025 KEGG:D06533 KEGG:G00370 KNApSAcK:C00001151 MetaCyc:SUCROSE PDBeChem:SUC PMID:11021636 PMID:11093712 PMID:11111003 PMID:12065720 PMID:12706980 PMID:13508893 PMID:15291457 PMID:15660210 PMID:15792978 PMID:15845855 PMID:16228482 PMID:16304615 PMID:16313996 PMID:16525719 PMID:16660545 PMID:16663947 PMID:16665852 PMID:17233733 PMID:17439666 PMID:17597061 PMID:18625236 PMID:19199566 PMID:19726178 PMID:21703290 PMID:21972845 PMID:22085755 PMID:22311778 PMID:22404833 PMID:22751876 Reaxys:1435311 Reaxys:90825 Wikipedia:Sucrose SUCROSE Sucrose beta-D-fructofuranosyl alpha-D-glucopyranoside sucrose chebi_ontology 1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside Cane sugar Saccharose Sacharose White sugar beta-D-Fruf-(2<->1)-alpha-D-Glcp sacarosa table sugar CHEBI:17992 sucrose CHEBI:17992 Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity. molecular entity chebi_ontology entidad molecular entidades moleculares entite moleculaire molecular entities molekulare Entitaet CHEBI:23367 molecular entity CHEBI:23367 A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances. chemical entity chebi_ontology CHEBI:24431 chemical entity CHEBI:24431 An inorganic chloride salt having sodium(1+) as the counterion. 0 ClNa InChI=1S/ClH.Na/h1H;/q;+1/p-1 FAPWRFPIFSIZLT-UHFFFAOYSA-M 58.44247 57.95862 [Na+].[Cl-] CAS:7647-14-5 Gmelin:13673 KEGG:C13563 KEGG:D02056 MetaCyc:NACL PPDB:595 Reaxys:3534976 Wikipedia:Sodium_Chloride sodium chloride chebi_ontology Kochsalz NaCl Natriumchlorid chlorure de sodium cloruro sodico common salt halite natrii chloridum rock salt salt table salt CHEBI:26710 sodium chloride CHEBI:26710 A dipeptide obtained by formal condensation of the alpha-carboxy group of L-aspartic acid with the amino group of methyl L-phenylalaninate. Commonly used as an artificial sweetener. 0 C14H18N2O5 InChI=1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 294.304 294.12157 C(C[C@@H](C(N[C@@H](CC1=CC=CC=C1)C(=O)OC)=O)N)(=O)O CHEBI:45047 CAS:22839-47-0 DrugBank:DB00168 HMDB:HMDB0001894 KEGG:C11045 KEGG:D02381 PDBeChem:PME PMID:1771173 PMID:2013754 PMID:21150094 PMID:21372000 PMID:22354473 PMID:24355796 PMID:24925367 PMID:24944748 PMID:24965331 PMID:25431414 PMID:25543075 PMID:25786106 PMID:25951455 PMID:25991916 PMID:26015492 PMID:26099025 PMID:26159964 PMID:26247507 PMID:26308194 PMID:26321723 PMID:26377607 PMID:26582819 PMID:26593524 PMID:26912665 PMID:27015640 PMID:27038223 PMID:27088715 PMID:27127997 PMID:27216413 PMID:27298583 PMID:27492574 PMID:27565676 PMID:27614095 PMID:27640132 PMID:27699780 PMID:27728881 PMID:27840415 PMID:27845306 PMID:30000570 PMID:37291632 PMID:37297402 PMID:37454665 Patent:US3492131 Reaxys:2223850 Wikipedia:Aspartame Aspartame methyl L-alpha-aspartyl-L-phenylalaninate chebi_ontology 1-methyl N-L-alpha-aspartyl-L-phenylalanate 3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester 3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid AminoSweet Asp-phe-ome Aspartylphenylalanine methyl ester E 951 L-Aspartyl-L-phenylalanine methyl ester NutraSweet Sanecta aspartam aspartamo aspartamum CHEBI:2877 aspartame CHEBI:2877 0 C6H14O6 182.172 182.07904 CHEBI:15093 CHEBI:26724 CHEBI:26726 CHEBI:33795 CHEBI:33796 CHEBI:9201 Beilstein:1721909 Gmelin:83165 Wikipedia:Sorbitol glucitol chebi_ontology Sorbitol gulitol rel-(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol CHEBI:30911 glucitol CHEBI:30911 A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent. 0 C7H5NO3S InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9) CVHZOJJKTDOEJC-UHFFFAOYSA-N 183.18500 182.99901 O=C1NS(=O)(=O)c2ccccc12 CHEBI:49717 CAS:81-07-2 Gmelin:4203 HMDB:HMDB0029723 KEGG:D01085 MetaCyc:CPD-5581 PDBeChem:LSA PMID:24456165 PMID:24549104 PMID:24739358 PMID:24780866 Reaxys:6888 Wikipedia:Saccharin 1,2-benzisothiazol-3(2H)-one 1,1-dioxide Saccharin chebi_ontology 1,1-Dioxo-1,2-benzisothiazol-3(2H)-one 1,1-Dioxo-1,2-dihydro-benzo[d]isothiazol-3-one 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide 1,2-Benzisothiazolin-3-one 1,1-dioxide 1,2-Dihydro-2-ketobenzisosulfonazole 1,2-Dihydro-2-ketobenzisosulphonazole 2,3-Dihydro-3-oxobenzisosulfonazole 2,3-Dihydro-3-oxobenzisosulphonazole 3-Hydroxybenzisothiazole-S,S-dioxide Anhydro-o-sulfaminebenzoic acid Benzo-2-sulphimide Benzoic acid sulfimide Benzoic sulfimide Benzoic sulphimide Benzosulfimide Benzosulphimide Benzoylsulfonic Imide Saccharimide Saccharine o-Benzoic sulfimide o-Benzosulfimide o-Sulfobenzimide o-Sulfobenzoic acid imide CHEBI:32111 saccharin CHEBI:32111 0 AlH3O3 H3AlO3 InChI=1S/Al.3H2O/h;3*1H2/q+3;;;/p-3 WNROFYMDJYEPJX-UHFFFAOYSA-K 78.00356 77.98976 [H]O[Al](O[H])O[H] CHEBI:30193 CHEBI:31195 CAS:21645-51-2 Drug_Central:4250 Gmelin:22216 KEGG:C13391 KEGG:D02859 Wikipedia:Aluminum_Hydroxide aluminium(3+) hydroxide aluminium(III) hydroxide trihydroxidoaluminium chebi_ontology Al(OH)3 Aluminiumhydroxid Aluminum hydroxide CHEBI:33130 aluminium hydroxide CHEBI:33130 CAS:7632-05-5 Wikipedia:Sodium_phosphates sodium phosphate chebi_ontology phosphoric acid, sodium salt sodium orthophosphate sodium phosphates sodium salt of phosphoric acid CHEBI:37586 sodium phosphate CHEBI:37586 A (1->6)-alpha-D-glucan which has extra branching consisting of (1->2), (1->3) or (1->4) linkages. CAS:9004-54-0 KEGG:C00372 KEGG:D00060 KEGG:D06541 KEGG:G10502 PMID:8154046 chebi_ontology (1,6-alpha-D-Glucosyl)m (1,6-alpha-D-Glucosyl)m+1 (1,6-alpha-D-Glucosyl)n (1,6-alpha-D-Glucosyl)n+1 1,6-alpha-D-Glucan Dextran 40 Dextran 70 Dextran 75 dextran dextrane dextrano dextrans dextranum CHEBI:52071 dextran CHEBI:52071 A polymer composed of PEG-ylated sorbitan, where the total number of poly(ethylene glycol) units is 20 (w + x + y + z = 20) and a single terminal is capped by a dodecanoyl group. 0 C58H114O26 1226.75977 1226.760 CAS:9005-64-5 KEGG:C11624 KEGG:D05565 Reaxys:8187252 Reaxys:8973037 Wikipedia:Polysorbate_20 chebi_ontology Polyoxyethylene (20) sorbitan monolaurate Polyoxyethylene sorbitan monolaurate Polysorbate Polysorbate 20 Tween 20 polisorbato polysorbate polysorbatum CHEBI:53424 polysorbate 20 CHEBI:53424 A polymer composed of PEG-ylated sorbitan, where the total number of poly(ethylene glycol) units is 20 (w + x + y + z = 20) and a single terminal is capped by an oleoyl group. 0 C64H124O26 1308.83802 1308.838 CHEBI:9785 CAS:9005-65-6 KEGG:C11625 KEGG:D01067 Reaxys:8187125 Reaxys:8190601 Reaxys:8898414 Reaxys:9040798 Wikipedia:Polysorbate_80 chebi_ontology Glycol (polysorbate 80) Polyethylene oxide sorbitan mono-oleate Polyoxyethylene (20) sorbitan monooleate Polyoxyethylene sorbitan monooleate Polyoxyethylene sorbitan oleate Polysorbate 80 Tween 80 polisorbato polysorbate polysorbatum CHEBI:53426 polysorbate 80 CHEBI:53426 An organic sodium salt that is the monosodium salt of glutamic acid. 0 C5H8NNaO4 InChI=1S/C5H9NO4.Na/c6-3(5(9)10)1-2-4(7)8;/h3H,1-2,6H2,(H,7,8)(H,9,10);/q;+1/p-1 LPUQAYUQRXPFSQ-UHFFFAOYSA-M 169.11110 169.03510 [Na+].[NH3+]C(CCC([O-])=O)C([O-])=O PMID:22293291 Reaxys:17003240 sodium 2-azaniumylpentanedioate chebi_ontology MSG sodium 2-ammoniopentanedioate sodium glutamate CHEBI:64220 monosodium glutamate CHEBI:64220 A broad-spectrum highly toxic antibiotic or mixture of antibiotics produced by a streptomyces (Streptomyces fradiae) and used medically especially to treat local infections. CAS:1404-04-2 DrugBank:DB00994 KEGG:C00384 KEGG:D08260 Neomycin chebi_ontology CHEBI:7507 neomycin CHEBI:7507 An alkylmercury compound (approximately 49% mercury by weight) used as an antiseptic and antifungal agent. 0 C9H9HgNaO2S C9H9HgO2S.Na InChI=1S/C7H6O2S.C2H5.Hg.Na/c8-7(9)5-3-1-2-4-6(5)10;1-2;;/h1-4,10H,(H,8,9);1H2,2H3;;/q;;2*+1/p-2 RTKIYNMVFMVABJ-UHFFFAOYSA-L 404.81233 405.99274 [Na+].CC[Hg]Sc1ccccc1C([O-])=O CAS:54-64-8 Gmelin:1677155 KEGG:D00864 PMID:18837732 PMID:21616561 PMID:21785120 PMID:22015977 PMID:22366633 PMID:22658806 PMID:22811707 PMID:23145070 PMID:23223227 PMID:23282150 PMID:23401210 PMID:23554557 PMID:23843785 PMID:23949514 PMID:23965928 PMID:23992327 PMID:25042713 PPDB:3062 Reaxys:8169555 VSDB:3062 Thimerosal sodium [(2-carboxylatophenyl)sulfanyl](ethyl)mercurate(1-) sodium ethyl[2-(sulfanyl-kappaS)benzoato(2-)]mercurate(1-) chebi_ontology Merthiolate Thiomersal [(o-carboxyphenyl)thio]ethylmercury sodium salt ethyl(2-mercaptobenzoato-S)mercury sodium salt ethylmercurithiosalicylate sodium ethylmercurithiosalicylic acid sodium salt mercurothiolate o-(ethylmercurithio)benzoic acid sodium salt sodium ethylmercurithiosalicylate sodium merthiolate thiomersal thiomersalate thiomersalum tiomersal CHEBI:9546 thimerosal CHEBI:9546 CL:0000000 A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane. CALOHA:TS-2035 FBbt:00007002 FMA:68646 GO:0005623 KUPO:0000002 MESH:D002477 VHOG:0001533 WBbt:0004017 XAO:0003012 ZFA:0009000 The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one). cell CL:0000113 A vertebrate phagocyte with a single nucleus. This extended description was generated by ChatGPT and reviewed by the CellGuide team, who added references, and by the CL editors, who approved it for inclusion in CL. It may contain information that applies to only to some subtypes and species, and so should not be considered definitional. Mononuclear phagocytes are immune cells that form a critical part of the body's innate immune system, the body's first line of defense against infections. Mononuclear phagocytes are characterized by the presence of a single, large nucleus. The ‘Mononuclear Phagocyte System’ nomenclature was introduced to distinguish mononuclear monocytes and macrophages from other cells with multiple nuclei. However, the cells within the mononuclear phagocyte system represent a highly heterogeneous group, all of which are able to perform highly efficient phagocytosis - engulfing and digesting microbes and cellular debris to fight infections and to maintain normal tissue homeostasis. In addition to phagocytosis, mononuclear phagocytes also secrete chemical compounds to recruit other immune cells to a site of infection. These cells produce different types of signaling molecules, including cytokines, chemokines, and reactive oxygen species, triggering a cascade of responses to ensure rapid and efficient containment and neutralization of invading pathogens. These cells are also involved in antigen presentation, a process essential for stimulating an adaptive immune response. They can process and present antigens to T cells, thereby linking the innate and adaptive immune responses. Mononuclear phagocytes play key roles in tissue repair and remodeling. After infection or injury, these cells help in the clearance of dead cells and debris, a crucial step in the initiation of tissue remodeling and the resolution of inflammation. Overall, mononuclear phagocytes are versatile cells that have tailored their functions to meet the unique challenges of different tissues within the body. They are pivotal in homeostasis, immunity, and inflammation, making them important aspects in a range of human diseases including infection, autoimmunity, and cancer. BTO:0001433 ZFA:0009064 https://cellxgene.cziscience.com/cellguide/CL_0000113 mononuclear phagocyte CL:0000182 The main structural component of the liver. They are specialized epithelial cells that are organized into interconnected plates called lobules. Majority of cell population of liver, polygonal in shape, arranged in plates or trabeculae between sinusoids; may have single nucleus or binucleated. This extended description was generated by ChatGPT and reviewed by the CellGuide team, who added references, and by the CL editors, who approved it for inclusion in CL. It may contain information that applies to only to some subtypes and species, and so should not be considered definitional. Hepatocytes are the major cell type constituting 70-80% of the liver's cytoplasmic mass, playing crucial roles in maintaining the body's metabolic homeostasis. Dimensions of mature hepatocytes typically range from 20 to 30 μm in humans, but size may vary depending on their location within the liver lobule. Hepatocytes are characterized by high biosynthetic, enzymatic, and endocytic activity. They contain abundant mitochondria, smooth and rough endoplasmic reticulum, peroxisomes, lysosomes, and a large nucleus that is often binucleate. The liver consists of three zones - the periportal Zone 1, midzone 2, and pericentral Zone 3 - which have differential nutrient and oxygen status, and damage susceptibility; hepatocytes in the different zones show signifcant functional heterogeneity ('hepatocyte functional zonation'). Hepatocytes are involved in a multitude of critical functions including the metabolism of lipids, carbohydrates, and proteins, the synthesis of serum proteins (e.g., albumin, transferrin, and lipoproteins), the detoxification and excretion of endogenous and exogenous substances, the storage of vitamins and minerals, and the production and secretion of bile. Heterocytes demonstrate a remarkable regenerative capacity, which enables the liver to recover from injury and loss of tissue mass. Notably, hepatocytes perform biotransformation with both phase I and phase II enzymes, which modify drugs, xenobiotics, and various substances for elimination from the body. Phase I enzymes, such as cytochrome P450, catalyze both oxidative and reductive reactions of many xenobiotics; many of the products of phase I enzymes are substrates for the phase II enzymes, which catalyze conjugation reactions. Alterations in hepatocyte function have significant implications for overall human health and disease. Certain conditions, such as hepatitis, cirrhosis, and liver cancer, can profoundly affect hepatocyte structure and function, thereby disrupting the liver's ability to perform its vital roles within the body. As the primary site for drug metabolism, changes in hepatocyte function can also impact the effectiveness and toxicity of pharmaceuticals. The regenerative ability of hepatocytes makes them valuable cells for liver regenerative medicine and bioartificial liver support systems, and their study has provided significant insights into liver biology and disease. BTO:0000575 CALOHA:TS-0454 FMA:14515 ZFA:0009111 https://cellxgene.cziscience.com/cellguide/CL_0000182 Hepatocytes are reportedly MHC Class I-positive and MHC Class II-positive. hepatocyte CL:0000219 A cell that moves by its own activities. ZFA:0009136 motile cell CL:0000226 A cell with a single nucleus. single nucleate cell CL:0000232 A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen. BTO:0000424 CALOHA:TS-0290 FMA:81100 RBC red blood cell erythrocyte CL:0000234 Any cell capable of ingesting particulate matter via phagocytosis. BTO:0001044 FMA:83806 MESH:D010586 ZFA:0009140 phagocyte CL:0000235 A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells. BTO:0000801 CALOHA:TS-0587 FMA:63261 FMA:83585 MESH:D008264 ZFA:0009141 histiocyte Morphology: Diameter 30_M-80 _M, abundant cytoplasm, low N/C ratio, eccentric nucleus. Irregular shape with pseudopods, highly adhesive. Contain vacuoles and phagosomes, may contain azurophilic granules; markers: Mouse & Human: CD68, in most cases CD11b. Mouse: in most cases F4/80+; role or process: immune, antigen presentation, & tissue remodelling; lineage: hematopoietic, myeloid. macrophage CL:0000255 Any cell that in taxon some Eukaryota. MESH:D005057 eukaryotic cell CL:0000518 A phagocyte in vertebrates that is able to phagocytosis. phagocyte (sensu Vertebrata) CL:0000738 An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue. BTO:0000751 CALOHA:TS-0549 FMA:62852 MESH:D007962 NCIT:C12529 ZFA:0009309 leucocyte white blood cell immune cell leukocyte CL:0000763 A cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage. BTO:0001441 CALOHA:TS-0647 MESH:D022423 ZFA:0009324 myeloid cell CL:0000766 A cell of the monocyte, granulocyte, or mast cell lineage. ZFA:0009326 myeloid leukocyte CL:0000842 A leukocyte with a single non-segmented nucleus in the mature form. BTO:0000878 CALOHA:TS-0768 FMA:86713 ZFA:0009357 mononuclear leukocyte peripheral blood mononuclear cell mononuclear cell CL:0000988 A cell of a hematopoietic lineage. BTO:0000574 CALOHA:TS-2017 FMA:70366 FMA:83598 ZFA:0005830 haematopoietic cell haemopoietic cell hemopoietic cell hematopoietic cell CL:0002242 A cell containing at least one nucleus. 2010-09-07T03:32:33Z FMA:67513 nucleate cell A bacterial pneumonia has_material_basis_in Streptococcus pneumoniae. ICD10CM:J13 ICD9CM:481 disease_ontology DOID:0040084 Streptococcus pneumonia DOID:0040084 A viral infectious disease that results_in infection located_in joint, has_material_basis_in Chikungunya virus (Alphavirus chikungunya), which is transmitted_by Aedes mosquito bite. The infection has_symptom fever, has_symptom arthralgia, and has_symptom maculopapular rash. GARD:6038 Chikungunya fever disease_ontology DOID:0050012 chikungunya DOID:0050012 A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions. infectious disease DOID:10115 DOID:11078 DOID:1304 DOID:1321 DOID:2040 DOID:2288 DOID:3099 DOID:4120 DOID:4620 DOID:5256 DOID:945 DOID:95 DOID:9532 DOID:9696 ICD9CM:079.0 UMLS_CUI:C0001485 infectious disease disease_ontology DOID:0050117 DO:wk disease by infectious agent DOID:0050117 A viral infectious disease that results_in inflammation located_in brain, has_material_basis_in Tick-borne encephalitis virus (Orthoflavivirus encephalitidis), which is transmitted_by Ixodes ticks. The infection has_symptom drowsiness, has_symptom confusion, has_symptom sensory disturbances, and has_symptom paralysis. DOID:0050176 DOID:10251 DOID:10252 GARD:5216 ICD10CM:A84.1 ICD9CM:063.2 MESH:D004675 SNOMEDCT_US_2023_03_01:16901001 UMLS_CUI:C0014054 Central European encephalitis Far Eastern TBE Russian spring-summer encephalitis Siberian tick-borne encephalitis Taiga encephalitis Western European tick-borne encephalitis west-Siberian encephalitis disease_ontology DOID:0050175 tick-borne encephalitis DOID:0050175 A bacterial infectious disease that results_in infection by bacteria as a result of their presence or activity within the normal, healthy host, and their intrinsic virulence is, in part, a necessary consequence of their need to reproduce and spread. disease_ontology DOID:0050338 primary bacterial infectious disease DOID:0050338 An organ system cancer located_in the respiratory system that is characterized by uncontrolled cellular proliferation in the respiratory tract. disease_ontology DOID:0050615 respiratory system cancer DOID:0050615 A cancer that is classified based on the organ it starts in. snadendla 2011-06-13T03:28:33Z MESH:D009371 disease_ontology DOID:0050686 organ system cancer DOID:0050686 A cancer that is classified by the type of cell from which it is derived. snadendla 2011-06-13T03:28:50Z disease_ontology DOID:0050687 cell type cancer DOID:0050687 A B-cell lymphocytic neoplasm due to CD5 positive antigen-naive pregerminal center B-cell within the mantle zone that surrounds normal germinal center follicles. lschriml 2012-09-18T02:00:45Z GARD:6969 ICDO:9673/3 MESH:D020522 disease_ontology DOID:0050746 mantle cell lymphoma DOID:0050746 A hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs. DOID:1033 DOID:353 ICD10CM:C85.9 ICDO:9590/3 MESH:D008223 NCI:C3208 NCI:C7065 SNOMEDCT_US_2023_03_01:118600007 SNOMEDCT_US_2023_03_01:414628006 UMLS_CUI:C0024299 UMLS_CUI:C0598798 lymphoid cancer disease_ontology DOID:0060058 lymphoma DOID:0060058 An immune system cancer that is located_in the lymphatic system and is characterized by uncontrolled cellular proliferation of lymphoid tissue. lschriml 2011-05-11T01:05:14Z disease_ontology DOID:0060073 lymphatic system cancer DOID:0060073 An organ system cancer located_in the immune system that is characterized by uncontrolled cellular proliferation in organs of the immune system. lschriml 2011-06-08T01:11:18Z ICDO:9392/3 disease_ontology DOID:0060083 immune system cancer DOID:0060083 An organ system benign neoplam that is located_in the thoracic cavity. lschriml 2011-07-15T01:55:57Z disease_ontology DOID:0060097 thoracic benign neoplasm DOID:0060097 An organ system cancer located_in the muscular and skeletal organs and characterized by uncontrolled cellular proliferation of the musculoskeletal organs. lschriml 2011-07-15T02:30:51Z DOID:0060124 skeletal system cancer disease_ontology DOID:0060100 musculoskeletal system cancer DOID:0060100 A gastrointestinal system cancer that is located_in the pharynx. lschriml 2011-07-27T01:26:34Z MESH:D010610 NCI:C3325 SNOMEDCT_US_2023_03_01:126685009 UMLS_CUI:C0031347 pharyngeal neoplasm pharynx neoplasm disease_ontology pharyngeal cancer DOID:0060119 pharynx cancer DOID:0060119 A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function. DOID:1290 ICD10CM:M89.9 MESH:D001847 SNOMEDCT_US_2023_03_01:76069003 UMLS_CUI:C0005940 disease_ontology skeletal disease DOID:0080001 bone disease DOID:0080001 A bacterial meningitis that has_material_basis_in Neisseria meningitidis infection. ICD10CM:A39.0 ICD9CM:036.0 MESH:D008585 disease_ontology DOID:0080176 meningococcal meningitis DOID:0080176 A bacterial meningitis that has_material_basis_in Haemophilus influenzae infection. ICD10CM:G00.0 ICD9CM:320.0 MESH:D008583 disease_ontology DOID:0080179 haemophilus meningitis DOID:0080179 A gastrointestinal system cancer that is located_in the hepatobiliary system. disease_ontology DOID:0080355 hepatobiliary system cancer DOID:0080355 A Coronavirus infectious disease that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2, a subtype of Betacoronavirus pandemicum. ICD10CM:U07.1 MESH:D000086382 NCI:C171133 SNOMEDCT_US_2023_03_01:840539006 UMLS_CUI:C5203670 2019 Novel Coronavirus (2019-nCoV) 2019-nCoV infection COVID19 SARS-CoV-2 infection Wuhan coronavirus infection Wuhan seafood market pneumonia virus infection disease_ontology DOID:0080600 COVID-19 DOID:0080600 An immune system disease that is characterized by recognition by mature donor T cells, that contaminate the allogeneic bone marrow, of the recipient's tissue as foreign, causing a severe inflammatory disease characterized by rashes, diarrhea, and liver disease, and that has_material_basis_in an associated with variation in the interleukin-10 gene (IL10) on chromosome 1q32. ICD11:4B24 MESH:D006086 MIM:614395 ORDO:39812 GvHD graft versus host disease disease_ontology DOID:0081267 graft-versus-host disease DOID:0081267 An intestinal cancer that is located_in the small intestine. GARD:9385 ICD10CM:C17 ICD9CM:152.9 NCI:C7523 SNOMEDCT_US_2023_03_01:363509000 UMLS_CUI:C0153425 disease_ontology DOID:10154 small intestine cancer DOID:10154 A gastrointestinal system cancer that is located_in the intestine. ICD10CM:C26.0 ICD9CM:159.0 MESH:D007414 NCI:C4572 SNOMEDCT_US_2023_03_01:93838000 UMLS_CUI:C0346627 malignant intestinal tumors malignant neoplasm of intestine disease_ontology DOID:10155 intestinal cancer DOID:10155 A viral infectious disease that results in inflammation located in salivary gland, has_material_basis_in Mumps rubulavirus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face. GARD:7116 ICD10CM:B26 ICD9CM:072 MESH:D009107 NCI:C29888 SNOMEDCT_US_2023_03_01:154352008 UMLS_CUI:C0026780 disease_ontology DOID:10264 mumps DOID:10264 A male reproductive organ cancer that is located_in the prostate. DOID:514 ICD10CM:C61 ICD9CM:185 KEGG:05215 MESH:D011471 MIM:176807 MIM:300147 MIM:300704 MIM:601518 MIM:602759 MIM:608656 MIM:608658 MIM:609299 MIM:609558 MIM:610321 MIM:610997 MIM:611100 MIM:611868 MIM:611928 MIM:611955 MIM:611958 MIM:611959 NCI:C3343 NCI:C7378 ORDO:1331 SNOMEDCT_US_2023_03_01:126906006 SNOMEDCT_US_2023_03_01:93974005 UMLS_CUI:C0033578 UMLS_CUI:C0376358 NGP - new growth of prostate hereditary prostate cancer malignant tumor of the prostate prostate cancer, familial prostate neoplasm prostatic cancer prostatic neoplasm tumor of the prostate disease_ontology DOID:10283 Xref MGI. OMIM mapping confirmed by DO. [SN]. prostate cancer DOID:10283 A disease by infectious agent that results_in infection, has_material_basis_in Bacteria. ICD10CM:A49.9 MESH:D001424 NCI:C2890 SNOMEDCT_US_2023_03_01:87628006 UMLS_CUI:C0004623 disease_ontology DOID:104 bacterial infectious disease DOID:104 A gastrointestinal system cancer that is located_in the stomach. DOID:10539 DOID:10542 DOID:10543 DOID:4713 GARD:7704 ICD10CM:C16 ICD10CM:C16.2 ICD10CM:C16.5 ICD10CM:C16.6 ICD9CM:151 ICD9CM:151.4 ICD9CM:151.5 ICD9CM:151.6 MESH:D013274 MIM:613659 NCI:C3387 NCI:C9331 SNOMEDCT_US_2023_03_01:126824007 SNOMEDCT_US_2023_03_01:269459004 SNOMEDCT_US_2023_03_01:269460009 SNOMEDCT_US_2023_03_01:93717002 SNOMEDCT_US_2023_03_01:94074003 UMLS_CUI:C0024623 UMLS_CUI:C0038356 UMLS_CUI:C0153421 UMLS_CUI:C0153422 UMLS_CUI:C0153423 gastric cancer gastric neoplasm disease_ontology DOID:10534 OMIM mapping confirmed by DO. [SN]. stomach cancer DOID:10534 A tauopathy that is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability and results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid. GARD:10254 ICD10CM:G30 ICD9CM:331.0 KEGG:05010 MESH:D000544 NCI:C2866 SNOMEDCT_US_2023_03_01:73768007 UMLS_CUI:C0002395 Alzheimer disease Alzheimers dementia disease_ontology DOID:10652 Xref MGI. OMIM mapping confirmed by DO. [SN]. Alzheimer's disease DOID:10652 A viral infectious disease that results_in infection located_in brain, has_material_basis_in Japanese encephalitis virus (Orthoflavivirus japonicum), which is transmitted_by Culex tritaeniorhynchus mosquito bite. The infection has_symptom headache, has_symptom high fever, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions, and has_symptom spastic paralysis. GARD:6797 ICD10CM:A83.0 ICD9CM:062.0 MESH:D004672 NCI:C34577 SNOMEDCT_US_2023_03_01:266194002 UMLS_CUI:C0014057 Japanese B encephalitis disease_ontology DOID:10844 Japanese encephalitis DOID:10844 A female reproductive system disease that is located_in the ovary. MESH:D010049 NCI:C26841 SNOMEDCT_US_2023_03_01:5552004 UMLS_CUI:C0029928 disease_ontology DOID:1100 ovarian disease DOID:1100 An urinary system cancer that results_in malignant growth located_in the urinary bladder. DOID:5428 GARD:12210 ICD10CM:C67 ICD9CM:188 KEGG:05219 MESH:D001749 MIM:109800 NCI:C2901 NCI:C9334 SNOMEDCT_US_2023_03_01:126885006 SNOMEDCT_US_2023_03_01:363455001 UMLS_CUI:C0005684 UMLS_CUI:C0005695 bladder cancer tumor of the bladder disease_ontology DOID:11054 OMIM mapping confirmed by DO. [SN]. urinary bladder cancer DOID:11054 A brucellosis that involves an infection caused by Brucella suis [NCBITaxon:29461] in swine and humans. The disease has_symptom fever, has_symptom chills, has_symptom malaise, has_symptom diaphoresis, has_symptom arthralgia, has_symptom myalgia, has_symptom headache, has_symptom anorexia, and has_symptom fatigue. disease_ontology DOID:11076 Brucella suis brucellosis DOID:11076 A primary bacterial infectious disease that is caused by the bacteria of the genus Brucella, when humans come in contact with contaminated animals or animal products or ingestion of infected food products. The disease has_symptom fever, has_symptom sweat, has_symptom headache, has_symptom back pain, has_symptom physical weakness, has_symptom joint pain and has_symptom fatigue. DOID:0050060 GARD:5966 ICD10CM:A23 ICD9CM:023 MESH:D002006 NCI:C84602 SNOMEDCT_US_2023_03_01:154296006 UMLS_CUI:C0006309 Maltese fever undulant fever disease_ontology Bang's disease Gibraltar fever Malta fever Mediterranean fever DOID:11077 brucellosis DOID:11077 A primary bacterial infectious disease that is a zoonotic infectious disease affecting multiple organs, has_material_basis_in Coxiella burnetii, which is transmitted_by inhalation of air contaminated by barnyard dust containing dried placental material, birth fluids, or excreta of infected herd animals, transmitted_by ingestion of contaminated milk, transmitted_by tick bites and transmitted_by contact with infected person. The infection has_symptom fever, has_symptom headache, has_symptom cough, has_symptom pleuritic chest pain, has_symptom myalgia and has_symptom arthralgia. GARD:7515 ICD10CM:A78 ICD9CM:083.0 MESH:D011778 NCI:C34970 SNOMEDCT_US_2023_03_01:266205000 UMLS_CUI:C0034362 Infection due to Coxiella burnetii disease_ontology DOID:11100 Q fever DOID:11100 A cell type cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm. DOID:3936 ICD10CM:C49 ICD9CM:171.9 ICDO:8800/3 SNOMEDCT_US_2023_03_01:93765001 UMLS_CUI:C0153519 connective and soft tissue neoplasm tumor of soft tissue and skeleton disease_ontology DOID:1115 sarcoma DOID:1115 A commensal bacterial infectious disease that results_in inflammation located_in respiratory tract, has_material_basis_in Bordetella pertussis, or has_material_basis_in Bordetella parapertussis, which produce toxins that paralyze the cilia of the respiratory epithelial cells. The infection is characterized by a prolonged, high-pitched, deeply indrawn breath (whoop). DOID:11333 DOID:11751 KEGG:05133 MESH:D001885 SNOMEDCT_US_2023_03_01:26484003 UMLS_CUI:C0006015 WC - Whooping cough bordetella infection whooping cough disease_ontology DOID:1116 pertussis DOID:1116 A viral infectious disease that has_material_basis_in human papillomaviruses, which establish productive infections only in the stratified epithelium of the skin or mucous membranes. These viruses cause warts and sometimes tumors. They are transmitted_by sexual contact. MESH:D030361 HPV disease_ontology DOID:11166 Human papillomavirus infectious disease DOID:11166 A viral infectious disease that results in inflammation located in brain or located in spinal cord, has_material_basis_in Rabies virus, which is transmitted by bite of an infected animal, or transmitted by contact of mucous membranes with saliva of an infected animal. The infection has symptom fever, has symptom headache, has symptom prickling or itching sensation at the site of bite, has symptom anxiety, has symptom confusion, has symptom agitation, has symptom delirium, has symptom difficulty swallowing, has symptom hydrophobia, and has symptom paralysis. GARD:7516 ICD10CM:A82 ICD9CM:071 MESH:D011818 NCI:C28182 SNOMEDCT_US_2023_03_01:14168008 UMLS_CUI:C0034494 Lyssa disease_ontology DOID:11260 rabies DOID:11260 A primary bacterial infectious disease that results in prolonged contraction of skeletal muscle fibers, has_material_basis_in Clostridium tetani, which produces tetanospasmin, a neurotoxin, which is carried to the brain and spinal cord, where it binds irreversibly to receptors inhibiting neurotransmission. Damaged upper motor neurons cannot control reflex responses to afferent sensory stimuli. GARD:5144 ICD10CM:A35 ICD9CM:037 MESH:D013742 NCI:C85185 SNOMEDCT_US_2023_03_01:154312006 UMLS_CUI:C0039614 Infection due to Clostridium tetani clostridial tetanus disease_ontology DOID:11338 tetanus DOID:11338 A primary bacterial infectious disease that is characterized by sore throat, low fever, and an adherent membrane (a pseudomembrane) on the tonsils, pharynx, and/or nasal cavity. A milder form of diphtheria can be restricted to the skin. It is caused by Corynebacterium diphtheriae, an aerobic Gram-positive bacterium. Diphtheria toxin spreads through the bloodstream and can lead to potentially life-threatening complications that affect other organs of the body, such as the heart and kidneys. DOID:4132 GARD:1875 MESH:D003354 SNOMEDCT_US_2023_03_01:397434007 UMLS_CUI:C0010153 corynebacterium infection disease_ontology DOID:11405 diphtheria DOID:11405 A primary bacterial infectious disease that results_in infection, has_material_basis_in Borrelia burgdorferi, which is transmitted_by blacklegged tick (Ixodes scapularis) or transmitted_by western blacklegged tick (Ixodes pacificus). The infection has_symptom fever, has_symptom headache, has_symptom fatigue, and has_symptom skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. DOID:12233 GARD:12073 ICD10CM:A69.2 ICD9CM:088.81 MESH:D008193 MESH:D020852 NCI:C45161 SNOMEDCT_US_2023_03_01:154376000 SNOMEDCT_US_2023_03_01:715507005 UMLS_CUI:C0024198 UMLS_CUI:C0752235 Bannwarth syndrome Bannworth's syndrome Lyme borreliosis Neurological Lyme disease lyme neuroboInOwlrreliosis neuroboInOwlrreliosis disease_ontology DOID:11729 Lyme disease DOID:11729 A nervous system cancer that is located in the peripheral nervous system. DOID:3194 MESH:D010524 MESH:D018317 NCI:C3321 NCI:C4972 SNOMEDCT_US_2023_03_01:126980002 SNOMEDCT_US_2023_03_01:189946005 UMLS_CUI:C0031118 UMLS_CUI:C0206727 neoplasm of peripheral nerve nerve sheath neoplasm tumor of PNS disease_ontology DOID:1192 peripheral nervous system neoplasm DOID:1192 An organ system cancer that arises in the head or neck region. This region includes the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx. GARD:12425 MESH:D006258 NCI:C3077 SNOMEDCT_US_2023_03_01:255055008 UMLS_CUI:C0018671 head and neck neoplasm head and neck tumours head/neck neoplasm tumor of head and neck disease_ontology DOID:11934 head and neck cancer DOID:11934 A reproductive organ cancer that is manifested in the female genitals. This includes organs such as the ovaries, fallopian tubes, uterus, cervix, vagina and vulva. DOID:1244 DOID:1281 ICD10CM:C57 ICD9CM:184 MESH:D005833 NCI:C3053 NCI:C4913 SNOMEDCT_US_2023_03_01:126907002 SNOMEDCT_US_2023_03_01:188207007 UMLS_CUI:C0017416 UMLS_CUI:C0153585 UMLS_CUI:C0699889 female reproductive cancer malignant Gynecologic tumor malignant neoplasm of female genital organ disease_ontology DOID:120 female reproductive organ cancer DOID:120 An immune system disease that is an exaggerated immune response to allergens, such as insect venom, dust mites, pollen, pet dander, drugs or some foods. allergic disease ICD10CM:T78.40 MESH:D006967 NCI:C3114 SNOMEDCT_US_2023_03_01:257550005 UMLS_CUI:C0020517 allergic hypersensitivity disease hypersensitivity hypersensitivity reaction type I disease disease_ontology DOID:1205 allergic disease DOID:1205 A viral infectious disease that results in infection, has_material_basis_in Dengue virus (Orthoflavivirus denguei), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding. DOID:0050142 GARD:6254 ICD10CM:A90 ICD9CM:061 MESH:D003715 NCI:C34528 SNOMEDCT_US_2023_03_01:38362002 UMLS_CUI:C0011311 Dengue Fever breakbone fever classic dengue disease_ontology classical dengue DOID:12205 dengue disease DOID:12205 A parasitic protozoa infectious disease characterized as a vector-borne infectious disease caused by the presence of protozoan parasites of the genus Plasmodium in the red blood cells, transmitted from an infected to an uninfected individual by the bite of anopheline mosquitoes, and characterized by periodic attacks of chills and fever that coincide with mass destruction of blood cells and the release of toxic substances by the parasite at the end of each reproductive cycle. DOID:12552 EFO:0001068 GARD:6961 ICD10CM:B54 ICD9CM:084 MESH:D008288 NCI:C34797 ORDO:673 SNOMEDCT_US_2023_03_01:154374002 UMLS_CUI:C0024530 induced malaria disease_ontology DOID:12365 Xref MGI. malaria DOID:12365 A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells. DOID:9145 ICD10CM:C95.90 ICD9CM:208 ICDO:9800/3 MESH:D007938 NCI:C3161 SNOMEDCT_US_2023_03_01:255049003 UMLS_CUI:C0023418 disease_ontology DOID:1240 leukemia DOID:1240 A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis A virus (Hepatovirus ahepa), which is transmitted_by ingestion of contaminated food or water, or transmitted_by direct contact with an infected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice. DOID:12547 MESH:D006506 NCI:C3096 SNOMEDCT_US_2023_03_01:40468003 UMLS_CUI:C0019159 Viral hepatitis, type A disease_ontology Viral hepatitis A DOID:12549 hepatitis A DOID:12549 A viral infectious disease that results_in infection located_in upper respiratory tract or located_in lower respiratory tract, has_material_basis_in Human respiratory syncytial virus, which is transmitted_by droplet spread of nasal secretions from an infected person while coughing or sneezing, or transmitted_by contaminated fomites. The infection has_symptom runny nose, has_symptom fever, has_symptom cough, has_symptom wheezing, and has_symptom respiratory distress. MESH:D018357 NCI:C3354 SNOMEDCT_US_2023_03_01:186750007 UMLS_CUI:C0035235 RSV respiratory syncytial virus disease_ontology DOID:1273 respiratory syncytial virus infectious disease DOID:1273 A central nervous system cancer that is characterized by the growth of abnormal cells in the tissues of the brain. DOID:2125 DOID:2126 DOID:3543 DOID:6649 DOID:911 ICD10CM:C71 ICD9CM:191 ICD9CM:239.6 MESH:D001932 NCI:C170814 NCI:C2907 NCI:C3568 NCI:C5115 NCI:C7710 SNOMEDCT_US_2023_03_01:126952004 SNOMEDCT_US_2023_03_01:428061005 SNOMEDCT_US_2023_03_01:93727008 UMLS_CUI:C0006118 UMLS_CUI:C0153633 UMLS_CUI:C0220624 UMLS_CUI:C0750974 UMLS_CUI:C0750979 UMLS_CUI:C1334557 BT - Brain tumour adult brain tumor adult malignant brain neoplasm brain neoplasm brain neoplasm, adult malignant brain tumour malignant primary brain neoplasm malignant primary brain tumor malignant tumor of Brain malignant tumor of adult brain neoplasm of brain primary brain neoplasm primary brain tumor primary malignant neoplasm of brain tumor of the Brain disease_ontology DOID:1319 brain cancer DOID:1319 A respiratory system cancer that is located_in the lung. DOID:13075 DOID:1322 DOID:9881 ICD10CM:C34.1 ICD10CM:C34.2 ICD10CM:C34.3 ICD9CM:162.3 ICD9CM:162.4 ICD9CM:162.5 ICD9CM:162.8 MIM:211980 MIM:608935 MIM:612571 MIM:612593 MIM:614210 SNOMEDCT_US_2023_03_01:187860004 SNOMEDCT_US_2023_03_01:187864008 SNOMEDCT_US_2023_03_01:187868006 SNOMEDCT_US_2023_03_01:187874006 UMLS_CUI:C0024624 UMLS_CUI:C0153491 UMLS_CUI:C0153492 UMLS_CUI:C0153493 disease_ontology lung neoplasm DOID:1324 lung cancer DOID:1324 A primary bacterial infectious disease that is a communicable systemic illness, has_material_basis_in Salmonella enterica subsp enterica serovar Typhi, which is transmitted_by ingestion of food or water contaminated with the feces of an infected person. The infection has_symptom fever, has_symptom diarrhea, has_symptom prostration, has_symptom headache, has_symptom splenomegaly, has_symptom liver enlargement, has_symptom eruption of rose-colored spots, and has_symptom leukopenia. DOID:3054 GARD:9564 ICD10CM:A01.0 ICD9CM:002.0 MESH:D014435 NCI:C35089 SNOMEDCT_US_2023_03_01:186091002 UMLS_CUI:C0041466 Typhoid disease_ontology DOID:13258 typhoid fever DOID:13258 A disease by infectious agent that is carried out by a parasite which by definition is a pathogen that simultaneously injures and derives sustenance from its host. DOID:11681 DOID:13509 DOID:1396 DOID:1494 DOID:2114 DOID:2293 DOID:2922 DOID:3564 DOID:4191 DOID:886 DOID:948 DOID:9639 DOID:9644 ICD10CM:H44.12 ICD9CM:360.13 NCI:C34587 SNOMEDCT_US_2023_03_01:57100005 UMLS_CUI:C0014238 Ectoparasitic disease parasitemia disease_ontology DOID:1398 parasitic infectious disease DOID:1398 A malaria described as a severe form of the disease caused by a parasite Plasmodium falciparum, which is marked by irrregular recurrence of paroxysms and prolonged or continuous fever. ICD10CM:B50 ICD9CM:084.0 MESH:D016778 NCI:C34798 SNOMEDCT_US_2023_03_01:62676009 UMLS_CUI:C0024535 Malaria fever, subtertian falciparum malaria malignant tertian fever disease_ontology DOID:14067 Plasmodium falciparum malaria DOID:14067 A brucellosis that involves an infection caused by Brucella melitensis [NCBITaxon:29459] in cattle, goats, sheep and humans. The disease has_symptom fever, has_symptom malaise, has_symptom anorexia, has_symptom limb pain and has_symptom back pain. ICD10CM:A23.0 ICD9CM:023.0 SNOMEDCT_US_2023_03_01:186305007 UMLS_CUI:C0302362 disease_ontology DOID:14456 Brucella melitensis brucellosis DOID:14456 A brucellosis that involves an infection caused by Brucella abortus [NCBITaxon:235] in cattle and humans. The disease has_symptom fever, has_symptom chills, has_symptom sweats, has_symptom weight loss, has_symptom malaise, has_symptom headaches, has_symptom myalgia, and has_symptom arthralgia. ICD10CM:A23.1 ICD9CM:023.1 MESH:D002007 SNOMEDCT_US_2023_03_01:427795000 UMLS_CUI:C0302363 disease_ontology DOID:14457 Brucella abortus brucellosis DOID:14457 A disease that is characterized by abnormally rapid cell division. neoplasm DOID:0000818 cell process disease neoplasm disease_ontology DOID:14566 disease of cellular proliferation DOID:14566 A primary bacterial infectious disease that is described as an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae, which is characterized by profuse watery diarrhea, vomiting, leg cramps, circulatory collapse and shock. GARD:6043 ICD10CM:A00 ICD9CM:001 MESH:D002771 SNOMEDCT_US_2023_03_01:186087007 UMLS_CUI:C0008354 Cholera - Vibrio cholerae Cholera due to Vibrio cholerae Vibrio cholerae disease_ontology DOID:1498 cholera MESH:D002771 DOID:1498 A disease of anatomical entity that is located_in reproductive system organs. DOID:6309 NCI:C27613 UMLS_CUI:C1335037 genital system disease disease_ontology DOID:15 reproductive system disease DOID:15 A head and neck cancer that has_material_basis_in epithelial cells and is located in the upper aerodigestive tract, including the lip, oral cavity (mouth), nasal cavity, paranasal sinuses, pharynx, and larynx. NCI:C6077 UMLS_CUI:C1334927 carcinoma of the neck disease_ontology carcinoma of neck DOID:1542 head and neck carcinoma DOID:1542 A disease of anatomical entity that located_in the respiratory system which extends from the nasal sinuses to the diaphragm. DOID:3226 ICD10CM:J98 ICD9CM:519 SNOMEDCT_US_2023_03_01:155603009 UMLS_CUI:C0029582 disease_ontology DOID:1579 respiratory system disease DOID:1579 A connective tissue disease that develops from an antecedent Group A Streptococcal pharyngeal infection and has_symptom carditis, has_symptom polyarthritis, has_symptom chorea, has_symptom erythema marginatum, has_symptom subcutaneous nodules, has_symptom arthralgia, has_symptom prolonged PR interval, and/or has_symptom fever. DOID:1006 DOID:1007 GARD:5699 ICD10CM:I00 ICD10CM:I00-I02 ICD9CM:390 ICD9CM:390-392.99 MESH:D012213 NCI:C34984 SNOMEDCT_US_2023_03_01:155265007 SNOMEDCT_US_2023_03_01:274095001 UMLS_CUI:C0035436 UMLS_CUI:C0264743 ACUTE RHEUMATIC FEVER RhF - Rheumatic fever disease_ontology DOID:1586 rheumatic fever MESH:D012213 DOID:1586 An organ system cancer that originates in the mammary gland. DOID:1648 DOID:4241 ICD10CM:C50 MESH:D001943 MIM:114480 NCI:C9335 SNOMEDCT_US_2023_03_01:254837009 UMLS_CUI:C0006142 breast tumor malignant neoplasm of breast malignant tumor of the breast mammary cancer mammary tumor primary breast cancer disease_ontology mammary neoplasm DOID:1612 Xref MGI. OMIM mapping confirmed by DO. [SN]. breast cancer DOID:1612 A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis. ICD10CM:C80.1 ICD9CM:199 ICDO:8000/3 MESH:D009369 NCI:C9305 SNOMEDCT_US_2023_03_01:269513004 UMLS_CUI:C0006826 malignant neoplasm malignant tumor primary cancer disease_ontology DOID:162 Updating out dated UMLS CUI. cancer DOID:162 A disease of anatomical entity that occurs in the muscular and/or skeletal system. MESH:D009140 NCI:C107377 SNOMEDCT_US_2023_03_01:268047003 UMLS_CUI:C0026857 disease_ontology DOID:17 musculoskeletal system disease DOID:17 An organ system cancer located_in endocrine system that is characterized by uncontrolled cellular proliferation of the hormone producing glands of the endocrine system. DOID:10009 ICD10CM:C75.9 ICD9CM:194.9 MESH:D004701 NCI:C3010 NCI:C3575 SNOMEDCT_US_2023_03_01:127015005 SNOMEDCT_US_2023_03_01:93780007 UMLS_CUI:C0014132 UMLS_CUI:C0153658 Endocrine tumor endocrine neoplasm malignant Endocrine tumor malignant neoplasm of endocrine gland malignant tumour of endocrine gland neoplasm of endocrine gland neoplasm of endocrine system disease_ontology DOID:170 endocrine gland cancer DOID:170 NCI:C7633 UMLS_CUI:C1377610 Mesothelioma of Peritoneum disease_ontology DOID:1789 benign peritoneal mesothelioma DOID:1789 An endocrine gland cancer located_in the pancreas. DOID:14356 DOID:1797 DOID:3588 DOID:9859 GARD:9364 ICD10CM:C25.0 ICD10CM:C25.1 ICD10CM:C25.2 ICD9CM:157.0 ICD9CM:157.1 ICD9CM:157.2 ICD9CM:157.8 KEGG:05212 MESH:D010190 NCI:C3305 ORDO:1333 ORDO:217074 SNOMEDCT_US_2023_03_01:126859007 SNOMEDCT_US_2023_03_01:187796007 SNOMEDCT_US_2023_03_01:93715005 SNOMEDCT_US_2023_03_01:93823001 SNOMEDCT_US_2023_03_01:94082003 UMLS_CUI:C0030297 UMLS_CUI:C0153458 UMLS_CUI:C0153459 UMLS_CUI:C0153460 UMLS_CUI:C0153463 Ca body of pancreas Ca head of pancreas Ca tail of pancreas malignant neoplasm of body of pancreas malignant neoplasm of head of pancreas malignant neoplasm of tail of pancreas pancreas neoplasm pancreatic neoplasm pancreatic tumor disease_ontology DOID:1793 Xref MGI. pancreatic cancer DOID:1793 A disease of anatomical entity that is located_in kidney, ureter, bladder and urethra. DOID:579 NCI:C27599 UMLS_CUI:C1335051 Non-neoplastic urinary tract disease urinary tract disease disease_ontology DOID:18 urinary system disease DOID:18 A connective tissue cancer that is located_in bone and is characterized by uncontrolled cellular proliferation that destroys normal bone tissue. DOID:3348 MESH:D001859 NCI:C9343 SNOMEDCT_US_2023_03_01:126537000 UMLS_CUI:C0005967 CA - bone cancer bone neoplasm bone tumour malignant bone neoplasm malignant bone tumour malignant neoplasm of bone malignant osseous tumor neoplasm of bone osseous tumor disease_ontology DOID:184 bone cancer DOID:184 A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from melanocytes which are found in skin, the bowel and the eye. EFO:0000756 ICDO:8720/3 KEGG:05218 MESH:D008545 NCI:C3224 SNOMEDCT_US_2023_03_01:2092003 UMLS_CUI:C0025202 Naevocarcinoma malignant melanoma disease_ontology DOID:1909 melanoma MESH:D008545 DOID:1909 An organ system cancer that is manifested in the reproductive organs. DOID:1900 NCI:C3674 UMLS_CUI:C0178830 Reproductive tumor malignant reproductive system neoplasm disease_ontology cancer of reproductive system DOID:193 reproductive organ cancer DOID:193 EFO:0003914 ICD10CM:I70 ICD9CM:440 MESH:D050197 NCI:C35768 SNOMEDCT_US_2023_03_01:155414001 UMLS_CUI:C0004153 disease_ontology DOID:1936 atherosclerosis MESH:D050197 DOID:1936 A female reproductive organ cancer that is located_in fallopian tube. DOID:1961 GARD:9162 ICD10CM:C57.0 ICD9CM:183.2 MESH:D005185 NCI:C3032 NCI:C7480 SNOMEDCT_US_2023_03_01:126916003 SNOMEDCT_US_2023_03_01:93794008 UMLS_CUI:C0015558 UMLS_CUI:C0153579 fallopian tube neoplasm malignant neoplasm of uterine tube malignant tumor of fallopian tube malignant tumour of fallopian tube neoplasm of fallopian tube tumor of the fallopian tube tumor, fallopian tube, malignant disease_ontology DOID:1964 fallopian tube cancer DOID:1964 A colorectal cancer that is located_in the rectum. DOID:1989 ICD10CM:C20 ICD9CM:154.1 MESH:D012004 NCI:C7418 NCI:C9382 SNOMEDCT_US_2023_03_01:254582000 SNOMEDCT_US_2023_03_01:93984006 UMLS_CUI:C0007113 UMLS_CUI:C0949022 carcinoma of rectum carcinoma of the rectum malignant Rectal tumor malignant neoplasm of rectum malignant rectum tumor malignant tumor of rectum rectal cancer disease_ontology cancer of rectum DOID:1993 rectum cancer DOID:1993 A musculoskeletal system cancer that is located_in connective tissue. MESH:D009372 SNOMEDCT_US_2023_03_01:126598008 UMLS_CUI:C0027656 Tumour of connective tissue connective tissue neoplasm mesenchymal tissue malignant neoplasm neoplasm of connective tissues disease_ontology DOID:201 connective tissue cancer DOID:201 A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus (Orthohepadnavirus hominoidei), which is transmitted_by sexual contact, blood transfusions, or fomites like needles or syringes. The infection has_symptom fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, clay-colored bowel movements, joint pain, and jaundice. DOID:12591 DOID:12592 DOID:2042 EFO:0004197 MESH:D006509 NCI:C3097 SNOMEDCT_US_2023_03_01:66071002 UMLS_CUI:C0019163 chronic hepatitis B hepatitis B infection disease_ontology Serum hepatitis DOID:2043 hepatitis B DOID:2043 A primary bacterial infectious disease that has_material_basis_in Francisella tularensis, which is transmitted by dog tick bite (Dermacentor variabilis), transmitted by deer flies (Chrysops sp) or transmitted by contact with infected animal tissues. GARD:396 ICD9CM:021.8 SNOMEDCT_US_2023_03_01:186298002 UMLS_CUI:C0029835 disease_ontology DOID:2123 tularemia DOID:2123 A colorectal cancer that is located_in the colon. ICD10CM:C18 ICD9CM:153 MESH:D003110 NCI:C9242 SNOMEDCT_US_2023_03_01:363406005 UMLS_CUI:C0007102 disease_ontology DOID:219 colon cancer DOID:219 A reproductive system disease that impairs the ability to reproduce and is located in the uterus, vagina, cervix, ovaries or fallopian tubes. ICD9CM:629.9 MESH:D005831 SNOMEDCT_US_2023_03_01:38233001 UMLS_CUI:C0017411 disease_ontology DOID:229 female reproductive system disease DOID:229 A female reproductive organ cancer that is located_in the ovary. DOID:0060070 DOID:2144 DOID:9595 GARD:7295 ICD10CM:C56 ICD9CM:183.0 MESH:D010051 MIM:167000 MIM:607893 NCI:C4984 NCI:C7431 ORDO:213500 ORDO:213517 SNOMEDCT_US_2023_03_01:123843001 SNOMEDCT_US_2023_03_01:372117006 SNOMEDCT_US_2023_03_01:93934004 UMLS_CUI:C0919267 UMLS_CUI:C1140680 UMLS_CUI:C1299247 malignant Ovarian tumor malignant tumour of ovary ovarian neoplasm ovary neoplasm primary ovarian cancer tumor of the Ovary disease_ontology DOID:2394 Xref MGI. OMIM mapping confirmed by DO. [SN]. ovarian cancer DOID:2394 An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes. DOID:1034 DOID:2532 MESH:D019337 NCI:C27134 SNOMEDCT_US_2023_03_01:414388001 UMLS_CUI:C0376544 Hematologic malignancy Hematologic neoplasm Hematological tumors blood cancer hematopoietic and lymphoid system tumor hematopoietic cancer hematopoietic neoplasm hematopoietic tumors malignant hematopoietic neoplasm disease_ontology DOID:2531 hematologic cancer DOID:2531 A urinary system cancer that is located_in the kidney. DOID:11834 DOID:3676 ICD10CM:C64 ICD9CM:189.0 MESH:D007680 NCI:C120456 NCI:C3150 NCI:C7548 SNOMEDCT_US_2023_03_01:126880001 SNOMEDCT_US_2023_03_01:93849006 UMLS_CUI:C0022665 UMLS_CUI:C0494158 UMLS_CUI:C0740457 malignant neoplasm of kidney except pelvis malignant tumour of kidney renal cancer disease_ontology DOID:263 kidney cancer DOID:263 A disease of anatomical entity that is located_in endocrine glands which secretes a type of hormone directly into the bloodstream to regulate the body. ICD10CM:E34.9 ICD9CM:259.9 MESH:D004700 NCI:C3009 SNOMEDCT_US_2023_03_01:67432001 UMLS_CUI:C0014130 disease_ontology DOID:28 endocrine system disease DOID:28 A disease of anatomical entity that is located_in the immune system. EFO:0000540 ICD10CM:D89.9 ICD9CM:279.9 SNOMEDCT_US_2023_03_01:154782004 UMLS_CUI:C0041806 disease_ontology DOID:2914 immune system disease DOID:2914 A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from epithelial cells, which originate in glandular tissue. ICDO:8140/3 MESH:D000230 NCI:C2852 SNOMEDCT_US_2023_03_01:35917007 UMLS_CUI:C0001418 disease_ontology DOID:299 adenocarcinoma MESH:D000230 DOID:299 A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells. DOID:2428 DOID:6570 ICDO:8010/3 MESH:D002277 MESH:D009375 NCI:C2916 NCI:C3709 SNOMEDCT_US_2023_03_01:188083002 SNOMEDCT_US_2023_03_01:269513004 SNOMEDCT_US_2023_03_01:71298006 UMLS_CUI:C0007097 UMLS_CUI:C0553707 UMLS_CUI:C1368683 epithelial cancer epithelioma malignant Epithelioma disease_ontology DOID:305 carcinoma DOID:305 A malignant astrocytoma characterized by the presence of small areas of necrotizing tissue that is surrounded by anaplastic cells as well as the presence of hyperplastic blood vessels, and that has_material_basis_in abnormally proliferating cells derives_from multiple cell types including astrocytes and oligondroctyes. DOID:3075 DOID:3080 GARD:2491 ICDO:9440/3 MESH:D005909 NCI:C129295 NCI:C39750 NCI:C9094 SNOMEDCT_US_2023_03_01:63634009 UMLS_CUI:C0017636 UMLS_CUI:C0278878 UMLS_CUI:C1514422 GBM adult glioblastoma multiforme glioblastoma multiforme grade IV adult Astrocytic tumor primary glioblastoma multiforme spongioblastoma multiforme disease_ontology DOID:3068 glioblastoma DOID:3068 A malignant glioma that is has_material_basis_in astrocyte cells, a type of star-shaped glial cell, located in the brain and spinal cord. DOID:4861 ICDO:9400/3 MESH:D001254 NCI:C4951 NCI:C60781 SNOMEDCT_US_2023_03_01:189914005 SNOMEDCT_US_2023_03_01:99131000119108 UMLS_CUI:C0004114 UMLS_CUI:C0750935 Astrocytic tumor astrocytoma of Cerebrum astrocytoma of brain astroglioma cerebral astrocytoma disease_ontology DOID:3069 malignant astrocytoma MESH:D001254 DOID:3069 An organ system cancer located_in the nervous system that affects the central or peripheral nervous system. DOID:1193 DOID:3195 DOID:4695 ICD9CM:192.9 MESH:D009380 NCI:C35562 SNOMEDCT_US_2023_03_01:188306000 UMLS_CUI:C0027665 UMLS_CUI:C0153643 UMLS_CUI:C1334956 malignant neoplasm of nervous system neoplasm of nervous system nervous system neoplasm neural neoplasm neural tumor tumor of the nervous system disease_ontology DOID:3093 nervous system cancer DOID:3093 A gastrointestinal system disease that is located_in the liver and/or biliary tract. MESH:D004066 NCI:C3959 UMLS_CUI:C0267792 liver and biliary tract disease disease_ontology DOID:3118 hepatobiliary disease DOID:3118 An organ system cancer located_in gastrointestinal tract that is manifested in organs of the gastrointestinal system. DOID:4945 DOID:8377 ICD10CM:C26.9 ICD9CM:239.0 MESH:D004067 MESH:D005770 NCI:C3052 NCI:C4890 SNOMEDCT_US_2023_03_01:128348002 SNOMEDCT_US_2023_03_01:276806006 SNOMEDCT_US_2023_03_01:428905002 UMLS_CUI:C0012243 UMLS_CUI:C0017185 UMLS_CUI:C0685938 GI tumor digestive system cancer gastrointestinal tract cancer disease_ontology DOID:3119 gastrointestinal system cancer DOID:3119 A viral infectious disease that results in infection of primates, rodents and humans, located in skin, has_material_basis_in Monkeypox virus (Orthopoxvirus monkeypox), which is transmitted by contact with the animal's blood, body fluids, rash, or with the body fluids of a sick person, transmitted by fomites, and transmitted by respiratory droplets. The infection has symptom fever, has symptom muscle ache, has symptom headache, and has symptom lymphadenopathy. GARD:10722 ICD10CM:B04 ICD9CM:059.01 MESH:D045908 NCI:C128421 SNOMEDCT_US_2023_03_01:240466002 UMLS_CUI:C0276180 monkeypox disease_ontology DOID:3292 November 2022 WHO name update. mpox DOID:3292 A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system. ICD10CM:G96.9 MESH:D002493 NCI:C2934 SNOMEDCT_US_2023_03_01:267144009 UMLS_CUI:C0007682 disease_ontology DOID:331 central nervous system disease DOID:331 A bone sarcoma that is located_in bone that has_material_basis_in cells of mesenchymal origin. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). DOID:183 GARD:7284 ICDO:9180/3 MESH:D012516 MESH:D018213 MIM:259500 NCI:C9145 ORDO:668 SNOMEDCT_US_2023_03_01:189878003 UMLS_CUI:C0029463 UMLS_CUI:C0206639 Osteogenic sarcoma Skeletal sarcoma bone tissue neoplasm osteoid sarcoma disease_ontology DOID:3347 OMIM mapping confirmed by DO. [SN]. osteosarcoma DOID:3347 A connective tissue cancer that has_material_basis_in neural crest cells derives_from undeveloped, undifferentiated neuroectoderm. DOID:0050607 DOID:4158 DOID:4390 DOID:4391 DOID:4392 DOID:4980 GARD:6390 ICDO:9364/3 MESH:C563168 MESH:D012512 MESH:D018241 MIM:612219 NCI:C27901 NCI:C27903 NCI:C4817 NCI:C7542 NCI:C7806 NCI:C9341 SNOMEDCT_US_2023_03_01:134210007 SNOMEDCT_US_2023_03_01:73676002 SNOMEDCT_US_2023_03_01:76909002 UMLS_CUI:C0553580 UMLS_CUI:C0684337 UMLS_CUI:C0796547 UMLS_CUI:C0863029 UMLS_CUI:C0877849 UMLS_CUI:C1334408 Ewing's family localized tumor Ewing's sarcoma/peripheral primitive neuroectodermal tumor Ewing's tumor Ewings sarcoma Ewings sarcoma-primitive neuroectodermal tumor PNET of Thoracopulmonary Region localized Ewing sarcoma localized Ewing's sarcoma localized Ewing's sarcoma/peripheral primitive neuroectodermal tumor localized Ewing's tumor localized peripheral primitive neuroectodermal tumor peripheral primitive neuroectodermal tumor disease_ontology DOID:3369 OMIM mapping confirmed by DO. [SN]. Ewing sarcoma DOID:3369 A female reproductive system disease that is located_in the uterus. ICD10CM:N85.9 ICD9CM:621.9 MESH:D014591 NCI:C26907 SNOMEDCT_US_2023_03_01:237068005 UMLS_CUI:C0042131 disease_ontology DOID:345 uterine disease DOID:345 A hepatobiliary system cancer that is located_in the liver. DOID:12300 DOID:269 DOID:7330 DOID:915 DOID:919 ICD10CM:C22.0 ICD10CM:C22.9 ICD9CM:155.0 ICD9CM:155.2 MESH:D008113 NCI:C34803 NCI:C7692 SNOMEDCT_US_2023_03_01:126851005 SNOMEDCT_US_2023_03_01:187771009 SNOMEDCT_US_2023_03_01:93870000 UMLS_CUI:C0023903 UMLS_CUI:C0024620 UMLS_CUI:C0345904 UMLS_CUI:C0854795 Ca liver - primary Resectable malignant neoplasm of Liver hepatic cancer hepatic neoplasm malignant hepato-biliary neoplasm malignant neoplasm of liver malignant neoplasm of liver, not specified as primary or secondary malignant neoplasm of liver, primary malignant tumor of liver neoplasm of liver non-resectable primary hepatic malignant neoplasm primary liver cancer primary malignant neoplasm of liver resectable malignant neoplasm of the liver disease_ontology DOID:3571 liver cancer DOID:3571 A nervous system cancer that is located_in the central nervous system. DOID:0060093 DOID:1318 EFO:0000326 ICD10CM:C72.9 MESH:D016543 NCI:C4627 NCI:C9293 SNOMEDCT_US_2023_03_01:126951006 SNOMEDCT_US_2023_03_01:93744007 UMLS_CUI:C0085136 UMLS_CUI:C0348374 CNS neoplasm central nervous system tumor central nervous system tumors malignant neoplasm of central nervous system malignant tumor of CNS neoplasm of central nervous system disease_ontology DOID:3620 central nervous system cancer DOID:3620 A female reproductive organ cancer that is located_in the uterus. DOID:4363 ICD10CM:C55 ICD9CM:179 MESH:D014594 NCI:C3435 NCI:C3552 SNOMEDCT_US_2023_03_01:126908007 SNOMEDCT_US_2023_03_01:371973000 UMLS_CUI:C0042138 UMLS_CUI:C0153567 CA - cancer of uterus Tumour of uterus malignant neoplasm of uterus malignant uterine tumor neoplasm of uterus uterine tumor uterus neoplasm disease_ontology DOID:363 uterine cancer DOID:363 A stomach carcinoma that derives_from epithelial cells of glandular origin. NCI:C4004 SNOMEDCT_US_2023_03_01:408647009 UMLS_CUI:C0278701 adenocarcinoma of stomach stomach adenocarcinoma disease_ontology DOID:3717 gastric adenocarcinoma DOID:3717 A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum. DOID:10284 ICD10CM:C63.9 ICD9CM:187.9 MESH:D005834 NCI:C3054 NCI:C8561 SNOMEDCT_US_2023_03_01:126895004 SNOMEDCT_US_2023_03_01:363515000 UMLS_CUI:C0017417 UMLS_CUI:C0153606 male genital cancer male reproductive system neoplasm malignant neoplasm of male genital organ malignant neoplasm of male genital organ or tract malignant neoplasm of male genital organs malignant tumor of male Reproductive system malignant tumor of male genital organ neoplasm of male genital organ tumor of male Reproductive system disease_ontology male genital neoplasm DOID:3856 male reproductive organ cancer DOID:3856 A lung cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells and is located_in the lungs and has_symptom cough and has_symptom chest discomfort or pain and has_symptom weight loss and has_symptom hemoptysis. EFO:0001071 NCI:C4878 SNOMEDCT_US_2023_03_01:154485001 UMLS_CUI:C0684249 cancer of lung disease_ontology carcinoma of lung DOID:3905 OMIM mapping confirmed by DO. [SN]. lung carcinoma DOID:3905 A lung carcinoma that is characterized as any type of epithelial lung cancer other than small cell lung carcinoma. EFO:0003060 KEGG:05223 MESH:D002289 NCI:C2926 SNOMEDCT_US_2023_03_01:254637007 UMLS_CUI:C0007131 NSCLC Non-small cell lung cancer non-small cell lung carcinoma disease_ontology DOID:3908 lung non-small cell carcinoma DOID:3908 A primary bacterial infectious disease that is located_in lungs, located_in lymph nodes, located_in pericardium, located_in brain, located_in pleura or located_in gastrointestinal tract, has_material_basis_in Mycobacterium tuberculosis, which is transmitted_by droplets released into the air when an infected person coughs or sneezes. DOID:10096 DOID:12688 DOID:12691 DOID:415 DOID:9901 DOID:9902 GARD:7827 MESH:D014375 SNOMEDCT_US_2023_03_01:15202009 UMLS_CUI:C0041295 disease_ontology DOID:399 tuberculosis MESH:D014376 DOID:399 An organ system cancer that is located_in the kidneys, ureteres, bladder or urethra. ICD10CM:C68.9 ICD9CM:189.9 SNOMEDCT_US_2023_03_01:448233000 UMLS_CUI:C0348371 disease_ontology DOID:3996 urinary system cancer DOID:3996 A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism. MESH:D004194 NCI:C2991 SNOMEDCT_US_2023_03_01:64572001 UMLS_CUI:C0012634 disease_ontology DOID:4 disease DOID:4 An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues. autoimmune disease ICD9CM:720 MIM:109100 UMLS_CUI:C0003089 autoimmune hypersensitivity disease hypersensitivity reaction type II disease disease_ontology DOID:417 Xref MGI. autoimmune disease DOID:417 A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Bundibugyo virus (Orthoebolavirus bundibugyoense), Sudan ebolavirus (Orthoebolavirus sudanense), Tai Forest ebolavirus (Orthoebolavirus taiense), or Zaire ebolavirus (Orthoebolavirus zairense), which are transmitted_by contact with the body fluids of an infected animal or person, transmitted by contaminated fomites, or transmitted by infected medical equipment. The infection has_symptom fever, has_symptom headache, has_symptom joint pain, has_symptom muscle aches, has_symptom sore throat, has_symptom weakness, has_symptom diarrhea, has_symptom vomiting, has_symptom stomach pain, has_symptom rash, has_symptom red eyes, has_symptom hiccups, and has_symptom internal and external bleeding. GARD:2035 ICD10CM:A98.4 MESH:D019142 NCI:C36171 SNOMEDCT_US_2023_03_01:123323003 UMLS_CUI:C0282687 Ebola Ebola disease Ebola hemorrhagic fever disease_ontology DOID:4325 Ebola virus disease DOID:4325 A female reproductive organ cancer that is located_in the cervix. DOID:4361 ICD10CM:C53 ICD9CM:180 MESH:D002583 MIM:603956 NCI:C2940 NCI:C9311 SNOMEDCT_US_2023_03_01:123841004 SNOMEDCT_US_2023_03_01:254885005 UMLS_CUI:C0007847 UMLS_CUI:C0007873 cervical neoplasm cervix cancer cervix uteri cancer neoplasm of uterine cervix tumor of the Cervix Uteri uterine cervical neoplasm disease_ontology DOID:4362 cervical cancer DOID:4362 A biliary tract cancer that is located_in the bile duct. DOID:10019 ICD10CM:C24.0 ICD9CM:156.1 MESH:D001650 NCI:C2898 NCI:C7483 SNOMEDCT_US_2023_03_01:93790004 UMLS_CUI:C0005396 UMLS_CUI:C0153453 Ca extrahepatic bile ducts bile duct tumor malignant neoplasm of the extrahepatic bile duct disease_ontology DOID:4606 bile duct cancer DOID:4606 A reproductive system disease that affects male reproductive organs. ICD10CM:N50.9 ICD9CM:608.9 MESH:D005832 SNOMEDCT_US_2023_03_01:64557000 UMLS_CUI:C0017412 disease_ontology DOID:48 male reproductive system disease DOID:48 A bile duct carcinoma that derives_from epithelial cells of glandular origin. NCI:C27813 SNOMEDCT_US_2023_03_01:70179006 UMLS_CUI:C1370800 disease_ontology DOID:4896 bile duct adenocarcinoma DOID:4896 A bile duct cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells. MESH:D001650 NCI:C27814 SNOMEDCT_US_2023_03_01:70179006 UMLS_CUI:C0740277 disease_ontology DOID:4897 bile duct carcinoma DOID:4897 A bile duct adenocarcinoma that has_material_basis_in bile duct epithelial cells. DOID:5249 ICD10CM:C22.1 ICDO:8160/3 MESH:D018281 NCI:C4436 NCI:C8265 SNOMEDCT_US_2023_03_01:70179006 UMLS_CUI:C0206698 UMLS_CUI:C0280725 adult primary Cholangiocarcinoma adult primary cholangiocellular carcinoma cholangiosarcoma disease_ontology DOID:4947 cholangiocarcinoma DOID:4947 A viral infectious disease that results in destruction located in motor neurons, has_material_basis_in Human poliovirus 1, has_material_basis_in Human poliovirus 2, or has_material_basis_in Human poliovirus 3, which are transmitted by ingestion of food or water contaminated with feces, or transmitted by direct contact with the oral secretions. The infection has symptom fever, has symptom sore throat, has symptom headache, has symptom vomiting, has symptom fatigue, has symptom neck stiffness, has symptom muscle spasms, and has symptom acute flaccid paralysis. GARD:7413 ICD10CM:A80 ICD9CM:045 MESH:D011051 NCI:C35550 SNOMEDCT_US_2023_03_01:54839009 UMLS_CUI:C0032371 disease_ontology DOID:4953 poliomyelitis DOID:4953 A hematopoietic cancer that derives_from the blood-forming stem cells of the bone marrow. DOID:2356 DOID:2761 EFO:0004251 ICD10CM:D47.1 MESH:D009196 SNOMEDCT_US_2023_03_01:128925001 UMLS_CUI:C0027022 bone Marrow tumor bone marrow neoplasm malignant bone Marrow tumor malignant neoplasm of bone marrow disease_ontology DOID:4960 bone marrow cancer DOID:4960 A gastrointestinal system cancer that is located_in the esophagus. DOID:10291 DOID:10292 DOID:10448 DOID:1102 DOID:1104 GARD:6383 ICD10CM:C15.3 ICD10CM:C15.4 ICD10CM:C15.5 ICD9CM:150.2 ICD9CM:150.3 ICD9CM:150.4 ICD9CM:150.5 ICD9CM:150.8 MESH:D004938 MIM:133239 NCI:C3028 NCI:C3533 NCI:C3534 NCI:C3535 NCI:C4764 SNOMEDCT_US_2023_03_01:126817006 SNOMEDCT_US_2023_03_01:187729008 SNOMEDCT_US_2023_03_01:93656003 SNOMEDCT_US_2023_03_01:93877002 SNOMEDCT_US_2023_03_01:93895004 SNOMEDCT_US_2023_03_01:94119000 UMLS_CUI:C0014859 UMLS_CUI:C0153413 UMLS_CUI:C0153414 UMLS_CUI:C0153415 UMLS_CUI:C0153416 UMLS_CUI:C0496775 Ca lower third oesophagus Ca middle third oesophagus esophagus cancer malignant neoplasm of distal third of esophagus malignant neoplasm of lower third of oesophagus malignant neoplasm of middle third of oesophagus malignant neoplasm of proximal third of esophagus malignant neoplasm of upper third esophagus malignant tumor of Distal Third of esophagus malignant tumor of Proximal Third of esophagus malignant tumor of abdominal esophagus malignant tumor of the middle Third of the esophagus disease_ontology DOID:5041 esophageal cancer DOID:5041 A viral infectious disease that results in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted by sexual contact, transmitted by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted by congenital method, and transmitted by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has symptom diarrhea, has symptom fatigue, has symptom fever, has symptom vaginal yeast infection, has symptom headache, has symptom mouth sores, has symptom muscle aches, has symptom sore throat, and has symptom swollen lymph glands. ICD10CM:B20 ICD9CM:042-042.99 MESH:D015658 NCI:C3108 SNOMEDCT_US_2023_03_01:86406008 UMLS_CUI:C0019693 HIV infection disease_ontology DOID:526 human immunodeficiency virus infectious disease DOID:526 A gastrointestinal system disease that is located_in the intestine. DOID:10759 DOID:11222 DOID:11789 DOID:8531 DOID:8558 DOID:8591 ICD10CM:K63.9 ICD9CM:569.9 MESH:D007410 NCI:C26801 SNOMEDCT_US_2023_03_01:266483008 UMLS_CUI:C0021831 disease_ontology DOID:5295 intestinal disease DOID:5295 A lung carcinoma that has_material_basis_in primitive-appearing cells that are smaller than normal cells and is located_in the lung. DOID:0050875 KEGG:05222 MESH:D055752 MIM:182280 NCI:C4917 SNOMEDCT_US_2023_03_01:254632001 UMLS_CUI:C0149925 disease_ontology DOID:5409 OMIM mapping confirmed by DO. [SN]. lung small cell carcinoma DOID:5409 A stomach cancer that is located_in the stomach. EFO:0000178 NCI:C4911 SNOMEDCT_US_2023_03_01:154446008 UMLS_CUI:C0699791 cancer of the stomach carcinoma of stomach gastric carcinoma disease_ontology DOID:5517 stomach carcinoma DOID:5517 A head and neck carcinoma that has_material_basis_in squamous cells that line the moist, mucosal surfaces inside the head and neck. GARD:8503 MESH:D000077195 MIM:275355 NCI:C34447 SNOMEDCT_US_2023_03_01:716659002 UMLS_CUI:C1168401 carcinoma of the head and neck squamous cell carcinoma of the head and neck squamous cell carcinomas of head and neck disease_ontology DOID:5520 OMIM mapping confirmed by DO. [SN]. head and neck squamous cell carcinoma DOID:5520 A nervous system disease that affects the peripheral nervous system. DOID:13069 NCI:C119734 NCI:C27587 UMLS_CUI:C0031117 UMLS_CUI:C1335029 disease_ontology peripheral nerve disease peripheral neuropathy DOID:574 peripheral nervous system disease DOID:574 A Human immunodeficiency virus infectious disease that results_in reduction in the numbers of CD4-bearing helper T cells below 200 per microliter of blood or 14% of all lymphocytes thereby rendering the subject highly vulnerable to life-threatening infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. Opportunistic infections are common in people with AIDS. EFO:0000765 ICD10CM:B20 MESH:D000163 NCI:C2851 SNOMEDCT_US_2023_03_01:62479008 UMLS_CUI:C0001175 AIDS acquired Immune deficiency disease_ontology acquired immune deficiency syndrome DOID:635 acquired immunodeficiency syndrome MESH:D000163 DOID:635 A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage. MESH:D003240 NCI:C26729 SNOMEDCT_US_2023_03_01:201432001 UMLS_CUI:C0009782 connective tissue disorder disorder of connective tissue disease_ontology DOID:65 connective tissue disease DOID:65 A mature B-cell neoplasm that is composed of plasma cells. EFO:0000200 MESH:D010265 SNOMEDCT_US_2023_03_01:71390001 UMLS_CUI:C1136084 Plasma cell dyscrasia Plasma cell tumour Plasmacytic tumor disease_ontology DOID:6536 plasma cell neoplasm DOID:6536 A liver carcinoma that has_material_basis_in undifferentiated hepatocytes and located_in the liver. DOID:5005 EFO:0000182 ICD10CM:C22.0 ICDO:8170/3 MESH:D006528 MIM:114550 NCI:C3099 ORDO:88673 SNOMEDCT_US_2023_03_01:154469006 UMLS_CUI:C2239176 Hepatoma disease_ontology DOID:684 OMIM mapping confirmed by DO. [SN]. hepatocellular carcinoma DOID:684 A liver cancer that has_material_basis_in epithelial cells. NCI:C7927 UMLS_CUI:C0279000 Liver and Intrahepatic bile duct carcinoma disease_ontology DOID:686 liver carcinoma DOID:686 A disease that manifests in a defined anatomical structure. DOID:1 DOID:2 DOID:5 DOID:71 DOID:72 DOID:8 disease_ontology DOID:7 disease of anatomical entity DOID:7 A non-Hodgkin lymphoma that has_material_basis_in B cells. GARD:5877 MESH:D016393 NCI:C3457 SNOMEDCT_US_2023_03_01:109979007 UMLS_CUI:C0079731 B-cell lymphocytic neoplasm disease_ontology DOID:707 B-cell lymphoma DOID:707 A disease of anatomical entity that has_material_basis_in hematopoietic cells. ICD10CM:D75.9 ICD9CM:289.9 MESH:D006402 NCI:C26323 SNOMEDCT_US_2023_03_01:154785002 UMLS_CUI:C0018939 Blood disease Blood dyscrasia DISEASE OF THE BLOOD AND BLOOD-FORMING ORGANS Hematological disease blood disorder disease of haematopoietic system disease of hematopoietic system haematopoietic system disease disease_ontology DOID:74 hematopoietic system disease DOID:74 A primary bacterial infectious disease that results_in infection located_in skin, located_in lung lymph nodes or located_in gastrointestinal tract, has_material_basis_in Bacillus anthracis, transmitted_by contact with infected animals or animal products, transmitted_by airborne spores or transmitted_by ingestion of undercooked meat from infected animals and has_symptom skin ulcer, has_symptom nausea, has_symptom poor appetite, has_symptom bloody diarrhea, has_symptom fever or has_symptom shortness of breath. GARD:8157 ICD10CM:A22 ICD9CM:022 MESH:D000881 NCI:C84565 SNOMEDCT_US_2023_03_01:154295005 UMLS_CUI:C0003175 disease_ontology DOID:7427 anthrax disease DOID:7427 An autonomic nervous system neoplasm that derives_from immature nerve cells. EFO:0000621 GARD:7185 ICDO:9500/3 MESH:D009447 NCI:C3270 ORDO:635 SNOMEDCT_US_2023_03_01:432328008 UMLS_CUI:C0027819 disease_ontology DOID:769 Xref MGI. OMIM mapping confirmed by DO. [SN]. neuroblastoma DOID:769 A disease of anatomical entity that is located_in the gastrointestinal tract. DOID:27 DOID:944 ICD10CM:K92.9 ICD9CM:520-579.99 MESH:D004066 SNOMEDCT_US_2023_03_01:53619000 UMLS_CUI:C0012242 GIT disease Gastroenteropathy alimentary system disease digestive system disorder gastrointestinal disease gastrointestinal disorder disease_ontology DOID:77 gastrointestinal system disease DOID:77 A viral infectious disease that results in infection, located in respiratory tract, has_material_basis_in Influenzavirus A (Alphainfluenzavirus), has_material_basis_in Influenzavirus B (Betainfluenzavirus), or has_material_basis_in Influenzavirus C (Gammainfluenzavirus), which are transmitted_by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has_symptom chills, has_symptom fever, has_symptom sore throat, has_symptom runny nose, has_symptom muscle pains, has_symptom severe headache, has_symptom cough, and has_symptom weakness. DOID:8468 ICD10CM:J11.1 ICD9CM:487 MESH:D007251 NCI:C53482 SNOMEDCT_US_2023_03_01:155559006 UMLS_CUI:C0021400 Influenza with other manifestations flu influenza with non-respiratory manifestation disease_ontology DOID:8469 influenza DOID:8469 A bone inflammation disease that involves a response to irritation or injury, characterized by joint pain, swelling, stiffness located_in joint. ICD10CM:M19.90 MESH:D001168 NCI:C2883 SNOMEDCT_US_2023_03_01:372091005 UMLS_CUI:C0003864 Inflammatory disorder of joint disease_ontology DOID:848 arthritis MESH:D001168 DOID:848 A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide. DOID:11894 DOID:11895 DOID:29 DOID:766 ICD10CM:J98.4 MESH:D008171 NCI:C3198 SNOMEDCT_US_2023_03_01:266374002 UMLS_CUI:C0024115 disease_ontology DOID:850 Updating out dated CUI and removing lung abscess as a synonym. lung disease DOID:850 A viral infectious disease that results_in infection located_in nerve fiber, has_material_basis_in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted_by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has_symptom rash which is followed by blisters, has_symptom headache, has_symptom fever, has_symptom malaise, has_symptom itching, has_symptom burning pain, and has_symptom paresthesia. DOID:8554 DOID:8555 DOID:8772 DOID:8801 DOID:9085 ICD10CM:B02 ICD9CM:053 MESH:D006562 NCI:C71079 SNOMEDCT_US_2023_03_01:186514003 UMLS_CUI:C0019360 Shingles herpes zona disease_ontology DOID:8536 herpes zoster DOID:8536 A pharynx cancer that is located_in the oropharynx. DOID:8684 DOID:8851 DOID:8949 DOID:9168 ICD10CM:C10 ICD10CM:C10.2 ICD10CM:C10.3 ICD10CM:C10.8 ICD9CM:146 ICD9CM:146.5 ICD9CM:146.6 ICD9CM:146.7 NCI:C7398 SNOMEDCT_US_2023_03_01:187686007 SNOMEDCT_US_2023_03_01:93933005 SNOMEDCT_US_2023_03_01:93971002 UMLS_CUI:C0153382 UMLS_CUI:C0153388 UMLS_CUI:C0153389 UMLS_CUI:C0153390 Oropharyngeal carcinoma malignant Oropharyngeal tumor malignant tumor of oropharynx malignant tumour of mesopharynx oropharyngeal cancer disease_ontology DOID:8557 oropharynx cancer DOID:8557 A viral infectious disease that results_in infection located_in skin, has_material_basis_in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has_symptom fever, has_symptom cough, has_symptom coryza, has_symptom conjunctivitis, and has_symptom maculopapular, erythematous rash. DOID:8621 DOID:8963 DOID:9112 GARD:3434 ICD10CM:B05 ICD9CM:055 MESH:D008457 NCI:C96406 SNOMEDCT_US_2023_03_01:154338006 UMLS_CUI:C0025007 morbilli disease_ontology DOID:8622 measles DOID:8622 A disease of anatomical entity that is located_in the central nervous system or located_in the peripheral nervous system. ICD10CM:G98 ICD9CM:349.9 MESH:D009422 NCI:C26835 SNOMEDCT_US_2023_03_01:155262005 UMLS_CUI:C0027765 disease_ontology DOID:863 nervous system disease DOID:863 A viral infectious disease that results_in infection located_in skin, has_material_basis_in Human herpesvirus 3, which is transmitted_by direct contact with secretions from the rash, or transmitted_by droplet spread of respiratory secretions. The infection has_symptom anorexia, has_symptom myalgia, has_symptom nausea, has_symptom fever, has_symptom headache, has_symptom sore throat, and has_symptom blisters. DOID:8658 DOID:8693 DOID:9243 ICD10CM:B01.9 ICD9CM:052 MESH:D002644 NCI:C97132 SNOMEDCT_US_2023_03_01:186508005 UMLS_CUI:C0008049 varicella disease_ontology DOID:8659 chickenpox MESH:D002644 DOID:8659 A viral infectious disease that results in infection located in skin, has_material_basis_in Variola virus (Orthopoxvirus variola), which is transmitted by droplets from oral, nasal or pharyngeal mucosa, transmitted by contact with the body fluids, or transmitted by fomites. The infection results in formation of lesions, first on the face, hands and forearms and later on the trunk. GARD:7444 ICD10CM:B03 ICD9CM:050 MESH:D012899 NCI:C35027 SNOMEDCT_US_2023_03_01:266193008 UMLS_CUI:C0037354 Ordinary smallpox disease_ontology DOID:8736 smallpox DOID:8736 A pneumonia involving inflammation of the lungs caused by bacteria. DOID:13815 ICD10CM:J15.9 ICD9CM:482.9 MESH:D018410 NCI:C26704 SNOMEDCT_US_2023_03_01:53084003 UMLS_CUI:C0004626 Pneumonia due to other gram-negative bacteria gram-negative pneumonia disease_ontology DOID:874 bacterial pneumonia DOID:874 A viral infectious disease that results_in infection located_in skin, has_material_basis_in Rubella virus (Rubivirus rubellae), which is transmitted_by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted_by congenital method. The infection has_symptom rash on the face which spreads to the trunk and limbs, has_symptom fever, has_symptom lymphadenopathy, has_symptom joint pains, has_symptom headache, and has_symptom conjunctivitis. DOID:11765 DOID:1463 DOID:1464 DOID:8780 DOID:8816 DOID:8909 DOID:9106 DOID:9116 DOID:9162 DOID:9179 GARD:4742 ICD10CM:B06.9 ICD9CM:056 MESH:D012409 NCI:C85051 SNOMEDCT_US_2023_03_01:266192003 UMLS_CUI:C0035920 german measles disease_ontology DOID:8781 rubella DOID:8781 A viral infectious disease that results_in inflammation located_in facial nerve, which leads to paralysis of one side of the face, has_material_basis_in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The infection has_symptom vesicular rash of the ear or mouth, has_symptom tinnitus, has_symptom vertigo, has_symptom otalgia, and has_symptom headache. GARD:7525 ICD10CM:B02.21 ICD9CM:053.11 MESH:D016697 NCI:C84763 SNOMEDCT_US_2023_03_01:21954000 UMLS_CUI:C0017409 Geniculate herpes zoster Herpes zoster auricularis Herpetic geniculate ganglionitis Ramsay Hunt syndrome type 2 Ramsay Hunt syndrome type II Ramsey Hunt syndrome geniculate neuralgia nervus intermedius neuralgia disease_ontology DOID:9210 herpes zoster oticus DOID:9210 A large intestine cancer that is located_in the colon and/or located_in the rectum. ICD10CM:C18.9 KEGG:05210 MESH:D015179 MIM:114500 NCI:C2956 NCI:C4978 SNOMEDCT_US_2023_03_01:126837005 SNOMEDCT_US_2023_03_01:93854002 UMLS_CUI:C0009404 UMLS_CUI:C0346629 disease_ontology DOID:9256 Xref MGI. OMIM mapping confirmed by DO. [SN]. colorectal cancer DOID:9256 A pharynx cancer that is located in the nasopharynx, the uppermost region of the pharynx or throat, where the nasal passages and auditory tubes join the remainder of the upper respiratory tract. DOID:8813 DOID:8814 DOID:9057 DOID:9144 DOID:9197 DOID:9229 GARD:7163 ICD10CM:C11 ICD10CM:C11.0 ICD10CM:C11.1 ICD10CM:C11.2 ICD10CM:C11.3 ICD9CM:147 ICD9CM:147.0 ICD9CM:147.1 ICD9CM:147.2 ICD9CM:147.3 MESH:D009303 MIM:161550 MIM:607107 NCI:C9321 ORDO:150 SNOMEDCT_US_2023_03_01:187692001 SNOMEDCT_US_2023_03_01:187693006 SNOMEDCT_US_2023_03_01:187700006 SNOMEDCT_US_2023_03_01:363398003 SNOMEDCT_US_2023_03_01:93919005 SNOMEDCT_US_2023_03_01:94078000 UMLS_CUI:C0153392 UMLS_CUI:C0153393 UMLS_CUI:C0153394 UMLS_CUI:C0153395 UMLS_CUI:C0153396 UMLS_CUI:C0238301 Nasopharyngeal carcinoma malignant Nasopharyngeal tumor malignant neoplasm of nasopharynx nasopharynx cancer disease_ontology carcinoma of nasopharynx DOID:9261 Xref MGI. OMIM mapping confirmed by DO. [SN]. nasopharynx carcinoma DOID:9261 A disease by infectious agent that results in infection, has_material_basis_in Viruses. DOID:1329 ICD10CM:A94 ICD10CM:B34.9 ICD9CM:060-066.99 MESH:D001102 MESH:D014777 NCI:C3439 NCI:C34396 SNOMEDCT_US_2023_03_01:34014006 SNOMEDCT_US_2023_03_01:40610006 UMLS_CUI:C0003723 UMLS_CUI:C0042769 Viral Infection Viral disease virus infection disease_ontology DOID:934 viral infectious disease DOID:934 A glucose metabolism disease that is characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. DOID:0081062 ICD10CM:E08-E13 ICD9CM:250 MESH:D003920 NCI:C2985 SNOMEDCT_US_2023_03_01:267467004 UMLS_CUI:C0011849 diabetes disease_ontology DOID:9351 diabetes mellitus DOID:9351 A meningitis that has_material_basis_in a bacterial infection. GARD:5881 ICD10CM:G00 ICD9CM:320 MESH:D016920 NCI:C118297 SNOMEDCT_US_2023_03_01:267680008 UMLS_CUI:C0085437 disease_ontology DOID:9470 bacterial meningitis DOID:9470 A myeloid neoplasm that is located_in the plasma cells in bone marrow. EFO:0001378 GARD:7108 ICD10CM:C90.0 ICD9CM:203.0 MESH:D009101 MIM:254500 NCI:C3242 ORDO:29073 SNOMEDCT_US_2023_03_01:94705007 UMLS_CUI:C0026764 myeloma disease_ontology DOID:9538 OMIM mapping confirmed by DO. [SN]. multiple myeloma DOID:9538 A viral infectious disease that results in infection, has_material_basis_in Yellow fever virus (Orthoflavivirus flavi), which is transmitted by Aedes, transmitted by Haemagogus, or transmitted by Sabethes species of mosquitoes. The infection has symptom fever, has symptom muscle pain, has symptom backache, has symptom headache, has symptom shivers, has symptom loss of appetite, has symptom jaundice, and has symptom bleeding from the mouth, nose, eyes or stomach leading to vomitus containing blood. DOID:9683 DOID:9684 GARD:7914 ICD10CM:A95 ICD9CM:060 MESH:D015004 NCI:C35547 SNOMEDCT_US_2023_03_01:154345006 UMLS_CUI:C0043395 Sylvatic yellow fever Yellow fever, sylvan jungle yellow fever urban yellow fever disease_ontology DOID:9682 yellow fever DOID:9682 fma FMA:12278 Hormone FMA:12278 An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). Wikipedia:Adaptive_immune_system acquired immune response immune memory response biological_process GO:0002250 adaptive immune response GO:0002250 An immune response taking place in mucosal tissues, including those of the intestinal tract, nasal and upper respiratory tract, and genital tract. GO:0002386 GO:0002422 immune response in MALT immune response in mucosal-associated lymphoid tissue immune response in urogenital tract biological_process GO:0002385 mucosal immune response GO:0002385 Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. biological_process GO:0006955 immune response GO:0006955 A biological process is the execution of a genetically-encoded biological module or program. It consists of all the steps required to achieve the specific biological objective of the module. A biological process is accomplished by a particular set of molecular functions carried out by specific gene products (or macromolecular complexes), often in a highly regulated manner and in a particular temporal sequence. https://github.com/geneontology/go-ontology/issues/24968 jl 2012-09-19T15:05:24Z GO:0000004 GO:0007582 GO:0044699 Wikipedia:Biological_process biological process physiological process biological_process single organism process single-organism process GO:0008150 Note that, in addition to forming the root of the biological process ontology, this term is recommended for the annotation of gene products whose biological process is unknown. When this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this. biological_process GO:0008150 A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. antibody cellular_component GO:0019814 Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available. immunoglobulin complex GO:0019814 A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. GO:0043234 macromolecular complex macromolecule complex protein containing complex protein complex protein-protein complex cellular_component GO:0032991 A protein complex in this context is meant as a stable set of interacting proteins which can be co-purified by an acceptable method, and where the complex has been shown to exist as an isolated, functional unit in vivo. Acceptable experimental methods include stringent protein purification followed by detection of protein interaction. The following methods should be considered non-acceptable: simple immunoprecipitation, pull-down experiments from cell extracts without further purification, colocalization and 2-hybrid screening. Interactions that should not be captured as protein complexes include: 1) enzyme/substrate, receptor/ligand or any similar transient interactions, unless these are a critical part of the complex assembly or are required e.g. for the receptor to be functional; 2) proteins associated in a pull-down/co-immunoprecipitation assay with no functional link or any evidence that this is a defined biological entity rather than a loose-affinity complex; 3) any complex where the only evidence is based on genetic interaction data; 4) partial complexes, where some subunits (e.g. transmembrane ones) cannot be expressed as recombinant proteins and are excluded from experiments (in this case, independent evidence is necessary to find out the composition of the full complex, if known). Interactions that may be captured as protein complexes include: 1) enzyme/substrate or receptor/ligand if the complex can only assemble and become functional in the presence of both classes of subunits; 2) complexes where one of the members has not been shown to be physically linked to the other(s), but is a homologue of, and has the same functionality as, a protein that has been experimentally demonstrated to form a complex with the other member(s); 3) complexes whose existence is accepted based on localization and pharmacological studies, but for which experimental evidence is not yet available for the complex as a whole. protein-containing complex GO:0032991 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism. GO:0051869 physiological response to stimulus biological_process GO:0050896 Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC. response to stimulus GO:0050896 A protein complex composed of two identical immunoglobulin heavy chains of an IgG isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgG immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. mah 2010-03-24T01:44:53Z IgG1 IgG2 IgG2a IgG2b IgG2c IgG3 IgG4 cellular_component GO:0071735 Note that an IgG immunoglobulin complex has the function of antigen binding if a suitable antigen is available. Also, IgG isotypes vary by species. IgG immunoglobulin complex GO:0071735 A protein complex composed of two identical immunoglobulin heavy chains of the IgD isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgD immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. mah 2010-03-24T01:44:53Z cellular_component GO:0071738 Note that an IgD immunoglobulin complex has the function of antigen binding if a suitable antigen is available. IgD immunoglobulin complex GO:0071738 A protein complex composed of two identical immunoglobulin heavy chains of the IgE isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgE immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. mah 2010-03-24T01:44:53Z cellular_component GO:0071742 Note that an IgE immunoglobulin complex has the function of antigen binding if a suitable antigen is available. IgE immunoglobulin complex GO:0071742 A protein complex composed of two identical immunoglobulin heavy chains of the IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and sometimes complexed with J chain or J chain and secretory component. An IgA immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. mah 2010-03-24T01:44:53Z IgA1 antibody IgA2 antibody cellular_component GO:0071745 Note that an IgA immunoglobulin complex has the function of antigen binding if a suitable antigen is available. IgA immunoglobulin complex GO:0071745 A protein complex composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and in its circulating form complexed with J chain in polymeric forms. An IgM immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. mah 2010-03-24T01:44:53Z cellular_component GO:0071753 Note that an IgM immunoglobulin complex has the function of antigen binding if a suitable antigen is available. IgM immunoglobulin complex GO:0071753 IAO:0000001 conditional specification A directive information entity that specifies what should happen if the trigger condition is fulfilled. PlanAndPlannedProcess Branch OBI branch derived OBI_0000349 conditional specification IAO:0000003 measurement unit label Examples of measurement unit labels are liters, inches, weight per volume. A measurement unit label is as a label that is part of a scalar measurement datum and denotes a unit of measure. 2009-03-16: provenance: a term measurement unit was proposed for OBI (OBI_0000176) , edited by Chris Stoeckert and Cristian Cocos, and subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definition of this, different, term. 2009-03-16: review of this term done during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI. PERSON: Alan Ruttenberg PERSON: Melanie Courtot measurement unit label IAO:0000005 objective specification In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction. A directive information entity that describes an intended process endpoint. When part of a plan specification the concretization is realized in a planned process in which the bearer tries to effect the world so that the process endpoint is achieved. 2009-03-16: original definition when imported from OBI read: "objective is an non realizable information entity which can serve as that proper part of a plan towards which the realization of the plan is directed." 2014-03-31: In the example of usage ("In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction") there is a protocol which is the ChIP assay protocol. In addition to being concretized on paper, the protocol can be concretized as a realizable entity, such as a plan that inheres in a person. The objective specification is the part that says that some protein and DNA interactions are identified. This is a specification of a process endpoint: the boundary in the process before which they are not identified and after which they are. During the realization of the plan, the goal is to get to the point of having the interactions, and participants in the realization of the plan try to do that. Answers the question, why did you do this experiment? PERSON: Alan Ruttenberg PERSON: Barry Smith PERSON: Bjoern Peters PERSON: Jennifer Fostel goal specification OBI Plan and Planned Process/Roles Branch OBI_0000217 objective specification IAO:0000007 Pour the contents of flask 1 into flask 2 A directive information entity that describes an action the bearer will take. Alan Ruttenberg OBI Plan and Planned Process branch action specification IAO:0000009 datum label A label is a symbol that is part of some other datum and is used to either partially define the denotation of that datum or to provide a means for identifying the datum as a member of the set of data with the same label http://www.golovchenko.org/cgi-bin/wnsearch?q=label#4n GROUP: IAO 9/22/11 BP: changed the rdfs:label for this class from 'label' to 'datum label' to convey that this class is not intended to cover all kinds of labels (stickers, radiolabels, etc.), and not even all kind of textual labels, but rather the kind of labels occuring in a datum. datum label IAO:0000013 journal article Examples are articles published in the journals, Nature and Science. The content can often be cited by reference to a paper based encoding, e.g. Authors, Title of article, Journal name, date or year of publication, volume and page number. A report that is published in a journal. PERSON: Alan Ruttenberg PERSON: Chris Stoeckert OBI_0000159 group:OBI journal article IAO:0000027 data item Data items include counts of things, analyte concentrations, and statistical summaries. An information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements. 2/2/2009 Alan and Bjoern discussing FACS run output data. This is a data item because it is about the cell population. Each element records an event and is typically further composed a set of measurment data items that record the fluorescent intensity stimulated by one of the lasers. 2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum. 2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym. 2014-03-31: See discussion at http://odontomachus.wordpress.com/2014/03/30/aboutness-objects-propositions/ JAR: datum -- well, this will be very tricky to define, but maybe some information-like stuff that might be put into a computer and that is meant, by someone, to denote and/or to be interpreted by some process... I would include lists, tables, sentences... I think I might defer to Barry, or to Brian Cantwell Smith JAR: A data item is an approximately justified approximately true approximate belief PERSON: Alan Ruttenberg PERSON: Chris Stoeckert PERSON: Jonathan Rees data data item IAO:0000030 information content entity Examples of information content entites include journal articles, data, graphical layouts, and graphs. A generically dependent continuant that is about some thing. 2014-03-10: The use of "thing" is intended to be general enough to include universals and configurations (see https://groups.google.com/d/msg/information-ontology/GBxvYZCk1oc/-L6B5fSBBTQJ). information_content_entity 'is_encoded_in' some digital_entity in obi before split (040907). information_content_entity 'is_encoded_in' some physical_document in obi before split (040907). Previous. An information content entity is a non-realizable information entity that 'is encoded in' some digital or physical entity. PERSON: Chris Stoeckert OBI_0000142 information content entity IAO:0000032 10 feet. 3 ml. A scalar measurement datum is a measurement datum that is composed of two parts, numerals and a unit label. 2009-03-16: we decided to keep datum singular in scalar measurement datum, as in this case we explicitly refer to the singular form Would write this as: has_part some 'measurement unit label' and has_part some numeral and has_part exactly 2, except for the fact that this won't let us take advantage of OWL reasoning over the numbers. Instead use has measurment value property to represent the same. Use has measurement unit label (subproperty of has_part) so we can easily say that there is only one of them. PERSON: Alan Ruttenberg PERSON: Melanie Courtot scalar measurement datum IAO:0000033 An information content entity whose concretizations indicate to their bearer how to realize them in a process. 2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was "is the specification of a process that can be concretized and realized by an actor" with alternative term "instruction".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term. 2013-05-30 Alan Ruttenberg: What differentiates a directive information entity from an information concretization is that it can have concretizations that are either qualities or realizable entities. The concretizations that are realizable entities are created when an individual chooses to take up the direction, i.e. has the intention to (try to) realize it. 8/6/2009 Alan Ruttenberg: Changed label from "information entity about a realizable" after discussions at ICBO Werner pushed back on calling it realizable information entity as it isn't realizable. However this name isn't right either. An example would be a recipe. The realizable entity would be a plan, but the information entity isn't about the plan, it, once concretized, *is* the plan. -Alan PERSON: Alan Ruttenberg PERSON: Bjoern Peters directive information entity IAO:0000064 algorithm PMID: 18378114.Genomics. 2008 Mar 28. LINKGEN: A new algorithm to process data in genetic linkage studies. A plan specification which describes the inputs and output of mathematical functions as well as workflow of execution for achieving an predefined objective. Algorithms are realized usually by means of implementation as computer programs for execution by automata. Philippe Rocca-Serra PlanAndPlannedProcess Branch OBI_0000270 adapted from discussion on OBI list (Matthew Pocock, Christian Cocos, Alan Ruttenberg) algorithm IAO:0000078 curation status specification The curation status of the term. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value. Better to represent curation as a process with parts and then relate labels to that process (in IAO meeting) PERSON:Bill Bug GROUP:OBI:<http://purl.obolibrary.org/obo/obi> OBI_0000266 curation status specification IAO:0000088 report Examples of reports are gene lists and investigation reports. These are not published (journal) articles but may be included in a journal article. A document assembled by an author for the purpose of providing information for the audience. A report is the output of a documenting process and has the objective to be consumed by a specific audience. Topic of the report is on something that has completed. A report is not a single figure. Examples of reports are journal article, patent application, grant progress report, case report (not patient record). 2009-03-16: comment from Darren Natale: I am slightly uneasy with the sentence "Topic of the report is on something that has completed." Should it be restricted to those things that are completed? For example, a progress report is (usually) about something that definitely has *not* been completed, or may include (only) projections. I think the definition would not suffer if the whole sentence is deleted. 2009-03-16: this was report of results with definition: A report is a narrative object that is a formal statement of the results of an investigation, or of any matter on which definite information is required, made by some person or body instructed or required to do so. 2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI. 2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'document'. Alan restored as there are OBI dependencies and this merits further discussion disagreement about where reports go. alan: only some gene lists are reports. Is a report all the content of some document? The example of usage suggests that a report may be part of some article. Term needs clarification PERSON: Alan Ruttenberg PERSON: Chris Stoeckert PERSON: Melanie Courtot GROUP: OBI OBI_0000099 report IAO:0000100 data set Intensity values in a CEL file or from multiple CEL files comprise a data set (as opposed to the CEL files themselves). A data item that is an aggregate of other data items of the same type that have something in common. Averages and distributions can be determined for data sets. 2009/10/23 Alan Ruttenberg. The intention is that this term represent collections of like data. So this isn't for, e.g. the whole contents of a cel file, which includes parameters, metadata etc. This is more like java arrays of a certain rather specific type 2014-05-05: Data sets are aggregates and thus must include two or more data items. We have chosen not to add logical axioms to make this restriction. person:Allyson Lister person:Chris Stoeckert OBI_0000042 group:OBI data set IAO:0000102 data about an ontology part Data about an ontology part is a data item about a part of an ontology, for example a term Person:Alan Ruttenberg data about an ontology part IAO:0000104 plan specification PMID: 18323827.Nat Med. 2008 Mar;14(3):226.New plan proposed to help resolve conflicting medical advice. A directive information entity with action specifications and objective specifications as parts, and that may be concretized as a realizable entity that, if realized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified. 2009-03-16: provenance: a term a plan was proposed for OBI (OBI_0000344) , edited by the PlanAndPlannedProcess branch. Original definition was " a plan is a specification of a process that is realized by an actor to achieve the objective specified as part of the plan". It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term. 2014-03-31: A plan specification can have other parts, such as conditional specifications. 2022-01-16 Updated definition to that proposed by Clint Dowloand, IAO Issue 231. Alternative previous definition: a plan is a set of instructions that specify how an objective should be achieved Alan Ruttenberg Clint Dowland OBI Plan and Planned Process branch OBI_0000344 2/3/2009 Comment from OBI review. Action specification not well enough specified. Conditional specification not well enough specified. Question whether all plan specifications have objective specifications. Request that IAO either clarify these or change definitions not to use them plan specification https://github.com/information-artifact-ontology/IAO/issues/231#issuecomment-1010455131 IAO:0000109 measurement datum Examples of measurement data are the recoding of the weight of a mouse as {40,mass,"grams"}, the recording of an observation of the behavior of the mouse {,process,"agitated"}, the recording of the expression level of a gene as measured through the process of microarray experiment {3.4,luminosity,}. A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device. 2/2/2009 is_specified_output of some assay? person:Chris Stoeckert OBI_0000305 group:OBI measurement datum IAO:0000225 obsolescence reason specification The reason for which a term has been deprecated. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value. The creation of this class has been inspired in part by Werner Ceusters' paper, Applying evolutionary terminology auditing to the Gene Ontology. PERSON: Alan Ruttenberg PERSON: Melanie Courtot obsolescence reason specification IAO:0000310 document A journal article, patent application, laboratory notebook, or a book A collection of information content entities intended to be understood together as a whole PERSON: Lawrence Hunter document IAO:0000311 publication journal article, newspaper story, book, etc. A document that is the output of a publishing process. PERSON: Chris Stoeckert PERSON: Jie Zheng PERSON: Lawrence Hunter published document Revisit the term in Octorber 2020. Improve the defintion. publication IAO:0000409 denotator type The Basic Formal Ontology ontology makes a distinction between Universals and defined classes, where the formal are "natural kinds" and the latter arbitrary collections of entities. A denotator type indicates how a term should be interpreted from an ontological perspective. Alan Ruttenberg Barry Smith, Werner Ceusters denotator type IAO:0020000 identifier An information content entity that is the outcome of a dubbing process and is used to refer to one instance of entity shared by a group of people to refer to that individual entity. Justin Whorton Mathias Brochhausen proper name https://github.com/information-artifact-ontology/IAO/issues/237 Mathias Brochhausen Sep 29, 2016: The current definition has been amended from the previous version: "A proper name is an information content entity that is the outcome of a dubbing process and is used to refer to one instance of entity shared by a group of people to refer to that individual entity." to more accuratly reflect the necessary and sufficient condition on the class. (MB) identifier IAO:8000000 ontology module I have placed this under 'data about an ontology part', but this can be discussed. I think this is OK if 'part' is interpreted reflexively, as an ontology module is the whole ontology rather than part of it. ontology file This class and it's subclasses are applied to OWL ontologies. Using an rdf:type triple will result in problems with OWL-DL. I propose that dcterms:type is instead used to connect an ontology URI with a class from this hierarchy. The class hierarchy is not disjoint, so multiple assertions can be made about a single ontology. ontology module IAO:8000001 base ontology module An ontology module that comprises only of asserted axioms local to the ontology, excludes import directives, and excludes axioms or declarations from external ontologies. base ontology module IAO:8000002 editors ontology module An ontology module that is intended to be directly edited, typically managed in source control, and typically not intended for direct consumption by end-users. source ontology module editors ontology module IAO:8000003 main release ontology module An ontology module that is intended to be the primary release product and the one consumed by the majority of tools. TODO: Add logical axioms that state that a main release ontology module is derived from (directly or indirectly) an editors module main release ontology module IAO:8000004 bridge ontology module An ontology module that consists entirely of axioms that connect or bridge two distinct ontology modules. For example, the Uberon-to-ZFA bridge module. bridge ontology module IAO:8000005 import ontology module A subset ontology module that is intended to be imported from another ontology. TODO: add axioms that indicate this is the output of a module extraction process. import file import ontology module IAO:8000006 subset ontology module An ontology module that is extracted from a main ontology module and includes only a subset of entities or axioms. ontology slim subset ontology subset ontology module IAO:8000007 curation subset ontology module A subset ontology that is intended as a whitelist for curators using the ontology. Such a subset will exclude classes that curators should not use for curation. curation subset ontology module IAO:8000008 analysis ontology module An ontology module that is intended for usage in analysis or discovery applications. analysis subset ontology module IAO:8000009 single layer ontology module A subset ontology that is largely comprised of a single layer or strata in an ontology class hierarchy. The purpose is typically for rolling up for visualization. The classes in the layer need not be disjoint. ribbon subset single layer subset ontology module IAO:8000010 exclusion subset ontology module A subset of an ontology that is intended to be excluded for some purpose. For example, a blacklist of classes. antislim exclusion subset ontology module IAO:8000011 external import ontology module An imported ontology module that is derived from an external ontology. Derivation methods include the OWLAPI SLME approach. external import external import ontology module IAO:8000012 species subset ontology module A subset ontology that is crafted to either include or exclude a taxonomic grouping of species. taxon subset species subset ontology module IAO:8000013 reasoned ontology module An ontology module that contains axioms generated by a reasoner. The generated axioms are typically direct SubClassOf axioms, but other possibilities are available. reasoned ontology module IAO:8000014 generated ontology module An ontology module that is automatically generated, for example via a SPARQL query or via template and a CSV. TODO: Add axioms (using PROV-O?) that indicate this is the output-of some reasoning process generated ontology module IAO:8000015 template generated ontology module An ontology module that is automatically generated from a template specification and fillers for slots in that template. template generated ontology module IAO:8000016 taxonomic bridge ontology module taxonomic bridge ontology module IAO:8000017 ontology module subsetted by expressivity ontology module subsetted by expressivity IAO:8000018 obo basic subset ontology module A subset ontology that is designed for basic applications to continue to make certain simplifying assumptions; many of these simplifying assumptions were based on the initial version of the Gene Ontology, and have become enshrined in many popular and useful tools such as term enrichment tools. Examples of such assumptions include: traversing the ontology graph ignoring relationship types using a naive algorithm will not lead to cycles (i.e. the ontology is a DAG); every referenced term is declared in the ontology (i.e. there are no dangling clauses). An ontology is OBO Basic if and only if it has the following characteristics: DAG Unidirectional No Dangling Clauses Fully Asserted Fully Labeled No equivalence axioms Singly labeled edges No qualifier lists No disjointness axioms No owl-axioms header No imports obo basic subset ontology module IAO:8000019 ontology module subsetted by OWL profile ontology module subsetted by OWL profile IAO:8000020 EL++ ontology module EL++ ontology module IDO:0000403 A symbiont role borne by an organism in virtue of the fact that it derives a growth, survival, or fitness advantage from symbiosis while the other symbiont's growth, survival, or fitness is reduced. Albert Goldfain Alexander Diehl Lindsay Cowell In the medical community, the term 'parasite' is used with the narrower meaning of eukaryotic pathogen. The role is realized in processes that result in the parasite's growth, survival, or fitness advantage or in the other organism's growth, survival, or fitness reduction. parasite role IDO:0000409 A symbiont host role borne by an organism in virtue of the fact that its partner in symbiosis reaches developmental maturity or reproduces sexually in the host. Albert Goldfain Alexander Diehl Lindsay Cowell primary host role The role is realized in developmental and reproduction processes of the host's partner in symbiosis. definitive host role IDO:0000418 An infectious agent transporter role that is borne by an organism active in the transfer of an infectious agent to an organism of another Species and in which the agent is infectious. Albert Goldfain Alexander Diehl Lindsay Cowell The role is realized in a transmission process. A bearer of a vector role is also a bearer of a host role. infectious agent vector role IDO:0000420 An infectious agent vector role borne by an organism in virtue of the fact that the infectious agent multiplies in the vector. Albert Goldfain Alexander Diehl Lindsay Cowell biological vector of infectious agent role IDO:0000450 A disposition to initiate processes that result in a disorder. Albert Goldfain Alexander Diehl Lindsay Cowell pathogenicity A pathogenic disposition is realized in processes that create a disorder. The use of 'initiates' is intended to convey that a pathogenic disposition is realized when processes resulting in a disorder begin because of some action on the part of the bearer of the disposition. By this interpretation of 'initiates', disorder-causing entities such as glass, UV light, and toxins do not have a pathogenic disposition. pathogenic disposition IDO:0000528 A material entity with a pathogenic disposition. Albert Goldfain Alexander Diehl Lindsay Cowell pathogen IDO:0000547 A biological macromolecule produced by a pathogen and that has a virulence factor disposition. Albert Goldfain Alexander Diehl Lindsay Cowell virulence factor IDO:0000586 A part of an extended organism that itself has as part a population of one or more infectious agents and that (1) exists as a result of processes initiated by members of the infectious agent population and is (2) clinically abnormal in virtue of the presence of this infectious agent population, or (3) has a disposition to bring clinical abnormality to immunocompetent organisms of the same Species as the host (the organism corresponding to the extended organism) through transmission of a member or offspring of a member of the infectious agent population. Albert Goldfain Alexander Diehl Lindsay Cowell The organism corresponding to the extended organism is host to the infectious agents. By this definition, parts of the host can be considered part of the infection. infection MONDO:0005065 A usually malignant and aggressive neoplasm of the mesothelium which is often associated with exposure to asbestos. mesothelioma MONDO:0005194 Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice. Rotavirus infection MONDO:0023644 A carcinoma arising in the lip or oral cavity. Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums. Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma. Lip carcinomas are usually basal cell or squamous cell carcinomas. lip and oral cavity carcinoma NCBITaxon:10090 NCBITaxon:85055 GC_ID:1 house mouse mouse ncbi_taxonomy Mus musculus NCBITaxon:10114 GC_ID:1 rat rats ncbi_taxonomy Rattus NCBITaxon:10141 NCBITaxon:84274 GC_ID:1 domestic guinea pig guinea pig ncbi_taxonomy Cavia aperea porcellus Cavia cobaya Mus porcellus Cavia porcellus NCBITaxon:10150 GC_ID:1 chinchillas chinchillas and viscachas ncbi_taxonomy Chinchillidae NCBITaxon:10239 GC_ID:1 ncbi_taxonomy Vira Viridae viruses Viruses NCBITaxon:10240 GC_ID:1 ncbi_taxonomy Poxviridae NCBITaxon:10241 GC_ID:1 ncbi_taxonomy Chordopoxvirinae NCBITaxon:10242 GC_ID:1 ncbi_taxonomy Orthopoxvirus NCBITaxon:10244 NCBITaxon:130669 NCBITaxon:130670 MPXV GC_ID:1 monkey pox virus mpox mpox virus ncbi_taxonomy Monkeypox virus NCBITaxon:10245 GC_ID:1 vaccinia virus VV ncbi_taxonomy Vaccinia virus NCBITaxon:10255 NCBITaxon:12871 GC_ID:1 small pox virus smallpox smallpox virus variola virus VAR ncbi_taxonomy Variola virus NCBITaxon:10258 GC_ID:1 Contagious pustular dermatitis virus ncbi_taxonomy Orf virus NCBITaxon:10260 GC_ID:1 ncbi_taxonomy Avipoxvirus NCBITaxon:10261 FWPV GC_ID:1 Avipoxvirus clade A1 Fowlpoxvirus fowl poxvirus fowlpox virus FP fowlpox virus FPV ncbi_taxonomy Fowlpox virus NCBITaxon:10264 GC_ID:1 Pigeon pox virus Pigeon poxvirus pigeonpox virus PPV ncbi_taxonomy Pigeonpox virus NCBITaxon:102793 GC_ID:1 Avian influenza virus H5N1 H5N1 ncbi_taxonomy H5N1 subtype NCBITaxon:10292 GC_ID:1 ncbi_taxonomy Herpesviridae NCBITaxon:10293 GC_ID:1 Alphaherpesviruses ncbi_taxonomy Alphaherpesvirinae NCBITaxon:10294 GC_ID:1 ncbi_taxonomy Simplexvirus NCBITaxon:10298 HSV-1 HSV1 GC_ID:1 Herpes simplex virus type 1 Human herpesvirus type 1 herpes simplex virus 1 HSV-1 herpes simplex virus HSV-1 herpes simplex virus type 1 HSV-1 herpes simplex virus type 1 HSV1 herpes simplex virus type-1 HSV-1 ncbi_taxonomy Herpes simplex virus 1 Human herpesvirus 1 Human alphaherpesvirus 1 NCBITaxon:10310 HSV2 GC_ID:1 Herpes simplex virus (type 2) Herpes simplex virus II Herpes simplex virus type 2 Herpes simplex virus type 2 (HSV-2) Human herpesvirus 2 ncbi_taxonomy Herpes simplex virus 2 herpes simplex virus type 2 HSV-2 Human alphaherpesvirus 2 NCBITaxon:10319 GC_ID:1 ncbi_taxonomy Varicellovirus NCBITaxon:10320 NCBITaxon:11265 NCBITaxon:12738 BoHV-1 GC_ID:1 Bovine herpesvirus 1 Bovine herpesvirus type 1 Bovine herpesvirus-1 Bovine rhinotracheitis virus bovine herpesvirus 1 BHV 1 bovine herpesvirus 1 BHV-1 bovine herpesvirus 1 BHV1 bovine herpesvirus BHV-1 bovine herpesvirus type 1 BHV-1 bovine herpesvirus type-1 BHV-1 infectious bovine rhinotracheitis virus BHV-1 ncbi_taxonomy Infectious bovine rhinotracheitis virus bovine alphaherpesvirus 1 NCBITaxon:10326 EHV-1 GC_ID:1 Equid herpesvirus 1 Equine herpesvirus 1 Equine herpesvirus type 1 Equine herpesvirus-1 equine abortion virus equine herpesvirus 1 EHV-1 equine herpesvirus type-1 ncbi_taxonomy equine herpesvirus type 1 EHV-1 Equid alphaherpesvirus 1 NCBITaxon:10334 GC_ID:1 Felid herpesvirus 1 Feline alphaherpesvirus 1 Feline herpesvirus 1 Feline herpesvirus type 1 feline herpesvirus feline herpesvirus type 1 FHV-1 feline herpesvirus-1 feline herpesvirus-1 FHV-1 ncbi_taxonomy Felid alphaherpesvirus 1 NCBITaxon:10335 HHV-3 VZV GC_ID:1 Human herpes virus 3 Human herpesvirus 3 Varicella Zoster Virus Varicella-zoster virus varicella zoster virus VZV varicella-zoster virus VZV ncbi_taxonomy Human alphaherpesvirus 3 NCBITaxon:10345 NCBITaxon:44156 PRV GC_ID:1 Alphaherpesvirus pseudorabies virus PRV Aujeszky's disease virus Pseudorabies Virus PRV Pseudorabies virus Suid herpesvirus 1 Suid herpesvirus type 1 ncbi_taxonomy Suid alphaherpesvirus 1 NCBITaxon:10357 GC_ID:1 Betaherpesviruses ncbi_taxonomy Betaherpesvirinae NCBITaxon:10358 GC_ID:1 ncbi_taxonomy Cytomegalovirus NCBITaxon:10359 HHV-5 GC_ID:1 Human cytomegalovirus Human herpesvirus 5 human herpesvirus type 5 ncbi_taxonomy Human betaherpesvirus 5 NCBITaxon:10366 GC_ID:1 Mouse cytomegalovirus 1 Murid herpesvirus 1 Murine cytomegalovirus murine cytomegalovirus (MCMV) murine cytomegalovirus MCMV murine herpesvirus 1 ncbi_taxonomy Murid betaherpesvirus 1 NCBITaxon:10386 NCBITaxon:10342 NCBITaxon:12743 NCBITaxon:46620 GaHV-1 ILTV GC_ID:1 Avian infectious laryngotracheitis virus Gallid herpesvirus 1 Gallid herpesvirus type 1 Laryngotracheitis virus infectious laryngotracheitis virus ILTV ncbi_taxonomy Infectious laryngotracheitis virus Gallid alphaherpesvirus 1 NCBITaxon:10390 NCBITaxon:38013 NCBITaxon:39111 NCBITaxon:43684 GaHV-2 MDV1 GC_ID:1 Gallid herpesvirus 2 Gallid herpesvirus type 2 Marek disease virus Marek disease virus type 1 Marek's disease herpesvirus Marek's disease herpesvirus 1 Marek's disease virus Marek's disease virus (MDV) Marek's disease virus MDV Marek's disease virus MDV1 Marek's disease virus serotype 1 MDV-1 Marek's disease virus type 1 MDV1 Mareks disease virus ncbi_taxonomy Marek's disease virus type 1 Gallid alphaherpesvirus 2 NCBITaxon:10405 GC_ID:1 mammalian hepatitis B-type viruses ncbi_taxonomy Orthohepadnavirus NCBITaxon:10407 HBV GC_ID:1 Human hepatitis B virus hepatitis B virus (HBV) hepatitis B virus HBV hepatitis B virus, HBV human hepatitis B virus HBV ncbi_taxonomy Hepatitis B virus NCBITaxon:104388 NCBITaxon:72150 GC_ID:1 Anatid Herpes virus-1 Anatid herpesvirus 1 Duck enteritis virus Duck plague virus ncbi_taxonomy anatid alphaherpesvirus 1 NCBITaxon:10469 GC_ID:1 Baculovirus Baculovirus sp. ncbi_taxonomy unidentified baculovirus NCBITaxon:10497 ASFV GC_ID:1 African swine fever virus ASF African swine fever virus ASFV African swine fever virus, ASFV ncbi_taxonomy African swine fever virus NCBITaxon:10508 GC_ID:1 ncbi_taxonomy Adenoviridae NCBITaxon:10509 GC_ID:1 ncbi_taxonomy Mastadenovirus NCBITaxon:10512 NCBITaxon:12607 GC_ID:1 Canine adenovirus type 1 Canine adenovirus type 1 Cav-1 Mastadenovirus c1 Mastadenovirus can1 canine adenovirus type 1 Can1 dog adenovirus 1 ncbi_taxonomy Canine adenovirus 1 NCBITaxon:10514 GC_ID:1 Canine adenovirus type 2 Canine adenovirus type 2 Cav-1 Mastadenovirus c2 Mastadenovirus can2 dog adenovirus 2 ncbi_taxonomy Canine adenovirus 2 NCBITaxon:10535 GC_ID:1 Adenovirus ncbi_taxonomy unidentified adenovirus NCBITaxon:10537 GC_ID:1 Canine adenovirus Canine adenovirus A ncbi_taxonomy Canine mastadenovirus A NCBITaxon:10566 GC_ID:1 Human Papilloma Virus human papillomavirus HPV ncbi_taxonomy Human papillomavirus NCBITaxon:10571 GC_ID:1 ncbi_taxonomy Bovine papillomavirus NCBITaxon:107819 GC_ID:11 ncbi_taxonomy Clostridium perfringens (type D) Clostridium perfringens D NCBITaxon:10786 FPLV GC_ID:1 Feline panleucopenia virus Feline panleukopaenia virus ncbi_taxonomy Feline panleukopenia virus NCBITaxon:10787 GC_ID:1 ncbi_taxonomy Feline panleukopenia virus (strain 193) NCBITaxon:10788 CPV GC_ID:1 ncbi_taxonomy Canine parvovirus NCBITaxon:10792 MEV GC_ID:1 ncbi_taxonomy Mink enteritis virus NCBITaxon:10796 PPV GC_ID:1 porcine parvovirus PPV ncbi_taxonomy Porcine parvovirus NCBITaxon:10892 GC_ID:1 Orbiviridae Orbiviruses ncbi_taxonomy Orbivirus NCBITaxon:10912 GC_ID:1 Rotaviruses ncbi_taxonomy Rotavirus NCBITaxon:10913 GC_ID:1 ncbi_taxonomy Porcine rotavirus NCBITaxon:10927 GC_ID:1 bovine rotavirus BRV ncbi_taxonomy Bovine rotavirus NCBITaxon:10937 GC_ID:1 ncbi_taxonomy Equine rotavirus NCBITaxon:10993 GC_ID:1 ncbi_taxonomy Birnaviridae NCBITaxon:10995 NCBITaxon:12740 IBDV GC_ID:1 Avian infectious bursal disease virus Gumboro virus Infectious bursal disease virus of chickens infectious bursal disease virus IBDV ncbi_taxonomy Infectious bursal disease virus NCBITaxon:11002 NCBITaxon:12744 IPNV GC_ID:1 infectious pancreatic necrosis virus IPNV ncbi_taxonomy Infectious pancreatic necrosis virus NCBITaxon:11019 GC_ID:1 Alphaviridae arboviruses group A ncbi_taxonomy Alphavirus NCBITaxon:11021 GC_ID:1 Eastern equine encephalomyelitis virus eastern equine encephalomyelitis EEE eastern equine encephalomyelitis virus EEEV ncbi_taxonomy Eastern equine encephalitis virus NCBITaxon:11034 GC_ID:1 ncbi_taxonomy Sindbis virus NCBITaxon:11036 VEE VEEV GC_ID:1 Venezuelan equine encephalitis VEE Venezuelan equine encephalitis virus VEE Venezuelan equine encephalomyelitis virus ncbi_taxonomy Venezuelan equine encephalitis virus NCBITaxon:11039 GC_ID:1 ncbi_taxonomy Western equine encephalomyelitis virus Western equine encephalitis virus NCBITaxon:11040 GC_ID:1 ncbi_taxonomy Rubivirus NCBITaxon:11041 GC_ID:1 ncbi_taxonomy Rubella virus NCBITaxon:11047 EAV GC_ID:1 ncbi_taxonomy Equine arteritis virus NCBITaxon:11050 GC_ID:1 Flavivirus (arbovirus group B) ncbi_taxonomy Flaviviridae NCBITaxon:11051 GC_ID:1 arboviruses group B ncbi_taxonomy Flavivirus NCBITaxon:11072 GC_ID:1 Japanese encephalitis (JE) virus Japanese encephalitis virus JE Japanese encephalitis virus JEV ncbi_taxonomy Japanese encephalitis virus NCBITaxon:11082 WNV GC_ID:1 ncbi_taxonomy West Nile virus NCBITaxon:11084 TBEV GC_ID:1 FSME virus Tick born encephalitis virus tick-borne encephalitis virus TBE virus tick-borne encephalitis virus TBEV ncbi_taxonomy Tick-borne encephalitis virus NCBITaxon:11089 YFV GC_ID:1 Flavivirus febricis yellow fever virus YFV ncbi_taxonomy Yellow fever virus NCBITaxon:11095 GC_ID:1 PMID:12832207 PMID:7747470 ncbi_taxonomy Pestivirus NCBITaxon:11096 NCBITaxon:12625 NCBITaxon:54314 GC_ID:1 PMID:7747470 Hog cholera virus Pestivirus type 2 classical swine fever virus CSFV swine fever virus ncbi_taxonomy Classical swine fever virus NCBITaxon:11099 NCBITaxon:121864 BVDV BVDV-1 GC_ID:1 PMID:7747470 Bovine viral diarrhea virus Bovine viral diarrhea virus type 1 Bovine viral diarrhea virus-1 Mucosal disease virus Pestivirus type 1 bovine viral diarrhea virus BVDV bovine viral diarrhea virus type I ncbi_taxonomy Bovine viral diarrhea virus 1 NCBITaxon:111105 GC_ID:11 PMID:11411686 PMID:28066339 ncbi_taxonomy Porphyromonas gulae NCBITaxon:11118 GC_ID:1 ncbi_taxonomy Coronaviridae NCBITaxon:11120 IBV GC_ID:1 Avian infectious bronchitis virus avian infectious bronchitis coronavirus IBV avian infectious bronchitis virus IBV avian infectious bronchitis virus, IBV infectious bronchitis virus IBV ncbi_taxonomy Infectious bronchitis virus NCBITaxon:11128 BCV BECV GC_ID:1 Bovine enteritic coronavirus Bovine enteritic coronavirus BECV bovine coronavirus BCV bovine enteric coronavirus calf diarrheal coronavirus neonatal calf diarrhea virus ncbi_taxonomy Bovine coronavirus NCBITaxon:11135 FIPV GC_ID:1 ncbi_taxonomy Feline infectious peritonitis virus NCBITaxon:11149 NCBITaxon:12859 TGEV GC_ID:1 Porcine transmissable gastroenteritis coronavirus Porcine transmissible gastroenteritis coronavirus porcine transmissible gastroenteritis virus transmissible gastroenteritis coronavirus transmissible gastroenteritis virus TGEV ncbi_taxonomy Transmissible gastroenteritis virus NCBITaxon:11153 GC_ID:1 Canine enteric coronavirus canine coronavirus CCV ncbi_taxonomy Canine coronavirus NCBITaxon:11157 GC_ID:1 negative-sense genome single-stranded RNA viruses ncbi_taxonomy Mononegavirales NCBITaxon:11158 GC_ID:1 ncbi_taxonomy Paramyxoviridae NCBITaxon:11216 NCBITaxon:11202 HPIV-3 HPIV3 GC_ID:1 Human parainfluenza 3 virus Human parainfluenza virus 3 Human parainfluenza virus type 3 Parainfluenza virus type 3 human parainfluenza virus 3 HPIV3 human parainfluenza virus type 3 PIV3 parainfluenza virus type 3 PIV-3 ncbi_taxonomy human parainfluenza virus Human respirovirus 3 NCBITaxon:11229 GC_ID:1 Morbilliviruses ncbi_taxonomy Morbillivirus NCBITaxon:11234 NCBITaxon:11230 GC_ID:1 Cell-associated subacute sclerosing panencephalitis Measles virus Subacute sclerosing panencephalitis virus measles virus MV rougeole virus rubeola virus subacute sclerose panencephalitis virus subacute sclerosing panencephalitis virus, SSPEV ncbi_taxonomy Measles morbillivirus NCBITaxon:11241 RDV GC_ID:1 Rinderpest virus rinderpest virus RPV rinderpest virus RV ncbi_taxonomy Rinderpest morbillivirus NCBITaxon:11244 GC_ID:1 Pneumovirinae ncbi_taxonomy Pneumoviridae NCBITaxon:11246 NCBITaxon:12604 BRS BRSV GC_ID:1 bovine RSV bovine respiratory syncytial virus BRSV ncbi_taxonomy Bovine orthopneumovirus NCBITaxon:11250 HRSV GC_ID:1 Human orthopneumovirus human RSV ncbi_taxonomy human respiratory syncytial virus NCBITaxon:11266 NCBITaxon:11267 GC_ID:1 Filovirus ncbi_taxonomy Filoviridae NCBITaxon:11270 GC_ID:1 PMID:16186241 ncbi_taxonomy Rhabdoviridae NCBITaxon:11286 GC_ID:1 ncbi_taxonomy Lyssavirus NCBITaxon:11287 NCBITaxon:12873 NCBITaxon:12874 VHSV GC_ID:1 Haemorrhagic septicemia virus Hemorrhagic septicemia virus Viral haemorrhagic septicaemia virus hemorragic septicemy virus of fish viral haemorrhagic scepticaemia virus VHS viral haemorrhagic septicaemia virus VHSV viral hemorrhagic septicemia virus VHSV ncbi_taxonomy Viral hemorrhagic septicemia virus NCBITaxon:11290 IHNV GC_ID:1 ncbi_taxonomy Infectious hematopoietic necrosis virus NCBITaxon:11292 GC_ID:1 Rabies lyssavirus Rabies virus ncbi_taxonomy Lyssavirus rabies NCBITaxon:11308 GC_ID:1 ncbi_taxonomy Orthomyxoviridae NCBITaxon:11309 GC_ID:1 Influenza virus Influenza virus sp. Influenzavirus avian influenza virus ncbi_taxonomy unidentified influenza virus NCBITaxon:11318 GC_ID:1 Dhori thogotovirus Dhori virus Tick-borne virus ncbi_taxonomy Thogotovirus dhoriense NCBITaxon:11320 FLUAV GC_ID:1 Human Influenza A Virus Influenza virus type A influenza A virus ncbi_taxonomy Influenza A virus NCBITaxon:114727 GC_ID:1 H1N1 ncbi_taxonomy H1N1 subtype NCBITaxon:11520 FLUBV GC_ID:1 Influenza virus type B ncbi_taxonomy Influenza B virus NCBITaxon:11588 RVFV GC_ID:1 ncbi_taxonomy Rift Valley fever virus NCBITaxon:11636 NCBITaxon:11835 NCBITaxon:11872 NCBITaxon:36380 GC_ID:1 Avian reticuloendotheliosis virus reticuloendotheliosis virus A REV-A reticuloendotheliosis virus REV-A ncbi_taxonomy Reticuloendotheliosis virus NCBITaxon:11646 GC_ID:1 Lentivirinae ncbi_taxonomy Lentivirus NCBITaxon:11673 FIV GC_ID:1 feline immunodeficiency virus FIV ncbi_taxonomy Feline immunodeficiency virus NCBITaxon:11723 NCBITaxon:11677 NCBITaxon:11739 NCBITaxon:11740 CIV SIV GC_ID:1 Chimpanzee immunodeficiency virus Chimpanzee immunodeficiency virus (SIV(CPZ)) Simian immunodeficiency virus SIVcpz simian immunodeficiency virus SIV simian immunodeficiency virus, SIV simian immunodeficiency viruses SIV ncbi_taxonomy Simian immunodeficiency virus NCBITaxon:117565 GC_ID:1 fish fishes ncbi_taxonomy Agnatha Hyperotreti Myxini NCBITaxon:117571 NCBITaxon:40673 GC_ID:1 bony vertebrates ncbi_taxonomy Euteleostomi NCBITaxon:11768 NCBITaxon:11920 GC_ID:1 Feline leukemia provirus feline leukemia virus FeLV ncbi_taxonomy Feline leukemia virus NCBITaxon:11901 BLV GC_ID:1 bovine leukemia virus BLV bovine leukemia virus, BLV ncbi_taxonomy Bovine leukemia virus NCBITaxon:119088 GC_ID:1 ncbi_taxonomy Enoplea NCBITaxon:119210 GC_ID:1 H3N2 ncbi_taxonomy H3N2 subtype NCBITaxon:11974 GC_ID:1 ncbi_taxonomy Caliciviridae NCBITaxon:11976 NCBITaxon:12806 NCBITaxon:31701 RHDV GC_ID:1 Rabbit haemorrhagic disease virus rabbit hemorrhagic disease virus RHDV ncbi_taxonomy Rabbit hemorrhagic disease virus NCBITaxon:11978 FCV GC_ID:1 Feline vesivirus feline calicivirus FCV ncbi_taxonomy Feline calicivirus NCBITaxon:12058 GC_ID:1 ncbi_taxonomy Picornavirus Picornaviridae NCBITaxon:12059 NCBITaxon:12128 GC_ID:1 Enteroviruses ncbi_taxonomy Enterovirus NCBITaxon:12066 GC_ID:1 ncbi_taxonomy Coxsackievirus NCBITaxon:1206794 GC_ID:1 ncbi_taxonomy Ecdysozoa NCBITaxon:12080 HPV-1 PV1 GC_ID:1 Human poliovirus 1 Human poliovirus type 1 Polio virus 1 Poliovirus type 1 poliovirus type 1 PV1 ncbi_taxonomy Poliovirus 1 NCBITaxon:12083 HPV-2 GC_ID:1 Human Poliovirus type 2 Human poliovirus 2 Poliovirus type 2 ncbi_taxonomy Poliovirus 2 NCBITaxon:12086 HPV-3 GC_ID:1 Human poliovirus 3 Human poliovirus type 3 Polio virus 3 ncbi_taxonomy Poliovirus serotype 3 Poliovirus type 3 Poliovirus 3 NCBITaxon:12091 GC_ID:1 ncbi_taxonomy Hepatovirus NCBITaxon:12092 HAV GC_ID:1 Hepatitis A virus ncbi_taxonomy Hepatovirus A NCBITaxon:12110 FMDV GC_ID:1 Foot and mouth disease virus foot and mouth disease virus FMDV foot-and-mouth disease virus FMDV ncbi_taxonomy Foot-and-mouth disease virus NCBITaxon:1224 GC_ID:11 PMID:11321122 PMID:11837318 purple photosynthetic bacteria and relatives ncbi_taxonomy "Alphaproteobacteriota" Whitman et al. 2018 Alphaproteobacteriota Proteobacteria Proteobacteriota proteobacteria Pseudomonadota NCBITaxon:12264 CPMV GC_ID:1 ncbi_taxonomy Cowpea mosaic virus NCBITaxon:1236 GC_ID:11 PMID:23334881 ncbi_taxonomy Proteobacteria gamma subdivision Pseudomonadia Purple bacteria, gamma subdivision g-proteobacteria gamma proteobacteria gamma subdivision gamma subgroup Gammaproteobacteria NCBITaxon:1238 GC_ID:11 PMID:1371057 ncbi_taxonomy Piscirickettsia salmonis NCBITaxon:1239 GC_ID:11 PMID:10555317 PMID:11034484 PMID:11542017 PMID:15143038 PMID:25403554 PMID:37409558 PMID:38376502 low G+C Gram-positive bacteria low GC Gram+ ncbi_taxonomy Bacillaeota Bacillota corrig. Gibbons and Murray 2021 Bacillus/Clostridium group Clostridium group firmicutes Low G+C firmicutes clostridial firmicutes firmicutes Bacillota NCBITaxon:12455 BDV GC_ID:1 PMID:25449305 Borna disease virus BDV ncbi_taxonomy Borna disease virus NCBITaxon:12475 NCBITaxon:12682 HDV GC_ID:1 Hepatitis D virus hepatitis delta virus HDV ncbi_taxonomy Hepatitis delta virus NCBITaxon:12618 CAV GC_ID:1 Chicken infectious anemia virus chicken anaemia agent CAA chicken anemia virus CAV chicken anemia virus, CAV ncbi_taxonomy chicken anaemia agent virus CAA Chicken anemia virus NCBITaxon:12637 GC_ID:1 ncbi_taxonomy Dengue virus NCBITaxon:12721 HIV GC_ID:1 ncbi_taxonomy AIDS virus Human immunodeficiency virus NCBITaxon:1279 GC_ID:11 PMID:10319469 PMID:10319495 PMID:10425778 PMID:10758876 PMID:12656157 PMID:17220435 PMID:9734063 ncbi_taxonomy Aurococcus Staphylococcus NCBITaxon:1280 NCBITaxon:325213 NCBITaxon:46170 NCBITaxon:72759 GC_ID:11 PMID:31023808 PMID:8573498 ncbi_taxonomy Micrococcus aureus Micrococcus pyogenes Staphlococcus pyogenes citreus Staphylococcus aureus subsp. anaerobius Staphylococcus pyogenes aureus Staphylococcus aureus NCBITaxon:12814 RSV GC_ID:1 respiratory syncytial virus RS respiratory syncytial virus RS virus respiratory syncytial virus RSV ncbi_taxonomy Respiratory syncytial virus NCBITaxon:12845 GC_ID:1 ncbi_taxonomy Swine influenza virus NCBITaxon:1301 GC_ID:11 PMID:10555340 PMID:14657115 PMID:1720654 PMID:19620365 PMID:19880633 PMID:7537076 PMID:8995803 ncbi_taxonomy Streptococcus NCBITaxon:1307 GC_ID:11 PMID:23245487 PMID:5220563 PMID:9731300 PMID:9734065 ncbi_taxonomy Streptococcus suis NCBITaxon:1311 NCBITaxon:76757 GC_ID:11 PMID:15774692 PMID:8995807 ncbi_taxonomy Streptoccocus de la mammite Streptococcus agalactiae contagiosae Streptococcus difficile Streptococcus difficilis Streptococcus mastitidis Streptococcus agalactiae NCBITaxon:1313 GC_ID:11 ncbi_taxonomy Diplococcus pneumoniae Micrococcus pneumoniae Streptococcus pneumoniae NCBITaxon:1314 GC_ID:11 ncbi_taxonomy Micrococcus scarlatinae Streptococcus erysipelatos Streptococcus hemolyticus Streptococcus scarlatinae Streptococcus pyogenes NCBITaxon:1335626 MERS MERS-CoV GC_ID:1 MERS coronavirus MERS virus Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Middle East respiratory syndrome coronavirus ncbi_taxonomy Middle East respiratory syndrome-related coronavirus NCBITaxon:1336 GC_ID:11 ncbi_taxonomy Streptococcus equi NCBITaxon:13488 GC_ID:1 ncbi_taxonomy Dicentrarchus NCBITaxon:13489 GC_ID:1 European sea bass European seabass ncbi_taxonomy Labrax labrax Morone labrax Perca labrax Roccus labrax Sciaena labrax Dicentrarchus labrax NCBITaxon:136 GC_ID:11 PMID:11075904 PMID:11542017 PMID:16558735 PMID:1917844 PMID:23908650 ncbi_taxonomy spirochetes Spirochaetales NCBITaxon:1385 NCBITaxon:2954866 GC_ID:11 PMID:30896383 ncbi_taxonomy Bacillus/Staphylococcus group Caryophanales Bacillales NCBITaxon:1386 GC_ID:11 PMID:10843090 PMID:11491334 PMID:1742196 PMID:2223602 PMID:23475340 PMID:7727277 PMID:8138135 PMID:8863420 Bacillus Bacillus rRNA group 1 ncbi_taxonomy Bacillus <firmicutes> NCBITaxon:138950 NCBITaxon:138953 GC_ID:1 Enterovirus EV-C Human enterovirus C Poliovirus ncbi_taxonomy Enterovirus C NCBITaxon:139 GC_ID:11 PMID:1380285 PMID:1503971 PMID:24744012 PMID:7699027 PMID:7981102 PMID:8995796 PMID:9336916 Lyme disease spirochete ncbi_taxonomy Borrelia burgdorferi Borreliella burgdorferi NCBITaxon:1392 NCBITaxon:1494525 NCBITaxon:1494531 NCBITaxon:1494577 GC_ID:11 PMID:8123566 anthrax anthrax bacterium ncbi_taxonomy Bacillus cereus var. anthracis Bacteridium anthracis Bacillus anthracis NCBITaxon:1437010 GC_ID:1 PMID:11743200 PMID:11791233 ncbi_taxonomy Boreotheria Boreoeutheria NCBITaxon:1485 NCBITaxon:69207 GC_ID:11 PMID:26643615 PMID:27488356 ncbi_taxonomy Anaerobacter Anaerobacter Duda et al. 1996 Clostridium NCBITaxon:1489388 GC_ID:1 ncbi_taxonomy Euteleosteomorpha NCBITaxon:1491 NCBITaxon:29368 GC_ID:11 PMID:10028279 PMID:15244052 ncbi_taxonomy Bacillus botulinus Bacillus putrificus Botulobacillus botulinus Clostridium putrificum Ermengemillus botulinus Pacinia putrifica Clostridium botulinum NCBITaxon:149539 NCBITaxon:1245786 NCBITaxon:2588446 NCBITaxon:2588447 NCBITaxon:41533 NCBITaxon:592 GC_ID:11 PMID:10758910 Salmonella enterica serovar Enteritidis ncbi_taxonomy Bacillus enteritidis Salmonella enteritidis Salmonella enterica subsp. enterica serovar Enteritidis NCBITaxon:149595 GC_ID:1 ncbi_taxonomy Canine parainfluenza virus NCBITaxon:150052 GC_ID:11 PMID:11043982 ncbi_taxonomy Yersinia enterocolitica subsp. enterocolitica NCBITaxon:1502 NCBITaxon:1683536 NCBITaxon:3298488 GC_ID:11 PMID:1374625 PMID:184898 ncbi_taxonomy Bacterium welchii Clostridium perfringens (Veillon and Zuber 1898) Hauduroy et al. 1937 (Approved Lists 1980) Clostridium plagarum Clostridium perfringens NCBITaxon:1506574 NCBITaxon:10781 GC_ID:1 Parvovirus Parvoviruses ncbi_taxonomy Protoparvovirus NCBITaxon:1513 GC_ID:11 ncbi_taxonomy Bacillus tetani Clostridium tetani NCBITaxon:151340 GC_ID:1 PMID:20206957 Papillomavirus ncbi_taxonomy Papillomaviridae NCBITaxon:151341 GC_ID:1 ncbi_taxonomy Polyomaviridae NCBITaxon:153135 NCBITaxon:11762 GC_ID:1 MLV-related viruses Mammalian type C retrovirus group Mammalian type C retroviruses mammalian type C oncoviruses type C oncoviruses ncbi_taxonomy Gammaretrovirus NCBITaxon:1549675 GC_ID:1 ncbi_taxonomy Galloanseri Galloanserae NCBITaxon:160 GC_ID:11 ncbi_taxonomy Microspironema pallidum Spirillum pallidum Spirochaeta pallida Spironema pallidum Treponema pallidum NCBITaxon:162145 HMPV GC_ID:1 ncbi_taxonomy human metapneumovirus NCBITaxon:162387 GC_ID:1 ncbi_taxonomy Metapneumovirus NCBITaxon:1639 NCBITaxon:1634566 NCBITaxon:2293539 NCBITaxon:2293540 NCBITaxon:2293541 NCBITaxon:2293542 NCBITaxon:2293543 NCBITaxon:2293544 NCBITaxon:2293545 NCBITaxon:2293546 NCBITaxon:2293547 NCBITaxon:2364651 NCBITaxon:2364652 NCBITaxon:2364653 NCBITaxon:2364654 NCBITaxon:2364655 NCBITaxon:2364656 NCBITaxon:2364657 NCBITaxon:2364658 NCBITaxon:2364659 NCBITaxon:2364660 NCBITaxon:2482733 NCBITaxon:2482734 NCBITaxon:2482735 NCBITaxon:2482736 NCBITaxon:2482737 NCBITaxon:2482738 NCBITaxon:2482739 NCBITaxon:2482740 NCBITaxon:2482741 NCBITaxon:2482742 NCBITaxon:2482743 NCBITaxon:2482744 NCBITaxon:2482745 NCBITaxon:2482746 NCBITaxon:2482747 NCBITaxon:2482748 NCBITaxon:2482749 NCBITaxon:2484857 NCBITaxon:2484858 NCBITaxon:2485082 NCBITaxon:2485083 NCBITaxon:2485084 NCBITaxon:2485085 NCBITaxon:2485086 NCBITaxon:2485087 NCBITaxon:2485088 NCBITaxon:2485089 NCBITaxon:2485090 NCBITaxon:2485091 NCBITaxon:2485092 NCBITaxon:2485093 NCBITaxon:2485094 NCBITaxon:2485095 NCBITaxon:2485096 NCBITaxon:2486732 NCBITaxon:2486733 NCBITaxon:2486734 NCBITaxon:2486735 NCBITaxon:2486736 NCBITaxon:2486737 NCBITaxon:2486738 NCBITaxon:2486739 NCBITaxon:2486740 NCBITaxon:2486741 GC_ID:11 PMID:17773427 PMID:1906732 PMID:8782698 ncbi_taxonomy Bacterium monocytogenes Bacterium monocytogenes hominis Corynebacterium infantisepticum Corynebacterium parvulum Erysipelothrix monocytogenes Listerella hepatolytica Listeria monocytogenes NCBITaxon:1648 GC_ID:11 PMID:1503975 PMID:8427802 ncbi_taxonomy Bacillus insidiosus Bacillus rhusiopathiae suis Bacterium rhusiopathiae Erysipelothrix erysipeloides Erysipelothrix insidiosa Erysipelothrix murisepticus Erysipelothrix porci Erysipelothrix rhusiopathiae NCBITaxon:1649845 GC_ID:11 ncbi_taxonomy Yersinia pseudotuberculosis complex NCBITaxon:1653394 GC_ID:1 ncbi_taxonomy Mammarenavirus NCBITaxon:1678143 NCBITaxon:12461 NCBITaxon:2953663 GC_ID:1 ncbi_taxonomy Orthohepevirus A Paslahepevirus balayani NCBITaxon:169418 GC_ID:1 ncbi_taxonomy Mustelinae NCBITaxon:171 NCBITaxon:29512 NCBITaxon:29514 NCBITaxon:29516 GC_ID:11 PMID:10425768 PMID:1581182 PMID:19868121 PMID:9103653 ncbi_taxonomy Leptospira NCBITaxon:1716 NCBITaxon:144193 GC_ID:11 PMID:10425754 PMID:19661509 PMID:29760685 PMID:30186281 PMID:7547284 PMID:7547291 PMID:7547293 PMID:8186090 ncbi_taxonomy Turicella Corynebacterium NCBITaxon:1717 GC_ID:11 PMID:7729671 ncbi_taxonomy Bacillus diphtheriae Bacterium diphtheriae Microsporon diphthericum Microsporon diphtheriticum Mycobacterium diphtheriae Pacinia loeffleri Corynebacterium diphtheriae NCBITaxon:1719 GC_ID:11 ncbi_taxonomy Bacillus pseudotuberculosis Bacillus pseudotuberculosis-ovis Corynebacterium ovis Corynebacterium preisz-nocardi Corynebacterium pseudotuberculosis-ovis Mycobacterium tuberculosis-ovis Corynebacterium pseudotuberculosis NCBITaxon:173 NCBITaxon:2843297 NCBITaxon:2843299 GC_ID:11 PMID:15545494 PMID:19867994 PMID:19868337 PMID:19972157 PMID:25288661 PMID:9542090 ncbi_taxonomy Leptospira icteroides Spirochaeta biflexa Spirochaeta icterogenes Spirochaeta icterohaemorrhagiae Spirochaeta interrogans Spirochaeta nodosa Leptospira interrogans NCBITaxon:175121 GC_ID:1 ncbi_taxonomy Passeroidea NCBITaxon:176 GC_ID:11 ncbi_taxonomy Leptospira hardjo Leptospira interrogans serovar Hardjo NCBITaxon:1763 GC_ID:11 PMID:1380284 PMID:1581193 PMID:16014496 PMID:1883713 PMID:2275850 PMID:31296783 PMID:31649146 PMID:31649147 PMID:34554081 PMID:7547284 PMID:7547304 PMID:7907223 PMID:8863452 ncbi_taxonomy Mycobacterium Lehmann and Neumann 1896 (Approved Lists 1980) Mycobacterium NCBITaxon:1764 GC_ID:11 PMID:2397193 PMID:8347508 ncbi_taxonomy Bacillus tuberculosis gallinarum Mycobacterium tuberculosis avium Mycobacterium tuberculosis typus gallinaceus Tuberculose des oiseaux Mycobacterium avium NCBITaxon:1765 NCBITaxon:115863 GC_ID:11 PMID:10618079 PMID:11931153 PMID:14657105 PMID:29205127 ncbi_taxonomy Mycobacterium bovis Mycobacterium tuberculosis typus bovinus Mycobacterium tuberculosis var. bovis Mycobacterium tuberculosis variant bovis NCBITaxon:1769 GC_ID:11 ncbi_taxonomy Bacillus leprae Mycobacterium leprae NCBITaxon:1773 NCBITaxon:2528440 GC_ID:11 PMID:29205127 ncbi_taxonomy Bacillus tuberculosis Bacterium tuberculosis Mycobacterium tuberculosis (Zopf 1883) Lehmann and Neumann 1896 (Approved Lists 1980) Mycobacterium tuberculosis typus humanus Mycobacterium tuberculosis var. hominis Mycobacterium tuberculosis NCBITaxon:1781 GC_ID:11 PMID:12089250 PMID:20668542 PMID:38415640 ncbi_taxonomy Mycobacterium balnei Mycobacterium platypoecilus Mycobacterium marinum NCBITaxon:1783272 NCBITaxon:31968 NCBITaxon:3376104 GC_ID:11 PMID:18988685 Terrabacteria group ncbi_taxonomy Firmacutes Firmicuteota Firmicutes Firmicutes corrig. Gibbons and Murray 1978 (Approved Lists 1980) Terrabacteria Terrabacterida Bacillati NCBITaxon:180252 GC_ID:1 Marek's disease-like viruses ncbi_taxonomy Mardivirus NCBITaxon:180255 GC_ID:1 Infectious laryngo-tracheitis-like viruses Infectious laryngotracheitis-like viruses ncbi_taxonomy Iltovirus NCBITaxon:186537 GC_ID:1 Marburg-like viruses ncbi_taxonomy Marburgvirus NCBITaxon:186625 GC_ID:1 ncbi_taxonomy Clupeocephala NCBITaxon:186778 GC_ID:1 ncbi_taxonomy Novirhabdovirus NCBITaxon:1868215 GC_ID:1 ncbi_taxonomy Orthopneumovirus NCBITaxon:186938 GC_ID:1 ncbi_taxonomy Respirovirus NCBITaxon:1891747 NCBITaxon:10625 BFPyV GC_ID:1 Aves polyomavirus 1 BFDV Budgerigar fledgling disease polyomavirus Budgerigar fledgling disease virus Budgerigar fledgling polyomavirus ncbi_taxonomy Gammapolyomavirus avis NCBITaxon:1903411 GC_ID:11 PMID:27620848 ncbi_taxonomy Yersiniaceae NCBITaxon:194 GC_ID:11 PMID:11542086 PMID:12361288 PMID:16627635 PMID:1704793 PMID:19801389 PMID:29034857 PMID:38530055 ncbi_taxonomy Campylobacter NCBITaxon:196 GC_ID:11 PMID:11321120 PMID:1354478 ncbi_taxonomy Spirillum fetus Vibrio fetus Campylobacter fetus NCBITaxon:197 NCBITaxon:2172531 NCBITaxon:2182326 NCBITaxon:2201165 NCBITaxon:2211407 NCBITaxon:2211408 NCBITaxon:2211409 NCBITaxon:2293848 NCBITaxon:2293849 NCBITaxon:2293850 NCBITaxon:2303571 NCBITaxon:2305452 NCBITaxon:2305453 NCBITaxon:2305454 NCBITaxon:2305455 NCBITaxon:2305456 NCBITaxon:2305457 NCBITaxon:2305458 NCBITaxon:2305459 NCBITaxon:2340789 NCBITaxon:2478524 NCBITaxon:2572055 NCBITaxon:2572062 NCBITaxon:2572070 NCBITaxon:2572072 NCBITaxon:2572075 NCBITaxon:2572080 NCBITaxon:2572086 NCBITaxon:2870880 NCBITaxon:2870881 NCBITaxon:2893406 NCBITaxon:2916035 NCBITaxon:2916036 NCBITaxon:2939732 NCBITaxon:2950109 NCBITaxon:3042472 NCBITaxon:3042475 NCBITaxon:3042476 NCBITaxon:3042477 NCBITaxon:3042478 NCBITaxon:3042479 NCBITaxon:3042480 NCBITaxon:3042481 NCBITaxon:3042482 NCBITaxon:3042483 NCBITaxon:3042484 NCBITaxon:3042485 NCBITaxon:3042486 NCBITaxon:3042488 NCBITaxon:3109033 NCBITaxon:3109035 NCBITaxon:3109036 NCBITaxon:3109054 NCBITaxon:3109055 NCBITaxon:3231045 GC_ID:11 PMID:11321120 ncbi_taxonomy Campylobacter fetus subsp. jejuni Vibrio hepaticus Vibrio jejuni Campylobacter jejuni NCBITaxon:197911 GC_ID:1 Influenzavirus A ncbi_taxonomy Alphainfluenzavirus NCBITaxon:197912 GC_ID:1 Influenzavirus B ncbi_taxonomy Betainfluenzavirus NCBITaxon:197913 GC_ID:1 Influenzavirus C ncbi_taxonomy Gammainfluenzavirus NCBITaxon:1980410 GC_ID:1 ncbi_taxonomy Bunyavirales NCBITaxon:1980442 NCBITaxon:11598 GC_ID:1 ncbi_taxonomy Hantavirus Orthohantavirus NCBITaxon:1980915 NCBITaxon:38142 HIRRV GC_ID:1 Hirame novirhabdovirus Hirame rhabdovirus ncbi_taxonomy Novirhabdovirus hirame NCBITaxon:2 GC_ID:11 PMID:10425795 PMID:10425796 PMID:10425797 PMID:10490293 PMID:10843050 PMID:10939651 PMID:10939673 PMID:10939677 PMID:11211268 PMID:11321083 PMID:11321113 PMID:11411719 PMID:11540071 PMID:11542017 PMID:11542087 PMID:11760965 PMID:12054223 PMID:270744 PMID:32628106 PMID:36748408 PMID:7520741 PMID:8123559 PMID:8186100 PMID:8590690 PMID:9103655 PMID:9336922 eubacteria ncbi_taxonomy Bacteria (ex Cavalier-Smith 1987) Bacteria Woese et al. 2024 Bacteriobiota Monera Procaryotae Prokaryota Prokaryotae bacteria prokaryote prokaryotes Bacteria NCBITaxon:200644 GC_ID:11 ncbi_taxonomy Flavobacteriales NCBITaxon:203692 GC_ID:11 PMID:11837318 PMID:25288668 PMID:26654112 ncbi_taxonomy Spirochaetes Spirochaetia NCBITaxon:204722 GC_ID:11 PMID:12271122 Brucella suis str. 1330 ncbi_taxonomy Brucella melitensis biovar Suis str. 1330 Brucella suis ATCC 23444 Brucella suis NCTC 10316 Brucella suis 1330 NCBITaxon:205488 NCBITaxon:11268 GC_ID:1 Ebola virus EBO unidentified Ebola virus ncbi_taxonomy Ebola virus sp. NCBITaxon:206351 GC_ID:11 PMID:23575986 ncbi_taxonomy Neisseriales NCBITaxon:2093 NCBITaxon:29500 NCBITaxon:57371 GC_ID:4 PMID:10826816 PMID:11321109 PMID:11411711 PMID:11931184 PMID:13403276 PMID:15176735 PMID:16350067 PMID:16403858 PMID:25288662 PMID:8863441 PMID:8995799 ncbi_taxonomy Asterococcus Asteromyces Borrelomyces Bovimyces Eperythrozoon Haemobartonella Pleuropneumonia Mycoplasma NCBITaxon:2096 GC_ID:4 ncbi_taxonomy Mycoplasma gallisepticum Mycoplasmoides gallisepticum NCBITaxon:2099 GC_ID:4 PMID:11491338 PMID:1316139 PMID:1374621 PMID:8573513 ncbi_taxonomy Mycoplasma hyopneumoniae Mycoplasma suipneumoniae Mesomycoplasma hyopneumoniae NCBITaxon:210 NCBITaxon:219 GC_ID:11 PMID:11931154 PMID:1995031 PMID:8186097 PMID:8494747 ncbi_taxonomy Campylobacter pylori Campylobacter pylori subsp. pylori Campylobacter pyloridis Helicobacter nemestrinae Helicobacter pylori NCBITaxon:2109 GC_ID:4 ncbi_taxonomy Mycoplasma synoviae Mycoplasmopsis synoviae NCBITaxon:211880 GC_ID:11 ncbi_taxonomy Leptospira canicola Leptospira interrogans serovar Canicola NCBITaxon:213849 GC_ID:11 PMID:16403855 ncbi_taxonomy Campylobacterales NCBITaxon:2157 GC_ID:11 PMID:10425795 PMID:10425796 PMID:10425797 PMID:10490293 PMID:10843050 PMID:10939651 PMID:10939673 PMID:10939677 PMID:11211268 PMID:11321083 PMID:11321113 PMID:11411719 PMID:11540071 PMID:11541975 PMID:11542064 PMID:11542149 PMID:11760965 PMID:12054223 PMID:25527841 PMID:270744 PMID:32628106 PMID:36748408 PMID:8123559 PMID:8590690 PMID:9103655 PMID:9336922 ncbi_taxonomy Archaebacteria Archaebiota Mendosicutes Metabacteria Monera Procaryotae Prokaryota Prokaryotae archaea prokaryote prokaryotes Archaea NCBITaxon:2169991 NCBITaxon:11619 GC_ID:1 Argentinian mammarenavirus Junin arenavirus Junin mammarenavirus Junin virus Junn mammarenavirus ncbi_taxonomy Mammarenavirus juninense NCBITaxon:224914 GC_ID:11 PMID:11756688 ncbi_taxonomy Brucella melitensis ATCC 23456 Brucella melitensis bv. 1 str. 16M NCBITaxon:234 GC_ID:11 PMID:28066370 PMID:32373076 PMID:35335701 PMID:37395662 PMID:8573514 ncbi_taxonomy Brucella NCBITaxon:235 GC_ID:11 Brucella melitensis bv. Abortus ncbi_taxonomy Bacterium abortus Brucella melitensis biovar Abortus Brucella abortus NCBITaxon:236 GC_ID:11 Brucella melitensis bv. Ovis ncbi_taxonomy Brucella melitensis biovar Ovis Brucella ovis NCBITaxon:2497569 GC_ID:1 Negative-strand RNA viruses ncbi_taxonomy Negarnaviricota NCBITaxon:2497571 GC_ID:1 ncbi_taxonomy Polyploviricotina NCBITaxon:2501931 GC_ID:1 ncbi_taxonomy Orthocoronavirinae NCBITaxon:2559587 GC_ID:1 RNA viruses RNA viruses and viroids ncbi_taxonomy Riboviria NCBITaxon:2560069 GC_ID:1 ncbi_taxonomy Avulavirinae NCBITaxon:2560076 GC_ID:1 ncbi_taxonomy Orthoparamyxovirinae NCBITaxon:2560080 GC_ID:1 ncbi_taxonomy Rubulavirinae NCBITaxon:2560319 NCBITaxon:11176 NDV GC_ID:1 Avian Paramyxovirus Serotype I Avian avulavirus 1 Avian orthoavulavirus 1 Avian paramyxovirus type 1 Avian paramyxovirus type-1 Newcastle disease virus Newcastle disease virus NDV ncbi_taxonomy avian paramyxovirus 1 NCBITaxon:2560602 NCBITaxon:11161 NCBITaxon:1979165 GC_ID:1 Mumps virus ncbi_taxonomy Mumps rubulavirus Mumps orthorubulavirus NCBITaxon:260963 GC_ID:1 ncbi_taxonomy Avulavirus NCBITaxon:260964 GC_ID:1 ncbi_taxonomy Henipavirus NCBITaxon:2611341 GC_ID:1 PMID:30257078 ncbi_taxonomy Metamonada NCBITaxon:2611352 GC_ID:1 ncbi_taxonomy Discoba NCBITaxon:262698 GC_ID:11 PMID:15805518 Brucella abortus biovar 1 str. 9-941 Brucella abortus bv. 1 strain 9-941 ncbi_taxonomy Brucella abortus bv. 1 str. 9-941 NCBITaxon:263 GC_ID:11 ncbi_taxonomy Bacterium tularense Brucella tularensis Francisella tularense Pasteurella tularensis Francisella tularensis NCBITaxon:2697049 SARS-CoV-2 GC_ID:1 2019-nCoV COVID-19 virus HCoV-19 Human coronavirus 2019 SARS-2 SARS-CoV2 SARS2 ncbi_taxonomy Severe acute respiratory syndrome coronavirus 2 NCBITaxon:2732005 GC_ID:1 ncbi_taxonomy Bamfordvirae NCBITaxon:2732092 GC_ID:1 ncbi_taxonomy Shotokuvirae NCBITaxon:2732396 GC_ID:1 ncbi_taxonomy Orthornavirae NCBITaxon:2732406 GC_ID:1 Tombus-Noda-like virus sp. ncbi_taxonomy Kitrinoviricota NCBITaxon:2732415 GC_ID:1 ncbi_taxonomy Cossaviricota NCBITaxon:2732421 GC_ID:1 ncbi_taxonomy Papovaviricetes NCBITaxon:2732461 GC_ID:1 ncbi_taxonomy Alsuviricetes NCBITaxon:2732506 GC_ID:1 ncbi_taxonomy Pisoniviricetes NCBITaxon:2732514 GC_ID:1 ncbi_taxonomy Revtraviricetes NCBITaxon:2732525 GC_ID:1 ncbi_taxonomy Pokkesviricetes NCBITaxon:2732541 NCBITaxon:10880 GC_ID:1 ncbi_taxonomy Reoviridae Reovirales NCBITaxon:2732543 GC_ID:1 ncbi_taxonomy Hepelivirales NCBITaxon:2759 GC_ID:1 PMID:23020233 PMID:30257078 eucaryotes eukaryotes ncbi_taxonomy Eucarya Eucaryotae Eukarya Eukaryotae eukaryotes Eukaryota NCBITaxon:27592 GC_ID:1 ncbi_taxonomy Bovinae NCBITaxon:2790996 GC_ID:4 PMID:31385780 PMID:31971499 PMID:35947640 ncbi_taxonomy Mycoplasmoidales NCBITaxon:28115 NCBITaxon:29525 GC_ID:11 PMID:1503973 ncbi_taxonomy Bacteroides macacae Bacteroides melaninogenicus subsp. macacae Bacteroides salivosus Porphyromonas salivosa Porphyromonas macacae NCBITaxon:28174 NCBITaxon:707 GC_ID:11 ncbi_taxonomy Listonella ordalii Vibrio ordalii NCBITaxon:28211 GC_ID:11 PMID:11541974 PMID:11837318 PMID:16166687 PMID:16403855 PMID:19060069 ncbi_taxonomy Alphabacteria Proteobacteria alpha subdivision Purple bacteria, alpha subdivision a-proteobacteria alpha proteobacteria alpha subdivision alpha subgroup Alphaproteobacteria NCBITaxon:28216 GC_ID:11 PMID:16403855 PMID:28581923 ncbi_taxonomy Proteobacteria beta subdivision Purple bacteria, beta subdivision b-proteobacteria beta proteobacteria beta subdivision beta subgroup Betaproteobacteria NCBITaxon:28344 NCBITaxon:12796 NCBITaxon:70172 PRRSV GC_ID:1 Porcine reproductive and respiratory syndrome virus (PRRSV) Porcine respiratory and reproductive syndrome virus porcine reproductive and respiratory syndrome virus PRRSV porcine reproductive and respiratory syndrome virus, PRRSV ncbi_taxonomy Porcine reproductive and respiratory syndrome virus NCBITaxon:28450 NCBITaxon:1435366 NCBITaxon:1435368 NCBITaxon:1435988 NCBITaxon:1439853 NCBITaxon:1487954 NCBITaxon:1487955 GC_ID:11 PMID:12734250 PMID:1283774 ncbi_taxonomy Bacillus pseudomallei Bacterium whitmori Loefflerella pseudomallei Malleomyces pseudomallei Pseudomonas pseudomallei Burkholderia pseudomallei NCBITaxon:286 NCBITaxon:212745 GC_ID:11 PMID:10758879 PMID:10939664 PMID:15950132 PMID:18048745 PMID:7727274 PMID:9103607 RNA similarity group I ncbi_taxonomy "Chlorobacterium" Guillebeau 1890, nom. rejic. Opin. 6 (not "Chlorobacterium" Lauterborn 1916) Chryseomonas Flavimonas Liquidomonas Loefflerella Pseudomonas Migula 1894 (Approved Lists 1980) Serpens Serpens Hespell 1977 (Approved Lists 1980) Pseudomonas NCBITaxon:287 NCBITaxon:1224290 NCBITaxon:1437768 NCBITaxon:1437769 NCBITaxon:1437770 NCBITaxon:1508364 NCBITaxon:1607811 NCBITaxon:1607813 NCBITaxon:1683559 NCBITaxon:1683561 NCBITaxon:1851858 NCBITaxon:1851865 NCBITaxon:1860124 NCBITaxon:2952935 NCBITaxon:665948 NCBITaxon:912077 NCBITaxon:931955 NCBITaxon:931956 NCBITaxon:931957 NCBITaxon:931958 NCBITaxon:932477 GC_ID:11 ncbi_taxonomy Bacillus aeruginosus Bacillus pyocyaneus Bacterium aeruginosum Bacterium pyocyaneum Micrococcus pyocyaneus Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) Pseudomonas polycolor Pseudomonas pyocyanea probable synonym or variety: "Pseudomonas polycolor" Clara 1930 Pseudomonas aeruginosa NCBITaxon:2871093 GC_ID:1 avian encephalomyelitis virus ncbi_taxonomy tremovirus A1 NCBITaxon:2895623 GC_ID:4 PMID:31385780 PMID:31971499 PMID:35947640 ncbi_taxonomy Metamycoplasmataceae NCBITaxon:2901879 SARS-CoV GC_ID:1 SARS coronavirus SARS virus ncbi_taxonomy Severe acute respiratory syndrome coronavirus NCBITaxon:29176 GC_ID:1 ncbi_taxonomy Neospora caninum NCBITaxon:29459 GC_ID:11 PMID:8573514 ncbi_taxonomy Micrococcus melitensis Streptococcus Miletensis Brucella melitensis NCBITaxon:29461 GC_ID:11 Brucella melitensis bv. Suis ncbi_taxonomy Brucella melitensis biovar Suis Brucella suis NCBITaxon:2946186 NCBITaxon:689832 GC_ID:1 ncbi_taxonomy Sedoreovirinae Sedoreoviridae NCBITaxon:2946633 GC_ID:1 ncbi_taxonomy Heptrevirinae NCBITaxon:29486 GC_ID:11 ncbi_taxonomy Yersinia ruckeri NCBITaxon:29546 GC_ID:11 PMID:7547305 PMID:7857801 PMID:7981108 PMID:8123559 PMID:8347512 PMID:9226893 ncbi_taxonomy Candidatus intracellularis Ileal symbiont intracellularis Lawsonia intracellularis NCBITaxon:3044472 GC_ID:1 ncbi_taxonomy Orthoherpesviridae NCBITaxon:3044782 GC_ID:1 ncbi_taxonomy Orthoflavivirus NCBITaxon:3052223 NCBITaxon:45337 NCBITaxon:63330 GC_ID:1 PMID:7701348 Equine morbillivirus Hendra henipavirus Hendra virus ncbi_taxonomy Henipavirus hendraense NCBITaxon:3052225 NCBITaxon:121791 GC_ID:1 Nipah henipavirus Nipah virus Nipah-virus ncbi_taxonomy Henipavirus nipahense NCBITaxon:3052230 NCBITaxon:11103 HCV GC_ID:1 Hepacivirus C Hepatitis C virus hepatitis C virus HCV human hepatitis C virus human hepatitis C virus HCV human hepatitis virus C HCV post-transfusion hepatitis non A non B virus ncbi_taxonomy Hepacivirus hominis NCBITaxon:3052303 NCBITaxon:11623 NCBITaxon:12748 LCMV GC_ID:1 Lymphocytic choriomeningitis mammarenavirus Lymphocytic choriomeningitis virus lymphocytic choriomeningitis virus LCMV ncbi_taxonomy Mammarenavirus choriomeningitidis NCBITaxon:3052310 NCBITaxon:11620 GC_ID:1 Lassa mammarenavirus Lassa virus ncbi_taxonomy Mammarenavirus lassaense NCBITaxon:3052342 NCBITaxon:11232 GC_ID:1 Canine morbillivirus ncbi_taxonomy Morbillivirus canis NCBITaxon:3052518 NCBITaxon:11593 NCBITaxon:1980519 CCHFV GC_ID:1 Crimean-Congo haemorrhagic fever virus Crimean-Congo hemorrhagic fever nairovirus Crimean-Congo hemorrhagic fever orthonairovirus Crimean-Congo hemorrhagic virus ncbi_taxonomy Crimean-Congo hemorrhagic fever virus Orthonairovirus haemorrhagiae NCBITaxon:3052707 NCBITaxon:1511906 GC_ID:1 Carnivore protoparvovirus 1 Protoparvovirus carnivoran 1 ncbi_taxonomy Protoparvovirus carnivoran1 NCBITaxon:3052729 NCBITaxon:11215 GC_ID:1 Bovine parainfluenza 3 virus Bovine parainfluenza virus 3 Bovine parainfluenza virus type 3 Bovine respirovirus 3 ncbi_taxonomy Respirovirus bovis NCBITaxon:3072906 GC_ID:1 ncbi_taxonomy Musteloidea NCBITaxon:3073809 GC_ID:1 ncbi_taxonomy Australaves NCBITaxon:314145 GC_ID:1 PMID:11214318 PMID:11214319 PMID:12878460 ncbi_taxonomy Laurasiatheria NCBITaxon:314146 GC_ID:1 PMID:11214319 PMID:12082125 PMID:12878460 PMID:15522813 ncbi_taxonomy Euarchontoglires NCBITaxon:314147 GC_ID:1 PMID:11214319 PMID:12082125 PMID:15522813 Rodents and rabbits ncbi_taxonomy Glires NCBITaxon:314293 GC_ID:1 ncbi_taxonomy Anthropoidea Simiiformes NCBITaxon:32524 GC_ID:1 amniotes ncbi_taxonomy Amniota NCBITaxon:32561 GC_ID:1 diapsids ncbi_taxonomy Diapsida Sauria NCBITaxon:327045 GC_ID:1 ncbi_taxonomy Orthoretrovirinae NCBITaxon:329639 NCBITaxon:186155 GC_ID:1 Canine parvovirus-1 Minute virus of canines ncbi_taxonomy Canine minute virus NCBITaxon:33154 GC_ID:1 ncbi_taxonomy Fungi/Metazoa group opisthokonts Opisthokonta NCBITaxon:33213 GC_ID:1 ncbi_taxonomy Bilateria NCBITaxon:33317 GC_ID:1 ncbi_taxonomy Protostomia NCBITaxon:33340 GC_ID:1 ncbi_taxonomy Neoptera NCBITaxon:333774 GC_ID:1 ncbi_taxonomy unclassified Papillomaviridae NCBITaxon:3344809 GC_ID:1 ncbi_taxonomy Herpes Simplexvirus NCBITaxon:33550 GC_ID:1 guinea pigs and others ncbi_taxonomy Hystricognathi Hystricomorpha NCBITaxon:33554 GC_ID:1 carnivores ncbi_taxonomy carnivores Carnivora NCBITaxon:3379134 GC_ID:11 ncbi_taxonomy Pseudomonadati NCBITaxon:33892 BCG GC_ID:11 ncbi_taxonomy Mycobacterium bovis BCG bacillus Calmette-Guerin bacillus Calmette-Guerin BCG Mycobacterium tuberculosis variant bovis BCG NCBITaxon:34085 GC_ID:11 PMID:13200095 PMID:22427448 PMID:8240957 PMID:9103649 ncbi_taxonomy Moraxella anatipestifer Pasteurella anapestifer Pasteurella anatipestifer Pfeifferella anatipestifer Riemerella anatipestifer NCBITaxon:353210 GC_ID:1 ncbi_taxonomy Replication competent viruses NCBITaxon:35324 GC_ID:1 ncbi_taxonomy unclassified Orthomyxoviridae NCBITaxon:35500 GC_ID:1 ncbi_taxonomy Pecora NCBITaxon:359391 GC_ID:11 PMID:16299333 PMID:20462421 ncbi_taxonomy Brucella melitensis biovar Abortus 2308 Brucella abortus 2308 NCBITaxon:36362 NCBITaxon:10624 GC_ID:1 Polyomavirus Polyomaviruses ncbi_taxonomy Polyomavirus sp. NCBITaxon:36420 GC_ID:1 ncbi_taxonomy H1N1 swine influenza virus NCBITaxon:36470 GC_ID:11 ncbi_taxonomy Streptococcus sp. (group A) group A streptococci group A streptococcus Streptococcus sp. 'group A' NCBITaxon:36855 GC_ID:11 Brucella melitensis bv. Canis ncbi_taxonomy Brucella melitensis biovar Canis Brucella canis NCBITaxon:37124 GC_ID:1 ncbi_taxonomy Chikungunya virus NCBITaxon:379584 GC_ID:1 ncbi_taxonomy Caniformia NCBITaxon:38170 GC_ID:1 Avian reovirus ncbi_taxonomy Avian orthoreovirus NCBITaxon:38345 GC_ID:11 PMID:1581182 ncbi_taxonomy Leptospira grippotyphosa Leptospira kirschneri serovar Grippotyphosa NCBITaxon:38525 GC_ID:1 Avian pneumovirus ncbi_taxonomy avian metapneumovirus NCBITaxon:38568 GC_ID:1 Leishmania ncbi_taxonomy Leishmania <subgenus> NCBITaxon:38574 GC_ID:1 ncbi_taxonomy Leishmania donovani species complex NCBITaxon:39107 NCBITaxon:109679 GC_ID:1 ncbi_taxonomy Murinae NCBITaxon:391902 GC_ID:1 ncbi_taxonomy Bos bubalis bubalis Bubalus bubalis bubalis NCBITaxon:393305 GC_ID:11 Yersinia enterocolitica subsp. enterocolitica str. 8081 Yersinia enterocolitica subsp. enterocolitica strain 8081 ncbi_taxonomy Yersinia enterocolitica subsp. enterocolitica 8081 NCBITaxon:39744 GC_ID:1 ncbi_taxonomy Rubulavirus NCBITaxon:39944 CpHV-1 GC_ID:1 Caprine herpesvirus 1 Caprine herpesvirus type 1 goat herpesvirus ncbi_taxonomy Caprine alphaherpesvirus 1 NCBITaxon:40050 NCBITaxon:10896 AHSV GC_ID:1 African horse sickness group African horse sickness virus African horse sickness virus (AHSV) African horsesickness virus ncbi_taxonomy African horse sickness virus AHSV Orbivirus alphaequi NCBITaxon:40051 NCBITaxon:12591 GC_ID:1 Bluetongue virus group bluetongue virus BTV ncbi_taxonomy Bluetongue virus NCBITaxon:400570 GC_ID:1 ncbi_taxonomy Quailpox virus NCBITaxon:40119 GC_ID:1 ncbi_taxonomy Parvovirinae NCBITaxon:40269 GC_ID:11 PMID:18048732 ncbi_taxonomy Vibrio salmonicida Aliivibrio salmonicida NCBITaxon:40674 GC_ID:1 mammals ncbi_taxonomy mammals Mammalia NCBITaxon:41678 TAdV-3 GC_ID:1 Marble spleen disease virus Turkey adenovirus serotype 3 Turkey haemorrhagic enteritis virus Turkey hemorrhagic enteritis virus hemorrhagic enteritis virus ncbi_taxonomy Turkey adenovirus 3 NCBITaxon:418101 GC_ID:1 ncbi_taxonomy Vinckeia Plasmodium (Vinckeia) NCBITaxon:418103 GC_ID:1 ncbi_taxonomy Plasmodium Plasmodium (Plasmodium) NCBITaxon:422676 GC_ID:1 ncbi_taxonomy Hematozoa Vivier 1982 Aconoidasida NCBITaxon:423054 GC_ID:1 ncbi_taxonomy Eimeriorina NCBITaxon:42890 GC_ID:1 ncbi_taxonomy Sarcocystis neurona NCBITaxon:430066 GC_ID:11 Brucella abortus str. S19 Brucella abortus strain S19 ncbi_taxonomy Brucella abortus S19 NCBITaxon:44088 CNPV GC_ID:1 Avipoxvirus clade B1 Canary poxvirus ncbi_taxonomy Canarypox virus NCBITaxon:444163 NCBITaxon:399128 GC_ID:11 PMID:18218934 ncbi_taxonomy Brucella microti NCBITaxon:444178 GC_ID:11 Brucella ovis str. ATCC 25840 Brucella ovis strain ATCC 25840 ncbi_taxonomy Brucella ovis ATCC 25840 NCBITaxon:452646 NCBITaxon:9667 GC_ID:1 American mink mink ncbi_taxonomy Mustela vison Neovison vison Neogale vison NCBITaxon:464095 GC_ID:1 ncbi_taxonomy Picornavirales NCBITaxon:470137 GC_ID:11 PMID:19346311 Brucella suis str. ATCC 23445 Brucella suis strain ATCC 23445 ncbi_taxonomy Brucella suis ATCC 23445 NCBITaxon:4751 GC_ID:1 PMID:11062127 PMID:12684019 ncbi_taxonomy Mycota fungi Fungi NCBITaxon:476 GC_ID:11 ncbi_taxonomy Haemophilus bovis Moraxella (subgen. Moraxella Lwoff 1939) bovis Moraxella duplex des bovids Moraxella bovis NCBITaxon:483179 GC_ID:11 PMID:19346311 Brucella canis str. ATCC 23365 Brucella canis strain ATCC 23365 ncbi_taxonomy Brucella canis ATCC 23365 NCBITaxon:487 GC_ID:11 ncbi_taxonomy Diplokokkus intracellularis meningitidis Micrococcus intracellularis Micrococcus meningitidis Micrococcus meningitidis cerebrospinalis Neisseria weichselbaumii Neisseria meningitidis NCBITaxon:50294 PsHV-1 GC_ID:1 Pacheco's disease virus Psittacid herpesvirus 1 ncbi_taxonomy Psittacid alphaherpesvirus 1 NCBITaxon:504568 GC_ID:1 trouts, salmons & chars ncbi_taxonomy Salmoninae NCBITaxon:517 GC_ID:11 PMID:11491321 ncbi_taxonomy Bordetella NCBITaxon:518 NCBITaxon:514 GC_ID:11 PMID:8240949 PMID:8782670 PMID:9226899 ncbi_taxonomy Alcaligenes bronchicanis Alcaligenes bronchisepticus Bacillus bronchicanis Bacillus bronchisepticus Bacterium bronchisepticus Brucella bronchiseptica Haemophilus bronchisepticus Bordetella bronchiseptica NCBITaxon:520 GC_ID:11 PMID:8240949 ncbi_taxonomy Bacterium tussis-convulsivae Haemophilus pertussis Hemophilus pertussis Microbe de la coqueluche Bordetella pertussis NCBITaxon:521 GC_ID:11 PMID:4074238 ncbi_taxonomy Bordetella avium NCBITaxon:543 GC_ID:11 PMID:10555323 PMID:10555334 PMID:16166704 PMID:27620848 ncbi_taxonomy Enterobacteraceae enterobacteria gamma-3 proteobacteria Enterobacteriaceae NCBITaxon:54315 NCBITaxon:136447 NCBITaxon:64986 NCBITaxon:96055 BVDV type II BVDV-2 GC_ID:1 PMID:7747470 Bovine viral diarrhea virus genotype 2 Bovine viral diarrhea virus type 2 Bovine viral diarrhea virus-2 bovine viral diarrhea virus type II pestivirus type 4 ncbi_taxonomy Bovine viral diarrhea virus 2 NCBITaxon:544448 GC_ID:11 Tenericutes ncbi_taxonomy "Mollicutaeota" Oren et al. 2015 "Tenericutes" Murray 1984 Mollicutota Mycoplasmatota NCBITaxon:546272 GC_ID:11 PMID:19346311 Brucella melitensis str. ATCC 23457 Brucella melitensis strain ATCC 23457 ncbi_taxonomy Brucella melitensis ATCC 23457 NCBITaxon:548681 GC_ID:1 ncbi_taxonomy Herpesvirales NCBITaxon:5500 GC_ID:1 ncbi_taxonomy Coccidioides NCBITaxon:55601 NCBITaxon:28167 NCBITaxon:665 GC_ID:11 PMID:21296930 ncbi_taxonomy Achromobacter ichthyodermis Listonella anguillara Listonella anguillarum Pseudomonas ichthyodermis Vibrio ichthyodermis Vibrio piscium Vibrio piscium var. japonicus Vibrio anguillarum NCBITaxon:55987 NCBITaxon:155284 NCBITaxon:86501 GC_ID:1 Salmon isavirus ncbi_taxonomy Isavirus salaris NCBITaxon:560210 GC_ID:1 ncbi_taxonomy Dintheria NCBITaxon:562 NCBITaxon:1637691 NCBITaxon:1806490 NCBITaxon:469598 NCBITaxon:662101 NCBITaxon:662104 GC_ID:11 PMID:10319482 E. coli Escherichia/Shigella coli ncbi_taxonomy Bacillus coli Bacterium coli Bacterium coli commune Enterococcus coli Escherichia coli NCBITaxon:5654 GC_ID:1 ncbi_taxonomy Trypanosomatidae NCBITaxon:5658 GC_ID:1 Leishmania ncbi_taxonomy Leishmania <genus> NCBITaxon:5659 NCBITaxon:31284 GC_ID:1 ncbi_taxonomy Leishmania (Leishmania) amazonensis Leishmania mexicana amazonensis Leishmania amazonensis NCBITaxon:5661 GC_ID:1 ncbi_taxonomy Leishmania (Leishmania) donovani Leishmania donovani NCBITaxon:5664 GC_ID:1 ncbi_taxonomy Leishmania (Leishmania) major Leishmania tropica major Leishmania major NCBITaxon:56690 NCBITaxon:33701 NCBITaxon:5724 GC_ID:1 PMID:12046599 PMID:15734659 PMID:22000167 ncbi_taxonomy Tritrichomonas suis NCBITaxon:5671 NCBITaxon:5662 GC_ID:1 ncbi_taxonomy Leishmania (Leishmania) infantum Leishmania donovani infantum Leishmania infantum NCBITaxon:568815 NCBITaxon:399127 GC_ID:11 PMID:19653890 Brucella microti str. CCM 4915 Brucella microti strain CCM 4915 ncbi_taxonomy Brucella sp. CCM 4915 Brucella microti CCM 4915 NCBITaxon:5690 GC_ID:1 ncbi_taxonomy Trypanosoma NCBITaxon:5691 GC_ID:1 ncbi_taxonomy Trypanosoma (Trypanozoon) brucei Trypanosoma brucei subgroup Trypanosoma brucei NCBITaxon:5693 GC_ID:1 ncbi_taxonomy Trypanosoma cruzi NCBITaxon:5741 GC_ID:1 PMID:11432808 PMID:19135417 ncbi_taxonomy Giardia duodenalis Giardia lamblia Lamblia intestinalis Giardia intestinalis NCBITaxon:5759 GC_ID:1 ncbi_taxonomy Entamoeba histolytica NCBITaxon:5761 GC_ID:1 ncbi_taxonomy Naegleria NCBITaxon:5762 GC_ID:1 ncbi_taxonomy Naegleria gruberi NCBITaxon:5763 GC_ID:1 brain-eating amoeba ncbi_taxonomy Naegleria fowleri NCBITaxon:5794 GC_ID:1 apicomplexans ncbi_taxonomy apicomplexans Apicomplexa NCBITaxon:5800 GC_ID:1 ncbi_taxonomy Eimeria NCBITaxon:5802 GC_ID:1 ncbi_taxonomy Eimeria tenella NCBITaxon:5804 GC_ID:1 ncbi_taxonomy Eimeria maxima NCBITaxon:5807 NCBITaxon:2200815 NCBITaxon:2200816 NCBITaxon:2200817 NCBITaxon:2200818 NCBITaxon:2200819 NCBITaxon:2200820 NCBITaxon:2200821 NCBITaxon:2200822 NCBITaxon:2200823 NCBITaxon:2200824 NCBITaxon:2200825 NCBITaxon:2200826 GC_ID:1 ncbi_taxonomy Cryptosporidium parvum NCBITaxon:5809 GC_ID:1 ncbi_taxonomy Sarcocystids Sarcocystidae NCBITaxon:5811 GC_ID:1 ncbi_taxonomy Toxoplasma gondii NCBITaxon:5820 GC_ID:1 ncbi_taxonomy Plasmodium NCBITaxon:5821 GC_ID:1 ncbi_taxonomy Plasmodium berghei NCBITaxon:5825 GC_ID:1 ncbi_taxonomy Plasmodium chabaudi NCBITaxon:5833 GC_ID:1 malaria parasite P. falciparum ncbi_taxonomy Plasmodium (Laverania) falciparum Plasmodium falciparum NCBITaxon:5850 GC_ID:1 ncbi_taxonomy Plasmodium knowlesi NCBITaxon:5855 GC_ID:1 malaria parasite P. vivax ncbi_taxonomy Haemamoeba vivax Haemamoeba vivax Grassi and Feletti, 1890 Plasmodium vivax NCBITaxon:5861 GC_ID:1 ncbi_taxonomy Plasmodium yoelli Plasmodium yoelii NCBITaxon:5863 GC_ID:1 Piroplasmids ncbi_taxonomy Piroplasmida NCBITaxon:5864 GC_ID:1 ncbi_taxonomy Babesia NCBITaxon:5865 GC_ID:1 ncbi_taxonomy Babesia bovis NCBITaxon:5866 GC_ID:1 ncbi_taxonomy Babesia bigemina NCBITaxon:5867 GC_ID:1 ncbi_taxonomy Babesia canis NCBITaxon:5873 GC_ID:1 ncbi_taxonomy Theileria NCBITaxon:5874 GC_ID:1 ncbi_taxonomy Theileria annulata NCBITaxon:5875 GC_ID:1 ncbi_taxonomy Theileria parva NCBITaxon:590 GC_ID:11 PMID:10319519 PMID:10939679 PMID:12072558 PMID:15653929 PMID:15653930 PMID:3231714 PMID:37486130 PMID:9731304 ncbi_taxonomy Salmonella NCBITaxon:59201 NCBITaxon:149049 GC_ID:11 PMID:15653929 PMID:15653930 PMID:7149525 ncbi_taxonomy Salmonella cholerae-suis subsp. cholerae-suis Salmonella choleraesuis subsp. choleraesuis Salmonella enterica I Salmonella enterica subsp. I Salmonella enterica subsp. Subsp. I Salmonella enterica subsp. Subsp. Ixxx Salmonella enterica subsp. enterica NCBITaxon:594 NCBITaxon:41510 GC_ID:11 ncbi_taxonomy Salmonella enterica serovar Gallinarum Salmonella gallinarum Salmonella enterica subsp. enterica serovar Gallinarum NCBITaxon:6181 GC_ID:1 ncbi_taxonomy Schistosoma NCBITaxon:6182 GC_ID:1 ncbi_taxonomy Schistosoma japonicum NCBITaxon:6183 GC_ID:1 ncbi_taxonomy Schistosoma mansoni NCBITaxon:619591 GC_ID:1 ncbi_taxonomy Monkeypox virus Zaire-96-I-16 NCBITaxon:620 GC_ID:11 PMID:26834722 ncbi_taxonomy Shigella NCBITaxon:622 GC_ID:11 PMID:12054222 Escherichia/Shigella dysenteriae ncbi_taxonomy Bacillus dysenteriae Bacillus dysentericus Bacillus shigae Eberthella dysenteriae Shigella shigae Shigella dysenteriae NCBITaxon:623 GC_ID:11 Escherichia flexneri Escherichia/Shigella flexneri ncbi_taxonomy Shigella paradysenteriae Shigella flexneri NCBITaxon:624 GC_ID:11 ncbi_taxonomy Bacterium sonnei Shigella sonnei NCBITaxon:629 GC_ID:11 Yersinia ncbi_taxonomy Yersinia <enterobacteria> NCBITaxon:632 GC_ID:11 PMID:15084509 ncbi_taxonomy Bacillus pestis Bacterium pestis Pasteurella pestis Pestisella pestis Yersinia pseudotuberculosis subsp. pestis Yersinia pestis NCBITaxon:633 NCBITaxon:1161941 GC_ID:11 PMID:2223608 PMID:23919959 ncbi_taxonomy Bacillus pseudotuberkulosis Bacterium pseudotuberculosis Pasteurella lymphangitidis Pasteurella pseudotuberculosis Shigella pseudotuberculosis Yersinia pseudotuberculosis NCBITaxon:6334 GC_ID:1 ncbi_taxonomy Trichina spiralis Trichinella spiralis NCBITaxon:635 GC_ID:11 Edwardsiella ncbi_taxonomy Asakusa group Bartholomew group Edwardsiella <enterobacteria> NCBITaxon:636 NCBITaxon:1471792 NCBITaxon:1471793 GC_ID:11 PMID:27539016 ncbi_taxonomy Edwardsiella anguillimortifera Paracolobactrum anguillimortiferum Edwardsiella tarda NCBITaxon:641 GC_ID:11 PMID:15143042 PMID:4954820 PMID:8427811 ncbi_taxonomy gamma-3 proteobacteria Vibrionaceae NCBITaxon:642 GC_ID:11 PMID:11155981 PMID:12067377 PMID:12807216 PMID:1380286 PMID:1380289 PMID:15388703 PMID:16560691 PMID:17012583 PMID:17158971 PMID:19567585 PMID:7520733 PMID:8347521 PMID:8934910 ncbi_taxonomy Aeromonas NCBITaxon:644 NCBITaxon:1426505 NCBITaxon:1426713 NCBITaxon:1471787 NCBITaxon:1471788 NCBITaxon:1538469 NCBITaxon:329135 NCBITaxon:329140 NCBITaxon:346633 NCBITaxon:346634 NCBITaxon:582196 NCBITaxon:582198 NCBITaxon:582214 NCBITaxon:582215 NCBITaxon:582216 NCBITaxon:582217 NCBITaxon:582218 NCBITaxon:582219 NCBITaxon:582220 NCBITaxon:582221 NCBITaxon:582222 NCBITaxon:582223 NCBITaxon:582224 NCBITaxon:582225 NCBITaxon:582226 NCBITaxon:582228 NCBITaxon:582229 NCBITaxon:582231 NCBITaxon:582236 NCBITaxon:582237 NCBITaxon:582240 NCBITaxon:582250 NCBITaxon:582251 NCBITaxon:582253 NCBITaxon:582254 NCBITaxon:582265 NCBITaxon:582266 NCBITaxon:582267 NCBITaxon:582279 NCBITaxon:582282 NCBITaxon:582284 NCBITaxon:582286 NCBITaxon:582287 NCBITaxon:582289 NCBITaxon:582290 NCBITaxon:582291 NCBITaxon:582292 NCBITaxon:582295 NCBITaxon:582297 NCBITaxon:582299 NCBITaxon:582300 NCBITaxon:582302 NCBITaxon:582303 NCBITaxon:582304 NCBITaxon:582305 NCBITaxon:582306 NCBITaxon:582307 NCBITaxon:582308 NCBITaxon:582309 NCBITaxon:582310 NCBITaxon:582311 NCBITaxon:582312 NCBITaxon:582313 NCBITaxon:582314 NCBITaxon:582315 NCBITaxon:582316 NCBITaxon:582317 NCBITaxon:582318 NCBITaxon:582319 NCBITaxon:582320 NCBITaxon:582321 NCBITaxon:582322 NCBITaxon:582323 NCBITaxon:582324 NCBITaxon:98358 GC_ID:11 PMID:16560691 PMID:19965992 PMID:932684 ncbi_taxonomy Aeromonas dourgesi Aeromonas hydrophila (Chester 1901) Stanier 1943 (Approved Lists 1980) Aeromonas liquefaciens Bacillus hydrophilus fuscus Bacterium hydrophilum Proteus hydrophilus Proteus ichthyosmius Pseudomonas hydrophila Aeromonas hydrophila NCBITaxon:645 NCBITaxon:1055664 NCBITaxon:697046 GC_ID:11 PMID:19965992 ncbi_taxonomy Bacillus salmonicida Bacterium salmonicida Proteus salmonicida Aeromonas salmonicida NCBITaxon:64895 NCBITaxon:1618316 GC_ID:11 PMID:10515907 PMID:10758897 PMID:16585709 PMID:24744012 PMID:27930271 PMID:28141502 PMID:30154058 PMID:30586413 PMID:31454394 PMID:31722850 PMID:31836459 PMID:32320380 PMID:35816828 PMID:36748499 PMID:7981102 PMID:8573491 PMID:8934900 PMID:8995795 PMID:9336916 Lyme Disease Borrelia ncbi_taxonomy Borrelia burgdorferi group Borrelia burgdorferi sensu lato Borreliella NCBITaxon:662 NCBITaxon:705 GC_ID:11 PMID:1371064 PMID:17978204 PMID:21057054 PMID:21296930 PMID:24409173 PMID:4935323 PMID:7520733 PMID:8590667 ncbi_taxonomy Beneckea Listonella Microspira Pacinia Vibrio NCBITaxon:666 NCBITaxon:140100 NCBITaxon:376726 GC_ID:11 PMID:1015934 PMID:9272984 ncbi_taxonomy Bacillo virgola del Koch Bacillus cholerae Bacillus cholerae-asiaticae Kommabacillus Liquidivibrio cholerae Microspira comma Pacinia cholerae-asiaticae Spirillum cholerae Spirillum cholerae-asiaticae Vibrio albensis Vibrio cholera Vibrio cholerae biovar albensis Vibrio cholerae bv. albensis Vibrio cholerae-asiaticae Vibrio comma Vibrio cholerae NCBITaxon:67780 GC_ID:11 ncbi_taxonomy Edwardsiella ictaluri NCBITaxon:691956 NCBITaxon:352473 DHV-1 GC_ID:1 Duck hepatitis A virus Duck hepatitis virus 1 Duck hepatitis virus type 1 ncbi_taxonomy Avihepatovirus A NCBITaxon:693995 GC_ID:1 ncbi_taxonomy Coronavirinae NCBITaxon:693997 GC_ID:1 Alphacoronavirus-1 ncbi_taxonomy Alphacoronavirus 1 NCBITaxon:694002 NCBITaxon:156439 GC_ID:1 Coronavirus group 2 Group 2 species ncbi_taxonomy Coronavirus Betacoronavirus NCBITaxon:694009 NCBITaxon:227859 NCBITaxon:311178 HCoV-SARS SARS SARSr-CoV SARSrCoV GC_ID:1 Human coronavirus (strain SARS) SARS-like coronavirus SARS-related coronavirus ncbi_taxonomy Severe acute respiratory syndrome-related coronavirus NCBITaxon:70796 GC_ID:1 ncbi_taxonomy Tremovirus A NCBITaxon:70999 GC_ID:1 kissing bugs ncbi_taxonomy Triatominae NCBITaxon:712 GC_ID:11 PMID:10843050 PMID:15280320 PMID:15388716 PMID:17220461 PMID:2223605 PMID:29923825 ncbi_taxonomy Pasteurellaceae NCBITaxon:715 GC_ID:11 PMID:1847295 ncbi_taxonomy Haemophilus pleuropneumoniae Actinobacillus pleuropneumoniae NCBITaxon:7164 GC_ID:1 Anopheles ncbi_taxonomy Anopheles <genus> NCBITaxon:72273 GC_ID:11 ncbi_taxonomy Thiomicrospira group Thiothrix/Francisella group Thiotrichales NCBITaxon:724 GC_ID:11 PMID:1736960 ncbi_taxonomy Haemophilus NCBITaxon:727 GC_ID:11 ncbi_taxonomy Bacterium influenzae Coccobacillus pfeifferi Haemophilus meningitidis Influenza-bacillus Mycobacterium influenzae Haemophilus influenzae NCBITaxon:731 NCBITaxon:163489 NCBITaxon:214923 GC_ID:11 PMID:13130032 PMID:4333932 ncbi_taxonomy Haemophilus agni Haemophilus ovis Haemophilus somnifer Haemophilus somnus Hemophilus agni Histophilus ovis Histophilus somni NCBITaxon:738 GC_ID:11 PMID:5821848 ncbi_taxonomy Haemophilus parasuis Glaesserella parasuis NCBITaxon:747 GC_ID:11 PMID:15184562 ncbi_taxonomy Bacterium multocidum Micrococcus gallicidus Pasteurella cholerae-gallinarum Pasteurella gallicida Pasteurella multocida NCBITaxon:75985 NCBITaxon:746 GC_ID:11 PMID:10028248 PMID:8782683 ncbi_taxonomy Pasteurella haemolytica Newsom and Cross 1932 (Approved Lists 1980) Mannheimia haemolytica NCBITaxon:766 GC_ID:11 PMID:11760958 PMID:8240958 rickettsias ncbi_taxonomy alpha-1 proteobacteria Rickettsiales NCBITaxon:76803 GC_ID:1 ncbi_taxonomy Arteriviridae NCBITaxon:76804 GC_ID:1 ncbi_taxonomy Nidovirales NCBITaxon:77054 NCBITaxon:61430 GC_ID:1 ncbi_taxonomy Theileria hirci Theileria lestoquardi NCBITaxon:7742 GC_ID:1 Vertebrata vertebrates ncbi_taxonomy vertebrates Vertebrata <vertebrates> NCBITaxon:777 GC_ID:11 PMID:9226923 ncbi_taxonomy Rickettsia burneti Rickettsia diaporica Coxiella burnetii NCBITaxon:780 GC_ID:11 PMID:10939649 PMID:11491333 PMID:14662925 PMID:9103608 ncbi_taxonomy Rickettsia NCBITaxon:7898 GC_ID:1 fish fishes ray-finned fishes ncbi_taxonomy Actinopterygi Osteichthyes bony fishes Actinopterygii NCBITaxon:79668 GC_ID:11 ncbi_taxonomy Clostridium perfringens C NCBITaxon:7995 GC_ID:1 catfishes ncbi_taxonomy Siluriformes NCBITaxon:8015 GC_ID:1 PMID:15062801 salmonids ncbi_taxonomy Salmonidae NCBITaxon:8022 NCBITaxon:1311475 GC_ID:1 rainbow trout ncbi_taxonomy Oncorhynchus nerka mykiss Parasalmo mykiss Salmo mykiss Oncorhynchus mykiss NCBITaxon:80840 GC_ID:11 PMID:16403855 ncbi_taxonomy Burkholderia/Oxalobacter/Ralstonia group Burkholderiales NCBITaxon:810 NCBITaxon:83553 GC_ID:11 PMID:10319462 PMID:11211265 PMID:21048221 PMID:21048222 PMID:23620152 PMID:25618261 PMID:9103632 PMID:9103637 ncbi_taxonomy "Prowazekia" Coles 1953 Bedsonia Chlamydophila Miyagawanella Rakeia Rickettsiaformis Chlamydia NCBITaxon:813 GC_ID:11 PMID:10192388 PMID:10319462 PMID:8102247 PMID:8347519 ncbi_taxonomy Chlamydozoon trachomatis Rickettsia trachomae Rickettsia trachomatis Chlamydia trachomatis NCBITaxon:83334 GC_ID:11 ncbi_taxonomy Escherichia coli O157:H7 NCBITaxon:83554 NCBITaxon:812 GC_ID:11 PMID:10319462 PMID:12807198 PMID:8102247 PMID:8347519 ncbi_taxonomy Chlamydophila psittaci Chlamydozoon psittaci Ehrlichia psittaci Rickettsia psittaci Rickettsiaformis psittacosis Chlamydia psittaci NCBITaxon:83555 GC_ID:11 PMID:10319462 PMID:12807198 PMID:25618261 ncbi_taxonomy Chlamydia psittaci (Lillie 1930) Page 1968 Chlamydia psittaci serotype 1 Chlamydophila abortus Chlamydia abortus NCBITaxon:83558 NCBITaxon:811 GC_ID:11 PMID:10319462 PMID:8102247 PMID:8347519 ncbi_taxonomy Chlamydophila pneumoniae Chlamydia pneumoniae NCBITaxon:83560 GC_ID:11 PMID:10319462 agent of mouse pneumonitis ncbi_taxonomy Chlamydia trachomatis MoPn Chlamydia muridarum NCBITaxon:836 GC_ID:11 PMID:15774632 PMID:24158948 PMID:25481042 PMID:8186083 PMID:8590687 ncbi_taxonomy Porphyromonas NCBITaxon:85007 NCBITaxon:1761 GC_ID:11 PMID:11837321 PMID:1736962 PMID:19244447 PMID:31157615 ncbi_taxonomy Corynebacteriales Corynebacteriales Goodfellow and Jones 2015 Corynebacteriineae Corynebacteriineae corrig. Stackebrandt et al. 1997 Corynebacterineae Mycobacteriales Janke 1924 (Approved Lists 1980) Mycobacteriineae Mycobacteriales NCBITaxon:85708 PCV2 GC_ID:1 Porcine circovirus Type II Porcine circovirus type 2 Porcine circovirus-2 ncbi_taxonomy Porcine circovirus 2 NCBITaxon:8782 GC_ID:1 birds ncbi_taxonomy avian birds Aves NCBITaxon:8825 GC_ID:1 ncbi_taxonomy Neognathae NCBITaxon:8835 GC_ID:1 ducks ncbi_taxonomy Anas NCBITaxon:9005 NCBITaxon:9099 GC_ID:1 turkeys ncbi_taxonomy Phasianidae NCBITaxon:90062 GC_ID:11 ncbi_taxonomy Leptospira interrogans serovar Icterohaemorrhagiae NCBITaxon:9031 GC_ID:1 Gallus domesticus bantam chicken chickens ncbi_taxonomy Gallus gallus domesticus Phasianus gallus Gallus gallus NCBITaxon:90370 NCBITaxon:41530 NCBITaxon:601 NCBITaxon:72667 GC_ID:11 PMID:10319519 PMID:10758910 PMID:15653930 PMID:16558776 PMID:9336938 ncbi_taxonomy Bacillus typhi Bacterium (subgen. Eberthella) typhi Salmonella choleraesuis serovar Typhi Salmonella choleraesuis typhi Salmonella enterica ser. typhi Salmonella enterica serotype Typhi Salmonella enterica serovar Typhi Salmonella typhi Salmonella enterica subsp. enterica serovar Typhi NCBITaxon:90371 NCBITaxon:41532 NCBITaxon:59210 NCBITaxon:602 GC_ID:11 PMID:10758910 PMID:15653930 PMID:9336938 ncbi_taxonomy Bacillus typhimurium Salmonella choleraesuis serotype typhimurium Salmonella enterica 1,4,[5],12,:i:1,2 Salmonella enterica ser. typhimurium Salmonella enterica serotype Typhimurium Salmonella enterica serovar Typhimurium Salmonella enterica subsp. enterica serovar 1,4,[5],12:i:1,2 Salmonella typhi-murium Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium NCBITaxon:9103 GC_ID:1 common turkey turkey wild turkey ncbi_taxonomy Meleagris gallopavo NCBITaxon:91061 GC_ID:11 ncbi_taxonomy Bacillus/Lactobacillus/Streptococcus group Firmibacteria Bacilli NCBITaxon:91347 GC_ID:11 PMID:27620848 ncbi_taxonomy Enterobacteriaceae and related endosymbionts Enterobacteriaceae group Enterobacteriales gamma-3 proteobacteria Enterobacterales NCBITaxon:91561 GC_ID:1 even-toed ungulates & whales ncbi_taxonomy Cetartiodactyla even-toed ungulates & whales Artiodactyla NCBITaxon:9224 GC_ID:1 parrot parrots ncbi_taxonomy Psittacidae NCBITaxon:94063 GC_ID:11 ncbi_taxonomy Leptospira sp. Pomona NCBITaxon:9443 GC_ID:1 primate ncbi_taxonomy Primata primates Primates NCBITaxon:9479 GC_ID:1 New World monkeys monkey monkeys ncbi_taxonomy Platyrrhini NCBITaxon:950 GC_ID:11 PMID:11760958 PMID:1736961 PMID:7537065 Potomac horse fever agent equine monocytic ehrlichiosis agent ncbi_taxonomy Ehrlichia risticii Neorickettsia risticii NCBITaxon:9526 GC_ID:1 ncbi_taxonomy Catarrhini NCBITaxon:9534 GC_ID:1 African green monkey African green monkeys grivet savanah monkey ncbi_taxonomy Cercopithecus aethiops Ceropithecus aethiops Simia aethiops Chlorocebus aethiops NCBITaxon:9606 GC_ID:1 human ncbi_taxonomy Homo sapiens NCBITaxon:9608 GC_ID:1 dog, coyote, wolf, fox ncbi_taxonomy Canidae NCBITaxon:9611 GC_ID:1 ncbi_taxonomy Canis NCBITaxon:9612 GC_ID:1 gray wolf grey wolf ncbi_taxonomy Canis lupus NCBITaxon:9615 GC_ID:1 dog dogs ncbi_taxonomy Canis borealis Canis canis Canis domesticus Canis familiaris Canis lupus borealis Canis lupus familiaris NCBITaxon:9625 NCBITaxon:68731 NCBITaxon:9609 GC_ID:1 ncbi_taxonomy Fennecus Vulpes NCBITaxon:9654 GC_ID:1 northern raccoon raccoon ncbi_taxonomy Ursus lotor Procyon lotor NCBITaxon:9669 NCBITaxon:77150 GC_ID:1 black ferret domestic ferret ferret ncbi_taxonomy Mustela furo Mustela putorius furo NCBITaxon:9682 GC_ID:1 ncbi_taxonomy Felis NCBITaxon:9685 NCBITaxon:36475 GC_ID:1 PMID:17600185 PMID:8581300 PMID:8603894 cat cats domestic cat ncbi_taxonomy Felis domesticus Felis silvestris catus Felis catus NCBITaxon:976 NCBITaxon:171554 GC_ID:11 PMID:11541229 PMID:11542017 PMID:28066339 BCF group Bacteroides-Cytophaga-Flexibacter group CFB group Cytophaga-Flexibacter-Bacteroides phylum ncbi_taxonomy "Bacteroidota" Whitman et al. 2018 Bacteroidetes CFB group bacteria Sphingobacteria Bacteroidota NCBITaxon:9768 GC_ID:1 sei whale ncbi_taxonomy Balaenoptera borealis NCBITaxon:9788 GC_ID:1 horses ncbi_taxonomy Equidae NCBITaxon:9796 GC_ID:1 domestic horse equine horse ncbi_taxonomy Equus przewalskii f. caballus Equus przewalskii forma caballus Equus caballus NCBITaxon:9823 GC_ID:1 pig pigs swine wild boar ncbi_taxonomy Sus scrofa NCBITaxon:9850 GC_ID:1 deer ncbi_taxonomy Cervidae NCBITaxon:9895 GC_ID:1 ncbi_taxonomy Bovidae NCBITaxon:9900 GC_ID:1 ncbi_taxonomy Bison NCBITaxon:9901 GC_ID:1 American bison Bison ncbi_taxonomy Bos (Bison) bison Bos bison Bison bison NCBITaxon:9913 NCBITaxon:272461 GC_ID:1 bovine cow dairy cow domestic cattle domestic cow ox ncbi_taxonomy Bos bovis Bos primigenius taurus Bos taurus NCBITaxon:9925 NCBITaxon:57076 GC_ID:1 domestic goat goat goats ncbi_taxonomy Capra aegagrus hircus Capra hircus NCBITaxon:9935 GC_ID:1 ncbi_taxonomy Ovis NCBITaxon:9940 NCBITaxon:9936 GC_ID:1 domestic sheep lambs sheep wild sheep ncbi_taxonomy Ovis ammon aries Ovis orientalis aries Ovis ovis Ovis aries NCBITaxon:996 NCBITaxon:29531 GC_ID:11 PMID:11594628 PMID:16560903 PMID:29593693 ncbi_taxonomy Chondrococcus columnaris Cytophaga columnaris Flavobacterium columnare (Bernardet and Grimont 1989) Bernardet et al. 1996 Flexibacter columnaris Flexibacter columnaris (ex Davis 1922) Bernardet and Grimont 1989 Flavobacterium columnare NCBITaxon:9963 GC_ID:1 ncbi_taxonomy Caprinae NCBITaxon:9986 NCBITaxon:34833 NCBITaxon:9985 GC_ID:1 European rabbit Japanese white rabbit domestic rabbit rabbit rabbits ncbi_taxonomy Lepus cuniculus Oryctolagus cuniculus NCBITaxon:9989 GC_ID:1 rodent ncbi_taxonomy rodents Rodentia NCIT:C85994 A test to determine if a subject has ever had a tuberculosis infection. A small amount of purified tuberculosis protein is placed under the skin of the forearm and a positive skin reaction indicates previous exposure to Mycobacterium tuberculosis. Tuberculin Skin Test OAE:0000001 a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event. Melanie Courtot and YH: More work is needed on how to restrict the scope of a term to be an 'adverse event', notably regarding temporal association. When is an appropirate time interval between a medical intervention and an adverse event observed? One week, one month, one year, or a lifetime? For some well-studied medical interventions (e.g., administration of many vaccines or drugs), we probably have a general idea. For many new interventions, we don't know much. In OAE, this issue is associated with defining the 'adverse event incubation time'. YH: An adverse event is a process that has specified output of some adverse medical outcome (e.g., symptom, sign or accident) after a medical intervention (or process) (e.g., administration of drug or vaccine). The medical intervention can be an administration of a drug, a vaccine (i.e., vaccination), or a special nutritional product (for example, dietary supplement, infant formula, medical food), surgery, or usage of a medical device. YH: An adverse event is possibly induced by the medical intervention. It can be caused by the medical intervention, or may not be caused by the medical intervention. One ultimate goal (or the goal in clinics) of study adverse events is to assess if the adverse event outcome is due to the medical intervention. YH: In development of OAE, we initially use vaccine adverse event as our use case. A vaccine adverse event is associated with a vaccination (i.e. a medical intervention), regardless of whether it is considered vaccine-related, and includes any side effect, injury, toxicity, or sensitivity reaction or significant failure of immunization (i.e., a pharmacologic action). Ref: Baylor NW and Midthum K. Regulation and testing of vaccines. In: Vaccines (Editors: Plotkin S, Orenstein W, and Offit P). 2008. p1623. YH: The current term 'adverse event' is different from the term definition shown in our paper: He Y, Xiang Z, Sarntivijai S, Toldo L, Ceusters W. OAE: a realism-based biomedical ontology for the representation of adverse events. Adverse Event Representation Workshop, International Conference on Biomedical Ontologies (ICBO), University at Buffalo, NY, July 26-30, 2011. Full lenghth conference proceeding paper. We made the name changing in order to make OAE cover the broader sense of the 'adverse event' which does not assume definite causal effect between an adverse event and a medical intervention. In current definition, the adverse event emphasizes the time association and assumes a likelihood of such a causal association. This term 'adverse event' is stil under the OGMS:pathological bodily process. The 'adverse event' defined in the above paper has now been changed to a new term: 'causal adverse event'. See more information in the new publication: Yongqun He Y, Sirarat Sarntivijai, Yu Lin, Zuoshuang Xiang, Abra Guo, Shelley Zhang, Desikan Jagannathan, Luca Toldo, Cui Tao and Barry Smith. OAE: The Ontology of Adverse Events. Journal of Biomedical Semantics. 2014, 5:29 doi:10.1186/2041-1480-5-29. PMID: 25093068.PMCID: PMC4120740. YH: The main scope of OAE includes: (1) represent terms and relations in the area of adverse events, (2) assess possible associations between an adverse event and a medical intervention, particularly, identify any causal effect of a medical intervention to an adverse event; and (2) understand the mechanism (including molecular mechanisms) of causal adverse events. YH: There has been discussion regarding whether the term 'side effect' is an alternative term for 'adverse event'. In AERO, the term 'AERO:adverse event' represents a subset of those adverse events for which causality has been established. In OAE, an adverse event for which causality has been established is called 'causal adverse event'. Yongqun He AE adverse reaction WEB: http://en.wikipedia.org/wiki/Adverse_event WEB: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm WEB: http://www.ncbi.nlm.nih.gov/pubmed/25093068 The OAE official website is: http://www.oae-ontology.org/. adverse event OAE:0000004 an adverse event that occurs after a vaccination. YH vaccine adverse event OAE:0000055 A contraindication is a disposition that increases the risk of harm involved in using a particular drug, carrying out a medical procedure, or engaging in a particular activity such that the risk of harm exceeds a threshold. An contraindication serves as a reason to withhold a certain medical treatment. Yongqun He, Sirarat Sarntivijai, Mathias Brochhausen, William Hogan, ‎Philip E. Empey http://en.wikipedia.org/wiki/Contraindication contraindication OAE:0000097 an adverse event that is induced by a vaccination. YH vaccine-induced adverse event OBI:0000011 planned process Injecting mice with a vaccine in order to test its efficacy A process that realizes a plan which is the concretization of a plan specification. 'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.) We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some objectives is a planned process. Bjoern Peters branch derived 6/11/9: Edited at workshop. Used to include: is initiated by an agent This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call) planned process OBI:0000014 regulator role Fact sheet - Regulating the companies The role of the regulator. Ofwat is the economic regulator of the water and sewerage industry in England and Wales. http://www.ofwat.gov.uk/aptrix/ofwat/publish.nsf/Content/roleofregulator_factsheet170805 a regulatory role involved with making and/or enforcing relevant legislation and governmental orders Person:Jennifer Fostel regulator OBI regulator role OBI:0000016 regulation-assigned role Approval letter Regulation-assigned role is a regulatory role defined by legislation or governmental orders Person: Jennifer Fostel regulation-assigned role OBI:0000017 regulatory role Regulatory agency, Ethics committee, Approval letter; example: Browse these EPA Regulatory Role subtopics http://www.epa.gov/ebtpages/enviregulatoryrole.html Feb 29, 2008 a role which inheres in material entities and is realized in the processes of making, enforcing or being defined by legislation or orders issued by a governmental body. GROUP: Role branch OBI, CDISC govt agents responsible for creating regulations; proxies for enforcing regulations. CDISC definition: regulatory authorities. Bodies having the power to regulate. NOTE: In the ICH GCP guideline the term includes the authorities that review submitted clinical data and those that conduct inspections. These bodies are sometimes referred to as competent regulatory role OBI:0000047 processed material Examples include gel matrices, filter paper, parafilm and buffer solutions, mass spectrometer, tissue samples Is a material entity that is created or changed during material processing. PERSON: Alan Ruttenberg processed material OBI:0000067 evaluant role When a specimen of blood is assayed for glucose concentration, the blood has the evaluant role. When measuring the mass of a mouse, the evaluant is the mouse. When measuring the time of DNA replication, the evaluant is the DNA. When measuring the intensity of light on a surface, the evaluant is the light source. a role that inheres in a material entity that is realized in an assay in which data is generated about the bearer of the evaluant role Role call - 17nov-08: JF and MC think an evaluant role is always specified input of a process. Even in the case where we have an assay taking blood as evaluant and outputting blood, the blood is not the specified output at the end of the assay (the concentration of glucose in the blood is) examples of features that could be described in an evaluant: quality.... e.g. "contains 10 pg/ml IL2", or "no glucose detected") GROUP: Role Branch OBI Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term. evaluant role OBI:0000070 assay Assay the wavelength of light emitted by excited Neon atoms. Count of geese flying over a house. A planned process that has the objective to produce information about a material entity (the evaluant) by examining it. 12/3/12: BP: the reference to the 'physical examination' is included to point out that a prediction is not an assay, as that does not require physical examiniation. Discussion on OBI call 2023-05-01 resulted in an agreement to revise the textual definition of 'assay'. https://github.com/obi-ontology/obi/issues/1683. PlanAndPlannedProcess Branch measuring scientific observation OBI branch derived study assay any method assay OBI:0000086 reagent role Buffer, dye, a catalyst, a solvating agent. A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer. PERSON:Matthew Brush reagent PERSON:Matthew Brush Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term. May 28 2013. Updated definition taken from ReO based on discussions initiated in Philly 2011 workshop. Former defnition described a narrower view of reagents in chemistry that restricts bearers of the role to be chemical entities ("a role played by a molecular entity used to produce a chemical reaction to detect, measure, or produce other substances"). Updated definition allows for broader view of reagents in the domain of biomedical research to include larger materials that have parts that participate chemically in a molecular reaction or interaction. (copied from ReO) Reagents are distinguished from instruments or devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in or have parts that participate in some chemical interaction or reaction during their intended participation in some technique. By contrast, instruments do not participate in a chemical reaction/interaction during the technique. Reagents are distinguished from study subjects/evaluants in that study subjects and evaluants are that about which conclusions are drawn and knowledge is sought in an investigation - while reagents, by definition, are not. It should be noted, however, that reagent and study subject/evaluant roles can be borne by instances of the same type of material entity - but a given instance will realize only one of these roles in the execution of a given assay or technique. For example, taq polymerase can bear a reagent role or an evaluant role. In a DNA sequencing assay aimed at generating sequence data about some plasmid, the reagent role of the taq polymerase is realized. In an assay to evaluate the quality of the taq polymerase itself, the evaluant/study subject role of the taq is realized, but not the reagent role since the taq is the subject about which data is generated. In regard to the statement that reagents are 'distinct' from the specified outputs of a technique, note that a reagent may be incorporated into a material output of a technique, as long as the IDENTITY of this output is distinct from that of the bearer of the reagent role. For example, dNTPs input into a PCR are reagents that become part of the material output of this technique, but this output has a new identity (ie that of a 'nucleic acid molecule') that is distinct from the identity of the dNTPs that comprise it. Similarly, a biotin molecule input into a cell labeling technique are reagents that become part of the specified output, but the identity of the output is that of some modified cell specimen which shares identity with the input unmodified cell specimen, and not with the biotin label. Thus, we see that an important criteria of 'reagent-ness' is that it is a facilitator, and not the primary focus of an investigation or material processing technique (ie not the specified subject/evaluant about which knowledge is sought, or the specified output material of the technique). reagent role OBI:0000094 material processing A cell lysis, production of a cloning vector, creating a buffer. A planned process which results in physical changes in a specified input material PERSON: Bjoern Peters PERSON: Frank Gibson PERSON: Jennifer Fostel PERSON: Melanie Courtot PERSON: Philippe Rocca Serra material transformation OBI branch derived material processing OBI:0000181 population PMID12564891. Environ Sci Technol. 2003 Jan 15;37(2):223-8. Effects of historic PCB exposures on the reproductive success of the Hudson River striped bass population. a population is a collection of individuals from the same taxonomic class living, counted or sampled at a particular site or in a particular area 1/28/2013, BP, on the call it was raised that we may want to switch to an external ontology for all populatin terms: http://code.google.com/p/popcomm-ontology/ PERSON: Philippe Rocca-Serra adapted from Oxford English Dictionnary rem1: collection somehow always involve a selection process population OBI:0000237 antigen role A role of a material entity that is being recognized in whole or in part by receptors of the immune system such as antibodies or T cell receptors. An antigen is a substance that prompts the generation of antibodies and can cause an immune response. Wikipedia http://en.wikipedia.org/wiki/Antigen. In the strict sense, immunogens are those substances that elicit a response from the immune system, whereas antigens are defined as substances that bind to specific antibodies. Not all antigens produce an immunogenic response, but all immunogens are antigens Role Branch OBI 9Mar09 waiting for discussion with immunology terms antigen role OBI:0000245 organization PMID: 16353909.AAPS J. 2005 Sep 22;7(2):E274-80. Review. The joint food and agriculture organization of the United Nations/World Health Organization Expert Committee on Food Additives and its role in the evaluation of the safety of veterinary drug residues in foods. An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members. BP: The definition summarizes long email discussions on the OBI developer, roles, biomaterial and denrie branches. It leaves open if an organization is a material entity or a dependent continuant, as no consensus was reached on that. The current placement as material is therefore temporary, in order to move forward with development. Here is the entire email summary, on which the definition is based: 1) there are organization_member_roles (president, treasurer, branch editor), with individual persons as bearers 2) there are organization_roles (employer, owner, vendor, patent holder) 3) an organization has a charter / rules / bylaws, which specify what roles there are, how they should be realized, and how to modify the charter/rules/bylaws themselves. It is debatable what the organization itself is (some kind of dependent continuant or an aggregate of people). This also determines who/what the bearer of organization_roles' are. My personal favorite is still to define organization as a kind of 'legal entity', but thinking it through leads to all kinds of questions that are clearly outside the scope of OBI. Interestingly enough, it does not seem to matter much where we place organization itself, as long as we can subclass it (University, Corporation, Government Agency, Hospital), instantiate it (Affymetrix, NCBI, NIH, ISO, W3C, University of Oklahoma), and have it play roles. This leads to my proposal: We define organization through the statements 1 - 3 above, but without an 'is a' statement for now. We can leave it in its current place in the is_a hierarchy (material entity) or move it up to 'continuant'. We leave further clarifications to BFO, and close this issue for now. PERSON: Alan Ruttenberg PERSON: Bjoern Peters PERSON: Philippe Rocca-Serra PERSON: Susanna Sansone GROUP: OBI organization OBI:0000272 protocol PCR protocol, has objective specification, amplify DNA fragment of interest, and has action specification describes the amounts of experimental reagents used (e..g. buffers, dNTPS, enzyme), and the temperature and cycle time settings for running the PCR. A plan specification which has sufficient level of detail and quantitative information to communicate it between investigation agents, so that different investigation agents will reliably be able to independently reproduce the process. PlanAndPlannedProcess Branch OBI branch derived + wikipedia (http://en.wikipedia.org/wiki/Protocol_%28natural_sciences%29) study protocol protocol OBI:0000274 adding a material entity into a target Injecting a drug into a mouse. Adding IL-2 to a cell culture. Adding NaCl into water. is a process with the objective to place a material entity bearing the 'material to be added role' into a material bearing the 'target of material addition role'. Class was renamed from 'administering substance', as this is commonly used only for additions into organisms. BP branch derived adding a material entity into a target OBI:0000281 intraperitoneal injection is the injection of a material entity (bearing the administered substance role) into the peritoneum (bearing the target role) of an organism using a syringe BP intraperitoneal injection OBI:0000319 material to be added role drug added to a buffer contained in a tube; substance injected into an animal; A role of a material entity that is realized in an "adding a material entity into a target" process where the bearer of the role is added into another material entity (the target). Role Branch OBI 9 March 09 from discussion with PA branch material to be added role OBI:0000383 transfer function A transfer function is a function to displace a material from one location to another. Bill Bug Daniel Schober Frank Gibson Melanie Courtot transfer function OBI:0000422 syringe Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe.Ann Pharmacother. 2008 Jan;42(1):46-52. Epub 2007 Dec 4. PMID: 18056832 A processed material which is used to introduce or draw fluids from a material entity. A syringe is made of a piston and body. the movement of the piston in the body determines the amount/volume of fluid to inject or draw Philippe Rocca-Serra OBI Instrument adapted from Wikipedia syringe OBI:0000426 injection Multiple Small-Dose Injections Can Reduce the Passage of Sclerosant Foam into Deep Veins During Foam Sclerotherapy for Varicose Veins. Eur J Vasc Endovasc Surg. 2008 Oct 13. PMID: 18922712 injection is process which aims at introducing a compound or a mixture into a material entity (either biological entity or instrument) by relying on devices such as syringe or injector connection, attached or forced into a vascular system (veins of an organism or tubes of a machine) or in a tissue. Philippe Rocca-Serra OBI Biomaterial injection OBI:0000429 intraperitoneal administration Rats were injected intraperitoneally with either rrIL-6 (250 ng/0.5 ml) or equal-volume sterile saline twice within an interval of 24 h The administration of a substance into the peritoneum of an organism Person:Bjoern Peters intraperitoneal administration OBI:0000434 adding material objective creating a mouse infected with LCM virus is the specification of an objective to add a material into a target material. The adding is asymmetric in the sense that the target material largely retains its identity BP adding material objective OBI:0000441 assay objective the objective to determine the weight of a mouse. an objective specification to determine a specified type of information about an evaluated entity (the material entity bearing evaluant role) PPPB branch PPPB branch assay objective OBI:0000444 target of material addition role peritoneum of an animal receiving an interperitoneal injection; solution in a tube receiving additional material; location of absorbed material following a dermal application. A role of a material entity that is realized in an "adding a material entity into a target" process where the bearer of the role (the target) receives the addition of another material entity. From Branch discussion with BP, AR, MC -- there is a need for the recipient to interact with the administered material. for example, a tooth receiving a filling was not considered to be a target role. GROUP: Role Branch OBI target of material addition role OBI:0000450 regulatory agency The US Environmental Protection Agency A regulatory agency is a organization that has responsibility over or for the legislation (acts and regulations) for a given sector of the government. GROUP: OBI Biomaterial Branch WEB: en.wikipedia.org/wiki/Regulator regulatory agency OBI:0000456 material transformation objective The objective to create a mouse infected with LCM virus. The objective to create a defined solution of PBS. an objective specifiction that creates an specific output object from input materials. PERSON: Bjoern Peters PERSON: Frank Gibson PERSON: Jennifer Fostel PERSON: Melanie Courtot PERSON: Philippe Rocca-Serra artifact creation objective GROUP: OBI PlanAndPlannedProcess Branch material transformation objective OBI:0000457 manufacturing A planned process with the objective to produce a processed material which will have a function for future use. A person or organization (having manufacturer role) is a participant in this process Manufacturing implies reproducibility and responsibility AR This includes a single scientist making a processed material for personal use. PERSON: Bjoern Peters PERSON: Frank Gibson PERSON: Jennifer Fostel PERSON: Melanie Courtot PERSON: Philippe Rocca-Serra GROUP: OBI PlanAndPlannedProcess Branch manufacturing OBI:0000458 manufacturing objective is the objective to manufacture a material of a certain function (device) PERSON: Bjoern Peters PERSON: Frank Gibson PERSON: Jennifer Fostel PERSON: Melanie Courtot PERSON: Philippe Rocca-Serra GROUP: OBI PlanAndPlannedProcess Branch manufacturing objective OBI:0000571 manufacturer role With respect to The Accuri C6 Flow Cytometer System, the organization Accuri bears the role manufacturer role. With respect to a transformed line of tissue culture cells derived by a specific lab, the lab whose personnel isolated the cll line bears the role manufacturer role. With respect to a specific antibody produced by an individual scientist, the scientist who purifies, characterizes and distributes the anitbody bears the role manufacturer role. Manufacturer role is a role which inheres in a person or organization and which is realized by a manufacturing process. GROUP: Role Branch OBI manufacturer role OBI:0000576 scattered molecular aggregate the sodium and chloride ions in a glass of salt water a material entity that consists of all the molecules of a specific type that are located in some bounded region and which is part of a more massive material entity that has parts that are other such aggregates PERSON: Alan Ruttenberg Collective Discussion in Karslruhe with, among others, Alan Rector, Stefan Schulz, Marijke Keet, Melanie Courtot, and Alan Ruttenberg. With inspiration from the paper Granularity, scale and collectivity: When size does and does not matter, Alan Recto, Jeremy Rogers, Thomas Bittner, Journal of Biomedical Informatics 39 (2006) 333-349 scattered molecular aggregate OBI:0000652 material combination Mixing two fluids. Adding salt into water. Injecting a mouse with PBS. is a material processing with the objective to combine two or more material entities as input into a single material entity as output. created at workshop as parent class for 'adding material into target', which is asymmetric, while combination encompasses all addition processes. bp bp material combination OBI:0000673 statistical hypothesis test A statistical hypothesis test data transformation is a data transformation that has objective statistical hypothesis test. James Malone PERSON: James Malone statistical hypothesis test OBI:0000675 statistical hypothesis test objective is a data transformation objective where the aim is to estimate statistical significance with the aim of proving or disproving a hypothesis by means of some data transformation. James Malone Person:Helen Parkinson hypothesis test objective WEB: http://en.wikipedia.org/wiki/Statistical_hypothesis_testing statistical hypothesis test objective OBI:0000685 creating a mixture of molecules in solution The production of PBS is a process with the objective to prepare a liquid solution of one or more chemicals at desired concentrations. Bjoern Peters PERSON: Helen Parkinson creating a mixture of molecules in solution OBI:0000686 material combination objective is an objective to obtain an output material that contains several input materials. PPPB branch bp material combination objective OBI:0000712 pathogen challenge The administration of a live pathogenic organism to a host. pathogen challenge OBI:0000718 pathogen role Pathogen: An agent of disease. A disease producer. The term pathogen most commonly is used to refer to infectious organisms. These include bacteria (such as staph), viruses (such as HIV), and fungi (such as yeast). Less commonly, pathogen refers to a noninfectious agent of disease such as a chemical. http://www.medterms.com/script/main/art.asp?articlekey=6383 pathogen role is a role which inheres in an organism and realized in the process of disease course in the organism bearing host role caused by the organism bearing pathogen role GROUP: Role Branch OBI 6 April 2009: from the Vaccine Community pathogen role OBI:0000725 host role In biology, a host is an organism that harbors a virus or parasite, or a mutual or commensal symbiont, typically providing nourishment and shelter. http://en.wikipedia.org/wiki/Host_(biology) 30 March 09 host role is a role played by an organism and realized by providing nourishment, shelter or a means of reproduction to another organism within the organism playing the host role 30Mar09 virus reproducing inside a cell; bacteria causing a disease, host can be harmed or not. we want to avoid a cat sitting on my lap and an animal care technician; these are not examples or hosts; dental cares = on tooth, but part of outer layer of tooth, so covered by "within" in the definition GROUP: Role Branch 30 Mar09 submitted by vaccine community OBI http://en.wikipedia.org/wiki/Host_(biology) host role OBI:0000750 independent variable specification In a study in which gene expression is measured in patients between 8 month to 4 years old that have mild or severe malaria and in which the hypothesis is that gene expression in that age group is a function of disease status, disease status is the independent variable. a directive information entity that is part of a study design. Independent variables are entities whose values are selected to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled 2/2/2009 Original definition - In the design of experiments, independent variables are those whose values are controlled or selected by the person experimenting (experimenter) to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled. In the Philly 2013 workshop the label was chosen to distinguish it from "dependent variable" as used in statistical modelling. See: http://en.wikipedia.org/wiki/Statistical_modeling PERSON: Alan Ruttenberg PERSON: Bjoern Peters PERSON: Chris Stoeckert experimental factor independent variable Web: http://en.wikipedia.org/wiki/Dependent_and_independent_variables 2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify thisdefinition please notify OBI. study factor study design independent variable OBI:0000751 dependent variable specification In a study in which gene expression is measured in patients between 8 month to 4 years old that have mild or severe malaria and in which the hypothesis is that gene expression in that age group is a function of disease status, the gene expression is the dependent variable. dependent variable specification is part of a study design. The dependent variable is the event studied and expected to change when the independent variable varies. 2/2/2009 In the design of experiments, independent variables are those whose values are controlled or selected by the person experimenting (experimenter) to determine its relationship to an observed phenomenon (the dependent variable). In such an experiment, an attempt is made to find evidence that the values of the independent variable determine the values of the dependent variable (that which is being measured). The independent variable can be changed as required, and its values do not represent a problem requiring explanation in an analysis, but are taken simply as given. The dependent variable on the other hand, usually cannot be directly controlled. In the Philly 2013 workshop the label was chosen to distinguish it from "dependent variable" as used in statistical modelling. See: http://en.wikipedia.org/wiki/Statistical_modeling PERSON: Alan Ruttenberg PERSON: Bjoern Peters PERSON: Chris Stoeckert dependent variable WEB: http://en.wikipedia.org/wiki/Dependent_and_independent_variables 2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify thisdefinition please notify OBI. study design dependent variable OBI:0000806 material maintenance objective An objective specification maintains some or all of the qualities of a material over time. PERSON: Bjoern Peters PERSON: Bjoern Peters material maintenance objective OBI:0000835 manufacturer A person or organization that has a manufacturer role. manufacturer OBI:0000838 material maintenance A planned process with the objective to maintain some or all of the characteristics of an input material over time. material maintenance OBI:0000852 record of missing knowledge A statement in a journal article indicating that the age of a patient at the onset of disease is not known. A statement indicating that the weight of a mouse was not measured. An information content entity created to indicate that information about something is not available to the person recording it. This class should probably end up in IAO. It could be further breaken down to indicate different kinds of lack of knowledge, e.g. inability to determine something vs. no attempt made to determine something vs. no informatino available if it was even attempted to determine something. The design pattern should be generalizable. 'unknown sex' is the first example, and needed immediately. Bjoern Peters record of missing knowledge OBI:0000938 categorical measurement datum A measurement datum that is reported on a categorical scale. Bjoern Peters nominal mesurement datum Bjoern Peters categorical measurement datum OBI:0000968 device A voltmeter is a measurement device which is intended to perform some measure function. An autoclave is a device that sterlizes instruments or contaminated waste by applying high temperature and pressure. A material entity that is designed to perform a function in a scientific investigation, but is not a reagent. 2012-12-17 JAO: In common lab usage, there is a distinction made between devices and reagents that is difficult to model. Therefore we have chosen to specifically exclude reagents from the definition of "device", and are enumerating the types of roles that a reagent can perform. 2013-6-5 MHB: The following clarifications are outcomes of the May 2013 Philly Workshop. Reagents are distinguished from devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in some chemical interaction or reaction during the realization of their experimental role. By contrast, devices do not participate in such chemical reactions/interactions. Note that there are cases where devices use reagent components during their operation, where the reagent-device distinction is less clear. For example: (1) An HPLC machine is considered a device, but has a column that holds a stationary phase resin as an operational component. This resin qualifies as a device if it participates purely in size exclusion, but bears a reagent role that is realized in the running of a column if it interacts electrostatically or chemically with the evaluant. The container the resin is in (“the column”) considered alone is a device. So the entire column as well as the entire HPLC machine are devices that have a reagent as an operating part. (2) A pH meter is a device, but its electrode component bears a reagent role in virtue of its interacting directly with the evaluant in execution of an assay. (3) A gel running box is a device that has a metallic lead as a component that participates in a chemical reaction with the running buffer when a charge is passed through it. This metallic lead is considered to have a reagent role as a component of this device realized in the running of a gel. In the examples above, a reagent is an operational component of a device, but the device itself does not realize a reagent role (as bearing a reagent role is not transitive across the part_of relation). In this way, the asserted disjointness between a reagent and device holds, as both roles are never realized in the same bearer during execution of an assay. PERSON: Helen Parkinson instrument OBI development call 2012-12-17. device OBI:0000969 dose specification a protocol specifying to administer 1 ml of vaccine to a mouse a directive information entity that describes the dose that will be administered to a target dose specification OBI:0000984 dose An organism has been injected 1ml of vaccine A measurement datum that measures the quantity of something that may be administered to an organism or that an organism may be exposed to. Quantities of nutrients, drugs, vaccines and toxins are referred to as doses. dose OBI:0001930 categorical value specification A value specification that is specifies one category out of a fixed number of nominal categories PERSON:Bjoern Peters categorical value specification OBI:0001933 value specification The value of 'positive' in a classification scheme of "positive or negative"; the value of '20g' on the quantitative scale of mass. An information content entity that specifies a value within a classification scheme or on a quantitative scale. This term is currently a descendant of 'information content entity', which requires that it 'is about' something. A value specification of '20g' for a measurement data item of the mass of a particular mouse 'is about' the mass of that mouse. However there are cases where a value specification is not clearly about any particular. In the future we may change 'value specification' to remove the 'is about' requirement. PERSON:Bjoern Peters value specification OBI:0003456 in vivo challenge The administration of a challenge to a live host. Hector Guzman-Orozco IEDB in vivo challenge OBI:0003610 reactant role A role borne by a biological or chemical entity that participates or has molecular components that participate in a chemical reaction. Sebastian Duesing reactant role OBI:0100026 organism animal fungus plant virus A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs. 10/21/09: This is a placeholder term, that should ideally be imported from the NCBI taxonomy, but the high level hierarchy there does not suit our needs (includes plasmids and 'other organisms') 13-02-2009: OBI doesn't take position as to when an organism starts or ends being an organism - e.g. sperm, foetus. This issue is outside the scope of OBI. GROUP: OBI Biomaterial Branch WEB: http://en.wikipedia.org/wiki/Organism organism OBI:0100046 phosphate buffered saline solution PMID: 16279733.Dent Mater J. 2005 Sep;24(3):414-21.PBS buffer solutions with different pH values can change porosity of DNA-chitosan complexes. Phosphate buffered saline (abbreviated PBS) is a buffer solution commonly used in biochemistry. It is a salty solution containing sodium chloride, sodium phosphate and in some preparations potassium chloride and potassium phosphate. The buffer helps to maintain a constant pH. The concentration usually matches the human body (isotonic). PERSON: Melanie Courtot PERSON: Philippe Rocca-Serra PERSON: Tina Boussard PBS buffer WEB: http://en.wikipedia.org/wiki/Phosphate_buffered_saline phosphate buffered saline solution OBI:0200000 data transformation The application of a clustering protocol to microarray data or the application of a statistical testing method on a primary data set to determine a p-value. A planned process that produces output data from input data. Elisabetta Manduchi Helen Parkinson James Malone Melanie Courtot Philippe Rocca-Serra Richard Scheuermann Ryan Brinkman Tina Hernandez-Boussard data analysis data processing Branch editors data transformation OBI:0200166 data transformation objective normalize objective An objective specification to transformation input data into output data Modified definition in 2013 Philly OBI workshop James Malone PERSON: James Malone data transformation objective OBI:0200201 ANOVA A statistical hypothesis test in which the means of several groups are all equal. James Malone ANOVA OBI:0302729 chemical solution PMID: 18289311.Anesth Analg. 2008 Apr;106(4):1078-86.Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. A material entity that is made up of at least 2 scattered molecular aggregates, one playing the role of solvent and the other one playing the role of solute. PERSON: Bjoern Peters PERSON: Philippe Rocca-Serra liquid chemical solution GROUP: OBI Biomaterial Branch chemical solution OBI:0302731 buffer role A buffer of carbonic acid (H2CO3) and bicarbonate (HCO3-) is present in blood plasma, to maintain a pH between 7.35 and 7.45. http://en.wikipedia.org/wiki/Buffer_solution a role which inheres in some molecular entity realized during the process of buffering Person:Helen Parkinson Person:Philippe Rocca-Serra buffer OBI buffer role OBI:0302732 solvent role PMID: 18373502.Transfusion. 2008 Mar 25. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors. solvent role is a role which inheres in a molecular entity capable of ensuring the dissolution of another chemical entity and realized by the process of solvation The class CHEBI:solvent is logically equivalent to this class, iff it is properly subsumed under the BFO:role branch. The label and textual definition of this CHEBI class are however misleadingly denoting the material entity that bears this role and not the role itself. The OBI modeling was needed as what is considered a solvent in a mixture can depend on the intent of the person creating the mixture. It would be great if this could be dealt with in CHEBI itself. See also https://github.com/obi-ontology/obi/issues/1771. Philippe Rocca-Serra adpated from wikipedia (http://en.wikipedia.org/wiki/Solvatation) solvent role OBI:0302733 solute role PMID: 18380397.Pharmazie. 2008 Feb;63(2):113-21.Deviations of drug solubility in water-cosolvent mixtures from the Jouyban-Acree model--effect of solute structure. solute role is a role played by a chemical entity which is dissolved by another chemical entity (the solvent) when creating a solution Philippe Rocca-Serra adapted from wikipedia (http://en.wikipedia.org/wiki/Solute) solute role OBI:0302893 storage PMID: 18550121.Total Prostate Specific Antigen Stability Confirmed After Long-Term Storage of Serum at -80C. J Urol. 2008 Jun 10. A planned process with the objective to preserve and protect material entities by placing them in an identified location which may have a controlled environment. Philippe Rocca-Serra OBI-Branch storage OBI:0500000 study design a matched pairs study design describes criteria by which subjects are identified as pairs which then undergo the same protocols, and the data generated is analyzed by comparing the differences between the paired subjects, which constitute the results of the executed study design. A plan specification comprised of protocols (which may specify how and what kinds of data will be gathered) that are executed as part of an investigation and is realized during a study design execution. Editor note: there is at least an implicit restriction on the kind of data transformations that can be done based on the measured data available. PERSON: Chris Stoeckert experimental design rediscussed at length (MC/JF/BP). 12/9/08). The definition was clarified to differentiate it from protocol. study design OBI:0600007 administering substance in vivo Balb/c mice received an intracameral or subconjunctival injection of trinitrophenylated spleen cells injecting mice with 10 ug morphine intranasally, a patient taking two pills of 1 mg aspirin orally A process by which a substance is intentionally given to an organism resulting in exposure of the organism to that substance. 2009-11-10. Tracker: https://sourceforge.net/tracker/?func=detail&aid=2893050&group_id=177891&atid=886178 Different routes and means of administration should go as children underneath this Update the definition based on the discussion. Details see the tracker: https://sourceforge.net/p/obi/obi-terms/738/ needs roles such as perturber and perturbee (children of input role). Perturb is too strong. Host might be the name for one role. Others considered: Doner, Donated, Acceptor. Bjoern Peters Person:Bjoern Peters IEDB administering substance in vivo OBI:1110034 antigen A material entity that has the antigen role. IEDB IEDB antigen OGG:0000000002 A gene is a material entity that represents the entire DNA sequence required for synthesis of a functional protein or RNA molecule. Oliver He WEB: http://www.ncbi.nlm.nih.gov/books/NBK21640/ gene OGG:2000000002 A gene of an organism of Bacteria Yue Liu, Bin Zhao, Oliver He 2 gene of Bacteria OGG:2000001224 A gene of an organism of Proteobacteria Yue Liu, Bin Zhao, Oliver He 1224 gene of Proteobacteria OGG:2000083332 A gene of an organism of Mycobacterium tuberculosis H37Rv Yue Liu, Bin Zhao, Oliver He 83332 gene of Mycobacterium tuberculosis H37Rv OGG:2000224914 A gene of an organism of Brucella melitensis bv. 1 str. 16M Yue Liu, Bin Zhao, Oliver He 224914 gene of Brucella melitensis bv. 1 str. 16M OGG:2060083332 A gene of Mycobacterium tuberculosis H37Rv that has a protein-coding gene disposition Bin Zhao, Oliver He 83332 protein-coding gene of Mycobacterium tuberculosis H37Rv OGG:2060224914 A gene of Brucella melitensis bv. 1 str. 16M that has a protein-coding gene disposition Bin Zhao, Oliver He 224914 protein-coding gene of Brucella melitensis bv. 1 str. 16M OGG:3000885459 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 885459 Rv3602c 20140405 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 20980199 Pantoate--beta-alanine ligase PanC (pantothenate synthetase) (pantoate activating enzyme) panC OGG:3000885594 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 885594 Rv1821 20140329 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 17030572; 18487341; 19240020; 20980199; 24297168 Possible preprotein translocase ATPase SecA2 secA2 OGG:3000885596 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 885596 Rv3601c 20140405 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 20980199 Probable aspartate 1-decarboxylase precursor PanD (aspartate alpha-decarboxylase) panD OGG:3000886960 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 886960 Rv1293 20140405 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 16511157; 19543810; 20980199 Diaminopimelate decarboxylase LysA (DAP decarboxylase) lysA OGG:3000887603 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 887603 Rv2930 20140322 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 15749014; 20553505; 20980199 Fatty-acid-AMP ligase FadD26 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) fadD26 OGG:3000887681 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 887681 Rv2192c 20140405 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 16337227; 20980199; 23363292 Probable anthranilate phosphoribosyltransferase TrpD trpD OGG:3000888225 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 888225 Rv2987c 20140405 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 19194004; 20980199 Probable 3-isopropylmalate dehydratase (small subunit) LeuD (isopropylmalate isomerase) (alpha-IPM isomerase) (IPMI) leuD OGG:3000888491 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 888491 Rv2938 20140322 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 20980199 Probable daunorubicin-dim-transport integral membrane protein ABC transporter DrrC drrC OGG:3000888751 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 888751 Rv1221 20140406 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 16513743; 18192397; 18606740; 18657035; 20980199 Alternative RNA polymerase sigma factor SigE sigE OGG:3000888772 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 888772 Rv0757 20140322 83332 protein-coding NCBI-supplied PMID: 9634230; 12368430; 16573683; 18052041; 18065542; 18065544; 18282096; 18757548; 18946503; 19820095; 20363229; 20814030; 20980199; 21634789; 22072719; 22880126 Possible two component system response transcriptional positive regulator PhoP phoP OGG:3001197075 Bin Zhao, Yue Liu, Oliver He WEB: http://www.ncbi.nlm.nih.gov/gene 1197075 BMEI1364 20140222 224914 I protein-coding NCBI-supplied PMID: 11756688; 12271122; 23161025 transcriptional regulatory protein MUCR BMEI1364 OGMS:0000060 Albert Goldfain creation date: 2009-06-23T11:53:49Z bodily process OGMS:0000061 A bodily process that is clinically abnormal. Albert Goldfain http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf creation date: 2009-06-23T11:54:29Z pathological bodily process OGMS:0000063 The totality of all processes through which a given disease instance is realized. Albert Goldfain http://ontology.buffalo.edu/medo/Disease_and_Diagnosis.pdf creation date: 2009-06-23T11:55:44Z disease course OPL:0000004 A hindgut that is a part of or originated from a Triatominae bug. Priti Parikh Triatominae hindgut OPL:0000007 An exflagellated microgametocyte stage in the lifecycle of Plasmodium falciparum that occurs in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum exflagellated microgametocyte stage Plasmodium falciparum exflagellated microgametocyte stage OPL:0000010 A microgametocyte stage in the Plasmodium falciparum lifecycle that occurs either in the bloodstream of a human host or the midgut of a mosquito vector. C. Janse Chris Stoeckert Jie Zheng P. Parkh S. Khan. P. falciparum microgametocyte stage Plasmodium falciparum microgametocyte stage OPL:0000026 A gamete stage in apicomplexan parasites when exflagellated microgametocyte divides into microgamete. Chris Stoeckert Jie Zheng Matt Berriman microgamete stage OPL:0000028 A gametocyte stage where a cell differentiates into a female sexual form called macrogametocyte. Chris Stoeckert Jie Zheng Priti Parikh macrogametocyte stage OPL:0000032 A midgut that is a part of or originated from an Anopheles mosquito. Jie Zheng Anopheles midgut OPL:0000033 A parasite lifecycle stage of trypanosomes. In trypomastigote stage, the kinetoplast is near the posterior end of the body, and the flagellum lies attached to the cell body for most of its length by an undulating membrane. Chris Stoeckert Jie Zheng Priti Parikh Wikipedia: Trypanosomatid trypomastigote stage OPL:0000035 An erythrocytic schizont stage in the Plasmodium falciparum lifecycle that occurs in the infected erythrocytes of a human host. updated according to OPL terms Plasmodium final excel file from C. Janse, S. Khan C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum erythorcytic schizont stage Plasmodium falciparum erythrocytic schizont stage OPL:0000036 A parasite lifecycle stage of apicomplexan species where a daughter cell, called merozoite is produced from schizont through schizogony. adjusted to be more general Chris Stoeckert Jie Zheng Priti Parikh http://www.biology.ualberta.ca/parasites/parpub/text/text/glossarM.htm merozoite stage OPL:0000040 A hepatocyte that is a part of or originated from a human (Homo sapiens). Priti Parikh human hepatocyte FMA:14515 Homo sapiens hepatocyte OPL:0000042 An erythrocytic ring trophozoite stage in the Plasmodium falciparum life cycle that occurs in erythrocytes of a human host. During this stage some Plasmodium falciparum merozoites undergo asexual reproduction cycle in erythrocytes and form young trophozoites that are referred to as "ring form" due to their morphology. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum erythrocytic ring trophozoite stage Wikipedia: Plasmodium falciparum biology Plasmodium falciparum erythrocytic ring trophozoite stage OPL:0000048 A lifecycle stage of Trypanosoma brucei. Chris Stoeckert Jie Zheng Priti Parikh T. brucei lifecycle stage Trypanosoma brucei lifecycle stage OPL:0000050 A Plasmodium falciparum gametocyte that is a male gametocyte and found in either bloodstream of a human host or midgut of a mosquito vector. The microgametocyte is a precursor cell of the microgamete. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum microgametocyte Plasmodium falciparum microgametocyte OPL:0000057 A parasite lifecycle stage of some protozoan parasites that is a non-reproductive, feeding and growing stage. Chris Stoeckert Jie Zheng Priti Parikh http://www.biology.ualberta.ca/parasites/parpub/text/text/glossarT.htm trophozoite stage OPL:0000059 A schizont stage that occurs in hepatocyte where sporozoites mature into a schizont. Chris Stoeckert Jie Zheng Matt Berriman Priti Parikh PMID:11006474 hepatic schizont stage OPL:0000060 A Plasmodium falciparum divides through schizogony. Depending on its location, it is either called hepatic or erythrocytic schizont. The schizont is a dividing stage with 2 or more nuclei. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum schizont Plasmodium falciparum schizont OPL:0000068 A macrogametocyte stage in the Plasmodium falciparum lifecycle that occurs either in the bloodstream of a human host or the midgut of a mosquito vector. gametocytes are mainly found in the blood C. Janse Chris Stoeckert Jie Zheng Priti Parikh S. Khan P. falciparum macrogametocyte stage Plasmodium falciparum macrogametocyte stage OPL:0000073 A parasite lifecycle stage of sporozoa consisting of a zygote enclosed by cyst wall. Chris Stoeckert Jie Zheng Priti Parikh Mosby's Medical Dictionary, 8th edition. � 2009, Elsevier. (http://medical-dictionary.thefreedictionary.com/oocyst) oocyst stage OPL:0000075 A macrogamete stage in the Plasmodium falciparum lifecycle that occurs in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum macrogamete stage Plasmodium falciparum macrogamete stage OPL:0000078 A schizont stage that occurs in erythrocytes where trophozoites mature into a schizont and schizont produces daughter trophozoites or merozoites. Chris Stoeckert Jie Zheng Matt Berriman Priti Parikh PMID: 11006474 erythrocytic schizont stage OPL:0000084 A parasite lifecycle stage that is the multinucleate stage in the development of some members of the Sarcodina and some sporozoans during schizogony. Chris Stoeckert Jie Zheng Priti Parikh http://medical-dictionary.thefreedictionary.com/schizont schizont stage OPL:0000085 A gamete stage in parasites when macrogametocytes produce macrogametes through the process known as gametogenesis. Chris Stoeckert Jie Zheng Priti Parikh http://www.tulane.edu/~wiser/malaria/mal_lc.PDF macrogamete stage OPL:0000089 A Plasmodium falciparum that is a 'banana-shaped' form and originates from the round zygote. The ookinete is found in the midgut of a mosquito vector and traverses the midgut wall of a mosquito vector. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum ookinete Wikipedia: Plasmodium falciparum biology Plasmodium falciparum ookinete OPL:0000093 A hepatic schizont stage in the lifecycle of Plasmodium falciparum that occurs in the infected hepatocytes of a human host. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum hepatic schizont stage Plasmodium falciparum hepatic schizont stage OPL:0000096 An erythrocyte that is a part of or originated from a human (Homo sapiens). Priti Parikh human RBC human erythrocyte human red blood cell FMA:62845 Homo sapiens erythrocyte OPL:0000103 A merozoite stage in the Plasmodium falciparum lifecycle that occurs in the bloodstream or hepatocytes of a human host. Chris Stoeckert Priti Parikh P. falciparum merozoite stage Plasmodium falciparum merozoite stage OPL:0000110 A Plasmodium falciparum schizont that is found in infected erythrocytes of a human host. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum erythrocytic schizont Plasmodium falciparum erythrocytic schizont OPL:0000113 An oocyst stage in the Plasmodium falciparum lifecycle that occurs on the hemocoel side of the midgut of a mosquito vector. During this stage Plasmodium falciparum ookinete invades and escapes midgut wall of mosquito and embed itself onto the exterior of the gut membrane and develop encysted zygote, called oocyst. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum oocyst stage Plasmodium falciparum oocyst stage OPL:0000115 A sporozoite stage in the Plasmodium falciparum lifecycle that occurs in the salivary glands of the mosquito and invades hepatocytes in the human host. C. Janse Chris Stoeckert Jie Zheng Matt Berrimen Priti Parikh S. Khan P. falciparum sporozoite stage Plasmodium falciparum sporozoite stage OPL:0000117 Blood that is part of or originated from a human (Homo sapiens). previous def was: blood of human Chris Stoeckert human blood OPL Homo sapiens blood OPL:0000119 A microgametocyte stage in some apicomplexan parasites where microgametocyte gets matured and form microgamete through the process known as exflagellation. Chris Stoeckert Jie Zheng Priti Parikh exflagellated microgametocyte stage OPL:0000121 A salivary gland that is a part of or originated from an Anopheles mosquito. Priti Parikh Anopheles salivary gland OPL:0000130 A Plasmodium falciparum that is produced in a schizont, found in the bloodstream of a human host and invades erythrocytes. Chris Stoeckert Jie Zheng Priti Parkh P. falciparum merozoite Plasmodium falciparum merozoite OPL:0000137 A Plasmodium falciparum is formed in the oocyst. It migrates to and resides in the salivary glands of the mosquito vector. A distinction is made between oocyst-derived and salivary gland-derived sporozoites. Sporozoites invade hepatocytes in the vertebrate host. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum sporozoite Wikipedia: Plasmodium falciparum biology Plasmodium falciparum sporozoite OPL:0000138 A Plasmodium falciparum that oocyst is formed, after traversal of the midgut wall by the ookinete stage, on the hemocoel side of the midgut wall of the mosquito vector. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum oocyst Plasmodium falciparum oocyst OPL:0000140 An early trophozoite stage of Plasmodium sp. where a large central vacuole and peripheral nucleus give an appearance of a signet ring. Chris Stoeckert Jie Zheng Priti Parikh http://www.biology.ualberta.ca/parasites/parpub/text/text/glossarR.htm erythrocytic ring trophozoite stage OPL:0000143 A gametocyte stage where a cell differentiates into a male sexual form called microgametocyte. Chris Stoeckert Jie Zheng Priti Parikh microgametocyte stage OPL:0000146 A Plasmodium falciparum is a feeding form. The trophozoite stage has only 1 nucleus. Depending on its location, it is either called hepatic or erythrocytic trophozoite. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum trophozoite Plasmodium falciparum trophozoite OPL:0000150 A life cycle stage where a cell differentiates into male or female sexual forms. Chris Stoeckert Jie Zheng Priti Parikh gametocyte stage OPL:0000152 A parasite lifecycle stage of some sporozoans where cells divide through sporogony producing daughter cells called sporozoites that infect new hosts. Chris Stoeckert Jie Zheng Priti Parikh http://www.biology.ualberta.ca/parasites/parpub/text/text/glossarS.htm sporozoite stage OPL:0000153 A parasite lifecycle stage of some sporozoans where motile and elongated zygote is formed by the fertilization of the macrogamete during the sexual reproductive phase of the sporozoan life cycle, specifically the malarial parasite Plasmodium. Chris Stoeckert Jie Zheng Priti Parikh Mosby's Medical Dictionary, 8th edition. � 2009, Elsevier. (http://medical-dictionary.thefreedictionary.com/ookinete) ookinete stage OPL:0000158 A schizont stage in the Plasmodium falciparum lifecycle that occurs in erythrocytes or in hepatocytes. updated according to OPL terms Plasmodium final excel file from C. Janse, S. Khan C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum schizont stage Plasmodium falciparum schizont stage OPL:0000161 A Plasmodium falciparum zygote is formed after fertilisation of the macrogamete by a microgamete in the midgut of the mosquito vector. This round form is the only diploid stage in the Plasmodium falciparum life cycle. C. Janse Chris Stoeckert Jie Zheng P. Parkh S. Khan P. falciparum zygote Wikipedia: Plasmodium falciparum biology Plasmodium falciparum zygote OPL:0000162 A Plasmodium falciparum microgametocyte that is matured with flagellated motile microgametes still attached to its central body. Exflagellated microgametocyte of Plasmodium falciparum is found in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Matt Berriman Priti Parikh P. falciparum exflagellated microgametocyte Plasmodium falciparum exflagellated microgametocyte OPL:0000164 A Trypanosoma cruzi that is found in the bloodstream of infected mammals. It is a non-dividing form that is infectious for its insect vector. Chris Stoeckert Jie Zheng Priti Parikh T. cruzi trypomastigote http://dna.kdna.ucla.edu/parasite_course-old/cruzi_files/intro.htm Trypanosoma cruzi trypomastigote OPL:0000165 A lifecycle stage of Plasmodium falciparum. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum lifecycle stage Plasmodium falciparum lifecycle stage OPL:0000167 A Plasmodium falciparum gamete that is a matured form of the macrogametocyte and is found in the midgut of a mosquito vector. The macrogamete is fertilized by the microgamete, forming the zygote Chris Stoeckert Jie Zheng P. falciparum macrogamete Plasmodium falciparum macrogamete OPL:0000169 A trypomastigote stage in the Trypanosoma cruzi lifecycle that occurs either in the vertebrate host or an insect vector. Chris Stoeckert Jie Zheng Priti Parikh T. cruzi trypomastigote stage Trypanosoma cruzi trypomastigote stage OPL:0000170 A microgamete stage in the Plasmodium falciparum lifecycle that occurs in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum microgamete stage Plasmodium falciparum microgamete stage OPL:0000171 A parasite role which is realized only during parasitic infection of a human. previous def was not about a role. Chris Stoeckert Priti Parikh human parasite role OPL:0000174 A Plasmodium falciparum gamete that is a matured form of exflagellated microgametocyte and found in the midgut of a mosquito vector. The microgamete fertilizes the macrogamete, forming the zygote. Chris Stoeckert Jie Zheng P. falciparum microgamete Plasmodium falciparum microgamete OPL:0000175 A trypomastigote stage in the Trypanosoma brucei lifecycle that occurs in the vertebrate host. Chris Stoeckert Jie Zheng Priti Parikh T. brucei trypomastigote stage Trypanosoma brucei trypomastigote stage OPL:0000181 A life cycle stage of a parasite. Chris Stoeckert Jie Zheng Priti Parikh parasite lifecycle stage OPL:0000182 A Trypanosoma brucei that is a Trypomastigote form of Trypanosoma brucei. In this form the large kinetoplast is postnuclear and is at the most posterior part of the body and the flagellum emerges from the flagellar pocket, and runs along the entire length of the body as an undulating membrane. Chris Stoeckert Jie Zheng Priti Parikh T. brucei trypomastigote http://dna.kdna.ucla.edu/parasite_course-old/african%20tryps%20new_files/contents1.htm Trypanosoma brucei trypomastigote OPL:0000185 A lifecycle stage of Trypanosoma cruzi. Chris Stoeckert Jie Zheng Priti Parikh T. cruzi lifecycle stage Trypanosoma cruzi lifecycle stage OPL:0000187 An ookinete stage in the Plasmodium falciparum lifecycle that occurs in the midgut of a mosquito vector and on the outside of the midgut. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum ookinete stage Plasmodium falciparum ookinete stage OPL:0000190 A Plasmodium falciparum schizont that is found in infected hepatocytes (i.e., liver cells) of a human host. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum hepatic schizont Plasmodium falciparum hepatic schizont OPL:0000192 A gametocyte stage in the lifecycle of Plasmodium falciparum. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum gametocyte stage Plasmodium falciparum gametocyte stage OPL:0000199 A zygote stage in the Plasmodium falciparum lifecycle that occurs in the midgut of the mosquito vector where a microgamete and a macrogamete fertilizes each other to produce a diploid cell. Chris Stoeckert Jie Zheng Priti Parikh P. falciparum zygote stage Wikipedia: Plasmodium falciparum biology Plasmodium falciparum zygote stage OPL:0000206 A Plasmodium falciparum gametocyte that is a female gametocyte and found either in bloodstream of a human host or midgut of mosquito vector. The macrogametocyte is a precursor of the macrogamete. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum macrogametocyte Plasmodium falciparum macrogametocyte OPL:0000207 An erythrocytic trophozoite stage in the Plasmodium falciparum life cycle that occurs in erythrocytes of a human host. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum erythrocytic trophozoite stage Plasmodium falciparum erythrocytic trophozoite stage OPL:0000222 A Plasmodium falciparum erythrocytic trophozoite that is found in erythrocytes. It is a young trophozoite stage that has a typical 'ring-like' appearance. Ring-form trophozoites of Plasmodium falciparum are often thin and delicate, measuring on average 1/5 the diameter of the red blood cell. C. Janse Chris Stoeckert Jie Zheng Priti Parkh S. Khan P. falciparum erythrocytic ring trophozoite http://www.dpd.cdc.gov/dpdx/html/frames/m-r/malaria/falciparum/body_malariadffalcring.htm Plasmodium falciparum erythrocytic ring trophozoite OPL:0000232 An organism living in, with, or on another organism in parasitism. Individual members of parasite species, such as Leishmania, Plasmodium, Trypanosoma, etc. are members of this class. Jie Zheng Priti Parikh http://www.merriam-webster.com/dictionary/parasite?show=0&t=1310398415 parasite organism OPL:0000241 A Plasmodium falciparum merozoite that is produced in a hepatic schizont and released into the bloodstream of a human host. These forms invade erythrocytes. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum hepatic merozoite Plasmodium falciparum hepatic merozoite OPL:0000242 A Plasmodium falciparum merozoite that is produced in an erythrocytic schizont and released into the bloodstream of a human host. These forms invade erythrocytes. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum erythrocytic merozoite Plasmodium falciparum erythrocytic merozoite OPL:0000243 A trophozoite stage in some protozoan parasite life cycle that occurs in erythrocytes. definition adapted from that for P. falciparum erythrocytic trophozoite stage and parent trophozoite stage Chris Stoeckert erythrocytic trophozoite stage OPL:0000244 A Plasmodium falciparum trophozoite that is found in erythrocytes. It is a feeding stage with a single nucleus. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum erythrocytic trophozoite Plasmodium falciparum erythrocytic trophozoite OPL:0000245 An erythrocytic merozoite stage in the Plasmodium falciparum lifecycle that occurs in the bloodstream of a human host. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum erythrocytic merozoite stage Plasmodium falciparum erythrocytic merozoite stage OPL:0000246 A hepatic merozoite stage in the Plasmodium falciparum lifecycle that occurs in the hepatocyte of a human host. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum hepatic merozoite stage Plasmodium falciparum hepatic merozoite stage OPL:0000247 A merozoite stage in the Plasmodium lifecycle that occurs in the hepatocyte of a vertebrate host. definition adapted from that for P. falciparum hepatic merozoite stage Chris Stoeckert Jie Zheng hepatic merozoite stage OPL:0000248 A merozoite stage in the apicomplexan lifecycle that occurrs in the bloodstream of a vertebrate host. definition adapted from that for P. falciparum salivary erythrocytic merozoite stage and from the general merozoite definition Chris Stoeckert Jie Zheng erythrocytic merozoite stage OPL:0000249 A Plasmodium falciparum that is located either in the bloodstream of the human host or midgut of mosquito vector. Gametocytes are the precursor cells of the macro- or micro-gametes. C. Janse Chris Stoeckert Jie Zheng K. Louis S Khan Plasmodium falciparum gametocyte OPL:0000250 A hepatic trophozoite stage in the Plasmodium falciparum life cycle that occurs in hepatocytes of a human host. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum hepatic trophozoite stage Plasmodium falciparum hepatic trophozoite stage OPL:0000251 A trophozoite stage in the Plasmodium falciparum lifecycle that occurs in a human host. Chris Stoeckert Jie Zheng P. falciparum trophozoite stage Plasmodium falciparum trophozoite stage OPL:0000252 A sporozoite stage in the Plasmodium falciparum lifecycle that occurs in the hemocoel and the salivary glands of the mosquito. Sporozoites invade hepatocytes in the human host. C. Janse Chris Stoeckert Jie Zheng S. Khan Plasmodium falciparum oocyst-derived sporozoite stage OPL:0000253 A sporozoite stage in the Plasmodium lifecycle that occurs in the hemocoel and the salivary glands of the mosquito. Sporozoites invade hepatocytes in the vertebrate host. definition adapted from that for P. falciparum salivary gland derived sporozoite stage Chris Stoeckert salivary gland-derived sporozoite stage OPL:0000254 A salivary gland-derived sporozoite stage in the Plasmodium falciparum lifecycle that occurs in the hemocoel and the salivary glands of the mosquito. Sporozoites invade hepatocytes in the human host. C. Janse Chris Stoeckert Jie Zheng S. Khan Plasmodium falciparum salivary gland-derived sporozoite stage OPL:0000255 A Plasmodium falciparum sporozoite that is formed in the oocyst. It migrates to and resides in the salivary glands of the mosquito vector. Sporozoites invade hepatocytes in a human host. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum salivary gland-derived sporozoite Plasmodium falciparum salivary gland-derived sporozoite OPL:0000256 A sporozoite stage in some parasite lifecycle that occurs in the hemocoel and the salivary glands of the mosquito. Sporozoites invade hepatocytes in the vertebrate host. definition adapted from that for P. falciparum oocyte derived sporozoite stage Chris Stoeckert oocyst-derived sporozoite stage OPL:0000257 A Plasmodium falciparum trophozoite that is found in hepatocytes of a human host. It is a feeding stage with a single nucleus C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum hepatic trophozoite Plasmodium falciparum hepatic trophozoite OPL:0000258 A Plasmodium falciparum that is found in midgut of mosquito vector. There are two forms of gametes: micro- and macrogametocytes. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum gamete Plasmodium falciparum gamete OPL:0000259 A Plasmodium falciparum sporozoite that is found in the infected hepatocytes of a human host. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum oocyst-derived sporozoite Plasmodium falciparum oocyst-derived sporozoite OPL:0000260 A life cycle stage of some parasites that develop into mature sexual cells. Jie Zheng gamete stage OPL:0000261 A trophozoite stage in some protozoan parasite life cycle that occurs in hepatocytes. definition adapted from that for P. falciparum hepatic trophozoite stage and from parent trophozoite stage Chris Stoeckert hepatic trophozoite stage OPL:0000262 A gamete stage in the Plasmodium falciparum lifecycle that occurs in the midgut of a mosquito vector. C. Janse Chris Stoeckert Jie Zheng S. Khan P. falciparum gamete stage Plasmodium falciparum gamete stage OPL:0000264 A Plasmodium that is found in the midgut of a mosquito vector during gamete lifecycle stage. There are two forms of gametes: micro- and macrogametocytes. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium gamete OPL:0000265 A Plasmodium gamete that is in a matured form of the macrogametocyte and found in the midgut of a mosquito vector. The macrogamete is fertilized by the microgamete, forming the zygote. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium macrogamete OPL:0000266 A Plasmodium gamete that is in a matured form of exflagellated microgametocyte and found in the midgut of a mosquito vector. The microgamete fertilises the macrogamete, forming the zygote. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium microgamete OPL:0000267 A Plasmodium that is located either in the bloodstream of the vertebrate host or midgut of mosquito vector during gametocyte stage. Gametocytes are the precursor cells of the macro- or microgametes Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium gametocyte OPL:0000268 A Plasmodium gametocyte that is a female gametocyte of Plasmodium and found either in the bloodstream of the vertebrate host or midgut of mosquito vector. The macrogametocyte is a precursor of the macrogamete. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium macrogametocyte OPL:0000269 A Plasmodium gametocyte that is a male gametocyte of Plasmodium and found either in the bloodstream of a vertebrate host or midgut of a mosquito vector. The microgametocyte is a precursor cell of the microgamete Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium microgametocyte OPL:0000270 A Plasmodium that is during merozoite lifecycle stage, occurs in the bloodstream of a vertebrate host. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium merozoite OPL:0000271 A Plasmodium merozoite that is produced in an erythrocytic schizont and released into the bloodstream of a vertebrate host. These forms invade erythrocytes. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium erythrocytic merozoite OPL:0000272 A Plasmodium merozoite that is produced in a hepatic schizont and released into the bloodstream of a vertebrate host. These forms invade erythrocytes. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium hepatic merozoite OPL:0000273 A Plasmodium that is formed after traversal of the midgut wall by the ookinete stage, on the hemocoel side of the midgut wall of the mosquito vector. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium oocyst OPL:0000274 A Plasmodium that is a 'banana-shaped' form originates from the round zygote. The ookinete is found in the midgut of a mosquito vector and traverses the midgut wall of a mosquito vector. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium ookinete OPL:0000275 A Plasmodium that is a form divides through schizogony. Depending on its location, it is either called hepatic or erythrocytic schizont. The schizont is a dividing stage with 2 or more nuclei. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium schizont OPL:0000276 A Plasmodium schizont that is found in infected erythrocytes of a vertebrate host. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium erythrocytic schizont OPL:0000277 A Plasmodium schizont that is found in infected hepatocytes (i.e. liver cells) of a vertebrate host. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium hepatic schizont OPL:0000278 A Plasmodium that is formed in the oocyst and migrates to and reside in the salivary glands of the mosquito vector. A distinction is made between oocyst-derived and salivary gland-derived sporozoites. Sporozoites invade hepatocytes in the vertebrate host. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium sporozoite OPL:0000279 A Plasmodium sporozoite that is found in the infected hepatocytes of a vertebrate host. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium oocyst-derived sporozoite OPL:0000280 A Plasmodium sporozoite that is found in the salivary glands of the mosquito vector. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium salivary gland-derived sporozoite OPL:0000281 A Plasmodium that is a feeding form which has a single nucleus during the trophozoite stage. Depending on its location, it is either called hepatic or erythrocytic trophozoite. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium trophozoite OPL:0000282 A Plasmodium trophozoite that is found in erythrocytes of a vertebrate host. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium erythrocytic trophozoite OPL:0000283 A Plasmodium erythrocytic trophozoite that has a typical 'ring-like' appearance. Ring-form trophozoites of Plasmodium are often thin and delicate, measuring on average 1/5 the diameter of the red blood cell. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium erythrocytic ring trophozoite OPL:0000284 A Plasmodium trophozoite that is found in hepatocytes. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium hepatic trophozoite OPL:0000285 A Plasmodium that is formed after fertilization of the macrogamete by a microgamete in the midgut of the mosquito vector. This round form is the only diploid stage in the Plasmodium life cycle. Chris Stoeckert Jie Zheng Ulrike Boehme https://github.com/OPL-ontology/OPL/issues/2 GeneDB Plasmodium zygote OPL:0000286 A gamete stage in the Plasmodium lifecycle that occurs in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Plasmodium gamete stage OPL:0000287 A macrogamete stage in the Plasmodium lifecycle that occurs in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Plasmodium macrogamete stage OPL:0000288 A microgamete stage in the Plasmodium lifecycle that occurs in the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Plasmodium microgamete stage OPL:0000289 A gametocyte stage in the lifecycle of Plasmodium. Chris Stoeckert Jie Zheng Plasmodium gametocyte stage OPL:0000290 A macrogametocyte stage in the Plasmodium lifecycle that occurs either in the bloodstream of a vertebrate host or the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Plasmodium macrogametocyte stage OPL:0000291 A microgametocyte stage in the Plasmodium lifecycle that occurs either in the bloodstream of a vertebrate host or the midgut of a mosquito vector. Chris Stoeckert Jie Zheng Plasmodium microgametocyte stage OPL:0000292 A merozoite stage in the Plasmodium lifecycle that occurs in the bloodstream or hepatocytes of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium merozoite stage OPL:0000293 An erythrocytic merozoite stage in the Plasmodium lifecycle that occurs in the bloodstream of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium erythrocytic merozoite stage OPL:0000294 A hepatic merozoite stage in the Plasmodium lifecycle that occurs in the hepatocyte of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium hepatic merozoite stage OPL:0000295 An oocyst stage in the Plasmodium lifecycle that occurs on the hemocoel side of the midgut of a mosquito vector. During this stage Plasmodium ookinete invades and escapes midgut wall of mosquito and embed itself onto the exterior of the gut membrane and develop encysted zygote, called oocyst. Chris Stoeckert Jie Zheng Plasmodium oocyst stage OPL:0000296 An ookinete stage in the Plasmodium lifecycle that occurs in the midgut of a mosquito vector and on the outside of the midgut. Chris Stoeckert Jie Zheng Plasmodium ookinete stage OPL:0000297 A schizont stage in the Plasmodium lifecycle that occurs in erythrocytes or in hepatocytes. Chris Stoeckert Jie Zheng Plasmodium schizont stage OPL:0000298 An erythrocytic schizont stage in the Plasmodium lifecycle that occurs in the infected erythrocytes of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium erythrocytic schizont stage OPL:0000299 A hepatic schizont stage in the Plasmodium lifecycle that occurs in the infected hepatocytes of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium hepatic schizont stage OPL:0000300 A sporozoite stage in the Plasmodium lifecycle that occurs in the salivary glands of the mosquito and invades hepatocytes in the vertebrate host. Chris Stoeckert Jie Zheng Plasmodium sporozoite stage OPL:0000301 A sporozoite stage in the Plasmodium lifecycle that develops in oocyst of the mosquito midgut. Chris Stoeckert Jie Zheng Omar harb Plasmodium oocyst-derived sporozoite stage OPL:0000302 A salivary gland-derived sporozoite stage in the Plasmodium lifecycle that occurs in the salivary glands of the mosquito and invades hepatocytes in the vertebrate host. Chris Stoeckert Jie Zheng Omar harb Plasmodium salivary gland-derived sporozoite stage OPL:0000303 A trophozoite stage in the Plasmodium lifecycle that occurs in a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium trophozoite stage OPL:0000304 An erythrocytic trophozoite stage in the Plasmodium life cycle that occurs in erythrocytes of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium erythrocytic trophozoite stage OPL:0000305 An erythrocytic ring trophozoite stage in the Plasmodium life cycle that occurs in erythrocytes of a vertebrate host. During this stage some Plasmodium merozoites undergo asexual reproduction cycle in erythrocytes and form young trophozoites that are referred to as "ring form" due to their morphology. Chris Stoeckert Jie Zheng Plasmodium erythrocytic ring trophozoite stage OPL:0000306 A hepatic trophozoite stage in the Plasmodium life cycle that occurs in hepatocytes of a vertebrate host. Chris Stoeckert Jie Zheng Plasmodium hepatic trophozoite stage OPL:0000307 A zygote stage in the Plasmodium lifecycle that occurs in the midgut of the mosquito vector where a microgamete and a macrogamete fertilizes each other to produce a diploid cell. Chris Stoeckert Jie Zheng Plasmodium zygote stage OPL:0000310 Blood that is part of or originated from a vertebrate. Jie Zheng OPL Vertebrate blood OPL:0000311 An erythrocyte that is a part of or originated from a vertebrate. Jie Zheng OPL Vertebrate erythrocyte OPL:0000312 A hepatocyte that is a part of or originated from a vertebrate. Jie Zheng OPL Vertebrate hepatocyte OPL:0000313 Cerebrospinal fluid that is a part of or originated from a mammal. Jie Zheng Mammalia cerebrospinal fluid OPL:0000320 Blood that is part of or originated from a mammalia. Jie Zheng Mammalia blood OPL:0000321 A macrophage that is a part of or originated from a mammalia. Jie Zheng Mammalia macrophage OPL:0000325 A parasite lifecycle stage that parasite replicates rapidly within the host cell. Anthony Huffman Jie Zheng https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744739/ tachyzoite stage OPL:0000327 A Plasmodium vivax is formed in the oocyst. It migrates to and resides in the gut of the mosquito vector. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/21 He Group Plasmodium vivax sporozoite OPL:0000328 A Plasmodium vivax that is found in the bloodstream of the human host and invades erythrocytes. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/21 He Group Plasmodium vivax merozoite OPL:0000330 A Plasmodium berghei is formed in the oocyst. It migrates to and resides in the gut of the mosquito vector. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/21 He Group Plasmodium berghei sporazoite OPL:0000332 A Neospora caninum that is found intracellular in the intermediate hosts in which asexual replication takes place. Anthony Huffman Jie Zheng https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890850/ https://github.com/OPL-ontology/OPL/issues/21 He Group Neospora caninum tachyzoite OPL:0000336 A Sarcocystis neurona that is found in the bloodstream of the human host and invades erythrocytes. Anthony Huffman Jie Zheng https://www.ncbi.nlm.nih.gov/books/NBK574577/ https://github.com/OPL-ontology/OPL/issues/21 He Group Sarcocystis neurona merozoite OPL:0000338 A Toxoplasma gondii that is formed in tissue in a host and replicates quickly. This replaces the previous term as . Anthony Huffman Jie Zheng Toxoplasma gondii trophozoite https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106833/ https://github.com/OPL-ontology/OPL/issues/21 He Group Toxoplasma gondii tachyzoite OPL:0000348 A sporozoite stage in Plasmodium vivax life cycle. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/21 He Group Plasmodium vivax sporozoite stage OPL:0000349 A merozoite stage in the Plasmodium vivax life cycle. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/21 He Group Plasmodium vivax merozoite stage OPL:0000351 A sporozoite stage in the Plasmodium berghei life cycle. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/21 He Group Plasmodium berghei sporazoite stage OPL:0000353 A tachyzoite stage in the Neospora caninum life cycle. Anthony Huffman Jie Zheng https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890850/ https://github.com/OPL-ontology/OPL/issues/21 He Group Neospora caninum tachyzoite stage OPL:0000357 A merozoite stage in the Sarcocystis neurona life cycle. Anthony Huffman Jie Zheng https://wcvm.usask.ca/learnaboutparasites/parasites/sarcocystis-neurona.php https://github.com/OPL-ontology/OPL/issues/21 He Group Sarcocystis neurona merozoite stage OPL:0000359 A tachyzoite stage in the Toxoplasma gondii life cycle. Tachyzoites can be found in various organs and tissues during the acute phase of Toxoplasma gondii infection, including lymph nodes, spleen, liver, lungs, and the central nervous system. Anthony Huffman Jie Zheng https://www.ncbi.nlm.nih.gov/pmc/articles/PMC106833/ https://github.com/OPL-ontology/OPL/issues/21 He Group Toxoplasma gondii tachyzoite stage OPL:0000369 An erythrocyte that is a part of or originated from a Canis lupus familiaris. Jie Zheng He Group Canis lupus familiaris erythrocyte OPL:0000374 A lifecycle stage of Plasmodium vivax. Jie Zheng He Group Plasmodium vivax lifecycle stage OPL:0000375 A lifecycle stage of Plasmodium berghei. Jie Zheng He Group Plasmodium berghei lifecycle stage OPL:0000376 A lifecycle stage of Neospora caninum. Jie Zheng He Group Neospora caninum lifecycle stage OPL:0000379 A lifecycle stage of Sarcocystis neurona. Jie Zheng He Group Sarcocystis neurona lifecycle stage OPL:0000380 A lifecycle stage of Toxoplasma gondii. Jie Zheng He Group Toxoplasma gondii lifecycle stage OPL:0000385 A Plasmodium yoelii in sporozoite stage. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium yoelii sporozoite OPL:0000386 A Plasmodium yoelii in merozoite stage. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium yoelii merozoite OPL:0000387 A Plasmodium yoelii in gametocyte stage. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium yoelii gametocyte OPL:0000389 A Plasmodium chabaudi in sporozoite stage. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium chabaudi sporozoite OPL:0000393 A Plasmodium knowlesi in sporozoite stage. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium knowlesi sporozoite OPL:0000394 A Plasmodium knowlesi in merozoite stage. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium knowlesi merozoite OPL:0000400 A sporozoite stage in the Plasmodium yoelii. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium yoelii sporozoite stage OPL:0000401 A merozoite stage in the Plasmodium yoelii. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium yoelii merozoite stage OPL:0000402 A gametocyte stage in the Plasmodium yoelii. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium yoelii gametocyte stage OPL:0000404 A sporozoite stage in the Plasmodium chabaudi. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium chabaudi sporozoite stage OPL:0000408 A sporozoite stage in the Plasmodium knowlesi. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium knowlesi sporozoite stage OPL:0000409 A merozoite stage in the Plasmodium knowlesi. Anthony Huffman Jie Zheng https://www.cdc.gov/dpdx/malaria/index.html https://github.com/OPL-ontology/OPL/issues/24 He Group Plasmodium knowlesi merozoite stage OPL:0000414 An erythrocyte that is a part of or originated from a primate. Jie Zheng primate erythrocyte He Group He Group Primates erythrocyte OPL:0000415 A lifecycle stage of Plasmodium yoelii. Jie Zheng He Group He Group Plasmodium yoelii lifecycle stage OPL:0000416 A lifecycle stage of Plasmodium chabaudi. Jie Zheng He Group He Group Plasmodium chabaudi lifecycle stage OPL:0000417 A lifecycle stage of Plasmodium knowlesi. Jie Zheng He Group He Group Plasmodium knowlesi lifecycle stage OPMI:0000441 Yingtong Liu, Anthony Huffman, Oliver He biomarker role OPMI:0000445 Material entity that has a measurable quality, or that participates in a measurement process profile, which can be used as an indicator of an underlying biological state or identity. The NIH Biomarkers and Surrogate Endpoint Working Group defined a biomarker as “A characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention” (https://pubmed.ncbi.nlm.nih.gov/11240971/). However, the definition of 'characteriistc' is unclear, so we do not use the exact definintion in the ontology. Yingtong Liu, Anthony Huffman, Oliver He https://en.wikipedia.org/wiki/Biomarker https://en.wikipedia.org/wiki/Biomarker_(cell) https://en.wikipedia.org/wiki/Biomarker_(medicine) biomarker OPMI:0000446 Biomarker that has a measurable quality or process profile(s), that can be used as an indicator of an underlying immune state or identity. Anthony Huffman, Oliver He A biomarker that is indicative of an immune response https://pubmed.ncbi.nlm.nih.gov/22072636/ https://pubmed.ncbi.nlm.nih.gov/32286245/ immune biomarker A dependent entity that inheres in a bearer by virtue of how the bearer is related to other entities PATO:0000072 quality PATO:0000001 quality PATO:0000001 A time quality inhering in a bearer by virtue of how long the bearer has existed. quality PATO:0000011 age PATO:0000011 A physical quality which inheres in a bearer by virtue of the number of the bearer's repetitive actions in a particular time. quality PATO:0000044 frequency PATO:0000044 An organismal quality inhering in a bearer by virtue of the bearer's ability to undergo sexual reproduction in order to differentiate the individuals or types involved. quality PATO:0000047 biological sex PATO:0000047 A quality in which events occur in sequence. quality PATO:0000165 time PATO:0000165 An organismal quality inhering in a bearer or a population by virtue of the bearer's disposition to survive and develop normally or the number of surviving individuals in a given population. quality PATO:0000169 viability PATO:0000169 A viability quality inhering in a bearer or a population by virtue of the bearer's ability to survive or the long term survival ability of a given population. quality PATO:0000719 viable PATO:0000719 A 3-D extent quality inhering in a bearer by virtue of the bearer's amount of 3-dimensional space it occupies. quality PATO:0000918 volume PATO:0000918 A quality of a physical entity that exists through action of continuants at the physical level of organisation in relation to other entities. PATO:0002079 Wikipedia:Physical_property relational physical quality quality PATO:0001018 physical quality PATO:0001018 A physical quality inhering in a bearer by virtue of ratio of the bearer's output to the bearer's input. quality PATO:0001029 efficiency PATO:0001029 A quality which inheres in a continuant. PATO:0001237 PATO:0001238 snap:Quality monadic quality of a continuant multiply inhering quality of a physical entity quality of a continuant quality of a single physical entity quality of an object quality of continuant monadic quality of an object monadic quality of continuant quality PATO:0001241 Relational qualities are qualities that hold between multiple entities. Normal (monadic) qualities such as the shape of a eyeball exist purely as a quality of that eyeball. A relational quality such as sensitivity to light is a quality of that eyeball (and connecting nervous system) as it relates to incoming light waves/particles. physical object quality PATO:0001241 A viability quality inhering in a bearer by virtue of the cessation of the bearer's life. quality PATO:0001422 dead PATO:0001422 An efficiency quality inhering in a bearer by virtue of the bearer's lacking efficiency. quality PATO:0001677 inefficient PATO:0001677 An efficiency quality inhering in a bearer by virtue of the bearer's having efficiency. quality PATO:0001678 efficient PATO:0001678 A quality that inheres in an entire organism or part of an organism. quality PATO:0001995 organismal quality PATO:0001995 A quality inhering in a bearer by virtue of the severity of infectious disease caused by the bearer in a target organism. 2009-10-30T05:04:06Z quality PATO:0002146 virulence PATO:0002146 A virulence that is relatively low. 2009-10-30T05:05:02Z attenuated quality PATO:0002147 reduced virulence PATO:0002147 A quality of an object that has a value that is decreased compared to normal or average. 2011-06-16T06:51:54Z quality PATO:0002303 decreased object quality PATO:0002303 An amino acid chain that is produced de novo by ribosome-mediated translation of a genetically-encoded mRNA, and any derivatives thereof. natural protein native protein protein PR:000000001 The definition above excludes protein complexes, which some also consider a protein. Those who wish to refer to a class representing both senses of the word are directed to CHEBI:36080. Note that the definition allows for experimentally-manipulated genes, and allows for artifically-produced derivatives that mimic those found naturally. Proteins (in the sense defined here) that descended from a common ancestor can be classified into families and superfamilies composed of products of evolutionarily-related genes. The domain architecture of a protein is described by the order of its constituent domains. Proteins with the same domains in the same order are defined as homeomorphic [PRO:WCB). protein PR:000000001 A protein that has a core domain composition consisting of a signal peptide, an extracellular domain with multiple Leucine rich repeat (Pfam:PF13855) domain (LRR), a cysteine-rich region, a single-pass transmembrane domain and a C-terminal cytoplasmic tail containing a TIR domain (Pfam:PF01582). PIRSF:PIRSF800008 fam:TLR protein PR:000001096 Category=family. Toll-like receptor PR:000001096 A Toll-like receptor that is a translation product of the human TLR2 gene or a 1:1 ortholog thereof. IUPHARobj:1752 CD282 TLR2 Toll/interleukin-1 receptor-like protein 4 protein TIL4 PR:000001153 Category=gene. Toll-like receptor 2 PR:000001153 A Toll-like receptor that is a translation product of the human TLR3 gene or a 1:1 ortholog thereof. IUPHARobj:1753 CD283 TLR3 protein PR:000001154 Category=gene. Toll-like receptor 3 PR:000001154 A Toll-like receptor that is a translation product of the human TLR4 gene or a 1:1 ortholog thereof. Toll IUPHARobj:1754 CD284 TLR4 protein Lps PR:000001155 Category=gene. Toll-like receptor 4 PR:000001155 A Toll-like receptor that is a translation product of the human TLR7 gene or a 1:1 ortholog thereof. IUPHARobj:1757 TLR7 protein UNQ248/PRO285 PR:000001158 Category=gene. Toll-like receptor 7 PR:000001158 A Toll-like receptor that is a translation product of the human TLR8 gene or a 1:1 ortholog thereof. IUPHARobj:1758 CD288 TLR8 protein UNQ249/PRO286 PR:000001159 Category=gene. Toll-like receptor 8 PR:000001159 A protein that is a translation product of the human NLRP3 gene or a 1:1 ortholog thereof. IUPHARobj:1770 CLR1.1 NLRP3 PYRIN-containing APAF1-like protein 1 angiotensin/vasopressin receptor AII/AVP-like caterpiller protein 1.1 cold autoinflammatory syndrome 1 protein cold autoinflammatory syndrome 1 protein homolog cryopyrin mast cell maturation-associated-inducible protein 1 protein C1orf7 CIAS1 Mmig1 NALP3 PYPAF1 PR:000011271 Category=gene. NACHT, LRR and PYD domains-containing protein 3 PR:000011271 A SODC domain protein that is a translation product of the human SOD1 gene or a 1:1 ortholog thereof. SOD1 protein PR:000015399 Category=gene. superoxide dismutase [Cu-Zn] PR:000015399 OBSOLETE. A material entity that minimally consists of a protein. PR:000064867 protein PR:000050567 Note: Made obsolete since the term definition was much broader than intended. Originally meant to include only single proteins (and derivatives thereof; PR:000000001), protein-containing complexes (GO:0032991), and protein aggregates (PR:000050566), it instead also included cells defined as having certain protein attachments. obsolete protein-containing material entity true PR:000050567 A protein that is a translation product of the S gene in SARS-CoV-2. GenPept:YP_009724390 UniProtKB:P0DTC2 E2 (SARS-CoV-2) S (SARS2) S glycoprotein (SARS-CoV-2) peplomer protein (SARS-CoV-2) surface glycoprotein (SARS-CoV-2) protein 2 GU280_gp02 S PR:P0DTC2 Category=organism-gene. Note: 1273 aa protein. Undergoes additional processing by proteolytic cleavage. spike glycoprotein (SARS-CoV-2) PR:P0DTC2 PR:P0DTC4 Category=organism-gene. Note: 75 aa protein. A protein that is a translation product of the E gene in SARS-CoV-2. E (SARS2) envelope protein (SARS-CoV-2) sM protein (SARS-CoV-2) UniProtKB:P0DTC4 envelope small membrane protein (SARS-CoV-2) The olfactory organ of vertebrates, consisting of nares, olfactory epithelia and the structures and skeletal framework of the nasal cavity. Organ that is the specialized structure of the face that contains olfactory neurons. The peripheral olfactory organ is paired[ZFA:0000047]. a protuberance in vertebrates that houses the nostrils, or nares, which admit and expel air for respiration in conjunction with the mouth. Behind the nose are the olfactory mucosa and the sinuses. Behind the nasal cavity, air next passes through the pharynx, shared with the digestive system, and then into the rest of the respiratory system. In humans, the nose is located centrally on the face; on most other mammals, it is on the upper tip of the snout[WP]. GO: The nose is the specialized structure of the face that serves as the organ of the sense of smell and as part of the respiratory system. Includes the nasi externus (external nose) and cavitas nasi (nasal cavity)[Wikipedia:Nose]. the organ that is specialized for smell and is part of the respiratory system the structure of the nose varies across vertebrates. In tetrapods the nose is part of the respiratory system.[PMID:25312359] BTO:0000840 CALOHA:TS-2037 EHDAA2:0001274 EHDAA:1502 EMAPA:16542 EV:0100037 EV:0100370 FMA:46472 GAID:77 MA:0000281 MAT:0000139 MESH:D009666 MIAA:0000139 NCIT:C12756 SCTID:181195007 TAO:0000047 UMLS:C0028429 Wikipedia:Nose ZFA:0000047 galen:Nose nasal sac nose peripheral olfactory organ uberon nasus olfactory apparatus proboInOwlscis UBERON:0000004 nose UBERON:0000004 http://upload.wikimedia.org/wikipedia/commons/d/d0/Canine-nose.jpg Multi-tissue structure that is comprised of a secretory epithelial layer (mesothelium) and a connective tissue layer. A multi-tissue structure that is comprised of a secretory epithelial layer and a connective tissue layer.[TAO] a smooth membrane consisting of a thin layer of cells which excrete serous fluid. Serous membranes line and enclose several body cavities, known as serous cavities, where they secrete a lubricating fluid which reduces friction from muscle movement. Serosa is not to be confused with adventitia, a connective tissue layer which binds together structures rather than reducing friction between them. Each serous membrane is composed of a secretory epithelial layer and a connective tissue layer underneath. The epithelial layer, known as mesothelium, consists of a single layer of avascular flat nucleated cells (cuboidal epithelium) which produce the lubricating serous fluid. This fluid has a consistency similar to thin mucus. These cells are bound tightly to the underlying connective tissue. The connective tissue layer provides the blood vessels and nerves for the overlying secretory cells, and also serves as the binding layer which allows the whole serous membrane to adhere to organs and other structures.[WP] in FMA, SM = mesothelium + connective tissue. It excludes the cavity. Serous sac = SM + cavity. Note that the SM is a subtype of wall in FMA. FMA:9581 GAID:19 MESH:D012704 NCIT:C13169 SCTID:362878009 TAO:0005425 UMLS:C0036760 Wikipedia:Serous_membrane ZFA:0005425 tunica serosa wall of serous sac uberon serosa UBERON:0000042 serous membrane UBERON:0000042 http://upload.wikimedia.org/wikipedia/commons/4/4e/Ens.png http://upload.wikimedia.org/wikipedia/en/thumb/4/4e/Ens.png/200px-Ens.png Material anatomical entity that is a single connected structure with inherent 3D shape generated by coordinated expression of the organism's own genome. AAO:0010825 AEO:0000003 BILA:0000003 CARO:0000003 EHDAA2:0003003 EMAPA:0 FBbt:00007001 FMA:305751 FMA:67135 GAID:781 HAO:0000003 MA:0003000 MESH:D000825 SCTID:362889002 TAO:0000037 TGMA:0001823 VHOG:0001759 XAO:0003000 ZFA:0000037 http://dbpedia.org/ontology/AnatomicalStructure biological structure connected biological structure uberon UBERON:0000061 anatomical structure UBERON:0000061 Anatomical structure that performs a specific function or group of functions [WP]. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. CARO v1 does not include a generic 'organ' class, only simple and compound organ. CARO v2 may include organ, see https://github.com/obophenotype/caro/issues/4 BIRNLEX:4 CARO:0020004 EFO:0000634 EMAPA:35949 ENVO:01000162 FMA:67498 MA:0003001 NCIT:C13018 SCTID:272625005 UMLS:C0178784 WBbt:0003760 Wikipedia:Organ_(anatomy) uberon anatomical unit body organ element UBERON:0000062 organ UBERON:0000062 A multicellular structure that is a part of an organ. currently defined in a very broad sense, may be replaced by more specific classes in the future AAO:0011124 BIRNLEX:16 EFO:0000635 FMA:82472 SCTID:113343008 SCTID:91717005 cardinal organ part uberon regional part of organ UBERON:0000064 organ part UBERON:0000064 A spatiotemporal region encompassing some part of the life cycle of an organism. this class represents a proper part of the life cycle of an organism. The class 'life cycle' should not be placed here the WBls class 'all stages' belongs here as it is the superclass of other WBls stages we map the ZFS unknown stage here as it is logically equivalent to saying *some* life cycle stage BILS:0000105 EFO:0000399 FBdv:00007012 FMA:24120 HsapDv:0000000 MESH:D008018 MmusDv:0000000 OlatDv:0000010 PdumDv:0000090 WBls:0000002 XAO:1000000 ZFS:0000000 ZFS:0100000 ncithesaurus:Developmental_Stage developmental stage stage uberon UBERON:0000105 life cycle stage UBERON:0000105 A stage at which the organism is a single cell produced by means of sexual reproduction. As in all metazoans, eumetazoan development begins with a fertilized egg, or zygote.[well established][VHOG] BILS:0000106 BilaDO:0000005 EFO:0001322 EHDAA:27 FBdv:00005288 IDOMAL:0000302 NCIT:C12601 PdumDv:0000100 VHOG:0000745 Wikipedia:Zygote XAO:1000001 ZFS:0000001 1-cell stage fertilized egg stage one cell stage uberon fertilized egg stage one-cell stage zygote zygotum UBERON:0000106 zygote stage UBERON:0000106 The proximal portion of the digestive tract, containing the oral cavity and bounded by the oral opening. In vertebrates, this extends to the pharynx and includes gums, lips, tongue and parts of the palate. Typically also includes the teeth, except where these occur elsewhere (e.g. pharyngeal jaws) or protrude from the mouth (tusks). Cavity in which food is initially ingested and generally contains teeth, tongue and glands.[AAO] Molecular and developmental cell lineage data suggest that the acoel mouth opening is homologous to the mouth of protostomes and deuterostomes and that the last common ancestor of the Bilateria (the 'urbilaterian') had only this single digestive opening.[well established][VHOG] oral some AOs place this as developing from the stomodeum but we weaken this to developmental contribution, as the mouth includes non-ectodermal derivatives in FMA, the tongue, palate etc are part of the mouth which is itself a subdivision of the face. ZFA includes a separate class 'oral region' which is part of the mouth, but excludes tongue and lips AAO:0010355 BTO:0001090 BTO:0004698 CALOHA:TS-1315 EFO:0000825 EHDAA2:0001326 EHDAA:542 EMAPA:16262 FBbt:00003126 FMA:49184 GAID:75 MA:0000341 MA:0002474 MAT:0000038 MESH:D009055 MIAA:0000038 SCTID:21082005 TADS:0000040 TAO:0000547 TAO:0000590 TGMA:0000131 VHOG:0000280 VHOG:0000812 Wikipedia:Mouth XAO:0003029 ZFA:0000547 ZFA:0000590 galen:Mouth http://purl.oboInOwllibrary.org/oboInOwl/uberon/images/lamprey_sucker_rosava_3238889218.jpg regio oralis adult mouth uberon cavital oralis cavitas oris cavum oris mouth cavity oral region oral vestibule rima oris stoma stomatodaeum trophic apparatus vestibule of mouth vestibulum oris UBERON:0000165 mouth https://github.com/obophenotype/uberon/issues/661 UBERON:0000165 http://upload.wikimedia.org/wikipedia/commons/0/06/Mouth_illustration-Otis_Archives.jpg A fluid that is composed of blood plasma and erythrocytes. This class excludes blood analogues, such as the insect analog of blood. See UBERON:0000179 haemolymphatic fluid. A complex mixture of cells suspended in a liquid matrix that delivers nutrients to cells and removes wastes. (Source: BioGlossary, www.Biology-Text.com)[TAO] Highly specialized circulating tissue consisting of several types of cells suspended in a fluid medium known as plasma.[AAO] relationship loss: subclass specialized connective tissue (AAO:0000571)[AAO] Recent findings strongly suggest that the molecular pathways involved in the development and function of blood cells are highly conserved among vertebrates and various invertebrates phyla. (...) There is now good reason to believe that, in vertebrates and invertebrates alike, blood cell lineages diverge from a common type of progenitor cell, the hemocytoblast.[well established][VHOG] AAO:0000046 BTO:0000089 CALOHA:TS-0079 EFO:0000296 EHDAA2:0000176 EHDAA:418 EMAPA:16332 ENVO:02000027 EV:0100047 FMA:9670 GAID:965 MA:0000059 MESH:D001769 MIAA:0000315 NCIT:C12434 TAO:0000007 UMLS:C0005767 VHOG:0000224 Wikipedia:Blood XAO:0000124 ZFA:0000007 galen:Blood portion of blood vertebrate blood uberon whole blood UBERON:0000178 blood UBERON:0000178 Anatomical entity that has mass. AAO:0010264 AEO:0000006 BILA:0000006 CARO:0000006 EHDAA2:0003006 FBbt:00007016 FMA:67165 HAO:0000006 TAO:0001836 TGMA:0001826 VHOG:0001721 uberon UBERON:0000465 material anatomical entity UBERON:0000465 An expanded region of the vertebrate alimentary tract that serves as a food storage compartment and digestive organ. A stomach is lined, in whole or in part by a glandular epithelium. Portion of alimentary canal with increased circular and longitudinal smooth muscle. Bounded posteriorly by the pyloric sphincter. Mucosal lining has increased folding.[AAO] It appears that the stomach has an ancient origin. The stomach first appears in the fish lineage. The prevertebrate chordates do not have a true stomach, whereas the cartilaginous and bony fish do. Although most fish do have a true stomach, some fish species appear to have lost the stomach secondarily. The remaining vertebrate lineages do have a true stomach (at least in the adult animal), although there is great variation in the size and shape of the stomach.[well established][VHOG] We restrict this to the vertebrate specific structure - see the grouping class 'food storage organ' for analogous structures in other species. Teleosts: Zebrafish is functionally stomach-less, but may retain ontogenic footprint. Although the precise shape and size of the stomach varies widely among different vertebrates, the relative positions of the oesophageal and duodenal openings remain relatively constant. As a result, the organ always curves somewhat to the left before curving back to meet the pyloric sphincter. However, lampreys, hagfishes, chimaeras, lungfishes, and some teleost fish have no stomach at all, with the oesophagus opening directly into the intestine. The gastric lining is usually divided into two regions, an anterior portion lined by fundic glands, and a posterior with pyloric glands. Cardiac glands are unique to mammals, and even then are absent in a number of species. The distributions of these glands vary between species, and do not always correspond with the same regions as in man. Furthermore, in many non-human mammals, a portion of the stomach anterior to the cardiac glands is lined with epithelium essentially identical to that of the oesophagus. Ruminants, in particular, have a complex stomach, the first three chambers of which are all lined with oesophageal mucosa AAO:0000579 ANISEED:1235297 BTO:0001307 CALOHA:TS-0980 EFO:0000837 EHDAA2:0001915 EHDAA:2993 EMAPA:17021 EV:0100070 FMA:7148 GAID:293 MA:0000353 MAT:0000051 MESH:D013270 MIAA:0000051 NCIT:C12391 SCTID:181246003 TAO:0002121 UMLS:C0038351 VHOG:0000408 Wikipedia:Stomach XAO:0000128 galen:Stomach stomach chamber uberon anterior intestine gaster mesenteron ventriculus UBERON:0000945 stomach UBERON:0000945 https://upload.wikimedia.org/wikipedia/commons/e/e0/Stomach_diagram.svg Saliva-secreting exocrine glands of the oral cavity[GO]. currently we define saliva and salivary glands very generally in functional terms but it may be more appropriate to split this class. From WP: In most vertebrates, saliva does not contain any enzymes, consisting of mucus and water only, and its primary function is to moisten food while eating. As a result, true salivary glands are rarely found in fish or aquatic tetrapods, although there are often individual mucus-secreting cells. Amphibians have a single salivary gland, the intermaxillary gland, located in the forward part of the palate. Reptiles and birds normally have only very small glands on the lips, palate, and base of the mouth, although there are some birds with large glands, which produce a sticky saliva that helps in nest-building. The distinct parotid, submandibular, and sublingual glands are only developed in mammals. A gland that produces the saliva. [Bemis_WE, Functional_Anatomy_of_the_Vertebrates:_An_Evolutionary_Perspective, Glossary_G-25, Grande_L, Liem_KF, Third_Edition_(2001)_Orlando_Fla.:_Harcourt_College_Publishers, Walker_WF][VHOG] In air-feeding animals, the lack of water column to lubricate the food has been compensated for by the evolution of the salivary glands. These glands are present only in amniotes and are controlled by the parasympathetic system.[well established][VHOG] The salivary glands in mammals are exocrine glands, glands with ducts, that produce saliva. They also secrete amylase, an enzyme that breaks down starch into maltose. In other organisms such as insects, salivary glands are often used to produce biologically important proteins like silk or glues, and fly salivary glands contain polytene chromosomes that have been useful in genetic research. The salivary glands of some species are modified to produce enzymes; salivary amylase is found in many, but by no means all, bird and mammal species (including humans, as noted above). Furthermore, the venom glands of poisonous snakes, Gila monsters, and some shrews, are modified salivary glands BTO:0001203 CALOHA:TS-0892 EFO:0000859 EHDAA2:0001775 EHDAA:7987 EMAPA:17751 EV:0100059 FBbt:00005382 FMA:9597 GAID:937 MA:0000346 MAT:0000079 MESH:D012469 MIAA:0000079 NCIT:C12426 SCTID:181236000 UMLS:C0036098 VHOG:0000376 Wikipedia:Salivary_gland galen:SalivaryGland salivary gland uberon glandulae salivariae UBERON:0001044 saliva-secreting gland UBERON:0001044 http://upload.wikimedia.org/wikipedia/commons/5/51/Illu_quiz_hn_02.jpg Middle subdivision of a digestive tract[CJM]. In vertebrates: The middle part of the alimentary canal from the stomach, or entrance of the bile duct, to, or including, the large intestine[GO]. Note we define this generically to include invertebrates (partly for consistency with GO), but the class may be split in future. We may explicitly make this a developmental class The bilaterian gut is typically a complete tube that opens to the exterior at both ends. It consists of mouth, foregut, midgut, hindgut, and anus (reference 1); Although all vertebrates have a digestive tract and accessory glands, various parts of this system are not necessarily homologous, analogous, or even present in all species. Therefore, broad comparisons can be best made under the listings of headgut, foregut, midgut, pancreas and biliary system, hindgut (reference 2).[well established][VHOG] In humans: originates from the foregut at the opening of the bile duct into the duodenum and continues through the small intestine and much of the large intestine until the transition to the hindgut about two-thirds of the way through the transverse colon in FMA this represents an embryonic region. BILA:0000086 BTO:0000863 EFO:0001950 EHDAA2:0001185 EHDAA:983 EMAPA:16255 FBbt:00005383 FMA:45617 MA:0001564 NCIT:C34210 SCTID:361410004 TGMA:0001036 UMLS:C0231052 VHOG:0000290 Wikipedia:Midgut XAO:0000103 uberon mesenteron UBERON:0001045 midgut UBERON:0001045 http://upload.wikimedia.org/wikipedia/commons/3/3d/Illu_small_intestine.jpg The caudalmost subdivision of a digestive tract. Note we define this generically to include invertebrates (partly for consistency with GO), but the class may be split in future (vertebrates have some contribution from NC - https://github.com/obophenotype/uberon/wiki/The-neural-crest). We may explicitly make this a developmental class the caudal portion of the primitive digestive tube of the embryo The bilaterian gut is typically a complete tube that opens to the exterior at both ends. It consists of mouth, foregut, midgut, hindgut, and anus (reference 1); Although all vertebrates have a digestive tract and accessory glands, various parts of this system are not necessarily homologous, analogous, or even present in all species. Therefore, broad comparisons can be best made under the listings of headgut, foregut, midgut, pancreas and biliary system, hindgut (reference 2).[well established][VHOG] in FMA this class has no children. In MA it has a single child hindgut epithelium AAO:0011052 BILA:0000087 BTO:0000510 EHDAA2:0000779 EHDAA:975 EMAPA:16715 FBbt:00005384 FMA:45618 MA:0001527 NCIT:C34188 SCTID:362856002 TGMA:0001020 UMLS:C0231053 VHOG:0000459 Wikipedia:Hindgut XAO:0000104 uberon metenteron UBERON:0001046 hindgut UBERON:0001046 http://upload.wikimedia.org/wikipedia/commons/f/f7/Gray472.png Biological entity that is either an individual member of a biological species or constitutes the structural organization of an individual member of a biological species. AAO:0010841 AEO:0000000 BFO:0000004 BILA:0000000 BIRNLEX:6 CARO:0000000 EHDAA2:0002229 FBbt:10000000 FMA:62955 HAO:0000000 MA:0000001 NCIT:C12219 TAO:0100000 TGMA:0001822 UMLS:C1515976 WBbt:0000100 XAO:0000000 ZFA:0100000 uberon UBERON:0001062 anatomical entity UBERON:0001062 Muscle tissue that consists primarily of skeletal muscle fibers. TODO - add skeletal muscle organ? See GO:0060538 skeletal muscle organ development. Todo - group FBbt:00005073 - somatic muscle. Muscle, composed of long cylindrical, multinucleated cells that attaches to the skeleton via tendons.[TAO] Tissue which consists of skeletal muscle fibers surrounded by endomysium. Examples: Skeletal muscle tissue of biceps, Skeletal muscle tissue of diaphragm[FMA] This result implies the following views in terms of evolutionary differentiation: (1) Arthropod striated muscle and vertebrate skeletal and cardiac muscles share a common ancestor. In other words, they did not evolve independently (...) (5) The divergence of vertebrate skeletal and cardiac muscles/vertebrate smooth muscle and nonmuscle is at least before that of vertebrates/arthropods. In other words, emergence of skeletal and cardiac musle type tissues preceded the vertebrate/arthropod divergence (ca. 700 MYA).[well established][VHOG] skeletal muscle EMAPA:32716 FMA:14069 MA:0002439 NCIT:C13050 SCTID:426215008 UMLS:C0242692 Wikipedia:Skeletal_striated_muscle uberon skeletal muscle system somatic muscle UBERON:0001134 skeletal muscle tissue UBERON:0001134 https://upload.wikimedia.org/wikipedia/commons/c/c0/Skeletal_muscle.jpg Distensible musculomembranous organ situated in the anterior part of the pelvic cavity in which urine collects before excretion[MP]. A saccular organ in which urine accumulates before discharge from the body. [Bemis_WE, Functional_Anatomy_of_the_Vertebrates:_An_Evolutionary_Perspective, Glossary_G-29, Grande_L, Liem_KF, Third_Edition_(2001)_Orlando_Fla.:_Harcourt_College_Publishers, Walker_WF][VHOG] Anatomical structure which consists of a membranous sac used to temporarily store urine until it is excreted from the body.[AAO] In tetrapods, the urinary bladder arises as an outpocketing of the cloaca. (...) The tetrapod urinary bladder appears first among amphibians and is present in Sphenodon, turtles, most lizards, ostriches among birds, and all mammals.[well established][VHOG] vesical The urinary bladder evolved in tetrapods. Birds to not possess a true urinary bladder, although Palaeognathae have an undifferentiated cloacal outpocketing that serves a similar function[https://github.com/obophenotype/uberon/issues/454] bladder AAO:0000623 BTO:0001418 CALOHA:TS-1090 EFO:0000290 EHDAA2:0000174 EHDAA:9328 EMAPA:18321 EV:0100098 FMA:15900 GAID:0000004 MA:0000380 MAT:0000122 MESH:D001743 MIAA:0000122 NCIT:C12414 SCTID:302512001 UMLS:C0005682 VHOG:0000740 Wikipedia:Urinary_bladder XAO:0000154 galen:UrinaryBladder vesica urinaria uberon urocyst vesica UBERON:0001255 urinary bladder UBERON:0001255 https://cdn.humanatlas.io/digital-objects/ref-organ/urinary-bladder-female/v1.2/assets/3d-vh-f-urinary-bladder.glb https://cdn.humanatlas.io/digital-objects/ref-organ/urinary-bladder-male/v1.2/assets/3d-vh-m-urinary-bladder.glb https://upload.wikimedia.org/wikipedia/commons/3/30/Urinary_system.svg A clear, colorless, bodily fluid, that occupies the subarachnoid space and the ventricular system around and inside the brain and spinal cord. many sources state the CP as sole producer of CSF, but this is disputed [DOI:10.1007/s11064-015-1581-6] Portion of organism substance that is a clear fluid that occupies the subarachnoid space and the ventricular system around and inside the brain.[TAO] In vertebrates, at early stages of Central Nervous System (CNS) development, the architecture of the brain primordium reveals the presence of the cavity of brain vesicles, which is filled by Embryonic Cerebro-Spinal Fluid (E-CSF). (...) Rat and chick E-CSF proteomes are similar, although rat is more complex in certain groups of proteins, e.g., apolipoproteins, which may be involved in the control of neural diversity, and has soluble enzymes present, just like adult human CSF, but unlike chick E-CSF, revealing phylogenetic brain differences between these groups of vertebrates.[uncertain][VHOG] EHDAA2 models this as developing from CP, which is wrong the FMA def states that this is subarachnoid spaces only. ZFA def states subarachnoid spaces and brain ventricles, but not SC (and has part_of to brain). Circulation: It circulates from the lateral ventricles to the foramen of Monro (Interventricular foramen), third ventricle, aqueduct of Sylvius (Cerebral aqueduct), fourth ventricle, foramen of Magendie (Median aperture) and foramina of Luschka (Lateral apertures), subarachnoid space over brain and spinal cord. It should be noted that the CSF moves in a pulsatile manner throughout the CSF system with nearly zero net flow. CSF is reabsorbed into venous sinus blood via arachnoid granulations. BIRNLEX:1798 BTO:0000237 CALOHA:TS-0130 EFO:0000329 EHDAA2:0004441 ENVO:02000029 EV:0100311 FMA:20935 GAID:1181 MA:0002503 MAT:0000499 MESH:D002555 NCIT:C12692 TAO:0002184 UMLS:C0007806 VHOG:0001278 Wikipedia:Cerebrospinal_fluid ZFA:0001626 CSF cerebral spinal fluid uberon liquor cerebrospinalis spinal fluid UBERON:0001359 cerebrospinal fluid UBERON:0001359 Any of the tubular branching vessels that carry blood from the capillaries toward the heart. TODO - check with MA - vein vs venous blood vessel Part of the circulatory system composed of blood vessels which carry blood from other organs, tissues, and cells to the heart.[AAO] The appearance of Chordata and subsequently the vertebrates is accompanied by a rapid structural diversification of this primitive linear heart: looping, unidirectional circulation, an enclosed vasculature, and the conduction system.[well established][VHOG] venous venous subtree venous vessel AAO:0010212 AEO:0000209 BTO:0000234 CALOHA:TS-1108 EFO:0000816 EHDAA2:0003254 EMAPA:35906 EV:0100031 FMA:50723 GAID:492 MA:0000067 MAT:0000037 MESH:D014680 MIAA:0000037 NCIT:C12814 SCTID:181367001 TAO:0000082 UMLS:C0042449 VHOG:0001743 Wikipedia:Vein XAO:0000115 ZFA:0000082 galen:Vein venous tree organ part uberon vascular element vena venae UBERON:0001638 vein UBERON:0001638 http://upload.wikimedia.org/wikipedia/commons/c/c2/Venous_system_en.svg A vessel through which blood circulates in the body. consider adopting the EMAPA superclass 'vascular element', which includes microvasculature (e.g. capillaries), vascular plexus Any of the vessels through which blood circulates in the body. [XAO:0001011_][VHOG] Any of the vessels through which blood circulates in the body.[AAO] The appearance of Chordata and subsequently the vertebrates is accompanied by a rapid structural diversification of this primitive linear heart: looping, unidirectional circulation, an enclosed vasculature, and the conduction system.[well established][VHOG] annelids have blood vessels, but this class is not applicable to annelids. FMA:63183 Blood vessel is categorized as 'general anatomical term'. Suggestion to map to region of vascular tree from Terry H at JAX vascular element AAO:0011004 AEO:0000207 BTO:0001102 CALOHA:TS-0080 EFO:0000817 EHDAA2:0003252 EHDAA:240 EMAPA:32743 EMAPA:35993 FMA:50722 FMA:63183 GAID:169 MA:0000060 MAT:0000393 MESH:D001808 NCIT:C12679 NLXANAT:090901 SCTID:361097006 TAO:0002137 UMLS:C0005847 VHOG:0001250 Wikipedia:Blood_vessel XAO:0001011 ZFA:0005314 region of vascular tree organ vascular tree organ region uberon vas sanguineum UBERON:0001981 blood vessel UBERON:0001981 http://upload.wikimedia.org/wikipedia/commons/2/29/Circulatory_System_en.svg Lowermost layer of the integumentary system in vertebrates. Types of cells that are found in the hypodermis are fibroblasts, adipose cells, and macrophages. It is derived from the mesoderm, but unlike the dermis, it is not derived from the dermatome region of the mesoderm. The hypodermis is used mainly for fat storage[WP]. A layer separating the inner face of the dermis from the subjacent muscle cells. It is covered on both sides by a basement membrane. It contains pigment cells. Le Guellec et al, 2004.[TAO] A layer separating the inner face of the dermis from the subjacent muscle cells. It is covered on both sides by a basement membrane. It contains pigment cells[FMA:70544]. hypodermal subcutaneous subcutaneus BTO has 'subcutis', as part of dermis. We follow FMA in having distinct classes for hypodermis and superficial fascia, and including these as part of the non-skin intgeument. BTO:0001314 CALOHA:TS-2366 EMAPA:37505 FMA:70544 MESH:D040521 NCIT:C33645 TAO:0001136 UMLS:C0278403 Wikipedia:Hypodermis ZFA:0001136 hypoderm vertebrate hypodermis uberon sub-tegumental tissue subcutaneous tissue subcutis subtegumental tissue superficial fascia tela subcutanea UBERON:0002072 hypodermis UBERON:0002072 http://upload.wikimedia.org/wikipedia/commons/6/6d/Skin.svg The organ covering the body that consists of the dermis and epidermis. consider 'integumentary system' for invertebrates MA uses the term skin to refer to what is called here: zone of skin BTO:0001253 CALOHA:TS-0934 EFO:0000962 EHDAA2:0001844 EMAPA:17525 FMA:7163 MESH:D012867 MFMO:0000099 NCIT:C12470 SCTID:181469002 UMLS:C1123023 Wikipedia:Skin XAO:0000023 galen:Skin entire skin skin organ uberon entire integument integument integumental organ pelt skin UBERON:0002097 skin of body UBERON:0002097 http://upload.wikimedia.org/wikipedia/commons/6/6d/Skin.svg https://cdn.humanatlas.io/digital-objects/ref-organ/skin-female/v1.4/assets/3d-vh-f-skin.glb https://cdn.humanatlas.io/digital-objects/ref-organ/skin-male/v1.3/assets/3d-vh-m-skin.glb A serous membrane that lines the peritoneal cavity[VHOG,modified]. TODO - in ZFA is_a epithelium An epithelium that lines the peritoneal cavity.[TAO] Serous membrane that forms the lining of the abdominal cavity or the coelom. It covers most of the intra-abdominal organs, supports the abdominal organs, and serves as a conduit for their blood and lymph vessels and nerves. It is composed of a layer of mesothelium.[AAO] peritoneal todo: check MA/EMAPA. AAO:0010814 BTO:0001472 CALOHA:TS-2072 EV:0100087 FMA:9584 GAID:18 MA:0000449 MESH:D010537 NCIT:C12770 TAO:0005120 UMLS:C0031153 VHOG:0001257 Wikipedia:Peritoneum XAO:0000139 ZFA:0005120 galen:Peritoneum uberon peritonaeum UBERON:0002358 peritoneum UBERON:0002358 http://upload.wikimedia.org/wikipedia/commons/5/5f/Gray1040.png Muscle tissue is a contractile tissue made up of actin and myosin fibers[GO]. One of the four types of tissue in traditional classifications. Tissue that contains cells with contractile filaments that move past each other and change the size of the cell. Muscle tissue also is separated into three distinct categories.[AAO] AAO:0000306 AEO:0000122 CALOHA:TS-0642 EHDAA2:0003122 EMAPA:32715 FMA:9641 MA:0002437 MESH:D009132 NCIT:C12435 SCTID:91727004 UMLS:C2328219 Wikipedia:Muscle_tissue galen:MuscleTissue muscular tissue portion of muscle tissue textus muscularis uberon UBERON:0002385 Vertebrate muscle is categorized into three major muscle types defined by their structural and functional properties: skeletal, cardiac and smooth. In Dmel the counterparts are somatic, heart/cardiac and visceral. Here we take a cell type based approach. muscle tissue UBERON:0002385 An organ that functions as a secretory or excretory organ. glandular AAO:0000212 AEO:0000096 BTO:0000522 EFO:0000797 EHDAA2:0003096 EHDAA:2161 EMAPA:18425 FBbt:00100317 FMA:7146 FMA:86294 HAO:0000375 MA:0003038 MAT:0000021 MIAA:0000021 NCIT:C13319 SCTID:134358001 UMLS:C1285092 Wikipedia:Gland WikipediaCategory:Glands galen:Gland glandular organ uberon Druese glandula UBERON:0002530 gland UBERON:0002530 http://upload.wikimedia.org/wikipedia/commons/a/a1/Gray1026.png A gland that is part of a digestive tract [Automatically generated definition]. EMAPA:18815 MA:0003202 digestive tract gland gland of digestive tract gland of lower gastrointestinal tract gut gland lower gastrointestinal tract gland uberon UBERON:0003408 gland of digestive tract UBERON:0003408 An anatomical structure that develops (entirely or partially) from the mesoderm. Grouping term for query purposes mesodermal derivative uberon UBERON:0004120 mesoderm-derived structure UBERON:0004120 An anatomical structure that develops (entirely or partially) from the ectoderm. Grouping term for query purposes ectodermal deriviative uberon UBERON:0004121 ectoderm-derived structure UBERON:0004121 A proximal-distal subdivision of the digestive tract. intended to denote both embryonic and adult structures. Note the FMA grouping here is not quite correct. FBbt:00100315 FMA:71131 uberon alimentary system subdivision gut section intestinal tract segment of intestinal tract subdivision of alimentary system UBERON:0004921 subdivision of digestive tract UBERON:0004921 Liquid components of living organisms. includes fluids that are excreted or secreted from the body as well as body water that normally is not. fluid BIRNLEX:20 EMAPA:37441 FMA:280556 GAID:266 MESH:D001826 Wikipedia:Body_fluid galen:BodyFluid body fluid uberon UBERON:0006314 bodily fluid UBERON:0006314 An anatomical structure that has more than one cell as a part. CARO:0010000 FBbt:00100313 multicellular structure uberon UBERON:0010000 multicellular anatomical structure UBERON:0010000 Gland of the epithelium lining the oral cavity. The most common are the salivary glands. Note that Kardong classifies lacrimal glands here. EHDAA2 includes pituitary primordium, as this develops from oral mucosa UBERON:0003293 EHDAA2:0001327 EHDAA:2181 EMAPA:16572 EMAPA:16723 VHOG:0000652 buccal gland uberon gland of oral opening gland of oral region mouth gland oral cavity gland oral region gland UBERON:0010047 oral gland UBERON:0010047 Any of the organs or elements that are part of the digestive system. Examples: tongue, esophagus, spleen, crop, lunge feeding organ, tooth elements. EMAPA:37843 SCTID:272627002 digestive organ digestive system organ uberon UBERON:0013765 digestive system element UBERON:0013765 A membranous sac in animals that serves as the receptacle of a liquid or contains gas. BTO:0000123 bladder uberon UBERON:0018707 bladder organ UBERON:0018707 VO:0000000 A pathogen component in vaccine that contains only a part of the pathogen organism instead of the whole organism. Oliver He vaccine component part of pathogen organism in vaccine VO:0000001 Material entity that is manufactured to realize the vaccine function. Many vaccines are developed to protect against infectious pathogens that causes infectious diseases. Many vaccines are also being developed against other diseases such as cancer, allergy, and autoimmune diseases. Allen Xiang Anna Maria Masci Barry Smith Bjoern Peters Jie Zheng Lindsay Cowell Melanie Courtot Oliver He Ronak Sutariya MeSH: D014612 vaccine vaccine VO:0000002 Process of administering a vaccine in vivo to a recipient (e.g., a human), with the intent to invoke a protective or therapeutic adaptive immune response. Anna Maria Masci Barry Smith Bjoern Peters Jie Zheng Oliver He vaccine administration process vaccination VO:0000003 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=96 http://purl.bioontology.org/ontology/RXNORM/833083 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180810.htm 96 ACAM2000 Active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142572.pdf BL 125158 vaccine ACAM2000 vaccine VO:0000004 Preparation: The vaccine consists of the Haemophilus b capsular polysaccharide (polyribosyl-ribitol-phosphate, PRP), a high molecular weight polymer prepared from the Haemophilus influenzae type b (HiB) strain 1482 grown in a semi-synthetic medium, covalently bound to tetanus toxoid. The tetanus toxoid is prepared by extraction, ammonium sulfate purification, and formalin inactivation of the toxin from cultures of Clostridium tetani (Harvard strain) grown in a modified Mueller and Miller medium. The toxoid is filter sterilized prior to the conjugation process. When ActHIB vaccine is reconstituted with saline diluent, each single dose of 0.5 mL is formulated to contain 10 mu g of purified capsular polysaccharide conjugated to 24 mu g of inactivated tetanus toxoid, and 8.5% of sucrose (ActHIB 2005). Reference: http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157&keywords= Kallan Roan Oliver He PMID:1517908 PMID:1735812 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=157 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm174743.htm 157 ActHIB ActHIB vaccine is indicated for the active immunization of infants and children 2 months through 5 years of age for the prevention of invasive disease caused by H influenzae type b. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109841.pdf 103935 vaccine ActHIB vaccine VO:0000005 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=371 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=383 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=774 http://purl.bioontology.org/ontology/RXNORM/605718 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172481.htm 371 383 774 Adacel Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 10 through 64 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142764.pdf BL 125111 vaccine Adacel vaccine VO:0000006 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=325 WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094043.htm 325 AFLURIA For active immunization of persons ages 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM263239.pdf BL 125254 vaccine Afluria vaccine VO:0000007 Oliver He Attenuvax vaccine Product Name: Measles Virus Vaccine, Live Attenuvax vaccine VO:0000008 Oliver He vaccine-induced response vaccine-induced lymphocyte activation VO:0000009 Oliver He vaccine-induced response vaccine-induced B cell antigen processing and presentation VO:0000010 Oliver He vaccine-induced response vaccine-induced B cell cytokine production VO:0000011 Oliver He B cell epitope in vaccine material entity vaccine B cell epitope VO:0000012 Oliver He vaccine-induced response vaccine-induced B cell mediated immunity VO:0000013 A vaccine that protects against Bacillus anthrax that causes anthrax. Oliver He anthrax vaccine MeSH: D022122 vaccine Bacillus anthracis vaccine VO:0000014 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=15 http://purl.bioontology.org/ontology/RXNORM/404894 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133822.htm 15 Biothrax For the active immunization for the prevention of disease caused by Bacillus anthracis in persons between 18 and 65 years of age at high risk of exposure. https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/UCM074923.pdf BL 103821 vaccine Biothrax vaccine VO:0000015 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=372 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=385 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=772 http://purl.bioontology.org/ontology/RXNORM/583411 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172925.htm 372 385 772 Boostrix Booster immunization against tetanus, diphtheria and pertussis as a single dose in individuals 10 years of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/UCM152842.pdf BL 125106 vaccine Boostrix vaccine VO:0000017 whole organism vaccine that uses killed pathogen organism as its component. Asiyah Yu Lin vaccine killed vaccine VO:0000018 A Brucella abortus vaccine that expresses Cu/Zn SOD with DNA plasmid pcDNA. Oliver He PMID:15039330 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=138 138 vaccine Brucella abortus DNA vaccine pcDNA-SOD VO:0000019 Allen Xiang Oliver He vaccine component pVAX DNA vaccine plasmid VO:0000020 A bacterial vaccine vector that uses B. abortus vaccine strain RB51 as the vector. Oliver He vaccine component Brucella abortus strain RB51 vaccine vector VO:0000021 Brucella abortus vaccine RB51 is a Brucella abortus vaccine that is licensed in the USA since 1992. Oliver He B. abortus RB51 Brucella RB-51 Brucella RB51 SRB51 PMID:10534009 PMID:11193615 PMID:11500423 PMID:11504226 PMID:11504238 PMID:11553603 PMID:11768128 PMID:12119140 PMID:12438380 PMID:12704101 PMID:1439207 PMID:16713034 PMID:17653832 PMID:17894637 PMID:18836016 PMID:1908158 PMID:19362381 PMID:19439382 PMID:7622248 PMID:7806364 PMID:7927779 PMID:8039890 PMID:8740701 PMID:8890203 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=10 WEB: http://rb51.com 10 vaccine Brucella abortus vaccine RB51 VO:0000022 A live attenuated Brucella abortus vaccine that is licensed and used in many countries. Oliver He Brucella S19 Brucella strain-19 PMID:11058778 PMID:8039890 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=109 109 vaccine Brucella abortus vaccine strain 19 VO:0000024 Allen Xiang Oliver He vaccine component pVAX1 DNA vaccine plasmid VO:0000025 A vaccine that protects against Brucella that causes brucellosis in animals and humans. Oliver He brucellosis vaccine MeSH: D002004 vaccine Brucella vaccine VO:0000026 Allen Xiang Oliver He VO:0000217 vaccine component pCMV4 DNA vaccine plasmid VO:0000027 Allen Xiang Oliver He vaccine component pAp031 DNA vaccine plasmid VO:0000028 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3180 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=368 http://purl.bioontology.org/ontology/RXNORM/139056 3180 368 Comvax vaccine Product Name: Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) & Hepatitis B Vaccine (Recombinant) Comvax vaccine VO:0000029 Vaccine components see http://www.vaccinesafety.edu/components-DTaP.htm Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=356 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=363 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=775 http://purl.bioontology.org/ontology/RXNORM/352572 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241874.pdf 356 363 775 DAPTACEL Indicated for active immunization against diphtheria, tetanus and pertussis as a five dose series in infants and children 6 weeks through 6 years of age (prior to 7th birthday). https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM103037.pdf 103666 vaccine Daptacel vaccine VO:0000030 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=369 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=386 369 386 DECAVAC vaccine Product Name: Tetanus & Diphtheria Toxoids Adsorbed for Adult Use Decavac vaccine VO:0000031 A vaccine for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. MENHIBRIX is approved for use in children 6 weeks of age through 18 months of age. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3832 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3833 http://purl.bioontology.org/ontology/RXNORM/1437912 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm308566.htm 3832 3833 MenHibrix Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b for children 6 weeks of age through 18 months of age. BL 125363/0 vaccine MenHibrix vaccine VO:0000032 A vaccine that is composed of a plasmid vaccine vector (a circular double stranded DNA molecule) containing the whole of parts of genes encoding one or more vaccine antigen proteins. Oliver He genetic vaccine naked DNA vaccine nucleic acid vaccine vaccine DNA vaccine VO:0000033 Oliver He Diphtheria and Tetanus Toxoids Adsorbed USP by Sanofi Pasteur Inc VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=313 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=353 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=362 313 353 362 vaccine Product Name: Diphtheria & Tetanus Toxoids Adsorbed Diphtheria and Tetanus Toxoids Adsorbed USP vaccine by Sanofi Pasteur Inc VO:0000034 Oliver He Product Name: Diphtheria & Tetanus Toxoids Adsorbed This term is obsolete since there is another term with the same meaning. obsolete Diphtheria and Tetanus Toxoids Adsorbed by Sanofi Pasteur Ltd true VO:0000035 A vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, Dryvax is a live-virus preparation of vaccinia prepared from calf lymph. Dryvax is a freeze-dried calf lymph smallpox vaccine. It is the world's oldest smallpox vaccine, created in the late 19th century by American Home Products, a predecessor of Wyeth. By the 1940s, Wyeth was the leading US manufacturer of the vaccine and the only manufacturer by the 1960s. After world health authorities declared smallpox had been eradicated from nature in 1980, Wyeth stopped making the vaccine. Oliver He http://en.wikipedia.org/wiki/Dryvax Dryvax vaccine Product Name: Smallpox Vaccine, Dried, Calf Lymph Type Dryvax vaccine VO:0000036 A CFA/I‐expressing vaccine. Oliver He PMID:17566016 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=116 116 vaccine ETEC vaccine ACAM2010 VO:0000037 A viral vaccine that protects against infection of an adenovirus. Oliver He Samantha G. Sayers vaccine adenovirus vaccine VO:0000038 An assay that measures the persistent survival of live vaccine in a host in vivo. Oliver He assay vaccine persistence assay VO:0000039 Allen Xiang Oliver He vaccine component pBacPAK9 DNA vaccine plasmid VO:0000040 Allen Xiang Oliver He vaccine component pBC12/CMV DNA vaccine plasmid VO:0000041 A bacterial vaccine that prevents against Escherichia coli infection. Oliver He E. coli vaccine MeSH: D022361 vaccine Escherichia coli vaccine VO:0000042 Allen Xiang Oliver He vaccine component pBHT DNA vaccine plasmid VO:0000043 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=327 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112845.htm 327 FluLaval Active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. FLULAVAL is approved for use in persons 6 months of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM112904.pdf BL 125163 vaccine Product Name: Influenza Virus Vaccine, Trivalent, Types A and B FluLaval VO:0000044 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=328 WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094047.htm 328 FluMist For the active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. BL 125020 vaccine FluMist VO:0000045 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=326 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112850.htm 326 Fluarix For active immunization of persons 3 years of age and older for the prevention of disease caused by influenza virus subtypes A and type B contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM335392.pdf BL 125127 vaccine Fluarix vaccine VO:0000046 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=329 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112852.htm 329 Fluvirin For active immunization of persons 4 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123694.pdf BL 103837 vaccine Product Name: Influenza Virus Vaccine, Trivalent, Types A and B Fluvirin VO:0000047 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=330 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm 330 Fluzone Fluzone is indicated for active immunization of persons 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM619664.pdf BL 103914 vaccine Product Name: Influenza Virus Vaccine, Trivalent, Types A and B Fluzone VO:0000048 A gene that once deleted, would make an attenuated microbe that can be used as a live attenuated vaccine against virulent pathogen. Allen Xiang Asiyah Yu Lin Oliver He gene virmugen VO:0000049 Quadrivalent vaccine meaning it protects against 4 strains of virus (types 6, 11, 16, and 18). The vaccine was made using genetic engineering techniques. The genes that encode a specific protein from each of these strains are expressed in yeast in large-scale fermentation cultures. Protein purification methods are then used to isolate the proteins and make the vaccine. Cited from: http://biotech.about.com/b/2008/09/03/gardasil-safety-of-genetically-engineered-hpv-vaccine-still-in-question.htm Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=337 http://purl.bioontology.org/ontology/RXNORM/659877 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042.htm 337 Gardasil - Prevention of vulvar and vaginal cancer - Vaccination in females 9 through 26 years of age for prevention of the following diseases caused by Human Papillomavirus (HPV) Types 6, 11, 16, and 18: - Cervical Cancer - Genital warts (condyloma acuminata) and the following precancerous or dysplastic lesions: - Cervical adenocarcinoma in situ (AIS)cancer - Cervical intraepithelial neoplasia (CIN) grade 2 and grade 3 - Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3 - Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3 - Cervical intraepithelial neoplasia (CIN) grade 1 - Vaccination in boys and men 9 through 26 years of age for the prevention of genital warts caused by HPV types 6 and 11 - Vaccination in people ages 9 through 26 years for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM111263.pdf 125126 vaccine Gardasil vaccine VO:0000050 a lentivirus vaccine vector that uses a HIV strain as the vector Oliver He vaccine component HIV based lentivirus vaccine vector VO:0000051 Oliver He organism Balb/c mouse VO:0000052 OHDSI Vaccine WG Havrix VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=320 320 HAVRIX HAVRIX is indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV. https://www.fda.gov/media/119388/download?attachment BL 103475 vaccine Havrix vaccine VO:0000053 Vaccine that protects against Neisseria meningitidis infection. Oliver He Meningococcal vaccine MeSH: D022401 vaccine Neisseria meningitidis vaccine VO:0000054 IPOL, Poliovirus Vaccine Inactivated is a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). IPOL vaccine is a highly purified, inactivated poliovirus vaccine with enhanced potency. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=338 http://purl.bioontology.org/ontology/RXNORM/287617 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180053.htm 338 IPOL IPOL vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children and adults for the prevention of poliomyelitis caused by poliovirus Types 1, 2, and 3. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM133479.pdf 103930 vaccine IPOL vaccine VO:0000055 A jourmal article that mentions a vaccine, which was retrieved from PubMed and annotated using VO-SciMinner. Asiyah Yu Lin PMID:21871085 information content entity vaccine related journal article VO:0000063 The Imovax(R) 9 Rabies Vaccine is a sterile, stable, freeze-dried 10 suspension of rabies virus prepared from strain PM-1503-3M. Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=341 http://purl.bioontology.org/ontology/RXNORM/1659730 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180097.htm 341 IMOVAX Vaccine for use in all age groups for pre-exposure and post-exposure prophylaxis against rabies. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM133484.pdf 103931 vaccine Imovax Rabies (USA) VO:0000064 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=355 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=361 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=776 http://purl.bioontology.org/ontology/RXNORM/224903 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101568.htm 355 361 776 INFANRIX For active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM124514.pdf BL 103647 vaccine Infanrix vaccine VO:0000065 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=324 WEB: http://atomicnewsreview.org/2009/10/22/approval-for-the-arepanrix%E2%84%A2-gsk-vaccine-in-canada/ 324 vaccine Product Name: Influenza Virus Vaccine, H5N1 (for National Stockpile) influenza virus vaccine H5N1 (Sanofi Pasteur Inc) VO:0000066 JE-VAX is a sterile, lyophilized vaccine for subcutaneous use, prepared by inoculating mice intracerebrally with Japanese encephalitis (JE) virus, "Nakayama-NIH" strain. Kallan Roan Oliver He https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179149.htm JE-Vax Indicated for Active Immunization against JE for persons one year age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123761.pdf vaccine JE-Vax vaccine VO:0000067 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=358 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=365 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5551 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5581 http://purl.bioontology.org/ontology/RXNORM/801721 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172495.htm 358 365 5551 5581 KINRIX Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with INFANRIX(R) and/or PEDIARIX(R) for the first three doses and INFANRIX(R) for the fourth dose. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf BL 125260 vaccine Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine Trade Name: KINRIX Kinrix vaccine VO:0000068 a bacterial vaccine vector that uses L. moncytogenes as the vector. Oliver He vaccine component Listeria monocytogenes vaccine vector NCBI Taxonomy ID: 1639 VO:0000069 A Measles-Mumps-Rubella vaccine that is live attenuated and manufactured by Merck & Co, Inc. Kallan Roan Oliver He MMR II VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=374 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=375 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=601 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm094050.htm 374 375 601 M-M-R II M-M-R II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123789.pdf BL 101069 vaccine M-M-R II vaccine VO:0000070 A Measles-Mumps vaccine that is manufactured by Merck and used for human. Oliver He M-M-Vax MEASLES + MUMPS (MM-VAX) MM-VAX http://novaccine.com/wp-content/uploads/2014/02/mmvax_package_insert.pdf M-M-Vax vaccine Product Name: Measles and Mumps Virus Vaccine, Live M-M-Vax vaccine VO:0000071 Menactra, Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Kallan Roan Oliver He Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=381 WEB: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm176044.htm 381 Menactra Active immunization of individuals 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM131170.pdf 125089 vaccine Product Name: Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine Trade Name: Menactra Menactra vaccine VO:0000072 Kallan Roan Oliver He Menomune A C Y W135 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=316 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179991.htm 316 Menomune-A/C/Y/W-135 For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune - A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM308370.pdf BL 103926 vaccine Menomune A/C/Y/W-135 vaccine VO:0000073 Oliver He Meruvax II vaccine Product Name: Rubella Virus Vaccine Live Meruvax II vaccine VO:0000074 Oliver He Mumpsvax vaccine Product Name: Mumps Virus Vaccine Live Mumpsvax vaccine VO:0000075 Allen Xiang Oliver He vaccine component pBI/tTA DNA vaccine plasmid VO:0000076 Allen Xiang Oliver He vaccine component pBISIA DNA vaccine plasmid VO:0000077 A Mycobacterium vaccine that protects against Mycobacterium tuberculosis. Oliver He tuberculosis vaccine vaccine Mycobacterium tuberculosis vaccine VO:0000078 Mycobax is a BCG vaccine that is made by Sanofi Pasteur, Ltd. Ref: http://www.biopharma.com/cgi/full6.lasso?Key=412.65916 Oliver He Mycobax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=315 315 Mycobax vaccine Product Name: BCG Vaccine Mycobax vaccine VO:0000079 an influenza vaccine that is similar to Fluzone but has high dose. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=754 WEB: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM305079.pdf https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm 754 Fluzone High-Dose is indicated for active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM619541.pdf BL 103914 vaccine Product Name: Influenza Virus Vaccine, Trivalent, Types A and B Fluzone High-dose VO:0000080 Allen Xiang Oliver He vaccine component pBK-SFV DNA vaccine plasmid VO:0000081 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=453 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181973.htm 453 Active immunization of persons 4 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182242.pdf 103837 vaccine influenza A (H1N1) 2009 Monovalent Vaccine (Novartis) VO:0000082 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=357 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=364 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=610 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=611 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=760 http://purl.bioontology.org/ontology/RXNORM/352877 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm146759.htm 357 364 610 611 760 Pediarix For active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday). https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241874.pdf BL 103907 vaccine Pediarix vaccine VO:0000083 PedvaxHIB is a highly purified capsular polysaccharide (polyribosylribitol phosphate or PRP) of Haemophilus influenzae type b (Haemophilus b, Ross strain) that is covalently bound to an outer membrane protein complex (OMPC) of the B11 strain of Neisseria meningitidis serogroup B. Kallan Roan Oliver He PMID:2791073 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=161 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm253644.htm 161 Liquid PedvaxHIB Liquid PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM253652.pdf BL 103237/5285 vaccine PedvaxHIB vaccine VO:0000084 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=359 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=367 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=613 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=614 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=765 http://purl.bioontology.org/ontology/RXNORM/674453 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm 359 367 613 614 765 Pentacel For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease caused by Haemophilus influenzae type b when administered to infants and children 6 weeks through 4 years of age (prior to fifth birthday). https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf 125145 vaccine Pentacel vaccine VO:0000085 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=319 319 vaccine Product Name: Plague Vaccine Plague vaccine by Greer Laboratories Inc VO:0000086 Allen Xiang Oliver He vaccine component pBudCE4.1 DNA vaccine plasmid VO:0000087 a malaria vaccine that protects against malaria caused by Plasmodium falciparum. Oliver He vaccine Plasmodium falciparum vaccine VO:0000088 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=317 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm179996.htm 317 Pneumovax 23 PNEUMOVAX 23 is indicated for active immunization against pneumococcal disease caused by those pneumococcal types included in the vaccine in persons 50 years of age or older and persons greater than or equal to 2 years of age who are at increased risk for pneumococcal disease. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM257088.pdf BLA 101094 vaccine Product Name: Pneumococcal Vaccine, Polyvalent Pneumovax 23 vaccine VO:0000089 Oliver He Poliovax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=339 339 Poliovax vaccine Product Name: Poliovirus Vaccine Inactivated (Human Diploid Cell) Poliovax vaccine VO:0000090 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=318 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm180017.htm https://www.prevnar13.com/ 318 Prevnar - Immunization of infants 2, 4, 6 and 12-15 months of age to prevent invasive pneumococcal disease. - Immunization of infants and toddlers against otitis media caused by vaccine serotypes. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM137038.pdf vaccine Product Name: Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) STN: BLA 101094 Prevnar vaccine VO:0000091 A Measles-Mumps-Rubella-Vericella vaccine that is live and manufactured by Merck & Co, Inc. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=376 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=377 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=378 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=379 WEB: http://www.merck.com/product/usa/pi_circulars/p/proquad/proquad_pi.pdf https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm188806.htm 376 377 378 379 PROQUAD For vaccination against measles, mumps, rubella, and varicella in children 12 months to 12 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM123793.pdf 125108 vaccine ProQuad vaccine VO:0000092 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5567 WEB: https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm112854.htm 5567 Fluzone Intradermal Fluzone Intradermal Quadrivalent indicated for active immunization for use in adults 18 through 64 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM566500.pdf BL 103914 vaccine Fluzone Intradermal Quadrivalent VO:0000093 A vaccine adjuvant that is formed as a mineral salt. Oliver He Samantha G. Sayers vaccine adjuvant mineral salt vaccine adjuvant VO:0000094 RabAvert Rabies Vaccine is a sterile, freeze-dried vaccine obtained by growing the fixed-virus strain Flury Low Egg Passage (LEP) in primary cultures of chicken fibroblasts. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6181 WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf http://purl.bioontology.org/ontology/RXNORM/219579 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133517.htm 6181 RabAvert Pre-exposure and post-exposure immunization of children and adults https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM312931.pdf BL 103334 vaccine RabAvert vaccine VO:0000095 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=340 340 vaccine Product Name: Rabies Vaccine Adsorbed Rabies vaccine Adsorbed by BioPort Corp VO:0000096 Kallan Roan Oliver He Samantha G. Sayers VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3116 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm247508.htm 3116 Indicated for active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM247515.pdf BL 125296/0 143 40213264 Adenovirus, type 4 and type 7, live, oral Adenovirus types 4 and 7 SNOMEDCT: 442561000 UMLS_CUI: C0695130 vaccine Adenovirus Type 4 and Type 7 Vaccine, Live, Oral VO:0000097 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=344 http://purl.bioontology.org/ontology/RXNORM/496892 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094063.htm 344 RotaTeq For prevention of rotavirus gastroenteritis in infants 6 weeks to 32 weeks of age caused by types G1, G2, G3, G4, and G9. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142288.pdf BL 125122 vaccine RotaTeq vaccine VO:0000098 a lentivirus vaccine vector that uses a SIV strain as the vector Oliver He vaccine component SIV based lentivirus vaccine vector NCBI Taxonomy ID: 11723 VO:0000099 Allen Xiang Oliver He vaccine component Pcaggs DNA vaccine plasmid VO:0000100 Oliver He https://academic.oup.com/cid/article/32/1/76/311106 vaccine-induced response T helper type 1 (Th1) lymphocytes secrete secrete interleukin (IL)-2, interferon-γ, and lymphotoxin-α and stimulate type 1 immunity, which is characterized by intense phagocytic activity. https://academic.oup.com/cid/article/32/1/76/311106 vaccine-induced T-helper 1 type immune response VO:0000101 Oliver He https://academic.oup.com/cid/article/32/1/76/311106 vaccine-induced response Th2 cells secrete IL-4, IL-5, IL-9, IL-10, and IL-13 and stimulate type 2 immunity, which is characterized by high antibody titers. https://academic.oup.com/cid/article/32/1/76/311106 vaccine-induced T-helper 2 type immune response VO:0000102 Kallan Roan Oliver He Tenivac VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=370 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=384 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm152800.htm 370 384 TENIVAC Indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM152826.pdf 103171 vaccine TENIVAC vaccine VO:0000103 Kallan Roan Oliver He BCG Live VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=351 351 TICE BCG For the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder. For the prophylaxis of primary or recurrent state Ta and/or T1 papillary tumors following transurethral resection (TUR). https://www.fda.gov/media/76396/download?attachment 102821 cancer vaccine TICE BCG VO:0000104 Typhim Vi, Typhoid Vi Polysaccharide Vaccine, for intramuscular use, is a sterile solution containing the cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=352 http://purl.bioontology.org/ontology/RXNORM/114883 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094072.htm 352 Typhim Vi For active immunization against typhoid fever for persons two years of age or older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142811.pdf 103936 vaccine TYPHIM VI vaccine VO:0000105 Oliver He T cell epitope in vaccine material entity vaccine T cell epitope VO:0000106 Oliver He vaccine-induced response vaccine-induced T cell mediated immunity VO:0000107 Oliver He vaccine-induced response T cell vaccine antigen processing and presentation VO:0000108 Oliver He vaccine Brucella abortus vaccine VO:0000109 Oliver He Tetanus Toxoid Adsorbed by Aventis Pasteur Inc VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=631 631 vaccine Product Name: Tetanus Toxoid Adsorbed Tetanus Toxoid Adsorbed by Aventis Pasteur Inc vaccine VO:0000110 E. coli Int280a has been found to be a protective antigen. This subunit vaccine uses E. coli Int280a combined with adjuvant. This antigen can be used for development of type-specific EPEC or EHEC vaccine. Oliver He PMID:11500434 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=277 277 vaccine E. coli O157:H7 intimin vaccine VO:0000111 Oliver He Tetanus and Diphtheria Toxoids Adsorbed by MA Biologic Lab VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5574 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5582 5574 5582 vaccine Product Name: Tetanus & Diphtheria Toxoids Adsorbed for Adult Use Tetanus and Diphtheria Toxoids Adsorbed vaccine by MA Biologic Lab VO:0000112 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=354 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=366 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=777 354 366 777 Tripedia vaccine Product Name: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed Tripedia vaccine VO:0000113 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=349 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=350 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094035.htm 349 350 Twinrix Active immunization of persons 18 years of age or older against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM110079.pdf BL 103850 vaccine Twinrix vaccine VO:0000114 Allen Xiang Oliver He vaccine component pCAGGST7 DNA vaccine plasmid VO:0000115 vaccine-induced response vaccine-induced T cell activation VO:0000116 Allen Xiang Oliver He vaccine component pCBINT DNA vaccine plasmid VO:0000117 Allen Xiang Oliver He vaccine component pCdm7 DNA vaccine plasmid VO:0000118 A vaccine adjuvant that contains microbial derived material. Oliver He Samantha G. Sayers vaccine adjuvant microbial derivative vaccine adjuvant VO:0000119 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=347 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094073.htm 347 Indicated for active immunization for the prevention of varicella in individuals 12 months of age and older https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142812.pdf https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142813.pdf BL 103552 vaccine Varivax vaccine VO:0000120 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=248 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094070.htm 248 Vivotif For immunization of adults and children greater than 6 years of age against disease caused by Salmonella typhi. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142807.pdf 103123 vaccine Vivotif (USA) VO:0000121 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=346 http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm180913.htm 346 YF-Vax For active immunization of persons 9 months of age and older who: - Are living in or traveling to endemic areas; - Travelling internationally to countries that require evidence of vaccination from entering travelers or; - Laboratory Personnel who might be expose to virulent yellow fever virus or to concentrated preparations of the yellow fever vaccine strain by direct or indirect contact or by aerosols should by vaccinated. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142831.pdf BL 103915 vaccine YF-Vax vaccine VO:0000122 a viral vaccine vector that uses Yellow fever vaccine strain 17D as the vector. Oliver He PMID: 16755933 vaccine component Yellow fever 17D vaccine vector NCBI Taxonomy ID: 11090 VO:0000123 A viral vaccine that protects against infection with Yellow fever virus. Oliver He yellow fever vaccine vaccine yellow fever virus vaccine VO:0000124 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=348 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm136941.htm 348 Zostavax For prevention of herpes zoster (shingles) in individuals 50 years of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM132831.pdf https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM285015.pdf 125123 vaccine Zostavax vaccine VO:0000125 Oliver He vaccine licensed turkey vaccine VO:0000126 a vaccine organism that is live and attenuated Oliver He organism live attenuated vaccine organism VO:0000127 An aluminum vaccine adjuvant that contains aluminum hydroxide. Oliver He alum vaccine adjuvant aluminum hydroxide vaccine adjuvant VO:0000128 An aluminum vaccine adjuvant that is aluminum phosphate. Oliver He Samantha G. Sayers Adju-Phos® Al(PO)4 vaccine adjuvant aluminum phosphate vaccine adjuvant VO:0000129 Vaccination frequency is a qualitative term that represents how many times vaccination has occurred. Oliver He quality vaccination frequency VO:0000130 Allen Xiang Oliver He vaccine component pcDNA I/Amp DNA vaccine plasmid VO:0000131 A mineral salt vaccine adjuvant composed of calcium phosphate. Oliver He Samantha G. Sayers CaHPO4 vaccine adjuvant calcium phosphate vaccine adjuvant VO:0000132 Allen Xiang Oliver He vaccine component pcDNA3 DNA vaccine plasmid VO:0000133 An emulsion vaccine adjuvant that consists of a water-in-oil emulsion of aqueous antigen in paraffin (mineral) oil of low specific gravity and low viscosity. It is named after Jules T. Freund (1890-1960), Hungarian-born American immunologist. It is a water in oil emulsion. Oliver He Samantha G. Sayers vaccine adjuvant Freund's emulsified oil adjuvant VO:0000134 vaccine-induced response vaccine-induced T cell proliferation VO:0000135 Oliver He vaccine-induced response vaccine-induced adaptive immune response VO:0000136 a viral vaccine vector that uses an adenovirus as the vector. Oliver He vaccine component adenovirus vaccine vector NCBI Taxonomy ID: 10508 VO:0000137 A vaccine role that indicates the vaccine being a combination vaccine. Oliver He role combination vaccine role VO:0000139 A Freund's emulsified oil adjuvant that contains inactivated and dried mycobacteria, usually Mycobacterium tuberculosis (the pathogenic agent of tuberculosis). Oliver He vaccine adjuvant complete Freund's adjuvant VO:0000140 Oliver He role agglutinating antibody role VO:0000141 Oliver He obsolete virulence factor true VO:0000142 A Freund's emulsified oil adjuvant that does not contain the mycobacterial components. Oliver He vaccine adjuvant incomplete Freund's adjuvant VO:0000143 A microbial derivative vaccine adjuvant consisting of cholera toxin (CT) from Vibrio cholerae. Oliver He Samantha G. Sayers CT cholera toxin vaccine adjuvant cholera toxin vaccine adjuvant VO:0000144 a viral vaccine vector that uses an alphavirus as the vector. Oliver He vaccine component alphavirus vaccine vector NCBI Taxonomy ID: 11019 VO:0000145 A vaccine vector role that inheres in a recombinant vaccine vector as a vaccine component. The combination of a recombinant vaccine vector and a heterogenous protective antigen(s) inserted inside the vector for a recombinant vector vaccine. Asiyah Yu Lin Oliver He role recombinant vaccine vector role VO:0000146 A microbial derivative vaccine adjuvant that is the P40 particulate fraction isolated from Corynebacterium. Oliver He Samantha G. Sayers PMID:8447157 vaccine adjuvant Corynebacterium-derived P40 vaccine adjuvant VO:0000147 an adjuvant role that inheres in a vaccine component which is added as part of a vaccine and induces enhanced adaptive immune response to the vaccine antigen. Oliver He role The Latin "adjuvans" means to help, particularly to reach a goal. Adjuvant therapy for cancer is surgery followed by chemotherapy or radiation to help decrease the risk of the cancer recurring (coming back). An adjuvant is a substance that helps and enhances the pharmacological effect of a drug or increases the ability of an antigen to stimulate the immune system. vaccine adjuvant role VO:0000148 Oliver He role antibody role VO:0000150 A titer of antibody that shows how much antibody an organism has produced that recognizes a particular epitope, expressed as the greatest dilution ratio (or its reciprocal) that still gives a positive result. ELISA is a common means of determining antibody titers. Oliver He WEB: http://en.wikipedia.org/wiki/Antibody_titer data item antibody titer VO:0000151 an organismal quality that indicates an organism (e.g., human) is immunized against a disease. To assign the state of 'immunized', we will need to do some assay to measure indicators of immunity, e.g., antibody titers in serum samples. Asiyah Yu Lin Oliver He quality immunized VO:0000152 a bacterial vaccine against an infection with F. tularensis. Oliver He vaccine Francisella tularensis vaccine VO:0000153 A vaccine preparation that results in the generation of a toxoid vaccine Oliver He vaccine preparation toxoid vaccine preparation VO:0000154 A Brucella abortus gene that has the name sodC and comes from strain 2308. Oliver He gene IMMUNOGENICITY: The SodC protein induces antigen-specific Th1 immune response, as indicated by the specific induction of serum IgG2a, but not IgG1, antibodies and by the secretion of IFN-alpha but not IL-4, by the Cu/Zn SOD-stimulated splenocytes. This gene has been used for vaccine development [PubMed: 10816475][PubMed: 11953393][PubMed: 12933826]. MUTATION: An isogenic sodC mutant constructed from B abortus 2308 by gene replacement exhibited much greater susceptibility to killing by exogenous O(2)(-) than the parental 2308 strain, supporting a role for SodC in protecting this bacterium from O(2)(-) stress. The B abortus sodC mutant was much more sensitive to killing by cultured resident peritoneal macrophages from C57BL6J mice than 2308, and its attenuation in cultured murine macrophages was enhanced when these phagocytes were treated with gamma interferon. The attenuation of the B abortus sodC mutant in both resting and IFN-gamma-activated macrophages was alleviated in the presence of the NADPH oxidase inhibitor apocynin. Consistently, the B abortus sodC mutant also displayed significant attenuation in infected C57BL6J mice compared to the parental strain. These findings suggest that SodC protects B abortus 2308 from the respiratory burst of host macrophages [PubMed: 15845493]. sodC from B. abortus strain 2308 NCBI Gene GI: 3827840; NCBITaxon: 234 VO:0000155 Oliver He obsolete bacterial gene true VO:0000156 Oliver He gene viral gene VO:0000157 Oliver He gene HIV gene VO:0000158 Allen Xiang Oliver He vaccine component pcDNA3.1 DNA vaccine plasmid VO:0000159 Brucella abortus cattle vaccine RB51 was developed by serial passages of virulent B. abortus strain 2308 in vitro in rifampin agar plates (Reference: PMID: 1908158). A live attenuated vaccine prepraration process that is performed by serial passages in vitro for pathogen attenuation. Oliver He vaccine preparation live attenuated vaccine preparation by serial passages in vitro VO:0000160 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=454 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181971.htm 454 Active immunization of persons 6 months of age and older against influenza disease caused by pandemic (H1N1) 2009 virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182404.pdf 103914 vaccine influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur) VO:0000161 Oliver He E. coli gene gene Escherichia coli gene VO:0000162 a virulence of vaccine organism that shows an avirulent pheontype of the organism as the major component of a vaccine. The avirulence means that an vaccine organism is not virulent and does not cause pathogenic phenotype in a host organism. Oliver He quality vaccine organism avirulent VO:0000163 vaccine-induced response vaccine-induced gene up-regulation controlling intracellular bacterial replication VO:0000164 Oliver He gene Mycobacterium tuberculosis gene VO:0000165 A vaccine that targets against a bacterial disease. Oliver He MeSH: D001428 vaccine bacterial vaccine VO:0000166 a vaccine vector that uses a live bacterium as the vector Oliver He vaccine component bacterial vaccine vector NCBI Taxonomy ID: 2 VO:0000167 Allen Xiang Oliver He vaccine component pcDNA3.1V5HisTOPO/TA DNA vaccine plasmid VO:0000168 Oliver He gene Salmonella gene VO:0000169 Oliver He gene Shigella gene VO:0000170 Oliver He gene protozoan gene VO:0000171 Oliver He gene Plasmodium gene VO:0000172 Oliver He gene Plasmodium falciparum gene VO:0000173 a virulence of vaccine organism that shows an attenuated pheontype of the organism as the major component of a vaccine. Oliver He quality vaccine organism live attenuated VO:0000174 Oliver He gene Leishmania gene VO:0000175 Allen Xiang Oliver He vaccine component pCEP4 DNA vaccine plasmid VO:0000176 vaccine-induced response vaccine-induced T cell differentiation VO:0000177 Vaccine that prevents or treats cancer. Anna Maria Masci Barry Smith Jie Zheng Oliver He neoplasm vaccine tumor vaccine MeSH:D019496 cancer vaccine cancer vaccine VO:0000178 A vaccine preparation that results in the generation of a inactivated vaccine Oliver He vaccine preparation inactivated vaccine preparation VO:0000179 a processed material that is output of the vaccine preparation and part of a vaccine. Oliver He cardinal part of vaccine vaccine ingredient vaccine component vaccine component VO:0000180 Oliver He vaccine-induced response vaccine-induced cell activation VO:0000181 A microbial derivative vaccine adjuvant made from bacterial lipopolysaccharide (LPS) of gram-negative bacteria. Oliver He Samantha G. Sayers LPS vaccine adjuvant vaccine adjuvant lipopolysaccharide vaccine adjuvant VO:0000182 Oliver He vaccine-induced response vaccine-induced antibacterial agglutination antibody response VO:0000183 Oliver He gene Japanese encephalitis virus gene VO:0000184 Oliver He gene Ebola virus gene VO:0000185 Oliver He gene Influenza virus gene VO:0000186 A vaccine that uses RNA(s) derived from a pathogen organism. Using RNA may eliminate the problem of having to tailor a vaccine for each individual patient with their specific immunity. The advantage of RNA is that it can be used for all immunity types and can be taken from a single cell. DNA vaccines need to produce RNA which then prompts the manufacture of proteins. However, RNA vaccine eliminates the step from DNA to RNA. Oliver He mRNA vaccine https://en.wikipedia.org/wiki/RNA_vaccine vaccine RNA vaccine VO:0000187 A synthetic vaccine adjuvant formulated to correspond to a component found in a water-soluble extract of cell walls of mycobacteria used in complete Freund's adjuvant (CFA). Oliver He Samantha G. Sayers MDP muramyl dipeptide PMID:344799 vaccine adjuvant muramyl dipeptide vaccine adjuvant VO:0000188 Oliver He gene Dengue virus gene VO:0000189 A titer measurement of viable bacterial or fungal numbers. Unlike in direct microscopic counts where all cells, dead and living, are counted, CFU measures viable cells. By convenience the results are given as CFU/mL (colony-forming units per milliliter) for water, and CFU/g (colony-forming units per gram) for soil or other porous material. Oliver He CFU WEB: http://en.wikipedia.org/wiki/Colony-forming_unit data item colony forming unit VO:0000190 An emulsion vaccine adjuvant that contains an organic polymer with some antigenic epitopes which might be shared with other organic polymers acting as immunostimulators. Oliver He Samantha G. Sayers squalene vaccine adjuvant squalene vacccine adjuvant VO:0000191 A synthetic vaccine adjuvant that is an emulsifier called Arlacel A. Oliver He Samantha G. Sayers arlacel A PMID:2042393 vaccine adjuvant arlacel A vaccine adjuvant VO:0000192 A Montanide vaccine adjuvant that is Montanide 103. Oliver He Montanide 103 vaccine adjuvant Montanide 103 vaccine adjuvant VO:0000193 A microbial derivitive vaccine adjuvant that contains components from killed Bordetella pertussis. The killed B. pertussis has a strong adjuvant effect on the diphtheria and tetanus toxoids in the DPT vaccines. Oliver He vaccine adjuvant Bordetella pertussis component vaccine adjuvant VO:0000194 a USA licensed vaccine role that inheres ina vaccine approven to be by the US FDA to be used for humans in the USA. Oliver He role FDA licensed vaccine role VO:0000195 Conjugate vaccine is vaccine that conjugates/links antigens to the molecules that form the outer coat of disease-causing bacteria to promote an immune response. Oliver He vaccine A conjugate vaccine is created by covalently attaching a poor (polysaccharide organism) antigen to a carrier protein (preferably from the same microorganism), thereby conferring the immunological attributes of the carrier on the attached antigen. --from wikipedia. conjugate vaccine VO:0000196 A vaccine preparation that results in the generation of a recombinant vector vaccine Oliver He vaccine preparation recombinant vector vaccine preparation VO:0000197 Oliver He obsolete West Nile virus gene true VO:0000198 Oliver He gene chickenpox virus gene VO:0000199 Oliver He gene Rubella virus gene VO:0000200 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657331 vaccine component influenza A virus A/California/7/2009 (H1N1) antigen VO:0000201 Characteristics: Inactivated baculovirus expressed PCV2 ORF2 protein; adjuvanted Oliver He Porcilis-PCV2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=387 387 vaccine Porcilis-PCV2 vaccine VO:0000202 Oliver He gene Hepatitis A virus gene VO:0000203 Characteristics: Inactivated PCD1-2 chimera; adjuvanted Oliver He Suvaxyn PCV2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=388 388 vaccine Suvaxyn PCV2 vaccine VO:0000206 Oliver He vaccine licensed pig vaccine VO:0000207 A vaccine contraindication is a contraindication that increases the risks of a vaccination. Oliver He contraindication for vaccination disposition vaccine contraindication VO:0000208 A vaccine role that is not licensed or in clinical trial; instead, it has been experimently approved to induce protection or treatment effect in vivo in at least an experimental animal model. Oliver He role vaccine in research role VO:0000209 Allen Xiang Oliver He vaccine component pHIS64 DNA vaccine plasmid VO:0000210 an immune response detection assay that detects specific antiviral antibodies in a test serum. The serum, usually a twofold dilution series, is mixed with a standard number, usually 4 to 8 HA units, of virus and incubated prior to the addition of a standard suspension of erythrocytes. The highest dilution of serum that inhibits hemagglutination is the HI titer of the serum. For example, influenza (AI) viruses agglutinate erythrocytes through the interaction of the virus surface glycoprotein, the hemagglutinin (HA), with receptors on the surface of the erythrocyte. Inhibition of the agglutination reaction by HA subtype-specific antisera is the basis of the hemagglutination-inhibition (HI) assay. Oliver He HI assay assay hemagglutination-inhibition assay VO:0000211 an organismal quality of a whole organism vaccine where the whole organism is inactivated/killed and lacks the capability of replication. Oliver He vaccine organism killed quality vaccine organism inactivated VO:0000212 a DNA vaccine plasmid that uses the plasmid labeled pCI. Allen Xiang Oliver He WEB: http://www.ncbi.nlm.nih.gov/nuccore/5870896 vaccine component pCI DNA vaccine plasmid VO:0000213 Oliver He disposition hypersensitivity to chicken product VO:0000214 Allen Xiang Oliver He vaccine component pCI-neo DNA vaccine plasmid VO:0000215 Allen Xiang Oliver He vaccine component pCMV DNA vaccine plasmid VO:0000216 Allen Xiang Oliver He vaccine component pCMV-1 DNA vaccine plasmid VO:0000217 Allen Xiang Oliver He obsolete pCMV4 DNA vaccine plasmid true VO:0000218 Oliver He disposition hypersensitivity to chicken egg VO:0000219 a vaccine component that is used to dissolve vaccine powder into liquid. The vaccine in a powder form has to be reconstituted by mixing vaccine powder with vaccine solvent before administered. Oliver He vaccine diluent vaccine liquid diluent vaccine component vaccine solvent VO:0000220 Allen Xiang Oliver He vaccine component pCMVI.UBF3/2 DNA vaccine plasmid VO:0000221 Allen Xiang Oliver He vaccine component pCMV-3FUB DNA vaccine plasmid VO:0000222 Allen Xiang Oliver He vaccine component pCMV-int DNA vaccine plasmid VO:0000223 Allen Xiang Oliver He vaccine component pCMV-LacZ DNA vaccine plasmid VO:0000224 Oliver He disposition hypersensitivity to antibiotic VO:0000225 Oliver He disposition hypersensitivity to neomycin VO:0000226 Oliver He disposition hypersensitivity to polymyxin VO:0000227 Oliver He disposition reaction to previous vaccination VO:0000228 a vaccine component that contains the solid form of all vaccine components. A vaccine can be reconstituted by mixing vaccine powder with vaccine solvent. Oliver He vaccine component vaccine powder VO:0000229 A vaccine preparation that results in the generation of a bacterial vaccine Allen Xiang Oliver He vaccine preparation bacterial vaccine preparation VO:0000230 Allen Xiang Oliver He vaccine component pCMV-LIC DNA vaccine plasmid VO:0000231 Allen Xiang Oliver He vaccine component pCMVLuc DNA vaccine plasmid VO:0000232 Allen Xiang Oliver He vaccine component pCR3 DNA vaccine plasmid VO:0000233 Oliver He disposition life-threatening reaction to previous vaccination VO:0000234 Allen Xiang Oliver He vaccine component pCR3.1 DNA vaccine plasmid VO:0000235 Oliver He disposition life-threatening reaction to previous influenza vaccination VO:0000236 Allen Xiang Oliver He vaccine component pCR4-TOPO DNA vaccine plasmid VO:0000237 Oliver He disposition hypersensitivity to gentamicin VO:0000238 Oliver He dominant epitope in vaccine material entity vaccine dominant epitope VO:0000239 Oliver He vaccine-induced response vaccine-induced down-regulated gene expression VO:0000240 Oliver He disposition hypersensitity to gelatin VO:0000241 A vaccine prepraration process that is performed by heat inactivation of virulent pathogen. Oliver He vaccine preparation inactivated vaccine preparation using heat inactivation VO:0000242 CFU reduction assay is an assay that measures the reduction of the colony forming units of infected pathogens in vaccine-vaccinated animals compared to nonvaccinated animals. Oliver He assay CFU reduction assay VO:0000243 assay of CFU reduction in spleen is a CFU reduction assay that is measured using the extracted spleen as the tissue for isolation of infected pathogens. Oliver He assay assay of CFU reduction in spleen VO:0000244 Arginine is a conditionally essential amino acid, meaning most of the time it can be manufactured by the human body, and does not need to be obtained directly through the diet. The biosynthetic pathway however does not produce sufficient arginine, and some must still be consumed through diet. Individuals who have poor nutrition or certain physical conditions may be advised to increase their intake of foods containing arginine. Infants are unable to meet their requirements and thus arginine is nutritionally essential for infants. Oliver He disposition hypersensitity to arginine VO:0000245 A physical quality inhering in a bearer by virtue of the bearer being fit to be eaten. Melanie has submitted this term and its two subclasses to obo: http://sourceforge.net/tracker/?func=detail&aid=2873643&group_id=76834&atid=595654 Melanie Courtot Oliver He quality edibility VO:0000246 A quality of edibility that inheres in a bearer by virtue of the bearer being suitable for oral ingestion as food, drug, or vaccine. Oliver He quality This term may be submitted to PATO. edible VO:0000247 Vaccine efficacy is an efficacy of a vaccine in induction of protective immune response in vivo or protection against infection of a virulent pathogen. Specifically, vaccine efficacy (VE) is the percentage reduction in disease incidence attributable to vaccination, calculated by means of the following equation: VE(%) = (U - V)/U x 100 where U = the incidence in unvaccinated people and V = the incidence in vaccinated people. Ref: Hadler TC, et al. Immunization in developing countries. In: Vaccines. Editors: Plotkin S, et al. 2008. p1542-71. Oliver He quality vaccine efficacy VO:0000248 Oliver He disposition history of asthma VO:0000249 Oliver He vaccine-induced response vaccine-induced antiviral neutralizing antibody response VO:0000250 Allen Xiang Oliver He vaccine component pcREV DNA vaccine plasmid VO:0000251 A DNA vaccine plasmid vector that has the plasmid label pgp.LAMP-1. This plasmid has a CMV promoter and contains the human lysosomal-associated membrane protein-1 signal sequence. Oliver He Rebecca Racz vaccine component pgp.LAMP-1 DNA vaccine plasmid PMID: 19356616 VO:0000252 Allen Xiang Oliver He vaccine component pDRVISV1.0 DNA vaccine plasmid VO:0000253 Allen Xiang Oliver He vaccine component pECK DNA vaccine plasmid VO:0000254 A DNA vaccine plasmid vector that has the plasmid label pES. This plasmid has a CMV promoter and contains a kanamycin resistance gene. Oliver He Rebecca Racz vaccine component pES DNA vaccine plasmid PMID: 19406186 VO:0000255 Oliver He disposition usage of bronchodilator VO:0000256 Allen Xiang Oliver He vaccine component pET21a DNA vaccine plasmid VO:0000257 Allen Xiang Oliver He vaccine component pET-28a DNA vaccine plasmid VO:0000258 Allen Xiang Oliver He vaccine component pGA DNA vaccine plasmid VO:0000259 Allen Xiang Oliver He vaccine component pGEX-3X DNA vaccine plasmid VO:0000260 Oliver He vaccine-induced response vaccine-induced follicular dendritic cell activation VO:0000261 Oliver He disposition usage of steroid VO:0000262 Allen Xiang Oliver He vaccine component pIRES DNA vaccine plasmid VO:0000263 sodBFt is a live vaccine strain mutant of Francisella tularensis with reduced Fe-superoxide dismutase gene expression. Ref: PMID:18692537. Oliver He sodB(Ft) PMID:16923916 PMID:18692537 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=55 55 vaccine C57BL/6 mice were vaccinated intranasally (i.n.) with the sodB(Ft) mutant and challenged i.n. with lethal doses of F. tularensis SchuS4. SodB(Ft) vaccinated mice following SchuS4 challenge exhibited significantly reduced bacterial burden in lungs, liver and spleen, regulated production of pro-inflammatory cytokines and less severe histopathological lesions compared to the LVS vaccinated mice. The sodB(Ft) vaccination induced a potent humoral immune response and protection against SchuS4 required both CD4 and CD8 T cells in the vaccinated mice sodB(Ft) vaccine VO:0000266 Oliver He disposition fungal disease VO:0000267 A vaccine that targets against a fungus infection. Oliver He MeSH: D005657 vaccine fungal vaccine VO:0000271 A live attenuated Francisella tularensis vaccine. It is available in American Type Culture Collection with ATCC ID: 29684. Oliver He F. tularensis vaccine LVS PMID:16912944 PMID:8757866 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=52 52 vaccine Francisella tularensis vaccine LVS VO:0000272 Allen Xiang Oliver He vaccine component pIRES2 DsRed2 DNA vaccine plasmid VO:0000273 vaccine-induced response vaccine-induced T cell interferon-gamma production VO:0000274 Allen Xiang Oliver He vaccine component pING DNA vaccine plasmid VO:0000275 Allen Xiang Oliver He vaccine component pJW24 DNA vaccine plasmid VO:0000276 Allen Xiang Oliver He vaccine component pJW4303 DNA vaccine plasmid VO:0000277 Allen Xiang Oliver He vaccine component pK0 DNA vaccine plasmid VO:0000278 To induce or modify protective or therapeutic immune response against a disease. PERSPN: Oliver He: There has been hot discussion about whether we use 'vaccine function' or 'vaccine role'. Vaccine role may not be the good term to use. Vaccine is designed to be 'vaccine', so it should be vaccine function. One special case is cowpox virus. The cowpox virus can be mixed with some liquid like water and used as a smallpox vaccine. In this case, people often say: the cowpox virus has a 'vaccine role'. However, the cowpox virus vaccine is a processed material of a mix of the virus with water. The virus is a virus, it is not a vaccine per se. Therefore, vaccine role may not be an accurate term. Alan Ruttenburg Allen Xiang Anna Maria Masci Barry Smith Jie Zheng Melanie Courtot Oliver He disposition vaccine function VO:0000279 Allen Xiang Oliver He vaccine component pK3 DNA vaccine plasmid VO:0000280 Allen Xiang Oliver He vaccine component pMV60 DNA vaccine plasmid VO:0000282 Allen Xiang Oliver He vaccine component pMAMneoBlue DNA vaccine plasmid VO:0000283 a viral vaccine vector that uses a herpesvirus as the vector. Oliver He vaccine component herpesvirus vaccine vector NCBI Taxonomy ID: 10292 VO:0000284 Allen Xiang Oliver He vaccine component pMASIA DNA vaccine plasmid VO:0000285 Allen Xiang Oliver He vaccine component pND DNA vaccine plasmid VO:0000286 Oliver He vaccine-induced host gene response vaccine-induced response vaccine-induced gene response VO:0000287 An immune system process that is realized in the calibrated response of the recipient to a vaccine. The definition of this term is based on the definition of 'immune response (GO:0006955)' . It is a child term of this GO term. Asiyah Yu Lin Oliver He vaccine-induced host immune response vaccine-induced response vaccine-induced immune response VO:0000288 Process that specifies the organism's response to an administered vaccine. Asiyah Yu Lin Jie Zheng Oliver He vaccine-induced host response https://github.com/vaccineontology/VO/issues/781 process vaccine-induced response VO:0000289 a process that specifies host response to a vaccine adjuvant. Oliver He process host response to vaccine adjuvant VO:0000290 Process that specifies host response to a vaccine component. Oliver He process host response to vaccine component VO:0000291 a process that specifies host response to a vaccine antigen. Oliver He process host response to vaccine antigen VO:0000292 a process that specifies host response to a vaccine vector. Oliver He process host response to vaccine vaccine vector VO:0000293 Allen Xiang Oliver He vaccine component pND2 DNA vaccine plasmid VO:0000294 Allen Xiang Oliver He vaccine component pNGVL DNA vaccine plasmid VO:0000295 A viral vaccine that protects against infection with human immunodeficiency virus that causes AIDS. Oliver He AIDS vaccine HIV vaccine vaccine human immunodeficiency virus vaccine VO:0000297 Allen Xiang Oliver He vaccine component pNL3-gal DNA vaccine plasmid VO:0000298 Allen Xiang Oliver He vaccine component pN4a-gal DNA vaccine plasmid VO:0000299 A legal organization that represents an association of people with a specific objective. Oliver He https://en.wikipedia.org/wiki/Company material entity company VO:0000300 Oliver He B. melitensis strain VTRM1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=135 135 vaccine Brucella melitensis strain VTRM1 vaccine VO:0000301 Allen Xiang Oliver He vaccine component pRc/CMV DNA vaccine plasmid VO:0000302 Allen Xiang Oliver He vaccine component pRc/CMV2 DNA vaccine plasmid VO:0000303 Oliver He B. suis VTRS1 Brucella suis strain VTRS1 PMID:17428946 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=136 136 vaccine Brucella suis strain VTRS1 vaccine VO:0000304 Allen Xiang Oliver He vaccine component pRK DNA vaccine plasmid VO:0000305 Allen Xiang Oliver He vaccine component pRSV DNA vaccine plasmid VO:0000306 Allen Xiang Oliver He vaccine component pRSV0 DNA vaccine plasmid VO:0000307 KKF24 is a recombinant strain of Francisella novicida U112 with iglC mutation (F. novicida delta-iglC::ermC). PMID:14680699. Oliver He Rebecca Racz KKF24 PMID:16552035 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=60 60 vaccine An iglC mutant is highly attenuated in mice. Inoculated mice were challenged 30 days later with wild type F. tularensis and were highly protected KKF24 vaccine VO:0000308 Oliver He F. tularensis vaccine LVS LPS F. tularensis vaccine LVS lipopolysaccharide PMID:10722593 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=58 58 vaccine Francisella tularensis vaccine LVS LPS VO:0000309 Oliver He obsolete vaccine-induced antibody mediated immune response true VO:0000310 a vaccine additive that stabilizes the vaccine emulsification manufacturing process and makes emulsion of the vaccine easier. Asiyah Yu Lin Oliver He WEB: http://www.ncbi.nlm.nih.gov/pubmed/16337664 vaccine component Emulsifiers help bind ingredients together and keep them from separating, most commonly with oil and water. An emulsifier is also a surfactant that reduces the surface tension of a liquid and results in an easier, smoother spread. Reference: http://www.wisegeek.org/what-is-polysorbate-80.htm vaccine emulsifier VO:0000311 Oliver He B. melitensis lipopolysaccharide vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=137 137 vaccine Brucella melitensis lipopolysaccharide vaccine VO:0000312 Oliver He B. melitensis LPS-GBOMP noncovalent complex vaccine B. melitensis LPS-GBOMP subunit vaccine PMID:8723881 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=307 307 vaccine Brucella melitensis LPS-GBOMP noncovalent complex vaccine VO:0000313 Allen Xiang Oliver He vaccine component pSC65 DNA vaccine plasmid VO:0000314 Allen Xiang Oliver He vaccine component pSG2 DNA vaccine plasmid VO:0000315 A whole organism vaccine that uses an inativated pathogen organism as its component. Oliver He inactivated organism vaccine killed vaccine vaccine inactivated vaccine VO:0000316 Allen Xiang Oliver He vaccine component pSG5 DNA vaccine plasmid VO:0000317 Allen Xiang Oliver He vaccine component Psin DNA vaccine plasmid VO:0000318 Allen Xiang Oliver He vaccine component pTARGET DNA vaccine plasmid VO:0000319 Allen Xiang Oliver He vaccine component pTH DNA vaccine plasmid VO:0000320 Allen Xiang Oliver He vaccine component pTHamp DNA vaccine plasmid VO:0000321 Oliver He B. abortus DNA vaccine expressing BCSP31, SOD and L7/L12 PMID:17570767 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=211 211 vaccine Brucella abortus DNA vaccine encoding BCSP31, SOD and L7/L12 VO:0000322 Allen Xiang Oliver He vaccine component pTR600 DNA vaccine plasmid VO:0000323 Oliver He recombinant B. abortus L7/L12 vaccine PMID:8873388 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=111 111 vaccine Brucella abortus conjugate vaccine using L7/L12 VO:0000324 Allen Xiang Oliver He vaccine component pTVG4 DNA vaccine plasmid VO:0000325 Oliver He B. melitensis DNA vaccine encoding Omp31 PMID:17428946 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=293 293 vaccine Brucella melitensis DNA vaccine encoding Omp31 VO:0000326 Allen Xiang Oliver He vaccine component pUC18 DNA vaccine plasmid VO:0000327 Allen Xiang Oliver He vaccine component pUC19 DNA vaccine plasmid VO:0000328 Allen Xiang Oliver He vaccine component pV1J DNA vaccine plasmid VO:0000329 bacterial vaccine that protect against Mycoplasma hyopneumoniae infection Asiyah Yu Lin vaccine Mycoplasma hyopneumoniae vaccine VO:0000330 A quality of edibility that inheres in a bearer by virtue of the bearer being not suitable for oral ingestion. Melanie Courtot Oliver He quality inedible VO:0000331 Allen Xiang Oliver He vaccine component pVCL(pCXN2-mVIN) DNA vaccine plasmid VO:0000332 tertiary vaccination is a vaccination that is performed at the third time in a row. Oliver He Thom Todd vaccination tertiary vaccination VO:0000333 Protozoa are a diverse group of unicellular eukaryotic organisms,[1] many of which are motile. Originally, protozoa had been defined as unicellular protists with animal-like behavior, e.g., movement. Protozoa were regarded as the partner group of protists to protophyta, which have plant-like behaviour, e.g., photosynthesis.(http://en.wikipedia.org/wiki/Protozoa) Asiyah Yu Lin organism Protozoa VO:0000334 Allen Xiang Oliver He vaccine component pVR1012 DNA vaccine plasmid VO:0000335 A vaccination site that is used for injection of a vaccine. Asiyah Yu Lin Oliver He site vaccine injection site VO:0000336 Allen Xiang Oliver He vaccine component pVR1012x/s DNA vaccine plasmid VO:0000337 Allen Xiang Oliver He vaccine component pWRG1644 DNA vaccine plasmid VO:0000338 A B. melitensis vaccine that is recombinant B. melitensis Rev. 1 vaccine with the bp26 deletion. It has similar vaccine efficacy to Rev. 1. Its advantage compared to Rev. 1 is that this feature of bp26 deletion promotes diagnosis. PMID:17070627. Oliver He B. melitensis bp26 deletion vaccine Brucella CGV26 CGV26 PMID:16519974 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=295 295 vaccine Brucella melitensis bp26 deletion vaccine VO:0000339 A spontaneous mutant of the SCHU S4 strain that protects against virulent F. tularensis infection. Oliver He F. tularensis vaccine FSC043 PMID:16299332 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=57 57 vaccine Francisella tularensis vaccine FSC043 VO:0000340 A route of administration that inject the material(such as vaccines, allergens) directly into a muscle. Asiyah Yu Lin Oliver He intramuscular injection route site intramuscular route VO:0000341 A rounte of administration that located in nose. Oliver He site intranasal route VO:0000342 Oliver He site intranasal route by drop VO:0000343 Oliver He site intranasal route by spray VO:0000344 A route of administration that located in the peritoneum. Asiyah Yu Lin Oliver He site intraperitoneal route VO:0000345 Oliver He B. melitensis WR201 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=308 308 vaccine Brucella melitensis WR201 vaccine VO:0000346 Allen Xiang Oliver He vaccine component pWRG7077 DNA vaccine plasmid VO:0000347 Oliver He B. abortus bacA mutant Brucella abortus bacA mutant PMID:17196866 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=301 301 vaccine Brucella abortus bacA mutant vaccine VO:0000348 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=452 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181975.htm 452 Active immunization of persons ages 6 months and older against influenza disease caused by pandemic (H1N1) 2009 virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182401.pdf 125254 vaccine influenza A (H1N1) 2009 Monovalent vaccine (CSL Limited) VO:0000349 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=456 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181970.htm 456 Active immunization of individuals 2-49 years of age against influenza disease caused by pandemic (H1N1) 2009 virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182406.pdf 125020 vaccine influenza A (H1N1) 2009 Monovalent vaccine (MedImmune LLC) VO:0000350 Vaccine role that is characteristic of a live virulent vaccine. Jie Zheng role live virulent vaccine role VO:0000351 A synthetic vaccine adjuvant that is PCPP salt. Samantha G. Sayers Adjumer PCPP salt polyidi (carboxylatophenoxy) lphosphazene polyphosphazene PMID:75551218 vaccine adjuvant Adjumer vaccine adjuvant VO:0000352 Megan Egg is a Salmonella vaccine that that consists of a double gene-deleted S. enterica serovar Typhimurium strain and is formulated fro immunization of pullets. Megan Egg contains the same Megan Vac1 organism but Megan Vac1 is used for younger birds (broilers). Oliver He Megan Egg VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=752 WEB: http://www.fda.gov/ohrms/dockets/dockets/00n0504/00N-0504_emc-001650-02.pdf 752 vaccine Megan Egg vaccine VO:0000353 Allen Xiang Oliver He vaccine component pWRM DNA vaccine plasmid VO:0000354 Oliver He PMID:16481077 obsolete B. ovis microparticle subunit vaccine true VO:0000355 Allen Xiang Oliver He vaccine component pzz DNA vaccine plasmid VO:0000356 Allen Xiang Oliver He vaccine component pME18100 DNA vaccine plasmid VO:0000357 Allen Xiang Oliver He vaccine component pVIVO2 DNA vaccine plasmid VO:0000358 Oliver He Brucella rSurA protein vaccine Brucella recombinant SurA protein PMID:17686554 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=445 445 vaccine Brucella recombinant SurA protein vaccine VO:0000359 a viral vaccine vector that uses a lentivirus as the vector. Oliver He vaccine component lentivirus vaccine vector NCBI Taxonomy ID: 11646 VO:0000360 Allen Xiang Oliver He vaccine component pcDNA1.1/Amp DNA vaccine plasmid VO:0000361 Oliver He vaccine-induced response vaccine-induced leukocyte activation VO:0000362 a licensed human vaccine that is licensed in the USA. Oliver He FDA licensed vaccine https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093833.htm vaccine USA licensed human vaccine VO:0000363 A vaccine that is licensed for commercial use. Oliver He vaccine licensed vaccine VO:0000364 Allen Xiang Oliver He vaccine component pRK7 DNA vaccine plasmid VO:0000365 Oliver He vaccine component lipopolysaccharide of pathogen organism as vaccine component VO:0000366 A particulate antigen delivery system vaccine adjuvant that contains particles made up of concentric lipid membranes containing phospholipids and other lipids in a bilayer configuration separated by aqueous compartments. It is a relatively stable but non-covalently-bound complex of saponin adjuvant Quil-A, cholesterol and amphipathic antigen in a molar ratio of approximately 1:1:1. The spectrum of viral capsid antigens and non-viral amphipathic antigens of relevance for human vaccination, incorporated into ISCOMs, comprises influenza, measles, rabies, gp340 from EB-virus, gp120 from HIV, Plasmodium falciparum and Trypanosoma cruzi. Oliver He http://www.vaccination.inoz.com/adjuvants.html vaccine adjuvant liposome-based vaccine adjuvant VO:0000367 A vaccine that is made from microbes that have been attenuated (weakened) in the laboratory so that they can't cause disease. Oliver He attenuated vaccine vaccine live attenuated vaccine VO:0000368 a vaccine organism that is live Oliver He organism live vaccine organism VO:0000370 Vaccine that uses a live, pathogenic (disease-causing) microorganism to stimulate the immune system. Oliver He vaccine live virulent vaccine VO:0000371 quaternary vaccination is a vaccination that is performed at the fourth time in a row. Oliver He Thom Todd vaccination quaternary vaccination VO:0000372 A vaccine that is used to improve conception. Oliver He vaccine profertility vaccine VO:0000373 Oliver He PMID:17686554 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=292 292 vaccine Brucella recombinant DnaK protein vaccine VO:0000374 Oliver He divalent DNA B. abortus vaccine using L7/L12 and Omp16 PMID:16622210 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=302 302 vaccine divalent DNA Brucella abortus vaccine using L7/L12 and Omp16 VO:0000375 'Mycobacterium avium relA mutant vaccine' includes a gene mutation of relA from virulent Mycobacterium avium. A live attenuated vaccine prepraration process that is performed by mutation of a gene(s) from a virulent pathogen. Allen Xiang Asiyah Yu Lin Oliver He vaccine preparation live attenuated vaccine preparation by gene mutant VO:0000376 A route of administration that is through the membrane covering the muscles and nerves at the back of the eyeball Asiyah Yu Lin site subtenon route http://ncim.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=CL426248 VO:0000377 An oral route of administration that is underneath the tongue. site sublingual route http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38300 VO:0000378 Asiyah Yu Lin site intravaginal route VO:0000379 vaccination intravaginal vaccination VO:0000380 vaccination YH subtenon vaccination VO:0000381 vaccination sublingual vaccination VO:0000382 vaccination pharyngeal mucosal vaccination VO:0000383 a vaccine-induced T cell interferon-gramm production that results from the addition of a vaccine adjuvant Oliver He vaccine-induced response vaccine-induced, adjuvant boosted T cell interferon-gramm production VO:0000384 Oliver He PMID:18472194 vaccine adjuvant IL-15 plasmid vaccine adjuvant VO:0000385 Oliver He B. abortus DNA vaccine encoding L7/L12 and P39 PMID:16537031 vaccine Brucella abortus DNA vaccine encoding L7/L12 and P39 VO:0000386 Oliver He attenuated Brucella abortus with deletion of znuA PMID:16790759 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=288 288 vaccine attenuated Brucella abortus with deletion of znuA vaccine VO:0000387 Oliver He vaccine-induced response mucosal immune response to vaccine VO:0000388 A microbial derivative vaccine adjuvant that is derived from E. coli heat labile toxin LT. Oliver He Samantha G. Sayers vaccine adjuvant E. coli LT toxin derived vaccine adjuvant VO:0000389 viral vaccine that is used to protect against Feline panleukopenia virus infection Asiyah Yu Lin vaccine Feline panleukopenia virus vaccine VO:0000390 Vaccine that used for immunizing birds. Asiyah Yu Lin obsolete birds vaccine true VO:0000391 Vaccine that protects against Leptospira spp. infection. Asiyah Yu Lin vaccine Leptospira spp. vaccine VO:0000392 a Campylobacter bacterial vaccine that is used to protect against Campylobacter fetus infection Asiyah Yu Lin vaccine Campylobacter fetus vaccine VO:0000393 bacterial vaccine that is used to protect against Pseudomonas aeruginosa infection Asiyah Yu Lin vaccine Pseudomonas aeruginosa vaccine VO:0000394 Bordetella bacterial vaccine that is used to protect against Bordetella bronchiseptica infection Asiyah Yu Lin vaccine Bordetella bronchiseptica vaccine VO:0000395 Allen Xiang Asiyah Yu Lin Oliver He a vaccine organism that is inactived/killed killed vaccine organism organism inactivated vaccine organism VO:0000396 vaccine licensed rabbit vaccine VO:0000397 Oliver He role neutralizing antibody role VO:0000398 A live attenuated Brucella melitensis vaccine that is composed of live Brucella melitensis attenuated mutant vjbR::Tn5 (BMEII1116) delivered using a microsphere delivery system. Oliver He microencapsulated B. melitensis mutant vaccine PMID:18362129 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=304 304 vaccine The deletion of vjbR gene in Brucella melitensis strain 16M made a live attenuated vaccine and provided significance protection against mice microencapsulated Brucella melitensis mutant vaccine VO:0000399 A vaccine-induced adjuvant boosted T cell interferon-gramm production that results from the addition of a IL-15 vaccine adjuvant Oliver He PMID: 18472194 vaccine-induced response vaccine-induced T cell interferon-gramm production boosted by IL-15 vaccine adjuvant VO:0000400 A vaccine that contains one vaccine for priming and at least one other vaccine for boosting. Oliver He Rebecca Racz vaccine prime-boost vaccine VO:0000401 A prime-boost vaccine that contains one DNA vaccine for priming and at least one other vaccine for boosting. Oliver He Rebecca Racz vaccine prime-boost vaccine with DNA vaccine priming VO:0000402 AIDSVAX PMID:12848591 http://en.wikipedia.org/wiki/AIDSVAX vaccine AIDSVAX vaccine VO:0000403 Oliver He complex of porin and S-LPS from B. abortus strain 2308 porin-S-LPS from B. abortus strain 2308 PMID:2844673 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=291 291 vaccine porin-S-LPS from Brucella abortus strain 2308 vaccine VO:0000404 Oliver He B. abortus RB51WboA Brucella abortus RB51WboA PMID:15327798 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=13 13 vaccine Brucella abortus RB51WboA vaccine VO:0000405 The AIDSVAX that is bicovalent vaccine including two kinds of gp120 protein: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1 (MN and GNE8 are strain names). link to another well-known study: VAX004 linkto the clinical trail database by : ClinicalTrials.gov Identifier: NCT00002441 AIDSVAX B/B vaccine AIDSVAX B/B vaccine VO:0000406 AIDSVAX B/E vaccine AIDSVAX B/E vaccine VO:0000407 Oliver He recombinant O. anthropi 49237SOD PMID:11953393 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=113 113 vaccine recombinant O. anthropi 49237SOD vaccine VO:0000408 Oliver He vaccine-induced response organ or tissue specific immune response to vaccine VO:0000409 Oliver He vaccine licensed horse vaccine VO:0000410 Pandemrix is an influenza vaccine for influenza pandemics, such as the H1N1 2009 flu pandemic colloquially called the swine flu. The vaccine was developed by GlaxoSmithKline and patented in September 2006. Asiyah Yu Lin Pandemrix H1N1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3957 http://en.wikipedia.org/wiki/Pandemrix 3957 vaccine ATC code:J07BB02 As well as the active antigen derived from A/California/7/2009 (H1N1), the vaccine contains an immunologic adjuvant AS03 which consists of DL-alpha-tocopherol (vitamin E), squalene and polysorbate 80. Thiomersal (thimerosal) is added as a preservative. Being manufactured in chicken eggs, it contains trace amounts of egg proteins. Additional important non-medicinal ingredients are formaldehyde, sodium deoxycholate, and sucrose. (http://en.wikipedia.org/wiki/Pandemrix) Pandemrix vaccine VO:0000411 Oliver He B. melitensis Bp26 and Tf protein vaccine B. melitensis Bp26 and trigger factor PMID:17239499 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=300 300 vaccine Brucella melitensis Bp26 and Tf protein vaccine VO:0000412 A Brucella subunit vaccine that uses recombinant Brucella melitensis 16M P39, a putative periplasmic binding protein. Oliver He B. melitensis P39 recombinant protein vaccine PMID:11447155 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=198 198 vaccine Brucella melitensis P39 recombinant protein vaccine VO:0000413 Oliver He rBLSOmp31 recombinant chimera BLSOmp31 PMID:17442465 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=212 212 vaccine recombinant chimera BLSOmp31 vaccine VO:0000414 Panvax is an H1N1 unadjuvanted monovalent vaccine. Melanie Courtot Oliver He Panvax WEB: http://www.infowars.com/h1n1-panvax-training-powerpoint-received-by-health-care-workers-in-australia/ vaccine Panvax vaccine VO:0000415 A role inheres in a material entity, that has been added into a vaccine's formulation by the manufacture for a specific purpose. For example: adjuvant to enhance the effect of immunogen, perservatives, stablizers and those materials added for affecting PH and isotonicity. Asiyah Yu Lin Oliver He Page 73, Chapter 6, Vaccine, 5th Edition. EXPERT CONSULT by Plotkin SA., et. al. 2008 role vaccine additive role VO:0000416 A route of administration that is located in the vein Oliver He Thom Todd site intravenous route VO:0000417 A vaccine that protects against some protozoan disease. Oliver He parasite vaccine parasitic vaccine MeSH: D016052 vaccine protozoan vaccine VO:0000418 Oliver He Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine injection 0.5mL vial WEB: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm176044.htm SNOMEDCT: 416532007 UMLS_CUI:C1563043 vaccine Product Name: Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine injection 0.5mL vial Trade Name: Menactra Menactra injection 0.5mL vial VO:0000419 a Varicella-zoster virus vaccine that is live attenuated. Oliver He vaccine Varicella-zoster virus live vaccine VO:0000420 a vaccine component that originates from an organism such as a pathogen or a modified organism. Oliver He vaccine component pathogen organism component in vaccine VO:0000421 Oliver He B. abortus pcDNA-BLS VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=199 199 vaccine Brucella abortus pcDNA-BLS VO:0000422 A cancer vaccine that is used against melanoma, a malignant tumor of melanocytes. Oliver He WEB: http://en.wikipedia.org/wiki/Melanoma SNOMEDCT:373869007 UMLS_CUI:C0796561 cancer vaccine melanoma vaccine VO:0000423 Oliver He escheriosome-encapsulated B. abortus L7/L12 escheriosome-mediated delivery of B. abortus L7/L12 PMID:17931756 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=298 298 vaccine escheriosome-mediated delivery of Brucella abortus L7/L12 vaccine VO:0000424 a pneumococcal vaccine that is formed using polyvalent polysaccharides Oliver He WEB: http://www.who.int/vaccines/en/pneumococcus.shtml vaccine The most common form of the polyvalent pneumococcal vaccine is called the protein-polysaccharide combinations which is known as conjugate vaccines and contain 7-11 selected polysaccharides bound to a protein carrier. The protein-polysaccharide combinations are able to induce a T-cell dependent immune response. These vaccines are likely to be protective even in children under two years of age, and may reduce pneumococcal transmission through a herd effect. polyvalent pneumococcal vaccine VO:0000425 Oliver He WEB: http://www.ncbi.nlm.nih.gov/pubmed/10700309 vaccine a Staphyloccoccus vaccine that is made using engineered toxoid. Staphylococcus toxoid vaccine VO:0000426 period of persistence of vaccine induced immune response is a temporal interval during which a vaccine-induced immune response continuously exists. This term is related to the process 'persistence of vaccine induced immune response'. Melanie Courtot Oliver He temporal region period of persistence of vaccine induced immune response VO:0000427 A vaccine clinical trial that investigates the safety profile of a vaccine in a small group (10-50) of healthy volunteers. Oliver He process phase 1 vaccine trial VO:0000428 A vaccine clinical trial that studies vaccine efficacy with a target population (numbering 50-100). Different dosage levels will also be explored at this stage to determine the optimum dose. Oliver He process phase 2 vaccine trial VO:0000429 A vaccine clinical trial that takes the trial to a large-scale safety and efficacy study in a relevant patient population, usually in excess of 3,000. Oliver He process phase 3 vaccine trial VO:0000430 The final stage of vaccine clinical evaluation. Phase IV occurs after a vaccine or therapy is licensed and is being used by large numbers of people. These studies are not always required or completed. Oliver He process phase 4 vaccine trial VO:0000431 Seven F. tularensis proteins including IglC (rLm/iglC) were expressed in recombinant L. monocytogenes (rLm) vaccines. These 7 F. tularensis proteins are: AcpA, Bfr, DnaK, GroEL, IglC, Pld and KatG from SchuS4 strain. Allen Xiang Oliver He F. tularensis DNA vaccine rLm/iglC rLm/iglC rLm/iglC vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=929 929 vaccine Francisella tularensis DNA vaccine rLm/iglC VO:0000432 A subunit nontypeable H. influenzae vaccine that uses Hap protein. Oliver He nontypeable H. influenzae Hap protein vaccine PMID:15557618 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=170 170 vaccine Nontypeable Haemophilus influenzae Hap protein vaccine VO:0000433 Smallpox virus vaccine that uses vaccinia virus. The vaccine is made from a laboratory strain of the live vaccinia virus that has been attenuated, or weakened, so that it stimulates an immune response without causing the severe disease associated with smallpox. Oliver He WEB: http://en.wikipedia.org/wiki/Vaccinia vaccine Vaccinia virus is well known for its role as a vaccine that helped eradicate the smallpox disease, making it the first human disease to be successfully eradicated by science. vaccinia virus vaccine VO:0000434 Mixed Bacterial Vaccine (MBV, Coley's Toxins) is a historical, vaguely defined preparation of heat-inactivated Streptococcus pyogenes and Serratia marcescens used as non-specific immunotherapy in the treatment of cancer. Oliver He PMID:22847809 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6314 6314 cancer vaccine Mixed Bacterial Vaccine VO:0000435 Vaccine vector that is a DNA plasmid used to deliver the genetic code into the cells within the body. Oliver He vaccine component DNA vaccine plasmid vector VO:0000436 Oliver He B. melitensis DNA vaccine encoding Omp31 boosted with Omp31 pCIBLSOmp31 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=446 446 vaccine Brucella melitensis DNA vaccine encoding Omp31 boosted with Omp31 VO:0000437 Vaccine that protects against Moraxella bovis infection. Moraxella bovis is a Gram-negative, aerobic, oxidase-positive diplococcus that is implicated in infectious bovine keratoconjunctivitis, an eye disease of cattle, also colloquially known as Pink Eye. Oliver He WEB: http://en.wikipedia.org/wiki/Moraxella_bovis vaccine Moraxella bovis vaccine VO:0000438 a Moraxella bovis vaccine that is prepared using a bacterial bacterin. Oliver He vaccine Moraxella bovis bacterin vaccine VO:0000439 a USA licensed vaccine role that indicates the vaccine is for veterinary uses. Oliver He role USDA licensed vaccine role VO:0000440 WEB: http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/09-15-2009/0005094621&EDATE @2009/10/06 WEB: http://www.examiner.com/x-7707-Infectious-Disease-Examiner~y2009m9d15-News-Release-H1N1-vaccines-get-FDA-approval-expected-to-be-available-in-4-weeks @2009/10/06. H1N1 vaccines get FDA approval. Food and Drug Administration announced today that it has approved four vaccines against the 2009 H1N1 influenza virus. Obtaining FDA licensure of this vaccine for A (H1N1) pandemic response is a key milestone that will enable Sanofi Pasteur to provide a licensed vaccine to the U.S. government to support pandemic immunization efforts vaccine approval process is a processual entity that involves approval of a vaccine. Alan Ruttenburg Allen Xiang Melanie Courtot Oliver He vaccine product approval process WEB: http://energycommerce.house.gov/images/stories/Documents/PDF/publications/109_health.pdf @2009/10/06. This is the US Health Law which includes a section about vaccine. WEB: http://www.hhs.gov/nvpo/factsheets/fs_tableII_doc2.htm @2009/10/06 #Following the FDA's review of a license application, the sponsor and the FDA may present their findings to the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC). This non-FDA expert committee (scientists, physicians, biostatisticians, and a consumer representative) provides advice to the Agency regarding the safety and efficacy of the vaccine for the proposed indication. process vaccine approval process VO:0000441 Role of a material entity in an investigation, which has not been experimentally or clinically verified to induce a protection or treatment in vivo in a recipient organism. This role should be a subclass of 'test substance role', which will be mireoted from OBI by OntoFox. Bjoern Peters Oliver He role vaccine candidate role VO:0000442 CFU measurement assay is an assay that measures the colony forming unit (CFU) of a bacterium in a specific location (e.g., spleen of a mouse). Melanie Courtot Oliver He assay CFU measurement assay VO:0000443 A measurement datum that measues the vaccine effectiveness. It is assessed with respect to prevention of the disease against which the vaccine is given. One simple method to estimate vaccine effectiveness is to use routine data on notifications of disease cases in vaccinated and unvaccinatted children and to compare the porportion of cases vaccinated with the vaccine covervage among the same age group in the general population. If p is the proportion vaccinated in the population and c is the proportion of cases reported to be vaccinated, then VE = (p-c)/p(1-c) x 100%. Melanie Courtot Oliver He Hadler TC, et al. Immunization in developing countries. In: Vaccines. Editors: Plotkin S, et al. 2008. p1542-71. WEB: http://en.wikipedia.org/wiki/Influenza_vaccine data item vaccine effectiveness rate VO:0000444 vaccine licensing is a vaccine approval process that involves in licensing a vaccine. Allen Xiang Oliver He process vaccine licensing VO:0000446 Allen Xiang Oliver He vaccine licensed chicken vaccine VO:0000447 a viral vaccine vector that uses an poxvirus as the vector. Oliver He vaccine component poxvirus vaccine vector NCBI Taxonomy ID: 10240 VO:0000448 a Salmonella vaccine against infection with S. paratyphi, which causes paratyphoid fevers. Paratyphoid fevers are a group of enteric illnesses caused by serotypic strains of the Salmonella genus of bacteria, S. Paratyphi. paratyphoid vaccine WED: http://en.wikipedia.org/wiki/Paratyphoid_fever vaccine Salmonella paratyphi vaccine VO:0000449 Oliver He Moraxella Bovis Bacterin Piliguard Pinkeye-1 Trivalent WEB: http://www.jefferspet.com/%252332moraxella-bovis-bacterin-piliguard-pinkeye-1-trivalent/camid/liv/cp/16435/ vaccine Moraxella Bovis Bacterin Piliguard Pinkeye-1 trivalent vaccine VO:0000450 Oliver He Brucella vaccine using nonpathogenic alphaproteobacteria PMID:17715332 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=275 275 vaccine NPAP Brucella vaccine VO:0000451 A viral vaccine that protects against infection with Parainfluenza 3 virus. Oliver He vaccine Parainfluenza 3 virus vaccine VO:0000452 A vaccine function realized by the process of vaccination and leading to induction of an adaptive immune response to prevent a specific disorder. Jie Zheng Oliver He prophylactic vaccine function disposition preventive vaccine function VO:0000453 Oliver He information content entity prime boost regimen VO:0000454 Colibacillosis, caused by avian pathogenic Escherichia coli (APEC), is a major problem for the poultry industry in the world. Oliver He PMID:16863080 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=134 134 vaccine APEC vaccine using GST-Iss fusion protein VO:0000455 a vaccine that is used for prevention against a disease. Oliver He vaccine prophylactic vaccine VO:0000456 Protection efficacy is an efficiency that is associated with protection by a biological product (e.g., vaccine) against a disease. Oliver He quality protection efficacy VO:0000457 An antigen that stimulates protective immunity when used in vivo. Oliver He role protective antigen role VO:0000458 Oliver He E. coli heat-labile enterotoxin B-subunit (LB-T) vaccine PMID:11500434 vaccine E. coli LB-T vaccine VO:0000459 Oliver He PMID:14670317 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=274 274 vaccine E. coli O157:H7 subunit vaccine expressing Esps and Tir VO:0000460 an influenza virus vaccine against equine influenza viral infection Oliver He vaccine equine influenza vaccine VO:0000461 An influenza vaccine for avian use Asiyah Yu Lin Oliver He vaccine avian influenza vaccine VO:0000463 Bacterial vaccine against infection with Coxiella burnetii which causes Q fever Oliver He Q fever vaccine WEB: http://en.wikipedia.org/wiki/Q_fever vaccine Coxiella burnetii vaccine VO:0000464 Oliver He vaccine component protein of pathogen organism as vaccine component VO:0000465 a S. aureus vaccine that uses bacterin as the protective antigen. Oliver He SNOMEDCT: 52974007 UMLS_CUI: C0310856 vaccine Staphylococcus aureus bacterin vaccine VO:0000466 Oliver He PMID:17188785 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=125 125 vaccine soybean-expressed E. coli LTB vaccine VO:0000467 a S. aureus vaccine that uses the bacterial phage lysate as the protective antigen. Oliver He SNOMEDCT: 34679007 UMLS_CUI: C0311044 vaccine Staphylococcus aureus phage lysate vaccine VO:0000468 a Mycoplasma gallisepticum vaccine that uses bacterin as the protective antigen Oliver He vaccine Mycoplasma gallisepticum bacterin vaccine VO:0000469 a bacterial vaccine that uses bacterin from a bacterial strain isolated from a herd with a purpose to generate hard-specific vaccine. Oliver He WEB: http://addisonlabs.com/products/autogenous-bacterins.php vaccine autogenous bacterin vaccine VO:0000470 an autogenous bacterin vaccine that is prepared for poultry use. WEB: http://www.hygieialabs.com/autopoultry.html vaccine autogenous poulty bacterin vaccine VO:0000471 Oliver He nontypeable H. influenzae vaccine vaccine Nontypeable Haemophilus influenzae vaccine VO:0000472 Nontypeable Haemophilus influenzae (NTHi) is a nonencapsulated Haemophilus influenzae (a gram-negative bacterium). It is the cause of a number of human respiratory tract diseases, such as otitis media, sinusitis, bronchitis, and pneumonia. Oliver He NTHi organism nontypeable Haemophilus influenzae VO:0000473 Oliver He non-typeable H. influenzae rLP4/rLP6 and Moraxella catarrhalis UspA2 protein vaccine rLP4/rLP6/UspA2 PMID:15308371 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=169 169 vaccine Nontypeable Haemophilus influenzae rLP4/rLP6 and Moraxella catarrhalis UspA2 protein vaccine VO:0000474 Oliver He killed nontypeable H. influenzae whole-cell vaccine PMID:1859055 PMID:1953532 PMID:2184330 PMID:2867396 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=163 163 vaccine killed nontypeable Haemophilus influenzae whole-cell vaccine VO:0000475 a Rabies virus vaccine against Rabies in animal Oliver He vaccine animal Rabies vaccine VO:0000477 a Rabies virus vaccine against Rabies in human Oliver He vaccine human Rabies vaccine VO:0000478 Oliver He PMID:14688094 PMID:17258324 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=122 122 vaccine E. coli vaccine using intimin polypeptide VO:0000479 Oliver He nontypeable H. influenzae cell membrane vaccine (CM-Hi) PMID:10353870 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=194 194 vaccine Nontypeable Haemophilus influenzae cell membrane vaccine (CM-Hi) VO:0000480 Oliver He Nontypeable H. influenzae lipooligosaccharide-tetanus toxoid conjugate vaccine nontypeable H. influenzae LOS-TT conjugate vaccine PMID:12706701 PMID:9353024 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=164 164 vaccine Nontypeable Haemophilus influenzae LOS-TT conjugate vaccine VO:0000481 Oliver He PMID:17145948 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=127 127 vaccine E. coli subunit vaccine using IroN VO:0000482 A vaccine preparation process that uses recombinant molecular technology to prepare recombinant protein. Oliver He vaccine preparation recombinant protein vaccine preparation VO:0000483 A subunit vaccine that is made using a part of whole organism as subunit for vaccine development. Oliver He vaccine protein subunit vaccine VO:0000484 A vaccine that uses a modified virus or bacterium as the vector to deliver vaccine antigen(s) to the cells of the host body. Oliver He vaccine recombinant vector vaccine VO:0000485 Oliver He PMID:17145948 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=128 128 vaccine E. coli subunit vaccine using CO393 VO:0000486 A chicken egg protein allergen where the protein allergen is ovalbumin, the main protein found in egg write, making up 60-65% of the total protein. Oliver He WEB: http://en.wikipedia.org/wiki/Ovalbumin material entity chicken ovalbumin egg protein allergen VO:0000487 a S. typhi vaccine that is live and orally administerred Oliver He 25 40213242 typhoid vaccine, live, oral vaccine typhoid live oral vaccine VO:0000488 Oliver He PMID:14688094 PMID:17258324 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=126 126 vaccine E. coli subunit vaccine using FyuA VO:0000489 A licensed vaccine role that is bears in a licensed human vaccine. Discussed among Barry Smith, Anna Maria Masci, Jie Zheng and Oliver He. The vaccine recipient will be associate with vaccine directly rather than using the role. Oliver He obsolete licensed human vaccine role true VO:0000490 Process that results in an adaptive immune response to one or more antigens. Allen Xiang Anna Maria Masci Barry Smith Bjoern Peters Jie Zheng Oliver He WEB: http://en.wikipedia.org/wiki/Immunization process immunization VO:0000491 An immunization that involves the introduction of foreign molecules into a recipient body, in a way which causes the recipient to actively induce adaptive immunity against the immunization target. Allen Xiang Anna Maria Masci Barry Smith Jie Zheng Oliver He WEB: http://en.wikipedia.org/wiki/Immunization process active immunization VO:0000492 An immunization where pre-synthesized elements of the immune system are transferred to an organism so that the body does not need to produce these elements itself. Currently, antibodies can be used for passive immunization. This method of immunization works very quickly. However, it is short lasting. The antibodies are naturally broken down. If there are no B cells to produce more antibodies, they will disappear. Anna Maria Masci Barry Smith Jie Zheng Oliver He WEB: http://en.wikipedia.org/wiki/Immunization process passive immunization VO:0000493 natural active immunization is an active immunization that occur naturally when a person or animal comes in contact with antigens includeing microbes. Allen Xiang Oliver He WEB: http://en.wikipedia.org/wiki/Immunization process natural active immunization VO:0000494 Immunization that is induced by a vaccine via vaccination process. Allen Xiang Anna Maria Masci Barry Smith Jie Zheng Oliver He artificial active immunization WEB: http://en.wikipedia.org/wiki/Immunization process vaccine immunization VO:0000495 induction of adaptive immune response to antigen is an active immunization process that results in induction of adaptive immune response to some antigens, for example, in a vaccine. Allen Xiang Oliver He process induction of adaptive immune response to antigen VO:0000496 Process that prevents a disorder that is the physical basis of a disease. Allen Xiang Oliver He process disorder prevention VO:0000497 Process that leads to treat a disorder that is the physical basis of a disease. Allen Xiang Oliver He process disorder treatment VO:0000498 modification of adaptive immune response to antigen is an active immunization process that results in modification of an adaptive immune response to some antigens, for example, in a therapeutic vaccine. Allen Xiang Oliver He process modification of adaptive immune response to antigen VO:0000499 Allen Xiang Oliver He obsolete preventive infectious disease vaccine function true VO:0000500 infection disorder prevention is a process that prevents a disorder that is the physical basis of an infectious disease. Allen Xiang Oliver He process infection disorder prevention VO:0000501 Oliver He PMID:17145948 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=281 281 vaccine E. coli vaccine using verocytotoxin toxoid VO:0000502 Oliver He Inactivated ETEC expressing CFA/I and CFA/II PMID:1612730 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=286 286 vaccine Inactivated ETEC expressing CFA/I and CFA/II vaccine VO:0000503 Oliver He vaccine licensed sheep vaccine VO:0000504 a vaccine role that indicates the vaccine being a whole organism vaccine. Oliver He role whole organism vaccine role VO:0000505 Oliver He PMID:1612730 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=278 278 vaccine EHEC O157 subunit vaccine using his-tagged N-terminal intimin VO:0000506 an organism that is used as part of a vaccine Oliver He organism vaccine organism VO:0000507 A Canada licensed vaccine role that indicates the vaccine is for veterinary uses. Discussed among Barry Smith, Anna Maria Masci, Jie Zheng and Oliver He. The vaccine recipient will be associate with vaccine directly rather than using the role. Oliver He obsolete Canada licensed veterinary vaccine role true VO:0000508 a diphtheria vaccine that uses diphtheria toxoid Oliver He vaccine Diphtheria toxoid vaccine VO:0000509 Oliver He nontypeable H. influenzae P5 peptide MVF/H3 vaccine PMID:10603411 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=193 193 vaccine Nontypeable Haemophilus influenzae P5 peptide MVF/H3 vaccine VO:0000510 Oliver He nontypeable H. influenzae rTbpB vaccine PMID:10225866 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=195 195 vaccine Nontypeable Haemophilus influenzae rTbpB vaccine VO:0000511 ACAM2007 is a vaccine candidate expressing CFA/II. Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=115 WEB: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095642/ 115 vaccine ETEC vaccine ACAM2007 VO:0000512 a viral vaccine against a disease caused by a virus belong to Poxviridae. vaccine Pox vaccine VO:0000513 a Pox vaccine for Quail pox Oliver He vaccine Quail pox vaccine VO:0000514 a Salmonella vaccine against both typhoid caused by S. typhi and paratyphoid caused by S. paratyphi. Oliver He vaccine typhoid-paratyphoid vaccine VO:0000515 Oliver He quality rough phenotype VO:0000516 a protein from human Oliver He protein human protein VO:0000517 ACAM2017 was derived from ACAM2007. Genes aroC, ompC, and ompF were deleted, while CS1 and pStrep were added. Oliver He PMID:17566016 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=117 WEB: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095642/ 117 vaccine ETEC vaccine ACAM2017 VO:0000518 DNA vaccine contains the gene fragment encoding AAs 173-764 of PA. Oliver He B. anthracis DNA vaccine encoding PA63 PMID:9987172 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=23 23 vaccine Bacillus anthracis DNA vaccine encoding PA63 VO:0000519 Oliver He protein human ACPP GenBank: AC020633; Protein RefSeq: NP_001090 VO:0000521 Oliver He B. anthracis DNA vaccine encoding PA83 and LF PMID:15342913 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=30 30 vaccine Bacillus anthracis DNA vaccine encoding PA83 and LF VO:0000522 Oliver He DAAV using PA and PGA PMID:12960361 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=24 24 vaccine DAAV using PA and PGA vaccine VO:0000523 Oliver He quality smooth phenotype VO:0000526 Oliver He rPA with adjuvant Nanoemulsion PMID:17502384 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=309 309 vaccine rPA with adjuvant nanoemulsion vaccine VO:0000528 Oliver He M. tuberculosis arabinomannan-protein conjugate PMID:12922145 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=223 223 vaccine Mycobacterium tuberculosis arabinomannan-protein conjugate vaccine VO:0000532 A route of administration that is loacted in the hypodermis (subcutaneous tissue) region. Asiyah Yu Lin Oliver He site subcutaneous route VO:0000533 Oliver He subdominant epitope in vaccine material entity vaccine subdominant epitope VO:0000534 A vaccine that is composed of a purified protein(s) or other antigenic determinant(s) from a disease-causing organism. A subunit vaccine does not include the whole organism of a pathogen, so the subunits have less risk of causing adverse reactions. Oliver He vaccine subunit vaccine VO:0000535 Oliver He recombinant S. typhimurium secreting M. tuberculosis ESAT-6 PMID:11427279 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=176 176 vaccine recombinant Salmonella typhimurium secreting Mycobacterium tuberculosis ESAT-6 vaccine VO:0000536 Oliver He Ag85B and ESAT-6 fusion protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=171 171 vaccine Ag85B and ESAT-6 fusion protein vaccine VO:0000539 Asiyah Yu Lin Oliver He vaccine equine EEV, VEV and WEV encephalomyelitis-influenza vaccine-tetanus toxoid VO:0000540 time of survival of live vaccine inside host is a temporal interval during which a live vaccine survives inside a host organism. This entity is related to the process survival of live vaccine inside host. Melanie Courtot Oliver He temporal region time of survival of live vaccine inside host VO:0000541 Asiyah Yu Lin Oliver He vaccine equine EEV, VEE & WEV encephalomyelitis-tetanus toxoid VO:0000542 Asiyah Yu Lin vaccine equine EEV, VEV and WEV encephalomyelitis-rhinopneumonitis-influenza vaccine-tetanus toxoid VO:0000543 Oliver He attenuated M. bovis strain WAg539 PMID:15784584 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=177 177 vaccine attenuated Mycobacterium bovis strain WAg539 vaccine VO:0000544 a vaccinee that is a human being organism human vaccinee VO:0000545 a population of human beings who are vaccinated. https://github.com/vaccineontology/VO/issues/630 material entity human vaccinee population VO:0000546 a population group that are vaccinated with a specific vaccine Oliver He vaccinee group https://github.com/vaccineontology/VO/issues/630 material entity vaccinee population VO:0000548 material entity human vaccinee population at age 2-17 years old VO:0000549 Oliver He quality bacterial phenotype VO:0000550 A vaccine that is used for treatment for a disease. Oliver He vaccine therapeutic vaccine VO:0000551 A licensed vaccine role that is bears in a licensed veterinary vaccine. Discussed among Barry Smith, Anna Maria Masci, Jie Zheng and Oliver He. The vaccine recipient will be associate with vaccine directly rather than using the role. Oliver He obsolete licensed veterinary vaccine role true VO:0000552 Oliver He attenuated M. bovis strain WAg520 PMID:10225931 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=179 179 vaccine attenuated Mycobacterium bovis strain WAg520 vaccine VO:0000554 material entity human vaccinee at age 2-17 years old VO:0000555 A titer (or titre) is a measure of concentration. Titer testing employs serial dilution to obtain approximate quantitative information from an analytical procedure that inherently only evaluates as positive or negative. The titer corresponds to the highest dilution factor that still yields a positive reading; for example, positive readings in the first 8 serial twofold dilutions translate into a titer of 1:256. Oliver He WEB:http://en.wikipedia.org/wiki/Titer data item titer VO:0000556 a vaccine that is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms. Ningxian Fan Oliver He WEB: http://coastalcarolinaresearch.com/?p=679 vaccine multivalent vaccine VO:0000557 Oliver He attenuated M. bovis strain WAg522 PMID:10225931 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=180 180 vaccine attenuated Mycobacterium bovis strain WAg522 vaccine VO:0000558 Oliver He recombinant nontypeable H. influenzae protein P6 with AdDP PMID:15031801 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=189 189 vaccine recombinant nontypeable Haemophilus influenzae protein P6 vaccine with AdDP adjuvant VO:0000559 A synthetic vaccine adjuvant, adamantylamide dipeptide (AdDP) is the desmuramyl analog of MDP. Oliver He Samantha G. Sayers AdDP PMID:8375945 vaccine adjuvant adamantylamide dipeptide vaccine adjuvant VO:0000560 A toxin is a poisonous substance produced within living cells or organisms; man-made substances created by artificial processes are thus excluded. Oliver He material entity The term was first used by organic chemist Ludwig Brieger (1849-1919).[3] For a toxic substance not produced within living organisms, "toxicant" and "toxics" are also sometimes used.[citation needed]. Toxins can be small molecules, peptides, or proteins that are capable of causing disease on contact with or absorption by body tissues interacting with biological macromolecules such as enzymes or cellular receptors. Toxins vary greatly in their severity, ranging from usually minor and acute (as in a bee sting) to almost immediately deadly (as in botulinum toxin).-- from Wikipedia. toxin VO:0000561 A vaccine containing a toxoid, used to protect against toxins produced by certain bacteria. A toxoid (also called inactivated toxin) is a processed toxin that has been treated by chemical means, heat, or irradiation and is no longer capable of causing disease. Oliver He vaccine toxoid vaccine VO:0000562 A vaccine function realized the process of vaccination and leading to induction of an adaptive immune response to treat an existing specific disorder. Jie Zheng Oliver He disposition therapeutic vaccine function VO:0000563 a combination vaccine that is used against both bacterial and viral infections. Oliver He vaccine bacterial and viral combination vaccine VO:0000564 Oliver He Rebecca Racz M. tuberculosis secA2 mutant PMID:17671656 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=222 222 vaccine Vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Guerin vaccination Mycobacterium tuberculosis secA2 mutant vaccine VO:0000565 Oliver He rBCG-Ag85A[Tokyo] PMID:17720625 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=236 236 vaccine rBCG-Ag85A[Tokyo] vaccine VO:0000566 Vaccine that protects against Vibrio infection. Oliver He https://en.wikipedia.org/wiki/Vibrio vaccine Vibrio vaccine VO:0000567 Oliver He PMID:16520093 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=166 166 vaccine DNA vaccine Rv1806-1807 VO:0000568 A vaccine that protects against Campylobacter bacterial infectioni. Allen Xiang Oliver He vaccine Campylobacter vaccine VO:0000569 Oliver He vaccine-induced response vaccine-induced up-regulated gene expression VO:0000571 a viral vaccine vector that uses an AAV virus as the vector. Oliver He Shunzhou Deng Adeno-associated virus vector PMID: 24702846; PMID: 24568220; PMID: 24660751; PMID: 24849042; PMID: 24742767; PMID: 24827459 vaccine component AAV vaccine vector NCBI Taxonomy ID: 272636 VO:0000572 vaccination protocol is the protocol of a vaccination procedure. Oliver He vaccination schedule information content entity vaccination protocol VO:0000573 A vaccine that protects against Chlamydia bacterial infection. Allen Xiang Oliver He vaccine Chlamydia vaccine VO:0000574 A path that is located in gross anatomical part of an organism (e.g., human) and is used for administering a vaccine, a drug, fluid, poison, or other substance into the body. CDISC has a codelist: Rout of Administration. Desription from CDISC: The course by which a substance was administered in order to reach the site of action in the body. CDISC_SDTM_Route_of_Administration_Terminology Asiyah Yu Lin Oliver He http://en.wikipedia.org/wiki/Route_of_administration site route of administration http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38114 http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66729 VO:0000575 vaccine candidate is a processed material that is designed to prevent or ameliorate a disorder in a target organism by modulating adaptive immune responses in that organism by administrating the vaccine. During our call, we decided not to say vaccine candidate is an output of vaccine preparation, which may be reserved for vaccine alone. -- Aug 4, 2009. Alan Ruttenburg Allen Xiang Bjoern Peters Lindsay Cowell Melanie Courtot Oliver He material entity vaccine candidate VO:0000576 vaccine preservative that has thimerosal as part. Oliver He vaccine component thimerosal vaccine preservative VO:0000577 A subunit vaccine that uses small peptide(s) as immunoepitopes. Jie Zheng Oliver He epitope vaccine peptide-based synthetic vaccine https://en.wikipedia.org/wiki/Peptide_vaccine vaccine peptide vaccine VO:0000578 H1N1 Influenza vaccine is an Influenza virus vaccine that is used to vaccinate against H1N1 Influenza subtype vaccine. Oliver He vaccine H1N1 influenza vaccine VO:0000579 bacterial vaccine that is used to protect against Haemophilus somnus infection Asiyah Yu Lin vaccine Haemophilus somnus vaccine VO:0000580 A vaccine component is a chemical substance added to a vaccine to enhance and direct the immune response to a protective antigen. Vaccine adjuvants may cause a range of serious side-effects. Oliver He Paola Roncaglia https://github.com/vaccineontology/VO/issues/809 vaccine adjuvant vaccine adjuvant VO:0000581 Oliver He gene H. influenzae gene VO:0000582 A vaccine regulatory process that is for vaccine producer to apply for vaccine license. Oliver He process vaccine license application VO:0000583 Encodes for protein P4 Oliver He gene nontypeable H. influenzae gene hel (encoding P4) VO:0000584 An assay that is used to detect the immune response of a host to vaccination of a vaccine. Oliver He assay immune response detection assay VO:0000585 immunization objective is the specification of an objective to achieve immunization. Allen Xiang Oliver He WEB: http://en.wikipedia.org/wiki/Immunization information content entity immunization objective VO:0000586 a multivalent vaccine that is designed to immunize against at least one bacterial disease and one viral disease. Ningxian Fan Oliver He vaccine multivalent vaccine against bacterial and viral diseases VO:0000587 a bacterial vaccine against infection of Bordetella bacterial infection Oliver He https://en.wikipedia.org/wiki/Bordetella vaccine Bordetella vaccine VO:0000588 Oliver He Rebecca Racz M. tuberculosis phoP mutant SO2 PMID:16564606 PMID:17084814 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=178 178 vaccine Study evaluated immunogenicity and protection against Mycobacterium tuberculosis in rhesus monkeys with an attenuated M. tuberculosis with a disrupted phoP gene (SO2) as a single-dose vaccine. SO2 treatment showed reduced average lung bacterial counts (1.0 and 1.2 log respectively, compared with 0.4 log for BCG) and significant protective effect by reduction in C-reactive protein levels, body weight loss, and decrease of erythrocyte-associated hematologic parameters (MCV, MCH, Hb, Ht) as markers of inflammatory infection, all relative to non-vaccinated controls Mycobacterium tuberculosis phoP mutant SO2 vaccine VO:0000589 A bacterial vaccine that is used to protect against Aeromonas bacterial infection Oliver He vaccine Aeromonas vaccine VO:0000590 vaccine preparation is a manufacturing process to produce a vaccine. Bjoern Peters Oliver He vaccine generation vaccine production process vaccine preparation VO:0000591 An assay that is used to detect if a vaccine protects a host against infection of virulent pathogen after vaccine immunization. Oliver He vaccine challenge experiment assay vaccine protection assay VO:0000592 Vaccine that protects against Mycobacterium bacterial infection. Oliver He Rebecca Racz https://en.wikipedia.org/wiki/Mycobacterium vaccine Mycobacterium vaccine VO:0000593 Oliver He vaccine-induced response vaccine specific T cell cytokine production VO:0000594 Oliver He vaccine-induced response vaccine specific T cell mediated cytotoxicity VO:0000595 A dose of vaccine specified by the vaccine manufacturer, distributor, or a regulatory agent. Melanie Courtot Oliver He data item vaccine dose VO:0000596 Planned process by which a vaccine is tested clinically for safety and effectiveness. Clinical trials are conducted in phases. Classically, clinical trials unfold in three phases in order to gather data and information about a vaccine and its performance. This will form the basis of a dossier submitted to regulatory authorities by way of an application for licensure. After a vaccine is licensed and is being used by large numbers of people, a Phase IV study may or may not be taken for vaccine clinical evaluation. Most vaccines against a pathogen (e.g., HIV) are not tested by vaccinating people and then deliberately exposing them to virulent pathogen (e.g., HIV). This strategy is never for a vaccine against a disease as serious as HIV. The best way to determine if a vaccine is effective is to test it in a randomized, controlled, double-blind clinical trial. This type of trial is often referred to as the gold standard in medical research and provides the strongest evidence for the efficacy of a vaccine. Oliver He process vaccine clinical trial VO:0000597 obsolete class true VO:0000598 A vaccine that uses whole organism as its component Oliver He WEB: http://onlinelibrary.wiley.com/doi/10.1038/npg.els.0000491/full vaccine whole organism vaccine VO:0000599 Vaccine vector that is a genetically engineered virus or bacterium used to deliver genetic code into the cells within the body. a vaccine component that uses a microbe (e.g., bacterium, virus, and parasitic organism) as a vector that is inserted with the DNA(s) of a heterologous protective antigen(s) to generate a "recombinant vector vaccine". The microorganism used as a vector generally has a stable non or low pathogenic phenotype for the species the vaccine is intended for. Jie Zheng Oliver He recombinant vector WEB: http://en.wikipedia.org/wiki/Vaccine WEB: http://www.biosafety.be/GT/Regulatory/Veterinary_vaccines/EMEA_000404en.pdf WEB: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003856.pdf vaccine component recombinant vaccine vector VO:0000600 an orthopoxvirus vaccine vector that uses vaccinia virus as the vector Oliver He vaccine component vaccinia virus vector NCBI Taxonomy ID: 10245 VO:0000601 Vaccine that protects against Yersinia bacterial infection. Allen Xiang Oliver He vaccine Yersinia vaccine VO:0000602 A bacterial vaccine that is used to protect against Edwardsiella bacterial infection Asiyah Yu Lin vaccine Edwardsiella vaccine VO:0000603 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=173 173 vaccine BCG mutant secreting listeriolysin VO:0000604 Vaccine that protects against Mycoplasma bacterial infection. Oliver He vaccine Mycoplasma vaccine VO:0000605 A Canada licensed vaccine role that indicates the vaccine is used for human Discussed among Barry Smith, Anna Maria Masci, Jie Zheng and Oliver He. The vaccine recipient will be associate with vaccine directly rather than using the role. Oliver He obsolete Canada licensed human vaccine role true VO:0000606 Oliver He delta ureC hly+ rBCG PMID:16110326 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=437 437 vaccine delta ureC hly+ rBCG vaccine VO:0000609 A vaccine that targets against a viral disease. Oliver He MeSH: D014765 vaccine viral vaccine VO:0000610 a vaccine vector that uses a virus as the vector. Oliver He vaccine component viral vaccine vector NCBI Taxonomy ID: 10239 VO:0000611 bacterial vaccine that is used to protect against Haemophilus parasuis infection Asiyah Yu Lin vaccine Haemophilus parasuis vaccine VO:0000612 a virulence of vaccine that shows a virulent pheontype of the organism as the major component of a vaccine. The virulent phenotype means that an vaccine organism is virulent and is able to cause a pathogenic phenotype in a host organism. Oliver He quality vaccine organism virulent VO:0000613 M' (intended to refer to a male biological sex), 'Male', 'Man', '1' (intended to refer to a male biological sex) A biological sex datum that represents the biological sex of an animal (including human) as being male. Oliver He Paul Fabry data item male biological sex datum VO:0000614 Oliver He Nontypeable H. influenzae protein P6 with cholera toxin PMID:15297063 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=188 188 vaccine Nontypeable Haemophilus influenzae protein P6 with cholera toxin vaccine VO:0000615 Role that inheres in a prepared material entity that is designed to induce protection or treatment for a disease or infection. Oliver He role vaccine role VO:0000616 Animal model of vaccine research is a role played by some organism (e.g., mouse) that is used for vaccine research. Oliver He role animal model of vaccine research VO:0000617 A role that inheres in a material entity that becomes an ingredient of a vaccine. Oliver He role vaccine component role VO:0000618 Oliver He role vaccine antigen role VO:0000619 vaccine E. coli live attenuated vaccine VO:0000620 Vaccine that protects against Pasteurella multocida infection. Asiyah Yu Lin vaccine Pasteurella multocida vaccine VO:0000621 Animal model of vaccine research is a role played by some organism (e.g., mouse) that is used for vaccine research in the laboratory. Oliver He role laboratory animal model of vaccine research VO:0000622 a vaccine antigen role that inheres in a vaccine antigen which is capable of inducing protective immunity. Oliver He role vaccine protective antigen role VO:0000623 A vaccine role that indicates the vaccine being a DNA vaccine. Oliver He role DNA vaccine role VO:0000624 A vaccine role that indicates the vaccine being a subunit vaccine. Oliver He role subunit vaccine role VO:0000625 A vaccine role that indicates the vaccine being a conjugate vaccine. Oliver He role conjugate vaccine role VO:0000626 Survival assessment is an assay that measures the occurence of death events in one or more organisms that are monitored over time. Need to point out more specifically that survival/death is measured. Oliver He process survival assessment VO:0000627 A vaccine used to prevent infection by Haemophilus influenzae type b (Hib) bacteria. The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Oliver He H. influenzae Type b capsular polysaccharide vaccine Hib polysaccharide vaccine PMID:335348 PMID:6387614 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=165 https://www.mayoclinic.org/drugs-supplements/haemophilus-b-polysaccharide-vaccine-intramuscular-route-injection-route/description/drg-20064142 165 vaccine Haemophilus influenzae type b capsular polysaccharide vaccine VO:0000628 An E. coli vaccine that uses subunit antigen type. vaccine E. coli subunit vaccine VO:0000629 Oliver He B. anthracis recombinant vaccine using PA domain 4 PMID:11854261 PMID:15935874 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=20 20 vaccine Bacillus anthracis recombinant vaccine using PA domain 4 VO:0000630 A licensed vaccine role is a regulation-assigned role that indicates that a vaccine obtains official approval for commercial production and selling on the market. Oliver He role licensed vaccine role VO:0000631 A vaccine in clinical trial role is a regulation-assigned role that inheres in a vaccine that is currently in clinical trial. In medical research, clinical trials are conducted to allow safety and efficacy data to be collected for new drugs or devices. Oliver He role vaccine in clinical trial role VO:0000632 Vaccine induced immue response mediated hrough a body fluid Asiyah Yu Lin vaccine-induced antibody mediated immune response vaccine-induced response vaccine-induced humoral immune response VO:0000633 A B. melitensis vaccine that is recombinant B. melitensis Rev. 1 vaccine with the p39 gene deletion. Oliver He B. melitensis Rev. 1 P39 deletion mutant B. melitensis Rev. 1 with P39 deletion PMID:9784574 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=448 448 vaccine Brucella melitensis Rev. 1 with P39 deletion vaccine VO:0000634 Asiyah Yu Lin vaccination intravenous vaccination VO:0000635 a licensed vaccine with license for human use. Oliver He vaccine licensed human vaccine VO:0000636 A vaccine role that indicates the vaccine being a recombinant vector vaccine. Oliver He role recombinant vector vaccine role VO:0000637 bacterial vaccine that is used to protect against Flavobacterium columnare infection Asiyah Yu Lin vaccine Flavobacterium columnare vaccine VO:0000639 A bacterial vaccine that protects against infection with Clostridium spp. Oliver He https://en.wikipedia.org/wiki/Clostridium vaccine Clostridium vaccine VO:0000640 a Clostridium vaccine that protects against infection with Clostridium tetani that causes tenanus. Kallan Roan Oliver He Tetanus toxoid vaccine tetanus vaccine https://vaccine-safety-training.org/tetanus-vaccine-example.html vaccine Clostridium tetani vaccine 2 VO:0000641 Combination vaccine is a vaccine that induces protection against multiple infectious diseases or several different serotypes of the same organism. The anitgens contained in combination vaccines are either formulated together by the manufacturer or physically mixed by a health care provider just prior to administration. Both approaches require licensure. Ref: Baylor NW and Midthum K. Regulation and testing of vaccines. In: Vaccines (Editors: Plotkin S, Orenstein W, and Offit P). 2008. p1624. Oliver He combo vaccine https://github.com/vaccineontology/VO/issues/621 MeSH: D017778 vaccine combination vaccine VO:0000642 A viral vaccine that protects against infection with influenza virus. Oliver He Influenza vaccine vaccine There is no single 'influenza virus' in NCBI_Taxon. We usually use: ('unidentified influenza virus' or 'Influenzavirus A' or 'Influenzavirus B' or 'Influenzavirus C') However, even this may not be comprehensive. influenza virus vaccine VO:0000643 a vaccine with license that is used for cattle. Oliver He vaccine licensed cattle vaccine VO:0000644 A viral vaccine that protects against infection with Hepatitis B virus. Oliver He hepatitis B vaccine https://en.wikipedia.org/wiki/Hepatitis_B_vaccine vaccine Hepatitis B virus vaccine VO:0000645 Oliver He vaccine licensed fish vaccine VO:0000646 A viral vaccine that protects against infection with Hepatitis A virus. Oliver He hepatitis A vaccine vaccine Hepatitis A virus vaccine VO:0000647 Oliver He vaccine licensed goat vaccine VO:0000648 A bacteria vaccine that prevents against Yersinia pestis infection that causes plague. Oliver He Plague vaccine vaccine Yersinia pestis vaccine VO:0000649 Oliver He vaccine licensed dog vaccine VO:0000650 A viral vaccine that protects against infection with Rabies virus. Oliver He rabies vaccine vaccine Rabies virus vaccine VO:0000651 A viral vaccine that protects against infection with Smallpox virus. Oliver He smallpox vaccine vaccine Smallpox virus vaccine VO:0000652 Oliver He vaccine licensed cat vaccine VO:0000653 Oliver He vaccine licensed ferret vaccine VO:0000654 A viral vaccine that protects against infection with Measles virus. Oliver He measles vaccine vaccine Measles virus vaccine VO:0000655 Oliver He vaccine licensed deer vaccine VO:0000656 A viral vaccine that protects against infection with Mumps virus. Oliver He mumps vaccine vaccine Mumps virus vaccine VO:0000657 Oliver He vaccine licensed bird vaccine VO:0000658 A viral vaccine that protects against infection with Rotavirus. Oliver He vaccine Rotavirus vaccine VO:0000659 In most cases HibTITER was administered concomitantly with other vaccines including DTP, DTaP, hepatitis B vaccine, IPV, OPV, pneumococcal 7-valent conjugate vaccine, MMR, and/or meningococcal group C conjugate vaccine (not licensed in the US). Oliver He PMID:2057256 PMID:9353019 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=160 160 vaccine HIBTITER vaccine VO:0000660 Ref: http://www.rxlist.com/prohibit-drug.htm Oliver He PMID:2057256 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=162 162 vaccine ProHIBiT vaccine VO:0000661 Vaccine that protects against Haemophilus infection. Oliver He https://en.wikipedia.org/wiki/Haemophilus MeSH: D018073 vaccine Haemophilus vaccine VO:0000662 A vaccine that protects against Haemophilus influenzae type b infection. Hector Guzman-Orozco Oliver He Haemophilus b vaccine Hib vaccine vaccine Haemophilus influenzae serotype b vaccine VO:0000663 A live attenuated Shigella flexneri 2a vaccine that carries deletions of the plasmid-borne virulence gene icsA (mediating intra- and intercellular spread) and the chromosomal locus iuc (encoding aerobactin). Oliver He SC602 PMID:10377124 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=259 259 vaccine SC602 vaccine VO:0000664 A viral vaccine that protects against infection with Poliovirus. Oliver He polio vaccine vaccine Poliovirus vaccine VO:0000665 A viral vaccine that protects against infection with Japanese encephalitis virus. Oliver He Japanese encephalitis vaccine vaccine Japanese encephalitis virus vaccine VO:0000666 CVD 1208 is derived from wild type Shigella flexneri 2a strain 2457T and has defined deletions in four genes: (1) the guaBA chromosomal operon that encodes two enzymes (inositol 5'-monophosphate dehydrogenase and guanosine 5'synthase) essential for de novo purine biosynthesis; (2) set, a locus in a chromosomal pathogenicity island that encodes Shigella enterotoxin (ShET); (3) Pic, an autotransporter mucinase encoded on the opposite strand from set; and (4) sen, an invasiveness plasmid gene encoding ShET. Oliver He CVD 1208 PMID:15499528 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=441 441 vaccine CVD 1208 vaccine VO:0000667 a vaccine against human papillomavirus infection Oliver He SNOMEDCT: 424519000 UMLS_CUI: C1512511 vaccine human papillomavirus vaccine VO:0000668 CVD 1208S is the same thing as CVD 1208, but CVD 1208S was prepared using animal-free media. Oliver He CVD 1208S PMID:17938573 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=272 272 vaccine CVD 1208S vaccine VO:0000669 a Herpesvirus vaccine that is used against Varicella-zoster virus infection. Kallan Roan Oliver He Varicella vaccine chickenpox and shingles virus vaccine vaccine Varicella-zoster virus vaccine VO:0000670 A Shigella flexneri vaccine that is an aro-D mutant derivative of EcSf2a-1. Oliver He EcSf2a-2 PMID:1587589 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=267 267 vaccine EcSf2a-2 vaccine VO:0000671 A Salmonella vaccine against typhoid fever (or called typoid), caused by Salmonella enterica enterica, serovar Typhi. Oliver He typhoid vaccine vaccine Salmonella typhi vaccine VO:0000672 Oliver He heat-killed virulent Shigella flexneri 2a PMID:10102148 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=268 268 vaccine heat-killed virulent Shigella flexneri 2a vaccine VO:0000673 Oliver He PMID:1937767 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=269 269 vaccine Shigella Sfl 124 vaccine VO:0000674 Oliver He Recombinant SFL124-27 expressing S. dysenteriae type 1 O antigen PMID:9169740 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=258 258 vaccine recombinant SFL124-27 expressing Shigella dysenteriae type 1 O antigen vaccine VO:0000675 a Streptococcal vaccine that is used against S. pneumoniae infection, which causes pneumococcal diseases. Oliver He pneumococcal vaccine WEB: http://www.who.int/vaccines/en/pneumococcus.shtml vaccine Streptococcus pneumoniae vaccine VO:0000676 Oliver He Rebecca Racz S. dysenteriae 1 strain WRSd1 PMID:12010984 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=263 263 vaccine An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri Shigella dysenteriae 1 strain WRSd1 vaccine VO:0000677 A live attenuated Shigella flexneri 2a vaccine with specific deletion mutations in virG, sen, set, and guaBA. Oliver He S. flexneri 2a strain CVD 1207 PMID:10678904 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=260 260 vaccine Shigella flexneri 2a strain CVD 1207 vaccine VO:0000678 A stable attenuated Shigella sonnei strain with virG mutation. PMID:9712824. Oliver He Rebecca Racz PMID:11895966 PMID:9712824 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=264 264 vaccine A virG mutant (WRSS1) is attenuated in guinea pigs and induced significant protection from challenge with wild type Shigella sonnei An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri Shigella sonnei virG mutant vaccine VO:0000679 Oliver He vaccine Shigella sonnei vaccine VO:0000680 Oliver He vaccine Shigella flexneri vaccine VO:0000681 Oliver He vaccine Shigella dysenteriae vaccine VO:0000682 Oliver He S. flexneri 2a LPS vaccine complexed with N. meningitidis proteosomes PMID:8500877 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=270 270 vaccine Shigella flexneri 2a LPS vaccine complexed with Neisseria meningitidis proteosomes vaccine VO:0000683 Process that regulates vaccine-related processes, such as vaccine trial, vaccine license application. Oliver He process vaccine regulation VO:0000684 Process of transporting vaccine from one place to another place. Oliver He process vaccine transportation VO:0000685 A recombinant vector vaccine role that inheres in a bacterium that carries a vaccine antigen for development of a particular vaccine Oliver He obsolete recombinant bacterial vector vaccine role true VO:0000692 A subunit vaccine role that indicates the vaccine being a peptide vaccine. Jie Zheng role peptide vaccine role VO:0000702 A recombinant vector vaccine role that inheres in a virus that carries a vaccine antigen for development of a particular vaccine Oliver He obsolete recombinant viral vector vaccine role true VO:0000704 a vaccine residual that is from antibiotics used during the manufacture process. Asiyah Yu Lin Oliver He vaccine component antibiotics vaccine residual VO:0000705 Oliver He assay vaccine specific antibody test VO:0000706 A vaccine regulation process for vaccine clinical trials. Oliver He process vaccine trial regulation VO:0000707 A vaccination process that occurs at the first time to a host organization in a specified period. Oliver He prime vaccination vaccination primary vaccination VO:0000708 A vaccination process that occurs after the primer vaccination with a purpose to boost host immune response to vaccine antigen. Oliver He vaccination boost vaccination VO:0000709 Oliver He vaccine Brucella melitensis vaccine VO:0000710 Oliver He Brucella melitensis Rev 1 Brucella melitensis Rev. 1B. melitensis strain Rev. 1 PMID:13416171 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=110 110 vaccine Brucella melitensis strain Rev. 1 vaccine VO:0000712 a viral vaccine that is inactivated killed viral vaccine vaccine inactivated viral vaccine VO:0000713 Oliver He disposition vaccine allergen disposition VO:0000714 a licensed human vaccine that is licensed in Canada Oliver He vaccine Canada licensed human vaccine VO:0000715 A vaccine preparation that results in the generation of a DNA vaccine Oliver He vaccine preparation DNA vaccine preparation VO:0000716 A vaccine preparation that results in the generation of a conjugate vaccine Oliver He vaccine preparation conjugate vaccine preparation VO:0000717 A vaccine preparation that results in the generation of a subunit vaccine Oliver He vaccine preparation subunit vaccine preparation VO:0000718 A vaccine preparation that results in the generation of a live attenuated vaccine Oliver He vaccine preparation live attenuated vaccine preparation VO:0000719 A vaccine preparation that results in the generation of a RNA vaccine Oliver He vaccine preparation RNA vaccine preparation VO:0000720 Oliver He B. abortus strain RB51SOD Brucella abortus strain RB51SOD PMID:10816475 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=11 11 vaccine Brucella abortus strain RB51SOD vaccine VO:0000721 a Brucella vaccine against infection wtih B. suis Oliver He vaccine Brucella suis vaccine VO:0000722 An orally administrable brucellosis vaccine that was was developed in China. It is effective for oral vaccination of sheep, goats, cattle and pigs. Oliver He Brucella suis S2 Brucella suis strain 2 PMID:3541425 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=447 447 vaccine Brucella suis strain 2 vaccine VO:0000723 Oliver He B. abortus strain 45/20 Brucella abortus strain 45/20 PMID:8236802 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=123 123 vaccine Brucella abortus strain 45/20 vaccine VO:0000724 Oliver He vaccine cytomegalovirus vaccine VO:0000725 A viral vaccine that protects against infection with Dengue virus. Oliver He Dengue vaccine vaccine Dengue virus vaccine VO:0000726 A viral vaccine that protects against infection with Ebola virus. Oliver He Ebola vaccine vaccine Ebola virus vaccine VO:0000727 A viral vaccine that protects against infection with Herpesvirus. Oliver He vaccine Herpesvirus vaccine VO:0000728 A vaccine role that indicates the vaccine being a RNA vaccine. Oliver He role RNA vaccine role VO:0000729 Oliver He vaccine Herpes simplex virus vaccine VO:0000730 Oliver He obsolete Marek disease vaccine true VO:0000731 A Measles-Mumps vaccine that also protects against infection with Rubella virus. Oliver He MMR 03 40213183 measles, mumps and rubella virus vaccine MMR vaccine MMR is usually live attenuated. Measles-Mumps-Rubella vaccine VO:0000732 A Corynebacterium diphtheriae vaccine that also protect against infection with Clostridium tetani. Oliver He vaccine Diphtheria-Tetanus vaccine VO:0000733 Oliver He CVD 1204(pGA1-CS2) PMID:11292735 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=265 265 vaccine CVD 1204(pGA1-CS2) vaccine VO:0000734 Oliver He CVD 1204(pGA1-CS3) PMID:11292735 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=442 442 vaccine CVD 1204(pGA1-CS3) vaccine VO:0000735 A bacterial vaccine that protects against infection with Corynebacterium diphtheriae that causes Diphtheria. Oliver He diphtheria vaccine vaccine Corynebacterium diphtheriae vaccine VO:0000736 A Measles virus vaccine that also protects against infection with Mumps virus. Oliver He vaccine Measles-Mumps vaccine VO:0000737 A Measles-Mumps-Rubella vaccine that also protects against Varicella. Kallan Roan Oliver He https://www.cdc.gov/vaccines/hcp/vis/vis-statements/mmrv.html 94 40213184 measles, mumps, rubella, and varicella virus vaccine vaccine Measles-Mumps-Rubella-Varicella vaccine VO:0000738 Oliver He DTP vaccine 01 40213291 diphtheria, tetanus toxoids and pertussis vaccine DTP vaccine Diphtheria-Tetanus-Pertussis vaccine VO:0000739 Oliver He PMID:17507120 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=273 273 vaccine Shigella ribosome-based vaccine (SRB) VO:0000740 A malaria vaccine that comprises recombinant Plasmodium falciparum (P. falciparum) blood-stage proteins MSP1, MSP2 and RESA, formulated with the adjuvant Montanide ISA 720. Oliver He P. falciparum vaccine Combination B PMID:14604568 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=206 206 vaccine Plasmodium falciparum vaccine combination B VO:0000741 Oliver He organism Haemophilus influenzae serotype b VO:0000742 A vaccine that protects against diphtheria, tetanus, pertussis, and poliovirus. Kallan Roan Oliver He DTaP/IPV vaccine diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine vaccine Diphtheria-Tetanus-Pertussis-Poliovirus vaccine VO:0000743 A vaccine used to prevent infections of diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis B, and poliovirus. Kallan Roan Oliver He DTaP/IPV/HepB vaccine https://www.hendricks.org/HealthLibrary/default.aspx?sid=1&pTitle=%2CDrug&ContentTypeID=26&ContentID=2783&alpha=D&AdditionalTitle=Diphtheria+Toxoid%2C+Tetanus+Toxoid%2C+Acellular+Pertussis+Vaccine%2C+DTaP%3B+Hepatitis+B+Vaccine%2C+Recombinant%3B+Inactivated+Poliovirus+Vaccine%2C+IPV 110 40213286 DTaP-hepatitis B and poliovirus vaccine DTaP-Hep B-IPV vaccine Diphtheria-Tetanus-Pertussis-Poliovirus-Hepatitis B vaccine VO:0000744 A vaccine that protects against, Diphtheria, Tetanus, Pertussis (whooping cough), Polio, and Haemophilus influenzae type b. Kallan Roan Oliver He DTaP/IPV/Hib vaccine https://www.healthlinkbc.ca/healthlinkbc-files/dtap-ipv-hib-vaccine vaccine Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b vaccine VO:0000745 Oliver He 104 40213303 hepatitis A and hepatitis B vaccine vaccine licensed human Hepatitis A & B vaccine VO:0000746 a viral vaccine against Hepatitis B virus and at the same time against bacterial H. influenzae serotype b. Oliver He vaccine Haemophilus b and Hepatitis B vaccine VO:0000747 A vaccine that contains DNA and modified vaccinia virus Ankara (MVA) encoding thrombospondin-related adhesion protein (TRAP) with a multiple-epitope string ME (ME-TRAP). This vaccine is used with a prime-boost regime by DNA priming and MVA boosting. Oliver He DNA and MVA encoding ME-TRAP PMID:16988273 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=210 210 vaccine DNA and MVA encoding ME-TRAP vaccine VO:0000748 A viral vaccine that protects against infection with Papillomavirus. Oliver He obsolete Papillomavirus vaccine MeSH: D053918 true VO:0000749 A viral vaccine that protects against infection with Parainfluenza virus. Oliver He parainfluenza vaccine vaccine Parainfluenza virus vaccine VO:0000750 A viral vaccine that protects against infection with Pseudorabies virus. Oliver He pseudorabies vaccine vaccine Pseudorabies virus vaccine VO:0000751 A viral vaccine that prevents against infection with Simian immunodeficiency virus. Oliver He SAIDS vaccine vaccine Simian immunodeficiency virus vaccine VO:0000752 A viral vaccine that protects against West Nile virus infection. Oliver He vaccine West Nile virus vaccine VO:0000753 A viral vaccine that prevents infection with Respiratory syncytial virus. Oliver He vaccine Respiratory syncytial virus vaccine VO:0000754 A vaccine that is used in conjunction with diagnostic tests to differentiate vaccinated animals from carrier animals. It can be a subunit or a gene-deleted vaccine. Oliver He MeSH: D022581 vaccine marker vaccine VO:0000755 A vaccine that is edible and derived from an edible plant. The transgenic plant is used as recombinant protein production system. The edible plant tissue functions as an oral vaccine. Oliver He MeSH: D022462 vaccine edible vaccine VO:0000756 A subunit vaccine that is produced by using only the antigenic part of the disease causing organism. It often requires a "booster" every few years to maintain their effectiveness. Oliver He vaccine acellular vaccine VO:0000757 A particulate antigen delivery system vaccine adjuvant that consists of an assembly of antigens in multimeric form and presents an antigen to induce specific immunologic responses. The assembly is attached to a matrix with a built-in adjuvant, saponin. ISCOMs induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines. MeSH term: D20.215.894.860.449. Oliver He ISCOM The immunostimulating complex vaccine adjuvant ISCOM vaccine adjuvant VO:0000758 Oliver He vaccine Plasmodium vivax vaccine VO:0000759 A vaccine that is used to prevent conception. Oliver He antifertility vaccine MeSH: D022642 vaccine contraceptive vaccine VO:0000760 A vaccine that prevents or treats Alzheimer disease. Oliver He MeSH: D023582 vaccine Alzheimer vaccine VO:0000761 Plasmodium vaccine is a vaccine that prevents against Plasmodium species causing malaria. It is made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents. Oliver He Plasmodium vaccine malarial Vaccine vaccine malaria vaccine VO:0000762 a protozoan vaccine that prevents against infection with Leishmania. Oliver He Leishmaniasis vaccine vaccine Leishmania vaccine VO:0000763 A bacterial vaccine that prevents infection with Vibrio cholera. Oliver He cholera vaccine vaccine Vibrio cholerae vaccine VO:0000764 Vaccine that protects against Borrelia burgdorferi infection causing Lyme disease. Oliver He Lyme disease vaccine MeSH: D022123 vaccine Borrelia burgdorferi vaccine VO:0000765 A bacterial vaccine that prevents against Bordetella pertussis infection that causes pertussis or whooping cough. Khadeejah Khan Oliver He Acellular Pertussis Vaccine Pertussis vaccine vaccine Bordetella pertussis vaccine VO:0000766 Vaccine that protects against Pseudomonas infection. Oliver He MeSH: D054406 vaccine Pseudomonas vaccine VO:0000767 Vaccine that protects against Rickettsia infection. Typhus is any of several similar diseases caused by Rickettsia bacteria. So Rickettsial vaccine is also called typhus vaccine. Oliver He typhus vaccine WEB: http://en.wikipedia.org/wiki/Typhus_vaccine MeSH: D012290 vaccine Rickettsial vaccine VO:0000768 Vaccine that protects against Salmonella species infection. Oliver He https://en.wikipedia.org/wiki/Salmonella MeSH: D022562 vaccine Salmonella vaccine VO:0000769 Vaccine that protects against Shigella species infection. Oliver He MeSH: D022281 vaccine Shigella vaccine VO:0000770 Vaccine that protects against Staphylococcus infection. Oliver He Staph vaccine Staphylococcus vaccine MeSH: D013209 vaccine Staphylococcal vaccine VO:0000771 BCG Vaccine is a Mycobacterium tuberculosis vaccine that is a live attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin; BCG). Oliver He Bacillus Calmette Guerin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=143 https://github.com/vaccineontology/VO/issues/776 143 For the prevention of tuberculosis in persons not previously infected with M. tuberculosis who are at high risk for exposure. https://www.fda.gov/media/78331/download?attachment 103050 19 40213271 Bacillus Calmette-Guerin vaccine vaccine BCG vaccine VO:0000772 Vaccine that protects against streptococcal infection. Oliver He Streptococcus vaccine https://en.wikipedia.org/wiki/Streptococcus MeSH: D022541 vaccine Streptococcal vaccine VO:0000773 Oliver He MSP3-LSP with aluminium hydroxide PMID:17280744 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=207 207 vaccine MSP3-LSP subunit vaccine with aluminium hydroxide adjuvant VO:0000774 RTS,S/AS02A is a pre-erythrocytic vaccine candidate based on Plasmodium falciparum circumsporozoite surface antigen. Oliver He P. falciparum RTS,S/AS02A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=200 200 vaccine Plasmodium falciparum RTS,S/AS02A vaccine VO:0000775 Oliver He P. falciparum MSP1 from transgenic mice with Freund's adjuvant PMID:11752405 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=234 234 vaccine Plasmodium falciparum MSP1 from transgenic mice vaccine with Freund's adjuvant VO:0000776 Oliver He P. vivax PVS25 with Montanide ISA-720 PMID:16291764 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=208 208 vaccine P. vivax PVS25 vaccine with Montanide ISA-720 adjuvant VO:0000777 A recombinant E. coli-expressed protein based upon the apical membrane antigen-1 (AMA-1) of the 3D7 clone formulated with the AS02A adjuvant. PMID:17442466. Oliver He P. falciparum FMP1/AS02A PMID:17442466 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=232 232 vaccine Plasmodium falciparum FMP1/AS02A vaccine VO:0000778 Oliver He P. falciparum ABRA protein vaccine PMID:11489167 PMID:9400530 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=204 204 vaccine Plasmodium falciparum ABRA protein vaccine VO:0000779 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus NP protein. Oliver He obsolete NP-VRP true VO:0000780 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus GP protein. Oliver He GP-VRP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=69 69 vaccine GP-VRP vaccine VO:0000781 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus VP24 protein. Oliver He VRP expressing VP24 alphavirus replicon expressing VP24 PMID:11485406 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=65 65 vaccine VRP expressing VP24 vaccine VO:0000782 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus VP30 protein. Oliver He VRP expressing VP30 alphavirus replicon expressing VP30 PMID:11485406 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=66 66 vaccine VRP expressing VP30 vaccine VO:0000783 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus VP35 protein. Oliver He VRP expressing VP35 alphavirus replicon expressing VP35 PMID:11485406 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=67 67 vaccine VRP expressing VP35 vaccine VO:0000784 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus VP40 protein. Oliver He VRP expressing VP40 alphavirus replicon expressing VP40 PMID:11485406 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=68 68 vaccine VRP expressing VP40 vaccine VO:0000785 A DNA vaccine that encodes for a secreted form of Ebola virus GP protein. Oliver He PMID:9427604 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=73 73 vaccine DNA vaccine expressing sGP VO:0000786 A vaccine combination that includes a DNA vaccine and a recombinant adenovirus Ad5 expressing the same codon-optimized SIV gag gene. The DNA vaccine is used for priming, and the Ad5 vaccine is used for boosting. PMID:11797011. Oliver He DNA and adenoviral vector Ad5 expressing SIV gag protein PMID:11797011 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=145 145 vaccine DNA and adenoviral vector Ad5 expressing SIV gag protein vaccine VO:0000787 A gene that is a pathogen gene used for vaccine preparation or a host gene encoding for an immune factor important in induction of protective immunity. a vaccine-associated gene that exists in a pathogen and has been engineered for vaccine develoment. This gene can encode for protective antigen that is overexpressed for vaccine development. This gene can also be a virulence factor that is mutated to attenuate a virulent pathogen with the purpose of making attenuated vaccine. The term 'gene' has appears in several ontologies, such as Sequence Ontology (SO) and Protein Ontology (PRO). We may choose to use a 'gene' term from other ontologies. The 'gene' term in SO has ID: SO:0000704. Oliver He obsolete gene true VO:0000788 A recombinant adenovirus (Ad5) expressing the codon-optimized SIV gag gene. PMID:11797011. Oliver He adenoviral vector Ad5 expressing SIV gag protein PMID:11797011 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=444 444 vaccine adenoviral vector Ad5 expressing SIV gag protein vaccine VO:0000789 A vaccine combination that includes a DNA vaccine and a replication-defective chimeric Ad5 vector with the Ad35 fiber (Ad5/35) that express the same codon-optimized SIV gag gene. The DNA vaccine is used for priming, and the Ad5/35 vaccine is used for boosting. PMID:16079886. Oliver He DNA and Ad5/35 vector expressing HIV gp160 protein PMID:16079886 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=146 146 vaccine DNA and Ad5/35 vector expressing HIV gp160 protein vaccine VO:0000790 Oliver He gene Brucella gene VO:0000791 Oliver He gene human gene VO:0000792 Oliver He gene mouse gene VO:0000793 A Brucella gene that is from B. abortus. Oliver He gene Brucella abortus gene VO:0000794 A Brucella abortus gene that has the name wboA and comes from strain 2308. Brucella abortus gene wboA is interrupted in Brucella abortus cattle vaccine RB51. Oliver He gene wboA from B. abortus strain 2308 VO:0000795 Interferon-gamma (IFN-g) is an indicative of Th1 immune response. It is produced in host immunized by vaccines such as Brucella abortus cattle vaccine RB51. Oliver He gene mouse Ifng VO:0000796 Interferon-gamma (IFN-g) is an indicative of Th1 immune response. Oliver He gene human ifng VO:0000797 Oliver He gene cattle gene VO:0000798 Interferon-gamma (IFN-g) is an indicative of Th1 immune response. It is produced in host immunized by vaccines such as Brucella abortus cattle vaccine RB51. Oliver He gene Ifng from cattle VO:0000800 a storage process that is specifically for vaccine. Oliver He process vaccine storage VO:0000801 a vaccine storage that is execuated at room temperature. Room temperature is also referred to as ambient temperature. Room temperature denotes a certain temperature within enclosed space at which humans are accustomed. Room temperature is usually indicated by general human comfort, with the common range of 10 degree C (50 degree F) to 28 degree C (82.4 degree F). Oliver He process vaccine storage at room temperature VO:0000802 vaccine storage that is executed in refrigerator, usually 0-10^C. Oliver He process vaccine storage in refrigerator VO:0000803 vaccine storage that is executed in freezer under 0^C. Oliver He process vaccine storage in freezer VO:0000804 Effectiveness is physical quality that represents the capability of a single physical entity (e.g., vaccine) producing an effect (e.g, protection against a disease). Oliver He quality effectiveness VO:0000805 Oliver He quality effective VO:0000806 Oliver He quality ineffective VO:0000807 A vaccine role that indicates the vaccine being a toxoid vaccine. Oliver He role toxoid vaccine role VO:0000808 A vaccination process that is implemented fast. Oliver He vaccine rapid implementation vaccination rapid vaccination VO:0000809 A measure datum that measures the coverage of vaccination in a specific area during a specific time period. Melanie Courtot Oliver He immunization coverage WEB: http://www.sanofipasteur.com/sanofi-pasteur2/front/index.jsp?siteCode=SP_CORP&codeRubrique=19 WEB: http://www.who.int/immunization_monitoring/routine/immunization_coverage/en/ data item vaccination coverage VO:0000810 A DNA vaccine plasmid vector that has the plasmid label pSCAR . CMV promotor is used. Oliver He Rebecca Racz vaccine component pSCAR DNA vaccine plasmid PMID: 18022294; PMID: 19712769. VO:0000811 Oliver He material entity vaccine epitope VO:0000812 a licensed vaccine role that indicates the vaccine occurs in USA. Oliver He role USA licensed vaccine role VO:0000813 A cattle vaccine with license that is used in USA. Oliver He vaccine USA licensed cattle vaccine VO:0000814 A dose of vaccine that is used in a vaccination. Vaccination dose may be and may be not the same as the vaccine dose. Oliver He data item vaccination dose VO:0000815 Oliver He quality monthly VO:0000816 Oliver He quality biweekly VO:0000817 A HIV vaccine that is composed of a DNA vaccine expressing conserved, multiple HIV epitopes. PMID:16359234. Oliver He PMID:16359234 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=149 149 vaccine DNA vaccine expressing multiple HIV epitopes VO:0000819 A HIV vaccine that is made of recombinant HIV gp120 protein adjuvanted with the adjuvant NanoEmulsion. PMID:18260780. Oliver He recombinant HIV gp120 with adjuvant NanoEmulsion PMID:18260780 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=310 310 vaccine recombinant HIV gp120 with adjuvant NanoEmulsion vaccine VO:0000820 Aeromonas bacterial vaccine that is used to protect against Aeromonas salmonicida infection. Oliver He vaccine Aeromonas salmonicida vaccine VO:0000822 A cocktail vaccine of V3014-packaged VRPs expressing the SIVsm H-4i nonmyristylated matrix-capsid region, full-length gp160, and a secreted form of gp160 (gp140). PMID:12120997. Oliver He Gag-VRPs PMID:10462249 PMID:12120997 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=156 156 vaccine Gag-VRPs vaccine VO:0000823 a bacterial vaccine against V. anguillarum infection Oliver He vaccine Vibrio anguillarum vaccine VO:0000824 A recombinant modified vaccinia Ankara (MVA) expressing HIV Gag, Pol, and Env proteins. PMID:16472543. Oliver He MVA expressing HIV Gag, Pol and Env proteins PMID:16472543 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=153 153 vaccine MVA expressing HIV Gag, Pol and Env proteins vaccine VO:0000825 A SIV vaccine that is composed of a DNA vaccine and a poxvirus vector expressing the same SIV antigens. PMID:15258286. Oliver He PMID:15258286 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=154 154 vaccine DNA and poxvirus priming-boosting SIV vaccine VO:0000826 A B. abortus vaccine that is recombinant B. abortus strain 19 vaccine with the p39 gene deletion. Oliver He B. abortus S19 P39 deletion mutant Brucella abortus S19 with P39 deletion PMID:9784574 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=449 449 vaccine Brucella abortus S19 with P39 deletion vaccine VO:0000827 A Yersinia pestis vaccine that uses a recombinant Ad5-based vector (E1a, partial E1b, and partial E3 deletion) to express Y. pestis V antigen. Oliver He AdsecV PMID:17041851 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=48 48 vaccine AdsecV vaccine VO:0000828 A Yersinia pestis vaccine that is a pigmentation negative mutant of Y. pestis derived from a fully virulent strain. Oliver He Yersinia EV-76 Yersinia EV76 PMID:4988692 PMID:8578841 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=32 32 vaccine Yersinia EV76 vaccine VO:0000829 A Yersinia pestis subunit vaccine that uses Y. pestis F1 protein as antigen. Oliver He Y. pestis F1 protein vaccine PMID:312163 PMID:8675324 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=36 36 vaccine Yersinia pestis F1 protein vaccine VO:0000830 A Y. pestis subunit vaccine that uses recombinant F1 and V antigens. PMID:312163. Oliver He PMID:10930691 PMID:12922126 PMID:15908389 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=50 50 vaccine rF1 + rV vaccine VO:0000831 A Y. pestis subunit vaccine that uses recombinant Y. pestis V antigen. PMID:7622205. Oliver He Recombinant Y. pestis V antigen vaccine PMID:7622205 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=44 44 vaccine recombinant Yersinia pestis V antigen vaccine VO:0000832 Oliver He modified Y. pestis with TLR4-stimulating LPS PMID:16980981 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=35 35 vaccine modified Yersinia pestis with TLR4-stimulating LPS vaccine VO:0000833 A Yersinia pestis subunit vaccine that contains staphylococcal protein A-V antigen fusion peptide (PAV). PMID:7622225. Oliver He Yersinia PAV PMID:7622225 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=62 62 vaccine Yersinia PAV vaccine VO:0000834 Oliver He recombinant Y. pestis YopD protein vaccine PMID:10024607 PMID:8890210 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=37 37 vaccine recombinant Yersinia pestis YopD protein vaccine VO:0000835 In vitro-cultured merozoites, chemically inactivated Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=433 433 vaccine Epm vaccine VO:0000836 A Y. pestis subunit vaccine that uses Y. pestis YscF protein as antigen. PMID:15978133. Oliver He Y. pestis YscF subunit vaccine PMID:15978133 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=81 81 vaccine Yersinia pestis YscF subunit vaccine VO:0000837 Oliver He PMID:16546306 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=56 56 vaccine microencapsulated Caf1 and LcrV vaccine VO:0000838 Live temperature-sensitive mutant strain for subcutaneous or intramuscular injection Oliver He Ovilis Enzovax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=417 417 vaccine Ovilis Enzovax vaccine VO:0000839 Fowlpox virus-vectored H5 Oliver He Trovac AI H5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=402 402 vaccine Trovac AI H5 vaccine VO:0000840 A Y. pestis vaccine that uses the recombinant V10 (rV10), a variant (lacking residues 271 to 300) of Yersinia pestis LcrV. PMID:16861680. Oliver He PMID:16861680 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=54 54 vaccine recombinant Yersinia rV10 vaccine VO:0000842 Killed oral vaccine Oliver He AquaVac ERM VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=413 413 vaccine AquaVac ERM vaccine VO:0000843 Oliver He vaccine Feline leukemia virus vaccine VO:0000844 Live temperature-sensitive mutant strain; spray inhalation or drinking water Oliver He Art Vax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=420 420 vaccine Art Vax vaccine VO:0000845 Oliver He VSV vector expressing Y. pestis lcrV PMID:16959385 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=47 47 vaccine VSV vector expressing Yersinia pestis lcrV vaccine VO:0000847 A formalin-inactivated preparation that was manufactured by Cutter Biologicals (a division of Miles Laboratories, Inc.). It is now available only from Greer Laboratories, Inc. The killed or inactivated plague vaccine is prepared from Y. pestis organisms grown in artificial media and then inactivated in formaldehyde. Oliver He PMID:8578841 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=31 http://www.cdc.gov/mmwr/preview/mmwrhtml/00044836.htm 31 vaccine Plague vaccine USP VO:0000849 A vaccine that stimulates the pig's own immune system to produce specific antibodies against GnRF. This temporarily inhibits testes function and thus stops the production and accumulation of boar taint-causing compounds. Peptide-protein conjugate and water-miscible adjuvant; control of boar taint Oliver He Improvac WEB: http://www.improvac.co.nz/sites/improvac/en-nz/Pages/productoverview.aspx vaccine Improvac vaccine VO:0000850 Vaccine component that is added to the immunogen by the vaccine manufacturer for a specific purpose. Additives include adjuvants, preservatives and stablizers, as well as materials that are added to affect pH and isotonicity. Oliver He Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73. vaccine component vaccine additive VO:0000851 Vaccine additive that is added to a vaccine formulation to prevent the growth of bacteria or fungi that inadvertently may be introduced into the vaccine during use. Ref: Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73. Oliver He antimicrobial agent in vaccine vaccine component vaccine preservative VO:0000852 Killed vaccine against periodontitis Oliver He Periovac VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=412 412 vaccine Periovac vaccine VO:0000853 Vaccine additive that helps to protect the vaccine from adverse conditions such as the freeze-drying process (for those vaccines that are freeze-dried) or heat. Oliver He Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 75. vaccine component vaccine stabilizer VO:0000854 A vaccine component that remains from the vaccine manufacturing process. Although no all manufacturing residuals may be identified and quantified, their presence and quantity is assumed to be constant because of the constancy of the manufacturing process. Oliver He Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 73. vaccine component vaccine residual VO:0000855 a vaccine residual that is used to inactivate bacteria and viruses or to detoxify bacterial toxins. For example, formaldehyde is a frequently used inactivation agent in vaccine preparation. Oliver He Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 78. vaccine component inactivation residual in vaccine VO:0000856 a vaccine residual that is generatead from cell culture for vaccine preparation. Examples include: antibiotics, sensitizing substances, bacterial and cellular residuals, and adventitious agents. Oliver He Finn TM and Egan W, in Vaccines fifth edition, 2008. Page 78-81. vaccine component cell culture residual in vaccine VO:0000857 Measurement process profile determined by the measurement data generated from a measurement process which indicates the degree of immunological protection in the vaccine recipient. Anna Maria Masci Barry Smith Jie Zheng Oliver He CoP correlate of protection https://github.com/vaccineontology/VO/issues/603 process profile correlated profile of immune protection VO:0000858 Correlated profile of immune protection that is reflected by serologic antibody levels. Oliver He serologic correlate of protection https://github.com/vaccineontology/VO/issues/603 process profile serologic correlated profile of immune protection VO:0000859 Correlated profile of immune protection that is reflected by a cell mediated immune response. Oliver He cell mediated immune correlate of protection https://github.com/vaccineontology/VO/issues/603 process profile cell mediated correlated profile of immune protection VO:0000860 Vaccine effectiveness is an effectiveness associated with a vaccine. Oliver He Hadler TC, et al. Immunization in developing countries. In: Vaccines. Editors: Plotkin S, et al. 2008. p1542-71. quality vaccine effectiveness VO:0000862 Canada is a country that exists in north America. Oliver He site Canada VO:0000863 In vitro-cultured supernatant antigens, reduce clinical disease Oliver He Pirodog VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=434 434 vaccine Pirodog vaccine VO:0000864 a licensed status that occurs in Canada. Oliver He role Canada licensed vaccine role VO:0000865 Vaccine that protects against Porphyromonas gulae infection. Oliver He vaccine Porphyromonas gulae vaccine VO:0000866 Oliver He Fluviral S/F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=571 571 vaccine Fluviral S/F vaccine VO:0000867 Influvac is an Influenza virus vaccine that is manufactured by Solvay Pharma. Oliver He Influvac VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=597 597 vaccine Influvac vaccine VO:0000868 Vaxigrip is an Influenza virus vaccine that is manufactured by 'Sanofi Pasteur Limited. Melanie Courtot Oliver He Vaxigrip VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=642 642 vaccine Vaxigrip vaccine VO:0000870 Oliver He vaccine Babesia bigemina vaccine by local veterinary institutes VO:0000871 Canarypox virus-vectored vaccine Oliver He Purevax Feline Rabies VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=404 404 vaccine Purevax Feline Rabies vaccine VO:0000872 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=430 430 vaccine Babesia bovis vaccine by local veterinary institutes VO:0000873 Oliver He PGA/ME pGPA-incorporated microemulsion PMID:16730934 vaccine PGA/ME vaccine VO:0000874 Anthrax Spore Vaccine is a B. anthracis vaccine that is prepared with a relatively nonpathogenic, noncapsulated variant strain of B. anthracis, originally developed at the Onderstepoort Laboratory, Pretoria, South Africa. Further work was conducted in England, India and in many other countries. Vaccine Strain is Sterne 34F2. The vaccine is a suspension of viable Bacillus anthracis spores in saponin. Oliver He B. anthracis Sterne strain spore vaccine PMID:3084385 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=17 17 vaccine Anthrax Spore vaccine VO:0000875 Oliver He pSecTag-PA83 PMID:15293452 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=451 451 vaccine pSecTag-PA83 vaccine VO:0000876 Oliver He pCMV/ER-PA83 PMID:15293452 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=29 29 vaccine pCMV/ER-PA83 vaccine VO:0000878 Canarypox virus-vectored vaccine Oliver He RECOMBITEKEquine WNV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=396 396 vaccine RECOMBITEKEquine WNV vaccine VO:0000879 Oliver He organism Porphyromonas denticanis VO:0000880 pCLF4 is a Bacillus anthracis vaccine that contains the N-terminal region (amino acids [aa] 10-254) of Bacillus anthracis LF cloned into the pCI expression plasmid. Oliver He pCLF4 PMID:11401993 PMID:15068841 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=28 28 vaccine pCLF4 vaccine VO:0000881 Equity Oestrus Control Vaccine for Horses is prepared from an analogue of gonadotropin releasing factor (GnRF) linked to a carrier protein. It has an adjuvant that enhances the level and duration of the immune response to GnRF with minimal injection site reactivity. It is used as an aid in the control of oestrus and oestrus-related behaviour in fillies and mares not intended for breeding. Peptide-protein conjugate and proprietary adjuvant (immunostimulating complex); control of estrus and estrus-related behavior Oliver He Equity Equity Oestrus Control Vaccine for Horses WEB: https://www.pfizeranimalhealth.com.au/products/352/equityreg-oestrus-control-vaccine.aspx vaccine Equity vaccine VO:0000882 single-dose Vaxigrip vaccine single-dose Vaxigrip vaccine VO:0000883 The difference between single-dose and multi-dose Vaxigrip is that multi-dose Vaxigrip contains preservative thimoseral. We still have not made it defined class since we still need to figure out how to represent multi-dose vs. single dose. The previous method discussed brief needs vetting. --YH Allen Xiang Melanie Courtot Oliver He multi-dose Vaxigrip vaccine multi-dose Vaxigrip vaccine VO:0000884 A mineral salt vaccine adjuvant that is composed of some aluminum compound. Oliver He vaccine adjuvant aluminum vaccine adjuvant VO:0000885 a role inhers in a vaccine component that when added into a vccine formmulation, it can prevent the growth of bacteria or fungi that inadvertently may be introduced into the vaccine during administrating process or the manufacturing process. Asiyah Yu Lin Oliver He P73 Chapter 6, Vaccine 5th edition by Plotkin, S. et al. role The CFR requires that, with certain defined exceptions, preservatives must be added to mulitdose vials of vaccine. (P73 Chapter 6, Vaccine 5th edition by Plotkin, S. et al.) vaccine preservative role VO:0000886 A route of administration that located in the mouth Oliver He site oral route VO:0000887 A route of administration that inject the material(such as vaccines, allergens) into the skin itself. Asiyah Yu Lin Oliver He intradermal injection route site intradermal route VO:0000888 Oliver He vaccine component phenol vaccine preservative VO:0000889 Recombinant ApxII, TbpB, CysL, OmlA(1), and OmlA(2) proteins Oliver He PleuroStar APP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=421 421 vaccine PleuroStar APP vaccine VO:0000891 Oliver He vaccine component phenoxy ethanol vaccine preservative VO:0000897 Age at vaccination is the age of an experiment animal at the time of vaccination. Oliver He quality age at vaccination VO:0000898 Culture-derived schizonts Oliver He vaccine Theileria annulata vaccine by local veterinary institutes VO:0000899 Dose is a measurement data that measures the quantity of something that may be eaten by or administered to an organism, or that an organism may be exposed to. Quantities of nutrients, drugs, vaccines and toxins are referred to as doses. Melanie Courtot Oliver He http://en.wikipedia.org/wiki/Dose_%28biochemistry%29 obsolete on 2/1/2020, using the OBI dose term (OBI_0000984) instead. obsolete dose true VO:0000900 A dose of a virulent pathogen used for a vaccine challenge process. Oliver He data item challenge dose VO:0000902 Canarypox virus-vectored vaccine Oliver He PROTEQ-FLU (European Union) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=393 393 vaccine PROTEQ-FLU vaccine (European Union) VO:0000903 Secondary vaccination is a vaccination that is performed immediately after the primary or the first vaccination. Oliver He Thom Todd vaccination secondary vaccination VO:0000906 Protozoan vaccine that is used to protect against Eimeria spp. (Eimeria) infection. Asiyah Yu Lin Oliver He vaccine Eimeria vaccine VO:0000907 Oliver He material entity surface antigens from the zona pellucida VO:0000909 Oliver He vaccine Theileria annulata vaccine VO:0000910 vaccine allergen is a material entity that is capable of stimulating a type-I hypersensitivity reaction in atopic individuals who has been vaccinated with a vaccine. Allen Xiang Oliver He WEB: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf material entity vaccine allergen VO:0000911 passive immunization that Immunity is transferred from mother to fetus through placental transfer of IgG or colostral transfer of IgA. Asiyah Yu Lin http://pathmicro.med.sc.edu/ghaffar/immunization-ver2.htm process passive immunization using natural maternal antibody VO:0000912 chicken egg protein allergen is a vaccine allergen that is composed of chicken egg protein. Egg protein may come from NCIS thesaurus egg - poultry, combination of minimal anatomy terminology and NCBI taxonomy... Eventually, this term chicken egg protein allergen may become a cross product of sevreal ontology terms. Allen Xiang Melanie Courtot Oliver He material entity chicken egg protein allergen VO:0000913 Allen Xiang Oliver He material entity latex vaccine allergen VO:0000915 Allen Xiang Oliver He material entity gelatin vaccine allergen VO:0000916 Allen Xiang Oliver He material entity protamine sulfate vaccine allergen VO:0000917 Allen Xiang Oliver He material entity polymyxin B vaccine allergen VO:0000918 Canarypox virus-vectored vaccine Oliver He EURIFEL FeLV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=405 405 vaccine EURIFEL FeLV vaccine VO:0000919 Vaccine component that is used as antigen to produce an immune responce protect against the specific pathogen or disease. This is a modified or partial form of the virus, bacteria or the toxin that causes the disease against which the vaccine protects. The vaccine antigen is altered from its original form so it no longer causes disease but it can produce an immune response.(Vaccine components FactSheet of NCIRS) Asiyah Yu Lin Oliver He vaccine antigenic component vaccine component To create this term for cover some other vaccines such as cancer vaccine and so on. vaccine antigen VO:0000920 a cell culture residual in vaccine that is bovine albumin. Allen Xiang Oliver He vaccine component bovine albumin cell culture residual in vaccine VO:0000921 a cell culture residual in vaccine that is bovine serum. Oliver He vaccine component bovine serum cell culture residual in vaccine VO:0000922 a vaccine stablizer that is based on monosodium glutamate. Asiyah Yu Lin Oliver He C5H8NNaO4 vaccine component http://www.novaccine.com/vaccine-ingredients/results.asp?sc=13 monosodium glutamate stabliizer VO:0000923 Modified live virus Oliver He RECOMBITEK Corona MLV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=407 407 vaccine RECOMBITEK Corona MLV vaccine VO:0000924 vaccine component glutaraldehyde vaccine additive VO:0000925 Infected blood from splenectomized calves Oliver He vaccine Babesia bovis vaccine VO:0000926 a cell culture residual in vaccine that is human albumin. Oliver He vaccine component human albumin cell culture residual in vaccine VO:0000927 a cell culture residual in vaccine that is human serum. Oliver He vaccine component human serum cell culture residual in vaccine VO:0000928 Reference: http://www.raboral.com/ Vaccinia virus recombinant Oliver He Raboral VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=403 403 vaccine Raboral vaccine VO:0000929 a vaccine stabilizer that is a polysorbate 20. It encourages the suspension of one liquid in another and has mild toxicity. Asiyah Yu Lin Oliver He vaccine component Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Reference: http://www.sciencelab.com/msds.php?msdsId=9926640 http://www.novaccine.com/vaccine-ingredients/results.asp?sc=95 polysorbate 20 vaccine stabilizer VO:0000930 a vaccine emulsifier that uses polysorbate 80, also known as polyoxyethylene sorbitan monooleate or Tween(TM) 80. Asiyah Yu Lin Oliver He Tween 80 vaccine emulsifier WEB: http://www.wisegeek.org/what-is-polysorbate-80.htm vaccine component Tween 80 is an amber-colored, viscous liquid with a slightly bitter taste. The product is a derivative of sorbitol and oleic acid. polysorbate 80 vaccine emulsifier VO:0000931 a cell culture residual in vaccine that is residual protein from cell culture. Oliver He vaccine component vaccine residual protein from cell culture VO:0000932 Oliver He vaccine canine coronavirus vaccine VO:0000933 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3095 3095 vaccine E. coli CS3 in PLGA microspheres VO:0000934 a vaccine stabilizer that is specifically made by sorbitol. Asiyah Yu Lin Oliver He glucitol vaccine component Sorbitol, also known as glucitol, is a sugar alcohol that the human body metabolizes slowly. It can be obtained by reduction of glucose, changing the aldehyde group to a hydroxyl group. Sorbitol is found in apples, pears, peaches, and prunes. It is synthesized by sorbitol-6-phosphate dehydrogenase, and converted to fructose by succinate dehydrogenase and sorbitol dehydrogenase. Succinate dehydrogenase is an enzyme complex that participates in the citric acid cycle. (wikipedia) sorbitol vaccine stabilizer VO:0000935 Oliver He vaccine Sarcocystis neurona vaccine VO:0000936 A vaccine that is made of a TK-negative (TK -) and gI/gE-negative (gI/gE -) pseudorabies virus (PRV) mutant to protect pigs against Aujeszky's disease. Aujeszky's disease is also known as pseudorabies. It is a disease primarily of pigs and is caused by porcine herpesvirus 1. This disease is characterized by respiratory, reproductive and nervous signs. gE- and thymidine kinase-deleted marker vaccine Oliver He Suvaxyn Aujeszky VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=389 389 vaccine Suvaxyn Aujeszky vaccine VO:0000937 a cell culture residual in vaccine that is sucrose albumin. Oliver He vaccine component sucrose albumin cell culture residual in vaccine VO:0000938 A synthetic vaccine adjuvant that is derived from Xanthomonas campestris, has a pentasaccharide repeating unit structure, and its terminus contains a mannose moiety which acts as a toll-like receptor 2 agonist. Asiyah Yu Lin PMID:19608270 http://www.sciencedirect.com/science/article/pii/S0142961209006371 vaccine adjuvant xanthan gum vaccine ajuvant VO:0000939 a cell culture residual in vaccine that is from yeast extract. Oliver He vaccine component yeast extract cell culture residual in vaccine VO:0000940 a cell culture residual in vaccine that is yeast protein. Oliver He vaccine component yeast protein cell culture residual in vaccine VO:0000941 DNA vaccine Oliver He Apex-IHN VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=410 410 vaccine Apex-IHN vaccine VO:0000942 DTP-Hib vaccine vaccine Diphtheria-Tetanus-Pertussis-Haemophilus b vaccine VO:0000943 vaccine Diphtheria-Tetanus-Poliovirus vaccine VO:0000944 V. cholerae and E. coli vaccine vaccine Vibrio cholerae and E. coli vaccine VO:0000945 A Measles virus vaccine that is also used against Rubella virus infection. Oliver He 04 40213168 measles and rubella virus vaccine M/R vaccine Measles-Rubella vaccine VO:0000946 A vaccine that protects against, Diphtheria, Tetanus, Pertussis (whooping cough), Polio, Hepatitis B, and Haemophilus influenzae type b. Kallan Roan Oliver He DTaP/IPV/HepB/Hib vaccine https://www.nhsinform.scot/healthy-living/immunisation/vaccines/the-6-in-1-vaccine vaccine Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b-Hepatitis B vaccine VO:0000947 Live flavivirus chimera vaccine Oliver He PreveNile VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=394 394 vaccine PreveNile vaccine VO:0000948 a bacterial vaccine against S. equi infection Oliver He vaccine Streptococcus equi vaccine VO:0000949 a bacterial vaccine against Mycoplasma gallisepticum infection Oliver He vaccine Mycoplasma gallisepticum vaccine VO:0000950 Hepatitis A virus-Typhoid vaccine vaccine Salmonella typhi-Hepatitis A vaccine VO:0000951 Baculovirus recombinant E2 protein without emulsion Oliver He Bayovac CSF E2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=391 391 vaccine Bayovac CSF E2 vaccine VO:0000952 Tick-borne virus vaccine vaccine Dhori virus vaccine VO:0000953 Pharyngeal mucosal route is an oral route of administration. Oliver He Thom Todd site pharyngeal mucosal route VO:0000954 Chimera virus on NDV backbone; field trials in 2007 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=400 400 vaccine Intervet avian influenza virus vaccine VO:0000955 assay host survival to pathogen challenge after vaccination VO:0000956 a B. abortus vaccine that uses a conjugate vaccine format Oliver He vaccine Brucella abortus conjugate vaccine VO:0000957 a B. abortus vaccine that uses a recombinant vector. Oliver He vaccine Brucella abortus recombinant vector vaccine VO:0000958 A vaccine that protects against Herpes simplex virus type 1. Allen Xiang Oliver He Herpes simplex virus type 1 vaccine Herpes simplex virus type 1 vaccine VO:0000960 Oliver He vaccine killed infectious bursal disease virus vaccine VO:0000961 Oliver He vaccine live attenuated infectious bursal disease virus vaccine VO:0000962 An E. coli vaccine that uses a live mutant by knocking out one gene(s) from a wild type E. coli. Oliver He vaccine recombinant E. coli mutant vaccine VO:0000963 an E. coli vaccine that uses toxoid antigen Oliver He vaccine E. coli toxoid vaccine VO:0000965 Oliver He PMID: http://www.ncbi.nlm.nih.gov/pubmed/9682399 vaccine potato expressed E. coli LB-T vaccine VO:0000966 An E. coli vaccine that uses a recombinant vaccine vector to express an E. coli antigen(s) vaccine recombinant vaccine vector E. coli vaccine VO:0000967 Oliver He rBCG-Stx2B vaccine rBCG-Stx3B vaccine VO:0000968 A DNA vaccine plasmid vector that has the plasmid label pBLUESCRIPT. Oliver He Rebecca Racz Davidson College - pBLUESCRIPT: Plasmids and Phages Combine For pBluescript [http://www.bio.davidson.edu/Courses/Molbio/MolStudents/spring2003/Keogh/plasmids.html] vaccine component Derived from pUC vectors; cross between phages and plasmids and therefore in a special category called "phagemids" (Davidson College - pBLUESCRIPT) The plasmid length is: 2961 pBLUESCRIPT DNA vaccine plasmid DNAVaxDB Plasmid ID: 180 VO:0000969 A DNA vaccine plasmid vector that has the plasmid label nkCMVint. Oliver He Rebecca Racz vaccine component A pUC-18-based plasmid; also contains intron A and an SV40 polyadenylation termination signal sequence. It has a CMV promoter. nkCMVint DNA vaccine plasmid DNAVaxDB Plasmid ID: 181 PMID: 9234529 VO:0000970 Oliver He vaccine E. coli Tir protein vaccine VO:0000972 Oliver He luteinizing hormone-releasing hormone material entity LHRH VO:0000973 Oliver He vaccine E. coli Shiga toxin 2B vaccine VO:0000974 vaccine inactivated E. coli vaccine VO:0000975 An E. coli vaccine against uropathogenic E. coli infections Oliver He UPEC vaccine vaccine uropathogenic E. coli vaccine VO:0000976 An E. coli vaccine against extraintestinal pathogenic E. coli infections Oliver He ExPEC vaccine vaccine extraintestinal pathogenic E. coli vaccine VO:0000977 An E. coli vaccine against enterohemorrhagic E. coli infections Oliver He EHEC vaccine vaccine enterohemorrhagic E. coli vaccine VO:0000978 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5555 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm335836.htm 5555 Flublok For active immunization against disease caused by influenza virus subtypes A and type B contained in the vaccine. Flublok is approved for use in persons 18 years of age and older. 125285 vaccine Flublok VO:0000979 Live or inactivated gE-deleted marker vaccine Oliver He Bovilis IBR Marker VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=392 392 vaccine Bovilis IBR Marker vaccine VO:0000980 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5560 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm328629.htm 5560 FLUCELVAX For active immunization of persons 4 years of age and older for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM329134.pdf 125408 vaccine Flucelvax VO:0000981 Baculovirus recombinant E2 protein without emulsion Oliver He Porcilis Pesti VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=390 390 vaccine Porcilis Pesti vaccine VO:0000982 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5564 5564 FluMist Quadrivalent For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FluMist Quadrivalent is approved for use in persons 2 through 49 years of age https://www.fda.gov/media/160349/download?attachment 125020 vaccine FluMist Quadrivalent vaccine VO:0000983 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5565 5565 FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.FLUARIX QUADRIVALENT is approved for use in persons aged 6 months and older https://www.fda.gov/media/79278/download?attachment BL 125127 vaccine Fluarix Quadrivalent VO:0000984 a tetanus vaccine manusfactured by Sanofi Pasteur Inc. that is only for booster use (not recommended for primary immunization) Oliver He Tetanus Toxoid (for Boost use Only) by Sanofi Pasteur Inc VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=314 WEB: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142732.pdf 314 vaccine Tetanus Toxoid vaccine (for Boost use Only) by Sanofi Pasteur Inc VO:0000985 a viral vaccine that is used to protect against fowl pox virus infection Oliver He vaccine fowl pox vaccine VO:0000986 Asiyah Yu Lin obsolete avian influenza vaccine true VO:0000987 Viral vaccine that is used to protect against Bovine herpesvirus 1 infection. Asiyah Yu Lin Oliver He BHV-1 vaccine bovine rhinotracheitis vaccine vaccine bovine herpesvirus 1 vaccine VO:0000988 Infection followed by drug treatment Oliver He vaccine Theileria parva vaccine by local veterinary institutes VO:0000990 Asiyah Yu Lin bovine parainfluenza 3 vaccine vaccine Bovine parainfluenza 3 virus vaccine VO:0000991 A DNA vaccine plasmid vector that has the plasmid label pDONR221. The plasmid length is 4762. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2394/ Invitrogen: http://tools.invitrogen.com/content/sfs/manuals/gateway_pdonr_vectors.pdf pDONR221 Sequence: http://tools.invitrogen.com/content/sfs/vectors/pdonr221_seq.txt vaccine component pDONR221 DNA vaccine plasmid VO:0000992 A DNA vaccine plasmid vector that has the plasmid label pCN3. The plasmid promoter is CMV. Oliver He Rebecca Racz vaccine component pCN3 DNA vaccine plasmid PMID: 19596416; PMID: 21059395. VO:0000993 A DNA vaccine plasmid vector that has the plasmid label V1R. Oliver He Rebecca Racz vaccine component V1R DNA vaccine plasmid PMID: 11797011; PMID: 15258286 VO:0000994 Oliver He vaccine Toxoplasma gondii vaccine VO:0000995 A DNA vaccine plasmid vector that has the plasmid label pVAC1 3.0. The manufacturer is Invitrogen. Oliver He Rebecca Racz vaccine component pVAC1 3.0 DNA vaccine plasmid PMID: 20884037 VO:0000996 A contraceptive vaccine that has proven highly effective in deer and can be used to control populations. Crude ZPA preparation; supplied to research groups only no longer available Oliver He SpayVac http://terramar.bc.ca/ vaccine SpayVac vaccine VO:0000997 A DNA vaccine plasmid vector that has the plasmid label pSin-CMV-Vac. The promoter is CMV. Oliver He Rebecca Racz vaccine component pSin-CMV-Vac DNA vaccine plasmid PMID: 22702835; PMID: 23637502 VO:0000998 A DNA vaccine plasmid vector that has the plasmid label pGACAG. The promoter is CAG and the antibiotics resistance gene is kanamycin. Oliver He Rebecca Racz vaccine component pGACAG DNA vaccine plasmid PMID: 17203206 VO:0000999 A DNA vaccine plasmid vector that has the plasmid label pVCL1012. The promoter is HCMV and the manufacturer is Vical Inc. Oliver He Rebecca Racz vaccine component pVCL1012 DNA vaccine plasmid PMID: 15652666 VO:0001000 A DNA vaccine plasmid vector that has the plasmid label pSCA1. Oliver He Rebecca Racz vaccine component pSCA1 DNA vaccine plasmid PMID: 22819169 VO:0001002 A DNA vaccine plasmid vector that has the plasmid label phCMV1. This plasmid is 4200 base pairs long, has a CMV promoter, contains kanamycin and neomycin antibiotics resistance genes, and is manufactured by Genlantis. Oliver He Rebecca Racz WEB: http://www.genlantis.com/faq-phcmv.html vaccine component phCMV1 DNA vaccine plasmid PMID: 19540885 VO:0001003 A DNA vaccine plasmid vector that has the plasmid label pCJ-3. This plasmid has a CMV promoter and a kanamycin resistance gene. Oliver He Rebecca Racz vaccine component pCJ-3 DNA vaccine plasmid PMID: 16949850 VO:0001004 A DNA vaccine plasmid vector that has the plasmid label pcDNA3.1/V5-His. This plasmid has a CMV promoter. Oliver He Rebecca Racz vaccine component pcDNA3.1/V5-His DNA vaccine plasmid PMID: 22445688 VO:0001005 A DNA vaccine plasmid vector that has the plasmid label pSecTag2 C. This plasmid is 5167 base pairs long, has a CMV promoter and ampicillin and zeocin resistance genes. Oliver He Rebecca Racz WEB: http://tools.invitrogen.com/content/sfs/manuals/psectag2_man.pdf vaccine component pSecTag2 C DNA vaccine plasmid VO:0001007 A DNA vaccine plasmid vector that has the plasmid label pBC12/CMV/IL-2. Oliver He Rebecca Racz NIH AIDS Reagent Program - pBC12/CMV/IL-2: [https://www.aidsreagent.org/reagentdetail.cfm?t=expression_vectors&id=159] vaccine component Derived from plasmid pBC12/CMV; expresses IL-2 (NIH AIDS Reagent Program - pBC12/CMV/IL-2). Its length is: 4732. pBC12/CMV/IL-2 DNA vaccine plasmid DNAVaxDB Plasmid ID: 182 VO:0001008 Cultured trophozoites, reduces disease and cyst shedding Oliver He Giardiavax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=432 432 vaccine Giardiavax vaccine VO:0001009 The plant-based Newcastle disease virus vaccine is a Newcastle disease virus vaccine that is developed by Dow AgroSciences LLC. It uses technology discovered at Washington University. It is the first plant-made animal vaccine approved for sale in the United States. HN recombinant produced in plant cell lines (registered but not on market) Oliver He vaccine plant-based Newcastle disease virus vaccine VO:0001012 Oliver He vaccine classical swine fever virus vaccine VO:0001013 A Measles-Mumps-Rubella vaccine that is manufactured by Sanofi Aventis. Oliver He Morupar vaccine Morupar vaccine VO:0001014 A live attenuated quality of a bacterial vaccine strain. Oliver He obsolete bacterial vaccine organism live attenuated true VO:0001015 A live attenuated quality of a virus vaccine strain. Oliver He obsolete viral vaccine organism live attenuated true VO:0001016 Fowlpox virus vectored Oliver He Vectormune FP-ND VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=399 399 vaccine Vectormune FP-ND vaccine VO:0001017 A live attenuated vaccine that protects against Marek's disease virus. Allen Xiang Oliver He Marek's; disease virus vaccine live attenuated Marek's disease virus vaccine VO:0001018 A live attenuated viral vaccine that protects aganist Newcastle disease virus infection. Oliver He vaccine live attenuated Newcastle disease virus vaccine VO:0001019 an avian reovirus vaccine that using live attenauted reovirus. Asiyah Yu Lin vaccine live attenuated avian reovirus vaccine VO:0001020 Sporulated oocysts of several or all of the avian species Oliver He Advent VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=424 424 vaccine Advent vaccine VO:0001021 a feline panleukopenia virus vaccine where the virus used is live attenuated. Oliver He vaccine live attenuated feline panleukopenia virus vaccine VO:0001022 Megan Vac1 is a Salmoneela vaccine that consists of a double gene-deleted S. enterica serovar Typhimurium strain and is designed for protection of broilers to reduce Salmonella contamination. Oliver He Megan Vac1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=423 WEB: http://www.fda.gov/ohrms/dockets/dockets/00n0504/00N-0504_emc-001650-02.pdf 423 vaccine Megan Vac1 vaccine VO:0001023 a bacterial vaccine vector that uses TB vaccine BCG as the vector. Oliver He vaccine component BCG vaccine vector NCBI Taxonomy ID: 33892 VO:0001024 an avian influenza vaccine that uses inactivated viral organism Oliver He vaccine inactivated avian influenza vaccine VO:0001025 a viral vaccine vector that uses a vesicular stomatitis virus (VSV) as the vector. Oliver He vaccine component vesicular stomatitis virus vaccine vector NCBI Taxonomy ID: 11276 VO:0001026 Killed oral vaccine Oliver He AquaVac Furuvac VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=414 414 vaccine AquaVac Furuvac vaccine VO:0001028 a parasite vaccine vector using a live attenuated Leishmania tarentolae strain. Carly Martin Oliver He vaccine component Leishmania tarentolae vaccine vector NCBI Taxonomy ID: 5689 VO:0001029 PMID:23969885 cancer vaccine autologous dendritic cell melanoma vaccine VO:0001030 obsolete vaccine-induced mouse immune response true VO:0001031 WEB: http://www.ncbi.nlm.nih.gov/pubmed/21907709 a bacterial vaccine vector using a live attenuated Salmonella enterica strain SL3261. Carly Martin Oliver He vaccine component Salmonella typhimurium SL3261 vaccine vector VO:0001032 WEB: http://www.ncbi.nlm.nih.gov/pubmed/21964456 a bacterial vaccine vector using a live attenuated Edwardsiella tarda strain EIB202 Carly Martin Oliver He vaccine component Edwardsiella tarda EIB202 vaccine vector NCBI Taxonomy ID: 498217 VO:0001033 Oliver He vaccine Babesia bigemina vaccine VO:0001034 a vaccine vector that uses a parasite as the vector. Carly Martin Oliver He vaccine component parasite vaccine vector VO:0001035 a bacterial vaccine against Yersinia ruckeri infection Oliver He vaccine Yersinia ruckeri vaccine VO:0001036 WEB: http://www.ncbi.nlm.nih.gov/pubmed/23403993 a bacterial vaccine vector using a live attenuated Streptococcus gordonii vaccine vector. Carly Martin Oliver He vaccine component Streptococcus gordonii vaccine vector NCBI Taxonomy ID: 1302 VO:0001037 WEB: http://www.ncbi.nlm.nih.gov/pubmed/16823926 a bacterial vaccine vector using a live attenuated Bordetella pertussis BPZE as a vaccine vector. Carly Martin Oliver He vaccine component Bordetella pertussis BPZE vaccine vector VO:0001038 WEB: http://www.ncbi.nlm.nih.gov/pubmed/9767712 a bacterial vaccine vector using the HS93Tox- mutant of the serovar 7 strain of Actinobacillus pleuropneumoniae. This mutant lacks the genes encoding the toxin ApxA and the post-translational activating protein ApxC, but still has genes required for secretion, making it a good vector. Carly Martin Oliver He vaccine component Actinobacillus pleuropneumoniae HS93Tox vaccine vector VO:0001040 an Avipox virus vaccine vector that uses a fowlpox virus as the vector Oliver He Shunzhou Deng vaccine component fowlpox virus vaccine vector NCBI Taxonomy ID: 10261 pmid: 10729156 VO:0001041 A Listeria monocytogenes vaccine vector that uses the highly attenuated LM1-2 strain Oliver He PMID: 23027427 vaccine component L. monocytogenes LM1-2 vaccine vector VO:0001042 Oliver He Shunzhou Deng BHV-4 vaccine vector bovine herpesvirus 4 vaccine vector PMID: 23830977; PMID: 23300989; PMID: 21320537; PMID: 24752229 vaccine component BoHV-4 vaccine vector NCBI Taxonomy ID: 10385 VO:0001043 an Avipox virus vaccine vector that uses an attenuated canarypox virus strain Oliver He Shunzhou Deng Poulet et al. 2007, PubMed PMID: 17227690. WEB: http://en.wikipedia.org/wiki/Canarypox vaccine component canarypox vaccine vector NCBI Taxonomy ID: 44088 VO:0001044 a bacterial vaccine vector that uses an attenuated Vibrio cholerae strain Oliver He Shunzhou Deng PMID: 9529093 vaccine component Vibrio cholerae vaccine vector NCBI Taxonomy ID: 666 VO:0001045 a viral vaccine vector that uses an avian paramyxovirus strain Oliver He Shunzhou Deng avian paramyxovirus type 3 vaccine vector PMID: 21525340 vaccine component APMV-3 vaccine vector NCBI Taxonomy ID: 207246 VO:0001046 a herpesvirus vaccine vector that uses a herpes simplex virus strain Oliver He Shunzhou Deng HSV vaccine vector PMID: 22713696; PMID: 19428888; PMID: 20835362; PMID: 16996101 vaccine component Herpes simplex virus vaccine vector VO:0001047 an adenovirus vaccine vector that uses the simian adenovirus ChAd63 strain. Oliver He Shunzhou Deng PMID: 22275401; PMID: 23526949; PMID: 22363582 vaccine component simian adenovirus ChAd63 vaccine vector NCBI Taxonomy ID: 413684 VO:0001048 an orthopoxvirus vaccine vector that uses an attenuated Raccoon poxvirus strain Oliver He Shunzhou Deng PMID: 22921740 vaccine component raccoon poxvirus vaccine vector NCBI Taxonomy ID: 10256 VO:0001049 Live temperature-sensitive mutant strain; eye drop administration Oliver He Vaxsafe MS VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=418 418 vaccine Vaxsafe MS vaccine VO:0001050 A herpesevirus vaccine vector that uses an established live-virus vaccine against Aujeszky's disease of swine, pseudorabies virus (PrV) strain Bartha (PrV-Ba), to serve as vector. Oliver He Shunzhou Deng PrV vaccine vector Suid herpesvirus 1 strain Bartha vaccine vector PMID: 24431235 vaccine component pseudorabies virus strain Bartha vaccine vector NCBI Taxonomy ID: 1006205 VO:0001051 an adenovirus vaccine vector that uses a porcine adenovirus 3 strain Oliver He Shunzhou Deng PAV3 vaccine vector PMID: 11402666; PMID: 21179494; PMID: 10091994; PMID: 12954206; PMID: 17565687 vaccine component porcine adenovirus 3 vaccine vector NCBI Taxonomy ID: 35265 VO:0001052 a viral vaccine vector that uses a poliovirus strain Oliver He Shunzhou Deng PV vaccine vector PMID: 19003009; PMID: 12423772; PMID: 17196342 vaccine component poliovirus vaccine vector NCBI Taxonomy ID: 138950 VO:0001053 In vitro-cultured supernatant antigens, reduce clinical disease Oliver He Nobivac Piro vaccine Nobivac Piro vaccine VO:0001054 Live submucosal vaccine; deletions in aroA gene Oliver He Equilis StrepE VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=416 416 vaccine Equilis StrepE vaccine VO:0001055 an adenovirus vaccine vector that uses a chimpanzee adenovirus strain Oliver He Shunzhou Deng vaccine component chimpanzee adenovirus vaccine vector NCBI Taxonomy ID: 310542 VO:0001056 a viral vaccine vector that uses a measles virus strain Oliver He Shunzhou Deng MV vaccine vector PMID: 24084235; PMID: 24606680; PMID: 23642239; PMID: 23550539; PMID: 23516477 vaccine component measles virus vaccine vector NCBI Taxonomy ID: 11234 VO:0001057 a viral vaccine vector that uses a Coxsackievirus strain Oliver He Shunzhou Deng PMID: 20824074; PMID: 11115722; PMID: 19053211; PMID: 20088713; PMID: 21389776; PMID: 19941986; PMID: 11160741 vaccine component Coxsackievirus vaccine vector NCBI Taxonomy ID: 12066 VO:0001059 a poxvirus vaccine vector that uses an attenuated Oka varicella virus strain Oliver He Shunzhou Deng Human herpesvirus 3 strain Oka vaccine vaccine PMID: 10720546; PMID: 16615495; PMID: 18053621 vaccine component Oka varicella vaccine vector NCBI Taxonomy ID: 341980 VO:0001060 a viral vaccine vector that uses a NewCastle virus strain Oliver He Shunzhou Deng NDV vaccine vector PMID: 23845804 vaccine component Newcastle disease virus vaccine vector NCBI Taxonomy ID: 11176 VO:0001061 Oliver He vaccine Theileria parva vaccine VO:0001062 a viral vaccine vector that uses a myxoma virus strain Oliver He Shunzhou Deng PMID: 10627521; PMID: 12951040; PMID: 14972520; PMID: 8719525; PMID: 12057600; PMID: 18474552; PMID: 21835800; PMID: 22244980 vaccine component myxoma virus vaccine vector NCBI Taxonomy ID: 10273 VO:0001063 a viral vaccine vector that uses a Maraba virus strain Oliver He Shunzhou Deng PMID: 24322333 vaccine component Maraba virus vaccine vector NCBI Taxonomy ID: 1046251 VO:0001064 a bacterial vaccine vector that uses an attenuated Mycobacterium smegmatis strain Oliver He Shunzhou Deng PMID: 22546648; PMID: 21900527 vaccine component Mycobacterium smegmatis vaccine vector NCBI Taxonomy ID: 1772 VO:0001065 Oliver He vaccine Neospora caninum vaccine VO:0001066 a bacterial vaccine vector that uses an attenuated Lactobacillus gasseri strain Oliver He Shunzhou Deng PMID: 21375708; PMID: 20722604; PMID: 21900526 vaccine component Lactobacillus gasseri vaccine vector NCBI Taxonomy ID: 1596 VO:0001067 Oliver He Shunzhou Deng HVT vaccine vector Meleagrid herpesvirus 1 vaccine vector PMID: 22845318 vaccine component herpesvirus of turkey vaccine vector NCBI Taxonomy ID: 37108 VO:0001068 A Herpes simplex virus vaccine vector that uses a virus type 1 strain Oliver He Shunzhou Deng HSV-1 vaccine vector PMID: 19428888 vaccine component Herpes simplex virus vaccine 1 vector NCBI Taxonomy ID: 10298 VO:0001070 a bacterial vaccine vector that uses an E. coli strain Oliver He Shunzhou Deng PMID: 24746937 vaccine component E. coli vaccine vector NCBI Taxonomy ID: 562 VO:0001071 Killed oral vaccine Reference: http://www.spaquaculture.com/default.aspx?pageid=553 Oliver He AquaVac Vibrio VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=415 415 vaccine AquaVac Vibrio vaccine VO:0001072 a viral vaccine vector that uses a duck enteritis virus strain Oliver He Shunzhou Deng Anatid herpesvirus 1 vaccine vector PMID: 23267833 vaccine component duck enteritis virus vector NCBI Taxonomy ID: 104388 VO:0001073 a herpesvirus vaccine vector that uses a CMV virus strain Oliver He Shunzhou Deng Cytomegalovirus vaccine vector PMID: 23811402 vaccine component CMV vaccine vector NCBI Taxonomy ID: 10358 VO:0001074 Oliver He vaccine Babesia canis vaccine VO:0001075 a bacterial vaccine vector that uses a Salmonella typhi strain Oliver He Shunzhou Deng vaccine component Salmonella typhi vaccine vector NCBI Taxonomy ID: 90370 VO:0001076 a recombinant vector vaccine that uses a homologous vector, i.e., when the target species of the vaccine is a natural host for the vector. Oliver He WEB: http://www.biosafety.be/GT/Regulatory/Veterinary_vaccines/EMEA_000404en.pdf vaccine recombinant homologous vector vaccine VO:0001077 a bacterial vaccine against Mycoplasma synoviae infection Oliver He vaccine Mycoplasma synoviae vaccine VO:0001078 a recombinant vector vaccine that uses a homologous vector, i.e., when the target species of the vaccine is not one of the natural hosts for the vector. Oliver He WEB: http://www.biosafety.be/GT/Regulatory/Veterinary_vaccines/EMEA_000404en.pdf vaccine recombinant heterologous vector vaccine VO:0001080 Oliver He material entity Androstenedione VO:0001081 an adenovirus vaccine vector that uses an Adenovirus serotype 5 strain. Oliver He human adenovirus 5 vaccine vector vaccine component adenovirus serotype 5 vaccine vector NCBI Taxonomy ID: 28285 VO:0001082 an adenovirus vaccine vector that contains a deletion of the gp64 gene. As a result of the deletion, this vector is unable to propagate infection from cell to cell, and this defect results from both a severe reduction in the production of budded virions and the absence of GP64 on virions. Oliver He PMID: 17989172 vaccine component AcMNPV vector NCBI Taxonomy ID: 46015 VO:0001083 protozoan vaccine that is used to protect against Giardia intestinalis infection Oliver He vaccine Giardia duodenalis vaccine VO:0001084 a viral vaccine vector that uses a baculovirus as the vector Oliver He PMID: 22705893 vaccine component baculovirus vaccine vector NCBI Taxonomy ID: 10469 VO:0001085 Chlamydia bacterial vaccine against C. abortus infection Oliver He vaccine Chlamydophila abortus vaccine VO:0001086 an adenovirus vaccine vector that uses a complex adenovirus as the vector strain. Oliver He CAdVax vaccine vector PMID: 19776190; PMID: 18480438; PMID: 17634508; PMID: 18216185; PMID: 16501083 vaccine component complex adenovirus vaccine vector VO:0001087 an adenovirus vaccine vector that uses a human adenovirus as the vector strain. Oliver He HAd vaccine vector PMID: 16297508; PMID: 15761255 vaccine component human adenovirus vaccine vector VO:0001088 a viral vaccine vector that uses a murine leukemia virus as the vaccine vector Oliver He WEB: http://en.wikipedia.org/wiki/Murine_leukemia_virus vaccine component murine leukemia viral vector vaccine NCBI Taxonomy ID: 11786 VO:0001089 Allen Xiang Oliver He WEB: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm information content entity CDC recommendation of the use of Influenza A (h1N1) 2009 vaccine VO:0001090 A population group that have priority for vaccination when a vaccine is first available. Allen Xiang Oliver He vaccination target group material entity vaccinee priority group VO:0001091 Chimera H5N3 virus, inactivated in oil-based adjuvant Oliver He Poulvac FluFend I AI H5N3 RG VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=401 401 vaccine Poulvac FluFend I AI H5N3 RG vaccine VO:0001093 a vaccinia vaccine vector that uses the highly attenuated NYVAC as vector A highly attenuated vaccinia virus strain, NYVAC (vP866), was derived from a plaque-cloned isolate of the Copenhagen vaccine strain by the precise deletion of 18 open reading frames (ORFs) from the viral genome. Source: http://www.ncbi.nlm.nih.gov/pubmed/1566575 Oliver He PMID: 22930439;; PMID: 24069354; PMID: 1566575 vaccine component NYVAC vaccine vector NCBI Taxonomy ID: 10249 (for Vaccinia virus Copenhagen) VO:0001094 Allen Xiang Asiyah Yu Lin WEB: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm material entity pregnant women VO:0001095 passive immunization by injecting a recipient with pre-made antibody, antitoxin, epitope, etc. Asiyah Yu Lin process passive immunization by injecting pre-made immune element VO:0001096 A vaccine used to increase the fecundity in breeding ewes. Ovastim increases the number of multiple ovulations and therefore the number of multiple births. Increased ovulation/twinning Oliver He Ovastim WEB: http://www.virbac.co.nz/p-virbacnzpuben/display.aspx?srv=p-virbacnz&typ=pub&lang=en&cmd=view&style=styles/specie.xsl&select=PRODUCT[@ID$eq$PRODUCT_264]&affp=& vaccine Ovastim vaccine VO:0001097 Canarypox virus-vectored vaccine (HA and F antigens) Oliver He RECOMBITEK rDistemper VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=408 408 vaccine RECOMBITEK rDistemper vaccine VO:0001098 Allen Xiang Asiyah Yu Lin WEB: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm material entity persons living with or providing care for infants aged <6 months VO:0001099 Allen Xiang Asiyah Yu Lin WEB: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm material entity health-care and emergency medical services personnel VO:0001100 Allen Xiang Asiyah Yu Lin WEB: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm material entity persons aged 6 months--24 years VO:0001101 Allen Xiang Asiyah Yu Lin WEB: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr58e0821a1.htm material entity persons aged 25--64 years with medical conditions at higher risk for influenza-related complications VO:0001102 a viral vaccine vector that uses a retroviral strain Oliver He PMID: 2839718 vaccine component retroviral vaccine vector NCBI Taxonomy ID: 11632 Vaxvec: 23 VO:0001103 Inactivation is a processual entity that produces inactive material. Allen Xiang Melanie Courtot Oliver He process inactivation VO:0001104 Oliver He a retroviral vaccine vector where a Rous sarcoma virus (a retrovirus) is used vaccine component Rous sarcoma virus vaccine vector NCBI Taxonomy ID: 11886 Vaxvec: 20 VO:0001105 Vaccine that protects against Lawsonia intracellularis infection. Oliver He vaccine Lawsonia intracellularis vaccine VO:0001106 a poxvirus vaccine vector that uses a swinepox virus as the vector Oliver He Shunzhou Deng vaccine component swinepox virus vaccine vector NCBI Taxonomy ID: 10276 PMID: 22515033; PMID: 21807055; PMID: 22884664; PMID: 23135159 VO:0001107 a vaccinia virus vector that uses the Modified Vaccinia Ankara (MVA) virus. Oliver He PMID: 24933081 vaccine component Modified Vaccinia Ankara (MVA) virus vaccine vector NCBI Taxonomy ID: 467144 VO:0001108 a poxvirus vaccine vector that uses an ORF virus which is a parapoxvirus. Oliver He Shunzhou Deng vaccine component ORF virus vaccine vector NCBI Taxonomy ID: 10258 VO:0001109 a vaccinia virus vector that uses the MVTT vaccine strain as the vector. MVTT is an attenuated vaccine strain. Oliver He Shunzhou Deng vaccinia virus TianTan vaccine vector vaccine component MVTT vaccine vector NCBI Taxonomy ID: 10253 VO:0001110 a fertility vaccine that enhance fertility in sheep. Linked to human serum albumin; increased ovulation/twinning withdrawn Oliver He Fecundin WEB: http://www.journals.elsevierhealth.com/periodicals/anirep/article/PII0378432093901125/abstract vaccine Fecundin vaccine VO:0001111 A poxvirus vaccine vector that uses an attenuated lumpy skin disease virus as the vector. Oliver He Shunzhou Deng LSDV vaccine vector vaccine component lumpy skin disease virus vaccine vector NCBI Taxonomy ID: 59509 VO:0001112 a viral vaccine vector that uses a bovine parainfluenza virus strain as vector Oliver He Shunzhou Deng PMID: 22570186; PMID: 24478424. vaccine component bovine parainfluenza virus vaccine vector NCBI Taxonomy ID: 11215 VO:0001113 Gametocyte antigen(s); transmission blocking through maternal antibody transfer Oliver He CoxAbic VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=436 436 vaccine CoxAbic vaccine VO:0001114 Bordetella bacterial vaccine against infection of B. avium Oliver He vaccine Bordetella avium vaccine VO:0001115 a poxvirus vaccine vector that uses an attenuated capripoxvirus strain as the vaccine vector Oliver He Shunzhou Deng vaccine component capripoxvirus vaccine vector NCBI Taxonomy ID: 10265 VO:0001116 Survival of live vaccine inside host is a process that represents the survival of a live vaccine inside its host. The time of the survival is often important for the success of the live vaccine. Oliver He process survival of live vaccine inside host VO:0001117 Persistence of vaccine induced immune response is a processual entity that indicates the persistence of an immune reponse induced by a vaccine in a vaccinated host. Oliver He process persistence of vaccine induced immune response VO:0001118 a bacterial vaccine vector that uses a Corynebacterium pseudotuberculosis strain as the vaccine vector Oliver He Shunzhou Deng vaccine component Corynebacterium pseudotuberculosis vaccine vector NCBI Taxonomy ID: 1719 VO:0001120 Killed tachyzoites, reduces abortion Oliver He Bovilis Neoguard VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=431 431 vaccine Bovilis Neoguard vaccine VO:0001121 a viral vaccine vector that uses a rhabdovirus-based viral strain as the vaccine vector Oliver He Shunzhou Deng vaccine component rhabdovirus-based vaccine vector NCBI Taxonomy ID: 11270 VO:0001122 a recombinant vaccine vector that uses Saccharomyces cerevisiae as the vaccine vector Oliver He Shunzhou Deng vaccine component Saccharomyces cerevisiae vaccine vector NCBI Taxonomy ID: 4932 VO:0001123 Modified live virus Oliver He RECOMBITEK Canine Parvo VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=406 406 vaccine RECOMBITEK Canine Parvo vaccine VO:0001124 a viral vaccine vector that uses a Venezuelan equine encephalitis virus strain as the vaccine vector Oliver He Shunzhou Deng Venezuelan equine encephalitis virus vaccine vector vaccine component VEE vaccine vector NCBI Taxonomy ID: 11036 VO:0001125 Oliver He vaccine Eimeria maxima vaccine VO:0001126 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=753 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm192126.htm 753 Agriflu Active immunization of adults 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. BL 125297/32 vaccine Agriflu VO:0001127 live attenuated Brucella vaccine is a live attenuated vaccine that protects against a Brucella infection. Oliver He vaccine live attenuated Brucella vaccine VO:0001128 a canarypox vaccine vector that uses an attenuated canarypox virus strain ALVAC. The ALVAC vector is a canarypox virus clone obtained after four rounds of plaque purification of a strain from a vaccine for canaries. Oliver He Shunzhou Deng ALVAC WEB: http://www.ncbi.nlm.nih.gov/pubmed/17227690 vaccine component ALVAC vaccine vector VO:0001129 an adenovirus vaccine vector that is not able to replicate. Oliver He vaccine component non-replicating adenovirus accine vector VO:0001130 a bacterial vaccine against A. pleuropneumoniae infection Oliver He vaccine Actinobacillus pleuropneumoniae vaccine VO:0001131 an adenovirus vaccine vector that is able to replicate. Oliver He vaccine component replicating adenovirus accine vector VO:0001132 assay of CFU reduction in liver is a CFU reduction assay that is measured using the extracted liver as the tissue for isolation of infected pathogens. Oliver He assay assay of CFU reduction in liver VO:0001133 assay of CFU reduction in lung is a CFU reduction assay that is measured using the extracted lung as the tissue for isolation of infected pathogens. Oliver He assay assay of CFU reduction in lung VO:0001134 live attenuated Brucella vaccine is a live attenuated vaccine that protects against a Brucella abortus infection. Oliver He vaccine live attenuated Brucella abortus vaccine VO:0001135 live attenuated Brucella vaccine is a live attenuated vaccine that protects against a Brucella melitensis infection. Oliver He vaccine live attenuated Brucella melitensis vaccine VO:0001136 live attenuated Brucella vaccine is a live attenuated vaccine that protects against a Brucella suis infection. Oliver He vaccine live attenuated Brucella suis vaccine VO:0001137 Oliver He vaccine Eimeria tenella vaccine VO:0001138 S48 strain with a lost ability to form cysts after passages in mice Oliver He Ovilis Toxovax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=429 429 vaccine Ovilis Toxovax vaccine VO:0001139 vaccine viability is a viability of a vaccine organism. Allen Xiang Oliver He quality vaccine organism viability VO:0001140 DNA vaccine Oliver He West Nile-Innovator DNA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=395 395 vaccine West Nile-Innovator DNA vaccine VO:0001141 a recombinant vaccine vector that uses a fungus as the vaccine vector Oliver He vaccine component fungal vaccine vector NCBI Taxonomy ID: 4751 VO:0001142 Oliver He vaccine Leishmania donovani vaccine VO:0001143 a poxvirus vaccine vector that uses an avipox virus as the vector Oliver He vaccine component Avipox virus vaccine vector NCBI Taxonomy ID: 10260 VO:0001144 Oliver He pCIBLSOmp31 PMID:17600596 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=139 139 vaccine Brucella DNA vaccine encoding chimera BLSOmp31 VO:0001145 vaccine being viable is a vaccine viability that indicates a vaccine uses live organism. Allen Xiang Oliver He quality vaccine organism live VO:0001146 a poxvirus vaccine vector that uses an orthopox virus as the vector Oliver He vaccine component Orthopoxvirus vaccine vector NCBI Taxonomy ID: 10242 VO:0001147 A cytokine vaccine adjuvant that contains IL-12. Allen Xiang Oliver He vaccine adjuvant IL-12 vacince adjuvant VO:0001148 Allen Xiang Oliver He quality no vaccine protection VO:0001149 Allen Xiang Oliver He quality significant vaccine protection VO:0001150 Allen Xiang Oliver He quality enhanced significant protection VO:0001151 Vaccine that protects against Piscirickettsia salmonis infection. Asiyah Yu Lin vaccine Piscirickettsia salmonis vaccine VO:0001152 An E. coli vaccine against enterotoxigenic E. coli infections Oliver He ETEC vaccine vaccine enterotoxigenic E. coli vaccine VO:0001153 Increased ovulation/twinning Oliver He Androvax vaccine Androvax vaccine VO:0001154 B. abortus L7/L12 is a B. abortus subunit vaccine using L7/L12 that is formed by recombinant Human Serum Albumin (HAS)-L7/L12 fusion protein. Oliver He B. abortus HSA-L7/L12 Brucella abortus Human serum albumin (HAS)-L7/L12 PMID:19293473 vaccine Brucella abortus HSA-L7/L12 vaccine VO:0001155 An E. coli vaccine against Shiga toxin-producing E. coli (STEC) infections Oliver He STEC vaccine WEB: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2238053/ vaccine shiga toxin-producing E. coli vaccine VO:0001156 a vaccine against avian pathogenic Escherichia coli (APEC) infection, a major problem for the poultry industry in the world. Oliver He APEC vaccine vaccine avian pathogenic E. coli vaccine VO:0001157 Oliver He an E. coli vaccine against O157 E. coli strain infections vaccine E. coli O157 vaccine VO:0001158 Extracted ApxI, ApxII, ApxIII, and outer membrane proteins Oliver He Porcilis APP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=422 422 vaccine Porcilis APP vaccine VO:0001159 PUREVAX Ferret Distemper is a lyophilized ferret vaccine of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus. Canarypox virus-vectored vaccine Oliver He PUREVAX Ferret Distemper VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=409 http://www.drugs.com/vet/purevax-ferret-distemper.html 409 vaccine PUREVAX Ferret Distemper vaccine VO:0001160 Allen Xiang Oliver He information content entity vaccination dose specification VO:0001161 Allen Xiang Oliver He information content entity challenge dose specification VO:0001162 specification of time interval after vaccination for challenge is a plan specification that specifies the time interval after vacciation for challenge Allen Xiang Oliver He information content entity specification of vaccination-challenge interval VO:0001163 pathogen challenge protocol is a protocol that is used for a pathogen challenge process. Allen Xiang Oliver He information content entity pathogen challenge protocol VO:0001164 A titer measurement of viable bacterial or fungal numbers. It equals to a reduction of a CFU count from another CFU count. This term is often used as a measurement of a vaccine protection study. Allen Xiang Oliver He data item reduction of colony forming unit VO:0001165 intraperitoneal pathogen challenge is a pathogen challenge process that occurs in the intraperitoneal site of a host. Allen Xiang Oliver He process intraperitoneal pathogen challenge VO:0001166 a vaccination process that occurs in the intraperitoneal route Allen Xiang Oliver He vaccination intraperitoneal vaccination VO:0001167 Oliver He KLH-s-FimH1-25 with CFA and then IFA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4329 4329 vaccine KLH-s-FimH1-25 with CFA and then IFA vaccine VO:0001168 an E. coli subunit vaccine that uses E. coli FimH adhesin protein as teh antigen, and uses the complete Freund's adjuvant (CFA) in the first vaccination and the incomplete Freund's adjuvant (IFA) in the boost vaccination. Oliver He E. coli FimH with CFA and then IFA PMID: http://www.ncbi.nlm.nih.gov/pubmed/9110982 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4330 4330 vaccine E. coli FimH with CFA and then IFA vaccine VO:0001169 E. coli DNA vaccine is a DNA vaccine that protects against an E. coli infection. Oliver He vaccine E. coli DNA vaccine VO:0001170 a vaccine organism that is a specific strain Oliver He organism vaccine strain VO:0001171 B. melitensis bp26 and omp31 deletion vaccine is a Brucella melitensis vaccine that has double deletions of bp26 and omp31. Oliver He B. melitensis Rev. 1 with bp26 and omp31 deletions CGV2631 PMID:17070627 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=779 779 vaccine Brucella melitensis Rev. 1 with bp26 and omp31 deletions vaccine VO:0001172 pCIOmp31 is a B. melitensis DNA vaccine expressing Omp31 that uses the pCI plasmid. Oliver He pCIOmp31 PMID:16177328 vaccine pCIOmp31 vaccine VO:0001173 pTargeTomp31 is a B. melitensis DNA vaccine expressing Omp31 that uses the pTargeT mammalian expression system vector (Promega, USA). Oliver He pTargeTomp31 PMID:17014873 vaccine pTargeTomp31 vaccine VO:0001175 B. abortus L7/L12 fused to MBP is a B. abortus subunit vaccine using L7/L12 that uses recombinant L7/L12 fused on maltose binding protein MBP. Oliver He B. abortus L7/L12 fused to MBP PMID:8873388 vaccine Brucella abortus L7/L12 fused to MBP vaccine VO:0001176 inactivated influenza vaccine is an inactivated viral vaccine that targets at influenza viral infections. Oliver He vaccine inactivated influenza vaccine VO:0001177 Precocious and egg-passaged lines Oliver He Livacox VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=426 426 vaccine Livacox vaccine VO:0001178 live attenuated influenza vaccine is a live attenuated vaccine that protects against influenza viral infection. Oliver He vaccine live attenuated influenza vaccine VO:0001180 process laboratory test VO:0001181 Live temperature-sensitive mutant strain; eye drop administration Oliver He Vaxsafe MG VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=419 419 vaccine Vaxsafe MG vaccine VO:0001182 a vaccine role that is borne by an organism strain serving as a vaccine Oliver He role vaccine strain role VO:0001183 Peptide conjugated to keyhole limpet hemocyanin in mycobacterium-oil adjuvant (AdjuVac); contraceptive vaccine to control wildlife registration reported to be in progress Oliver He GonaCon WEB: http://www.aphis.usda.gov/wildlife_damage/nwrc/research/reproductive_control/gonacon.shtml a contraceptive vaccine that is used in wildlife population vaccine GonaCon vaccine VO:0001184 process vaccine protection ANOVA VO:0001185 In ovo delivery using proprietary platform injection system Oliver He Inovocox VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=425 425 vaccine Inovocox vaccine VO:0001186 A data set that represents a set of data for a list of variables (e.g., vaccination dose) for the data analysis of an vaccine investigation study. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccine investigation data set VO:0001187 a vaccination that occurs in the intramuscular route. Asiyah Yu Lin Oliver He vaccination intramuscular vaccination VO:0001188 A measurement datum that represents a vaccine strain. Different strains can be represented using distinct digital numbers. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccine strain datum VO:0001189 A measurement datum that represents vaccine viability. 0 = live; 1 = irradiated; 2 = killed. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccine viability datum VO:0001190 A measurement datum that indicates the usage of a vaccine adjuvant. Different digital numbers can be used to represent different adjuvants. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccine adjuvant usage datum VO:0001191 A measurement datum that represents a specific protective antigen used in a vaccine. The antigen can be represented by a described digit. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccine protective antigen datum VO:0001192 A measurement datum that represents a specific mutated gene from a vaccine strain. The mutated can be represented by a described digit. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item mutated gene in vaccine strain datum VO:0001193 A measurement datum that represents a specific mouse strain used for vaccination. Different strains can be represented using discretized digitals. For example, 0 = BALB/c; 1 = CD1; 2 = mixed/outbred; 3 = C57BL/6; 4 = OF1; 5 = 129/Sv; 6 = Swiss albino. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccination mouse strain datum VO:0001194 A measurement datum that represents the biological sex of an animal. The result can be represented using a discretized digit, for example, 0 = female; 1 = male. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item biological sex datum VO:0001195 A measurement datum that represents a specific route (e.g., i.p.) used for vaccination. Different routes can be represented using discretized digitals. 0 = IP; 1 = PO; 2 = SC; 3 = IM; 4 = IN; 6 = IG; 7 = IV; 8 = ID. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccination route datum VO:0001196 A vaccination dose that is used with the unit of colony forming units (CFU). Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccination dose (unit: CFU) VO:0001197 An age range at vaccination that represents the animal age (unit: day) at the time of vaccination. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item animal age at vaccination in days VO:0001198 A measurement datum that represents a specific pathogen strain used for animal challenge study. Different pathogen strains can be represented using discretized digitals. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item pathogen strain for challenge datum VO:0001199 A measurement datum that represents a specific pathogen used for animal challenge study. Different pathogens can be represented using discretized digitals. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item pathogen challenge datum VO:0001200 Native fucose-mannose-ligand antigen complex Oliver He Leishmune VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=435 435 vaccine Leishmune vaccine VO:0001201 Live oral vaccine Oliver He Enterisol Ileitis VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=411 411 vaccine Enterisol Ileitis vaccine VO:0001202 A challenge dose that is represented with the unit of colony forming units (CFU). Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item challenge dose (unit: CFU) VO:0001203 A measurement datum that represents a length of days as the interval between a vaccination and a challenge in a specific vaccine protection study. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccination-challenge interval in days VO:0001204 A colony forming unit (CFU) from the sample of mouse spleen. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item CFU per spleen VO:0001205 A reduction of colony forming unit that was measured with the unit of colony forming units (CFU) from the sample of mouse spleen. Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item CFU reduction per spleen VO:0001206 A measurement datum that represents a type of vaccine protection efficacy as an outcome of a vaccine protection study. The result can be represented as a digit, for example, 0 = no protection, and 1 = protection (determined by a p-value cutoff). Oliver He He Y, Xiang Z, Todd T, Courtot M, Brinkman R, Zheng J, Stoeckert CJ, Malone J, Rocca-Serra P, Sansone S, Fostel J, Soldatova LN, Peters B, Rutternberg A. Ontology representation and ANOVA analysis of vaccine protection investigation. Proceeding of Bio-Ontologies 2010: Semantic Applications in Life Sciences, ISMB, July 9-10, 2010. Boston, MA, USA. Full length paper. URL: http://www.hegroup.org/docs/ANOVA_Vaccine_usecase_camera.pdf Todd TE, Tibi O, Lin Y, Sayers S, Bronner DN, Xiang Z, He Y. Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates. BMC Bioinformatics. 2013, 14(Suppl 6):S3. PMID: 23735014. PMCID: PMC3633026. data item vaccine protection efficacy datum VO:0001207 A Chlamydia bacterial vaccine against Chlamydia trachomatis infection Ningxian Fan Oliver He Ronak Sutariya vaccine Chlamydia trachomatis vaccine VO:0001208 B. abortus BLS-L7/L12 is a B. abortus subunit vaccine using L7/L12 that is made as a recombinant BLS-L7/L12 fusion protein vaccine. Oliver He B. abortus BLS-L7/L12 recombinant Brucella BLS-L7/L12 fusion protein vaccine recombinant Brucella lumazine synthase and L7/L12 fusion protein vaccine PMID:19596411 vaccine Brucella abortus BLS-L7/L12 vaccine VO:0001209 vaccine protection efficacy measurement is an assay that measures the protection efficayc of a vaccine. Oliver He assay vaccine protection efficacy measurement VO:0001210 a subunit vaccien that uses LPS as protective antigen Oliver He vaccine lipopolysaccharide subunit vaccine VO:0001211 viral vaccine that is used to protect against African swine fever virus infection Ningxian Fan Oliver He Ronak Sutariya vaccine African swine fever virus vaccine VO:0001213 A viral vaccine that protects against infection with Foot-and-mouth disease virus. Ningxian Fan Oliver He Ronak Sutariya vaccine Foot-and-mouth disease virus vaccine VO:0001214 Bacterial vaccine that uses inactivated bacterial organism. Oliver He vaccine inactivated bacterial vaccine VO:0001215 an anti-reproductive vaccine for cattle. The vaccine is based on the established principle that antibodies to the hypothalamic releasing hormone, gonadotrophin releasing hormone (GnRH) block the action of GnRH on pituitary secretion of luteinizing hormone and follicle stimulating hormone, leading to gonadal atrophy in mammals. The vaccine comprises an immunogenic GnRH:ovalbumin conjugate formulated in a novel double adjuvant system and is administered in a two-dose treatment regimen. LHRH peptide conjugated to ovalbumin; oil emulsion adjuvant withdrawn in 1996 Oliver He Vaxstrate WEB: http://www.ncbi.nlm.nih.gov/pubmed/1370000 vaccine Vaxstrate vaccine VO:0001216 A viral vaccine that protects against infection with Lymphocytic choriomeningitis mammarenavirus Ningxian Fan Oliver He Ronak Sutariya obsolete Lymphocytic choriomeningitis mammarenavirus vaccine true VO:0001217 Bacterial vaccine that is live and attenuated. Oliver He vaccine live attenuated bacterial vaccine VO:0001218 Vaccine that is used for animals (excluding humans), for example, pet, domestic, wildlife, and livestock animals. Oliver He vaccine veterinary vaccine VO:0001220 a viral vaccine that is live attenuated Oliver He vaccine live attenuated viral vaccine VO:0001221 a B. abortus vaccine that uses subunit antigen Oliver He vaccine Brucella abortus subunit vaccine VO:0001222 A viral vaccine that protects aganist Newcastle disease virus infection. Oliver He vaccine Newcastle disease virus vaccine VO:0001223 Oliver He vaccine Brucella melitensis subunit vaccine VO:0001224 A viral vaccine that protects against infection with Viral hemorrhagic septicemia virus Ningxian Fan Oliver He Ronak Sutariya vaccine Viral hemorrhagic septicemia virus vaccine VO:0001225 Oliver He vaccine Brucella abortus DNA vaccine VO:0001226 Oliver He vaccine Brucella melitensis DNA vaccine VO:0001227 A viral vaccine that protects against infection with Human herpesvirus 5. Ningxian Fan Oliver He Ronak Sutariya vaccine Human betaherpesvirus 5 vaccine VO:0001228 A viral vaccine that protects against infection with Coxsackievirus Ningxian Fan Oliver He Ronak Sutariya vaccine Coxsackievirus vaccine VO:0001229 A protozoan vaccine that protects against infection with Schistosoma japonicum Ningxian Fan Oliver He Ronak Sutariya vaccine Schistosoma japonicum vaccine VO:0001230 Vaccine that protects against Treponema pallidum infection. Oliver He Ronak Sutariya vaccine Treponema pallidum vaccine VO:0001231 A vaccine that protects against Leishmania major. Oliver He Ronak Sutariya vaccine Leishmania major vaccine VO:0001232 Allen Xiang Oliver He material entity protective antigen VO:0001233 A vaccine preparation that results in the generation of a viral vaccine Allen Xiang Oliver He vaccine preparation viral vaccine preparation VO:0001234 A vaccine preparation that results in the generation of a protozoan vaccine Allen Xiang Oliver He vaccine preparation protozoan vaccine preparation VO:0001235 A vaccine preparation that results in the generation of a fungal vaccine Allen Xiang Oliver He vaccine preparation fungal vaccine preparation VO:0001236 vaccine trivalent influenza vaccine VO:0001237 A microbial derivative vaccine adjuvant compsed of CpG DNA. Oliver He PMID:12899580 vaccine adjuvant CpG DNA vaccine adjuvant VO:0001238 An emulsion vaccine adjuvant that is a stable oil-in-water emulsion. Samantha G. Sayers http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=M6661%7CSIGMA&N25=0&QS=ON&F=SPEC vaccine adjuvant Ribi vaccine adjuvant VO:0001239 A synthetic vaccine adjuvant named RC529 that is a lipid A mimetic. Samantha G. Sayers PMID:16204643 vaccine adjuvant RC529 vaccine adjuvant VO:0001240 An aluminum vaccine adjuvant that is aluminum potassium sulfate (AlK(SO4)2). Allen Xiang Samantha G. Sayers vaccine adjuvant aluminum potassium sulfate adjuvant VO:0001241 An aluminum hydroxide vaccine adjuvant that is a gel that is made by precipitation of aluminum hydroxide Al(OH)3 under alkaline conditions. Allen Xiang Samantha G. Sayers Alhydrogel PMID:7551218 vaccine adjuvant Alhydrogel vaccine adjuvant VO:0001242 A cholera toxin derived vaccine adjuvant made of the B subunit of the cholera toxin from Vibrio cholerae. Samantha G. Sayers CTB cholera toxin B vaccine adjuvant cholera toxin B subunit vaccine adjuvant VO:0001244 Allen Xiang Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1115 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm201667.htm https://www.prevnar13.com/ 1115 Prevnar 13 - Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 weeks through 5 years of age (prior to the 6th birthday). - Active immunization for the prevention of otitis media caused by S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F. No otitis media efficacy data are available for serotypes 1, 3, 5, 6A, 7F, and 19A In children 6 weeks through 5 years of age (prior to the 6th birthday). - Active immunization for the prevention of invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in children 6 years through 17 years of age (prior to the 18th birthday). - Active immunization for the prevention of pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in adults 18 years of age and older. - Limitations: Prevnar 13 does not protect against disease caused by S. pneumoniae serotypes that are not in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM574852.pdf 125324 vaccine Prevnar 13 vaccine VO:0001245 SYNFLORIX is indicated for active immunization of infants and children from 6 weeks up to 5 years of age against Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F and invasive disease caused by these serotypes (including sepsis, meningitis, bacteraemic pneumonia, pleural empyema and bacteraemia). Allen Xiang VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1114 WEB: http://www.gsk.ca/english/docs-pdf/product-monographs/Synflorix.pdf 1114 vaccine Synflorix vaccine VO:0001246 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1113 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm201342.htm 1113 Menveo For active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 when administered to individuals 2 months to 55 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM201349.pdf 125300 vaccine Menveo vaccine VO:0001247 Melanie Courtot Oliver He Arepanrix H1N1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1116 1116 vaccine Arepanrix H1N1 vaccine VO:0001248 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1117 1117 vaccine Intanza vaccine VO:0001249 An aqueous formula of the synthetic vaccine adjuvant RC529. RC529-AF can be obtained from Corixa Corporation (Seattle, WA). RC529 vaccine adjuvant in an aqueour formulation PMID: 15308371 vaccine adjuvant RC529-AF vaccine adjuvant VO:0001250 A microbial derivative vaccine adjuvant derived from the lipopolysaccharide (LPS) of Salmonella minnesota R595. Samantha G. Sayers 3-O-deacylated monophosphoryl lipid A vaccine adjuvant 3D-MLA MPL vaccine adjuvant PMID:10768940 PMID:7551218 https://www.frontiersin.org/articles/10.3389/fimmu.2020.577823 vaccine adjuvant monophosphoryl lipid A vaccine adjuvant VO:0001251 An E. coli LT toxin derived vaccine adjuvant that is a mutant form of LT containing a Ser-Lys substitution in position 63 which has been shown to be totally devoid of toxicity stable to protease treatment and able to act as mucosal adjuvant. LTK63 is an enzymatically inactive mutant of the heat-labile enterotoxin of Escherichia coli. It can be used as a potent mucosal adjuvant. Samantha G. Sayers PMID:10790422 PMID:17920733 PMID:9607006 vaccine adjuvant LTK63 vaccine mutant VO:0001252 is a bacterial toxin (usually an exotoxin) whose toxicity has been weakened or suppressed either by chemical (formalin) or heat treatment, while other properties, typically immunogenicity, are maintained. Oliver He WEB: http://en.wikipedia.org/wiki/Toxoid material entity toxoid VO:0001253 Oliver He vaccine capsular polysaccharide subunit vaccine VO:0001254 Oliver He vaccine component capsular polysaccharide of pathogen organism as vaccine component VO:0001255 a subunit vaccine that uses polysaccharide as protective antigen Oliver He vaccine polysaccharide subunit vaccine VO:0001256 Oliver He vaccine component polysaccharide of pathogen organism as vaccine component VO:0001257 The specification of an objective to prevent a disorder. Oliver He information content entity prevention of disorder objective VO:0001258 The specification of an objective to ameliorate a disorder. Oliver He information content entity amelioration of disorder objective VO:0001259 A microbial derivative vaccine adjuvant derived from heat-killed Corynebacterium parvum. Samantha G. Sayers PMID:4596278 PMID:5483667 PMID:7591056 vaccine adjuvant killed Corynebacterium parvum vaccine adjuvant VO:0001260 An emulsion vaccine adjuvant which is a water-in-oil adjuvant with CRL-8300 (a block copolymer), squalene, and sorbitan monooleate. Samantha G. Sayers Titermax Gold vaccine adjuvant Titermax Gold vaccine adjuvant VO:0001261 A synthetic vaccine adjuvant that is dimethyldioctadecylammonium bromide (DDA), a lipophilic quaternary ammonium salt known as a good adjuvant when co-administered systemically or nasally with an antigen. Samantha G. Sayers Dimethyl dioctadecyl ammonium bromide PMID:1439129 vaccine adjuvant DDA vaccine adjuvant VO:0001262 A liposome-based vaccine adjuvant that have a positive surface charge. Samantha G. Sayers PMID:19874860 vaccine adjuvant cationic liposomal vaccine adjuvant DDA:TDB VO:0001263 A tenosactive compound vaccine adjuvant that contains purified extract from the bark of the South American tree Quillaja saponaria Molina. Samantha G. Sayers PMID:7551218 vaccine adjuvant QuilA vaccine adjuvant VO:0001264 A combination vaccine adjuvant comprised of monophosphoryl lipid A (MPL), QS21 and an oil in water emulsion. monophosphoryl lipid A (MPL), QS21 and an oil in water emulsion. Samantha G. Sayers PMID:15187142 PMID:15780441 vaccine adjuvant AS02 vaccine adjuvant VO:0001265 A combination vaccine adjuvant that is a combination of 50 ug of the immunoenhancer MPL (3-O-desacyl-4′-monophosphoryl lipid A) with 500 ug of aluminium salt. Samantha G. Sayers PMID:21527299 vaccine adjuvant AS04 vaccine adjuvant VO:0001266 An emulsion vaccine adjuvant which is an emulsion plus DDA. Samantha G. Sayers Emulsigen D VSA-3 PMID:16187717 vaccine adjuvant VSA-3 vaccine adjuvant VO:0001267 A tensoactive compound vaccine adjuvant that is derived from saponin, a compound that is an immunostimulator found in the plant P. senega. vaccine adjuvant saponin vaccine adjuvant VO:0001268 A Montanide vaccine adjuvant that is formulated as water-in-oil emulsions and induces high antibody titers in several animal species. It is a vaccine adjuvant composed of metabolizable oil and a surfactant system designed to make a water-in-oil emulsion. It has been used since 1992 in more than 50 clinical trials related to therapeutic vaccines against various diseases such as cancer and malaria. Oliver He Samantha G. Sayers Montanide ISA 720 Montanide ISA 720 VG PMID:15752840 WEB: http://www.seppic.com/human-health/vaccine-adjuvant/montanide-isa-720-@/view-1044-seproduit.html?menuid=,979,&lang=en vaccine adjuvant Montanide ISA 720 vaccine adjuvant VO:0001269 A Montanide vaccine adjuvant that is a mineral oil adjuvant. vaccine adjuvant Montanide incomplete Seppic adjuvant VO:0001270 A Montanide vaccine adjuvant that is a vaccine adjuvant composed of a light mineral oil and a surfactant system designed to make a water-in-oil emulsion. Samantha G. Sayers Montanide ISA51 WEB: http://www.seppic.com/human-health/vaccine-adjuvant/montanide-isa-51-@/view-1042-seproduit.html?menuid=,979,&lang=en vaccine adjuvant Montanide ISA51 vaccine adjuvant VO:0001271 An emulsion vaccine adjuvant developed by Montanide. Oliver He Samantha G. Sayers http://www.montanide.com/ vaccine adjuvant Montanide vaccine adjuvant VO:0001272 An E. coli LT toxin derived vaccine adjuvant composed of the B subunit of E. coli heat-labile toxin. Oliver He Samantha G. Sayers B subunit of E. coli heat-labile enterotoxin vaccine adjuvant EtxB vaccine adjuvant VO:0001273 A synthetic vaccine adjuvant with the tradename Polygen. Oliver He Samantha G. Sayers URL: http://www.mvp-technologies.com/adjuvants/Polygen%20Final%20Technical%20Bulletin.pdf vaccine adjuvant Polygen vaccine adjuvant VO:0001274 Role that inheres in an organism that is the target of a vaccine administration (vaccination process). Allen Xiang Anna Maria Masci Barry Smith Jie Zheng Oliver He https://github.com/vaccineontology/VO/issues/677 role vaccine recipient role VO:0001275 A role that represents a target (i.e., some disorder) of immunization. Allen Xiang Oliver He role immunization target role VO:0001276 Allen Xiang Oliver He process bacterial vaccine immunization VO:0001277 Allen Xiang Oliver He process viral vaccine immunization VO:0001278 Allen Xiang Oliver He process cancer vaccine immunization VO:0001279 Allen Xiang Oliver He process parasite vaccine immunization VO:0001280 obsolete immunization target role of pathogen true VO:0001281 Allen Xiang Oliver He obsolete immunization target role of bacterial pathogen true VO:0001282 Allen Xiang Oliver He obsolete immunization target role of viral pathogen true VO:0001283 Allen Xiang Oliver He obsolete immunization target role of parasite pathogen true VO:0001284 Allen Xiang Oliver He obsolete immunization target role of fungal pathogen true VO:0001285 A carbohydrate vaccine adjuvant, which enhances both humoral and cell-mediated immunity to oligopeptides in experimental animal models. Samantha G. Sayers PMID:7551218 vaccine adjuvant Algal Glucan vaccine adjuvant VO:0001286 A combination vaccine adjuvant that suspension of 1-2um ovoids of immune stimulant gamma inulin (g-IN) in which alum is embedded as a carrier for protein or other anionic antigens. Samantha G. Sayers PMID:1887671 vaccine adjuvant Algammulin vaccine adjuvant VO:0001287 A synthetic vaccine adjuvant that is Bay R1005 (N-(2-Deoxy-2-L-leucylamino beta-D-glucopyranosyl)-N-octadecyldodecanoylamide hydroacetate ). Samantha G. Sayers BAY R1005 N-( 2-Deoxy-2-L-leucylamino-β-D-glucopyranosyl)-N-octadecyldodecanoylamide hydroacetate PMID:7551218 vaccine adjuvant BAY R1005 vaccine adjuvant VO:0001288 A synthetic vaccine adjuvant that is N, N-dioctadecyl-N', N'-bis(2-hydroxyethyl) propanediamine (Avridine). Samantha G. Sayers Avridine CP20,96 N, N-dioctadecyl-N', N'-bis( 2-hydroxyethyl) propanediamine PMID:7551218 vaccine adjuvant Avridine vaccine adjuvant VO:0001289 A calcium phosphate vaccine adjuvant that is a gel prepared by precipitating soluable calcium and phosphate salts. Samantha G. Sayers calcium phosphate gel PMID:7551218 vaccine adjuvant calcium phosphate gel vaccine adjuvant VO:0001290 A microbial derivative vaccine adjuvant composed of the CTA1-DD fusion protein. Samantha G. Sayers CTA1-DD gene fusion protein PMID:7551218 vaccine adjuvant cholera toxin A1-subunit-ProteinA D-fragment fusion protein VO:0001291 A mineral salt vaccine adjuvant that is composed of Deoxycholic acid sodium salt (DOC) complexed with aluminum hydroxide. Samantha G. Sayers DOC/Alum Complex PMID:7551218 vaccine adjuvant DOC/Alum Complex vaccine adjuvant VO:0001292 A carbohydrate adjuvant that is a highly specific activator of the alternative pathway of complement in vitro and in vivo, and is composed of linear (unbranched) b-D-(2-1) polyfructofuranosyl-a-D-glucose. Samantha G. Sayers PMID:3265692 PMID:7551218 vaccine adjuvant gamma Inulin vaccine adjuvant VO:0001293 A combination vaccine adjuvant that is comprised of a mixture of GMDP, DDA, and Zinc L-proline salt complex (ZnPro8). Samantha G. Sayers PMID:15953835 PMID:7551218 vaccine adjuvant Gerbu vaccine adjuvant VO:0001294 A cytokine vaccine adjuvant that includes GM-CSF. Oliver He Samantha G. Sayers vaccine adjuvant GM-CSF vaccine adjuvant VO:0001295 A synthetic vaccine adjuvant containing GMDP, a higly effective primary adjuvant. Samantha G. Sayers GMDP N-acetylglucosaminyl-(b1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine PMID:7551218 vaccine adjuvant GMDP vaccine adjuvant VO:0001296 An IFN-gamma vaccine adjuvant that is composed of recombinant hIFN-gamma. Oliver He Samantha G. Sayers vaccine adjuvant recombinant hIFN-gamma/Interferon-g vaccine adjuvant VO:0001297 A cytokine vaccine adjuvant that includes IL-1b. Oliver He Samantha G. Sayers vaccine adjuvant interleukin-1b vaccine adjuvant VO:0001298 A cytokine vaccine adjuvant that includes IL-2. Oliver He Samantha G. Sayers IL-2 vaccine adjuvant vaccine adjuvant interleukin-2 vaccine adjuvant VO:0001299 A cytokine vaccine adjuvant that includes IL-7. Oliver He Samantha G. Sayers IL-7 vaccine adjuvant vaccine adjuvant interleukin-7 vaccine adjuvant VO:0001300 A synthetic vaccine adjuvant that includes loxoribine which is a guanosine analog derivatized at position N7 and C8, and activates TLR-7. Samantha G. Sayers 7-allyl-8-oxoguanosine Loxoribine PMID:7551218 vaccine adjuvant Loxoribine vaccine adjuvant VO:0001301 An emulsion vaccine adjuvant consisting of an oil (squalene)-in-water nano emulsion. Samantha G. Sayers MF59 PMID:20488726 vaccine adjuvant MF59 vaccine adjuvant VO:0001302 A liposome-based vaccine adjuvant that consists of liposomes containing the synthetic lipophilic analog of muramyl dipeptide, muramyl tripeptide phosphatidylethanolamine (MTP-PE). Samantha G. Sayers MTP-PE MTP-PE Liposomes PMID:1431559 vaccine adjuvant MTP-PE Liposomes vaccine adjuvant VO:0001303 A synthetic vaccine adjuvant made of murametide that has adjuvant activity similar to MDP. Samantha G. Sayers Murametide Nac-Mur-L-Ala-D-Gln-OCH3 PMID:7551218 vaccine adjuvant Murametide vaccine adjuvant VO:0001304 A synthetic vaccine adjuvant called murapalmitine. Samantha G. Sayers Murapalmitine Nac-Mur-L-Thr-D-isoGIn-sn-glyceroI dipalmitoyl PMID:7551218 vaccine adjuvant Murapalmitine vaccine adjuvant VO:0001305 A synthetic vaccine adjuvant that includes an MDP analog called D-Murapalmitine. Samantha G. Sayers D-Murapalmitine Nac-Mur-D-Ala-D-isoGln-sn-glycerol dipalmitoyl PMID:7551218 vaccine adjuvant D-Murapalmitine vaccine adjuvant VO:0001306 A synthetic vaccine adjuvant that is composed of neuraminidase-galactose oxidase (NAGO) a mixture of mixture of the two enzymes-neuraminidase and galactose oxidase. Samantha G. Sayers NAGO Neuraminidase-galactose oxidase PMID:7551218 vaccine adjuvant NAGO vaccine adjuvant VO:0001307 A synthetic vaccine adjuvant consisting of multi-lamellar vesicles comprising a mixture of non-ionic surfactant (e.g., 1-monopalmitoyl-rac-glycerol), cholesterol and dicetyl phosphate used as a primary vaccine adjuvant for entrapped antigen. Samantha G. Sayers NISV non-ionic surfactant vesicles PMID:7551218 vaccine adjuvant non-ionic surfactant vesicles vaccine adjuvant VO:0001308 A synthetic vaccine adjuvant made from the emulsion polymerization of methyl methacrylate. Samantha G. Sayers PMMA Polymethyl methacrylate PMID:7551218 vaccine adjuvant PMMA vaccine adjuvant VO:0001309 A synthetic vaccine adjuvant synthesized from stable protein phospholipid-calcium precipitates. Samantha G. Sayers protein cochleates PMID:7551218 vaccine adjuvant protein cochleates vaccine adjuvant VO:0001310 A saponin vaccine adjuvant that is composed of extracts from the bark of the Quillaja saponaria Molina tree. Specifically, it is an acylated 3, 28-bisdesmodic triterpene glycosides (1,3) or "saponin" with a molecular formula of C92O46H148 and molecular weight of 1990 Da. QS-21 is one of the active fractions of the bark of Chilean tree, Quillaja saponaria, purified using a reverse-phase chromatography (RP-HPLC). Oliver He Randi Vita Samantha G. Sayers QS-21 Stimulon™ QS-21 Adjuvant PMID:27213168 PMID:7551218 vaccine adjuvant QS-21 vaccine adjuvant VO:0001311 An aluminum vaccine adjuvant that is a synthetic oxyhydroxide of aluminum (aluminum hydroxide) prepared by acid-base precipitation. Samantha G. Sayers Rehydragel HPA PMID:7551218 vaccine adjuvant Rehydragel HPA vaccine adjuvant VO:0001312 An aluminum hydroxide vaccine adjuvant that is a low visosity aluminum hydroxide gel. Samantha G. Sayers Rehydragel LV PMID:7551218 vaccine adjuvant Rehydragel LV vaccine adjuvant VO:0001313 A cytokine vaccine adjuvant that contains the 163-171 peptide of IL-1β. Oliver He Samantha G. Sayers IL-1β 163-171 peptide vaccine adjuvant Sclavo peptide vaccine adjuvant Sclavo peptide vaccine adjuvant VO:0001314 An emulsion vaccine adjuvant that is a water-in-oil emulsion that is used as an adjuvant and has immunostimulating properties similar to Freund's complete adjuvant (FCA). Samantha G. Sayers Specol PMID:1439130 vaccine adjuvant Specol vaccine adjuvant VO:0001315 An emulsion vaccine adjuvant that is an emulsion of squalane (5%), Tween 80( 0.2%), Pluronic L121( 1.25%), phosphate-buffered saline pH 7.4, and antigen. Samantha G. Sayers PMID:7551218 vaccine adjuvant SPT (Antigen Formulation) VO:0001316 A synthetic vaccine adjuvant stearyl tyrosine is considered an "organic equivelant" of aluminum hydroxide. Samantha G. Sayers stearyl tyrosine PMID:7551218 vaccine adjuvant stearyl tyrosine vaccine adjuvant VO:0001317 A synthetic vaccine adjuvant called Theramide that is composed of N-acetylglucosaminyl-N-acetylinuramyl-L-Ala-D-isoGlu-L-Ala-dipalmitoxy propylamide (DTP-DPP). Samantha G. Sayers Theramide PMID:7551218 vaccine adjuvant Theramide vaccine adjuvant VO:0001318 A synthetic vaccine adjuvant that is a copolymer (CRL1005), based on a 12 kDa polyoxypropylene (POP) core with 5% POE. Samantha G. Sayers CRL1005 PMID:10717336 vaccine adjuvant CRL1005 vaccine adjuvant VO:0001319 An emulsion vaccine adjuvant and is made from non-toxic lipid droplets a few hundred nanometers in diameter and made from surfactants approved for human consumption and common food substances that are 'Generally Recognized as Safe' (GRAS) by the FDA. Samantha G. Sayers http://nano.med.umich.edu/platforms/Nanoemulsions.html vaccine adjuvant nanoemulsion vaccine adjuvant VO:0001320 An emusion vaccine adjuvant that contains alpha-tocopherol and squalene, two biodegradable polyprenyls, in an oil-in-water emulsion. Samantha G. Sayers AS03 PMID:21256188 801 AS03 Adjuvant AS03 Adjuvant vaccine adjuvant AS03 vaccine adjuvant VO:0001321 An E. coli LT toxin derived vaccine adjuvant that is a mutant form of E.coli heat-labile toxin. Samantha G. Sayers LTR192G PMID:11803061 vaccine adjuvant LTR192G vaccine adjuvant VO:0001322 A microbial derivative vaccine adjuvant containing E. coli heat-labile toxin. Samantha G. Sayers E. coli heat-labile toxin, LT LT Oral Adjuvant LT-OA PMID:7551218 vaccine adjuvant E. coli heat-labile toxin vaccine adjuvant VO:0001323 An aluminum vaccine adjuvant that is a a proprietary aluminum hydroxyphosphate sulfate formulation that is both physically and functionally distinct from traditional aluminum phosphate and aluminum hydroxide adjuvants. Samantha G. Sayers AAHSA Merck Aluminum Adjuvant PMID:17581283 vaccine adjuvant amorphous aluminum hydroxyphosphate sulfate adjuvant VO:0001324 Matrix-S vaccine adjuvant Matrix-S vaccine adjuvant VO:0001325 Brucella BFR antigen vaccine recombinant Brucella abortus Bfr protein vaccine PMID:11447155 vaccine Brucella abortus subunit vaccine using Bfr VO:0001326 Brucella abortus Omp16 vaccine PMID:18981242 vaccine Brucella abortus subunit vaccine using Omp16 VO:0001327 B. melitensis DNA vaccine encoding Bp26 and Tf vaccine Brucella melitensis DNA vaccine encoding Bp26 and Tf VO:0001328 A synthetic vaccine adjuvant contiaing imiquimod a imidazoquinoline. Samantha G. Sayers 1-(2-methypropyl)-IH-imidazo[4,5-c]quinolin-4-amine Aldara™ R-837 S26308 PMID:18566444 PMID:7551218 vaccine adjuvant imiquimod vaccine adjuvant VO:0001329 A synthetic vaccine adjuvant, resiquimod is a chemical analog of imiquimod. Samantha G. Sayers PMID:15068862 vaccine adjuvant resiquimod vaccine adjuvant VO:0001330 An emulsion vaccine adjuvant containing 2.5% squalene. Samantha G. Sayers PMID:20193791 vaccine adjuvant AF03 vaccine adjuvant VO:0001331 A microbial derivative vaccine adjuvant composed of flagellin from gram-negative bacteria. Samantha G. Sayers FliC PMID:16428759 PMID:21048152 vaccine adjuvant Flagellin vaccine adjuvant VO:0001332 A synthetic vaccine adjuvant containing Poly(I:C), a synthetic double stranded analog of RNA. Samantha G. Sayers polyriboinosinic-polyribocytidylic acid WEB: http://en.wikipedia.org/wiki/Polyinosinic:polycytidylic_acid vaccine adjuvant poly(I:C) vaccine adjuvant VO:0001333 A particulate antigen delivery system vaccine adjuvant that is a vaccine adjuvant comprising cholesterol, phospholipid and saponin but without antigen. ISCOMATRIX is identical to ISCOMs except that it does not contain antigen. Ref: PMID: 17336431. Samantha G. Sayers PMID:19450632 vaccine adjuvant ISCOMATRIX vaccine adjuvant VO:0001334 A saponin vaccine adjuvant that is made from highly purified saponins. Oliver He Samantha G. Sayers WEB: http://www.isconova.com/products/abisco-research-reagent/abisco-100.aspx vaccine adjuvant Abisco-100 vaccine adjuvant VO:0001335 A particulate antigen delivery system vaccine adjuvant that is albumin-heparin microparticles vaccine adjuvant that is prepared from albumin and heparin stabilized by cross-linking reaction with EDC. Samantha G. Sayers PMID:16734558 vaccine adjuvant albumin-heparin microparticles vaccine adjuvant VO:0001336 A combination vaccine adjuvant and is based on the combination of Monophosphoryl Lipid A(MPL), QS21 (a purified fraction of Saponin extracted from Quillarja Saponaria), and a proprietary oil in water emulsion. Samantha G. Sayers http://www.pasteur.fr/applications/euroconf/vaccins/vaccins-abs.html vaccine adjuvant AS-2 vaccine adjuvant VO:0001337 A cytokine vaccine adjuvant that includes B7-2. Oliver He Samantha G. Sayers vaccine adjuvant B7-2 vaccine adjuvant VO:0001338 A synthetic vaccine adjuvant that is a local anaesthetic drug belonging to the amino amide group, and is used as a vaccine adjuvant in DNA vaccines. Samantha G. Sayers PMID:15246629 WEB: http://en.wikipedia.org/wiki/Bupivacaine vaccine adjuvant Bupivacaine vaccine adjuvant VO:0001339 A liposome-based vaccine adjuvant that is composed of virus sized liposomes that contain a DNA plasmid. Samantha G. Sayers cationic liposome-DNA complex JVRS-100 PMID:19285425 vaccine adjuvant cationic liposome-DNA complex JVRS-100 vaccin adjuvant VO:0001340 A synthetic vaccine adjuvant that is DHEA, which is relatively stable and can be directly incorporated into vaccine formulations. Samantha G. Sayers 5-androsten-3β-ol-17-one DHA Dehydroepiandrosterone androstenolone prasterone transdehydroandrosterone PMID:7551218 vaccine adjuvant DHEA vaccine adjuvant VO:0001341 A synthetic vaccine adjuvant that is PLGA, which has been used in the controlled delivery of peptide drugs. Samantha G. Sayers PLGA PLGA microspheres Polyester poly (DL-lactide-co-glycolide) PMID:15560948 vaccine adjuvant DL-PGL (Polyester poly (DL-lactide-co-glycolide)) vaccine adjuvant VO:0001342 A cytokine vaccine adjuvant that uses the adjuvant effect of cytokine IL-15. Oliver He Samantha G. Sayers vaccine adjuvant IL-15 vaccine adjuvant VO:0001343 A liposome-based vaccine adjuvant which is prepared from dehydration-rehydration vesicles (DRVs). Samantha G. Sayers PMID:7551218 vaccine adjuvant immunoliposomes containing antibodies to costimulatory molecules VO:0001344 An E. coli LT toxin derived vaccine adjuvant that is a mutant form of heat-labile Escherichia coli enterotoxin (LT) that contains a substitution Ala -> Arg in position 72 of the A subunit. Samantha G. Sayers PMID:9529328 vaccine adjuvant LTK72 vaccine adjuvant VO:0001345 A microbial derivative vaccine adjuvant containing MPL and squalene. Samantha G. Sayers PMID:12213399 vaccine adjuvant MPL-SE vaccine adjuvant VO:0001346 a vaccine preservative that contains formaldehyde. Oliver He Samantha G. Sayers WEB: http://www.mja.com.au/public/issues/184_04_200206/eld10500_fm.pdf vaccine component formaldehyde vaccine preservative VO:0001347 A microbial derived vaccine adjuvant made of E112K mC, a mutated CT created by substituting a single amino acid in the ADP-ribosyltransferase active centre, glutamate to lysine at position 112. Samantha G. Sayers mCT non-toxic mutant E112K of Cholera Toxin mCT-E112K PMID:11251876 vaccine adjuvant non-toxic mutant E112K of Cholera Toxin mCT-E112K vaccine adjuvant VO:0001348 A microbial derivative vaccine adjuvant that is derived from cholera toxin. Oliver He Samantha G. Sayers vaccine adjuvant cholera toxin derived vaccine adjuvant VO:0001349 A combination vaccine adjuvant that is composed of threonyl-MDP (0.05-1%) in an emulsion vehicle [5% squalane, 2.5% Pluronic(R) L121, 0.2% Polysorbate 80 and phosphate buffered saline (pH 7.4)]. Samantha G. Sayers PMID:7551218 vaccine adjuvant SAF-1 vaccine adjuvant VO:0001350 A liposome-based vaccine adjuvant that includes the glycoproteins of Sendai virus. Samantha G. Sayers PMID:7551218 vaccine adjuvant Sendai Proteoliposomes, Sendai-containing Lipid Matrices VO:0001351 A synthetic vaccine adjuvant that is threonyl muramyl dipeptide (TMDP). Samantha G. Sayers N-acetyl muramyl-L-threonyl-D-isoglutamine Termurtide™ [thr1 ]-MDP PMID:7551218 vaccine adjuvant threonyl muramyl dipeptide (TMDP) vaccine adjuvant VO:0001352 A microbial derivative vaccine adjuvant made of virus like particles (VLPS) containing the yeast retrotransposon Ty which has the amino acids 1-381 of the pI protein encoded. Samantha G. Sayers Ty-VLPs PMID:7551218 vaccine adjuvant ty particles vaccine adjuvant VO:0001353 A vaccine adjuvant that contains active cytokine compound. Oliver He Samantha G. Sayers vaccine adjuvant cytokine vaccine adjuvant VO:0001354 A vaccine adjuvant that is composed of differnt compounds under more than one category. Oliver He Samantha G. Sayers vaccine adjuvant combination vaccine adjuvant VO:0001355 vaccine adjuvant emulsion vaccine adjuvant VO:0001356 A vaccine adjuvant that serves as a particulate antigen delivery system. Oliver He Samantha G. Sayers vaccine adjuvant particulate antigen delivery system vaccine adjuvant VO:0001357 A vaccine adjuvant that contains synthetic material. Oliver He Philip Huang Samantha G. Sayers vaccine adjuvant synthetic vaccine adjuvant VO:0001358 A vaccine adjuvant that includes tensioactive material. Tensioactive materials, surfactants or active surface agents are chemical substances with a polar-non polar structure. These substances have a tendency to locate themselves at the surface creating an adsorbed monomolecular layer on the interface. Oliver He Samantha G. Sayers tensioactive compound vaccine adjuvant WEB: http://www.citt.ufl.edu/team/sepulveda/html/en_tensioactivos.htm vaccine adjuvant tensoactive compound vaccine adjuvant VO:0001359 A vaccine adjuvant that is primarily composed of carbohydrates. Oliver He Samantha G. Sayers vaccine adjuvant carbohydrate vaccine adjuvant VO:0001360 A cytokine vaccine adjuvant that includes IFN-gamma. Oliver He Samantha G. Sayers vaccine adjuvant IFN-gamma vaccine adjuvant VO:0001361 a role that is inherenced in a gene that can be mutated in a virulent pathogen, leading to an attenuated strain serving as a live attenuated vaccine strain. Asiyah Yu Lin Oliver He role virmugen role VO:0001362 a vaccine that targets for allergy. Asiyah Yu Lin Oliver He vaccine allergy vaccine VO:0001363 bacterial vaccine that is used to protect against Clostridium perfringens infection Asiyah Yu Lin vaccine Clostridium perfringens vaccine VO:0001364 information content entity human immunization objective VO:0001365 A viral vaccine that protects against infection with CCHF virus Ningxian Fan Oliver He Ronak Sutariya CCHF vaccine vaccine Crimean-Congo Haemorrhagic Fever vaccine VO:0001366 A viral vaccine that protects against infection with Caprine herpesvirus type 1 virus Ningxian Fan Oliver He Ronak Sutariya vaccine Caprine herpesvirus type 1 vaccine VO:0001367 an inactivation vaccine that is prepared by heat inactivation. Asiyah Yu Lin Oliver He vaccine heat-killed vaccine VO:0001368 an inactivation vaccine that is prepared by irradiation inactivation. Asiyah Yu Lin Oliver He vaccine irradiation-inactivated vaccine VO:0001369 an inactivation vaccine that is prepared by H2O2 inactivation. Asiyah Yu Lin Oliver He vaccine H2O2-killed vaccine VO:0001370 an inactivation vaccine that is prepared by formalin inactivation. Asiyah Yu Lin Oliver He vaccine formalin-killed vaccine VO:0001371 A vaccine prepraration process that is performed by H2O2 inactivation of virulent pathogen. Oliver He vaccine preparation inactivated vaccine preparation using H2O2 inactivation VO:0001372 an organismal quality that indicates an organism (e.g., human) is not yet immunized against a disease. Oliver He quality unimmunized VO:0001373 an organismal quality that indicates an organism (e.g., human) is immunized against a disease through vaccination with a licensed vaccine. Oliver He quality immunized by vaccination with a licensed vaccine VO:0001374 an organism that is vaccinated with a vaccine Asiyah Yu Lin Melanie Courtot Oliver He vaccinated organism organism vaccinee VO:0001375 A Streptococcus vaccine against Streptococcus agalactiae infection. Oliver He Ronak Sutariya vaccine Streptococcus agalactiae vaccine VO:0001376 an organismal quality that indicates an organism (e.g., human) is vaccinated with a vaccine. Oliver He quality vaccinated VO:0001377 an organismal quality that indicates an organism (e.g., human) is unvaccinated with any vaccine. Oliver He quality unvaccinated VO:0001378 a vaccinated quality that indicates an organism is vaccinated with a licensed vaccine. Oliver He quality vaccinated with a licensed vaccine VO:0001379 a unvaccinated quality that indicates an organism has not been vaccinated with a licensed vaccine. Oliver He quality unvaccinated with a licensed vaccine VO:0001380 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:8306370 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3066 https://github.com/vaccineontology/VO/issues/295 3066 cancer vaccine B16 Vaccine adjuvanted by Loxoribine VO:0001381 an organism that is immunized for a disease Asiyah Yu Lin Melanie Courtot Oliver He organism immunized organism VO:0001382 A viral vaccine that protects against infection with Rabbit hemorrhagic disease virus Ningxian Fan Oliver He Ronak Sutariya vaccine rabbit hemorrhagic disease virus vaccine VO:0001383 an organism that is unvaccinated with a vaccine Asiyah Yu Lin Melanie Courtot Oliver He organism unvaccinated organism VO:0001384 A bacterial gene from Actinobacillus pleuropneumoniae. Oliver He Rebecca Racz gene Actinobacillus pleuropneumoniae gene VO:0001385 A vaccine that protects against Trypanosoma cruzi. Oliver He T. cruzi vaccine vaccine Trypanosoma cruzi vaccine VO:0001386 A T. cruzi DNA vaccine that uses a DNA plasmid pGFP expressing T. cruzi CRP-10 protein. Oliver He T. cruzi DNA vaccine encoding CRP-10 vaccine Trypanosoma cruzi DNA vaccine encoding CRP-10 VO:0001387 A T. cruzi DNA vaccine that uses a DNA plasmid pGFP expressing T. cruzi G2 protein. Oliver He T. cruzi DNA vaccine encoding G2 vaccine Trypanosoma cruzi DNA vaccine encoding G2 VO:0001388 A T. cruzi DNA vaccine that uses a DNA plasmid pGFP expressing T. cruzi G4 protein. Oliver He T. cruzi DNA vaccine encoding G4 vaccine Trypanosoma cruzi DNA vaccine encoding G4 VO:0001389 A T. cruzi DNA vaccine that uses a DNA plasmid expressing T. cruzi TSA-1 protein. Oliver He T. cruzi DNA vaccine encoding TSA-1 vaccine Trypanosoma cruzi DNA vaccine encoding TSA-1 VO:0001390 A T. cruzi DNA vaccine that uses a DNA plasmid pGFP expressing T. cruzi TSA-1 protein. Oliver He T. cruzi DNA vaccine pGFP-TSA1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=811 811 vaccine Trypanosoma cruzi DNA vaccine pGFP-TSA1 VO:0001391 A T. cruzi subunit vaccine that uses T. cruzi PAR1 protein as protective antigen. Oliver He T. cruzi PAR1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=806 806 vaccine Trypanosoma cruzi PAR1 protein vaccine VO:0001392 A T. cruzi subunit vaccine that uses T. cruzi PAR2 protein as protective antigen. Oliver He T. cruzi PAR2 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=810 810 vaccine Trypanosoma cruzi PAR2 protein vaccine VO:0001393 A T. cruzi vaccine that uses attenuated Salmonella to express T. cruzi Cruzipain protein. Oliver He T. cruzi vaccine using attenuated Salmonella expressing T. cruzi Cruzipain VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=804 804 vaccine Trypanosoma cruzi vaccine using attenuated Salmonella expressing Trypanosoma cruzi Cruzipain VO:0001394 A T. cruzi vaccine that uses Sendai virus vector to express T. cruzi amastigote surface protein-2. Oliver He T. cruzi vaccine using Sendai virus vector expressing amastigote surface protein-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=802 802 vaccine Trypanosoma cruzi vaccine using Sendai virus vector expressing amastigote surface protein-2 VO:0001395 a vaccine that contains two or more individual vaccines. Oliver He vaccine cocktail vaccine VO:0001396 a cocktail vaccine that contains both subunit vaccine and inactivated whole organism vaccines. Oliver He vaccine cocktail vaccine containing subunit vaccine and inactivated whole organism vaccine VO:0001397 a prime-boost vaccine with DNA vaccine priming that contains a subunit vaccine for boosting Oliver He vaccine vaccine containing DNA vaccine for priming and subunit vaccine for boosting VO:0001398 a prime-boost vaccine with a DNA vaccine priming that contains a Ad vector vaccine for boosting Oliver He vaccine vaccine containing DNA vaccine for priming and Ad vector vaccine for boosting VO:0001399 a conjugate vaccine that conjugate more than one open reading frames of protective antigens or conjugate a protective antigen to a carrier protein. An example of fusion protein vaccine is Mtb72f fusion protein vaccine. Reference: PubMed: 15187142. Oliver He fusion protein vaccine vaccine fusion conjugate protein vaccine VO:0001400 A Brucella gene that is from B. melitensis. Oliver He Rebecca Racz gene Brucella melitensis gene VO:0001401 A Brucella gene that is from B. suis. Oliver He gene Brucella suis gene VO:0001402 A bacterial gene that is from Bacillus anthracis. Oliver He Rebecca Racz gene Bacillus anthracis gene VO:0001403 A bacterial gene that is from Listeria monocytogenes. Oliver He Rebecca Racz gene Listeria monocytogenes gene VO:0001404 A bacterial gene that is from Mycobacterium avium. Oliver He Rebecca Racz gene Mycobacterium avium gene VO:0001405 A bacterial gene that is from Staphylococcus aureus. Oliver He Rebecca Racz gene Staphylococcus aureus gene VO:0001406 A bacterial gene that is from Aeromonas hydrophila. Oliver He Rebecca Racz gene Aeromonas hydrophila gene VO:0001407 A bacterial gene that is from Bordetella bronchiseptica. Oliver He Rebecca Racz gene Bordetella bronchiseptica gene VO:0001408 A bacterial gene that is from Aeromonas salmonicida. Oliver He Rebecca Racz gene Aeromonas salmonicida gene VO:0001409 A bacterial gene that is from Bordetella pertussis. Oliver He Rebecca Racz gene Bordetella pertussis gene VO:0001410 A bacterial gene that is from Borrelia burgdorferi. Oliver He Rebecca Racz gene Borrelia burgdorferi gene VO:0001411 A bacterial gene that is from Burkholderia pseudomallei. Oliver He Rebecca Racz gene Burkholderia pseudomallei gene VO:0001412 A bacterial gene that is from Edwardsiella ictaluri. Oliver He Rebecca Racz gene Edwardsiella ictaluri gene VO:0001413 A bacterial gene that is from Edwardsiella tarda. Oliver He Rebecca Racz gene Edwardsiella tarda gene VO:0001414 A bacterial gene that is from Francisella tularensis. Oliver He Rebecca Racz gene Francisella tularensis gene VO:0001415 A bacterial gene that is from Mannheimia haemolytica. Oliver He Rebecca Racz gene Mannheimia haemolytica gene VO:0001416 A bacterial gene that is from Mycoplasma gallisepticum. Oliver He Rebecca Racz gene Mycoplasma gallisepticum gene VO:0001417 A bacterial gene that is from Neisseria meningitidis. Oliver He Rebecca Racz gene Neisseria meningitidis gene VO:0001418 A bacterial gene that is from Pasteurella multocida. Oliver He Rebecca Racz gene Pasteurella multocida gene VO:0001419 A bacterial gene that is from Salmonella Typhi. Oliver He Rebecca Racz gene Salmonella Typhi gene VO:0001420 A bacterial gene that is from Salmonella Gallinarum. Oliver He Rebecca Racz gene Salmonella Gallinarum gene VO:0001421 A bacterial gene that is from Salmonella Typhimurium. Oliver He Rebecca Racz gene Salmonella Typhimurium gene VO:0001422 A bacterial gene that is from Salmonella Enteritidis. Oliver He Rebecca Racz gene Salmonella Enteritidis gene VO:0001423 A bacterial gene that is from Vibrio cholerae. Oliver He Rebecca Racz gene Vibrio cholerae gene VO:0001424 A viral gene that is from Bovine herpesvirus 1. Oliver He Rebecca Racz gene Bovine herpesvirus 1 gene VO:0001425 A bacterial gene that is from Yersinia enterocolitica. Oliver He Rebecca Racz gene Yersinia enterocolitica gene VO:0001426 A bacterial gene that is from Yersinia pestis. Oliver He Rebecca Racz gene Yersinia pestis gene VO:0001427 A bacterial gene that is from Yersinia pseudotuberculosis. Oliver He Rebecca Racz gene Yersinia pseudotuberculosis gene VO:0001428 A bacterial gene that is from Yersinia ruckeri. Oliver He Rebecca Racz gene Yersinia ruckeri gene VO:0001429 A viral gene that is from Bovine Respiratory Syncytial Virus. Oliver He Rebecca Racz gene Bovine Respiratory Syncytial Virus gene VO:0001430 A viral gene that is from Classical swine fever virus. Oliver He Rebecca Racz gene Classical swine fever virus gene VO:0001431 A viral gene that is from Equid herpesvirus 1. Oliver He Rebecca Racz gene Equid herpesvirus gene VO:0001432 A viral gene that is from Feline herpesvirus 1. Oliver He Rebecca Racz gene Feline herpesvirus 1 gene VO:0001433 A viral gene that is from Feline immunodeficiency virus. Oliver He Rebecca Racz gene Feline immunodeficiency virus gene VO:0001434 A viral gene that is from Feline infectious peritonitis virus. Oliver He Rebecca Racz gene Feline infectious peritonitis virus gene VO:0001435 A viral gene that is from Gallid herpesvirus 1. Oliver He Rebecca Racz gene Gallid herpesvirus 1 gene VO:0001436 A viral gene that is from Hepatitis B virus. Oliver He Rebecca Racz gene Hepatitis B virus gene VO:0001437 A viral gene that is from Human herpesvirus 1. Oliver He Rebecca Racz gene Human herpesvirus 1 gene VO:0001438 A viral gene that is from Human metapneumovirus. Oliver He Rebecca Racz gene Human metapneumovirus gene VO:0001439 A viral gene that is from Human Respiratory Syncytial Virus. Oliver He Rebecca Racz gene Human Respiratory Syncytial Virus gene VO:0001440 A viral gene that is from Infectious Hematopoietic Necrosis Virus. Oliver He Rebecca Racz gene Infectious Hematopoietic Necrosis Virus gene VO:0001441 A viral gene that is from Porcine respiratory and reproductive syndrome virus. Oliver He Rebecca Racz gene Porcine respiratory and reproductive syndrome virus gene VO:0001442 A viral gene that is from Pseudorabies virus. Oliver He Rebecca Racz Suid herpesvirus 1 gene gene Pseudorabies virus gene VO:0001443 A viral gene that is from Rabies virus. Oliver He Rebecca Racz gene Rabies virus gene VO:0001444 A viral gene that is from SARS-CoV. Oliver He Rebecca Racz gene SARS-CoV gene VO:0001445 A viral gene that is from Simian Immunodeficiency Virus. Oliver He Rebecca Racz gene Simian Immunodeficiency Virus gene VO:0001446 A viral gene that is from Tick-borne Encephalitis Virus. Oliver He Rebecca Racz gene Tick-borne Encephalitis Virus gene VO:0001447 A viral gene that is from VEE Virus. Oliver He Rebecca Racz gene VEE Virus gene VO:0001448 A viral gene that is from West Nile virus. Oliver He Rebecca Racz VO:0000197 gene West Nile virus gene VO:0001449 A viral gene that is from Western equine encephalomyelitis virus. Oliver He Rebecca Racz gene Western equine encephalomyelitis virus gene VO:0001450 A protozoan gene that is from Leishmania donovani. Oliver He Rebecca Racz gene Leishmania donovani gene VO:0001451 A Plasmodium gene that is from Plasmodium berghei. Oliver He Rebecca Racz gene Plasmodium berghei gene VO:0001452 A Plasmodium gene that is from Plasmodium yoelii. Oliver He Rebecca Racz gene Plasmodium yoelii gene VO:0001453 A protozoan gene that is from Toxoplasma gondii. Oliver He Rebecca Racz gene Toxoplasma gondii gene VO:0001454 A viral gene that is from Human herpesvirus 2. Oliver He Rebecca Racz gene Human herpesvirus 2 gene VO:0001455 A viral vaccine that protects against infection with Rinderpest virus Ningxian Fan Oliver He Ronak Sutariya vaccine rinderpest virus vaccine VO:0001456 bacterial vaccine that is used to protect against Erysipelothrix rhusiopathiae infection Asiyah Yu Lin vaccine Erysipelothrix rhusiopathiae vaccine VO:0001457 protozoan vaccine that is used to protect against Tritrichomonas suis infection Asiyah Yu Lin vaccine Trichomonas foetus vaccine VO:0001459 protozoan vaccine that is used to protect against Eimeria spp. (Eimeria) infection Asiyah Yu Lin obsolete Eimeria spp. vaccine true VO:0001460 viral vaccine that is used to protect against Orf Virus infection Asiyah Yu Lin vaccine Orf Virus vaccine VO:0001461 Vaccine that used for immunizing birds. Asiyah Yu Lin Jie Zheng Aves vaccine vaccine bird vaccine VO:0001462 Vaccine that used for immunizing fishes. Asiyah Yu Lin Jie Zheng vaccine fish vaccine VO:0001463 viral vaccine that is used to protect against Fowlpox virus infection Asiyah Yu Lin obsolete Fowlpox virus vaccine true VO:0001464 Vaccine that used for immunizing carnivora. Asiyah Yu Lin Jie Zheng vaccine carnivora vaccine VO:0001465 Vaccine that used for immunizing cat (felis catus). Asiyah Yu Lin Jie Zheng vaccine cat vaccine VO:0001466 Vaccine that used for immunizing cattle. Asiyah Yu Lin Jie Zheng vaccine cattle vaccine VO:0001467 Vaccine that used for immunizing dog (Canis familiaris). Asiyah Yu Lin Jie Zheng vaccine dog vaccine VO:0001468 Vaccine that used for immunizing chicken. Asiyah Yu Lin Jie Zheng vaccine chicken vaccine VO:0001469 Vaccine that used for immunizing duck. Asiyah Yu Lin Jie Zheng vaccine duck vaccine VO:0001470 Vaccine that used for immunizing catfish. Asiyah Yu Lin Jie Zheng vaccine catfish vaccine VO:0001471 Vaccine that used for immunizing gray wolf. Asiyah Yu Lin Jie Zheng vaccine gray wolf vaccine VO:0001472 Vaccine that used for immunizing horse. Asiyah Yu Lin Jie Zheng vaccine horse vaccine VO:0001473 Vaccine that used for immunizing parrot. Asiyah Yu Lin Jie Zheng vaccine parrot vaccine VO:0001474 Vaccine that used for immunizing pig. Asiyah Yu Lin Jie Zheng vaccine pig vaccine VO:0001475 Vaccine that used for immunizing sei whale. Asiyah Yu Lin Jie Zheng vaccine sei whale vaccine VO:0001476 Vaccine that used for immunizing sheep. Asiyah Yu Lin Jie Zheng vaccine sheep vaccine VO:0001477 Vaccine that used for immunizing salmoninae (tourts, salmons & chars). Asiyah Yu Lin Jie Zheng vaccine salmoninae vaccine VO:0001478 Vaccine that used for immunizing turkey. Asiyah Yu Lin Jie Zheng vaccine turkey vaccine VO:0001479 The objective that intends to produce vaccine via the vaccine preparation process. Oliver He information content entity vaccine target specification VO:0001480 A viral vaccine that protects against infection with African horse sickness virus Ningxian Fan Oliver He Ronak Sutariya vaccine African horse sickness virus vaccine VO:0001481 viral vaccine that is used to protect against Pigeonpox virus infection Asiyah Yu Lin vaccine Pigeonpox virus vaccine VO:0001482 viral vaccine that is used to protect against Bovine herpesvirus 1 infection Asiyah Yu Lin Oliver He BHV-1 vaccine Bovine rhinotracheitis vaccine obsolete bovine herpesvirus 1 vaccine true VO:0001483 A viral vaccine that protects against infection with Borna disease virus Ningxian Fan Oliver He Ronak Sutariya vaccine Borna disease virus vaccine VO:0001484 A viral vaccine that protects against infection with Caprine herpesvirus 1 Ningxian Fan Oliver He Ronak Sutariya obsolete Caprine herpesvirus 1 vaccine true VO:0001485 A vaccine licensed in the USA Kallan Roan Oliver He https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093833.htm vaccine USA licensed vaccine VO:0001486 viral vaccine that is used to protect against Equid herpesvirus 1 infection Asiyah Yu Lin vaccine Equid herpesvirus 1 vaccine VO:0001487 viral vaccine that is used to protect against Feline herpesvirus 1 (Felid herpesvirus 1) infection Asiyah Yu Lin Oliver He vaccine Feline herpesvirus 1 vaccine VO:0001488 Viral vaccine that is used to protect against Gallid herpesvirus 1 infection Asiyah Yu Lin Ningxian Fan Oliver He Ronak Sutariya https://en.wikipedia.org/wiki/Gallid_herpesvirus_1 vaccine Gallid herpesvirus 1 vaccine VO:0001489 viral vaccine that is used to protect against Canine adenovirus type 1 (Canine adenovirus 1) infection Asiyah Yu Lin vaccine canine adenovirus type 1 vaccine VO:0001490 viral vaccine that is used to protect against Canine Adenovirus Type 2 (Canine adenovirus 2) infection Asiyah Yu Lin vaccine canine adenovirus Type 2 vaccine VO:0001491 viral vaccine that is used to protect against Bovine papillomavirus infection Asiyah Yu Lin vaccine Bovine papillomavirus vaccine VO:0001492 viral vaccine that is used to protect against Avian Polyomavirus infection Asiyah Yu Lin vaccine avian polyomavirus vaccine VO:0001493 viral vaccine that is used to protect against Mink enteritis virus infection Asiyah Yu Lin vaccine Mink enteritis virus vaccine VO:0001494 viral vaccine that is used to protect against Porcine parvovirus infection Asiyah Yu Lin vaccine Porcine parvovirus vaccine VO:0001495 viral vaccine that is used to protect against Porcine rotavirus infection Asiyah Yu Lin vaccine Porcine rotavirus vaccine VO:0001496 viral vaccine that is used to protect against Equine rotavirus infection Asiyah Yu Lin vaccine Equine rotavirus vaccine VO:0001497 viral vaccine that is used to protect against Infectious Bursal Disease Virus (IBDV) infection Asiyah Yu Lin Ningxian Fan Oliver He Ronak Sutariya IBDV vaccine vaccine infectious bursal disease virus vaccine VO:0001498 viral vaccine that is used to protect against Eastern Equine Encephalitis Virus infection Asiyah Yu Lin vaccine Eastern Equine Encephalitis Virus vaccine VO:0001499 viral vaccine that is used to protect against VEE Virus (Venezuelan equine encephalitis virus) infection Asiyah Yu Lin vaccine VEE Virus vaccine VO:0001500 viral vaccine that is used to protect against Equine arteritis virus infection Asiyah Yu Lin vaccine Equine arteritis virus vaccine VO:0001501 viral vaccine that is used to protect against Bovine viral diarrhea virus 1 infection Asiyah Yu Lin vaccine Bovine viral diarrhea virus 1 vaccine VO:0001502 viral vaccine that is used to protect against Infectious Bronchitis Virus (IBV) infection Asiyah Yu Lin vaccine Infectious Bronchitis Virus vaccine VO:0001503 viral vaccine that is used to protect against Bovine coronavirus infection Asiyah Yu Lin vaccine bovine coronavirus vaccine VO:0001504 viral vaccine that is used to protect against Feline infectious peritonitis virus infection Asiyah Yu Lin Oliver He vaccine Feline infectious peritonitis virus vaccine VO:0001505 viral vaccine that is used to protect against Transmissible gastroenteritis virus infection Asiyah Yu Lin vaccine Transmissible gastroenteritis virus vaccine VO:0001506 Asiyah Yu Lin Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00023647 PMID:12833467 obsolete Bovine Parainfluenza 3 Virus vaccine true VO:0001507 viral vaccine that is used to protect against Bovine Respiratory Syncytial Virus infection Asiyah Yu Lin vaccine Bovine Respiratory Syncytial Virus vaccine VO:0001508 viral vaccine that is used to protect against Feline immunodeficiency virus infection Asiyah Yu Lin vaccine Feline immunodeficiency virus vaccine VO:0001509 viral vaccine that is used to protect against Feline calicivirus infection Asiyah Yu Lin Oliver He vaccine Feline calicivirus vaccine VO:0001510 viral vaccine that is used to protect against Chicken Anemia Virus infection Asiyah Yu Lin vaccine chicken anemia virus vaccine VO:0001511 viral vaccine that is used to protect against Porcine respiratory and reproductive syndrome virus (Porcine reproductive and respiratory syndrome virus) infection Asiyah Yu Lin vaccine Porcine respiratory and reproductive syndrome virus vaccine VO:0001512 Vaccine that protects against Riemerella anatipestifer infection. Asiyah Yu Lin vaccine Riemerella anatipestifer vaccine VO:0001513 viral vaccine that is used to protect against Avian Reovirus (Avian orthoreovirus) infection Asiyah Yu Lin vaccine avian reovirus vaccine VO:0001514 viral vaccine that is used to protect against avian pneumovirus (avian metapneumovirus) infection Asiyah Yu Lin vaccine avian pneumovirus vaccine VO:0001515 viral vaccine that is used to protect against Bluetongue virus infection Asiyah Yu Lin vaccine Bluetongue virus vaccine VO:0001516 viral vaccine that is used to protect against Turkey hemorrhagic enteritis virus (Turkey adenoirus 3) infection Asiyah Yu Lin vaccine Turkey hemorrhagic enteritis virus vaccine VO:0001517 viral vaccine that is used to protect against Canarypox virus infection Asiyah Yu Lin vaccine Canarypox virus vaccine VO:0001518 viral vaccine that is used to protect against Psittacid herpesvirus 1 infection Asiyah Yu Lin vaccine Psittacid herpesvirus 1 vaccine VO:0001519 A vaccine that protects against infection with Mycobacterium bovis Ningxian Fan Oliver He Ronak Sutariya vaccine Mycobacterium bovis vaccine VO:0001520 viral vaccine that is used to protect against Infectious salmon anemia virus infection Asiyah Yu Lin vaccine Infectious salmon anemia virus vaccine VO:0001521 An Edwardsiella bacterial vaccine that is used to protect against Edwardsiella ictaluri infection Asiyah Yu Lin vaccine Edwardsiella ictaluri vaccine VO:0001522 viral vaccine that is used to protect against Avian Encephalomyelitis Virus infection Asiyah Yu Lin Oliver He vaccine avian encephalomyelitis virus vaccine VO:0001523 Vaccine that protects against Mannheimia haemolytica infection. Asiyah Yu Lin vaccine Mannheimia haemolytica vaccine VO:0001524 viral vaccine that is used to protect against Porcine circovirus 2 infection Asiyah Yu Lin Oliver He vaccine porcine circovirus 2 vaccine VO:0001525 viral vaccine that is used to protect against Duck enteritis virus (Anatid herpesvirus 1) infection Asiyah Yu Lin vaccine Duck enteritis virus vaccine VO:0001526 viral vaccine that is used to protect against Canine parainfluenza virus infection Asiyah Yu Lin vaccine canine parainfluenza virus vaccine VO:0001527 viral vaccine that is used to protect against Avian Paramyxovirus infection Asiyah Yu Lin vaccine avian paramyxovirus vaccine VO:0001528 viral vaccine that is used to protect against Duck hepatitis virus 1 (Duck hepatitis A virus) infection Asiyah Yu Lin vaccine Duck hepatitis virus 1 vaccine VO:0001530 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1557 1557 USDA: 1623.10 vaccine Canary Pox Modified Live Virus Vaccine (USDA: 1623.10) VO:0001531 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2092 2092 USDA: 1881.10 vaccine Pigeon Pox Live Virus Vaccine (USDA: 1881.10) VO:0001532 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2093 2093 USDA: 1881.12 vaccine Pigeon Pox Live Virus Vaccine (USDA: 1881.12) VO:0001533 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2094 2094 USDA: 1881.14 vaccine Pigeon Pox Live Virus Vaccine (USDA: 1881.14) VO:0001534 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2111 2111 USDA: 18E1.10 vaccine Quail Pox Live Virus Vaccine (USDA: 18E1.10) VO:0001535 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1925 1925 USDA: 1635.20 vaccine Fox Encephalitis Killed Virus Vaccine (USDA: 1635.20) VO:0001536 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1967 1967 USDA: 1451.00 vaccine Mink Distemper Modified Live Virus Vaccine (USDA: 1451.00) VO:0001537 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1968 1968 USDA: 1451.01 vaccine Mink Distemper Modified Live Virus Vaccine (USDA: 1451.01) VO:0001538 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1969 1969 USDA: 1451.20 vaccine Mink Distemper Modified Live Virus Vaccine (USDA: 1451.20) VO:0001539 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1972 1972 vaccine Mink Enteritis vaccine VO:0001540 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1766 1766 USDA: 15C5.21 vaccine Feline calicivirus Killed Virus Vaccine (USDA: 15C5.21) VO:0001541 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1765 1765 USDA: 15C1.22 vaccine Feline calicivirus Modified Live Virus Vaccine (USDA: 15C1.22) VO:0001542 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1767 1767 USDA: 15A5.21 vaccine Feline immunodeficiency virus Killed Virus Vaccine (USDA: 15A5.21) VO:0001543 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1768 1768 USDA: 15A5.23 vaccine Feline immunodeficiency virus Killed Virus Vaccine (USDA: 15A5.23) VO:0001544 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1771 1771 USDA: 15A1.20 vaccine Feline Infectious Peritonitis Modified Live Virus Vaccine (USDA: 15A1.20) VO:0001545 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1772 1772 USDA: 1555.20 vaccine Feline Leukemia Killed Virus Vaccine (USDA: 1555.20) VO:0001546 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1773 1773 USDA: 1555.21 vaccine Feline Leukemia Killed Virus Vaccine (USDA: 1555.21) VO:0001547 Asiyah Yu Lin USDA: 1555.22 vaccine Feline Leukemia Killed Virus Vaccine (USDA: 1555.22) VO:0001548 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1775 1775 USDA: 1555.R1 vaccine Feline Leukemia Killed Virus Vaccine (USDA: 1555.R1) VO:0001549 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1776 1776 USDA: 1555.R3 vaccine Feline Leukemia Live Canarypox Vector Vaccine (USDA: 1555.R3) VO:0001550 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1819 1819 USDA: 1565.20 vaccine Feline Panleukopenia Killed Virus Vaccine (USDA: 1565.20) VO:0001551 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1815 1815 USDA: 1561.00 vaccine Feline Panleukopenia Modified Live Virus Vaccine (USDA: 1561.00) VO:0001552 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1816 1816 USDA: 1561.20 vaccine Feline Panleukopenia Modified Live Virus Vaccine (USDA: 1561.20) VO:0001553 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1817 1817 USDA: 1561.21 vaccine Feline Panleukopenia Modified Live Virus Vaccine (USDA: 1561.21) VO:0001554 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1818 1818 USDA: 1561.23 vaccine Feline Panleukopenia Modified Live Virus Vaccine (USDA: 1561.23) VO:0001555 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1820 1820 USDA: 16A1.22 vaccine Feline Rhinotracheitis Modified Live Virus Vaccine (USDA: 16A1.22) VO:0001556 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1714 1714 USDA: 1531.00 vaccine Edwardsiella ictaluri Avirulent Live Culture Vaccine (USDA: 1531.00) VO:0001557 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1122 1122 USDA: 1011.00 vaccine Anthrax Spore live culture Vaccine (USDA: 1011.00) VO:0001558 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1179 1179 USDA: 1095.20 vaccine Bovine Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 1095.20) VO:0001559 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1180 1180 USDA: 1095.21 vaccine Bovine Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 1095.21) VO:0001560 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1178 1178 USDA: 1091.20 vaccine Bovine Respiratory Syncytial Virus Vaccine Modified Live Virus (USDA: 1091.20) VO:0001561 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1186 1186 USDA: 1105.20 vaccine Bovine Rhinotracheitis Killed Virus Vaccine (USDA: 1105.20) VO:0001562 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1181 1181 USDA: 1101.00 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine (USDA: 1101.00) VO:0001563 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1182 1182 USDA: 1101.20 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine (USDA: 1101.20) VO:0001564 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1183 1183 USDA: 1101.21 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine (USDA: 1101.21) VO:0001565 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1184 1184 USDA: 1101.22 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine (USDA: 1101.22) VO:0001566 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1185 1185 USDA: 1101.B0 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine (USDA: 1101.B0) VO:0001567 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1354 1354 USDA: 1205.00 vaccine Bovine Virus Diarrhea Killed Virus Vaccine (USDA: 1205.00) VO:0001568 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1355 1355 USDA: 1205.20 vaccine Bovine Virus Diarrhea Killed Virus Vaccine (USDA: 1205.20) VO:0001569 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1356 1356 USDA: 1205.21 vaccine Bovine Virus Diarrhea Killed Virus Vaccine (USDA: 1205.21) VO:0001570 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1357 1357 USDA: 1205.22 vaccine Bovine Virus Diarrhea Killed Virus Vaccine (USDA: 1205.22) VO:0001571 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1358 1358 USDA: 1205.25 vaccine Bovine Virus Diarrhea Killed Virus Vaccine (USDA: 1205.25) VO:0001572 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1351 1351 USDA: 1201.00 vaccine Bovine Virus Diarrhea Modified Live Virus Vaccine (USDA: 1201.00) VO:0001573 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1352 1352 USDA: 1201.20 vaccine Bovine Virus Diarrhea Modified Live Virus Vaccine (USDA: 1201.20) VO:0001574 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1353 1353 USDA: 1201.22 vaccine Bovine Virus Diarrhea Modified Live Virus Vaccine (USDA: 1201.22) VO:0001575 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1383 1383 USDA: 1251.01 vaccine Brucella Abortus Strain 19, Live Culture Vaccine (USDA: 1251.01) VO:0001576 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1384 1384 USDA: 1251.02 vaccine Brucella Abortus Strain 19, Live Culture, Reduced Dose Vaccine (USDA: 1251.02) VO:0001577 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1385 1385 USDA: 1261.00 vaccine Brucella Abortus Strain RB-51, Live Culture Vaccine (USDA: 1261.00) VO:0001578 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2077 2077 USDA: 1841.00 vaccine Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1841.00) VO:0001579 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2078 2078 USDA: 1841.20 vaccine Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1841.20) VO:0001580 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2121 2121 USDA: 19A1.00 vaccine Salmonella Choleraesuis Avirulent Live Culture Vaccine (USDA: 19A1.00) VO:0001581 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2122 2122 USDA: 19A1.01 vaccine Salmonella Choleraesuis Avirulent Live Culture Vaccine (USDA: 19A1.01) VO:0001582 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2123 2123 USDA: 19D1.R0 vaccine Salmonella Dublin Live Culture Vaccine (USDA: 19D1.R0) VO:0001583 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2143 2143 USDA: 1859.00 vaccine Trichomonas Foetus Killed Protozoa Vaccine (USDA: 1859.00) VO:0001584 Asiyah Yu Lin Wart Vaccine (Colorado Serum) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2144 2144 USDA: 1985.50 vaccine Wart Killed Virus Vaccine (USDA: 1985.50) VO:0001585 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1124 1124 USDA: 1015.I0 vaccine Avian Encephalomyelitis Killed Virus Vaccine (USDA: 1015.10) VO:0001586 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1125 1125 USDA: 1051.10 vaccine Avian Encephalomyelitis Live Virus Vaccine (USDA: 1051.10) VO:0001587 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1126 1126 USDA: 1051.11 vaccine Avian Encephalomyelitis Live Virus Vaccine (USDA: 1051.11) VO:0001588 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1127 1127 USDA: 1051.12 vaccine Avian Encephalomyelitis Live Virus Vaccine (USDA: 1051.12) VO:0001589 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1147 1147 USDA: 1057.H0 vaccine avian influenza H10N9 Subtype, Killed Virus Vaccine (USDA: 1057.H0) VO:0001590 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1149 1149 USDA: 1057.H2 vaccine avian influenza H2N2 Subtype, Killed Virus Vaccine (USDA: 1057.H2) VO:0001591 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1150 1150 USDA: 1057.H3 vaccine avian influenza H3N4 Subtype, Killed Virus Vaccine (USDA: 1057.H3) VO:0001592 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1151 1151 USDA: 1057.H4 vaccine avian influenza H4N6 Subtype, Killed Virus Vaccine (USDA: 1057.H4) VO:0001593 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1152 1152 USDA: 1057.H5 vaccine avian influenza H5N2 Subtype, Killed Virus Vaccine (USDA: 1057.H5) VO:0001594 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1146 1146 USDA: 1057.14 vaccine avian influenza H5N9 Subtype, Killed Virus Vaccine (USDA: 1057.14) VO:0001595 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1153 1153 USDA: 1057.H6 vaccine avian influenza H6N8 Subtype, Killed Virus Vaccine (USDA: 1057.H6) VO:0001596 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1158 1158 USDA: 10F5.12 vaccine avian influenza H7N2 Subtype, Killed Virus Vaccine (USDA: 10F5.12) VO:0001597 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1154 1154 USDA: 1057.H7 vaccine avian influenza H7N3 Subtype, Killed Virus Vaccine (USDA: 1057.H7) VO:0001598 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1159 1159 USDA: 10F5.13 vaccine avian influenza H7N3 Subtype, Killed Virus Vaccine (USDA: 10F5.13) VO:0001599 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1148 1148 USDA: 1057.H1 vaccine avian influenza H1N1 Subtype, Killed Virus Vaccine (USDA: 1057.H1) VO:0001600 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1157 1157 USDA: 10F5.10 vaccine avian influenza H5N2 Subtype, Killed Virus Vaccine (USDA: 10F5.10) VO:0001601 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1156 1156 USDA: 1057.R3 vaccine avian influenza H5N3 Subtype, Killed Virus Vaccine (USDA: 1057.R3) VO:0001602 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1155 1155 USDA: 1057.H9 vaccine avian influenza H9N2 Subtype, Killed Virus Vaccine (USDA: 1057.H9) VO:0001603 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1163 1163 USDA: 10C5.11 vaccine Avian Paramyxovirus Type 1, Killed Virus Vaccine (USDA: 10C5.11) VO:0001604 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1162 1162 USDA: 10C5.10 vaccine Avian Paramyxovirus Type 3, Killed Virus Vaccine (USDA: 10C5.10) VO:0001605 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1164 1164 USDA: 1A31.20 vaccine Avian Pneumovirus Modified Live Virus Vaccine (USDA: 1A31.20) VO:0001606 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1166 1166 USDA: 1045.00 vaccine Avian Reovirus Killed Virus Vaccine (USDA: 1045.00) VO:0001607 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1167 1167 USDA: 1045.01 vaccine Avian Reovirus Killed Virus Vaccine (USDA: 1045.01) VO:0001608 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1168 1168 USDA: 1045.02 vaccine Avian Reovirus Killed Virus Vaccine (USDA: 1045.02) VO:0001609 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1169 1169 USDA: 1045.30 vaccine Avian Reovirus Killed Virus Vaccine (USDA: 1045.30) VO:0001610 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1361 1361 USDA: 1231.11 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1231.11) VO:0001611 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1373 1373 USDA: 1231.1M vaccine Bronchitis Ark Type, Live Virus Vaccine (USDA: 1231.1M) VO:0001612 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1375 1375 USDA: 1231.20 vaccine Bronchitis Ark Type, Live Virus Vaccine (USDA: 1231.20) VO:0001613 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1376 1376 USDA: 1231.21 vaccine Bronchitis Ark Type, Live Virus Vaccine (USDA: 1231.21) VO:0001614 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1377 1377 USDA: 1231.22 vaccine Bronchitis Ark Type, Live Virus Vaccine (USDA: 1231.22) VO:0001615 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1365 1365 USDA: 1231.15 vaccine Bronchitis Conn Type, Live Virus Vaccine (USDA: 1231.15) VO:0001616 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1368 1368 USDA: 1231.1D vaccine Bronchitis Delaware Type, Modified Live Virus Vaccine (USDA: 1231.1D) VO:0001617 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1371 1371 USDA: 1231.1J vaccine Bronchitis Georgia Type, Live Virus Vaccine (USDA: 1231.1J) VO:0001618 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1372 1372 USDA: 1231.1L vaccine Bronchitis Georgia Type, Live Virus Vaccine (USDA: 1231.1L) VO:0001619 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1382 1382 USDA: 1235.15 vaccine Bronchitis Mass & Ark Types, Killed Virus Vaccine (USDA: 1235.15) VO:0001620 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1363 1363 USDA: 1231.13 vaccine Bronchitis Mass & Ark Types, Live Virus Vaccine (USDA: 1231.13) VO:0001621 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1364 1364 USDA: 1231.14 vaccine Bronchitis Mass & Conn Types, Live Virus Vaccine (USDA: 1231.14) VO:0001622 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1370 1370 USDA: 1231.1G vaccine Bronchitis Mass & Conn Types, Live Virus Vaccine (USDA: 1231.1G) VO:0001623 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1374 1374 USDA:1231.1N vaccine Bronchitis Mass & Conn Types, Live Virus Vaccine (USDA:1231.1N) VO:0001624 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1362 1362 USDA: 1231.12 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1231.12) VO:0001625 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1366 1366 USDA: 1231.18 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1231.18) VO:0001626 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1367 1367 USDA: 1231.1A vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1231.1A) VO:0001627 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1369 1369 USDA: 1231.1F vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1231.1F) VO:0001628 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1378 1378 USDA: 1232.10 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1232.10) VO:0001629 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1379 1379 USDA: 1232.15 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1232.15) VO:0001630 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1380 1380 USDA: 1233.10 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1233.10) VO:0001631 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1381 1381 USDA: 1235.10 vaccine Bronchitis Mass Type, Live Virus Vaccine (USDA: 1235.10) VO:0001632 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1403 1403 USDA: 1275.00 vaccine Bursal Disease Killed Virus Vaccine (USDA: 1275.00) VO:0001633 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1404 1404 USDA: 1275.02 vaccine Bursal Disease Killed Virus Vaccine (USDA: 1275.02) VO:0001634 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1405 1405 USDA: 1275.20 vaccine Bursal Disease Killed Virus Vaccine (USDA: 1275.20) VO:0001635 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1386 1386 USDA: 1271.00 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.00) VO:0001636 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1387 1387 USDA: 1271.01 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.01) VO:0001637 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1388 1388 USDA: 1271.02 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.02) VO:0001638 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1389 1389 USDA: 1271.04 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.04) VO:0001639 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1390 1390 USDA: 1271.0A vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.0A) VO:0001640 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1391 1391 USDA: 1271.10 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.10) VO:0001641 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1392 1392 USDA: 1271.11 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.11) VO:0001642 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1393 1393 USDA: 1271.12 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.12) VO:0001643 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1394 1394 USDA: 1271.13 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.13) VO:0001644 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1396 1396 USDA: 1271.16 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.16) VO:0001645 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1397 1397 USDA: 1271.17 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.17) VO:0001646 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1398 1398 USDA: 1271.18 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.18) VO:0001647 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1399 1399 USDA: 1271.19 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.19) VO:0001648 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1400 1400 USDA: 1271.40 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.40) VO:0001649 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1401 1401 USDA: 1271.41 vaccine Bursal Disease Live Virus Vaccine (USDA: 1271.41) VO:0001650 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1402 1402 USDA: 1272.00 vaccine Bursal Disease Live Virus Vaccine (USDA: 1272.00) VO:0001651 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1395 1395 USDA: 1271.15 vaccine Bursal Disease Modified Live VirusVaccine (USDA: 1271.15) VO:0001652 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1409 1409 USDA: 12B5.01 vaccine Bursal Disease Standard & Variant, Killed Virus Vaccine (USDA: 12B5.01) VO:0001653 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1410 1410 USDA: 12B5.40 vaccine Bursal Disease Standard & Variant, Killed Virus Vaccine (USDA: 12B5.40) VO:0001654 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1411 1411 USDA: 12B5.41 vaccine Bursal Disease Standard & Variant, Killed Virus Vaccine (USDA: 12B5.41) VO:0001655 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1412 1412 USDA: 12B5.4A vaccine Bursal Disease Standard & Variant, Killed Virus Vaccine (USDA: 12B5.4A) VO:0001656 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1407 1407 USDA: 12B1.00 vaccine Bursal Disease Standard & Variant, Live Virus Vaccine (USDA: 12B1.00) VO:0001657 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1408 1408 USDA: 12B1.01 vaccine Bursal Disease Standard & Variant, Live Virus Vaccine (USDA: 12B1.01) VO:0001658 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1406 1406 USDA: 12A5.00 vaccine Bursal Disease Variant, Killed Virus Vaccine (USDA: 12A5.00) VO:0001659 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1413 1413 USDA: 12L1.00 vaccine Bursal Disease Variant, Live Virus Vaccine (USDA: 12L1.00) VO:0001660 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1697 1697 USDA: 10A1.00 vaccine Chicken Anemia Virus Live Virus Vaccine (USDA: 10A1.00) VO:0001661 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1698 1698 USDA: 10A1.01 vaccine Chicken Anemia Virus Live Virus Vaccine (USDA: 10A1.01) VO:0001662 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1699 1699 USDA: 10A1.10 vaccine Chicken Anemia Virus Modified Live Virus Vaccine (USDA: 10A1.10) VO:0001663 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1702 1702 USDA: 1431.50 vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.50) VO:0001664 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1703 1703 USDA: 1431.51 vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.51) VO:0001665 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1705 1705 USDA: 1431.56 vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.56) VO:0001666 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1706 1706 USDA: 1431.57 vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.57) VO:0001667 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1707 1707 USDA: 1431.58 vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.58) VO:0001668 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1708 1708 USDA: 1431.59 vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.59) VO:0001669 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1709 1709 USDA: 1431.5C vaccine Coccidiosis Live Oocysts Vaccine (USDA: 1431.5C) VO:0001670 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1704 1704 USDA: 1431.55 vaccine Coccidiosis Live Oocysts, Chicken Isolates Vaccine (USDA: 1431.55) VO:0001671 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1903 1903 USDA: 1601.01 vaccine Fowl Laryngotracheitis Modified Live Virus Vaccine (USDA: 1601.01) VO:0001672 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1904 1904 USDA: 1601.02 vaccine Fowl Laryngotracheitis Modified Live Virus Vaccine (USDA: 1601.02) VO:0001673 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1905 1905 USDA: 1601.11 vaccine Fowl Laryngotracheitis Modified Live Virus Vaccine (USDA: 1601.11) VO:0001674 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1906 1906 USDA: 1601.13 vaccine Fowl Laryngotracheitis Modified Live Virus Vaccine (USDA: 1601.13) VO:0001675 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1907 1907 USDA: 1601.14 vaccine Fowl Laryngotracheitis Modified Live Virus Vaccine (USDA: 1601.14) VO:0001676 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1908 1908 USDA: 1601.15 vaccine Fowl Laryngotracheitis Modified Live Virus Vaccine (USDA: 1601.15) VO:0001677 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1913 1913 USDA: 1621.00 vaccine Fowl Pox Live Virus Vaccine (USDA: 1621.00) VO:0001678 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1914 1914 USDA: 1621.10 vaccine Fowl Pox Live Virus Vaccine (USDA: 1621.10) VO:0001679 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1915 1915 USDA: 1621.11 vaccine Fowl Pox Live Virus Vaccine (USDA: 1621.11) VO:0001680 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1916 1916 USDA: 1621.13 vaccine Fowl Pox Live Virus Vaccine (USDA: 1621.13) VO:0001681 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1917 1917 USDA: 1621.14 vaccine Fowl Pox Live Virus Vaccine (USDA: 1621.14) VO:0001682 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1918 1918 USDA: 1622.00 vaccine Fowl Pox Live Virus Vaccine (USDA: 1622.00) VO:0001683 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1945 1945 USDA: 16L1.00 vaccine Marek's Disease Serotype 1, Live Virus Vaccine (USDA: 16L1.00) VO:0001684 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1948 1948 USDA: 16L1.04 vaccine Marek's Disease Serotype 1, Live Virus Vaccine (USDA: 16L1.04) VO:0001685 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1952 1952 USDA: 16L1.09 vaccine Marek's Disease Serotype 1, Live Virus Vaccine (USDA: 16L1.09) VO:0001686 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1934 1934 USDA: 1631.00 vaccine Marek's Disease Serotype 2, Live Virus Vaccine (USDA: 1631.00) VO:0001687 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1936 1936 USDA: 1641.00 vaccine Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 1641.00) VO:0001688 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1937 1937 USDA: 1641.01 vaccine Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 1641.01) VO:0001689 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1938 1938 USDA: 1641.06 vaccine Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 1641.06) VO:0001690 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1949 1949 USDA: 16L1.06 vaccine Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 16L1.06) VO:0001691 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1946 1946 USDA: 16L1.01 vaccine Marek's Disease Serotypes 1 & 2 & 3, Live Virus Vaccine (USDA: 16L1.01) VO:0001692 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1935 1935 USDA: 1631.R0 vaccine Marek's Disease Serotypes 1 & 3, Live Herpesvirus Chimera Vaccine (USDA: 1631.R0) VO:0001693 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1944 1944 USDA: 16G1.02 vaccine Marek's Disease Serotypes 1 & 3, Live Virus Vaccine (USDA: 16G1.02) VO:0001694 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1947 1947 USDA: 16L1.02 vaccine Marek's Disease Serotypes 1 & 3, Live Virus Vaccine (USDA: 16L1.02) VO:0001695 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1951 1951 USDA: 16L1.08 vaccine Marek's Disease Serotypes 1 & 3, Live Virus Vaccine (USDA: 16L1.08) VO:0001696 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1939 1939 USDA: 1651.00 vaccine Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1651.00) VO:0001697 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1940 1940 USDA: 1651.01 vaccine Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1651.01) VO:0001698 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1941 1941 USDA: 1651.02 vaccine Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1651.02) VO:0001699 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1942 1942 USDA: 1651.05 vaccine Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1651.05) VO:0001700 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1943 1943 USDA: 16G1.00 vaccine Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 16G1.00) VO:0001701 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1950 1950 USDA: 16L1.07 vaccine Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 16L1.07) VO:0001702 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1973 1973 USDA: 1751.00 vaccine Mycoplasma Gallisepticum Live Culture Vaccine (USDA: 1751.00) VO:0001703 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1974 1974 USDA: 1751.01 vaccine Mycoplasma Gallisepticum Live Culture Vaccine (USDA: 1751.01) VO:0001704 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1981 1981 USDA: 1711.10 vaccine Newcastle Disease B1 Type, B1 Strain, Live Virus Vaccine (USDA: 1711.10) VO:0001705 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1982 1982 USDA: 1711.12 vaccine Newcastle Disease B1 Type, B1 Strain, Live Virus Vaccine (USDA: 1711.12) VO:0001706 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1983 1983 USDA: 1711.14 vaccine Newcastle Disease B1 Type, B1 Strain, Live Virus Vaccine (USDA: 1711.14) VO:0001707 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1984 1984 USDA: 1711.18 vaccine Newcastle Disease B1 Type, B1 Strain, Live Virus Vaccine (USDA: 1711.18) VO:0001708 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1991 1991 USDA: 17A2.10 vaccine Newcastle Disease B1 Type, B1 Strain, Live Virus Vaccine (USDA: 17A2.10) VO:0001709 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1993 1993 USDA: 17B1.10 vaccine Newcastle Disease B1 Type, C2 Strain, Live VirusVaccine (USDA: 17B1.10) VO:0001710 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1985 1985 USDA: 1721.0A vaccine Newcastle Disease B1 Type, LaSota Strain, Live Virus Vaccine (USDA: 1721.0A) VO:0001711 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1986 1986 USDA: 1721.10 vaccine Newcastle Disease B1 Type, LaSota Strain, Live Virus Vaccine (USDA: 1721.10) VO:0001712 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1987 1987 USDA: 1721.11 vaccine Newcastle Disease B1 Type, LaSota Strain, Live Virus Vaccine (USDA: 1721.11) VO:0001713 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1988 1988 USDA: 1721.15 vaccine Newcastle Disease B1 Type, LaSota Strain, Live Virus Vaccine (USDA: 1721.15) VO:0001714 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1989 1989 USDA: 1721.16 vaccine Newcastle Disease B1 Type, LaSota Strain, Live Virus Vaccine (USDA: 1721.16) VO:0001715 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1990 1990 USDA: 1721.17 vaccine Newcastle Disease B1 Type, LaSota Strain, Live Virus Vaccine (USDA: 1721.17) VO:0001716 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1977 1977 USDA: 1705.10 vaccine Newcastle Disease Killed Virus Vaccine (USDA: 1705.10) VO:0001717 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1978 1978 USDA: 1705.11 vaccine Newcastle Disease Killed Virus Vaccine (USDA: 1705.11) VO:0001718 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1979 1979 USDA: 1705.13 vaccine Newcastle Disease Killed Virus Vaccine (USDA: 1705.13) VO:0001719 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1980 1980 USDA: 1705.15 vaccine Newcastle Disease Killed Virus Vaccine (USDA: 1705.15) VO:0001720 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1976 1976 USDA: 1701.10 vaccine Newcastle Disease VG/GA Strain, Live Virus Vaccine (USDA: 1701.10) VO:0001721 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1992 1992 USDA: 17A2.V1 vaccine Newcastle Disease VG/GA Strain, Live Virus Vaccine (USDA: 17A2.V1) VO:0001722 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2087 2087 USDA: 1871.01 vaccine Pasteurella Multocida Avirulent Live Culture, Avian Isolate Vaccine (USDA: 1871.01) VO:0001723 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2088 2088 USDA: 1871.02 vaccine Pasteurella Multocida Avirulent Live Culture, Avian Isolate Vaccine (USDA: 1871.02) VO:0001724 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2089 2089 USDA: 1871.03 vaccine Pasteurella Multocida Avirulent Live Culture, Avian Isolate Vaccine (USDA: 1871.03) VO:0001725 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2090 2090 USDA: 1871.04 vaccine Pasteurella Multocida Avirulent Live Culture, Avian Isolate Vaccine (USDA: 1871.04) VO:0001726 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2091 2091 USDA: 1871.05 vaccine Pasteurella Multocida Avirulent Live Culture, Avian Isolate Vaccine (USDA: 1871.05) VO:0001727 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2124 2124 USDA: 19C1.00 vaccine Salmonella Typhimurium Live Culture Vaccine (USDA: 19C1.00) VO:0001728 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2125 2125 USDA: 19C1.01 vaccine Salmonella Typhimurium Live Culture Vaccine (USDA: 19C1.01) VO:0001729 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2126 2126 USDA: 19C1.02 vaccine Salmonella Typhimurium Live Culture Vaccine (USDA: 19C1.02) VO:0001730 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2139 2139 USDA: 1951.10 vaccine Tenosynovitis Live Virus Vaccine (USDA: 1951.10) VO:0001731 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2135 2135 USDA: 1951.01 vaccine Tenosynovitis Modified Live Virus Vaccine (USDA: 1951.01) VO:0001732 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2136 2136 USDA: 1951.02 vaccine Tenosynovitis Modified Live Virus Vaccine (USDA: 1951.02) VO:0001733 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2137 2137 USDA: 1951.03 vaccine Tenosynovitis Modified Live Virus Vaccine (USDA: 1951.03) VO:0001734 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2138 2138 USDA: 1951.04 vaccine Tenosynovitis Modified Live Virus Vaccine (USDA: 1951.04) VO:0001735 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2140 2140 USDA: 1951.11 vaccine Tenosynovitis Modified Live Virus Vaccine (USDA: 1951.11) VO:0001736 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2141 2141 USDA: 1952.01 vaccine Tenosynovitis Modified Live Virus Vaccine (USDA: 1952.01) VO:0001737 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1712 1712 USDA: 1461.10 vaccine Duck Virus Enteritis Modified Live Virus Vaccine (USDA: 1461.10) VO:0001738 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1713 1713 USDA: 14B1.10 vaccine Duck Virus Hepatitis Modified Live Virus Vaccine (USDA: 14B1.10) VO:0001739 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2120 2120 USDA: 1811.00 vaccine Riemerella Anatipestifer Avirulent Live Culture Vaccine (USDA: 1811.00) VO:0001740 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1902 1902 USDA: 17F1.00 vaccine Flavobacterium Columnare Avirulent Live Culture Vaccine (USDA: 17F1.00) VO:0001741 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1172 1172 USDA: 1081.00 vaccine Bordetella Bronchiseptica Avirulent Live Culture Vaccine (USDA: 1081.00) VO:0001742 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1173 1173 USDA: 1081.01 vaccine Bordetella Bronchiseptica Avirulent Live Culture Vaccine (USDA: 1081.01) VO:0001743 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1562 1562 USDA: 14P5.20 vaccine Canine Coronavirus Killed Virus Vaccine (USDA: 14P5.20) VO:0001744 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1563 1563 USDA: 14P5.21 vaccine Canine Coronavirus Killed Virus Vaccine (USDA: 14P5.21) VO:0001745 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1561 1561 USDA: 14P1.20 vaccine Canine Coronavirus Modified Live Virus Vaccine (USDA: 14P1.20) VO:0001746 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1691 1691 USDA: 15K5.20 vaccine canine influenza H3N8, killed virus vaccine (USDA: 15K5.20) VO:0001747 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1692 1692 USDA: 1421.21 vaccine Canine Parainfluenza Modified Live Virus Vaccine (USDA: 1421.21) VO:0001748 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1711 1711 USDA: 1471.R0 vaccine Distemper Live Canarypox Vector Vaccine (USDA: 1471.R0) VO:0001749 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1710 1710 USDA: 1471.10 vaccine Distemper Modified Live Virus Vaccine (USDA: 1471.10) VO:0001750 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1926 1926 USDA: 18G5.00 vaccine Giardia Lamblia Killed Protozoa Vaccine (USDA: 18G5.00) VO:0001751 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1975 1975 USDA: 1N11.00 vaccine Neospora Caninum Killed Protozoa Vaccine (USDA: 1N11.00) VO:0001752 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2085 2085 USDA: 18P5.20 vaccine Parvovirus Killed Virus Vaccine (USDA: 18P5.20) VO:0001753 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2086 2086 USDA: 18P5.21 vaccine Parvovirus Killed Virus Vaccine (USDA: 18P5.21) VO:0001754 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2079 2079 USDA: 18M1.20 vaccine Parvovirus Modified Live Virus Vaccine (USDA: 18M1.20) VO:0001755 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2080 2080 USDA: 18M1.21 vaccine Parvovirus Modified Live Virus Vaccine (USDA: 18M1.21) VO:0001756 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2081 2081 USDA: 18M1.22 vaccine Parvovirus Modified Live Virus Vaccine (USDA: 18M1.22) VO:0001757 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2082 2082 USDA: 18M1.23 vaccine Parvovirus Modified Live Virus Vaccine (USDA: 18M1.23) VO:0001758 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2083 2083 USDA: 18M1.25 vaccine Parvovirus Modified Live Virus Vaccine (USDA: 18M1.25) VO:0001759 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2084 2084 USDA: 18M1.29 vaccine Parvovirus Modified Live Virus Vaccine (USDA: 18M1.29) VO:0001760 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2115 2115 USDA: 1905.20 vaccine Rabies Killed Virus Vaccine (USDA: 1905.20) VO:0001761 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2116 2116 USDA: 1905.21 vaccine Rabies Killed Virus Vaccine (USDA: 1905.21) VO:0001762 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2117 2117 USDA: 1905.22 vaccine Rabies Killed Virus Vaccine (USDA: 1905.22) VO:0001763 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2118 2118 USDA: 1905.23 vaccine Rabies Killed Virus Vaccine (USDA: 1905.23) VO:0001764 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2119 2119 USDA: 1905.24 vaccine Rabies Killed Virus Vaccine (USDA: 1905.24) VO:0001765 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2113 2113 USDA: 1901.R1 vaccine Rabies Live Canarypox Vector Vaccine (USDA: 1901.R1) VO:0001766 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2114 2114 USDA: 1901.R6 vaccine Rabies Live Canarypox Vector Vaccine (USDA: 1901.R6) VO:0001767 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2112 2112 USDA: 1901.R0 vaccine Rabies Live Vaccinia Vector Vaccine (USDA: 1901.R0) VO:0001768 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1731 1731 USDA: 1531.20 vaccine Equine Arteritis Modified Live Virus Vaccine (USDA: 1531.20) VO:0001769 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1735 1735 USDA: 1505.10 vaccine equine influenza killed virus vaccine (USDA: 1505.10) VO:0001770 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1736 1736 USDA: 1505.20 vaccine equine influenza killed virus vaccine (USDA: 1505.20) VO:0001771 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1737 1737 USDA: 1505.21 vaccine equine influenza killed virus vaccine (USDA: 1505.21) VO:0001772 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1738 1738 USDA: 1505.24 vaccine equine influenza killed virus vaccine (USDA: 1505.24) VO:0001773 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1739 1739 USDA: 1505.25 vaccine equine influenza killed virus vaccine (USDA: 1505.25) VO:0001774 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1740 1740 USDA: 1505.28 vaccine equine influenza killed virus vaccine (USDA: 1505.28) VO:0001775 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1734 1734 USDA: 1501.R0 vaccine equine influenza live canarypox vector vaccine (USDA: 1501.R0) VO:0001776 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1732 1732 USDA: 1501.10 vaccine equine influenza modified live virus vaccine (USDA: 1501.10) VO:0001777 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1733 1733 USDA: 1501.20 vaccine equine influenza modified live virus vaccine (USDA: 1501.20) VO:0001778 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1742 1742 USDA: 1525.20 vaccine Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.20) VO:0001779 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1743 1743 USDA: 1525.21 vaccine Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.21) VO:0001780 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1744 1744 USDA: 1525.22 vaccine Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.22) VO:0001781 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1745 1745 USDA: 1525.24 vaccine Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.24) VO:0001782 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1741 1741 USDA: 1521.20 vaccine Equine Rhinopneumonitis Modified Live Virus Vaccine (USDA: 1521.20) VO:0001783 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1756 1756 USDA: 1E15.20 vaccine Equine Rotavirus Killed Virus Vaccine (USDA: 1E15.20) VO:0001784 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2127 2127 USDA: 1831.00 vaccine Streptococcus Equi Live Culture Vaccine (USDA: 1831.00) VO:0001785 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1165 1165 USDA: 1A15.00 vaccine Avian Polyomavirus Killed Virus Vaccine (USDA: 1A15.00) VO:0001786 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1701 1701 USDA: 1585.20 vaccine Chlamydia Psittaci Killed Chlamydia Vaccine (USDA: 1585.20) VO:0001787 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1700 1700 USDA: 1581.20 vaccine Chlamydia Psittaci Modified Live Chlamydia Vaccine (USDA: 1581.20) VO:0001788 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2076 2076 USDA: 18C5.00 vaccine Pacheco's Disease Killed Virus Vaccine (USDA: 18C5.00) VO:0001789 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1757 1757 USDA: 1541.00 vaccine Erysipelothrix Rhusiopathiae Avirulent Live Culture Vaccine (USDA: 1541.00) VO:0001790 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1758 1758 USDA: 1541.01 vaccine Erysipelothrix Rhusiopathiae Avirulent Live Culture Vaccine (USDA: 1541.01) VO:0001791 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1759 1759 USDA: 1541.02 vaccine Erysipelothrix Rhusiopathiae Avirulent Live Culture Vaccine (USDA: 1541.02) VO:0001792 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1760 1760 USDA: 1541.03 vaccine Erysipelothrix Rhusiopathiae Avirulent Live Culture Vaccine (USDA: 1541.03) VO:0001793 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1761 1761 USDA: 1541.04 vaccine Erysipelothrix Rhusiopathiae Avirulent Live Culture Vaccine (USDA: 1541.04) VO:0001794 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1927 1927 USDA: 19J1.00 vaccine Haemophilus Parasuis Avirulent Live Culture Vaccine (USDA: 19J1.00) VO:0001795 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1929 1929 USDA: 10L1.00 vaccine Lawsonia Intracellularis Avirulent Live Culture Vaccine (USDA: 10L1.00) VO:0001796 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1930 1930 USDA: 10L1.01 vaccine Lawsonia Intracellularis Avirulent Live Culture Vaccine (USDA: 10L1.01) VO:0001797 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1931 1931 USDA: 10L1.02 vaccine Lawsonia Intracellularis Avirulent Live Culture Vaccine (USDA: 10L1.02) VO:0001798 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2095 2095 USDA: 19K5.20 vaccine Porcine Circovirus Type 2, Killed Virus Vaccine (USDA: 19K5.20) VO:0001799 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2102 2102 USDA: 19T1.20 vaccine Porcine Reproductive & Respiratory Syndrome Reproductive & Respiratory Form, Modified Live Virus Vaccine (USDA: 19T1.20) VO:0001800 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2103 2103 USDA: 19T1.21 vaccine Porcine Reproductive & Respiratory Syndrome Reproductive & Respiratory Form, Modified Live Virus Vaccine (USDA: 19T1.21) VO:0001801 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2101 2101 USDA: 19S5.20 vaccine Porcine Reproductive & Respiratory Syndrome Reproductive Form, Killed Virus Vaccine (USDA: 19S5.20) VO:0001802 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2098 2098 USDA: 19Q1.20 vaccine Porcine Reproductive & Respiratory Syndrome Reproductive Form, Modified Live Virus Vaccine (USDA: 19Q1.20) VO:0001803 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2099 2099 USDA: 19S1.20 vaccine Porcine Reproductive & Respiratory Syndrome Respiratory Form, Modified Live Virus Vaccine (USDA: 19S1.20) VO:0001804 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2100 2100 USDA: 19S1.21 vaccine Porcine Reproductive & Respiratory Syndrome Respiratory Form, Modified Live Virus Vaccine (USDA: 19S1.21) VO:0001805 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2104 2104 USDA: 19E1.20 vaccine Porcine Rotavirus Modified Live Virus Vaccine (USDA: 19E1.20) VO:0001806 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2107 2107 USDA: 1891.20 vaccine Pseudorabies Modified Live Virus Vaccine (USDA: 1891.20) VO:0001807 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2108 2108 USDA: 1891.22 vaccine Pseudorabies Modified Live Virus Vaccine (USDA: 1891.22) VO:0001808 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2109 2109 USDA: 1891.R2 vaccine Pseudorabies Modified Live Virus Vaccine (USDA: 1891.R2) VO:0001809 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2110 2110 USDA: 1891.R4 vaccine Pseudorabies Modified Live Virus Vaccine (USDA: 1891.R4) VO:0001810 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2134 2134 USDA: 19A5.2P vaccine swine influenza pH1N1, killed virus vaccine (USDA: 19A5.2P) VO:0001811 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2142 2142 USDA: 1961.20 vaccine Transmissible Gastroenteritis Modified Live Virus Vaccine (USDA: 1961.20) VO:0001812 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2147 2147 USDA: 1995.20 vaccine West Nile Virus Killed Virus Vaccine (USDA: 1995.20) VO:0001813 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2148 2148 USDA: 1995.22 vaccine West Nile Virus Killed Virus Vaccine (USDA: 1995.22) VO:0001814 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2145 2145 USDA: 1991.R0 vaccine West Nile Virus Live Canarypox Vector Vaccine (USDA: 1991.R0) VO:0001815 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2146 2146 USDA: 1991.R1 vaccine West Nile Virus Live Flavivirus Chimera Vaccine (USDA: 1991.R1) VO:0001816 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1170 1170 USDA: 1061.00 vaccine Bluetongue Modified Live Virus Vaccine (USDA: 1061.00) VO:0001817 Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5554 WEB: https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM518295.pdf 5554 Afluria Quadrivalent Active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Afluria Quadrivalent is approved for use in persons 6 months of age and older. https://www.fda.gov/media/117022/download?attachment BL 125254 vaccine Afluria Quadrivalent VO:0001819 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1123 1123 USDA: 1K11.00 vaccine Arthrobacter Live Culture Vaccine (USDA: 1K11.00) VO:0001820 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1171 1171 USDA: 1021.01 vaccine Bordetella Avium Avirulent Live Culture Vaccine (USDA: 1021.01) VO:0001821 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1762 1762 USDA: 1551.02 vaccine Escherichia coli avirulent live culture vaccine (USDA: 1551.02) VO:0001822 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1764 1764 USDA: 15R1.00 vaccine Escherichia coli avirulent live culture vaccine (USDA: 15R1.00) VO:0001823 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1763 1763 USDA: 1551.R0 vaccine Escherichia coli live culture vaccine (USDA: 1551.R0) VO:0001824 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1928 1928 USDA: 17E1.20 vaccine Hemorrhagic Enteritis Live Virus Vaccine (USDA: 17E1.20) VO:0001825 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2096 2096 USDA: 19K5.R0 vaccine Porcine Circovirus Type 2, Killed Baculovirus Vector Vaccine (USDA: 19K5.R0) VO:0001826 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2128 2128 USDA: 19A5.12 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.12) VO:0001827 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2129 2129 USDA: 19A5.22 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.22) VO:0001828 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2130 2130 USDA: 19A5.23 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.23) VO:0001829 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2131 2131 USDA: 19A5.24 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.24) VO:0001830 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2132 2132 USDA: 19A5.26 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.26) VO:0001831 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2133 2133 USDA: 19A5.29 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.29) VO:0001832 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1970 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1971 1970 1971 USDA: 1679.31 vaccine Mink Distemper-Enteritis Modified Live & Killed Virus Vaccine (USDA: 1679.31) VO:0001833 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2884 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2885 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2886 2884 2885 2886 USDA: 4929.31 vaccine Mink Distemper-Enteritis Modified Live & Killed Virus Vaccine-Clostridium Botulinum Type C Bacterin-Toxoid (USDA: 4929.31) VO:0001834 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2887 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2888 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2889 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2890 2887 2888 2889 2890 USDA: 4949.20 vaccine Mink Distemper-Enteritis Modified Live & Killed Virus Vaccine-Clostridium botulinum Type C-Pseudomonas aeruginosa Bacterin-Toxoid (USDA: 4949.20) VO:0001835 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2891 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2892 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2893 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2894 2891 2892 2893 2894 USDA: 4949.31 vaccine Mink Distemper-Enteritis Modified Live & Killed Virus Vaccine-Clostridium botulinum Type C-Pseudomonas aeruginosa Bacterin-Toxoid (USDA: 4949.31) VO:0001836 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2881 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2882 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2883 2881 2882 2883 USDA: 4929.20 vaccine Mink Distemper-Enteritis Modified Live Virus & Killed Virus Vaccine-Clostridium botulinum Type C Bacterin-Toxoid (USDA: 4929.20) VO:0001837 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2895 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2896 2895 2896 USDA: 4955.20 vaccine Mink Enteritis Killed Virus Vaccine-Clostridium botulinum Type C Bacterin-Toxoid (USDA: 4955.20) VO:0001838 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2897 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2898 2897 2898 USDA: 4955.21 vaccine Mink Enteritis Killed Virus Vaccine-Clostridium botulinum Type C Bacterin-Toxoid (USDA: 4955.21) VO:0001839 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2899 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2900 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2901 2899 2900 2901 USDA: 49A5.20 vaccine Mink Enteritis Killed Virus Vaccine-Clostridium botulinum Type C-Pseudomonas aeruginosa Bacterin-Toxoid (USDA: 49A5.20) VO:0001840 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2902 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2903 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2904 2902 2903 2904 USDA: 49A5.21 vaccine Mink Enteritis Killed Virus Vaccine-Clostridium botulinum Type C-Pseudomonas aeruginosa Bacterin-Toxoid (USDA: 49A5.21) VO:0001841 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1769 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1770 1769 1770 USDA: 15D5.R0 vaccine Feline Immunodeficiency-Leukemia Virus Killed Virus Vaccine (USDA: 15D5.R0) VO:0001842 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1777 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1778 1777 1778 USDA: 1A69.20 vaccine Feline Leukemia-Chlamydia Psittaci Killed Virus, Killed Chlamydia Vaccine (USDA: 1A69.20) VO:0001843 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1779 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1780 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1781 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1782 1779 1780 1781 1782 USDA: 15B5.20 vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Killed Virus Vaccine (USDA: 15B5.20) VO:0001844 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1783 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1784 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1785 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1786 1783 1784 1785 1786 USDA: 15B5.21 vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Killed Virus Vaccine (USDA: 15B5.21) VO:0001845 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1787 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1788 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1789 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1790 1787 1788 1789 1790 USDA: 15B9.20 vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Modified Live & Killed Virus Vaccine (USDA: 15B9.20) VO:0001846 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1791 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1792 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1793 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1794 1791 1792 1793 1794 USDA: 15B9.21 vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Modified Live & Killed Virus Vaccine (USDA: 15B9.21) VO:0001847 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1795 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1796 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1797 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1798 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1799 1795 1796 1797 1798 1799 USDA: 1559.20 vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Killed Virus, Killed Chlamydia Vaccine (USDA: 1559.20) VO:0001848 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1800 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1801 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1802 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1803 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1804 1800 1801 1802 1803 1804 USDA: 1559.23 vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Killed Virus, Killed Chlamydia Vaccine (USDA: 1559.23) VO:0001849 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1810 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1811 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1812 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1813 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1814 1810 1811 1812 1813 1814 USDA: 1559.2C vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Modified Live & Killed Virus, Killed Chlamydia Vaccine (USDA: 1559.2C) VO:0001850 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1805 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1806 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1807 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1808 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1809 1805 1806 1807 1808 1809 USDA: 1559.2B vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Modified Live & Killed Virus, Modified Live Chlamydia Vaccine (USDA: 1559.2B) VO:0001851 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1821 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1822 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1823 1821 1822 1823 USDA: 16F1.20 vaccine Feline Rhinotracheitis-Calici-Chlamydia Psittaci Modified Live Virus, Modified Live Chlamydia Vaccine (USDA: 16F1.20) VO:0001852 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1824 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1825 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1826 1824 1825 1826 USDA: 16F1.21 vaccine Feline Rhinotracheitis-Calici-Chlamydia Psittaci Modified Live Virus, Modified Live Chlamydia Vaccine (USDA: 16F1.21) VO:0001853 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1839 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1840 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1841 1839 1840 1841 USDA: 16D5.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Killed Virus Vaccine (USDA: 16D5.20) VO:0001854 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1842 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1843 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1844 1842 1843 1844 USDA: 16D5.23 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Killed Virus Vaccine (USDA: 16D5.23) VO:0001855 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1851 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1852 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1853 1851 1852 1853 USDA: 16D9.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live & Killed Virus Vaccine (USDA: 16D9.20) VO:0001856 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1827 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1828 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1829 1827 1828 1829 USDA: 16D1.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live Virus Vaccine (USDA: 16D1.20) VO:0001857 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1830 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1831 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1832 1830 1831 1832 USDA: 16D1.22 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live Virus Vaccine (USDA: 16D1.22) VO:0001858 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1833 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1834 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1835 1833 1834 1835 USDA: 16D1.23 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live Virus Vaccine (USDA: 16D1.23) VO:0001859 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1836 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1837 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1838 1836 1837 1838 USDA: 16D1.24 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live Virus Vaccine (USDA: 16D1.24) VO:0001860 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1845 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1846 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1847 1845 1846 1847 USDA: 16D8.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live Virus Vaccine (USDA: 16D8.20) VO:0001861 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1848 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1849 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1850 1848 1849 1850 USDA: 16D8.21 vaccine Feline Rhinotracheitis-Calici-Panleukopenia Modified Live Virus Vaccine (USDA: 16D8.21) VO:0001862 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1862 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1863 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1864 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1865 1862 1863 1864 1865 USDA: 16E5.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Killed Virus, Killed Chlamydia Vaccine (USDA: 16E5.20) VO:0001863 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1866 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1867 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1868 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1869 1866 1867 1868 1869 USDA: 16E5.23 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Killed Virus, Killed Chlamydia Vaccine (USDA: 16E5.23) VO:0001864 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1870 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1871 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1872 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1873 1870 1871 1872 1873 USDA: 16E6.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Modified Live Virus, Killed Chlamydia Vaccine (USDA: 16E6.20) VO:0001865 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1854 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1855 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1856 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1857 1854 1855 1856 1857 USDA: 16E1.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Modified Live Virus, Modified Live Chlamydia Vaccine (USDA: 16E1.20) VO:0001866 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1858 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1859 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1860 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1861 1858 1859 1860 1861 USDA: 16E1.24 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Modified Live Virus, Modified Live Chlamydia Vaccine (USDA: 16E1.24) VO:0001867 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1874 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1875 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1876 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1877 1874 1875 1876 1877 USDA: 16E8.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Modified Live Virus, Modified Live Chlamydia Vaccine (USDA: 16E8.20) VO:0001868 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1878 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1879 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1880 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1881 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1882 1878 1879 1880 1881 1882 USDA: 1619.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci-Rabies Modified Live & Killed Virus, Modified Live Chlamydia Vaccine (USDA: 1619.20) VO:0001869 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1883 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1884 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1885 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1886 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1887 1883 1884 1885 1886 1887 USDA: 1619.R1 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci-Rabies Modified Live Virus and Chlamydia, Canarypox Vector Vaccine (USDA: 1619.R1) VO:0001870 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1888 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1889 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1890 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1891 1888 1889 1890 1891 USDA: 16T9.20 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Modified Live & Killed Virus Vaccine (USDA: 16T9.20) VO:0001871 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1892 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1893 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1894 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1895 1892 1893 1894 1895 USDA: 16T9.R0 vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Modified Live Virus, Canarypox Vector Vaccine (USDA: 16T9.R0) VO:0001872 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1896 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1897 1896 1897 USDA: 16C1.20 vaccine Feline Rhinotracheitis-Calicivirus Modified Live Virus Vaccine (USDA: 16C1.20) VO:0001873 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1898 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1899 1898 1899 USDA: 16C1.21 vaccine Feline Rhinotracheitis-Calicivirus Modified Live Virus Vaccine (USDA: 16C1.21) VO:0001874 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1900 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1901 1900 1901 USDA: 16C1.22 vaccine Feline Rhinotracheitis-Calicivirus Modified Live Virus Vaccine (USDA: 16C1.22) VO:0001875 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1174 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1175 1174 1175 USDA: 1161.00 vaccine Bovine Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1161.00) VO:0001876 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1176 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1177 1176 1177 USDA: 1161.20 vaccine Bovine Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1161.20) VO:0001877 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2152 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2153 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2154 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2155 2152 2153 2154 2155 USDA: 45H5.20 vaccine Bovine Rhinotracheitis Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid (USDA: 45H5.20) VO:0001878 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2156 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2157 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2158 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2159 2156 2157 2158 2159 USDA: 45H5.21 vaccine Bovine Rhinotracheitis Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid (USDA: 45H5.21) VO:0001879 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2160 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2161 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2162 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2163 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2164 2160 2161 2162 2163 2164 USDA: 4109.20 vaccine Bovine Rhinotracheitis Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica-Pasteurella Multocida-Salmonella Typhimurium Bacterin-Toxoid (USDA: 4109.20) VO:0001880 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2165 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2166 2165 2166 USDA: 4019.00 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4019.00) VO:0001881 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2167 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2168 2167 2168 USDA: 4059.00 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin (USDA: 4059.00) VO:0001882 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2169 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2170 2169 2170 USDA: 4069.20 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine-Leptospira Hardjo-Pomona Bacterin (USDA: 4069.20) VO:0001883 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2171 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2172 2171 2172 USDA: 4089.00 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4089.00) VO:0001884 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2173 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2174 2173 2174 USDA: 4089.20 vaccine Bovine Rhinotracheitis Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4089.20) VO:0001885 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2187 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2188 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2189 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2190 2187 2188 2189 2190 USDA: 4265.00 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Killed Virus Vaccine-Mannheimia Haemolytica-Pasteurella Multocida Bacterin (USDA: 4265.00) VO:0001886 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1187 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1188 1187 1188 USDA: 1121.00 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1121.00) VO:0001887 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1189 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1190 1189 1190 USDA: 1121.20 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1121.20) VO:0001888 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1191 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1192 1191 1192 USDA: 1121.21 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1121.21) VO:0001889 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1193 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1194 1193 1194 USDA: 1121.24 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1121.24) VO:0001890 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1195 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1196 1195 1196 USDA: 1121.31 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1121.31) VO:0001891 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2175 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2176 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2177 2175 2176 2177 USDA: 4139.20 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine-Haemophilus somnus Bacterin (USDA: 4139.20) VO:0001892 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2178 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2179 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2180 2178 2179 2180 USDA: 4129.00 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4129.00) VO:0001893 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2181 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2182 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2183 2181 2182 2183 USDA: 4179.00 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin (USDA: 4179.00) VO:0001894 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2184 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2185 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2186 2184 2185 2186 USDA: 4209.00 vaccine Bovine Rhinotracheitis-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4209.00) VO:0001895 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1197 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1198 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1199 1197 1198 1199 USDA: 1071.00 vaccine Bovine Rhinotracheitis-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1071.00) VO:0001896 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1200 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1201 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1202 1200 1201 1202 USDA: 1071.20 vaccine Bovine Rhinotracheitis-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1071.20) VO:0001897 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1203 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1204 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1205 1203 1204 1205 USDA: 1071.21 vaccine Bovine Rhinotracheitis-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1071.21) VO:0001898 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1206 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1207 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1208 1206 1207 1208 USDA: 1071.22 vaccine Bovine Rhinotracheitis-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1071.22) VO:0001899 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1209 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1210 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1211 1209 1210 1211 USDA: 1071.23 vaccine Bovine Rhinotracheitis-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1071.23) VO:0001900 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1212 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1213 1212 1213 USDA: 11B5.20 vaccine Bovine Rhinotracheitis-Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 11B5.20) VO:0001901 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1224 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1225 1224 1225 USDA: 1155.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine (USDA: 1155.20) VO:0001902 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1226 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1227 1226 1227 USDA: 1155.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine (USDA: 1155.30) VO:0001903 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2195 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2196 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2197 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2198 2195 2196 2197 2198 USDA: 4145.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4145.20) VO:0001904 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2199 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2200 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2201 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2202 2199 2200 2201 2202 USDA: 4145.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4145.21) VO:0001905 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2203 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2204 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2205 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2206 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2207 2203 2204 2205 2206 2207 USDA: 43S5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid (USDA: 43S5.20) VO:0001906 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2208 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2209 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2210 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2211 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2212 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2213 2208 2209 2210 2211 2212 2213 USDA: 43T5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica-Pasteurella Multocida-Salmonella Typhimurium Bacterin-Toxoid (USDA: 43T5.20) VO:0001907 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2214 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2215 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2216 2214 2215 2216 USDA: 4335.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4335.20) VO:0001908 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2217 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2218 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2219 2217 2218 2219 USDA: 4336.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4336.30) VO:0001909 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1214 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1215 1214 1215 USDA: 1151.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine (USDA: 1151.00) VO:0001910 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1216 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1217 1216 1217 USDA: 1151.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine (USDA: 1151.20) VO:0001911 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1218 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1219 1218 1219 USDA: 1151.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine (USDA: 1151.22) VO:0001912 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1220 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1221 1220 1221 USDA: 1151.23 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine (USDA: 1151.23) VO:0001913 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1222 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1223 1222 1223 USDA: 1151.26 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine (USDA: 1151.26) VO:0001914 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2191 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2192 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2193 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2194 2191 2192 2193 2194 USDA: 4141.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4141.20) VO:0001915 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2220 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2221 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2222 2220 2221 2222 USDA: 4339.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4339.00) VO:0001916 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2223 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2224 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2225 2223 2224 2225 USDA: 4359.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin (USDA: 4359.00) VO:0001917 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2226 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2227 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2228 2226 2227 2228 USDA: 4399.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Leptospira Hardjo-Pomona Bacterin (USDA: 4399.20) VO:0001918 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2229 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2230 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2231 2229 2230 2231 USDA: 4389.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4389.00) VO:0001919 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2232 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2233 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2234 2232 2233 2234 USDA: 4389.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4389.20) VO:0001920 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2235 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2236 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2237 2235 2236 2237 USDA: 4389.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4389.21) VO:0001921 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1252 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1253 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1254 1252 1253 1254 USDA: 1175.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Killed Virus Vaccine (USDA: 1175.20) VO:0001922 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2252 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2253 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2254 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2255 2252 2253 2254 2255 USDA: 4435.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4435.20) VO:0001923 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1228 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1229 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1230 1228 1229 1230 USDA: 1171.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.00) VO:0001924 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1231 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1232 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1233 1231 1232 1233 USDA: 1171.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.20) VO:0001925 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1234 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1235 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1236 1234 1235 1236 USDA: 1171.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.22) VO:0001926 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1237 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1238 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1239 1237 1238 1239 USDA: 1171.24 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.24) VO:0001927 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1240 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1241 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1242 1240 1241 1242 USDA: 1171.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.25) VO:0001928 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1243 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1244 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1245 1243 1244 1245 USDA: 1171.26 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.26) VO:0001929 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1246 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1247 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1248 1246 1247 1248 USDA: 1171.27 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.27) VO:0001930 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1249 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1250 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1251 1249 1250 1251 USDA: 1171.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine (USDA: 1171.30) VO:0001931 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2238 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2239 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2240 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2241 2238 2239 2240 2241 USDA: 4560.24 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4560.24) VO:0001932 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2242 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2243 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2244 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2245 2242 2243 2244 2245 USDA: 4560.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4560.25) VO:0001933 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2246 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2247 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2248 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2249 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2250 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2251 2246 2247 2248 2249 2250 2251 USDA: 4489.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Haemophilus somnus-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4489.30) VO:0001934 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2256 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2257 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2258 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2259 2256 2257 2258 2259 USDA: 4439.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4439.00) VO:0001935 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2260 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2261 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2262 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2263 2260 2261 2262 2263 USDA: 4439.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4439.20) VO:0001936 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2264 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2265 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2266 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2267 2264 2265 2266 2267 USDA: 4479.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin (USDA: 4479.00) VO:0001937 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2268 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2269 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2270 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2271 2268 2269 2270 2271 USDA: 4509.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4509.00) VO:0001938 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2486 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2487 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2488 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2489 2486 2487 2488 2489 USDA: 44A5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Mannheimia Haemolytica Bacterin (USDA: 44A5.20) VO:0001939 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1255 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1256 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1257 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1258 1255 1256 1257 1258 USDA: 1181.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.00) VO:0001940 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1259 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1260 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1261 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1262 1259 1260 1261 1262 USDA: 1181.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.20) VO:0001941 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1263 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1264 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1265 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1266 1263 1264 1265 1266 USDA: 1181.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.21) VO:0001942 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1267 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1268 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1269 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1270 1267 1268 1269 1270 USDA: 1181.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.22) VO:0001943 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1271 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1272 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1273 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1274 1271 1272 1273 1274 USDA: 1181.23 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.23) VO:0001944 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1275 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1276 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1277 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1278 1275 1276 1277 1278 USDA: 1181.24 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.24) VO:0001945 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1279 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1280 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1281 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1282 1279 1280 1281 1282 USDA: 1181.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.25) VO:0001946 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1283 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1284 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1285 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1286 1283 1284 1285 1286 USDA: 1181.26 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.26) VO:0001947 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1287 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1288 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1289 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1290 1287 1288 1289 1290 USDA: 1181.28 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.28) VO:0001948 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1291 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1292 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1293 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1294 1291 1292 1293 1294 USDA: 1181.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 1181.30) VO:0001949 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1295 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1296 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1297 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1298 1295 1296 1297 1298 USDA: 1185.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 1185.20) VO:0001950 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1299 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1300 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1301 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1302 1299 1300 1301 1302 USDA: 1185.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 1185.22) VO:0001951 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2277 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2278 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2279 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2280 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2281 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2282 2277 2278 2279 2280 2281 2282 USDA: 44M5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Campylobacter Fetus-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44M5.20) VO:0001952 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2283 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2284 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2285 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2286 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2287 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2288 2283 2284 2285 2286 2287 2288 USDA: 44M5.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Campylobacter Fetus-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44M5.22) VO:0001953 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2313 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2314 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2315 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2316 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2317 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2318 2313 2314 2315 2316 2317 2318 USDA: 44B5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B5.20) VO:0001954 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2319 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2320 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2321 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2322 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2323 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2324 2319 2320 2321 2322 2323 2324 USDA: 44B6.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B6.20) VO:0001955 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2325 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2326 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2327 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2328 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2329 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2330 2325 2326 2327 2328 2329 2330 USDA: 44B6.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B6.21) VO:0001956 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2343 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2344 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2345 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2346 2343 2344 2345 2346 USDA: 44C5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44C5.20) VO:0001957 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2347 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2348 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2349 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2350 2347 2348 2349 2350 USDA: 44C7.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44C7.20) VO:0001958 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2367 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2368 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2369 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2370 2367 2368 2369 2370 USDA: 44D5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44D5.20) VO:0001959 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2375 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2376 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2377 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2378 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2379 2375 2376 2377 2378 2379 USDA: 44D7.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44D7.20) VO:0001960 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2380 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2381 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2382 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2383 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2384 2380 2381 2382 2383 2384 USDA: 44D7.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44D7.22) VO:0001961 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2405 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2406 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2407 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2408 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2409 2405 2406 2407 2408 2409 USDA: 4477.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica Bacterin (USDA: 4477.20) VO:0001962 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2426 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2427 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2428 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2429 2426 2427 2428 2429 USDA: 4465.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4465.20) VO:0001963 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2430 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2431 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2432 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2433 2430 2431 2432 2433 USDA: 4465.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4465.21) VO:0001964 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2434 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2435 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2436 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2437 2434 2435 2436 2437 USDA: 4465.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4465.22) VO:0001965 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2438 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2439 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2440 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2441 2438 2439 2440 2441 USDA: 4466.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4466.20) VO:0001966 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2442 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2443 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2444 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2445 2442 2443 2444 2445 USDA: 4466.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4466.21) VO:0001967 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2482 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2483 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2484 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2485 2482 2483 2484 2485 USDA: 4475.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona-Mannheimia Haemolytica Bacterin (USDA: 4475.20) VO:0001968 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1303 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1304 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1305 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1306 1303 1304 1305 1306 USDA: 1187.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1187.20) VO:0001969 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1307 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1308 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1309 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1310 1307 1308 1309 1310 USDA: 1187.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1187.21) VO:0001970 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1311 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1312 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1313 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1314 1311 1312 1313 1314 USDA: 1187.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1187.22) VO:0001971 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1315 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1316 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1317 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1318 1315 1316 1317 1318 USDA: 1187.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1187.25) VO:0001972 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1319 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1320 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1321 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1322 1319 1320 1321 1322 USDA: 1189.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1189.00) VO:0001973 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1323 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1324 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1325 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1326 1323 1324 1325 1326 USDA: 1189.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1189.21) VO:0001974 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1327 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1328 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1329 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1330 1327 1328 1329 1330 USDA: 1189.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine (USDA: 1189.30) VO:0001975 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2331 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2332 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2333 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2334 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2335 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2336 2331 2332 2333 2334 2335 2336 USDA: 44B9.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B9.21) VO:0001976 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2337 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2338 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2339 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2340 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2341 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2342 2337 2338 2339 2340 2341 2342 USDA: 44B9.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B9.22) VO:0001977 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2371 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2372 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2373 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2374 2371 2372 2373 2374 USDA: 44F9.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44F9.20) VO:0001978 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2454 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2455 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2456 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2457 2454 2455 2456 2457 USDA: 4469.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.20) VO:0001979 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2458 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2459 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2460 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2461 2458 2459 2460 2461 USDA: 4469.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.22) VO:0001980 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2470 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2471 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2472 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2473 2470 2471 2472 2473 USDA: 4469.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.25) VO:0001981 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2478 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2479 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2480 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2481 2478 2479 2480 2481 USDA: 4469.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.30) VO:0001982 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2289 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2290 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2291 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2292 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2293 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2294 2289 2290 2291 2292 2293 2294 USDA: 44B1.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B1.20) VO:0001983 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2295 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2296 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2297 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2298 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2299 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2300 2295 2296 2297 2298 2299 2300 USDA: 44B1.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B1.22) VO:0001984 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2301 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2302 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2303 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2304 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2305 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2306 2301 2302 2303 2304 2305 2306 USDA: 44B1.23 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B1.23) VO:0001985 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2307 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2308 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2309 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2310 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2311 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2312 2307 2308 2309 2310 2311 2312 USDA: 44B1.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44B1.25) VO:0001986 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2351 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2352 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2353 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2354 2351 2352 2353 2354 USDA: 44C9.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44C9.20) VO:0001987 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2355 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2356 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2357 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2358 2355 2356 2357 2358 USDA: 44C9.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44C9.21) VO:0001988 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2359 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2360 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2361 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2362 2359 2360 2361 2362 USDA: 44C9.23 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44C9.23) VO:0001989 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2363 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2364 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2365 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2366 2363 2364 2365 2366 USDA: 44C9.24 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus Bacterin (USDA: 44C9.24) VO:0001990 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2385 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2386 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2387 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2388 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2389 2385 2386 2387 2388 2389 USDA: 44D9.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44D9.20) VO:0001991 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2390 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2391 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2392 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2393 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2394 2390 2391 2392 2393 2394 USDA: 44D9.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44D9.21) VO:0001992 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2395 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2396 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2397 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2398 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2399 2395 2396 2397 2398 2399 USDA: 44D9.23 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44D9.23) VO:0001993 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2400 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2401 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2402 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2403 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2404 2400 2401 2402 2403 2404 USDA: 44D9.24 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Haemophilus somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 44D9.24) VO:0001994 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2410 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2411 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2412 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2413 2410 2411 2412 2413 USDA: 4461.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4461.20) VO:0001995 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2414 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2415 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2416 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2417 2414 2415 2416 2417 USDA: 4461.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4461.21) VO:0001996 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2418 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2419 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2420 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2421 2418 2419 2420 2421 USDA: 4461.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4461.22) VO:0001997 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2422 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2423 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2424 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2425 2422 2423 2424 2425 USDA: 4461.25 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4461.25) VO:0001998 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2446 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2447 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2448 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2449 2446 2447 2448 2449 USDA: 4469.00 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.00) VO:0001999 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2450 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2451 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2452 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2453 2450 2451 2452 2453 USDA: 4469.01 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.01) VO:0002000 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2462 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2463 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2464 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2465 2462 2463 2464 2465 USDA: 4469.23 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.23) VO:0002001 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2466 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2467 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2468 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2469 2466 2467 2468 2469 USDA: 4469.24 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.24) VO:0002002 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2474 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2475 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2476 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2477 2474 2475 2476 2477 USDA: 4469.26 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4469.26) VO:0002003 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2272 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2273 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2274 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2275 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2276 2272 2273 2274 2275 2276 USDA: 4L49.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Hardjo Bacterin (USDA: 4L49.20) VO:0002004 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2490 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2491 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2492 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2493 2490 2491 2492 2493 USDA: 4X49.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Mannheimia Haemolytica Toxoid (USDA: 4X49.20) VO:0002005 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2494 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2495 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2496 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2497 2494 2495 2496 2497 USDA: 4X49.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Mannheimia Haemolytica Toxoid (USDA: 4X49.21) VO:0002006 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2498 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2499 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2500 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2501 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2502 2498 2499 2500 2501 2502 USDA: 45B9.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid (USDA: 45B9.20) VO:0002007 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2503 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2504 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2505 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2506 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2507 2503 2504 2505 2506 2507 USDA: 45B9.21 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Modified Live Virus Vaccine-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid (USDA: 45B9.21) VO:0002008 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1331 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1332 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1333 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1334 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1335 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1336 1331 1332 1333 1334 1335 1336 USDA: 11A8.22 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus-Mannheimia Haemolytica-Pasteurella Multocida Modified Live Virus, Avirulent Live Culture Vaccine (USDA: 11A8.22) VO:0002009 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1346 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1347 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1348 1346 1347 1348 USDA: 11A5.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 11A5.20) VO:0002010 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1337 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1338 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1339 1337 1338 1339 USDA: 11A1.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 11A1.20) VO:0002011 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1340 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1341 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1342 1340 1341 1342 USDA: 11A1.26 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 11A1.26) VO:0002012 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1343 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1344 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1345 1343 1344 1345 USDA: 11A1.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Modified Live Virus Vaccine (USDA: 11A1.30) VO:0002013 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2508 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2509 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2510 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2511 2508 2509 2510 2511 USDA: 4367.20 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4367.20) VO:0002014 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2512 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2513 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2514 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2515 2512 2513 2514 2515 USDA: 4367.26 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4367.26) VO:0002015 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2516 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2517 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2518 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2519 2516 2517 2518 2519 USDA: 4367.30 vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4367.30) VO:0002016 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1350 1350 USDA: 1935.20 vaccine Bovine Rotavirus-Coronavirus Modified Killed Virus Vaccine (USDA: 1935.20) VO:0002017 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1349 1349 USDA: 1931.20 vaccine Bovine Rotavirus-Coronavirus Modified Live Virus Vaccine (USDA: 1931.20) VO:0002018 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2520 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2521 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2522 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2523 2520 2521 2522 2523 USDA: 4570.20 vaccine Bovine Rotavirus-Coronavirus Killed Virus Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid (USDA: 4570.20) VO:0002019 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2524 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2525 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2526 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2527 2524 2525 2526 2527 USDA: 4570.22 vaccine Bovine Rotavirus-Coronavirus Killed Virus Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid (USDA: 4570.22) VO:0002020 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2528 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2529 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2530 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2531 2528 2529 2530 2531 USDA: 4575.20 vaccine Bovine Rotavirus-Coronavirus Killed Virus Vaccine-Clostridium Perfringens Types C & D-Escherichia Coli Bacterin-Toxoid (USDA: 4575.20) VO:0002021 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2532 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2533 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2534 2532 2533 2534 USDA: 4585.20 vaccine Bovine Rotavirus-Coronavirus Killed Virus Vaccine-Escherichia Coli Bacterin (USDA: 4585.20) VO:0002022 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2535 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2536 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2537 2535 2536 2537 USDA: 4585.22 vaccine Bovine Rotavirus-Coronavirus Killed Virus Vaccine-Escherichia Coli Bacterin (USDA: 4585.22) VO:0002023 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2538 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2539 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2540 2538 2539 2540 USDA: 45B5.21 vaccine Bovine Virus Diarrhea Killed Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 45B5.21) VO:0002024 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2541 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2542 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2543 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2544 2541 2542 2543 2544 USDA: 4C95.20 vaccine Bovine Virus Diarrhea Killed Virus Vaccine-Haemophilus somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid (USDA: 4C95.20) VO:0002025 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2545 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2546 2545 2546 USDA: 4595.21 vaccine Bovine Virus Diarrhea Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4595.21) VO:0002026 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2547 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2548 2547 2548 USDA: 4595.25 vaccine Bovine Virus Diarrhea Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4595.25) VO:0002027 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2549 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2550 2549 2550 USDA: 4599.00 vaccine Bovine Virus Diarrhea Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4599.00) VO:0002028 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1359 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1360 1359 1360 USDA: 12A5.20 vaccine Bovine Virus Diarrhea-Respiratory Syncytial Virus Killed Virus Vaccine (USDA: 12A5.20) VO:0002029 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1932 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1933 1932 1933 USDA: 1861.01 vaccine Mannheimia Haemolytica-Pasteurella Multocida Avirulent Live Culture Vaccine (USDA: 1861.01) VO:0002030 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1143 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1144 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1145 1143 1144 1145 USDA:1D61.R0 vaccine Avian Encephalomyelitis-Fowl Pox-Mycoplasma Gallisepticum Live Fowl Pox Vector, Live Virus Vaccine (USDA:1D61.R0) VO:0002031 JZ: it may be same as term VO:0002048, USDA: 12C2.50, current USDA numbers are not correct since manufacturer is not same. Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1437 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1438 1437 1438 vaccine Bursal Disease-Marek's Disease Variant, Serotypes 2 & 3, Live Virus Vaccine (USDA: ) VO:0002032 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1160 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1161 1160 1161 USDA: 1061.R0 vaccine avian influenza-Fowl Pox H5 Subtype, Live Fowl Pox Vector Vaccine (USDA: 1061.R0) VO:0002033 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1130 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1131 1130 1131 USDA: 10M1.10 vaccine Avian Encephalomyelitis-Fowl Pox Live Virus Vaccine (USDA: 10M1.10 ) VO:0002034 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1132 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1133 1132 1133 USDA: 10M1.11 vaccine Avian Encephalomyelitis-Fowl Pox Live Virus Vaccine (USDA: 10M1.11) VO:0002035 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1134 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1135 1134 1135 USDA: 10M1.13 vaccine Avian Encephalomyelitis-Fowl Pox Live Virus Vaccine (USDA: 10M1.13) VO:0002036 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1136 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1137 1136 1137 USDA: 10M1.14 vaccine Avian Encephalomyelitis-Fowl Pox Live Virus Vaccine (USDA: 10M1.14) VO:0002037 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1138 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1139 1138 1139 USDA: 10M1.40 vaccine Avian Encephalomyelitis-Fowl Pox Live Virus Vaccine (USDA: 10M1.40) VO:0002038 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1140 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1141 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1142 1140 1141 1142 USDA: 10S1.R0 vaccine Avian Encephalomyelitis-Fowl Pox-Laryngotracheitis Live Virus, Live Fowl Pox Vector Vaccine (USDA: 10S1.R0) VO:0002039 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1128 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1129 1128 1129 USDA: 10T1.40 vaccine Avian Encephalomyelitis-Chicken Anemia Virus-Fowl Pox C155Live and Modified Live C212Virus Vaccine (USDA: 10T1.40)+C433 VO:0002040 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1414 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1415 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1416 1414 1415 1416 USDA: 1281.R0 vaccine Bursal Disease-Marek's Disease Serotypes 1 & 2 & 3, Live Virus, Live Marek's Disease Vector Vaccine (USDA: 1281.R0) VO:0002041 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1417 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1418 1417 1418 USDA: 1281.R1 vaccine Bursal Disease-Marek's Disease Serotypes 1 & 3, Live Virus, Live Marek's Disease Vector Vaccine (USDA: 1281.R1) VO:0002042 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1419 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1420 1419 1420 USDA: 1282.50 vaccine Bursal Disease-Marek's Disease Variant, Serotype 3, Live Virus Vaccine (USDA: 1282.50) VO:0002043 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1421 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1422 1421 1422 USDA: 1288.42 vaccine Bursal Disease-Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 1288.42) VO:0002044 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1423 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1424 1423 1424 USDA: 1288.43 vaccine Bursal Disease-Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1288.43) VO:0002045 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1425 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1426 1425 1426 USDA: 1288.44 vaccine Bursal Disease-Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1288.44) VO:0002046 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1427 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1428 1427 1428 USDA: 1288.45 vaccine Bursal Disease-Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1288.45) VO:0002047 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1429 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1430 1429 1430 USDA: 1288.4A vaccine Bursal Disease-Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 1288.4A) VO:0002048 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1431 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1432 1431 1432 USDA: 12C2.50 vaccine Bursal Disease-Marek's Disease Variant, Serotypes 2 & 3, Live Virus Vaccine (USDA: 12C2.50) VO:0002049 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1433 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1434 1433 1434 USDA: 12C2.51 vaccine Bursal Disease-Marek's Disease Variant, Serotypes 2 & 3, Live Virus Vaccine (USDA: 12C2.51) VO:0002050 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1435 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1436 1435 1436 USDA: 12C2.52 vaccine Bursal Disease-Marek's Disease Variant Strain, Serotypes 2 & 3, Live Virus Vaccine (USDA: 12C2.52) VO:0002051 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1439 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1440 1439 1440 USDA: 12C8.40 vaccine Bursal Disease-Marek's Disease Standard & Variant, Serotype 3, Live Virus Vaccine (USDA: 12C8.40) VO:0002052 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1441 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1442 1441 1442 USDA: 12C8.42 vaccine Bursal Disease-Marek's Disease Standard & Variant, Serotypes 2 & 3, Live Virus Vaccine (USDA: 12C8.42) VO:0002053 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1443 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1444 1443 1444 USDA: 12C8.43 vaccine Bursal Disease-Marek's Disease Standard & Variant, Serotype 3, Live Virus Vaccine (USDA: 12C8.43) VO:0002054 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1445 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1446 1445 1446 USDA: 12C8.44 vaccine Bursal Disease-Marek's Disease Standard & Variant, Serotypes 2 & 3, Live Virus Vaccine (USDA: 12C8.44) VO:0002055 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1539 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1540 1539 1540 USDA: 12D5.01 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.01) VO:0002056 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1541 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1542 1541 1542 USDA: 12D5.02 vaccine Bursal Disease-Reovirus Killed Virus Vaccine (USDA: 12D5.02) VO:0002057 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1543 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1544 1543 1544 USDA: 12D5.03 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.03) VO:0002058 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1545 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1546 1545 1546 USDA: 12D5.04 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.04) VO:0002059 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1547 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1548 1547 1548 USDA: 12D5.30 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.30) VO:0002060 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1465 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1466 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1467 1465 1466 1467 USDA: 12D5.45 vaccine Bursal Disease-Newcastle Disease-Bronchitis Standard & Variant, Mass & Ark Types, Killed Virus Vaccine (USDA: 12D5.45) VO:0002061 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1549 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1550 1549 1550 USDA: 12D5.E0 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.E0) VO:0002062 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1551 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1552 1551 1552 USDA: 12D5.F0 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.F0) VO:0002063 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1553 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1554 1553 1554 USDA: 12D5.F1 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.F1) VO:0002064 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1555 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1556 1555 1556 USDA: 12D5.T0 vaccine Bursal Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12D5.T0) VO:0002065 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1457 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1458 1457 1458 USDA: 12G5.10 vaccine Bursal Disease-Newcastle Disease Killed Virus Vaccine (USDA: 12G5.10) VO:0002066 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1459 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1460 1459 1460 USDA: 12G5.11 vaccine Bursal Disease-Newcastle Disease Killed Virus Vaccine (USDA: 12G5.11) VO:0002067 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1461 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1462 1461 1462 USDA: 12G5.42 vaccine Bursal Disease-Newcastle Disease Standard & Variant, Killed Virus Vaccine (USDA: 12G5.42) VO:0002068 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1463 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1464 1463 1464 USDA: 12G5.43 vaccine Bursal Disease-Newcastle Disease Killed Virus Vaccine (USDA: 12G5.43) VO:0002069 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1468 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1469 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1470 1468 1469 1470 USDA: 12H1.4M vaccine Bursal Disease-Newcastle Disease-Bronchitis B1 Type, B1 Strain, Mass & Ark Types, Live Virus Vaccine (USDA: 12H1.4M) VO:0002070 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1471 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1472 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1473 1471 1472 1473 USDA: 12H1.67 vaccine Bursal Disease-Newcastle Disease-Bronchitis B1 Type, B1 Strain, Mass & Ark Types, Live Virus Vaccine (USDA: 12H1.67) VO:0002071 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1474 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1475 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1476 1474 1475 1476 USDA: 12J5.40 vaccine Bursal Disease-Newcastle Disease-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 12J5.40) VO:0002072 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1477 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1478 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1479 1477 1478 1479 USDA: 12J5.43 vaccine Bursal Disease-Newcastle Disease-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 12J5.43) VO:0002073 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1480 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1481 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1482 1480 1481 1482 USDA: 12J5.61 vaccine Bursal Disease-Newcastle Disease-Bronchitis Standard & Variant, Mass Type, Killed Virus Vaccine (USDA: 12J5.61) VO:0002074 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1483 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1484 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1485 1483 1484 1485 USDA: 12J5.62 vaccine Bursal Disease-Newcastle Disease-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 12J5.62) VO:0002075 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1486 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1487 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1488 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1489 1486 1487 1488 1489 USDA: 12M5.00 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Standard & Variant, Mass Type, Killed Virus Vaccine (USDA: 12M5.00) VO:0002076 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1490 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1491 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1492 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1493 1490 1491 1492 1493 USDA: 12M5.01 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Standard & Variant, Mass Type, Killed Virus Vaccine (USDA: 12M5.01) VO:0002077 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1494 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1495 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1496 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1497 1494 1495 1496 1497 USDA: 12M5.11 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Mass Type, Killed Virus Vaccine (USDA: 12M5.11) VO:0002078 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1498 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1499 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1500 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1501 1498 1499 1500 1501 USDA: 12M5.40 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Killed Virus Vaccine (USDA: 12M5.40) VO:0002079 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1502 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1503 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1504 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1505 1502 1503 1504 1505 USDA: 12M5.41 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Standard & Variant, Mass & Ark Types, Killed Virus Vaccine (USDA: 12M5.41) VO:0002080 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1506 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1507 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1508 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1509 1506 1507 1508 1509 USDA: 12M5.42 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Standard & Variant, Mass & Ark Types, Killed Virus Vaccine (USDA: 12M5.42) VO:0002081 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1510 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1511 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1512 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1513 1510 1511 1512 1513 USDA: 12M5.43 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Mass Type, Killed Virus Vaccine (USDA: 12M5.43) VO:0002082 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1514 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1515 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1516 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1517 1514 1515 1516 1517 USDA: 12M5.50 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Mass Type, Killed Virus Vaccine (USDA: 12M5.50) VO:0002083 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1518 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1519 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1520 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1521 1518 1519 1520 1521 USDA: 12M5.90 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Mass Type, Killed Virus Vaccine (USDA: 12M5.90) VO:0002084 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1522 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1523 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1524 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1525 1522 1523 1524 1525 USDA: 12M5.91 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Mass Type, Killed Virus Vaccine (USDA: 12M5.91) VO:0002085 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1526 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1527 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1528 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1529 1526 1527 1528 1529 USDA: 12M5.E0 vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Standard & Variant, Mass Type, Killed Virus Vaccine (USDA: 12M5.E0) VO:0002086 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1530 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1531 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1532 1530 1531 1532 USDA: 12P5.40 vaccine Bursal Disease-Newcastle Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12P5.40) VO:0002087 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1533 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1534 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1535 1533 1534 1535 USDA: 12P5.41 vaccine Bursal Disease-Newcastle Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12P5.41) VO:0002088 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1536 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1537 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1538 1536 1537 1538 USDA: 12P5.E0 vaccine Bursal Disease-Newcastle Disease-Reovirus Standard & Variant, Killed Virus Vaccine (USDA: 12P5.E0) VO:0002089 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1558 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1559 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1560 1558 1559 1560 USDA: 12X1.20 vaccine Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Modified Live Virus & Avirulent Live Culture Vaccine (USDA: 12X1.20) VO:0002090 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1657 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1658 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1659 1657 1658 1659 USDA: 1331.20 vaccine Canine Distemper-Adenovirus Type 2-Parvovirus Modified Live Virus Vaccine (USDA: 1331.20) VO:0002091 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1660 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1661 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1662 1660 1661 1662 USDA: 1331.25 vaccine Canine Distemper-Adenovirus Type 2-Parvovirus Modified Live Virus Vaccine (USDA: 1331.25) VO:0002092 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1663 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1664 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1665 1663 1664 1665 USDA: 1331.27 vaccine Canine Distemper-Adenovirus Type 2-Parvovirus Modified Live Virus Vaccine (USDA: 1331.27) VO:0002093 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1666 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1667 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1668 1666 1667 1668 USDA: 1331.30 vaccine Canine Distemper-Adenovirus Type 2-Parvovirus Modified Live Virus Vaccine (USDA: 1331.30) VO:0002094 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1669 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1670 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1671 1669 1670 1671 USDA: 1331.R1 vaccine Canine Distemper-Adenovirus Type 2-Parvovirus Modified Live Virus, Canarypox Vector Vaccine (USDA: 1331.R1) VO:0002095 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1605 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1606 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1607 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1608 1605 1606 1607 1608 USDA: 1341.20 vaccine Canine Distemper-Adenovirus Type 2-Measles-Parainfluenza Modified Live Virus Vaccine (USDA: 1341.20) VO:0002096 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1685 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1686 1685 1686 USDA: 1351.20 vaccine Canine Distemper-Measles Modified Live Virus Vaccine (USDA: 1351.20) VO:0002097 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1682 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1683 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1684 1682 1683 1684 USDA: 1381.21 vaccine Canine Distemper-Hepatitis-Parainfluenza Modified Live Virus Vaccine (USDA: 1381.21) VO:0002098 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1576 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1577 1576 1577 USDA: 13A1.20 vaccine Canine Distemper-Adenovirus Type 2 Modified Live Virus Vaccine (USDA: 13A1.20) VO:0002099 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1578 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1579 1578 1579 USDA: 13A1.27 vaccine Canine Distemper-Adenovirus Type 2 Modified Live Virus Vaccine (USDA: 13A1.27) VO:0002100 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1609 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1610 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1611 1609 1610 1611 USDA: 13C1.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza Modified Live Virus Vaccine (USDA: 13C1.20) VO:0002101 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1612 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1613 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1614 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1615 1612 1613 1614 1615 USDA: 13D1.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.20) VO:0002102 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1616 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1617 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1618 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1619 1616 1617 1618 1619 USDA: 13D1.21 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.21) VO:0002103 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1620 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1621 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1622 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1623 1620 1621 1622 1623 USDA: 13D1.22 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.22) VO:0002104 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1624 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1625 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1626 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1627 1624 1625 1626 1627 USDA: 13D1.23 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.23) VO:0002105 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1628 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1629 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1630 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1631 1628 1629 1630 1631 USDA: 13D1.25 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.25) VO:0002106 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1632 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1633 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1634 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1635 1632 1633 1634 1635 USDA: 13D1.27 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.27) VO:0002107 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1636 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1637 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1638 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1639 1636 1637 1638 1639 USDA: 13D1.28 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.28) VO:0002108 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1640 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1641 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1642 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1643 1640 1641 1642 1643 USDA: 13D1.29 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.29) VO:0002109 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1644 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1645 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1646 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1647 1644 1645 1646 1647 USDA: 13D1.R1 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus, Canarypox Vector Vaccine (USDA: 13D1.R1) VO:0002110 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1648 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1649 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1650 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1651 1648 1649 1650 1651 USDA: 13D1.T0 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine (USDA: 13D1.T0) VO:0002111 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1652 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1653 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1654 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1655 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1656 1652 1653 1654 1655 1656 USDA: 13G9.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus-Rabies Modified Live & Killed Virus Vaccine (USDA: 13G9.20) VO:0002112 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1672 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1673 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1674 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1675 1672 1673 1674 1675 USDA: 13H9.20 vaccine Canine Distemper-Adenovirus Type 2-Parvovirus-Rabies Modified Live & Killed Virus Vaccine (USDA: 13H9.20) VO:0002113 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1687 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1688 1687 1688 USDA: 13P1.20 vaccine Canine Distemper-Parvovirus Modified Live Virus Vaccine (USDA: 13P1.20) VO:0002114 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1689 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1690 1689 1690 USDA: 13P1.27 vaccine Canine Distemper-Parvovirus Modified Live Virus Vaccine (USDA: 13P1.27) VO:0002115 A horse Encephalomyelitis-Influenza-West Nile Virus vaccine that is inactivated and manufactured by Wyeth Pharmaceuticals Inc. Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1717 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1718 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1719 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1720 1717 1718 1719 1720 USDA: 13W5.20 vaccine Encephalomyelitis-Influenza-West Nile Virus Eastern & Western, Killed Virus Vaccine (USDA: 13W5.20) VO:0002116 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1715 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1716 1715 1716 USDA: 1475.00 vaccine Encephalomyelitis Eastern & Western, Killed Virus Vaccine (USDA: 1475.00) VO:0002117 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1676 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1677 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1678 1676 1677 1678 USDA: 14D7.20 vaccine Canine Distemper-Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14D7.20) VO:0002118 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1679 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1680 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1681 1679 1680 1681 USDA: 14D9.27 vaccine Canine Distemper-Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14D9.27) VO:0002119 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1693 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1694 1693 1694 USDA: 14M1.20 vaccine Canine Parainfluenza-Bordetella Bronchiseptica Modified Live Virus, Avirulent Live Culture Vaccine (USDA: 14M1.20) VO:0002120 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1695 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1696 1695 1696 USDA: 14M1.22 vaccine Canine Parainfluenza-Bordetella Bronchiseptica Modified Live Virus, Avirulent Live Culture Vaccine (USDA: 14M1.22) VO:0002121 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1564 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1565 1564 1565 USDA: 14R1.20 vaccine Canine Coronavirus-Parvovirus Modified Live Virus Vaccine (USDA: 14R1.20) VO:0002122 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1566 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1567 1566 1567 USDA: 14R7.20 vaccine Canine Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14R7.20) VO:0002123 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1568 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1569 1568 1569 USDA: 14R7.21 vaccine Canine Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14R7.21) VO:0002124 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1570 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1571 1570 1571 USDA: 14R7.22 vaccine Canine Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14R7.22) VO:0002125 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1572 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1573 1572 1573 USDA: 14R7.25 vaccine Canine Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14R7.25) VO:0002126 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1574 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1575 1574 1575 USDA: 14R7.29 vaccine Canine Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 14R7.29) VO:0002127 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1721 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1722 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1723 1721 1722 1723 USDA: 14W5.22 vaccine Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus Vaccine (USDA: 14W5.22) VO:0002128 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1724 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1725 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1726 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1727 1724 1725 1726 1727 USDA: 14W5.23 vaccine Encephalomyelitis-West Nile Virus Eastern & Western & Venezuelan, Killed Virus Vaccine (USDA: 14W5.23) VO:0002129 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1728 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1729 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1730 1728 1729 1730 USDA: 14W7.R0 vaccine Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus, Live Canarypox Vector Vaccine (USDA: 14W7.R0) VO:0002130 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1746 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1747 1746 1747 USDA: 1515.24 vaccine Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.24) VO:0002131 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1748 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1749 1748 1749 USDA: 1515.26 vaccine Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.26) VO:0002132 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1750 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1751 1750 1751 USDA: 1515.27 vaccine Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.27) VO:0002133 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1752 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1753 1752 1753 USDA: 1515.2A vaccine Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.2A) VO:0002134 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1754 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1755 1754 1755 USDA: 1518.20 vaccine Equine Rhinopneumonitis-Influenza Modified Live & Killed Virus Vaccine (USDA: 1518.20) VO:0002135 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1580 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1581 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1582 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1583 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1584 1580 1581 1582 1583 1584 USDA: 1591.R1 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live Virus; Canarypox Vector Vaccine (USDA: 1591.R1) VO:0002136 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1585 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1586 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1587 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1588 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1589 1585 1586 1587 1588 1589 USDA: 1599.20 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 1599.20) VO:0002137 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1590 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1591 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1592 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1593 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1594 1590 1591 1592 1593 1594 USDA: 1599.21 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 1599.21) VO:0002138 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1595 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1596 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1597 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1598 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1599 1595 1596 1597 1598 1599 USDA: 1599.25 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 1599.25) VO:0002139 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1600 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1601 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1602 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1603 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1604 1600 1601 1602 1603 1604 USDA: 1599.29 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine (USDA: 1599.29) VO:0002140 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1921 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1922 1921 1922 USDA: 15E2.00 vaccine Fowl Pox-Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 15E2.00) VO:0002141 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1909 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1910 1909 1910 USDA: 16J1.R1 vaccine Fowl Laryngotracheitis-Marek's Disease Serotype 3, Live Marek's Disease Vector Vaccine (USDA: 16J1.R1) VO:0002142 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1911 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1912 1911 1912 USDA: 16J1.R2 vaccine Fowl Laryngotracheitis-Marek's Disease Serotypes 2 & 3, Modified Live & Live Marek's Disease Vector Vaccine (USDA: 16J1.R2) VO:0002143 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1953 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1954 1953 1954 USDA: 16N1.R0 vaccine Marek's Disease-Newcastle Disease Serotype 3, Live Marek's Disease Vector Vaccine (USDA: 16N1.R0) VO:0002144 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1955 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1956 1955 1956 USDA: 16N1.R1 vaccine Marek's Disease-Newcastle Disease Serotypes 1 & 3, Live Virus, Live Marek's Disease Vector Vaccine (USDA: 16N1.R1) VO:0002145 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1957 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1958 1957 1958 USDA: 16N1.R2 vaccine Marek's Disease-Newcastle Disease Serotypes 1 & 2 & 3, Live Virus, Live Marek's Disease Vector Vaccine (USDA: 16N1.R2) VO:0002146 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1963 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1964 1963 1964 USDA: 16T1.00 vaccine Marek's Disease-Tenosynovitis Serotypes 2 & 3, Live & Modified Live Virus Vaccine (USDA: 16T1.00) VO:0002147 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1965 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1966 1965 1966 USDA: 16T1.03 vaccine Marek's Disease-Tenosynovitis Serotypes 2 & 3, Live Virus Vaccine (USDA: 16T1.03) VO:0002148 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1996 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1997 1996 1997 USDA: 1761.11 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass Type, Live Virus Vaccine (USDA: 1761.11) VO:0002149 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1998 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1999 1998 1999 USDA: 1761.12 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass Type, Live Virus Vaccine (USDA: 1761.12) VO:0002150 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2000 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2001 2000 2001 USDA: 1761.13 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Conn Type, Live Virus Vaccine (USDA: 1761.13) VO:0002151 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2002 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2003 2002 2003 USDA: 1761.14 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1761.14) VO:0002152 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2004 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2005 2004 2005 USDA: 1761.15 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1761.15) VO:0002153 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2006 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2007 2006 2007 USDA: 1761.17 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1761.17) VO:0002154 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2008 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2009 2008 2009 USDA: 1761.18 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass Type, Live Virus Vaccine (USDA: 1761.18) VO:0002155 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2010 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2011 2010 2011 USDA: 1761.19 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass Type, Live Virus Vaccine (USDA: 1761.19) VO:0002156 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2012 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2013 2012 2013 USDA: 1761.1A vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Conn Type, Live Virus Vaccine (USDA: 1761.1A) VO:0002157 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2014 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2015 2014 2015 USDA: 1762.11 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass Type, Live Virus Vaccine (USDA: 1762.11) VO:0002158 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2016 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2017 2016 2017 USDA: 1762.13 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Conn Type, Live Virus Vaccine (USDA: 1762.13) VO:0002159 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2018 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2019 2018 2019 USDA: 1762.1H vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1762.1H) VO:0002160 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2020 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2021 2020 2021 USDA: 1771.11 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.11) VO:0002161 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2022 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2023 2022 2023 USDA: 1771.12 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.12) VO:0002162 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2024 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2025 2024 2025 USDA: 1771.14 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1771.14) VO:0002163 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2026 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2027 2026 2027 USDA: 1771.17 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1771.17) VO:0002164 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2028 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2029 2028 2029 USDA: 1771.18 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.18) VO:0002165 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2030 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2031 2030 2031 USDA: 1771.19 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.19) VO:0002166 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2032 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2033 2032 2033 USDA: 1771.1A vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass Type, Live Virus Vaccine (USDA: 1771.1A) VO:0002167 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2034 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2035 2034 2035 USDA: 1775.10 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 1775.10) VO:0002168 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2036 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2037 2036 2037 USDA: 1775.11 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 1775.11) VO:0002169 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2038 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2039 2038 2039 USDA: 1776.10 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 1776.10) VO:0002170 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2040 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2041 2040 2041 USDA: 1785.10 vaccine Newcastle-Bronchitis Mass & Ark Types, Killed Virus Vaccine (USDA: 1785.10) VO:0002171 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2042 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2043 2042 2043 USDA: 1785.11 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine (USDA: 1785.11) VO:0002172 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2044 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2045 2044 2045 USDA: 1785.12 vaccine Newcastle-Bronchitis Mass & Ark Types, Killed Virus Vaccine (USDA: 1785.12) VO:0002173 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2046 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2047 2046 2047 USDA: 1791.14 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1791.14) VO:0002174 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2048 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2049 2048 2049 USDA: 1791.15 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1791.15) VO:0002175 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2050 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2051 2050 2051 USDA: 1791.19 vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass Type, Live Virus Vaccine (USDA: 1791.19) VO:0002176 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2052 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2053 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2054 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2055 2052 2053 2054 2055 USDA: 1791.1X vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Ark Types, Live Virus Vaccine (USDA: 1791.1X) VO:0002177 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2056 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2057 2056 2057 USDA: 17A1.1M vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Ark Types, Live Virus Vaccine (USDA: 17A1.1M) VO:0002178 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2058 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2059 2058 2059 USDA: 17A1.1N vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Ark Types, Live Virus Vaccine (USDA: 17A1.1N) VO:0002179 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2060 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2061 2060 2061 USDA: 17A2.1M vaccine Newcastle-Bronchitis B1 Type, B1 Strain, Mass & Ark Types, Live Virus Vaccine (USDA: 17A2.1M) VO:0002180 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2062 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2063 2062 2063 USDA: 17B1.17 vaccine Newcastle-Bronchitis B1 Type, LaSota Strain, Mass & Conn Types Vaccine (USDA: 17B1.17) VO:0002181 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1994 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1995 1994 1995 USDA: 17C1.R0 vaccine Newcastle Disease-Fowl Pox Live Fowl Pox Vector Vaccine (USDA: 17C1.R0) VO:0002182 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1959 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1960 1959 1960 USDA: 17H1.R1 vaccine Marek's Disease-Newcastle Disease Serotypes 2 & 3, Live Virus & Live Marek's Disease Vector Vaccine (USDA: 17H1.R1) VO:0002183 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1961 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1962 1961 1962 USDA: 17H1.R2 vaccine Marek's Disease-Newcastle Disease Serotypes 2 & 3, Live Virus & Live Marek's Disease Vector Vaccine (USDA: 17H1.R2) VO:0002184 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2072 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2073 2072 2073 USDA: 17P5.10 vaccine Newcastle-Paramyxovirus Type 3, Killed Virus Vaccine (USDA: 17P5.10) VO:0002185 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2064 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2065 2064 2065 USDA: 17V1.10 vaccine Newcastle-Bronchitis VG/GA Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 17V1.10) VO:0002186 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2066 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2067 2066 2067 USDA: 17V1.11 vaccine Newcastle-Bronchitis VG/GA Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 17V1.11) VO:0002187 generated using OntoRat Asiyah Yu Lin obsolete Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.12) USDA: 19A5.12 violinID:2128 true VO:0002188 generated using OntoRat Asiyah Yu Lin obsolete Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.22) USDA: 19A5.22 violinID:2129 true VO:0002189 generated using OntoRat Asiyah Yu Lin obsolete Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.23) USDA: 19A5.23 violinID:2130 true VO:0002190 generated using OntoRat Asiyah Yu Lin obsolete Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.24) USDA: 19A5.24 violinID:2131 true VO:0002191 generated using OntoRat Asiyah Yu Lin obsolete Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.26) USDA: 19A5.26 violinID:2132 true VO:0002192 generated using OntoRat Asiyah Yu Lin obsolete Swine Influenza H1N1 & H3N2, Killed Virus Vaccine (USDA: 19A5.29) USDA: 19A5.29 violinID:2133 true VO:0002193 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2105 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2106 2105 2106 USDA: 19H1.20 vaccine Porcine Rotavirus-Transmissible Gastroenteritis Modified Live Virus Vaccine (USDA: 19H1.20) VO:0002194 generated using OntoRat Asiyah Yu Lin obsolete Porcine Circovirus Type 2, Killed Baculovirus Vector Vaccine (USDA: 19K5.R0) USDA: 19K5.R0 violinID:2096 true VO:0002195 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2097 2097 USDA: 19K5.R1 vaccine Porcine Circovirus Type 1 - Type 2 Chimera, Killed Virus Vaccine (USDA: 19K5.R1) VO:0002196 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1447 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1448 1447 1448 USDA: 1A82.50 vaccine Bursal Disease-Marek's Disease Serotype 3, Live Virus Vaccine (USDA: 1A82.50) VO:0002197 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1449 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1450 1449 1450 USDA: 1A88.R0 vaccine Bursal Disease-Marek's Disease Serotype 3, Live Marek's Disease Vector Vaccine (USDA: 1A88.R0) VO:0002198 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1451 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1452 1451 1452 USDA: 1A88.R1 vaccine Bursal Disease-Marek's Disease Serotypes 2 & 3, Live Virus, Live Marek's Disease Vector Vaccine (USDA: 1A88.R1) VO:0002199 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1453 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1454 1453 1454 USDA: 1A88.R2 vaccine Bursal Disease-Marek's Disease Serotypes 2 & 3, Live Virus, Live Marek's Disease Vector Vaccine (USDA: 1A88.R2) VO:0002200 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1455 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1456 1455 1456 USDA: 1B82.50 vaccine Bursal Disease-Marek's Disease Serotypes 2 & 3, Live Virus Vaccine (USDA: 1B82.50) VO:0002201 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1923 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1924 1923 1924 USDA: 1D51.R0 vaccine Fowl Pox-Mycoplasma Gallisepticum Live Fowl Pox Vector Vaccine (USDA: 1D51.R0) VO:0002202 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1919 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1920 1919 1920 USDA: 1F31.R0 vaccine Fowl Pox-Laryngotracheitis Live Fowl Pox Vector Vaccine (USDA: 1F31.R0) VO:0002203 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2068 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2069 2068 2069 USDA: 1XB1.10 vaccine Newcastle-Bronchitis B1 Type, C2 Strain, Mass Type, Live Virus Vaccine (USDA: 1XB1.10) VO:0002204 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2070 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2071 2070 2071 USDA: 1XC1.10 vaccine Newcastle-Bronchitis B1 Type, C2 Strain, Mass & Conn Types, Live Virus Vaccine (USDA: 1XC1.10) VO:0002205 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2150 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2151 2150 2151 USDA: 40A5.20 vaccine Bovine Respiratory Syncytial Virus Killed Virus Vaccine-Haemophilus somnus Bacterin (USDA: 40A5.20) VO:0002206 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2574 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2575 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2576 2574 2575 2576 USDA: 4629.20 vaccine Canine Distemper-Adenovirus Type 2 Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4629.20) VO:0002207 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2571 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2572 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2573 2571 2572 2573 USDA: 4629.27 vaccine Canine Distemper-Adenovirus Type 2 Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 4629.27) VO:0002208 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2696 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2697 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2698 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2699 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2700 2696 2697 2698 2699 2700 USDA: 4637.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4637.20) VO:0002209 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2701 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2702 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2703 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2704 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2705 2701 2702 2703 2704 2705 USDA: 4637.22 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4637.22) VO:0002210 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2706 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2707 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2708 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2709 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2710 2706 2707 2708 2709 2710 USDA: 4637.23 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4637.23) VO:0002211 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2671 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2672 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2673 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2674 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2675 2671 2672 2673 2674 2675 USDA: 4637.29 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 4637.29) VO:0002212 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2711 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2712 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2713 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2714 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2715 2711 2712 2713 2714 2715 USDA: 4639.21 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4639.21) VO:0002213 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2716 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2717 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2718 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2719 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2720 2716 2717 2718 2719 2720 USDA: 4639.22 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4639.22) VO:0002214 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2676 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2677 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2678 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2679 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2680 2676 2677 2678 2679 2680 USDA: 4639.25 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 4639.25) VO:0002215 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2686 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2687 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2688 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2689 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2690 2686 2687 2688 2689 2690 USDA: 4639.27 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 4639.27) VO:0002216 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2691 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2692 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2693 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2694 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2695 2691 2692 2693 2694 2695 USDA: 4639.28 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 4639.28) VO:0002217 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2721 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2722 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2723 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2724 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2725 2721 2722 2723 2724 2725 USDA: 4639.R1 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus, Live Canarypox Vector Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4639.R1) VO:0002218 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2667 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2668 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2669 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2670 2667 2668 2669 2670 USDA: 4659.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4659.20) VO:0002219 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2589 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2590 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2591 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2592 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2593 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2594 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2595 2589 2590 2591 2592 2593 2594 2595 USDA: 46B9.21 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 46B9.21) VO:0002220 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2569 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2570 2569 2570 USDA: 46D5.27 vaccine Canine Coronavirus Killed Virus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract (USDA: 46D5.27) VO:0002221 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2567 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2568 2567 2568 USDA: 46E5.20 vaccine Canine Coronavirus Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 46E5.20) VO:0002222 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2559 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2560 2559 2560 USDA: 46E5.21 vaccine Canine Coronavirus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 46E5.21) VO:0002223 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2563 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2564 2563 2564 USDA: 46E5.23 vaccine Canine Coronavirus Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 46E5.23) VO:0002224 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2561 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2562 2561 2562 USDA: 46E5.24 vaccine Canine Coronavirus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 46E5.24) VO:0002225 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2565 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2566 2565 2566 USDA: 46E5.25 vaccine Canine Coronavirus Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 46E5.25) VO:0002226 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2632 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2633 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2634 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2635 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2636 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2637 2632 2633 2634 2635 2636 2637 USDA: 46J7.20 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 46J7.20) VO:0002227 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2638 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2639 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2640 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2641 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2642 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2643 2638 2639 2640 2641 2642 2643 USDA: 46J7.22 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 46J7.22) VO:0002228 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2726 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2727 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2728 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2729 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2730 2726 2727 2728 2729 2730 USDA: 46J8.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 46J8.20) VO:0002229 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2644 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2645 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2646 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2647 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2648 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2649 2644 2645 2646 2647 2648 2649 USDA: 46J9.20 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 46J9.20) VO:0002230 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2614 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2615 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2616 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2617 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2618 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2619 2614 2615 2616 2617 2618 2619 USDA: 46J9.21 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 46J9.21) VO:0002231 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2596 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2597 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2598 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2599 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2600 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2601 2596 2597 2598 2599 2600 2601 USDA: 46J9.25 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 46J9.25) VO:0002232 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2620 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2621 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2622 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2623 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2624 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2625 2620 2621 2622 2623 2624 2625 USDA: 46J9.26 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 46J9.26) VO:0002233 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2626 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2627 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2628 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2629 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2630 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2631 2626 2627 2628 2629 2630 2631 USDA: 46J9.27 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 46J9.27) VO:0002234 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2602 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2603 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2604 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2605 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2606 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2607 2602 2603 2604 2605 2606 2607 USDA: 46J9.29 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 46J9.29) VO:0002235 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2650 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2651 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2652 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2653 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2654 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2655 2650 2651 2652 2653 2654 2655 USDA: 46J9.R1 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live Virus, Live Canarypox Vector Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 46J9.R1) VO:0002236 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2656 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2657 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2658 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2659 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2660 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2661 2656 2657 2658 2659 2660 2661 USDA: 46L9.27 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract (USDA: 46L9.27) VO:0002237 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2662 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2663 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2664 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2665 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2666 2662 2663 2664 2665 2666 USDA: 46P9.27 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract (USDA: 46P9.27) VO:0002238 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2799 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2800 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2801 2799 2800 2801 USDA: 46W5.21 vaccine Encephalomyelitis-Influenza-West Nile Virus Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 46W5.21) VO:0002239 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2551 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2552 2551 2552 USDA: 47A5.20 vaccine Canine Coronavirus Killed Virus Vaccine-Borrelia Burgdorferi Bacterin (USDA: 47A5.20) VO:0002240 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2738 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2739 2738 2739 USDA: 47B1.20 vaccine Canine Parvovirus Modified Live Virus Vaccine-Leptospira Canicola Icterohaemorrhagiae Bacterin (USDA: 47B1.20) VO:0002241 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2577 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2578 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2579 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2580 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2581 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2582 2577 2578 2579 2580 2581 2582 USDA: 47C5.20 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Borrelia Burgdorferi Bacterin (USDA: 47C5.20) VO:0002242 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2583 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2584 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2585 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2586 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2587 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2588 2583 2584 2585 2586 2587 2588 USDA: 47C5.29 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Borrelia Burgdorferi Bacterin (USDA: 47C5.29) VO:0002243 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2553 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2554 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2555 2553 2554 2555 USDA: 47E5.20 vaccine Canine Coronavirus Killed Virus Vaccine-Borrelia Burgdorferi Bacterin-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract (USDA: 47E5.20) VO:0002244 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2556 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2557 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2558 2556 2557 2558 USDA: 47E5.21 vaccine Canine Coronavirus Killed Virus Vaccine-Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract (USDA: 47E5.21) VO:0002245 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2681 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2682 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2683 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2684 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2685 2681 2682 2683 2684 2685 USDA: 47K1.20 vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterin (USDA: 47K1.20) VO:0002246 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2608 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2609 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2610 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2611 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2612 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2613 2608 2609 2610 2611 2612 2613 USDA: 47L9.20 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterin (USDA: 47L9.20) VO:0002247 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2731 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2732 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2733 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2734 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2735 2731 2732 2733 2734 2735 USDA: 47P9.22 vaccine Canine Distemper-Hepatitis-Parainfluenza-Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 47P9.22) VO:0002248 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2768 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2769 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2770 2768 2769 2770 USDA: 4835.20 vaccine Encephalomyelitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.20) VO:0002249 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2771 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2772 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2773 2771 2772 2773 USDA: 4835.23 vaccine Encephalomyelitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.23) VO:0002250 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2774 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2775 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2776 2774 2775 2776 USDA: 4835.24 vaccine Encephalomyelitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.24) VO:0002251 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2777 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2778 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2779 2777 2778 2779 USDA: 4835.45 vaccine Encephalomyelitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.45) VO:0002252 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2780 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2781 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2782 2780 2781 2782 USDA: 4835.46 vaccine Encephalomyelitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4835.46) VO:0002253 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2802 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2803 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2804 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2805 2802 2803 2804 2805 USDA: 4844.30 vaccine Encephalomyelitis-Rhinopneumonitis Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4844.30) VO:0002254 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2806 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2807 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2808 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2809 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2810 2806 2807 2808 2809 2810 USDA: 4845.23 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.23) VO:0002255 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2811 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2812 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2813 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2814 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2815 2811 2812 2813 2814 2815 USDA: 4845.24 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.24) VO:0002256 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2816 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2817 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2818 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2819 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2820 2816 2817 2818 2819 2820 USDA: 4845.32 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.32) VO:0002257 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2821 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2822 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2823 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2824 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2825 2821 2822 2823 2824 2825 USDA: 4845.33 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.33) VO:0002258 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2826 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2827 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2828 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2829 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2830 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2831 2826 2827 2828 2829 2830 2831 USDA: 4847.22 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.22) VO:0002259 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2832 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2833 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2834 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2835 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2836 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2837 2832 2833 2834 2835 2836 2837 USDA: 4847.23 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.23) VO:0002260 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2838 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2839 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2840 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2841 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2842 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2843 2838 2839 2840 2841 2842 2843 USDA: 4847.24 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.24) VO:0002261 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2844 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2845 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2846 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2847 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2848 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2849 2844 2845 2846 2847 2848 2849 USDA: 4847.32 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.32) VO:0002262 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2850 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2851 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2852 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2853 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2854 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2855 2850 2851 2852 2853 2854 2855 USDA: 4855.R2 vaccine Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Eastern & Western, Killed Virus, Killed Flavivirus Chimera Vaccine-Tetanus Toxoid (USDA: 4855.R2) VO:0002263 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2740 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2741 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2742 2740 2741 2742 USDA: 4865.00 vaccine Encephalomyelitis Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.00) VO:0002264 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2743 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2744 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2745 2743 2744 2745 USDA: 4865.01 vaccine Encephalomyelitis Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.01) VO:0002265 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2746 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2747 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2748 2746 2747 2748 USDA: 4865.21 vaccine Encephalomyelitis Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.21) VO:0002266 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2749 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2750 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2751 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2752 2749 2750 2751 2752 USDA: 4865.23 vaccine Encephalomyelitis Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.23) VO:0002267 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2753 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2754 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2755 2753 2754 2755 USDA: 4865.26 vaccine Encephalomyelitis Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.26) VO:0002268 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2756 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2757 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2758 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2759 2756 2757 2758 2759 USDA: 4865.27 vaccine Encephalomyelitis Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4865.27) VO:0002269 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2760 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2761 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2762 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2763 2760 2761 2762 2763 USDA: 4867.20 vaccine Encephalomyelitis Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4867.20) VO:0002270 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2764 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2765 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2766 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2767 2764 2765 2766 2767 USDA: 4867.21 vaccine Encephalomyelitis Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4867.21) VO:0002271 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2783 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2784 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2785 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2786 2783 2784 2785 2786 USDA: 4875.23 vaccine Encephalomyelitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.23) VO:0002272 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2787 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2788 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2789 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2790 2787 2788 2789 2790 USDA: 4875.24 vaccine Encephalomyelitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.24) VO:0002273 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2791 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2792 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2793 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2794 2791 2792 2793 2794 USDA: 4875.A0 vaccine Encephalomyelitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.A0) VO:0002274 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2795 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2796 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2797 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2798 2795 2796 2797 2798 USDA: 4875.A1 vaccine Encephalomyelitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4875.A1) VO:0002275 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2911 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2912 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2913 2911 2912 2913 USDA: 48B5.10 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine-Mycoplasma Gallisepticum Bacterin (USDA: 48B5.10) VO:0002276 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2914 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2915 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2916 2914 2915 2916 USDA: 48B6.10 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine-Mycoplasma Gallisepticum Bacterin (USDA: 48B6.10) VO:0002277 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2933 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2934 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2935 2933 2934 2935 USDA: 48C5.01 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 48C5.01) VO:0002278 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2936 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2937 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2938 2936 2937 2938 USDA: 48C5.20 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 48C5.20) VO:0002279 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2939 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2940 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2941 2939 2940 2941 USDA: 48C5.21 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 48C5.21) VO:0002280 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2942 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2943 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2944 2942 2943 2944 USDA: 48C5.22 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 48C5.22) VO:0002281 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2917 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2918 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2919 2917 2918 2919 USDA: 48D6.10 vaccine Newcastle-Bronchitis Mass Type, Killed Virus Vaccine-Salmonella Enteritidis Bacterin (USDA: 48D6.10) VO:0002282 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2905 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2906 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2907 2905 2906 2907 USDA: 48D7.10 vaccine Newcastle Disease-Bronchitis Mass & Ark Types, Killed Virus Vaccine-Salmonella Enteritidis Bacterin (USDA: 48D7.10) VO:0002283 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2908 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2909 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2910 2908 2909 2910 USDA: 48D7.11 vaccine Newcastle Disease-Bronchitis Mass & Ark Types, Killed Virus Vaccine-Salmonella Enteritidis Bacterin (USDA: 48D7.11) VO:0002284 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2856 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2857 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2858 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2859 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2860 2856 2857 2858 2859 2860 USDA: 48W5.20 vaccine Encephalomyelitis-West Nile Virus Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.20) VO:0002285 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2861 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2862 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2863 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2864 2861 2862 2863 2864 USDA: 48W5.21 vaccine Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.21) VO:0002286 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2865 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2866 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2867 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2868 2865 2866 2867 2868 USDA: 48W5.22 vaccine Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.22) VO:0002287 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2869 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2870 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2871 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2872 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2873 2869 2870 2871 2872 2873 USDA: 48W5.23 vaccine Encephalomyelitis-West Nile Virus Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 48W5.23) VO:0002288 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2874 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2875 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2876 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2877 2874 2875 2876 2877 USDA: 48W9.R0 vaccine Encephalomyelitis-West Nile Virus Eastern & Western, Killed Virus, Live Canarypox Vector Vaccine-Tetanus Toxoid (USDA: 48W9.R0) VO:0002289 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3010 3010 USDA: 4905.20 vaccine Rabies Killed Virus Vaccine-Ehrlichia Risticii Bacterin (USDA: 4905.20) VO:0002290 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2922 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2923 2922 2923 USDA: 4906.20 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae Bacterin (USDA: 4906.20) VO:0002291 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2951 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2952 2951 2952 USDA: 4960.00 vaccine Parvovirus Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 4960.00) VO:0002292 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2945 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2946 2945 2946 USDA: 4975.01 vaccine Parvovirus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4975.01) VO:0002293 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2947 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2948 2947 2948 USDA: 4975.20 vaccine Parvovirus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4975.20) VO:0002294 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2949 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2950 2949 2950 USDA: 4975.22 vaccine Parvovirus Killed Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4975.22) VO:0002295 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2920 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2921 2920 2921 USDA: 4989.00 vaccine Parainfluenza 3 Modified Live Virus Vaccine-Leptospira Pomona Bacterin (USDA: 4989.00) VO:0002296 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3035 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3036 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3037 3035 3036 3037 USDA: 4990.00 vaccine Trichomonas Foetus Vaccine, Killed Protozoa-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4990.00) VO:0002297 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3011 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3012 3011 3012 USDA: 4993.20 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae Bacterin (USDA: 4993.20) VO:0002298 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3013 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3014 3013 3014 USDA: 4993.21 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae Bacterin (USDA: 4993.21) VO:0002299 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3015 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3016 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3017 3015 3016 3017 USDA: 4994.20 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Mycoplasma Hyopneumoniae Bacterin (USDA: 4994.20) VO:0002300 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3018 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3019 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3020 3018 3019 3020 USDA: 4994.21 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Mycoplasma Hyopneumoniae Bacterin (USDA: 4994.21) VO:0002301 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3021 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3022 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3023 3021 3022 3023 USDA: 4994.23 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Mycoplasma Hyopneumoniae Bacterin (USDA: 4994.23) VO:0002302 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3024 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3025 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3026 3024 3025 3026 USDA: 4994.24 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Mycoplasma Hyopneumoniae Bacterin (USDA: 4994.24) VO:0002303 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3027 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3028 3027 3028 USDA: 4995.22 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Mycoplasma Hyopneumoniae Bacterin (USDA: 4995.22) VO:0002304 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3029 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3030 3029 3030 USDA: 4995.23 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Mycoplasma Hyopneumoniae Bacterin (USDA: 4995.23) VO:0002305 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3031 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3032 3031 3032 USDA: 4995.25 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Mycoplasma Hyopneumoniae Bacterin (USDA: 4995.25) VO:0002306 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3033 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3034 3033 3034 USDA: 4995.26 vaccine Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Mycoplasma Hyopneumoniae Bacterin (USDA: 4995.26) VO:0002307 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3003 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3004 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3005 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3006 3003 3004 3005 3006 USDA: 49B1.21 vaccine Porcine Rotavirus-Transmissible Gastroenteritis Modified Live Virus Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid (USDA: 49B1.21) VO:0002308 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2991 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2992 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2993 2991 2992 2993 USDA: 49C1.21 vaccine Porcine Rotavirus Modified Live Virus Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid (USDA: 49C1.21) VO:0002309 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2953 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2954 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2955 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2956 2953 2954 2955 2956 USDA: 49F6.22 vaccine Parvovirus-Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 49F6.22) VO:0002310 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2957 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2958 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2959 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2960 2957 2958 2959 2960 USDA: 49F6.23 vaccine Parvovirus-Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 49F6.23) VO:0002311 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2961 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2962 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2963 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2964 2961 2962 2963 2964 USDA: 49F6.24 vaccine Parvovirus-Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 49F6.24) VO:0002312 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2965 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2966 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2967 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2968 2965 2966 2967 2968 USDA: 49G6.22 vaccine Parvovirus-Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 49G6.22) VO:0002313 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2969 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2970 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2971 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2972 2969 2970 2971 2972 USDA: 49G6.23 vaccine Parvovirus-Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 49G6.23) VO:0002314 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2973 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2974 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2975 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2976 2973 2974 2975 2976 USDA: 49G6.24 vaccine Parvovirus-Swine Influenza H1N1 & H3N2, Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 49G6.24) VO:0002315 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2994 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2995 2994 2995 USDA: 49K1.20 vaccine Porcine Rotavirus Modified Live Virus Vaccine-Escherichia Coli Bacterin (USDA: 49K1.20) VO:0002316 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2977 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2978 2977 2978 USDA: 49K5.R1 vaccine Porcine Circovirus Type 2, Killed Baculovirus Vector Vaccine- Mycoplasma Hyopneumoniae Bacterin (USDA: 49K5.R1) VO:0002317 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2984 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2985 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2986 2984 2985 2986 USDA: 49K9.R0 vaccine Porcine Reproductive & Respiratory Syndrome-Circovirus Reproductive & Respiratory Form, Type 2, Modifed Live Virus,Killed Baculovirus Vector Vaccine-Mycoplasma Hyopneumoniae Bacterin (USDA: 49K9.R0) VO:0002318 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3007 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3008 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3009 3007 3008 3009 USDA: 49P1.20 vaccine Porcine Rotavirus-Transmissible Gastroenteritis Modified Live Virus Vaccine-Escherichia Coli Bacterin (USDA: 49P1.20) VO:0002319 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2996 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2997 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2998 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2999 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3000 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3001 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3002 2996 2997 2998 2999 3000 3001 3002 USDA: 49T9.21 vaccine Porcine Rotavirus-Transmissible Gastroenteritis Modified Live Virus Vaccine-Bordetella Bronchiseptica-Clostridium Perfringens Type C-Erysipelothrix Rhusiopathiae-Escherichia Coli-Pasteurella Multocida Bacterin-Toxoid (USDA: 49T9.21) VO:0002320 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2878 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2879 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2880 2878 2879 2880 USDA: 4A45.20 vaccine Infectious Salmon Anemia Virus Killed Virus Vaccine-Aeromonas Salmonicida-Vibrio Anguillarum-Ordalii-Salmonicida Bacterin (USDA: 4A45.20) VO:0002321 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2924 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2925 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2926 2924 2925 2926 USDA: 4BC5.20 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4BC5.20) VO:0002322 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2927 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2928 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2929 2927 2928 2929 USDA: 4BC5.21 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4BC5.21) VO:0002323 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2930 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2931 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2932 2930 2931 2932 USDA: 4BC5.22 vaccine Parvovirus Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4BC5.22) VO:0002324 Asiyah Yu Lin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2987 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2988 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2989 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2990 2987 2988 2989 2990 USDA: 4P19.20 vaccine Porcine Reproductive & Respiratory Syndrome-Parvovirus Reproductive Form, Modified Live & Killed Virus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin (USDA: 4P19.20) VO:0002325 vaccine avian encephalomyelitis-chicken anemia virus-fowl pox vaccine VO:0002326 Asiyah Yu Lin vaccine avian encephalomyelitis-fowl pox vaccine VO:0002327 Asiyah Yu Lin vaccine avian encephalomyelitis-fowl pox-laryngotracheitis vaccine VO:0002328 Asiyah Yu Lin vaccine avian encephalomyelitis-fowl pox-Mycoplasma gallisepticum vaccine VO:0002329 Asiyah Yu Lin vaccine avian influenza-fowl pox vaccine VO:0002330 Asiyah Yu Lin vaccine Bovine Parainfluenza 3-Respiratory Syncytial Virus vaccine VO:0002331 Asiyah Yu Lin vaccine bovine rhinotracheitis vaccine-haemophilus somnus-mannheimia haemolytica-pasteurella multocida bacterin-toxoid VO:0002332 Asiyah Yu Lin vaccine Bovine Rhinotracheitis Vaccine-Haemophilus Somnus-Mannheimia Haemolytica-Pasteurella Multocida-Salmonella Typhimurium Bacterin-Toxoid VO:0002333 Asiyah Yu Lin vaccine Bovine Rhinotracheitis Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae- Pomona Bacterin VO:0002334 Asiyah Yu Lin vaccine Bovine Rhinotracheitis Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin VO:0002335 Asiyah Yu Lin vaccine Bovine Rhinotracheitis Vaccine-Leptospira Hardjo-Pomona Bacterin VO:0002336 Asiyah Yu Lin vaccine bovine rhinotracheitis vaccine-leptospira pomona bacterin VO:0002337 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Parainfluenza 3 Vaccine-Mannheimia Haemolytica-Pasteurella Multocida Bacterin VO:0002338 Asiyah Yu Lin vaccine bovine rhinotracheitis-parainfluenza 3 vaccine VO:0002339 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Parainfluenza 3 Vaccine-Haemophilus Somnus Bacterin VO:0002340 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Parainfluenza 3 Vaccine-Leptospira Canicola-Grippotyphosa-HardjoIcterohaemorrhagiae-Pomona Bacterin VO:0002341 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Parainfluenza 3 Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin VO:0002342 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Parainfluenza 3 Vaccine-Leptospira Pomona Bacterin VO:0002343 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Parainfluenza 3-Respiratory Syncytial Virus Vaccine VO:0002344 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Respiratory Syncytial Virus vaccine VO:0002345 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea vaccine VO:0002346 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Campylobacter Fetus-Leptospira CanicolaGrippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002347 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Haemophilus Somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid VO:0002348 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Haemophilus Somnus-Mannheimia Haemolytica-Pasteurella Multocida-Salmonella Typhimurium Bacterin-Toxoid VO:0002349 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Leptospira Canicola-Grippotyphosa-HardjoIcterohaemorrhagiae-Pomona Bacterin VO:0002350 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin VO:0002351 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Leptospira Hardjo-Pomona Bacterin VO:0002352 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea Vaccine-Leptospira Pomona Bacterin VO:0002353 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Vaccine VO:0002354 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002355 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002356 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Vaccine-Leptospira Grippotyphosa-Hardjo-Pomona Bacterin VO:0002357 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Mannheimia Haemolytica Bacterin VO:0002358 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine VO:0002359 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Campylobacter Fetus-Haemophilus Somnus-Leptospira Canicola-Grippotyphosa-HardjoIcterohaemorrhagiae-Pomona Bacterin VO:0002360 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002361 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Haemophilus Somnus Bacterin VO:0002362 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Haemophilus Somnus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002363 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Haemophilus Somnus-Mannheimia Haemolytica Bacterin VO:0002364 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002365 Asiyah Yu Lin vaccine chicken bursal disease-Newcastle disease vaccine VO:0002366 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona-Mannheimia Haemolytica Bacterin VO:0002367 Asiyah Yu Lin vaccine Bursal Disease-Newcastle Disease-Bronchitis Vaccine VO:0002368 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Leptospira Hardjo Bacterin VO:0002369 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Mannheimia Haemolytica Toxoid VO:0002370 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid VO:0002371 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus-Mannheimia Haemolytica-Pasteurella Multocida Vaccine VO:0002372 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Vaccine VO:0002373 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Respiratory Syncytial Virus Vaccine-Leptospira Pomona Bacterin VO:0002374 Asiyah Yu Lin vaccine Bovine Rotavirus-Coronavirus vaccine VO:0002375 Asiyah Yu Lin vaccine Bovine Rotavirus-Coronavirus Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid VO:0002376 Asiyah Yu Lin vaccine Bovine Rotavirus-Coronavirus Vaccine-Clostridium Perfringens Types C & D-Escherichia Coli Bacterin-Toxoid VO:0002377 Asiyah Yu Lin vaccine Bovine Rotavirus-Coronavirus Vaccine-Escherichia Coli Bacterin VO:0002378 Asiyah Yu Lin vaccine Bovine Virus Diarrhea Vaccine-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-HardjoIcterohaemorrhagiae-Pomona Bacterin VO:0002379 Asiyah Yu Lin vaccine Bovine Virus Diarrhea Vaccine-Haemophilus Somnus-Mannheimia Haemolytica-Pasteurella Multocida Bacterin-Toxoid VO:0002380 Asiyah Yu Lin vaccine Bovine Virus Diarrhea Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002381 Asiyah Yu Lin vaccine Bovine Virus Diarrhea Vaccine-Leptospira Pomona Bacterin VO:0002382 Asiyah Yu Lin vaccine Bursal disease-Mareks disease vaccine VO:0002383 Asiyah Yu Lin vaccine Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Vaccine VO:0002384 Asiyah Yu Lin vaccine chicken Bursal Disease-Newcastle Disease-Reovirus Vaccine VO:0002385 Asiyah Yu Lin vaccine chicken bursal disease-reovirus vaccine VO:0002386 Asiyah Yu Lin vaccine Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica vaccine VO:0002387 Asiyah Yu Lin vaccine Canine Coronavirus Vaccine-Borrelia Burgdorferi Bacterin-Leptospira Canicola-GrippotyphosaIcterohaemorrhagiae-Pomona Bacterial Extract VO:0002388 Asiyah Yu Lin vaccine Canine Coronavirus Vaccine-Borrelia Burgdorferi Bacterin-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract VO:0002389 Asiyah Yu Lin vaccine Canine Coronavirus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract VO:0002390 Asiyah Yu Lin vaccine Canine Coronavirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract VO:0002391 Asiyah Yu Lin vaccine Canine Coronavirus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract VO:0002392 Asiyah Yu Lin vaccine Canine Coronavirus Vaccine-Borrelia Burgdorferi Bacterin VO:0002393 Asiyah Yu Lin vaccine Canine Coronavirus-Parvovirus Vaccine VO:0002394 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2 vaccine VO:0002395 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine VO:0002396 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2 Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract VO:0002397 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2 Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin VO:0002398 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus vaccine-Borrelia Burgdorferi Bacterin VO:0002399 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine-Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract VO:0002400 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract VO:0002401 Asiyah Yu Lin vaccine horse EEV, VEV, WEV encephalomyelitis and West Nile Virus vaccine VO:0002402 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterin VO:0002403 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin VO:0002404 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract VO:0002405 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parvovirus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract VO:0002406 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Measles-Parainfluenza Vaccine VO:0002407 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza Vaccine VO:0002408 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine VO:0002409 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine-Leptospira CanicolaGrippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract VO:0002410 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine-Leptospira CanicolaGrippotyphosa-Icterohaemorrhagiae-Pomona Bacterin VO:0002411 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract VO:0002412 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin VO:0002413 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine VO:0002414 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parvovirus-Rabies Vaccine VO:0002415 Asiyah Yu Lin vaccine Canine Distemper-Hepatitis-Parainfluenza vaccine VO:0002416 Asiyah Yu Lin vaccine Canine Distemper-Measles vaccine VO:0002417 Asiyah Yu Lin vaccine Canine Distemper-Parvovirus vaccine VO:0002418 Asiyah Yu Lin vaccine canine parainfluenza-bordetella bronchiseptica vaccine VO:0002419 Asiyah Yu Lin vaccine canine parvovirus vaccine-leptospira canicola icterohaemorrhagiae bacterin VO:0002420 Asiyah Yu Lin Oliver He vaccine equine EEV and WEV encephalomyelitis vaccine-tetanus toxoid VO:0002421 Asiyah Yu Lin Oliver He vaccine equine rhinopneumonitis-influenza vaccine VO:0002422 Asiyah Yu Lin Oliver He vaccine equine EEV and WEV encephalomyelitis-influenza vaccine-tetanus toxoid VO:0002423 Asiyah Yu Lin vaccine equine EEV and WEV encephalomyelitis-influenza-West Nile virus vaccine-tetanus toxoid VO:0002424 a viral vaccine against horse EEV, WEV, and VEE viral infections Asiyah Yu Lin Oliver He vaccine horse encephalomyelitis EEV, VEV, and WEV combination vaccine VO:0002425 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin VO:0002426 Asiyah Yu Lin vaccine Canine Distemper-Hepatitis-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin VO:0002427 Asiyah Yu Lin vaccine Feline Immunodeficiency-Leukemia virus vaccine VO:0002428 Asiyah Yu Lin vaccine equine EEV and WEV encephalomyelitis-rhinopneumonitis vaccine-tetanus toxoid VO:0002429 Asiyah Yu Lin vaccine equine EEV and WEV encephalomyelitis-rhinopneumonitis-influenza vaccine-tetanus toxoid VO:0002430 Asiyah Yu Lin vaccine equine EEV and WEV encephalomyelitis-rhinopneumonitis-influenza-West Nile Virus vaccine-tetanus toxoid VO:0002431 Asiyah Yu Lin vaccine horse EEV, VEV, WEV encephalomyelitis-West Nile Virus Vaccine-Tetanus Toxoid VO:0002432 Asiyah Yu Lin vaccine Feline Leukemia-Chlamydia Psittaci vaccine VO:0002433 Asiyah Yu Lin vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine VO:0002434 Asiyah Yu Lin vaccine Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine VO:0002435 Asiyah Yu Lin vaccine Feline Rhinotracheitis-Calici-Chlamydia Psittaci Vaccine VO:0002436 Asiyah Yu Lin vaccine Feline Rhinotracheitis-Calici-Panleukopenia Vaccine VO:0002437 Asiyah Yu Lin vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine VO:0002438 Asiyah Yu Lin vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci-Rabies Vaccine VO:0002439 Asiyah Yu Lin vaccine Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Vaccine VO:0002440 Asiyah Yu Lin vaccine Feline Rhinotracheitis-Calicivirus vaccine VO:0002441 Asiyah Yu Lin vaccine Fowl Laryngotracheitis-Mareks Disease vaccine VO:0002442 Asiyah Yu Lin vaccine Infectious Salmon Anemia Virus Vaccine-Aeromonas Salmonicida-Vibrio Anguillarum-Ordalii-Salmonicida Bacterin VO:0002443 Asiyah Yu Lin Fowl Pox-Laryngotracheitis Vaccine vaccine fowlpox-Laryngotracheitis vaccine VO:0002444 Asiyah Yu Lin Fowl Pox-Mareks Disease Vaccine vaccine fowlpox-Mareks Disease vaccine VO:0002445 Asiyah Yu Lin Fowl Pox-Mycoplasma Gallisepticum Vaccine vaccine fowlpox-Mycoplasma Gallisepticum vaccine VO:0002446 Asiyah Yu Lin vaccine Mannheimia Haemolytica-Pasteurella Multocida vaccine VO:0002447 Asiyah Yu Lin vaccine Mareks Disease-Newcastle Disease vaccine VO:0002448 Asiyah Yu Lin vaccine chicken Mareks disease-tenosynovitis vaccine VO:0002449 Asiyah Yu Lin vaccine Mink Distemper-Enteritis Vaccine-Clostridium Botulinum Type C Bacterin-Toxoid VO:0002450 Asiyah Yu Lin vaccine Mink Distemper-Enteritis Vaccine-Clostridium Botulinum Type C-Pseudomonas Aeruginosa Bacterin-Toxoid VO:0002451 Asiyah Yu Lin vaccine Mink Enteritis Vaccine-Clostridium Botulinum Type C Bacterin-Toxoid VO:0002452 Asiyah Yu Lin SNOMEDCT: 55262006 UMLS_CUI:C0310936 vaccine Mink Enteritis Vaccine-Clostridium Botulinum Type C-Pseudomonas Aeruginosa Bacterin-Toxoid VO:0002453 Asiyah Yu Lin vaccine Newcastle Disease-Bronchitis Vaccine-Salmonella Enteritidis Bacterin VO:0002454 Asiyah Yu Lin vaccine Newcastle-Bronchitis Vaccine-Mycoplasma Gallisepticum Bacterin VO:0002455 A viral vaccine that protects against infection with Hirame rhabdovirus Ningxian Fan Oliver He Ronak Sutariya vaccine Hirame rhabdovirus vaccine VO:0002456 Asiyah Yu Lin vaccine Newcastle Disease-Fowlpox vaccine VO:0002457 Asiyah Yu Lin vaccine Newcastle-Bronchitis vaccine VO:0002458 Asiyah Yu Lin vaccine Newcastle-Paramyxovirus vaccine VO:0002459 Asiyah Yu Lin vaccine bovine parainfluenza 3 vaccine-Leptospira Pomona vaccine VO:0002460 Asiyah Yu Lin vaccine Parvovirus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002461 Asiyah Yu Lin vaccine Parvovirus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-HardjoIcterohaemorrhagiae-Pomona Bacterin VO:0002462 Asiyah Yu Lin vaccine Parvovirus Vaccine-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002463 Asiyah Yu Lin vaccine Porcine Parvovirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae vaccine VO:0002464 Asiyah Yu Lin vaccine Parvovirus-Swine Influenza Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Bratislava-CanicolaGrippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002465 Asiyah Yu Lin vaccine Parvovirus-Swine Influenza Vaccine-Erysipelothrix Rhusiopathiae-Leptospira CanicolaGrippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002466 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus-Rabies Virus Vaccine VO:0002467 Asiyah Yu Lin vaccine Porcine Circovirus Vaccine- Mycoplasma Hyopneumoniae Bactin VO:0002468 Asiyah Yu Lin vaccine Porcine Rotavirus-Transmissible Gastroenteritis Vaccine-Bordetella Bronchiseptica-Clostridium Perfringens Type C-Erysipelothrix Rhusiopathiae-Escherichia Coli-Pasteurella Multocida Bacterin-Toxoid VO:0002469 Asiyah Yu Lin vaccine Porcine Rotavirus-Transmissible Gastroenteritis Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid VO:0002470 Asiyah Yu Lin vaccine Porcine Rotavirus-Transmissible Gastroenteritis Vaccine-Escherichia Coli Bacterin VO:0002471 Asiyah Yu Lin vaccine Porcine Rotavirus Vaccine-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid VO:0002472 Asiyah Yu Lin vaccine Porcine Reproductive & Respiratory Syndrome-Circovirus Vaccine-Mycoplasma Hyopneumoniae Bacterin VO:0002473 Asiyah Yu Lin vaccine Porcine Reproductive & Respiratory Syndrome-Parvovirus Vaccine-Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002474 Asiyah Yu Lin vaccine Porcine Rotavirus Vaccine-Escherichia Coli Bacterin VO:0002475 Asiyah Yu Lin vaccine Porcine Rotavirus-Transmissible Gastroenteritis vaccine VO:0002476 Asiyah Yu Lin vaccine Rabies vaccine-Ehrlichia Risticii Bacterin VO:0002477 Asiyah Yu Lin vaccine Swine Influenza vaccine VO:0002478 Asiyah Yu Lin Oliver He vaccine Swine Influenza Vaccine-Erysipelothrix Rhusiopathiae Bacterin VO:0002479 Asiyah Yu Lin vaccine Swine Influenza Vaccine-Erysipelothrix Rhusiopathiae-Mycoplasma Hyopneumoniae Bacterin VO:0002480 Asiyah Yu Lin Oliver He USDA: 4995.22 vaccine Swine Influenza Vaccine-Mycoplasma Hyopneumoniae Bacterin VO:0002481 Asiyah Yu Lin vaccine Trichomonas Foetus-Campylobacter Fetus-Leptospira vaccine VO:0002482 Asiyah Yu Lin vaccine Canine Distemper-Coronavirus-Parvovirus Vaccine VO:0002483 A horse vaccine that protects against EEE, VEE, WEE, influenza virius infection, and West Nile virus infection. Asiyah Yu Lin vaccine horse Encephalomyelitis-Influenza-West Nile Virus vaccine VO:0002484 Asiyah Yu Lin vaccine Mink Distemper-Enteritis vaccine VO:0002485 Asiyah Yu Lin Oliver He vaccine porcine parvovirus-erysipelothrix rhusiopathiae vaccine VO:0002486 Asiyah Yu Lin vaccine Bovine Virus Diarrhea-Respiratory Syncytial Virus vaccine VO:0002487 Asiyah Yu Lin vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterial Extract VO:0002488 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Vaccine-Leptospira Pomona Bacterin VO:0002489 Asiyah Yu Lin vaccine Bovine Respiratory Syncytial Virus Virus Vaccine-Haemophilus somnus Bacterin VO:0002490 Asiyah Yu Lin vaccine Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3 Vaccine-Haemophilus somnus-Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin VO:0002491 Asiyah Yu Lin USDA: 12X1.21 vaccine Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Modified Live Virus & Avirulent Live Culture Vaccine (USDA: 12X1.21) VO:0002492 Asiyah Yu Lin USDA: 46L9.20 vaccine Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Modified Live & Killed Virus Vaccine-Leptospira Icterohaemorrhagiae Bacterial Extract (USDA: 46L9.20) VO:0002493 Asiyah Yu Lin USDA: 16J1.R3 vaccine Fowl Laryngotracheitis-Marek's Disease Serotype 3, Live Marek's Disease Vector Vaccine (USDA: 16J1.R3) VO:0002494 Asiyah Yu Lin vaccine created according to WHO Technical Report Series, No. 927, 2005 Annex 3 Recommendations for the production and control of influenza vaccine (inactivated) influenza vaccine (whole virion, inactivated) VO:0002495 Asiyah Yu Lin vaccine created according to WHO Technical Report Series, No. 927, 2005 Annex 3 Recommendations for the production and control of influenza vaccine (inactivated) influenza vaccine (split virion, inactivated) VO:0002496 Asiyah Yu Lin vaccine created according to WHO Technical Report Series, No. 927, 2005 Annex 3 Recommendations for the production and control of influenza vaccine (inactivated) influenza vaccine (surface antigens, inactivated) VO:0002497 Asiyah Yu Lin vaccine created according to WHO Technical Report Series, No. 927, 2005 Annex 3 Recommendations for the production and control of influenza vaccine (inactivated) influenza vaccine (inactivated, adjuvanted) VO:0002499 vaccine influenza A (H1N1) 2009 monovalent vaccine (IDB) VO:0002500 Vaccine that protects against Listeria monocytogenes infection. Oliver He Rebecca Racz vaccine Listeria monocytogenes vaccine VO:0002501 A vaccine that protects against Mycobacterium avium. Oliver He Rebecca Racz vaccine Mycobacterium avium vaccine VO:0002502 A bacterial vaccine that protects against infection with Staphylococcus aureus. Oliver He Rebecca Racz vaccine Staphylococcus aureus vaccine VO:0002503 A bacterial gene that is from Streptococcus. Oliver He Rebecca Racz gene Streptococcus gene VO:0002504 A bacterial gene that is from Streptococcus equi. Oliver He Rebecca Racz gene Streptococcus equi gene VO:0002505 Aeromonas vaccine that protects against Aeromonas hydrophila infection. Oliver He Rebecca Racz vaccine Aeromonas hydrophila vaccine VO:0002506 An Edwardsiella bacterial vaccine that protects against Edwardsiella tarda. Oliver He Rebecca Racz vaccine Edwardsiella tarda vaccine VO:0002507 A bacterial vaccine that protects against infections by Salmonella typhimurium species. Oliver He Rebecca Racz vaccine Salmonella typhimurium vaccine VO:0002508 A bacterial vaccine that protects against infections by Salmonella enterica subsp. enterica serovar Gallinarum. Oliver He Rebecca Racz vaccine Salmonella gallinarum vaccine VO:0002509 A bacterial vaccine that protects against infections by Salmonella enterica subsp. enterica serovar Enteritidis. Oliver He Rebecca Racz vaccine Salmonella enteritidis vaccine VO:0002510 A bacterial vaccine that protects against infections by Yersinia pseudotuberculosis. Oliver He Rebecca Racz vaccine Yersinia pseudotuberculosis vaccine VO:0002511 A viral vaccine that protects against infection of human metapneumovirus. Oliver He Rebecca Racz vaccine human metapneumovirus vaccine VO:0002512 A viral vaccine that protects against infection of Human respiratory syncytial virus. Oliver He Rebecca Racz vaccine Human respiratory syncytial virus vaccine VO:0002513 a malaria vaccine that protects against malaria caused by Plasmodium berghei. Oliver He Rebecca Racz vaccine Plasmodium berghei vaccine VO:0002514 a malaria vaccine that protects against malaria caused by Plasmodium yoelii. Oliver He Rebecca Racz vaccine Plasmodium yoelii vaccine VO:0002515 A protozoan gene that is from Leishmania infantum. Oliver He Rebecca Racz gene Leishmania infantum gene VO:0002516 Oliver He Rebecca Racz gene The mutant strain, with deletion of apxIA gene, obtained in this study offered a level of cross-serovar protection against A. pleuropneumoniae infection in mice and pigs (Reference: PMID: 16930871). apxIA from Actinobacillus pleuropneumoniae NCBI_Gene_ID: 4850247; PMID: 16930871 VO:0002517 Oliver He Rebecca Racz gene In the intra-peritoneal mouse model, the virulence of the mutant strain decreased at least 100 fold compared with the parent strain. The mutant was evaluated as a potential vaccine using a vaccination-challenge trial. The death number and lung lesion score in the vaccinated pigs given the serovar 1 challenge were obviously lower than those in the unvaccinated pigs apxIC from Actinobacillus pleuropneumoniae NCBI_Protein_ID: 1477456; PMID: 18062275 VO:0002518 Oliver He Rebecca Racz gene Deletion in ureC and apxIIA genes of Actinobacillus pleuropneumoniae serotype 2 prototype provides attenuation and protection in pigs against challenge with the virulent parent strain of A. pleuropneumoniae apxIIA from Actinobacillus pleuropneumoniae NCBI_Protein_ID: 255959000; PMID: 12438394 VO:0002519 Oliver He Rebecca Racz VO:0002520 gene In the present study, the gene encoding the ApxII-activating protein, apxIIC, was insertionally inactivated on the chromosome of a serovar 7 strain, HS93. Pigs vaccinated with live HS93C-Ampr via the intranasal route were protected against a cross-serovar challenge with a virulent serovar 1 strain of A. pleuropneumoniae apxIIC from Actinobacillus pleuropneumoniae NCBI_Protein_ID: 52630373; PMID: 10085043 VO:0002520 Oliver He Rebecca Racz In the present study, the gene encoding the ApxII-activating protein, apxIIC, was insertionally inactivated on the chromosome of a serovar 7 strain, HS93. Pigs vaccinated with live HS93C-Ampr via the intranasal route were protected against a cross-serovar challenge with a virulent serovar 1 strain of A. pleuropneumoniae obsolete apxIIC from Actinobacillus pleuropneumoniae NCBI_Protein_ID: 52630373; PMID: 10085043 true VO:0002521 Oliver He Rebecca Racz gene An apxIIIB mutant, in combination with an apxIIID mutation, is highly attenuated in pigs and induces significant protection from challenge with wild type A. pleuropneumoniae. The mutant also was slightly attenuated in mice and induced protection in mice against challenge from the parent strain apxIIIB from Actinobacillus pleuropneumoniae NCBI_Nucleotide_ID: 470686; PMID: 19887737 VO:0002522 Oliver He Rebecca Racz gene An apxIIID mutant, in combination with an apxIIIB mutation, is highly attenuated in pigs and induces significant protection from challenge with wild type A. pleuropneumoniae. The mutant also was slightly attenuated in mice and induced protection in mice against challenge from the parent strain apxIIID from Actinobacillus pleuropneumoniae NCBI_Nucleotide_ID: 470687; PMID: 19887737 VO:0002523 Oliver He Rebecca Racz gene A precisely defined DeltaapxIICDeltaapxIVA double-deletion mutant of A. pleuropneumoniae was constructed based on HB04C(-) by transconjugation and counterselection. The results demonstrated that the DeltaapxIICDeltaapxIVA double mutant strain was less virulent than HB04C(-). Despite attenuation of virulence, the DeltaapxIICDeltaapxIVA double mutant remains immunogenic and conferred a similar level of protective immunity to pigs against challenge with a lethal dose of a heterologous fully virulent standard serovar 1 strain of A. pleuropneumoniae apxIVA from Actinobacillus pleuropneumoniae NCBI_Protein_ID: 6671152; PMID: 17767980 VO:0002524 Oliver He Rebecca Racz gene Deletions were introduced into the ureC and apxIIA genes of an Actinobacillus pleuropneumoniae serotype 2 strain by homologous recombination and counterselection. The double-mutant contains no foreign DNA, is highly attenuated, protects pigs from homologous challenge upon a single aerosol application ureC from Actinobacillus pleuropneumoniae NCBI_Protein_ID: 303253439; PMID: 12438394 VO:0002525 Oliver He Rebecca Racz gene An mntA deletion mutant, generated by allelic replacement, in Bacillus anthracis was attenuated and provided protection for guinea pigs against lethal spore dose (60 LD50) of the virulent B. anthracis Vollum strain mntA from Bacillus anthracis NCBI_Gene_ID: 7848141; PMID: 16194238 VO:0002526 Oliver He Rebecca Racz VO:0002527 gene An actA mutant is attenuated in mice and induced significant protection from challenge with wild type L. monocytogenes actA from Listeria monocytogenes NCBI_Gene_ID: 987035; PMID: 12763691 VO:0002527 Oliver He Rebecca Racz An actA mutant is attenuated in mice and induced significant protection from challenge with wild type L. monocytogenes obsolete actA from Listeria monocytogenes NCBI_Gene_ID: 987035; PMID: 12763691 true VO:0002528 Oliver He Rebecca Racz gene A plcB mutant, in combination with an actA mutant, is attenuated in mice and induces significant protection from challenge with wild type L. monocytogenes plcB from Listeria monocytogenes NCBI_Gene_ID: 987036; PMID: 12763691 VO:0002529 Oliver He Rebecca Racz gene A M. avium relA mutant is attenuated in calves and goats. This mutant also elicited an immune response in goats that limited colonization by challenge wild type M. avium relA from Mycobacterium avium NCBI_Gene_ID: 2717869; PMID: 21565243 VO:0002530 Oliver He Rebecca Racz gene A drrC mutant is highly attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis drrC from Mycobacterium tuberculosis NCBI_Gene_ID: 888491; PMID: 14702160 VO:0002531 Oliver He Rebecca Racz gene An fadD26 mutant is attenuated in mice and induced significant protection from challenge with wild type M. tuberculosis fadD26 from Mycobacterium tuberculosis NCBI_Gene_ID: 887603; PMID: 15958066 VO:0002532 Oliver He Rebecca Racz gene Deletion of leuD gene was shown to be highly attenuated. Immunocompetent BALB/c mice vaccinated with the DleuD auxotroph were protected as well as BCG in terms of survival following an intravenous or aerosol challenge with virulent M. tuberculosis leuD from Mycobacterium tuberculosis NCBI_Gene_ID: 888225; PMID: 10768986 VO:0002533 Oliver He Rebecca Racz gene A lysA mutant, in combination with a secA2 mutation, is highly attenuated in mice and induced significant protection from challenge with wild type M. tuberculosis lysA from Mycobacterium tuberculosis NCBI_Gene_ID: 886960; PMID: 21264335 VO:0002534 Oliver He Rebecca Racz gene A Mce-2 mutant in Mycobacterium tuberculosis is attenuated and provides protection against challenge for mice mce-2 from Mycobacterium tuberculosis NCBI_Gene_ID: 925014; PMID: 16388878 VO:0002535 Oliver He Rebecca Racz gene A mce-3 mutant in Mycobacterium tuberculosis is attenuated and provides protection against challenge for mice mce-3 from Mycobacterium tuberculosis NCBI_Gene_ID: 923491; PMID: 16388878 VO:0002536 Oliver He Rebecca Racz VO:0002537 gene A panCD mutant is attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis panC from Mycobacterium tuberculosis NCBI_Gene_ID: 885459; PMID: 12219086 VO:0002537 Oliver He Rebecca Racz A panCD mutant is attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis obsolete panC from Mycobacterium tuberculosis NCBI_Gene_ID: 885459; PMID: 12219086 true VO:0002538 Oliver He Rebecca Racz VO:0002539 gene A panCD mutant is attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis panD from Mycobacterium tuberculosis NCBI_Gene_ID: 885596; PMID: 12219086 VO:0002539 Oliver He Rebecca Racz A panCD mutant is attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis obsolete panD from Mycobacterium tuberculosis NCBI_Gene_ID: 885596; PMID: 12219086 true VO:0002540 Oliver He Rebecca Racz gene Study evaluated immunogenicity and protection against Mycobacterium tuberculosis in rhesus monkeys with an attenuated M. tuberculosis with a disrupted phoP gene (SO2) as a single-dose vaccine. SO2 treatment showed reduced average lung bacterial counts (1.0 and 1.2 log respectively, compared with 0.4 log for BCG) and significant protective effect by reduction in C-reactive protein levels, body weight loss, and decrease of erythrocyte-associated hematologic parameters (MCV, MCH, Hb, Ht) as markers of inflammatory infection, all relative to non-vaccinated controls phoP from Mycobacterium tuberculosis NCBI_Gene_ID: 888772; PMID: 19367339 VO:0002541 Oliver He Rebecca Racz gene A proC mutant is highly attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis that is equal to the protection induced by the current vaccine BCG proC from Mycobacterium tuberculosis NCBI_Gene_ID: 887256; PMID: 11160012 VO:0002542 Oliver He Rebecca Racz gene RD1 and panCD mutants in Mycobacterium tuberculosis were attenuated and provided protection in CD4-deficient mice against an aerosol challenge with virulent M. tuberculosis RD1 from Mycobacterium tuberculosis NCBI_Gene_ID: 885777; PMID: 16860907 VO:0002543 Oliver He Rebecca Racz gene Vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Gu√©rin vaccination secA2 from Mycobacterium tuberculosis NCBI_Gene_ID: 885594; PMID: 17671656 VO:0002544 A viral vaccine that protects against infection with Reticuloendotheliosis virus Ningxian Fan Oliver He Ronak Sutariya vaccine Reticuloendotheliosis virus vaccine VO:0002545 Oliver He Rebecca Racz gene A sigE mutant is highly attenuated in mice and induced significant protection from challenge with wild type M. tuberculosis, more so than the existing vaccine BCG sigE from Mycobacterium tuberculosis NCBI_Gene_ID: 888751; PMID: 20457786 VO:0002546 Oliver He Rebecca Racz gene A trpD mutant is highly attenuated in mice and induces more protection from challenge with wild type M. tuberculosis than that induced by the current vaccine BCG trpD from Mycobacterium tuberculosis NCBI_Gene_ID: 887681; PMID: 11160012 VO:0002547 Oliver He Rebecca Racz gene An aroA mutant is attenuated in mice and induced significant protection from challenge with wild type S. aureus aroA from Staphylococcus aureus NCBI_Gene_ID: 8614197; PMID: 16714581 VO:0002548 Oliver He Rebecca Racz gene A vicK mutant is attenuated in mice and induced protection from challenge with wild type S. equi vicK from Streptococcus equi NCBI_Gene_ID: 6760966; PMID: 19088917 VO:0002549 Oliver He Rebecca Racz gene An A. hydrophila aroA mutant is highly attenuated in trout, and a single immunization conferred significant protection from challenge with wild type A. hydrophila aroA from Aeromonas hydrophila NCBI_Gene_ID: 4489425; PMID: 9573055 VO:0002550 Oliver He Rebecca Racz gene The aroA gene was inactivated by inserting a fragment expressing kanamycin resistance within the coding sequence and challenged in fish. The LD50 for unvaccinated fish was 71. In contrast, the LD50 was 1.8 x 104 in fish vaccinated once and 3 x 105 in fish vaccinated twice aroA from Aeromonas salmonicida NCBI_Gene_ID: 4997369; PMID: 8478107 VO:0002551 Oliver He Rebecca Racz VO:0002552 gene Inactivation of the aroA gene highly attenuates B. bronchiseptica, severely impairing its ability to colonize and survive in the respiratory tract of mice. Upon challenge with wild type B. bronchiseptica, the mice immunised with live attenuated B. bronchiseptica aroA mutant had rapidly reduced numbers of B. bronchiseptica in their respiratory tract aroA from Bordetella bronchiseptica NCBI_Gene_ID: 2659145; PMID: 12009288 VO:0002552 Oliver He Rebecca Racz Inactivation of the aroA gene highly attenuates B. bronchiseptica, severely impairing its ability to colonize and survive in the respiratory tract of mice. Upon challenge with wild type B. bronchiseptica, the mice immunised with live attenuated B. bronchiseptica aroA mutant had rapidly reduced numbers of B. bronchiseptica in their respiratory tract obsolete aroA from Bordetella bronchiseptica NCBI_Gene_ID: 2659145; PMID: 12009288 true VO:0002553 Oliver He Rebecca Racz gene A double mutant strain of Bordetella Bronchiseptica lacking adenylate cyclase(cyaA gene) and type III secretion(bscN gene) is attenuated and provides protection in mice against 5 x 105 CFU of RB50, the B. Bronchiseptica parent strain. bscN from Bordetella bronchiseptica NCBI_Gene_ID: 2662485; PMID: 17452472 VO:0002554 Oliver He Rebecca Racz gene A double mutant strain of Bordetella Bronchiseptica lacking adenylate cyclase(cyaA gene) and type III secretion(bscN gene) is attenuated and provides protection in mice against 5 x 105 CFU of RB50, the B. Bronchiseptica parent strain cyaA from Bordetella bronchiseptica NCBI_Gene_ID: 2661688; PMID: 17452472 VO:0002555 Oliver He Rebecca Racz gene A dnt mutant in Bordetella bronchiseptica was attenuated and provides protection in guinea pigs against intranasal challenge with strain L3 dnt from Bordetella bronchiseptica NCBI_Gene_ID: 2661538; PMID: 3182989 VO:0002556 Oliver He Rebecca Racz gene A trpE mutant, in combination with an aroA mutation, is attenuated in mice and induces significant protection from challenge with wild type B. bronchiseptica trpE from Bordetella bronchiseptica NCBI_Protein_ID: 8515760; PMID: 12694904 VO:0002557 Oliver He Rebecca Racz gene An aroA mutant is highly attenuated in mice and induces significant protection from challenge with wild type B. pertussis aroA from Bordetella pertussis NCBI_Protein_ID: 144037; PMID: 2407655 VO:0002558 Oliver He Rebecca Racz gene A live attenuated B. pertussis vaccine strain BPZE1, developed by deleting dnt gene, protects mice upon a single intranasal administration dnt from Bordetella pertussis NCBI_Gene_ID: 2666936; PMID: 18762220 VO:0002559 Oliver He Rebecca Racz gene A flagella-less mutant of Borrelia burgdorferi (HB19Fla-) was attenuated in immunodeficient SCID mice. Mice were challenged 28 days later with virulent strain Sh. 2 and were protected from challenge fla from Borrelia burgdorferi NCBI_Protein_ID: 435009; PMID: 8627071 VO:0002560 Oliver He Rebecca Racz gene A asp24 mutation in Brucella abortus is attenuated and provides significant protection in mice asp24 from B. abortus NCBI_Protein_ID: 2353000; PMID: 17664263 VO:0002561 Oliver He Rebecca Racz gene A bp26 mutant in Brucella melitensis was attenuated and provided protection against challenge in mice bp26 from B. melitensis NCBI_Protein_ID: 265991532; PMID: 15246618 VO:0002562 Oliver He Rebecca Racz gene Brucella DeltaexsA mutant showed decreased survival in mice compared to the survival of parental strain S2308. This demonstrated that ExsA is critical for full bacterial virulence. The B. abortus exsA deletion mutant was used as a live vaccine candidate. Challenge experiments revealed that the exsA mutant strain induced superior protective immunity in BALB/c mice compared to the protective immunity induced by strain S19 or RB51 exsA from B. abortus NCBI_Gene_ID: 3787220; PMID: 12183550 VO:0002563 Oliver He Rebecca Racz gene Unmarked rough B. abortus and B. melitensis deletion mutants of manBA (including manA and manB) were attenuated. These mutants provided protection against virulent Brucella challenge in mice manA from B. melitensis NCBI_Protein_ID: 260563601; PMID: 16790778 VO:0002564 Oliver He Rebecca Racz gene Mutants manB and manA were attenuated in Brucella melitensis and provided protection against challenge in mice's livers manB from B. melitensis NCBI_Gene_ID: 1198671; PMID: 17664263 VO:0002565 Oliver He Rebecca Racz gene A mucR mutant has a significantly reduced degree of colonization in mice and protects against wild type B. melitensis 16M mucR from B. melitensis NCBI_Gene_ID: 1197075; PMID: 21708998 VO:0002566 Oliver He Rebecca Racz gene A omp25 mutant is attenuated and provides protection against challenge in mice omp25 from B. melitensis NCBI_Gene_ID: 1196960; PMID: 12151196 VO:0002567 Oliver He Rebecca Racz gene A omp31 mutant in Brucella melitensis was attenuated and provided protection against challenge in mice omp31 from B. melitensis NCBI_Gene_ID: 7676420; PMID: 15246618 VO:0002568 Oliver He Rebecca Racz gene A pgk mutant is attenuated in mice and induces significant protection from challenge with wild type B. abortus pgk from B. abortus NCBI_Gene_ID: 3788256; PMID: 20194591 VO:0002569 Oliver He Rebecca Racz gene A pgm mutant is attenuated in mice and induces significant protection from challenge with wild type B. abortus pgm from B. abortus NCBI_Gene_ID: 3788847; PMID: 14573645 VO:0002570 Oliver He Rebecca Racz gene Mice infected with delta purE201 developed only five to eight times normal spleen weight at 1 week p.i. and produced no interleukin-6 in their serum, which is much lower than the mice infected with the parental strain (16M) purE from B. melitensis NCBI_Gene_ID: 1196006; PMID: 8675325 VO:0002571 Oliver He Rebecca Racz gene A purE/purK mutant of B. melitensis 16M was attenuated in mice when given intraperitoneally. Nine weeks after immunization, mice were protected from challenge with wild type B. melitensis purK from B. melitensis NCBI_Protein_ID: 20141763; PMID: 7642258 VO:0002572 Oliver He Rebecca Racz gene A virB2 mutant is attenuated in Brucella melitensis and provides protection in mice virB2 from B. abortus NCBI_Gene_ID: 3827981; PMID: 17664263 VO:0002573 Oliver He Rebecca Racz gene The deletion of vjbR gene in Brucella melitensis strain 16M made a live attenuated vaccine and provided significance protection against mice vjbR from B. melitensis NCBI_Gene_ID: 1198888; PMID: 21530111 VO:0002574 Oliver He Rebecca Racz gene Deletion of gene znuA attenuates Brucella abortus and this live attenuated vaccine was challenged in mice. These mice showed significantly fewer spenic CFU znuA from Brucella spp. NCBI_Gene_ID: 3827700; PMID: 16790759 VO:0002575 Oliver He Rebecca Racz gene The aroC deletion in the resultant mutant, designated A2ŒîaroC, was confirmed by PCR, Southern hybridization and failure of the mutant to grow in a defined medium without aromatic compounds. The constructed unmarked aroC mutant of B. pseudomallei is attenuated in both BALB/c and C57Bl/6 mice and is able to confer significant protection in C57Bl/6 mice aroC from Burkholderia pseudomallei NCBI_Gene_ID: 4899749; PMID: 19323044 VO:0002576 Oliver He Rebecca Racz gene An asd mutant is highly attenuated in mice. This mutant was also able to protect against acute inhalation melioidosis caused by challenge with wild type B. pseudomallei asd from Burkholderia pseudomallei NCBI_Protein_ID: 2358232; PMID: 21807903 VO:0002577 Oliver He Rebecca Racz gene Mice that were challenged with a higher dose of mutant 56:65 purM were protected purM from Burkholderia pseudomallei NCBI_Gene_ID: 3092877; PMID: 19121696 VO:0002578 Oliver He Rebecca Racz gene Although 30:93a purN -immunized mice were challenged with a 10-fold higher dose of WT E8, mice were strongly protected and showed no signs of clinical illness until the experiment was terminated purN from Burkholderia pseudomallei NCBI_Gene_ID: 3092878; PMID: 19121696 VO:0002579 Oliver He Rebecca Racz gene A crp mutant is attenuated in zebrafish and catfish that were immunized intramuscularly and intracoelomically, respectively. Six weeks after immunization, both zebrafish and catfish were protected from challenge with wild type E. ictaluri crp from Edwardsiella ictaluri NCBI_Gene_ID: 7962173; PMID: 22015784 VO:0002580 Oliver He Rebecca Racz VO:0002581 VO:0002582 gene An aroC mutant is attenuated in zebra fish. The aroC mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 68.3% aroC from Edwardsiella tarda NCBI_Gene_ID: 8608790; PMID: 21777261 VO:0002581 Oliver He Rebecca Racz An aroC mutant is attenuated in zebra fish. The aroC mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 68.3% obsolete aroC from Edwardsiella tarda NCBI_Gene_ID: 8608790; PMID: 21777261 true VO:0002582 Oliver He Rebecca Racz An aroC mutant is attenuated in zebra fish. The aroC mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 68.3% obsolete aroC from Edwardsiella tarda NCBI_Gene_ID: 8608790; PMID: 21777261 true VO:0002583 Oliver He Rebecca Racz gene An esrB mutant is highly attenuated in fish (turbot), with an LD50 of 10(8.1)cfu/fish. Vaccination with this mutant elicited significant protection from wild type E. tarda esrB from Edwardsiella tarda NCBI_Gene_ID: 8607237; PMID: 17478097 VO:0002584 Oliver He Rebecca Racz gene An aroC and esrC mutant is attenuated in zebra fish. This mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 71.3% esrC from Edwardsiella tarda NCBI_Gene_ID: 8607212; PMID: 21777261 VO:0002585 Oliver He Rebecca Racz gene An aroC and slyA mutant is attenuated in zebra fish. This mutant is also protective against challenge from wild type E. tarda, resulting in a relative percent survival of 80.1% slyA from Edwardsiella tarda NCBI_Gene_ID: 8608031; PMID: 21777261 VO:0002586 Oliver He Rebecca Racz gene A carAB mutant is attenuated in turkeys and induces significant protection from challenge with wild type E. coli carA from Escherichia coli NCBI_Gene_ID: 949025; PMID: 8063392 VO:0002587 Oliver He Rebecca Racz gene A carAB mutant is attenuated in turkeys and induces significant protection from challenge with wild type E. coli carB from Escherichia coli NCBI_Gene_ID: 944775; PMID: 8063392 VO:0002588 Oliver He Rebecca Racz gene A ler deletion mutant derived from wild-type EHEC O157:H7 86-24 was constructed by use of suicide vector pCVD442. Following challenge of 7-day-old suckling mice with O157:H7 EDL933, 75.2% born to group B mothers (immunized with F25) sur- vived, as did 83.0% born to group C mothers (immunized with F105). The surviving suckling mice consistently gained body weight. Only 16.8% of sucking mice born to control group mice survived the challenge ler from Escherichia coli NCBI_Gene_ID: 8219269; PMID: 19682616 VO:0002589 Oliver He Rebecca Racz gene Deletion of waaL results in a strain that stimulates enhanced urothelial cytokine secretion, which is an enhanced innate immune response. Inoculation with the vaccine strain protected mice against challenge with a broad range of clinical uropathogenic E. coli isolates and produced immunity that lasted >=8 weeks. rfaL from Escherichia coli NCBI_Gene_ID: 948148; PMID: 19522648 VO:0002590 Oliver He Rebecca Racz gene There was a deletion in gene capB of F. tularensis live vaccine strain. LVS capB, while much less virulent than LVS, induces potent protective immunity against lethal LVS i.n. challenge in mice, comparable to that induced by LVS capB from Francisella tularensis NCBI_Gene_ID: 3952402; PMID: 20643859 VO:0002591 Oliver He Rebecca Racz gene A clpB mutant in Francisella tularensis subspecies tularensis strain SCHU S4 was attenuated and provided protection against aerosol challenge in mice clpB from Francisella tularensis NCBI_Gene_ID: 3192509; PMID: 20018266 VO:0002592 Oliver He Rebecca Racz gene A FTL0552 mutant in Francisella tularensis was attenuated and provided partial protection in mice against challenge with a lethal dose of the virulent SchuS4 strain when compared to naive mice FTL0552 from Francisella tularensis NCBI_Gene_ID: 3952730; PMID: 18613792] VO:0002593 Oliver He Rebecca Racz gene An FTT0918 mutant showed significantly reduced virulence in mice. Mice that recovered from infection with the mutant were protected 2 months later from challenge with wild type F. tularensis FTT0918 from Francisella tularensis NCBI_Gene_ID: 3191684; PMID: 16299332 VO:0002594 Oliver He Rebecca Racz gene A galU mutant is attenuated in mice, with only transient weight loss observed. Two months after inoculation, mice were challenge with wild type F. tularensis and were protected, once again only experiencing transient weight loss galU from Francisella tularensis NCBI_Gene_ID: 3191600; PMID: 21819572 VO:0002595 Oliver He Rebecca Racz gene A guaA mutant is highly attenuated in mice and induces significant protection from challenge with parent strain F. tularensis LVS guaA from Francisella tularensis NCBI_Gene_ID: 3951701; PMID: 19368784 VO:0002596 Oliver He Rebecca Racz gene A guaB mutant is attenuated in mice and induces significant protection from challenge with parent strain F. tularensis LVS guaB from Francisella tularensis NCBI_Gene_ID: 3952496; PMID: 19368784 VO:0002597 Oliver He Rebecca Racz gene Intranasal vaccination with KKF235 (F. tularensis subsp. novicida mutant (DeltaiglB) ) protected mice from subsequent homotypic challenge with U112 as well as heterotypic challenge with F. tularensis subsp. holarctica (LVS). Most significantly, oral immunization with KKF235 protected mice from a highly lethal subsp. tularensis (SCHU S4) pulmonary challenge iglB from Francisella tularensis NCBI_Gene_ID: 4548125; PMID: 20016043 VO:0002598 Oliver He Rebecca Racz gene An iglC mutant is highly attenuated in mice. Inoculated mice were challenged 30 days later with wild type F. tularensis and were highly protected iglC from Francisella tularensis NCBI_Gene_ID: 4548124; PMID: 16552035 VO:0002599 Oliver He Rebecca Racz gene A purMCD mutant in Francisela tularensis was attenuated. A low dosage of F. tularensis LVS delta purMCD mutant provided protection against challenge in mice purC/purD from Francisella tularensis NCBI_Gene_ID: 3952576; PMID: 16861631 VO:0002600 Oliver He Rebecca Racz gene Mice, which had been immunized with at least 6.95 x 103 cfu of F. tularensis U112 purF::Cm, were protected against the subsequent F. tularensis subspecies novicida challenge. purF from Francisella tularensis NCBI_Gene_ID: 4548578; PMID: 16930871 VO:0002601 Oliver He Rebecca Racz gene A purMCD mutant in Francisella tularensis was attenuated. A low dose of the F. tularensis LVS delta purMCD mutant provided protection against subsequent lethal challenge with the LVS parental strain purM from Francisella tularensis NCBI_Gene_ID: 3952575; PMID: 16861631 VO:0002602 Oliver He Rebecca Racz gene C57BL/6 mice were vaccinated intranasally (i.n.) with the sodB(Ft) mutant and challenged i.n. with lethal doses of F. tularensis SchuS4. SodB(Ft) vaccinated mice following SchuS4 challenge exhibited significantly reduced bacterial burden in lungs, liver and spleen, regulated production of pro-inflammatory cytokines and less severe histopathological lesions compared to the LVS vaccinated mice. The sodB(Ft) vaccination induced a potent humoral immune response and protection against SchuS4 required both CD4 and CD8 T cells in the vaccinated mice sodB from Francisella tularensis NCBI_Gene_ID: 4548021; PMID: 18692537 VO:0002603 Oliver He Rebecca Racz gene A sodC mutant in Francisella tularensis subspecies holarctica was attenuated and provided protection and cleared the infection against lethal challenge in nearly 50% of the mice infected with the delta-sodC mutant. sodC from Francisella tularensis NCBI_Protein_ID: 1314283; PMID: 19684141 VO:0002604 Oliver He Rebecca Racz gene A wbtA mutant in Francisella tularensis was attenuated and provided protection in mice against challenge with an otherwise lethal dose of either F. tularensis LVS or a fully virulent clinical isolate of F. tularensis type B wbtA from Francisella tularensis NCBI_Gene_ID: 3191939; PMID: 17296751 VO:0002605 Oliver He Rebecca Racz gene A wbtI mutant is attenuated in mice. The mutant protected against a low dose challenge with the parental strain, but was less effective against higher doses. However, increasing the immunization dose increased the resistance to higher challenge doses wbtI from Francisella tularensis NCBI_Gene_ID: 5522688; PMID: 17768257 VO:0002606 Oliver He Rebecca Racz gene An aroA mutant is highly attenuated in mice and induced significant protection after two doses from challenge with wild type M. haemolytica aroA from Mannheimia haemolytica NCBI_Protein_ID: 451485; PMID: 7839583 VO:0002607 Oliver He Rebecca Racz gene An lpd mutant is highly attenuated in chickens and induces significant protection from challenge with wild type M. gallisepticum lpd from Mycoplasma gallisepticum NCBI_Gene_ID: 1089767; PMID: 18342996 VO:0002608 Oliver He Rebecca Racz gene A metH mutant, in combination with a siaD mutation, is attenuated in mice and induces significant protection from challenge with wild type N. meningitidis metH from Neisseria meningitidis NCBI_Gene_ID: 903064; PMID: 14688114 VO:0002609 Oliver He Rebecca Racz gene An rfaF mutant, in combination with a siaD mutation, is attenuated in mice and induces significant protection from challenge with wild type N. meningitidis rfaF from Neisseria meningitidis NCBI_Gene_ID: 904029; PMID: 14688114 VO:0002610 Oliver He Rebecca Racz VO:0002611 gene A siaD mutant, in combination with either a metH or rfaF mutation, is attenuated in mice and induces protection from challenge with wild type N. meningitidis siaD from Neisseria meningitidis NCBI_Gene_ID: 903210; PMID: 14688114 VO:0002611 Oliver He Rebecca Racz A siaD mutant, in combination with either a metH or rfaF mutation, is attenuated in mice and induces protection from challenge with wild type N. meningitidis obsolete siaD from Neisseria meningitidis NCBI_Gene_ID: 903210; PMID: 14688114 true VO:0002612 Oliver He Rebecca Racz gene An aroA mutant is highly attenuated in calves and induces significant protection from challenge with wild type P. multocida aroA from Pasteurella multocida NCBI_Protein_ID: 581456; PMID: 17875632 VO:0002613 Oliver He Rebecca Racz gene An aroA mutant is attenuated in mice and induced significant protection from challenge with wild type S. typhi Ty2 aroA from Salmonella Typhi NCBI_Gene_ID: 1068996; PMID: 3039297 VO:0002614 Oliver He Rebecca Racz VO:0002615 gene Inactivation of AroC results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" aroC from Salmonella Typhi NCBI_Gene_ID: 1069415; PMID: 17582563 VO:0002615 Oliver He Rebecca Racz Inactivation of AroC results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" obsolete aroC from Salmonella spp. NCBI_Gene_ID: 1069415; PMID: 17582563 true VO:0002616 Oliver He Rebecca Racz gene Inactivation of AroD results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" aroD from Salmonella Typhi NCBI_Gene_ID: 1070649; PMID: 17582563 VO:0002617 Oliver He Rebecca Racz VO:0002618 gene An asd mutant, alone or in combination with a rfc mutation, is attenuated in mice and induces significant protection from challenge with wild type Salmonella typhimurium asd from Salmonella Typhimurium NCBI_Protein_ID: 267995764; PMID: 20799091 VO:0002618 Oliver He Rebecca Racz An asd mutant, alone or in combination with a rfc mutation, is attenuated in mice and induces significant protection from challenge with wild type Salmonella typhimurium obsolete asd from Salmonella spp. NCBI_Protein_ID: 267995764; PMID: 20799091 true VO:0002619 Oliver He Rebecca Racz gene An atpA mutant is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium atpA from Salmonella Typhimurium NCBI_Protein_ID: 301160399; PMID: 19649318 VO:0002620 Oliver He Rebecca Racz gene A cbiA mutant, in combination with a cobS mutation, is attenuated in chickens and induces significant protection from challenge with wild type S. Gallinarum. This mutant was also able to provide some protection against S. Enteritidis cbiA from Salmonella Gallinarum NCBI_Gene_ID: 6923268; PMID: 20153354 VO:0002621 Oliver He Rebecca Racz gene A guaBA and clpP mutant (CVD 1941) is attenuated in mice after oral immunization. This mutant is also protective, and had a vaccine efficacy of 76% against challenge with wild type Salmonella Enteritidis clpP from Salmonella Enteritidis NCBI_Gene_ID: 6950532; PMID: 21807911 VO:0002622 Oliver He Rebecca Racz VO:0002623 VO:0002624 gene A mutation in clpP (CS2007) causes hyperflagellation. These hyperflagellated bacteria are attenuated in mice, and an LD50 for CS2007 could not be determined because mice did not die after inoculation with the highest dose. CS2007 also elicited protection in mice from challenge with wild type S. typhimurium clpP from Salmonella Typhimurium NCBI_Gene_ID: 1251968; PMID: 2496146 VO:0002623 Oliver He Rebecca Racz A mutation in clpP (CS2007) causes hyperflagellation. These hyperflagellated bacteria are attenuated in mice, and an LD50 for CS2007 could not be determined because mice did not die after inoculation with the highest dose. CS2007 also elicited protection in mice from challenge with wild type S. typhimurium obsolete clpP from Salmonella spp. NCBI_Gene_ID: 1251968; PMID: 2496146 true VO:0002624 Oliver He Rebecca Racz A mutation in clpP (CS2007) causes hyperflagellation. These hyperflagellated bacteria are attenuated in mice, and an LD50 for CS2007 could not be determined because mice did not die after inoculation with the highest dose. CS2007 also elicited protection in mice from challenge with wild type S. typhimurium obsolete clpP from Salmonella spp. NCBI_Gene_ID: 1251968; PMID: 2496146 true VO:0002625 Oliver He Rebecca Racz gene A cobS mutant, in combination with a cbiA mutation, is attenuated in chickens and induces significant protection from challenge with wild type S. Gallinarum. This mutant was also able to provide some protection against S. Enteritidis cobS from Salmonella Gallinarum NCBI_Gene_ID: 6923296; PMID: 20153354 VO:0002626 Oliver He Rebecca Racz gene A gyrA-cpxA-rpoB Salmonella Typhimurium mutant was attenuated and protected against challenge in pigs cpxA from Salmonella Typhimurium NCBI_Gene_ID: 1255585; PMID: 15542179 VO:0002627 Oliver He Rebecca Racz gene A cpxR mutant, in combination with a lon mutation, is highly attenuated in mice and induces significant protection from challenge with wild type S. gallinarum cpxR from Salmonella Gallinarum NCBI_Gene_ID: 6923307; PMID: 20487719 VO:0002628 Oliver He Rebecca Racz gene A cya and crp mutant is attenuated in mice. Thirty days after immunization, mice were protected from oral challenge with wild type S. typhimurium crp from Salmonella Typhimurium NCBI_Gene_ID: 1254989; PMID: 3316029 VO:0002629 Oliver He Rebecca Racz gene A crp mutant is attenuated in mice and induces significant protection from challenge with wild type S. gallinarum crp from Salmonella Gallinarum NCBI_Protein_ID: 46811321; PMID: 17488512 VO:0002630 Oliver He Rebecca Racz gene A cya and crp mutant is attenuated in mice. Thirty days after immunization, mice were protected from oral challenge with wild type S. typhimurium cya from Salmonella Typhimurium NCBI_Protein_ID: 581756; PMID: 3316029 VO:0002631 Oliver He Rebecca Racz gene A fliC mutant, in combination with a guaB mutant, is attenuated in mice and chickens and induces significant protection from challenge with wild type S. enterica fliC from Salmonella Enteritidis NCBI_Protein_ID: 119351647; PMID: 17261603 VO:0002632 Oliver He Rebecca Racz gene A guaBA, clpP, and fliD mutant (CVD 1923) is attenuated in mice after oral immunization. This mutant is also protective, with a vaccine efficacy of 80% in mice against wild type challenge from Salmonella Typhimurium fliD from Salmonella Typhimurium NCBI_Gene_ID: 1253481; PMID: 21807911 VO:0002633 Oliver He Rebecca Racz gene A gal E mutant in strain Ty2 was isolated, attenuated, and protected mice against lethal challenge galE from Salmonella Typhi NCBI_Gene_ID: 1067209; PMID: 1092768 VO:0002634 Oliver He Rebecca Racz gene A guaBA and clpP mutant (CVD 1941) is attenuated in mice after oral immunization. This mutant is also protective in mice and had a vaccine efficacy of 76% against challenge with wild type Salmonella Enteritidis guaA from Salmonella Enteritidis NCBI_Gene_ID: 6948075; PMID: 21807911 VO:0002635 Oliver He Rebecca Racz VO:0002636 gene A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium guaA from Salmonella Typhimurium NCBI_Gene_ID: 1254032; PMID: 21807911 VO:0002636 Oliver He Rebecca Racz A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium obsolete guaA from Salmonella spp. NCBI_Gene_ID: 1254032; PMID: 21807911 true VO:0002637 Oliver He Rebecca Racz VO:0002638 gene A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium guaB from Salmonella Typhimurium NCBI_Gene_ID: 1254033; PMID: 21807911 VO:0002638 Oliver He Rebecca Racz A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium obsolete guaB from Salmonella spp. NCBI_Gene_ID: 1254033; PMID: 21807911 true VO:0002639 Oliver He Rebecca Racz VO:0002640 gene A guaB mutant, in combination with a fliC mutant, is attenuated in mice and chickens and induced significant protection from challenge with wild type S. enterica guaB from Salmonella Enteritidis NCBI_Gene_ID: 6949287; PMID: 17261603 VO:0002640 Oliver He Rebecca Racz A guaB mutant, in combination with a fliC mutant, is attenuated in mice and chickens and induced significant protection from challenge with wild type S. enterica obsolete guaB from Salmonella spp. NCBI_Gene_ID: 6949287; PMID: 17261603 true VO:0002641 Oliver He Rebecca Racz gene A gyrA-cpxA-rpoB Salmonella Typhimurium mutant was attenuated and protected against challenge in pigs gyrA from Salmonella Typhimurium NCBI_Gene_ID: 1253794; PMID: 15542179 VO:0002642 Oliver He Rebecca Racz gene Oral immunization with the Salmonella hfq deletion mutant efficiently protects mice against subsequent oral challenge with virulent strain of Salmonella Typhimurium hfq from Salmonella Typhimurium NCBI_Gene_ID: 1255887; PMID: 21347426 VO:0002643 Oliver He Rebecca Racz gene A htrA mutant in Salmonella typhimurium is attenuated and provides protection in mice against an oral challenge with virulent S. typhimurium SL1344 htrA from Salmonella Typhimurium NCBI_Protein_ID: 301156836; PMID: 1584006] VO:0002644 Oliver He Rebecca Racz gene A lon mutant, in combination with a cpxR mutation, is highly attenuated in mice and induces significant protection from challenge with wild type S. gallinarum lon from Salmonella Gallinarum NCBI_Gene_ID: 6923289; PMID: 20487719 VO:0002645 Oliver He Rebecca Racz gene An lppA mutant, in combination with an lppB/msbB mutation, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium lppA from Salmonella Typhimurium NCBI_Protein_ID: 323129647; PMID: 17997275 VO:0002646 Oliver He Rebecca Racz VO:0002647 gene An lppB mutant, in combination with an msbB mutant or an msbB/lppA mutant, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium lppB from Salmonella Typhimurium NCBI_Protein_ID: 267993263; PMID: 17997275 VO:0002647 Oliver He Rebecca Racz An lppB mutant, in combination with an msbB mutant or an msbB/lppA mutant, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium obsolete lppB from Salmonella spp. NCBI_Protein_ID: 267993263; PMID: 17997275 true VO:0002648 Oliver He Rebecca Racz VO:0002649 gene An msbB mutant, in combination with an lppB or lppAB mutation, is attenuated in mice and induces significant protection from challenge with S. Typhimurium msbB from Salmonella Typhimurium NCBI_Protein_ID: 4104731; PMID: 17997275 VO:0002649 Oliver He Rebecca Racz An msbB mutant, in combination with an lppB or lppAB mutation, is attenuated in mice and induces significant protection from challenge with S. Typhimurium obsolete msbB from Salmonella spp. NCBI_Protein_ID: 4104731; PMID: 17997275 true VO:0002650 Oliver He Rebecca Racz gene In a pig infection experiment including two oral immunizations with SalmoporcDeltaompD (OmpD, nmpC) and challenge with a multiresistant S. enterica serovar Typhimurium DT104 clinical isolate, we confirmed the protective efficacy of SalmoporcDeltaompD in pigs, showing a significant reduction of both clinical symptoms and colonization of lymph nodes and intestinal tract nmpC from Salmonella Typhimurium NCBI_Protein_ID: 517159; PMID: 17296750 VO:0002651 Oliver He Rebecca Racz gene A nuoG mutant is attenuated in chickens and induced significant protection from challenge with wild type S. Gallinarum nuoG from Salmonella Gallinarum NCBI_Gene_ID: 6924283; PMID: 9682335 VO:0002652 Oliver He Rebecca Racz gene An ompR mutant is attenuated in mice after oral challenge. Twenty eight days after immunization, mice were challenged with wild type S. typhimurium and were significantly protected ompR from Salmonella Typhimurium NCBI_Protein_ID: 301160045; PMID: 2543631 VO:0002653 Oliver He Rebecca Racz gene Three S. typhi deletion mutants (phoP, rpoS, and rpoS-phoP double mutant) were constructed and characterized with respect to invasiveness, virulence, and protective immune response compared with wild-type Ty2. All S. typhi mutants showed an increase in the specific serum IgG levels and T-cell-mediated immunity, and showed equal protection abilities against a wild-type Ty2 challenge after two rounds of immunization in BALB/c mice phoP from Salmonella Typhi NCBI_Gene_ID: 1071307; PMID: 17725620 VO:0002654 Oliver He Rebecca Racz gene A poxA mutant is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium poxA from Salmonella Typhimurium NCBI_Gene_ID: 1255870; PMID: 9826331 VO:0002655 Oliver He Rebecca Racz gene A ppGpp-defective Salmonella Gallinarum, which is attained by mutating the relA and spoT genes, is attenuated in chickens and induces protection from oral challenge with wild type S. Gallinarum relA from Salmonella Gallinarum NCBI_Gene_ID: 6922678; PMID: 21046347 VO:0002656 Oliver He Rebecca Racz gene An rfc mutant, in combination with an asd mutation, is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium rfc from Salmonella Typhimurium NCBI_Protein_ID: 267993210; PMID: 20799091 VO:0002657 Oliver He Rebecca Racz gene A gyrA-cpxA-rpoB Salmonella Typhimurium mutant was attenuated and protected against challenge in pigs rpoB from Salmonella Typhimurium NCBI_Gene_ID: 255679; PMID: 15542179 VO:0002658 Oliver He Rebecca Racz gene Immunizations with Salmonella typhimurium rpoS and rpoS aroA mutants protected susceptible BALB/c mice against subsequent oral challenge with virulent S. typhimurium. When administered orally or intraperitoneally, rpoS derivatives of the mouse-virulent S. typhimurium strains, C52 and SL1344, were highly attenuated and were efficient single-dose live vaccines rpoS from Salmonella Typhimurium NCBI_Protein_ID: 301159483; PMID: 8899717 VO:0002659 Oliver He Rebecca Racz gene A ruvB mutant is attenuated in mice and induced significant protection from challenge with wild type S. Typhimurium ruvB from Salmonella Typhimurium NCBI_Gene_ID: 1253415; PMID: 20670908 VO:0002660 Oliver He Rebecca Racz gene A ppGpp-defective Salmonella Gallinarum, which is attained by mutating the relA and spoT genes, is attenuated in chickens and induces protection from oral challenge with wild type S. Gallinarum spoT from Salmonella Gallinarum NCBI_Gene_ID: 6924903; PMID: 21046347 VO:0002661 Oliver He Rebecca Racz gene A surA mutant (BRD1115) is attenuated in BALB/c mice and induces protection from challenge with wild type S. typhimurium surA from Salmonella Typhimurium NCBI_Gene_ID: 1251610; PMID: 10678914 VO:0002662 Oliver He Rebecca Racz gene A tolA mutant is attenuated in mice and induced significant protection from challenge with wild type S. Typhimurium tolA from Salmonella Typhimurium NCBI_Protein_ID: 301157338; PMID: 19118362 VO:0002663 Oliver He Rebecca Racz gene A trxA mutant is attenuated in mice and induced significant protection from challenge with wild type S. Typhimurium trxA from Salmonella Typhimurium NCBI_Protein_ID: 301160436; PMID: 19884329 VO:0002664 Oliver He Rebecca Racz gene A wecA mutant (DSM645) is attenuated in C57BL/6J mice through i.p. and oral immunization. This mutant also protects against challenge with S. typhimurium strains TML and SL1344 30 days after immunization wecA from Salmonella Typhimurium NCBI_Protein_ID: 20140863; PMID: 22025511 VO:0002665 Oliver He Rebecca Racz gene A znuABC mutant is attenuated in mice and induced significant protection against a challenge infection in the large intestine with wild type Salmonella typhimurium znuA from Salmonella Typhimurium NCBI_Gene_ID: 253412; PMID: 21219981 VO:0002666 Oliver He Rebecca Racz gene A znuABC mutant is attenuated in mice and induced significant protection against a challenge infection in the large intestine with wild type Salmonella typhimurium znuB from Salmonella Typhimurium NCBI_Gene_ID: 1253414; PMID: 21219981 VO:0002667 Oliver He Rebecca Racz gene A znuABC mutant is attenuated in mice and induced significant protection against a challenge infection in the large intestine with wild type Salmonella typhimurium znuC from Salmonella Typhimurium NCBI_Gene_ID: 1253413; PMID: 21219981 VO:0002668 Oliver He Rebecca Racz VO:0002669 VO:0002670 VO:0002671 gene An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri aroA from Shigella NCBI_Gene_ID: 1077373; PMID: 7927802 VO:0002669 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete aroA from Shigella NCBI_Gene_ID: 1077373; PMID: 7927802 true VO:0002670 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete aroA from Shigella NCBI_Gene_ID: 1077373; PMID: 7927802 true VO:0002671 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete aroA from Shigella NCBI_Gene_ID: 1077373; PMID: 7927802 true VO:0002672 Oliver He Rebecca Racz VO:0002673 gene An aroD mutant is highly attenuated in monkeys and induces significant protection from challenge with wild type S. flexneri aroD from Shigella NCBI_Gene_ID: 1078189; PMID: 8356844 VO:0002673 Oliver He Rebecca Racz An aroD mutant is highly attenuated in monkeys and induces significant protection from challenge with wild type S. flexneri obsolete aroD from Shigella NCBI_Gene_ID: 1078189; PMID: 8356844 true VO:0002674 Oliver He Rebecca Racz gene An envZ mutant (SC433) is greatly decreased in virulence in macaque monkeys, though some mild clinical signs were still recorded. This mutant is also highly protective against a challenge of wild type S. flexneri delivered 1 month after inoculation envZ from Shigella NCBI_Gene_ID: 4207729; PMID: 1887672 VO:0002675 Oliver He Rebecca Racz VO:0002676 gene An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri icsA/virG from Shigella NCBI_Gene_ID: 1238021; PMID: 7927802 VO:0002676 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete icsA/virG from Shigella NCBI_Gene_ID: 1238021; PMID: 7927802 true VO:0002677 Oliver He Rebecca Racz gene A virG, senA, senB, and msbB2 mutant (WRSs3) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs3 is comparable to live attenuated vaccine strain WRSS1 msbB2 from Shigella NCBI_Gene_ID: 3670926; PMID: 19932216] VO:0002678 Oliver He Rebecca Racz VO:0002679 gene A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 senA from Shigella NCBI_Gene_ID: 3671021; PMID: 19932216 VO:0002679 Oliver He Rebecca Racz A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 obsolete senA from Shigella NCBI_Gene_ID: 3671021; PMID: 19932216 true VO:0002680 Oliver He Rebecca Racz VO:0002681 gene A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 senB from Shigella NCBI_Gene_ID: 3668265; PMID: 19932216 VO:0002681 Oliver He Rebecca Racz A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 obsolete senB from Shigella NCBI_Gene_ID: 3668265; PMID: 19932216 true VO:0002682 Oliver He Rebecca Racz VO:0002683 gene A virG mutant (WRSS1) is attenuated in guinea pigs and induced significant protection from challenge with wild type Shigella sonnei virG from Shigella NCBI_Gene_ID: 3670887; PMID: 9712824 VO:0002683 Oliver He Rebecca Racz A virG mutant (WRSS1) is attenuated in guinea pigs and induced significant protection from challenge with wild type Shigella sonnei obsolete virG from Shigella NCBI_Gene_ID: 3670887; PMID: 9712824 true VO:0002684 Oliver He Rebecca Racz gene A hemA mutant is highly attenuated in mice and rabbits and induces protection from challenge with wild type V. cholerae in rabbits hemA from Vibrio cholerae NCBI_Protein_ID: 12656010; PMID: 16102875 VO:0002685 Oliver He Rebecca Racz gene An aroA mutant is highly attenuated in mice, and after 3 doses induces significant protection from challenge with wild type Y. enterocolitica aroA from Yersinia enterocolitica NCBI_Gene_ID: 4713234; PMID: 2777382 VO:0002686 Oliver He Rebecca Racz gene A htrA mutant in Yersinia enterocolitica was attenuated and provided partial protection against challenge in mice htrA from Yersinia enterocolitica NCBI_Gene_ID: 4715899; PMID: 8675311 VO:0002687 Oliver He Rebecca Racz gene A ompR mutant in Yersinia enterocolitica was attenuated and provided a partial protection from challenge in mice ompR from Yersinia enterocolitica NCBI_Gene_ID: 4716266; PMID: 9711851 VO:0002688 Oliver He Rebecca Racz gene A sodA mutant in Yersinia enterocolitica was highly attenuated and mice immunized with a single oral dose of the mutant strain were protected against a lethal oral-challenge infection with wild-type Y. enterocolitica sodA from Yersinia enterocolitica NCBI_Gene_ID: 4716532; PMID: 10496939 VO:0002689 Oliver He Rebecca Racz gene A guaBA mutant is attenuated in mice and induced significant protection from challenge with wild type Y. pestis guaA from Yersinia pestis NCBI_Gene_ID: 1146310; PMID: 0096773 VO:0002690 Oliver He Rebecca Racz gene A guaBA mutant is attenuated in mice and induced significant protection from challenge with wild type Y. pestis guaB from Yersinia pestis NCBI_Gene_ID: 1146309; PMID: 0096773 VO:0002691 Oliver He Rebecca Racz gene An IpxM mutant is attenuated in mice and guinea pigs. This mutant also conferred modest protection from challenge with wild type Y. pestis in Balb/c mice and significant protection in guinea pigs and outbred mice ipxM from Yersinia pestis NCBI_Gene_ID: 1174901; PMID: 17913308 VO:0002692 Oliver He Rebecca Racz gene An nlpD mutant is highly attenuated in mice and induced significant protection from challenge with wild type Y. pestis nlpD from Yersinia pestis NCBI_Protein_ID: 224483371; PMID: 19759820 VO:0002693 Oliver He Rebecca Racz gene A pcm mutant is highly attenuated in mice and induced significant protection from challenge with wild type Y. pestis pcm from Yersinia pestis NCBI_Protein_ID: 224483370; PMID: 14742535 VO:0002694 Oliver He Rebecca Racz gene An smpB mutant, in combination with an ssrA mutation, is attenuated in mice and induces significant protection from challenge with wild type Y. pestis smpB from Yersinia pestis NCBI_Gene_ID: 1173949; PMID: 20065026 VO:0002695 Oliver He Rebecca Racz gene An smpB mutant, in combination with an ssrA mutation, is attenuated in mice and induces significant protection from challenge with wild type Y. pestis ssrA from Yersinia pestis NCBI_Gene_ID: 1173948; PMID: 20065026 VO:0002696 Oliver He Rebecca Racz gene A yopH mutant is highly attenuated in mice and induced significant protection from challenge with wild type Y. pestis yopH from Yersinia pestis NCBI_Gene_ID: 1172712; PMID: 17652523 VO:0002697 Oliver He Rebecca Racz gene A phoP mutant in Yersinia pseudotuberculosis (Yptb) was attenuated and provided protection against oral challenge with virulent Yptb in mice phoP from Yersinia pseudotuberculosis NCBI_Gene_ID: 2956268; PMID: 17194509 VO:0002698 Oliver He Rebecca Racz gene An aroA mutant is highly attenuated in rainbow trout and induces significant protection from challenge with wild type Y. ruckeri aroA from Yersinia ruckeri NCBI_Protein_ID: 15420539; PMID: 16083447 VO:0002699 Oliver He Rebecca Racz gene A thymidine kinase-deficient mutant (B8-D53) showed no detectable thymidine kinase-inducing activity and was attenuated in calves. B8-D53 also induced protection from challenge with wild type BHV-1 UL23 from Bovine herpesvirus 1 NCBI_Gene_ID: 1487380; PMID: 2994602 VO:0002700 Oliver He Rebecca Racz gene A deletion of BHV-1 gE gene in strain A is considered as a live attenuated vaccine. After challenge, vaccinated calves were protected against disease and virus shedding was reduced US8 from Bovine herpesvirus 1 NCBI_Gene_ID: 1487407; PMID: 8023552 VO:0002701 Oliver He Rebecca Racz gene A glycoprotein G deletion in bovine respiratory syncytial virus(rBRSV) and recombinant rBRSV was attenuated and provided protection against a BRSV challenge infection in calves glycoprotein G from Bovine Respiratory Syncytial Virus NCBI_Gene_ID: 1489813; PMID: 12414977 VO:0002702 Oliver He Rebecca Racz gene An N269A/Q mutation in the E(rns) protein created an attenuated mutant in swine. This mutant was able to induce effective protection in swine against challenge with wild type CSFV E(rns) from Classical swine fever virus NCBI_Protein_ID: 130457; PMID: 17904607 VO:0002703 Oliver He Rebecca Racz gene An N to A amino acid substitution was made in the N594 site of the E1 glycoprotein, resulting in attenuation of the virus in swine. This attenuated virus induced protection against challenge with wild type CSFV E1 from Classical swine fever virus NCBI_Protein_ID: 325461; PMID: 19203774 VO:0002704 Oliver He Rebecca Racz gene A E2 mutant in Classical swine fever virus is attenuated and provides protection in pigs after oronasal vaccination (not intradermal vaccination) against lethal challenge dose of CSFV strain Eystrup E2 gene from Classical swine fever virus NCBI_Gene_ID: 920146; PMID: 15837238 VO:0002705 Oliver He Rebecca Racz gene A glycoprotein E mutant is attenuated in mice and hamsters and induced significant protection from challenge with wild type Equid herpesvirus in mice gE from Equid herpesvirus NCBI_Protein_ID: 330789; PMID: 17085880 VO:0002706 Oliver He Rebecca Racz gene A glycoprotein I mutant is attenuated in mice and hamsters and induced significant protection from challenge with wild type Equid herpesvirus in mice gI from Equid herpesvirus NCBI_Protein_ID: 330788; PMID: 17085880 VO:0002707 A thymidine kinase-deficient mutant (PR1) is attenuated in mice and induced significant protection from challenge with wild type EHV-1 5 weeks after vaccination. In foals, PR1 also showed attenuation; however, the mutant induced only partial protection from challenge with EHV-1 Oliver He Rebecca Racz process TK from Equid herpesvirus NCBI_Protein_ID: 59214; PMID: 16930871 VO:0002708 Oliver He Rebecca Racz gene A thymidine kinase-deficient mutant (C7301dlTK) is attenuated in cats and induced significant protection from wild type FHV-1 4 weeks after vaccination UL23 from Feline herpesvirus 1 NCBI_Gene_ID: 8658565; PMID: 8645090 VO:0002709 Oliver He Rebecca Racz gene Feline immunodeficiency virus (FIV) made defective in the accessory gene ORF-A were previously shown to be greatly attenuated in its ability to replicate in lymphocytes but to grow normally or near normally in other cell types. 3/9 vaccinees (cats) showed no evidence of the challenge virus over a 15-month observation period. In the other vaccinees, the challenge virus was predominant for various periods of time, but pre-existing viral loads and CD4 lymphocyte counts were either unaffected or altered only marginally and transiently ORF-A from Feline immunodeficiency virus NCBI_Gene_ID: 1724707; PMID: 15680433 VO:0002710 Oliver He Rebecca Racz gene A vif mutant in feline immunodeficiency virus was attenuated and FIV-pPPR delta vif proviral DNA protected cats against challenge with the homologous FIV-PPR biological isolate. vif from Feline immunodeficiency virus NCBI_Gene_ID: 1724709; PMID: 10891409 VO:0002711 Oliver He Rebecca Racz gene A 3abc deletion mutant in Feline infectious peritonitis virus (FIPV) was attenuated and provided protection against virulent FIPV strain 79-1146 challenge in kittens 3a from Feline infectious peritonitis virus NCBI_Gene_ID: 10040181; PMID: 15047802 VO:0002712 Oliver He Rebecca Racz gene A 3abc deletion mutant in Feline infectious peritonitis virus (FIPV) was attenuated and provided protection against virulent FIPV strain 79-1146 challenge in kittens 3b from Feline infectious peritonitis virus NCBI_Gene_ID: 10040182; PMID: 15047802 VO:0002713 Oliver He Rebecca Racz gene A 3abc deletion mutant in Feline infectious peritonitis virus (FIPV) was attenuated and provided protection against virulent FIPV strain 79-1146 challenge in kittens 3c from Feline infectious peritonitis virus NCBI_Gene_ID: 10040183; PMID: 15047802 VO:0002714 Oliver He Rebecca Racz gene A 7ab deletion mutant in Feline infectious peritonitis virus is attenuated and provides protection against virulent FIPV strain 79-1146 challenge in kittens 7a from Feline infectious peritonitis virus NCBI_Gene_ID: 10040187; PMID: 15047802 VO:0002715 Oliver He Rebecca Racz gene A 7ab deletion mutant in Feline infectious peritonitis virus is attenuated and provides protection against virulent FIPV strain 79-1146 challenge in kittens 7b from Feline infectious peritonitis virus NCBI_Gene_ID: 10040188; PMID: 15047802 VO:0002716 Oliver He Rebecca Racz gene A UL0 mutant in infectious laryngotracheitis virus (ILTV) was attenuated. Chickens immunized with UL0-negative ILTV were protected from clinical disease after subsequent infection with virulent ILTV UL0 from Gallid herpesvirus 1 NCBI_Gene_ID: 3239037; PMID: 14645915 VO:0002717 Oliver He Rebecca Racz gene A thymidine-kinase mutant is attenuated in chickens and induced protection from challenge with wild type GHV-1 UL23 from Gallid herpesvirus 1 NCBI_Gene_ID: 3239035; PMID: 12021870 VO:0002718 Oliver He Rebecca Racz gene A UL47 mutant in avian infectious laryngotracheitis virus is attenuated and provides protection in chicken against subsequent challenge infection with virulent ILTV UL47 from Gallid herpesvirus 1 NCBI_Gene_ID: 3239064; PMID: 17325345 VO:0002719 Oliver He Rebecca Racz gene Researchers generated a series of woodchuck hepatitis virus (WHV) X mutants. Woodchucks inoculated with X mutants, including those with no serologic evidence of infection, were protected from later challenge with infectious Woodchuck Hepatitis Virus, suggesting previous infection with resulting protective immunity HBVgp3 X protein from Hepatitis B virus NCBI_Gene_ID: 944566; PMID: 11714744 VO:0002720 Oliver He Rebecca Racz gene KOS-gDA3C is attenuated with mutations in gD gene in causing skin lesions at the inoculation and zosteriform sites, yet it is as effective as rKOS-gDA3C in protecting mice against HSV-1 challenge gD from Herpes simplex virus type 1 and 2 NCBI_Protein_ID: 19548971; PMID: 18243431 VO:0002721 Oliver He Rebecca Racz gene A gH mutant is attenuated in mice and induces significant protection from challenge with wild type HSV-1 gH from Herpes simplex virus type 1 and 2 NCBI_Protein_ID: 138315; PMID: 8289395 VO:0002722 Oliver He Rebecca Racz gene A live-attenuated HSV-2 ICP0 virus provides significant protection against wild-type HSV-2 (MS strain) challenge in mice iCP0 from Herpes simplex virus type 1 and 2 NCBI_Gene_ID: 1487289; PMID: 21412438 VO:0002723 Oliver He Rebecca Racz gene A thymidine kinase-deficient (TK) mutant was found to be attenuated in mice. This mutant induced complete protection from challenge with wild type HSV TK from Herpes simplex virus type 1 and 2 NCBI_Gene_ID: 2703374; PMID: 212476 VO:0002724 Oliver He Rebecca Racz gene A UL29 mutant is attenuated in mice and induces significant protection from challenge with wild type HSV-1 UL29 from Herpes simplex virus type 1 and 2 NCBI_Gene_ID: 2703458; PMID: 8289372 VO:0002725 Oliver He Rebecca Racz gene An HSV-1 gE (Us8) deletion strain, NS-gEnull, was used as a live attenuated vaccine. After HSV-1 challenge, latent virus was recovered by DRG explant cocultures from <10% of vaccinated mice compared with 100% of mock-vaccinated mice US8 from Herpes simplex virus type 1 and 2 NCBI_Gene_ID: 2703448; PMID: 18562543 VO:0002726 Oliver He Rebecca Racz gene A G mutant is attenuated in African green monkeys and induces protection from challenge with wild type HMPV G protein from Human metapneumovirus NCBI_Protein_ID: 75549950; PMID: 16160190 VO:0002727 Oliver He Rebecca Racz gene An M2-2 mutant is attenuated in African green monkeys and induced protection from challenge with wild type HMPV M2-2 from Human metapneumovirus NCBI_Protein_ID: 75549952; PMID: 16160190 VO:0002728 Oliver He Rebecca Racz gene An M2-2 mutant of human respiratory syncytial virus A2 is attenuated in African green monkeys. When challenged with wild type RSV, two doses provided complete protection against challenge in the lower respiratory tract and a significant reduction of the challenge virus in the upper respiratory tract M2-2 from Human Respiratory Syncytial Virus NCBI_Protein_ID: 81925031; PMID: 12922094 VO:0002729 Oliver He Rebecca Racz gene A mutation in the non-virion protein of IHNV causes attenuated growth in rainbow trout and is able to provide significant protection from subsequent challenge with wild type IHNV NV from Infectious Hematopoietic Necrosis Virus NCBI_Gene_ID: 1489849; PMID: 15047826 VO:0002730 Oliver He Rebecca Racz gene Mutant influenza virus that lacks the transmembrane and cytoplasmic tail domains of M2 (M2 knockout [M2KO]) from Influenza A virus (A/Puerto Rico/8/34(H1N1)) is attenuated in both cell culture and mice. Mice intranasally vaccinated with M2KO virus developed protective immune responses and survived a lethal challenge with the wild-type virus, suggesting that the M2KO virus has potential as a live attenuated vaccine M2 from Influenza virus NCBI_Gene_ID: 956528; PMID: 19321619 VO:0002731 Oliver He Rebecca Racz gene Intranasal inoculation of mice, pigs, horses, and macaques with NS1-modified influenza virus strains induced robust humoral and cellular immune responses, and generated immune protection against challenge with wild-type virus NS1 from Influenza virus NCBI_Protein_ID: 505039; PMID: 19768406 VO:0002732 Oliver He Rebecca Racz gene A mutation in the GP5 protein attenuates HP-PRRSV in piglets. This mutant (HuN4-F112) induces protection against challenge with wild type HP-PRRSV GP5 protein from Porcine respiratory and reproductive syndrome virus NCBI_Protein_ID: 149389584; PMID: 19339125 VO:0002733 Oliver He Rebecca Racz gene A glycoprotein E mutant, in combination with UL23 and glycoprotein G mutations, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV glycoprotein E from Pseudorabies virus NCBI_Protein_ID: 307634504; PMID: 12488067 VO:0002734 Oliver He Rebecca Racz gene A glycoprotein G mutant, in combination with UL23 and glycoprotein E mutations, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV glycoprotein G from Pseudorabies virus NCBI_Protein_ID: 15422177; PMID: 12488067 VO:0002735 Oliver He Rebecca Racz gene A glycoprotein M, gM, deletion in pseudorabies virus was attenuated and induced protection in piglets against intranasal challenge with 108 p.f.u. of the highly virulent PrV strain NIA-3 glycoprotein M from Pseudorabies virus NCBI_Protein_ID: 1478255; PMID: 9292000 VO:0002736 Oliver He Rebecca Racz gene A gp50+gp63 deletion mutant in Pseudorabies virus was attenuated and provided protection from clinical signs of Aujeszky's disease after a challenge inoculation with the virulent wild-type PRV strain NIA-3 gp50 from Pseudorabies virus NCBI_Gene_ID: 2952548; PMID: 8178562 VO:0002737 Oliver He Rebecca Racz gene A gp50+gp63 deletion mutant in Pseudorabies virus was attenuated and provided protection from clinical signs of Aujeszky's disease after a challenge inoculation with the virulent wild-type PRV strain NIA-3 gp63 from Pseudorabies virus NCBI_Gene_ID: 2952540; PMID: 8178562 VO:0002738 Oliver He Rebecca Racz gene A UL23 mutant, in combination with mutations in glycoproteins G and E, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV UL23 from Pseudorabies virus NCBI_Gene_ID: 2952559; PMID: 12488067 VO:0002739 Oliver He Rebecca Racz gene A UL50 mutant is attenuated in pseudorabies virus and induces significant protection in pigs from challenge with the highly virulent NIA-3 strain of PrV UL50 from Pseudorabies virus NCBI_Gene_ID: 2952537; PMID: 9228681 VO:0002740 Oliver He Rebecca Racz gene Researchers intranasally inoculated pigs, the natural host of this virus, with mutant PRV strains in which the genes encoding the protein kinase (US3) proteins were inactivated. After challenge infection with the virulent PRV strain NIA-3, no virus was excreted by wt PRV- and PK- mutant-immunized animals, indicating complete protective immunity US3 from Pseudorabies virus NCBI_Gene_ID: 2952561; PMID: 7975253 VO:0002741 Oliver He Rebecca Racz gene A glycoprotein G mutant in rabies virus is attenuated. After a one-dose intramuscular vaccination, the ERAg3m virus protected 100% of mice and hamsters from lethal challenge. In co-infections, using a lethal dose of street rabies virus mixed with ERAg3m, 100% of hamsters and 90% of mice survived and were protected against subsequent infection glycoprotein G from Rabies virus NCBI_Gene_ID: 1489856; PMID: 21514343 VO:0002742 Oliver He Rebecca Racz gene A P gene mutant is attenuated in mice and induces significant protection from challenge with wild type Rabies virus P protein from Rabies virus NCBI_Protein_ID: 291220682; PMID: 15896403 VO:0002743 Oliver He Rebecca Racz gene An E mutant is attenuated in hamsters and induces significant protection from challenge with wild type SARS E from SARS-CoV NCBI_Gene_ID: 1489671; PMID: 18463152 VO:0002744 Oliver He Rebecca Racz gene A SIV nef mutant is attenuated in rhesus monkeys and induces protection from challenge with wild type SIV nef from Simian Immunodeficiency Virus NCBI_Gene_ID: 1490008; PMID: 1470917 VO:0002745 Oliver He Rebecca Racz gene A virus with a mutation in protein C is attenuated in mice and induced protection from challenge with wild type TBE virus C protein from Tick-borne Encephalitis Virus NCBI_Protein_ID: 206570298; PMID: 11884577 VO:0002746 Oliver He Rebecca Racz gene A VEE mutant with a PE2 cleavage signal mutation and a suppressor mutation in E1 is highly attenuated in mice and provides complete protection against challenge with wild type VEE E1 glycoprotein from VEE Virus NCBI_Protein_ID: 798795; PMID: 7676619 VO:0002747 Oliver He Rebecca Racz gene A VEE mutant with a PE2 cleavage signal mutation and a suppressor mutation in E1 is highly attenuated in mice and provides complete protection against challenge with wild type VEE PE2 from VEE Virus NCBI_Protein_ID: 229558446; PMID: 7676619 VO:0002748 Oliver He Rebecca Racz gene A virus with a C protein mutation is attenuated in mice and induces significant protection from challenge with wild type West Nile virus C protein from West Nile virus NCBI_Protein_ID: 158516889; PMID: 20600500 VO:0002749 Oliver He Rebecca Racz VO:0002750 gene A PE2 mutant combined with a deletion in E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur E1 from Western equine encephalomyelitis virus NCBI_Protein_ID: 17148717; PMID: 12641414 VO:0002750 Oliver He Rebecca Racz A PE2 mutant combined with a deletion in E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur obsolete E1 from Western equine encephalomyelitis virus NCBI_Protein_ID: 17148717; PMID: 12641414 true VO:0002751 Oliver He Rebecca Racz VO:0002752 gene A PE2 mutant combined with a deletion in E2 (WE2102) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur E2 gene from Western equine encephalomyelitis virus NCBI_Protein_ID: 29611992; PMID: 12641414 VO:0002752 Oliver He Rebecca Racz A PE2 mutant combined with a deletion in E2 (WE2102) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur obsolete E2 from Western equine encephalomyelitis virus NCBI_Protein_ID: 29611992; PMID: 12641414 true VO:0002753 Oliver He Rebecca Racz VO:0002754 gene A PE2 mutant combined with either a deletion in E2 (WE2102) or E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of these two strains would occur PE2 from Western equine encephalomyelitis virus NCBI_Protein_ID: 90811336; PMID: 12641414 VO:0002754 Oliver He Rebecca Racz A PE2 mutant combined with either a deletion in E2 (WE2102) or E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of these two strains would occur obsolete PE2 from Western equine encephalomyelitis virus NCBI_Protein_ID: 90811336; PMID: 12641414 true VO:0002755 Oliver He Rebecca Racz gene A cen1 mutant is attenuated in mice and hamsters and induces significant protection from challenge with wild type L. donovani cen1 from Leishmania donovani NCBI_Protein_ID: 15488542; PMID: 19592661 VO:0002756 Oliver He Rebecca Racz gene A Leishmania infantum deletion mutant of HSP70-II gene is attenuated and provides protection against Leishmania infection in the L. major-BALB/c infection model. Also, DeltaHSP70-II is a safe live vaccine as immunodeficient SCID mice, and hamsters, infected with mutant parasites did not develp any sign of pathology HSP70 II from Leishmania infantum NCBI_Gene_ID: 5073319; PMID: 21794145 VO:0002757 Oliver He Rebecca Racz gene A genetically attenuated parasite (GAP) with a mutation in the FabB/FabF gene is attenuated in mice by arresting in the late liver stage. It also conferred complete protection in mice from challenge with wild type Plasmodium fabB/fabF from Plasmodium falciparum NCBI_Gene_ID: 3885996; PMID: 21669394 VO:0002758 Oliver He Rebecca Racz gene Genetically attenuated P36p-deficient Plasmodium berghei sporozoites provide protection against sporozoites challenge in mice p36p from Plasmodium berghei NCBI_Gene_ID: 3424772; PMID: 7604034 VO:0002759 Oliver He Rebecca Racz gene A genetically attenuated parasite (GAP) with deletions in p52 and p36 are attenuated in mice. Mice immunized with the mutant were completely protected against challenge with wild type Plasmodium sporozoites py36 from Plasmodium yoelii NCBI_Protein_ID: 23479924; PMID: 17517871 VO:0002760 Oliver He Rebecca Racz gene A genetically attenuated parasite (GAP) with deletions in p52 and p36 are attenuated in mice. Mice immunized with the mutant were completely protected against challenge with wild type Plasmodium sporozoites py52 from Plasmodium yoelii NCBI_Protein_ID: 15193062; PMID: 17517871 VO:0002761 Oliver He Rebecca Racz gene Deletion of UIS3 in Plasmodium yoelii provided attenuation and full protection in mice by Pyuis3(-) sporozoites required at least 2 immunizations against challenges with infectious sporozoites UIS3 from Plasmodium yoelii NCBI_Gene_ID: 3830198; PMID: 17624848 VO:0002762 Oliver He Rebecca Racz gene A mic2 mutant is attenuated in mice and induces protection from challenge with wild type T. gondii mic2 from Toxoplasma gondii NCBI_Protein_ID: 1923217; PMID: 16933991 VO:0002763 Oliver He Rebecca Racz VO:0002764 gene An OMPDC mutant, alone or in combination with an UP mutation, is attenuated in mice and induces significant protection from challenge with wild type T. gondii OMPDC from Toxoplasma gondii NCBI_Gene_ID: 7899615; PMID: 20605980 VO:0002764 Oliver He Rebecca Racz An OMPDC mutant, alone or in combination with an UP mutation, is attenuated in mice and induces significant protection from challenge with wild type T. gondii obsolete OMPDC from Toxoplasma gondii NCBI_Gene_ID: 7899615; PMID: 20605980 true VO:0002765 Oliver He Rebecca Racz gene A UP mutant, in combination with an OMPDC mutation, is attenuated in mice and induces significant protection from wild type T. gondii UP from Toxoplasma gondii NCBI_Gene_ID: 900273; PMID: 20605980 VO:0002766 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3284 3284 vaccine The mutant strain, with deletion of apxIA gene, obtained in this study offered a level of cross-serovar protection against A. pleuropneumoniae infection in mice and pigs (Reference: PMID:16930871). Actinobacillus pleuropneumoniae apxIA mutant vaccine VO:0002767 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3112 3112 vaccine In the intra-peritoneal mouse model, the virulence of the mutant strain decreased at least 100 fold compared with the parent strain. The mutant was evaluated as a potential vaccine using a vaccination-challenge trial. The death number and lung lesion score in the vaccinated pigs given the serovar 1 challenge were obviously lower than those in the unvaccinated pigs Actinobacillus pleuropneumoniae ApxIC mutant vaccine VO:0002768 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3118 3118 vaccine Deletion in ureC and apxIIA genes of Actinobacillus pleuropneumoniae serotype 2 prototype provides attenuation and protection in pigs against challenge with the virulent parent strain of A. pleuropneumoniae Deletions were introduced into the ureC and apxIIA genes of an Actinobacillus pleuropneumoniae serotype 2 strain by homologous recombination and counterselection. The double-mutant contains no foreign DNA, is highly attenuated, protects pigs from homologous challenge upon a single aerosol application Actinobacillus pleuropneumoniae ureC and apxIIA double mutant deletion vaccine VO:0002769 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3120 3120 vaccine A precisely defined DeltaapxIICDeltaapxIVA double-deletion mutant of A. pleuropneumoniae was constructed based on HB04C(-) by transconjugation and counterselection. The results demonstrated that the DeltaapxIICDeltaapxIVA double mutant strain was less virulent than HB04C(-). Despite attenuation of virulence, the DeltaapxIICDeltaapxIVA double mutant remains immunogenic and conferred a similar level of protective immunity to pigs against challenge with a lethal dose of a heterologous fully virulent standard serovar 1 strain of A. pleuropneumoniae. (Reference: PubMed: 17767980) In the present study, the gene encoding the ApxII-activating protein, apxIIC, was insertionally inactivated on the chromosome of a serovar 7 strain, HS93. Pigs vaccinated with live HS93C-Ampr via the intranasal route were protected against a cross-serovar challenge with a virulent serovar 1 strain of A. pleuropneumoniae Actinobacillus pleuropneumoniae apxIIC and apxIVA double deletion mutant vaccine VO:0002770 Oliver He Rebecca Racz In the present study, the gene encoding the ApxII-activating protein, apxIIC, was insertionally inactivated on the chromosome of a serovar 7 strain, HS93. Pigs vaccinated with live HS93C-Ampr via the intranasal route were protected against a cross-serovar challenge with a virulent serovar 1 strain of A. pleuropneumoniae obsolete A. pleuropneumoniae HS93C-Ampr true VO:0002771 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3119 3119 vaccine An apxIIIB mutant, in combination with an apxIIID mutation, is highly attenuated in pigs and induces significant protection from challenge with wild type A. pleuropneumoniae. The mutant also was slightly attenuated in mice and induced protection in mice against challenge from the parent strain An apxIIID mutant, in combination with an apxIIIB mutation, is highly attenuated in pigs and induces significant protection from challenge with wild type A. pleuropneumoniae. The mutant also was slightly attenuated in mice and induced protection in mice against challenge from the parent strain Actinobacillus pleuropneumoniae apxIIIB and apxIIID double mutant vaccine VO:0002772 Oliver He Rebecca Racz An apxIIID mutant, in combination with an apxIIIB mutation, is highly attenuated in pigs and induces significant protection from challenge with wild type A. pleuropneumoniae. The mutant also was slightly attenuated in mice and induced protection in mice against challenge from the parent strain obsolete Actinobacillus pleuropneumoniae apxIIIB and apxIIID double mutant vaccine true VO:0002773 Oliver He Rebecca Racz A precisely defined DeltaapxIICDeltaapxIVA double-deletion mutant of A. pleuropneumoniae was constructed based on HB04C(-) by transconjugation and counterselection. The results demonstrated that the DeltaapxIICDeltaapxIVA double mutant strain was less virulent than HB04C(-). Despite attenuation of virulence, the DeltaapxIICDeltaapxIVA double mutant remains immunogenic and conferred a similar level of protective immunity to pigs against challenge with a lethal dose of a heterologous fully virulent standard serovar 1 strain of A. pleuropneumoniae. (Reference: PubMed: 17767980) obsolete Actinobacillus pleuropneumoniae apxIIC and apxIVA double deletion mutant vaccine true VO:0002774 Oliver He Rebecca Racz Deletions were introduced into the ureC and apxIIA genes of an Actinobacillus pleuropneumoniae serotype 2 strain by homologous recombination and counterselection. The double-mutant contains no foreign DNA, is highly attenuated, protects pigs from homologous challenge upon a single aerosol application obsolete Actinobacillus pleuropneumoniae ureC and apxIIA double mutant deletion vaccine true VO:0002775 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3115 3115 vaccine An mntA deletion mutant, generated by allelic replacement, in Bacillus anthracis was attenuated and provided protection for guinea pigs against lethal spore dose (60 LD50) of the virulent B. anthracis Vollum strain Bacillus anthracis mntA deletion mutant vaccine VO:0002776 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3214 3214 vaccine An actA mutant is attenuated in mice and induced significant protection from challenge with wild type L. monocytogenes Listeria monocytogenes actA mutant vaccine VO:0002777 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3215 3215 vaccine A plcB mutant, in combination with an actA mutant, is attenuated in mice and induces significant protection from challenge with wild type L. monocytogenes An actA mutant is attenuated in mice and induced significant protection from challenge with wild type L. monocytogenes Listeria monocytogenes actA/plcB mutant vaccine VO:0002778 Oliver He Rebecca Racz A plcB mutant, in combination with an actA mutant, is attenuated in mice and induces significant protection from challenge with wild type L. monocytogenes obsolete Listeria monocytogenes actA/plcB mutant vaccine true VO:0002779 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3212 3212 vaccine A M. avium relA mutant is attenuated in calves and goats. This mutant also elicited an immune response in goats that limited colonization by challenge wild type M. avium Mycobacterium avium relA mutant vaccine VO:0002780 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3203 3203 vaccine A drrC mutant is highly attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis Mycobacterium tuberculosis drrC mutant vaccine VO:0002781 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3204 3204 vaccine An fadD26 mutant is attenuated in mice and induced significant protection from challenge with wild type M. tuberculosis Mycobacterium tuberculosis fadD26 mutant vaccine VO:0002782 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3205 3205 vaccine Deletion of leuD gene was shown to be highly attenuated. Immunocompetent BALB/c mice vaccinated with the DleuD auxotroph were protected as well as BCG in terms of survival following an intravenous or aerosol challenge with virulent M. tuberculosis Mycobacterium tuberculosis leuD mutant vaccine VO:0002783 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3206 3206 vaccine A lysA mutant, in combination with a secA2 mutation, is highly attenuated in mice and induced significant protection from challenge with wild type M. tuberculosis Mycobacterium tuberculosis lysA/secA2 mutant vaccine VO:0002784 Oliver He Rebecca Racz vaccine A Mce-2 mutant in Mycobacterium tuberculosis is attenuated and provides protection against challenge for mice Mycobacterium tuberculosis mce-2/mce-3 mutant vaccine VO:0002785 A viral vaccine that protects against infection with Chikungunya virus Ningxian Fan Oliver He Ronak Sutariya vaccine chikungunya virus vaccine VO:0002786 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3208 3208 vaccine A panCD mutant is attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis Mycobacterium tuberculosis panCD mutant vaccine VO:0002787 RD1 and panCD mutants in Mycobacterium tuberculosis were attenuated and provided protection in CD4-deficient mice against an aerosol challenge with virulent M. tuberculosis Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3281 3281 vaccine A panCD mutant is attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis Mycobacterium tuberculosis RD1/panCD mutant vaccine VO:0002788 a bacterial vaccine against Streptococcus suis infection Ningxian Fan Oliver He Ronak Sutariya vaccine Streptococcus suis vaccine VO:0002789 Vaccine against infection with Corynebacterium pseudotuberculosis. Ningxian Fan Oliver He Ronak Sutariya vaccine Corynebacterium pseudotuberculosis vaccine VO:0002790 Oliver He Rebecca Racz Study evaluated immunogenicity and protection against Mycobacterium tuberculosis in rhesus monkeys with an attenuated M. tuberculosis with a disrupted phoP gene (SO2) as a single-dose vaccine. SO2 treatment showed reduced average lung bacterial counts (1.0 and 1.2 log respectively, compared with 0.4 log for BCG) and significant protective effect by reduction in C-reactive protein levels, body weight loss, and decrease of erythrocyte-associated hematologic parameters (MCV, MCH, Hb, Ht) as markers of inflammatory infection, all relative to non-vaccinated controls obsolete M. tuberculosis phoP mutant SO2 true VO:0002791 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3209 3209 vaccine A proC mutant is highly attenuated in mice and induces significant protection from challenge with wild type M. tuberculosis that is equal to the protection induced by the current vaccine BCG Mycobacterium tuberculosis proC mutant vaccine VO:0002792 A protozoan vaccine against Trichinella spiralis infection Ningxian Fan Oliver He Ronak Sutariya vaccine Trichinella spiralis vaccine VO:0002793 A vaccine that prevents or treats atherosclerosis disease. Oliver He Ronak Sutariya http://www.onlinejacc.org/content/64/25/2779 vaccine atherosclerosis vaccine VO:0002794 Oliver He Rebecca Racz Vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Guerin vaccination. obsolete M. tuberculosis secA2 mutant true VO:0002795 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3211 3211 vaccine A sigE mutant is highly attenuated in mice and induced significant protection from challenge with wild type M. tuberculosis, more so than the existing vaccine BCG Mycobacterium tuberculosis sigE mutant vaccine VO:0002796 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3210 3210 vaccine A trpD mutant is highly attenuated in mice and induces more protection from challenge with wild type M. tuberculosis than that induced by the current vaccine BCG Mycobacterium tuberculosis trpD mutant vaccine VO:0002797 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3149 3149 vaccine An aroA mutant is attenuated in mice and induced significant protection from challenge with wild type S. aureus Staphylococcus aureus aroA mutant vaccine VO:0002798 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3148 3148 vaccine A vicK mutant is attenuated in mice and induced protection from challenge with wild type S. equi Streptococcus equi vicK mutant vaccine VO:0002799 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3114 3114 vaccine An A. hydrophila aroA mutant is highly attenuated in trout, and a single immunization conferred significant protection from challenge with wild type A. hydrophila Aeromonas hydrophila aroA mutant vaccine VO:0002800 Oliver He Rebecca Racz The aroA gene was inactivated by inserting a fragment expressing kanamycin resistance within the coding sequence and challenged in fish. The LD50 for unvaccinated fish was 71. In contrast, the LD50 was 1.8 x 104 in fish vaccinated once and 3 x 105 in fish vaccinated twice obsolete A. salmonicida live-attenuated vaccine encoding AroA true VO:0002801 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3122 3122 vaccine Inactivation of the aroA gene highly attenuates B. bronchiseptica, severely impairing its ability to colonize and survive in the respiratory tract of mice. Upon challenge with wild type B. bronchiseptica, the mice immunised with live attenuated B. bronchiseptica aroA mutant had rapidly reduced numbers of B. bronchiseptica in their respiratory tract Bordetella bronchiseptica aroA mutant vaccine (strain BBS18) VO:0002802 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3268 3268 vaccine A trpE mutant, in combination with an aroA mutation, is attenuated in mice and induces significant protection from challenge with wild type B. bronchiseptica Inactivation of the aroA gene highly attenuates B. bronchiseptica, severely impairing its ability to colonize and survive in the respiratory tract of mice. Upon challenge with wild type B. bronchiseptica, the mice immunised with live attenuated B. bronchiseptica aroA mutant had rapidly reduced numbers of B. bronchiseptica in their respiratory tract Bordetella bronchiseptica aroA/trpE mutant vaccine VO:0002803 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3123 3123 vaccine A double mutant strain of Bordetella Bronchiseptica lacking adenylate cyclase(cyaA gene) and type III secretion(bscN gene) is attenuated and provides protection in mice against 5 x 105 CFU of RB50, the B. Bronchiseptica parent strain Bordetella bronchiseptica bscN and cyaA double mutant vaccine VO:0002804 Oliver He Rebecca Racz A double mutant strain of Bordetella Bronchiseptica lacking adenylate cyclase(cyaA gene) and type III secretion(bscN gene) is attenuated and provides protection in mice against 5 x 105 CFU of RB50, the B. Bronchiseptica parent strain. obsolete Bordetella bronchiseptica bscN and cyaA double mutant vaccine true VO:0002805 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3124 3124 vaccine A dnt mutant in Bordetella bronchiseptica was attenuated and provides protection in guinea pigs against intranasal challenge with strain L3 Bordetella bronchiseptica dnt mutant vaccine VO:0002806 Oliver He Rebecca Racz A trpE mutant, in combination with an aroA mutation, is attenuated in mice and induces significant protection from challenge with wild type B. bronchiseptica obsolete Bordetella bronchiseptica aroA/trpE mutant vaccine true VO:0002807 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3134 3134 vaccine An aroA mutant is highly attenuated in mice and induces significant protection from challenge with wild type B. pertussis Bordetella pertussis aroA mutant vaccine VO:0002808 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3176 3176 vaccine A live attenuated B. pertussis vaccine strain BPZE1, developed by deleting dnt gene, protects mice upon a single intranasal administration Bordetella pertussis dnt mutant vaccine VO:0002809 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3267 3267 vaccine A flagella-less mutant of Borrelia burgdorferi (HB19Fla-) was attenuated in immunodeficient SCID mice. Mice were challenged 28 days later with virulent strain Sh. 2 and were protected from challenge Borrelia burgdorferi fla mutant vaccine VO:0002810 Oliver He Rebecca Racz B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=299 299 vaccine A asp24 mutation in Brucella abortus is attenuated and provides significant protection in mice A virB2 mutant is attenuated in Brucella melitensis and provides protection in mice Mutants manB and manA were attenuated in Brucella melitensis and provided protection against challenge in mice's livers Unmarked rough B. abortus and B. melitensis deletion mutants of manBA (including manA and manB) were attenuated. These mutants provided protection against virulent Brucella challenge in mice Brucella abortus and Brucella melitensis mutants with unmarked deletion of asp24, virB2, or manBA vaccine VO:0002811 A vaccine that prevents or treats diabetes. Oliver He Ronak Sutariya https://www.ncbi.nlm.nih.gov/pubmed/12956615 vaccine diabetes vaccine VO:0002812 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3260 3260 vaccine Brucella DeltaexsA mutant showed decreased survival in mice compared to the survival of parental strain S2308. This demonstrated that ExsA is critical for full bacterial virulence. The B. abortus exsA deletion mutant was used as a live vaccine candidate. Challenge experiments revealed that the exsA mutant strain induced superior protective immunity in BALB/c mice compared to the protective immunity induced by strain S19 or RB51 Brucella abortus exsA mutant vaccine VO:0002813 A vaccine that prevents or treats a non-infectious disease. Oliver He Ronak Sutariya https://www.ncbi.nlm.nih.gov/pubmed/12831367 There are mainly five types of non-infectious diseases, which are diabetes, allergies, cardiovascular diseases, cancer and genetic diseases. URL: http://www.ychlpyss.edu.hk/~bio/share/0405/f6homework/Non-infectious%20disease/noninfectiousdisease(ths).htm obsolete non-infectious disease vaccine true VO:0002814 Oliver He Rebecca Racz Mutants manB and manA were attenuated in Brucella melitensis and provided protection against challenge in mice's livers Unmarked rough B. abortus and B. melitensis deletion mutants of manBA (including manA and manB) were attenuated. These mutants provided protection against virulent Brucella challenge in mice obsolete B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA true VO:0002815 Oliver He Rebecca Racz A mucR mutant has a significantly reduced degree of colonization in mice and protects against wild type B. melitensis 16M obsolete B. melitensis mucR mutant vaccine true VO:0002816 Oliver He Rebecca Racz A omp25 mutant is attenuated and provides protection against challenge in mice obsolete B. melitensis omp25 mutant vaccine true VO:0002817 Oliver He Rebecca Racz A omp31 mutant in Brucella melitensis was attenuated and provided protection against challenge in mice obsolete B. melitensis omp31 mutant vaccine true VO:0002818 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3264 3264 vaccine A pgk mutant is attenuated in mice and induces significant protection from challenge with wild type B. abortus Brucella abortus pgk mutant vaccine VO:0002819 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3263 3263 vaccine A pgm mutant is attenuated in mice and induces significant protection from challenge with wild type B. abortus Brucella abortus pgm mutant vaccine VO:0002820 Oliver He Rebecca Racz B. melitensis WR201 (16MΔpurEK) vaccine A purE/purK mutant of B. melitensis 16M was attenuated in mice when given intraperitoneally. Nine weeks after immunization, mice were protected from challenge with wild type B. melitensis Mice infected with delta purE201 developed only five to eight times normal spleen weight at 1 week p.i. and produced no interleukin-6 in their serum, which is much lower than the mice infected with the parental strain (16M) Brucella melitensis WR201 (16MΔpurEK) vaccine VO:0002821 Oliver He Rebecca Racz A purE/purK mutant of B. melitensis 16M was attenuated in mice when given intraperitoneally. Nine weeks after immunization, mice were protected from challenge with wild type B. melitensis obsolete B. melitensis WR201 (16M-delta-purEK) true VO:0002822 Oliver He Rebecca Racz A virB2 mutant is attenuated in Brucella melitensis and provides protection in mice obsolete B. abortus and B. melitensis mutants with unmarked deletion of asp24, virB2, or manBA true VO:0002823 A vaccine that prevents or treats arthritis. Oliver He Ronak Sutariya https://www.ncbi.nlm.nih.gov/pubmed/12956615 vaccine arthritis vaccine VO:0002824 Oliver He Rebecca Racz live attenuated B. abortus with deletion of znuA vaccine Deletion of gene znuA attenuates Brucella abortus and this live attenuated vaccine was challenged in mice. These mice showed significantly fewer spenic CFU live attenuated Brucella abortus with deletion of znuA vaccine VO:0002825 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3179 3179 vaccine The aroC deletion in the resultant mutant, designated A2 Delta aroC, was confirmed by PCR, Southern hybridization and failure of the mutant to grow in a defined medium without aromatic compounds. The constructed unmarked aroC mutant of B. pseudomallei is attenuated in both BALB/c and C57Bl/6 mice and is able to confer significant protection in C57Bl/6 mice. Burkholderia pseudomallei aroC deletion mutant vaccine VO:0002826 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3272 3272 vaccine An asd mutant is highly attenuated in mice. This mutant was also able to protect against acute inhalation melioidosis caused by challenge with wild type B. pseudomallei Burkholderia pseudomallei asd mutant vaccine VO:0002827 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3257 3257 vaccine Mice that were challenged with a higher dose of mutant 56:65 purM were protected Burkholderia pseudomallei purM mutant vaccine VO:0002828 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3258 3258 vaccine Although 30:93a purN -immunized mice were challenged with a 10-fold higher dose of WT E8, mice were strongly protected and showed no signs of clinical illness until the experiment was terminated Burkholderia pseudomallei purN mutant vaccine VO:0002829 Oliver He Rebecca Racz E. ictaluri crp mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3283 3283 vaccine A crp mutant is attenuated in zebrafish and catfish that were immunized intramuscularly and intracoelomically, respectively. Six weeks after immunization, both zebrafish and catfish were protected from challenge with wild type E. ictaluri Edwardsiella ictaluri crp mutant vaccine VO:0002830 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3273 3273 vaccine An aroC mutant is attenuated in zebra fish. The aroC mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 68.3% Edwardsiella tarda aroC mutant vaccine VO:0002831 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3275 3275 vaccine An aroC and slyA mutant is attenuated in zebra fish. This mutant is also protective against challenge from wild type E. tarda, resulting in a relative percent survival of 80.1% An aroC mutant is attenuated in zebra fish. The aroC mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 68.3% Edwardsiella tarda aroC/slyA mutant vaccine VO:0002832 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3274 3274 vaccine An aroC and esrC mutant is attenuated in zebra fish. This mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 71.3% An aroC mutant is attenuated in zebra fish. The aroC mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 68.3% Edwardsiella tarda aroC/esrC mutant vaccine VO:0002833 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3253 3253 vaccine An esrB mutant is highly attenuated in fish (turbot), with an LD50 of 10(8.1)cfu/fish. Vaccination with this mutant elicited significant protection from wild type E. tarda Edwardsiella tarda esrB mutant vaccine VO:0002834 Oliver He Rebecca Racz An aroC and esrC mutant is attenuated in zebra fish. This mutant is also protective against challenge with wild type E. tarda and has a relative percent survival of 71.3% obsolete Edwardsiella tarda aroC/esrC mutant vaccine true VO:0002835 Oliver He Rebecca Racz An aroC and slyA mutant is attenuated in zebra fish. This mutant is also protective against challenge from wild type E. tarda, resulting in a relative percent survival of 80.1% obsolete Edwardsiella tarda aroC/slyA mutant vaccine true VO:0002836 Oliver He Rebecca Racz Escherichia coli carAB mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3248 3248 vaccine A carAB mutant is attenuated in turkeys and induces significant protection from challenge with wild type E. coli E. coli carAB mutant vaccine VO:0002837 A vaccine that prevents or treats an autoimmune disease. Oliver He Ronak Sutariya https://www.ncbi.nlm.nih.gov/pubmed/15196997 vaccine autoimmune disease vaccine VO:0002838 Oliver He Rebecca Racz Escherichia coli ler mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3249 3249 vaccine A ler deletion mutant derived from wild-type EHEC O157:H7 86-24 was constructed by use of suicide vector pCVD442. Following challenge of 7-day-old suckling mice with O157:H7 EDL933, 75.2% born to group B mothers (immunized with F25) sur- vived, as did 83.0% born to group C mothers (immunized with F105). The surviving suckling mice consistently gained body weight. Only 16.8% of sucking mice born to control group mice survived the challenge E. coli ler mutant vaccine VO:0002839 Oliver He Rebecca Racz Escherichia coli rfaL mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3279 3279 vaccine Deletion of waaL results in a strain that stimulates enhanced urothelial cytokine secretion, which is an enhanced innate immune response. Inoculation with the vaccine strain protected mice against challenge with a broad range of clinical uropathogenic E. coli isolates and produced immunity that lasted >= 8 weeks. E. coli rfaL mutant vaccine VO:0002840 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3232 3232 vaccine There was a deletion in gene capB of F. tularensis live vaccine strain. LVS capB, while much less virulent than LVS, induces potent protective immunity against lethal LVS i.n. challenge in mice, comparable to that induced by LVS Francisella tularensis capB mutant vaccine VO:0002841 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3280 3280 vaccine A clpB mutant in Francisella tularensis subspecies tularensis strain SCHU S4 was attenuated and provided protection against aerosol challenge in mice Francisella tularensis clpB mutant vaccine VO:0002842 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3233 3233 vaccine A FTL0552 mutant in Francisella tularensis was attenuated and provided partial protection in mice against challenge with a lethal dose of the virulent SchuS4 strain when compared to naive mice Francisella tularensis FTL0552 mutant vaccine VO:0002843 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3234 3234 vaccine An FTT0918 mutant showed significantly reduced virulence in mice. Mice that recovered from infection with the mutant were protected 2 months later from challenge with wild type F. tularensis Francisella tularensis FTT0918 mutant vaccine VO:0002844 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3278 3278 vaccine A galU mutant is attenuated in mice, with only transient weight loss observed. Two months after inoculation, mice were challenge with wild type F. tularensis and were protected, once again only experiencing transient weight loss Francisella tularensis galU mutant vaccine VO:0002845 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3235 3235 vaccine A guaA mutant is highly attenuated in mice and induces significant protection from challenge with parent strain F. tularensis LVS Francisella tularensis guaA mutant vaccine VO:0002846 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3236 3236 vaccine A guaB mutant is attenuated in mice and induces significant protection from challenge with parent strain F. tularensis LVS Francisella tularensis guaB mutant vaccine VO:0002847 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3237 3237 vaccine Intranasal vaccination with KKF235 (F. tularensis subsp. novicida mutant (DeltaiglB) ) protected mice from subsequent homotypic challenge with U112 as well as heterotypic challenge with F. tularensis subsp. holarctica (LVS). Most significantly, oral immunization with KKF235 protected mice from a highly lethal subsp. tularensis (SCHU S4) pulmonary challenge Francisella tularensis IglB mutant vaccine VO:0002848 Oliver He Rebecca Racz An iglC mutant is highly attenuated in mice. Inoculated mice were challenged 30 days later with wild type F. tularensis and were highly protected obsolete KKF24 true VO:0002849 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3238 3238 vaccine A purMCD mutant in Francisela tularensis was attenuated. A low dosage of F. tularensis LVS delta purMCD mutant provided protection against challenge in mice A purMCD mutant in Francisella tularensis was attenuated. A low dose of the F. tularensis LVS delta purMCD mutant provided protection against subsequent lethal challenge with the LVS parental strain Francisella tularensis purMCD mutant vaccine VO:0002850 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3239 3239 vaccine Mice, which had been immunized with at least 6.95x103 cfu of F. tularensis U112 purF::Cm, were protected against the subsequent F. tularensis subspecies novicida challenge. Francisella tularensis purF mutant vaccine VO:0002851 Oliver He Rebecca Racz A purMCD mutant in Francisella tularensis was attenuated. A low dose of the F. tularensis LVS delta purMCD mutant provided protection against subsequent lethal challenge with the LVS parental strain obsolete Francisella tularensis purMCD mutant vaccine true VO:0002852 A Streptococcus vaccine against Streptococcus pyogenes infection. Oliver He Ronak Sutariya vaccine Streptococcus pyogenes vaccine VO:0002853 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3240 3240 vaccine A sodC mutant in Francisella tularensis subspecies holarctica was attenuated and provided protection and cleared the infection against lethal challenge in nearly 50% of the mice infected with the deletion of sodC mutant. Francisella tularensis sodC mutant vaccine VO:0002854 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3241 3241 vaccine A wbtA mutant in Francisella tularensis was attenuated and provided protection in mice against challenge with an otherwise lethal dose of either F. tularensis LVS or a fully virulent clinical isolate of F. tularensis type B Francisella tularensis wbtA mutant vaccine VO:0002855 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3242 3242 vaccine A wbtI mutant is attenuated in mice. The mutant protected against a low dose challenge with the parental strain, but was less effective against higher doses. However, increasing the immunization dose increased the resistance to higher challenge doses Francisella tularensis wbtI mutant vaccine VO:0002856 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3213 3213 vaccine An aroA mutant is highly attenuated in mice and induced significant protection after two doses from challenge with wild type M. haemolytica Mannheimia haemolytica aroA mutant vaccine VO:0002857 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3202 3202 vaccine An lpd mutant is highly attenuated in chickens and induces significant protection from challenge with wild type M. gallisepticum Mycoplasma gallisepticum lpd mutant vaccine VO:0002858 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3200 3200 vaccine A metH mutant, in combination with a siaD mutation, is attenuated in mice and induces significant protection from challenge with wild type N. meningitidis A siaD mutant, in combination with either a metH or rfaF mutation, is attenuated in mice and induces protection from challenge with wild type N. meningitidis Neisseria meningitidis metH/siaD mutant vaccine VO:0002859 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3201 3201 vaccine A siaD mutant, in combination with either a metH or rfaF mutation, is attenuated in mice and induces protection from challenge with wild type N. meningitidis An rfaF mutant, in combination with a siaD mutation, is attenuated in mice and induces significant protection from challenge with wild type N. meningitidis Neisseria meningitidis rfaF/siaD mutant vaccine VO:0002860 Oliver He Rebecca Racz A siaD mutant, in combination with either a metH or rfaF mutation, is attenuated in mice and induces protection from challenge with wild type N. meningitidis obsolete Neisseria meningitidis metH/siaD mutant vaccine true VO:0002861 Oliver He Rebecca Racz A siaD mutant, in combination with either a metH or rfaF mutation, is attenuated in mice and induces protection from challenge with wild type N. meningitidis obsolete Neisseria meningitidis rfaF/siaD mutant vaccine true VO:0002862 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3199 3199 vaccine An aroA mutant is highly attenuated in calves and induces significant protection from challenge with wild type P. multocida Pasteurella multocida aroA mutant vaccine VO:0002863 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3156 3156 vaccine An aroA mutant is attenuated in mice and induced significant protection from challenge with wild type S. typhi Ty2 Salmonella typhi aroA mutant vaccine VO:0002864 Oliver He Rebecca Racz Aro-deleted S. Typhi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=249 249 vaccine Inactivation of AroC results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" Inactivation of AroD results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" Aro-deleted S. Typhi vaccine VO:0002865 Oliver He Rebecca Racz CVD 908-htrA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=252 252 vaccine Inactivation of AroC results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" CVD 908-htrA vaccine VO:0002866 Oliver He Rebecca Racz Inactivation of AroD results in attenuation in humans, and the deletions of both AroC and AroD provide a high level of safety against restoration of pathogenicity by recombination. An aroC/aroD-deleted derivative of S. Typhi strain Ty2 (the parent strain of Ty21a) is designated the strain "CVD 908" obsolete Aro-deleted S. Typhi true VO:0002867 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3157 3157 vaccine An asd mutant, alone or in combination with a rfc mutation, is attenuated in mice and induces significant protection from challenge with wild type Salmonella typhimurium Salmonella Typhimurium asd mutant vaccine VO:0002868 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3158 3158 vaccine An asd mutant, alone or in combination with a rfc mutation, is attenuated in mice and induces significant protection from challenge with wild type Salmonella typhimurium An rfc mutant, in combination with an asd mutation, is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium Salmonella Typhimurium asd/rfc mutant vaccine VO:0002869 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3159 3159 vaccine An atpA mutant is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium Salmonella Typhimurium atpA mutant vaccine VO:0002870 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3160 3160 vaccine A cbiA mutant, in combination with a cobS mutation, is attenuated in chickens and induces significant protection from challenge with wild type S. Gallinarum. This mutant was also able to provide some protection against S. Enteritidis A cobS mutant, in combination with a cbiA mutation, is attenuated in chickens and induces significant protection from challenge with wild type S. Gallinarum. This mutant was also able to provide some protection against S. Enteritidis Salmonella Gallinarum cbiA/cobS mutant vaccine VO:0002871 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3271 3271 vaccine A guaBA and clpP mutant (CVD 1941) is attenuated in mice after oral immunization. This mutant is also protective in mice and had a vaccine efficacy of 76% against challenge with wild type Salmonella Enteritidis A guaBA and clpP mutant (CVD 1941) is attenuated in mice after oral immunization. This mutant is also protective, and had a vaccine efficacy of 76% against challenge with wild type Salmonella Enteritidis Salmonella Enteritidis guaBA/clpP mutant vaccine VO:0002872 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3161 3161 vaccine A mutation in clpP (CS2007) causes hyperflagellation. These hyperflagellated bacteria are attenuated in mice, and an LD50 for CS2007 could not be determined because mice did not die after inoculation with the highest dose. CS2007 also elicited protection in mice from challenge with wild type S. typhimurium Salmonella Typhimurium clpP mutant vaccine VO:0002873 Oliver He Rebecca Racz A mutation in clpP (CS2007) causes hyperflagellation. These hyperflagellated bacteria are attenuated in mice, and an LD50 for CS2007 could not be determined because mice did not die after inoculation with the highest dose. CS2007 also elicited protection in mice from challenge with wild type S. typhimurium obsolete Salmonella Typhimurium guaBA/clpP mutant vaccine (merged to VO_0002872) true VO:0002874 Oliver He Rebecca Racz A mutation in clpP (CS2007) causes hyperflagellation. These hyperflagellated bacteria are attenuated in mice, and an LD50 for CS2007 could not be determined because mice did not die after inoculation with the highest dose. CS2007 also elicited protection in mice from challenge with wild type S. typhimurium obsolete Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine (merged to VO_0002872) true VO:0002875 Oliver He Rebecca Racz A cobS mutant, in combination with a cbiA mutation, is attenuated in chickens and induces significant protection from challenge with wild type S. Gallinarum. This mutant was also able to provide some protection against S. Enteritidis obsolete Salmonella Gallinarum cbiA/cobS mutant vaccine true VO:0002876 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3162 3162 vaccine A gyrA-cpxA-rpoB Salmonella Typhimurium mutant was attenuated and protected against challenge in pigs Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine VO:0002877 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3163 3163 vaccine A cpxR mutant, in combination with a lon mutation, is highly attenuated in mice and induces significant protection from challenge with wild type S. gallinarum A lon mutant, in combination with a cpxR mutation, is highly attenuated in mice and induces significant protection from challenge with wild type S. gallinarum Salmonella Gallinarum cpxR/Ion mutant vaccine VO:0002878 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3290 3290 vaccine A cya and crp mutant is attenuated in mice. Thirty days after immunization, mice were protected from oral challenge with wild type S. typhimurium Salmonella Typhimurium cya/crp mutant vaccine VO:0002879 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3164 3164 vaccine A crp mutant is attenuated in mice and induces significant protection from challenge with wild type S. gallinarum Salmonella Gallinarum crp mutant vaccine VO:0002880 Oliver He Rebecca Racz A cya and crp mutant is attenuated in mice. Thirty days after immunization, mice were protected from oral challenge with wild type S. typhimurium obsolete Salmonella Typhimurium cya/crp mutant vaccine true VO:0002881 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3165 3165 vaccine A fliC mutant, in combination with a guaB mutant, is attenuated in mice and chickens and induces significant protection from challenge with wild type S. enterica A guaB mutant, in combination with a fliC mutant, is attenuated in mice and chickens and induced significant protection from challenge with wild type S. enterica JZ: based on comment,VO:0002890 should be 'Salmonella enterica fliC/guaB mutant vaccine'. Salmonella enterica fliC/guaB mutant vaccine VO:0002882 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3270 3270 vaccine A guaBA, clpP, and fliD mutant (CVD 1923) is attenuated in mice after oral immunization. This mutant is also protective, with a vaccine efficacy of 80% in mice against wild type challenge from Salmonella Typhimurium Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine VO:0002883 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3166 3166 vaccine A gal E mutant in strain Ty2 was isolated, attenuated, and protected mice against lethal challenge Salmonella Typhi galE mutant vaccine VO:0002884 Oliver He Rebecca Racz A guaBA and clpP mutant (CVD 1941) is attenuated in mice after oral immunization. This mutant is also protective in mice and had a vaccine efficacy of 76% against challenge with wild type Salmonella Enteritidis obsolete Salmonella Enteritidis guaBA/clpP mutant vaccine true VO:0002885 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3269 3269 vaccine A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium Salmonella Typhimurium guaBA/clpP mutant vaccine VO:0002886 Oliver He Rebecca Racz A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium obsolete Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine (merged to VO_0002885) true VO:0002887 Oliver He Rebecca Racz A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium obsolete Salmonella Typhimurium guaBA/clpP mutant vaccine true VO:0002888 Oliver He Rebecca Racz A guaBA and clpP mutant (CVD 1921) of Salmonella Typhimurium is attenuated in mice after oral immunization. The mutant was also protective, rendering a vaccine efficacy of 86% in mice against challenge with wild type Salmonella Typhimurium obsolete Salmonella Typhimurium guaBA/clpP/fliD mutant vaccine (merged to VO_0002885) true VO:0002889 Oliver He Rebecca Racz A guaB mutant, in combination with a fliC mutant, is attenuated in mice and chickens and induced significant protection from challenge with wild type S. enterica obsolete Salmonella enterica fliC/guaB mutant vaccine true VO:0002890 Oliver He Rebecca Racz A guaB mutant, in combination with a fliC mutant, is attenuated in mice and chickens and induced significant protection from challenge with wild type S. enterica obsolete Salmonella Enteritidis guaBA/clpP mutant vaccine true VO:0002891 Oliver He Rebecca Racz A gyrA-cpxA-rpoB Salmonella Typhimurium mutant was attenuated and protected against challenge in pigs obsolete Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine true VO:0002892 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3167 3167 vaccine Oral immunization with the Salmonella hfq deletion mutant efficiently protects mice against subsequent oral challenge with virulent strain of Salmonella Typhimurium Salmonella Typhimurium hfq mutant vaccine VO:0002893 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3168 3168 vaccine A htrA mutant in Salmonella typhimurium is attenuated and provides protection in mice against an oral challenge with virulent S. typhimurium SL1344 Salmonella Typhimurium htrA mutant vaccine VO:0002894 Oliver He Rebecca Racz A lon mutant, in combination with a cpxR mutation, is highly attenuated in mice and induces significant protection from challenge with wild type S. gallinarum obsolete Salmonella Gallinarum cpxR/Ion mutant vaccine true VO:0002895 Oliver He Rebecca Racz Salmonella Typhimurium IppA/IppB/msbB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3169 3169 vaccine An lppA mutant, in combination with an lppB/msbB mutation, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium An lppB mutant, in combination with an msbB mutant or an msbB/lppA mutant, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium An msbB mutant, in combination with an lppB or lppAB mutation, is attenuated in mice and induces significant protection from challenge with S. Typhimurium Salmonella Typhimurium IppA/IppB/msbB vaccine VO:0002896 Oliver He Rebecca Racz An lppB mutant, in combination with an msbB mutant or an msbB/lppA mutant, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium obsolete Salmonella Typhimurium IppA/IppB/msbB true VO:0002897 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3170 3170 vaccine An lppB mutant, in combination with an msbB mutant or an msbB/lppA mutant, is attenuated in mice and induces significant protection from challenge with wild type S. Typhimurium An msbB mutant, in combination with an lppB or lppAB mutation, is attenuated in mice and induces significant protection from challenge with S. Typhimurium Salmonella Typhimurium IppB/msbB mutant vaccine VO:0002898 Oliver He Rebecca Racz An msbB mutant, in combination with an lppB or lppAB mutation, is attenuated in mice and induces significant protection from challenge with S. Typhimurium obsolete Salmonella Typhimurium IppA/IppB/msbB true VO:0002899 Oliver He Rebecca Racz An msbB mutant, in combination with an lppB or lppAB mutation, is attenuated in mice and induces significant protection from challenge with S. Typhimurium obsolete Salmonella Typhimurium IppB/msbB mutant vaccine true VO:0002900 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3291 3291 vaccine In a pig infection experiment including two oral immunizations with SalmoporcDeltaompD (OmpD, nmpC) and challenge with a multiresistant S. enterica serovar Typhimurium DT104 clinical isolate, we confirmed the protective efficacy of SalmoporcDeltaompD in pigs, showing a significant reduction of both clinical symptoms and colonization of lymph nodes and intestinal tract Salmonella Typhimurium ompD/nmpC mutant vaccine VO:0002901 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3171 3171 vaccine A nuoG mutant is attenuated in chickens and induced significant protection from challenge with wild type S. Gallinarum Salmonella Gallinarum nuoG mutant vaccine VO:0002902 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3172 3172 vaccine An ompR mutant is attenuated in mice after oral challenge. Twenty eight days after immunization, mice were challenged with wild type S. typhimurium and were significantly protected Salmonella Typhimurium ompR mutant vaccine VO:0002903 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3173 3173 vaccine Three S. typhi deletion mutants (phoP, rpoS, and rpoS-phoP double mutant) were constructed and characterized with respect to invasiveness, virulence, and protective immune response compared with wild-type Ty2. All S. typhi mutants showed an increase in the specific serum IgG levels and T-cell-mediated immunity, and showed equal protection abilities against a wild-type Ty2 challenge after two rounds of immunization in BALB/c mice Salmonella Typhi phoP mutant vaccine VO:0002904 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3174 3174 vaccine A poxA mutant is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium Salmonella Typhimurium poxA mutant vaccine VO:0002905 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3175 3175 vaccine A ppGpp-defective Salmonella Gallinarum, which is attained by mutating the relA and spoT genes, is attenuated in chickens and induces protection from oral challenge with wild type S. Gallinarum Salmonella Gallinarum relA/spoT mutant vaccine VO:0002906 Oliver He Rebecca Racz An rfc mutant, in combination with an asd mutation, is attenuated in mice and induces significant protection from challenge with wild type S. typhimurium obsolete Salmonella Typhimurium asd/rfc mutant vaccine true VO:0002907 Oliver He Rebecca Racz A gyrA-cpxA-rpoB Salmonella Typhimurium mutant was attenuated and protected against challenge in pigs obsolete Salmonella Typhimurium gyrA/cpxA/rpoB mutant vaccine true VO:0002908 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3181 3181 vaccine Immunizations with Salmonella typhimurium rpoS and rpoS aroA mutants protected susceptible BALB/c mice against subsequent oral challenge with virulent S. typhimurium. When administered orally or intraperitoneally, rpoS derivatives of the mouse-virulent S. typhimurium strains, C52 and SL1344, were highly attenuated and were efficient single-dose live vaccines Salmonella Typhimurium rpoS mutant vaccine VO:0002909 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3182 3182 vaccine A ruvB mutant is attenuated in mice and induced significant protection from challenge with wild type S. Typhimurium Salmonella Typhimurium ruvB mutant vaccine VO:0002910 Oliver He Rebecca Racz A ppGpp-defective Salmonella Gallinarum, which is attained by mutating the relA and spoT genes, is attenuated in chickens and induces protection from oral challenge with wild type S. Gallinarum obsolete Salmonella Gallinarum relA/spoT mutant vaccine true VO:0002911 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3183 3183 vaccine A surA mutant (BRD1115) is attenuated in BALB/c mice and induces protection from challenge with wild type S. typhimurium Salmonella Typhimurium surA mutant vaccine VO:0002912 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3184 3184 vaccine A tolA mutant is attenuated in mice and induced significant protection from challenge with wild type S. Typhimurium Salmonella Typhimurium tolA mutant vaccine VO:0002913 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3185 3185 vaccine A trxA mutant is attenuated in mice and induced significant protection from challenge with wild type S. Typhimurium Salmonella Typhimurium trxA mutant vaccine VO:0002914 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3282 3282 vaccine A wecA mutant (DSM645) is attenuated in C57BL/6J mice through i.p. and oral immunization. This mutant also protects against challenge with S. typhimurium strains TML and SL1344 30 days after immunization Salmonella Typhimurium wecA mutant vaccine VO:0002915 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3186 3186 vaccine A znuABC mutant is attenuated in mice and induced significant protection against a challenge infection in the large intestine with wild type Salmonella typhimurium Salmonella Typhimurium znuABC mutant vaccine VO:0002916 Oliver He Rebecca Racz A znuABC mutant is attenuated in mice and induced significant protection against a challenge infection in the large intestine with wild type Salmonella typhimurium obsolete Salmonella Typhimurium znuABC mutant vaccine true VO:0002917 Oliver He Rebecca Racz A znuABC mutant is attenuated in mice and induced significant protection against a challenge infection in the large intestine with wild type Salmonella typhimurium obsolete Salmonella Typhimurium znuABC mutant vaccine true VO:0002918 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete CVD 1204(pGA1-CS2) true VO:0002919 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete S. dysenteriae 1 strain WRSd1 true VO:0002920 Oliver He Rebecca Racz S. flexneri 2a strain CVD 1203 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=262 262 vaccine An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri Shigella flexneri 2a strain CVD 1203 vaccine VO:0002921 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete S. sonnei strain WRSS1 true VO:0002922 Oliver He Rebecca Racz S. flexneri strain Sfl 124 vaccine An aroD mutant is highly attenuated in monkeys and induces significant protection from challenge with wild type S. flexneri Shigella flexneri strain Sfl 124 vaccine VO:0002923 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3151 3151 vaccine An aroD mutant is highly attenuated in monkeys and induces significant protection from challenge with wild type S. flexneri Shigella flexneri aroD mutant vaccine VO:0002924 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3152 3152 vaccine An envZ mutant (SC433) is greatly decreased in virulence in macaque monkeys, though some mild clinical signs were still recorded. This mutant is also highly protective against a challenge of wild type S. flexneri delivered 1 month after inoculation Shigella flexneri envZ mutant vaccine VO:0002925 a Brucella vaccine against infection wtih B. ovis Oliver He vaccine Brucella ovis vaccine VO:0002926 Oliver He Rebecca Racz An aroA and virG mutant (CVD 1203) is attenuated in guinea pigs, as shown by the Sereny test. Guinea pigs inoculated with CVD 1203 were also protected from challenge with wild type S. flexneri obsolete SC602 true VO:0002927 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3153 3153 vaccine A virG, senA, senB, and msbB2 mutant (WRSs3) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs3 is comparable to live attenuated vaccine strain WRSS1 Shigella sonnei virG/senA/senB/msbB2 mutant vaccine VO:0002928 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3154 3154 vaccine A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 Shigella sonnei virG/senA/senB mutant vaccine VO:0002929 Oliver He Rebecca Racz A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 obsolete Shigella sonnei virG/senA/senB/msbB2 mutant vaccine true VO:0002930 Oliver He Rebecca Racz A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 obsolete Shigella sonnei virG/senA/senB mutant vaccine true VO:0002931 Oliver He Rebecca Racz A virG, senA, and senB mutant (WRSs2) is attenuated in guinea pigs and induced significant protection from challenge with wild type S. sonnei. Attenuation and protection from WRSs2 is comparable to live attenuated vaccine strain WRSS1 obsolete Shigella sonnei virG/senA/senB/msbB2 mutant vaccine true VO:0002932 Oliver He Rebecca Racz A virG mutant (WRSS1) is attenuated in guinea pigs and induced significant protection from challenge with wild type Shigella sonnei obsolete Shigella sonnei virG/senA/senB mutant vaccine true VO:0002933 Oliver He Rebecca Racz A virG mutant (WRSS1) is attenuated in guinea pigs and induced significant protection from challenge with wild type Shigella sonnei obsolete Shigella sonnei virG/senA/senB/msbB2 mutant vaccine true VO:0002934 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3142 3142 vaccine A hemA mutant is highly attenuated in mice and rabbits and induces protection from challenge with wild type V. cholerae in rabbits Vibrio cholerae hemA mutant vaccine VO:0002935 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3135 3135 vaccine An aroA mutant is highly attenuated in mice, and after 3 doses induces significant protection from challenge with wild type Y. enterocolitica Yersinia enterocolitica aroA mutant vaccine VO:0002936 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3136 3136 vaccine A htrA mutant in Yersinia enterocolitica was attenuated and provided partial protection against challenge in mice Yersinia enterocolitica htrA mutant vaccine VO:0002937 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3137 3137 vaccine A ompR mutant in Yersinia enterocolitica was attenuated and provided a partial protection from challenge in mice Yersinia enterocolitica ompR mutant vaccine VO:0002938 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3138 3138 vaccine A sodA mutant in Yersinia enterocolitica was highly attenuated and mice immunized with a single oral dose of the mutant strain were protected against a lethal oral-challenge infection with wild-type Y. enterocolitica Yersinia enterocolitica sodA mutant vaccine VO:0002939 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3128 3128 vaccine A guaBA mutant is attenuated in mice and induced significant protection from challenge with wild type Y. pestis Yersinia pestis guaBA mutant vaccine VO:0002940 Oliver He Rebecca Racz A guaBA mutant is attenuated in mice and induced significant protection from challenge with wild type Y. pestis obsolete Yersinia pestis guaBA mutant vaccine true VO:0002941 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3129 3129 vaccine An IpxM mutant is attenuated in mice and guinea pigs. This mutant also conferred modest protection from challenge with wild type Y. pestis in Balb/c mice and significant protection in guinea pigs and outbred mice Yersinia pestis IpxM mutant vaccine VO:0002942 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3130 3130 vaccine An nlpD mutant is highly attenuated in mice and induced significant protection from challenge with wild type Y. pestis Yersinia pestis nlpD mutant vaccine VO:0002943 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3131 3131 vaccine A pcm mutant is highly attenuated in mice and induced significant protection from challenge with wild type Y. pestis Yersinia pestis pcm mutant vaccine VO:0002944 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3132 3132 vaccine An smpB mutant, in combination with an ssrA mutation, is attenuated in mice and induces significant protection from challenge with wild type Y. pestis Yersinia pestis smpB/ssrA mutant vaccine VO:0002945 Oliver He Rebecca Racz An smpB mutant, in combination with an ssrA mutation, is attenuated in mice and induces significant protection from challenge with wild type Y. pestis obsolete Yersinia pestis smpB/ssrA mutant vaccine true VO:0002946 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3133 3133 vaccine A yopH mutant is highly attenuated in mice and induced significant protection from challenge with wild type Y. pestis Yersinia pestis yopH mutant vaccine VO:0002947 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3127 3127 vaccine A phoP mutant in Yersinia pseudotuberculosis (Yptb) was attenuated and provided protection against oral challenge with virulent Yptb in mice Yersinia pseudotuberculosis phoP mutant vaccine VO:0002948 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3126 3126 vaccine An aroA mutant is highly attenuated in rainbow trout and induces significant protection from challenge with wild type Y. ruckeri Yersinia ruckeri aroA mutant vaccine VO:0002949 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3266 3266 vaccine A thymidine kinase-deficient mutant (B8-D53) showed no detectable thymidine kinase-inducing activity and was attenuated in calves. B8-D53 also induced protection from challenge with wild type BHV-1 Bovine herpesvirus 1 UL23 mutant vaccine VO:0002950 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3178 3178 vaccine A deletion of BHV-1 gE gene in strain A is considered as a live attenuated vaccine. After challenge, vaccinated calves were protected against disease and virus shedding was reduced Bovine herpesvirus 1 US8 (gE) mutant vaccine VO:0002951 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3265 3265 vaccine A glycoprotein G deletion in bovine respiratory syncytial virus(rBRSV) and recombinant rBRSV was attenuated and provided protection against a BRSV challenge infection in calves Bovine respiratory syncytial virus glycoprotein G mutant vaccine VO:0002952 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3254 3254 vaccine An N269A/Q mutation in the E(rns) protein created an attenuated mutant in swine. This mutant was able to induce effective protection in swine against challenge with wild type CSFV Classical swine fever virus E(rns) mutant vaccine VO:0002953 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3255 3255 vaccine An N to A amino acid substitution was made in the N594 site of the E1 glycoprotein, resulting in attenuation of the virus in swine. This attenuated virus induced protection against challenge with wild type CSFV Classical swine fever virus E1 mutant vaccine VO:0002954 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3256 3256 vaccine A E2 mutant in Classical swine fever virus is attenuated and provides protection in pigs after oronasal vaccination (not intradermal vaccination) against lethal challenge dose of CSFV strain Eystrup Classical swine fever virus E2 mutant vaccine VO:0002955 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3250 3250 vaccine A glycoprotein E mutant is attenuated in mice and hamsters and induced significant protection from challenge with wild type Equid herpesvirus in mice Equid herpesvirus gE mutant vaccine VO:0002956 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3251 3251 vaccine A glycoprotein I mutant is attenuated in mice and hamsters and induced significant protection from challenge with wild type Equid herpesvirus in mice Equid herpesvirus gI mutant vaccine VO:0002957 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3252 3252 vaccine A thymidine kinase-deficient mutant (PR1) is attenuated in mice and induced significant protection from challenge with wild type EHV-1 5 weeks after vaccination. In foals, PR1 also showed attenuation; however, the mutant induced only partial protection from challenge with EHV-1 Equid herpesvirus TK mutant vaccine VO:0002958 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3247 3247 vaccine A thymidine kinase-deficient mutant (C7301dlTK) is attenuated in cats and induced significant protection from wild type FHV-1 4 weeks after vaccination Feline herpesvirus 1 UL23 mutant vaccine VO:0002959 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3245 3245 vaccine Feline immunodeficiency virus (FIV) made defective in the accessory gene ORF-A were previously shown to be greatly attenuated in its ability to replicate in lymphocytes but to grow normally or near normally in other cell types. 3/9 vaccinees (cats) showed no evidence of the challenge virus over a 15-month observation period. In the other vaccinees, the challenge virus was predominant for various periods of time, but pre-existing viral loads and CD4 lymphocyte counts were either unaffected or altered only marginally and transiently Feline immunodeficiency virus ORF-A mutant vaccine VO:0002960 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3246 3246 vaccine A vif mutant in feline immunodeficiency virus was attenuated and a vif-deleted FIV provirus DNA protected cats against challenge with the homologous FIV-PPR biological isolate. Feline immunodeficiency virus vif mutant vaccine VO:0002961 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3243 3243 vaccine A 3abc deletion mutant in Feline infectious peritonitis virus (FIPV) was attenuated and provided protection against virulent FIPV strain 79-1146 challenge in kittens Feline infectiour peritonitis virus 3abc mutant vaccine VO:0002962 Oliver He Rebecca Racz A 3abc deletion mutant in Feline infectious peritonitis virus (FIPV) was attenuated and provided protection against virulent FIPV strain 79-1146 challenge in kittens obsolete Feline infectiour peritonitis virus 3abc mutant vaccine true VO:0002963 Oliver He Rebecca Racz A 3abc deletion mutant in Feline infectious peritonitis virus (FIPV) was attenuated and provided protection against virulent FIPV strain 79-1146 challenge in kittens obsolete Feline infectiour peritonitis virus 3abc mutant vaccine true VO:0002964 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3244 3244 vaccine A 7ab deletion mutant in Feline infectious peritonitis virus is attenuated and provides protection against virulent FIPV strain 79-1146 challenge in kittens Feline infectious peritonitis virus 7ab mutant vaccine VO:0002965 Oliver He Rebecca Racz A 7ab deletion mutant in Feline infectious peritonitis virus is attenuated and provides protection against virulent FIPV strain 79-1146 challenge in kittens obsolete Feline infectious peritonitis virus 7ab mutant vaccine true VO:0002966 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3228 3228 vaccine A UL0 mutant in infectious laryngotracheitis virus (ILTV) was attenuated. Chickens immunized with UL0-negative ILTV were protected from clinical disease after subsequent infection with virulent ILTV Gallid herpesvirus 1 UL0 mutant vaccine VO:0002967 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3229 3229 vaccine A thymidine-kinase mutant is attenuated in chickens and induced protection from challenge with wild type GHV-1 Gallid herpesvirus 1 UL23 mutant vaccine VO:0002968 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3230 3230 vaccine A UL47 mutant in avian infectious laryngotracheitis virus is attenuated and provides protection in chicken against subsequent challenge infection with virulent ILTV Gallid herpesvirus 1 UL47 mutant vaccine VO:0002969 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3227 3227 vaccine Researchers generated a series of woodchuck hepatitis virus (WHV) X mutants. Woodchucks inoculated with X mutants, including those with no serologic evidence of infection, were protected from later challenge with infectious Woodchuck Hepatitis Virus, suggesting previous infection with resulting protective immunity Hepatitis B virus X protein mutant vaccine VO:0002970 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3222 3222 vaccine KOS-gDA3C is attenuated with mutations in gD gene in causing skin lesions at the inoculation and zosteriform sites, yet it is as effective as rKOS-gDA3C in protecting mice against HSV-1 challenge Herpes simplex virus 1 gD mutant vaccine VO:0002971 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3223 3223 vaccine A gH mutant is attenuated in mice and induces significant protection from challenge with wild type HSV-1 Herpes simplex virus 1 gH mutant vaccine VO:0002972 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3224 3224 vaccine A live-attenuated HSV-2 ICP0 virus provides significant protection against wild-type HSV-2 (MS strain) challenge in mice Herpes simplex virus 2 ICP0 mutant vaccine VO:0002973 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3225 3225 vaccine A thymidine kinase-deficient (TK) mutant was found to be attenuated in mice. This mutant induced complete protection from challenge with wild type HSV Herpes simplex virus 1 TK mutant vaccine VO:0002974 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3226 3226 vaccine A UL29 mutant is attenuated in mice and induces significant protection from challenge with wild type HSV-1 Herpes simplex virus 1 UL29 mutant vaccine VO:0002975 Oliver He Rebecca Racz An HSV-1 gE (Us8) deletion strain, NS-gEnull, was used as a live attenuated vaccine. After HSV-1 challenge, latent virus was recovered by DRG explant cocultures from <10% of vaccinated mice compared with 100% of mock-vaccinated mice obsolete Herpes simplex virus type 1 DNA vaccine encoding GE true VO:0002976 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3220 3220 vaccine A G mutant is attenuated in African green monkeys and induces protection from challenge with wild type HMPV human metapneumovirus G protein mutant vaccine VO:0002977 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3221 3221 vaccine An M2-2 mutant is attenuated in African green monkeys and induced protection from challenge with wild type HMPV human metapneumovirus M2-2 mutant vaccine VO:0002978 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3219 3219 vaccine An M2-2 mutant of human respiratory syncytial virus A2 is attenuated in African green monkeys. When challenged with wild type RSV, two doses provided complete protection against challenge in the lower respiratory tract and a significant reduction of the challenge virus in the upper respiratory tract Human Respiratory Syncytial Virus M2-2 mutant vaccine VO:0002979 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3218 3218 vaccine A mutation in the non-virion protein of IHNV causes attenuated growth in rainbow trout and is able to provide significant protection from subsequent challenge with wild type IHNV Infectious Hematopoietic Necrosis Virus NV mutant vaccine VO:0002980 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1016 1016 vaccine Mutant influenza virus that lacks the transmembrane and cytoplasmic tail domains of M2 (M2 knockout [M2KO]) from Influenza A virus (A/Puerto Rico/8/34(H1N1)) is attenuated in both cell culture and mice. Mice intranasally vaccinated with M2KO virus developed protective immune responses and survived a lethal challenge with the wild-type virus, suggesting that the M2KO virus has potential as a live attenuated vaccine influenza virus CTA1-3M2e-DD protein vaccine VO:0002981 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3217 3217 vaccine Intranasal inoculation of mice, pigs, horses, and macaques with NS1-modified influenza virus strains induced robust humoral and cellular immune responses, and generated immune protection against challenge with wild-type virus influenza virus NS1 mutant vaccine VO:0002982 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3194 3194 vaccine A mutation in the GP5 protein attenuates HP-PRRSV in piglets. This mutant (HuN4-F112) induces protection against challenge with wild type HP-PRRSV Porcine respiratory and reproductive syndrome virus GP5 protein mutant vaccine VO:0002983 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3189 3189 vaccine A UL23 mutant, in combination with mutations in glycoproteins G and E, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV A glycoprotein E mutant, in combination with UL23 and glycoprotein G mutations, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV A glycoprotein G mutant, in combination with UL23 and glycoprotein E mutations, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine VO:0002984 Oliver He Rebecca Racz A glycoprotein G mutant, in combination with UL23 and glycoprotein E mutations, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV obsolete Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine true VO:0002985 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3190 3190 vaccine A glycoprotein M, gM, deletion in pseudorabies virus was attenuated and induced protection in piglets against intranasal challenge with 108 p.f.u. of the highly virulent PrV strain NIA-3 Psuedorabies virus glycoprotein M mutant vaccine VO:0002986 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3191 3191 vaccine A gp50+gp63 deletion mutant in Pseudorabies virus was attenuated and provided protection from clinical signs of Aujeszky's disease after a challenge inoculation with the virulent wild-type PRV strain NIA-3 Pseudorabies virus gp50/gp63 mutant vaccine VO:0002987 Oliver He Rebecca Racz A gp50+gp63 deletion mutant in Pseudorabies virus was attenuated and provided protection from clinical signs of Aujeszky's disease after a challenge inoculation with the virulent wild-type PRV strain NIA-3 obsolete Pseudorabies virus gp50/gp63 mutant vaccine true VO:0002988 Oliver He Rebecca Racz A UL23 mutant, in combination with mutations in glycoproteins G and E, is attenuated in raccoons, with a 75% survival rate. This mutant also provides some protection from wild type PRV obsolete Pseudorabies virus glycoprotein E/G/UL23 mutant vaccine true VO:0002989 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3192 3192 vaccine A UL50 mutant is attenuated in pseudorabies virus and induces significant protection in pigs from challenge with the highly virulent NIA-3 strain of PrV Pseudorabies virus UL50 mutant vaccine VO:0002990 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3193 3193 vaccine Researchers intranasally inoculated pigs, the natural host of this virus, with mutant PRV strains in which the genes encoding the protein kinase (US3) proteins were inactivated. After challenge infection with the virulent PRV strain NIA-3, no virus was excreted by wt PRV- and PK- mutant-immunized animals, indicating complete protective immunity Pseudorabies virus US3 mutant vaccine VO:0002991 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3187 3187 vaccine A glycoprotein G mutant in rabies virus is attenuated. After a one-dose intramuscular vaccination, the ERAg3m virus protected 100% of mice and hamsters from lethal challenge. In co-infections, using a lethal dose of street rabies virus mixed with ERAg3m, 100% of hamsters and 90% of mice survived and were protected against subsequent infection Rabies virus glycoprotein G mutant vaccine VO:0002992 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3188 3188 vaccine A P gene mutant is attenuated in mice and induces significant protection from challenge with wild type Rabies virus Rabies virus P protein mutant vaccine VO:0002993 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3155 3155 vaccine An E mutant is attenuated in hamsters and induces significant protection from challenge with wild type SARS SARS-CoV E gene mutant vaccine VO:0002994 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3150 3150 vaccine A SIV nef mutant is attenuated in rhesus monkeys and induces protection from challenge with wild type SIV Simian Immunodeficiency Virus nef mutant vaccine VO:0002995 Oliver He Rebecca Racz vaccine A virus with a mutation in protein C is attenuated in mice and induced protection from challenge with wild type TBE virus ick-borne Encephalitis Virus C protein mutant vaccine VO:0002996 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3143 3143 vaccine A VEE mutant with a PE2 cleavage signal mutation and a suppressor mutation in E1 is highly attenuated in mice and provides complete protection against challenge with wild type VEE VEE Virus PE2/E1 mutant vaccine VO:0002997 Oliver He Rebecca Racz A VEE mutant with a PE2 cleavage signal mutation and a suppressor mutation in E1 is highly attenuated in mice and provides complete protection against challenge with wild type VEE obsolete VEE Virus PE2/E1 mutant vaccine true VO:0002998 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3141 3141 vaccine A virus with a C protein mutation is attenuated in mice and induces significant protection from challenge with wild type West Nile virus West Nile virus C protein mutant vaccine VO:0002999 Oliver He Rebecca Racz A PE2 mutant combined with a deletion in E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur obsolete WEEV DNA Vaccine encoding 6K-E1 Protein true VO:0003000 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3139 3139 vaccine A PE2 mutant combined with a deletion in E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur Western equine encephalomyelitis virus PE2/E1 mutant vaccine VO:0003001 Oliver He Rebecca Racz A PE2 mutant combined with a deletion in E2 (WE2102) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur obsolete WEEV Subunit E2 Protein Vaccine true VO:0003002 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3140 3140 vaccine A PE2 mutant combined with a deletion in E2 (WE2102) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of this strain would occur Western equine encephalomyelitis virus PE2/E2 mutant virus VO:0003003 Oliver He Rebecca Racz vaccine A PE2 mutant combined with either a deletion in E2 (WE2102) or E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of these two strains would occur Western equine encephalomyelitis virus PE2/E1 or E2 mutant vaccine VO:0003004 Oliver He Rebecca Racz A PE2 mutant combined with either a deletion in E2 (WE2102) or E1 (WE2130) induced low-level viremia in chickens and protected against challenge with wild type WEE after 2 weeks. This study also found that it is unlikely that mosquito transmission of these two strains would occur obsolete Western equine encephalomyelitis virus PE2/E2 mutant virus true VO:0003005 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3216 3216 vaccine A cen1 mutant is attenuated in mice and hamsters and induces significant protection from challenge with wild type L. donovani Leishmania donovani cen1 mutant vaccine VO:0003006 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3277 3277 vaccine A Leishmania infantum deletion mutant of HSP70-II gene is attenuated and provides protection against Leishmania infection in the L. major-BALB/c infection model. Also, DeltaHSP70-II is a safe live vaccine as immunodeficient SCID mice, and hamsters, infected with mutant parasites did not develp any sign of pathology Leishmania infantum HSP70 II mutant vaccine VO:0003007 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3195 3195 vaccine A genetically attenuated parasite (GAP) with a mutation in the FabB/FabF gene is attenuated in mice by arresting in the late liver stage. It also conferred complete protection in mice from challenge with wild type Plasmodium Plasmodium FabB/FabF mutant vaccine VO:0003008 Oliver He Rebecca Racz P. berghei p36p mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3196 3196 vaccine Genetically attenuated P36p-deficient Plasmodium berghei sporozoites provide protection against sporozoites challenge in mice Plasmodium berghei p36p mutant vaccine VO:0003009 Oliver He Rebecca Racz P. yoelii p36/p52 mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3197 3197 vaccine A genetically attenuated parasite (GAP) with deletions in p52 and p36 are attenuated in mice. Mice immunized with the mutant were completely protected against challenge with wild type Plasmodium sporozoites Plasmodium yoelii p36/p52 mutant vaccine VO:0003010 Oliver He Rebecca Racz A genetically attenuated parasite (GAP) with deletions in p52 and p36 are attenuated in mice. Mice immunized with the mutant were completely protected against challenge with wild type Plasmodium sporozoites obsolete P. yoelii p36/p52 mutant vaccine true VO:0003011 Oliver He Rebecca Racz P. yoelii UIS3 mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3198 3198 vaccine Deletion of UIS3 in Plasmodium yoelii provided attenuation and full protection in mice by Pyuis3(-) sporozoites required at least 2 immunizations against challenges with infectious sporozoites Plasmodium yoelii UIS3 mutant vaccine VO:0003012 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3144 3144 vaccine A mic2 mutant is attenuated in mice and induces protection from challenge with wild type T. gondii Toxoplasma gondii mic2 mutant vaccine VO:0003013 Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3145 3145 vaccine An OMPDC mutant, alone or in combination with an UP mutation, is attenuated in mice and induces significant protection from challenge with wild type T. gondii Toxoplasma gondii OMPDC mutant vaccine VO:0003014 Oliver He Rebecca Racz vaccine A UP mutant, in combination with an OMPDC mutation, is attenuated in mice and induces significant protection from wild type T. gondii An OMPDC mutant, alone or in combination with an UP mutation, is attenuated in mice and induces significant protection from challenge with wild type T. gondii Toxoplasma gondii OMPDC/UP mutant vaccine VO:0003015 Oliver He Rebecca Racz A UP mutant, in combination with an OMPDC mutation, is attenuated in mice and induces significant protection from wild type T. gondii obsolete Toxoplasma gondii OMPDC/UP mutant vaccine true VO:0003016 A route of administration that located in the stomach, so that the material is taken into body through stomach directly. Asiyah Yu Lin site intragastric route VO:0003017 An intragastric route that has a vaccine injection site located in stomach. Asiyah Yu Lin site intragastric injection route VO:0003018 vaccination that occurs in the intagastric route. Asiyah Yu Lin vaccination intragastric vaccination VO:0003019 vaccination process that occurs in intradermal route. Asiyah Yu Lin vaccination intradermal vaccination VO:0003020 vaccination process that occurs in intranasal route Asiyah Yu Lin vaccination intranasal vaccination VO:0003021 vaccination process that occurs in oral route. Asiyah Yu Lin vaccination oral vaccination VO:0003022 vaccination process that occurs in the subcutaneous route Asiyah Yu Lin vaccination subcutaneous vaccination VO:0003023 A vaccine prepration process that mixes vaccine lyophilized powder and diluent liquid. The process forms a vaccine that can be used for administration. This term can also be considered as a child term of OBI term 'material combination'. Asiyah Yu Lin Oliver He WEB: http://www.thehaiticonnection.org/medical/reconstitution.pdf vaccine preparation A vaccine may include vaccine powder and solvent. When the two mix, we get a vaccine solution, which can be used to inject. Examples: http://www.medicines.org.uk/guides/acwy%20vax/Vaccinations%20%28all%29/ http://www.medicines.org.uk/guides/menitorix/Vaccinations%20%28all%29/ http://www.medicines.org.uk/guides/priorix/Vaccinations%20%28all%29/ Use only the specific diluent provided by the manufacturer for each type of vaccine to ensure adequate potency and safety of the resulting mixture. vaccine reconstitution VO:0003024 a vaccine powder that is freeze-dried and lyophilized. Asiyah Yu Lin Oliver He vaccine component lyophilized vaccine powder VO:0003025 a role inheres in the vaccine component when it is added into vaccine's formulation, it tends to stabilizes an emulsion by increasing its kinetic stablity. Asiyah Yu Lin role vaccine emulsifier role VO:0003026 a role inheres in vaccine component when added into vaccine's formulation, it tends to inhibit the reaction between two or more other vaccine substances in the final vaccine formulation; it also helps to protect the vaccine from adverse conditions such as the freeze-drying process or heat. Asiyah Yu Lin role vaccine stabilizer role VO:0003027 a protein vaccine stablizer that is specifically human serum albumin. Asiyah Yu Lin vaccine component human serum albumin vaccine additive VO:0003028 the serum albumin that is part of human it is subclass of 'serum albumin (PR:000003918)' Asiyah Yu Lin protein human serum albumin UniProtKB:P02768 VO:0003029 a vaccine stabilizer that is gelatin. Asiyah Yu Lin vaccine component gelatin vaccine stabilizer VO:0003030 Gelatin is a mixture of peptides and proteins produced by partial hydrolysis of collagen extracted from the skin, boiled crushed bones, connective tissues, organs and some intestines of animals such as domesticated cattle, chicken, and pigs.(wikipedia) Asiyah Yu Lin material entity gelatin VO:0003031 a vaccine-induced gene response that represents a vaccine adverse event response associated with a host susceptibility gene. Oliver He host susceptibility gene response to vaccine adverse event vaccine-induced response susceptibility gene response to vaccine adverse event VO:0003032 host immune factor-induced control of intracellular replication of live attenuated vaccine vaccine-induced response immune factor-induced control of intracellular replication of live attenuated vaccine VO:0003033 a protein vaccine stablizer that is specifically bovine serum albumin. Asiyah Yu Lin Oliver He vaccine component bovine serum albumin vaccine additive VO:0003034 a vaccine stabilizer that is specifically made by a sugar. Asiyah Yu Lin Oliver He vaccine component sugar vaccine stabilizer VO:0003035 a vaccine stabilizer that is generated based on amino acids. Asiyah Yu Lin Oliver He vaccine component amino acid vaccine stabilizer VO:0003036 a vaccine stabilizer that is specifically made by a sucrose. Asiyah Yu Lin Oliver He vaccine component sucrose vaccine stabilizer VO:0003037 a vaccine stabilizer that is specifically made by a lactose. Asiyah Yu Lin Oliver He vaccine component lactose vaccine stabilizer VO:0003038 a vaccine stabilizer that is a protein. Asiyah Yu Lin Oliver He vaccine component protein vaccine stabilizer VO:0003039 a polysorbate 20 vaccine stabilizer that is Alkest TW20. Asiyah Yu Lin Oliver He vaccine component Alkest TW 20 vaccine stabilizer VO:0003040 a polysorbate 20 vaccine stabilizer that is Tween 20. Asiyah Yu Lin Oliver He vaccine component Tween 20 vaccine stabilizer VO:0003041 an antibiotics vaccine residual that has the antibiotics of neomycin. Asiyah Yu Lin Oliver He vaccine component neomycin residual VO:0003042 the vaccine antiegn that induces protective immune response. Asiyah Yu Lin Oliver He vaccine component protective vaccine antigen VO:0003043 A viral vaccine against infection of an Sindbis virus. Oliver He Ronak Sutariya vaccine Sindbis virus vaccine VO:0003044 A viral vaccine against infection of a Lymphocytic choriomeningitis virus. Oliver He Ronak Sutariya Lymphocytic choriomeningitis mammarenavirus vaccine vaccine Lymphocytic choriomeningitis virus vaccine VO:0003045 obsolete RB51 induced protection against B.suis true VO:0003046 A protozoan vaccine against Schistosoma mansoni Oliver He Ronak Sutariya vaccine Schistosoma mansoni vaccine VO:0003047 A protozoan vaccine against Schistosoma infection Oliver He Ronak Sutariya vaccine Schistosoma vaccine VO:0003048 when the vaccination of a significant portion of a population (or herd), in contagious diseases that are transmitted from individual to individual, chains of infection are likely to be disrupted, so the large numbers of a population are immue or less susceptible to the disease. Asiyah Yu Lin http://en.wikipedia.org/wiki/Herd_immunity vaccine-induced response vaccine-induced herd immunity VO:0003049 The conjugate protein is a part of a conjugate vaccine and acts as a carrier protein that is covalently attached to a vaccine antigen with poor antigenicity (e.g., a polysaccharide). A conjugate protein is able to induce T-cell-dependent immune responses and stimulate the production of immune memory. Asiyah Yu Lin Oliver He vaccine component vaccine conjugate protein VO:0003050 A role inheres in a material eneitity that union itself chemically with a relative weak vaccine antigen to form a new whole that can create an effective miinuogen. The Asiyah Yu Lin role vaccine conjugate role VO:0003051 Asiyah Yu Lin site epicutaneous (application onto the skin) percutaneous route VO:0003052 Administration of a drug by the way of absorption through the skin, usually for systemic action. The route allows sustained therapeutic plasma drug levels and avoids first pass effect. Simplicity of administration tends to result in high patient compliance.|YL vaccination percutaneous vaccination VO:0003053 site intravesical route VO:0003054 The injection of a given substance directly into the bladder via a urethral catheter instead of being injected under the skin. Asiyah Yu Lin vaccination intravesical vaccination VO:0003055 A viral vaccine against infection of an infectious pancreatic necrosis virus. Oliver He Ronak Sutariya vaccine Infectious pancreatic necrosis virus vaccine VO:0003056 A viral vaccine against infection of a viral haemorrhagic septicaemia virus. Oliver He Ronak Sutariya obsolete viral haemorrhagic septicaemia virus vaccine true VO:0003057 An vaccine-induced host response that shows augmented protection and cellular immunity after a host protein is used as adjuvant. Oliver He Rebecca Racz obsolete augmented protection and cellular immunity using host protein as adjuvant true VO:0003058 A vaccine that protects against Mycobacterium marinum. Oliver He Ronak Sutariya vaccine Mycobacterium marinum vaccine VO:0003059 A viral vaccine that protects against infection with Hepatitis D virus. Oliver He vaccine Hepatitis D virus vaccine VO:0003060 viral vaccine that is used to protect against Monkeypox virus infection Oliver He Ronak Sutariya vaccine Monkeypox virus vaccine VO:0003061 viral vaccine that is used to protect against Bovine viral diarrhea virus 2 infection Oliver He Ronak Sutariya vaccine Bovine viral diarrhea virus 2 vaccine VO:0003062 A viral vaccine that protects against infection with Murine Cytomegalovirus (or called murid herpesvirus 1). Ningxian Fan Oliver He Ronak Sutariya murine cytomegalovirus vaccine vaccine Murid herpesvirus 1 vaccine VO:0003063 obsolete RB51 induced protection against B.abortus true VO:0003064 obsolete RB51 induced protection against B.canis true VO:0003065 obsolete RB51 induced protection against B.Melitensis true VO:0003066 Kallan Roan Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5576 http://purl.bioontology.org/ontology/RXNORM/1601403 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm431374.htm https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf 5576 BEXSERO Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM431447.pdf BL 125546 vaccine Bexsero vaccine VO:0003067 Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5556 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM524684.pdf 5556 Flublok Quadrivalent For active immunization against disease caused by influenza A subtype viruses and influenza type B viruses contained in the vaccine. Flublok Quadrivalent is approved for use in persons 18 years of age and older. https://www.fda.gov/vaccines-blood-biologics/vaccines/flublok-quadrivalent 125285 vaccine Flublok Quadrivalent VO:0003068 obsolete RB51 induced host immune response true VO:0003070 Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5561 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM502899.pdf 5561 Flucelvax Quadrivalent For active immunization for the prevention of influenza disease caused by influenza virus subtypes A and types B contained in the vaccine https://www.fda.gov/media/115862/download?attachment BL 125408 vaccine Flucelvax Quadrivalent VO:0003071 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5562 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm366061.htm https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM404086.pdf 5562 FluLaval For active immunization of persons 6 months of age and older for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM619548.pdf BL 125163 vaccine FluLaval Quadrivalent VO:0003072 Oliver He Omar Tibi FluLaval Tetra VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5563 http://ca.gsk.com/media/590283/flulaval-tetra.pdf 5563 FluLaval Tetra vaccine Product Name: Quadrivalent Influenza Vaccine (Split Virion, Inactivated) FluLaval Tetra vaccine VO:0003073 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5566 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm356091.htm 5566 Fluzone Quadrivalent For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM356094.pdf BL 103914 vaccine Fluzone Quadrivalent VO:0003074 Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5568 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM513242.pdf 5568 Fluzone Quadrivalent Southern Hemisphere Fluzone Quadrivalent Southern Hemisphere is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. https://www.fda.gov/media/120054/download?attachment 103914 vaccine Product Name: Influenza Virus Vaccine Fluzone Quadrivalent - Southern Hemisphere Formulation VO:0003075 Kallan Roan Khadeejah Khan Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5546 http://purl.bioontology.org/ontology/RXNORM/1597095 https://www.cancer.org/latest-news/fda-approves-gardasil-9-hpv-vaccine.html https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm426445.htm 5546 Gardasil 9 Indicated in girls and women 9 through 45 years of age for the prevention of the following diseases: - Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. (1.1) Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.1) And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: - Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS). (1.1) - Cervical intraepithelial neoplasia (CIN) grade 1. (1.1) - Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3. (1.1) - Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3. (1.1) - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.1) GARDASIL 9 is indicated in boys and men 9 through 45 years of age for the prevention of the following diseases: - Anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58. (1.2) - Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.2) And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.2) https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM426457.pdf 125508 vaccine Gardasil 9 vaccine VO:0003077 obsolete RB51 induced protection against B. ovis true VO:0003080 Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5578 http://www.pfizer.ca/sites/g/files/g10028126/f/201604/Nimenrix_PM_184020_23Mar2016_E.pdf 5578 vaccine Nimenrix vaccine VO:0003081 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5577 http://purl.bioontology.org/ontology/RXNORM/1593136 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm421020.htm 5577 TRUMENBA Indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM421139.pdf BL 125549 vaccine Trumenba vaccine VO:0003082 Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5569 http://purl.bioontology.org/ontology/RXNORM/1812946 https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM506235.pdf 5569 VAXCHORA VAXCHORA is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1. VAXCHORA is approved for use in persons 2 through 64 years of age traveling to cholera-affected areas. https://www.fda.gov/media/179631/download?attachment 125597 vaccine Vaxchora vaccine VO:0003083 Oliver He Omar Tibi H5N1 vaccine GSK VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5553 https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/UCM376464.pdf 5553 Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is a vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons (6 months and older) at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine. https://www.fda.gov/media/87479/download 125419 vaccine Product Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted by GSK VO:0003084 Oliver He Omar Tibi H1N1 vaccine GSK https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM190377.pdf vaccine Product Name: Influenza A (H1N1) 2009 Monovalent Vaccine influenza A (H1N1) 2009 monovalent vaccine (GlaxoSmithKline) VO:0003085 Oliver He Omar Tibi Adacel-Polio VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5549 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5571 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5579 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5583 https://www.vaccineshoppecanada.com/document.cfm?file=adacel-polio_e.pdf 5549 5571 5579 5583 Adacel-Polio vaccine Adacel-Polio vaccine VO:0003086 obsolete RB51 induced immune protection true VO:0003087 obsolete RB51 induced immune response without protection true VO:0003088 Oliver He Omar Tibi Boostrix-Polio VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5550 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5572 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5580 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5584 https://ca.gsk.com/media/589683/boostrix-polio.pdf 5550 5572 5580 5584 Boostrix-Polio vaccine Boostrix-Polio vaccine VO:0003090 This vaccine is given to provide protection against diphtheria, tetanus, and pertussis in children between 6 weeks and 7 years old. Kallan Roan Oliver He Tri-Immunol https://www.drugs.com/mmx/tri-immunol.html https://www.hendricks.org/HealthLibrary/default.aspx?sid=1&pTitle=%2CDrug&ContentTypeID=26&ContentID=215&alpha=T&AdditionalTitle=Tri-Immunol vaccine discontinued now Tri-Immunol vaccine VO:0003091 Influenza virus vaccine is used to prevent infection caused by influenza virus types A and B. Kallan Roan Oliver He Fluogen https://www.drugs.com/mtm/fluogen-injectable.html vaccine Fluogen vaccine VO:0003092 monovalent vaccine agianst poliomyelitis for infants 6-12 weeks of age, all immunized children up to 18 years of age, and high risk adults. Kallan Roan Oliver He https://www.rxlist.com/orimune-drug.htm vaccine Orimune vaccine VO:0003093 A malaria vaccine that consists of hepatitis B surface antigen virus-like particles, incorporating a portion of the Plasmodium falciparum-derived circumsporozoite protein and a liposome-based adjuvant. Oliver He Randi Vita P. falciparum RTS,S/AS01 PMID:20078211 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5945 https://en.wikipedia.org/wiki/RTS,S https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829262/ 5945 Mosquirix vaccine In July 2015, RTS,S/AS01 was approved by the European Medicines Agency for immunization of children aged 6 weeks to 17 months against malaria under Article 58,12. Plasmodium falciparum RTS,S/AS01 vaccine VO:0003094 vaccine Pnu-Imune vaccine VO:0003095 Revaxis is a Diphtheria, Tetanus and Poliomyelitis (inactivated) vaccine manufactured by Sanofi Pasteur. This vaccine helps boost protection against diphtheria, tetanus and poliomyelitis (polio). 3-in-1 diphtheria, polio and tetanus vaccine (Revaxis) http://www.netdoctor.co.uk/medicines/infections/a8594/revaxis-diphtheria-polio-and-tetanus-vaccine/ https://www.medicines.org.uk/emc/files/pil.5581.pdf https://www.medicines.org.uk/emc/product/5581/smpc https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166496/ vaccine Revaxis is used for preventing diphtheria, tetanus and polio in children from six years of age, adolescents and adults. Revaxis is used for a booster vaccination against these diseases. It is given to teenagers at 14 years of age as part of the British childhood immunisation schedule. Revaxis vaccine VO:0003096 a Diphthpheria-Tetanus Absorbed vaccine for children 7 years of age and adults. Kallan Roan Oliver He Ditanrix http://drug-info.in/ditanrix-diphtheria-tetanus-vaccine-adsorbed-glaxosmithkline vaccine Ditanrix vaccine VO:0003097 A rotavirus vaccine against severe diarrheal disease. Kallan Roan Oliver He https://web.stanford.edu/~siegelr/ShadmanRotashieldPaper.pdf vaccine discontinued in 2008 Rotashield vaccine VO:0003098 A more attenuated measles vaccine that targets measles virus strain Moraten. Kallan Roan Oliver He http://apps.who.int/iris/bitstream/handle/10665/266590/PMC2554544.pdf?sequence=1&isAllowed=y https://jamanetwork.com/journals/jama/article-abstract/341314 vaccine Developed sometime in 1968 therefore assumed to be discontinued Moraten vaccine VO:0003100 An inactIve vaccine used to prevent tetanus. Kallan Roan Oliver He http://www.catalog.md/drugs/tevax.html https://www.atoute.org/n/IMG/pdf/Constituants_des_vaccins_version-actualisee.pdf vaccine Discontinued in 2003 Tevax vaccine VO:0003101 An active immunization against cholera, indicated only for individuals traveling to or residing in countries where cholera is endemic or epidemic. Kallan Roan Oliver He https://www.rxlist.com/cholera-vaccine-drug.htm#indications vaccine Cholera vaccine, USP VO:0003102 A combination vaccine designed to protect against six different diseases. a hexavalent vaccine that has been withrawn on June 2012 by the European commission Hexavax http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2012/08/WC500130968.pdf vaccine Hexavax vaccine VO:0003103 A vaccine used to help prevent rabies infection in people who either have been, or are at risk of being bitten, licked or scratched by an animal infected with rabies virus. Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6178 http://www.who.int/immunization_standards/vaccine_quality/Rabipur_Product_Insert.pdf 6178 vaccine Rabipur vaccine VO:0003104 https://www.ndrugs.com/?s=rabiesvax vaccine Rabiesvax vaccine VO:0003105 LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by SmithKline Beecham Biologicals. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. Discontinued in 2002 Kallan Roan Oliver He Lymerix lipoprotein outer surface a vaccine https://wayback.archive-it.org/7993/20170405164754/https://www.fda.gov/ohrms/dockets/ac/01/briefing/3680b2_03.pdf https://www.rxlist.com/lymerix-drug.htm vaccine Lymerix vaccine VO:0003106 DTP vaccine DTwP vaccine vaccine diphtheria, tetanus and whole cell pertussis vaccine VO:0003107 A human diploid cell vaccine against rabies, a viral infectious disease. Kallan Roan Oliver He https://www.researchgate.net/publication/27190851_Vaccination_against_rabies_and_protective_antibodies_-_Comparison_of_ELISA_and_fluorescent_antibody_virus_neutralization_FAVN_assays vaccine Rabivac vaccine VO:0003108 This absorbed recombinant hepatitis B vaccine is indicated for active immunization against hepatitis B virus infection caused by all known subtypes in subjects of any age considered at risk of exposure to the virus. Kallan Roan Oliver He Genhevac B Genhevac B Pasteur https://www.mesvaccins.net/web/vaccines/48-genhevac-b-pasteur https://www.ncbi.nlm.nih.gov/pubmed/8106774 vaccine Discontinued in 2016 Genhevac B vaccine VO:0003109 HPV77/DE5 strain Kallan Roan Oliver He Meruvax I http://americanhistory.si.edu/collections/search/object/nmah_733733 vaccine Older version of Meruvax II Meruvax I vaccine VO:0003110 A vaccine for indivuduals who at risk or recently exposed to rabies. Kallan Roan Oliver He Rabie-Vax https://onlinelibrary.wiley.com/doi/pdf/10.1002/0471704210.app4 https://www.redalyc.org/html/579/57912962006/ vaccine Rabie-Vax vaccine VO:0003111 Kallan Roan Oliver He Mumpsvax II A vaccine for individuals to protect against mumps virus. https://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/cps-_monographs/CPS-_(General_Monographs-_M)/MUMPSVAX.html vaccine Mumpsvax II vaccine VO:0003112 Kallan Roan Oliver He A live RA 27/3 strain rubella vaccine http://www.meppo.com/pdf/drugs/1538-RUDIVAX-1321626694.pdf https://www.ncbi.nlm.nih.gov/pubmed/6531969 vaccine Rudivax vaccine VO:0003113 An adsorbed diphtheria, tetanus, pertussis and inactivated poliomyelitis vaccine. Tetracoq https://www.mesvaccins.net/web/vaccines/63-tetracoq https://www.researchgate.net/publication/289445706_Efficacy_and_safety_of_Tetracoq_vaccine vaccine European/French vaccine Often administered with a HIB vaccine. Tetracoq vaccine VO:0003114 A vaccine for Diphtheria, haemophilus influenzae, pertussis, and tetanus diseases. Trihibit https://www.drugs.com/mtm/trihibit.html vaccine Discontinued in 2011 Trihibit vaccine VO:0003115 A vaccine against flu (influenza) in adults, especially in those who run an increased risk of experiencing associated complications in case they fall ill with flu. Kallan Roan Oliver He Optaflu https://www.medicines.org.uk/emc/files/pil.6163.pdf vaccine Seasonal The vaccine targets three strains of influenza virus, and is free of chicken/egg protein. Optaflu vaccine VO:0003116 A vaccine used to prevent diphtheria and tetanus in individuals over 6 years of age. TD-Rix http://www.catalog.md/drugs/td-rix.html https://www.impfkritik.de/upload/pdf/fachinfo/Td-Rix-GSK-2006-07.pdf vaccine European/German vaccine TD-Rix vaccine VO:0003117 A combined live virus vaccine used to prevent measles, mumps, and rubella. Virivac http://vacvine.com/Vaccines/Details/319 vaccine need better source Virivac vaccine VO:0003118 A vaccine used to protect against measles, mumps, and rubella for 12-15 month-old individuals. Kallan Roan Oliver He M-M-R I https://www.ncbi.nlm.nih.gov/pubmed/18400341 vaccine M-M-R I vaccine VO:0003119 Active immunization against Haemophilius influenzae type b in recommended routinely for children at 24 months of age and for children at 15 months of age enrolled in child care facilities. Kallan Roan Oliver He HIBIMUNE Hib-Imune https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745871/ https://www.ndrugs.com/?s=hib-imune vaccine Discontinued in 1988 Hib-Imune vaccine VO:0003120 Oliver He Randi Vita MVA expressing antigen 85A MVA85A modified vaccinia virus Ankara expressing antigen 85A https://www.ncbi.nlm.nih.gov/pubmed/15502839 vaccine MVA85A vaccine VO:0003121 A Haemophilus influenzae type B conjugate vaccine manufactured by GSB. https://www.drugs.com/mtm/omnihib.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745871/ vaccine Discontinued Vaccine OmniHIB vaccine VO:0003122 A vaccine against diphtheria, tetanus, and pertussis. Kallan Roan Oliver He https://www.rxlist.com/certiva-drug.htm vaccine Certiva vaccine VO:0003124 obsolete Fluogen true VO:0003126 A TB vaccine that uses attenuated fowlpox strain FP9 to express mycobacterial mycolyl transferase Ag85A. Oliver He FP85A PMID:15196215 vaccine FP85A vaccine VO:0003129 Pharmacotherapeutic group (ATC code): J 07 AN 01. Oliver He Randi Vita http://www.immune.org.nz/vaccines/available-vaccines/bcg-vaccine-ssi https://www.hse.ie/eng/health/immunisation/hcpinfo/vaccineordering/bcgpil14.pdf vaccine Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, 2-8 x 10^5 CFU per dose. BCG vaccine SSI VO:0003130 A TB vaccine that uses BCG as vaccine vector. Oliver He vaccine recombinant BCG vaccine VO:0003131 A TB vaccine that recombinant BCG strain with the replacment of its urease C encoding gene with the listeriolysin encoding gene from Listeria monocytogenes. Oliver He Randi Vita BCGΔureC::hly VPM1002 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610719/ vaccine VPM1002 vaccine VO:0003133 The MRK adenovirus type 5 human immunodeficiency virus type 1 clade B gag/pol/nef vaccine is a replication-incompetent adenovirus type 5-vectored vaccine that elicits cell-mediated immunity against conserved human immunodeficiency virus proteins. Oliver He Randi Vita MRKAd5 HIV-1 gag/pol/nef PMID:18433307 https://www.ncbi.nlm.nih.gov/pubmed/18433307 vaccine MRKAd5 HIV-1 gag/pol/nef vaccine VO:0003134 A Yellow fever virus vaccine that uses the live attenated 17D strain. Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6144 6144 vaccine YF-17D vaccine VO:0003135 A Yellow fever virus vaccine that uses the live attenated 17DD strain. Oliver He Randi Vita https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903908/ vaccine Two distinct strains of live attenuated yellow fever virus vaccine, 17D and 17DD, have been widely used. They have the same origin, from a yellow fever virus isolated from a patient with non fatal yellow fever named Asibi, from Ghana, in 1927. The 17D strain, used for vaccine production, corresponds to passage level 235-240 and the 17DD to a passage level 286-287. The comparison of the nucleotide sequences of all 17D vaccines showed an overall homology of 99.2%. YF-17DD vaccine VO:0003136 A YF-17DD vaccine t hat is manufactured by Bio-Manguinhos Oliver He Randi Vita YF 17DD-YFV vaccine YF 17DD-YFV vaccine VO:0003138 a licensed N. meningitidis vaccine that includes meningococcal polysaccharides from Groups A, C, Y and W-135 combined, and is manufactured by GSK. Oliver He Randi Vita ACWYVax http://www.mhra.gov.uk/home/groups/comms-ic/documents/drugsafetymessage/con425089.pdf vaccine ACWY Vax vaccine VO:0003139 It is live attenuated YFV vaccine strain 17D manufactured in China, France, Senegal, and the USA. In powder and solvent for suspension for injection in pre-filled syringe. Oliver He Randi Vita 17D-204 https://www.medicines.org.uk/emc/product/1683/smpc vaccine Stamaril vaccine VO:0003140 A cancer vaccine against non-small cell lung cancer (NSCLC) NSCLC vaccine cancer vaccine non-small cell lung cancer vaccine VO:0003141 A non-small cell lung cancer mRNA-derived vaccine that contains modified mRNAs encoding cancer-testis antigen NY-ESO-1, melanoma-associated antigens C1 (MAGE-C1/CT7) and C2 (MAGE-C2/CT10), survivin, and the oncofetal antigen 5T4 with potential antitumor and immunomodulatory activities. Oliver He Randi Vita CV9201 https://www.cancer.gov/publications/dictionaries/cancer-drug/def/non-small-cell-lung-cancer-mrna-derived-vaccine-cv9201 cancer vaccine CV9201 vaccine VO:0003142 A vaccine role that indicates a clinical trial status of a vaccine Oliver He obsolete clinical trial vaccine role true VO:0003143 vaccine licensed influenza vaccine VO:0003144 Oliver He Randi Vita https://www.medicines.org.uk/emc/product/6355/smpc vaccine Imuvac vaccine VO:0003148 LIPO-5 is a therapeutic HIV vaccine made up of lipopeptides, Study Names: VRI02/ANRS 149 LIGHT; NCT01492985 Oliver He Randi Vita ANRS HIV-LIPO-5 HIV-LIPO-5 LIPO-5 https://aidsinfo.nih.gov/drugs/572/lipo-5/0/patient vaccine LIPO-5 is in Phase II development as a therapeutic HIV vaccine. (LIPO-5 is also being studied as a preventive HIV vaccine.) LIPO-5 vaccine VO:0003150 A Hepatitis B virus vaccine that uses recombinant Hepatitis B surface antigen as the antigen Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/797752 https://en.wikipedia.org/wiki/Hepatitis_B_vaccine 797752 hepatitis B surface antigen vaccine 528323 CUI: C0062527 RXAUI: 2850925 TUI: T116, T129, T121 vaccine Hepatitis B surface antigen vaccine VO:0003152 A Hepatitis B surface antigen viral vaccine that utilizes a cytidine-phosphate-guanosine oligodeoxynucleotide (CpGODN) 1018, as an adjuvant. Kallan Roan Oliver He Randi Vita HBsAg-1018 http://purl.bioontology.org/ontology/RXNORM/1994348 https://www.ncbi.nlm.nih.gov/pubmed/22342916 For prevention of infection caused by all known subtypes of hepatitis B virus. HEPLISAV-B is approved for use in adults 18 years of age and older https://www.fda.gov/media/108745/download?attachment 125428 vaccine HEPLISAV-B vaccine VO:0003154 A CpG DNA vaccine adjuvant that is a short, synthetic, unmethylated CpG oligodeoxynucleotide (CpG ODN) with immunostimulatory activity. ISS 1018 is a short, synthetic, unmethylated CpG oligodeoxynucleotide (CpG ODN) with immunostimulatory activity. ISS 1018 signals through Toll-like receptor 9 (TLR9) to induce the production of immunoglobulin by B cells and interferon (IFN) -alpha, IFN-beta, interleukin-12 (IL-12), and tumor necrosis factor - alpha (TNF-alpha) by plasmacytoid dendritic cells (pDC). ISS 1018 CpG ODN promotes antigen presentation and co-stimulatory molecule expression. ISS 1018 is currently being investigated in combination with HBsAg vaccine as a prophylactic treatment for to prevent Hepatitis B in adults. It is also being investigated in combination with rituximab for treatment of b-cell or non-hodgkin's lymphoma. Kallan Roan Oliver He ISS 1018 CpG ODN ISS 1018 CpG oligodeoxynucleotide ISS-1018 https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iss-1018-cpg-oligodeoxynucleotide https://www.drugbank.ca/drugs/DB05463 vaccine adjuvant ISS 1018 CpG ODN vaccine adjuvant DrugBank Accession number: DB05463 VO:0003155 Kallan Roan Oliver He Randi Vita A recombinant vesicular stomatitis virus Indiana serotype (rVSV) vector vaccine taht expresses Zaire GP https://www.ncbi.nlm.nih.gov/pubmed/15937495 204 702662 Ebola Zaire vaccine, live, recombinant, 1mL dose Ebola Zaire vaccine, live, recombinant, 1mL dose vaccine rVSV-ZEBOV VO:0003156 A human paillomavirus vaccine that has the vaccine antigen ingredient of monovalent non-infectious, L1 recombinant HPV-like particles (VLP). Kallan Roan Oliver He Randi Vita HPV-16 L1 VLP https://www.ncbi.nlm.nih.gov/pubmed/12854090 vaccine HPV-16 L1 VLP vaccine VO:0003165 An inactivated Japanese encephalitis vaccine (JVax *) for use by certain travelers to and expatriates in Asia. Kallan Roan Oliver He J-Vax https://www.cdc.gov/mmwr/preview/mmwrhtml/00018184.htm vaccine J-Vax vaccine VO:0003167 Kallan Roan Oliver He A viral vaccine that protects against infection with Poliovirus administered orally. http://polioeradication.org/polio-today/polio-prevention/the-vaccines/opv/ https://www.who.int/biologicals/areas/vaccines/polio/opv/en/ vaccine Oral Poliovirus vaccine VO:0003168 A combination vaccine that protects against diphtheria, tetanus, pertussis, and Haemophilus influenzae type B. Kallan Roan Oliver He DTaP-Hib vaccine 50 40213287 DTaP-Haemophilus influenzae type b conjugate vaccine DTaP-Hib vaccine Contains pertussis in acellular form. Diphtheria-Tetanus-Acellular Pertussis-Haemophilus b vaccine VO:0003169 A combination vaccine with whole cell that protects against diphtheria, tetanus, pertussis, and Haemophilus influenzae type B. Kallan Roan Oliver He vaccine Contains killed whole cells of bacterium that causes pertussis. Diphtheria-Tetanus-Whole Cell Pertussis-Haemophilus b vaccine VO:0003170 A vaccine used to develop immunity to rabies. Kallan Roan Oliver He Imovax ID vaccine Discontinued Imovax ID vaccine VO:0003171 A live virus vaccine for immunization against measles and rubella. Kallan Roan Oliver He MR-VAX II https://www.rxlist.com/m-r-vax-ii-drug.htm vaccine MR-VAX II vaccine VO:0003172 Kallan Roan Oliver He DTP-HepB vaccine vaccine Diphtheria-Tetanus-Pertussis-Hepatitis B vaccine VO:0003173 Active immunzation against diphtheria, tetanus, pertussis and hepatitis B (HBV) in infants from 6 weeks onwards Kallan Roan Oliver He Tritanrix Tritanrix HB https://www.ema.europa.eu/en/tritanrix-hb-h-w-3838 vaccine Tritanrix vaccine VO:0003174 A vaccine used to prevent diphtheria, tetanus, pertussis, and Haemophilus type B infections. Kallan Roan Oliver He DTP-ActHIB https://www.hendricks.org/HealthLibrary/default.aspx?sid=1&pTitle=%2CDrug&ContentTypeID=26&ContentID=1027&alpha=A&AdditionalTitle=ActHIB%C2%AE+With+DTP vaccine DTP-ActHIB vaccine VO:0003175 An oral vaccine against adenovirus serotype 4. Kallan Roan Oliver He Adenovirus Type 4 https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Adenovirus vaccine The vaccine is in a form of white enteric-coated tablets. It is typically administered with Adenovirus type 7 vaccine. Adenovirus Type 4 vaccine VO:0003176 An oral vaccine against adenovirus serotype 7. Adenovirus Type 7 Kallan Roan, Oliver He The vaccine is in a form of peach-colored enteric-coated tablets. It is typically administered with Adenovirus type 4 vaccine. https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Adenovirus vaccine Adenovirus Type 7 vaccine VO:0003177 A vaccine that contains ActHIB and protects against, Diphtheria, Tetanus, Pertussis (whooping cough), Polio, and Haemophilus influenzae type b. Kallan Roan Oliver He DTAP/IPV/ACT-HIB https://insights.ovid.com/pubmed?pmid=9849987 vaccine Diphtheria-Tetanus-Pertussis-Poliovirus-ACT-Hib vaccine VO:0003178 Active immunization against tetanus, diphtheria, pertussis, and poliomyelitis for individuals between 3 months and 6 years of age. Kallan Roan Oliver He Quatro Virelon https://www.impfkritik.de/upload/pdf/fachinfo/quatro-virelon-chiron-behring.pdf vaccine Quatro Virelon vaccine VO:0003180 A vaccine that protects adolescents and adults from tetanus, diphtheria, and pertussis. Kallan Roan Oliver He https://www.cdc.gov/vaccines/hcp/vis/vis-statements/tdap.html 115 40213230 tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed Tdap vaccine Tdap is different than the DTaP vaccine, which is given to infants and children in five doses, starting at 2 months of age. TDAP VO:0003181 A measles virus vaccine manufactured outside of the U.S. Kallan Roan Oliver He vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Measles virus vaccine foreign to USA VO:0003182 A Mumps-Rubella vaccine manufactured outside of the U.S. Kallan Roan Oliver He vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Mumps-Rubella vaccine foreign to USA VO:0003183 A Diphtheria-Tetanus-Pertussis-Poliovirus-Hepatitis B vaccine manufactured outside of the U.S Kallan Roan Oliver He vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Diphtheria-Tetanus-Pertussis-Poliovirus-Hepatitis B vaccine foreign to USA VO:0003184 A Diphtheria-Tetanus-Pertussis-Poliovirus vaccine manufactured outside of the U.S. Kallan Roan Oliver He vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Diphtheria-Tetanus-Pertussis-Poliovirus vaccine foreign to USA VO:0003185 A Haemophilis influenzae Type b capsular polysaccharide vaccine manufactured outside of the U.S. Kallan Roan Oliver He HIB Polysaccharide foreign to USA https://www.drugs.com/mmx/haemophilus-influenzae-type-b-polysaccharide-vaccine.html vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. HIB Polysaccharide vaccine foreign to USA VO:0003186 A Hepatitis B vaccine manufactured outside of the U.S. Kallan Roan Oliver He https://www.ema.europa.eu/documents/product-information/hbvaxpro-epar-product-information_en.pdf vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Hepatitis B vaccine foreign to USA VO:0003187 A Diphtheria-Tetanus-Poliovirus vaccine manufactured outside of the U.S. Kallan Roan Oliver He https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166496/ vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Diphtheria-Tetanus-Poliovirus vaccine foreign to USA VO:0003188 A Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b-Hepatitis B vaccine manufactured outside of the U.S. Kallan Roan Oliver He https://www.ema.europa.eu/medicines/human/EPAR/hexyon vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b-Hepatitis B vaccine foreign to USA VO:0003189 A seasonal Influenza virus vaccine manufactured outside of the U.S. Kallan Roan Oliver He http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/types-of-seasonal-influenza-vaccine vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. seasonal influenza virus vaccine foreign to USA VO:0003190 A Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b vaccine manufactured outside of the U.S Kallan Roan Oliver He DTaP/IPV/Hib vaccine foreign to USA https://ca.gsk.com/media/590970/infanrix-ipv-hib.pdf vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Diphtheria-Tetanus-Pertussis-Poliovirus-Haemophilus b vaccine foreign to USA VO:0003191 Kallan Roan Oliver He http://vk.ovg.ox.ac.uk/ppv vaccine A pneumococcal vaccine manufactured outside of the U.S. This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Pneumococcal vaccine foreign to USA VO:0003192 An active immunizing combination agent that is used to prevent infection caused by certain groups of meningococcal bacteria and Haemophilus influenza type b (Hib) bacteria. Kallan Roan Oliver He https://www.mayoclinic.org/drugs-supplements/meningococcal-vaccine-and-haemophilus-b-vaccine-intramuscular-route/description/drg-20075601 vaccine Meningococcal Conjugate and Haemophilis B Vaccine VO:0003193 A Meningicoccal Conjugate and Haemophilis B Vaccine manufactured outside of the U.S. Kallan Roan Oliver He vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Meningococcal Conjugate and Haemophilis B Vaccine foreign to USA VO:0003194 A tick-borne encephalitis virus vaccine used to prevent subtype Far Eastern tick-borne encephalitis virus (formerly known as Russian Spring Summer encephalitis virus). Kallan Roan Oliver He https://www.who.int/immunization/sage/1_TBE_PP_Draft_13_Mar_2011_SAGE_apr_2011.pdf?ua=1 vaccine Spring Summer Encephalitis vaccine VO:0003195 A polysaccharide vaccine to prevent typhoid caused Salmonella typhi. Acetone is used to inactivate culture, and dried. Kallan Roan Oliver He https://www.cdc.gov/mmwr/pdf/rr/rr4314.pdf https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366340 vaccine Acetone-Dried Typhoid Vi Polysaccharide vaccine VO:0003196 acellular pertussis vaccine, inactivated http://purl.bioontology.org/ontology/RXNORM/798302 798302 acellular pertussis vaccine, inactivated 529218 vaccine inactivated acellular pertussis vaccine VO:0003197 A vaccine to protect individuals against infections caused by hepatitis A virus and typhoid fever bacteria. Kallan Roan Oliver He Hepatitis A and Vi Polysaccharide typhoid vaccine foreign to USA https://www.ncbi.nlm.nih.gov/pubmed/9772328 vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. Hepatitis A virus-Typhoid vaccine foreign to USA VO:0003199 B. pertussis pertactin vaccine Bordetella pertussis pertactin vaccine vaccine Bordetella pertussis pertactin vaccine, inactivated VO:0003200 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300186 vaccine Bordetella pertussis toxoid vaccine, inactivated VO:0003201 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated VO:0003202 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300182 vaccine Bordetella pertussis fimbriae 2/3 vaccine, inactivated VO:0003203 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300380 vaccine Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML VO:0003204 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300185 1300185 Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML 42800491 vaccine Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML VO:0003205 Khadeejah Khan Oliver He vaccine Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML VO:0003206 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300366 1300366 Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML 42800495 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML VO:0003207 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300381 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML VO:0003208 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300187 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML VO:0003209 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300307 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML VO:0003210 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1988802 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML VO:0003211 A monovalent vaccine used to protect against H1N1 influenza virus. Kallan Roan Oliver He https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181950.htm vaccine human H1N1 influenza monovalent vaccine VO:0003212 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854930 854930 Streptococcus pneumoniae type 1 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 1 vaccine 40163661 vaccine pneumococcal capsular polysaccharide type 1 vaccine VO:0003213 Kallan Roan Oliver He DP+IPV vaccine vaccine Diphtheria Toxoid-Pertussis-Poliovirus vaccine VO:0003214 DT+IPV+HIB+HEPB vaccine vaccine Diphtheria-Tetanus-Poliovirus-Haemophilus B-Hepatitis B vaccine VO:0003215 vaccine seasonal Influenza A27:H29 vaccine VO:0003216 For the prevention of influenza caused by Influenza Virus, Types A and B. For the Southern Hemisphere 2017 season, the vaccine is indicated for use only in persons aged 5 years and over. Kallan Roan Oliver He https://www.medsafe.govt.nz/profs/Datasheet/f/Fluvaxinj.pdf vaccine Fluvax vaccine VO:0003217 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854934 854934 Streptococcus pneumoniae type 11A capsular polysaccharide antigen pneumococcal capsular polysaccharide type 11A vaccine 40163670 vaccine pneumococcal capsular polysaccharide type 11A vaccine VO:0003218 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854936 854936 Streptococcus pneumoniae type 12F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 12F vaccine 40163672 vaccine pneumococcal capsular polysaccharide type 12F vaccine VO:0003219 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854938 854938 Streptococcus pneumoniae type 14 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 14 vaccine 40163674 vaccine pneumococcal capsular polysaccharide type 14 vaccine VO:0003220 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854940 854940 Streptococcus pneumoniae type 15B capsular polysaccharide antigen pneumococcal capsular polysaccharide type 15B vaccine 40163676 vaccine pneumococcal capsular polysaccharide type 15B vaccine VO:0003221 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854942 854942 Streptococcus pneumoniae type 17F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 17F vaccine 40163678 vaccine pneumococcal capsular polysaccharide type 17F vaccine VO:0003222 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854944 854944 Streptococcus pneumoniae type 18C capsular polysaccharide antigen pneumococcal capsular polysaccharide type 18C vaccine 40163680 vaccine pneumococcal capsular polysaccharide type 18C vaccine VO:0003223 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854946 854946 Streptococcus pneumoniae type 19A capsular polysaccharide antigen pneumococcal capsular polysaccharide type 19A vaccine 40163682 vaccine pneumococcal capsular polysaccharide type 19A vaccine VO:0003224 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854948 854948 Streptococcus pneumoniae type 19F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 19F vaccine 40163684 vaccine pneumococcal capsular polysaccharide type 19F vaccine VO:0003225 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854950 854950 Streptococcus pneumoniae type 2 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 2 vaccine 40163686 vaccine pneumococcal capsular polysaccharide type 2 vaccine VO:0003226 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854952 854952 Streptococcus pneumoniae type 20 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 20 vaccine 40163688 vaccine pneumococcal capsular polysaccharide type 20 vaccine VO:0003227 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854954 854954 Streptococcus pneumoniae type 22F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 22F vaccine 40163690 vaccine pneumococcal capsular polysaccharide type 22F vaccine VO:0003228 http://purl.bioontology.org/ontology/RXNORM/830263 obsolete 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Recombivax] true VO:0003229 obsolete Hepatitis A virus-Typhoid vaccine true VO:0003230 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830260 830260 hepatitis B surface antigen vaccine 0.04 MG/ML 19133385 vaccine Hepatitis B Surface Antigen vaccine 0.04 MG/ML VO:0003231 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1994352 1994352 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Heplisav-B] Heplisav-B 20 MCG per 0.5 ML Injection 793520 CUI: C4534702 RXAUI: 9712934, 9712933, 9712931, 9712937 TUI: T200 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Heplisav-B] VO:0003232 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854962 854962 Streptococcus pneumoniae type 4 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 4 vaccine 40163698 vaccine pneumococcal capsular polysaccharide type 4 vaccine VO:0003233 obsolete 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection true VO:0003234 obsolete 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection true VO:0003235 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657332 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML 46276184 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML VO:0003236 Kallan Roan Oliver He Hepatyrix vaccine Hepatyrix vaccine VO:0003237 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830212 830212 hepatitis B surface antigen vaccine 0.01 MG/ML [Recombivax] 19133370 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [Recombivax] VO:0003238 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658155 1658155 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injection [Recombivax] Recombivax HB 5 MCG per 0.5 ML Injection 46275242 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [Recombivax] VO:0003239 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830245 830245 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] 1 ML Recombivax HB, Hepatitis B vaccine (recombinant) adult formulation Prefilled Syringe 19133378 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] VO:0003240 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5575 5575 vaccine BCG vaccine (by Organon Teknika) VO:0003241 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658150 1658150 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injection [Recombivax] 1 ML Recombivax 0.01 MG/ML Injection 46275237 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [Recombivax] VO:0003242 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657683 1657683 hepatitis B surface antigen vaccine Injection [Recombivax] 46276309 vaccine Hepatitis B Surface Antigen Vaccine Injection [Recombivax] VO:0003243 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830244 830244 hepatitis B surface antigen vaccine Prefilled Syringe [Recombivax] 40156563 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Recombivax] VO:0003244 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830253 830253 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] Recombivax HB 5 MCG per 0.5 ML Prefilled Syringe 19133380 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] VO:0003245 vaccine Recombivax Injectable Product VO:0003246 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854970 854970 Streptococcus pneumoniae type 8 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 8 vaccine 40163706 vaccine pneumococcal capsular polysaccharide type 8 vaccine VO:0003247 The site that is the part of the host body and the entrance point where a vaccine is administered. Asiyah Yu Lin site it is not the natural anatomical part where the body has access toward outside, such as mouth or nose. But rather the holes on the skin made by needdles used for vaccination. vaccination site VO:0003248 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854958 854958 Streptococcus pneumoniae type 3 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 3 vaccine 40163694 vaccine pneumococcal capsular polysaccharide type 3 vaccine VO:0003249 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854960 854960 Streptococcus pneumoniae type 33F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 33F vaccine 40163696 vaccine pneumococcal capsular polysaccharide type 33F vaccine VO:0003250 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854966 854966 Streptococcus pneumoniae type 6B capsular polysaccharide antigen pneumococcal capsular polysaccharide type 6B vaccine 40163702 vaccine pneumococcal capsular polysaccharide type 6B vaccine VO:0003251 A trivalent inactive influenza virus vaccine. Kallan Roan Oliver He Flu-imune https://cvi.asm.org/content/cdli/1/1/16.full.pdf vaccine Vaccine sold for 1993-1994 influenza season. Flu-Imune vaccine VO:0003252 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854956 854956 Streptococcus pneumoniae type 23F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 23F vaccine 40163692 vaccine pneumococcal capsular polysaccharide type 23F vaccine VO:0003253 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854968 854968 Streptococcus pneumoniae type 7F capsular polysaccharide antigen pneumococcal capsular polysaccharide type 7F vaccine 40163704 vaccine pneumococcal capsular polysaccharide type 7F vaccine VO:0003254 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854972 854972 Streptococcus pneumoniae type 9N capsular polysaccharide antigen pneumococcal capsular polysaccharide type 9N vaccine 40163708 vaccine pneumococcal capsular polysaccharide type 9N vaccine VO:0003255 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854964 854964 Streptococcus pneumoniae type 5 capsular polysaccharide antigen pneumococcal capsular polysaccharide type 5 vaccine 40163700 vaccine pneumococcal capsular polysaccharide type 5 vaccine VO:0003256 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797753 797753 hepatitis B surface antigen vaccine 0.02 MG/ML 528324 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML VO:0003257 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830236 830236 hepatitis B surface antigen vaccine 0.005 MG/ML 19133373 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML VO:0003258 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798427 798427 hepatitis B surface antigen vaccine Prefilled Syringe [Engerix-B] 40150695 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B] VO:0003259 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658156 1658156 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injection hepatitis B surface antigen vaccine 20 MCG per 1 ML Injection 46275243 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection VO:0003260 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1658708 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML 46275391 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML VO:0003261 A quadrivalent influenza vaccine against two influenza A strains and two influenza B strains. Kallan Roan Oliver He QIV Dresden https://www.ncbi.nlm.nih.gov/pubmed/24022123 vaccine QIV Dresden vaccine VO:0003262 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658142 1658142 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injection hepatitis B surface antigen vaccine 10 MCG per 0.5 ML Injection 46275229 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection VO:0003263 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798422 798422 hepatitis B surface antigen vaccine 0.02 MG/ML [Engerix-B] 19063453 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Engerix-B] VO:0003264 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798428 798428 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Engerix-B 20 MCG per 1 ML Prefilled Syringe 528328 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] VO:0003265 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658157 1658157 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injection [Engerix-B] Engerix-B 20 MCG per 1 ML Injection 46275244 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] VO:0003266 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658144 1658144 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injection [Engerix-B] Engerix-B 10 MCG per 0.5 ML Injection 46275231 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] VO:0003267 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798430 798430 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Engerix-B, Hepatitis B Surface Antigen Vaccine, Adsorbed (Pediatric Dose) 0.5 ML Prefilled Syringe 19130426 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] VO:0003268 A combination vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b (Hib). Kallan Roan Oliver He Infanrix Quinta https://www.mesvaccins.net/web/vaccines/15-infanrixquinta vaccine Infanrix Quinta vaccine VO:0003269 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854937 vaccine pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML VO:0003270 http://purl.bioontology.org/ontology/RXNORM/1994350 1994350 hepatitis B surface antigen vaccine Injection [Heplisav-B] 793518 vaccine Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B] VO:0003271 A combination vaccine against diphtheria, tetanus, pertussis, hepatitis B, and poliovirus. Kallan Roan Oliver He Infanrix Penta http://www.gsk.com.au/resources.ashx/vaccineproductschilddataproinfo/28/FileName/700FA5039310414550A80719A7B644CD/PI_Infanrix_Penta.pdf vaccine Infanrix Penta vaccine VO:0003272 http://purl.bioontology.org/ontology/RXNORM/1292432 1292432 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection varicella-zoster virus vaccine live (Oka-Merck) strain 19,400 PFU per 0.65 ML Injection 42800034 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection VO:0003273 http://purl.bioontology.org/ontology/RXNORM/1292422 1292422 varicella-zoster virus vaccine live (Oka-Merck) strain 42800027 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain VO:0003274 http://purl.bioontology.org/ontology/RXNORM/1658006 1658006 varicella-zoster virus vaccine live (Oka-Merck) strain Injection 46275138 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection VO:0003275 http://purl.bioontology.org/ontology/RXNORM/1292423 1292423 varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML 42800029 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML VO:0003276 http://purl.bioontology.org/ontology/RXNORM/1292457 1292457 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection varicella-zoster virus vaccine live (Oka-Merck) strain 1350 PFU per 0.5 ML Injection 42800030 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection VO:0003277 http://purl.bioontology.org/ontology/RXNORM/1292424 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Product VO:0003278 http://purl.bioontology.org/ontology/RXNORM/1292436 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 20000 UNT/ML VO:0003279 http://purl.bioontology.org/ontology/RXNORM/1292430 1292430 varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML 42800033 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML VO:0003280 http://purl.bioontology.org/ontology/RXNORM/1292432 obsolete 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection true VO:0003281 http://purl.bioontology.org/ontology/RXNORM/1658013 1658013 varicella-zoster virus vaccine live (Oka-Merck) strain Injection [Zostavax] 46275142 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection [Zostavax] VO:0003282 http://purl.bioontology.org/ontology/RXNORM/1292433 1292433 varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML [Zostavax] 42800036 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML [Zostavax] VO:0003283 http://purl.bioontology.org/ontology/RXNORM/1292435 1292435 0.65 ML varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection [Zostavax] Zostavax 19,400 PFU per 0.65 ML Injection 42800035 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Injection [Zostavax] VO:0003284 vaccine pneumococcal capsular polysaccharide vaccine VO:0003285 vaccine Streptococcus pneumoniae capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003286 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901622 901622 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174009 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003287 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901627 901627 Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174014 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003288 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901630 901630 Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174017 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003289 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901621 901621 Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174007 vaccine Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003290 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901635 901635 Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML 40174022 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML VO:0003291 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901638 901638 Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174025 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003292 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901626 901626 Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174013 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003293 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901629 901629 Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174016 vaccine Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003294 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901632 901632 Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174019 vaccine Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003295 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901634 901634 Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174021 vaccine Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003296 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901625 901625 Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174012 vaccine Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003297 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901623 901623 Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174010 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003298 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901637 901637 Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 40174024 vaccine Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0003299 Khadeejah Khan Oliver He vaccine L1 protein, Human papillomavirus vaccine VO:0003300 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798268 798268 L1 protein, human papillomavirus type 6 vaccine 529116 vaccine L1 protein, Human papillomavirus type 6 Vaccine VO:0003301 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798262 798262 L1 protein, human papillomavirus type 11 vaccine 529076 vaccine L1 protein, Human papillomavirus type 11 Vaccine VO:0003302 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798266 798266 L1 protein, human papillomavirus type 18 vaccine 529114 vaccine L1 protein, Human papillomavirus type 18 Vaccine VO:0003303 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798264 798264 L1 protein, human papillomavirus type 16 vaccine 529112 vaccine L1 protein, Human papillomavirus type 16 Vaccine VO:0003304 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1596930 1596930 L1 protein, human papillomavirus type 31 vaccine 45892474 vaccine L1 protein, Human papillomavirus type 31 Vaccine VO:0003305 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1596931 1596931 L1 protein, human papillomavirus type 33 vaccine 45892475 vaccine L1 protein, Human papillomavirus type 33 Vaccine VO:0003306 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1596932 1596932 L1 protein, human papillomavirus type 45 vaccine 45892476 vaccine L1 protein, Human papillomavirus type 45 Vaccine VO:0003307 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1596933 1596933 L1 protein, human papillomavirus type 52 vaccine 45892477 vaccine L1 protein, Human papillomavirus type 52 Vaccine VO:0003308 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1596934 1596934 L1 protein, human papillomavirus type 58 vaccine 45892478 vaccine L1 protein, Human papillomavirus type 58 Vaccine VO:0003309 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854957 vaccine pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML VO:0003310 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854939 vaccine pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML VO:0003311 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854969 vaccine pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML VO:0003312 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854965 vaccine pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML VO:0003313 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854935 vaccine pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML VO:0003314 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854933 vaccine pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML VO:0003315 A combination vaccine against diphtheria, tetanus, acellular pertussis, and inactivated poliomyelitis for individuals ages from 16 months to 13 years of age. Kallan Roan Oliver He Infanrix Tetra https://www.mesvaccins.net/web/vaccines/51-infanrixtetra vaccine Infanrix Tetra vaccine VO:0003316 A vaccine that can be given to children after the age of 2 months up to 2 years to prevent infectious diseases caused by Haemophilus influenzae type b (Hib) and Neisseria meningitidis group C (MenC) bacteria. Kallan Roan Oliver He https://www.medicines.org.uk/emc/files/pil.167.pdf vaccine Menitorix vaccine VO:0003317 Kallan Roan Oliver He SHINGRIX Indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM581605.pdf 125614 vaccine Shingrix vaccine VO:0003318 A vaccine against tetanus, diphtheria, pertussis, and inactivated poliovirus manufactured outside of the U.S. Kallan Roan Oliver He https://www.nhsinform.scot/healthy-living/immunisation/vaccines/the-4-in-1-vaccine vaccine This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. TDAP/IPV vaccine foreign to USA VO:0003319 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854941 vaccine pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML VO:0003320 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854943 vaccine pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML VO:0003321 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854945 vaccine pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML VO:0003322 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854947 vaccine pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML VO:0003323 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854931 854931 Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML 40163664 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML VO:0003324 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854949 vaccine pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML VO:0003325 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854951 vaccine pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML VO:0003326 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854953 vaccine pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML VO:0003327 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854955 vaccine pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML VO:0003328 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854959 vaccine pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML VO:0003329 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854961 vaccine pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML VO:0003330 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854963 vaccine pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML VO:0003331 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854971 vaccine pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML VO:0003332 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854973 vaccine pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML VO:0003333 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901636 901636 Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 40174023 vaccine Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003334 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901620 901620 Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 40174004 vaccine Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003335 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798220 798220 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 528986 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003336 a vaccine-induced down-regulation gene expression that occurs in live attenuated vaccine and compared with the host system infected with live wild type virulent strain which is the parent strain of this live attenuated vaccine. Oliver He Rebecca Racz vaccine-induced response live attenuated vaccine-induced down-regulated gene expression compared to infection with wild type pathogen VO:0003337 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798222 798222 Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 528988 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003338 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901624 901624 Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 40174011 vaccine Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003339 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798224 798224 Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 528990 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003340 Khadeejah Khan Oliver He vhttp://purl.bioontology.org/ontology/RXNORM/798226 798226 Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 529042 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003341 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901628 901628 Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 40174015 vaccine Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003342 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798228 798228 Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 529044 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003343 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901631 901631 Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 40174018 vaccine Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003344 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/901633 901633 Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 40174020 vaccine Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003345 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798230 798230 Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 529046 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003346 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798232 798232 Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 529072 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine VO:0003347 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593128 1593128 meningococcal group B vaccine 45775636 vaccine meningococcal group B vaccine VO:0003348 A vaccine-induced up-regulation gene expression that occurs in live attenuated vaccine and compared with the host system infected with live wild type virulent strain which is the parent strain of this live attenuated vaccine. Oliver He Rebecca Racz vaccine-induced response live attenuated vaccine-induced up-regulated gene expression compared to infection with wild type pathogen VO:0003349 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601397 1601397 meningococcal group B vaccine 0.1 MG/ML 45892091 vaccine meningococcal group B vaccine 0.1 MG/ML VO:0003350 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593133 1593133 meningococcal group B vaccine Prefilled Syringe 45775639 vaccine meningococcal group B vaccine Prefilled Syringe VO:0003351 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593132 vaccine meningococcal group B vaccine Injectable Product VO:0003352 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300181 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML VO:0003353 Kallan Roan Oliver He https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094070.htm Vivotif For immunization of adults and children greater than 6 years of age against disease caused by Salmonella typhi. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142807.pdf 103123 vaccine Vivotif vaccine VO:0003354 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762601 762601 Salmonella typhi Ty21a live antigen Delayed Release Oral Capsule [Vivotif] 40148796 vaccine Typhoid Vaccine Live Ty21a Delayed Release Oral Capsule [Vivotif] VO:0003356 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762602 762602 Salmonella typhi Ty21a live antigen 2000000000 UNT Delayed Release Oral Capsule [Vivotif] Vivotif Berna 2,000,000,000 UNT Delayed Release Oral Capsule 19129379 vaccine Typhoid Vaccine Live Ty21a 2000000000 UNT Delayed Release Oral Capsule [Vivotif] VO:0003357 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1187406 vaccine Vivotif Oral Product VO:0003358 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1187407 vaccine Vivotif Pill VO:0003359 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601405 1601405 meningococcal group B vaccine Prefilled Syringe [Bexsero] 45892098 vaccine meningococcal group B vaccine Prefilled Syringe [Bexsero] VO:0003360 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601231 vaccine component Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen VO:0003361 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1601398 Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML 45892092 vaccine Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML VO:0003362 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601233 vaccine component Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen VO:0003363 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1601399 Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML 45892093 vaccine Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML VO:0003364 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601236 1601236 Outer Membrane Vesicles (Neisseria Meningitidis Group B Nz98/254 Strain) 44012722 OMOP1131632 vaccine Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle VO:0003365 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601400 1601400 Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML 45892094 vaccine Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML VO:0003366 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593127 vaccine component Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen VO:0003367 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1593129 Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML 45775637 vaccine Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML VO:0003368 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593130 vaccine Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen VO:0003369 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593131 1593131 Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML 45775638 vaccine Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML VO:0003370 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601232 vaccine component Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen VO:0003371 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804187 804187 yellow fever virus strain 17D-204 live antigen 532274 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain VO:0003372 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1876704 1876704 yellow fever virus strain 17D-204 live antigen 2000 UNT/ML 1593652 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML VO:0003373 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1876705 1876705 0.5 ML yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection yellow fever vaccine (generic for Stamaril) 0.5 ML Injection 1593653 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injection VO:0003374 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300183 vaccine Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML VO:0003375 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1162391 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain Injectable Product VO:0003376 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1876709 vaccine Stamaril Injectable Product VO:0003377 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1876708 1876708 yellow fever virus strain 17D-204 live antigen Injection [Stamaril] 1593656 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain Injection [Stamaril] VO:0003378 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1876710 1876710 0.5 ML yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection [Stamaril] STAMARIL 0.5 ML Injection 1593658 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injection [Stamaril] VO:0003379 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658238 1658238 yellow fever virus strain 17D-204 live antigen Injection 46275267 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain Injection VO:0003380 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658239 1658239 0.5 ML yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection yellow fever vaccine (generic for YF-Vax) 0.5 ML Injection 46275268 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injection VO:0003381 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804188 804188 yellow fever virus strain 17D-204 live antigen 4000 UNT/ML 19131659 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML VO:0003382 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1292826 1292826 yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injectable Suspension yellow fever vaccine (generic for YF-Vax) Injectable Suspension 42800061 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML Injectable Suspension VO:0003383 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/806586 806586 diphtheria toxoid vaccine, inactivated 5 UNT/ML 19132128 vaccine diphtheria toxoid vaccine, inactivated 5 UNT/ML VO:0003384 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798306 798306 tetanus toxoid vaccine, inactivated 529411 vaccine tetanus toxoid vaccine, inactivated VO:0003385 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798307 798307 tetanus toxoid vaccine, inactivated 10 UNT/ML 19130407 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML VO:0003386 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300379 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML VO:0003387 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300364 1300364 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML 42800471 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML VO:0003388 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1988801 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML VO:0003389 Khadeejah Khan Oliver He vaccine acellular pertussis vaccine VO:0003391 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/829893 829893 acellular pertussis vaccine, inactivated 0.116 MG/ML 529275 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML VO:0003392 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/801826 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML VO:0003393 A trivalent influenza vaccine contianing two A influenza strains and one B influenza strain. Kallan Roan Oliver He TIV Dresden https://www.clinicalleader.com/doc/results-phase-presented-gsks-quadrivalent-influenza-vaccines-0001 vaccine TIV Dresden vaccine VO:0003394 An inactivated quadrivalent influenza vaccine against 2 influenza A strains and 2 influenza B strains for infants 6 months up to 23 months, and if needed it can be administered to children 2 to 17 years old with compromised immune systems and those considered vulnerable and high risk. Kallan Roan Oliver He QIV Quebec https://globalnews.ca/news/2254967/a-first-for-flu-season-a-new-more-robust-four-strain-vaccine/ vaccine QIV Quebec vaccine VO:0003395 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/805373 805373 diphtheria toxoid vaccine, inactivated 30 UNT/ML 19131876 vaccine diphtheria toxoid vaccine, inactivated 30 UNT/ML VO:0003396 A clostridium tetani vaccine that consists of formaldehyde inactivated tetanospasmin (aka tetanus toxoid). Hector Guzman-Orozco Oliver He https://en.wikipedia.org/wiki/Clostridium_tetani vaccine tetanus toxoid vaccine VO:0003397 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/374054 374054 tetanus toxoid vaccine, inactivated Injectable Solution 40086961 vaccine tetanus toxoid vaccine, inactivated Injectable Solution VO:0003398 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/374444 374444 tetanus toxoid vaccine, inactivated Injectable Suspension 40086962 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension VO:0003399 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1164846 vaccine tetanus toxoid vaccine, inactivated Injectable Product VO:0003400 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/792155 792155 tetanus toxoid vaccine, inactivated Prefilled Syringe 40149494 vaccine tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0003401 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/801712 801712 tetanus toxoid vaccine, inactivated 20 UNT/ML 19131358 vaccine tetanus toxoid vaccine, inactivated 20 UNT/ML VO:0003402 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/792156 792156 0.5 ML tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe tetanus toxoid vaccine 10 UNT per 0.5 ML Prefilled Syringe 529656 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0003403 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/204527 204527 tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension 19027665 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0003404 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/205262 205262 tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension 19028830 vaccine tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension VO:0003405 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/318242 318242 tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution 529484 vaccine tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution VO:0003406 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/316782 316782 tetanus toxoid vaccine, inactivated 8 UNT/ML 529482 vaccine tetanus toxoid vaccine, inactivated 8 UNT/ML VO:0003407 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/331444 331444 tetanus toxoid vaccine, inactivated 4 UNT/ML 529485 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML VO:0003408 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798444 798444 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 530007 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine VO:0003409 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657731 1657731 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine Injection 46276399 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injection VO:0003410 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1159739 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Product VO:0003411 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798447 798447 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML Injection Haemophilus b conjugate vaccine (meningococcal protein conjugate) 0.5 ML Injection 530009 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML Injection VO:0003412 Khadeejah Khan Oliver He vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injection [PedvaxHIB] VO:0003413 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798445 798445 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML 530008 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML VO:0003414 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798451 798451 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML Injection [PedvaxHIB] PedvaxHIB, Haemophilus b conjugate vaccine (Meningococcal protein conjugate) 0.5 ML Injection 530010 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML Injection [PedvaxHIB] VO:0003415 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1160330 vaccine Hepatitis B Surface Antigen Vaccine Injectable Product VO:0003416 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798420 798420 hepatitis B surface antigen vaccine Injectable Suspension 40150691 vaccine Hepatitis B Surface Antigen Vaccine Injectable Suspension VO:0003417 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830237 830237 hepatitis B surface antigen vaccine 0.005 MG/ML Injectable Suspension hepatitis B surface antigen vaccine 5 MCG/ML Injectable Suspension 19133374 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Suspension VO:0003418 38 40213224 rubella and mumps virus vaccine rubella/mumps vaccine Mumps-Rubella Vaccine VO:0003419 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798425 798425 hepatitis B surface antigen vaccine Prefilled Syringe 40150694 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe VO:0003420 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798426 798426 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe hepatitis B surface antigen vaccine 20 MCG/ML Prefilled Syringe, 1 ML 528327 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe VO:0003421 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657681 1657681 hepatitis B surface antigen vaccine Injection 46276308 vaccine Hepatitis B Surface Antigen Vaccine Injection VO:0003422 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830243 830243 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe hepatitis B surface antigen vaccine 10 MCG per 1 ML Prefilled Syringe 19133377 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe VO:0003423 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798438 798438 hepatitis B surface antigen vaccine 0.01 MG/ML 528353 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML VO:0003424 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/830252 830252 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe hepatitis B surface antigen vaccine 5 MCG per 0.5 ML Prefilled Syringe 19133379 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe VO:0003425 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798429 798429 0.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe hepatitis B surface antigen vaccine 10 MCG per 0.5 ML Prefilled Syringe 528329 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe VO:0003426 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658149 1658149 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injection hepatitis B surface antigen vaccine 10 MCG per 1 ML Injection 46275236 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection VO:0003427 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658154 1658154 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injection hepatitis B surface antigen vaccine 5 MCG per 0.5 ML Injection 46275241 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection VO:0003428 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799447 1799447 Salmonella typhi Ty21a live antigen 2000000000 UNT [Vivotif] 36249294 vaccine Typhoid Vaccine Live Ty21a 2000000000 UNT [Vivotif] VO:0003429 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/807271 807271 diphtheria toxoid vaccine, inactivated 4 UNT/ML 19132297 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML VO:0003430 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1160325 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Product VO:0003431 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798362 798362 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML 529661 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML VO:0003432 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798476 798476 hepatitis A vaccine (inactivated) strain HM175 Prefilled Syringe 40150663 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe VO:0003433 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798361 798361 hepatitis A vaccine (inactivated) strain HM175 529660 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 VO:0003434 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/803362 803362 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML 19131617 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML VO:0003435 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658057 1658057 hepatitis A vaccine (inactivated) strain HM175 Injection 46275168 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injection VO:0003436 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658065 1658065 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection 46275174 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection VO:0003437 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658058 1658058 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection 46275169 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injection VO:0003438 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799445 1799445 Salmonella typhi Ty21a live antigen 2000000000 UNT 36249293 vaccine Typhoid Vaccine Live Ty21a 2000000000 UNT VO:0003439 Vaccine component role inheres in a vaccine vector. Jie Zheng role vaccine vector role VO:0003440 A trivalent influenza vaccine containing two strains of influenza A and one strain of influenza B for use in people 18 years to 64 years for use during the 2012-2013 season. Kallan Roan Oliver He Fluzone Intradermal Trivalent http://www.news.sanofi.us/2014-12-12-Sanofi-Pasteur-Announces-FDA-Approval-of-Fluzone-R-Intradermal-Quadrivalent-Influenza-Vaccine-for-Adults vaccine Fluzone Intradermal Trivalent vaccine VO:0003441 Meningococcal conjugate vaccine, which contains four of the most common types of meningococcal bacteria (serogroups A, C, W, and Y), is used to prevent infection caused by meningococcal bacteria. Kallan Roan Oliver He https://www.everydayhealth.com/drugs/meningococcal-conjugate-vaccine vaccine meningococcal conjugate vaccine VO:0003442 A DTaP vaccine used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past. Kallan Roan Oliver He https://www.cdc.gov/mmwr/preview/mmwrhtml/00048610.htm vaccine Acel-Imune vaccine VO:0003443 vaccine Typhoid Vi Polysaccharide vaccine VO:0003444 This term was used by the USA VAERS system to indicate the source, which is foreign to USA here, of the vaccine. https://wonder.cdc.gov/wonder/help/vaers.html vaccine vaccine foreign to USA VO:0003445 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762598 762598 Salmonella typhi Ty21a live antigen 2000000000 UNT Delayed Release Oral Capsule typhoid vaccine live Ty21a 2,000,000,000 UNT Delayed Release Oral Capsule 523204 vaccine Typhoid Vaccine Live Ty21a 2000000000 UNT Delayed Release Oral Capsule VO:0003446 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762595 762595 Salmonella typhi Ty21a live antigen typhoid vaccine live Ty21a 523202 vaccine Typhoid Vaccine Live Ty21a VO:0003447 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762597 762597 Salmonella typhi Ty21a live antigen Delayed Release Oral Capsule 40148795 vaccine Typhoid Vaccine Live Ty21a Delayed Release Oral Capsule VO:0003448 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1159372 vaccine Typhoid Vaccine Live Ty21a Pill VO:0003449 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1159371 vaccine Typhoid Vaccine Live Ty21a Oral Product VO:0003450 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1660921 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML 46276011 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML VO:0003451 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1186748 vaccine Twinrix Injectable Product VO:0003452 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1724009 influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML 35606413 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML VO:0003453 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657222 vaccine component influenza A virus A/Christchurch/16/2010 (H1N1) antigen VO:0003454 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798305 798305 diphtheria toxoid vaccine, inactivated 13.4 UNT/ML 19130406 vaccine diphtheria toxoid vaccine, inactivated 13.4 UNT/ML VO:0003455 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798304 798304 diphtheria toxoid vaccine, inactivated 529303 vaccine diphtheria toxoid vaccine, inactivated VO:0003456 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/801709 801709 diphtheria toxoid vaccine, inactivated 50 UNT/ML 19131356 vaccine diphtheria toxoid vaccine, inactivated 50 UNT/ML VO:0003457 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/807414 807414 diphtheria toxoid vaccine, inactivated 25 UNT/ML 19132352 vaccine diphtheria toxoid vaccine, inactivated 25 UNT/ML VO:0003458 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658102 1658102 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta] Vaqta 50 UNT per 1 ML Injection 46275198 vaccine 1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection [Vaqta] VO:0003459 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/802012 vaccine Hepatitis A Vaccine, Inactivated 50 UNT/ML [Vaqta] VO:0003460 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/836636 836636 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] Vaqta 25 UNT per 0.5 ML Prefilled Syringe 596900 vaccine 0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe [Vaqta] VO:0003461 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658106 1658106 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta] Vaqta 25 UNT per 0.5 ML Injection 46275202 vaccine 0.5 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Injection [Vaqta] VO:0003462 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1187568 vaccine Vaqta Injectable Product VO:0003463 OHDSI Vaccine WG 836634 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] Vaqta 50 UNT per 1 ML Prefilled Syringe 596898 vaccine 1 ML Hepatitis A Vaccine, Inactivated 50 UNT/ML Prefilled Syringe [Vaqta] VO:0003464 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/253174 vaccine Hepatitis A Vaccine, Inactivated VO:0003465 OHDSI Vaccine WG vaccine Hepatitis A Vaccine, Inactivated Prefilled Syringe [Vaqta] VO:0003466 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658101 vaccine Hepatitis A Vaccine, Inactivated Injection [Vaqta] VO:0003467 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658099 vaccine Hepatitis A Vaccine, Inactivated Injection VO:0003468 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1160328 vaccine Hepatitis A Vaccine, Inactivated Injectable Product VO:0003469 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657223 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML 46276097 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML VO:0003470 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657224 vaccine component influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen VO:0003471 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1658709 influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML 46275392 vaccine influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML VO:0003472 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657225 influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML 46276099 vaccine influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML VO:0003473 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1723999 influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML 35606409 vaccine influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML VO:0003474 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1664468 influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML 46287742 vaccine influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML VO:0003475 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657130 vaccine component influenza A virus A/South Australia/55/2014 (H3N2) antigen VO:0003476 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657132 influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML 46275997 vaccine influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML VO:0003477 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657127 vaccine component influenza A virus A/Brisbane/10/2010 (H1N1) antigen VO:0003478 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657129 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML 46275994 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML VO:0003479 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657226 https://www.fludb.org/brc/fluStrainDetails.spg?strainName=B/Brisbane/60/2008&decorator=influenza vaccine component influenza B virus B/Brisbane/60/2008 antigen VO:0003480 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657227 influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML 46276101 vaccine influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML VO:0003481 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1664469 influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML 46287743 vaccine influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML VO:0003482 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1661110 influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML 46276042 vaccine influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML VO:0003483 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1801177 influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML 36249504 vaccine influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML VO:0003484 Vaccine that protects against Neisseriales infection. vaccine against Neisseriales vaccine against Neisseriales bacterial infection https://en.wikipedia.org/wiki/Neisseriaceae vaccine Neisseriales vaccine VO:0003485 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1946982 influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML 792418 vaccine influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML VO:0003486 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657133 vaccine component influenza B virus B/Utah/9/2014 antigen VO:0003487 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657135 influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML 46276000 vaccine influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML VO:0003488 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657228 vaccine component influenza B virus B/Phuket/3073/2013 antigen VO:0003489 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1657229 influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML 46276103 vaccine influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML VO:0003490 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1660923 influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML 46276013 vaccine influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML VO:0003491 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1658710 influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML 46275393 vaccine influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML VO:0003492 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1946983 influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML 792419 vaccine influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML VO:0003493 Jie Zheng Khadeejah Khan Oliver He Xingxian Li 1664470 influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML 46287744 vaccine influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML VO:0003494 Vaccine that protects against Spirochaetes infection. vaccine against Spirochaetes https://en.wikipedia.org/wiki/Spirochaete vaccine Spirochaetes vaccine VO:0003495 Khadeejah Khan Oliver He vaccine human influenza virus vaccine VO:0003496 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1116738 vaccine influenza virus vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain VO:0003497 Khadeejah Khan Oliver He vaccine influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus VO:0003498 Khadeejah Khan Oliver He vaccine human influenza A (H1N1) virus vaccine VO:0003499 Khadeejah Khan Oliver He vaccine human influenza A (H1N1)-like virus vaccine VO:0003500 Khadeejah Khan Oliver He vaccine human influenza A (H3N2)-like virus vaccine VO:0003501 Khadeejah Khan Oliver He vaccine human influenza A (H3N2) virus vaccine VO:0003502 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1541617 1541617 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 45776076 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus VO:0003503 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1541618 1541618 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML 45776077 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML VO:0003504 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1005931 1005931 influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 40225028 vaccine influenza virus vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain VO:0003505 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1005932 1005932 influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML 40225029 vaccine influenza virus vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML VO:0003506 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1111368 1111368 influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML 40240138 vaccine influenza virus vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML VO:0003507 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304122 1304122 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 42873956 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus VO:0003508 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304300 1304300 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML 42873959 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML VO:0003509 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304309 1304309 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML 42873958 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML VO:0003510 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304123 1304123 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML 42873957 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML VO:0003511 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1303851 vaccine influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML VO:0003512 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304299 vaccine influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.12 MG/ML VO:0003513 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304308 vaccine influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML VO:0003514 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1005929 vaccine influenza virus vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain VO:0003515 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1005930 vaccine influenza virus vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML VO:0003516 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1111367 1111367 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML 40240135 vaccine influenza virus vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.09 MG/ML VO:0003517 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1006250 vaccine influenza virus vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain VO:0003518 A vaccine that is used against an infection by a pathogen under Borreliella. vaccine against Borreliella https://en.wikipedia.org/wiki/Borrelia vaccine Borreliella vaccine VO:0003519 Khadeejah Khan Oliver He vaccine human influenza B virus vaccine VO:0003520 Khadeejah Khan Oliver He human influenza B-like virus vaccine human influenza B-like virus vaccine VO:0003521 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1303855 1303855 influenza B virus vaccine, B-Wisconsin-1-2010-like virus 42873961 vaccine influenza B virus vaccine, B-Wisconsin-1-2010-like virus VO:0003522 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1304310 1304310 influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML 42873963 vaccine influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML VO:0003523 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/857921 857921 influenza B virus vaccine B/Brisbane/60/2008 antigen 40164828 vaccine influenza virus vaccine, Inactivated B-Brisbane-60-2008 VO:0003524 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/857922 857922 influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML 40164829 vaccine influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML VO:0003525 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1111369 1111369 influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML 40240139 vaccine influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.09 MG/ML VO:0003526 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427022 1427022 influenza B virus vaccine, B-Massachusetts-2-2012-like virus 43531944 vaccine influenza B virus vaccine, B-Massachusetts-2-2012-like virus VO:0003527 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427023 1427023 influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML 43531945 vaccine influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML VO:0003528 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1429576 1429576 influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML 43532652 vaccine influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML VO:0003529 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1429589 1429589 influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML 43532656 vaccine influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML VO:0003530 Khadeejah Khan Oliver He 1543760 Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 UNT/ML influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML 43137645 45776787 OMOP472229 vaccine influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML VO:0003531 Kallan Roan Oliver He vaccine Proteobacteria vaccine VO:0003532 vaccine Betaproteobacteria vaccine VO:0003533 Vaccine that protects against Yersiniaceae infection. vacccine against Yersiniaceae https://en.wikipedia.org/wiki/Yersiniaceae vaccine Yersiniaceae vaccine VO:0003534 A vaccine that is used against an infection by a pathogen under Corynebacterium. vaccine against Corynebacterium https://en.wikipedia.org/wiki/Corynebacterium vaccine Corynebacterium vaccine VO:0003535 vaccine Gammaproteobacteria vaccine VO:0003536 A vaccine that is used against an infection by a pathogen under Bacillus. vaccine against Bacillus https://en.wikipedia.org/wiki/Bacillus vaccine Bacillus vaccine VO:0003537 A vaccine that is used against an infection by a pathogen under Varicellovirus. vaccine against Varicellovirus https://en.wikipedia.org/wiki/Varicellovirus vaccine Varicellovirus vaccine VO:0003538 A vaccine that is used against an infection by a pathogen under Papillomaviridae. Oliver He vaccine against Papillomaviridae https://en.wikipedia.org/wiki/Papillomaviridae MeSH: D053918 vaccine Papillomaviridae vaccine VO:0003539 A vaccine that is used against an infection by a pathogen under Orthopoxvirus. vaccine against Orthopoxvirus https://en.wikipedia.org/wiki/Orthopoxvirus vaccine Orthopoxvirus vaccine VO:0003540 Vaccine that protects against Orthohepadnavirus infection. vaccine against Orthohepadnavirus https://en.wikipedia.org/wiki/Orthohepadnavirus vaccine Orthohepadnavirus vaccine VO:0003541 A vaccine that is used against an infection by a pathogen under Reoviridae. vaccine against Reoviridae https://en.wikipedia.org/wiki/Reoviridae vaccine Reoviridae vaccine VO:0003542 A vaccine that is used against an infection by a pathogen under Sedoreovirinae. vaccine against Sedoreovirinae https://en.wikipedia.org/wiki/Sedoreovirinae vaccine Sedoreovirinae vaccine VO:0003543 A vaccine that is used against an infection by a pathogen under Morbillivirus. vaccine against Morbillivirus https://en.wikipedia.org/wiki/Morbillivirus vaccine Morbillivirus vaccine VO:0003544 A vaccine that is used against an infection by a pathogen under Rubulavirus. vaccine against Rubulavirus https://en.wikipedia.org/wiki/Rubulavirus vaccine Rubulavirus vaccine VO:0003545 A vaccine that is used against an infection by a pathogen under Lyssavirus. vaccine against Lyssavirus https://en.wikipedia.org/wiki/Lyssavirus vaccine Lyssavirus vaccine VO:0003546 A vaccine that is used against an infection by a pathogen under Flaviviridae. vaccine against Flaviviridae https://en.wikipedia.org/wiki/Flaviviridae vaccine Flaviviridae vaccine VO:0003547 A vaccine that is used against an infection by a pathogen under Enterovirus. vaccine against Enterovirus https://en.wikipedia.org/wiki/Enterovirus vaccine Enterovirus vaccine VO:0003548 A vaccine that is used against an infection by a pathogen under Hepatovirus. vaccine against Hepatovirus https://en.wikipedia.org/wiki/Hepatitis_A#Virology vaccine Hepatovirus vaccine VO:0003549 A vaccine that is used against an infection by a pathogen under Rubivirus. vaccine against Rubivirus https://en.wikipedia.org/wiki/Rubella_virus vaccine Rubivirus vaccine VO:0003550 vaccine Alphaproteobacteria vaccine VO:0003551 vaccine Enterobacterales vaccine VO:0003552 vaccine Enterobacteriaceae vaccine VO:0003553 Vaccine that protects against Spirochaetia infection. vaccine Spirochaetia vaccine VO:0003554 vaccine Firmicutes vaccine VO:0003555 vaccine Bacilli vaccine VO:0003556 vaccine Lactobacillales vaccine VO:0003559 Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/901644 901644 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo... Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) 0.5 ML Prefilled Syringe 40173508 vaccine Prevnar 13 vaccine 0.5 ML Prefilled Syringe VO:0003561 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/854974 854974 Streptococcus pneumoniae type 9V capsular polysaccharide antigen pneumococcal capsular polysaccharide type 9V vaccine 40163710 vaccine pneumococcal capsular polysaccharide type 9V vaccine VO:0003562 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/854975 vaccine pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML VO:0003563 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1182409 CUI: C3236244 RXAUI: 3843751 TUI: T200 vaccine Pneumovax 23 Injectable Product VO:0003564 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658471 CUI: C4033793 RXAUI: 7253076 TUI: T200 vaccine Pneumovax 23 Injection VO:0003565 Kallan Roan Oliver He Pneumovax 23 (Pneumococcal vaccine polyvalent) 0.5 ML Injection http://purl.bioontology.org/ontology/RXNORM/1658472 CUI: C3887855 RXAUI: 7253077, 7253108, 7253095 TUI: T200 vaccine PNEUMOVAX 23 0.5 ML Injection VO:0003566 Kallan Roan Oliver He Pneumovax 23 (Pneumococcal vaccine polyvalent) Injectable Solution http://purl.bioontology.org/ontology/RXNORM/854981 CUI: C1154308 RXAUI: 2977679, 7253371, 3270831 TUI: T200 vaccine PNEUMOVAX 23 vaccine Injectable Solution VO:0003567 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1547581 CUI: C3855233 RXAUI: 6400287 TUI: T200 vaccine PNEUMOVAX 23 vaccine Prefilled Syringe VO:0003568 Kallan Roan Oliver He Pneumovax 23 (Pneumococcal vaccine polyvalent) 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1547582 CUI: C3853732 RXAUI: 7253508, 6400288, 6400291 TUI: T200 vaccine PNEUMOVAX 23 vaccine 0.5 ML Prefilled Syringe VO:0003569 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1177656 CUI: C3231573 RXAUI: 3844071 TUI: T200 vaccine Prevnar 13 Injectable Product VO:0003570 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/901643 901643 Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe [Prevnar 13] 40174006 CUI: C2746125 RXAUI: 3060990 TUI: T200 vaccine Prevnar 13 vaccine Prefilled Syringe VO:0003571 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/854967 CUI: C2709771 RXAUI: 2977666 vaccine pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML VO:0003572 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1179526 CUI: C3233397 RXAUI: 3844185 TUI: T200 vaccine ProQuad Injectable Product VO:0003573 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658000 1658000 measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection [ProQuad] 46275135 CUI: C4033818 RXAUI: 7252149 TUI: T200 vaccine ProQuad vaccine Injection VO:0003574 Kallan Roan Oliver He ProQuad Measles, Mumps, Rubella, and Varicella Virus Vaccine Live 0.5 ML Injection http://purl.bioontology.org/ontology/RXNORM/1292443 1292443 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection [ProQuad] ProQuad Measles, Mumps, Rubella, and Varicella Virus Vaccine Live 0.5 ML Injection 42799832 CUI: C1698231 RXAUI: 7252150, 7250950, 7253644 TUI: T200 vaccine ProQuad vaccine 0.5 ML Injection VO:0003575 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/854979 CUI: C2709781 RXAUI: 2977677 TUI: T200 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 10A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 11A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 12F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 14 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 15B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 17F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 18C vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19A vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 19F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 2 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 20 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 22F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 23F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 3 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 33F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 4 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 5 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 6B vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 7F vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 8 vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9N vaccine 0.05 MG/ML / pneumococcal capsular polysaccharide type 9V vaccine 0.05 MG/ML [Pneumovax 23] VO:0003576 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/901642 901642 Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML [Prevnar 13] 40174008 CUI: C2746124 RXAUI: 3060989 TUI: T200 vaccine Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML [Prevnar 13] VO:0003577 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1292441 1292441 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML [ProQuad] 42799825 CUI: C2364511 RXAUI: 4609906 TUI: T200 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 20000 UNT/ML [ProQuad] VO:0003578 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658703 1658703 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone 2015-2016] 46275383 CUI: C4033722 RXAUI: 7253467 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone 2015-2016] VO:0003579 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427028 CUI: C3645245 RXAUI: 5473440 TUI: T116, T121 vaccine Fluzone Quadrivalent 2013-2014 Formula vaccine VO:0003580 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658712 1658712 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML [Fluzone 2015-2016] 46275395 CUI: C4033721 RXAUI: 7253478 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML [Fluzone 2015-2016] VO:0003581 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658713 1658713 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2015-2016] 46275396 CUI: C4033789 RXAUI: 7253479 TUI: T200 vaccine Fluzone 2015-2016 High-Dose vaccine Prefilled Syringe VO:0003582 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658714 1658714 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2015-2016] Fluzone 2015-2016 high-dose vaccine 0.5 ML Prefilled Syringe 46275397 CUI: C4026367 RXAUI: 7253480, 7253494, 7707297 TUI: T200 vaccine Fluzone 2015-2016 High-Dose vaccine 0.5 ML Prefilled Syringe VO:0003583 Kallan Roan Oliver He Fluzone 2015-2016 45 MCG (15 MCG x 3) in 0.5 ML Injectable Suspension http://purl.bioontology.org/ontology/RXNORM/1658706 1658706 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2015-2016] Fluzone 2015-2016 45 MCG (15 MCG x 3) in 0.5 ML Injectable Suspension 46275385 CUI: C4033789 RXAUI: 7264732, 7253470, 7264735 TUI: T200 vaccine Fluzone 2015-2016 vaccine Injectable Suspension VO:0003584 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801179 CUI: C4271565 RXAUI: 8237155 TUI: T116, T129, T121 vaccine Fluzone 2016-2017 vaccine VO:0003585 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801180 1801180 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML [Fluzone 2016-2017] 36249507 CUI: C4271631 RXAUI: 8237156 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML [Fluzone 2016-2017] VO:0003586 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801182 CUI: C4271735 RXAUI: 8237158 TUI: T200 vaccine Fluzone 2016-2017 Injectable Product VO:0003587 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801181 1801181 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2016-2017] 36249508 CUI: C4271674 RXAUI: 8237157 TUI: T200 vaccine Fluzone 2016-2017 High-Dose vaccine Prefilled Syringe VO:0003588 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801183 1801183 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2016-2017] Fluzone 2016-2017 high-dose vaccine 0.5 ML Prefilled Syringe 36249510 CUI: C4270825 RXAUI: 8237163, 8237162, 8237159 TUI: T200 vaccine Fluzone 2016-2017 High-Dose vaccine 0.5 ML Prefilled Syringe VO:0003589 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928340 CUI: C4490427 RXAUI: 9198824 TUI: T116 vaccine Fluzone 2017-2018 vaccine VO:0003590 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928343 CUI: C4490430 RXAUI: 9198827 TUI: T200 vaccine Fluzone 2017-2018 Injectable Product VO:0003591 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928341 1928341 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML [Fluzone 2017-2018] 1593354 CUI: C4490428 RXAUI: 9198825 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML [Fluzone 2017-2018] VO:0003592 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928342 1928342 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2017-2018] 1593355 CUI: C4490429 RXAUI: 9198826 TUI: T200 vaccine Fluzone 2017-2018 high-dose vaccine Prefilled Syringe VO:0003593 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928344 1928344 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2017-2018] Fluzone 2017-2018 high-dose vaccine 0.5 ML Prefilled Syringe 1593357 CUI: C4325062 RXAUI: 9198828, 9198831, 9198832 TUI: T200 vaccine Fluzone 2017-2018 high-dose vaccine 0.5 ML Prefilled Syringe VO:0003594 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050419 CUI: C4719042 RXAUI: 10289780 TUI: T109 vaccine Fluzone 2018-2019 vaccine VO:0003595 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050422 CUI: C4719045 RXAUI: 10289783 TUI: T200 vaccine RXN STRENGTH: 0.12 MG/ML (expressed as influenza A virus A/Michigan/45/2015 (H1N1) antigen) / 0.12 MG/ML (expressed as influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen) / 0.12 MG/ML (expressed as influenza B virus B/Maryland/15/2016 antigen) Fluzone 2018-2019 Injectable Product VO:0003596 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050420 2050420 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML [Fluzone 2018-2019] 35200033 CUI: C4719043 RXAUI: 10289781 TUI: T200 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML [Fluzone 2018-2019] VO:0003597 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050421 2050421 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2018-2019] 35200034 CUI: C4719044 RXAUI: 10289782 TUI: T200 vaccine Fluzone 2018-2019 high-dose vaccine Prefilled Syringe VO:0003598 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050423 2050423 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019] Fluzone 2018-2019 high-dose vaccine 0.5 ML Prefilled Syringe 35201913 CUI: C4719046 RXAUI: 10289784, 10289785, 10289786 TUI: T200 vaccine Fluzone 2018-2019 high-dose vaccine 0.5 ML Prefilled Syringe VO:0003599 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1794331 vaccine component CUI: C4256803 RXAUI: 8222490 TUI: T116, T129, T121 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen VO:0003600 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928289 vaccine component CUI: C4490394 RXAUI: 9198755 TUI: T116, T129, T121 influenza A virus A/Michigan/45/2015 (H1N1) antigen VO:0003601 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048564 vaccine component CUI: C4704008 RXAUI: 10279285 TUI: T116, T129, T121 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen VO:0003602 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048563 vaccine component CUI: C4704007 RXAUI: 10279284 TUI: T116, T129, T121 influenza B virus B/Maryland/15/2016 antigen VO:0003603 Jie Zheng Kallan Roan Oliver He Xingxian Li 2050417 influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML 35200031 vaccine influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML VO:0003604 Jie Zheng Kallan Roan Oliver He Xingxian Li 1928338 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML 1593351 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML VO:0003605 Jie Zheng Kallan Roan Oliver He Xingxian Li 2050416 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML 35200030 vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML VO:0003606 Jie Zheng Kallan Roan Oliver He Xingxian Li 1801176 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML 36249503 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML VO:0003607 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427031 CUI: C3645248 RXAUI: 5473443 TUI: T200 vaccine Fluzone Quadrivalent 2013-2014 Formula Injectable Product VO:0003608 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427029 1427029 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone Quadrivalent 2013-2014 Formula] 43531928 CUI: C3645246 RXAUI: 5473441 TUI: T200 vaccine influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone Quadrivalent 2013-2014 Formula] VO:0003609 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427038 1427038 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula] 43531927 CUI: C3645252 RXAUI: 5473453 TUI: T200 vaccine Fluzone Quadrivalent 2013-2014 Formula Influenza Virus Vaccine Prefilled Syringe VO:0003610 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1427052 1427052 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula] Fluzone Quadrivalent Pediatric Dose for 6-35 Months of Age 2013-2014 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe 43531875 CUI: C3537276 RXAUI: 5488148, 5473470, 5473464 TUI: T200 vaccine Fluzone Quadrivalent 2013-2014 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe VO:0003611 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537557 CUI: C3817309 RXAUI: 6338534 TUI: T116, T121 vaccine Fluzone Quadrivalent 2014-2015 Formula vaccine VO:0003612 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537560 CUI: C3819823 RXAUI: 6338537 TUI: T200 vaccine Fluzone Quadrivalent 2014-2015 Formula Injectable Product VO:0003613 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1598360 1598360 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Fluzone Quadrivalent 2014-2015 Formula] 45892707 CUI: C3872179 RXAUI: 6821895 TUI: T200 vaccine influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Fluzone Quadrivalent 2014-2015 Formula] VO:0003614 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537559 1537559 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] 44818126 CUI: C3819658 RXAUI: 6338536 TUI: T200 vaccine Fluzone Quadrivalent 2014-2015 Formula Prefilled Syringe VO:0003615 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1598361 1598361 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] Fluzone Quadrivalent 2014-2015 Formula 0.1 ML Prefilled Syringe 45892708 CUI: C3871481 RXAUI: 6821896, 6821899 TUI: T200 vaccine Fluzone Quadrivalent 2014-2015 Formula 0.1 ML Prefilled Syringe VO:0003616 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659725 CUI: C4026655 RXAUI: 7255357 TUI: T116, T129, T121 vaccine Fluzone Quadrivalent 2015-2016 vaccine VO:0003617 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659728 CUI: C4047088 RXAUI: 7255360 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 Injectable Product VO:0003618 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659726 1659726 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2015-2016] 46275640 CUI: C4046959 RXAUI: 7255358 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2015-2016] VO:0003619 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661112 1661112 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Fluzone Quadrivalent 2015-2016] 46276044 CUI: C4046937 RXAUI: 7258293 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Fluzone Quadrivalent 2015-2016] VO:0003620 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659747 1659747 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2015-2016] 46275655 CUI: C4047035 RXAUI: 7255391 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 Injection VO:0003621 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659748 1659748 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2015-2016] 46275656 CUI: C4046210 RXAUI: 7255392, 7707326 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 vaccine 0.5 ML Injection VO:0003622 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659729 1659729 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2015-2016] 46275642 CUI: C4018869 RXAUI: 7707300, 7255361 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 vaccine Injectable Suspension VO:0003623 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659736 1659736 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2015-2016] 46275646 CUI: C4047037 RXAUI: 7255373 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 vaccine Prefilled Syringe VO:0003624 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661113 1661113 0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] 46276045 CUI: C4032740 RXAUI: 7707304, 7258294 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 vaccine 0.1 ML Prefilled Syringe VO:0003625 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659755 1659755 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] 46275737 CUI: C4026368 RXAUI: 7255401, 7707633 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 vaccine 0.25 ML Prefilled Syringe VO:0003626 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659737 1659737 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] 46275647 CUI: C4046211 RXAUI: 7707379, 7255374 TUI: T200 vaccine Fluzone Quadrivalent 2015-2016 vaccine 0.5 ML Prefilled Syringe VO:0003627 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801071 CUI: C4224224 RXAUI: 8236907 TUI: T116, T129, T121 vaccine Fluzone Quadrivalent 2016-2017 vaccine VO:0003628 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801074 CUI: C4271738 RXAUI: 8236910 TUI: T200 vaccine Fluzone Quadrivalent 2016-2017 Injectable Product VO:0003629 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801173 1801173 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2016-2017] 36249500 CUI: C4271632 RXAUI: 8237145 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2016-2017] VO:0003630 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801072 1801072 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Fluzone Quadrivalent 2016-2017] 36249401 CUI: C4271637 RXAUI: 8236908 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Fluzone Quadrivalent 2016-2017] VO:0003631 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801188 1801188 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2016-2017] 36249515 CUI: C4271673 RXAUI: 8237172 TUI: T200 vaccine Fluzone Quadrivalent 2016-2017 Formula Injection VO:0003632 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801189 1801189 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2016-2017] Fluzone Quadrivalent 2016-2017 Formula 0.5 ML Injection 36249516 CUI: C4270930 RXAUI: 8237177, 8237176, 8237173 TUI: T200 vaccine RXN STRENGTH: 0.03 MG/ML (expressed as influenza A virus A/California/7/2009 (H1N1) antigen) / 0.03 MG/ML (expressed as influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen) / 0.03 MG/ML (expressed as influenza B virus B/Brisbane/60/2008 antigen) / 0.03 MG/ML (expressed as influenza B virus B/Phuket/3073/2013 antigen) Fluzone Quadrivalent 2016-2017 Formula 0.5 ML Injection VO:0003633 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801193 1801193 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2016-2017] Fluzone Quadrivalent 2016-2017 Injectable Suspension 36249520 CUI: C4224210 RXAUI: 8237184, 8237186, 8237185 TUI: T200 vaccine RXN STRENGTH: 0.03 MG/ML (expressed as influenza A virus A/California/7/2009 (H1N1) antigen) / 0.03 MG/ML (expressed as influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen) / 0.03 MG/ML (expressed as influenza B virus B/Brisbane/60/2008 antigen) / 0.03 MG/ML (expressed as influenza B virus B/Phuket/3073/2013 antigen) Fluzone Quadrivalent 2016-2017 Injectable Suspension VO:0003634 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801073 1801073 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2016-2017] 36249402 CUI: C4271678 RXAUI: 8236909 TUI: T200 vaccine Fluzone Quadrivalent 2016-2017 vaccine Prefilled Syringe VO:0003635 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801075 1801075 0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] Fluzone Quadrivalent 2016-2017 vaccine 0.1 ML Prefilled Syringe 36249404 CUI: C4270829 RXAUI: 8236914, 8237166, 8236911 TUI: T200 vaccine Fluzone Quadrivalent 2016-2017 vaccine 0.1 ML Prefilled Syringe VO:0003636 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801174 1801174 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] Fluzone Quadrivalent 2016-2017 vaccine 0.25 ML Prefilled Syringe 36249501 CUI: C4224209 RXAUI: 8237169, 8237148, 8237146 TUI: T200 vaccine Fluzone Quadrivalent 2016-2017 vaccine 0.25 ML Prefilled Syringe VO:0003637 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801186 1801186 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] 36249513 CUI: C4270931 RXAUI: 8237168, 8237167, 8237165 TUI: T200 vaccine Fluzone Quadrivalent 2016-2017 vaccine 0.5 ML Prefilled Syringe VO:0003638 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928313 CUI: C4325215 RXAUI: 9198781 TUI: T116, T129, T121 vaccine Fluzone Quadrivalent 2017-2018 vaccine VO:0003639 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928316 CUI: C4490411 RXAUI: 9198784 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 Injectable Product VO:0003640 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928314 1928314 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2017-2018] 1593196 CUI: C4490409 RXAUI: 9198782 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2017-2018] VO:0003641 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928469 1928469 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Fluzone Quadrivalent 2017-2018] 1593534 CUI: C4490475 RXAUI: 9199188 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Fluzone Quadrivalent 2017-2018] VO:0003642 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928315 1928315 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2017-2018] 1593332 CUI: C4490410 RXAUI: 9198783 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine Injection VO:0003643 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928317 1928317 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2017-2018] 1593334 CUI: C4490412 RXAUI: 9198785, 9198856, 9198855 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine 0.5 ML Injection VO:0003644 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928356 1928356 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2017-2018] 1593517 CUI: C4319521 RXAUI: 9198884, 9198850, 9198885 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine Injectable Suspension VO:0003645 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928331 1928331 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2017-2018] 1593344 CUI: C4490420 RXAUI: 9198810 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine Prefilled Syringe VO:0003646 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928359 1928359 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] 1593519 CUI: C4490439 RXAUI: 9198872, 9198871, 9198873 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003647 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928332 1928332 0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] Fluzone Quadrivalent 2017-2018 vaccine 0.25 ML Prefilled Syringe 1593345 CUI: C4325067 RXAUI: 9198880, 9198881, 9198811 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine 0.25 ML Prefilled Syringe VO:0003648 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928470 1928470 0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] Fluzone Quadrivalent 2017-2018 vaccine 0.1 ML Prefilled Syringe 1593535 CUI: C4325068 RXAUI: 9199192, 9199191, 9199189 TUI: T200 vaccine Fluzone Quadrivalent 2017-2018 vaccine 0.1 ML Prefilled Syringe VO:0003649 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050773 CUI: C4719179 RXAUI: 10290520 TUI: T116, T129, T121 vaccine Fluzone Quadrivalent 2018-2019 vaccine VO:0003650 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050776 CUI: C4719182 RXAUI: 10290523 TUI: T200 vaccine Fluzone Quadrivalent 2018-2019 Injectable Product VO:0003651 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050774 2050774 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2018-2019] 35200056 CUI: C4719180 RXAUI: 10290521 TUI: T200 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2018-2019] VO:0003652 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050781 2050781 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2018-2019] 35200061 CUI: C4719187 RXAUI: 10290530 TUI: T200 vaccine Fluzone Quadrivalent 2018-2019 vaccine Injection VO:0003653 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050782 2050782 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2018-2019] 35201919 CUI: C4719188 RXAUI: 10290531, 10290534, 10290535 TUI: T200 vaccine Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Injection VO:0003654 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050787 2050787 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2018-2019] Fluzone Quadrivalent 2018-2019 vaccine Injectable Suspension 35200067 CUI: C4553813 RXAUI: 10290540, 10290538, 10290539 TUI: T200 vaccine Fluzone Quadrivalent 2018-2019 vaccine Injectable Suspension VO:0003655 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050775 2050775 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2018-2019] 35200057 CUI: C4719181 RXAUI: 10290522 TUI: T200 vaccine Fluzone Quadrivalent 2018-2019 Vaccine Prefilled Syringe VO:0003656 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050789 2050789 0.25 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2018-2019] Fluzone Quadrivalent Pediatric Dose for 6-35 Months of Age 2018-2019 Vaccine 0.25 ML Prefilled Syringe 35201921 CUI: C4719194 RXAUI: 10290543, 10290544, 10290545 TUI: T200 vaccine Fluzone Quadrivalent Pediatric Dose for 6-35 Months of Age 2018-2019 Vaccine 0.25 ML Prefilled Syringe VO:0003657 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050777 2050777 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2018-2019] 35201917 RXAUI: 10290524, 10290528, 10290527 TUI: T200 vaccine Fluzone Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003658 Jie Zheng Kallan Roan Oliver He Xingxian Li 1660922 influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML 46276012 vaccine influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML VO:0003659 Jie Zheng Kallan Roan Oliver He Xingxian Li 1794431 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML 36249494 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML VO:0003660 Jie Zheng Kallan Roan Oliver He Xingxian Li 1801069 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML 36249398 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML VO:0003661 Jie Zheng Kallan Roan Oliver He Xingxian Li 1928310 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML 1593193 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML VO:0003662 Jie Zheng Kallan Roan Oliver He Xingxian Li 1928291 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML 1593183 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML VO:0003663 Jie Zheng Kallan Roan Oliver He Xingxian Li 2048958 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML 1559888 vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML VO:0003664 Jie Zheng Kallan Roan Oliver He Xingxian Li 2048959 influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML 1559889 vaccine influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML VO:0003665 Kallan Roan Oliver He RXAUI: 3850144 http://purl.bioontology.org/ontology/RXNORM/1186641 CUI: C3240393 TUI: T200 vaccine YF-Vax Injectable Product VO:0003666 Kallan Roan Oliver He 1658240 yellow fever virus strain 17D-204 live antigen Injection [YF-Vax] 46275269 CUI: C4033799 RXAUI: 7252581 TUI: T200 vaccine YF-VAX Injection VO:0003667 Kallan Roan Oliver He 0.5 ML YF-Vax 4000 UNT/ML Injection http://purl.bioontology.org/ontology/RXNORM/1658241 1658241 0.5 ML yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection [YF-Vax] YF-Vax 0.5 ML Injection 46275270 CUI: C4019051 RXAUI: 7252591, 7252583, 7252590, 7252582 TUI: T200 vaccine YF-VAX 0.5 ML Injection VO:0003668 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1292828 1292828 yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injectable Suspension [YF-Vax] YF-Vax 4000 UNT/ML Injectable Suspension 42800062 CUI: C0710788 RXAUI: 4610776, 4610775, 7251861 TUI: T200 vaccine YF-Vax 4000 UNT/ML Injectable Suspension VO:0003669 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1292827 1292827 yellow fever virus strain 17D-204 live antigen Injectable Suspension [YF-Vax] 42800064 CUI: C2356379 RXAUI: 4610774 TUI: T200 vaccine YF-Vax Injectable Suspension VO:0003670 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/804191 804191 yellow fever virus strain 17D-204 live antigen 4000 UNT/ML [YF-Vax] 19131661 CUI: C2356378 RXAUI: 2860284 TUI: T200 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 4000 UNT/ML [YF-Vax] VO:0003671 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1184551 CUI: C3238354 RXAUI: 3843231 TUI: T200 vaccine PedvaxHIB Injectable Product VO:0003672 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798449 798449 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML [PedvaxHIB] 19030111 CUI: C2344386 RXAUI: 2851572 TUI: T200 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML [PedvaxHIB] VO:0003673 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657733 1657733 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine Injection [PedvaxHIB] 46276400 CUI: C4033832 RXAUI: 7251648 TUI: T200 vaccine PedvaxHIB vaccine Injection VO:0003674 Vaccine component that is used to deliver genetic code into the cells to produce antigen. Jie Zheng vaccine component vaccine vector VO:0003675 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657326 CUI: C4026630 RXAUI: 7251220 TUI: T116, T129, T121 vaccine Fluvirin 2015-2016 vaccine VO:0003676 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657329 CUI: C4033912 RXAUI: 7251223 TUI: T200 vaccine Fluvirin 2015-2016 Injectable Product VO:0003677 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657327 1657327 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluvirin 2015-2016] 46276180 CUI: C4033751 RXAUI: 7251221 TUI: T200 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluvirin 2015-2016] VO:0003678 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657330 1657330 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2015-2016] 46276182 CUI: C4026364 RXAUI: 7251224, 7251264 TUI: T200 vaccine Fluvirin 2015-2016 vaccine Injectable Suspension VO:0003679 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659982 1659982 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluvirin 2015-2016] 46275887 CUI: C4047024 RXAUI: 7255800 TUI: T200 vaccine Fluvirin 2015-2016 vaccine Prefilled Syringe VO:0003680 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659983 1659983 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2015-2016] 46275888 CUI: C4026365 RXAUI: 7255801, 7255804 TUI: T200 vaccine Fluvirin 2015-2016 vaccine 0.5 ML Prefilled Syringe VO:0003681 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801153 CUI: C4224219 RXAUI: 8237127 TUI: T116, T129, T121 vaccine Fluvirin 2016-2017 vaccine VO:0003682 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801156 CUI: C4271736 RXAUI: 8237130 TUI: T200 vaccine Fluvirin 2016-2017 Injectable Product VO:0003683 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801154 1801154 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluvirin 2016-2017] 36249428 CUI: C4271633 RXAUI: 8237128 TUI: T200 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluvirin 2016-2017] VO:0003684 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801157 1801157 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2016-2017] Fluvirin 2016-2017 vaccine Injectable Suspension 36249431 CUI: C4224195 RXAUI: 8237131, 8237133, 8237132 TUI: T200 vaccine Fluvirin 2016-2017 vaccine Injectable Suspension VO:0003685 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801162 1801162 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluvirin 2016-2017] 36249433 CUI: C4271675 RXAUI: 8237137 TUI: T200 vaccine Fluvirin 2016-2017 vaccine Prefilled Syringe VO:0003686 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801163 1801163 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2016-2017] Fluvirin 2016-2017 vaccine 0.5 ML Prefilled Syringe 36249434 CUI: C4270826 RXAUI: 8237141, 8237142, 8237138 TUI: T200 vaccine Fluvirin 2016-2017 vaccine 0.5 ML Prefilled Syringe VO:0003687 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928970 CUI: C4325210 RXAUI: 9199995 TUI: T116, T129, T121 vaccine Fluvirin 2017-2018 vaccine VO:0003688 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928973 CUI: C4490746 RXAUI: 9199998 TUI: T200 vaccine Fluvirin 2017-2018 Injectable Product VO:0003689 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928971 1928971 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluvirin 2017-2018] 1593906 CUI: C4490744 RXAUI: 9199996 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluvirin 2017-2018] VO:0003690 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928974 1928974 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Fluvirin 2017-2018] Fluvirin 2017-2018 vaccine Injectable Suspension 1593909 CUI: C4325059 RXAUI: 9200000, 9199999, 9200001 TUI: T200 vaccine Fluvirin 2017-2018 vaccine Injectable Suspension VO:0003691 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928978 1928978 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluvirin 2017-2018] 1593910 CUI: C4490747 RXAUI: 9200007 TUI: T200 vaccine Fluvirin 2017-2018 vaccine Prefilled Syringe VO:0003692 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928982 1928982 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2017-2018] Fluvirin 2017-2018 vaccine 0.5 ML Prefilled Syringe 1593911 CUI: C4325061 RXAUI: 9200013, 9200018, 9200017 TUI: T200 vaccine Fluvirin 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003693 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657232 CUI: C4026648 RXAUI: 7251209 TUI: T116, T129, T121 vaccine Fluarix Quadrivalent 2015-2016 vaccine VO:0003694 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657235 CUI: C4033913 RXAUI: 7251212 TUI: T200 vaccine Fluarix Quadrivalent 2015-2016 Injectable Product VO:0003695 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657233 1657233 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2015-2016] 46276106 CUI: C4033752 RXAUI: 7251210 TUI: T200 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2015-2016] VO:0003696 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657234 1657234 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2015-2016] 46276107 CUI: C4033850 RXAUI: 7251211 TUI: T200 vaccine Fluarix Quadrivalent 2015-2016 vaccine Prefilled Syringe VO:0003697 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657236 1657236 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2015-2016] 46276108 CUI: C4026362 RXAUI: 7707241, 7251213 TUI: T200 vaccine Fluarix Quadrivalent 2015-2016 vaccine 0.5 ML Prefilled Syringe VO:0003698 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799119 CUI: C4224221 RXAUI: 8233865 TUI: T116, T129, T121 vaccine Fluarix Quadrivalent 2016-2017 vaccine VO:0003699 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799122 CUI: C4271754 RXAUI: 8233868 TUI: T200 vaccine Fluarix Quadrivalent 2016-2017 Injectable Product VO:0003700 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799120 1799120 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2016-2017] 36249178 CUI: C4271658 RXAUI: 8233866 TUI: T200 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2016-2017] VO:0003701 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799121 1799121 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2016-2017] 36249179 CUI: C4271699 RXAUI: 8233867 TUI: T200 vaccine Fluarix Quadrivalent 2016-2017 vaccine Prefilled Syringe VO:0003702 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799123 1799123 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2016-2017] Fluarix Quadrivalent 2016-2017 vaccine 0.5 ML Prefilled Syringe 36249181 CUI: C4224206 RXAUI: 8233903, 8233902, 8233869 TUI: T200 vaccine Fluarix Quadrivalent 2016-2017 vaccine 0.5 ML Prefilled Syringe VO:0003703 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928303 CUI: C4490400 RXAUI: 9198769 TUI: T116, T129, T121 vaccine Fluarix Quadrivalent 2017-2018 vaccine VO:0003704 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928306 CUI: C4490403 RXAUI: 9198772 TUI: T200 vaccine Fluarix Quadrivalent 2017-2018 Injectable Product VO:0003705 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928304 1928304 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2017-2018] 1593187 CUI: C4490401 RXAUI: 9198770 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2017-2018] VO:0003706 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928305 1928305 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2017-2018] 1593188 CUI: C4490402 RXAUI: 9198771 TUI: T200 vaccine Fluarix Quadrivalent 2017-2018 vaccine Prefilled Syringe VO:0003707 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928307 1928307 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2017-2018] Fluarix Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe 1593190 CUI: C4325064 RXAUI: 9198814, 9198808, 9198773 TUI: T200 vaccine Fluarix Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003708 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048962 CUI: C4704189 RXAUI: 10279939 TUI: T116, T129, T121 vaccine Fluarix Quadrivalent 2018-2019 vaccine VO:0003709 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048965 CUI: C4704192 RXAUI: 10279942 TUI: T200 vaccine Fluarix Quadrivalent 2018-2019 Injectable Product VO:0003710 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048963 2048963 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2018-2019] 1559891 CUI: C4704190 RXAUI: 10279940 TUI: T200 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2018-2019] VO:0003711 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048964 2048964 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2018-2019] 1559892 CUI: C4704191 RXAUI: 10279941 TUI: T200 vaccine Fluarix Quadrivalent 2018-2019 vaccine Prefilled Syringe VO:0003712 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048966 2048966 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2018-2019] Fluarix Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe 1560162 CUI: C4704193 RXAUI: 10279943, 10279945, 10279944 TUI: T200 vaccine Fluarix Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003713 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928290 vaccine component CUI: C4490395 RXAUI: 9198756 TUI: T116, T129, T121 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen VO:0003714 Jie Zheng Kallan Roan Oliver He Xingxian Li 1928300 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML 1593184 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML VO:0003715 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661803 CUI: C4020099 RXAUI: 7264715 TUI: T129, T121 vaccine Afluria 2015-2016 vaccine VO:0003716 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661806 CUI: C4047061 RXAUI: 7264718 TUI: T200 vaccine Afluria 2015-2016 Injectable Product VO:0003717 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661804 1661804 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016] 46276263 CUI: C4046916 RXAUI: 7264716 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016] VO:0003718 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661812 1661812 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria 2015-2016] Afluria 2015-2016 45 MCG (15 MCG x 3) in 0.5 ML Injectable Suspension 46276315 CUI: C4018775 RXAUI: 7264729, 7707306, 7264733 TUI: T200 vaccine afluria 2015-2016 vaccine Injectable Suspension VO:0003719 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661805 1661805 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2015-2016] 46276264 CUI: C4046988 RXAUI: 7264717 TUI: T200 vaccine Afluria 2015-2016 Prefilled Syringe VO:0003720 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1661807 1661807 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2015-2016] Afluria 2015-2016 0.5 ML Prefilled Syringe 46276265 CUI: C4018774 RXAUI: 7264719, 7264723, 7707305 TUI: T200 vaccine Afluria 2015-2016 0.5 ML Prefilled Syringe VO:0003721 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799399 CUI: C4224216 RXAUI: 8234382 TUI: T116, T129, T121 vaccine Afluria 2016-2017 vaccine VO:0003722 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799402 CUI: C4271746 RXAUI: 8234385 TUI: T200 vaccine Afluria 2016-2017 Injectable Product VO:0003723 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799400 1799400 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Afluria 2016-2017] 36249261 CUI: C4271652 RXAUI: 8234383 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Afluria 2016-2017] VO:0003724 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799413 1799413 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension [Afluria 2016-2017] Afluria 2016-2017 vaccine Injectable Suspension 36249272 CUI: C4224196 RXAUI: 8234404, 8234405, 8234406 TUI: T200 vaccine Afluria 2016-2017 vaccine Injectable Suspension VO:0003725 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799401 1799401 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2016-2017] 36249262 CUI: C4271691 RXAUI: 8234384 TUI: T200 vaccine Afluria 2016-2017 vaccine Prefilled Syringe VO:0003726 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799403 1799403 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2016-2017] Afluria 2016-2017 vaccine 0.5 ML Prefilled Syringe 36249264 CUI: C4224214 RXAUI: 8236926, 8234386, 8236927 TUI: T200 vaccine afluria 2016-2017 vaccine 0.5 ML Prefilled Syringe VO:0003727 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942128 CUI: C4325193 RXAUI: 9267473 TUI: T129, T121 vaccine Afluria 2017-2018 vaccine VO:0003728 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942131 CUI: C4519949 RXAUI: 9267476 TUI: T200 vaccine Afluria 2017-2018 Injectable Product VO:0003729 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942129 1942129 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML [Afluria 2017-2018] 793953 CUI: C4519947 RXAUI: 9267474 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML [Afluria 2017-2018] VO:0003730 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942158 1942158 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Injectable Suspension [Afluria 2017-2018] Afluria 2017-2018 vaccine Injectable Suspension 793961 CUI: C4325058 RXAUI: 9267492, 9267490, 9267491 TUI: T200 vaccine Afluria 2017-2018 vaccine Injectable Suspension VO:0003731 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942130 1942130 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2017-2018] 793954 CUI: C4519948 RXAUI: 1942130 TUI: T200 vaccine Afluria 2017-2018 vaccine Prefilled Syringe VO:0003732 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942132 1942132 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2017-2018] Afluria 2017-2018 vaccine 0.5 ML Prefilled Syringe 793956 CUI: C4325060 RXAUI: 9267481, 9267480, 9267477 TUI: T200 vaccine Afluria 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003733 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050767 CUI: C4719173 RXAUI: 10290502 TUI: T116, T129, T121 vaccine Afluria 2018-2019 vaccine VO:0003734 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050770 CUI: C4719176 RXAUI: 10290505 TUI: T200 vaccine Afluria 2018-2019 Injectable Product VO:0003735 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050768 2050768 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Afluria 2018-2019] 35200051 CUI: C4719174 RXAUI: 10290503 TUI: T200 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Afluria 2018-2019] VO:0003736 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050771 2050771 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Injectable Suspension [Afluria 2018-2019] Afluria 2018-2019 vaccine Injectable Suspension 35200054 CUI: C4719177 RXAUI: 10290510, 10290509, 10290506 TUI: T200 vaccine afluria 2018-2019 vaccine Injectable Suspension VO:0003737 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050802 2050802 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2018-2019] 35200077 CUI: C4719203 RXAUI: 10290573 TUI: T200 vaccine Afluria 2018-2019 vaccine Prefilled Syringe VO:0003738 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050803 2050803 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] Afluria 2018-2019 vaccine 0.5 ML Prefilled Syringe 35201923 CUI: C4719204 RXAUI: 10292876, 10290577, 10292877 TUI: T200 vaccine Afluria 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003739 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1858962 CUI: C4293490 RXAUI: 8698886 TUI: T200 vaccine Afluria Quadrivalent 2016-2017 Formula Injectable Product VO:0003740 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1858960 1858960 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2016-2017 Formula] 1718581 CUI: C4293406 RXAUI: 8698884 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2016-2017 Formula] VO:0003741 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1858966 1858966 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2016-2017 Formula] Afluria Quadrivalent 2016-2017 Formula Influenza Virus Vaccine Injectable Suspension 1718587 CUI: C4293383 RXAUI: 8698910, 8698890, 8698911 TUI: T200 vaccine Afluria Quadrivalent 2016-2017 Formula Influenza Virus Vaccine Injectable Suspension VO:0003742 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1858961 1858961 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2016-2017 Formula] 1718582 CUI: C4293449 RXAUI: 8698885 TUI: T200 vaccine Afluria Quadrivalent 2016-2017 Formula Prefilled Syringe VO:0003743 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1858963 1858963 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2016-2017 Formula] Afluria Quadrivalent 2016-2017 Formula 0.5 ML Prefilled Syringe 1718584 CUI: C4283663 RXAUI: 8698892, 8698891, 8698887 TUI: T200 vaccine Afluria Quadrivalent 2016-2017 Formula 0.5 ML Prefilled Syringe VO:0003744 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1858959 CUI: C4293360 RXAUI: 8698883 TUI: T116, T129, T121 vaccine Afluria Quadrivalent 2016-2017 Formula vaccine VO:0003745 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942162 CUI: C4325196 RXAUI: 9267495 TUI: T129, T121 vaccine Afluria Quadrivalent 2017-2018 vaccine VO:0003746 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942165 CUI: C4519959 RXAUI: 9267498 TUI: T200 vaccine Afluria Quadrivalent 2017-2018 Injectable Product VO:0003747 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942163 1942163 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2017-2018] 793964 CUI: C4519957 RXAUI: 9267496 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2017-2018] VO:0003748 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942173 1942173 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2017-2018] 793972 CUI: C4325066 RXAUI: 9267520, 9267517, 9267516 TUI: T200 vaccine Afluria Quadrivalent 2017-2018 vaccine Injectable Suspension VO:0003749 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942164 1942164 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2017-2018] 793965 CUI: C4519958 RXAUI: 9267497 TUI: T200 vaccine Afluria Quadrivalent 2017-2018 vaccine Prefilled Syringe VO:0003750 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1942166 1942166 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2017-2018] 793967 CUI: C4325063 RXAUI: 9272502, 9267499, 9272501 TUI: T200 vaccine Afluria Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003751 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050791 CUI: C4719195 RXAUI: 10290555 TUI: T116, T129, T121 vaccine Afluria Quadrivalent 2018-2019 vaccine VO:0003752 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050794 CUI: C4719198 RXAUI: 10290558 TUI: T200 vaccine Afluria Quadrivalent 2018-2019 Injectable Product VO:0003753 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050792 2050792 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2018-2019] 35200069 CUI: C4719196 RXAUI: 10290556 TUI: T200 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2018-2019] VO:0003754 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050795 2050795 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2018-2019] 35200072 CUI: C4553815 RXAUI: 10322944, 10290561, 10290559 TUI: T200 vaccine Afluria Quadrivalent 2018-2019 vaccine Injectable Suspension VO:0003755 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050796 2050796 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2018-2019] 35200073 CUI: C4719199 RXAUI: 10290562 TUI: T200 vaccine Afluria Quadrivalent 2018-2019 vaccine Prefilled Syringe VO:0003756 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050797 2050797 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2018-2019] 35201922 CUI: C4553814 RXAUI: 10322943, 10322942, 10290563 TUI: T200 vaccine Afluria Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003757 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799102 CUI: C4224220 RXAUI: 8233849 TUI: T116, T129, T121 vaccine Flulaval Quadrivalent 2016-2017 vaccine VO:0003758 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799105 CUI: C4271755 RXAUI: 8233852 TUI: T200 vaccine Flulaval Quadrivalent 2016-2017 Injectable Product VO:0003759 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799103 1799103 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2016-2017] 36249170 CUI: C4271659 RXAUI: 8233850 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2016-2017] VO:0003760 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799205 1799205 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2016-2017] FLULAVAL QUADRIVALENT 2016-2017 vaccine Injectable Suspension 36249203 CUI: C4224211 RXAUI: 1799205 TUI: T200 vaccine FluLaval Quadrivalent 2016-2017 vaccine Injectable Suspension VO:0003761 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799104 1799104 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2016-2017] 36249171 CUI: C4271700 RXAUI: 8233851 TUI: T200 vaccine Flulaval Quadrivalent 2016-2017 vaccine Prefilled Syringe VO:0003762 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799106 1799106 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2016-2017] Flulaval Quadrivalent 2016-2017 vaccine 0.5 Prefilled Syringe 36249173 CUI: C4255281 RXAUI: 8233853, 8233905, 8233906 TUI: T200 vaccine Flulaval Quadrivalent 2016-2017 vaccine 0.5 Prefilled Syringe VO:0003763 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657335 CUI: C4026650 RXAUI: 7251229 TUI: T116, T129, T121 vaccine FluLaval Quadrivalent 2015-2016 vaccine VO:0003764 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657338 CUI: C4033911 RXAUI: 7251232 TUI: T200 vaccine FluLaval Quadrivalent 2015-2016 Injectable Product VO:0003765 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657336 1657336 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [FluLaval Quadrivalent 2015-2016] 46276187 CUI: C4033750 RXAUI: 7251230 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [FluLaval Quadrivalent 2015-2016] VO:0003766 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657339 1657339 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [FluLaval Quadrivalent 2015-2016] 46276189 CUI: C4018811 RXAUI: 7251233, 7707287 TUI: T200 vaccine FluLaval Quadrivalent 2015-2016 vaccine Injectable Suspension VO:0003767 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928325 CUI: C4325209 RXAUI: 9198793 TUI: T116, T129, T121 vaccine Flulaval Quadrivalent 2017-2018 vaccine VO:0003768 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928328 CUI: C4490418 RXAUI: 9198796 TUI: T200 vaccine Flulaval Quadrivalent 2017-2018 Injectable Product VO:0003769 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928326 1928326 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2017-2018] 1593339 CUI: C4490416 RXAUI: 9198794 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2017-2018] VO:0003770 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928329 1928329 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2017-2018] 1593342 CUI: C4319520 RXAUI: 9198867, 9198866, 9198797 TUI: T200 vaccine FluLaval Quadrivalent 2017-2018 vaccine Injectable Suspension VO:0003771 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928335 1928335 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2017-2018] 1593348 CUI: C4490423 RXAUI: 9198815 TUI: T200 vaccine Flulaval Quadrivalent 2017-2018 vaccine Prefilled Syringe VO:0003772 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928336 1928336 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2017-2018] Flulaval Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe 1593349 CUI: C4319519 RXAUI: 9198862, 9198816, 9198863 TUI: T200 vaccine Flulaval Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003773 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048970 CUI: C4704197 RXAUI: 10279949 TUI: T116, T129, T121 vaccine Flulaval Quadrivalent 2018-2019 vaccine VO:0003774 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048973 CUI: C4704200 RXAUI: 10279952 TUI: T200 vaccine Flulaval Quadrivalent 2018-2019 Injectable Product VO:0003775 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048971 2048971 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2018-2019] 1559898 CUI: C4704198 RXAUI: 10279950 TUI: T200 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2018-2019] VO:0003776 Kallan Roan Oliver He 2048974 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2018-2019] 1559901 CUI: C4552692 RXAUI: 10279953, 10279956, 10279954 TUI: T200 vaccine Flulaval Quadrivalent 2018-2019 vaccine Injectable Suspension VO:0003777 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048975 2048975 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2018-2019] 1559902 CUI: C4704201 RXAUI: 10279957 TUI: T200 vaccine Flulaval Quadrivalent 2018-2019 vaccine Prefilled Syringe VO:0003778 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2048976 2048976 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2018-2019] Flulaval Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe 1560163 CUI: C4552691 RXAUI: 10279960, 10279959, 10279958 TUI: T200 vaccine Flulaval Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003779 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657140 CUI: C4026649 RXAUI: 7251081 TUI: T116, T129, T121 vaccine Flucelvax 2015-2016 vaccine VO:0003780 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657143 CUI: C4033914 RXAUI: 7251084 TUI: T200 vaccine Flucelvax 2015-2016 Injectable Product VO:0003781 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657141 1657141 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML [Flucelvax 2015-2016] 46276051 CUI: C4033757 RXAUI: 7251082 TUI: T200 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML [Flucelvax 2015-2016] VO:0003782 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657142 1657142 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax 2015-2016] 46276052 CUI: C4033857 RXAUI: 7251083 TUI: T200 vaccine Flucelvax 2015-2016 vaccine Prefilled Syringe VO:0003783 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657144 1657144 0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2015-2016] FLUCELVAX 2015-2016 vaccine 0.5 ML Prefilled Syringe 46276053 CUI: C4026363 RXAUI: 7251085, 8725354, 7707232 TUI: T200 vaccine Flucelvax 2015-2016 vaccine 0.5 ML Prefilled Syringe VO:0003784 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801607 CUI: C4276115 RXAUI: 8238453 TUI: T129, T121 vaccine Flucelvax Quadrivalent 2016-2017 vaccine VO:0003785 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801610 CUI: C4276265 RXAUI: 8238456 TUI: T200 vaccine Flucelvax Quadrivalent 2016-2017 Injectable Product VO:0003786 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801608 1801608 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2016-2017] 40220718 CUI: C4276184 RXAUI: 8238454 TUI: T200 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2016-2017] VO:0003787 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801609 1801609 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2016-2017] 40220719 CUI: C4276248 RXAUI: 8238455 TUI: T200 vaccine Flucelvax Quadrivalent 2016-2017 Prefilled Syringe VO:0003788 Kallan Roan Oliver He 1801611 0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2016-2017] FLUCELVAX QUADRIVALENT 2016-2017 0.5 ML Prefilled Syringe 40220721 CUI: C4256265 RXAUI: 8238461, 8238460, 8238457 TUI: T200 vaccine Flucelvax Quadrivalent 2016-2017 0.5 ML Prefilled Syringe VO:0003789 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801603 vaccine component CUI: C4276030 RXAUI: 8238449 TUI: T116, T129, T121 influenza B virus B/Hong Kong/259/2010 antigen VO:0003790 Jie Zheng Kallan Roan Oliver He Xingxian Li 1801604 influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML 40220715 vaccine influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML VO:0003791 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928533 CUI: C4325207 RXAUI: 9199341 TUI: T116, T129, T121 vaccine Flucelvax Quadrivalent 2017-2018 vaccine VO:0003792 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928536 CUI: C4490504 RXAUI: 9199344 TUI: T200 vaccine Flucelvax Quadrivalent 2017-2018 Injectable Product VO:0003793 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928534 1928534 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2017-2018] 1593544 CUI: C4490502 RXAUI: 9199342 TUI: T200 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2017-2018] VO:0003794 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928537 1928537 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2017-2018] 1593686 CUI: C4490505 RXAUI: 9199345, 9199362, 9199359 TUI: T200 vaccine Flucelvax Quadrivalent 2017-2018 Injectable Suspension VO:0003795 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928539 1928539 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2017-2018] 1593688 CUI: C4490507 RXAUI: 9199347 TUI: T200 vaccine Flucelvax Quadrivalent 2017-2018 vaccine Prefilled Syringe VO:0003796 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928540 1928540 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2017-2018] Flucelvax Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe 1593689 CUI: C4325069 RXAUI: 9199352, 9199361, 9199348 TUI: T200 vaccine Flucelvax Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003797 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1986826 CUI: C4530100 RXAUI: 9698281 TUI: T129, T121 vaccine Shingrix Injectable Product VO:0003798 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1986827 1986827 varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML [Shingrix] 792783 CUI: C4530101 RXAUI: 9698282 TUI: T200 vaccine Varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML [Shingrix] VO:0003799 Kallan Roan Oliver He 0.5 ML Shingrix 0.1 MG/ML Injection http://purl.bioontology.org/ontology/RXNORM/1986830 1986830 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix] Shingrix vaccine 0.5 ML Injection 792786 RXAUI: 9698706, 9698285, 9698287, 9698286 TUI: T200 vaccine Shingrix vaccine 0.5 ML Injection VO:0003800 vaccine 0.5 ML Shingrix 0.1 MG/ML Injection VO:0003801 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1986821 1986821 varicella zoster virus glycoprotein E 792777 protein CUI: C0061673 RXAUI: 9698276 TUI: T116, T129, T121 Varicella zoster virus glycoprotein E VO:0003802 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1986820 protein CUI: C4530095 RXAUI: 9698275 TUI: T116, T129, T121 Varicella zoster virus glycoprotein E, recombinant VO:0003803 OHDSI Vaccine WG 1986822 varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML 792778 vaccine Varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML VO:0003804 http://purl.bioontology.org/ontology/RXNORM/1664639 vaccine component CUI: C4026651 RXAUI: 7266972 TUI: T116, T129, T121 influenza A virus A/Bolivia/559/2013 (H1N1) antigen VO:0003805 Jie Zheng Xingxian Li 1664467 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML 46287741 vaccine influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML VO:0003806 CUI: C4026651 RXAUI: 7266972 TUI: T116, T129, T121 vaccine FluMist 2015-2016 vaccine VO:0003807 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801825 CUI: C4276113 RXAUI: 8238995 TUI: T116, T129, T121 vaccine Flumist Quadrivalent 2016-2017 vaccine VO:0003808 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1946970 CUI: C4529647 RXAUI: 9278624 TUI: T116, T129, T121 vaccine Flumist Quadrivalent 2017-2018 vaccine VO:0003809 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1664644 1664644 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray [Flumist 2015-2016] 46287293 CUI: C4026361 RXAUI: 7266797, 7266977, 7266796 TUI: T200 vaccine FluMist Quadrivalent, 2015-2016 Formula Nasal Spray VO:0003810 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1664640 1664640 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML [Flumist 2015-2016] 46287291 CUI: C4050879 RXAUI: 7266973 TUI: T200 vaccine influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML [Flumist 2015-2016] VO:0003811 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801767 vaccine component CUI: C4276025 RXAUI: 8238906 TUI: T116, T129, T121 influenza A virus A/New Caledonia/71/2014 (H3N2) antigen VO:0003812 Jie Zheng Kallan Roan Oliver He Xingxian Li 1801822 influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML 40220742 vaccine influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML VO:0003813 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801826 1801826 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML [Flumist Quadrivalent 2016-2017] 40220775 CUI: C4276182 RXAUI: 8238996 TUI: T200 vaccine influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML [Flumist Quadrivalent 2016-2017] VO:0003814 Kallan Roan Oliver He FluMist Quadrivalent, Live Attenuated, 2016-2017 Formula Nasal Spray http://purl.bioontology.org/ontology/RXNORM/1801830 1801830 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray [Flumist Quadrivalent 2016-2017] 40220779 CUI: C4224207 RXAUI: 8239001, 8239002, 8239000 TUI: T200 vaccine FluMist Quadrivalent, 2016-2017 Formula Nasal Spray VO:0003815 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1946985 1946985 influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [Flumist Quadrivalent 2017-2018] 792421 CUI: C4529659 RXAUI: 9278648 TUI: T200 vaccine influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [Flumist Quadrivalent 2017-2018] VO:0003816 Kallan Roan Oliver He FluMist Quadrivalent, Live Attenuated, 2017-2018 Formula Nasal Spray http://purl.bioontology.org/ontology/RXNORM/1946986 1946986 influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [Flumist Quadrivalent 2017-2018] 792422 CUI: C4522486 RXAUI: 9278652, 9278649, 9278653 TUI: T200 vaccine FluMist Quadrivalent, 2017-2018 Formula Nasal Spray VO:0003817 Jie Zheng Kallan Roan Oliver He Xingxian Li 1946980 influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML 792416 vaccine influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML VO:0003818 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1946964 vaccine component CUI: C4522494 RXAUI: 9278618 TUI: T116, T129, T121 influenza A virus A/Slovenia/2903/2015 (H1N1) antigen VO:0003819 Jie Zheng Kallan Roan Oliver He Xingxian Li 1946981 influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML 792417 vaccine influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML VO:0003820 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2054182 CUI: C4719703 RXAUI: 10329701 TUI: T116, T129, T121 vaccine Flumist Quadrivalent 2018-2019 vaccine VO:0003821 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2054177 vaccine component CUI: C4719701 RXAUI: 10329696 TUI: T116, T129, T121 influenza B virus B/Colorado/06/2017 antigen VO:0003822 Jie Zheng Kallan Roan Oliver He Xingxian Li 2054271 influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML 35200282 vaccine influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML VO:0003823 http://purl.bioontology.org/ontology/RXNORM/2054273 2054273 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [Flumist Quadrivalent 2018-2019] 35200284 CUI: C4719750 RXAUI: 10329904 TUI: T200 vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [Flumist Quadrivalent 2018-2019] VO:0003824 FluMist Quadrivalent, Live Attenuated, 2018-2019 Formula Nasal Spray http://purl.bioontology.org/ontology/RXNORM/2054274 2054274 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [Flumist Quadrivalent 2018-2019] FluMist Quadrivalent, Live Attenuated, 2018-2019 Formula Nasal Spray 35200285 CUI: C4719751 RXAUI: 10329907, 10329905, 10329906 TUI: T200 vaccine FluMist Quadrivalent, 2018-2019 Formula Nasal Spray VO:0003825 Jie Zheng Kallan Roan Oliver He Xingxian Li 2054270 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML 35200281 vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML VO:0003826 OHDSI Vaccine WG vaccine Havrix Injectable Product VO:0003827 OHDSI Vaccine WG 798365 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML [Havrix] 19046487 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML [Havrix] VO:0003828 OHDSI Vaccine WG 1658066 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection [Havrix] Havrix 720 UNT per 0.5 ML Injection 46275175 vaccine Havrix pediatric/adolescent vaccine 720 UNT in 0.5 ML Injection VO:0003829 OHDSI Vaccine WG 1658060 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection [Havrix] Havrix 1440 UNT per 1 ML Injection 46275171 vaccine Havrix adult vaccine 1440 UNT in 1 ML Injection VO:0003830 OHDSI Vaccine WG 1658059 hepatitis A vaccine (inactivated) strain HM175 Injection [Havrix] 46275170 vaccine Havrix Injection VO:0003831 OHDSI Vaccine WG 798482 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Havrix, Hepatitis A Vaccine (Inactivated), (Pediatric Dose) 0.5 ML Prefilled Syringe 529687 vaccine Havrix, Hepatitis A Vaccine (Inactivated), (Pediatric Dose) 0.5 ML Prefilled Syringe VO:0003832 OHDSI Vaccine WG 798479 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Havrix, Hepatitis A Vaccine (Inactivated), (Adult Dose) 1 ML Prefilled Syringe 529685 vaccine Havrix, Hepatitis A Vaccine (Inactivated), (Adult Dose) 1 ML Prefilled Syringe VO:0003833 OHDSI Vaccine WG 798478 hepatitis A vaccine (inactivated) strain HM175 Prefilled Syringe [Havrix] 40150664 vaccine Havrix Prefilled Syringe VO:0003834 10 40213160 poliovirus vaccine, inactivated IPV vaccine poliovirus vaccine inactivated VO:0003835 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763096 763096 poliovirus vaccine inactivated, type 1 (Mahoney) 523283 CUI: C2242156 RXAUI: 5026693 TUI: T129, T121 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) VO:0003836 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763098 763098 poliovirus vaccine inactivated, type 2 (MEF-1) 523365 CUI: C2242158 RXAUI: 5026694 TUI: T129, T121 vaccine poliovirus vaccine inactivated, type 2 (MEF-1) VO:0003837 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763100 763100 poliovirus vaccine inactivated, type 3 (Saukett) 523367 CUI: C2242160 RXAUI: 5026695 TUI: T129, T121 vaccine poliovirus vaccine inactivated, type 3 (Saukett) VO:0003838 http://purl.bioontology.org/ontology/RXNORM/1178815 CUI: C3232713 RXAUI: 3842767 TUI: T200 vaccine PEDIARIX Injectable Product VO:0003839 http://purl.bioontology.org/ontology/RXNORM/829972 829972 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [PEDIARIX] 19034102 CUI: C2586685 RXAUI: 5027365 TUI: T200 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [PEDIARIX] VO:0003840 http://purl.bioontology.org/ontology/RXNORM/829988 829988 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [PEDIARIX] 40156527 CUI: C2586690 RXAUI: 5027414 TUI: T200 vaccine PEDIARIX vaccine Prefilled Syringe VO:0003841 http://purl.bioontology.org/ontology/RXNORM/829989 829989 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX] PEDIARIX DTaP-HepB-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine) 0.5 ML Prefilled Syringe 523290 CUI: C2586691 RXAUI: 3634543, 7253748, 5027677 TUI: T200 vaccine PEDIARIX vaccine 0.5 ML Prefilled Syringe VO:0003842 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763097 763097 poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML 19129478 CUI: C2242157 RXAUI: 5027171 TUI: T200 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML VO:0003843 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763099 763099 poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML 19129479 CUI: C2242159 RXAUI: 5027167 TUI: T200 vaccine poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML VO:0003844 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763101 763101 poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML 19129481 CUI: C2242161 RXAUI: 5027168 TUI: T200 vaccine poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML VO:0003845 http://purl.bioontology.org/ontology/RXNORM/1300806 CUI: C2719943 RXAUI: 4626294 TUI: T116, T129, T121 vaccine Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine VO:0003846 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1176753 CUI: C3230691 RXAUI: 3838525 TUI: T200 vaccine Ipol Injectable Product VO:0003847 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763104 763104 poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML [Ipol] 19129483 CUI: C2242163 RXAUI: 5027360 TUI: T200 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML [Ipol] VO:0003848 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/763106 763106 poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Suspension [Ipol] Ipol (poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML per 0.5 ML) Injectable Suspension 19129484 CUI: C1877934 RXAUI: 5027670, 6816444, 7253746 TUI: T200 vaccine IPOL vaccine Injectable Solution VO:0003849 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/807219 807219 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 532881 CUI: C0078221 RXAUI: 2863812 TUI: T116, T129, T121 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain VO:0003850 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1187511 CUI: C3241253 RXAUI: 3848865 TUI: T200 vaccine Typhim VI Injectable Product VO:0003851 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/807223 807223 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML [Typhim VI] 19132274 CUI: C2365227 RXAUI: 2863816 TUI: T200 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Typhim VI] VO:0003852 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/807225 807225 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Typhim Vi, Typhoid Vi Polysaccharide Vaccine Injectable Solution 19132275 CUI: C0711001 RXAUI: 7251850, 2863819, 2863818 TUI: T200 vaccine Typhim Vi Injectable Solution VO:0003853 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1486495 1486495 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe [Typhim VI] 44785330 CUI: C3701103 RXAUI: 5937066 TUI: T200 vaccine Typhim VI Prefilled Syringe VO:0003854 Kallan Roan Oliver He 0.5 ML Typhim VI 0.05 MG/ML Prefilled Syringe Typhim VI 25 MCG per 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1486496 1486496 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Typhim VI 25 MCG per 0.5 ML Prefilled Syringe 44785110 CUI: C0980908 RXAUI: 7252822, 5937069, 5937068, 5937067 TUI: T200 vaccine Typhim Vi 0.5 ML Prefilled Syringe VO:0003855 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/807220 807220 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML 19132272 CUI: C2365225 RXAUI: 2863813 TUI: T200 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML VO:0003856 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1361664 1361664 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML 43011517 CUI: C3528060 RXAUI: 5037103 TUI: T200 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML VO:0003857 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830464 830464 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 544505 CUI: C2586803 RXAUI: 5026921 TUI: T129, T121 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated VO:0003858 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830465 830465 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML 19133405 CUI: C2586804 RXAUI: 5027213 TUI: T200 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML VO:0003859 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659733 CUI: C4047087 RXAUI: 7255368 TUI: T200 vaccine Imovax Injectable Product VO:0003860 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1659731 1659731 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML [Imovax] 46275644 CUI: C4046958 RXAUI: 7255366 TUI: T200 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML [Imovax] VO:0003861 Kallan Roan Oliver He IMOVAX rabies vaccine 2.5 UNT in 1 ML Injection Imovax Rabies, Wistar Rabies Virus Strain PM-1503-3M (Human) 2.5 UNT per 1 ML Injection http://purl.bioontology.org/ontology/RXNORM/830470 CUI: C0711018 RXAUI: 7253451, 7250938, 7255369, 7255370 TUI: T200 vaccine 1 ML Imovax 2.5 UNT/ML Injection VO:0003862 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830457 830457 rabies virus vaccine flury-lep strain 544411 CUI: C2586798 RXAUI: 2939884 TUI: T129, T121 vaccine rabies virus vaccine flury-lep strain VO:0003863 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830458 830458 rabies virus vaccine flury-lep strain 2.5 UNT/ML 19133401 CUI: C2586799 RXAUI: 2939885 TUI: T200 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML VO:0003864 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1177669 CUI: C3231586 RXAUI: 3844818 TUI: T200 vaccine RabAvert Injectable Product VO:0003865 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830461 830461 rabies virus vaccine flury-lep strain 2.5 UNT/ML [RabAvert] 19133403 CUI: C2586802 RXAUI: 2939888 TUI: T200 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML [RabAvert] VO:0003866 Kallan Roan Oliver He RabAvert 2.5 UNT in 1 ML Injection RabAvert 2.5 UNT per 1 ML Injection http://purl.bioontology.org/ontology/RXNORM/830463 830463 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert] RabAvert 2.5 UNT per 1 ML Injection 19133404 CUI: C0711019 RXAUI: 7253136, 7250934, 7252193, 7252192 TUI: T200 vaccine 1 ML RabAvert 2.5 UNT/ML Injection VO:0003867 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1169861 CUI: C3223997 RXAUI: 3837729 TUI: T200 vaccine Hiberix Injectable Product VO:0003868 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300809 1300809 Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML [Hiberix] 42873208 CUI: C2719732 RXAUI: 4626297 TUI: T200 vaccine Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML [Hiberix] VO:0003869 Kallan Roan Oliver He 0.5 ML Hiberix 0.07 MG/ML Injection Hiberix (Haemophilus influenzae type b strain 20,752, capsular polysaccharide (10 MCG) inactivated tetanus toxoid (25 MCG) conjugate vaccine) per 0.5 ML Injection Hiberix (Haemophilus influenzae type b strain 20,752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine) 35 MCG per 0.5 ML Injection http://purl.bioontology.org/ontology/RXNORM/1300810 1300810 0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix] Hiberix (Haemophilus influenzae type b strain 20,752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine) 35 MCG per 0.5 ML Injection 42873449 CUI: C2719734 RXAUI: 7252256, 7252207, 7253591, 7252257, 7252206 TUI: T200 vaccine HIBERIX vaccine 0.5 ML Injection VO:0003870 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300807 1300807 Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML 42873207 CUI: C2719728 RXAUI: 4626295 TUI: T200 vaccine Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML VO:0003871 http://purl.bioontology.org/ontology/RXNORM/1170172 CUI: C3224301 RXAUI: 3831445 TUI: T200 vaccine COMVAX Injectable Product VO:0003872 Comvax (Haemophilus influenzae b (Ross strain) capsular polysaccharide (7.5 MCG) Meningococcal Protein (125 MCG) Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine 5 MCG) per 0.5 ML Injection Comvax, Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine Injection http://purl.bioontology.org/ontology/RXNORM/798443 798443 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection [COMVAX] Comvax (Haemophilus influenzae b (Ross strain) capsular polysaccharide (7.5 MCG) Meningococcal Protein (125 MCG) Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine 5 MCG) per 0.5 ML Injection 530006 CUI: C0714228 RXAUI: 7251580, 7251337, 7253592, 7251338 TUI: T200 vaccine COMVAX Injection 0.5 ML Injection VO:0003873 http://purl.bioontology.org/ontology/RXNORM/798441 798441 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML [COMVAX] 19016888 CUI: C2344381 RXAUI: 3020182 TUI: T200 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.265 MG/ML / Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [COMVAX] VO:0003874 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1367001 CUI: C3531472 RXAUI: 5048926 TUI: T116, T121 vaccine Flublok 2012-2013 Formula vaccine VO:0003875 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1367004 CUI: C3531475 RXAUI: 5048929 TUI: T200 vaccine Flublok 2012-2013 Formula Injectable Product VO:0003876 Kallan Roan Oliver He 1367005 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Injectable Solution [Flublok 2012-2013 Formula] 43012768 CUI: C3531476 RXAUI: 5048931, 5048930 TUI: T200 vaccine Flublok 2012-2013 Formula Influenza Virus Vaccine Injectable Solution VO:0003877 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1367002 1367002 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML [Flublok 2012-2013 Formula] 43012769 CUI: C3531473 RXAUI: 5048927 TUI: T200 vaccine Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML [Flublok 2012-2013 Formula] VO:0003878 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1442206 CUI: C3692550 RXAUI: 5532833 TUI: T116, T121 vaccine Flublok 2013-2014 Formula vaccine VO:0003879 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1442209 CUI: C3692553 RXAUI: 5532836 TUI: T200 vaccine Flublok 2013-2014 Formula Injectable Product VO:0003880 http://purl.bioontology.org/ontology/RXNORM/1442210 1442210 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2013-2014 Formula] 44507888 CUI: C3651109 RXAUI: 5532837, 5532838 TUI: T200 vaccine Flublok 2013-2014 Formula Influenza Virus Vaccine Injectable Solution VO:0003881 http://purl.bioontology.org/ontology/RXNORM/1442207 1442207 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Flublok 2013-2014 Formula] 44507889 CUI: C3692551 RXAUI: 5532834 TUI: T200 vaccine Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Flublok 2013-2014 Formula] VO:0003882 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537517 CUI: C3817315 RXAUI: 6338485 TUI: T116, T121 vaccine Flublok 2014-2015 Formula vaccine VO:0003883 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537520 CUI: C3819829 RXAUI: 6338488 TUI: T200 vaccine Flublok 2014-2015 Formula Injectable Product VO:0003884 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537521 1537521 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution [Flublok 2014-2015 Formula] 44818416 CUI: C3817268 RXAUI: 6338489, 6338490 TUI: T200 vaccine Flublok 2014-2015 Formula Influenza Virus Vaccine Injectable Solution VO:0003885 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1537518 1537518 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Flublok 2014-2015 Formula] 44818105 CUI: C3819293 RXAUI: 6338486 TUI: T200 vaccine Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Flublok 2014-2015 Formula] VO:0003886 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1660925 CUI: C4020135 RXAUI: 7258098 TUI: T129, T121 vaccine Flublok 2015-2016 vaccine VO:0003887 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1660928 CUI: C4047076 RXAUI: 7258101 TUI: T200 vaccine Flublok 2015-2016 Injectable Product VO:0003888 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1660926 1660926 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok 2015-2016] 46276016 CUI: C4046941 RXAUI: 7258099 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok 2015-2016] VO:0003889 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1660929 1660929 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection [Flublok 2015-2016] 46276018 CUI: C4019692 RXAUI: 7258105, 7258102 TUI: T200 vaccine Flublok 2015-2016 vaccine 0.5 ML Injection VO:0003890 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1803020 CUI: C4224215 RXAUI: 8241253 TUI: T116, T129, T121 vaccine Flublok 2016-2017 vaccine VO:0003891 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1803023 CUI: C4276258 RXAUI: 8241256 TUI: T200 vaccine Flublok 2016-2017 Injectable Product VO:0003892 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1803021 1803021 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML [Flublok 2016-2017] 40220829 CUI: C4276177 RXAUI: 8241254 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML [Flublok 2016-2017] VO:0003893 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1803024 1803024 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2016-2017] Flublok 2016-2017 vaccine 0.5 ML Injection 40220832 CUI: C4224212 RXAUI: 8241260, 8241257, 8241263 TUI: T200 vaccine Flublok 2016-2017 vaccine 0.5 ML Injection VO:0003894 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928876 CUI: C4490679 RXAUI: 9199818 TUI: T116, T129, T121 vaccine Flublok 2017-2018 vaccine VO:0003895 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928879 CUI: C4490682 RXAUI: 9199821 TUI: T200 vaccine Flublok 2017-2018 Injectable Product VO:0003896 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928877 1928877 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML [Flublok 2017-2018] 1593738 CUI: C4490680 RXAUI: 9199819 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML [Flublok 2017-2018] VO:0003897 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928880 1928880 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2017-2018] Flublok 2017-2018 vaccine 0.5 ML Injection 1593876 CUI: C4490683 RXAUI: 9199203, 9199204, 9199822 TUI: T200 vaccine Flublok 2017-2018 vaccine 0.5 ML Injection VO:0003898 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928347 CUI: C4490433 RXAUI: 9198836 TUI: T116, T129, T121 vaccine Flublok Quadrivalent 2017-2018 vaccine VO:0003899 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928350 CUI: C4490435 RXAUI: 9198839 TUI: T200 vaccine Flublok Quadrivalent 2017-2018 Injectable Product VO:0003900 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928361 1928361 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2017-2018] 1593521 CUI: C4490441 RXAUI: 9198889 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2017-2018] VO:0003901 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928362 1928362 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2017-2018] Flublok Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe 1593522 CUI: C4490442 RXAUI: 9198860, 9198861, 9198890 TUI: T200 vaccine Flublok Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003902 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928349 1928349 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2017-2018] 1593361 CUI: C4490434 RXAUI: 9198838 TUI: T200 vaccine Flublok Quadrivalent 2017-2018 vaccine Prefilled Syringe VO:0003903 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050378 CUI: C4719023 RXAUI: 10289675 TUI: T200 vaccine Flublok Quadrivalent 2018-2019 vaccine VO:0003904 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050381 CUI: C4719026 RXAUI: 10289678 TUI: T200 vaccine Flublok Quadrivalent 2018-2019 Injectable Product VO:0003905 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050379 2050379 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2018-2019] 35200024 CUI: C4719024 RXAUI: 10289676 TUI: T200 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2018-2019] VO:0003906 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050380 2050380 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2018-2019] 35200025 CUI: C4719025 RXAUI: 10289677 TUI: T200 vaccine Flublok Quadrivalent 2018-2019 vaccine Prefilled Syringe VO:0003907 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050382 2050382 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2018-2019] 35201911 CUI: C4719027 RXAUI: 10289680, 10289679, 10289681 TUI: T200 vaccine Flublok Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003908 Jie Zheng Xingxian Li 2050374 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML 35200021 vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML VO:0003909 Jie Zheng Xingxian Li 2050375 influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML 35200022 vaccine influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML VO:0003910 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1724002 CUI: C4060062 RXAUI: 7710863 TUI: T116, T121 vaccine FLUAD 2015-2016 vaccine VO:0003911 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801078 CUI: C4271566 RXAUI: 8236918 TUI: T116, T129, T121 vaccine Fluad 2016-2017 vaccine VO:0003912 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928961 CUI: C4325205 RXAUI: 9199981 TUI: T116, T129, T121 vaccine Fluad 2017-2018 vaccine VO:0003913 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050759 CUI: C4719165 RXAUI: 10290487 TUI: T116, T129, T121 vaccine Fluad 2018-2019 vaccine VO:0003914 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1723997 vaccine component CUI: C4059934 RXAUI: 7710856 TUI: T116, T129, T121 influenza B virus B/Brisbane/9/2014 antigen VO:0003915 Jie Zheng Kallan Roan Oliver He Xingxian Li 1724000 influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML 35606410 vaccine influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML VO:0003916 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1724005 CUI: C4060278 RXAUI: 7710866 TUI: T200 vaccine FLUAD 2015-2016 Injectable Product VO:0003917 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1724011 1724011 influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML [FLUAD 2015-2016] 35606415 CUI: C4060159 RXAUI: 7710874 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML [FLUAD 2015-2016] VO:0003918 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1724004 1724004 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [FLUAD 2015-2016] 35606412 CUI: C4060234 RXAUI: 7710865 TUI: T200 vaccine FLUAD 2015-2016 vaccine Prefilled Syringe VO:0003919 Kallan Roan Oliver He FLUAD 2015-2016 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1724012 1724012 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe [FLUAD 2015-2016] FLUAD 2015-2016 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 35606416 CUI: C4059806 RXAUI: 7710870, 7710875, 7716409 TUI: T200 vaccine FLUAD 2015-2016 vaccine 0.5 ML Prefilled Syringe VO:0003920 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801081 CUI: C4271737 RXAUI: 8236921 TUI: T200 vaccine Fluad 2016-2017 Injectable Product VO:0003921 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801079 1801079 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluad 2016-2017] 36249408 C4271636 RXAUI: 8236919 TUI: T200 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluad 2016-2017] VO:0003922 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801080 1801080 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2016-2017] 36249409 CUI: C4271677 RXAUI: 8236920 TUI: T200 vaccine Fluad 2016-2017 vaccine Prefilled Syringe VO:0003923 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1801082 1801082 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2016-2017] Fluad 2016-2017 vaccine 0.5 ML Prefilled Syringe 36249411 CUI: C4270828 RXAUI: 8236922, 8236925, 8236924 TUI: T200 vaccine Fluad 2016-2017 vaccine 0.5 ML Prefilled Syringe VO:0003924 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928964 CUI: C4490740 RXAUI: 9199984 TUI: T200 vaccine Fluad 2017-2018 Injectable Product VO:0003925 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928962 1928962 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluad 2017-2018] 1593898 CUI: C4490738 RXAUI: 9199982 TUI: T200 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML [Fluad 2017-2018] VO:0003926 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928963 1928963 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2017-2018] 1593899 CUI: C4490739 RXAUI: 9199983 TUI: T200 vaccine Fluad 2017-2018 vaccine Prefilled Syringe VO:0003927 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1928965 1928965 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2017-2018] Fluad 2017-2018 vaccine 0.5 ML Prefilled Syringe 1593901 CUI: C4325070 RXAUI: 9199987, 9199985, 9199986 TUI: T200 vaccine Fluad 2017-2018 vaccine 0.5 ML Prefilled Syringe VO:0003928 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050762 CUI: C4719168 RXAUI: 10290491 TUI: T200 vaccine Fluad 2018-2019 Injectable Product VO:0003929 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050760 2050760 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Fluad 2018-2019] 35200044 CUI: C4719166 RXAUI: 10290488 TUI: T200 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Fluad 2018-2019] VO:0003930 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050761 2050761 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2018-2019] 35200045 CUI: C4719167 RXAUI: 10290490 TUI: T200 vaccine Fluad 2018-2019 vaccine Prefilled Syringe VO:0003931 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050763 2050763 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2018-2019] Fluad 2018-2019 vaccine 0.5 ML Prefilled Syringe 35201915 CUI: C4719169 RXAUI: 10290492, 10290493, 10290494 TUI: T200 vaccine Fluad 2018-2019 vaccine 0.5 ML Prefilled Syringe VO:0003932 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1176026 CUI: C3229980 RXAUI: 3836903 TUI: T200 vaccine Gardasil Injectable Product VO:0003933 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798272 798272 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML [Gardasil] 19093987 CUI: C2344300 RXAUI: 2851350 TUI: T200 vaccine L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML [Gardasil] VO:0003934 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1656961 1656961 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 6 vaccine Injection [Gardasil] 46275945 CUI: C2344301 RXAUI: 7250795 TUI: T200 vaccine GARDASIL Injection VO:0003935 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798274 798274 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection [Gardasil] Gardasil, Human Papillomavirus Quadrivalent (Types 6,11,16,18) Vaccine, Recombinant 0.5 ML Injection 529079 CUI: C1714255 RXAUI: 7250530, 6836567, 7251909 TUI: T200 vaccine GARDASIL 0.5 ML Injection VO:0003936 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798277 798277 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 6 vaccine Prefilled Syringe [Gardasil] 40150716 CUI: C2344303 RXAUI: 2851356 TUI: T200 vaccine GARDASIL Prefilled Syringe VO:0003937 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798278 798278 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe [Gardasil] Gardasil, Human Papillomavirus Quadrivalent (Types 6,11,16,18) Vaccine, Recombinant 0.5 ML Prefilled Syringe 529081 CUI: C1725928 RXAUI: 2851357, 2980898, 6836565 TUI: T200 vaccine GARDASIL 0.5 ML Prefilled Syringe VO:0003938 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798265 798265 L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML 529113 CUI: C2344294 RXAUI: 2851343 TUI: T200 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.08 MG/ML VO:0003939 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798269 798269 L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML 529117 CUI: C2344298 RXAUI: 2851347 TUI: T200 vaccine L1 protein, Human papillomavirus type 6 Vaccine 0.04 MG/ML VO:0003940 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1301885 CUI: C2724165 RXAUI: 4627784 TUI: T116, T121 vaccine Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine VO:0003941 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1301887 CUI: C2724167 RXAUI: 4627786 TUI: T116, T129, T121 vaccine Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine VO:0003942 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1301886 1301886 human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML 42873274 CUI: C2725255 RXAUI: 4627785 TUI: T200 vaccine Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML VO:0003943 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1301888 1301888 human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML 42873275 CUI: C3474821 RXAUI: 4627787 TUI: T200 vaccine Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML VO:0003944 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1167355 CUI: C3221549 RXAUI: 3832040 TUI: T200 vaccine Cervarix Injectable Product VO:0003945 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1301890 1301890 human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML [Cervarix] 42873276 CUI: C2725256 RXAUI: 4627789 TUI: T200 vaccine Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML [Cervarix] VO:0003946 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/867488 867488 L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine Prefilled Syringe [Cervarix] 40167172 CUI: C2723809 RXAUI: 2999023 TUI: T200 vaccine CERVARIX Prefilled Syringe VO:0003947 Kallan Roan Oliver He Cervarix Human Papillomavirus bivalent (types 16 and 18) vaccine, recombinant 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1301891 1301891 0.5 ML human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix] Cervarix Human Papillomavirus bivalent (types 16 and 18) vaccine, recombinant 0.5 ML Prefilled Syringe 42873514 CUI: C2724157 RXAUI: 3266660, 4627790, 7236130 TUI: T200 vaccine CERVARIX 0.5 ML Prefilled Syringe VO:0003948 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/845525 845525 Japanese encephalitis virus vaccine, inactivated 19047598 CUI: C1579318 RXAUI: 2963098 TUI: T129, T121 vaccine Japanese encephalitis virus vaccine, inactivated VO:0003949 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300779 CUI: C3474322 RXAUI: 4626258 TUI: T129, T121 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated VO:0003950 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300780 1300780 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML 42873198 CUI: C2682867 RXAUI: 4626259 TUI: T200 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML VO:0003951 http://purl.bioontology.org/ontology/RXNORM/1167200 CUI: C3221394 RXAUI: 3838660 TUI: T200 vaccine Ixiaro Injectable Product VO:0003952 http://purl.bioontology.org/ontology/RXNORM/1300782 1300782 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML [Ixiaro] 42873199 CUI: C2682871 RXAUI: 4626261 TUI: T200 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML [Ixiaro] VO:0003953 http://purl.bioontology.org/ontology/RXNORM/845531 845531 Japanese encephalitis virus vaccine, inactivated Prefilled Syringe [Ixiaro] 40159359 CUI: C2682872 RXAUI: 2963104 TUI: T200 vaccine Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) Prefilled Syringe VO:0003954 Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) 0.012 MG/ML 0.5 ML Prefilled Syringe Ixiaro 6 MCG per 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1300783 1300783 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro] Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) 0.012 MG/ML 0.5 ML Prefilled Syringe 42873439 CUI: C2682873 RXAUI: 6833047, 4626263, 2984288, 4626262, 2994485 TUI: T200 vaccine 0.5 ML Ixiaro 0.012 MG/ML Prefilled Syringe VO:0003955 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1812935 1812935 Vibrio cholerae CVD 103-HGR strain live antigen 1718154 vaccine component CUI: C4291328 RXAUI: 8262960 TUI: T116, T129, T121 vibrio cholerae CVD 103-HGR strain live antigen VO:0003956 Jie Zheng Kallan Roan Oliver He Xingxian Li obsolete vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML true VO:0003957 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1812950 CUI: C4291505 RXAUI: 8262971 TUI: T200 vaccine Vaxchora Oral Product VO:0003958 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1172748 CUI: C3226798 RXAUI: 3838385 TUI: T200 vaccine Infanrix Injectable Product VO:0003959 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/854932 854932 Streptococcus pneumoniae type 10A capsular polysaccharide antigen pneumococcal capsular polysaccharide type 10A vaccine 40163668 vaccine pneumococcal capsular polysaccharide type 10A vaccine VO:0003960 vaccine component Neisseria meningitidis vaccine antigen VO:0003961 replication defective simian adenoviral vector expressing KH, a self-cleaving polyprotein comprising L. donovani KMP-11 and HASPB Oliver He Randi Vita VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5712 https://www.ncbi.nlm.nih.gov/pubmed/28498840 5712 vaccine ChAd63-KH vaccine VO:0003962 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1812948 CUI: C4291477 RXAUI: 8262969 TUI: T200 vaccine Vaxchora Oral Suspension VO:0003963 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1812951 1812951 Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension [Vaxchora] Vaxchora 12000000 UNT/ML Oral Suspension 1718165 CUI: C4271028 RXAUI: 8262973, 8262974, 8262972 TUI: T200 vaccine Vaxchora 1,200,000,000 UNT per 100 ML Oral Suspension VO:0003964 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1812947 obsolete vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML [Vaxchora] true VO:0003965 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050058 CUI: C4718905 RXAUI: 9712930 TUI: T200 vaccine Heplisav-B Injectable Product VO:0003966 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/2050058 2050058 hepatitis B surface antigen vaccine Prefilled Syringe [Heplisav-B] 35200003 CUI: C4718905 RXAUI: 10287780 TUI: T200 vaccine HEPLISAV-B Prefilled Syringe VO:0003967 Kallan Roan Oliver He 0.5 ML Heplisav-B 0.04 MG/ML Prefilled Syringe HEPLISAV-B 20 MCG in 0.5 ML Prefilled Syringe Heplisav-B 0.04 MG/ML per 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/2050059 2050059 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] 0.5 ML Heplisav-B 0.04 MG/ML Prefilled Syringe 35201909 CUI: C4553167 RXAUI: 10287788, 10287789, 10287781, 10287783, 10287782 TUI: T200 vaccine HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe VO:0003968 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1994349 1994349 hepatitis B surface antigen vaccine 0.04 MG/ML [Heplisav-B] 793517 CUI: C4541386 RXAUI: 9712928 TUI: T200 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Heplisav-B] VO:0003969 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/801829 CUI: C2346335 RXAUI: 5027208 TUI: T200 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML VO:0003970 http://purl.bioontology.org/ontology/RXNORM/1184583 CUI: C3238386 RXAUI: 3843263 TUI: T200 vaccine Pentacel Injectable Product VO:0003971 http://purl.bioontology.org/ontology/RXNORM/805376 805376 acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Pentacel] 19131878 CUI: C2364460 RXAUI: 5027344 TUI: T200 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Pentacel] VO:0003972 http://purl.bioontology.org/ontology/RXNORM/1657397 1657397 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Pentacel] 46276201 CUI: C4033845 RXAUI: 7251281 TUI: T200 vaccine Pentacel vaccine Injection VO:0003973 Pentacel DTaP-IPV/Hib (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)) 0.5 ML Injection 805378 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] Pentacel DTaP-IPV/Hib (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus (mIPV) and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)) 0.5 ML Injection 19131879 CUI: C2346346 RXAUI: 7251683, 7253749, 7250887 TUI: T200 vaccine Pentacel vaccine 0.5 ML Injection VO:0003974 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1171400 CUI: C3225481 RXAUI: 3838975 TUI: T200 vaccine Kinrix Injectable Product VO:0003975 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830550 830550 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Kinrix] 19133449 CUI: C2586836 RXAUI: 5027347 TUI: T200 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Kinrix] VO:0003976 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657886 1657886 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Kinrix] 46275091 CUI: C4033746 RXAUI: 7251903 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Kinrix] VO:0003977 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/830556 830556 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Kinrix] 40156660 CUI: C2586841 RXAUI: 5027411 TUI: T200 vaccine KINRIX vaccine Prefilled Syringe VO:0003978 Kallan Roan Oliver He KINRIX DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/830557 830557 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Kinrix] KINRIX DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) 0.5 ML Prefilled Syringe 19133452 CUI: C2586842 RXAUI: 7253751, 5027675, 3634544 TUI: T200 vaccine KINRIX vaccine 0.5 ML Prefilled Syringe VO:0003979 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657887 1657887 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Kinrix] 46275092 CUI: C2586837 RXAUI: 7251904 TUI: T200 vaccine KINRIX vaccine Injection VO:0003980 Kallan Roan Oliver He KINRIX DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) 0.5 ML Injection 830552 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Kinrix] 19133450 CUI: C2586838 RXAUI: 7250882, 7251905, 7253750 TUI: T200 vaccine KINRIX vaccine 0.5 ML Injection VO:0003981 CUI: C3222333 RXAUI: 3833478 TUI: T200 http://purl.bioontology.org/ontology/RXNORM/1168164 vaccine Daptacel Injectable Product VO:0003982 http://purl.bioontology.org/ontology/RXNORM/1300309 1300309 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Daptacel] 42800462 CUI: C2609933 RXAUI: 5027355 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Daptacel] VO:0003983 Daptacel DTaP (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Injection http://purl.bioontology.org/ontology/RXNORM/1300310 1300310 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Daptacel] Daptacel DTaP (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Injection 42800470 CUI: C1169838 RXAUI: 7251885, 7250857, 7250858, 7253754 TUI: T200 vaccine DAPTACEL vaccine 0.5 ML Injection VO:0003984 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1169952 CUI: C3224088 RXAUI: 3828634 TUI: T200 vaccine Adacel Injectable Product VO:0003985 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300190 1300190 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Adacel] 42800461 CUI: C2587006 RXAUI: 5027353 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Adacel] VO:0003986 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/904262 904262 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Adacel] 40173449 CUI: C2746860 RXAUI: 5027415 TUI: T200 vaccine Adacel Prefilled Syringe VO:0003987 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300191 1300191 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel] 42800265 CUI: C2746861 RXAUI: 4625204, 7252705, 5027658, 4625563 TUI: T200 vaccine Adacel 0.5 ML Prefilled Syringe VO:0003988 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657767 1657767 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adacel] 46276421 CUI: C4033829 RXAUI: 7251690 TUI: T200 vaccine Adacel Injection VO:0003989 Kallan Roan Oliver He Adacel (Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 5 MCG / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 5 MCG / Bordetella pertussis pertactin vaccine, inactivated 3 MCG / Bordetella pertussis toxoid vaccine, inactivated 2.5 MCG / Diphtheria Toxoid Vaccine 2 UNT / Tetanus Toxoid Vaccine 5 UNT) per 0.5 ML Injection Adacel Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) Injection http://purl.bioontology.org/ontology/RXNORM/1300206 1300206 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Adacel] Adacel Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) Injection 42800464 CUI: C1639148 RXAUI: 7250855, 7251691, 7252702, 7250854 TUI: T200 vaccine Adacel 0.5 ML Injection VO:0003990 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300383 1300383 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Infanrix] 42800480 CUI: C3152863 RXAUI: 5027354 RXNORM:1300383 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Infanrix] VO:0003991 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657878 1657878 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Infanrix] 46275088 CUI: C2368976 RXAUI: 7251893 TUI: T200 vaccine INFANRIX vaccine Injection VO:0003992 Kallan Roan Oliver He Infanrix (Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.025 MG / Bordetella pertussis pertactin vaccine, inactivated 0.008 MG / Bordetella pertussis toxoid vaccine, inactivated 0.025 MG / diphtheria toxoid vaccine, inactivated 25 UNT / tetanus toxoid vaccine, inactivated 10 UNT) per 0.5 ML Injection Infanrix DTaP (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Injection http://purl.bioontology.org/ontology/RXNORM/1300386 1300386 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Infanrix] 42800482 CUI: C0710622 RXAUI: 7250871, 7251894, 7250870, 7253756 TUI: T200 vaccine INFANRIX vaccine 0.5 ML Injection VO:0003993 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/824539 824539 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Infanrix] 40155131 CUI: C2368973 RXAUI: 5027387 TUI: T200 vaccine INFANRIX vaccine Prefilled Syringe VO:0003994 Kallan Roan Oliver He Infanrix (Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 25 MCG / Bordetella pertussis pertactin vaccine, inactivated 8 MCG / Bordetella pertussis toxoid vaccine, inactivated 25 MCG / diphtheria toxoid vaccine, inactivated 25 UNT / tetanus toxoid vaccine, inactivated 10 UNT) per 0.5 ML Prefilled Syringe Infanrix DTaP (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1300384 1300384 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Infanrix] 42800271 CUI: C2368974 RXAUI: 5027659, 7253755, 3633959, 4625557 TUI: T200 vaccine INFANRIX vaccine 0.5 ML Prefilled Syringe VO:0003995 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1175718 CUI: C3229697 RXAUI: 3831021 TUI: T200 vaccine Boostrix Injectable Product VO:0003996 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657603 1657603 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Boostrix] 46276285 CUI: C4033749 RXAUI: 7251494 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Boostrix] VO:0003997 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300369 1300369 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Boostrix] 42800472 CUI: C2364904 RXAUI: 5027356 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Boostrix] VO:0003998 Kallan Roan Oliver He acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Boostrix] http://purl.bioontology.org/ontology/RXNORM/1657466 1657466 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Boostrix] 46276207 CUI: C2364905 RXAUI: 7251319 TUI: T200 vaccine BOOSTRIX vaccine Injection VO:0003999 Kallan Roan Oliver He Boostrix (Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 8 MCG / Bordetella pertussis pertactin vaccine, inactivated 2.5 MCG / Bordetella pertussis toxoid vaccine, inactivated 8 MCG / diphtheria toxoid vaccine, inactivated 2.5 UNT / tetanus toxoid vaccine, inactivated 5 UNT) per 0.5 ML Injection Boostrix Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) Injection http://purl.bioontology.org/ontology/RXNORM/1300378 1300378 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Boostrix] 42800474 CUI: C2364906 RXAUI: 7250865, 7251497, 7253758, 7250866 TUI: T200 vaccine BOOSTRIX vaccine 0.5 ML Injection VO:0004000 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3259 3259 vaccine Brucella melitensis bp26 mutant vaccine VO:0004001 A omp25 mutant is attenuated and provides protection against challenge in mice Ningxian Fan Oliver He Rebecca Racz Ronak Sutariya B. melitensis omp25 mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3261 3261 vaccine Brucella melitensis omp25 mutant vaccine VO:0004002 A omp31 mutant in Brucella melitensis was attenuated and provided protection against challenge in mice Ningxian Fan Oliver He Rebecca Racz Ronak Sutariya B. melitensis omp31 mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3262 3262 vaccine Brucella melitensis omp31 mutant vaccine VO:0004003 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=826 826 vaccine Pseudorabies recombinant vector vaccine encoding gp50 protein VO:0004004 Ningxian Fan Oliver He Ronak Sutariya BoNT/C VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=91 91 vaccine BoNT/C vaccine VO:0004005 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae CbpA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=787 787 vaccine Streptococcus pneumoniae CbpA protein vaccine VO:0004006 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae ClpP protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=789 789 vaccine Streptococcus pneumoniae ClpP protein vaccine VO:0004007 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae PspA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=795 795 vaccine Streptococcus pneumoniae PspA protein vaccine VO:0004008 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae SrtA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=798 798 vaccine Streptococcus pneumoniae SrtA protein vaccine VO:0004009 Ningxian Fan Oliver He Ronak Sutariya N. caninum NcPDI Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=937 937 vaccine Neospora caninum NcPDI protein vaccine VO:0004010 Ningxian Fan Oliver He Ronak Sutariya N. caninum NcDG1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=944 944 vaccine Neospora caninum NcDG1 protein vaccine VO:0004011 Ningxian Fan Oliver He Ronak Sutariya N. meningitidis ExbB Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=947 947 vaccine Neisseria meningitidis ExbB protein vaccine VO:0004012 Ningxian Fan Oliver He Ronak Sutariya N. meningitidis LctP Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=948 948 vaccine Neisseria meningitidis LctP protein vaccine VO:0004013 Ningxian Fan Oliver He Ronak Sutariya N. meningitidis NspA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=956 956 vaccine Neisseria meningitidis NspA protein vaccine VO:0004014 Ningxian Fan Oliver He Ronak Sutariya N. miningitidis TBP2 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=957 957 vaccine Neisseria miningitidis TBP2 protein vaccine VO:0004015 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=998 998 vaccine influenza virus DNA vaccine encoding HA from influenza A virus (A/Hong Kong/1/68(H3N2)) VO:0004016 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=999 999 vaccine influenza virus DNA vaccine encoding HA from influenza A virus (A/environment/Hong Kong/156/1997(H5N1)) VO:0004017 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1003 1003 vaccine influenza virus HA protein vaccine (influenza A virus (A/Yamagata/120/1986(H1N1))) VO:0004018 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1004 1004 vaccine influenza virus HA protein vaccine (influenza A virus (A/Fukuoka/C29/85(H3N2))) VO:0004019 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1005 1005 vaccine influenza virus DNA vaccine encoding HA from influenza B virus (B/Ibaraki/2/85) VO:0004020 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1012 1012 vaccine influenza virus DNA vaccine encoding HA from influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) VO:0004021 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1014 1014 vaccine influenza virus DNA vaccine encoding HA from influenza A virus (A/equine/Kentucky/1/1981(H3N8)) VO:0004022 Ningxian Fan Oliver He Ronak Sutariya L. donovani GRP-78 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1029 1029 vaccine Leishmania donovani GRP-78 protein vaccine VO:0004023 Ningxian Fan Oliver He Ronak Sutariya L. donovani Beta-tubulin Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1031 1031 vaccine Leishmania donovani Beta-tubulin protein vaccine VO:0004024 Ningxian Fan Oliver He Ronak Sutariya T. pallidum GlpQ Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1069 1069 vaccine Treponema pallidum GlpQ protein vaccine VO:0004025 Ningxian Fan Oliver He Ronak Sutariya T. pallidum TmpB Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1070 1070 vaccine Treponema pallidum TmpB protein vaccine VO:0004026 Ningxian Fan Oliver He Ronak Sutariya T. pallidum Tp92 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1071 1071 vaccine Treponema pallidum Tp92 protein vaccine VO:0004027 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi DbpA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1072 1072 vaccine Borrelia burgdorferi DbpA Protein vaccine VO:0004028 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi OspA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1074 1074 vaccine Borrelia burgdorferi OspA protein vaccine VO:0004029 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi OspB Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1075 1075 vaccine Borrelia burgdorferi OspB protein vaccine VO:0004030 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi OspC Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1076 1076 vaccine Borrelia burgdorferi OspC protein vaccine VO:0004031 Ningxian Fan Oliver He Ronak Sutariya L. monocytogenes DNA Vaccine encoding hly VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1077 1077 vaccine Listeria monocytogenes DNA vaccine encoding hly VO:0004032 Ningxian Fan Oliver He Ronak Sutariya L. monocytogenes p60 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1078 1078 vaccine Listeria monocytogenes p60 Protein vaccine VO:0004033 Ningxian Fan Oliver He Ronak Sutariya L. donovani Hsp70 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1109 1109 vaccine Leishmania donovani Hsp70 protein vaccine VO:0004034 Ningxian Fan Oliver He Ronak Sutariya F. tularensis FopB Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1111 1111 vaccine Francisella tularensis FopB protein vaccine VO:0004035 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA vaccine ESAT-6 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3543 3543 vaccine Mycobacterium tuberculosis DNA vaccine ESAT-6 VO:0004036 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3576 3576 vaccine Ebola virus DNA vaccine EBOV GP VO:0004037 Ningxian Fan Oliver He Ronak Sutariya Ebola virus EBOV NP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3577 3577 vaccine Ebola virus EBOV NP vaccine VO:0004038 Ningxian Fan Oliver He Ronak Sutariya Nontypeable H. influenzae NucA Protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=192 192 vaccine Nontypeable Haemophilus influenzae NucA Protein vaccine VO:0004039 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=822 822 vaccine Psuedorabies DNA vaccine encoding IE180 protein VO:0004040 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=829 829 vaccine Pseudorabies Subunit gI protein vaccine VO:0004041 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=830 830 vaccine Pseudorabies Subunit gB protein vaccine VO:0004042 Ningxian Fan Oliver He Ronak Sutariya S. neurona SAG1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=835 835 vaccine Sarcocystis neurona SAG1 Protein vaccine VO:0004043 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=877 877 vaccine Rotavirus VP6 protein vaccine VO:0004044 Ningxian Fan Oliver He Ronak Sutariya L. major PSA-2 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1006 1006 vaccine Leishmania major PSA-2 protein vaccine VO:0004045 Ningxian Fan Oliver He Ronak Sutariya L. major H2B Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1009 1009 vaccine Leishmania major H2B protein vaccine VO:0004046 Ningxian Fan Oliver He Ronak Sutariya L. major DNA Vaccine encoding Gp63 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1013 1013 vaccine Leishmania major DNA vaccine encoding Gp63 VO:0004047 Ningxian Fan Oliver He Ronak Sutariya S. aureus ClfA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1082 1082 vaccine Staphylococcus aureus ClfA Protein vaccine VO:0004048 Ningxian Fan Oliver He Ronak Sutariya S. aureus CNA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1083 1083 vaccine Staphylococcus aureus CNA Protein vaccine VO:0004049 Ningxian Fan Oliver He Ronak Sutariya S. aureus FnbA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1084 1084 vaccine Staphylococcus aureus FnbA protein vaccine VO:0004050 Ningxian Fan Oliver He Ronak Sutariya S. agalactiae BPS Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1086 1086 vaccine Streptococcus agalactiae BPS protein vaccine VO:0004051 Ningxian Fan Oliver He Ronak Sutariya S. agalactiae Rib Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1087 1087 vaccine Streptococcus agalactiae Rib protein vaccine VO:0004052 Ningxian Fan Oliver He Ronak Sutariya S. agalactiae Sip Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1088 1088 vaccine Streptococcus agalactiae Sip protein vaccine VO:0004053 Ningxian Fan Oliver He Ronak Sutariya S. pyogenes Emm1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1089 1089 vaccine Streptococcus pyogenes Emm1 protein vaccine VO:0004054 Ningxian Fan Oliver He Ronak Sutariya S. pyogenes FbaA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1090 1090 vaccine Streptococcus pyogenes FbaA protein vaccine VO:0004055 Ningxian Fan Oliver He Ronak Sutariya S. pyogenes FBP54 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1091 1091 vaccine Streptococcus pyogenes FBP54 protein vaccine VO:0004056 Ningxian Fan Oliver He Ronak Sutariya S. pyogenes SfbI Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1092 1092 vaccine Streptococcus pyogenes SfbI protein vaccine VO:0004057 Ningxian Fan Oliver He Ronak Sutariya S. pyogenes Sib35 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1093 1093 vaccine Streptococcus pyogenes Sib35 protein vaccine VO:0004058 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA Vaccine encoding KatG VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1094 1094 vaccine Mycobacterium tuberculosis DNA vaccine encoding KatG VO:0004059 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis HBHA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1095 1095 vaccine Mycobacterium tuberculosis HBHA protein vaccine VO:0004060 Ningxian Fan Oliver He Ronak Sutariya H. pylori HspA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1097 1097 vaccine Helicobacter pylori HspA Protein vaccine VO:0004061 Ningxian Fan Oliver He Ronak Sutariya H. pylori HspB Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1098 1098 vaccine Helicobacter pylori HspB Protein vaccine VO:0004062 Ningxian Fan Oliver He Ronak Sutariya H. pylori GltA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1099 1099 vaccine Helicobacter pylori GltA Protein vaccine VO:0004063 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae PhpA-79 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1100 1100 vaccine Streptococcus pneumoniae PhpA-79 protein vaccine VO:0004064 Ningxian Fan Oliver He Ronak Sutariya N. meningitidis TbpA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1101 1101 vaccine Neisseria meningitidis TbpA protein vaccine VO:0004065 Ningxian Fan Oliver He Ronak Sutariya P. berghei MSP1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1105 1105 vaccine Plasmodium berghei MSP1 Protein vaccine VO:0004066 Ningxian Fan Oliver He Ronak Sutariya L. infantum SMT Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1108 1108 vaccine Leishmania infantum SMT protein vaccine VO:0004067 Ningxian Fan Oliver He Ronak Sutariya L. donovani HASPB1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1028 1028 vaccine Leishmania donovani HASPB1 protein vaccine VO:0004068 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae GtS Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=790 790 vaccine Streptococcus pneumoniae GtS protein vaccine VO:0004069 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae 6PGD Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=792 792 vaccine Streptococcus pneumoniae 6PGD protein vaccine VO:0004070 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae PiaA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=793 793 vaccine Streptococcus pneumoniae PiaA protein vaccine VO:0004071 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae RASV synthesizing PsaA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=794 794 vaccine Streptococcus pneumoniae RASV synthesizing PsaA vaccine VO:0004072 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=61 61 vaccine Ebola virus recombinant adenovirus vector vaccine ADV-GP/NP VO:0004073 Ningxian Fan Oliver He Ronak Sutariya GP and NP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=71 71 vaccine GP and NP vaccine VO:0004074 Ningxian Fan Oliver He Ronak Sutariya BoNT/A(Hc) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=74 74 vaccine BoNT/A(Hc) vaccine VO:0004075 Ningxian Fan Oliver He Ronak Sutariya PBT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=75 75 vaccine PBT vaccine VO:0004076 Ningxian Fan Oliver He Ronak Sutariya BoNT/F(Hc) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=76 76 vaccine BoNT/F(Hc) vaccine VO:0004077 Ningxian Fan Oliver He Ronak Sutariya BoNT/B(Hc) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=78 78 vaccine BoNT/B(Hc) vaccine VO:0004078 Ningxian Fan Oliver He Ronak Sutariya VRP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=82 82 vaccine VRP vaccine VO:0004079 Ningxian Fan Oliver He Ronak Sutariya V-LSN VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=83 83 vaccine V-LSN vaccine VO:0004080 Ningxian Fan Oliver He Ronak Sutariya V-LSG VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=84 84 vaccine V-LSG vaccine VO:0004081 Ningxian Fan Oliver He Ronak Sutariya V-LSG1 + V-LSG2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=85 85 vaccine V-LSG1 + V-LSG2 vaccine VO:0004082 Ningxian Fan Oliver He Ronak Sutariya V-LSG + V-LSN VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=86 86 vaccine V-LSG + V-LSN vaccine VO:0004083 Ningxian Fan Oliver He Ronak Sutariya V-LSG/N VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=87 87 vaccine V-LSG/N vaccine VO:0004084 Ningxian Fan Oliver He Ronak Sutariya HC of type C and D VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=88 88 vaccine HC of type C and D vaccine VO:0004085 Ningxian Fan Oliver He Ronak Sutariya ML29 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=89 89 vaccine ML29 vaccine VO:0004086 Ningxian Fan Oliver He Ronak Sutariya V-LSGPC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=90 90 vaccine V-LSGPC vaccine VO:0004087 Ningxian Fan Oliver He Ronak Sutariya VSV[Delta]G/LVGPC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=92 92 vaccine VSV[Delta]G/LVGPC vaccine VO:0004088 Ningxian Fan Oliver He Ronak Sutariya YFV17D/LAS-GPC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=93 93 vaccine YFV17D/LAS-GPC vaccine VO:0004089 Earlier investigational version of a smallpox vaccine developed by Acambis. It was part of the development process that led to the creation of ACAM2000. Ningxian Fan Oliver He Ronak Sutariya ACAM1000 vaccine ACAM1000 vaccine VO:0004090 Ningxian Fan Oliver He Ronak Sutariya CCSV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=97 97 vaccine CCSV vaccine VO:0004091 Ningxian Fan Oliver He Ronak Sutariya LC16m8 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=98 98 vaccine LC16m8 vaccine VO:0004092 Ningxian Fan Oliver He Ronak Sutariya MVA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=99 99 vaccine MVA vaccine VO:0004093 Ningxian Fan Oliver He Ronak Sutariya NYVAC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=100 100 vaccine NYVAC vaccine VO:0004094 Ningxian Fan Oliver He Ronak Sutariya dVV-L VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=101 101 vaccine dVV-L vaccine VO:0004095 Ningxian Fan Oliver He Ronak Sutariya IMV-EEV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=102 102 vaccine IMV-EEV vaccine VO:0004096 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=103 103 vaccine Smallpox DNA vaccine VO:0004097 Ningxian Fan Oliver He Ronak Sutariya MVA-BN VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=106 106 vaccine MVA-BN vaccine VO:0004098 Ningxian Fan Oliver He Ronak Sutariya LC16m0 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=107 107 vaccine LC16m0 vaccine VO:0004099 Ningxian Fan Oliver He Ronak Sutariya pABFHc2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=108 108 vaccine pABFHc2 vaccine VO:0004100 Ningxian Fan Oliver He Ronak Sutariya inactivated C. jejuni whole-cell (CWC) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=114 114 vaccine inactivated Campylobacter jejuni whole-cell vaccine VO:0004101 Ningxian Fan Oliver He Ronak Sutariya MBP fused on Campylobacter FlaA (MBP-FlaA) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=124 124 vaccine MBP fused on Campylobacter FlaA (MBP-FlaA) vaccine VO:0004102 Ningxian Fan Oliver He Ronak Sutariya Recombinant DOBV nucleocapsid protein (rDOBV N) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=140 140 vaccine recombinant DOBV nucleocapsid protein (rDOBV N) vaccine VO:0004103 Ningxian Fan Oliver He Ronak Sutariya Truncated Recombinant DoBV Nucleocapsid Proteins (Dob-N rNp) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=141 141 vaccine Truncated Recombinant DoBV Nucleocapsid Proteins (Dob-N rNp) vaccine VO:0004104 Ningxian Fan Oliver He Ronak Sutariya VEE virus complex-specific monoclonal antibody VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=167 167 vaccine VEE virus complex-specific monoclonal antibody vaccine VO:0004105 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=168 168 vaccine Live attenuated vaccine TC-83 VO:0004106 Ningxian Fan Oliver He Ronak Sutariya MVA85A prime and BCG boost PMID:15196215 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=172 172 vaccine MVA85A prime and BCG boost vaccine VO:0004107 Ningxian Fan Oliver He Ronak Sutariya BCG expressing MSP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=174 174 vaccine BCG expressing MSP vaccine VO:0004108 Ningxian Fan Oliver He Ronak Sutariya Mtb72f fusion protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=175 175 vaccine Mtb72f fusion protein vaccine VO:0004109 Ningxian Fan Oliver He Ronak Sutariya Recombinant RNA replicons from attenuated VEE virus VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=181 181 vaccine recombinant RNA replicons from attenuated VEE virus vaccine VO:0004110 Ningxian Fan Oliver He Ronak Sutariya Nontypeable H. influenzae Outer Membrane Protein P1 vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=182 182 vaccine Nontypeable Haemophilus influenzae Outer Membrane Protein P1 vaccine VO:0004111 Ningxian Fan Oliver He Ronak Sutariya Chimeric SIN/VEE Virus SIN-83 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=183 183 vaccine Chimeric SIN/VEE Virus SIN-83 vaccine VO:0004112 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=184 184 80 40213253 Venezuelan equine encephalitis, live, attenuated VEE, live vaccine Live attenuated VEE vaccines VO:0004113 Ningxian Fan Oliver He Ronak Sutariya Live attenuated V3526 virus VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=185 185 vaccine live attenuated V3526 virus vaccine VO:0004114 Ningxian Fan Oliver He Ronak Sutariya Nontypeable H. influenzae outer membrane recombinant P4 vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=187 187 vaccine Nontypeable Haemophilus influenzae outer membrane recombinant P4 vaccine VO:0004115 Ningxian Fan Oliver He Ronak Sutariya Non-typeable H. influenzae dLOS-P6 vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=196 196 vaccine Nontypeable Haemophilus influenzae dLOS-P6 vaccine VO:0004116 Ningxian Fan Oliver He Ronak Sutariya Defective adenovirus expressing VEEV E2 glycoprotein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=197 197 vaccine defective adenovirus expressing VEEV E2 glycoprotein vaccine VO:0004117 Ningxian Fan Oliver He Ronak Sutariya Marburg virus-like particles VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=216 216 vaccine Marburg virus-like particles vaccine VO:0004118 Ningxian Fan Oliver He Ronak Sutariya Adenovirus vectors expressing Marburg virus glycoprotein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=217 217 vaccine Adenovirus vectors expressing Marburg virus glycoprotein vaccine VO:0004119 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=218 218 vaccine DNA vaccine encoding ANDV glycoproteins VO:0004120 Ningxian Fan Oliver He Ronak Sutariya Chimaeric HBV core particles carrying Puumala virus nucleocapsid protein fragments VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=219 219 vaccine Chimaeric HBV core particles carrying Puumala virus nucleocapsid protein fragments vaccine VO:0004121 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=220 220 vaccine Avirulent Salmonella vaccine strain carrying C. jejuni cjaA gene VO:0004122 Ningxian Fan Oliver He Ronak Sutariya BCG auxotroph expressing HIV-1 clade immunogen VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=224 224 vaccine BCG auxotroph expressing HIV-1 clade immunogen vaccine VO:0004123 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA vaccine pAK4-sod VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=225 225 vaccine Mycobacterium tuberculosis DNA vaccine pAK4-sod VO:0004124 Ningxian Fan Oliver He Ronak Sutariya deltaphoP/Q S. typhimurium strains expressing PEB1-ss VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=226 226 vaccine deltaphoP/Q Salmonella typhimurium strains expressing PEB1-ss vaccine VO:0004125 Ningxian Fan Oliver He Ronak Sutariya Recombinant VEE Replicons expressing MBGV GP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=227 227 vaccine recombinant VEE Replicons expressing MBGV GP vaccine VO:0004126 Ningxian Fan Oliver He Ronak Sutariya Recombinant VEE Replicons expressing MBGV NP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=228 228 vaccine recombinant VEE Replicons expressing MBGV NP vaccine VO:0004127 Ningxian Fan Oliver He Ronak Sutariya Irradiated MBGV antigen VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=229 229 vaccine Irradiated MBGV antigen vaccine VO:0004128 Ningxian Fan Oliver He Ronak Sutariya Marburg virus glycoprotein expressed by baculovirus recombinants VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=230 230 vaccine Marburg virus glycoprotein expressed by baculovirus recombinants vaccine VO:0004129 Ningxian Fan Oliver He Ronak Sutariya Q-VAX VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=237 237 vaccine Q-VAX vaccine VO:0004130 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=238 238 vaccine Multivalent DNA vaccine for B. anthracis, Ebola virus, Marburg virus, and VEE virus VO:0004131 Ningxian Fan Oliver He Ronak Sutariya M-44 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=240 240 vaccine M-44 vaccine VO:0004132 Ningxian Fan Oliver He Ronak Sutariya Chloroform-methanol residue (CMR) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=241 241 vaccine Chloroform-methanol residue (CMR) vaccine VO:0004133 Ningxian Fan Oliver He Ronak Sutariya P1-HspB (fusion of protein 1 and heat-shock protein B) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=242 242 vaccine P1-HspB (fusion of protein 1 and heat-shock protein B) vaccine VO:0004134 Ningxian Fan Oliver He Ronak Sutariya Coxevac VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=243 243 vaccine Coxevac vaccine VO:0004135 Ningxian Fan Oliver He Ronak Sutariya Chlamyvax FQ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=244 244 vaccine Chlamyvax FQ vaccine VO:0004136 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=245 245 vaccine VSV-based vaccine expressing MBGV GP VO:0004137 Ningxian Fan Oliver He Ronak Sutariya Heterologous MARV Protein VLP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=246 246 vaccine heterologous MARV protein VLP vaccine VO:0004138 Ningxian Fan Oliver He Ronak Sutariya CVD 909 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=250 250 vaccine CVD 909 vaccine VO:0004139 Ningxian Fan Oliver He Ronak Sutariya CVD 915 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=253 253 vaccine CVD 915 vaccine VO:0004140 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=255 255 vaccine Broilact Chick Salmonella vaccine VO:0004141 Ningxian Fan Oliver He Ronak Sutariya Zoosaloral H. VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=256 256 vaccine Zoosaloral H. vaccine VO:0004142 Ningxian Fan Oliver He Ronak Sutariya Salmonella vacT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=257 257 vaccine Salmonella vacT vaccine VO:0004143 Ningxian Fan Oliver He Ronak Sutariya S. flexneri 2a strain CVD 1205 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=261 261 vaccine Shigella flexneri 2a strain CVD 1205 vaccine VO:0004144 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=276 276 vaccine E. coli heat-labile enterotoxin B-subunit (LB-T) vaccine VO:0004145 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=282 282 vaccine shiga toxin 2 B subunit vaccine VO:0004146 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=296 296 vaccine Brucella ovis microparticle subunit vaccine VO:0004147 Ningxian Fan Oliver He Ronak Sutariya Live, Attenuated Rifampin-Resistant Rough Mutants of Brucella melitensis VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=297 297 vaccine live, attenuated Rifampin-resistant rough mutants of Brucella melitensis vaccine VO:0004148 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=303 303 vaccine DNA vaccine co-expressing A85A and caspase-3 VO:0004149 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=305 305 vaccine Recombinant vaccinia A27L, D8L, and B5R Proteins with adjuvant MPL-TDM VO:0004150 Ningxian Fan Oliver He Ronak Sutariya Killed Vaccinia Virus with Adjuvant NanoEmulsion VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=311 311 vaccine killed vaccinia virus vaccine with adjuvant NanoEmulsion VO:0004151 Ningxian Fan Oliver He Ronak Sutariya Yellow Fever NS1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=781 781 vaccine yellow fever NS1 protein vaccine VO:0004152 Ningxian Fan Oliver He Ronak Sutariya vP869 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=783 783 vaccine vP869 vaccine VO:0004153 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=785 785 vaccine Varicella subunit vaccine encoding gI and gE glycoproteins VO:0004154 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=814 814 vaccine TBEV DNA vaccine encoding E protein VO:0004155 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=820 820 vaccine Pseduorabies Subunit Glycoprotein C vaccine VO:0004156 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=827 827 vaccine Pseudorabies recombinant vector vaccine encoding gp50 and gII protein VO:0004157 Ningxian Fan Oliver He Ronak Sutariya Y. pestis YscF Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=886 886 vaccine Yersinia pestis YscF protein vaccine VO:0004158 Ningxian Fan Oliver He Ronak Sutariya Y. pestis DNA vaccine encoding dfF1 Protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=906 906 vaccine Yersinia pestis DNA vaccine encoding dfF1 protein VO:0004159 Ningxian Fan Oliver He Ronak Sutariya RASV expressing Y. pestis Psn VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=908 908 vaccine RASV expressing Yersinia pestis Psn vaccine VO:0004160 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=914 914 vaccine Rotavirus VP2/VP 6 protein vaccine VO:0004161 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=917 917 vaccine Rotavirus VP4/VP7 protein vaccine VO:0004162 Ningxian Fan Oliver He Ronak Sutariya P. yoelii DNA vaccine encoding PyHEP17 Protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=927 927 vaccine Plasmodium yoelii DNA vaccine encoding PyHEP17 protein VO:0004163 Ningxian Fan Oliver He Ronak Sutariya N. caninum DNA vaccine encoding NcSAG1 and NcSRS2, combined with recombinant NcSAG1 and NcSRS2 proteins VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=935 935 vaccine Neospora caninum DNA vaccine encoding NcSAG1 and NcSRS2, combined with recombinant NcSAG1 and NcSRS2 Protein VO:0004164 Ningxian Fan Oliver He Ronak Sutariya N. caninum MIC10 and p24 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=946 946 vaccine Neospora caninum MIC10 and p24 protein vaccine VO:0004165 Ningxian Fan Oliver He Ronak Sutariya CCPS-P64kR VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=953 953 vaccine CCPS-P64kR vaccine VO:0004166 Ningxian Fan Oliver He Ronak Sutariya C. botulinum DNA vaccine pSCARSA/BHc VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=983 983 vaccine Clostridium botulinum DNA vaccine pSCARSA/BHc VO:0004167 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=991 991 vaccine influenza virus DNA vaccine encoding HA of Equine influenza virus H3N8 VO:0004168 Ningxian Fan Oliver He Ronak Sutariya Recombinant vesicular stomatitis virus encoding HA from Influenza A virus (A/WSN/1933(H1N1)) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=992 992 vaccine recombinant vesicular stomatitis virus encoding HA from Influenza A virus (A/WSN/1933(H1N1)) vaccine VO:0004169 Ningxian Fan Oliver He Ronak Sutariya Recombinant baculovirus encoding HA from Influenza A virus (A/Puerto Rico/8/1934(H1N1)) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=995 995 vaccine recombinant baculovirus encoding HA from Influenza A virus (A/Puerto Rico/8/1934(H1N1)) vaccine VO:0004170 Ningxian Fan Oliver He Ronak Sutariya Recombinant vaccinia virus encoding HA from Influenza B virus (Strain B/England/222/82) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=996 996 vaccine recombinant vaccinia virus encoding HA from Influenza B virus (Strain B/England/222/82) vaccine VO:0004171 Ningxian Fan Oliver He Ronak Sutariya L. major DNA Vaccine encoding LACKp24, TSA, LmSTI1 and CPa VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1000 1000 vaccine Leishmania major DNA vaccine encoding LACKp24, TSA, LmSTI1 and CPa VO:0004172 Ningxian Fan Oliver He Ronak Sutariya L. major DNA Vaccine encoding SP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1001 1001 vaccine Leishmania major DNA vaccine encoding SP VO:0004173 Ningxian Fan Oliver He Ronak Sutariya pCAGGoptiHA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1002 1002 vaccine pCAGGoptiHA vaccine VO:0004174 Ningxian Fan Oliver He Ronak Sutariya BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1)) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1007 1007 vaccine BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1)) vaccine VO:0004175 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1010 1010 vaccine Flagellin-based HA globular head fusion vaccine using HA protein from Influenza A virus (A/Viet Nam/1203/2004(H5N1)) VO:0004176 Ningxian Fan Oliver He Ronak Sutariya L. major H1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1011 1011 vaccine Leishmania major H1 protein vaccine VO:0004177 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1015 1015 vaccine influenza virus DNA vaccine encoding M1 from influenza A virus (A/chicken/Henan/12/2004(H5N1)) VO:0004178 Ningxian Fan Oliver He Ronak Sutariya AdH5-FluA NP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1021 1021 vaccine AdH5-FluA NP vaccine VO:0004179 Ningxian Fan Oliver He Ronak Sutariya L. donovani LD31 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1030 1030 vaccine Leishmania donovani LD31 protein vaccine VO:0004180 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1032 1032 vaccine Leishmania vaccine using recombinant L. tarentolae strain expressing A2 antigen VO:0004181 Ningxian Fan Oliver He Ronak Sutariya T. annulata Tams1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1055 1055 vaccine Theileria annulata Tams1 protein vaccine VO:0004182 Ningxian Fan Oliver He Ronak Sutariya S. typhi DnaJ Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1056 1056 vaccine Salmonella typhi DnaJ protein vaccine VO:0004183 Ningxian Fan Oliver He Ronak Sutariya S. typhi GroEL Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1057 1057 vaccine Salmonella typhi GroEL protein vaccine VO:0004184 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1060 1060 vaccine Salmonella IroN protein vaccine VO:0004185 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1062 1062 vaccine Salmonella DNA vaccine encoding SopB Protein VO:0004186 Ningxian Fan Oliver He Ronak Sutariya S. typimurium Vi4072 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1063 1063 vaccine Salmonella typimurium Vi4072 vaccine VO:0004187 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1068 1068 vaccine Measles Virus vaccine VEE/SIN-H VO:0004188 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi DbpA and OspA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1073 1073 vaccine Borrelia burgdorferi DbpA and OspA Protein vaccine VO:0004189 Ningxian Fan Oliver He Ronak Sutariya P. aeruginosa DNA Vaccine encoding OprF VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1079 1079 vaccine Pseudomonas aeruginosa DNA vaccine encoding OprF VO:0004190 Ningxian Fan Oliver He Ronak Sutariya P. aeruginosa OprI Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1080 1080 vaccine Pseudomonas aeruginosa OprI protein vaccine VO:0004191 Ningxian Fan Oliver He Ronak Sutariya P. aeruginosa PcrV Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1081 1081 vaccine Pseudomonas aeruginosa PcrV protein vaccine VO:0004192 Ningxian Fan Oliver He Ronak Sutariya S. aureus DNA Vaccine encoding PBP2a Protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1085 1085 vaccine Staphylococcus aureus DNA vaccine encoding PBP2a Protein VO:0004193 Ningxian Fan Oliver He Ronak Sutariya P. falciparum LSA-3 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1096 1096 vaccine Plasmodium falciparum LSA-3 protein vaccine VO:0004194 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1102 1102 vaccine P. chabaudi AMA1 Protein Vaccine VO:0004195 Ningxian Fan Oliver He Ronak Sutariya P. falciparum CS expressed in irradiated P. berghei as Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1103 1103 vaccine Plasmodium falciparum CS expressed in irradiated Plasmodium berghei vaccine VO:0004196 Ningxian Fan Oliver He Ronak Sutariya P. falciparum DNA Vaccine encoding EBA-175 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1104 1104 vaccine Plasmodium falciparum DNA vaccine encoding EBA-175 VO:0004197 Ningxian Fan Oliver He Ronak Sutariya pcDNA3-LiP0 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1106 1106 vaccine pcDNA3-LiP0 vaccine VO:0004198 Ningxian Fan Oliver He Ronak Sutariya VVr expressing L. infantum P36/LACK VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1107 1107 vaccine VVr expressing L. infantum P37/LACK vaccine VO:0004199 Ningxian Fan Oliver He Ronak Sutariya L. amazonensis CP Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1110 1110 vaccine Leishmania amazonensis CP Protein vaccine VO:0004200 Ningxian Fan Oliver He Ronak Sutariya S. agalactiae BipA Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1112 1112 vaccine Streptococcus agalactiae BipA protein vaccine VO:0004201 Ningxian Fan Oliver He Ronak Sutariya J5dLPS/OMP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1118 1118 vaccine J5dLPS/OMP vaccine VO:0004202 Ningxian Fan Oliver He Ronak Sutariya C. muridarum Tarp subunit vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1119 1119 vaccine Chlamydia muridarum Tarp subunit vaccine VO:0004203 Ningxian Fan Oliver He Ronak Sutariya C. jejuni PorA protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1120 1120 vaccine Campylobacter jejuni PorA protein vaccine VO:0004204 Ningxian Fan Oliver He Ronak Sutariya P. falciparum pfCelTos protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1121 1121 vaccine Plasmodium falciparum pfCelTos protein vaccine VO:0004205 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/806594 806594 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] 40153533 CUI: C2364909 RXAUI: 5027374 TUI: T200 vaccine BOOSTRIX vaccine Prefilled Syringe VO:0004206 Kallan Roan Oliver He Boostrix (Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 8 MCG / Bordetella pertussis pertactin vaccine, inactivated 2.5 MCG / Bordetella pertussis toxoid vaccine, inactivated 8 MCG / diphtheria toxoid vaccine, inactivated 2.5 UNT / tetanus toxoid vaccine, inactivated 5 UNT) per 0.5 ML Prefilled Syringe Boostrix Tdap (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) 0.5 ML Prefilled Syringe http://purl.bioontology.org/ontology/RXNORM/1300370 1300370 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Boostrix] 42800267 CUI: C2364910 RXAUI: 5027662, 7253757, 4625540, 4625564 TUI: T200 vaccine BOOSTRIX vaccine 0.5 ML Prefilled Syringe VO:0004207 http://purl.bioontology.org/ontology/RXNORM/1300365 CUI: C3474172 RXAUI: 4625526 TUI: T200 vaccine Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML VO:0004208 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1368371 1368371 Bacillus anthracis strain V770-NP1-R antigens 46274593 vaccine component CUI: C3535682 RXAUI: 5068281 TUI: T116, T129, T121 BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS VO:0004209 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2074 2074 vaccine Ovine Ecthyma live virus vaccine by Colorado Serum Company CZ Veterinaria VO:0004210 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2075 2075 vaccine Ovine Ecthyma live virus vaccine by Texas Agricultural Experiment Station VO:0004211 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2149 2149 vaccine West Nile Virus DNA Vaccine (USDA: 1995.D0) VO:0004212 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2736 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2737 2736 2737 vaccine Canine Parainfluenza Modified Live Virus Vaccine-Leptospira Canicola-Icterohaemorrhagiae Bacterin (USDA: 47A9.20) VO:0004213 Jie Zheng Kallan Roan Oliver He Xingxian Li obsolete BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS 0.1 MG/ML true VO:0004214 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2979 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2980 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2981 2979 2980 2981 vaccine Porcine Reproductive & Respiratory Syndrome Respiratory Form, Modified Live Virus Vaccine-Erysipelothrix Rhusiopathiae-Haemophilus Parasuis Bacterin (USDA: 49V9.20) VO:0004215 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1174360 CUI: C3228377 RXAUI: 3830942 TUI: T200 vaccine Biothrax Injectable Product VO:0004216 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1799963 obsolete BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS 0.1 MG/ML [Biothrax] true VO:0004217 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2982 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=2983 2982 2983 vaccine Porcine Reproductive & Respiratory Syndrome Respiratory Form, Modified Live Virus Vaccine-Haemophilus Parasuis Bacterin (USDA: 49Q9.20) VO:0004218 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/832681 CUI: C2608510 RXAUI: 2943547 TUI: T200 vaccine Biothrax Injectable Suspension VO:0004219 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine encoding MIC8 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3038 3038 vaccine Toxoplasma gondii DNA vaccine encoding MIC8 VO:0004220 Ningxian Fan Oliver He Ronak Sutariya S. aureus IsdB subunit vaccine (V710) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3039 3039 vaccine Staphylococcus aureus IsdB subunit vaccine (V710) VO:0004221 Ningxian Fan Oliver He Ronak Sutariya P. multocida rOmpH Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3040 3040 vaccine Pasteurella multocida rOmpH vaccine VO:0004222 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3046 3046 vaccine Inactivated PMV-3 vaccine with Specol VO:0004223 Ningxian Fan Oliver He Ronak Sutariya B. anthracis rPA Vaccine with Rehydragel HPA adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3047 3047 vaccine Bacillus anthracis rPA vaccine with Rehydragel HPA adjuvant VO:0004224 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3048 3048 vaccine Rotavirus Chimeric VP6 protein vaccine VO:0004225 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3050 3050 vaccine BHV1 gD subunit vaccine VO:0004226 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3051 3051 vaccine BVDV Inactivated vaccine VO:0004227 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:9725239 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3053 https://github.com/vaccineontology/VO/issues/369 1489079 3053 cancer vaccine Gene name: E7 cancer vaccine using E7 protein of human papillomavirus 16 and Algammulin VO:0004228 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:10931134 PMID:9725239 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3054 https://github.com/vaccineontology/VO/issues/370 1489079 3054 cancer vaccine Gene name: E7 cancer vaccine using E7 protein of human papillomavirus 16 and Quil-A VO:0004229 Ningxian Fan Oliver He Ronak Sutariya E. maxima oocysts with Arlacel A vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3056 3056 vaccine Eimeria maxima oocysts with Arlacel A vaccine VO:0004230 Ningxian Fan Oliver He Ronak Sutariya Tetanus Toxoid with Calcium Phosphate VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3057 3057 vaccine Tetanus Toxoid vaccine with Calcium Phosphate VO:0004231 Ningxian Fan Oliver He Ronak Sutariya Tetanus Toxoid with Stearyl Tyrosine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3058 3058 vaccine Tetanus Toxoid vaccine with Stearyl Tyrosine VO:0004232 Ningxian Fan Oliver He Ronak Sutariya V3 VLPs with Gamma inulin adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3059 3059 vaccine V3 VLPs vaccine with Gamma inulin adjuvant VO:0004233 Ningxian Fan Oliver He Ronak Sutariya gp120 recominant with GMDP adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3061 3061 vaccine gp120 recominant vaccine with GMDP adjuvant VO:0004234 Ningxian Fan Oliver He Ronak Sutariya gp120 recominant with MDP adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3062 3062 vaccine gp120 recominant vaccine with MDP adjuvant VO:0004235 Ningxian Fan Oliver He Ronak Sutariya rHA with IL-1Beta adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3063 3063 vaccine rHA with IL-1Beta adjuvant vaccine VO:0004236 Ningxian Fan Oliver He Ronak Sutariya rHA with IL-2 adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3064 3064 vaccine rHA with IL-2 adjuvant vaccine VO:0004237 Ningxian Fan Oliver He Ronak Sutariya rHA with IL-7 adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3065 3065 vaccine rHA with IL-7 adjuvant vaccine VO:0004238 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3067 3067 vaccine gp140, Gag and Tat protein vaccine with MF59 VO:0004239 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3068 3068 vaccine HBsAg liposomal MTP-PE vaccine VO:0004240 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3069 3069 vaccine synthetic OMP1 vaccine VO:0004241 Ningxian Fan Oliver He Ronak Sutariya L. donovani Recombinant Ld-Gamma-GCS in NIV system Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3070 3070 vaccine Leishmania donovani recombinant Ld-Gamma-GCS in NIV system vaccine VO:0004242 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3071 3071 vaccine inactivated HIV-2 vaccine with PMMA VO:0004243 Ningxian Fan Oliver He Ronak Sutariya P. falciparum MSP4 with AFCo1 Adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3072 3072 vaccine Plasmodium falciparum MSP4 vaccine with AFCo1 adjuvant vaccine VO:0004244 Ningxian Fan Oliver He Ronak Sutariya Inactivated split Mem 71 Virus with SPT adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3073 3073 vaccine Inactivated split Mem 71 Virus with SPT adjuvant vaccine VO:0004245 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3074 3074 cancer vaccine Recombinant Colorectal cancer antigen GA733 Vaccine VO:0004246 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3076 3076 vaccine Anthrax vaccine adsorbed with Squalene adjuvant VO:0004247 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3077 3077 vaccine Group A streptococcal recombinant fusion peptide vaccine VO:0004248 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3078 3078 cancer vaccine recombinant NY-ESO-1 protein vaccine adjuvanted with imiquimod VO:0004249 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3080 3080 vaccine Mutagrip vaccine with P40 adjuvant VO:0004250 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:28706878 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3081 https://github.com/vaccineontology/VO/issues/241 1489079 3081 cancer vaccine Gene name: E7 attenuated Listeria expressing cancer antigen vaccine VO:0004251 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3082 3082 vaccine recombinant S gene Hepatitis B vaccine with rIFN-gamma VO:0004252 Ningxian Fan Oliver He Ronak Sutariya Y. pestis F1 antigen Vaccine with Flagellin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3083 3083 vaccine Yersinia pestis F1 antigen vaccine with Flagellin VO:0004253 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3084 3084 vaccine inactivated H1N1(2009) vaccine with AF03 adjuvant VO:0004254 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3085 3085 cancer vaccine recombinant NY-ESO-1 ISCOMATRIX vaccine VO:0004255 Ningxian Fan Oliver He Ronak Sutariya Recombinant PA with Poly(I:C) Adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3086 3086 vaccine recombinant PA vaccine with Poly(I:C) adjuvant VO:0004256 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3087 3087 vaccine recombinant Tir protein vaccine VO:0004257 Ningxian Fan Oliver He Ronak Sutariya C. muridarum PmpG-1, PmpE/F-2, and MOMP Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3089 3089 vaccine Chlamydia muridarum PmpG-1, PmpE/F-2, and MOMP protein vaccine VO:0004258 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3091 3091 cancer vaccine synthetic MUC1 peptide vaccine VO:0004259 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3092 3092 vaccine HIV-2 DNA vaccine VO:0004260 Ningxian Fan Oliver He Ronak Sutariya Hepatitis B surface antigen (HBsAg) with JVRS-1000 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3093 3093 vaccine Hepatitis B surface antigen (HBsAg) with JVRS-1000 vaccine VO:0004261 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3094 3094 vaccine live TC-83 VEE vaccine with DHEA VO:0004262 Ningxian Fan Oliver He Ronak Sutariya obsolete E. coli CS3 in PLGA microspheres violinID: 3095 true VO:0004263 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3096 3096 vaccine MVA/IL-15/5Mtb vaccine VO:0004264 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3097 3097 vaccine rgp120 HIV vaccine with immunoliposomes VO:0004265 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3098 3098 vaccine pneumococcal polysaccharide conjugate vaccine serotype 1 (PNC-1) VO:0004266 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3099 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5966 3099 5966 vaccine LEISH-F1+MPL-SE vaccine VO:0004267 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3100 3100 vaccine HSV glycoproteins subunit vaccine VO:0004268 Ningxian Fan Oliver He Ronak Sutariya HIV-1 gp120 with mCT E112K VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3101 3101 vaccine HIV-1 gp120 with mCT E112K vaccine VO:0004269 Ningxian Fan Oliver He Ronak Sutariya P. falciparum MSA-2 subunit vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3103 3103 vaccine Plasmodium falciparum MSA-2 subunit vaccine VO:0004270 Ningxian Fan Oliver He Ronak Sutariya B. anthracis PA protein Vaccine with TMDP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3104 3104 vaccine Bacillus anthracis PA protein vaccine with TMDP VO:0004271 Ningxian Fan Oliver He Ronak Sutariya P. yoelii TyCS-VLP Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3105 3105 vaccine Plasmodium yoelii TyCS-VLP vaccine VO:0004272 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3106 3106 vaccine pVAX-P1 DNA vaccine VO:0004273 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3107 3107 vaccine YopE(67-77) protein vaccine VO:0004274 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3108 3108 vaccine HIV recombinant gp160 protein vaccine VO:0004275 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3110 3110 vaccine human apo B-100 peptide-2 protein vaccine VO:0004276 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3111 3111 vaccine MDA-modified human apo B-100 peptide vaccine VO:0004277 A mucR mutant has a significantly reduced degree of colonization in mice and protects against wild type B. melitensis 16M Ningxian Fan Oliver He Rebecca Racz Ronak Sutariya B. melitensis mucR mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3117 3117 vaccine Brucella melitensis mucR mutant vaccine VO:0004278 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3147 3147 vaccine Tick-borne Encephalitis Virus C protein mutant vaccine VO:0004279 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3207 3207 vaccine Mycobacterium tuberculosis mce-2 mutant vaccine VO:0004280 Ningxian Fan Oliver He Ronak Sutariya Aflunov VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3285 3285 vaccine Aflunov vaccine VO:0004281 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3286 3286 vaccine Fluad vaccine VO:0004282 Ningxian Fan Oliver He Ronak Sutariya Focetria VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3287 3287 vaccine Focetria vaccine VO:0004283 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3288 3288 vaccine Brucella abortus S19 vjbR mutant vaccine VO:0004284 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3289 3289 vaccine African Swine Fever Virus 9GL mutant vaccine VO:0004285 Ningxian Fan Oliver He Ronak Sutariya Recombinant B. abortus CobB protein with CFA/IFA adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3292 3292 vaccine recombinant Brucella abortus CobB protein vaccine with CFA/IFA adjuvant VO:0004286 Ningxian Fan Oliver He Ronak Sutariya Recombinant B. abortus AsnC protein with CFA/IFA adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3293 3293 vaccine recombinant Brucella abortus AsnC protein vaccine with CFA/IFA adjuvant VO:0004287 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3294 3294 vaccine M2 mutant from influenza A vaccine VO:0004288 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3296 3296 vaccine Mycobacterium tuberculosis mce-3 mutant vaccine VO:0004289 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3299 3299 vaccine Bovine Respiratory Syncytial Virus recombinant vector vaccine BHVl/BRSVG encoding the G protein VO:0004290 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3301 3301 vaccine influenza virus DNA vaccine BacPAKHA encoding EqfKY HA VO:0004291 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3303 3303 vaccine influenza virus DNA vaccine p188 encoding H7 VO:0004292 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3304 3304 vaccine influenza virus DNA vaccine pCMV/Hl encoding H1 VO:0004293 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3305 3305 vaccine influenza virus DNA vaccine pCMV/H7 VO:0004294 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3306 3306 vaccine influenza virus DNA vaccine pIRES/HA encoding HA VO:0004295 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3307 3307 vaccine influenza virus DNA vaccine pIRES/NA expressing NA VO:0004296 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3308 3308 vaccine influenza virus DNA vaccine pIRES/HA/IL-2 expressing HA VO:0004297 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3309 3309 vaccine influenza virus DNA vaccine pIRES/NA/IL-2 encoding NA VO:0004298 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3310 3310 vaccine influenza virus DNA vaccine pIRES/HA/GM-CSF encoding HA VO:0004299 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3311 3311 vaccine influenza virus DNA vaccine pIRES/NA/GM-CSF encoding NA VO:0004300 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3312 3312 vaccine influenza virus DNA vaccine pIRES/HA/IL-12p35 + pIRES/NA/IL-12p40 VO:0004301 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3316 3316 vaccine influenza virus DNA vaccine pRSV-NP encoding the coding sequence from influenza virus A/PR/8/34. VO:0004302 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3318 3318 vaccine influenza virus DNA vaccine pHA/NP147-155 encoding NP147-155 VO:0004303 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3320 3320 vaccine influenza virus DNA vaccine pBK-SFV-NP VO:0004304 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3322 3322 vaccine influenza virus DNA vaccine pBK-SFV-HA VO:0004305 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3324 3324 vaccine influenza virus DNA vaccine HA-DNA VO:0004306 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3327 3327 vaccine influenza virus DNA vaccine d1TTFC-NP encoding NP VO:0004307 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3330 3330 vaccine influenza virus DNA vaccine A/NP VO:0004308 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3331 3331 vaccine influenza virus DNA vaccine NP DNA VO:0004309 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3332 3332 vaccine influenza virus DNA vaccine HA DNA VO:0004310 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3333 3333 vaccine influenza virus DNA vaccine NA-DNA VO:0004311 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3338 3338 vaccine influenza virus DNA vaccine H5 DNA VO:0004312 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine pSAG1-ROP2-SAG2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3342 3342 vaccine Toxoplasma gondii DNA vaccine pSAG1-ROP2-SAG2 VO:0004313 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine pcDNA3.1-SAG1-ROP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3343 3343 vaccine Toxoplasma gondii DNA vaccine pcDNA3.1-SAG1-ROP2 VO:0004314 Ningxian Fan Oliver He Ronak Sutariya Y. pestis DNA vaccine F1-V DNA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3344 3344 vaccine Yersinia pestis DNA vaccine F1-V DNA VO:0004315 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3349 3349 vaccine Bovine herpesvirus 1 DNA vaccine pRSVgIV VO:0004316 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3350 3350 vaccine Bovine herpesvirus 1 recombinant vector vaccine BHVl/BRSVG VO:0004317 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3357 3357 vaccine Bovine herpesvirus 1 DNA vaccine pMASIAtgB encoding a truncated, secreted form of gB VO:0004318 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3359 3359 vaccine Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDFL encoding gD VO:0004319 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3360 3360 vaccine Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD VO:0004320 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3366 3366 vaccine Foot and mouth disease DNA vaccine pWRMHX encoding a minimal self-cleaving ribozyme VO:0004321 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3369 3369 vaccine IHNV DNA vaccine pCMV4-G VO:0004322 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3370 3370 vaccine IHNV DNA vaccine pCMV4-N encoding the nucleoprotein VO:0004323 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3372 3372 vaccine Murine cytomegalovirus DNA vaccine pcDNA-89 encoding pp89 VO:0004324 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3373 3373 vaccine Newcastle disease virus DNA vaccine pCAGF encoding the F protein VO:0004325 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3374 3374 vaccine PRRSV DNA vaccine GST-ORF5 encoding GP5 VO:0004326 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3375 3375 vaccine Rabies virus DNA vaccine pSG5rab.gp VO:0004327 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3376 3376 vaccine Lymphocytic choriomeningitis virus DNA vaccine pCMV-NP VO:0004328 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3379 3379 vaccine Human papillomavirus DNA vaccine VlJns-Ll encoding L1 VO:0004329 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3380 3380 vaccine Human papillomavirus DNA vaccine Pe7(pcDNA3-Sig/sE7/LAMP) encoding E7 VO:0004330 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3383 3383 vaccine Human papillomavirus DNA vaccine pC16-L1 encoding L1 VO:0004331 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3384 3384 vaccine Human papillomavirus DNA vaccine CRT/E7 DNA VO:0004332 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3388 3388 vaccine Human papillomavirus DNA vaccine E7IR VO:0004333 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3389 3389 vaccine Human papillomavirus DNA vaccine E7SH DNA VO:0004334 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3392 3392 vaccine Ebola virus DNA vaccine GP DNA VO:0004335 Ningxian Fan Oliver He Ronak Sutariya Ebola virus recombinant rAD-GP encoding GP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3393 3393 vaccine Ebola virus recombinant rAD-GP encoding GP vaccine VO:0004336 Ningxian Fan Oliver He Ronak Sutariya Ebola virus recombinant VSVΔG-GP encoding GP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3394 3394 vaccine Ebola virus recombinant VSVΔG-GP encoding GP vaccine VO:0004337 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3395 3395 vaccine Ebola virus recombinant vector vaccine EBO7 encoding GP from SEBOV and ZEBOV VO:0004338 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3396 3396 vaccine VHSV DNA vaccine pCMV-vhsG encoding glycoprotein G VO:0004339 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3397 3397 vaccine VHSV DNA vaccine pCMV-vhsN encoding nucleocapsid protein N and glycoprotein G VO:0004340 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3398 3398 vaccine Classical swine fever virus DNA vaccine pCI-gp55 VO:0004341 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3401 3401 vaccine Human cytomegalovirus DNA vaccine VCL-CB01 encoding phosphoprotein 65 and gB VO:0004342 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3426 3426 vaccine HIV DNA vaccine Ad26/Ad5HVR48 encoding HIV or SIV env or gag VO:0004343 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3430 3430 vaccine SIV DNA vaccine pVacc4 encoding env from mac239 VO:0004344 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3439 3439 vaccine HIV DNA vaccine SHIV-89.6 DNA (DNA/89.6) VO:0004345 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3449 3449 vaccine HIV DNA vaccine pCMN160 VO:0004346 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3468 3468 vaccine SIV DNA vaccine pSIVgag and pmacIL-15 encoding SIV core protein VO:0004347 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3478 3478 vaccine HIV recombinant vector vaccine MVA-gag encoding gag VO:0004348 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3481 3481 vaccine HIV DNA vaccine pHIS-SHIV-B VO:0004349 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3485 3485 vaccine HIV DNA vaccine SIVmac239 Gag-Pol-Nef and mock Env with rAd5 boost VO:0004350 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3491 3491 vaccine HIV recombinant vector vaccine MVA.HIVA encoding env and rev VO:0004351 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3497 3497 vaccine HIV DNA vaccine VlJns-tPA-gp120 VO:0004352 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3510 3510 vaccine Hepatitis B DNA vaccine PLGA-CTAB-DNA encoding the small envelope gene VO:0004353 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3516 3516 vaccine Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins VO:0004354 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3519 3519 vaccine Hepatitis B DNA vaccine pRc/CMV-HBs(S) encoding HBsAg VO:0004355 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3520 3520 vaccine influenza virus DNA vaccine pDNA encoding M2 and NP VO:0004356 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA vaccine pcDNA3.1+/Ag85A DNA encoding Ag85A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3522 3522 vaccine Mycobacterium tuberculosis DNA vaccine pcDNA3.1+/Ag85A DNA encoding Ag85A VO:0004357 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3524 3524 vaccine Hepatitis B DNA vaccine pS encoding major envelope proteins VO:0004358 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3525 3525 vaccine Hepatitis B DNA vaccine pCMV-HBs encoding HBsAg VO:0004359 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3528 3528 vaccine Hepatitis B DNA vaccine pCEA/HBsAg encoding CEA and HBsAg VO:0004360 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3533 3533 vaccine Hepatitis B DNA vaccine pCMV-S2.S encoding the HBV(ayw Strain) envelope protein. VO:0004361 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3538 3538 vaccine Coxsackievirus DNA vaccine pCMV/VPl encoding VP1 VO:0004362 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA vaccine encoding Ag85B, MPT64 and MPT83 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3540 3540 vaccine Mycobacterium tuberculosis DNA vaccine encoding Ag85B, MPT64 and MPT83 VO:0004363 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA vaccine (containing the ESAT-6, MPT-64, MPT-83, and KatG constructs) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3546 3546 vaccine Mycobacterium tuberculosis DNA vaccine (containing the ESAT-6, MPT-64, MPT-83, and KatG constructs) VO:0004364 Ningxian Fan Oliver He Ronak Sutariya M. tuberculosis DNA vaccine DNAAg85A encoding a single immunogenic M.tb Ag VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3547 3547 vaccine Mycobacterium tuberculosis DNA vaccine DNAAg85A encoding a single immunogenic M.tb Ag VO:0004365 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3548 3548 vaccine Herpes simplex virus DNA vaccine gD-2 encoding gD VO:0004366 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3549 3549 vaccine Herpes simplex virus DNA vaccine Delta-gB-2 encoding gB VO:0004367 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3550 3550 vaccine Herpes simplex virus DNA vaccine ICP-27 DNA encoding ICP-27 VO:0004368 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3551 3551 vaccine Herpes simplex virus DNA vaccine gB-DNA encoding gB VO:0004369 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3552 3552 vaccine Herpes simplex virus DNA vaccine gBDNA encoding gB VO:0004370 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3553 3553 vaccine Herpes simplex virus DNA vaccine encoding gD and gB from HSV-2 strain Curtis VO:0004371 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3555 3555 vaccine Rabies virus DNA vaccine pCMV-intA-rabies encoding glycoprotein G VO:0004372 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3556 3556 vaccine Rabies virus DNA vaccine encoding the ERA glycoprotein VO:0004373 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3557 3557 vaccine Leishmania major DNA vaccine KMP-11 VO:0004374 Ningxian Fan Oliver He Ronak Sutariya T. cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3558 3558 vaccine Trypanosoma cruzi DNA vaccine encoding TSA-1, ASP-1, ASP-2 VO:0004375 Ningxian Fan Oliver He Ronak Sutariya T. cruzi DNA vaccine encoding ASP-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3559 3559 vaccine Trypanosoma cruzi DNA vaccine encoding ASP-2 VO:0004376 Ningxian Fan Oliver He Ronak Sutariya T. cruzi DNA vaccine pUB-ASP-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3560 3560 vaccine Trypanosoma cruzi DNA vaccine pUB-ASP-2 VO:0004377 Ningxian Fan Oliver He Ronak Sutariya T. cruzi DNA vaccine pTS encoding T. cruzi antigens VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3561 3561 vaccine Trypanosoma cruzi DNA vaccine pTS encoding Trypanosoma cruzi antigens VO:0004378 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3565 3565 vaccine Lassa fever virus recombinant vector vaccine V-LSG encoding the glycoprotein VO:0004379 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3567 3567 vaccine Lassa fever virus recombinant vector vaccine V-LSG/N encoding the glycoprotein and the nucleoprotein VO:0004380 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3570 3570 vaccine Lassa fever virus recombinant vector vaccine YFV17D/LASV-GPC encoding the glycoprotein precursor VO:0004381 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3574 3574 vaccine Ebola virus recombinant vector vaccine pVSVXN2-Delta-G/ZEBOVsGP encoding GP VO:0004382 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3579 3579 vaccine Ebola virus recombinant adenovirus vaccine AdC7-ZGP encoding GP VO:0004383 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3580 3580 vaccine Ebola virus recombinant vector vaccine Ad-CMVZGP encoding the glycoprotein VO:0004384 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3581 3581 vaccine Ebola virus recombinant vector vaccine Ad-CAGoptZGP encoding the envelope glycoprotein VO:0004385 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3591 3591 vaccine Ebola virus DNA vaccine DNA/rAd5 encoding ZEBOV and SEBOV antigens VO:0004386 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine PA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3593 3593 vaccine Bacillus anthracis DNA vaccine PA VO:0004387 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3594 3594 vaccine Marburg virus DNA vaccine MARV GP encoding GP VO:0004388 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3596 3596 vaccine Marburg virus recombinant vector vaccine CAdVax-Panfilo VO:0004389 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3598 3598 vaccine Marburg virus DNA prime/boost vaccine DNA/rAd5-GP encoding GP from strain Angola VO:0004390 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3599 3599 vaccine Marburg virus DNA vaccine DNA-GP encoding GP VO:0004391 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3600 3600 vaccine Marburg virus recombinant vector vaccine MBGV GP VO:0004392 Ningxian Fan Oliver He Ronak Sutariya B. abortus DNA vaccine pcDNA3.1-p39-L7/L12 encoding p39-L7/L12 fusion protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3605 3605 vaccine Brucella abortus DNA vaccine pcDNA3.1-p39-L7/L12 encoding p39-L7/L12 fusion protein VO:0004393 Ningxian Fan Oliver He Ronak Sutariya B. abortus DNA vaccine pcDNA3-SOD encoding Cu-Zn SOD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3607 3607 vaccine Brucella abortus DNA vaccine pcDNA3-SOD encoding Cu-Zn SOD VO:0004394 Ningxian Fan Oliver He Ronak Sutariya B. melitensis DNA vaccine pCI-Omp31 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3611 3611 vaccine Brucella melitensis DNA vaccine pCI-Omp31 VO:0004395 Ningxian Fan Oliver He Ronak Sutariya B. melitensis DNA vaccine pCIBLSOmp31 encoding BLSOmp31 (fusion protein) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3613 3613 vaccine Brucella melitensis DNA vaccine pCIBLSOmp31 encoding BLSOmp31 (fusion protein) VO:0004396 Ningxian Fan Oliver He Ronak Sutariya B. melitensis DNA vaccine p-Omp25 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3615 3615 vaccine Brucella melitensis DNA vaccine p-Omp25 VO:0004397 Ningxian Fan Oliver He Ronak Sutariya B. melitensis DNA vaccine p-ialB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3616 3616 vaccine Brucella melitensis DNA vaccine p-ialB VO:0004398 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3617 3617 cancer vaccine Lymphoma DNA vaccine V-Alpha-V-Beta-V-Beta-FrC VO:0004399 Ningxian Fan Oliver He Ronak Sutariya P. falciparum recombinant vector vaccine MVA.ME-TRAP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3628 3628 vaccine Plasmodium falciparum recombinant vector vaccine MVA.ME-TRAP VO:0004400 An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA encoding for prostate specific antigen (PSA), a tumor marker secreted by prostatic epithelial and ductal cells. When reintroduced back to the patient, these PSA RNA pulsed autologous dendritic cells may elicit a cytotoxic T-cell (CTL) response against PSA-positive prostate cancer cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3643 https://github.com/vaccineontology/VO/issues/175 3643 cancer vaccine Glypican-3-derived peptide vaccine for human hepatocellular carcinoma VO:0004401 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3647 3647 vaccine EAE DNA vaccine pZZ/MBP68-85 encoding MBP VO:0004402 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3649 3649 vaccine EAU DNA vaccine IRBP-DNA encoding IRBP VO:0004403 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3652 3652 vaccine Autoimmune diabetes DNA vaccine pND2-SGAD55 VO:0004404 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3653 3653 vaccine Autoimmune diabetes DNA vaccine pCMV-1/rGAD65 encoding GAD VO:0004405 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3655 3655 vaccine Autoimmune diabetes DNA vaccine pND2-GAD65-BAX encoding GAD and BAX VO:0004406 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3656 3656 vaccine Insulin-dependent diabetes mellitus DNA vaccine JwGAD65 + IL-4 VO:0004407 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3661 3661 vaccine Adjuvant arthritis DNA vaccine pCMV3.65 encoding HSP65 VO:0004408 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3662 3662 vaccine Pristane-induced arthritis DNA vaccine DNA-hsp65 encoding Mycobacterium leprae 65-kDa heat shock protein VO:0004409 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3663 3663 vaccine Adjuvant arthritis DNA vaccine CII encoding type II collagen VO:0004410 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3664 3664 vaccine Adjuvant arthritis DNA vaccine pcDNA-CCOL2A1 encoding type II collagen VO:0004411 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3665 3665 vaccine Herpes simplex virus DNA vaccine pSIN-gB encoding gB VO:0004412 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3666 3666 vaccine Herpes simplex virus DNA vaccine pCI-gB encoding gB VO:0004413 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi DNA vaccine pCMV-ZS7/TPA encoding OspC from Borrelia burgdorferi sensu lato VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3669 3669 vaccine Borrelia burgdorferi DNA vaccine pCMV-ZS7/TPA encoding OspC from Borrelia burgdorferi sensu lato VO:0004414 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3672 3672 vaccine C. tetani DNA vaccine pcDNA3tetC encoding fragment C VO:0004415 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3673 3673 vaccine West Nile virus DNA vaccine pCBWN encoding prM and E VO:0004416 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine pDNA encoding PA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3677 3677 vaccine Bacillus anthracis DNA vaccine pDNA encoding PA VO:0004417 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine LF pDNA encoding LF VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3678 3678 vaccine Bacillus anthracis DNA vaccine LF pDNA encoding LF VO:0004418 Ningxian Fan Oliver He Ronak Sutariya E. acervulina DNA vaccine 3-1E VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3681 3681 vaccine Eimeria acervulina DNA vaccine 3-1E VO:0004419 Ningxian Fan Oliver He Ronak Sutariya H. rhabdovirus DNA vaccine pHRV-G encoding HIRRV and VHSV G proteins VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3682 3682 vaccine Hirame rhabdovirus DNA vaccine pHRV-G encoding HIRRV and VHSV G protein VO:0004420 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3687 3687 vaccine IHNV DNA vaccine pCDNA-G encoding G VO:0004421 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3689 3689 vaccine VEE virus DNA vaccine VEEV IA/B parent encoding structural genes VO:0004422 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3690 3690 vaccine VEE virus recombinant vector vaccine RAd/VEEV VO:0004423 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3691 3691 vaccine VEE virus recombinant vector vaccine RAd/VEEV#2 VO:0004424 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3692 3692 vaccine VEE virus recombinant vector vaccine RAd/VEEV#3 encoding TC-83 VO:0004425 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15879128 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3695 https://github.com/vaccineontology/VO/issues/316 8132375 3695 cancer vaccine Gene name: Fragment C from tetanus toxin Cancer DNA vaccine p.DOM-AH1 encoding fragment C VO:0004426 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:18273615 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3696 https://github.com/vaccineontology/VO/issues/378 21423 3696 cancer vaccine Gene name: E2A Carcinoma DNA vaccine pVAX/E2A VO:0004427 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:12384547 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3698 https://github.com/vaccineontology/VO/issues/292 1945467 3698 cancer vaccine Gene name: Immunoglobulin B-cell lymphoma DNA vaccine VCL-1642.XXX encoding a chimeric immunoglobulin molecule onsisting of tumor-specific variable (Id) regions VO:0004428 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:12231517 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3699 https://github.com/vaccineontology/VO/issues/387 1048 128168861 3699 cancer vaccine CEA Gene name: S Colorectal cancer DNA vaccine pCEA/HBsAg encoding carcinoembryonic antigen and hepatitis B surface antigen VO:0004429 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:12496961 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3700 https://github.com/vaccineontology/VO/issues/294 22178 7306 3700 cancer vaccine Gene name: TYRP1 Gene name: Tyrp1 B16 melanoma DNA vaccine pSin-hTRP-1 encoding TRP-1 VO:0004430 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:12496961 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3701 https://github.com/vaccineontology/VO/issues/293 22178 7306 3701 cancer vaccine Gene name: TYRP1 Gene name: Tyrp1 B16 melanoma DNA vaccine pCMV-hTRP-1 encoding TRP-1 VO:0004431 Ningxian Fan Oliver He Ronak Sutariya Melanoma DNA vaccine TA2M(TM) encoding tyrosinase peptides VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3705 7299 3705 cancer vaccine Melanoma DNA vaccine TA2M encoding tyrosinase peptides VO:0004432 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3713 https://github.com/vaccineontology/VO/issues/518 3713 cancer vaccine Gene name: Survivin Melanoma DNA vaccine VR-S8/VR-IL2/AD-S8 encoding survivin VO:0004433 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3717 https://github.com/vaccineontology/VO/issues/512 2922 3717 cancer vaccine Gene name: GRP Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP VO:0004434 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3718 https://github.com/vaccineontology/VO/issues/514 12981 4100 3718 cancer vaccine Gene name: GM-CSF Gene name: MAGEA1 Melanoma DNA vaccine pNL3-MAGE-1-GM VO:0004435 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3719 https://github.com/vaccineontology/VO/issues/513 12981 4100 3719 cancer vaccine Gene name: GM-CSF Gene name: MAGEA1 Melanoma DNA vaccine pN4a-MAGE-1-GM VO:0004436 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3720 https://github.com/vaccineontology/VO/issues/516 84004 3720 cancer vaccine Gene name: Mcam Melanoma DNA vaccine SINCp c-muMUC18 encoding MCAM/MUC18 VO:0004437 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3723 https://github.com/vaccineontology/VO/issues/485 17829 4582 3723 cancer vaccine Gene name: MUC1 Gene name: Muc1 Lung metastasis DNA vaccine pCEP4-MUC1 encoding MUC1 VO:0004438 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3724 https://github.com/vaccineontology/VO/issues/511 6490 3724 cancer vaccine Gene name: gp100 Melanoma DNA vaccine hugp100 encoding gp100 VO:0004439 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3726 https://github.com/vaccineontology/VO/issues/519 20431 3726 cancer vaccine Gene name: Pmel17 Melanoma DNA vaccine VR1012/mPmel17 VO:0004440 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3727 https://github.com/vaccineontology/VO/issues/509 1067130 1638 3727 cancer vaccine Gene name: HUMGP 75 Gene name: TRP-2 Melanoma DNA vaccine gp75 DNA encoding melanosomal membrane glycoproteins, gp75 Vaccine VO:0004441 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3728 https://github.com/vaccineontology/VO/issues/521 22178 3728 cancer vaccine Gene name: TRP-1 Melanoma recombinant vector vaccine rVVmTRP-1 encoding TRP-1 VO:0004442 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3729 https://github.com/vaccineontology/VO/issues/510 6490 3729 cancer vaccine Gene name: gp100 Melanoma DNA vaccine hTRP2 encoding TRP-2 VO:0004443 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3730 https://github.com/vaccineontology/VO/issues/515 104042 55118 3730 cancer vaccine Gene name: Trp2 Gene name: Ubiquitin Melanoma DNA vaccine pUB-TRP-2 encoding a fusion protein linking murine ubiquitin (UB) to the N-terminus of the full-length mTRP-2 VO:0004444 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3731 3731 cancer vaccine Neuroblastoma DNA vaccine HuDsec VO:0004445 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3736 3736 cancer vaccine Prostate cancer DNA vaccine pcDNA3-STEAP encoding six-transmembrane epithelial antigen VO:0004446 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3737 3737 cancer vaccine Prostate cancer DNA vaccine hPSMAt encoding PSMA VO:0004447 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3738 3738 cancer vaccine Prostate cancer DNA vaccine rPSMAt encoding PSMA VO:0004448 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3740 3740 cancer vaccine Prostate cancer DNA vaccine pVax-PSA VO:0004449 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3742 3742 cancer vaccine Prostate cancer DNA vaccine psig-3P-Fc encoding 3P(hPSM, hPAP, or hPSA)-Fc fusion protein VO:0004450 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3744 3744 cancer vaccine Prostate cancer DNA vaccine PSCA-HSP encoding PSCA and HSP VO:0004451 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3745 3745 cancer vaccine Prostate cancer DNA vaccine encoding PSCA VO:0004452 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3746 3746 cancer vaccine Prostate cancer DNA vaccine pmPSCA encoding PSCA VO:0004453 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine pMIC3i encoding the complete MIC3-ORF (RH(ERP) strain) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3754 3754 vaccine Toxoplasma gondii DNA vaccine pMIC3i encoding the complete MIC3-ORF (RH(ERP) strain) VO:0004454 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine pVR1020-GRA1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3755 3755 vaccine Toxoplasma gondii DNA vaccine pVR1020-GRA1 VO:0004455 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine T.g.HSP70 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3756 3756 vaccine Toxoplasma gondii DNA vaccine T.g.HSP70 VO:0004456 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine pCMV-Sjc97 encoding paramyosin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3757 3757 vaccine Chinese Schistosoma japonicum DNA vaccine pCMV-Sjc97 encoding paramyosin VO:0004457 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine pVAX/SjFABP encoding FABP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3758 3758 vaccine Chinese Schistosoma japonicum DNA vaccine pVAX/SjFABP encoding FABP VO:0004458 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine SjCTPI VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3760 3760 vaccine Chinese Schistosoma japonicum DNA vaccine SjCTPI VO:0004459 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine SjCTPI-Hsp70 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3761 3761 vaccine Chinese Schistosoma japonicum DNA vaccine SjCTPI-Hsp70 VO:0004460 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine pVIVO2-IL12-Sj23 encoding Sj23 and IL-12 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3762 3762 vaccine Chinese Schistosoma japonicum DNA vaccine pVIVO2-IL12-Sj23 encoding Sj23 and IL-12 VO:0004461 Ningxian Fan Oliver He Ronak Sutariya S. mansoni DNA vaccine Sm23-pcDNA encoding Sm23 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3763 3763 vaccine Schistosoma mansoni DNA vaccine Sm23-pcDNA encoding Sm23 VO:0004462 Ningxian Fan Oliver He Ronak Sutariya S. mansoni DNA vaccine pcDNA/CTSOD encoding SOD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3764 3764 vaccine Schistosoma mansoni DNA vaccine pcDNA/CTSOD encoding SOD VO:0004463 Ningxian Fan Oliver He Ronak Sutariya S. mansoni DNA vaccine pcDNA/GPXbb encoding glutathione-S-peroxidase, GPX VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3765 3765 vaccine Schistosoma mansoni DNA vaccine pcDNA/GPXbb encoding glutathione-S-peroxidase, GPX VO:0004464 Ningxian Fan Oliver He Ronak Sutariya S. mansoni DNA vaccine Sm-p80-pcDNA3 encoding the large subunit of S. mansoni calpain VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3767 3767 vaccine Schistosoma mansoni DNA vaccine Sm-p80-pcDNA3 encoding the large subunit of Schistosoma mansoni calpain VO:0004465 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3768 https://github.com/vaccineontology/VO/issues/520 7299 3768 cancer vaccine Gene name: Tyrosinase Melanoma DNA vaccine xenogeneic DNA encoding murine tyrosinase VO:0004466 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3770 3770 vaccine Dengue virus DNA vaccine sA encoding prM and E from Dengue Virus 4 VO:0004467 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3771 3771 vaccine Dengue virus DNA vaccine sB encoding E VO:0004468 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3772 3772 vaccine Dengue virus DNA vaccine sC encoding prM and E VO:0004469 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3773 3773 vaccine Dengue virus DNA vaccine sABC encoding prM and E VO:0004470 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3778 3778 vaccine Dengue virus DNA vaccine D1ME encoding prM and E VO:0004471 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3779 3779 vaccine Dengue virus DNA vaccine pE1D2 encoding E from Dengue Virus 2 strain New Guinea C VO:0004472 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3781 3781 vaccine Dengue virus DNA vaccine pcTPANS1 encoding NS1 fused to the tissue plasminogen activator signal sequence VO:0004473 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3783 3783 vaccine Dengue virus DNA vaccine 1040D2MEL encoding dengue-2 prM-E-LAMP chimeric protein VO:0004474 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3784 3784 vaccine Dengue virus DNA vaccine p1012D2ME encoding prM and E from DEN 2 New Guinea C strain VO:0004475 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3785 3785 vaccine Human papillomavirus DNA vaccine hCRTE6E7L2 DNA encoding CRT linked to E6, E7 and L2 VO:0004476 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine pTPA-PA63 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3792 3792 vaccine Bacillus anthracis DNA vaccine pTPA-PA63 VO:0004477 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine pLAMP1-PA63 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3793 3793 vaccine Bacillus anthracis DNA vaccine pLAMP1-PA63 VO:0004478 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine pTPA-P VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3795 3795 vaccine Bacillus anthracis DNA vaccine pTPA-P VO:0004479 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine pIMS-120 encoding PA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3796 3796 vaccine Bacillus anthracis DNA vaccine pIMS-120 encoding PA VO:0004480 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine pCPA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3801 3801 vaccine Bacillus anthracis DNA vaccine pCPA VO:0004481 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA vaccine PA83 furin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3802 3802 vaccine Bacillus anthracis DNA vaccine PA83 furin VO:0004482 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3805 3805 vaccine Vaccinia virus DNA vaccine A33R from strain IHD-J VO:0004483 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3808 3808 vaccine Vaccinia virus DNA vaccine B5R VO:0004484 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3810 3810 vaccine Vaccinia virus DNA vaccine pWRG/L1R VO:0004485 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3814 3814 vaccine Vaccinia virus DNA vaccine 4pox VO:0004486 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3815 3815 vaccine Vaccinia virus DNA vaccine wtD8L VO:0004487 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3816 3816 vaccine Vaccinia virus DNA vaccine tPA-D8L VO:0004488 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3822 3822 vaccine VEE virus DNA vaccine encoding 26S VO:0004489 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3823 3823 vaccine WEE virus DNA vaccine pVHX-6 encoding 26S VO:0004490 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3829 3829 vaccine VEE virus DNA vaccine pSTU-TRDF encoding VEEV E3-E2-6K VO:0004491 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3830 3830 vaccine Sindbis virus DNA vaccine encoding E2 VO:0004492 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3831 3831 vaccine FeLV DNA vaccine gag/pol and env VO:0004493 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3834 3834 vaccine IPNV DNA vaccine pEGFP-N1-SegA and pEGFP-N1-VP2 VO:0004494 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3836 3836 vaccine VHSV DNA vaccine pVHS-G encoding glycoproteins VO:0004495 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3837 3837 vaccine IHNV DNA vaccine pIHN-G encoding glycoproteins VO:0004496 Ningxian Fan Oliver He Ronak Sutariya M. marinum pCMV-85A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3838 3838 vaccine Mycobacterium marinum pCMV-85A vaccine VO:0004497 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3839 3839 vaccine avian influenza virus DNA vaccine pH5HA VO:0004498 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3840 3840 vaccine avian influenza virus DNA vaccine pN1NA encoding N1 neuraminidase VO:0004499 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3841 3841 vaccine avian influenza virus DNA vaccine pNP VO:0004500 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3842 3842 vaccine influenza virus DNA vaccine pCMVH5HA VO:0004501 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3844 3844 vaccine influenza virus DNA vaccine p-Beta-actinH7HA VO:0004502 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3845 3845 vaccine influenza virus DNA vaccine pCAGGoptiHA VO:0004503 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3846 3846 vaccine influenza virus DNA vaccine pCAGGHA VO:0004504 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3847 3847 vaccine avian influenza DNA vaccine pCMV-M VO:0004505 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3848 3848 vaccine avian influenza virus DNA vaccine pCMV-HA VO:0004506 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3849 3849 vaccine PRRSV DNA vaccine pCA-U-optiGP5 VO:0004507 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3852 3852 vaccine PRRSV DNA vaccine pIRESorf5/IFN-Gamma VO:0004508 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3853 3853 vaccine PRRSV DNA vaccine pIRESorf5/IL-2 VO:0004509 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3854 3854 vaccine PRRSV DNA vaccine pIRESorf7/IL-2 VO:0004510 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3857 3857 vaccine PRRSV DNA vaccine pCI-ORF5/ORF6 VO:0004511 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine SjC23-Hsp70 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3860 3860 vaccine Chinese Schistosoma japonicum DNA vaccine SjC23-Hsp70 VO:0004512 Ningxian Fan Oliver He Ronak Sutariya Chinese S. japonicum DNA vaccine SjC23 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3861 3861 vaccine Chinese Schistosoma japonicum DNA vaccine SjC23 VO:0004513 Ningxian Fan Oliver He Ronak Sutariya B. burgdorferi DNA vaccine encoding strain B31 OspA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3863 3863 vaccine Borrelia burgdorferi DNA vaccine encoding strain B31 OspA VO:0004514 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3864 3864 vaccine DNA vaccine expressing the E2 protein VO:0004515 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3865 3865 vaccine pCgap DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase VO:0004516 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3867 3867 vaccine DNA vaccine expressing PspA VO:0004517 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3868 3868 vaccine PsaA DNA vaccine VO:0004518 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3869 3869 cancer vaccine B16 melanoma DNA vaccine pSin-mTRP-1 VO:0004519 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3870 3870 vaccine Herpes Simplex Virus Type 1 DNA Vaccine pRSC-gD-IL-21 VO:0004520 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3871 3871 vaccine Herpes Simplex Virus Type 1 DNA Vaccine encoding 5gP VO:0004521 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3872 3872 vaccine Herpes Simplex Virus 2 DNA Vaccine Vaxfectin-gD2 VO:0004522 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3873 3873 vaccine Herpes Simplex Virus 2 DNA Vaccine encoding gD VO:0004523 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3874 3874 vaccine Herpes Simplex Virus 2 DNA Vaccine encoding gD with CD40L VO:0004524 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3876 3876 vaccine classicals swine fever virus DNA vaccine pcDNA/E2 with TRIF VO:0004525 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3878 3878 vaccine Avian pneumovirus DNA vaccine expressing the F gene VO:0004526 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3880 3880 vaccine Murine cytomegalovirus DNA vaccine pgM-pgN VO:0004527 Ningxian Fan Oliver He Ronak Sutariya E. maxima DNA vaccine pcDNA-Gam56 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3881 3881 vaccine Eimeria maxima DNA vaccine pcDNA-Gam56 VO:0004528 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine pVAX-TgMIC13 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3882 3882 vaccine Toxoplasma gondii DNA vaccine pVAX-TgMIC13 VO:0004529 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3883 3883 vaccine Hepatitis D DNA vaccine pcDNA3p27/Ad5F35p27 VO:0004530 Ningxian Fan Oliver He Ronak Sutariya L. major DNA vaccine pcLACK + IL-22 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3884 3884 vaccine Leishmania major DNA vaccine pcLACK + IL-22 VO:0004531 Ningxian Fan Oliver He Ronak Sutariya T. gondii DNA vaccine ROP8-pVAX-1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3885 3885 vaccine Toxoplasma gondii DNA vaccine ROP8-pVAX-1 VO:0004532 Ningxian Fan Oliver He Ronak Sutariya T. cruzi DNA vaccine encoding TSA-1 and Tc24 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3886 3886 vaccine Trypanosoma cruzi DNA vaccine encoding TSA-1 and Tc24 VO:0004533 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3887 3887 vaccine IBDV DNA vaccine pCAGoptiVP2/rVP2 VO:0004534 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3888 3888 vaccine IBDV DNA vaccine pCAGVP243-IL-18 VO:0004535 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3889 3889 vaccine IBV DNA vaccine pVAX1-16S1/M/N VO:0004536 Ningxian Fan Oliver He Ronak Sutariya P. multocida DNA vaccine pcDNA-OMPH + pcDNA-OMPA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3890 3890 vaccine Pasteurella multocida DNA vaccine pcDNA-OMPH + pcDNA-OMPA VO:0004537 Ningxian Fan Oliver He Ronak Sutariya P. multocida DNA vaccine pcDNA-OMPH/OMPA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3891 3891 vaccine Pasteurella multocida DNA vaccine pcDNA-OMPH/OMPA VO:0004538 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3892 3892 vaccine BVDV DNA vaccine encoding E2 VO:0004539 Ningxian Fan Oliver He Ronak Sutariya E. rhusiopathiae DNA vaccine pcD-ACSC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3893 3893 vaccine Erysipelothrix rhusiopathiae DNA vaccine pcD-ACSC VO:0004540 Ningxian Fan Oliver He Ronak Sutariya M. avium DNA vaccine DNA-Av35/p2AIL12 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3894 3894 vaccine Mycobacterium avium DNA vaccine DNA-Av35/p2AIL12 VO:0004541 Ningxian Fan Oliver He Ronak Sutariya S. aureus DNA vaccine pClfaSrtD13 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3895 3895 vaccine Staphylococcus aureus DNA vaccine pClfaSrtD13 VO:0004542 Ningxian Fan Oliver He Ronak Sutariya S. aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3896 3896 vaccine Staphylococcus aureus DNA vaccine encoding Efb, FnbpA, ClfA, Cna VO:0004543 Ningxian Fan Oliver He Ronak Sutariya B. anthracis DNA Vaccine expressing PA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3897 3897 vaccine Bacillus anthracis DNA vaccine expressing PA VO:0004544 Ningxian Fan Oliver He Ronak Sutariya A. pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3898 3898 vaccine Actinobacillus pleuropneumoniae DNA vaccine pcDNA-apxIA/pcDNA-apxIIA VO:0004545 Ningxian Fan Oliver He Ronak Sutariya B. pertussis DNA vaccine pcDNA/S1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3899 3899 vaccine Borrelia pertussis DNA vaccine pcDNA/S1 VO:0004546 Ningxian Fan Oliver He Ronak Sutariya B. abortus DNA vaccine pVF278 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3900 3900 vaccine Brucella abortus DNA vaccine pVF278 VO:0004547 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3902 3902 vaccine Dengue virus DNA vaccine expressing prM/E protein VO:0004548 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3903 3903 vaccine Dengue virus DNA vaccine D1ME-VRP VO:0004549 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3904 3904 vaccine Dengue virus DNA vaccine encoding NS1 VO:0004550 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3906 3906 vaccine Feline immunodeficiency virus recombinant vector vaccine FIV-Delta-RT VO:0004551 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3907 3907 vaccine Foot-and-Mouth Disease Virus DNA vaccine pSinCMV-Vac-MEG990 VO:0004552 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3908 3908 vaccine Foot-and-Mouth Disease Virus Cationic Microparticle-coated DNA vaccine VO:0004553 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3909 3909 vaccine FMDV DNA vaccine encoding P1 and non-structural proteins 2A, 3C, and 3D VO:0004554 Ningxian Fan Oliver He Ronak Sutariya C. trachomatis DNA vaccine pWRG7079::MOMP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3910 3910 vaccine Chlamydia trachomatis DNA vaccine pWRG7079::MOMP VO:0004555 Ningxian Fan Oliver He Ronak Sutariya C. pneumoniae DNA vaccine pHSP-60 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3911 3911 vaccine Chlamydophila pneumoniae DNA vaccine pHSP-61 VO:0004556 Ningxian Fan Oliver He Ronak Sutariya E. tarda DNA vaccine pCE18 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3912 3912 vaccine Edwardsiella tarda DNA vaccine pCE18 VO:0004557 Ningxian Fan Oliver He Ronak Sutariya E. tarda DNA vaccine pCE6 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3913 3913 vaccine Edwardsiella tarda DNA vaccine pCE6 VO:0004558 Ningxian Fan Oliver He Ronak Sutariya E. tarda DNA vaccine pCEsa1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3914 3914 vaccine Edwardsiella tarda DNA vaccine pCEsa1 VO:0004559 Ningxian Fan Oliver He Ronak Sutariya H. pylori DNA vaccine poipA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3915 3915 vaccine Helicobacter pylori DNA vaccine poipA VO:0004560 Ningxian Fan Oliver He Ronak Sutariya H. pylori DNA vaccine pcDNA3.1-hspA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3916 3916 vaccine Helicobacter pylori DNA vaccine pcDNA3.2-hspA VO:0004561 Ningxian Fan Oliver He Ronak Sutariya H. pylori DNA vaccine pcDNA3.1-hspB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3917 3917 vaccine Helicobacter pylori DNA vaccine pcDNA3.2-hspB VO:0004562 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3918 3918 vaccine Leptospira interrogans DNA vaccine ompL1-pcDNA3.1(+) VO:0004563 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3919 3919 vaccine Leptospira interrogans DNA vaccine pTARGET/ LigBrep VO:0004564 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3920 3920 vaccine SIV recombinant vector vaccine rAd5/rLCMV VO:0004565 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3921 3921 vaccine Laryngotracheitis DNA vaccine encoding gB VO:0004566 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3922 3922 vaccine Marburg virus recombinant vector vaccine MBGV GP/MBGV NP VO:0004567 Ningxian Fan Oliver He Ronak Sutariya H. rhabdovirus DNA Vaccine encoding N and G VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3923 3923 vaccine Hirame rhabdovirus DNA vaccine encoding N and G VO:0004568 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3924 3924 vaccine influenza virus DNA vaccine M2-DNA/M2-Ad VO:0004569 Ningxian Fan Oliver He Ronak Sutariya N. meningitidis DNA vaccine P3A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3926 3926 vaccine Neisseria meningitidis DNA vaccine P3A VO:0004570 Ningxian Fan Oliver He Ronak Sutariya P. aeruginosa DNA vaccine pGACAG-OprF/OprI VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3927 3927 vaccine Pseudomonas aeruginosa DNA vaccine pGACAG-OprF/OprI VO:0004571 Ningxian Fan Oliver He Ronak Sutariya P. aeruginosa DNA vaccine pGACAG-PcrV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3928 3928 vaccine Pseudomonas aeruginosa DNA vaccine pGACAG-PcrV VO:0004572 Ningxian Fan Oliver He Ronak Sutariya P. aeruginosa DNA vaccine pGACAG-OprF/OprI + pGACAG-PcrV + pGACAG-PilA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3929 3929 vaccine Pseudomonas aeruginosa DNA vaccine pGACAG-OprF/OprI + pGACAG-PcrV + pGACAG-PilA VO:0004573 Ningxian Fan Oliver He Ronak Sutariya Y. pestis DNA vaccine YscF-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3930 3930 vaccine Yersinia pestis DNA vaccine YscF-2 VO:0004574 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3931 3931 vaccine BRSV DNA vaccine VCL-Fb VO:0004575 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3932 3932 vaccine Duck hepatitis virus 1 DNA vaccine pSCA/VP1 VO:0004576 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3933 3933 vaccine Hantavirus DNA vaccine pWRG/HTN-M VO:0004577 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3934 3934 vaccine RHDV DNA vaccine pcDNA-VP60 VO:0004578 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3935 3935 vaccine HSV 2 DNA vaccine pVAX-HSV-2gD-HSP70 VO:0004579 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3936 3936 vaccine HRSV DNA vaccine DRF-412 VO:0004580 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3937 3937 vaccine HRSV DNA vaccine pND-G VO:0004581 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3938 3938 vaccine IBV DNA vaccine pVAX1-N VO:0004582 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3939 3939 vaccine IBV DNA vaccine pVAX-S1 with GM-CSF adjuvant VO:0004583 Ningxian Fan Oliver He Ronak Sutariya H. rhabdovirus DNA Vaccine encoding G VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3940 3940 vaccine Hirame rhabdovirus DNA vaccine encoding G VO:0004584 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3941 3941 vaccine Infectious Bronchitis virus DNA vaccine encoding S1, N, and M VO:0004585 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3942 3942 vaccine Infectious Bursal Disease virus DNA vaccine expressing VP2 VO:0004586 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3943 3943 vaccine Japanese encephalitis virus DNA vaccine P-JEV VO:0004587 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3944 3944 vaccine Japanese encephalitis virus DNA vaccine pCJ-3/E encoding E VO:0004588 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3946 3946 vaccine REV DNA vaccine VP22/gag and VP22/env VO:0004589 Ningxian Fan Oliver He Ronak Sutariya P. yoelii DNA vaccine pDIP/PyCSP. 1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3947 3947 vaccine Plasmodium yoelii DNA vaccine pDIP/PyCSPlasmodium 1 VO:0004590 Ningxian Fan Oliver He Ronak Sutariya P. yoelii DNA vaccine encoding PySSP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3948 3948 vaccine Plasmodium yoelii DNA vaccine encoding PySSP2 VO:0004591 Ningxian Fan Oliver He Ronak Sutariya P. berghei DNA vaccine encoding PbCSP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3949 3949 vaccine Plasmodium berghei DNA vaccine encoding PbCSP VO:0004592 Ningxian Fan Oliver He Ronak Sutariya P. yoelii DNA vaccine pPyHsp60-VR1012 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3950 3950 vaccine Plasmodium yoelii DNA vaccine pPyHsp60-VR1012 VO:0004593 Ningxian Fan Oliver He Ronak Sutariya P. yoelii DNA vaccine encoding MSP1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3951 3951 vaccine Plasmodium yoelii DNA vaccine encoding MSP1 VO:0004594 Ningxian Fan Oliver He Ronak Sutariya P. berghei DNA vaccine CSP-3p28 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3952 3952 vaccine Plasmodium berghei DNA vaccine CSP-3p28 VO:0004595 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3953 3953 vaccine P. knowlesi DNA vaccine encoding PkCSP, PkSSP2, PkAMA1, and PkMSP1p42 VO:0004596 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3954 3954 vaccine SHIV DNA vaccine encoding env and gag VO:0004597 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3955 3955 vaccine SHIV(Ba-L) DNA vaccine encoding env and gag VO:0004598 Ningxian Fan Oliver He Ronak Sutariya GSK1437173A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3956 3956 vaccine GSK1437174A vaccine VO:0004599 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3958 3958 vaccine Human cytomegalovirus DNA vaccine pcGB VO:0004600 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3960 3960 vaccine rBCG-SIVgag and rDIsSIVgag Prime-boost SHIV vaccine VO:0004601 Ningxian Fan Oliver He Ronak Sutariya S. pneumoniae pspA-rBCG Vector Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3961 3961 vaccine Streptococcus pneumoniae pspA-rBCG vector vaccine VO:0004602 Ningxian Fan Oliver He Ronak Sutariya T. gondii recombinant vaccine vector rBCGpMV361-TgCyP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3962 3962 vaccine Toxoplasma gondii recombinant vaccine vector rBCGpMV361-TgCyP VO:0004603 Ningxian Fan Oliver He Ronak Sutariya AE-Poxine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3963 3963 vaccine AE-Poxine vaccine VO:0004604 A dendritic cell vaccine consisting of dendritic cells (DCs) electroporated with mRNA encoding three adjuvants, CD40 ligand (CD40L), a constitutively active TLR4, and CD70 (all together termed TriMix); coelectroporated with full-length mRNA encoding MAGE-A3, MAGE-C2, Tyrosinase and gp100; and linked to DC-LAMP, with potential immunostimulating activity. Upon vaccination, the DCs may stimulate the immune system to mount an antigen-specific cytotoxic T-lymphocyte (CTL) response against the melanoma antigens. This may decrease cellular proliferation of melanoma cells expressing these antigens. Electroporation with the adjuvants CD40L and TLR4 allows for the generation of mature and active DCs; electroporation with CD70 provides a costimulatory signal to CD27+ naive T cells thereby supporting T-cell proliferation and inhibiting T-cell apoptosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5238 https://github.com/vaccineontology/VO/issues/286 4102 51438 6490 7099 7299 959 970 5238 cancer vaccine Gene name: CD40LG Gene name: CD70 Gene name: MAGEA3 Gene name: MAGEC2 Gene name: TLR4 Gene name: Tyrosinase Gene name: gp100 (PMEL) autologous TriMix-DC melanoma vaccine VO:0004605 Ningxian Fan Oliver He Ronak Sutariya SL3261 expressing T. spiralis Ag30 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3969 3969 vaccine SL3261 expressing Trichinella spiralis Ag30 vaccine VO:0004606 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3970 3970 vaccine Aeromonas hydrophila LSA34 vector vaccine WED/pUTDgap VO:0004607 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3972 3972 vaccine Actinobacillus pleuropneumoniae HS93Tox-/pIG-T1K vectored vaccine VO:0004608 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3973 3973 vaccine Bordetella pertussis BPZE vectored vaccine VO:0004609 Ningxian Fan Oliver He Ronak Sutariya pCR3.1-VS-HSP65-TP-GRP6-M2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3987 3987 cancer vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 vaccine VO:0004610 Ningxian Fan Oliver He Ronak Sutariya SRL172 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4001 4001 cancer vaccine SRL172 vaccine VO:0004611 Ningxian Fan Oliver He Ronak Sutariya VMCL VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4019 4019 cancer vaccine VMCL vaccine VO:0004612 Ningxian Fan Oliver He Ronak Sutariya Newcastle disease virus lysate VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4025 4025 cancer vaccine Newcastle disease virus lysate vaccine VO:0004613 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4044 4044 cancer vaccine smallpox vaccine VO:0004614 Ningxian Fan Oliver He Ronak Sutariya Yuanyi (Penny) Pan PMID:22896657 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4054 4054 cancer vaccine mRNA-electroporated dendritic cells encoding gp100 and tyrosinase as melanoma vaccine VO:0004615 Ningxian Fan Oliver He Ronak Sutariya pcDNA3-MCC/ST VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4057 4057 cancer vaccine pcDNA3-MCC/ST vaccine VO:0004616 The approach focuses on the use of five primary patient derived melanoma cells (MEL-2, MEL-V, 3MM, KFM, and GLM-2). These cells display differential in vitro migratory and invasive properties as well as have the ability to form solid tumors when implanted into BALB/c nude mice. The retention of the innate phenotype of these primary patient derived cells together with the expression of a multitude repertoire of melanoma associated antigens offers a novel opportunity to target melanoma so as to avoid immune evasion Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4064 https://github.com/vaccineontology/VO/issues/557 2315 6490 4064 cancer vaccine Gene name: MLANA Gene name: gp100 Multivalent immunotherapeutic vaccine VO:0004617 Ningxian Fan Oliver He Ronak Sutariya short overlapping peptides and full-length recombinant protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4079 4079 cancer vaccine short overlapping peptides and full-length recombinant protein vaccine VO:0004618 Ningxian Fan Oliver He Ronak Sutariya BCG-DHTM VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4082 4082 vaccine BCG-DHTM vaccine VO:0004619 Ningxian Fan Oliver He Ronak Sutariya rSPV-PCV2-cap VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4083 4083 vaccine rSPV-PCV2-cap vaccine VO:0004620 Ningxian Fan Oliver He Ronak Sutariya vFP89-H5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4084 4084 vaccine vFP89-H5 vaccine VO:0004621 Ningxian Fan Oliver He Ronak Sutariya vNDV-H5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4085 4085 vaccine vNDV-H5 vaccine VO:0004622 Ningxian Fan Oliver He Ronak Sutariya fp-IBD1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4087 4087 vaccine fp-IBD1 vaccine VO:0004623 Ningxian Fan Oliver He Ronak Sutariya rDEV-re6 (H5) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4088 4088 vaccine rDEV-re6 (H5) vaccine VO:0004624 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4089 4089 vaccine FPV-LT vaccine VO:0004625 Ningxian Fan Oliver He Ronak Sutariya rFPV-IBDV-VP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4091 4091 vaccine rFPV-IBDV-VP2 vaccine VO:0004626 Ningxian Fan Oliver He Ronak Sutariya LT-BCG- Ag85B /Rv3425 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4092 4092 vaccine LT-BCG- Ag85B /Rv3425 vaccine VO:0004627 Ningxian Fan Oliver He Ronak Sutariya L. T -PpSP15 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4095 4095 vaccine Leishmania T -PpSP15 vaccine VO:0004628 Ningxian Fan Oliver He Ronak Sutariya A2-CPA-CPB(-CTE)-recombinant L. tarentolae VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4096 4096 vaccine A2-CPA-CPB(-CTE)-recombinant L. tarentolae vaccine VO:0004629 Ningxian Fan Oliver He Ronak Sutariya L. T -HIV-1 Gag VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4097 4097 vaccine Leishmania tarentolae expressing HIV-1 Gag vaccine VO:0004630 Ningxian Fan Oliver He Ronak Sutariya AdC68- rabies virus glycoprotein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4099 4099 vaccine AdC68- rabies virus glycoprotein vaccine VO:0004631 Ningxian Fan Oliver He Ronak Sutariya rAd-GP (Ebola virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4100 4100 vaccine rAd-GP Ebola virus vaccine VO:0004632 Ningxian Fan Oliver He Ronak Sutariya HVT-ND VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4102 4102 vaccine HVT-ND vaccine VO:0004633 Ningxian Fan Oliver He Ronak Sutariya rHVT-H5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4103 4103 vaccine rHVT-H5 vaccine VO:0004634 Ningxian Fan Oliver He Ronak Sutariya rHVT-H5 (clade 2.2 H5N1 HPAIV) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4104 4104 vaccine rHVT-H5 (clade 2.2 H5N1 HPAIV) vaccine VO:0004635 Ningxian Fan Oliver He Ronak Sutariya rSPV-MRP (Streptococcus suis) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4106 4106 vaccine rSPV-MRP Streptococcus suis vaccine VO:0004636 Ningxian Fan Oliver He Ronak Sutariya rSPV-HA1 (Swine influenza virus H1N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4107 4107 vaccine rSPV-HA1 (Swine influenza virus H1N1) vaccine VO:0004637 Ningxian Fan Oliver He Ronak Sutariya HS93Tox-/pIG-T1K VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4108 4108 vaccine HS93Tox-/pIG-T1K vaccine VO:0004638 Ningxian Fan Oliver He Ronak Sutariya ALVAC-SIV/gp120 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4110 4110 vaccine ALVAC-SIV/gp120 vaccine VO:0004639 Ningxian Fan Oliver He Ronak Sutariya ALVAC-rabies VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4111 4111 vaccine ALVAC-rabies vaccine VO:0004640 Ningxian Fan Oliver He Ronak Sutariya E. coli-CPPs (Edwardsiella tarda) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4112 4112 vaccine E. coli-CPPs Edwardsiella tarda vaccine VO:0004641 Ningxian Fan Oliver He Ronak Sutariya CAdVax-ZEBOV/SEBOV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4113 4113 vaccine CAdVax-ZEBOV/SEBOV vaccine VO:0004642 Ningxian Fan Oliver He Ronak Sutariya CAdVax-RVFV glycoprotein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4114 4114 vaccine CAdVax-RVFV glycoprotein vaccine VO:0004643 Ningxian Fan Oliver He Ronak Sutariya CAdVax-Den12/Den34 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4115 4115 vaccine CAdVax-Den12/Den34 vaccine VO:0004644 Ningxian Fan Oliver He Ronak Sutariya CAdVax-Filoviruses (Ebola ) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4116 4116 vaccine CAdVax-Filoviruses (Ebola ) vaccine VO:0004645 Ningxian Fan Oliver He Ronak Sutariya CAdVa-Filoviruses (EbMarburg viruses) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4117 4117 vaccine CAdVa-Filoviruses (EbMarburg viruses) vaccine VO:0004646 Ningxian Fan Oliver He Ronak Sutariya cAdVaxM(fus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4118 4118 vaccine cAdVaxM(fus) vaccine VO:0004647 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4119 4119 vaccine cAdVax-based bivalent ebola virus vaccine (Sudan and Zaire species) VO:0004648 Ningxian Fan Oliver He Ronak Sutariya RB51-SRS2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4120 4120 vaccine RB51-SRS2 vaccine VO:0004649 Ningxian Fan Oliver He Ronak Sutariya RB51-MIC3/GRA6/MIC1/SRS2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4121 4121 vaccine RB51-MIC3/GRA6/MIC1/SRS2 vaccine VO:0004650 Ningxian Fan Oliver He Ronak Sutariya BPZE1- FHA (H1N1/PR8 influenza A virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4122 4122 vaccine BPZE1- FHA (H1N1/PR8 influenza A virus) vaccine VO:0004651 Ningxian Fan Oliver He Ronak Sutariya BV-RVG/RVG VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4124 4124 vaccine BV-RVG/RVG vaccine VO:0004652 Ningxian Fan Oliver He Ronak Sutariya BV-Dual-S1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4125 4125 vaccine BV-Dual-S1 vaccine VO:0004653 Ningxian Fan Oliver He Ronak Sutariya AcHERV-sH1N1-HA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4126 4126 vaccine AcHERV-sH1N1-HA vaccine VO:0004654 Ningxian Fan Oliver He Ronak Sutariya BV-H5/H7/H9 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4128 4128 vaccine BV-H5/H7/H9 vaccine VO:0004655 Ningxian Fan Oliver He Ronak Sutariya BacMam-sHAPQ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4129 4129 vaccine BacMam-sHAPQ vaccine VO:0004656 Ningxian Fan Oliver He Ronak Sutariya rBCGpMV361-TgCyP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4130 4130 vaccine rBCGpMV362-TgCyP vaccine VO:0004657 Ningxian Fan Oliver He Ronak Sutariya rBCG -Stx2B (Escherichia coli ) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4131 4131 vaccine rBCG -Stx2B E. coli vaccine VO:0004658 Ningxian Fan Oliver He Ronak Sutariya rDEV-us78HA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4136 4136 vaccine rDEV-us78HA vaccine VO:0004659 Ningxian Fan Oliver He Ronak Sutariya VSV-DeltaG-H5 (H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4137 4137 vaccine VSV-DeltaG-H5 (H5N1) vaccine VO:0004660 An Ebola virus vaccine that uses a recombinant vesicular stomatitis virus (rVSV) vector expressing an Ebola filovirus glycoprotein Kallan Roan Oliver He rVSV-EBOV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4140 4140 vaccine rVSV-EBOV vaccine VO:0004661 Ningxian Fan Oliver He Ronak Sutariya rVSV- SEBOV-GP and -VP40 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4141 4141 vaccine rVSV- SEBOV-GP and -VP40 vaccine VO:0004662 Ningxian Fan Oliver He Ronak Sutariya rVSVDeltaG-ANDV-GPC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4142 4142 vaccine rVSVDeltaG-ANDV-GPC vaccine VO:0004663 Ningxian Fan Oliver He Ronak Sutariya rMVA-GnGc (Rift Valley fever virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4143 4143 vaccine rMVA-GnGc (Rift Valley fever virus) vaccine VO:0004664 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4144 4144 vaccine rMVA-SIV-CD40L Simian immunodeficiency virus vaccine VO:0004665 Ningxian Fan Oliver He Ronak Sutariya rMVA-CCHF VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4145 4145 vaccine rMVA-CCHF vaccine VO:0004666 Ningxian Fan Oliver He Ronak Sutariya MVA-CHIKV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4146 4146 vaccine MVA-CHIKV vaccine VO:0004667 Ningxian Fan Oliver He Ronak Sutariya MVTT-HA-QH VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4149 4149 vaccine MVTT-HA-QH vaccine VO:0004668 Ningxian Fan Oliver He Ronak Sutariya S. gordonii -M6-Sj-F1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4150 4150 vaccine Schistosoma gordonii -M6-Sj-F1 vaccine VO:0004669 Ningxian Fan Oliver He Ronak Sutariya Streptococcus gordonii-TTFC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4151 4151 vaccine Streptococcus gordonii-TTFC vaccine VO:0004670 Ningxian Fan Oliver He Ronak Sutariya S. gordonii-PT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4152 4152 vaccine S. gordonii-PT vaccine VO:0004671 Ningxian Fan Oliver He Ronak Sutariya SL3261-L. major VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4153 4153 vaccine SL3261-Leishmania major vaccine VO:0004672 Ningxian Fan Oliver He Ronak Sutariya SL3261-L. donovani VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4154 4154 vaccine SL3261-L. donovani vaccine VO:0004673 quadrivalent influenza vaccine VO:0004674 Ningxian Fan Oliver He Ronak Sutariya SL3261-P. aeruginosa serogroup O11 O antigen VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4156 4156 vaccine SL3261-Pseudomonas aeruginosa serogroup O11 O antigen vaccine VO:0004675 Ningxian Fan Oliver He Ronak Sutariya SL3261- UreA and UreB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4157 4157 vaccine SL3262- UreA and UreB vaccine VO:0004676 Ningxian Fan Oliver He Ronak Sutariya SL3261 expressing streptococcal M protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4158 4158 vaccine SL3261 expressing streptococcal M protein vaccine VO:0004677 Ningxian Fan Oliver He Ronak Sutariya Schmidt-Ruppin Rous sarcoma virus-H7 (H7N7) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4159 4159 vaccine Schmidt-Ruppin Rous sarcoma virus-H7 (H7N7) vaccine VO:0004678 Ningxian Fan Oliver He Ronak Sutariya RBD-rAAV-SARS-CoV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4160 https://pubmed.ncbi.nlm.nih.gov/18708674/ 4160 vaccine RBD-rAAV-SARS-CoV vaccine VO:0004679 Ningxian Fan Oliver He Ronak Sutariya RBD-rAAV-SARS-CoV prime/RBD-specific T cell peptide boost VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4161 https://pubmed.ncbi.nlm.nih.gov/18289745/ 4161 vaccine RBD-rAAV-SARS-CoV prime/RBD-specific T cell peptide boost vaccine VO:0004680 Ningxian Fan Oliver He Ronak Sutariya rNDV-ILTV-gD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4162 4162 vaccine rNDV-ILTV-gD vaccine VO:0004681 Ningxian Fan Oliver He Ronak Sutariya rNDV-H5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4163 4163 vaccine rNDV-H5 vaccine VO:0004682 Ningxian Fan Oliver He Ronak Sutariya rNDV-H5 ( HPAI H5N1 challenge in mule ducks) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4164 4164 vaccine rNDV-H5 ( HPAI H5N1 challenge in mule ducks) vaccine VO:0004683 Ningxian Fan Oliver He Ronak Sutariya rNDV-H6 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4165 4165 vaccine rNDV-H6 vaccine VO:0004684 Ningxian Fan Oliver He Ronak Sutariya rAPMV3-F (newcastle disease) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4167 4167 vaccine rAPMV3-F newcastle disease vaccine VO:0004685 Ningxian Fan Oliver He Ronak Sutariya BoHV-4-A-gD(cp)gD(106)DeltaTK VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4168 4168 vaccine BoHV-4-A-gD(cp)gD(106)DeltaTK vaccine VO:0004686 Ningxian Fan Oliver He Ronak Sutariya BoHV-4-A-IgK-VP2gD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4169 4169 vaccine BoHV-4-A-IgK-VP2gD vaccine VO:0004687 Ningxian Fan Oliver He Ronak Sutariya HSVT[VP7/6/2] VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4172 4172 vaccine HSVT[VP7/6/2] vaccine VO:0004688 Ningxian Fan Oliver He Ronak Sutariya M. S- H. pylori -opm26 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4173 4173 vaccine M.S-Helicobacter pylori-opm26 vaccine VO:0004689 Ningxian Fan Oliver He Ronak Sutariya M.S-Delta-esx-3-IKEPLUS (M. tuberculosis) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4174 4174 vaccine M.S-Delta-esx-3-IKEPLUS Mycobacterium tuberculosis vaccine VO:0004690 Ningxian Fan Oliver He Ronak Sutariya YF17D- HIV-1 p24 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4175 4175 vaccine YF17D- HIV-1 p24 vaccine VO:0004691 Ningxian Fan Oliver He Ronak Sutariya RCN-HA (H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4176 4176 vaccine RCN-HA (H5N1) vaccine VO:0004692 Ningxian Fan Oliver He Ronak Sutariya RCN-F1-V (Yersinia pestis F1 and V) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4177 4177 vaccine RCN-F1-V Yersinia pestis F1 and V vaccine VO:0004693 Ningxian Fan Oliver He Ronak Sutariya RCN-rabies-G VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4178 4178 vaccine RCN-rabies-G vaccine VO:0004694 Ningxian Fan Oliver He Ronak Sutariya RCN-IRES-tPA-YpF1( Yersinia pestis) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4179 4179 vaccine RCN-IRES-tPA-YpF1 Yersinia pestis vaccine VO:0004695 Ningxian Fan Oliver He Ronak Sutariya PAV3-HA (H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4180 4180 vaccine PAV3-HA (H5N1) vaccine VO:0004696 Ningxian Fan Oliver He Ronak Sutariya PAV3-HA (A/Hanoi/30408/2005 H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4181 4181 vaccine PAV3-HA (A/Hanoi/30408/2005 H5N1) vaccine VO:0004697 Ningxian Fan Oliver He Ronak Sutariya rAd-P97c VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4182 4182 vaccine rAd-P97c vaccine VO:0004698 Ningxian Fan Oliver He Ronak Sutariya PrV-HA (swine-origin H1N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4183 4183 vaccine PrV-HA (swine-origin H1N1) vaccine VO:0004699 Ningxian Fan Oliver He Ronak Sutariya PrV-PCV2-ORF2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4184 4184 vaccine PrV-PCV2-ORF2 vaccine VO:0004700 Ningxian Fan Oliver He Ronak Sutariya rAdV-SFV-E2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4185 4185 vaccine rAdV-SFV-E2 vaccine VO:0004701 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4186 4186 vaccine Typhi strain Ty21a-LPS-Shigella VO:0004702 Ningxian Fan Oliver He Ronak Sutariya Typhi strain Ty21a-PA (Bacillus anthracis) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4187 4187 vaccine Typhi strain Ty21a-PA Bacillus anthracis vaccine VO:0004703 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4188 4188 vaccine Ty21a-O-Ps (Shigella dysenteriae ) VO:0004704 Ningxian Fan Oliver He Ronak Sutariya SabRV-SIV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4189 4189 vaccine SabRV-SIV vaccine VO:0004705 Ningxian Fan Oliver He Ronak Sutariya Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4190 4190 cancer vaccine poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope vaccine VO:0004706 Ningxian Fan Oliver He Ronak Sutariya SG33-VP2/5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4191 4191 vaccine SG33-VP2/5 vaccine VO:0004707 Ningxian Fan Oliver He Ronak Sutariya Myxoma-FCV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4192 4192 vaccine Myxoma-FCV vaccine VO:0004708 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4193 https://github.com/vaccineontology/VO/issues/496 727897 4193 cancer vaccine Gene name: MUC5B Maraba virus MG1 vaccine VO:0004709 Ningxian Fan Oliver He Ronak Sutariya rvOka-HN (mumps virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4194 4194 vaccine rvOka-HN mumps virus vaccine VO:0004710 Ningxian Fan Oliver He Ronak Sutariya rOka-gD2- HSV-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4195 4195 vaccine rOka-gD2- HSV-2 vaccine VO:0004711 Ningxian Fan Oliver He Ronak Sutariya rMV- SARS-CoV -S/Ssol VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4196 4196 vaccine rMV- SARS-CoV -S/Ssol vaccine VO:0004712 Ningxian Fan Oliver He Ronak Sutariya rMV- WNV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4197 4197 vaccine rMV- WNV vaccine VO:0004713 Ningxian Fan Oliver He Ronak Sutariya rMeV- SCD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4198 4198 cancer vaccine rMeV- SCD vaccine VO:0004714 Ningxian Fan Oliver He Ronak Sutariya rMV-Ed-G VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4199 4199 vaccine rMV-Ed-G vaccine VO:0004715 Ningxian Fan Oliver He Ronak Sutariya rLAG- PA-DCpep VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4200 4200 vaccine rLAG- PA-Dcpep vaccine VO:0004716 Ningxian Fan Oliver He Ronak Sutariya rMCMV-TRP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4201 4201 cancer vaccine rMCMV-TRP2 vaccine VO:0004717 Ningxian Fan Oliver He Ronak Sutariya rCMV- EBOV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4202 4202 vaccine rCMV- EBOV vaccine VO:0004718 Ningxian Fan Oliver He Ronak Sutariya rCMV-TT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4203 4203 vaccine rCMV-TT vaccine VO:0004719 Ningxian Fan Oliver He Ronak Sutariya CVB4/p24(73(3)) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4204 4204 vaccine CVB4/p24(73(3)) vaccine VO:0004720 Ningxian Fan Oliver He Ronak Sutariya rVCG- Chlamydia-cholera VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4205 4205 vaccine rVCG- Chlamydia-cholera vaccine VO:0004721 Ningxian Fan Oliver He Ronak Sutariya CVD 103-HgR- REPEC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4206 4206 vaccine CVD 103-HgR- REPEC vaccine VO:0004722 Ningxian Fan Oliver He Ronak Sutariya rVCG- MOMP/HSV-2-gD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4207 4207 vaccine rVCG- MOMP/HSV-2-gD vaccine VO:0004723 Ningxian Fan Oliver He Ronak Sutariya pRP-RSV-HSV-1-gB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4208 4208 vaccine pRP-RSV-HSV-2-gB vaccine VO:0004724 Ningxian Fan Oliver He Ronak Sutariya RSV-H7 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4209 4209 vaccine RSV-H7 vaccine VO:0004725 Ningxian Fan Oliver He Ronak Sutariya ALVAC-AHSV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4210 4210 vaccine ALVAC-AHSV vaccine VO:0004726 Ningxian Fan Oliver He Ronak Sutariya ALVAC-BTV-VP2/VP5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4211 4211 vaccine ALVAC-BTV-VP2/VP5 vaccine VO:0004727 Ningxian Fan Oliver He Ronak Sutariya ALVAC-HIV-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4212 4212 vaccine ALVAC-HIV-2 vaccine VO:0004728 Ningxian Fan Oliver He Ronak Sutariya ALVAC-RV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4213 4213 vaccine ALVAC-RV vaccine VO:0004729 Ningxian Fan Oliver He Ronak Sutariya FP-AI-H5(H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4214 4214 vaccine FP-AI-H5(H5N1) vaccine VO:0004730 Ningxian Fan Oliver He Ronak Sutariya ALVAC-AI-H5(H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4215 4215 vaccine ALVAC-AI-H5(H5N1) vaccine VO:0004731 Ningxian Fan Oliver He Ronak Sutariya ALVAC-WNV-prM/E VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4216 4216 vaccine ALVAC-WNV-prM/E vaccine VO:0004732 Ningxian Fan Oliver He Ronak Sutariya ALVAC-BTV-CP(VP2/VP5) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4218 4218 vaccine ALVAC-BTV-CP(VP2/VP5) vaccine VO:0004733 Ningxian Fan Oliver He Ronak Sutariya ALVAC-NiV-G VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4219 4219 vaccine ALVAC-NiV-G vaccine VO:0004734 Ningxian Fan Oliver He Ronak Sutariya ALVAC-NiV-F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4220 4220 vaccine ALVAC-NiV-F vaccine VO:0004735 Ningxian Fan Oliver He Ronak Sutariya ALVAC-EIV (equine influenza virus H3N8) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4221 4221 vaccine ALVAC-EIV (equine influenza virus H3N8) vaccine VO:0004736 Ningxian Fan Oliver He Ronak Sutariya ALVAC-WNV-PrM/E (dogs and cats) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4222 4222 vaccine ALVAC-WNV-PrM/E (dogs and cats) vaccine VO:0004737 Ningxian Fan Oliver He Ronak Sutariya ALVAC-HIV-2- env/gag/pol VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4223 4223 vaccine ALVAC-HIV-2- env/gag/pol vaccine VO:0004738 Ningxian Fan Oliver He Ronak Sutariya ALVAC-RHDV (vCP309) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4224 4224 vaccine ALVAC-RHDV (vCP309) vaccine VO:0004739 Several canarypox virus recombinants expressing human or murine p53 in wild-type or mutant form were constructed Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:12006514 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4225 7157 4225 cancer vaccine Gene name: TP53 (P53) ALVAC-P53 Vaccine VO:0004740 Ningxian Fan Oliver He Ronak Sutariya ALVAC-FL- env/gag VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4226 4226 vaccine ALVAC-FL- env/gag vaccine VO:0004741 Ningxian Fan Oliver He Ronak Sutariya ALVAC-MV-HA/F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4227 4227 vaccine ALVAC-MV-HA/F vaccine VO:0004742 Ningxian Fan Oliver He Ronak Sutariya FP-IBDV-VP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4228 4228 vaccine FP-IBDV-VP2 vaccine VO:0004743 Ningxian Fan Oliver He Ronak Sutariya rFPV-AI-H5A-IL6 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4229 4229 vaccine rFPV-AI-H5A-IL6 vaccine VO:0004744 Ningxian Fan Oliver He Ronak Sutariya rFPV-ILTV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4230 4230 vaccine rFPV-ILTV vaccine VO:0004745 Ningxian Fan Oliver He Ronak Sutariya vFP89-HA (H5N1 HPAI virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4231 4231 vaccine vFP89-HA (H5N1 HPAI virus) vaccine VO:0004746 Ningxian Fan Oliver He Ronak Sutariya rFPV-H5AI-L2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4232 4232 vaccine rFPV-H5AI-L2 vaccine VO:0004747 Ningxian Fan Oliver He Ronak Sutariya ALVAC-AI-H5 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4233 4233 vaccine ALVAC-AI-H5 vaccine VO:0004748 Ningxian Fan Oliver He Ronak Sutariya rPFV-CSFV-E0 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4234 4234 vaccine rPFV-CSFV-E0 vaccine VO:0004749 Ningxian Fan Oliver He Ronak Sutariya rMDV-IBDV-VP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4237 4237 vaccine rMDV-IBDV-VP2 vaccine VO:0004750 Ningxian Fan Oliver He Ronak Sutariya rFPV-IBDV-VP 2.4.3 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4239 4239 vaccine rFPV-IBDV-VP 2.4.3 vaccine VO:0004751 Ningxian Fan Oliver He Ronak Sutariya rFPV-NDV-H/F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4240 4240 vaccine rFPV-NDV-H/F vaccine VO:0004752 Ningxian Fan Oliver He Ronak Sutariya rFP-RPV-H/F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4241 4241 vaccine rFP-RPV-H/F vaccine VO:0004753 Ningxian Fan Oliver He Ronak Sutariya Ac-CMV-S1 (infectious bronchitis virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4242 4242 vaccine Ac-CMV-S1 infectious bronchitis virus vaccine VO:0004754 Ningxian Fan Oliver He Ronak Sutariya BV-GD-ORF2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4243 4243 vaccine BV-GD-ORF2 vaccine VO:0004755 Ningxian Fan Oliver He Ronak Sutariya rSPV/H3-2A-H1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4244 4244 vaccine rSPV/H3-2A-H1 vaccine VO:0004756 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4245 4245 vaccine HVT-ILT(FC-126 strain) vaccine VO:0004757 Ningxian Fan Oliver He Ronak Sutariya rBCG-Ag85A/Ag85B VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4246 4246 vaccine rBCG-Ag85A/Ag85B vaccine VO:0004758 Ningxian Fan Oliver He Ronak Sutariya rMVA- AHS-VP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4248 4248 vaccine rMVA- AHS-VP2 vaccine VO:0004759 Ningxian Fan Oliver He Ronak Sutariya rMVTT-HA-QH (H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4249 4249 vaccine rMVTT-HA-QH (H5N1) vaccine VO:0004760 Ningxian Fan Oliver He Ronak Sutariya rMVTT-SIV-gpe VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4250 4250 vaccine rMVTT-SIV-gpe vaccine VO:0004761 Ningxian Fan Oliver He Ronak Sutariya rMVTT- HPV16-E6/E7 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4251 4251 cancer vaccine rMVTT- HPV16-E6/E7 vaccine VO:0004762 Ningxian Fan Oliver He Ronak Sutariya rLSDV-Rabies-gP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4253 4253 vaccine rLSDV-Rabies-gP vaccine VO:0004763 Ningxian Fan Oliver He Ronak Sutariya rLSDV-RPV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4254 4254 vaccine rLSDV-RPV vaccine VO:0004764 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4255 https://github.com/vaccineontology/VO/issues/527 4100 4255 cancer vaccine Gene name: MAGEA1 MG1-hDCT vaccine VO:0004765 Ningxian Fan Oliver He Ronak Sutariya rORFV-D1701-V-HAh5n (H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4256 4256 vaccine rORFV-D1701-V-HAh5n (H5N1) vaccine VO:0004766 Ningxian Fan Oliver He Ronak Sutariya rORFV-RabG VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4257 4257 vaccine rORFV-RabG vaccine VO:0004767 Ningxian Fan Oliver He Ronak Sutariya rORFV-RHDV-VP60 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4258 4258 vaccine rORFV-RHDV-VP60 vaccine VO:0004768 Ningxian Fan Oliver He Ronak Sutariya rORFV-CSFV-E2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4259 4259 vaccine rORFV-CSFV-E2 vaccine VO:0004769 Ningxian Fan Oliver He Ronak Sutariya rORFV-p40(Borna disease virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4260 4260 vaccine rORFV-p40(Borna disease virus) vaccine VO:0004770 Ningxian Fan Oliver He Ronak Sutariya rORFV-PRV-gC/gD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4261 4261 vaccine rORFV-PRV-gC/gD vaccine VO:0004771 Ningxian Fan Oliver He Ronak Sutariya NYVAC-EHV-1- vP1014 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4262 4262 vaccine NYVAC-EHV-1- vP1014 vaccine VO:0004772 Ningxian Fan Oliver He Ronak Sutariya NYVAC- CDV-H/F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4263 4263 vaccine NYVAC- CDV-H/F vaccine VO:0004773 Ningxian Fan Oliver He Ronak Sutariya ALVAC- CDV-H/F VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4264 4264 vaccine ALVAC- CDV-H/F vaccine VO:0004774 Ningxian Fan Oliver He Ronak Sutariya NYVAC-HIV-1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4265 4265 vaccine NYVAC-HIV-1 vaccine VO:0004775 Ningxian Fan Oliver He Ronak Sutariya NYVAC-HIV-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4266 4266 vaccine NYVAC-HIV-2 vaccine VO:0004776 Ningxian Fan Oliver He Ronak Sutariya NYVAC-JEV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4267 4267 vaccine NYVAC-JEV vaccine VO:0004777 Ningxian Fan Oliver He Ronak Sutariya ALVAC-JEV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4268 4268 vaccine ALVAC-JEV vaccine VO:0004778 Ningxian Fan Oliver He Ronak Sutariya NYVAC-PRV- gII/ gp50 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4270 4270 vaccine NYVAC-PRV- gII/ gp50 vaccine VO:0004779 Ningxian Fan Oliver He Ronak Sutariya NYVAC-SIV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4271 4271 vaccine NYVAC-SIV vaccine VO:0004780 Ningxian Fan Oliver He Ronak Sutariya NYVAC-JEV- prM/E/ NS1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4274 4274 vaccine NYVAC-JEV- prM/E/ NS1 vaccine VO:0004781 Ningxian Fan Oliver He Ronak Sutariya VC-TetC/Tcf VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4275 4275 vaccine VC-TetC/Tcf vaccine VO:0004782 Ningxian Fan Oliver He Ronak Sutariya rAdV-SjTPI.opt VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4280 4280 vaccine rAdV-SjTPI.opt vaccine VO:0004783 Ningxian Fan Oliver He Ronak Sutariya rPIV5-H3 (influenza virus) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4282 4282 vaccine rPIV5-H3 (influenza virus) vaccine VO:0004784 Ningxian Fan Oliver He Ronak Sutariya rVEE-HA(H1N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4288 4288 vaccine rVEE-HA(H1N1) vaccine VO:0004785 Ningxian Fan Oliver He Ronak Sutariya rS.C-APP-ApxI/ApxII VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4289 4289 vaccine rS.C-APP-ApxI/ApxII vaccine VO:0004786 Ningxian Fan Oliver He Ronak Sutariya rS.C-APP-ApxIIA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4290 4290 vaccine rS.C-APP-ApxIIA vaccine VO:0004787 Ningxian Fan Oliver He Ronak Sutariya dVV-HA5(H5N1) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4293 4293 vaccine dVV-HA5(H5N1) vaccine VO:0004788 Ningxian Fan Oliver He Ronak Sutariya rCPV-BTV-Cpox VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4295 4295 vaccine rCPV-BTV-Cpox vaccine VO:0004789 Ningxian Fan Oliver He Ronak Sutariya rBCG-SIVgag VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4299 4299 vaccine rBCG-SIVgag vaccine VO:0004790 Ningxian Fan Oliver He Ronak Sutariya rBCG-S1PT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4300 4300 vaccine rBCG-S2PT vaccine VO:0004791 Ningxian Fan Oliver He Ronak Sutariya rBCGMSP1-15 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4301 4301 vaccine rBCGMSP1-15 vaccine VO:0004792 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4302 4302 vaccine rMVA-SIV-CD40L human immunodeficiency virus vaccine VO:0004793 Ningxian Fan Oliver He Ronak Sutariya HVT-LT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4304 4304 vaccine HVT-LT vaccine VO:0004794 Ningxian Fan Oliver He Ronak Sutariya NYVAC-Pf7 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4269 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4306 4269 4306 vaccine NYVAC-Pf7 vaccine VO:0004795 Ningxian Fan Oliver He Ronak Sutariya Toxminus-PLD toxoid VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4308 4308 vaccine Toxminus-PLD toxoid vaccine VO:0004796 Ningxian Fan Oliver He Ronak Sutariya MVA-PvTRAP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4309 4309 vaccine MVA-PvTRAP vaccine VO:0004797 Ningxian Fan Oliver He Ronak Sutariya ChAd63 -PvTRAP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4310 4310 vaccine ChAd63 -PvTRAP vaccine VO:0004798 Ningxian Fan Oliver He Ronak Sutariya NILV-Py CSP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4094 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4311 4094 4311 vaccine NILV-Py CSP vaccine VO:0004799 Ningxian Fan Oliver He Ronak Sutariya SAd-ME.TRAP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4277 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4312 4277 4312 vaccine SAd-ME.TRAP vaccine VO:0004800 Ningxian Fan Oliver He Ronak Sutariya NYVAC-CSP (malaria) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4272 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4313 4272 4313 vaccine NYVAC-CSP malaria vaccine VO:0004801 Ningxian Fan Oliver He Ronak Sutariya BDES-PfCSP (baculovirus dual expression system) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4314 4314 vaccine BDES-PfCSP vaccine (baculovirus dual expression system) VO:0004802 Ningxian Fan Oliver He Ronak Sutariya HDAd-sFsyn VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4315 4315 vaccine HDAd-sFsyn vaccine VO:0004803 Ningxian Fan Oliver He Ronak Sutariya LM1-2-E7 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4316 4316 vaccine LM1-2-E7 vaccine VO:0004804 Ningxian Fan Oliver He Ronak Sutariya BL21(DE3)/pUTa-E + pET28a-FT VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4317 4317 vaccine BL21(DE3)/pUTa-E + pET28a-FT vaccine VO:0004805 Ningxian Fan Oliver He Ronak Sutariya rVEE-Ebola-NP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4318 4318 vaccine rVEE-Ebola-NP vaccine VO:0004806 Ningxian Fan Oliver He Ronak Sutariya M. bovis DNA vaccine pCI-Ag85B VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4319 4319 vaccine Mycobacterium bovis DNA vaccine pCI-Ag85B VO:0004807 Ningxian Fan Oliver He Ronak Sutariya BCG Bacillus Calmette-Guérin Danish VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4320 4320 vaccine Bacillus Calmette-Guérin Danish vaccine VO:0004808 Ningxian Fan Oliver He Ronak Sutariya APSV Wetvax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4321 4321 vaccine APSV Wetvax vaccine VO:0004809 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4322 4322 vaccine A/Brisbane/59/2007(H1N1), A/Brisbane/10/2007(H3N2), B/Florida/4/2006; Sanofi-Pasteur 2008-2009 trivalent influenza vaccine VO:0004810 2010-2011 trivalent seasonal inactivated influenza vaccine 2010 consisting of Influenza A virus (A/California/7/2009(H1N1)), Influenza A virus (A/Texas/50/2012(H3N2)), Influenza B virus (B/Brisbane/60/2008) Ningxian Fan Oliver He Randi Vita Ronak Sutariya 2010-2011 trivalent seasonal inactivated influenza vaccine (A/California/7/09 (H1N1), A/Perth/16/2009 (H3N2), and B/Brisbane/60/2008) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4324 https://www.ncbi.nlm.nih.gov/pubmed/25596819 https://www.ncbi.nlm.nih.gov/pubmed/27317456 4324 vaccine 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008) VO:0004811 Ningxian Fan Oliver He Ronak Sutariya VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4325 4325 vaccine Recombinant Aeromonas hydrophila vaccine (Aera) VO:0004812 Ningxian Fan Oliver He Ronak Sutariya C-KCE (vBAC-C-KCE) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4326 4326 vaccine C-KCE (vBAC-C-KCE) vaccine VO:0004813 Ningxian Fan Oliver He Ronak Sutariya v2RVFH VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4327 4327 vaccine v2RVFH vaccine VO:0004814 Kallan Roan Oliver He Biothrax (anthrax vaccine adsorbed) 0.5 ML Injectable Suspension http://purl.bioontology.org/ontology/RXNORM/832682 832682 Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML Injectable Suspension [Biothrax] Biothrax 0.1 MG/ML Injectable Suspension 19045675 CUI: C1877319 RXAUI: 7241001, 8235202, 8235203, 8231134 TUI: T200 vaccine Biothrax 0.5 ML Injectable Suspension VO:0004815 http://purl.bioontology.org/ontology/RXNORM/805573 805573 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 19032599 CUI: C2364569 RXAUI: 2861602 TUI: T129, T121 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain VO:0004816 http://purl.bioontology.org/ontology/RXNORM/805574 805574 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000000 UNT/ML 19131937 CUI: C2364570 RXAUI: 2861603 TUI: T200 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 UNT/ML VO:0004817 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/805577 805577 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000000 UNT/ML [Rotarix] 19131939 CUI: C2364572 RXAUI: 2861607 TUI: T200 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 UNT/ML [Rotarix] VO:0004818 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/805579 805579 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000000 UNT/ML Oral Suspension [Rotarix] Rotarix, Rotavirus, live attenuated (RV1) G1P[8] Vaccine 1 ML Lyophilized Powder for Oral Suspension 19131940 CUI: C2343398 RXAUI: 8728820, 8728821, 2861609 TUI: T200 vaccine Rotarix, Rotavirus, live attenuated (RV1) G1P[8] Oral Vaccine VO:0004819 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1182565 CUI: C3236400 RXAUI: 3845652 TUI: T200 vaccine Rotarix Oral Liquid Product VO:0004820 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798292 798292 human-bovine reassortant rotavirus strain G4 vaccine human rotavirus A type G4P7(5) strain BRB live antigen 529214 CUI: C2344315 RXAUI: 2851375 TUI: T116, T129, T121 vaccine Human-Bovine Reassortant Rotavirus Strain G4 Vaccine VO:0004821 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798293 798293 human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML 529215 CUI: C2344316 RXAUI: 2851376 TUI: T200 vaccine Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 1000000 UNT/ML VO:0004822 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798294 798294 human-bovine reassortant rotavirus strain P1A[8] vaccine human rotavirus A type G6P1A(8) strain WI79 live antigen 529216 CUI: C2344317 RXAUI: 2851377 TUI: T116, T129, T121 vaccine Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine VO:0004823 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798288 798288 human-bovine reassortant rotavirus strain G2 vaccine human rotavirus A type G2P7(5) strain SC2 live antigen 529180 CUI: C2344311 RXAUI: 2851371 TUI: T116, T129, T121 vaccine Human-Bovine Reassortant Rotavirus Strain G2 Vaccine VO:0004824 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798290 798290 human-bovine reassortant rotavirus strain G3 vaccine human rotavirus A type G3P7(5) strain WI78 live antigen 529212 CUI: C2344313 RXAUI: 2851373 TUI: T116, T129, T121 vaccine Human-Bovine Reassortant Rotavirus Strain G3 Vaccine VO:0004825 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798286 798286 human-bovine reassortant rotavirus strain G1 vaccine human rotavirus A type G1P7(5) strain WI79 live antigen 529176 CUI: C2344309 RXAUI: 2851369 TUI: T116, T129, T121 vaccine Human-Bovine Reassortant Rotavirus Strain G1 Vaccine VO:0004826 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798291 798291 human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML 529213 CUI: C2344314 RXAUI: 2851374 TUI: T200 vaccine Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 1100000 UNT/ML VO:0004827 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798287 798287 human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML 529177 CUI: C2344310 RXAUI: 2851370 TUI: T200 vaccine Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 1100000 UNT/ML VO:0004828 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798295 798295 human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML 529217 CUI: C2344318 RXAUI: 2851378 TUI: T200 vaccine Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 1150000 UNT/ML VO:0004829 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798289 798289 human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML 529181 CUI: C2344312 RXAUI: 2851372 TUI: T200 vaccine Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 1400000 UNT/ML VO:0004830 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1182563 CUI: C3236398 RXAUI: 3845650 TUI: T200 vaccine RotaTeq Oral Liquid Product VO:0004831 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798298 798298 human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML / human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML / human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML [RotaTeq] 19063533 CUI: C2344321 RXAUI: 2851381 TUI: T200 vaccine Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 1400000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 1100000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 1000000 UNT/ML / Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 1150000 UNT/ML [RotaTeq] VO:0004832 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/798300 798300 human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML / human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML / human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML Oral Suspension [RotaTeq] RotaTeq, Rotavirus, live pentavalent (RV5) Oral Vaccine 19130404 CUI: C1698233 RXAUI: 8728818, 8728828, 2851383 TUI: T200 vaccine RotaTeq, Rotavirus, live pentavalent (RV5) Oral Vaccine VO:0004833 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1607807 CUI: C4018289 RXAUI: 6839906 TUI: T200 vaccine Quadracel Injectable Product VO:0004834 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1988804 1988804 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Quadracel] 792969 CUI: C4530672 RXAUI: 9702160 TUI: T200 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Quadracel] VO:0004835 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1607808 1607808 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] 46221250 CUI: C4018290 RXAUI: 7253752, 9702161 TUI: T200 vaccine Quadracel vaccine 0.5 ML Injection VO:0004836 http://purl.bioontology.org/ontology/RXNORM/901509 901509 Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 40173207 CUI: C2741588 RXAUI: 3060734 TUI: T129, T121 vaccine Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine VO:0004837 http://purl.bioontology.org/ontology/RXNORM/901507 901507 Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 40173205 CUI: C2741586 RXAUI: 3060732 TUI: T129, T121 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine VO:0004838 http://purl.bioontology.org/ontology/RXNORM/901511 901511 Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 40173209 CUI: C2741590 RXAUI: 3060736 TUI: T129, T121 vaccine Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine VO:0004839 http://purl.bioontology.org/ontology/RXNORM/901505 901505 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 40173198 CUI: C2741584 RXAUI: 3060730 TUI: T129, T121 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine VO:0004840 http://purl.bioontology.org/ontology/RXNORM/901510 901510 Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML 40173208 CUI: C2741589 RXAUI: 3060735 TUI: T200 vaccine Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML VO:0004841 http://purl.bioontology.org/ontology/RXNORM/901508 901508 Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML 40173206 CUI: C2741587 RXAUI: 3060733 TUI: T200 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML VO:0004842 http://purl.bioontology.org/ontology/RXNORM/901512 901512 Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML 40173210 CUI: C2741591 RXAUI: 3060737 TUI: T200 vaccine Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML VO:0004843 http://purl.bioontology.org/ontology/RXNORM/901506 901506 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML 40173201 CUI: C2741585 RXAUI: 3060731 TUI: T200 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML VO:0004844 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1184384 CUI: C3238199 RXAUI: 3840481 TUI: T200 vaccine Menveo Injectable Product VO:0004845 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/901516 901516 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML [Menveo] 40173202 CUI: C2741595 RXAUI: 3060741 TUI: T200 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML [Menveo] VO:0004846 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/901518 901518 0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection [Menveo] Menveo Meningococcal (groups A, C, Y and W-135) oligosaccharide Diphtheria CRM197 Conjugate Vaccine 0.5 ML Injection 40173204 CUI: C2741597 RXAUI: 7253602, 7251512, 7250930 TUI: T200 vaccine MENVEO vaccine 0.5 ML Injection VO:0004847 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593139 CUI: C3859502 RXAUI: 6809461 TUI: T200 vaccine Trumenba Injectable Product VO:0004848 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593137 1593137 Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML [Trumenba] 45775642 CUI: C3859500 RXAUI: 6809459 TUI: T200 vaccine Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML [Trumenba] VO:0004849 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593138 1593138 meningococcal group B vaccine Prefilled Syringe [Trumenba] 45775643 CUI: C3859501 RXAUI: 6809460 TUI: T200 vaccine Trumenba vaccine Prefilled Syringe VO:0004850 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1593140 1593140 0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba] Trumenba (meningococcal group B vaccine) 0.5 ML Prefilled Syringe 45775644 CUI: C3859503 RXAUI: 6809462, 6809488, 7253600, 6809470 TUI: T200 vaccine Trumenba vaccine 0.5 ML Prefilled Syringe VO:0004851 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601406 CUI: C3883559 RXAUI: 6827964 TUI: T200 vaccine Bexsero Injectable Product VO:0004852 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601404 1601404 meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML [Bexsero] 45892097 CUI: C3883499 RXAUI: 6827962 TUI: T200 vaccine meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML [Bexsero] VO:0004853 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1601407 1601407 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero] Bexsero Meningococcal Group B Vaccine 0.5 ML Prefilled Syringe 45892099 CUI: C3882668 RXAUI: 7253601, 6827965, 6827966, 6827968, 6827967 TUI: T200 vaccine BEXSERO vaccine 0.5 ML Prefilled Syringe VO:0004854 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/833079 CUI: C2608637 RXAUI: 2944708 TUI: T116, T121 vaccine smallpox vaccine live vaccinia virus VO:0004855 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/833080 CUI: C2608638 RXAUI: 2944709 TUI: T200 vaccine smallpox vaccine live vaccinia virus 500000000 UNT/ML VO:0004856 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1165898 CUI: C3220139 RXAUI: 3828366 TUI: T200 vaccine ACAM2000 Injectable Product VO:0004857 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/833086 833086 smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML Injectable Solution [ACAM2000] ACAM2000 smallpox (vaccinia) vaccine, live Injectable Solution 19133778 CUI: C2608644 RXAUI: 2944716, 2944715, 7252433 TUI: T200 vaccine ACAM2000 smallpox (vaccinia) vaccine, live Injectable Solution VO:0004858 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/833084 CUI: C2608642 RXAUI: 2944713 TUI: T200 vaccine smallpox vaccine live vaccinia virus 500000000 UNT/ML [ACAM2000] VO:0004859 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/29503 29503 meningococcal group C polysaccharide 509081 vaccine component CUI: C0065944 RXAUI: 436480, 5945194, 6410398 TUI: T109, T129, T121 meningococcal group C polysaccharide VO:0004860 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/314725 314725 meningococcal polysaccharide vaccine group Y 514015 CUI: C0982276 RXAUI: 1473942 TUI: T109, T129, T121 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y VO:0004861 Jie Zheng Kallan Roan Oliver He Xingxian Li 1437844 meningococcal group C polysaccharide 0.01 MG/ML 43560725 vaccine meningococcal group C polysaccharide 0.01 MG/ML VO:0004862 Jie Zheng Kallan Roan Oliver He Xingxian Li 350967 meningococcal group C polysaccharide 0.1 MG/ML 19097997 vaccine meningococcal group C polysaccharide 0.1 MG/ML VO:0004863 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1437845 1437845 meningococcal polysaccharide vaccine group Y 0.01 MG/ML 43560588 CUI: C3666862 RXAUI: 5495921 TUI: T200 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.01 MG/ML VO:0004864 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/350966 350966 meningococcal polysaccharide vaccine group Y 0.1 MG/ML 19097996 CUI: C1167602 RXAUI: 1545435 TUI: T200 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML VO:0004865 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1437915 CUI: C3666883 RXAUI: 5496016 TUI: T200 vaccine MenHibrix Injectable Product VO:0004866 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1437913 1437913 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML [MenHibrix] 43560549 CUI: C3666881 RXAUI: 5496014 TUI: T200 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.01 MG/ML [MenHibrix] VO:0004867 Kallan Roan Oliver He MenHibrix (meningococcal groups C and Y and Haemophilus b tetanus toxoid conjugate vaccine) 0.5 ML Injection http://purl.bioontology.org/ontology/RXNORM/1437916 1437916 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection [MenHibrix] MenHibrix (meningococcal groups C and Y and Haemophilus b tetanus toxoid conjugate vaccine) 0.5 ML Injection 43560548 CUI: C3537927 RXAUI: 7253596, 7251659, 7250946 TUI: T200 vaccine MENHIBRIX vaccine 0.5 ML Injection VO:0004868 http://purl.bioontology.org/ontology/RXNORM/1437843 CUI: C3666860 RXAUI: 5495919 TUI: T200 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML VO:0004869 http://purl.bioontology.org/ontology/RXNORM/1299785 organism CUI: C3159361 RXAUI: 4624424 TUI: T129, T121 HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 VO:0004870 http://purl.bioontology.org/ontology/RXNORM/1183840 CUI: C3237660 RXAUI: 3840468 TUI: T200 vaccine Menomune A/C/Y/W-135 Injectable Product VO:0004871 http://purl.bioontology.org/ontology/RXNORM/1802483 organism CUI: C4083103 RXAUI: 8240118 TUI: T129, T121 HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 VO:0004872 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1153474 54 adenovirus vaccine, type 4, live, oral adenovirus, type 4 CUI: C3207956 RXAUI: 3814359 TUI: T200 vaccine Adenovirus Type 4 Vaccine Live Oral Product VO:0004873 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1153475 CUI: C3207957 RXAUI: 3814360 TUI: T200 vaccine Adenovirus Type 4 Vaccine Live Pill VO:0004874 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1099935 CUI: C3153709 RXAUI: 6337850 TUI: T200 vaccine Adenovirus Type 4 Vaccine Live Delayed Release Oral Tablet VO:0004875 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1099936 CUI: C3153710 RXAUI: 6337174, 6364229 TUI: T200 vaccine Adenovirus Type 4 Vaccine Live 32000 UNT Delayed Release Oral Tablet VO:0004876 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1099934 CUI: C3153708 RXAUI: 3638491 TUI: T200 vaccine Adenovirus Type 4 Vaccine Live 32000 UNT VO:0004877 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1153476 55 adenovirus vaccine, type 7, live, oral adenovirus, type 7 CUI: C3207958 RXAUI: 3814361 TUI: T200 vaccine Adenovirus Type 7 Vaccine Live Oral Product VO:0004878 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1153661 CUI: C3208141 RXAUI: 3814362 TUI: T200 vaccine Adenovirus Type 7 Vaccine Live Pill VO:0004879 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1099939 CUI: C3153712 RXAUI: 6337292 TUI: T200 vaccine Adenovirus Type 7 Vaccine Live Delayed Release Oral Tablet VO:0004880 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1099940 CUI: C3153713 RXAUI: 6337842, 6364883 TUI: T200 vaccine Adenovirus Type 7 Vaccine Live 32000 UNT Delayed Release Oral Tablet VO:0004881 Kallan Roan Oliver He http://purl.bioontology.org/ontology/RXNORM/1099938 CUI: C3153711 RXAUI: 3638495 TUI: T200 vaccine Adenovirus Type 7 Vaccine Live 32000 UNT VO:0004882 http://purl.bioontology.org/ontology/RXNORM/568054 568054 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML [Menomune A/C/Y/W-135] 19118347 CUI: C1600470 RXAUI: 2283589 TUI: T200 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML [Menomune A/C/Y/W-135] VO:0004883 http://purl.bioontology.org/ontology/RXNORM/1658227 1658227 meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injection [Menomune A/C/Y/W-135] 46275262 CUI: C4033800 RXAUI: 7252552 TUI: T200 vaccine Menomune A/C/Y/W-135 Vaccine Injection VO:0004884 http://purl.bioontology.org/ontology/RXNORM/1658228 1658228 0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection [Menomune A/C/Y/W-135] Menomune A/C/Y/W-135 (meningococcal group A polysaccharide 50 MCG / meningococcal group C polysaccharide 50 MCG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 50 MCG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 50 MCG) per 0.5 ML Injection 46275263 CUI: C3887764 RXAUI: 7253594, 7252562, 7252553 TUI: T200 vaccine Menomune A/C/Y/W-135 Vaccine 0.5 ML Injection VO:0004885 http://purl.bioontology.org/ontology/RXNORM/207269 207269 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injectable Solution [Menomune A/C/Y/W-135] 19035048 CUI: C0708576 RXAUI: 3051640, 7253593, 5944304, 1155623 TUI: T200 vaccine Menomune A/C/Y/W-135 Vaccine Injectable Solution VO:0004886 http://purl.bioontology.org/ontology/RXNORM/314724 314724 meningococcal polysaccharide vaccine group W-135 514012 CUI: C0982275 RXAUI: 1473937 TUI: T200 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 VO:0004887 http://purl.bioontology.org/ontology/RXNORM/350965 350965 meningococcal polysaccharide vaccine group W-135 0.1 MG/ML 19097995 CUI: C1167601 RXAUI: 1545434 TUI: T200 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML VO:0004888 http://purl.bioontology.org/ontology/RXNORM/29501 29501 meningococcal group A polysaccharide 509079 vaccine component CUI: C0065942 RXAUI: 436468, 6410396, 2719265, 5945192 TUI: T200 meningococcal group A polysaccharide VO:0004889 Jie Zheng Xingxian Li 328467 meningococcal group A polysaccharide 0.1 MG/ML 509080 vaccine meningococcal group A polysaccharide 0.1 MG/ML VO:0004890 The gH1-Qbeta vaccine is a novel pandemic-influenza vaccine produced by covalently linking the globular head domain of haemagglutinin (gH1) from A/California/07/09 produced in E. coli to VLPs from the bacteriophage Qbeta Oliver He Randi Vita https://www.ncbi.nlm.nih.gov/pubmed/30573748 vaccine gH1-Qbeta vaccine VO:0004891 CN54gp140 + GLA https://www.ncbi.nlm.nih.gov/pubmed/29535712 vaccine A recombinant uncleaved clade C HIV-1 envelope gp140 protein (CN54gp140) CN54gp140 + GLA vaccine VO:0004893 Fluenz is a seasonal trivalent live attenuated influenza vaccine (LAIV) administered intranasally. The vaccine contained A/California/07/2009 (H1N1) pdm09-like strain, A/Victoria/361/2011 (H3N2)-like strain, and B/Massachusetts/2/2012-like strain. Oliver He Randi Vita https://www.ncbi.nlm.nih.gov/pubmed/26148331 vaccine Fluenz vaccine VO:0004894 quadrivalent seasonal inactivated influenza vaccine 2014 consisting of Influenza A virus (A/California/7/2009(H1N1)), Influenza A virus (A/Texas/50/2012(H3N2)), Influenza B virus (B/Brisbane/60/2008), Influenza B virus (B/Massachusetts/02/2012) Oliver He Randi Vita Avey et al 2019, paper submitted vaccine quadrivalent seasonal inactivated influenza vaccine 2014 VO:0004895 F' (intended to refer to a female biological sex), 'Female', 'Woman', '0' (intended to refer to a female biological sex) A biological sex datum that represents the biological sex of an animal (including human) as being female. Oliver He Paul Fabry data item female biological sex datum VO:0004896 I' (intended to refer to an intersex biological sex), 'Intersex', 'Hermaphrodite', 'Pseudo-hermaphrodite', '2' (intended to refer to an intersex biological sex) A biological sex datum that represents the biological sex of an animal (including human) as being intersex. Oliver He Paul Fabry data item intersex biological sex datum VO:0004897 A vaccine against coronavirus infection Hong Yu Oliver He vaccine coronavirus vaccine VO:0004898 Oliver He https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Perth/16/2009(H3N2)&decorator=influenza vaccine component Recommended by WHO for Vaccines: 2011-2012 Northern Hemisphere 2010 Southern Hemisphere 2011 Southern Hemisphere 2012 Southern Hemisphere 2010-2011 Northern Hemisphere Influenza A virus A/Perth/16/2009 (H3N2) antigen VO:0004899 2012-2013 trivalent seasonal inactivated influenza vaccine 2012-2013 Influenza A virus (A/California/7/2009 (H1N1)), Influenza A virus (A/Victoria/361/2011 (H3N2)), and Influenza B virus (B/Wisconsin/1/2010) Oliver He Randi Vita https://www.ncbi.nlm.nih.gov/pubmed/?term=30843873 vaccine 2012-2013 seasonal trivalent inactivated influenza vaccine (A/California/7/2009 (H1N1), A/Victoria/361/2011 (H3N2), and B/Wisconsin/1/2010) VO:0004900 MERS-CoV vaccine vaccine MERS vaccine VO:0004901 Oliver He https://www.drugbank.ca/drugs/DB14396 vaccine component influenza B virus B/Wisconsin/1/2010 antigen VO:0004902 Oliver He https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Victoria/361/2011(H3N2)&decorator=influenza vaccine component Recommended by WHO for Vaccines: 2013 Southern Hemisphere 2014 Southern Hemisphere 2012-2013 Northern Hemisphere 2013-2014 Northern Hemisphere influenza A virus A/Victoria/361/2011 (H3N2) antigen VO:0004903 Inactivated monovalent influenza A/H5N1 (3.75 mcg hemagglutinin [HA] A/Indonesia/05/2005) split-virus (SV) vaccine (Sanofi) Oliver He Randi Vita https://www.ncbi.nlm.nih.gov/pubmed/28099485 https://www.ncbi.nlm.nih.gov/pubmed/30566602 vaccine inactivated monovalent influenza A/H5N1 (3.75 mcg hemagglutinin [HA] A/Indonesia/05/2005) split-virus (SV) vaccine (Sanofi) VO:0004904 https://www.fludb.org/brc/fluStrainDetails.spg?strainName=A/Indonesia/5/2005(H5N1)&tabName=17535101%20No2&decorator=influenza&context=1544988803656 vaccine component Influenza A virus (A/Indonesia/05/2005) antigen VO:0004905 MERS-CoV S protein with alum and CpG adjuvant https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884803/ vaccine MERS-CoV S protein with alum and CpG adjuvant vaccine VO:0004906 protein MERS-CoV protein VO:0004907 protein MERS-CoV S protein VO:0004908 A coronavirus vaccine against the infection of SARS-CoV-2 (cause of COVID-19) Anthony Huffman Oliver He Philip Huang SARS-CoV-2 vaccine https://en.wikipedia.org/wiki/COVID-19_vaccine https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines vaccine COVID-19 vaccine VO:0004910 A Plasmodium falciparum vaccine that is composed of aseptic, purified, live (metabolically active), radiation-attenuated, cryopreserved Plasmodium falciparum sporozite. Oliver He Randi Vita Plasmodium falciparum sporozite Vaccine https://www.ncbi.nlm.nih.gov/pubmed/26469720 https://www.ncbi.nlm.nih.gov/pubmed/28216244 vaccine PfSPZ vaccine by Sanaria Inc VO:0004911 The fully infectious PfSPZ are attenuated in vivo by concomitant administration of an anti-malarial drug (chloroquine). Chloroquine kills disease-associated blood stages but does not affect pre-erythrocytic (sporozoite or liver) stages, which are exposed to the host's immune system. Sporozoites-induced protection is mediated by immunity against pre-erythrocytic stages. Oliver He Randi Vita PfSPZ Chemoprophylaxis Vaccine PfSPZ-Cvac https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775905/ https://www.ncbi.nlm.nih.gov/pubmed/26469720 https://www.ncbi.nlm.nih.gov/pubmed/28199305 vaccine PfSPZ-Cvac vaccine VO:0004912 Sanaria(R) PfSPZ-GA1 consists of purified, aseptic, cryopreserved Pf sporozoites (NF54 strain) genetically attenuated by removal of the b9 and slarp genes to halt development in the early liver stages. Oliver He Randi Vita PfSPZ-GA1 https://www.ncbi.nlm.nih.gov/pubmed/26469720 vaccine The parasite line was generated by the Leiden University Medical Center (LUMC) and RUMC in collaboration with Sanaria. Plasmodium falciparum with deletion b9 and slarp parasites invade hepatocytes but are incapable of sustaining liver stage development, similar to radiation-attenuated PfSPZ. The potential advantages of PfSPZ-GA1 are that (1) the PfSPZ are homogenous and have a precisely characterized genetic basis for attenuation; (2) manufacturing PfSPZ-GA1 cannot result in accidental exposure of staff to infectious parasites, thereby simplifying the approach to safety of operators and lowering costs. PfSPZ-GA1 also has the potential to induce more efficient protection than the radiation-attenuated PfSPZ Vaccine due to a different pattern of developmental arrest and antigen expression. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077156/ PfSPZ-GA1 vaccine VO:0004913 A vaccine role that inheres in a vaccine using virus-like particles (VLPs), multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccines. Anthony Huffman Oliver He virus like particle vaccine role https://pubmed.ncbi.nlm.nih.gov/20923267/ role virus-like particle vaccine role VO:0004914 A vaccine that uses virus-like particles (VLPs), multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccines. Anthony Huffman Oliver He virus like particle vaccine https://pubmed.ncbi.nlm.nih.gov/20923267/ vaccine virus-like particle vaccine VO:0004915 vaccine-induced T-helper 1 type immune response that is indicated by the presence of Interferon-gamma production Anthony Huffman Oliver He vaccine-induced response vaccine specific interferon-γ immune response VO:0004916 vaccine-induced T-helper 1 type immune response that is indicated by the presence of interleukin-2 production Anthony Huffman Oliver He vaccine-induced response vaccine specific IL-2 immune response VO:0004917 vaccine-induced T-helper 2 type immune response that is indicated by the presence of interleukin-4 production Anthony Huffman Oliver He vaccine-induced response vaccine specific interleukin-4 response VO:0004918 vaccine-induced T-helper 2 type immune response that is indicated by the presence of interleukin-10 production Anthony Huffman Oliver He vaccine-induced response vaccine specific interleukin-10 response VO:0004919 vaccine-induced T-helper 1 type immune response that is indicated by the presence of IgG2a production Anthony Huffman Oliver He https://www.ncbi.nlm.nih.gov/pmc/articles/PMC101669/ vaccine-induced response vaccine specific Th1 immune response indicated by IgG2a production VO:0004920 vaccine-induced T-helper 2 type immune response that is indicated by the presence of IgG1 production Anthony Huffman Oliver He https://www.ncbi.nlm.nih.gov/pmc/articles/PMC101669/ vaccine-induced response vaccine specific Th2 immune response indicated by IgG1 production VO:0004921 Anna Maria Masci Anthony Huffman Oliver He quality The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. human age VO:0004922 Anna Maria Masci Anthony Huffman Oliver He quality The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. child age VO:0004923 Anna Maria Masci Anthony Huffman Oliver He quality The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. adolescence age VO:0004924 Anna Maria Masci Anthony Huffman Oliver He quality The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. adult age VO:0004925 Anna Maria Masci Anthony Huffman Oliver He quality The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. senior age VO:0004926 Anna Maria Masci Anthony Huffman Oliver He data item age range at vaccination VO:0004927 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. human age range at vaccination VO:0004928 Anna Maria Masci Anthony Huffman Oliver He human age 0 to 12 years at vaccination data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human child age range at vaccination VO:0004929 Anna Maria Masci Anthony Huffman Oliver He human age 19 to 59 years at vaccination data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human adult age range at vaccination VO:0004930 Anna Maria Masci Anthony Huffman Oliver He human age 60 and above years at vaccination data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human senior age range at vaccination VO:0004931 Anna Maria Masci Anthony Huffman Oliver He human age 13 to 18 years at vaccination https://www.cdc.gov/vaccines/vpd/vaccines-age.html data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. human adolescence age range at vaccination VO:0004933 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 1 to 2 months at vaccination VO:0004934 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 4 months at vaccination VO:0004935 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 11 to 12 years at vaccination VO:0004936 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 4 to 6 years at vaccination VO:0004937 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 7 to 11 months at vaccination VO:0004938 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 12 to 23 months at vaccination VO:0004939 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 2 to 3 years at vaccination VO:0004940 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 6 months at vaccination VO:0004941 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 7 to 10 years at vaccination VO:0004942 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 19 to 26 years at vaccination VO:0004943 Anna Maria Masci Anthony Huffman Oliver He data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age 27 to 59 years at vaccination VO:0004944 A human child age range at vaccination with the range from the birth to one month after birth at when a vaccination is taken. HepB vaccination is sometimes taken within 12 hours after birth. Anna Maria Masci Anthony Huffman Jie Zheng Oliver He newborn age range at human vaccination https://www.cdc.gov/vaccines/parents/diseases/hepb.html data item The human age is classified into four categories as Child (0-12 years), Adolescence (13-18 years), Adult (19-59 years) and Senior Adult (60 years and above) which is discussed in the paper. Reference: https://ieeexplore.ieee.org/abstract/document/6416855. https://www.cdc.gov/vaccines/vpd/vaccines-age.html human age within one month at vaccination VO:0004987 A SARS-CoV-2 RNA vaccine formed from a lipid nanoparticle-formulated trimerized SARS-CoV-2 receptor-binding domain Oliver He Philip Huang Rohit Goru BNT162b2 PF-07302048 Tozinameran PMID: 32839784 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5784 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://en.wikipedia.org/wiki/Tozinameran https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine https://www.fda.gov/media/144246/download 5784 COMIRNATY For active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. https://www.fda.gov/media/151707/download?attachment 125742 vaccine Comirnaty vaccine VO:0004988 Oliver He Philip Huang protein SARS-CoV-2 protein VO:0004989 Replaced term with S protein of SARS-CoV-2 Wuhan strain (PR_P0DTC2) for ontology harmonization Anthony Huffman obsolete S protein of SARS-CoV-2 true VO:0004990 protein E protein of SARS-CoV-2 VO:0004991 BBV152 (also known as Covaxin) is an inactivated COVID-19 vaccine that is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. Oliver He Philip Huang Rohit Goru BBV152 COVAXIN VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5795 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://en.wikipedia.org/wiki/BBV152 https://go.drugbank.com/drugs/DB15847 5795 502 702666 SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) COVID-19 IV Non-US Vaccine (COVAXIN) vaccine COVAXIN vaccine VO:0004992 A recombinant coronavirus-like particle SARS-CoV-2 vaccine developed by Medicago Philip Huang CoVLP NCT04636697 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5796 5796 512 778259 SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) vaccine CoVLP vaccine VO:0004993 A P. falciparum malaria vaccine that is formed by tull length CS-expressing replication-deficient recombinant human adenovirus 35. Oliver He Randi Vita PMID:18455276 vaccine This is a term requested by Randi for the HIPC/ImmPort work Ad35.CS.01 malaria vaccine VO:0004994 A SARS-CoV-2 trimeric S protein subunit vaccine. Philip Huang SCB-2019 NCT04405908 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5797 5797 vaccine SCB-2019 vaccine VO:0004995 A SARS-CoV-2 S1-RBD-protein based vaccine developed by Vaxxinity Philip Huang UB-612 NCT04545749 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5798 5798 vaccine UB-612 vaccine VO:0004996 A SARS-CoV-2 replication-defective human adenovirus type 5/35 vector based vaccine expressing the S protein. Philip Huang AdCLD-CoV19 NCT04666012 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5800 5800 vaccine AdCLD-CoV19 vaccine VO:0004999 A SARS-CoV-2-RBD-Fc fusion protein designed to induce or boost a Th1/Th2 mixed immune response in patients against the Receptor Binding Domain (RBD) of the novel coronavirus spike protein. Philip Huang AKS-452 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5834 https://www.akstonbio.com/programs/covid-19-vaccine/ 5834 vaccine AKS-452 vaccine VO:0005000 A DNA vaccine plasmid vector that has the plasmid label pCAGGSP7. This plasmid has a polylinker containing KpnI, XhoI, ClaI, EcoRV, SmaI, Not1 and Sac1 sites inserted into the EcoRI site of pCAGGS. Oliver He Rebecca Racz vaccine component pCAGGSP7 DNA vaccine plasmid PMID:9711802 VO:0005001 A DNA vaccine plasmid vector that has the plasmid label pCAGGS/MCS. This plasmid has a chicken beta-actin promoter, contains a multiple cloning site between the EcoRI and BglII sites of the rabbit beta-globin gene, and has restriction sites for the enzymes SacI, ClaI, NsiI, Asp718, SmaI, SphI, XhoI, and NheI. Oliver He Rebecca Racz vaccine component pCAGGS/MCS DNA vaccine plasmid PMID: 9261394 VO:0005002 A DNA vaccine plasmid vector that has the plasmid label pWRG. This plasmid is a eukaryotic expression plasmid that contains the immediate early promoter and intron A of human cytomegalovirus. Oliver He Rebecca Racz vaccine component pWRG DNA vaccine plasmid PMID: 10403592 VO:0005003 A DNA vaccine plasmid vector that has the plasmid label pHW2000. This plasmid is derived from pHW12 and contains part of the human pol I promoter and murine terminator sequences, a CMV promoter, and the polyadenylation signal of the gene encoding bovine growth hormone. Oliver He Rebecca Racz vaccine component pHW2000 DNA vaccine plasmid PMID: 10662626 VO:0005004 A DNA vaccine plasmid vector that has the plasmid label pCMV/R. This plasmid is a mammalian expression vector with a CMV promoter. Oliver He Rebecca Racz vaccine component pCMV/R DNA vaccine plasmid PMID: 20660192 VO:0005005 A DNA vaccine plasmid vector that has the plasmid label VRC-9123. Oliver He Rebecca Racz vaccine component This plasmid was prepared under Good Manufacturing Practices at 4 mg/mL in phosphate buffered saline (PBS). VRC-9123 DNA vaccine plasmid PMID: 21975270 VO:0005006 A DNA vaccine plasmid vector that has the plasmid label pPJV7563. This plasmid has a human cytomegalovirus immediate early promoter. Oliver He Rebecca Racz vaccine component pPJV7563 DNA vaccine plasmid PMID: 20544035 VO:0005007 A DNA vaccine plasmid vector that has the plasmid label p188. This plasmid is a replication-defective derivative of pP1/H7. Oliver He Rebecca Racz vaccine component p188 DNA vaccine plasmid PMID: 8212843 VO:0005008 A DNA vaccine plasmid vector that has the plasmid label VR10551. This plasmid contains a human cytomegalovirus immediate early 1 promoter, a kanamycin resistance gene, intron A and a modified rabbit b-globin terminator. Oliver He Rebecca Racz vaccine component VR10551 DNA vaccine plasmid PMID: 17637571 VO:0005009 A DNA vaccine plasmid vector that has the plasmid label VCL-1632. This plasmid contains a CMV promoter, kanamycin resistance gene, the murine Kappa constant region sequence, a translational enhancer, the murine IgG2a heavy-chain sequence, and a translation terminator. This plasmid is derived from pUC-18. Oliver He Rebecca Racz vaccine component VCL-1632 DNA vaccine plasmid PMID: 12384547 VO:0005010 A DNA vaccine plasmid vector that has the plasmid label pSport-B-gal. This plasmid contains a CMV promoter. Oliver He Rebecca Racz vaccine component pSport-B-gal DNA vaccine plasmid PMID: 12496961 VO:0005011 A DNA vaccine plasmid vector that has the plasmid label pSin-B-gal. This plasmid contains a CMV promoter. Oliver He Rebecca Racz vaccine component pSin-B-gal DNA vaccine plasmid PMID: 10646851 VO:0005012 A DNA vaccine plasmid vector that has the plasmid label pLXSHD. This plasmid has a murine leukemia virus enhancer-promoter LTR. Oliver He Rebecca Racz vaccine component pLXSHD DNA vaccine plasmid PMID: 7533183 VO:0005013 A DNA vaccine plasmid vector that has the plasmid label WRG/BEN. This plasmid is based off of pWRG7077. It contains a CMV promoter and a kanamycin resistance gene. Oliver He Rebecca Racz vaccine component WRG/BEN DNA vaccine plasmid PMID: 9739060 VO:0005014 A DNA vaccine plasmid vector that has the plasmid label pNGVL4a. This plasmid has a CMV promoter and kanamycin and ampicillin resistance genes. Oliver He Rebecca Racz vaccine component There is an extra immunostimulatory sequence (450 bp) in pNGVL4a plasmid compared to pNGVL3 pNGVL4a DNA vaccine plasmid PMID: 11818167 VO:0005015 A DNA vaccine plasmid vector that has the plasmid label pNGVL3. This plasmid has a CMV promoter and kanamycin and ampicillin resistance genes. Oliver He Rebecca Racz vaccine component pNGVL3 DNA vaccine plasmid PMID: 11818167 VO:0005016 A DNA vaccine plasmid vector that has the plasmid label SINCp B-gal. This plasmid contains a CMV promoter. Oliver He Rebecca Racz vaccine component SINCp B-gal DNA vaccine plasmid PMID: 17024104 VO:0005017 A DNA vaccine plasmid vector that has the plasmid label Synchotrope TA2M. This plasmid is 3683 base pairs in length and has two copies of the murine CpG immune stimulatory sequence AACGTT inserted. Oliver He Rebecca Racz vaccine component It has been shown that plasmid half-life in human serum in vitro is 20 minutes Synchotrope TA2M DNA vaccine plasmid PMID: 12833467 VO:0005018 A DNA vaccine plasmid vector that has the plasmid label pCMV/myc/ER. This plasmid is 5066 base pairs in length and contains a CMV promoter and ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2236/ vaccine component pCMV/myc/ER DNA vaccine plasmid VO:0005019 A DNA vaccine plasmid vector that has the plasmid label pPA63-LAMP1. Oliver He Rebecca Racz vaccine component pPA63-LAMP1 DNA vaccine plasmid PMID: 19130551 VO:0005020 A DNA vaccine plasmid vector that has the plasmid label pSecTag2B. This plasmid is 5163 base pairs in length and contains a CMV promoter and ampicillin resistance gene. Oliver He Rebecca Racz Invitrogen:http://tools.invitrogen.com/content/sfs/manuals/psectag2_man.pdf; Sequence: http://tools.invitrogen.com/content/sfs/vectors/psectag2b_seq.txt vaccine component pSecTag2B DNA vaccine plasmid VO:0005021 A DNA vaccine plasmid vector that has the plasmid label pTPA-PA63-LAMP1. Oliver He Rebecca Racz vaccine component pTPA-PA63-LAMP1 DNA vaccine plasmid PMID: 19130551 VO:0005022 A DNA vaccine plasmid vector that has the plasmid label pTPA-PA63. Oliver He Rebecca Racz vaccine component pTPA-PA63 DNA vaccine plasmid PMID: 19130551 VO:0005023 A DNA vaccine plasmid vector that has the plasmid label VR2210. This plasmid contains a CMV promoter and kanamycin resistance gene. It was created through ligation of fragments of digested plasmid VR1012, hTPA, and B. burgdorferi B31 ospA. Oliver He Rebecca Racz vaccine component VR2210 DNA vaccine plasmid PMID: 8985201 VO:0005024 A DNA vaccine plasmid vector that has the plasmid label pCMV-TPA/ZS7. This plasmid contains a CMV promoter and is generated from pCMV-ZS7 by attaching hTPA to ospC ZS7. Oliver He Rebecca Racz vaccine component pCMV-TPA/ZS7 DNA vaccine plasmid PMID: 12941385; PMID: 10580194 VO:0005025 A DNA vaccine plasmid vector that has the plasmid label pABB-CRS2. This plasmid is a derivative of pCVD442 and contains a chloramphenicol resistance gene. Oliver He Rebecca Racz vaccine component pABB-CRS2 DNA vaccine plasmid PMID: 11562461 VO:0005026 A DNA vaccine plasmid vector that has the plasmid label pMASIA-tgD. This plasmid is based off of pMASIA and contains a CMV promoter and kanamycin resistance gene. Oliver He Rebecca Racz vaccine component pMASIA-tgD DNA vaccine plasmid PMID: 12466473 VO:0005027 A DNA vaccine plasmid vector that has the plasmid label pCMVi-UB. This plasmid was built from pCMV-5 and contains a CMV promoter. Oliver He Rebecca Racz vaccine component pCMVi-UB DNA vaccine plasmid PMID: 10433551 VO:0005028 A DNA vaccine plasmid vector that has the plasmid label pCI30. This plasmid contains a CMV promoter, ampicillin resistance gene, T7 RNA polymerase promoter, a multiple cloning region and a 6xHis tag coding sequence. Oliver He Rebecca Racz vaccine component pCI30 DNA vaccine plasmid PMID: 17239501; PMID: 11567754 VO:0005029 A DNA vaccine plasmid vector that has the plasmid label pCP15/60. Oliver He Rebecca Racz vaccine component pCP15/60 DNA vaccine plasmid VO:0005030 A DNA vaccine plasmid vector that has the plasmid label pUMVC3. This plasmid is 4030 base pairs in length and contains a CMV promoter and kanamycin resistance gene. Oliver He Rebecca Racz Aldevron: http://www.aldevron.com/products/dnas/umvc_expression/ vaccine component pUMVC3 DNA vaccine plasmid PMID: 12654810 VO:0005031 A DNA vaccine plasmid vector that has the plasmid label pcDNA1. This plasmid is 4000 base pairs in length and contains a CMV promoter. Oliver He Rebecca Racz Addgene: https://www.addgene.org/vector-database/2089/ vaccine component pcDNA1 DNA vaccine plasmid VO:0005032 A DNA vaccine plasmid vector that has the plasmid label pCAT. This plasmid is 4364 base pairs in length and contains an ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2051/ vaccine component pCAT DNA vaccine plasmid VO:0005033 A DNA vaccine plasmid vector that has the plasmid label pGT36. This plasmid is a derivative of pcDNA3 and contains a CMV promoter and a kanamycin resistance gene. Oliver He Rebecca Racz vaccine component pGT36 DNA vaccine plasmid PMID: 9569471] VO:0005034 A DNA vaccine plasmid vector that has the plasmid label VR1040. This plasmid contains four copies of the mouse immunostimulatory sequence and is similar to VR1012. Oliver He Rebecca Racz vaccine component VR1040 DNA vaccine plasmid PMID: 11883007 VO:0005035 A DNA vaccine plasmid vector that has the plasmid label pcTPA. This plasmid is based on pcDNA3 and contains the hTPA signal sequence. Oliver He Rebecca Racz vaccine component pcTPA DNA vaccine plasmid PMID: 16122850 VO:0005036 A DNA vaccine plasmid vector that has the plasmid label pMV10.1. This plasmid contains a CMV promoter and a kanamycin resistance gene. Oliver He Rebecca Racz vaccine component pMV10.1 DNA vaccine plasmid PMID: 16125280 VO:0005037 A DNA vaccine plasmid vector that has the plasmid label pET11d. This plasmid is 5674 base pairs in length and contains an ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2628/ vaccine component pET11d DNA vaccine plasmid PMID: 16520093 VO:0005038 A DNA vaccine plasmid vector that has the plasmid label pUMVC4b. This plasmid is 4478 base pairs in length and contains a CMV promoter and kanamycin and ampicillin resistance genes. Oliver He Rebecca Racz Aldevron: http://www.aldevron.com/products/dnas/umvc_expression/; Sequence: https://system.netsuite.com/c.606687/pUMVC4a.txt vaccine component pUMVC4b DNA vaccine plasmid VO:0005039 A DNA vaccine plasmid vector that has the plasmid label pRC. This plasmid is 7400 base pairs in length and contains CMV and RSV promoters. Oliver He Rebecca Racz vaccine component pRC DNA vaccine plasmid PMID: 9879611 VO:0005040 A DNA vaccine plasmid vector that has the plasmid label pAK-4. This plasmid is 6600 base pairs in length and contains a CMV promoter and kanamycin and ampicillin resistance genes. Oliver He Rebecca Racz vaccine component pAK-4 DNA vaccine plasmid PMID: 16157425 VO:0005041 A DNA vaccine plasmid vector that has the plasmid label pCMVi(-H3)Ubs. This plasmid contains a CMV promoter. Oliver He Rebecca Racz vaccine component pCMVi(-H3)Ubs DNA vaccine plasmid PMID: 10438054 VO:0005042 A DNA vaccine plasmid vector that has the plasmid label Auxo-GTU. Oliver He Rebecca Racz vaccine component patent applications, PCT/FI02/00379 filed 03.05.2002 and PCT/FI2004/ 000540 filed 15.09.2004 Auxo-GTU DNA vaccine plasmid PMID: 16359234 VO:0005043 A DNA vaccine plasmid vector that has the plasmid label pCMN160. This plasmid has a CMV promoter. Oliver He Rebecca Racz vaccine component pCMN160 DNA vaccine plasmid PMID: 9142121 VO:0005044 A DNA vaccine plasmid vector that has the plasmid label V1Jns. This plasmid contains the human CMV promoter, enhancer and intron A as well as the polyadenylation sequences of bovine growth hormone. Oliver He Rebecca Racz vaccine component V1Jns DNA vaccine plasmid PMID: 9127013 VO:0005045 A DNA vaccine plasmid vector that has the plasmid label pND-14. This plasmid contains a CMV promoter, ampicillin resistance gene, a tissue plasminogen activator leader sequence, a bovine growth hormone terminator, and constitutive transport element from simian retrovirus. Oliver He Rebecca Racz vaccine component pND-14 DNA vaccine plasmid PMID: 15149785 VO:0005046 A DNA vaccine plasmid vector that has the plasmid label pSecTag2A. This plasmid is 5159 base pairs in length and contains a CMV promoter and ampicillin reisistance gene. Oliver He Rebecca Racz Invitrogen: http://tools.invitrogen.com/content/sfs/manuals/psectag2_man.pdf; Sequence: http://tools.invitrogen.com/content/sfs/vectors/psectag2a_seq.txt vaccine component pSecTag2A DNA vaccine plasmid VO:0005047 A DNA vaccine plasmid vector that has the plasmid label pRc/CMV-HBs(S). This plasmid is 5618 base pairs in length and contains a CMV promoter and ampicillin resistance gene. Oliver He Rebecca Racz Bioresearch Online: http://www.bioresearchonline.com/doc/pRcCMV-HBsS-0001 vaccine component Also known as pCMV-S pRc/CMV-HBs(S) DNA vaccine plasmid VO:0005048 A DNA vaccine plasmid vector that has the plasmid label pcDNA. Oliver He Rebecca Racz vaccine component pcDNA DNA vaccine plasmid PMID: 15839423 VO:0005049 A DNA vaccine plasmid vector that has the plasmid label proVAX. This plasmid contains a CMV promoter and a hCG-beta leader sequence. Oliver He Rebecca Racz vaccine component proVAX DNA vaccine plasmid PMID: 17310492 VO:0005050 A DNA vaccine plasmid vector that has the plasmid label p1012. Oliver He Rebecca Racz vaccine component p1012 DNA vaccine plasmid PMID: 11117750 VO:0005051 A DNA vaccine plasmid vector that has the plasmid label pUSE-. This plasmid is a mammalian expression vector derived from pCI-neo. Oliver He Rebecca Racz vaccine component pUSE- DNA vaccine plasmid PMID: 11507187 VO:0005052 A DNA vaccine plasmid vector that has the plasmid label APL023. Oliver He Rebecca Racz vaccine component APL023 DNA vaccine plasmid PMID: 17241713 VO:0005053 A DNA vaccine plasmid vector that has the plasmid label pEGFP-N1. This plasmid is 4733 base pairs in length and contains a CMV promoter and kanamycin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2491/ vaccine component pEGFP-N1 DNA vaccine plasmid VO:0005054 A DNA vaccine plasmid vector that has the plasmid label pCDL-SRa296. This plasmid is 3700 base pairs in length and contains a SRalpha promoter. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2084/ vaccine component pCDL-SRa296 DNA vaccine plasmid PMID: 2827008 VO:0005055 A DNA vaccine plasmid vector that has the plasmid label pUSK. Oliver He Rebecca Racz vaccine component pUSK DNA vaccine plasmid PMID: 15121294 VO:0005056 A DNA vaccine plasmid vector that has the plasmid label pUBIQ. This plasmid is derived from pGEM3 and contains a CMV promoter and an ampicillin resistance gene. Oliver He Rebecca Racz vaccine component pUBIQ DNA vaccine plasmid PMID: 12922097 VO:0005057 A DNA vaccine plasmid vector that has the plasmid label pcDNA3.1/Hygro(-). This plasmid is 5596 base pairs in length and contains a CMV promoter and an ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2105/ vaccine component Differs from other pcDNA3.1 in drug resistance; +/- refers to orientation of f1 ori pcDNA3.1/Hygro(-) DNA vaccine plasmid VO:0005058 A DNA vaccine plasmid vector that has the plasmid label pCMV3ISS. This plasmid is a eukaryotic expression vector. Oliver He Rebecca Racz vaccine component pCMV3ISS DNA vaccine plasmid PMID: 18951941 VO:0005059 A DNA vaccine plasmid vector that has the plasmid label pWRG7079. This plasmid contains a CMV promoter and a kanamycin resistance gene and differs from pWRG7077 by the insertion of a TPA sequence. Oliver He Rebecca Racz vaccine component pWRG7079 DNA vaccine plasmid PMID: 12922144 VO:0005060 A DNA vaccine plasmid vector that has the plasmid label pVR1020. This plasmid contains a CMV promoter and kanamycin resistance gene. Oliver He Rebecca Racz vaccine component pVR1020 DNA vaccine plasmid PMID: 11292786 VO:0005061 A DNA vaccine plasmid vector that has the plasmid label nkCMVintpolyli. This plasmid contains a CMV promoter. Oliver He Rebecca Racz vaccine component nkCMVintpolyli DNA vaccine plasmid PMID: 8666931 VO:0005062 A DNA vaccine plasmid vector that has the plasmid label pcDNA3.1/V5-His-TOPO. This plasmid is 5523 base pairs in length and contains a CMV promoter and ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/5587/ vaccine component pcDNA3.1/V5-His-TOPO DNA vaccine plasmid VO:0005063 A DNA vaccine plasmid vector that has the plasmid label pIRES1neo. This plasmid is 5257 base pairs in length and contains an ampicillin resistance gene. Oliver He Rebecca Racz Metalife: http://www.metalife.com/Genbank/1899169 vaccine component pIRES1neo DNA vaccine plasmid VO:0005064 A DNA vaccine plasmid vector that has the plasmid label pRc/RSV. This plasmid is 5224 base pairs in length and contains a RSV LTR promoter and ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/3908/ vaccine component pRc/RSV DNA vaccine plasmid VO:0005065 A DNA vaccine plasmid vector that has the plasmid label pCI-TPA. This plasmid contains the N-terminal signal sequence of TPA. Oliver He Rebecca Racz vaccine component pCI-TPA DNA vaccine plasmid PMID: 19428891 VO:0005066 A DNA vaccine plasmid vector that has the plasmid label pCSIVgag. Oliver He Rebecca Racz vaccine component pCSIVgag DNA vaccine plasmid PMID: 18000037 VO:0005067 A DNA vaccine plasmid vector that has the plasmid label pVacc4. This plasmid is a derivative of pVacc1 and contains a CMV promoter. Oliver He Rebecca Racz vaccine component pVacc4 DNA vaccine plasmid PMID: 15004179 VO:0005068 A DNA vaccine plasmid vector that has the plasmid label pBC12B1. This plasmid is a eukaryotic expression vector. Oliver He Rebecca Racz vaccine component pBC12B1 DNA vaccine plasmid PMID: 10948115 VO:0005069 A DNA vaccine plasmid vector that has the plasmid label pGFP. This plasmid is 3300 base pairs in length and contains a lac promoter and an ampicillin resistance gene. Oliver He Rebecca Racz Clontech: http://www.clontech.com/xxclt_ibcGetAttachment.jsp?cItemId=17740 vaccine component pGFP DNA vaccine plasmid VO:0005070 A DNA vaccine plasmid vector that has the plasmid label pCMV-beta. This plasmid is 7164 base pairs in length and contains a CMV promoter and ampicllin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2245/ vaccine component pCMV-beta DNA vaccine plasmid VO:0005071 A DNA vaccine plasmid vector that has the plasmid label pSW3891. This plasmid contains a CMV promoter. Oliver He Rebecca Racz vaccine component pSW3891 DNA vaccine plasmid PMID: 16919703 VO:0005072 A DNA vaccine plasmid vector that has the plasmid label pJW4304. This plasmid is 5132 base pairs in length and contains a CMV promoter. Oliver He Rebecca Racz NIH AIDS Reagent Program: https://www.aidsreagent.org/reagentdetail.cfm?t=cloning_vectors&id=76 vaccine component pJW4304 DNA vaccine plasmid VO:0005073 A DNA vaccine plasmid vector that has the plasmid label pGT146-mIL-12. Oliver He Rebecca Racz vaccine component pGT146-mIL-12 DNA vaccine plasmid PMID: 18694965 VO:0005074 A DNA vaccine plasmid vector that has the plasmid label pDNAVACC. Oliver He Rebecca Racz vaccine component pDNAVACC DNA vaccine plasmid PMID: 21134447 VO:0005075 A DNA vaccine plasmid vector that has the plasmid label VR1055. This plasmid is derived from pUC19 and contains a CMV promoter, kanamycin resistance gene, a cloning polylinker, and a transcriptional terminator region derived from the rabbit beta-globin gene. Oliver He Rebecca Racz vaccine component VR1055 DNA vaccine plasmid PMID: 9990062 VO:0005076 A DNA vaccine plasmid vector that has the plasmid label pRSC. Oliver He Rebecca Racz vaccine component pRSC DNA vaccine plasmid PMID: 21185849 VO:0005077 A DNA vaccine plasmid vector that has the plasmid label pcDNA3.1(Zeo)+. This plasmid is 5015 base pairs in length and contains a zeocin selectable marker, a CMV promoter, and an ampicillin resistance gene. Oliver He Rebecca Racz Addgene: http://www.addgene.org/vector-database/2110/ vaccine component pcDNA3.1(Zeo)+ DNA vaccine plasmid VO:0005078 A DNA vaccine plasmid vector that has the plasmid label pVF. Oliver He Rebecca Racz vaccine component Also known as pVAX-Flag pVF DNA vaccine plasmid PMID: 23026687 VO:0005079 A SARS-CoV-2 vaccine consisting of autologous dendritic cells previously loaded ex vivo with spike protein. Philip Huang AV-COVID-19 NCT04386252 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5801 5801 vaccine AV-COVID-19 vaccine VO:0005081 A SARS-CoV-2 vaccine that includes a protein antigen, SARS-CoV-2 Spike RBD, adsorbed to the adjuvant Alhydrogel (Alum), in combination with another approved adjuvant, CpG 1018 Philip Huang Corbevax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5802 https://www.biologicale.com/news.html 5802 517 778264 SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) vaccine Corbevax vaccine VO:0005082 An authorized SARS-CoV-2 protein subunit vaccine based on recombinant RBD subunits manufactured by the Center for Genetic Engineering and Biotechnology (CIGB). Philip Huang Abdala CIGB-66 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5803 https://rpcec.sld.cu/en/trials/RPCEC00000345-En 5803 vaccine Abdala vaccine VO:0005083 A SARS-CoV-2 protein subunit vaccine based on recombinant RBD subunits manufactured by the Center for Genetic Engineering and Biotechnology (CIGB). Philip Huang CIGB-669 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5804 https://rpcec.sld.cu/en/trials/RPCEC00000345-En 5804 vaccine CIGB-669 vaccine VO:0005084 A SARS-CoV-2 inactivated virus vaccine by Shenzhen Kangtai Biological Products and Beijing Minhai Biotechnology Co. Oliver He Philip Huang KCONVAC NCT04852705 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5805 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5805 516 778263 SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) vaccine KCONVAC vaccine VO:0005085 A stabilised pre-fusion SARS-CoV-2 spike protein vaccine produced in a baculovirus expression system and manufactured by Sanofi Pasteur and GlaxoSmithKline Philip Huang CoV2 preS dTM VAT00002 PubMed ID: 33887209 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5833 5833 vaccine VAT00002 vaccine VO:0005087 An influenza virus vector SARS-CoV-2 vaccine administered as an intranasal spray manufactured by University of Hong Kong, Xiamen University, and Beijing Wantai Biological Pharmacy. Philip Huang DelNS1-2019-nCoV-RBD-OPT1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5806 http://www.chictr.org.cn/showprojen.aspx?proj=55421 5806 vaccine DelNS1-2019-nCoV-RBD-OPT1 vaccine VO:0005088 A SARS-CoV-2 protein subunit vaccine that relies on chemically synthesized peptide antigens of SARS-CoV-2 proteins, conjugated to a carrier protein and adsorbed on an aluminum-containing adjuvant (aluminum hydroxide). Philip Huang EpiVacCorona NCT04527575 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5794 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5794 509 702671 SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) COVID-19 PS Non-US Vaccine (EpiVacCorona) vaccine EpiVacCorona vaccine VO:0005089 A SARS-CoV-2 plasmid DNA vaccine developed by GeneOne Life Science. Philip Huang GLS-5310 NCT04673149 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5807 5807 vaccine GLS-5310 vaccine VO:0005090 A rVSV-SARS-CoV-2-S vaccine developed by the Israel Institute for Biological Research (IIBR). Philip Huang Brilife IIBR-100 NCT04608305 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5799 5799 vaccine IIBR-100 vaccine VO:0005091 A SARS-CoV-2 recombinant vector vaccine by Shenzhen Geno-Immune Medical Institute Philip Huang LV-SMENP-DC NCT04276896 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5808 5808 vaccine LV-SMENP-DC vaccine VO:0005092 A SARS-CoV-2 subunit vaccine with recombinant SARS-CoV-2 spike (S) protein and aluminum phosphate adjuvant Philip Huang Nanocovax NCT04683484 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5809 5809 vaccine Nanocovax vaccine VO:0005093 A SARS-CoV-2 inactivated vaccine manufactured by the Research Institute for Biological Safety Problems (Republic of Kazakhstan) Philip Huang QazCovid-in QazVac NCT04691908 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5810 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5810 501 702665 SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) COVID-19 IV Non-US Vaccine (QAZCOVID-IN) vaccine QazVac vaccine VO:0005094 A SARS-CoV-2 virus-like particle vaccine that contains the Receptor Binding Domain (RBD) of the SARS-CoV-2 spike (S) protein and is adjuvanted with aluminum. Philip Huang RBD-HBsAg VLP ACTRN12620001308987 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5811 5811 vaccine RBD-HBsAg VLP vaccine VO:0005095 A SARS-CoV-2 protein subunit vaccine by West China Hospital Philip Huang NCT04640402 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5812 5812 vaccine Recombinant SARS-CoV-2 vaccine (Sf9 cell) VO:0005096 A SARS-CoV-2 recombinant protein vaccine¬¨‚Ćthat uses the Baculovirus expression vector system. Philip Huang S-268019 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5813 https://www.shionogi.com/content/dam/shionogi/global/news/pdf/2020/12/e-201216.pdf 5813 vaccine S-268019 vaccine VO:0005097 A SARS-CoV-2 subunit vaccine developed by Finlay Vaccine Institute (IFV) Philip Huang FINLAY-FR-2 Soberana 02 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5814 https://rpcec.sld.cu/en/trials/RPCEC00000347-En 5814 vaccine Soberana 02 vaccine VO:0005098 A SARS-CoV-2 vaccine candidate that uses a measles virus vector platform, and is made by Merck. Development of the vaccine was discontinued on January 25, 2021. Oliver He Philip Huang V591 https://www.merck.com/news/merck-discontinues-development-of-sars-cov-2-covid-19-vaccine-candidates-continues-development-of-two-investigational-therapeutic-candidates/ vaccine V591 vaccine VO:0005099 A SARS-CoV-2 inactivated, Vero-cell based vaccine adjuvanted with aluminum and CpG 1018. It uses the manufacturing platform of Valneva's commercial Japanese encephalitis (JE) vaccine Philip Huang VLA2001 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5816 https://valneva.com/research-development/covid-19-vla2001/ 5816 518 716023 SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) vaccine VLA2001 vaccine VO:0005100 A SARS DNA vaccine that is made from recombinant plasmid containing nucleocapsid protein (N) sequence constructed then expressed and purified from E. coli bacteria. Anthony Huffman PMID:16423399 vaccine SARS N protein DNA vaccine VO:0005101 A SARS DNA combination vaccine that is made from recombinant plasmids' containing membrane protein (M) and nucleocapsid protein (N) sequences constructed then expressed and purified from E. coli bacteria. Anthony Huffman PMID:16423399 vaccine SARS N + SARS M DNA vaccine VO:0005102 A SARS DNA vaccine that is made from recombinant plasmid containing membrane protein (M) sequence constructed then expressed and purified from E. coli bacteria. Anthony Huffman PMID:16423399 vaccine SARS M protein DNA vaccine VO:0005103 A SARS DNA vaccine that is made from oral live-attenuated auxotrophic S. typhimurium aroA strain SL7207 that contained CTLA4HingeSARS800 with SARS-CoV S protein. Anthony Huffman PMID:15993989 vaccine Salmonella-CTLA4-S SARS DNA vaccine VO:0005104 A SARS DNA vaccine that is made from intraperitoneal recombinant spike polypeptide generated by amplififying gene encoding amino acids residues 14-667 of S protein that was cloned BamHI and KpnI sites of vector pQE-31 that was generated by Escherichia coli Anthony Huffman PMID:15993989 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5734 5734 vaccine Recombinant SARS spike polypeptide vaccine VO:0005105 A SARS DNA vaccine that is made from CTLA4HingeSARS800 DNA with SARS-CoV S protein Anthony Huffman PMID:15993989 vaccine SARS CTLA4-S DNA vaccine VO:0005106 A SARS DNA vaccine that is made from tpa-optimize800 DNA with SARS-CoV S protein Anthony Huffman PMID:15993989 vaccine SARS tPA-S DNA vaccine VO:0005107 A SARS DNA vaccine made from CTLA4HingeSARS800 DNA with SARS-CoV S protein Anthony Huffman PMID:15993989 vaccine Salmonella-tPA-S SARS DNA vaccine VO:0005108 A SARS recombinant vector vaccine that is made from of the highly attenuated modified vaccinia virus Ankara (MVA) containing the gene encoding full-length SARS-CoV S Anthony Huffman PMID:23142821 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5729 5729 vaccine SARS MA-ExoN vaccine VO:0005109 A SARS recombinant vector vaccine that is made from recombinant MA15 virulent mouse-adapted SARS-CoV (MA15) background of E-deleted vaccine candidate (rMA15-DeltaE). Anthony Huffman PMID:16423399 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5728 5728 vaccine SARS rMA15-ΔE vaccine VO:0005110 A SARS recombinant vector vaccine that is made from a recombinant live-attenuated modified vaccinia virus Ankara (MVA) that had a full-length SARS-CoV envelope Spike (S) glycoprotein gene introduced into the deletion III region of the MVA genome. Anthony Huffman PMID:15708987 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5726 5726 vaccine SARS ADS-MVA vaccine VO:0005111 A MERS subunit vaccine that has a combined adjuvant of aluminum hydroxide and CpG oligodeoxynucleotides. Anthony Huffman PMID:29618723 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5714 5714 vaccine MERS-CoV S vaccine adjuvanted with CpG and Alum VO:0005112 A MERS inactivated whole virus vaccine that has a combined adjuvant that has a combined adjuvant of aluminum hydroxide and CpG oligodeoxynucleotides. Anthony Huffman PMID:29618723 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5721 5721 vaccine Inactivated whole MERS-CoV (IV) vaccine with CpG and Alum VO:0005113 A SARS recombinant vector vaccine made from a recombinant form of the highly attenuated modified vaccinia virus Ankara (MVA) containing the gene encoding full-length SARS-CoV S Anthony Huffman PMID:15096611 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5725 5725 vaccine SARS MVA/S vaccine VO:0005114 A SARS inactivated vaccine made from whole killed (inactivated by beta-propiolactone) SARS-CoV Anthony Huffman PMID:16476986 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5730 5730 vaccine beta-propiolactone-inactivated SARS-CoV vaccine VO:0005115 A SARS recombinant vector vaccine made of combination of two adenovirus-based vectors, one expressing the nucleocapsid (N) and the other expressing the spike (S) protein Anthony Huffman PMID:16476986 vaccine SARS Ad S/N vaccine VO:0005116 A MERS recombinant vector vaccine made of a recombinant adenoviral vector encoding the the S1 extracellular domain of S protein Anthony Huffman PMID:25192975 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5720 5720 vaccine Ad5.MERS-S1 vaccine VO:0005117 A MERS recombinant vector vaccine made of a recombinant adenoviral vector encoding the full-length MERS-CoV S protein (Ad5.MERS-S) Anthony Huffman PMID:25192975 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5719 5719 vaccine Ad5.MERS-S vaccine VO:0005118 A MERS DNA vaccine made of plasmid that encoded S1 subunit only Anthony Huffman PMID:26218507 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5716 5716 vaccine MERS England1 S1 protein subunit vaccine VO:0005119 A MERS combination vaccine made of made of the VRC8400 plasmid that encodes the full-length, membrane anchore MERS spike protein and a DNA vaccine that is a plasmid that encoded S1 subunit Anthony Huffman PMID:26218507 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5717 5717 vaccine MERS England1 S DNA + England1 S protein subunit vaccine VO:0005120 A MERS DNA vaccine made of the VRC8400 plasmid that encodes the full-length, membrane anchore MERS spike protein Anthony Huffman PMID:26218507 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5715 5715 vaccine MERS England1 S DNA Vaccine VO:0005121 A MERS subunit vaccine made of neutralizing monoclonal antibodiesagainst MERS-CoV which bind to the ribosomal binding domain (RBD) of the MERS-CoV S protein that was expressed by baculovirus-insect cell sf9-derived recombinant MERS-CoV. Anthony Huffman PMID:28536429 vaccine MERS rRBD plus alum vaccine VO:0005122 A MERS DNA vaccine made of plasmid that encodes the first 725 amino acids of S from MERS-CoV Anthony Huffman PMID:28314561 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5718 5718 vaccine MERS-CoV pcDNA3.1-S1 DNA vaccine VO:0005123 A MERS recombinant vector virus made from chimeric virus based on the vesicular stomatitis virus (VSV) in which the G gene was replaced by MERS-CoV S gene (VSV≈í√ÆG-MERS). Anthony Huffman PMID:29246504 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5722 5722 vaccine VSVΔG-MERS vaccine VO:0005124 A MERS subunit vaccine made of a neutralizing monoclonal antibodiesagainst MERS-CoV which bind to the N-terminal domain (NTD) of the MERS-CoV S1 subunit that was expressed by baculovirus-insect cell sf9-derived recombinant MERS-CoV. Anthony Huffman PMID:28536429 vaccine MERS rNTD vaccine VO:0005125 A SARS inactivated vaccine made from inactivated whole virus by formalin and Ultraviolet radiation, hence Double Inactivated (DI) Vaccine Anthony Huffman PMID:22536382 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5742 5742 vaccine inactivated whole (formalin and UV radiation) SARS-CoV vaccine VO:0005126 A recombinant SARS DNA vaccine made from rDNA-expressed ectodomain of the S protein. Anthony Huffman PMID:22536382 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5743 5743 vaccine recombinant SARS DNA spike protein vaccine VO:0005127 A SARS VLP vaccine made from the SARS-CoV spike protein (S) and the Nucleocapsid (N), envelope (E) and membrane (M) proteins from mouse hepatitis coronavirus (MHV) Anthony Huffman PMID:22536382 vaccine Viral-like-particle S-MHV SARS vaccine VO:0005128 A SARS inactivated vaccine made from SARS-CoV inactivated by ultraviolet radiation and a Toll-Like Receptor Agonist Adjuvant is added to prevent eosinophilic immunopathology Anthony Huffman PMID:22536382 vaccine UV-Inactivated SARS + TLR agonist vaccine VO:0005129 A SARS inactivated vaccine made from SARS-CoV inactivated by ultraviolet radiation Anthony Huffman PMID:22536382 vaccine UV-Inactivated SARS vaccine VO:0005130 A MERS recombinant vector made from Venezuelan equine encephalitis replicons bearing epitopes of N protein from MERS. Crosslisted as SARS vaccine (VIOLINID:5754). Efficacy higher intranasally than subcutaneously. Anthony Huffman PMID:26954467 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5748 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5754 5748 5754 vaccine VRP-MERS-N vaccine VO:0005131 A SARS recombinant vector vaccine made from Venezuelan equine encephalitis replicons (VRP) encoding a SARS-CoV CD4+ T cell epitope vaccinated intranasally. Crosslisted as MERS vaccine (VIOLINID:5789). Efficacy higher intranasally than subcutaneously. Anthony Huffman PMID:26954467 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5749 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5755 5749 5755 vaccine VRP-SARS-N vaccine VO:0005132 A MERS DNA vaccine made of plasmid vaccines that encoded S1 subunit only Anthony Huffman PMID:26954467 vaccine rVV-SARS vaccine VO:0005133 A MERS recombinant vector vaccine made of live-attenuated measles virus (MV) vaccine encoding the MERS-CoV spike protein (MERS-S). Anthony Huffman PMID:26355094 vaccine MVvac2-MERS-S(H) vaccine VO:0005134 A MERS recombinant vector vaccine made of live-attenuated measles virus (MV) vaccine encoding the MERS-CoV nucleocapsid protein (MERS-N). Anthony Huffman PMID:29902727 vaccine MVvac2-MERS-N vaccine VO:0005135 A MERS recombinant vector made of Chimpanzee adenovirus Oxford 1 vector expressing S protein from MERS-CoV. Anthony Huffman PMID:29263883 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5751 5751 vaccine ChAdOx1-MERS-S vaccine VO:0005136 A MERS recombinant vector made of Adenovirus type 41 used as vector for MERS-CoV S protein. Anthony Huffman PMID:25762305 vaccine Ad41.MERS vaccine VO:0005137 A MERS VLP vaccine made from a recombinant baculovirus co-expresssing the spike S, envelope (E), and membrane (M) proteins of MERS. Anthony Huffman PMID:23986586 vaccine MVA-MERS vaccine VO:0005138 A SARS DNA vaccine made from encoding calrectulin linked to a SARS-CoV N protein Anthony Huffman PMID:15078946 vaccine CRT-N SARS vaccine VO:0005139 A SARS recombinant vector vaccine made from a line attenuated and recombinant SARS-CoV lacking the E gene Anthony Huffman PMID:18463152 vaccine rSARS-CoV-ΔE vaccine VO:0005140 A MERS recombinant vector made of MVvac2 (measle virus) expressing a soluble, truncated version of spike glycoprotein of MERS-CoV in its full length cloned into the MVvac2 genome and rescued. Anthony Huffman PMID:26355094 vaccine MVvac2-MERS-solS vaccine VO:0005141 A SARS-CoV-2 whole virus vaccine made from a purified inactivated SARS-CoV-2 virus. Anthony Huffman Oliver He Philip Huang Rohit Goru CoronaVac PiCoVacc PMID:32376603 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5761 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://en.wikipedia.org/wiki/CoronaVac 5761 511 702673 SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) vaccine CoronaVac vaccine VO:0005142 A SARS-CoV-2 subunit vaccine composed of the SARS-CoV-2 S protein receptor-binding domain produced in Chinese hamster ovary (CHO) cells and adjuvant aluminum hydroxide. Anthony Huffman Philip Huang ZF2001 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5764 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5764 vaccine ZF2001 vaccine VO:0005143 A SARS-CoV-2 RNA vaccine made of self-coding RNA encoding SARS-CoV-2 spike protein encapsulated within a lipid nanoparticle. Anthony Huffman Philip Huang LNP-nCoVsaRNA PMID:32647131 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5771 5771 vaccine LNP-nCoVsaRNA vaccine VO:0005144 A SARS-CoV-2 vaccine made from a recombinant adinvorius type-5 expressing SARS-CoV-2 S protein. Anthony Huffman Philip Huang Ad5-nCoV PMID:32450106 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5768 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5768 vaccine Ad5-nCoV vaccine VO:0005145 A MERS DNA Vaccine that is made of the plasmid pGX9109 expressing MERS S protein. Anthony Huffman PMID:32450106 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5769 5769 vaccine MERS GLS-5300 vaccine VO:0005146 A SARS DNA vaccine made of a single closed plasmid DNA marcromolecule (VRC-8138) that produces a deletion mutant of the SARS Spike glycoprotein Anthony Huffman PMID:18824060 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5770 5770 vaccine VRC-SRSDNA015-00-VP vaccine VO:0005147 A SARS-CoV recombinant vector vaccine that is made from the Newcastle disease virus from the mesogenic Beaudette C strainexpressing SARS-CoV S protein. Anthony Huffman PMID:17535926 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5766 5766 vaccine SARS NDV-BC/S vaccine VO:0005148 A SARS-CoV recombinant vector vaccine that is made from the Newcastle disease virus from the lentogenic LaSota strain expressing SARS-CoV S protein. Anthony Huffman PMID:17535926 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5767 5767 vaccine SARS NDV-VF/S vaccine VO:0005149 A SARS DNA vaccine made from rDNA-expressed ectodomain of the S protein. JZ: may be same as VO:0005126 Anthony Huffman PMID:16497416 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5745 5745 vaccine rDNA-expressed S SARS protein vaccine VO:0005150 A SARS DNA vaccine made up of arecombinat vector vaccine made from recombinant measles virus expressing S protein and recombinant measles virus expressing N protein. Anthony Huffman PMID:18346823 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5762 5762 vaccine rMV-S + rMV-N vaccine VO:0005151 A SARS-CoV recombinant vector made from a baculovirus vector expressing SARS-CoV S protein. Anthony Huffman PMID:22536382 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5763 5763 vaccine SARS-CoV Baculovirus S protein Vaccine VO:0005152 A MERS recombinant vector made of recombinant modified vaccinia virus Ankara (rMVA) vaccine vector carrying full MERS-CoV spike glycoprotein. Anthony Huffman PMID:32325037 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5752 5752 vaccine MVA-MERS-S vaccine VO:0005153 A SARS-CoV-2 single dose intranasal vaccine manufactured by Altimmune in collaboration with the University of Alabama-Birmingham. This vaccine was discontinued after a Phase 1 trial. Philip Huang AdCOVID https://altimmune.com/adcovid/ vaccine AdCOVID vaccine VO:0005154 A plasmid pCI-N, encoding the full-length N gene of SARS-CoV, was constructed and expressed in Escherichia coli DH5alpha [PMID: 15582659] vaccine SARS-CoV pCI-N DNA vaccine VO:0005155 A SARS-CoV 2 (rSARS-CoV-2) subunit vaccine made of nanoparticles composed of a trimeric full-length SARS-CoV-2 spike glycoprotein and Matrix-M1 adjuvant. Anthony Huffman Philip Huang Covovax Nuvaxovid PMID:32376603 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5791 5791 211 SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL vaccine NVX-CoV2373 vaccine VO:0005156 A SARS-CoV-2 RNA vaccine that has a lipid nanoparticle (LNP) platform and Spike protein antigen Anthony Huffman Philip Huang CoV2 SAM NCT04758962 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5842 5842 vaccine CoV2 SAM vaccine VO:0005157 A SARS-CoV2 RNA vaccine made of lipid nanoparticle with mRNA which encodes the S-2P antigen, made of the SARS-CoV-2 glycoprotein with a transmembrane anchor and intact S1-S2 cleavage site. Anthony Huffman Oliver He Philip Huang Rohit Goru COVID-19 Vaccine Moderna CX-024414 mRNA-1273 PMID:32663912 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5789 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://en.wikipedia.org/wiki/MRNA-1273 https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine 5789 vaccine Moderna COVID-19 vaccine VO:0005158 A SARS-CoV2 recombinat vector vaccine made of a chimpanzee adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein Anthony Huffman Philip Huang AZD1222 COVID-19 Vaccine AstraZeneca ChAdOx1 nCoV-19 PMID:32702298 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5774 https://en.wikipedia.org/wiki/AZD1222 5774 Covishield 210 724905 SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL vaccine Oxford-AstraZeneca COVID-19 vaccine VO:0005159 A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 vector expressing S protein. Anthony Huffman Oliver He Philip Huang Ad26.COV2.S Ad26COVS1 JNJ-78436735 Johnson & Johnson COVID-19 vaccine PMID:32731257 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5782 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5782 212 SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL vaccine Ad26.COV2.S vaccine VO:0005160 A SARS-CoV-2 inactivated whole virus vaccine that is developed by the Wuhan Institute of Biological Products. Anthony Huffman Philip Huang WIBP-CorV PMID:32789505 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5775 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5775 vaccine WIBP-CorV vaccine VO:0005161 A SARS-CoV-2 mRNA vaccine made of lipid nanoparticle-encapsulated mRNA (mRNA-LNP) encoding the receptor binding domain (RBD) of SARS-CoV-2 manufactured by Academy of Military Science (AMS), Walvax Biotechnology, and Suzhou Abogen Biosciences. Anthony Huffman Philip Huang ARCoV PMID:32795413 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5783 5783 vaccine ARCoV vaccine VO:0005162 A SARS-CoV-2 plasmid DNA vaccine that encodes the envelope protein. Anthony Huffman ZyCoV-D PMID:32800805 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5778 5778 514 778261 SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) vaccine ZyCoV-D vaccine VO:0005163 A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 and Ad5 vectors expressing S protein that lyophilised. Anthony Huffman Oliver He Philip Huang Rohit Goru Sputnik V PMID:32896291 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5777 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://en.wikipedia.org/wiki/Gam-COVID-Vac 5777 505 702668 SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) COVID-19 VVnr Non-US Vaccine (Sputnik V) vaccine Sputnik V vaccine VO:0005164 A SARS-CoV-2 investigational vaccine comprising a self-replicating (replicon) mRNA that encodes for the prefusion spike protein of 2019-nCoV formulated in a lipid nanoparticle Anthony Huffman Philip Huang ARCT-021 PMID:32973505 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5781 5781 vaccine ARCT-021 vaccine VO:0005165 A SARS-CoV-2 DNA vaccine developed by AnGes, named as AG0301-COVID19. Anthony Huffman AG0301-COVID19 NCT04463472 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5780 5780 vaccine AG0301-COVID19 vaccine VO:0005166 A SARS-CoV-2 inactivated whole virus vaccine that produced in Vero cells that is developed by the Beijing Institute of Biological Products. Anthony Huffman Philip Huang BBIBP-CorV ChiCTR2000032459, ChiCTR2000034780 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5776 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://en.wikipedia.org/wiki/BBIBP-CorV https://go.drugbank.com/drugs/DB15807 5776 510 702672 SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) vaccine BBIBP-CorV vaccine VO:0005167 A SARS-CoV-2 inactivated whole virus vaccine that is developed by the Chinese Academy of Medical Sciences . Anthony Huffman Philip Huang IMBCAMS COVID-19 vaccine PMID:32376603 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5785 5785 Covidful vaccine Chinese Academy of Medical Sciences COVID-19 vaccine VO:0005168 A SARS-CoV-2 mRNA vaccine developed by CureVac AG and CEPI. Anthony Huffman Philip Huang CVnCoV NCT04449276 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5786 5786 vaccine CVnCoV vaccine VO:0005169 A SARS-CoV 2 recombinant viral vector using Gorilla Adenovirus that encodes for SARS-CoV-2 Spike protein. Anthony Huffman Philip Huang GRAd-COV2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5787 https://www.covidx.eu/grad-cov2 5787 vaccine GRAd-COV2 vaccine VO:0005170 A SARS-CoV-2 DNA vaccine expressing the SARS-CoV-2 S protein Anthony Huffman Philip Huang GX-19 NCT04445389 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5788 5788 vaccine GX-19 vaccine VO:0005171 A SARS-CoV-2 subunit vaccine that is made of a protein subunit made of the RBD domain of the S protein. Anthony Huffman Philip Huang KBP-COVID-19 PMID:32973505 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5792 5792 vaccine KBP-COVID-19 vaccine VO:0005172 A DNA vaccine that expresses S protein from the pGX9501 vector Anthony Huffman Philip Huang INO-4800 PMID:32433465 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5793 5793 vaccine INO-4800 vaccine VO:0005173 A SARS-CoV-2 protein subunit vaccine developed by Adimmune Corporation. AdimrSC-2f is a candidate vaccine against COVID-19 developed by Adimmune Corporation (Adimmune). Using the baculovirus-insect cells expression system, the recombinant receptor binding domain (RBD) of SARS-CoV-2 spike (S) protein is amplified and purified. AdimrSC-2f is formulated in the different dosages of Spike (S) protein without/with aluminum content as adjuvant. Oliver He Philip Huang AdimrSC-2f NCT04522089 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5873 https://go.drugbank.com/drugs/DB16436 https://www.smartpatients.com/trials/NCT04522089 5873 vaccine AdimrSC-2f vaccine VO:0005174 A SARS-CoV-2 oral DNA vaccine that delivers plasmids containing synthetic DNA encoding spike protein from SARS-CoV-2. Philip Huang bacTRL-Spike NCT04334980 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5817 https://www.symvivo.com/covid-19 5817 vaccine bacTRL-Spike vaccine VO:0005175 A SARS-CoV-2 mRNA vaccine manufactured by Chulalongkorn University Philip Huang ChulaCov19 NCT04566276 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5818 5818 vaccine ChulaCov19 vaccine VO:0005176 Philip Huang A synthetic modified vaccinia Ankara (MVA)-based SARS-CoV-2 vaccine. obsolete COH04S1 true VO:0005177 an adenovirus vaccine vector that uses a gorilla adenovirus. Anthony Huffman vaccine component gorilla adenovirus vector VO:0005178 Anthony Huffman vaccine component adenovirus serotype 26 vaccine vector NCBI Taxonomy ID: 46928 VO:0005179 A nanoparticle vector composed of lipids. Anthony Huffman PMID: 20402623 vaccine component lipid nanoparticle vector VO:0005180 Vaccine vector that is a tiny particle, typically in the nanometer size range, used to deliver genetic code to specific cells within the body. Anthony Huffman PMID: 22353619 vaccine component nanoparticle vector VO:0005181 A chimpanzee adenovirus vaccine vector that patented by Oxford and derived from ChAd serotype Y25 that exchanges the native E4 orf4, orf6 and orf6/7 genes for those from HAdV-C5 PMID: 29527232 vaccine component chimpanzee adenovirus Oxford1 vaccine vector ChAdOx1 VO:0005182 A chimpanzee adenovirus vaccine vector developed by Oxford by deleting E1/E3 from ChAd68 with a modified E4 region. PMID: 29527232 vaccine component chimpanzee adenovirus Oxford2 vaccine vector ChAdOx2 VO:0005183 A SARS-CoV-2 DNA vaccine developed by Providence Health & Services. Philip Huang CORVax12 NCT04627675 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5820 5820 vaccine CORVax12 vaccine VO:0005184 A SARS-CoV-2 recombinant vector vaccine employing the lentiviral vector system and developed by Shenzhen Geno-Immune Medical Institute. Philip Huang NCT04299724 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5821 5821 vaccine COVID-19 aAPC vaccine VO:0005185 A SARS-CoV-2 refrigerator-stable mRNA vaccine by Moderna that encodes for the portions of the SARS-CoV-2 spike protein critical for neutralization, specifically the Receptor Binding Domain (RBD) and N-terminal Domain (NTD) Philip Huang mRNA-1283 NCT04813796 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5868 https://investors.modernatx.com/news-releases/news-release-details/first-participants-dosed-phase-1-study-evaluating-mrna-1283 5868 vaccine mRNA-1283 vaccine VO:0005186 A prophylactic plasmid DNA Vaccine for SARS CoV-2 by Entos Pharmaceuticals Philip Huang Covigenix VAX-001 NCT04591184 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5823 5823 vaccine Covigenix VAX-001 vaccine VO:0005187 A SARS-CoV-2 live, attenuated vaccine manufactured by Codagenix, Inc. Philip Huang COVI-VAC NCT04619628 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5824 5824 503 702680 SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) COVID-19 LAV Non-US Vaccine (COVIVAC) vaccine COVI-VAC vaccine VO:0005188 A SARS-CoV-2 inactivated vaccine developed by Health Institutes of Turkey Philip Huang ERUCOV-VAC Turkovac NCT04691947 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5836 5836 vaccine Turkovac vaccine VO:0005189 A SARS-CoV-2 human adenovirus serotype 5 (hAd5) vector vaccine with E1/E2b/E3 deletions expressing SARS-CoV-2 viral antigen spike fusion protein and nucleocapsid with an enhanced T-cell stimulation domain. Philip Huang hAd5-COVID-19 NCT04591717 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5825 5825 vaccine hAd5-COVID-19 vaccine VO:0005190 A SARS-CoV-2 subunit vaccine developed by University Hospital Tuebingen Philip Huang IMP CoVac-1 NCT04546841 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5826 5826 vaccine IMP CoVac-1 vaccine VO:0005191 A SARS-CoV-2 recombinant vector vaccine that contains a Modified Vaccinia Virus Ankara (MVA) vector expressing the SARS-CoV-2 spike protein (S) Philip Huang MVA-SARS-2-S NCT04569383 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5827 5827 vaccine MVA-SARS-2-S vaccine VO:0005192 A SARS-CoV-2 subunit vaccine that contains the Spike (S) protein with CpG 1018 and aluminum content as adjuvant. Philip Huang MVC-COV1901 NCT04487210 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5828 5828 515 778262 SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) vaccine MVC-COV1901 vaccine VO:0005193 A SARS-CoV-2 protein subunit vaccine developed by Vaxine Pty Ltd and CinnaGen Co. and adjuvanted with Advax Philip Huang COVAX-19 SpikoGen NCT04453852 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5829 5829 vaccine COVAX-19 vaccine VO:0005194 A SARS-CoV-2 subunit vaccine with the S1 component of the SARS-CoV-2 spike (S) protein and SWE adjuvant. Philip Huang COVAC NCT04702178 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5830 5830 vaccine COVAC vaccine VO:0005195 A SARS-CoV-2 vaccine that uses a recombinant vesicular stomatitis virus (rVSV) platform, and is made by Merck. Development of the vaccine was discontinued on January 25, 2021. Oliver He Philip Huang V590 https://www.merck.com/news/merck-discontinues-development-of-sars-cov-2-covid-19-vaccine-candidates-continues-development-of-two-investigational-therapeutic-candidates/ vaccine V590 vaccine VO:0005196 A SARS-CoV-2 adenoviral vector-based oral vaccine by Vaxart expressing a SARS-CoV-2 antigen and dsRNA adjuvant Philip Huang VXA-CoV2-1 NCT04563702 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5832 5832 vaccine VXA-CoV2-1 vaccine VO:0005197 A SARS-CoV-2 protein subunit vaccine manufactured by SK Bioscience Co., Ltd., and equipped with an aluminum hydroxide adjuvant Philip Huang SKYCovione NCT04750343 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5831 5831 vaccine SKYCovione vaccine VO:0005198 Oliver He Philip Huang Rohit Goru vaccine COVID-19 RNA vaccine VO:0005199 Oliver He Philip Huang Rohit Goru vaccine COVID-19 recombinant vector vaccine VO:0005200 Oliver He Philip Huang Rohit Goru vaccine COVID-19 recombinant adenoviral vector vaccine VO:0005201 Oliver He Philip Huang Rohit Goru vaccine COVID-19 inactivated vaccine VO:0005202 Philip Huang vaccine COVID-19 subunit vaccine VO:0005203 Philip Huang vaccine COVID-19 DNA vaccine VO:0005204 Philip Huang vaccine COVID-19 live, attenuated vaccine VO:0005205 Philip Huang vaccine COVID-19 virus-like particle vaccine VO:0005206 A saponin vaccine adjuvant comprised of 40 nm nanoparticles composed of Quillaja saponins, cholesterol and phospholipid. Philip Huang PMID:22844480 vaccine adjuvant Matrix-M vaccine adjuvant VO:0005207 A carbohydrate vaccine adjuvant derived from delta inulin Chemical Nature: Carbohydrate Mechanism of Action: Complement, Dendritic cells (unknown receptor), Other, Unknown Immune profile induced: mixed Th1/Th2 By routes: IM, IN, IP, SQ, inhalation, Point of Contact: Nikolai Petrovsky, Vaxine https://www.ncbi.nlm.nih.gov/pubmed/?term=31009889 https://www.ncbi.nlm.nih.gov/pubmed/?term=25520500 https://www.ncbi.nlm.nih.gov/pubmed/?term=28758637 https://www.ncbi.nlm.nih.gov/pubmed/?term=23864620 https://www.ncbi.nlm.nih.gov/pubmed/?term=24342245 https://www.ncbi.nlm.nih.gov/pubmed/?term=23306367 https://www.ncbi.nlm.nih.gov/pubmed/?term=21147758 https://www.ncbi.nlm.nih.gov/pubmed/?term=15479440 https://www.ncbi.nlm.nih.gov/pubmed/?term=26031451 https://www.ncbi.nlm.nih.gov/pubmed/?term=25659269 https://www.ncbi.nlm.nih.gov/pubmed/?term=33883559 https://www.ncbi.nlm.nih.gov/pubmed/?term=30312742 https://www.ncbi.nlm.nih.gov/pubmed/?term=21736913 https://www.ncbi.nlm.nih.gov/pubmed/?term=30218687 https://www.ncbi.nlm.nih.gov/pubmed/?term=25459531 https://www.ncbi.nlm.nih.gov/pubmed/?term=24958701 https://www.ncbi.nlm.nih.gov/pubmed/?term=25516480 https://www.ncbi.nlm.nih.gov/pubmed/?term=20130134 https://www.ncbi.nlm.nih.gov/pubmed/?term=23388724 https://www.ncbi.nlm.nih.gov/pubmed/?term=21169215 https://www.ncbi.nlm.nih.gov/pubmed/?term=30832356 https://www.ncbi.nlm.nih.gov/pubmed/?term=30322015 https://www.ncbi.nlm.nih.gov/pubmed/?term=28602608 https://www.ncbi.nlm.nih.gov/pubmed/?term=28676380 https://www.ncbi.nlm.nih.gov/pubmed/?term=33542494 https://www.ncbi.nlm.nih.gov/pubmed/?term=26232344 https://www.ncbi.nlm.nih.gov/pubmed/?term=22728225 https://www.ncbi.nlm.nih.gov/pubmed/?term=22728225 https://www.ncbi.nlm.nih.gov/pubmed/?term=25267153 https://www.ncbi.nlm.nih.gov/pubmed/?term=31300280 https://www.ncbi.nlm.nih.gov/pubmed/?term=28301280 https://www.ncbi.nlm.nih.gov/pubmed/?term=22717330 https://www.ncbi.nlm.nih.gov/pubmed/?term=26177480 https://www.ncbi.nlm.nih.gov/pubmed/?term=10000000 https://www.ncbi.nlm.nih.gov/pubmed/?term=27342914 https://www.ncbi.nlm.nih.gov/pubmed/?term=12 Nikolai Petrovsky Oliver He Philip Huang Wolfgang Leitner PMID:22728225 VAC: https://vac.niaid.nih.gov/view?id=37 https://www.ncbi.nlm.nih.gov/pubmed/?term=10000000 https://www.ncbi.nlm.nih.gov/pubmed/?term=12 https://www.ncbi.nlm.nih.gov/pubmed/?term=15479440 https://www.ncbi.nlm.nih.gov/pubmed/?term=20130134 https://www.ncbi.nlm.nih.gov/pubmed/?term=21147758 https://www.ncbi.nlm.nih.gov/pubmed/?term=21169215 https://www.ncbi.nlm.nih.gov/pubmed/?term=21736913 https://www.ncbi.nlm.nih.gov/pubmed/?term=22717330 https://www.ncbi.nlm.nih.gov/pubmed/?term=22728225 https://www.ncbi.nlm.nih.gov/pubmed/?term=23306367 https://www.ncbi.nlm.nih.gov/pubmed/?term=23388724 https://www.ncbi.nlm.nih.gov/pubmed/?term=23864620 https://www.ncbi.nlm.nih.gov/pubmed/?term=24342245 https://www.ncbi.nlm.nih.gov/pubmed/?term=24958701 https://www.ncbi.nlm.nih.gov/pubmed/?term=25267153 https://www.ncbi.nlm.nih.gov/pubmed/?term=25459531 https://www.ncbi.nlm.nih.gov/pubmed/?term=25516480 https://www.ncbi.nlm.nih.gov/pubmed/?term=25520500 https://www.ncbi.nlm.nih.gov/pubmed/?term=25659269 https://www.ncbi.nlm.nih.gov/pubmed/?term=26031451 https://www.ncbi.nlm.nih.gov/pubmed/?term=26177480 https://www.ncbi.nlm.nih.gov/pubmed/?term=26232344 https://www.ncbi.nlm.nih.gov/pubmed/?term=27342914 https://www.ncbi.nlm.nih.gov/pubmed/?term=28301280 https://www.ncbi.nlm.nih.gov/pubmed/?term=28602608 https://www.ncbi.nlm.nih.gov/pubmed/?term=28676380 https://www.ncbi.nlm.nih.gov/pubmed/?term=28758637 https://www.ncbi.nlm.nih.gov/pubmed/?term=30218687 https://www.ncbi.nlm.nih.gov/pubmed/?term=30312742 https://www.ncbi.nlm.nih.gov/pubmed/?term=30322015 https://www.ncbi.nlm.nih.gov/pubmed/?term=30832356 https://www.ncbi.nlm.nih.gov/pubmed/?term=31009889 https://www.ncbi.nlm.nih.gov/pubmed/?term=31300280 https://www.ncbi.nlm.nih.gov/pubmed/?term=33542494 https://www.ncbi.nlm.nih.gov/pubmed/?term=33883559 37 vaccine adjuvant Advax vaccine adjuvant VO:0005226 A SARS-CoV-2 protein subunit vaccine manufactured by the Razi Vaccine and Serum Research Institute with a Spike protein antigen Philip Huang Razi Cov Pars VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5779 5779 vaccine Razi Cov Pars vaccine VO:0005227 A SARS-CoV-2 recombinant adenoviral vector vaccine that is manufactured by Bharat Biotech International Ltd. and administered intranasally Philip Huang BBV154 NCT04751682 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5839 5839 vaccine BBV154 vaccine VO:0005228 A SARS-CoV-2 Chimpanzee Adenovirus serotype 6 vector vaccine manufactured by Gritstone Oncology and the National Institute of Allergy and Infectious Diseases Philip Huang ChAdV68-S NCT04776317 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5845 5845 vaccine ChAdV68-S vaccine VO:0005229 A SARS-CoV-2 inactivated vaccine by Shifa Pharmed Philip Huang COVIran Barakat VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5815 https://en.irct.ir/trial/52701 5815 vaccine COVIran Barakat vaccine VO:0005230 A SARS-CoV-2 plasmid DNA vaccine manufactured by Takis and Rottapharm Biotech Philip Huang COVID-eVax VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5838 https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-003734-20/IT 5838 vaccine COVID-eVax vaccine VO:0005231 A SARS-CoV-2 DNA vaccine manufactured by University of Sydney, Bionet Co., and Technovalia Philip Huang COVIGEN NCT04742842 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5837 5837 vaccine COVIGEN vaccine VO:0005232 A SARS-CoV-2 protein subunit vaccine by EuBiologics Co., Ltd. Philip Huang EuCorVac-19 NCT04783311 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5848 5848 vaccine EuCorVac-19 vaccine VO:0005233 A SARS-CoV-2 lipid nanoparticle (LNP)-encapsulated mRNA-based vaccine that encodes for a full-length, prefusion stabilized S protein of the SARS-CoV-2 B.1.351 variant Philip Huang mRNA-1273.351 NCT04785144 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5846 5846 vaccine mRNA-1273.351 vaccine VO:0005234 A SARS-CoV-2 protein subunit vaccine by SK Bioscience Philip Huang NBP2001 NCT04760743 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5844 5844 vaccine NBP2001 vaccine VO:0005235 A SARS-CoV-2 recombinant viral vector vaccine by Mahidol University Philip Huang NDV-HXP-S NCT04764422 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5841 5841 vaccine NDV-HXP-S vaccine VO:0005236 A SARS-CoV-2 mRNA vaccine by Providence Therapeutics Philip Huang PTX-COVID19-B NCT04765436 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5840 5840 vaccine PTX-COVID19-B vaccine VO:0005237 A SARS-CoV-2 protein subunit vaccine manufactured by Walter Reed Army Institute of Research Philip Huang SpFN NCT04784767 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5847 5847 vaccine SpFN vaccine VO:0005238 A SARS-CoV-2 virus-like particle vaccine that expresses a modified version of the SARS-CoV-2 spike (S) glycoprotein and is equipped with an aluminum phosphate adjuvant. It is manufactured by VBI Vaccines Inc. and is delivered intramuscularly. Philip Huang VBI-2902a NCT04773665 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5843 5843 vaccine VBI-2902a vaccine VO:0005239 A SARS-CoV-2 inactivated vaccine developed by Organization of Defensive Innovation and Research in Iran Philip Huang FAKHRAVAC https://en.irct.ir/trial/54133 vaccine FAKHRAVAC vaccine VO:0005240 A SARS-CoV-2 live, attenuated vaccine manufactured by Meissa Vaccines, Inc. that expresses the spike (S) protein of SARS-CoV-2. Philip Huang MV-014-212 NCT04798001 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5851 5851 vaccine MV-014-212 vaccine VO:0005241 A SARS-CoV-2 mRNA vaccine that is manufactured by Sanofi Pasteur Philip Huang MRT5500 NCT04798027 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5850 5850 vaccine MRT5500 vaccine VO:0005243 A SARS-CoV-2 inactivated whole virus vaccine developed by the Chumakov Centre at the Russian Academy of Sciences Philip Huang VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5852 http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php 5852 vaccine CoviVac (Russia) VO:0005244 A SARS-CoV-2 protein subunit vaccine manufactured by Instituto Finlay de Vacunas. It is used as a booster dose for the Soberana 02 COVID-19 vaccine Philip Huang Soberana Plus VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5853 https://rpcec.sld.cu/trials/RPCEC00000366-En 5853 vaccine Soberana Plus vaccine VO:0005245 A SARS-CoV-2 mRNA vaccine manufactured by Daiichi Sankyo Co., Ltd. Philip Huang DS-5670a VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5854 5854 vaccine DS-5670a vaccine VO:0005246 A SARS-CoV-2 recombinant Newcastle Disease Virus vector vaccine expressing membrane-anchored pre-fusion-stabilized trimeric SARS-CoV-2 S protein Philip Huang NCT04830800 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5855 5855 vaccine CoviVac (Vietnam) VO:0005247 A SARS-CoV-2 subunit vaccine developed by Livzon Mabpharm Inc. Philip Huang V-01 ChiCTR2100045107 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5856 5856 vaccine V-01 vaccine VO:0005248 A SARS-CoV-2 subunit vaccine developed by the National Vaccine and Serum Institute of China Philip Huang NCT04869592 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5857 5857 vaccine COVID-19 subunit vaccine by National Vaccine and Serum Institute of China VO:0005249 A SARS-COV-2 temperature-sensitive self-replicating RNA vaccine expressing the receptor binding domain of the SARS-CoV-2 spike protein. Philip Huang EXG-5003 NCT04863131 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5858 5858 vaccine EXG-5003 vaccine VO:0005250 A SARS-CoV-2 inactivated vaccine developed by KM Biologics Co., Ltd. Philip Huang KD-414 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5859 jRCT2071200106 5859 vaccine KD-414 vaccine VO:0005251 A COVID-19 virus-like particle vaccine developed by the Scientific and Technological Research Council of Turkey Philip Huang NCT04818281 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5862 5862 vaccine COVID-19 VLP vaccine by the Scientific and Technological Research Council of Turkey VO:0005252 A SARS-CoV-2 subunit vaccine by Jiangsu Rec-Biotechnology Co., Ltd. Philip Huang ReCOV NCT04818801 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5863 5863 vaccine ReCOV vaccine VO:0005253 A SARS-CoV-2 inactivated virus vaccine by Kocak Farma Philip Huang NCT04838080 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5860 5860 vaccine Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine VO:0005254 A SARS-CoV-2 recombinant adenoviral vector vaccine by Tetherex Pharmaceutical Corporation Philip Huang SC-Ad6-1 NCT04839042 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5864 5864 vaccine SC-Ad6-1 vaccine VO:0005255 A COVID-19 virus-like particle vaccine developed by Radboud University Philip Huang ABNCoV2 NCT04839146 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5865 5865 vaccine ABNCoV2 vaccine VO:0005256 A SARS-CoV-2 Lipid-Inorganic Nanoparticle (LION(TM)) formulated replicating mRNA vaccine that encodes for a full-length spike (S) protein of the SARS-CoV-2 virus Philip Huang HDT-301 NCT04844268 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5866 5866 vaccine HDT-301 vaccine VO:0005257 A SARS-CoV-2 inactivated virus vaccine by the Scientific and Technological Research Council of Turkey adjuvanted by aluminum hydroxide and CpG ODN Philip Huang NCT04866069 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5867 5867 vaccine COVID-19 inactivated vaccine by the Scientific and Technological Research Council of Turkey VO:0005258 An MF59-adjuvanted SARS-CoV-2 subunit vaccine based on recombinant SARS-CoV-2 spike glycoprotein stabilised in a pre-fusion conformation by a novel molecular clamp (spike glycoprotein-clamp [sclamp]) Philip Huang PubMed ID: 33887208 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5861 5861 vaccine MF59-adjuvanted SARS-CoV-2 Sclamp vaccine VO:0005259 A recombinant Newcastle Disease Virus vectored vaccine for SARS-CoV-2 by Laboratorio Avi-Mex Philip Huang NCT04871737 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5822 5822 vaccine COVID-19 rNDV vector vaccine by Laboratorio Avi-Mex VO:0005260 A SARS-CoV-2 mRNA vaccine by Shanghai East Hospital and Stemirna Therapeutics Philip Huang ChiCTR2100045984 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5869 5869 vaccine COVID-19 mRNA vaccine by Shanghai East Hospital and Stemirna Therapeutics VO:0005261 A SARS-CoV-2 subunit vaccine by OSE Immunotherapeutics Philip Huang CoVepiT NCT04885361 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5870 5870 vaccine CoVepiT vaccine VO:0005262 A SARS-CoV-2 recombinant viral vector vaccine by the German Center for Infection Research Philip Huang MVA-SARS-2-ST NCT04895449 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5924 5924 vaccine MVA-SARS-2-ST vaccine VO:0005263 A SARS-CoV-2 subunit vaccine that is orally administered and manufactured by Syneos Health Philip Huang CoV2-OGEN1 NCT04893512 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5872 5872 vaccine CoV2-OGEN1 vaccine VO:0005264 A COVID-19 vaccine that is authorized for emergent use, which is typically authorized based on an Emergency Use Authorization (EUA). Oliver He http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines COVID-19 vaccine 35894915 OMOP5042939 vaccine authorized COVID-19 vaccine VO:0005265 Oliver He http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php vaccine authorized COVID-19 RNA vaccine VO:0005266 Oliver He http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php vaccine authorized inactivated COVID-19 vaccine VO:0005267 Oliver He http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php vaccine authorized COVID-19 recombinant vector vaccine VO:0005268 Oliver He vaccine authorized COVID-19 recombinant adenoviral vector vaccine VO:0005269 Oliver He Philip Huang http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php vaccine authorized COVID-19 subunit vaccine VO:0005270 A vaccine adjuvant that includes IV270, which is a low-molecular weight TLR7 agonist conjugated to a phospholipid and is a highly potent and stable immune activator. Chemical Nature: Small molecule Receptor: TLR7 Mechanism of Action: Activation of innate immune pathways Immune profile induced: Th1-biased Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Induces epitope spreading, (4) Provides innate protection, (5) Promotes antibody affinity maturation, (6) Promotes antibody epitope spreading By routes: intramuscular and intranasal. Point of Contact: Dennis Carson, UCSD Dennis Carson Oliver He Wolfgang Leitner 1V270 PMID:25568203 PMID:28724768 PMID:32636840/ VAC: https://vac.niaid.nih.gov/view?id=6 6 vaccine adjuvant 1V270 vaccine adjuvant VO:0005271 Chemical Nature: Small molecule Receptor: TLR4 Mechanism of Action: Innate immune activation Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: (1) Induces mucosal immunity, (2) Anti-inflammatory, (3) Promotes antibody epitope spreading. By routes: intramuscular and intranasal. Point of Contact: Dennis Carson, UCSD Amogh Madireddi Dennis Carson Oliver He Wolfgang Leitner 2B182C VAC: https://vac.niaid.nih.gov/view?id=7 https://www.ncbi.nlm.nih.gov/pubmed/?term=25568203 https://www.ncbi.nlm.nih.gov/pubmed/?term=28724768 https://www.ncbi.nlm.nih.gov/pubmed/?term=32636840 7 vaccine adjuvant 2B182C vaccine adjuvant VO:0005272 A role of a material entity that binds to TLR7 and activates the receptor for pathogen recognition and activation of innate immunity. TLR7 agonist role Oliver He Toll-like receptor 7 agonist role https://en.wikipedia.org/wiki/TLR7 role TLR7 receptor role VO:0005273 A SARS-CoV-2 protein subunit vaccine manufactured by the Research Institute for Biological Safety Problems in Kazakhstan Philip Huang QazCoVac-P NCT04930003 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5874 5874 vaccine QazCoVac-P vaccine VO:0005274 https://en.wikipedia.org/wiki/T_helper_cell role Th1 immunity stimulatory role VO:0005275 https://en.wikipedia.org/wiki/T_helper_cell role Th2 immunity stimulatory role VO:0005276 A SARS-CoV-2 self-amplifying RNA vaccine sponsored by MRC/UVRI and LSHTM Uganda Research Unit Philip Huang LNP-nCOV saRNA-02 NCT04934111 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5875 5875 vaccine LNP-nCOV saRNA-02 vaccine VO:0005277 A multivalent SARS-CoV-2 mRNA booster vaccine which combines mRNA-1273, Moderna's authorized vaccine against ancestral strains, and mRNA-1273.351 in a single vaccine at the 50 ug dose level and lower. Philip Huang mRNA-1273.211 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5876 https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-it-has-shipped-variant-specific-vaccine 5876 vaccine mRNA-1273.211 vaccine VO:0005278 A peptide vaccine derived from the von Hippel-Lindau (VHL) tumor suppressor protein, a general transcription factor. In (H115D)VHL35 peptide, histidine is substituted for an aspartic acid in position 115. It might be used to elicit or boost cellular immunity to cancers that expressing the von Hippel-Lindau mutation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5304 https://github.com/vaccineontology/VO/issues/77 5304 cancer vaccine (H115D)VHL35 Peptide Vaccine VO:0005281 Chemical Nature: Small molecule Receptor: Dendritic cells (unknown receptor) Mechanism of Action: Innate immune activation Immune profile induced: Th1-biased Other Features/Characteristics: Other. Specify: Co-adjuvant for TLR4 ligands Point of Contact: Dennis Carson, UCSD Amogh Madireddi Dennis Carson Oliver He Wolfgang Leitner 2E151 VAC: https://vac.niaid.nih.gov/view?id=9 9 vaccine adjuvant 2E151 vaccine adjuvant VO:0005282 Chemical Nature: Small molecule Receptor: CLR (Dectin, Mincle) Mechanism of Action: None/Unknown Immune profile induced: Th17-component Other Features/Characteristics: None Point of Contact: Kendal Ryter, U. Montana & Inimmune Amogh Madireddi Kendal Ryter Oliver He Wolfgang Leitner UM-1098 VAC: https://vac.niaid.nih.gov/view?id=27 27 vaccine adjuvant UM-1098 vaccine adjuvant VO:0005283 Chemical Nature: Small molecule and Synthetic derivative of natural compound Receptor: Unknown and NLRP3 Mechanism of Action: Presumably the same as QS-21 in the absence of dose-limiting toxicity Immune profile induced: Th1-biased Other Features/Characteristics: None Point of Contact: Melissa Malhame, Adjuvance Technologies Amogh Madireddi Melissa Malhame Oliver He Wolfgang Leitner TQL-1055 VAC: https://vac.niaid.nih.gov/view?id=36 36 vaccine adjuvant TQL-1055 vaccine adjuvant VO:0005284 Chemical Nature: Emulsion Receptor: TLR2 and TLR4 Mechanism of Action: Activation of mucosal and systemic immunity Immune profile induced: Th1/Th17 Other Features/Characteristics: Promotes antibody affinity maturation Point of Contact: Ali Fattom, BlueWillow Biologics Ali Fattom Amogh Madireddi Oliver He Wolfgang Leitner NanoVax/NE01 VAC: https://vac.niaid.nih.gov/view?id=22 https://www.ncbi.nlm.nih.gov/pubmed/?term=31495593 https://www.ncbi.nlm.nih.gov/pubmed/?term=31515143 22 vaccine adjuvant NanoVax/NE01 vaccine adjuvant VO:0005285 Chemical Nature: Other Receptor: TLR4 Mechanism of Action: TLR4 agonist Immune profile induced: Th1-biased Other Features/Characteristics: None/Unknown Point of Contact: Darrick Carter, PAI Life Sciences Amogh Madireddi Darrick Carter Oliver He Wolfgang Leitner MiT4 VAC: https://vac.niaid.nih.gov/view?id=16 16 vaccine adjuvant MiT4 vaccine adjuvant VO:0005286 Chemical Nature: (1) Natural compound, (2) Carbohydrate, (3) Combination adjuvant Receptor: CLR (Dectin, Mincle) and NAIP Mechanism of Action: Activation of Dectin-2-expressing innate immune cells; dual targeting of injection site and draining lymph node. Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: Promotes antibody epitope spreading Point of Contact: Ivan Zanoni, Boston Children's Hospital Amogh Madireddi Ivan Zanoni Oliver He Wolfgang Leitner VAC: https://vac.niaid.nih.gov/view?id=14 14 vaccine adjuvant Mannadjuvant VO:0005287 Chemical Nature: Combination Adjuvant Receptor: TLR4 Mechanism of Action: TLR4 agonist plus potential inflammasome Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None/Unknown Point of Contact: Darrick Carter, PAI Life Sciences Amogh Madireddi Darrick Carter Oliver He Wolfgang Leitner LiT4 VAC: https://vac.niaid.nih.gov/view?id=20 20 vaccine adjuvant LiT4 vaccine adjuvant VO:0005288 Chemical Nature: Small molecule Receptor: TLR7 and TLR8 Mechanism of Action: None/Unknown Immune profile induced: Th1-biased Other Features/Characteristics: None Point of Contact: Kendal Ryter, U. Montana & Inimmune Amogh Madireddi Kendal Ryter Oliver He Wolfgang Leitner INI-4001 VAC: https://vac.niaid.nih.gov/view?id=28 28 vaccine adjuvant INI-4001 vaccine adjuvant VO:0005289 Chemical Nature: Small molecule Receptor: TLR4 Mechanism of Action: None/Unknown Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Kendal Ryter, U. Montana & Inimmune Amogh Madireddi Kendal Ryter Oliver He Wolfgang Leitner INI-2004 VAC: https://vac.niaid.nih.gov/view?id=26 26 vaccine adjuvant INI-2004 vaccine adjuvant VO:0005290 Chemical Nature: Small molecule Receptor: TLR4 Mechanism of Action: None/Unknown Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Kendal Ryter, U. Montana & Inimmune Amogh Madireddi Kendal Ryter Oliver He Wolfgang Leitner INI-2002 VAC: https://vac.niaid.nih.gov/view?id=29 29 vaccine adjuvant INI-2002 vaccine adjuvant VO:0005291 Chemical Nature: Small molecule and Combination adjuvant Receptor: TLR4 and TLR7 Mechanism of Action: Activation of antigen presenting cells and stimulating B cell proliferation Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Induces epitope spreading, (4) Provides innate protection, (5) Promotes antibody epitope spreading. By routes: intramuscular and intranasal. Point of Contact: Dennis Carson, UCSD Amogh Madireddi Dennis Carson Oliver He Wolfgang Leitner Fos47 VAC: https://vac.niaid.nih.gov/view?id=5 https://www.ncbi.nlm.nih.gov/pubmed/?term=25568203 https://www.ncbi.nlm.nih.gov/pubmed/?term=28724768 https://www.ncbi.nlm.nih.gov/pubmed/?term=32636840 5 vaccine adjuvant Fos47 vaccine adjuvant VO:0005292 Chemical Nature: Emulsion Receptor: TLR4 Mechanism of Action: Squalene emulsion plus TLR4 Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Darrick Carter, PAI Life Sciences Amogh Madireddi Darrick Carter Oliver He Wolfgang Leitner EmT4 VAC: https://vac.niaid.nih.gov/view?id=17 17 vaccine adjuvant EmT4 vaccine adjuvant VO:0005293 Chemical Nature: Emulsion Receptor: Unknown Mechanism of Action: Squalene emulsion possibly triggering inflammasome or through extracellular ATP Immune profile induced: None Other Features/Characteristics: None Point of Contact: Darrick Carter, PAI Life Sciences Amogh Madireddi Darrick Carter Oliver He Wolfgang Leitner Em VAC: https://vac.niaid.nih.gov/view?id=18 18 vaccine adjuvant Em vaccine adjuvant VO:0005294 Chemical Nature: (1) Synthetic derivative of natural compound, (2) Nucleic acid Receptor: TLR3 Mechanism of Action: TLR3, possibly RIG-I - agonist Immune profile induced: Th1-biased Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Provides innate protection. By routes: SQ, IM. Point of Contact: Carolina Lopez, University of Washington at St Louis Amogh Madireddi Carolina Lopez Oliver He Wolfgang Leitner DDO DDO (Defective viral genome-Derived Oligonucleotide) Defective viral genome-Derived Oligonucleotide VAC: https://vac.niaid.nih.gov/view?id=30 https://www.ncbi.nlm.nih.gov/pubmed/?term=24099876 https://www.ncbi.nlm.nih.gov/pubmed/?term=29861183 30 vaccine adjuvant defective viral genome-derived oligonucleotide vaccine adjuvant VO:0005295 Chemical Nature: Synthetic derivative of natural compound Receptor: Unknown Mechanism of Action: (1) Antigen carrier, (2) Innate immune enhancer/activator Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces CD8 T cells, (3) Provides innate protection, (4) Other, (5) Promotes antibody affinity maturation, (6) High stability. By routes: IM, IN, IP, IN, ID, IVag. Specify: Safe for systemic or mucosal administration Point of Contact: Tulin Morcol, Captivate Pharma Amogh Madireddi Oliver He Tulin Morcol Wolfgang Leitner CaPNP (CaPtivant)(TM) VAC: https://vac.niaid.nih.gov/view?id=11 https://www.ncbi.nlm.nih.gov/pubmed/?term=11063495 https://www.ncbi.nlm.nih.gov/pubmed/?term=12204953 https://www.ncbi.nlm.nih.gov/pubmed/?term=28716554 https://www.ncbi.nlm.nih.gov/pubmed/?term=28933657 https://www.ncbi.nlm.nih.gov/pubmed/?term=31591662 11 vaccine adjuvant CaPNP (CaPtivant)(TM) vaccine adjuvant VO:0005296 Chemical Nature: Small molecule, other Receptor: TLR4 Mechanism of Action: None Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: Other Point of Contact: Robert Ernst, University of Maryland - Baltimore Amogh Madireddi Oliver He Robert Ernst Wolfgang Leitner BECC470b VAC: https://vac.niaid.nih.gov/view?id=32 https://www.ncbi.nlm.nih.gov/pubmed/?term=28487429 https://www.ncbi.nlm.nih.gov/pubmed/?term=29861179 https://www.ncbi.nlm.nih.gov/pubmed/?term=33309485 32 vaccine adjuvant BECC470b vaccine adjuvant VO:0005297 Chemical Nature: (1) Synthetic derivative of natural compound, (2) other Receptor: TLR4 Mechanism of Action: None Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Robert Ernst, University of Maryland-Baltimore Amogh Madireddi Oliver He Robert Ernst Wolfgang Leitner BECC438s VAC: https://vac.niaid.nih.gov/view?id=33 33 vaccine adjuvant BECC438s vaccine adjuvant VO:0005298 Chemical Nature: Small molecule, other Receptor: TLR4 Mechanism of Action: None Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Robert Ernst, University of Maryland Baltimore Amogh Madireddi Oliver He Robert Ernst Wolfgang Leitner BECC438b VAC: https://vac.niaid.nih.gov/view?id=31 https://www.ncbi.nlm.nih.gov/pubmed/?term=28487429 https://www.ncbi.nlm.nih.gov/pubmed/?term=29861179 https://www.ncbi.nlm.nih.gov/pubmed/?term=33309485 31 vaccine adjuvant BECC438b vaccine adjuvant VO:0005299 Chemical Nature: Combination adjuvant Receptor: TLR4 Mechanism of Action: TLR4 and potentially inflammasome Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Darrick Carter, PAI Life Services Amogh Madireddi Darrick Carter Oliver He Wolfgang Leitner AlT4 VAC: https://vac.niaid.nih.gov/view?id=19 19 vaccine adjuvant AlT4 vaccine adjuvant VO:0005300 Chemical Nature: Combination adjuvant Receptor: TLR3 Mechanism of Action: TLR3 agonist plus potential inflammasome Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Darrick Carter, PAI Life Services Amogh Madireddi Darrick Carter Oliver He Wolfgang Leitner AlT3 VAC: https://vac.niaid.nih.gov/view?id=21 21 vaccine adjuvant AlT3 vaccine adjuvant VO:0005301 Chemical Nature: Small molecule Receptor: (1) TLR7, (2) TLR8 Mechanism of Action: TLR7/8 dual agonist - lymph node delivery Immune profile induced: Th1-biased Other Features/Characteristics: Promotes antibody affinity maturation Point of Contact: Sunil David, Virovax Amogh Madireddi Oliver He Sunil David Wolfgang Leitner Alhydroxiquim-II VAC: https://vac.niaid.nih.gov/view?id=12 https://www.ncbi.nlm.nih.gov/pubmed/?term=33521604 https://www.ncbi.nlm.nih.gov/pubmed/?term=33654090 12 vaccine adjuvant Alhydroxiquim-II vaccine adjuvant VO:0005302 Chemical Nature: (1) Synthetic derivative of natural compound, (2) Emulsion, (3) Combination adjuvant, (4) Other Receptor: TLR4 Mechanism of Action: Adjuplex enhances cross presentation to CD8 T cells and GLA stimulates TLR4 signaling Immune profile induced: Mixed Th1/Th17 Other Features/Characteristics: None Point of Contact: Marulasiddappa Suresh, UW Madison Amogh Madireddi Marulasiddappa Suresh Oliver He Wolfgang Leitner Adjuplex+GLA VAC: https://vac.niaid.nih.gov/view?id=15 https://www.ncbi.nlm.nih.gov/pubmed/?term=32984856 https://www.ncbi.nlm.nih.gov/pubmed/?term=33444400 https://www.ncbi.nlm.nih.gov/pubmed/?term=33767689 15 vaccine adjuvant Adjuplex+GLA vaccine adjuvant VO:0005303 Chemical Nature: Small molecule Receptor: Dendritic cells (unknown receptor) Mechanism of Action: Innate immune activation/enhancer Immune profile induced: Mixed Th1/Th2 Other Features/Characteristics: None Point of Contact: Dennis Carson, UCSD Amogh Madireddi Dennis Carson Oliver He Wolfgang Leitner 2F52 VAC: https://vac.niaid.nih.gov/view?id=8 https://www.ncbi.nlm.nih.gov/pubmed/?term=29751735 8 vaccine adjuvant 2F52 vaccine adjuvant VO:0005304 A role of a material entity that binds to TLR4 and activates the receptor for pathogen recognition and activation of innate immunity. TLR4 agonist role Amogh Madireddi Oliver He Toll-like receptor 4 agonist role https://en.wikipedia.org/wiki/TLR4 role TLR4 receptor role VO:0005305 A role of a material entity that binds to TLR3 and activates the receptor for pathogen recognition and activation of innate immunity. TLR3 agonist role Amogh Madireddi Oliver He Toll-like receptor 3 agonist role https://en.wikipedia.org/wiki/TLR3 role TLR3 receptor role VO:0005306 A role of a material entity that binds to TLR8 and activates the receptor for pathogen recognition and activation of innate immunity. TLR8 agonist role Amogh Madireddi Oliver He Toll-like receptor 8 agonist role https://en.wikipedia.org/wiki/TLR8 role TLR8 receptor role VO:0005307 A role of a material entity that binds to TLR2 and activates the receptor for pathogen recognition and activation of innate immunity. TLR2 agonist role Amogh Madireddi Oliver He Toll-like receptor 2 agonist role https://en.wikipedia.org/wiki/TLR2 role TLR2 receptor role VO:0005308 Process profile that reflects a pattern of a specific immune response. Oliver He process profile immune response profile VO:0005309 An immune profile that is characterized by the presence of Type 1 T helper (Th1) cells that produce interferon-gamma, interleukin (IL)-2, and tumor necrosis factor (TNF)-beta, which activate macrophages and are responsible for cell-mediated immunity and phagocyte-dependent protective responses. Amogh Madireddi Oliver He https://en.wikipedia.org/wiki/T_helper_cell https://pubmed.ncbi.nlm.nih.gov/10579123/ process profile Th1-biased immune profile VO:0005310 An immune profile that is characterized by the presence of T type 2 Th (Th2) cells that produce IL-4, IL-5, IL-10, and IL-13, which are responsible for strong antibody production, eosinophil activation, and inhibition of several macrophage functions, thus providing phagocyte-independent protective responses. Amogh Madireddi Oliver He https://en.wikipedia.org/wiki/T_helper_cell https://pubmed.ncbi.nlm.nih.gov/10579123/ process profile Th2-biased immune profile VO:0005311 An immune profile that is characterized by the presense of both Type 1 and Type 2 T helper (Th1 and Th2) cells. Amogh Madireddi Oliver He https://en.wikipedia.org/wiki/T_helper_cell https://pubmed.ncbi.nlm.nih.gov/10579123/ process profile Th1/Th2 mixed immune profile VO:0005313 An immune profile that is characterized by the presence of T helper 17 cells (Th17), a subset of pro-inflammatory T helper cells defined by their production of interleukin 17 (IL-17). They are related to T regulatory cells and the signals that cause Th17 to differentiate and inhibit Treg differentiation. Amogh Madireddi Oliver He https://en.wikipedia.org/wiki/T_helper_17_cell process profile Th17 immune profile VO:0005314 An immune profile that is characterized by the presense of both Type 1 and Type 17 T helper (Th1 and Th17) cells. Amogh Madireddi Oliver He https://en.wikipedia.org/wiki/T_helper_cell process profile Th1/Th17 mixed immune profile VO:0005315 A SARS-CoV-2 subunit vaccine by Clover Biopharmaceuticals AUS Pty Ltd that contains the S protein from the B.1.351 variant. Philip Huang SCB-2020S NCT04950751 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5879 5879 vaccine SCB-2020S vaccine VO:0005316 A SARS-CoV-2 subunit vaccine by Bagheiat-allah University of Medical Sciences Philip Huang Noora VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5877 https://en.irct.ir/trial/56987 5877 vaccine Noora vaccine VO:0005317 A SARS-CoV-2 subunit vaccine by Baiya Phytopharm Co., Ltd. Philip Huang Baiya SARS-CoV-2 Vax 1 NCT04953078 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5878 5878 vaccine Baiya SARS-CoV-2 Vax 1 vaccine VO:0005318 A SARS-CoV-2 recombinant vector vaccine manufactured by CyanVac LLC Philip Huang CVXGA1 NCT04954287 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5880 5880 vaccine CVXGA1 vaccine VO:0005319 A SARS-CoV-2 recombinant vector vaccine by AstraZeneca and Oxford University against variant strain B.1.351 Philip Huang AZD2816 NCT04973449 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5881 5881 vaccine AZD2816 vaccine VO:0005320 A SARS-CoV-2 subunit vaccine manufactured by Shanghai Zerun Biotechnology, Walvax Biotechnology, and CEPI Philip Huang 202-CoV NCT04990544 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5835 5835 vaccine 202-CoV vaccine VO:0005321 A SARS-CoV-2 protein subunit vaccine by Laboratorios HIPRA Philip Huang NCT05007509 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5883 5883 vaccine COVID-19 subunit vaccine by HIPRA VO:0005322 A SARS-CoV-2 DNA vaccine developed by AnGes, named as AG0302-COVID19. Philip Huang AG0302-COVID19 NCT04993586 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5882 5882 vaccine AG0302-COVID19 vaccine VO:0005323 Oliver He http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php vaccine authorized COVID-19 DNA vaccine VO:0005324 An Advax-CpG vaccine adjuvant that includes an inulin-based polysaccharide (Advax) and a CpG oligodeoxynucleotide CpG55.2. Pubmed References:Chemical Nature: (1) combination adjuvant Mechanism of Action: (1) complement, (2) dendritic cells, (3) other/unknown, (4) TLR9 Immune profile induced: mixed Th1 Other Features/Characteristics: (1) induces CD8 T cells, (2) provides innate protection, (3) anti-inflammatory, (4) promotes antibody affinity maturation, (5) effective in newborns, (6) high stability By routes: SQ, IM Point of Contact: Nikolai Petrovsky, Vaxine LTD Nikolai Petrovsky Oliver He Wolfgang Leitner Advax-CpG55.2 VAC: https://vac.niaid.nih.gov/view?id=38 https://pubmed.ncbi.nlm.nih.gov/32636840/ https://www.ncbi.nlm.nih.gov/pubmed/?term=32849580 https://www.ncbi.nlm.nih.gov/pubmed/?term=33301675 https://www.ncbi.nlm.nih.gov/pubmed/?term=34069575 38 vaccine adjuvant Advax-CpG55.2 vaccine adjuvant VO:0005325 A vaccine adjuvant that is synthesized by derivatizing a natural Momordica saponin in one step. VSA-2 is chemically stable. VSA-2 is much less toxic than QS-21. VSA-2 is more Th1-biased than QS-21. Momordica saponins are isolated from widely available and sustainable sources. Pubmed References: Chemical Nature: (1) Synthetic derivative of natural compound Mechanism of Action: unknown Immune profile induced: mixed Th1/Th2 Other Features/Characteristics: (1) synthetic saponin with lower toxicity and higher stability than QS21 By routes: SQ Point of Contact: Pengfei Wang, University of Alabama https://www.ncbi.nlm.nih.gov/pubmed/?term=32101001 Oliver He Pengfei Wang Wolfgang Leitner VSA-2 VAC: https://vac.niaid.nih.gov/view?id=42 https://www.ncbi.nlm.nih.gov/pubmed/?term=32101001 42 vaccine adjuvant VSA-2 vaccine adjuvant VO:0005326 A vaccine adjuvant that is prepared by derivatizing a natural Momordica saponin in one chemical step. VSA-1 is chemically more stable than QS-21. VSA-1 is much less toxic than QS-21. The Momordica saponins are from sustainable sources and widely available. Pubmed References: Chemical Nature: (1) Synthetic derivative of natural compound Mechanism of Action: unknown Immune profile induced: mixed Th1/Th2 Other Features/Characteristics: (1) synthetic saponin with lower toxicity and higher stability than QS21 By routes: SQ Point of Contact: Pengfei Wang, University of Alabama https://www.ncbi.nlm.nih.gov/pubmed/?term=31657920 Oliver He Pengfei Wang Wolfgang Leitner VSA-1 VAC: https://vac.niaid.nih.gov/view?id=41 https://www.ncbi.nlm.nih.gov/pubmed/?term=31657920 41 vaccine adjuvant VSA-1 vaccine adjuvant VO:0005327 A vaccine adjuvant that is a potent adjuvant for antibody and cellular responses to protein, polypeptide and small peptide antigens. rOv-ASP-1 stands for Recombinant Onchocerca volvulus activation-associated secreted protein-1. Pubmed References: Chemical Nature: (1) Protein Mechanism of Action: unknown Immune profile induced: Th1 Other Features/Characteristics: (1) Induces CD8 T cells, (2) provides innate protection, (3) promotes antibody affinity maturation. By routes: IM Point of Contact: Sara Lustigman, New York Blood Center Oliver He Sara Lustigman Wolfgang Leitner Recombinant O. volvulus activation-associated secreted protein-1 rOv-ASP-1 VAC: https://vac.niaid.nih.gov/view?id=43 https://www.ncbi.nlm.nih.gov/pubmed/?term=1583768 https://www.ncbi.nlm.nih.gov/pubmed/?term=18341617 https://www.ncbi.nlm.nih.gov/pubmed/?term=18675867 https://www.ncbi.nlm.nih.gov/pubmed/?term=22615877 https://www.ncbi.nlm.nih.gov/pubmed/?term=24681229 https://www.ncbi.nlm.nih.gov/pubmed/?term=25736195 https://www.ncbi.nlm.nih.gov/pubmed/?term=26795365 https://www.ncbi.nlm.nih.gov/pubmed/?term=29764680 https://www.ncbi.nlm.nih.gov/pubmed/?term=32471056 43 vaccine adjuvant rOv-ASP-1 vaccine adjuvant VO:0005329 A vaccine adjuvant that includes double mutant of heat-labile E. coli toxin (LT) at R192G/L211A or LT(R192G/L211A) Chemical Nature: protein Mechanism of Action: CGM1 ganglioside, cAMP, inflammasome Immune profile induced: mixed Th1/Th17 Other Features/Characteristics: Induces mucosal immunity (IM, ID, SQ, SL, oral, , transcutaneous), Induces epitope spreading, Promotes antibody affinity maturation, Effective in newborns, promotes antibody epitope spreading By routes: IM, ID, SL, oral, SQ, IN, IP, intragastric, transcutaneous, transdermal, buccal, intrarectal Point of Contact: Elizabeth Norton, Tulane University https://www.ncbi.nlm.nih.gov/pubmed/?term=21288994 https://www.ncbi.nlm.nih.gov/pubmed/?term=6803349 https://www.ncbi.nlm.nih.gov/pubmed/?term=26540197 https://www.ncbi.nlm.nih.gov/pubmed/?term=4927082 https://www.ncbi.nlm.nih.gov/pubmed/?term=26305793 https://www.ncbi.nlm.nih.gov/pubmed/?term=25111827 https://www.ncbi.nlm.nih.gov/pubmed/?term=24453241 https://www.ncbi.nlm.nih.gov/pubmed/?term=22202122 https://www.ncbi.nlm.nih.gov/pubmed/?term=25803825 https://www.ncbi.nlm.nih.gov/pubmed/?term=23541621 https://www.ncbi.nlm.nih.gov/pubmed/?term=26018536 https://www.ncbi.nlm.nih.gov/pubmed/?term=5461379 https://www.ncbi.nlm.nih.gov/pubmed/?term=3578125 https://www.ncbi.nlm.nih.gov/pubmed/?term=5216441 https://www.ncbi.nlm.nih.gov/pubmed/?term=19897067 https://www.ncbi.nlm.nih.gov/pubmed/?term=25944298 https://www.ncbi.nlm.nih.gov/pubmed/?term=6424635 https://www.ncbi.nlm.nih.gov/pubmed/?term=3916310 https://www.ncbi.nlm.nih.gov/pubmed/?term=4826740 https://www.ncbi.nlm.nih.gov/pubmed/?term=2884428 https://www.ncbi.nlm.nih.gov/pubmed/?term=30778066 https://www.ncbi.nlm.nih.gov/pubmed/?term=4893257 https://www.ncbi.nlm.nih.gov/pubmed/?term=28063704 https://www.ncbi.nlm.nih.gov/pubmed/?term=4375349 https://www.ncbi.nlm.nih.gov/pubmed/?term=28792004 https://www.ncbi.nlm.nih.gov/pubmed/?term=25765967 https://www.ncbi.nlm.nih.gov/pubmed/?term=25483682 https://www.ncbi.nlm.nih.gov/pubmed/?term=30638799 https://www.ncbi.nlm.nih.gov/pubmed/?term=21326197 https://www.ncbi.nlm.nih.gov/pubmed/?term=31757774 https://www.ncbi.nlm.nih.gov/pubmed/?term=31427449 https://www.ncbi.nlm.nih.gov/pubmed/?term=6957164 https://www.ncbi.nlm.nih.gov/pubmed/?term=33465933 https://www.ncbi.nlm.nih.gov/pubmed/?term=33465933 https://www.ncbi.nlm.nih.gov/pubmed/?term=33465933 https://www.ncbi.nlm.nih.gov/pubmed/?term=31641151 https://www.ncbi.nlm.nih.gov/pubmed/?term=27133878 https://www.ncbi.nlm.nih.gov/pubmed/?term=27676456 https://www.ncbi.nlm.nih.gov/pubmed/?term=27226279 https://www.ncbi.nlm.nih.gov/pubmed/?term=22406456 https://www.ncbi.nlm.nih.gov/pubmed/?term=30787109 https://www.ncbi.nlm.nih.gov/pubmed/?term=24403527 https://www.ncbi.nlm.nih.gov/pubmed/?term=24403527 https://www.ncbi.nlm.nih.gov/pubmed/?term=30563789 https://www.ncbi.nlm.nih.gov/pubmed/?term=31757774 https://www.ncbi.nlm.nih.gov/pubmed/?term=30473185 https://www.ncbi.nlm.nih.gov/pubmed/?term=30248001 https://www.ncbi.nlm.nih.gov/pubmed/?term=24049109 https://www.ncbi.nlm.nih.gov/pubmed/?term=30797634 https://www.ncbi.nlm.nih.gov/pubmed/?term=31482013 https://www.ncbi.nlm.nih.gov/pubmed/?term=29771685 https://www.ncbi.nlm.nih.gov/pubmed/?term=31757774 https://www.ncbi.nlm.nih.gov/pubmed/?term=25444830 Clinical trials: https://clinicaltrials.gov/ct2/show/NCT03922061 https://clinicaltrials.gov/ct2/show/NCT04232943 https://clinicaltrials.gov/ct2/show/NCT02531685 https://clinicaltrials.gov/ct2/show/NCT02052934 https://clinicaltrials.gov/ct2/show/NCT02531802 https://clinicaltrials.gov/ct2/show/NCT01147445 https://clinicaltrials.gov/ct2/show/NCT03548064 https://clinicaltrials.gov/ct2/show/ NCT01739231 https://clinicaltrials.gov/ct2/show/NCT03404674 https://clinicaltrials.gov/ct2/show/NCT03729219 https://clinicaltrials.gov/ct2/show/NCT04826094 Elizabeth Norton Oliver He Wolfgang Leitner dmLT VAC: https://vac.niaid.nih.gov/view?id=13 https://www.ncbi.nlm.nih.gov/pubmed/?term=19897067 https://www.ncbi.nlm.nih.gov/pubmed/?term=21288994 https://www.ncbi.nlm.nih.gov/pubmed/?term=22202122 https://www.ncbi.nlm.nih.gov/pubmed/?term=23541621 https://www.ncbi.nlm.nih.gov/pubmed/?term=24453241 https://www.ncbi.nlm.nih.gov/pubmed/?term=25111827 https://www.ncbi.nlm.nih.gov/pubmed/?term=25803825 https://www.ncbi.nlm.nih.gov/pubmed/?term=26018536 https://www.ncbi.nlm.nih.gov/pubmed/?term=26305793 https://www.ncbi.nlm.nih.gov/pubmed/?term=26540197 https://www.ncbi.nlm.nih.gov/pubmed/?term=3578125 https://www.ncbi.nlm.nih.gov/pubmed/?term=4927082 https://www.ncbi.nlm.nih.gov/pubmed/?term=5216441 https://www.ncbi.nlm.nih.gov/pubmed/?term=5461379 https://www.ncbi.nlm.nih.gov/pubmed/?term=6803349 13 vaccine adjuvant dmLT vaccine adjuvant VO:0005330 Chemical Nature: (1) other (Peptide) Mechanism of Action: C5aR1 on mononuclear phagocytes Immune profile induced: mixed Th1/Th2 Other Features/Characteristics: (1) Induces CD8 T cells, (2) provides innate protection, (3) promotes antibody affinity maturation. By routes: SQ, IP, IV. Point of Contact: Joseph Vetro, University of Nebraska Medical Center https://pubmed.ncbi.nlm.nih.gov/9013982/, https://pubmed.ncbi.nlm.nih.gov/9013982/, https://pubmed.ncbi.nlm.nih.gov/10516626/, https://pubmed.ncbi.nlm.nih.gov/10799917/, https://pubmed.ncbi.nlm.nih.gov/10799917/, https://pubmed.ncbi.nlm.nih.gov/12538044/, https://pubmed.ncbi.nlm.nih.gov/19428909/, https://pubmed.ncbi.nlm.nih.gov/21723901/ Joseph Vetro Oliver He Wolfgang Leitner CPDI-01 VAC: https://vac.niaid.nih.gov/view?id=39 https://pubmed.ncbi.nlm.nih.gov/10516626/ https://pubmed.ncbi.nlm.nih.gov/10799917/ https://pubmed.ncbi.nlm.nih.gov/12538044/ https://pubmed.ncbi.nlm.nih.gov/19428909/ https://pubmed.ncbi.nlm.nih.gov/21723901/ https://pubmed.ncbi.nlm.nih.gov/9013982/ 39 vaccine adjuvant CPDI-01 vaccine adjuvant VO:0005331 A recombiant vector vaccine that is has a viral vector. Anthony Huffman vaccine recombinant viral vector vaccine VO:0005332 A SARS-CoV-2 RNA vaccine by Arcturus Therapeutics, Inc., named as ARCT-165. Philip Huang ARCT-165 NCT05037097 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5888 5888 vaccine ARCT-165 vaccine VO:0005333 A SARS-CoV-2 monovalent protein subunit vaccine by Novavax immunizing against the B.1.351 (Beta) variant and containing the Matrix-M1 adjuvant Philip Huang SII B.1.351 NCT05029856 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5885 5885 vaccine SII B.1.351 vaccine VO:0005334 A SARS-CoV-2 bivalent protein subunit vaccine by Novavax containing antigen for both the ancestral strain and B.1.351 (Beta) variant. Philip Huang SII Bivalent NCT05029856 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5887 5887 vaccine SII Bivalent vaccine VO:0005335 A SARS-CoV-2 monovalent protein subunit vaccine by Novavax immunizing against the B.1.617.2 (Delta) variant and containing the Matrix-M1 adjuvant Philip Huang SII B.1.617.2 NCT05029856 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5886 5886 vaccine SII B.1.617.2 vaccine VO:0005336 A SARS-CoV-2 recombinant viral vector vaccine by Biocad Philip Huang AAV5-RBD-S NCT05037188 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5889 5889 vaccine AAV5-RBD-S vaccine VO:0005337 A vaccine adjuvant that includes UM-3005, a small molecule TLR7/8 agonist that can stimulate Th1-biased immune profile. Chemical Nature: (1) small molecule Mechanism of Action: TLR7/8 agonist Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Helene Bazin-Lee, InImmune Ani M. Bernardi Helene Bazin-Lee Oliver He Wolfgang Leitner UM-3005 VAC: https://vac.niaid.nih.gov/view?id=47 https://www.ncbi.nlm.nih.gov/pubmed/32210973 47 vaccine adjuvant UM-3005 vaccine adjuvant VO:0005338 A SARS-CoV-2 subunit vaccine by Sinocelltech Ltd. Philip Huang SCTV01C NCT05043311 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5890 5890 vaccine SCTV01C vaccine VO:0005339 A SARS-CoV-2 replication deficient human adenovirus vector vaccine expressing the spike, nucleocapsid and RNA polymerase proteins. Philip Huang Ad5-triCoV/Mac NCT05094609 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5899 5899 vaccine Ad5-triCoV/Mac vaccine VO:0005340 A SARS-CoV-2 DNA vaccine developed by Vaccibody AS encoding the receptor-binding domain Philip Huang VB10.2129 NCT05069623 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5893 5893 vaccine VB10.2129 vaccine VO:0005341 A SARS-CoV-2 T-Cell-based DNA vaccine developed by Vaccibody AS Philip Huang VB10.2210 NCT05069623 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5894 5894 vaccine VB10.2210 vaccine VO:0005342 A SARS-CoV-2 replication deficient chimpanzee adenovirus 68 vector vaccine expressing the spike, nucleocapsid and RNA polymerase proteins. Philip Huang ChAd-triCoV/Mac NCT05094609 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5900 5900 vaccine ChAd-triCoV/Mac vaccine VO:0005343 A SARS-CoV-2 subunit vaccine by PT Bio Farma Philip Huang NCT05067894 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5895 5895 vaccine COVID-19 subunit vaccine by PT Bio Farma VO:0005344 A SARS-CoV-2 DNA vaccine developed by Scancell Ltd. Philip Huang COVIDITY NCT05047445 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5891 5891 vaccine COVIDITY vaccine VO:0005345 A SARS-CoV-2 subunit vaccine by Yisheng Biopharma Philip Huang ACTRN12621001009808 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5892 5892 vaccine PIKA Recombinant COVID-19 Vaccine VO:0005346 A SARS-CoV-2 DNA vaccine developed by University of Hong Kong and Immuno Cure 3 Limited Philip Huang NCT05102643 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5896 5896 vaccine COVID-19 DNA vaccine by the University of Hong Kong and Immuno Cure 3 Limited VO:0005347 A SARS-CoV-2 RNA vaccine by Arcturus Therapeutics, Inc., named as ARCT-154. Philip Huang ARCT-154 ISRCTN15779782 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5884 5884 vaccine ARCT-154 vaccine VO:0005348 A COVID-19 virus-like particle vaccine developed by Yantai Patronus Biotech Co., Ltd. Philip Huang LYB001 NCT05137444 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5901 5901 vaccine LYB001 vaccine VO:0005349 A SARS-CoV-2 inactivated vaccine developed by the National Research Centre of Egypt Philip Huang Covi Vax NCT05128721 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5902 5902 vaccine Covi Vax vaccine VO:0005350 A SARS-CoV-2 subunit vaccine containing a T-cell priming specific cocktail of Coronaviruses peptides mounted on a gold nanoparticle. Philip Huang naNO-COVID NCT05113862 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5898 5898 vaccine naNO-COVID vaccine VO:0005351 A SARS-CoV-2 subunit vaccine by HK inno.N Corporation Philip Huang IN-B009 NCT05113849 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5897 5897 vaccine IN-B009 vaccine VO:0005352 A SARS-CoV-2 RNA vaccine manufactured by VLP Therapeutics Japan, LLC Philip Huang VLPCOV-01 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5903 jRCT2071210067 5903 vaccine VLPCOV-01 vaccine VO:0005353 A vaccine adjuvant that includes UM-3004, a small molecule TLR7/8 agonist that can stimulate Th1-biased immune profile. Chemical Nature: (1) small molecule Mechanism of Action: TLR7/8 agonist Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Helene Bazin-Lee, University of Montana Ani M. Bernardi Helene Bazin-Lee Oliver He Wolfgang Leitner UM-3004 VAC: https://vac.niaid.nih.gov/view?id=46 https://www.ncbi.nlm.nih.gov/pubmed/32210973 46 vaccine adjuvant UM-3004 vaccine adjuvant VO:0005354 A vaccine adjuvant that includes UM-3003, a small molecule TLR7/8 agonist that can stimulate Th1-biased immune profile. Chemical Nature: (1) small molecule Mechanism of Action: TLR7/8 agonist Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Helene Bazin-Lee, University of Montana Ani M. Bernardi Helene Bazin-Lee Oliver He Wolfgang Leitner UM-3003 VAC: https://vac.niaid.nih.gov/view?id=45 https://www.ncbi.nlm.nih.gov/pubmed/32210973 45 vaccine adjuvant UM-3003 vaccine adjuvant VO:0005355 A vaccine adjuvant made from the A subunit of heat-labile (LT) enterotoxin of Enterotoxigenic Escherichia coli (ETEC). This LTA1 adjuvant is able to induce Th1, Th2, and Th17 immune responses. Chemical Nature: (1) Protein Mechanism of Action: cAMP, inflammasome induction Immune profile induced: mixed Th1/Th2/Th17 Other Features/Characteristics: (1) Induces mucosal immunity, (2) Induces epitope spreading, (3) Promotes antibody affinity maturation, (4) Promotes antibody epitope spreading, (5) High stability Route of immunization: IM, IN, SL, ID, IP Point of Contact: Elizabeth Norton, Tulane University Ani M. Bernardi Elizabeth Norton Oliver He Wolfgang Leitner LTA1 VAC: https://vac.niaid.nih.gov/view?id=44 https://www.ncbi.nlm.nih.gov/pubmed/22526674 https://www.ncbi.nlm.nih.gov/pubmed/26305793 https://www.ncbi.nlm.nih.gov/pubmed/31427449 https://www.ncbi.nlm.nih.gov/pubmed/31641151 https://www.ncbi.nlm.nih.gov/pubmed/31929548 https://www.ncbi.nlm.nih.gov/pubmed/33986280 https://www.ncbi.nlm.nih.gov/pubmed/34516780 https://www.ncbi.nlm.nih.gov/pubmed/6957164 44 vaccine adjuvant LTA1 vaccine adjuvant VO:0005356 A carbohydrate vaccine adjuvant that is a glucan carbohydrate microcapsules with a beta(1-3)/beta(1-6) - linked glucan structure to allow targeting of antigens to macrophages or neutrophils through interactions with the beta-glucan receptor found uniquely on the surface of these cell types. Adjuvax- ligand complexes are formed by physically entrapping or crosslinking the ligand within the beta-glucan. Oliver He Randi Vita DOI: 10.1021 vaccine adjuvant Adjuvax vaccine adjuvant VO:0005357 A vaccine adjuvant that includes an inulin-based polysaccharide (Advax) and a CpG oligodeoxynucleotide (ODN). Pubmed References:Chemical Nature: (1) combination adjuvant Mechanism of Action: (1) complement, (2) dendritic cells, (3) other/unknown, (4) TLR9 Immune profile induced: mixed Th1 Other Features/Characteristics: (1) induces CD8 T cells, (2) provides innate protection, (3) anti-inflammatory, (4) promotes antibody affinity maturation, (5) effective in newborns, (6) high stability By routes: SQ, IM Point of Contact: Nikolai Petrovsky, Vaxine LTD Nikolai Petrovsky Oliver He Wolfgang Leitner Advax-2 Advax-CpG Advax-SM https://pubmed.ncbi.nlm.nih.gov/32636840/ https://www.ncbi.nlm.nih.gov/pubmed/?term=32849580 https://www.ncbi.nlm.nih.gov/pubmed/?term=33301675 https://www.ncbi.nlm.nih.gov/pubmed/?term=34069575 vaccine adjuvant Advax-CpG vaccine adjuvant VO:0005358 A combination vaccine adjuvant includes 3-O-desacyl-4'-monophosphoryl lipid A (MPL) from Salmonella minnesota and a saponin molecule (QS-21) purified from plant extract Quillaja saponaria Molina, combined in a liposomal formulation consisting of dioleoyl phosphatidylcholine (DOPC) and cholesterol in phosphate-buffered saline solution. Oliver He Randi Vita https://www.fda.gov/media/107538/download#:~:text=The%20AS01B%20adjuvant%20suspension%20is,DOPC)%20and%20cholesterol%20in%20phosphate%2D vaccine adjuvant AS01B vaccine adjuvant VO:0005359 An AS02 vaccine adjuvant contains 50 ug MPL and 50ug QS21, 250uL of SB62 (oil/water emulsion) in phosphate buffered saline (PBS) per volume of 0.5 mL. As02a https://clinicaltrials.gov/ct2/show/NCT00308061 vaccine adjuvant AS02A vaccine adjuvant VO:0005360 A carbohydrate vaccine adjuvant that is aminoglycan consisting of beta-(1->4)-linked D-glucosamine residues. Oliver He Randi Vita CHEBI:16261 PMID:24346613 vaccine adjuvant chitosan vaccine adjuvant VO:0005361 A Montanide vaccine adjuvant that is a water-dispersed liquid IMS 1313 nanoparticle combined with an immuno-stimulating compound. Oliver He Randi Vita IMS 1313 N VGPR IMS-1313 https://scialert.net/abstract/?doi=ijps.2018.167.174 vaccine adjuvant Montanide IMS 1313 vaccine adjuvant VO:0005362 A water-dispersed liquid nanoparticle combined with an immuno-stimulating compound. Oliver He Randi Vita ISA-206 PMID:8961504 vaccine adjuvant Montanide ISA 206 vaccine adjuvant VO:0005363 A Montanide vaccine adjuvant that Mannide oleate derivative in a mineral oil solution ( Seppic SA, France). Oliver He Randi Vita ISA-50 http://vetarhiv.vef.unizg.hr/papers/74-2/raman.pdf vaccine adjuvant Montanide ISA 50 vaccine adjuvant VO:0005364 A carbohydrate vaccine adjuvant that is tomatidine in which the hydroxy group at position 3 is linked to lycotetraose, a tetrasaccharide composed of two units of D-glucose, one unit of D-xylose, and one unit of D-galactose. Oliver He Randi Vita CHEBI:9630 vaccine adjuvant Tomatine vaccine adjuvant VO:0005365 A carbohydrate vaccine adjuvant that polysaccharide prepared from the cell wall of Saccaromyces cerevisiae (bakers' yeast). Oliver He Randi Vita PMID:11380697 vaccine adjuvant Zymosan vaccine adjuvant VO:0005366 An emulsion vaccine adjuvant that is oil-based adjuvant (Adjuvant XtendIII®; Grand Laboratories, Larchwood, IA). Oliver He Randi Vita vaccine adjuvant XtendIII vaccine adjuvant VO:0005367 A microbial derivative vaccine adjuvant that is monophosphoryl lipid A (detoxified endotoxin) from S. minnesota (MPL) and synthetic trehalose dicorynomycolate (TDM) in 2% oil (squalene)-Tween 80-water. Oliver He Randi Vita Monophosphoryl-lipid A + Trehalose dicorynomycolate https://www.sigmaaldrich.com/US/en/product/sigma/m6536 vaccine adjuvant MPL + TDM vaccine adjuvant VO:0005368 A muramyl dipeptide vaccine adjuvant that muramyl dipeptide derivative (threonyl-MDP) in an oil-in-water (o/w) emulsion vehicle. Oliver He Randi Vita SAF https://link.springer.com/protocol/10.1385/1-59259-083-7:229 vaccine adjuvant Syntex Adjuvant Formulation VO:0005369 A vaccine adjuvant that diester obtained by the formal condensation of the carboxy groups of phthalic acid with two molecules of butan-1-ol. Oliver He Randi Vita DBP CHEBI:34687 PMID:26319029 vaccine adjuvant dibutyl phthalate vaccine adjuvant VO:0005370 A vaccine adjuvant that includes naturally occurring trivalent alcohol. Oliver He Randi Vita glycerine, 1, 2, 3-propanetriol https://academic.oup.com/cid/article/45/10/1277/277413 vaccine adjuvant glycerol vaccine adjuvant VO:0005371 A vaccine adjuvant includes three palmitic acid groups that are bound in an ester and amide linkage to a cysteine residue. Oliver He Randi Vita Tripalmitoyl-S-glyceryl-cysteine PMID:24130558 vaccine adjuvant Pam3Cys vaccine adjuvant VO:0005372 A vaccine adjuvant that is equimolar mixture of the cationic lipid GAP-DMORIE [(±)-N-(3-aminopropyl)-N,N-dimethyl-2,3-bis(cis-9-tetradecenyloxy)-1-propanaminium bromide)] and a neutral colipid DPyPE (1,2-diphytanoyl-sn-glydero-3-phosphoethanolamine). Oliver He Randi Vita PMID:21118032 vaccine adjuvant Vaxfectin vaccine adjuvant VO:0005373 A vaccination process that involves adding a vaccine into a host prior to disease. Oliver He Randi Vita preventive vaccination https://en.wikipedia.org/wiki/Preventive_healthcare preventative vaccination vaccination prophylactic vaccination VO:0005374 A vaccination process that involves adding a vaccine into a host after a disease has occurred. Oliver He Randi Vita https://en.wikipedia.org/wiki/Therapeutic_vaccines vaccination therapeutic vaccination VO:0005375 A vaccine adjuant that is derived from Salmonella enterica serovar typhimurium and is able to induce Th1/Th2/Th17 immune responses through the mechanism of action of TLR4, inflammasome, and DC activation. Chemical Nature: other Mechanism of Action: TLR4; inflammasome; DC activation Immune profile induced: Th1/Th2/Th17 Receptor: TLR4, NLRP3 Storage information: -20 or -80C Point of Contact: Lisa Morici, Tulane University Lisa Morici Oliver He Wolfgang Leitner T-vant VAC: https://vac.niaid.nih.gov/view?id=61 https://www.ncbi.nlm.nih.gov/pubmed/?term=33498352 https://www.ncbi.nlm.nih.gov/pubmed/?term=34069796 61 vaccine adjuvant T-vant vaccine adjuvant VO:0005376 An immune profile that is characterized by the presense of Type 1 Type 2, and Th17 T helper cells. Amogh Madireddi Oliver He https://en.wikipedia.org/wiki/T_helper_cell https://pubmed.ncbi.nlm.nih.gov/10579123/ process profile Th1/Th2/Th17 mixed immune profile VO:0005378 A role of a material entity that binds to NLRP3. Oliver He https://en.wikipedia.org/wiki/NLRP3 role NLRP3 receptor role VO:0005379 Chemical Nature: Nucleic Acid Mechanism of Action: TLR/RLR-agonist Immune profile induced: Th1/Th2 Route of immunization: IM and IN Point of Contact: Xiaoliang Ren, Yisheng Bio Ongoing clinical trial: https://clinicaltrials.gov/ct2/show/NCT02657161 https://clinicaltrials.gov/ct2/show/NCT02956421 Oliver He Wolfgang Leitner Xiaoliang Ren PIKA VAC: https://vac.niaid.nih.gov/view?id=55 https://www.ncbi.nlm.nih.gov/pubmed/?term=17484805 https://www.ncbi.nlm.nih.gov/pubmed/?term=20538850 https://www.ncbi.nlm.nih.gov/pubmed/?term=21468931 https://www.ncbi.nlm.nih.gov/pubmed/?term=26765968 https://www.ncbi.nlm.nih.gov/pubmed/?term=28118938 https://www.ncbi.nlm.nih.gov/pubmed/?term=29174316 https://www.ncbi.nlm.nih.gov/pubmed/?term=34766005 55 vaccine adjuvant PIKA vaccine adjuvant VO:0005380 Chemical Nature: peptide Mechanism of Action: activation of mast cells, epithelial cells, macrophages and dendritic cells Immune profile induced: Th2-biased Route of immunization: IM and IN Point of Contact: Herman Staats, Duke University Herman Staats Oliver He Wolfgang Leitner Mastoparan 7 VAC: https://vac.niaid.nih.gov/view?id=53 https://www.ncbi.nlm.nih.gov/pubmed/?term=31068425 https://www.ncbi.nlm.nih.gov/pubmed/?term=32047657 https://www.ncbi.nlm.nih.gov/pubmed/?term=34566991 53 vaccine adjuvant Mastoparan 7 vaccine adjuvant VO:0005381 Chemical Nature: small molecule Mechanism of Action: mast cell activation Immune profile induced: Th2-biased Route of immunization: IN Point of Contact: Herman Staats, Duke University Herman Staats Oliver He Wolfgang Leitner Mast cell activator small molecules VAC: https://vac.niaid.nih.gov/view?id=54 https://www.ncbi.nlm.nih.gov/pubmed/?term=34566991 54 vaccine adjuvant Mast cell activator small molecules vaccine adjuvant VO:0005382 Chemical Nature: small molecule Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Ofer Levy, Precision Vaccines Program at Boston Children's Hospital Ofer Levy Oliver He Wolfgang Leitner Precision Vaccines Program (PVP)-037 VAC: https://vac.niaid.nih.gov/view?id=56 56 vaccine adjuvant Precision Vaccines Program (PVP)-037 vaccine adjuvant VO:0005383 Chemical Nature: small molecule Mechanism of Action: TLR4 agonist Immune profile induced: Th1/Th2 Route of immunization: IM and IN Point of Contact: Robert Ernst, University of Maryland - Baltimore Oliver He Robert Ernst Wolfgang Leitner BECC470s VAC: https://vac.niaid.nih.gov/view?id=60 60 vaccine adjuvant BECC470s vaccine adjuvant VO:0005384 Chemical Nature: small molecule Mechanism of Action: innate immune activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Helene Bazin-Lee, University of Montana Helene Bazin-Lee Oliver He Wolfgang Leitner TRAC478 VAC: https://vac.niaid.nih.gov/view?id=48 48 vaccine adjuvant TRAC478 vaccine adjuvant VO:0005385 Chemical Nature: small molecule Mechanism of Action: innate immune activation Immune profile induced: Th1/Th17 Route of immunization: IM and IN Point of Contact: Christopher Fox, AAHI Christopher Fox Oliver He Wolfgang Leitner GLA-3M-052-LS VAC: https://vac.niaid.nih.gov/view?id=58 https://www.ncbi.nlm.nih.gov/pubmed/?term=34248966 https://www.ncbi.nlm.nih.gov/pubmed/?term=34795290 58 vaccine adjuvant GLA-3M-052-LS vaccine adjuvant VO:0005386 Chemical Nature: small molecule Mechanism of Action: innate immune activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Christopher Fox, AAHI Christopher Fox Oliver He Wolfgang Leitner 3M-052-SE VAC: https://vac.niaid.nih.gov/view?id=57 https://www.ncbi.nlm.nih.gov/pubmed/?term=28429728 https://www.ncbi.nlm.nih.gov/pubmed/?term=30089691 https://www.ncbi.nlm.nih.gov/pubmed/?term=32213623 https://www.ncbi.nlm.nih.gov/pubmed/?term=34131024 https://www.ncbi.nlm.nih.gov/pubmed/?term=34972105 https://www.ncbi.nlm.nih.gov/pubmed/?term=35572573 57 vaccine adjuvant 3M-052-SE vaccine adjuvant VO:0005387 Chemical Nature: small molecule Mechanism of Action: innate immune activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Christopher Fox, AAHI Clinical trials: https://clinicaltrials.gov/ct2/show/NCT04177355 https://clinicaltrials.gov/ct2/show/NCT04915768 https://clinicaltrials.gov/ct2/show/NCT05197712 Christopher Fox Oliver He Wolfgang Leitner 3M-052-Alum VAC: https://vac.niaid.nih.gov/view?id=59 https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326 https://www.ncbi.nlm.nih.gov/pubmed/?term=32561559 https://www.ncbi.nlm.nih.gov/pubmed/?term=33971664 https://www.ncbi.nlm.nih.gov/pubmed/?term=34117252 https://www.ncbi.nlm.nih.gov/pubmed/?term=34266981 59 vaccine adjuvant 3M-052-Alum vaccine adjuvant VO:0005388 Chemical Nature: (1) emulsion Mechanism of Action: unknown Immune profile induced: Th1/Th17 Route of immunization: IM Point of Contact: Patrice Dubois, Vaccine Formulation Institute Clinical trial: https://clinicaltrials.gov/ct2/show/NCT04702178 Oliver He Patrice Dubois Wolfgang Leitner SWE VAC: https://vac.niaid.nih.gov/view?id=50 https://www.ncbi.nlm.nih.gov/pubmed/?term=30849373 https://www.ncbi.nlm.nih.gov/pubmed/?term=32411401 50 vaccine adjuvant SWE vaccine adjuvant VO:0005389 Chemical Nature: (1) Emulsion (with Saponin) Mechanism of Action: unknown Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Patrice Dubois, Vaccine Formulation Institute Oliver He Patrice Dubois Wolfgang Leitner SQ VAC: https://vac.niaid.nih.gov/view?id=52 https://www.ncbi.nlm.nih.gov/pubmed/?term=33688647 52 vaccine adjuvant SQ vaccine adjuvant VO:0005390 Chemical Nature: (1) other (liposome with Saponin) Mechanism of Action: unknown Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Patrice Dubois, Vaccine Formulation Institute Oliver He Patrice Dubois Wolfgang Leitner LQ VAC: https://vac.niaid.nih.gov/view?id=51 https://www.ncbi.nlm.nih.gov/pubmed/?term=32156809 https://www.ncbi.nlm.nih.gov/pubmed/?term=33688647 51 vaccine adjuvant LQ vaccine adjuvant VO:0005391 A SARS-CoV-2 RNA vaccine by Suzhou Abogen Biosciences Co., Ltd. Philip Huang ABO1009-DP NCT05434585 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5943 5943 vaccine ABO1009-DP vaccine VO:0005392 A SARS-CoV-2 protein subunit vaccine manufactured by ACM Biolabs. Philip Huang ACM-001 NCT05385991 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5938 5938 vaccine ACM-001 vaccine VO:0005393 A SARS-CoV-2 DNA vaccine developed by Imam Abdulrahman Bin Faisal University. Philip Huang Almansour-001 NCT05171946 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5920 5920 vaccine Almansour-001 vaccine VO:0005394 A synthetic modified vaccinia Ankara (MVA)-based SARS-CoV-2 vaccine Philip Huang NCT04639466 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5819 5819 vaccine Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 VO:0005395 A SARS-CoV-2 protein subunit vaccine manufactured by the University of Melbourne. Philip Huang DoCo-Pro-RBD-1 + MF59 NCT05272605 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5871 5871 vaccine DoCo-Pro-RBD-1 + MF59 vaccine VO:0005396 A SARS-CoV-2 inactivated vaccine developed by Eva Pharma. Philip Huang EgyVax NCT05218070 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5921 5921 vaccine EgyVax vaccine VO:0005397 A SARS-CoV-2 RNA vaccine by Gritstone Bio, Inc. Philip Huang GRT-R912 NCT05435027 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5944 5944 vaccine GRT-R912 vaccine VO:0005398 A SARS-CoV-2 RNA vaccine by the University of Melbourne. Philip Huang MIPSCo-mRNA-RBD-1 NCT05272605 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5927 5927 vaccine MIPSCo-mRNA-RBD-1 vaccine VO:0005399 A SARS-CoV-2 inactivated vaccine developed by Osve Pharmaceutical Company. Philip Huang Osvid-19 IRCT20210622051670N1 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5919 5919 vaccine Osvid-19 vaccine VO:0005400 A SARS-CoV-2 protein subunit vaccine manufactured by Speransa Therapeutics. Philip Huang Prime-2-CoV-Beta NCT05389319 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5936 5936 vaccine Prime-2-CoV-Beta vaccine VO:0005401 A SARS-CoV-2 RNA vaccine by Wuhan Recogen Biotechnology Co., Ltd. Philip Huang RH109 NCT05366296 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5930 5930 vaccine RH109 vaccine VO:0005402 A SARS-CoV-2 RNA vaccine by Walvax Biotechnology and Shanghai RNACure Biopharma Philip Huang RQ3013 NCT05394012 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5937 5937 vaccine RQ3013 vaccine VO:0005403 A SARS-CoV-2 RNA vaccine by RVAC Medicines Philip Huang RVM-V001 NCT05420077 vaccine RVM-V001 vaccine VO:0005404 A SARS-CoV-2 protein subunit vaccine manufactured by Vaxxas Pty Ltd Philip Huang VXS-1223 ACTRN12622000597796 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5932 5932 vaccine VXS-1223 vaccine VO:0005405 A SARS-CoV-2 RNA vaccine by ImmunityBio, Inc. Philip Huang AAHI-SC2 NCT05370040 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5935 5935 vaccine AAHI-SC2 vaccine VO:0005406 A SARS-CoV-2 protein subunit vaccine manufactured by Human Stem Cell Institute Philip Huang Betuvax-CoV2 NCT05270954 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5929 5929 vaccine Betuvax-CoV2 vaccine VO:0005407 A SARS-CoV-2 RNA vaccine by CanSino Biologics Inc. Philip Huang NCT05373472 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5934 5934 vaccine COVID-19 mRNA vaccine by CanSino Biologics VO:0005408 A SARS-CoV-2 RNA vaccine by EyeGene Inc. Philip Huang EG-COVID NCT05188469 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5923 5923 vaccine EG-COVID vaccine VO:0005409 A SARS-CoV-2 mRNA vaccine by Moderna that combines the mRNA-1273 COVID-19 vaccine and the mRNA-1010 influenza vaccine. Philip Huang mRNA-1073 NCT05375838 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5941 5941 vaccine mRNA-1073 vaccine VO:0005410 A SARS-CoV-2 mRNA vaccine by CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Philip Huang SYS6006 NCT05439824 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5931 5931 vaccine SYS6006 vaccine VO:0005411 A SARS-CoV-2 inactivated vaccine developed by Airlangga University Philip Huang NCT05226429 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5922 5922 vaccine UNAIR Inactivated COVID-19 Vaccine VO:0005412 A SARS-CoV-2 protein subunit vaccine manufactured by Livzon Pharmaceutical Group Inc. Philip Huang NCT05273528 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5928 5928 vaccine V-01-351/V-01D Bivalence Vaccine VO:0005413 A SARS-CoV-2 mRNA vaccine by Gennova Biopharmaceuticals Limited Philip Huang GEMCOVAC-19 CTRI/2022/04/041880 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5933 5933 vaccine GEMCOVAC-19 vaccine VO:0005414 A SARS-CoV-2 mRNA vaccine by AIM Vaccine Co., Ltd. Philip Huang LVRNA009 NCT05428592 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5925 5925 vaccine LVRNA009 vaccine VO:0005415 A SARS-CoV-2 bivalent mRNA vaccine by Moderna that contains the mRNA-1273 COVID-19 vaccine and the mRNA-1273.214 Omicron booster Philip Huang mRNA-1273.214 NCT05436834 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5939 5939 vaccine mRNA-1273.214 vaccine VO:0005416 A SARS-CoV-2 mRNA booster vaccine by Moderna that targets the Omicron variant Philip Huang mRNA-1273.529 NCT05249829 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5926 5926 vaccine mRNA-1273.529 vaccine VO:0005417 A SARS-CoV-2 inactivated vaccine developed by China National Biotec Group Company Limited Philip Huang NCT05374954 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5940 5940 vaccine Omicron COVID-19 inactivated vaccine by China National Biotec Group Company Limited VO:0005418 Oliver He http://www.violinet.org/cov19vaxkb/authorizedcov19vax.php vaccine authorized COVID-19 virus-like particle vaccine VO:0005419 Chemical Nature: other Mechanism of Action: Activation of APCs, activation of T cells and stimulating B cell proliferation (IgG) Immune profile induced: Th1-biased Route of immunization: IM and SQ Point of Contact: Matthew Heath, Allergy Therapeutics (UK) Ltd Ani Bernardi Ari Joffe Matthew Heath Oliver He Wolfgang Leitner MCT MCT vaccine adjuvant MicroCrystalline Tyrosine VAC: https://vac.niaid.nih.gov/view?id=25 https://www.ncbi.nlm.nih.gov/pubmed/?term=28347293 https://www.ncbi.nlm.nih.gov/pubmed/?term=28468322 https://www.ncbi.nlm.nih.gov/pubmed/?term=28953265 https://www.ncbi.nlm.nih.gov/pubmed/?term=29592962 25 vaccine adjuvant MicroCrystalline Tyrosine vaccine adjuvant VO:0005420 Chemical Nature: other Mechanism of Action: TLR4; Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Christopher Fox, AAHI Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=27142329 https://www.ncbi.nlm.nih.gov/pubmed/?term=21060869 https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089 https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089 https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089 https://www.ncbi.nlm.nih.gov/pubmed/?term=21816196 https://www.ncbi.nlm.nih.gov/pubmed/?term=21690242 https://www.ncbi.nlm.nih.gov/pubmed/?term=21060869 https://www.ncbi.nlm.nih.gov/pubmed/?term=22291184 https://www.ncbi.nlm.nih.gov/pubmed/?term=22291184 https://www.ncbi.nlm.nih.gov/pubmed/?term=23045649 https://www.ncbi.nlm.nih.gov/pubmed/?term=23045649 https://www.ncbi.nlm.nih.gov/pubmed/?term=22509423 https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687 https://www.ncbi.nlm.nih.gov/pubmed/?term=23904160 https://www.ncbi.nlm.nih.gov/pubmed/?term=23954378 https://www.ncbi.nlm.nih.gov/pubmed/?term=22425788 https://www.ncbi.nlm.nih.gov/pubmed/?term=22891286 https://www.ncbi.nlm.nih.gov/pubmed/?term=22891286 https://www.ncbi.nlm.nih.gov/pubmed/?term=23624057 https://www.ncbi.nlm.nih.gov/pubmed/?term=23624057 https://www.ncbi.nlm.nih.gov/pubmed/?term=23228811 https://www.ncbi.nlm.nih.gov/pubmed/?term=25024362 https://www.ncbi.nlm.nih.gov/pubmed/?term=25030053 https://www.ncbi.nlm.nih.gov/pubmed/?term=24404140 https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505 https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505 https://www.ncbi.nlm.nih.gov/pubmed/?term=24397898 https://www.ncbi.nlm.nih.gov/pubmed/?term=24397898 https://www.ncbi.nlm.nih.gov/pubmed/?term=24728521 https://www.ncbi.nlm.nih.gov/pubmed/?term=24728521 https://www.ncbi.nlm.nih.gov/pubmed/?term=25367751 https://www.ncbi.nlm.nih.gov/pubmed/?term=26541135 https://www.ncbi.nlm.nih.gov/pubmed/?term=25637347 https://www.ncbi.nlm.nih.gov/pubmed/?term=27005808 https://www.ncbi.nlm.nih.gov/pubmed/?term=26656121 https://www.ncbi.nlm.nih.gov/pubmed/?term=26874325 https://www.ncbi.nlm.nih.gov/pubmed/?term=26791076 https://www.ncbi.nlm.nih.gov/pubmed/?term=27466350 https://www.ncbi.nlm.nih.gov/pubmed/?term=27699241 https://www.ncbi.nlm.nih.gov/pubmed/?term=29176865 https://www.ncbi.nlm.nih.gov/pubmed/?term=27958370 https://www.ncbi.nlm.nih.gov/pubmed/?term=29263879 https://www.ncbi.nlm.nih.gov/pubmed/?term=29795025 https://www.ncbi.nlm.nih.gov/pubmed/?term=29983563 https://www.ncbi.nlm.nih.gov/pubmed/?term=29619252 https://www.ncbi.nlm.nih.gov/pubmed/?term=29619252 https://www.ncbi.nlm.nih.gov/pubmed/?term=27895131 https://www.ncbi.nlm.nih.gov/pubmed/?term=32636844 https://www.ncbi.nlm.nih.gov/pubmed/?term=29541075 https://www.ncbi.nlm.nih.gov/pubmed/?term=33705411 https://www.ncbi.nlm.nih.gov/pubmed/?term=35126135 https://www.ncbi.nlm.nih.gov/pubmed/?term=19679214 https://www.ncbi.nlm.nih.gov/pubmed/?term=26731269 https://www.ncbi.nlm.nih.gov/pubmed/?term=26453448 https://www.ncbi.nlm.nih.gov/pubmed/?term=26453448 https://www.ncbi.nlm.nih.gov/pubmed/?term=27456709 https://www.ncbi.nlm.nih.gov/pubmed/?term=32023469 https://www.ncbi.nlm.nih.gov/pubmed/?term=32402293 https://www.ncbi.nlm.nih.gov/pubmed/?term=32348377 https://www.ncbi.nlm.nih.gov/pubmed/?term=32697993 https://www.ncbi.nlm.nih.gov/pubmed/?term=29515589 https://www.ncbi.nlm.nih.gov/pubmed/?term=33046728 https://www.ncbi.nlm.nih.gov/pubmed/?term=31690678 https://www.ncbi.nlm.nih.gov/pubmed/?term=31174937 https://www.ncbi.nlm.nih.gov/pubmed/?term=30567978 https://www.ncbi.nlm.nih.gov/pubmed/?term=31362695 https://www.ncbi.nlm.nih.gov/pubmed/?term=29769270 https://www.ncbi.nlm.nih.gov/pubmed/?term=31521953 https://www.ncbi.nlm.nih.gov/pubmed/?term=28298421 Ongoing clinical trial: https://clinicaltrials.gov/ct2/show/NCT01484548 https://clinicaltrials.gov/ct2/show/NCT01751048 https://clinicaltrials.gov/ct2/show/NCT02071758 https://clinicaltrials.gov/ct2/show/NCT02465216 https://clinicaltrials.gov/ct2/show/NCT01927159 https://clinicaltrials.gov/ct2/show/NCT01599897 https://clinicaltrials.gov/ct2/show/NCT01154049 https://clinicaltrials.gov/ct2/show/NCT03302897 https://clinicaltrials.gov/ct2/show/NCT02465216 https://clinicaltrials.gov/ct2/show/NCT02508376 https://clinicaltrials.gov/ct2/show/NCT03806686 https://clinicaltrials.gov/ct2/show/NCT01949909 https://clinicaltrials.gov/ct2/show/NCT01540474 https://clinicaltrials.gov/ct2/show/NCT02014727 https://clinicaltrials.gov/ct2/show/NCT02647489 https://clinicaltrials.gov/ct2/show/NCT02658253 https://clinicaltrials.gov/ct2/show/NCT01991561 https://clinicaltrials.gov/ct2/show/NCT01596725 https://clinicaltrials.gov/ct2/show/NCT01147068 https://clinicaltrials.gov/ct2/show/NCT03820414 https://clinicaltrials.gov/ct2/show/NCT03220724 https://clinicaltrials.gov/ct2/show/NCT03409276 https://clinicaltrials.gov/ct2/show/NCT01864876 https://clinicaltrials.gov/ct2/show/NCT02115815 https://clinicaltrials.gov/ct2/show/NCT01397604 Ani Bernardi Ari Joffe Christopher Fox Oliver He Wolfgang Leitner GLA-SE VAC: https://vac.niaid.nih.gov/view?id=62 https://clinicaltrials.gov/ct2/show/NCT01484548 https://clinicaltrials.gov/ct2/show/NCT01751048 https://clinicaltrials.gov/ct2/show/NCT02071758 https://www.ncbi.nlm.nih.gov/pubmed/?term=20944089 https://www.ncbi.nlm.nih.gov/pubmed/?term=21060869 https://www.ncbi.nlm.nih.gov/pubmed/?term=27142329 62 vaccine adjuvant GLA-SE vaccine adjuvant VO:0005421 Chemical Nature: other Mechanism of Action: TLR4; Innate Immune Activation Immune profile induced: Mixed Th1/Th2 Route of immunization: IM Point of Contact: Christopher Fox, AAHI Ongoing clinical trial: https://clinicaltrials.gov/ct2/show/NCT02508376 https://clinicaltrials.gov/ct2/show/NCT02647489 https://clinicaltrials.gov/ct2/show/NCT04177355 https://clinicaltrials.gov/ct2/show/NCT03589794 Ani Bernardi Ari Joffe Christopher Fox Oliver He Wolfgang Leitner GLA-SLQ VAC: https://vac.niaid.nih.gov/view?id=63 https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687 https://www.ncbi.nlm.nih.gov/pubmed/?term=24465426 https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202 https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505 https://www.ncbi.nlm.nih.gov/pubmed/?term=26541135 https://www.ncbi.nlm.nih.gov/pubmed/?term=26862758 https://www.ncbi.nlm.nih.gov/pubmed/?term=31174937 https://www.ncbi.nlm.nih.gov/pubmed/?term=31690678 https://www.ncbi.nlm.nih.gov/pubmed/?term=32636844 63 vaccine adjuvant GLA-SLQ vaccine adjuvant VO:0005422 Chemical Nature: other Mechanism of Action: TLR4; Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Christopher Fox, AAHI Ani Bernardi Ari Joffe Christopher Fox Oliver He Wolfgang Leitner SLA-LSQ VAC: https://vac.niaid.nih.gov/view?id=64 https://www.ncbi.nlm.nih.gov/pubmed/?term=30302281 64 vaccine adjuvant SLA-LSQ vaccine adjuvant VO:0005423 Chemical Nature: other Mechanism of Action: TLR4; Innate Immune Activation Immune profile induced: n/a Route of immunization: IM Point of Contact: Christopher Fox, AAHI Ongoing clinical trial: https://clinicaltrials.gov/ct2/show/NCT03820414 https://clinicaltrials.gov/ct2/show/NCT02071758 Ani Bernardi Ari Joffe Christopher Fox Oliver He Wolfgang Leitner SLA-SE VAC: https://vac.niaid.nih.gov/view?id=65 https://www.ncbi.nlm.nih.gov/pubmed/?term=30386348 https://www.ncbi.nlm.nih.gov/pubmed/?term=31149350 https://www.ncbi.nlm.nih.gov/pubmed/?term=31891152 https://www.ncbi.nlm.nih.gov/pubmed/?term=32540272 https://www.ncbi.nlm.nih.gov/pubmed/?term=35459225 65 vaccine adjuvant SLA-SE vaccine adjuvant VO:0005424 Chemical Nature: other Mechanism of Action: TLR4; Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Christopher Fox, AAHI Ongoing clinical trial: https://clinicaltrials.gov/ct2/show/NCT02508376 https://clinicaltrials.gov/ct2/show/NCT02647489 https://clinicaltrials.gov/ct2/show/NCT04177355 https://clinicaltrials.gov/ct2/show/NCT03589794 Ani Bernardi Ari Joffe Christopher Fox Oliver He Wolfgang Leitner GLA-AF VAC: https://vac.niaid.nih.gov/view?id=66 https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687 https://www.ncbi.nlm.nih.gov/pubmed/?term=24465426 https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202 https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505 https://www.ncbi.nlm.nih.gov/pubmed/?term=26541135 https://www.ncbi.nlm.nih.gov/pubmed/?term=26862758 https://www.ncbi.nlm.nih.gov/pubmed/?term=31174937 https://www.ncbi.nlm.nih.gov/pubmed/?term=31690678 https://www.ncbi.nlm.nih.gov/pubmed/?term=32636844 66 vaccine adjuvant GLA-AF vaccine adjuvant VO:0005425 A cancer vaccine that is used against prostate cancer. Oliver He Yuanyi (Penny) Pan https://www.hopkinsmedicine.org/health/conditions-and-diseases/prostate-cancer/immunotherapy-for-prostate-cancer cancer vaccine prostate cancer vaccine VO:0005426 A cancer vaccine that is used against colorectal cancer Oliver He Yuanyi (Penny) Pan PMID:35990683 cancer vaccine colorectal cancer vaccine VO:0005427 A cancer vaccine that is used against lymphoma. Oliver He Yuanyi (Penny) Pan http://www.cancer.gov/news-events/cancer-currents-blog/2019/in-situ-vaccine-non-hodgkin-lymphoma cancer vaccine lymphoma vaccine VO:0005428 A cancer vaccine that is used against brain canceer. Oliver He Yuanyi (Penny) Pan https://www.criver.com/eureka/brain-cancer-vaccine-gliomas-moves-forward-clinic cancer vaccine brain cancer vaccine VO:0005429 A cancer vaccine that is used against liver canceer. Oliver He Yuanyi (Penny) Pan https://www.creative-biolabs.com/vaccine/liver-cancer-vaccines.htm cancer vaccine liver cancer vaccine VO:0005430 A cancer vaccine that is used against pancreatic canceer. Oliver He Yuanyi (Penny) Pan https://www.hopkinsmedicine.org/health/conditions-and-diseases/pancreatic-cancer/pancreatic-cancer-vaccine cancer vaccine pancreatic cancer vaccine VO:0005434 A recombinant viral vaccine vector that uses PVSRIPO, a recombinant nonpathogenic polio-rhinovirus chimera. PVSRIPO is an engineerable oncolytic virus whereas its internal ribosomal entry site element can be substituted to demolish its cytopathogenic effect. PVSRIPO has a natural inherent tropism for antigen-presenting cells (including dendritic cells and macrophages) due to the presence of the CD-155 receptor on their cellular surfaces. This enables it of inducing CD8+ T-cell mediate immune responses. Mina Ashraf Oliver He https://journals.aai.org/jimmunol/article/172/7/3994/71825/Cutting-Edge-CD96-Tactile-Promotes-NK-Cell-Target https://link.springer.com/article/10.1007/s00109-008-0433-0 https://pubmed.ncbi.nlm.nih.gov/31988324/ https://www.pnas.org/doi/abs/10.1073/pnas.93.6.2370 https://www.pnas.org/doi/full/10.1073/pnas.95.14.8216 https://www.sciencedirect.com/science/article/pii/B978012810514600009X?via%3Dihub vaccine component PVSRIPO vaccine vector VO:0005435 A Comirnaty COVID-19 mRNA vaccine produced by Pfizer-BioNTech,which is a bivalent vaccine that is effective against the original strain of COVID-19 as well as the Omicron BA.1 variant.A non-US vaccine product. Oliver He Yuanyi (Penny) Pan Comirnaty Bivalent PMID:36541943 https://secure.medicalletter.org/TML-article-1665f https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx Comirnaty vaccine Authorized by WHO 10/19/2022 - Counted toward immunity in US.Ref:https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech VO:0005436 A Comirnaty COVID-19 mRNA vaccine utilizes Lipid Nanoparticle-Self-amplifying RNA technology, available as a bivalent boosters against the original strain of COVID-19 as well as the Omicron BA.1 variant produced by Pfizer (PF) with a dose of 30 mcg/0.3 mL to provide enhanced protection. Oliver He Yuanyi (Penny) Pan PMID:36206167 https://secure.medicalletter.org/TML-article-1660c https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx Comirnaty vaccine EUA authorized Pfizer adult bivalent booster ages 12+ yrs, original strain + omicron BA.4/BA.5. Not Authorized by WHO. Non-US Tradename for same formulation (Comirnaty Bivalent) counted toward immunity in US. Ref:https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation VO:0005437 A Comirnaty COVID-19 mRNA vaccine utilizing Lipid Nanoparticle-Self-amplifying RNA technology against the original strain of COVID-19 without preservative ,which is produced by Pfizer (PF) with a dose of 30 mcg/0.3 mL. Oliver He Yuanyi (Penny) Pan https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx vaccine SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose VO:0005439 A vaccine that is made of immune globulin and used to immunize an individual against some disease(s). Oliver He Yuanyi (Penny) Pan https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150278/ https://github.com/vaccineontology/VO/issues/706 vaccine passive vaccine VO:0005440 anthrax immune globulin 181 anthrax immune globulin anthrax immune globulin vaccine licensed human anthrax immune globulin passive vaccine VO:0005441 CMVIG 29 cytomegalovirus immune globulin, intravenous CMVIG vaccine licensed human cytomegalovirus immune globulin passive vaccine, intravenous VO:0005442 Hepatitis A Immune Globulin passive vaccine is a passive vaccine that provides protection against hepatitis A through the passive transfer of an antibody. Hep A, IG provides temporary immunity to the virus for two to three months, if administered prior to exposure or within two weeks after exposure. Hep A,IG Hepatitis A immune globulin Stapleton, Jack T. "Passive immunization against hepatitis A." Vaccine 10 (1992): S45-S47. 154 Hepatitis A immune globulin Hep A, IG vaccine licensed human hepatitis A immune globulin passive vaccine VO:0005443 HBIG hepatitis B immune globulin 30 hepatitis B immune globulin HBIG vaccine licensed human hepatitis B immune globulin passive vaccine VO:0005444 IG 86 immune globulin, intramuscular IG vaccine licensed human immune globulin passive vaccine, intramuscular VO:0005445 IGIV 87 immune globulin, intravenous IGIV vaccine licensed human immune globulin passive vaccine, intravenous VO:0005446 IG,unspecified formulation 14 immune globulin, unspecified formulation IG, unspecified formulation vaccine licensed human immune globulin passive vaccine VO:0005447 34 rabies immune globulin RIG vaccine licensed human rabies immune globulin passive vaccine VO:0005448 RSV-IGIV respiratory syncytial virus immune globulin, intravenous 71 respiratory syncytial virus immune globulin, intravenous RSV-IGIV vaccine licensed human respiratory syncytial virus immune globulin passive vaccine, intravenous VO:0005449 157 Rho(D) Immune globulin - IM Rho(D) -IG IM vaccine licensed human Rho(D) immune globulin - IM passive vaccine VO:0005450 Rho(D) Immune globulin- IV or IM 156 Rho(D) Immune globulin- IV or IM Rho(D)-IG vaccine licensed human Rho(D) immune globulin- IV or IM passive vaccine VO:0005451 159 Rho(D) Unspecified formulation Rho(D) - Unspecified formulation vaccine licensed human Rho(D) immune globulin passive vaccine VO:0005452 13 180 tetanus immune globulin TIG tetanus immune globulin vaccine licensed human tetanus immune globulin passive vaccine VO:0005453 vaccinia immune globulin 79 vaccinia immune globulin vaccinia immune globulin vaccine licensed human vaccinia immune globulin passive vaccine VO:0005454 36 varicella zoster immune globulin VZIG vaccine licensed human varicella zoster immune globulin passive vaccine VO:0005455 117 varicella zoster immune globulin (Investigational New Drug) VZIG (IND) vaccine licensed human varicella zoster immune globulin passive vaccine (Investigational New Drug) VO:0005456 DTP-hepB-Hib plentavalent Non-US 198 724900 Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) DTP-hepB-Hib Pentavalent Non-US vaccine Diphtheria-Pertussis-Tetanus-Haemophilus B-Hepatitis B vaccine,(Pentavalent) VO:0005457 DTP-Hib-Hep B vaccine DTP-Haemophilus influenzae type b conjugate and hepatitis B vaccine VO:0005458 Oliver He Yuanyi (Penny) Pan Influenza, injectable, MDCK, quadrivalent, preservative 186 40213144 Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative Influenza, MDCK, quadrivalent, preservative vaccine influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative VO:0005459 DTP,unspecified formulation 107 40213283 diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation DTaP, unspecified formulation vaccine Diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation VO:0005460 22 40213292 DTP-Haemophilus influenzae type b conjugate vaccine DTP-Hib vaccine DTP-Haemophilus influenzae type b conjugate vaccine VO:0005461 A viral vaccine that protects against infection with influenza virus and with high-dose seasonal,quadrivalent,0.7ml dose,preservative free. Hong Yu Yuanyi (Penny) Pan Influenza,high-dose,quadrivalent vaccine influenza, high-dose seasonal, quadrivalent, 0.7ml dose, preservative free VO:0005462 Oliver He Yuanyi (Penny) Pan Influenza, injectable,quadrivalent, preservative free, pediatric 161 40213147 Influenza, injectable,quadrivalent, preservative free, pediatric Influenza, injectable,quadrivalent, preservative free, pediatric vaccine influenza, injectable, quadrivalent, preservative free, pediatric VO:0005463 Oliver He Yuanyi (Penny) Pan influenza, intradermal, quadrivalent, preservative free 166 40213148 influenza, intradermal, quadrivalent, preservative free, injectable influenza, intradermal, quadrivalent, preservative free vaccine influenza, intradermal, quadrivalent, preservative free, injectable VO:0005464 A poliovirus vaccine that contains two types of poliovirus and uses poliovirus particles that have been grown under controlled conditions and then killed to prevent disease caused from the vaccine. Oliver He Yuanyi (Penny) Pan OPV bivalent 178 40213192 Non-US bivalent oral polio vaccine (types 1 and 3) OPV bivalent vaccine Non-US bivalent oral polio vaccine (types 1 and 3) VO:0005465 A poliovirus vaccine that contains one type of poliovirus and uses poliovirus particles that have been grown under controlled conditions and then killed to prevent disease caused from the vaccine. Oliver He Yuanyi (Penny) Pan OPV ,monovalent, unspecified 179 40213191 Non-US monovalent oral polio vaccine, unspecified formulation OPV ,monovalent, unspecified vaccine Non-US monovalent oral polio vaccine, unspecified formulation VO:0005466 Oliver He Yuanyi (Penny) Pan Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed 09 40213228 tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed vaccine tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) VO:0005467 Oliver He Yuanyi (Penny) Pan Td, adsorbed, preservative free, adult use, Lf unspecified 196 724895 tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified Td, adsorbed, preservative free, adult use, Lf unspecified vaccine tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified VO:0005468 Oliver He Yuanyi (Penny) Pan Td (adult) 138 40213226 tetanus and diphtheria toxoids, not adsorbed, for adult use Td (adult) vaccine tetanus and diphtheria toxoids, not adsorbed, for adult use VO:0005469 A poliovirus vaccine that contains three types of poliovirus and uses poliovirus particles that have been grown under controlled conditions and then killed to prevent disease caused from the vaccine. Oliver He Yuanyi (Penny) Pan OPV 02 40213190 trivalent poliovirus vaccine, live, oral OPV vaccine trivalent poliovirus vaccine, live, oral VO:0005470 Oliver He Yuanyi (Penny) Pan DTaP,IPV,Hib,HepB 146 40213284 Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. DTaP,IPV,Hib,HepB vaccine Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. VO:0005471 A vaccine adjuvant 30:70 (w/w) Water-in-Oil (W/O) emulsion that stimulates a mixed Th1/Th2 response. Chemical Nature: emulsion Mechanism of Action: adjuvanted antigen depot at injection site Immune profile induced: Mixed Th1/Th2 Route of immunization: IM and SQ Point of Contact: Peter Blackburn, MerciaPharma Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=23595760 https://www.ncbi.nlm.nih.gov/pubmed/?term=24783964 https://www.ncbi.nlm.nih.gov/pubmed/?term=34429319 https://www.ncbi.nlm.nih.gov/pubmed/?term=34926305 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT02500680 https://clinicaltrials.gov/ct2/show/NCT02500680 https://clinicaltrials.gov/ct2/show/NCT03624062 https://clinicaltrials.gov/ct2/show/NCT02118077 Ari Joffe Oliver He Peter Blackburn Wolfgang Leitner MAS-1 VAC: https://vac.niaid.nih.gov/view?id=68 https://clinicaltrials.gov/ct2/show/NCT02118077 https://clinicaltrials.gov/ct2/show/NCT02500680 https://clinicaltrials.gov/ct2/show/NCT03624062 https://www.ncbi.nlm.nih.gov/pubmed/?term=23595760 https://www.ncbi.nlm.nih.gov/pubmed/?term=24783964 https://www.ncbi.nlm.nih.gov/pubmed/?term=34429319 https://www.ncbi.nlm.nih.gov/pubmed/?term=34926305 68 vaccine adjuvant MAS-1 vaccine adjuvant VO:0005472 A vaccine adjuvant that induces CD8 T cells and provides innate protection. Chemical Nature: small molecule Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: SQ Point of Contact: Taegyan Kang, Progeneer Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=36635335 Ongoing clinical trials: n/a Ari Joffe Oliver He Taegyan Kang Wolfgang Leitner ProLNG-S VAC: https://vac.niaid.nih.gov/view?id=34 https://www.ncbi.nlm.nih.gov/pubmed/?term=36635335 34 vaccine adjuvant ProLNG-S vaccine adjuvant VO:0005473 A vaccine adjuvant that is a lipid-based vaccine adjuvent based on cationic surfactant dimethyl-dioctadecyl ammonium (DDA) combined with C-type lectin agonist monomycoloyl glycerol (MMG) and TLR3 agonist poly I:C. CAF09b is able to induce CD8+ T-cell response. Chemical Nature: Liposome Mechanism of Action: n/a Immune profile induced: n/a Route of immunization: IN, IP, IM, Point of Contact: Gabriel Kristian Pedersen, Staten Serum Institute (SSI) Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=35163772 https://www.ncbi.nlm.nih.gov/pubmed/?term=33352684 https://www.ncbi.nlm.nih.gov/pubmed/?term=35036074 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT03715985 Ari Joffe Gabriel Kristian Pedersen Oliver He Wolfgang Leitner CAF09b VAC: https://vac.niaid.nih.gov/view?id=76 https://clinicaltrials.gov/ct2/show/NCT03715985 https://www.ncbi.nlm.nih.gov/pubmed/?term=33352684 https://www.ncbi.nlm.nih.gov/pubmed/?term=35036074 https://www.ncbi.nlm.nih.gov/pubmed/?term=35163772 76 vaccine adjuvant CAF09b vaccine adjuvant VO:0005474 A vaccine adjuvant that is a lipid-based nanosuspension of a synthetic TLR7/8 ligand that facilitates adsorption to aluminum oxyhydroxide via the structural properties of the helper lipid employed. Chemical Nature: Small molecule Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Valerie Soza, AAHI Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326 https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326 https://www.ncbi.nlm.nih.gov/pubmed/?term=36274085 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT04177355 https://clinicaltrials.gov/ct2/show/NCT05781542 https://clinicaltrials.gov/ct2/show/NCT05471076 https://clinicaltrials.gov/ct2/show/NCT04915768 https://clinicaltrials.gov/ct2/show/NCT05781542 Ari Joffe Oliver He Valerie Soza Wolfgang Leitner 3M-052-AF VAC: https://vac.niaid.nih.gov/view?id=69 https://clinicaltrials.gov/ct2/show/NCT04177355 https://clinicaltrials.gov/ct2/show/NCT04915768 https://clinicaltrials.gov/ct2/show/NCT05471076 https://clinicaltrials.gov/ct2/show/NCT05781542 https://www.ncbi.nlm.nih.gov/pubmed/?term=27847326 https://www.ncbi.nlm.nih.gov/pubmed/?term=36274085 69 vaccine adjuvant 3M-052-AF vaccine adjuvant VO:0005475 A vaccine adjuvant that reformulates Alhydrogel as a stable nanoparticle with the anionic polymer polyacrylic acid (PAA), leading to the induction of structure-dependent TH1 response. Chemical Nature: Small molecule Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Valerie Soza, AAHI Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=30622742 https://www.ncbi.nlm.nih.gov/pubmed/?term=31930264 Ari Joffe Oliver He Valerie Soza Wolfgang Leitner NanoAlum VAC: https://vac.niaid.nih.gov/view?id=71 https://www.ncbi.nlm.nih.gov/pubmed/?term=30622742 https://www.ncbi.nlm.nih.gov/pubmed/?term=31930264 71 vaccine adjuvant NanoAlum vaccine adjuvant VO:0005476 A vaccine adjuvant is a small molecule adjuvant that induces Th1-based immune response and is designed for use with self-amplifying RNA antigens. Chemical Nature: Small molecule Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Valerie Soza, AAHI Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=35911728 https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202 https://www.ncbi.nlm.nih.gov/pubmed/?term=34058388 https://www.ncbi.nlm.nih.gov/pubmed/?term=35308783 https://www.ncbi.nlm.nih.gov/pubmed/?term=36589712 https://www.ncbi.nlm.nih.gov/pubmed/?term=36323666 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT05370040 Ari Joffe Oliver He Valerie Soza Wolfgang Leitner NLC vaccine adjuvant Nanostructured Lipid Carrier Nanostructured Lipid Carrier (NLC) VAC: https://vac.niaid.nih.gov/view?id=70 https://clinicaltrials.gov/ct2/show/NCT05370040 https://www.ncbi.nlm.nih.gov/pubmed/?term=24551202 https://www.ncbi.nlm.nih.gov/pubmed/?term=34058388 https://www.ncbi.nlm.nih.gov/pubmed/?term=35308783 https://www.ncbi.nlm.nih.gov/pubmed/?term=35911728 https://www.ncbi.nlm.nih.gov/pubmed/?term=36323666 https://www.ncbi.nlm.nih.gov/pubmed/?term=36589712 70 vaccine adjuvant Nanostructured Lipid Carrier (NLC) vaccine adjuvant VO:0005477 Anthony Huffman protein Giardia spp. protein VO:0005478 PFS25/28 in Matrix M vaccine PFS25/28 in Matrix M vaccine VO:0005479 a malaria vaccine that protects against malaria caused by Plasmodium knowlesi. Anthony Huffman vaccine Plasmodium knowlesi vaccine VO:0005480 a malaria vaccine that protects against malaria caused by Plasmodium chabaudi. Anthony Huffman vaccine Plasmodium chabaudi vaccine VO:0005482 A vaccine adjuvant is an oil-in-water emulsion that induces Th1-based immune response. Chemical Nature: Small molecule Mechanism of Action: Innate Immune Activation Immune profile induced: n/a Route of immunization: IM Point of Contact: Valerie Soza, AAHI Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=32983577 https://www.ncbi.nlm.nih.gov/pubmed/?term=35459225 Ari Joffe Oliver He Valerie Soza Wolfgang Leitner SLA-AF VAC: https://vac.niaid.nih.gov/view?id=72 https://www.ncbi.nlm.nih.gov/pubmed/?term=32983577 https://www.ncbi.nlm.nih.gov/pubmed/?term=35459225 72 vaccine adjuvant SLA-AF vaccine adjuvant VO:0005483 A vaccine adjuvant is a gadoteridol-loaded cationic adjuvant formulation 01 that induced a Th1/Th17 type of immune response. Chemical Nature: Liposome system Mechanism of Action: n/a Immune profile induced: Th1/Th17 Route of immunization: IP, IM, IN, SQ, ID, SC, SL, intratracheal, endotracheal, Fish vaccination Point of Contact: Gabriel Kristian Pedersen, Staten Serum Institute (SSI) Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=31539263 https://www.ncbi.nlm.nih.gov/pubmed/?term=30555488 https://www.ncbi.nlm.nih.gov/pubmed/?term=29699790 https://www.ncbi.nlm.nih.gov/pubmed/?term=34044110 https://www.ncbi.nlm.nih.gov/pubmed/?term=26394776 https://www.ncbi.nlm.nih.gov/pubmed/?term=18776936 https://www.ncbi.nlm.nih.gov/pubmed/?term=30291987 https://www.ncbi.nlm.nih.gov/pubmed/?term=21124731 https://www.ncbi.nlm.nih.gov/pubmed/?term=29358939 https://www.ncbi.nlm.nih.gov/pubmed/?term=33072125 https://www.ncbi.nlm.nih.gov/pubmed/?term=35585969 https://www.ncbi.nlm.nih.gov/pubmed/?term=26494626 https://www.ncbi.nlm.nih.gov/pubmed/?term=26379666 https://www.ncbi.nlm.nih.gov/pubmed/?term=35124896 https://www.ncbi.nlm.nih.gov/pubmed/?term=34358167 https://www.ncbi.nlm.nih.gov/pubmed/?term=29541075 https://www.ncbi.nlm.nih.gov/pubmed/?term=31130946 https://www.ncbi.nlm.nih.gov/pubmed/?term=31906072 https://www.ncbi.nlm.nih.gov/pubmed/?term=32106599 https://www.ncbi.nlm.nih.gov/pubmed/?term=19492047 https://www.ncbi.nlm.nih.gov/pubmed/?term=33422991 https://www.ncbi.nlm.nih.gov/pubmed/?term=28414746 https://www.ncbi.nlm.nih.gov/pubmed/?term=33066267 https://www.ncbi.nlm.nih.gov/pubmed/?term=27958370 https://www.ncbi.nlm.nih.gov/pubmed/?term=23308247 https://www.ncbi.nlm.nih.gov/pubmed/?term=30984200 https://www.ncbi.nlm.nih.gov/pubmed/?term=20505822 https://www.ncbi.nlm.nih.gov/pubmed/?term=27525651 https://www.ncbi.nlm.nih.gov/pubmed/?term=23873630 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT00922363 https://clinicaltrials.gov/ct2/show/NCT01009762 https://clinicaltrials.gov/ct2/show/NCT02787109 https://clinicaltrials.gov/ct2/show/NCT01141205 https://clinicaltrials.gov/ct2/show/NCT03926728 Ari Joffe Gabriel Kristian Pedersen Oliver He Wolfgang Leitner CAF01 VAC: https://vac.niaid.nih.gov/view?id=75 https://clinicaltrials.gov/ct2/show/NCT00922363 https://clinicaltrials.gov/ct2/show/NCT01009762 https://clinicaltrials.gov/ct2/show/NCT01141205 https://clinicaltrials.gov/ct2/show/NCT02787109 https://clinicaltrials.gov/ct2/show/NCT03926728 https://www.ncbi.nlm.nih.gov/pubmed/?term=18776936 https://www.ncbi.nlm.nih.gov/pubmed/?term=21124731 https://www.ncbi.nlm.nih.gov/pubmed/?term=26394776 https://www.ncbi.nlm.nih.gov/pubmed/?term=29358939 https://www.ncbi.nlm.nih.gov/pubmed/?term=29699790 https://www.ncbi.nlm.nih.gov/pubmed/?term=30291987 https://www.ncbi.nlm.nih.gov/pubmed/?term=30555488 https://www.ncbi.nlm.nih.gov/pubmed/?term=31539263 https://www.ncbi.nlm.nih.gov/pubmed/?term=34044110 75 vaccine adjuvant CAF01 vaccine adjuvant VO:0005484 A cancer vaccine that is developed against breast cancer. Oliver He cancer vaccine breast cancer vaccine VO:0005485 A cancer vaccine that is developed against bladder cancer. Oliver He cancer vaccine bladder cancer vaccine VO:0005486 A cancer vaccine that is developed against lung cancer. Oliver He cancer vaccine lung cancer vaccine VO:0005487 A cancer vaccine that is developed against leukemia. Oliver He cancer vaccine leukemia cancer vaccine VO:0005488 A cancer vaccine that is developed against cervical cancer. Oliver He cancer vaccine cervical cancer vaccine VO:0005489 A cancer vaccine that is developed against colon cancer. Oliver He cancer vaccine colon cancer vaccine VO:0005490 A cancer vaccine that is developed against gastric cancer Oliver He cancer vaccine gastric cancer vaccine VO:0005491 A cancer vaccine that is developed against mesothelioma cancer. Oliver He cancer vaccine mesothelioma cancer vaccine VO:0005492 A cancer vaccine that is developed against myeloma cancer. Oliver He cancer vaccine myeloma cancer vaccine VO:0005493 A cancer vaccine that is developed against ovarian cancer. Oliver He cancer vaccine ovarian cancer vaccine VO:0005494 A cancer vaccine that is developed against renal cancer. Oliver He cancer vaccine renal cancer vaccine VO:0005495 A cancer vaccine that is developed against sarcoma cancer. Oliver He cancer vaccine sarcoma cancer vaccine VO:0005496 A cancer vaccine that is developed against esophageal cancer. Jie Zheng Oliver He Xingxian Li Yuanyi (Penny) Pan cancer vaccine esophageal cancer vaccine VO:0005497 A cancer vaccine that is developed against head and neck cancer. Jie Zheng Oliver He Xingxian Li Yuanyi (Penny) Pan cancer vaccine head and neck cancer vaccine VO:0005498 A cancer vaccine that is developed against nasopharyngeal cancer. Jie Zheng Oliver He Xingxian Li Yuanyi (Penny) Pan cancer vaccine nasopharyngeal cancer vaccine VO:0005499 A cancer vaccine that is developed against hepatocellular carcinoma. Jie Zheng Oliver He Xingxian Li Yuanyi (Penny) Pan cancer vaccine hepatocellular carcinoma vaccine VO:0005501 Anthony Huffman protein Plasmodium falciparum MSA2 VO:0005502 A vaccine that prevents or reduce the transmission of a disorder within a target host or among a population by inducing or modifying specific adaptive immune responses against the antigens present in the vaccine. https://github.com/vaccineontology/VO/issues/695 vaccine transmission-blocking vaccine VO:0005503 Vaccine that prevents or treats specific disease. Barry Smith Charles Tapley Hoyt Jie Zheng Oliver He Xingxian Li https://github.com/vaccineontology/VO/issues/619 vaccine vaccine against disease VO:0005504 Vaccine against an infectious disease caused by specific pathogen(s). Note that all infectious diseases are caused by some pathogens, so 'infectious disease vaccine' and 'vaccine against pathogen infection' are basically synonyms. Barry Smith Charles Tapley Hoyt Jie Zheng Oliver He Xingxian Li infectious disease vaccine vaccine against pathogen vaccine against pathogen infection https://github.com/vaccineontology/VO/issues/619 https://github.com/vaccineontology/VO/issues/747 vaccine vaccine against infectious disease VO:0005505 Vaccine that is developed and produced by specific technology or method. Barry Smith Charles Tapley Hoyt Jie Zheng Oliver He Xingxian Li https://github.com/vaccineontology/VO/issues/619 vaccine vaccine by mode of production VO:0005506 Gene expressing a protein which serves, either in whole or in part, as an antigen within a cancer vaccine. Anna Maria Masci Barry Smith Jie Zheng Oliver He https://github.com/vaccineontology/VO/issues/677 gene canvaxgen VO:0005507 Vaccine adjuvant that is primarily composed of protein and actives innate immune pathways to induce a mixed Th1/Th2 response. Chemical Nature: protein Mechanism of Action: Activation of innate immune pathways Immune profile induced: Th1/Th2 Route of immunization: SC, IN, SQ Point of Contact: Marcel Wuethrich, University of Wisconsin Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=28793349 https://www.ncbi.nlm.nih.gov/pubmed/?term=31900406 Ongoing clinical trials: none Jie Zheng Marcel Wuethrich Nilufer kosar Bl-Eng2 Pubmed:28793349 Pubmed:31900406 VAC: https://vac.niaid.nih.gov/view?id=97 https://github.com/vaccineontology/VO/issues/730 97 vaccine adjuvant Bl-Eng2 vaccine adjuvant VO:0005508 Combination vaccine adjuvant contains both Bl-Eng2 and adjuplex vaccine adjuvants and is able to induce a mixed Th1/Th2 response. Chemical Nature: Protein, Combination adjuvant Mechanism of Action: Activation of innate immune pathways Immune profile induced: Th1/Th2 Route of immunization: IN Point of Contact: Marcel Wuethrich, University of Wisconsin Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=33735218 Ongoing clinical trials: none Jie Zheng Marcel Wuethrich Nilufer kosar Bl-Eng2+Adjuplex Pubmed:33735218 VAC: https://vac.niaid.nih.gov/view?id=98 https://github.com/vaccineontology/VO/issues/731 98 vaccine adjuvant Bl-Eng2+Adjuplex vaccine adjuvant VO:0005509 Nucleic acid vaccine adjuvant that targets on cytokine receptor to induce a Th1-based response. Chemical Nature: nucleic acid Mechanism of Action: Cytokine Receptor Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Romain Micol, Combined Therapeutics Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=39047117 Ongoing clinical trials: none Jie Zheng Nilufer kosar Romain Micol IL-12-MOP (CTX-1796) Pubmed:39047117 VAC: https://vac.niaid.nih.gov/view?id=100 https://github.com/vaccineontology/VO/issues/740 100 vaccine adjuvant IL-12-MOP (CTX-1796) vaccine adjuvant VO:0005510 Botryococcene oil-in-water emulsion vaccine adjuvant made by EVAX Inc., which targets to induce a mixed Th1/Th2 response. Chemical Nature: Emulsion Mechanism of Action: Botryococcene oil-in-water emulsion Immune profile induced: Mixed Th1/Th2 Route of immunization: SQ Point of Contact: Chase Kempinski , EVAX Inc. Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=33051497 Ongoing clinical trials: none Chase Kempinski Jie Zheng Nilufer kosar EVAX-B Pubmed:33051497 VAC: https://vac.niaid.nih.gov/view?id=101 https://github.com/vaccineontology/VO/issues/759 101 vaccine adjuvant EVAX-B vaccine adjuvant VO:0005511 Squalene oil-in-water emulsion vaccine adjuvant made by EVAX Inc., which targets to induce a mixed Th1/Th2 response. Chemical Nature: Emulsion Mechanism of Action: Squalene oil-in-water emulsion Immune profile induced: Mixed Th1/Th2 Route of immunization: SQ Point of Contact: Chase Kempinski , EVAX Inc. Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=33051497 Ongoing clinical trials: none Chase Kempinski Jie Zheng Nilufer kosar EVAX-S Pubmed:33051497 VAC: https://vac.niaid.nih.gov/view?id=102 https://github.com/vaccineontology/VO/issues/760 102 vaccine adjuvant EVAX-S vaccine adjuvant VO:0005512 Vaccine adjuvant based on VesiVax® liposome. Chemical Nature: VesiVax® liposome Mechanism of Action: none Immune profile induced: none Route of immunization: SQ prime and IN boost, SQ, Combination sub-cheek, IN and ID, IN prime and sub-cheek boosts Point of Contact: Gary Fujii, Molecular Express Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=16713037 https://www.ncbi.nlm.nih.gov/pubmed/?term=17981684 https://www.ncbi.nlm.nih.gov/pubmed/?term=19835825 https://www.ncbi.nlm.nih.gov/pubmed/?term=21545821 https://www.ncbi.nlm.nih.gov/pubmed/?term=23313243 https://www.ncbi.nlm.nih.gov/pubmed/?term=26312747 https://www.ncbi.nlm.nih.gov/pubmed/?term=27997339 https://www.ncbi.nlm.nih.gov/pubmed/?term=28922045 https://www.ncbi.nlm.nih.gov/pubmed/?term=29420901 https://www.ncbi.nlm.nih.gov/pubmed/?term=3568049 Ongoing clinical trials: none Gary Fujii Jie Zheng Molecular Express ME-F-1051 (VesiVax®) Pubmed:16713037 Pubmed:19835825 Pubmed:21545821 Pubmed:23313243 Pubmed:26312747 Pubmed:27997339 Pubmed:28922045 Pubmed:29420901 Pubmed:3568049 VAC: https://vac.niaid.nih.gov/view?id=104 https://github.com/vaccineontology/VO/issues/784 104 vaccine adjuvant ME-F-1051 (VesiVax®) vaccine adjuvant VO:0005513 Liposome-based vaccine adjuvant with TLR4 agonist to induce a mixed Th1/Th2 response. Chemical Nature: Natural compound - Liposome formulation with TLR4 agonist Mechanism of Action: none Immune profile induced: Mixed Th1/Th2 Route of immunization: SQ, Combination of sub-cheek, IN and ID, IN prime with sub-cheek boosts, Point of Contact: Gary Fujii, Molecular Express Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=23313243 https://www.ncbi.nlm.nih.gov/pubmed/?term=26312747 https://www.ncbi.nlm.nih.gov/pubmed/?term=27997339 https://www.ncbi.nlm.nih.gov/pubmed/?term=35680499 https://www.ncbi.nlm.nih.gov/pubmed/?term=19835825 https://www.ncbi.nlm.nih.gov/pubmed/?term=21545821 https://www.ncbi.nlm.nih.gov/pubmed/?term=16713037 Ongoing clinical trials: none Gary Fujii Jie Zheng Molecular Express ME-F-1122 Pubmed:16713037 Pubmed:19835825 Pubmed:21545821 Pubmed:23313243 Pubmed:26312747 Pubmed:27997339 Pubmed:35680499 VAC: https://vac.niaid.nih.gov/view?id=103 https://github.com/vaccineontology/VO/issues/785 103 vaccine adjuvant ME-F-1122 vaccine adjuvant VO:0005514 Short class B CpG-containing sequence with phosphorothioate-linked nucleotides that is able to induce a Th1-biased response. Chemical Nature: Nucleic acid Mechanism of Action: CpG 1018 is a short class B CpG-containing sequence with phosphorothioate-linked nucleotides Immune profile induced: Th1-biased Route of immunization: IN, IM Point of Contact: Ben Wizel, Dynavax Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=24464743 https://www.ncbi.nlm.nih.gov/pubmed/?term=33649322 https://www.ncbi.nlm.nih.gov/pubmed/?term=33873199 https://www.ncbi.nlm.nih.gov/pubmed/?term=33888840 https://www.ncbi.nlm.nih.gov/pubmed/?term=38570604 https://www.ncbi.nlm.nih.gov/pubmed/?term=35927132 https://www.ncbi.nlm.nih.gov/pubmed/?term=35869085 https://www.ncbi.nlm.nih.gov/pubmed/?term=37703367 https://www.ncbi.nlm.nih.gov/pubmed/?term=39231203 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/ACTRN12624000064505 https://clinicaltrials.gov/ct2/show/NCT06334393 https://clinicaltrials.gov/ct2/show/NCT04177355 https://clinicaltrials.gov/ct2/show/NCT04672395 https://clinicaltrials.gov/ct2/show/NCT05188677 https://clinicaltrials.gov/ct2/show/NCT05011526 https://clinicaltrials.gov/ct2/show/NCT05364242 https://clinicaltrials.gov/ct2/show/NCT04956224 https://clinicaltrials.gov/ct2/show/NCT0486456 https://clinicaltrials.gov/ct2/show/ACTRN12620001177943 https://clinicaltrials.gov/ct2/show/NCT00251394 https://clinicaltrials.gov/ct2/show/NCT01282762 https://clinicaltrials.gov/ct2/show/NCT00346086 https://clinicaltrials.gov/ct2/show/NCT06569823 https://clinicaltrials.gov/ct2/show/NCT05245838 https://clinicaltrials.gov/ct2/show/NCT05506969 Ben Wizel Dynavax Jie Zheng CpG 1018 Pubmed:24464743 Pubmed:33649322 Pubmed:33873199 Pubmed:33888840 Pubmed:35869085 Pubmed:35927132 Pubmed:37703367 Pubmed:38570604 Pubmed:39231203 VAC: https://vac.niaid.nih.gov/view?id=105 https://github.com/vaccineontology/VO/issues/787 105 vaccine adjuvant CpG 1018 vaccine adjuvant VO:0005563 A vaccine that targets against a microbial eukaryote caused disease. Anthony Huffman Jie Zheng Oliver He vaccine microbial eukaryotic vaccine VO:0005800 A Inactivated vaccine that immunizes against Neospora caninum protozoa. Anthony Huffman N. caninum Killed Protozoa Vaccine vaccine Neospora caninum killed protozoa vaccine VO:0005801 A Inactivated vaccine that immunizes against Toxoplasma gondii trypmastigote. Anthony Huffman CTLVECNS VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6065 6065 vaccine CTLVECNS vaccine VO:0005802 A Live attenuated vaccine encoding a1-giardin and CWP2 that immunizes against Giardi lamblia trophozoite. Anthony Huffman G. lamblia bivalent DNA vaccine encoding a1-giardin and CWP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5993 5993 vaccine Giardia lamblia bivalent DNA vaccine encoding a1-giardin and CWP2 VO:0005803 A Live attenuated vaccine encoding a-enolase that immunizes against Giardi lamblia trophozoite. Anthony Huffman G. lamblia vaccine encoding a-enolase VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5991 5991 vaccine Giardia lamblia vaccine encoding a-enolase VO:0005804 A Live attenuated vaccine encoding a1-giardin that immunizes against Giardi lamblia trophozoite. Anthony Huffman G. lamblia vaccine encoding a1-giardin VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5989 5989 vaccine Giardia lamblia vaccine encoding a1-giardin VO:0005805 A Live attenuated vaccine expressing VSPH7 that immunizes against Giardi lamblia trophozoite. Anthony Huffman G. lamblia vaccine using attenuated Salmonella vaccine expressing VSPH7 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6004 6004 vaccine Giardia lamblia vaccine using attenuated Salmonella vaccine expressing VSPH7 VO:0005806 A Live attenuated vaccine p52(-)/p36(-) GAP that immunizes against Plasmodium falciparum sporozoite. Anthony Huffman p52(-)/p36(-) GAP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5952 5952 vaccine p52(-)/p36(-) GAP vaccine VO:0005807 A Live attenuated vaccine Pb(PfCS@UIS4) that immunizes against Plasmodium falciparum sporozoite. Anthony Huffman Pb(PfCS@UIS4) VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5988 5988 vaccine Pb(PfCS@UIS4) vaccine VO:0005808 A Live attenuated vaccine PfSPZ that immunizes against Plasmodium falciparum sporozoite. Anthony Huffman PfSPZ VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5950 5950 vaccine PfSPZ vaccine VO:0005809 A Live attenuated vaccine RH-AMA1KO that immunizes against Toxoplasma gondii trypmastigote. Anthony Huffman RH-AMA1KO VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6069 6069 vaccine RH-AMA1KO vaccine VO:0005810 A Live attenuated vaccine with GRA17 mutant that immunizes against Toxoplasma gondii trypmastigote. Anthony Huffman T. gondii GRA17 mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6082 6082 vaccine Toxoplasma gondii GRA17 mutant vaccine VO:0005811 A Live attenuated vaccine irradiated sterilised tachyzoites that immunizes against Toxoplasma gondii trypmastigote. Anthony Huffman T. gondii irradiated sterilised tachyzoites VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6090 6090 vaccine Toxoplasma gondii irradiated sterilised tachyzoites vaccine VO:0005812 A Live attenuated vaccine with LDH1 and LDH2 mutant that immunizes against Toxoplasma gondii trypmastigote. Anthony Huffman T. gondii LDH1 and LDH2 mutant vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6087 6087 vaccine Toxoplasma gondii LDH1 and LDH2 mutant vaccine VO:0005813 A Live attenuated vaccine with DSCG adjuvant that immunizes against Toxoplasma gondii trypmastigote. Anthony Huffman UV-attenuated Toxoplasma gondii with DSCG adjuvant VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6091 6091 vaccine UV-attenuated Toxoplasma gondii vaccine with DSCG adjuvant VO:0006000 adenovirus unspecified formulation 82 40213267 adenovirus vaccine, unspecified formulation adenovirus, unspecified formulation vaccine adenovirus vaccine unspecified formulation VO:0006001 botulinum antitoxin 27 botulinum antitoxin botulinum antitoxin vaccine botulinum antitoxin VO:0006002 cholera unspecified formulation 26 40213275 cholera vaccine, unspecified formulation cholera, unspecified formulation vaccine cholera vaccine unspecified formulation VO:0006003 cholera BivWC 173 40213273 cholera, BivWC cholera, BivWC vaccine cholera BivWC VO:0006004 cholera live attenuated 174 40213274 cholera, live attenuated cholera, live attenuated vaccine cholera live attenuated VO:0006005 diphtheria antitoxin 12 diphtheria antitoxin diphtheria antitoxin vaccine diphtheria antitoxin VO:0006006 Hib unspecified formulation 17 40213316 Haemophilus influenzae type b vaccine, conjugate unspecified formulation Hib, unspecified formulation vaccine Haemophilus influenzae type b vaccine conjugate unspecified formulation VO:0006007 Hib (PRP-D) 46 40213313 Haemophilus influenzae type b vaccine, PRP-D conjugate Hib (PRP-D) vaccine Haemophilus influenzae type b vaccine PRP-D conjugate VO:0006008 Hep A live attenuated 169 40213298 Hep A, live attenuated-IM Hep A, live attenuated vaccine Hep A live attenuated-IM VO:0006009 Hep A adult 52 40213296 hepatitis A vaccine, adult dosage Hep A, adult vaccine hepatitis A vaccine adult dosage VO:0006010 Hep A pediatric unspecified formulation 31 40213301 hepatitis A vaccine, pediatric dosage, unspecified formulation Hep A, pediatric, unspecified formulation vaccine hepatitis A vaccine pediatric dosage unspecified formulation VO:0006011 Hep A ped/adol 3 dose 84 40213300 hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule Hep A, ped/adol, 3 dose vaccine hepatitis A vaccine pediatric/adolescent dosage 3 dose schedule VO:0006012 Hep A unspecified formulation 85 40213302 hepatitis A vaccine, unspecified formulation Hep A, unspecified formulation vaccine hepatitis A vaccine unspecified formulation VO:0006013 HepB recombinant 3-antigen Al(OH)3 220 905414 Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted HepB recombinant, 3-antigen, Al(OH)3 vaccine Hepatitis B vaccine (recombinant) 3-antigen Al(OH)3 adjuvanted VO:0006014 Hep B adolescent/high risk infant 42 40213305 hepatitis B vaccine, adolescent/high risk infant dosage Hep B, adolescent/high risk infant vaccine hepatitis B vaccine adolescent/high risk infant dosage VO:0006015 Hep B unspecified formulation 45 40213308 hepatitis B vaccine, unspecified formulation Hep B, unspecified formulation vaccine hepatitis B vaccine unspecified formulation VO:0006016 Hep C 58 40213309 hepatitis C vaccine Hep C vaccine licensed human hepatitis C vaccine VO:0006017 Hep E 59 40213310 hepatitis E vaccine Hep E vaccine licensed human hepatitis E vaccine VO:0006018 herpes simplex 2 60 40213311 herpes simplex virus, type 2 vaccine herpes simplex 2 vaccine herpes simplex virus type 2 vaccine VO:0006019 typhus historical 131 40213247 Historical record of a typhus vaccination typhus, historical information content entity Historical record of a typhus vaccination VO:0006020 obsolete HPV unspecified formulation true VO:0006021 Rabies - IM Diploid cell culture 175 40213205 Human Rabies vaccine from human diploid cell culture Rabies - IM Diploid cell culture vaccine Human Rabies vaccine from human diploid cell culture VO:0006022 influenza nasal unspecified formulation 151 40213327 influenza nasal, unspecified formulation influenza nasal, unspecified formulation vaccine influenza nasal unspecified formulation VO:0006023 Retired CVX CODE influenza split (incl. purified surface antigen) 15 40213156 influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE influenza, split (incl. purified surface antigen) vaccine influenza virus vaccine split virus (incl. purified surface antigen) VO:0006024 influenza unspecified formulation 88 40213158 influenza virus vaccine, unspecified formulation influenza, unspecified formulation vaccine influenza virus vaccine unspecified formulation VO:0006025 influenza whole 16 40213159 influenza virus vaccine, whole virus influenza, whole vaccine influenza virus vaccine whole virus VO:0006026 Japanese Encephalitis unspecified formulation 129 40213163 Japanese Encephalitis vaccine, unspecified formulation Japanese Encephalitis, unspecified formulation vaccine Japanese Encephalitis vaccine unspecified formulation VO:0006027 A viral vaccine that protects against infection with Mammarenavirus juninense. Jie Zheng Oliver He Junin virus vaccine Junin virus vaccine VO:0006028 Mycobacterium vaccine that is used to protect against leprosy infection. Oliver He leprosy vaccine leprosy vaccine VO:0006029 meningococcal A polysaccharide (non-US) 191 706107 meningococcal A polysaccharide vaccine (non-US) meningococcal A polysaccharide (non-US) vaccine meningococcal A polysaccharide vaccine (non-US) VO:0006030 meningococcal AC polysaccharide (non-US) 192 706108 meningococcal AC polysaccharide vaccine (non-US) meningococcal AC polysaccharide (non-US) vaccine meningococcal AC polysaccharide vaccine (non-US) VO:0006031 meningococcal ACWY unspecified formulation 108 40213172 meningococcal ACWY vaccine, unspecified formulation meningococcal ACWY, unspecified formulation vaccine meningococcal ACWY vaccine unspecified formulation VO:0006032 meningococcal B unspecified 164 40213175 meningococcal B, unspecified formulation meningococcal B, unspecified vaccine meningococcal B unspecified formulation VO:0006033 meningococcal C conjugate 103 40213176 meningococcal C conjugate vaccine meningococcal C conjugate vaccine meningococcal C conjugate vaccine VO:0006034 meningococcal unknown serogroups 167 40213182 meningococcal vaccine of unknown formulation and unknown serogroups meningococcal, unknown serogroups vaccine meningococcal vaccine of unknown formulation and unknown serogroups VO:0006035 meningococcal polysaccharide (groups A C Y W-135) TT conjugate 203 724901 meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) vaccine meningococcal polysaccharide (groups A C Y W-135) tetanus toxoid conjugate vaccine 0.5mL dose preservative free VO:0006036 meningococcal MCV4 unspecified formulation 147 40213178 Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) meningococcal MCV4, unspecified formulation vaccine Meningococcal MCV4 unspecified conjugate formulation(groups A C Y and W-135) VO:0006037 Novel Influenza-H1N1-09 all formulations 128 40213187 Novel influenza-H1N1-09, all formulations Novel Influenza-H1N1-09, all formulations vaccine Novel influenza-H1N1-09 all formulations VO:0006038 Novel influenza-H1N1-09 127 40213186 Novel influenza-H1N1-09, injectable Novel influenza-H1N1-09 vaccine Novel influenza-H1N1-09 injectable VO:0006039 Novel Influenza-H1N1-09 nasal 125 40213188 Novel Influenza-H1N1-09, live virus for nasal administration Novel Influenza-H1N1-09, nasal vaccine Novel Influenza-H1N1-09 live virus for nasal administration VO:0006040 Novel influenza-H1N1-09 preservative-free 126 40213189 Novel influenza-H1N1-09, preservative-free, injectable Novel influenza-H1N1-09, preservative-free vaccine Novel influenza-H1N1-09 preservative-free injectable VO:0006041 Pneumococcal conjugate PCV15 polysaccharide CRM197 conjugate adjuvant PF 215 702674 Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF vaccine Pneumococcal conjugate vaccine 15-valent (PCV15) polysaccharide CRM197 conjugate adjuvant preservative free VO:0006042 c conjugate PCV20 polysaccharide CRM197 conjugate adjuvant PF 216 702675 Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF vaccine Pneumococcal conjugate vaccine 20-valent (PCV20) polysaccharide CRM197 conjugate adjuvant preservative free VO:0006043 PCV10 177 40213195 pneumococcal conjugate vaccine, 10 valent PCV10 vaccine pneumococcal conjugate vaccine 10 valent VO:0006044 Pneumococcal Conjugate unspecified formulation 152 40213200 Pneumococcal Conjugate, unspecified formulation Pneumococcal Conjugate, unspecified formulation vaccine Pneumococcal Conjugate unspecified formulation VO:0006045 rabies intradermal injection 40 40213207 rabies vaccine, for intradermal injection rabies, intradermal injection vaccine rabies vaccine for intradermal injection VO:0006046 rabies unspecified formulation 90 40213209 rabies vaccine, unspecified formulation rabies, unspecified formulation vaccine rabies vaccine unspecified formulation VO:0006047 RSV-MAb (new) 145 40213222 respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular RSV-MAb (new) vaccine respiratory syncytial virus monoclonal antibody (motavizumab) intramuscular VO:0006048 RSV-MAb 93 40213221 respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular RSV-MAb vaccine respiratory syncytial virus monoclonal antibody (palivizumab) intramuscular VO:0006049 Vaccine that protects against group A Streptococcus infection causing rheumatic fever. Jie Zheng Oliver He rheumatic fever vaccine vaccine rheumatic fever vaccine VO:0006050 rotavirus unspecified formulation 122 40213219 rotavirus vaccine, unspecified formulation rotavirus, unspecified formulation vaccine rotavirus vaccine unspecified formulation VO:0006051 rotavirus live tetravalent vaccine rotavirus tetravalent 74 40213218 rotavirus, live, tetravalent vaccine rotavirus, tetravalent vaccine rotavirus live tetravalent vaccine VO:0006052 COVID-19 D614 recomb preS dTM AS03 adjuvant add PF 10mcg/0.5mL 226 905419 SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL vaccine SARS-COV-2 (COVID-19) vaccine D614 prefusion spike recombinant protein subunit (CoV2 preS dTM) AS03 adjuvant added preservative free 10mcg/0.5mL dose VO:0006053 COVID-19 D614 recomb preS dTM AS03 adjuvant add PF 5mcg/0.5mL 225 905418 SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL vaccine SARS-COV-2 (COVID-19) vaccine D614 prefusion spike recombinant protein subunit (CoV2 preS dTM) AS03 adjuvant added preservative free 5mcg/0.5mL dose VO:0006054 COVID-19 mRNA LNP-S bivalent booster PF 10 mcg/0.2 mL 230 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 10 mcg/0.2 mL dose VO:0006055 COVID-19 mRNA LNP-S bivalent booster PF 10 mcg/0.2 mL dose 301 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 10 mcg/0.2 mL dose tris-sucrose formulation VO:0006056 COVID-19 mRNA LNP-S bivalent booster PF 30 mcg/0.3 mL dose 300 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 30 mcg/0.3 mL dose tris-sucrose formulation VO:0006057 COVID-19 mRNA LNP-S bivalent booster PF 50 mcg/0.5 mL or 25mcg/0.25 mL dose 229 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent booster preservative free 50 mcg/0.5 mL or 25 mcg/0.25 mL dose VO:0006058 COVID-19 mRNA LNP-S bivalent PF 3 mcg/0.2 mL dose 302 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP bivalent preservative free 3 mcg/0.2 mL dose tris-sucrose formulation VO:0006059 COVID-19 mRNA LNP-S PF 10 mcg/0.2 mL dose tris-sucrose 218 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 10 mcg/0.2mL dose tris-sucrose formulation VO:0006060 COVID-19 mRNA LNP-S PF 100 mcg/0.5mL dose or 50 mcg/0.25mL dose 207 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 100 mcg/0.5mL dose or 50 mcg/0.25mL dose VO:0006061 COVID-19 mRNA LNP-S PF 3 mcg/0.2 mL dose tris-sucrose 219 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 3 mcg/0.2mL dose tris-sucrose formulation VO:0006062 COVID-19 mRNA LNP-S PF 30 mcg/0.3 mL dose 208 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 30 mcg/0.3mL dose VO:0006063 COVID-19 mRNA LNP-S PF 30 mcg/0.3 mL dose tris-sucrose 217 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 30 mcg/0.3mL dose tris-sucrose formulation VO:0006064 COVID-19 mRNA LNP-S PF 50 mcg/0.5 mL dose 221 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free 50 mcg/0.5 mL dose VO:0006065 COVID-19 mRNA LNP-S PF pediatric 25 mcg/0.25 mL dose 228 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free pediatric 25 mcg/0.25 mL dose VO:0006066 COVID-19 mRNA LNP-S PF pediatric 50 mcg/0.5 mL dose 227 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose vaccine SARS-COV-2 (COVID-19) vaccine mRNA spike protein LNP preservative free pediatric 50 mcg/0.5 mL dose VO:0006067 SARS-COV-2 (COVID-19) vaccine UNSPECIFIED 213 724904 SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED vaccine SARS-COV-2 (COVID-19) vaccine UNSPECIFIED VO:0006068 COVID-19 mRNA bivalent original/Omicron BA.1 Non-US Vaccine (Spikevax Bivalent) Moderna 519 716024 SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna vaccine SARS-COV-2 COVID-19 mRNA bivalent original/Omicron BA.1 Non-US Vaccine (Spikevax Bivalent) Moderna VO:0006069 COVID-19 mRNA bivalent original/Omicron BA.1 Non-US Vaccine Product Pfizer-BioNTech 520 716025 SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech vaccine SARS-COV-2 COVID-19 mRNA bivalent original/Omicron BA.1 Non-US Vaccine Product (Comirnaty Bivalent) Pfizer-BioNTech VO:0006070 COVID-19 Non-US Vaccine Product Unknown 500 702664 SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown COVID-19 Non-US Vaccine, Product Unknown vaccine SARS-COV-2 COVID-19 Non-US Vaccine Specific Product Unknown VO:0006071 COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) 508 702681 SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) vaccine SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) VO:0006072 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro Chinese Acad of Sciences) 507 702670 SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) vaccine SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology Chinese Academy of Sciences) VO:0006073 SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Zifivax) 513 778260 SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) vaccine SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Zifivax) VO:0006074 COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology 506 702669 SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology vaccine SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA) CanSino Biological Inc./Beijing Institute of Biotechnology VO:0006075 COVID-19 VVnr Non-US Vaccine (Sputnik Light) 504 702667 SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) COVID-19 VVnr Non-US Vaccine (Sputnik Light) vaccine SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) VO:0006076 tetanus toxoid not adsorbed 142 40213233 tetanus toxoid, not adsorbed tetanus toxoid, not adsorbed vaccine tetanus toxoid not adsorbed VO:0006077 tetanus toxoid unspecified formulation 112 tetanus toxoid, unspecified formulation tetanus toxoid, unspecified formulation vaccine tetanus toxoid unspecified formulation VO:0006078 Tick-borne encephalitis vaccine (non-US) 77 40213235 Tick-borne encephalitis vaccine (non-US) Tick-borne encephalitis vaccine (non-US) vaccine Tick-borne encephalitis vaccine (non-US) VO:0006079 Tick-borne encephalitis inactivated PF 0.25mL 223 905416 Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose Tick-borne encephalitis, inactivated, PF, 0.25mL vaccine Tick-borne encephalitis vaccine inactivated preservative free 0.25mL dose VO:0006080 Tick-borne encephalitis inactivated PF 0.5mL 224 905417 Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose Tick-borne encephalitis, inactivated, PF, 0.5mL vaccine Tick-borne encephalitis vaccine inactivated preservative free 0.5mL dose VO:0006081 Tick-borne encephalitis unspecified 222 905415 Tick-borne encephalitis vaccine, unspecified Tick-borne encephalitis, unspecified vaccine Tick-borne encephalitis vaccine unspecified VO:0006082 Typhoid conjugate vaccine (TCV) 190 706106 Typhoid conjugate vaccine (non-US) Typhoid conjugate vaccine (TCV) vaccine Typhoid conjugate vaccine (non-US) VO:0006083 typhoid parenteral AKD (U.S. military) 53 40213244 typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) typhoid, parenteral, AKD (U.S. military) vaccine typhoid vaccine parenteral acetone-killed dried (U.S. military) VO:0006084 typhoid parenteral 41 40213243 typhoid vaccine, parenteral, other than acetone-killed, dried typhoid, parenteral vaccine typhoid vaccine parenteral other than acetone-killed dried VO:0006085 typhoid unspecified formulation 91 40213245 typhoid vaccine, unspecified formulation typhoid, unspecified formulation vaccine typhoid vaccine unspecified formulation VO:0006086 vaccinia (smallpox) diluted 105 40213249 vaccinia (smallpox) vaccine, diluted vaccinia (smallpox) diluted vaccine vaccinia (smallpox) vaccine diluted VO:0006087 Vaccinia smallpox monkeypox vaccine live PF SQ or ID injection 206 724903 Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection vaccine Vaccinia smallpox monkeypox vaccine live attenuated preservative free subcutaneous or intradermal injection VO:0006088 VEE unspecified formulation 92 40213254 Venezuelan equine encephalitis vaccine, unspecified formulation VEE, unspecified formulation vaccine Venezuelan equine encephalitis vaccine unspecified formulation VO:0006089 VEE inactivated 81 40213252 Venezuelan equine encephalitis, inactivated VEE, inactivated vaccine Venezuelan equine encephalitis inactivated VO:0006090 dengue fever vaccine 56 40213278 dengue fever vaccine, tetravalent dengue fever tetravalent vaccine tetravalent dengue fever vaccine VO:0006091 Ebola unspecified 214 702663 Ebola, unspecified Ebola, unspecified vaccine Ebola unspecified VO:0006092 A combination vaccine adjuvant that is liposome-based adjuvant of a synthetic TLR agonist and saponin induced a Th1-biased immune response. Chemical Nature: Combination adjuvant Mechanism of Action: n/a Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Maria Lawrenz, Vaccine Formulation Institute Jie Zheng Maria Lawrenz Nilufer kosar Oliver He Wolfgang Leitner LMQ VAC: https://vac.niaid.nih.gov/view?id=78 https://www.ncbi.nlm.nih.gov/pubmed/?term=36119058 https://www.ncbi.nlm.nih.gov/pubmed/?term=36634821 https://www.ncbi.nlm.nih.gov/pubmed/?term=37029167 https://github.com/vaccineontology/VO/issues/614 78 vaccine adjuvant LMQ vaccine adjuvant VO:0006093 A vaccine adjuvant that is a peptide which is able to induce Th1/Th2/Th17 immune responses through the mechanism of selectively activates C5aR1 on mononuclear phagocytes vs neutrophils. Chemical Nature: Other - Peptide Mechanism of Action: (Primary) Selectively activates C5aR1 on mononuclear phagocytes vs neutrophils Immune profile induced: Th1/Th2/Th17 Route of immunization: IP, IV Point of Contact: Joseph Vetro, University of Nebraska Medical Center Jie Zheng Joseph Vetro Nilufer kosar Oliver He Wolfgang Leitner CPDI-02 VAC: https://vac.niaid.nih.gov/view?id=40 https://www.ncbi.nlm.nih.gov/pubmed/?term=11710544 https://www.ncbi.nlm.nih.gov/pubmed/?term=19836478 https://www.ncbi.nlm.nih.gov/pubmed/?term=20965299 https://github.com/vaccineontology/VO/issues/615 40 vaccine adjuvant CPDI-02 vaccine adjuvant VO:0006094 A vaccine adjuvant with a Toll-like receptor 9 (TLR9)-active oligonucleotide that is able to induce Th1/Th2 immune responses. Chemical Nature: Nucleic acid Mechanism of Action: TLR9 agonist Immune profile induced: Mixed Th1/Th2 Route of immunization: IM, SQ Point of Contact: Nikolai Petrovsky, Vaxine LTD Jie Zheng Nikolai Petrovsky Nilufer kosar Oliver He Wolfgang Leitner CpG55.2 VAC: https://vac.niaid.nih.gov/view?id=10 https://www.ncbi.nlm.nih.gov/pubmed/?term=24554695 https://www.ncbi.nlm.nih.gov/pubmed/?term=27387453 https://www.ncbi.nlm.nih.gov/pubmed/?term=32156809 https://www.ncbi.nlm.nih.gov/pubmed/?term=32418798 https://www.ncbi.nlm.nih.gov/pubmed/?term=33479242 https://www.ncbi.nlm.nih.gov/pubmed/?term=34399628 https://www.ncbi.nlm.nih.gov/pubmed/?term=34420786 https://www.ncbi.nlm.nih.gov/pubmed/?term=34456075 https://github.com/vaccineontology/VO/issues/616 10 vaccine adjuvant CpG55.2 vaccine adjuvant VO:0006095 A combination vaccine adjuvant that includes AS01-mimic, Immune Stimulating Complex (ISCOM) with a TLR4 agonist. Chemical Nature: Combination adjuvant Mechanism of Action: Cytokine induction in draining lymph nodes with increased lymph flow and lymph antigen accumulation Immune profile induced: Mixed Th1/Th2 Route of immunization: s.c. / i.m. / i.n. Point of Contact: Katarzyna Kaczmarek Michaels, Massachusetts Institute of Technology Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=34860581 https://www.ncbi.nlm.nih.gov/pubmed/?term=36131022 https://www.ncbi.nlm.nih.gov/pubmed/?term=34878851 Jie Zheng Katarzyna Kaczmarek Michaels Nilufer kosar Oliver He Wolfgang Leitner SMNP VAC: https://vac.niaid.nih.gov/view?id=77 https://github.com/vaccineontology/VO/issues/632 77 vaccine adjuvant SMNP vaccine adjuvant VO:0006096 A combination vaccine adjuvant that is an AS01-mimic, liposomal adjuvant of a TLR4 agonist and saponin. Chemical Nature: - Natural compound - Synthetic derivative of natural compound - Combination adjuvant Mechanism of Action: MPLA: TLR4 agonist QS21: Sugar-lawn likely recog. by lectins to facilitate uptake by M_, DCs, etc Immune profile induced: Mixed Th1/Th2 Route of immunization: ID, IM Point of Contact: Mangala Rao, Walter Reed Army Institute of Research Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=34202178 https://www.ncbi.nlm.nih.gov/pubmed/?term=31827000 https://www.ncbi.nlm.nih.gov/pubmed/?term=34470866 https://www.ncbi.nlm.nih.gov/pubmed/?term=35632473 https://www.ncbi.nlm.nih.gov/pubmed/?term=36417525 https://www.ncbi.nlm.nih.gov/pubmed/?term=34914540 https://www.ncbi.nlm.nih.gov/pubmed/?term=32881968 https://www.ncbi.nlm.nih.gov/pubmed/?term=26372857 https://www.ncbi.nlm.nih.gov/pubmed/?term=36055874 https://www.ncbi.nlm.nih.gov/pubmed/?term=34202178 https://www.ncbi.nlm.nih.gov/pubmed/?term=36679887 https://www.ncbi.nlm.nih.gov/pubmed/?term=36934088 https://www.ncbi.nlm.nih.gov/pubmed/?term=34903722 https://www.ncbi.nlm.nih.gov/pubmed/?term=31775762 https://www.ncbi.nlm.nih.gov/pubmed/?term=28596090 https://www.ncbi.nlm.nih.gov/pubmed/?term=31151801 https://www.ncbi.nlm.nih.gov/pubmed/?term=34711815 https://www.ncbi.nlm.nih.gov/pubmed/?term=34159328 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT04268420 https://clinicaltrials.gov/ct2/show/NCT04296279 https://clinicaltrials.gov/ct2/show/NCT04784767 https://clinicaltrials.gov/ct2/show/NCT05500417 https://clinicaltrials.gov/ct2/show/NCT04826094 https://clinicaltrials.gov/ct2/show/NCT04658667 https://clinicaltrials.gov/ct2/show/NCT05423418 Jie Zheng Mangala Rao Nilufer kosar Oliver He Wolfgang Leitner ALFQ VAC: https://vac.niaid.nih.gov/view?id=79 https://github.com/vaccineontology/VO/issues/633 79 vaccine adjuvant ALFQ vaccine adjuvant VO:0006097 A vaccine adjuvant which is a small molecule TLR agonist that drives a mixed Th1/Th2 response. Chemical Nature: Small molecule Mechanism of Action: Innate immune activation Immune profile induced: Mixed Th1/Th2 Route of immunization: IM Point of Contact: Dennis Carson, UCSD Dennis Carson Jie Zheng Nilufer kosar Oliver He Wolfgang Leitner 2G023A VAC: https://vac.niaid.nih.gov/view?id=81 https://github.com/vaccineontology/VO/issues/648 81 vaccine adjuvant 2G023A vaccine adjuvant VO:0006098 A vaccine adjuvant, a small molecule TLR agonist that drives a mixed Th1/Th2 response. Chemical Nature: Small molecule Mechanism of Action: Innate immune activation Immune profile induced: Mixed Th1/Th2 Route of immunization: IM Point of Contact: Dennis Carson, UCSD Dennis Carson Jie Zheng Nilufer kosar Oliver He Wolfgang Leitner 2G053 VAC: https://vac.niaid.nih.gov/view?id=80 https://github.com/vaccineontology/VO/issues/649 80 vaccine adjuvant 2G053 vaccine adjuvant VO:0006099 A combination vaccine adjuvant of a synthetic TLR agonist and aluminum salt. Chemical Nature: - Synthetic derivative of natural compound - Combination adjuvant - Mineral salt Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: SQ, IM Point of Contact: Valerie Soza, Access to Advanced Health Institute (AAHI) Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=37454145 https://www.ncbi.nlm.nih.gov/pubmed/?term=24556505 https://www.ncbi.nlm.nih.gov/pubmed/?term=28828575 https://www.ncbi.nlm.nih.gov/pubmed/?term=30013570 https://www.ncbi.nlm.nih.gov/pubmed/?term=24211167 https://www.ncbi.nlm.nih.gov/pubmed/?term=23933525 https://www.ncbi.nlm.nih.gov/pubmed/?term=34597297 https://www.ncbi.nlm.nih.gov/pubmed/?term=36996185 https://www.ncbi.nlm.nih.gov/pubmed/?term=28464026 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT03910972 https://clinicaltrials.gov/ct2/show/NCT02126462 https://clinicaltrials.gov/ct2/show/NCT02839161 https://clinicaltrials.gov/ct2/show/NCT03110757 https://clinicaltrials.gov/ct2/show/NCT02337855 https://clinicaltrials.gov/ct2/show/NCT01717950 https://clinicaltrials.gov/ct2/show/NCT02476773 https://clinicaltrials.gov/ct2/show/NCT01261130 https://clinicaltrials.gov/ct2/show/NCT01385189 https://clinicaltrials.gov/ct2/show/NCT03172975 Jie Zheng Nilufer kosar Oliver He Valerie Soza Wolfgang Leitner GLA-Alum VAC: https://vac.niaid.nih.gov/view?id=83 https://github.com/vaccineontology/VO/issues/650 83 vaccine adjuvant GLA-Alum vaccine adjuvant VO:0006100 A combination vaccine adjuvant of a synthetic TLR4 agonist and aluminum salt. Chemical Nature: - Synthetic derivative of natural compound - Combination adjuvant - Mineral salt Mechanism of Action: Innate Immune Activation Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Valerie Soza, Access to Advanced Health Institute (AAHI) Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=26901122 https://www.ncbi.nlm.nih.gov/pubmed/?term=32983577 Jie Zheng Nilufer kosar Oliver He Valerie Soza Wolfgang Leitner SLA-Alum VAC: https://vac.niaid.nih.gov/view?id=82 https://github.com/vaccineontology/VO/issues/651 82 vaccine adjuvant SLA-Alum vaccine adjuvant VO:0006101 An emulsion vaccine adjuvant that includes squalene-based oil-in-water emulsion. Chemical Nature: Emulsion Mechanism of Action: n/a Immune profile induced: Mixed Th1/Th2 Route of immunization: IM, SQ Point of Contact: Valerie Soza, Access to Advanced Health Institute (AAHI) Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=19679214 https://www.ncbi.nlm.nih.gov/pubmed/?term=22896687 https://www.ncbi.nlm.nih.gov/pubmed/?term=28429728 https://www.ncbi.nlm.nih.gov/pubmed/?term=37495191 https://www.ncbi.nlm.nih.gov/pubmed/?term=36256646 https://www.ncbi.nlm.nih.gov/pubmed/?term=28089141 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT03330899 https://clinicaltrials.gov/ct2/show/NCT01612000 https://clinicaltrials.gov/ct2/show/NCT02464163 https://clinicaltrials.gov/ct2/show/NCT02464163 Jie Zheng Nilufer kosar Oliver He Valerie Soza Wolfgang Leitner Stable Emulsion (SE) VAC: https://vac.niaid.nih.gov/view?id=84 https://github.com/vaccineontology/VO/issues/652 84 vaccine adjuvant Stable Emulsion (SE) vaccine adjuvant VO:0006102 A nucleic acid vaccine adjuvant that is primarily composed of oligonucleotide. Jie Zheng vaccine adjuvant oligonucleotide vaccine adjuvant VO:0006103 An emulsion vaccine adjuvant that is squalene-based adjuvant, induces T follicular helper cells and humoral immune responses via alpha-tocopherol component. Chemical Nature: Emulsion Mechanism of Action: n/a Immune profile induced: Th1-biased Route of immunization: IM Point of Contact: Maki Hayase, Shionogi &Co., Ltd Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=36372670 https://www.ncbi.nlm.nih.gov/pubmed/?term=36891311 https://www.ncbi.nlm.nih.gov/pubmed/?term=36460696 https://www.ncbi.nlm.nih.gov/pubmed/?term=35691872 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT05212948 Jie Zheng Maki Hayase Nilufer kosar A-910823 PMID:36891311 VAC: https://vac.niaid.nih.gov/view?id=90 https://github.com/vaccineontology/VO/issues/666 90 vaccine adjuvant A-910823 vaccine adjuvant VO:0006104 An oligonucleotide vaccine adjuvant that is a TLR9-agonistic adjuant containing a CpG oligonucleotide annealed to a complementary strand with an amphiphilic chain unit, acts as a potent cancer vaccine adjuvant by targeting draining lymph nodes. Chemical Nature: Oligonucleotide Mechanism of Action: Activation of TLR9 signaling pathway Immune profile induced: Th1-biased Route of immunization: IM, SQ Point of Contact: Maki Hayase, Shionogi &Co., Ltd Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=35003132 https://www.ncbi.nlm.nih.gov/pubmed/?term=37243234 Ongoing clinical trials: N/A Jie Zheng Maki Hayase Nilufer kosar S-540956 PMID:35003132 PMID:37243234 VAC: https://vac.niaid.nih.gov/view?id=91 https://github.com/vaccineontology/VO/issues/667 91 vaccine adjuvant S-540956 vaccine adjuvant VO:0006105 A vaccine adjuvant which is a small molecule adjuvant that is able to induce a mixed Th1/Th2 response and active innate immunity. Chemical Nature: Small molecule Mechanism of Action: Activation of innate immunity Immune profile induced: Mixed Th1/Th2 Route of immunization: IM, ID Point of Contact: Ofer Levy, Precision Vaccines Program at Boston Children's Hospital It may actually be the world’s first small-molecule TLR3 agonist. Jie Zheng Nilufer kosar Ofer Levy Precision Vaccines Program (PVP)-057 VAC: https://vac.niaid.nih.gov/view?id=86 https://github.com/vaccineontology/VO/issues/676 86 vaccine adjuvant precision vaccines program-057 vaccine adjuvant VO:0006106 An emulsion vaccine adjuvant that targets on TLR-agonist. It is a nucleic acid-based adjuvant for chemical nature. Chemical Nature: Nucleic acid, Emulsion Mechanism of Action: Innate Immune Activation, preferential uptake by APCs Immune profile induced: Th1-biased Definition: TLR-agonist for target; nucleic acid-based adjuvant for chemical nature Route of immunization: SQ, IN, IM Point of Contact: Madhavan Nallani, ACM Biolabs Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=34618423 https://www.ncbi.nlm.nih.gov/pubmed/?term=36223228 Ongoing clinical trials: https://clinicaltrials.gov/ct2/show/NCT05385991 Jie Zheng Madhavan Nallani Nilufer kosar ACM-CpG VAC: https://vac.niaid.nih.gov/view?id=92 https://github.com/vaccineontology/VO/issues/690 92 vaccine adjuvant ACM-CpG vaccine adjuvant VO:0006107 A particulate antigen delivery system vaccine adjuvant derived from Cowpea mosaic virus that is able to induce a Th1-biased response. Chemical Nature: Nucleoprotein complex Mechanism of Action: recognized by PRRs Immune profile induced: Th1-biased Route of immunization: Intratumoral, intraperitoneally , IV Point of Contact: Nicole Steinmetz, University of California, San Diego Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=26689376 https://www.ncbi.nlm.nih.gov/pubmed/?term=37844250 Ongoing clinical trials: none Jie Zheng Nicole Steinmetz Nilufer kosar Wolfgang Leitner Cowpea mosaic virus Pubmed:26689376 Pubmed:37844250 VAC: https://vac.niaid.nih.gov/view?id=93 https://github.com/vaccineontology/VO/issues/684 93 vaccine adjuvant cowpea mosaic virus vaccine adjuvant VO:0006108 A nucleic acid vaccine adjuvant that targets on TLR3 agonist to induce a mixed Th1/Th2 response. Chemical Nature: dsRNA Mechanism of Action: TLR3 agonist Immune profile induced: Mixed Th1/Th2 category: nucleic-acid based adjuvant (TLR-agonist) synthetic derivative of natural compound Route of immunization: IM Point of Contact: Seungbin Cha, NA Vaccine Institute Pubmed References: https://www.ncbi.nlm.nih.gov/pubmed/?term=36761735 https://www.ncbi.nlm.nih.gov/pubmed/?term=38136298 Ongoing clinical trials: none Jie Zheng Nilufer kosar Seungbin Cha Nexavant Pubmed:36761735 Pubmed:38136298 VAC: https://vac.niaid.nih.gov/view?id=94 https://github.com/vaccineontology/VO/issues/694 94 vaccine adjuvant nexavant vaccine adjuvant VO:0006109 A vaccine adjuvant that is primarily composed of nucleic acid. Jie Zheng vaccine adjuvant nucleic acid vaccine adjuvant VO:0007000 A recombinant oncolytic adenovirus encoding the immunohematopoietic cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with potential antineoplastic activity. Upon administration, the oncolytic adenovirus selectively infects and replicates in tumor cells, which may result in tumor cells lysis. Synergistically, GM-CSF (sargramostim) expressed by the oncolytic adenovirus may promote a cytotoxic T cell response against tumor cells harboring the oncolytic adenovirus, resulting in an immune-mediated tumor cell death. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48412 NCT: https://clinicaltrials.gov/ct2/show/NCT00109655 PMID:28530155 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5475 https://github.com/vaccineontology/VO/issues/75 1437 5475 cancer vaccine Gene name: CSF-2 Oncolytic Adenovirus Encoding GM-CSF Vaccine VO:0007001 A non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the gene for interferon alpha-2b (IFN_2b) and the gene transfer enhancement agent Syn 3, with potential antineoplastic activity. Upon intravesical administration, recombinant adenovirus-interferon with Syn3 transfects both cancerous and normal bladder cells, and the adenovirus secretes interferon (IFN_2b) into the bladder. IFN exerts a direct antitumor killing effect and a bystander effect, thereby killing adjacent, non-transfected cancerous bladder cells. Syn 3 enhances the ability of the adenoviral vector to transfect cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C104743 NCT: https://clinicaltrials.gov/ct2/show/NCT02773849 PMID:28834453 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5047 https://github.com/vaccineontology/VO/issues/322 3440 5047 cancer vaccine Gene name: IFNA2 Recombinant Adenovirus-Interferon/Syn3 Vaccine VO:0007002 A cancer vaccine adjuvant consisting of a recombinant fowlpox virus encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF binds to specific cell surface receptors on various immuno-hematopoietic cell types, enhancing their proliferation and differentiation and stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Administration of recombinant fowlpox GM-CSF vaccine adjuvant may induce an immune response against tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2686 NCT: https://clinicaltrials.gov/ct2/show/NCT00072137 PMID:15780740 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4994 https://github.com/vaccineontology/VO/issues/328 1437 4994 cancer vaccine Gene name: GM-CSF Recombinant Fowlpox GM-CSF Vaccine Adjuvant VO:0007003 A peptide vaccine derived from cytomegalovirus (CMV) antigens with potential immunostimulating activity. Intradermal administration of the PEP-CMV vaccine may stimulate the immune system to mount a specific helper and cytotoxic T-lymphocyte (CTL) response against CMV-infected tumor cells. Infection with the herpesvirus CMV may play a significant role in tumor cell initiation and progression as well as chemoresistance. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C107243 NCT: https://clinicaltrials.gov/ct2/show/NCT02864368 PMID:31806885 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5259 https://github.com/vaccineontology/VO/issues/118 18826 5259 cancer vaccine Gene name: pp65(Lcp 1) PEP-CMV Vaccine VO:0007004 A cancer vaccine consisting of a human epidermal growth factor receptor variant III (EGFRvIIi)-specific peptide conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH) with potential antineoplastic activity. Vaccination with rindopepimut may elicit a cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing EGFRvIII. EGFRvIII, a functional variant of EGFR that is not expressed in normal tissues, was originally discovered in glioblastoma multiforme (GBM) and has also been found in various other cancers such as breast, ovarian, metastatic prostate, colorectal, and head and neck cancers. EGFRvIII contains an 83 amino acid deletion in its extracellular domain and has been shown to transform NIH/3T3 mouse embryonic fibroblast cells in vitro. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C69076 NCT: https://clinicaltrials.gov/ct2/show/NCT01498328 PMID:28844499 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5032 https://github.com/vaccineontology/VO/issues/120 1956 5032 cancer vaccine Gene name: EGFR PF-04948568 Vaccine VO:0007005 Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29786 PMID:21078216 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5192 https://github.com/vaccineontology/VO/issues/324 945006 5192 cancer vaccine Gene name: lacZ Recombinant Adenovirus-LacZ Vaccine VO:0007006 A personalized peptide-based cancer vaccine comprised of one or two de novo synthesized patient-specific tumor-mutated peptides associated with glioblastoma (GB), with potential immunomodulating and antineoplastic activities. Vaccination with synthetic GB mutated tumor-specific peptides vaccine therapy APVAC2 stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the selected mutated tumor-associated peptides, which results in decreased GB growth. These peptides are specifically selected and synthesized based on the expression of the patient‚Äö√†√∂‚àö√òs own mutated tumor-associated antigens, which were detected during individual tumor genome sequencing. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116332 NCT: https://clinicaltrials.gov/ct2/show/NCT02149225 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5086 5086 cancer vaccine Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2 VO:0007007 A personalized peptide-based cancer vaccine comprised of five to ten peptides associated with glioblastoma (GB), with potential immunomodulating and antineoplastic activities. Vaccination with synthetic GB tumor-associated peptides vaccine therapy APVAC1 stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the tumor associated peptides, and results in decreased GB growth. The peptides are derived from a glioma actively-personalized vaccine consortium (GAPVAC) warehouse and are specifically selected based on the patient's expression of tumor-associated antigens. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C116331 NCT: https://clinicaltrials.gov/ct2/show/NCT02149225 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5231 1956 5231 cancer vaccine Gene name: EGFR Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1 VO:0007008 An orally available DNA cancer vaccine containing an attenuated strain of the bacterium Salmonella typhimurium encoding murine vascular endothelial growth factor receptor 2 (VEGFR-2) (VXM01), with potential immunomodulating, anti-angiogenic and antineoplastic activity. Upon oral administration and successful transduction, VEGFR-2 DNA vaccine VXM01 expresses VEGFR-2 in addition to inducing the expression of T-cell activation markers, such as CD25, interleukin-2, the early T-cell activation antigen CD69 and the lymphocyte function-associated antigen LFA-2. The immune response targets the fast growing VEGFR-2 expressing endothelial cells found in the tumor vasculature, thereby blocking angiogenesis which may ultimately inhibit tumor cell proliferation. VEGFR-2 is a receptor tyrosine kinase overexpressed on proliferating endothelial cells in the tumor vasculature. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C99378 NCT: https://clinicaltrials.gov/ct2/show/NCT02718443 PMID:29632710 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5521 3791 5521 cancer vaccine Gene name: KDR VEGFR-2 DNA Vaccine VXM01 VO:0007009 A cancer peptide vaccine comprised of a human leukocyte antigen (HLA) A2/A3 restricted HER2/neu (ERBB2) peptide from the extracellular domain of the HER2 protein (E75 peptide) and combined with the immunoadjuvant granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating and antineoplastic activity. Upon intradermal injection, nelipepimut-S plus GM-CSF vaccine may induce a specific cytotoxic T-lymphocyte (CTL) response against HER2/neu-expressing tumor cell types. HER2/neu, a tumor-associated antigen and a member of the epidermal growth factor receptor family of tyrosine kinases, is overexpressed in various tumor cell types. GM-CSF potentiates the antitumor immune response. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C99228 NCT: https://clinicaltrials.gov/ct2/show/NCT02636582 PMID:33485895 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5363 https://github.com/vaccineontology/VO/issues/54 2064 5363 cancer vaccine Gene name: ERBB2 Nelipepimut-S Plus GM-CSF Vaccine VO:0007010 A cancer vaccine consisting of one or more long, synthetic peptides derived from patient-specific breast cancer tumor-associated antigens (TAAs), with potential immunomodulating and antineoplastic activities. Upon intramuscular administration of the personalized synthetic long peptide breast cancer vaccine, the peptides stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the TAAs, which results in tumor cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C121947 NCT: https://clinicaltrials.gov/ct2/show/NCT02427581 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5348 5348 cancer vaccine Personalized Synthetic Long Peptide Breast Cancer Vaccine VO:0007011 A plasmid DNA cancer vaccine encoding the intracellular domain (ICD) of the HER-2/neu proto-oncogene. Upon administration and after cellular uptake by skin or muscle cells, the pNGVL3-hICD vaccine plasmid expresses the HER-2/neu protein, which, after intracellular processing, may elicit both antigen-specific cytotoxic T-lymphocyte (CTL) and humoral immune responses against tumor cells expressing HER-2. The HER-2/neu ICD protein is highly immunogenic and, as a subdominant epitope, may be associated with decreased immune tolerance. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61146 NCT: https://clinicaltrials.gov/ct2/show/NCT05163223 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5040 https://github.com/vaccineontology/VO/issues/122 2064 5040 cancer vaccine Gene name: ERBB2 pNGVL3-hICD Vaccine VO:0007012 Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29785 PMID:11590241 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5530 https://github.com/vaccineontology/VO/issues/320 5530 cancer vaccine Recombinant Adenovirus-Cre Recombinase Vaccine VO:0007013 An immunotherapeutic composed of the Wilms tumor 1 (WT1) and an as of yet undisclosed adjuvant, with potential antineoplastic activity. Upon administration, the immune system may be stimulated to exert a cytotoxic T-lymphocyte (CTL) response against WT1-expressing tumor cells. The adjuvant stimulates the immune system's response to WT1. WT1, a tumor-associated antigen (TAA) and transcription factor, is overexpressed in a variety of tumor cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116880 NCT: https://clinicaltrials.gov/ct2/show/NCT01220128 PMID:30562862 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5297 https://github.com/vaccineontology/VO/issues/326 7490 5297 cancer vaccine Gene name: WT1 Recombinant Anti-WT1 Immunotherapeutic GSK2302024A Vaccine VO:0007014 A cancer vaccine consisting of a truncated recombinant HER2 peptide (dHER2) with potential antineoplastic activity. Upon administration, recombinant dHER2 vaccine may stimulate the host immune response to mount a cytotoxic T-lymphocyte response against tumor cells that overexpress the HER2 protein, resulting in tumor cell lysis. The HER2 protein is a tumor-associated antigen (TAA) that is overexpressed in a variety of cancers. dHER2 includes the extracellular domain (ECD) and a part of the intracellular domain (ICD) of the HER2 protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49177 NCT: https://clinicaltrials.gov/ct2/show/NCT00140738 PMID:26975189 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5241 2064 5241 cancer vaccine Gene name: ERBB2 Recombinant dHER2 Vaccine VO:0007015 A cancer vaccine containing autologous dendritic cells pulsed with a fusion product of an epitope of human tumor-associated epithelial mucin 1 (MUC1) antigen and the vaccine adjuvant mannan (oxidized mannose), with potential antineoplastic activity. When the modified dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC1 antigen, resulting in tumor cell lysis. Addition of manna in this vaccine, enhances immune recognition. MUC1 antigen, a high-molecular-weight transmembrane glycoprotein, is overexpressed on many tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C102782 NCT: https://clinicaltrials.gov/ct2/show/NCT00004156 PMID:9656453 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5077 4582 5077 cancer vaccine Gene name: MUC1 Recombinant Human MUC1-Oxidized Polymannose-pulsed Autologous Dendritic Cell Vaccine VO:0007016 A cancer vaccine comprised of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the 5T4 fetal oncoprotein (MVA-h5T4). Vaccination with recombinant modified vaccinia Ankara-5T4 vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing 5T4 fetal oncoprotein antigen, resulting in tumor cell lysis. The MVA viral vector, derived from the replication-competent strain Ankara, is a highly attentuated, replication-defective vaccinia strain incapable of virion assembly. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49087 NCT: https://clinicaltrials.gov/ct2/show/NCT00227474 PMID:18990081 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5058 https://github.com/vaccineontology/VO/issues/337 7162 5058 cancer vaccine Gene name: TPBG Recombinant Modified Vaccinia Ankara-5T4 Vaccine VO:0007017 A vaccinia virus based vaccine expressing human tumor associated epithelial mucin (DF3 antigen; MUC1). MUC1 antigen, a membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed in various tumors such as breast, prostate, and ovarian cancers. This vaccine could be used in development of immunotherapeutics against cancers expressing MUC1. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2510 NCT: https://clinicaltrials.gov/ct2/show/NCT00071942 PMID:9101412 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5281 https://github.com/vaccineontology/VO/issues/338 354 4582 5281 cancer vaccine Gene name: KLK3 Gene name: MUC1 Recombinant Vaccinia DF3/MUC1 Vaccine VO:0007018 A vaccine containing a recombinant vaccinia virus that encodes the gene for human mucin-1, a tumor-associated antigen. Upon administration, recombinant vaccinia-MUC-1 vaccine may elicit a MUC-1-specific cytotoxic T cell response against tumor cells bearing MUC-1. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2732 NCT: https://clinicaltrials.gov/ct2/show/NCT00071942 PMID:12898638 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5321 https://github.com/vaccineontology/VO/issues/347 4582 5321 cancer vaccine Gene name: MUC1 Recombinant Vaccinia-MUC-1 Vaccine VO:0007019 A vaccine containing a pancarcinoma carbohydrate antigen conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. Sialylated Tn antigen (sTn) is a monosaccharide glycan usually O-linked to serine or threonine residues of mucins found on most epithelial cancers. Conjugation with KLH, a hapten carrier and an immunostimulant, improves host immune responses. Vaccination with sTn-KLH vaccine may produce antibodies and elicit a cytotoxic T lymphocyte (CTL) response against those tumor cells expressing sTn, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1690 NCT: https://clinicaltrials.gov/ct2/show/NCT00003638 PMID:23983823 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5425 https://github.com/vaccineontology/VO/issues/361 5425 cancer vaccine Gene name: sialyl-Tn Sialyl Tn-KLH Vaccine VO:0007020 A vaccine comprised of a synthetic Sialyl-Tn antigen linked to the protein carrier, keyhole limpet hemocyanin (KLH), administered with immunostimulant, Detox. Vaccination with STn-KLH plus Detox may elicit an IgG-based anti-STn antibody response and ultimately a cytotoxic T-cell response against STn-expressing cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2501 NCT: https://clinicaltrials.gov/ct2/show/NCT00003638 PMID:7690215 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5061 https://github.com/vaccineontology/VO/issues/363 5061 cancer vaccine Gene name: sialyl-Tn STn-KLH plus Detox Vaccine VO:0007021 A cancer vaccine comprised of multiple synthetic breast cancer peptides and the adjuvant tetanus toxoid helper peptide emulsified in the adjuvant Montanide ISA-51 with immunopotentiation activity. Vaccination with this cancer vaccine may elicit a specific cytotoxic T-lymphocyte response against breast cancer cells. Synthetic breast cancer peptides may stimulate the immune response against cells that produce breast cancer markers such as erbB2 (HER2/neu) while tetanus toxoid helper peptide binds to class II MHC molecules as a nonspecific vaccine helper epitope, resulting in a long-term immunopotentiation by increasing the helper T-cell response. Montanide ISA-51, also known as incomplete Freund's adjuvant or IFA, is a stabilized water-in-oil emulsion adjuvant containing mineral oil with mannide oleate added as a surfactant that non-specifically stimulates cell-mediated immune responses to antigens. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61076 NCT: https://clinicaltrials.gov/ct2/show/NCT00304096 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5271 6007 5271 cancer vaccine Gene name: RHD Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine VO:0007022 A vaccine containing a clustered pancarcinoma carbohydrate antigen conjugated with keyhole limpet hemocyanin (KLH) with potential antineoplastic activity. Alpha-N-acetylgalactosamine (Tn) is a monosaccharide usually O-linked to serine or threonine residues of mucins found on most epithelial cancers with the highest expression on prostate cancer. This vaccine contains the Tn epitope cluster (c) that is synthesized by linking 3 copies of the Tn epitope on a threonine backbone to achieve the essential immunogenic structure. KLH is a hapten carrier and serves as an immunostimulant to improve immune recognition. Vaccination with Tn(c)-KLH vaccine may produce antibodies and elicit a cytotoxic T lymphocyte (CTL) response against those tumor cells expressing Tn antigen, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2474 NCT: https://clinicaltrials.gov/ct2/show/NCT00030823 PMID:9579798 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5025 5025 cancer vaccine Tn(c)-KLH Conjugate Vaccine VO:0007023 A population of activated, immortalized, interleukin-2 (IL-2)-dependent, cytotoxic natural killer (NK) cells with potential antitumor activity. Natural killer cells ZRx101 are derived from NK-92 cells, having been modified to target tumor-associated antigens (TAAs) upregulated in certain types of cancer. The NK-92 cell line was originally isolated from a patient with large granular lymphocytic (LGL) leukemia/lymphoma. (NCIT_C85466). Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C85466 NCT: https://clinicaltrials.gov/ct2/show/NCT00900809 PMID:18425107 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5026 https://github.com/vaccineontology/VO/issues/50 107653060 5026 cancer vaccine Gene name: IL12 Natural Killer Cells ZRx101 vaccine VO:0007024 A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2657 NCT: https://clinicaltrials.gov/ct2/show/NCT05479045 PMID:24397899 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5206 https://github.com/vaccineontology/VO/issues/55 1485 5206 cancer vaccine Gene name: CTAG1B NY-ESO-1 peptide vaccine VO:0007025 A plasmid DNA encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1 with potential immunostimulating and antitumor activities. Upon administration, NY-ESO-1 plasmid DNA cancer vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, resulting in tumor cell lysis. NY-ESO-1 is a tumor associated antigen (TAA) found in normal testes and expressed on the surfaces of various tumor cells, including melanoma, breast, bladder, prostate, lung, ovarian, and hepatocellular tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62452 NCT: https://clinicaltrials.gov/ct2/show/NCT00199849 PMID:15102697 PMID:21900253 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5283 https://github.com/vaccineontology/VO/issues/56 https://github.com/vaccineontology/VO/issues/58 1485 5283 cancer vaccine Gene name: CTAG1B NY-ESO-1 plasmid DNA cancer vaccine VO:0007026 A cancer vaccine composed of a recombinant form of the tumor antigen NY-ESO-1 and glucopyranosyl lipid adjuvant (GLA)-stable emulsion (GLA-SE), with potential antineoplastic and immunomodulating activities. Upon intramuscular injection, the adjuvant portion of the NY-ESO-1/GLA-SE vaccine ID-G30 binds to toll-like receptor subtype 4 (TLR-4) expressed on dendritic cells (DCs), monocytes, macrophages and B cells. The activated DCs present the NY-ESO-1 antigen to Th1 CD4 T-lymphocytes. This leads to the induction of cytotoxic T lymphocytes (CTLs) and the killing of NY-ESO-1-expressing tumor cells. This vaccine also induces specific antibody responses and increases the production of inflammatory cytokines. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113432 NCT: https://clinicaltrials.gov/ct2/show/NCT02015416 PMID:31069460 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5445 https://github.com/vaccineontology/VO/issues/85 1485 7099 5445 cancer vaccine Gene name: CTAG1B Gene name: TLR4 NY-ESO-1/GLA-SE vaccine ID-G305AmN VO:0007027 A recombinant nonapeptide used as an antineoplastic vaccine. NY-ESO-1b peptide vaccine contains the amino acid sequence SLLMWITQC, derived from the cancer-testis tumor antigen (NY-ESO-1), which is expressed on tumor cells of many different types, including melanomas. Vaccination with this peptide vaccine may elicit strong humoral and cellular immune responses to NY-ESO-1-expressing cancers. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68999 NCT: https://clinicaltrials.gov/ct2/show/NCT00199836 PMID:15501973 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5428 https://github.com/vaccineontology/VO/issues/112 1485 5428 cancer vaccine Gene name: CTAG1B NY-ESO-1b peptide vaccine VO:0007028 A tumor-associated antigen belonging to the family of immunogenic testicular proteins that are aberrantly expressed in human cancers in a lineage-nonspecific fashion. Reverse transcription-PCR analysis showed NY-ESO-1 mRNA expression in a variable proportion of a wide array of human cancers, including melanoma, breast cancer, bladder cancer, prostate cancer, and hepatocellular carcinoma; and restricted expression in normal tissues, with high-level mRNA expression found only in testis and ovary tissues. The gene for NY-ESO-1 maps to Xq28 and codes for an 18-kDa protein having no homology with any known protein. NY-ESO-1 elicits a strong, integrated humoral and cellular immune response in a high proportion of patients with NY-ESO-1-expressing tumors and is under investigation as a cancer immunotherapy agent. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26680 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5182 https://github.com/vaccineontology/VO/issues/76 1485 5182 cancer vaccine Gene name: CTAG1B NY-ESO-B vaccine VO:0007029 An E1B-55kDa-deleted adenovirus that is able to selectively replicate in and lyse TP53-deficient human tumor cells. After tumor cell lysis, released viruses infect neighboring tumor cells, tripping a chain of ONYX-015-mediated tumor cell cytotoxicity. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2830 NCT: https://clinicaltrials.gov/ct2/show/NCT00006106 PMID:11892945 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5486 https://github.com/vaccineontology/VO/issues/73 7157 5486 cancer vaccine Gene name: TP53 ONYX-015 vaccine VO:0007030 A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1986 NCT: https://clinicaltrials.gov/ct2/show/NCT00001827 PMID:24583792 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5255 7157 5255 cancer vaccine Gene name: TP53 p53 peptide vaccine VO:0007031 A peptide-based vaccine containing a pan HLA DR-binding epitope (PADRE) fused to a cytomegalovirus (CMV) peptide epitope, with potential anti-viral and immunomodulating activities. Upon administration, PADRE-CMV fusion peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against CMV in the CMV-infected host. The synthetic peptide PADRE is a universal helper T cell epitope. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78820 NCT: https://clinicaltrials.gov/ct2/show/NCT00722839 PMID:22402037 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5441 5441 cancer vaccine PADRE-CMV fusion peptide vaccine VO:0007032 A synthetic HIV-1 envelope peptide that was developed for use as a vaccine. Vaccination with PCLUS 3-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2786 NCT: https://clinicaltrials.gov/ct2/show/NCT00001386 PMID:10546852 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5451 https://github.com/vaccineontology/VO/issues/115 5451 cancer vaccine PCLUS 3-18MN vaccine VO:0007033 A synthetic HIV-1 envelope peptide that was developed for use as a vaccine. Vaccination with PCLUS 6.1-18MN may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) and T helper cell responses, and induce the production of neutralizing antibodies. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2787 NCT: https://clinicaltrials.gov/ct2/show/NCT00001386 PMID:10546852 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5443 https://github.com/vaccineontology/VO/issues/116 5443 cancer vaccine PCLUS 6.1-18MN vaccine VO:0007034 A cancer vaccine consisting of Her2/neu peptides incorporated into microspheres of poly (lactide-co-glycolide) (PLGA), a biodegradable polymer. Poly microsphere encapsulated HER2/neu oral vaccine has been investigated for use in immunotherapy for tumors positive for HER-2/neu, a tumor associated antigen that is overexpressed in various cancers, including breast and ovarian cancer.‚Äö√†√∂‚àö¬ß Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2718 NCT: https://clinicaltrials.gov/ct2/show/NCT02795988 PMID:29448628 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5176 2064 5176 cancer vaccine Gene name: ERBB2 poly microsphere encapsulated HER2/neu oral vaccine VO:0007035 A cancer vaccine containing a RAS oncogene-encoded peptide with potential antineoplastic activity. RAS peptide cancer vaccine may stimulate a RAS peptide-specific antitumoral T-cell cytotoxic immune response, resulting in an inhibition of tumor cell proliferation and tumor cell death. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2438 NCT: https://clinicaltrials.gov/ct2/show/NCT00019006 PMID:33016924 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5320 https://github.com/vaccineontology/VO/issues/189 3845 5320 cancer vaccine Gene name: KRAS RAS peptide cancer vaccine VO:0007036 A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 (rF-B7.1) vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2666 NCT: https://clinicaltrials.gov/ct2/show/NCT00030693 PMID:12969559 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5424 https://github.com/vaccineontology/VO/issues/329 941 5424 cancer vaccine Gene name: CD80 recombinant Fowlpox-B7.1 vaccine VO:0007037 A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2620 NCT: https://clinicaltrials.gov/ct2/show/NCT00028496 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5049 https://github.com/vaccineontology/VO/issues/330 1048 5049 cancer vaccine Gene name: CEACAM5 recombinant Fowlpox-CEA(6D)/TRICOM vaccine VO:0007038 A whole, heat-killed, recombinant Saccharomyces cerevisiae yeast-based vaccine genetically altered to express the carcinoembryonic antigen (CEA) peptide 610D with potential immunostimulating and antineoplastic activities. Upon administration, recombinant Saccharomyces cerevisia-CEA(610D) vaccine GI-6207 may stimulate a host cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells, which may result in tumor cell lysis. CEA, a tumor associated antigen, is overexpressed on a wide variety of human cancer cells including colorectal, gastric, lung, breast and pancreatic cancer cells. CEA 610D encodes for 9 amino acids (605-613) in which aspartate is substituted for asparagine at position 610 (610D) in order to strengthen the induction of the CTL response against CEA-expressing tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82371 NCT: https://clinicaltrials.gov/ct2/show/NCT00924092 PMID:22862954 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5152 1048 5152 cancer vaccine Gene name: CEACAM5 (CEA) recombinant Saccharomyces Cerevisia-CEA(610D)-expressing vaccine GI-6207 VO:0007039 A vaccine consisting of recombinant vaccinia virus encoding the tumor-associated antigen carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1, and LFA-3; also called TRICOM). Vaccination with recombinant vaccinia-CEA(6D)-TRICOM vaccine stimulates the host immune system to mount a T-cell response against tumor cells expressing the CEA antigen. The use of TRICOM in the vaccine may elicit a greater antitumor cytotoxic T lymphocyte (CTL) immune response compared to the use of vaccinia-CEA alone. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2619 NCT: https://clinicaltrials.gov/ct2/show/NCT00217373 PMID:27581603 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5037 https://github.com/vaccineontology/VO/issues/342 111518 5037 cancer vaccine Gene name: Cea-Mouse recombinant Vaccinia-CEA(6D)-TRICOM vaccine VO:0007040 An admixture of recombinant vaccinia virus encoding MUC-1 and recombinant vaccinia virus encoding the murine T-cell co-stimulatory molecule B7.1. MUC-1 is a glycosylated mucin that is overexpressed in breast, lung, pancreatic, prostate, stomach, colon, and ovarian carcinomas. Vaccination with MUC-1 in combination with B7.1 may enhance the cytotoxic T cell (CTL) immune response to tumors expressing MUC-1, compared to vaccination with MUC-1 alone. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29409 PMID:9101412 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5326 https://github.com/vaccineontology/VO/issues/348 12519 4582 5326 cancer vaccine Gene name: Cd80 Gene name: MUC1 recombinant Vaccinia-MUC1-B7 vaccine VO:0007041 A cancer vaccine consisting of a recombinant vaccinia viral vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with recombinant vaccinia- NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48419 NCT: https://clinicaltrials.gov/ct2/show/NCT00112957 PMID:29773080 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5389 https://github.com/vaccineontology/VO/issues/349 1485 5389 cancer vaccine Gene name: CTAG1B recombinant Vaccinia-NY-ESO-1 vaccine VO:0007042 A replication-incompetent, pathotropic, tumor matrix (collagen)-targeted, retroviral vector encoding an N-terminal deletion mutant form of the cyclin G1 gene with potential antineoplastic activity. Under the control of a hybrid long-terminal repeat/cytomegalovirus (CMV) promoter, retrovector encoding mutant anti-cyclin G expresses the mutant cyclin G1 construct, resulting in disruption of tumor cell cyclin G1 activity and decreased cellular proliferation and angiogenesis. This agent preferentially targets collagen of the tumor matrix because of the incorporation of the collagen-binding domain of von Willebrand factor (vWF) on the retrovector surface. Exploiting the collagen-targeting mechanism of vWF permits delivery of the retrovector to tumor sites where angiogenesis and collagen matrix exposure occur. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49082 NCT: https://clinicaltrials.gov/ct2/show/NCT00505271 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5437 https://github.com/vaccineontology/VO/issues/355 900 5437 cancer vaccine Gene name: CCNG1 retrovector encoding mutant Anti-Cyclin G1 vaccine VO:0007043 An autologous dendritic cell (DC) vaccine loaded with tumor-associated antigens (TAAs) derived from survivin, p53 and human epidermal growth factor receptor 2 (HER2 or ERBB2), with immunostimulating and antineoplastic activities. Upon administration, this DC vaccine may elicit a potent cytotoxic T-cell (CTL) response against tumor cells expressing these TAAs, resulting in tumor cell death. Survivin, p53 and HER2 are essential in neoplastic growth, and are considered to be universal tumor antigens. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114285 NCT: https://clinicaltrials.gov/ct2/show/NCT00978913 PMID:16096014 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5180 2064 373110 7157 5180 cancer vaccine Gene name: ERBB2 Gene name: Survivin Gene name: p53 survivin/p53/HER2 antigen-loaded autologous dendritic cell vaccine VO:0007044 A peptide vaccine containing a 15-mer peptide (DLAQMFFCFKELEGW), with C to M alteration at amino acid position 57, derived from the anti-apoptosis protein survivin, and conjugated with keyhole limpet hemocyanin (KLH), with potential immunopotentiating and antineoplastic activities. Upon subcutaneous administration of SVN53-67/M57-KLH peptide vaccine, this peptide is able to bind both HMC class I and II molecules and may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) as well as a T-helper cell response against survivin-expressing cancer cells. This may result in decreased tumor cell proliferation and ultimately tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family, expressed during embryonic development while absent in most normal adult cells, is upregulated in a variety of human cancers; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy. KLH may enhance immune recognition and may promote an enhanced response. As SVN53-67 is weakly immunogenic in humans, the M57 alteration may lead to greater affinity towards HLA-A*0201 and thus an enhanced antitumor immune response. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95705 NCT: https://clinicaltrials.gov/ct2/show/NCT02334865 PMID:27576783 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5008 https://github.com/vaccineontology/VO/issues/405 373110 5008 cancer vaccine Gene name: Survivin SVN53-67/M57-KLH peptide vaccine VO:0007045 A DNA vaccine consisting of a plasmid encoding the full-length sequence of the tumor-associated antigen (TAA) human telomerase reverse transcriptase (hTERT), which is the catalytic subunit of human telomerase and synthesizes telomeric DNA at the chromosome ends, containing two immunogenic mutations, with potential immunostimulating and antineoplastic activities. Upon intradermal vaccination of the hTERT-encoding DNA vaccine INO-1400 in combination with electroporation, hTERT protein is expressed and activates the immune system to mount a cytotoxic T-cell (CTL) response against telomerase-expressing tumor cells, which may result in tumor cell death. Telomerase prolongs the functional lifespan of cells via the restoration and maintenance of telomere length. Abnormally activated in tumorigenesis, telomerase is expressed in the majority of human cancer cells, but its expression is low or non-existent in normal cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C120118 NCT: https://clinicaltrials.gov/ct2/show/NCT02960594 PMID:34230114 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5171 https://github.com/vaccineontology/VO/issues/409 7015 5171 cancer vaccine Gene name: TERT synthetic hTERT DNA vaccine INO-1400 VO:0007046 A cancer vaccine consisting of E-PRA and E-PSM, two synthetic peptide analogs of PRAME (PReferential Antigen MElanoma) and PSMA (Prostate Specific Membrane Antigen), with potential immunostimulating activity. Upon direct administration into lymph nodes, synthetic peptides E-PRA and E-PSM vaccine may sitmulate a cytotoxic T-lymphocyte (CTL) response against PRAME- and PSMA-expressing tumor cells. PRAME and PSMA are tumor-associated antigens upregulated and expressed on the cell surfaces of certain tumor cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67098 NCT: https://clinicaltrials.gov/ct2/show/NCT00423254 PMID:21760528 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5496 https://github.com/vaccineontology/VO/issues/412 6277 5496 cancer vaccine Gene name: S100A6 synthetic peptides E-PRA and E-PSM vaccine VO:0007047 A peptide-based cancer vaccine, containing amino acid residues 27 through 35 of T cell receptor gamma alternate reading frame protein (TARP), with potential immunostimulatory and antineoplastic activities. Upon administration, TARP 27-35 peptide vaccine may stimulate a host cytotoxic T-cell (CTL) response against TARP-expressing tumor cells, resulting in tumor cell cytotoxicity. The nuclear protein TARP is commonly expressed on prostate and breast cancer cells and is highly immunogenic. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85462 NCT: https://clinicaltrials.gov/ct2/show/NCT00972309 PMID:27622067 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5448 https://github.com/vaccineontology/VO/issues/413 445347 5448 cancer vaccine Gene name: TARP TARP 27-35 peptide vaccine VO:0007048 A peptide-based cancer vaccine, consisting of amino acid residues 29 through 37 of T cell receptor gamma alternate reading frame protein (TARP) with a leucine-to-valine substitution at position 9, with potential immunostimulatory and antineoplastic activities. Upon administration, TARP 29-37-9V peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against TARP-expressing tumor cells, which may result in decreased tumor cell proliferation. The leucine-to-valine substitution at position 9 of this peptide improves its immunogenicity. The nuclear protein TARP is commonly expressed on prostate and breast cancer cells and is highly immunogenic. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C85463 NCT: https://clinicaltrials.gov/ct2/show/NCT02362464 PMID:27622067 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5242 https://github.com/vaccineontology/VO/issues/414 445347 5242 cancer vaccine Gene name: TARP TARP 29-37-9V peptide vaccine VO:0007049 A cancer vaccine consisting of a recombinant vector encoding the tumor-associated carcinoembryonic antigen (CEA) that is‚Äö√†√∂‚àö¬ßcontaminated‚Äö√†√∂‚àö¬ßwith bovine viral diarrhea virus (BVDV). The carcinoembryonic antigen (CEA) is a prevalent tumor marker expressed by a number of different cancers such as colorectal, breast, lung and ovarian carcinomas; vaccination with vaccinia virus genetically engineered to express‚Äö√†√∂‚àö¬ßCEA‚Äö√†√∂‚àö¬ßmay generate antitumoral T-cell responses.‚Äö√†√∂‚àö¬ßBVDV‚Äö√†√∂‚àö¬ßis an RNA pestivirus that may contaminate vaccines due to its presence in fetal calf serum used as a growth supplement in the tissue culture of mammalian cells used in vaccine production. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29476 PMID:35380920 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5295 https://github.com/vaccineontology/VO/issues/415 4153 5295 cancer vaccine Gene name: MBL2 TBC-CEA-Contaminated W/ BVDV vaccine VO:0007050 A lipid-based multi-peptide cancer vaccine targeted against multiple cancers with immunopotentiating activity. Therapeutic breast/ovarian/prostate peptide cancer vaccine DPX-0907 is a lyophilized liposomal proprietary preparation comprised of 7 tumor-specific HLA-A2-restricted epitopes (TAAs): topoisomerase II alpha, B-cell receptor-associated protein 31 (CDM protein), TNF-alpha-converting enzyme (TACE/ADAM17), Abelson homolog 2 (Abl2), gamma catenin (Junction plakoglobin), epithelial discoidin domain receptor 1 (EDDR1) and integrin beta 8 subunit. Upon vaccination, the lyophilized antigen/adjuvant/liposome complex is re-suspended in Montanide 1SA51 VG to create a depot effect, thereby presenting the TAAs to the immune system for a prolonged period of time. This may stimulate a potent cytotoxic T-lymphocyte (CTL) immune response against cancer cells that express these 7 TAAs and share epitopes with the vaccine epitope peptides, resulting in tumor cell lysis. The 7 TAAs are overexpressed on the surface of breast/ovarian and prostate cancer cells and play an important role in tumor cell growth and survival. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C91077 NCT: https://clinicaltrials.gov/ct2/show/NCT01095848 PMID:22862954 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5458 10134 27 3696 3728 6868 7153 780 5458 cancer vaccine Gene name: ABL2 Gene name: ADAM17 Gene name: BCAP31 Gene name: DDR1 Gene name: IGTB8 Gene name: JUP Gene name: TOP2A therapeutic Breast/Ovarian/Prostate peptide cancer vaccine DPX-0907 VO:0007051 A cancer vaccine containing URLC10 (up-regulated lung cancer 10) epitopes with potential immunostimulatory and antineoplastic activities. Upon administration, URL peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against URLC10-expressing tumor cells. Up-regulated in lung and esophageal cancers, the function of URLC10 is unknown. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74087 NCT: https://clinicaltrials.gov/ct2/show/NCT00624182 PMID:29568993 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5115 54742 5115 cancer vaccine Gene name: LY6K URLC10 peptide vaccine VO:0007052 A cancer vaccine containing five peptide epitopes with potential immunostimulatory and antitumor activity. Peptide epitopes in this vaccine are derived from: URLC10 (up-regulated lung cancer 10), TTK (TTK protein kinase), KOC1 (IGF II mRNA Binding Protein 3) and VEGFRs (vascular endothelial growth factor receptors) 1 and 2. Upon administration, URLC10-TTK-KOC1-VEGFR1-VEGFR2 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing URLC10, TTK, KCO1, VEGFR 1 and 2 peptides, resulting in cell lysis and decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74088 NCT: https://clinicaltrials.gov/ct2/show/NCT00632333 PMID:24708624 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5001 10643 54742 7422 5001 cancer vaccine Gene name: IGF2BP3 Gene name: LY6K Gene name: VEGFA URLC10-TTK-KOC1-VEGFR1-VEGFR2 multipeptide vaccine VO:0007053 A highly tumor-selective vaccinia virus (vv) with an engineered double deletion (DD) of the thymidine kinase (tk) and vaccinia growth factor genes and additions of both a cytosine deaminase (CD) gene and a somatostatin receptor (SR) gene with potential oncolytic viral activity. The tk and vaccinia growth factor gene deletions in intratumorally administered vaccinia virus (vvDD-CDSR) help to restrict its replication and cytolytic activity to tumor cells with large nucleotide pools and tumor cells with activation of the EGFR-Ras pathway. Addition of the CD gene to the viral genome allows control of oncolytic viral infection through the administration of the prodrug 5-fluorocytosine (5-FC), converted by CD to the antimetabolite 5-fluorouracil (5-FU) in cells infected with this agent. Addition of the SR gene allows anatomical localization of vaccinia virus (vvDD-CDSR) through the use of octreotide scintigraphy. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74089 NCT: https://clinicaltrials.gov/ct2/show/NCT00574977 PMID:27203445 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5296 45091589 5296 cancer vaccine Gene name: cdsR Vaccinia virus DD-CDSR vaccine VO:0007054 A vaccine consisting of two plasmids encoding the human cytomegalovirus (CMV) tegument phosphoprotein 65 (pp65), a major internal matrix protein, and glycoprotein B (gB), an important CMV component responsible for attachment and entry into cells, with immunostimulatory properties. Vaccination with VCL-CB01 may stimulate the host immune system to mount cellular and humoral immune responses against CMV positive cells, resulting in cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61327 NCT: https://clinicaltrials.gov/ct2/show/NCT00285259 PMID:22237175 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5390 3077579 5390 cancer vaccine Gene name: UL83 VCL-CB01 vaccine VO:0007055 A live attenuated bacteria injectable vaccine used to prevent typhoid, which is caused by Salmonella typhi. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97127 NCT: https://clinicaltrials.gov/ct2/show/NCT03294564 PMID:7487253 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5322 5322 vaccine Vi capsular polysaccharide typhoid vaccine VO:0007056 A synthetic peptide vaccine consisting of a HLA-DR15-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 124 through 138, a HLA class II-restricted WT1 peptide, with potential immunomodulating and antitumor activities. Vaccination with WT1 124-138 peptide may stimulate a CD4-positive helper T-lymphocyte-mediated immune response against WT1 expressing cells. Activated helper T-cells stimulate dendritic cells, and activate the proliferation of other T-lymphoctes and B-lymphocytes. This causes tumor cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing tumor cells. WT1, a zinc finger DNA-binding protein, is overexpressed in most types of leukemia and in a variety of solid cancers. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C104738 PMID:16220325 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5430 7490 5430 cancer vaccine Gene name: WT1 WT1 124-138 peptide vaccine VO:0007057 A synthetic peptide vaccine consisting of the amino acids 126 through 134 of the human Wilms' Tumor protein-1 (WT1) with potential antitumor activity. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. Vaccination with WT1 126-134 peptide vaccine may induce a WT1-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61442 NCT: https://clinicaltrials.gov/ct2/show/NCT01842139 PMID:26492414 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5089 7490 5089 cancer vaccine Gene name: WT1 WT1 126-134 peptide vaccine VO:0007058 A synthetic peptide vaccine consisting of a HLA-A24-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 235 through 243, a MHC class I-restricted peptide, with potential immunomodulating and antitumor activities. Vaccination with WT1 235-243 peptide may induce a WT1-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation. WT1, a zinc finger DNA-binding protein, is overexpressed in most types of leukemia and in a variety of solid cancers. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104734 PMID:23225417 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5029 7490 5029 cancer vaccine Gene name: WT1 WT1 235-243 peptide vaccine VO:0007059 A synthetic peptide vaccine consisting of a HLA-DRw53-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 247 through 261, a HLA class II-restricted WT1 peptide, with potential immunomodulating and antitumor activities. Vaccination with WT1 247-261 peptide may stimulate a CD4-positive helper T-lymphocyte-mediated immune response against WT1 expressing cells. Activated helper T-cells stimulate dendritic cells, and activate the proliferation of other T-lymphoctes and B-lymphocytes. This causes tumor cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing tumor cells. WT1, a zinc finger DNA-binding protein, is overexpressed in most types of leukemia and in a variety of solid cancers. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C104737 PMID:16220325 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5468 7490 5468 cancer vaccine Gene name: WT1 WT1 247-261 peptide vaccine VO:0007060 A cancer vaccine consisting of the DNA plasmid pNGVL4a-A encoding calreticulin (CRT) linked to a detox form of human papillomavirus (HPV) type 16 E7 antigen, with potential immunomodulating and antineoplastic activities. Upon administration, this vaccine may generate a potent cytotoxic T-lymphocyte (CTL) response against E7-expressing tumor cells, resulting in tumor cell death. For E7(detox), the amino acids in E7 at positions 24 (cysteine to glycine) and 26 (glutamic acid to glycine) were substituted. CRT, a 46 kDa protein located in the lumen of the cell's endoplasmic reticulum (ER), may potentiate MHC class I presentation of HPV-16 E7 to E7-specific CD8-positive T cells. In addition, pNGVL4a-A contains two short immunostimulatory DNA sequences (ISS) in the noncoding region, which may elicit the production of IFN- and IL-12 in transfected keratinocytes and dermal antigen presenting cells (APCs), resulting in a potent T helper cell type 1 response. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88289 NCT: https://clinicaltrials.gov/ct2/show/NCT00988559 PMID:26616223 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5011 https://github.com/vaccineontology/VO/issues/123 1489079 5011 cancer vaccine Gene name: HPV16 E7 pNGVL4a-CRT/E7(detox) DNA vaccine VO:0007061 An antigen-specific DNA cancer vaccine consisting of the coding sequences of a signal peptide (pNGVL4a-Sig), a detox form of the human papillomavirus type 16 (HPV-16) antigen E7, and the heat shock protein 70 (HSP70). Upon administration, this vaccine may generate potent cytotoxic CD8(+) T-cell responses against E7-expressing tumor cells, resulting in tumor cell death. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48418 NCT: https://clinicaltrials.gov/ct2/show/NCT00121173 PMID:30296681 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5069 https://github.com/vaccineontology/VO/issues/124 1489079 5069 cancer vaccine Gene name: HPV16 E7 pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine VO:0007062 A non-infectious recombinant, quadrivalent vaccine prepared from the highly purified virus-like particles (VLPs) of the major capsid (L1) protein of human papillomavirus (HPV) Types 6, 11, 16, and 18 with immunoprophylactic activity. The immunoprohylactic efficacy of L1 VLP vaccines, such as recombinant human papillomavirus quadrivalent vaccine, appear to be mediated by the development of humoral immune responses. HPV Types 16 and 18 account for approximately 70% of cervical cancers and HPV Types 6 and 11 account for approximately 90% of genital warts. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C61087 NCT: https://clinicaltrials.gov/ct2/show/NCT00411749 PMID:35997582 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5406 25479185 5406 cancer vaccine Gene name: L1 Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine VO:0007063 A non-infectious, recombinant, nonavalent vaccine prepared from highly purified virus-like particles (VLPs) comprised of the major capsid (L1) proteins from human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, and 58, with active immunizing activity. Upon administration, the recombinant HPV nonavalent vaccine activates the immune system to produce antibodies against the 9 HPV types. This protects against HPV infection and HPV-related cancers. Altogether, HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 account for the majority of the HPV types that cause cervical, vulvar, vaginal and anal cancers.‚Äö√†√∂‚àö¬ß Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C119664 PMID:26772631 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5342 25479185 7162 5342 cancer vaccine Gene name: L1 Gene name: TPBG Recombinant Human Papillomavirus Nonavalent Vaccine VO:0007064 A cancer vaccine comprised of a modified, replication-defective, vaccinia virus Ankara (MVA) strain encoding the tumor-associated antigens (TAAs) human papillomavirus type 16 (HPV16) subtypes E6 and E7, and human interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Vaccination with MVA-HPV16E6/E7-IL2 vaccine TG4001 stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing HPV16 E6 and E7, resulting in tumor cell lysis. Expression of IL-2 augments the specific CTL response against HPV16 E6- and E7-expressing tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88326 NCT: https://clinicaltrials.gov/ct2/show/NCT01022346 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5208 https://github.com/vaccineontology/VO/issues/340 1489078 1489079 5208 cancer vaccine Gene name: E6 Gene name: E7 Recombinant Vaccinia Viral Vector RO5217790 Vaccine VO:0007065 A therapeutic peptide vaccine consisting of thirteen synthetic long peptides (SLPs), which are 25-35 amino acids in size, derived from the human papillomavirus (HPV) type 16 oncoproteins E6 and E7, with potential immunostimulating and antitumor activities. Upon administration, synthetic long E6/E7 peptides vaccine HPV-01 is taken up and degraded into small pieces by dendritic cells. The processed viral epitopes are presented by dendritic cells, which may stimulate the host immune system to mount both cytotoxic T-cell lymphocyte (CTL) and helper T cell responses against HPV E6/E7-expressing tumor cells. This results in the destruction of tumor cells and leads to decreased tumor growth. The E6 and E7 oncoproteins are implicated in the tumorigenesis in a variety of cancers. The SLPs allow for optimal presentation by antigen-presenting cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C111037 NCT: https://clinicaltrials.gov/ct2/show/NCT02128126 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5186 https://github.com/vaccineontology/VO/issues/410 1489078 1489079 5186 cancer vaccine Gene name: E6 Gene name: E7 Synthetic Long E6/E7 Peptides Vaccine HPV-01 VO:0007066 A recombinant chimeric protein composed of the heat shock protein 65 (Hsp65) from Mycobacterium bovis, and the human papilloma viral (HPV) protein E7. Hsp65, similar to other members of its family of proteins, elicits a strong immune response and may be used to design vaccines against a number of different cancers. E7 protein is involved in carcinogenesis of anal and cervical tumors, and represents a tumor antigen that may be specifically targeted by lymphocytes. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2811 NCT: https://clinicaltrials.gov/ct2/show/NCT00493545 PMID:16691066 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5542 1489079 3329 5542 cancer vaccine Gene name: E7 Gene name: HSPD1 Verpasep Caltespen Vaccine VO:0007067 A synthetic vaccine used for cancer immunotherapy also known as Ras(cis 12)-Vaccinia Vaccine, RASVAC-C is based on a mutant peptide epitope of the Ras oncoprotein at codon 12 that induces recognition and induction of tumor-specific, cell-mediated immune responses. Ras is an intracellular GTP-binding protein involved in signal transduction and regulation of proliferation and differentiation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29401 NCT: https://clinicaltrials.gov/ct2/show/NCT00019591 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5504 https://github.com/vaccineontology/VO/issues/190 3845 5504 cancer vaccine Gene name: KRAS RASVAC-C Vaccine VO:0007068 A synthetic vaccine used for cancer immunotherapy also known as Ras(val 12)-Vaccinia Vaccine, RASVAC-V is based on a mutant peptide epitope of the Ras oncoprotein at codon 12 (valine instead of glycine) that induces recognition and induction of tumor-specific, cell-mediated immune responses. Ras is an intracellular GTP-binding protein involved in signal transduction and regulation of proliferation and differentiation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29402 NCT: https://clinicaltrials.gov/ct2/show/NCT00019591 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5497 https://github.com/vaccineontology/VO/issues/191 3845 5497 cancer vaccine Gene name: KRAS RASVAC-V Vaccine VO:0007069 A genetically-engineered adenovirus that contains the gene that encodes the human tumor-suppressor protein p53 with potential antineoplastic activity. Recombinant adenovirus-p53 SCH-58500 delivers p53 into tumor cells, which may result in p53-mediated cell cycle arrest and apoptosis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2423 NCT: https://clinicaltrials.gov/ct2/show/NCT00002960 PMID:16082381 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5470 https://github.com/vaccineontology/VO/issues/325 4771 7157 7490 5470 cancer vaccine Gene name: NF2 Gene name: TP53 (P53) Gene name: WT1 Recombinant Adenovirus-p53 SCH-58500 Vaccine VO:0007070 An immunocytokine consisting of human pro-inflammatory cytokine tumor necrosis factor alpha (TNFalpha) fused to a human single-chain variable fragment (scFv) directed against the extra-domain B (ED-B) of fibronectin (L19), with potential immunopotentiating and antineoplastic activities. Upon adinistration, the L19 moiety of onfekafusp alfa binds to the ED-B domain of fibronectin on tumor cells in the tumor neovasculature. In turn, the TNFalpha moiety may locally induce an immune response against ED-B fibronectin-expressing tumor cells and may specifically decrease the proliferation of ED-B-expressing tumor cells. ED-B is predominantly expressed during angiogenesis and tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C166939 NCT: https://clinicaltrials.gov/ct2/show/NCT01253837 PMID:12810649 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5219 https://github.com/vaccineontology/VO/issues/336 100136034 5219 cancer vaccine Gene name: tnf-alpha Recombinant Human Fusion Protein L19TNFalpha Vaccine VO:0007071 A cancer vaccine containing multiple peptide epitopes with potential immunostimulatory and antitumor activities. Peptide epitopes in this vaccine are derived from, URLC10 (up-regulated lung cancer 10), CDCA1 (cell division cycle-associated protein 1), KOC1 (IGF II mRNA Binding Protein 3). Upon administration, URLC10-CDCA1-KOC1 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing URLC10, CDCA1, KCO1 peptides, resulting in cell lysis and decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C95212 NCT: https://clinicaltrials.gov/ct2/show/NCT00681577 PMID:27720136 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5350 10643 54742 83540 5350 cancer vaccine Gene name: IGF2BP3 Gene name: LY6K Gene name: NUF2 URLC10-CDCA1-KOC1 Multipeptide Vaccine VO:0007072 A fusion DNA vaccine containing the first domain of fragment C (FrC) of tetanus toxin (TT865-1120) (p.DOM) fused to the human Wilms' Tumor gene-1 (WT1)-derived MHC class I-binding epitope WT1.126, with potential antitumor activity. Upon vaccination with p.DOM-WT1-126 DNA and subsequent electroporation, this vaccine may induce a WT1 epitope-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing cancer cells. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. The FrC of tetanus toxin contains the MHC II-binding sequence, p30, which induces T-helper cell activation for long-lasting immunity. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96738 NCT: https://clinicaltrials.gov/ct2/show/NCT01334060 PMID:27099895 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5165 https://github.com/vaccineontology/VO/issues/69 7490 5165 cancer vaccine Gene name: WT1 p.DOM-WT1-126 DNA Vaccine VO:0007073 A fusion DNA vaccine containing the first domain of fragment C (FrC) of tetanus toxin (TT865-1120) (p.DOM) fused to the human Wilms' Tumor gene-1 (WT1)-derived MHC class I-binding epitope WT1.37, with potential antitumor activity. Upon vaccination with p.DOM-WT1-37 DNA and subsequent electroporation, this vaccine may induce a WT1 epitope-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation in WT1-overexpressing cancer cells. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. The FrC of tetanus toxin contains the MHC II-binding sequence, p30, which induces T-helper cell activation for long-lasting immunity. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96737 NCT: https://clinicaltrials.gov/ct2/show/NCT01334060 PMID:27099895 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5471 https://github.com/vaccineontology/VO/issues/61 https://github.com/vaccineontology/VO/issues/62 7490 5471 cancer vaccine Gene name: WT1 p.DOM-WT1-37 DNA Vaccine VO:0007074 A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic activity. Vaccination with PR1 leukemia peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing proteinase 3, resulting in tumor cell lysis. Often overexpressed in leukemic cells, proteinase 3 is a serine proteinase that activates progelatinase A and is involved in angiogenesis and metastasis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2235 NCT: https://clinicaltrials.gov/ct2/show/NCT00004918 PMID:27654852 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5140 https://github.com/vaccineontology/VO/issues/139 140738 5140 cancer vaccine Gene name: TMEM37 PR1 Leukemia Peptide Vaccine VO:0007075 A vaccine made of cancer cells, parts of cancer cells, or pure tumor antigens (substances isolated from tumor cells). A tumor antigen vaccine may stimulate the body's immune system to find and kill cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2341 NCT: https://clinicaltrials.gov/ct2/show/NCT00100971 PMID:30348199 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5387 5387 cancer vaccine Tumor Cell Derivative Vaccine VO:0007076 A leukemia cancer vaccine comprised of a peptide derived from Wilms tumor gene 1 (WT1) protein, with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration, WT1 peptide vaccine OCV-501 may stimulate a CD4-positive helper T-lymphocyte-mediated immune response against WT1 expressing cells. WT1 protein, a zinc finger DNA-binding protein, is overexpressed in leukemic cells and in some solid tumors. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C106257 NCT: https://clinicaltrials.gov/ct2/show/NCT01961882 PMID:28321480 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5330 7490 5330 cancer vaccine Gene name: WT1 WT1 Peptide Vaccine OCV-501 VO:0007077 An immunotherapeutic consisting of the recombinant fusion protein WT1-A10 combined with the adjuvant ASO1B with potential immunostimulating and antineoplastic activities. Upon administration, WT1-A10/AS01B immunotherapeutic GSK2130579AWT1 may induce a WT1-specific cytotoxic T-lymphocyte (CTL) response against WT1-expressing tumor cells, resulting in cell lysis and the inhibition of cellular proliferation. The tumor-associated antigen WT1 (Wilms tumor protein-1) is overexpressed in most types of leukemia and in a variety of solid cancers. WT1-A10 is a 292 amino acid recombinant fusion protein consisting of a 12-mer truncated tat sequence (leader sequence) and amino acids number 2-281 of the WT1 sequence; ASO1B consists of a combination of the adjuvants monophosporyl lipd A (MPL) and Q21. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78865 NCT: https://clinicaltrials.gov/ct2/show/NCT00725283 PMID:16117707 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5354 7490 5354 cancer vaccine Gene name: WT1 WT1-A10/AS01B Immunotherapeutic GSK2130579A Vaccine VO:0007078 A recombinant vaccinia virus encoding carcinoembryonic antigen (CEA). CEA is overexpressed in several cancer cell types, including gastrointestinal, breast, and non-small cell lung cancers. Attenuated vaccinia virus is a highly effective immunizing agent that evokes both humoral and cell-mediated responses. Vaccination with this agent may evoke a cytotoxic immune response to CEA-expressing cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2809 NCT: https://clinicaltrials.gov/ct2/show/NCT00081848 PMID:7629885 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5401 https://github.com/vaccineontology/VO/issues/341 1048 5401 cancer vaccine Gene name: CEACAM5 Recombinant Vaccinia-CEA Vaccine VO:0007079 Human mesenchymal stem cells (MSCs) harvested from bone marrow of healthy adult donors and expanded ex vivo, with potential immunosuppressive activity. Remestemcel-L cells are hypo-immunogenic due to lack of major histocompatibility II (MHC II) molecule expression, eliciting little, if any, host immune response upon intravenous infusion. Infusion of allogeneic MSCs may result in: a) increased production of anti-inflammatory cytokines, such as interleukin-10, prostaglandin E, and hepatocyte growth factor; b) decreased mononuclear phagocyte expression of indoleamine 2,3,-dioxygenase, which catabolizes L-tryptophan into its pro-inflammatory metabolites; and c) modulated dendritic cell (DC)maturation and disrupted activities of natural killer (NK) cells and CD8+ and CD4+ T cells. In addition, pluripotent MSCs, upon administration, may be recruited to damaged tissue sites, differentiating along specific lineages when stimulated. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C67082 PMID:32018062 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4993 https://github.com/vaccineontology/VO/issues/353 4993 cancer vaccine Remestemcel-L Vaccine VO:0007080 A replication-competent oncolytic, telomerase-specific adenovirus serotype 5 (Ad5), with potential antineoplastic activity. OBP-301 contains the human telomerase reverse transcriptase (hTERT) gene promoter sequence that drives the expression of the E1A and E1B genes, and is linked to an internal ribosomal entry site (IRES). Upon administration, OBP-301 selectively infects and replicates in cancer cells that are expressing telomerase, which causes cell lysis. This adenovirus does not infect or replicate in normal, healthy cells. OBP-301 may also potentially be used as a chemosensitizer. hTERT, which encodes for the catalytic protein subunit of telomerase, is overexpressed in a variety of cancer cell types but not in normal, healthy cells. The insertion of an IRES further improves selectivity towards telomerase-expressing cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C119617 NCT: https://clinicaltrials.gov/ct2/show/NCT02293850 PMID:27673332 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5072 7015 5072 cancer vaccine Gene name: TERT Telomerase-specific Type 5 Adenovirus OBP-301 Vaccine VO:0007081 A proprietary cancer DNA vaccine that contains multiple natural and modified epitopes derived from the four tumor associated antigens, CEA, HER2/neu, p53, and MAGE 2/3. OSE 2101 also includes CAP1-6D, a heteroclitic CEA analog, and PADRE, a proprietary universal T-cell epitope that serves to enhance the immunogenicity of the epitopes. This agent has been shown to elicit cytotoxic T-lymphocyte responses against tumor cells expressing these multiple epitopes. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26645 NCT: https://clinicaltrials.gov/ct2/show/NCT02654587 PMID:18382135 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5528 https://github.com/vaccineontology/VO/issues/72 1048 2064 4101 4102 7157 5528 cancer vaccine Gene name: CEACAM5 Gene name: ERBB2 Gene name: MAGEA2 Gene name: MAGEA3 Gene name: TP53 EP-2101 Vaccine VO:0007082 A tumor-specific peptide encoded by patient-specific mutant p53 oncogene with potential immunostimulatory properties. The peptide (LPTGQDL) contains a frame shift mutation at amino acid position 134. It was used to pulse dendritic cells, which are then used in the adoptive immunotherapy setting and may stimulate the host immune system to mount a specific cytotoxic T lymphocyte response against tumor cells expressing the p35 mutation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38121 NCT: https://clinicaltrials.gov/ct2/show/NCT00049218 PMID:29301826 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5272 https://github.com/vaccineontology/VO/issues/125 https://github.com/vaccineontology/VO/issues/193 7157 5272 cancer vaccine Gene name: TP53 PR-151 Peptide Vaccine VO:0007083 An anti-idiotype murine monoclonal antibody (MoAb) specific to P3 MoAb with anti-metastatic effect. Racotumomab binds to the idiotype region of P3 MoAb and functionally mimics the three-dimensional structure of N-glycolyl ceramides of mono-sialyl lactose, the antigenic target of P3. As a result, this anti-idiotype antibody may stimulate the host immune system to elicit humoral and cellular immune responses against tumor cells expressing NeuGc-GM3 gangliosides, which are expressed in a wide variety of tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95024 NCT: https://clinicaltrials.gov/ct2/show/NCT01598454 PMID:26903265 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5201 https://github.com/vaccineontology/VO/issues/188 3265 3845 4893 5201 cancer vaccine Gene name: HRAS Gene name: KRAS Gene name: NRAS Racotumomab Vaccine VO:0007084 A replication-defective adenovirus containing a gene that encodes the human protein L523S with potential antineoplastic activity. Upon administration, recombinant adenovirus-L523S vaccine expresses L523S, which may stimulate antibody and cytotoxic T lymphocyte (CTL) responses against tumor cells expressing L523S. L523S is an RNA-binding protein that belongs to the KOC (K homology domain containing protein over-expressed in cancer) family of proteins. As an oncofetal protein, L523S is normally expressed in early embryonic tissues and certain normal adult tissues such as colon, fallopian tube, gall bladder, and ovary tissues but may be overexpressed in squamous cell cancers of the lung. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49289 NCT: https://clinicaltrials.gov/ct2/show/NCT00062907 PMID:16581300 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5074 https://github.com/vaccineontology/VO/issues/323 10643 5074 cancer vaccine Gene name: IGF2BP3 Recombinant Adenovirus-L523S Vaccine VO:0007085 A plasmid DNA encoding human L523S, an RNA-binding protein that belongs to the KOC (K homology domain containing protein overexpressed in cancer) family, with potential antineoplastic activity. Vaccination with L523S DNA may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells that express the L523S protein. As an oncofetal protein, L523S is normally expressed in early embryonic tissue, but is overexpressed in certain cancer cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49290 NCT: https://clinicaltrials.gov/ct2/show/NCT00062907 PMID:12750279 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5156 https://github.com/vaccineontology/VO/issues/327 10643 5156 cancer vaccine Gene name: IGF2BP3 Recombinant DNA-L523S Vaccine VO:0007086 A peptide vaccine preparation, containing recombinant human epidermal growth factor (rEGF) linked to the Neisseria meningitidis-derived recombinant immunogenic carrier protein P64k (rP64k) and mixed with the immunoadjuvant Montanide ISA 51, with potential active immunotherapy activity. Recombinant human EGF-rP64K/Montanide ISA 51 vaccine may trigger a humoral immune response against vaccine rEGF and rP64K and, so, against endogenous EGF. Antibody-mediated inhibition of endogenous EGF binding to its receptor, epithelial growth factor receptor (EGFR), may result in the inhibition of tumor cell proliferation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C70674 NCT: https://clinicaltrials.gov/ct2/show/NCT00516685 PMID:29661145 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5190 25003478 5190 cancer vaccine Gene name: LV28_RS26095 transcriptional regulator RegF Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine VO:0007087 An allogeneic lung cancer vaccine with potential immunostimulating and antineoplastic activities. Derived from allogeneic lung tumor cells, tergenpumatucel-L is engineered to express the murine alpha-1,3-galactosyltransferase (GalT), an enzyme humans lack. GalT catalyzes the expression of foreign alpha-1,3-galactosyl (alpha-gal) carbohydrate epitopes in glycoproteins and in glycolipids on the cell membranes of the allogeneic lung tumor cells present in the vaccine, essentially producing a 'xenograft'. The hyperacute rejection involves pre-existing human anti-alpha-gal antibodies that bind the foreign alpha-gal epitopes expressed by the vaccine tumor cell xenograft, resulting in complement-mediated cytotoxicity (CMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) towards endogenous lung tumor cells with unmodified carbohydrate epitopes. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66985 NCT: https://clinicaltrials.gov/ct2/show/NCT02460367 PMID:28238782 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5527 5527 cancer vaccine Tergenpumatucel-L Vaccine VO:0007088 A proprietary, allogeneic tumor cell vaccine expressing a recombinant secretory form of the heat shock protein gp96 fusion (gp96-Ig) with potential antineoplastic activity. Upon administration of viagenpumatucel-L, the irradiated live tumor cells continuously secrete gp96-Ig along with its chaperoned tumor associated antigens (TAAs) into the blood stream, thereby activating antigen presenting cells, natural killer cells and priming potent cytotoxic T lymphocytes (CTLs) to respond against TAAs on the endogenous tumor cells. Furthermore, this vaccine may induce long-lived memory T cells that could fight recurring cancer cells. gp96-Ig is constructed by replacing the KDEL retention sequence of gp96, normally an endoplasmatic reticulum-resident chaperone peptide, with the Fc portion of mouse and human IgG1. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61073 NCT: https://clinicaltrials.gov/ct2/show/NCT02439450 PMID:27364122 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5513 7184 5513 cancer vaccine Gene name: HSP90B1 Viagenpumatucel-L Vaccine VO:0007089 A cancer vaccine consisting of a mixture of a murine lymphoma-derived idiotype and interleukin-2 (IL-2) encapsulated in dimyristoylphosphatidylcholine liposomes. The use of a liposomal carrier confers immunogenicity to the naturally non-immunogenic idiotype. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2783 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5541 https://github.com/vaccineontology/VO/issues/74 107653060 5541 cancer vaccine Gene name: IL12 Oncovax-ID/IL-2 Vaccine VO:0007090 A lipid depot-based therapeutic cancer vaccine composed of survivin epitopes, a universal T Helper peptide and a polynucleotide adjuvant encapsulated in liposomes and then formulated in the hydrophobic carrier Montanide ISA51 VG, with potential immunopotentiating and antineoplastic activities. Upon injection of the maveropepimut-S, a depot is created at the injection site from which the antigens and adjuvant are released. This vaccine may elicit a long lasting cellular response against survivin-expressing cancers, resulting in a decrease in tumor cell proliferation and an induction of tumor cell death. Survivin, a member of the inhibitor of apoptosis (IAP) family expressed during embryonic development, is upregulated in a variety of human cancers while absent in most normal adult cells; its expression in tumors is associated with a more aggressive phenotype, decreased survival, and increased resistance to chemotherapy. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C97951 NCT: https://clinicaltrials.gov/ct2/show/NCT02323230 PMID:26405584 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5371 https://github.com/vaccineontology/VO/issues/364 373110 5371 cancer vaccine Gene name: Survivin Survivin Antigen Vaccine DPX-Survivac VO:0007091 A vaccine consisting of lymphoma-specific immunoglobulin that is not conjugated to a carrier molecule. Vaccination with unconjugated lymphoma Ig Id may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against lymphoma cells, resulting in decreased tumor growth.‚Äö√†√∂‚àö¬ß Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2821 PMID:18715553 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5046 5046 cancer vaccine Unconjugated Lymphoma Ig Id Vaccine VO:0007092 A peptide cancer vaccine consisting of peptides derived from the melanoma antigen NA-17, the human leukocyte antigen HLA-A2-restricted human melanoma antigen 3 (MAGE-3.A2) and the cancer-testis antigen (NY-ESO-1), with potential immunostimulating and antineoplastic activities. Upon administration, the NA-17/MAGE-3.A2/NY-ESO-1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing NA-17, MAGE-3.A2 and NY-ESO-1, resulting in tumor cell lysis. The tumor-associated antigens (TAAs) NA-17, MAGE-3.A2 and NY-ESO-1 are overexpressed in a variety of cancer cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96042 NCT: https://clinicaltrials.gov/ct2/show/NCT01308294 PMID:25941588 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5305 https://github.com/vaccineontology/VO/issues/48 1485 4102 5305 cancer vaccine Gene name: CTAG1B Gene name: MAGEA3 NA-17/MAGE-3.A2/NY-ESO-1 peptide vaccine VO:0007093 A peptide cancer vaccine comprised of human leukocyte antigen HLA-A2-restricted peptide derived from a metastatic melanoma cell line of patient NA17, with potential immunomodulating and antineoplastic activity. NA17. A2 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumors that express this antigen, which may result in a reduction in tumor size. This NA17 specific antigen, encoded by an intron sequence of N-acetylglucosaminyltransferase V (GnT-V) gene, is expressed in about 50% of melanomas. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2680 NCT: https://clinicaltrials.gov/ct2/show/NCT01307618 PMID:16133111 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5323 https://github.com/vaccineontology/VO/issues/49 107653060 2315 4102 6490 5323 cancer vaccine Gene name: IL12 Gene name: MAGEA3 Gene name: MLANA Gene name: PMEL NA17.A2 peptide vaccine VO:0007094 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with a peptide derived from the tumor associated antigen human cancer-testis antigen NY-ESO-1 (NY-ESO-1(157-165)), with potential immunostimulatory and antineoplastic activities. Upon administration, the NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccine may stimulate the immune system to mount both an anti-tumoral cytotoxic T-lymphocyte (CTL) and an antibody-mediated immune response against NY-ESO-1-expressing tumor cells, which may result in tumor cell lysis. NY-ESO-1 is expressed both in normal testes and on the surfaces of various tumor cells, and plays a key role in tumor cell proliferation and survival. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114380 NCT: https://clinicaltrials.gov/ct2/show/NCT00313508 PMID:16311731 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5100 1485 2315 4102 6490 7299 5100 cancer vaccine Gene name: CTAG1B Gene name: MAGEA3 Gene name: MLANA Gene name: PMEL Gene name: TYR NY-ESO-1(157-165) peptide-pulsed autologous dendritic cell vaccine VO:0007095 A cell-based cancer vaccine composed of dendritic cells (DC) pulsed with peptides derived from the tumor-associated antigens human cancer/testis antigen NY-ESO-1 and melanoma antigen recognized by T-cells (MART-1/Melan-A), with potential immunostimulatory and antineoplastic activities. Upon administration, the NY-ESO-1/MART-1 peptide-pulsed DC vaccine may stimulate the immune system to mount an anti-tumor cytotoxic T-lymphocyte (CTL) response against NY-ESO-1/MART-1-expressing tumor cells, which may result in tumor cell lysis. NY-ESO-1 is expressed both in normal testes and on the surfaces of various tumor cells. MART-1 is expressed by melanoma cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C120129 NCT: https://clinicaltrials.gov/ct2/show/NCT00798629 PMID:16311731 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5366 1485 2315 5366 cancer vaccine Gene name: CTAG1B Gene name: MLANA NY-ESO-1/MART-1 peptide-pulsed dendritic cell vaccine VO:0007096 A cancer vaccine consisting of PEP-3, a synthetic peptide encompassing a tumor-specific mutated segment of the epidermal growth factor receptor type vIII (EGFRvIII), conjugated to the naturally-occurring immunoadjuvant keyhole limpet hemocyanin (KLH) with potential immunostimulating and antineoplastic activities. Upon administration, PEP-3-KLH conjugate vaccine may induce a cytotoxic immune response against tumor cells that overexpress EGFRvIII; this antitumoral immune response may involve antibody-dependent cellular cytotoxicity (ADCC). Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C74070 NCT: https://clinicaltrials.gov/ct2/show/NCT00626015 PMID:14519652 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5480 https://github.com/vaccineontology/VO/issues/117 1956 5480 cancer vaccine Gene name: EGFR PEP-3-KLH conjugate vaccine VO:0007097 A whole cell vaccine derived from a distinct subset of dendritic cells (DCs) with a plasma cell-like morphology that exhibits immunomodulating activity. Plasmacytoid dendritic cells (pDCs) express a characteristic set of surface markers, such as CD123 (interleukin-3 receptor alpha chain), BDCA-2 (blood dendritic cell antigen 2; CD303) and BDCA-4 (CD304), as well as intracellular toll-like receptors 7 and 9. Upon stimulation, the activated pDCs produce substantial amounts of interferon (IFN) alpha, and to a lesser degree IFN-beta, as well as other cytokines and chemokines, such as tumor necrosis factor alpha and interleukins 1, 6 and 8. In addition, these pDCs, directly or indirectly stimulate T-cells, B-cells and natural killer cells. This may potentially lead to increased immunity against tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103192 NCT: https://clinicaltrials.gov/ct2/show/NCT01690377 PMID:30049538 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5006 https://github.com/vaccineontology/VO/issues/121 170482 3598 51284 54106 8829 5006 cancer vaccine Gene name: CLEC4C Gene name: IL13RA2 Gene name: NRP1 Gene name: TLR7 Gene name: TLR9 plasmacytoid dendritic cell vaccine VO:0007098 rime/boost vaccination proved to be of no advantage or even detrimental in therapeutic settings in B16F1 and transgenic adenocarcinoma of the mouse prostate (TRAMP) models, respectively Jie Zheng Jimmy Guo Oliver He Virginia He PMID:23539449 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4074 https://github.com/vaccineontology/VO/issues/140 4074 cancer vaccine prime/boost DC-TRP-2 melanoma vaccine VO:0007099 A melanoma vaccine comprised of a recombinant fowlpox vector construct encoding a modified epitope of the melanoma antigen glycoprotein 100 (gp100), ES-2092M(gp100), containing an endoplasmic reticulum signal sequence targeted to the endoplasmic reticulum apparatus. Vaccination with recombinant fowlpox-gp100p209 vaccine may stimulate the host immune system more efficiently to mount a cytotoxic T lymphocyte response against tumor cells expressing the gp100 antigen. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2806 NCT: https://clinicaltrials.gov/ct2/show/NCT00080353 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5274 6490 5274 cancer vaccine Gene name: gp100 (PMEL) recombinant Fowlpox-gp100p209 vaccine VO:0007100 A cancer vaccine consisting of a replication-defective recombinant fowlpox virus that encodes for the murine melanoma antigen glycoprotein 100 (mgp100) with potential antineoplastic activity. Vaccination with recombinant fowlpox-mgp100 vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the gp100 antigen, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2805 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5499 https://github.com/vaccineontology/VO/issues/332 5499 cancer vaccine recombinant Fowlpox-Mgp100 vaccine VO:0007101 A recombinant fowlpox virus vaccine with potential antineoplastic activity. Binding to the melanoma antigen tyrosinase, recombinant fowlpox-tyrosinase vaccine generates cellular immune responses against melanoma cells expressing the tyrosinase antigen; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2807 NCT: https://clinicaltrials.gov/ct2/show/NCT00054535 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5518 https://github.com/vaccineontology/VO/issues/335 7299 5518 cancer vaccine Gene name: Tyrosinase recombinant Fowlpox-Tyrosinase vaccine VO:0007102 A recombinant chaperone-peptide complex-based vaccine composed of a complex between heat shock protein hsp110 and the human melanoma-associated antigen gp100, with potential antineoplastic activity. Upon vaccination, recombinant hsp110-gp100 chaperone complex activates the immune system to exert a cytotoxic T cell immune response and antigen-specific interferon-gamma production against gp100-overexpressing cancer cells. Gp100, is overexpressed in a variety of cancer cell types. Hsp110, binds to and chaperones full-length proteins during heat shock; as an immunoadjuvant it is able to enhance an immune response against antigen(s) and stimulate T-lymphocyte activation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103830 NCT: https://clinicaltrials.gov/ct2/show/NCT01744171 PMID:12750279 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5359 6490 5359 cancer vaccine Gene name: gp100 (PMEL) recombinant human Hsp110-gp100 chaperone complex vaccine VO:0007103 A recombinant vaccinia virus encoding a modified peptide of the gp100 melanoma-melanocyte antigen with potential use in cancer immunotherapy. gp100 human antigen is a wild type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. gp100p209 is a fragment epitope of gp100 in which the threonine in position 2 is replaced with methionine; this modification may stimulate tumor infiltrating lymphocytes (TIL) more efficiently.‚Äö√†√∂‚àö¬ß Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29566 NCT: https://clinicaltrials.gov/ct2/show/NCT00116597 PMID:15133631 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5393 https://github.com/vaccineontology/VO/issues/344 6490 5393 cancer vaccine Gene name: gp100 (PMEL) recombinant Vaccinia-gp100:209-217 vaccine VO:0007104 A recombinant vaccinia virus encoding a modified peptide of the gp100 melanoma-melanocyte antigen with potential use in cancer immunotherapy. gp100 human antigen is a wild type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. This recombinant vaccinia Mgp100 encodes a fragment epitope of gp100 bearing 2 amino acids substitution; T->M at position 210 and 288 A ->V at position 210. This modification may stimulate tumor infiltrating lymphocytes (TIL) more efficiently. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C51978 PMID:12912944 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5505 https://github.com/vaccineontology/VO/issues/346 6490 5505 cancer vaccine Gene name: gp100 (PMEL) recombinant Vaccinia-Mgp100 vaccine VO:0007105 A cancer vaccine consisting of an inactivated recombinant vaccinia virus encoding epitope peptides derived from melanoma-related HLA-A2-restricted tumor-associated antigens (TAAs), including Melan-A(27-35), gp100(280-288) and tyrosinase(1-9), and two co-stimulatory B7 proteins, B7.1 (CD80) and B7.2 (CD86). Upon administration, recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine may stimulate a cytotoxic T-lymphocyte response against melanoma cells that express TAAs which share epitopes with the epitope peptides expressed by the vaccine viral vector, resulting in tumor cell lysis; vaccine viral vector-expressed co-stimulatory proteins B7.1 and B7.2 may enhance the cytotoxic T-lymphocyte immune response to the TAAs. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48638 PMID:30626434 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5232 12524 2315 6490 941 5232 cancer vaccine Gene name: CD80 Gene name: Cd86 Gene name: MLANA-Dupli Gene name: gp100 (PMEL) recombinant Vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine VO:0007106 A recombinant vaccinia virus encoding the melanocyte differentiation antigen tyrosinase-related protein-1 (TRP-1) with potential use in cancer immunotherapy. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29564 PMID:19047169 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5063 https://github.com/vaccineontology/VO/issues/352 22178 5063 cancer vaccine Gene name: TRP-1 recombinant Vaccinia-TRP1 vaccine VO:0007107 A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2430 NCT: https://clinicaltrials.gov/ct2/show/NCT01216436 PMID:26241951 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5194 https://github.com/vaccineontology/VO/issues/360 1493 8784 5194 cancer vaccine Gene name: CTLA4 Gene name: TNFRSF18 Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant VO:0007108 A recombinant plasmid DNA vaccine that encodes two peptides, tyrosinase 207-216 and tyrosinase 1-17, both of which are derived from human tyrosinase. Jie Zheng Jimmy Guo Oliver He Virginia He obsolete Synchotrope TA2M vaccine true VO:0007109 A recombinant plasmid DNA vaccine encoding epitopes of tyrosinase with potential antineoplastic activity. Synchotrope TA2M vaccine contains a plasmid encoding 2 epitopes, amino acid sequences 207-216 and 1-17 of tyrosinase, a protein frequently expressed by melanoma cells. Vaccination with the TA2M plasmid DNA vaccine may induce the production of anti-tyrosinase antibodies as well as elicit a cytotoxic T-lymphocyte (CTL) response against tyrosinase-expressing tumor cells, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2650 NCT: https://clinicaltrials.gov/ct2/show/NCT00023647 PMID:12833467 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4002 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5218 https://github.com/vaccineontology/VO/issues/407 7299 4002 5218 cancer vaccine Gene name: Tyrosinase Synchotrope TA2M DNA vaccine VO:0007110 A bivalent DNA vaccine encoding epitopes for both Melan-A (MART-1) and tyrosinase with potential antineoplastic activity. Synchrovax SEM plasmid DNA vaccine contains a plasmid pSEM that encodes 4 epitopes: Melan-A (26-35), Melan-A (31-96), tyrosinase (1-9), and tyrosinase (369-377). Both Melan-A and tyrosinase are tumor antigens associated with melanoma. Vaccination with this plasmid DNA vaccine may induce both humoral and cytotoxic lymphocyte (CTL) responses against cells expressing either or both of these antigens, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28549 NCT: https://clinicaltrials.gov/ct2/show/NCT00033228 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5506 https://github.com/vaccineontology/VO/issues/408 2315 7299 5506 cancer vaccine Gene name: MLANA-Dupli Gene name: Tyrosinase Synchrovax SEM plasmid DNA vaccine VO:0007111 A cancer vaccine containing synthetic epitope peptides derived from melanoma tumor-associated antigens (TAAs), including melanoma-melanocyte antigen gp100(280-288), melanoma-associated antigen tyrosinase(1-9), and melanoma-associated antigen melan-A(27-35). Upon administration, synthetic melanoma-associated antigens vaccine may stimulate a cytotoxic T-lymphocyte immune response against melanoma cells that express TAAs which share epitopes with the vaccine epitope peptides, resulting in tumor cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48639 NCT: https://clinicaltrials.gov/ct2/show/NCT00116597 PMID:11874634 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5217 https://github.com/vaccineontology/VO/issues/411 6490 5217 cancer vaccine Gene name: PMEL - obsolete synthetic melanoma-associated antigens vaccine VO:0007112 A RNA-lipoplex (RNA-LIP)-based cancer vaccine containing four naked ribonucleic acid (RNA)-drug products (DPs) RBL001.1, RBL002.2, RBL003.1, and RBL004.1 encoding the four melanoma-associated antigens (MAAs), the cancer-testis antigen NY-ESO-1, the human melanoma-associated antigen A3 (MAGE-A3), tyrosinase, and putative tyrosine-protein phosphatase (TPTE), encapsulated in liposomes, with potential antineoplastic activity. Upon intravenous administration of the tetravalent RNA-lipoplex cancer vaccine BNT111, the liposomes protect the RNA from degradation in the bloodstream, travel to the spleen and are taken up by antigen-presenting cells (APCs). The RNA is translocated to the cytoplasm and translated into the four tumor-associated proteins. The expressed proteins are processed and the human leukocyte antigen (HLA)-peptide complexes are presented to the immune system. This results in the production of various pro-inflammatory cytokines and induces antigen-specific CD8+ and CD4+ T-cell responses against the four selected MAAs NY-ESO-1, MAGE-A3, tyrosinase, and TPTE. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C122396 NCT: https://clinicaltrials.gov/ct2/show/NCT02410733 PMID:21093980 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5114 416115 5114 cancer vaccine Gene name: MAGE-1 tetravalent RNA-lipoplex cancer vaccine VO:0007113 Jie Zheng Jimmy Guo Oliver He Virginia He PMID:23090079 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4004 2315 6409 7299 4004 cancer vaccine Gene name: MLANA Gene name: PMEL Gene name: Tyrosinase TLR-9/GM vaccine VO:0007114 Jie Zheng Jimmy Guo Oliver He Virginia He PMID:23509826 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4075 4075 cancer vaccine TriMixDC-MEL Vaccine VO:0007115 A recombinant peptide consisting of amino acid residues 180 to 188 of the tyrosinase-related protein 2 (TRP2). Expressed by cells of melanocyte origin, TRP2 is an enzyme involved in the process that converts tyrosinase to melanin pigments. Vaccination with TRP-2: 180-188 peptide may induce cytotoxic T lymphocyte (CTL) responses to melanoma cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2815 NCT: https://clinicaltrials.gov/ct2/show/NCT00022438 PMID:16906394 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5325 1638 5325 cancer vaccine Gene name: TRP-2 TRP-2: 180-188 peptide vaccine VO:0007116 A recombinant peptide consisting of amino acid residues 1 to 9 of the tyrosinase-related protein 1 (TRP1). Expressed by cells of melanocyte origin, TRP1 is an enzyme involved in the process that converts tyrosinase to melanin pigments. Vaccination with TRP1(0RF3):1-9 may stimulate cytotoxic T cell responses to melanoma cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2816 NCT: https://clinicaltrials.gov/ct2/show/NCT00019383 PMID:8027058 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5487 22178 5487 cancer vaccine Gene name: TRP-1 TRP1(0RF3):1-9 peptide vaccine VO:0007117 A peptide vaccine containing a tyrosinase epitope conjugated with keyhole lymphocyte hemocyanin (KLH) with potential antineoplastic activity. Tyrosinase, one of the melanoma differentiation antigens, is the rate-limiting enzyme for melanin synthesis. This tyrosine epitope is conjugated with KLH, which serves as an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with tyrosinase-KLH peptide vaccine may produce anti-tyrosinase antibodies as well as elicit a cytotoxic T lymphocyte (CTL) response against cells expressing tyrosinase antigen, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2384 NCT: https://clinicaltrials.gov/ct2/show/NCT00028431 PMID:21143299 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5060 7299 5060 cancer vaccine Gene name: Tyrosinase tyrosinase-KLH vaccine VO:0007118 Jie Zheng Jimmy Guo Oliver He Virginia He PMID:14581425 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3999 tyrosinase240-251s, 368-376d vaccine 3999 cancer vaccine tyrosinase240-251S, 368-376D vaccine VO:0007119 A cancer vaccine with VMCL was not associated with a statistically significant improvement in OS or RFS, with CIs not ruling out important gains from such treatment. Jie Zheng Jimmy Guo Oliver He Virginia He PMID:12377961 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4007 4007 cancer vaccine vaccinia melanoma cell lysates (VMCL) vaccine VO:0007120 Jie Zheng Jimmy Guo Oliver He Virginia He PMID:3155379 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4023 4023 cancer vaccine Vaccinia melanoma oncolysates (VMO) vaccine VO:0007121 A recombinant vaccinia virus that encodes granulocyte-macrophage colony stimulating factor (GM-CSF). By activating T-cells and macrophages, vaccination with recombinant vaccinia GM-CSF may enhance the host immune system response to poorly immunogenic tumors, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2674 NCT: https://clinicaltrials.gov/ct2/show/NCT00002817 PMID:8894677 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5508 12981 5508 cancer vaccine Gene name: Csf2-Mouse Vaccinia-GM-CSF vaccine VO:0007122 A vaccine consisting of recombinant vaccinia virus, based on the modified vaccinia virus Ankara (MVA) that encodes the melanoma-associated antigen tyrosinase. Vaccination with vaccinia-tyrosinase may stimulate the host immune system to mount a cytotoxic T-cell response against tumor cells expressing tyrosinase. Tyrosinase is a melanoma-specific differentiation agent that catalyzes the synthesis of the melanin precursor L-3,4-dihydroxyphenylalanine (L-DOPA). Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2531 NCT: https://clinicaltrials.gov/ct2/show/NCT00019734 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5223 7299 5223 cancer vaccine Gene name: Tyrosinase Vaccinia-Tyrosinase vaccine VO:0007123 A plasmid DNA vaccine, encoding an epitope of mouse tyrosinase, with potential antineoplastic activity. Administered via intramuscular electroporation, vaccination with xenogeneic tyrosinase DNA vaccine may induce both humoral and cytotoxic lymphocyte (CTL) immune responses against melanoma cells that express tyrosinase, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C68839 NCT: https://clinicaltrials.gov/ct2/show/NCT00471133 PMID:4019903 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5416 7299 5416 cancer vaccine Gene name: Tyrosinase Xenogeneic Tyrosinase DNA vaccine VO:0007124 A recombinant replication-defective adenovirus which encodes the gene for the cytokine human interferon-beta (IFN-beta). Once inserted into and replicating in host tumor cells, recombinant adenovirus-hIFN-beta expresses human IFN-beta, which may stimulate an antiproliferative natural killer (NK) cell response against tumor cells and induce caspase-mediated tumor cell apoptosis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28550 NCT: https://clinicaltrials.gov/ct2/show/NCT00066404 PMID:19893592 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5510 https://github.com/vaccineontology/VO/issues/321 3456 5510 cancer vaccine Gene name: IFNB1 Recombinant Adenovirus-hIFN-beta Vaccine VO:0007125 A modified recombinant nonapeptide (LMLGEFLKL) derived from the anti-apoptosis protein survivin with potential immunopotentiating and antineoplastic activities. Upon administration, survivin Sur1M2 peptide vaccine may elicit humoral and cellular immune responses against survivin-expressing cancers, resulting in decreased tumor cell proliferation and tumor cell death. The survivin protein inhibits caspase activation and apoptosis; it is undetectable in normal adult tissues but is expressed by several human cancers including lung, colon, breast, pancreas, and prostate cancer as well as hematopoietic malignancies and skin cancers. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C71741 NCT: https://clinicaltrials.gov/ct2/show/NCT00499577 PMID:29057249 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5265 https://github.com/vaccineontology/VO/issues/365 7015 5265 cancer vaccine Gene name: TERT Survivin Sur1M2 Peptide Vaccine VO:0007126 A vaccine consisting of myeloma-specific immunoglobulin that is not conjugated to a carrier molecule. Vaccination with unconjugated myeloma Ig Id may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against myeloma cells, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2822 NCT: https://clinicaltrials.gov/ct2/show/NCT00001561 PMID:4108872 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5391 5391 cancer vaccine Unconjugated Myeloma Ig Id Vaccine VO:0007127 A peptide vaccine comprised of an epitope of human Wilms tumor 1 (WT-1) with potential antineoplastic activity. WT-1, a transcription factor, is overexpressed in most types of leukemia and in some solid cancers. Vaccination with the WT-1 analog peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against WT-1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C64635 NCT: https://clinicaltrials.gov/ct2/show/NCT01827137 PMID:25802083 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5341 7490 5341 cancer vaccine Gene name: WT1 WT1 Analog Peptide Vaccine VO:0007128 A peptide cancer vaccine comprised of a peptide derived from Wilms tumor gene 1 (WT1) protein, with potential immunomodulating and antineoplastic activities. Upon administration, WT2725 may induce a specific cytotoxic T-lymphocyte (CTL) response against WT1-overexpressing tumor cells. WT1 protein, a zinc finger DNA-binding protein, is overexpressed in leukemic cells and in a vast number of non-hematological solid tumors. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C102751 NCT: https://clinicaltrials.gov/ct2/show/NCT01621542 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5027 7490 5027 cancer vaccine Gene name: WT1 WT1 Peptide Vaccine WT2725 VO:0007129 A cancer vaccine containing immunogenic, HLA-A2-specific epitopes derived from X-box-binding protein 1-unspliced (XBP1-US), XBP1-spliced (SP), syndecan-1 (CD138), and CS1 (CD2 subset 1, CRACC, SLAMF7, CD319) with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration, XBP1-US/XBP1-SP/CD138/CS1 multipeptide vaccine PVX-410 may stimulate the immune system to induce a cytotoxic T-lymphocyte response against the four myeloma-specific antigens. The tumor associated antigens (TAAs) XBP1-US, XBP1-SP, CD138 and CS1, are overexpressed on the surface of multiple myeloma (MM) cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C103823 NCT: https://clinicaltrials.gov/ct2/show/NCT01718899 PMID:30128502 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5415 22433 57823 6382 5415 cancer vaccine Gene name: SDC1 Gene name: SLAMF7 Gene name: Xbp1 XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 VO:0007130 A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with autologous, lethally irradiated cancer cells and mixed with the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulatory and antineoplastic activities. Upon vaccination, ovapuldencel-T may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against the repertoire of tumor associated antigens (TAAs) found in the irradiated cancer cells. GM-CSF enhances the activation of dendritic cells (DCs) and promotes antigen presentation to both B- and T-lymphocytes. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C113651 NCT: https://clinicaltrials.gov/ct2/show/NCT02033616 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5481 https://github.com/vaccineontology/VO/issues/71 5481 cancer vaccine Ovapuldencel-T Vaccine VO:0007131 A cancer vaccine comprised of synthetic peptides corresponding to naturally-occurring peptides derived from ovarian cancer cell antigens. Ovarian cancer peptide vaccine may elicit a cytotoxic T-cell response against tumor cells expressing the related ovarian cancer cell antigens. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C48414 NCT: https://clinicaltrials.gov/ct2/show/NCT00091273 PMID:20445345 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5502 5502 cancer vaccine Ovarian Cancer Peptide Vaccine VO:0007132 A cancer vaccine containing autologous dendritic cells (DCs) that are transfected with mRNAs extracted from amplified ovarian cancer stem cells, and mRNAs of the universal tumor antigens human telomerase reverse transcriptase (hTERT) and survivin with potential immunostimulatory and antineoplastic activities. Upon administration, ovarian cancer stem cell/hTERT/survivin mRNAs-loaded autologous DC-006 vaccine may elicit a highly specific cytotoxic T-cell (CTL) response against ovarian cancer cells expressing hTERT, survivin, and specific ovarian cancer stem cell antigens. hTERT, the catalytic subunit of human telomerase, and survivin, a member of the inhibitor of apoptosis (IAP) family of proteins, may be upregulated in certain tumor cell types, playing key roles in tumor cell growth and survival. Ovarian cancer stem cells contain a specific range of antigens that are essential for the neoplastic growth and survival of ovarian cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C96739 NCT: https://clinicaltrials.gov/ct2/show/NCT01334047 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5403 7015 5403 cancer vaccine Gene name: TERT Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine VO:0007133 A dendritic cell (DC)-based cancer vaccine composed of autologous dendritic cells (DCs) activated with an ovarian tumor cell lysate containing tumor-associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, the ovarian tumor antigen-activated autologous DC vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells expressing ovarian tumor cell-specific antigens, which may result in ovarian tumor cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C115105 NCT: https://clinicaltrials.gov/ct2/show/NCT02107950 PMID:22862954 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5280 3696 3728 780 5280 cancer vaccine Gene name: DDR1 Gene name: ITGB8 Gene name: JUP Ovarian Tumor Antigen-activated Autologous Dendritic Cell Vaccine VO:0007134 A peptide vaccine consisting of 10 synthetic long peptides (SLPs), 25-30 amino acids in size and derived from the middle portion of p53 (amino acids 70-251), mixed with the adjuvant Montanide ISA-51 with potential immunostimulatory and antitumor activities. Upon administration, p53 synthetic long peptide (70-251) vaccine may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against p53-expressing tumor cells. p53, a tumor associated antigen (TAA), may be overexpressed in variety of cancer cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82420 NCT: https://clinicaltrials.gov/ct2/show/NCT00844506 PMID:26334096 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5278 https://github.com/vaccineontology/VO/issues/59 7157 5278 cancer vaccine Gene name: TP53 P53-Synthetic Long Peptides Vaccine VO:0007135 A cell-based cancer vaccine with potential antineoplastic activity. PA-1-STK ovarian carcinoma vaccine is produced by transducing the ovarian cancer cell line, PA-1, with the herpes simplex thymidine kinase (HSV-tk) gene, resulting in a cell line, PA-1-STK, that permanently expresses the HSV tk gene. Upon transfection into malignant cells, this vaccine is capable of sensitizing tumor cells in response to an antiviral drug such as ganciclovir, which is readily phosphorylated by the TK enzyme to its active form. Administration of ganciclovir following PA-1 STK transfection results in enhanced cytotoxicity of the transfected tumor cells. Additionally, adjacent non-transfected cells are also killed by the activated antiviral drug, a phenomenon referred to as the bystander effect that occurs with this type of suicide-gene transfer technique. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2428 NCT: https://clinicaltrials.gov/ct2/show/NCT00006216 PMID:7578411 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5245 https://github.com/vaccineontology/VO/issues/57 79447 5245 cancer vaccine Gene name: PAGR1 PA-1-STK Ovarian Carcinoma Vaccine VO:0007136 An oncolytic thymidine kinase (TK)-deleted vaccinia poxvirus expressing human GM-CSF (hGM-CSF) with antineoplastic activity. Upon intratumoral or intravenous administration, pexastimogene devacirepvec selectively infects and lyses tumor cells. While vaccinia displays a natural tumor cell tropism, deletion of the TK gene increases the tumor selectivity of vaccinia by limiting viral replication to cells expressing high levels of TK, such as certain cancer cells. hGM-CSF expression by this agent helps recruit antigen presenting cells (APCs), such as dendritic cells (DCs) and macrophages, to virally infected tumor cells, thereby initiating an antitumoral immune response. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C71533 NCT: https://clinicaltrials.gov/ct2/show/NCT02562755 PMID:31413923 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5078 https://github.com/vaccineontology/VO/issues/119 1437 5078 cancer vaccine Gene name: hGM-CSF Pexastimogene-devacirepvec Vaccine VO:0007137 A plasmid DNA vaccine containing mammalian expression vector pUMVC3, encoding epitopes of human insulin-like growth factor-binding protein 2 (hIGFBP-2) with potential immunostimulating and antineoplastic activities. Upon vaccination, pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against hIGFBP-2-expressing cells. The tumor associated antigen (TAA) hIGFBP-2, a member of the insulin like growth factor receptor family, is overexpressed in a number of cancer cell types and its expression has been associated with increased invasiveness. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95727 NCT: https://clinicaltrials.gov/ct2/show/NCT01322802 PMID:17102977 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5365 https://github.com/vaccineontology/VO/issues/186 3484 5365 cancer vaccine Gene name: hIGFBP-2 pUMVC3-hIGFBP-2 Multi-Epitope Plasmid DNA Vaccine VO:0007138 A recombinant retrovirus containing the modified murine retroviral vector MFG-S encoding a chimeric construct, MOv18-gamma. MOv18 is a murine monoclonal antibody developed against epitope of human folate binding protein, which is overexpressed on more than 90% of non-mucinous epithelial ovarian neoplasms. The chimeric construct (MOv18-gamma) encodes the variable region of MOv18 antibody, and the gamma chain of human T-cell receptor. This virion might be used to transduce autologous T lymphocytes, and reintroduced back to the patient after expansion ex vivo to invoke specific immune response against ovarian cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29192 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5131 https://github.com/vaccineontology/VO/issues/356 2348 5131 cancer vaccine Gene name: FOLR1 Retroviral Vector MFGS-MOv18-gamma Vaccine VO:0007139 A fowlpox vaccine containing the tumor-associated antigen mucin-1 (MUC1), found in pancreatic tumor cells, and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3; TRICOM), which is designed to enhance antigen presentation and activation of immune responses critical for tumor destruction. Vaccination with this agent may elicit a host immune response against MUC1-expressing tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29558 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5477 https://github.com/vaccineontology/VO/issues/357 4582 5477 cancer vaccine Gene name: MUC1 rF-MUC1(DF3)/TRICOM Vaccine VO:0007140 A whole cell vaccine comprised of irradiated allogenic pancreatic tumor cells transfected with a plasmid DNA encoding human sargramostim (GM-CSF). Vaccination results in expression of GM-CSF, which induces proliferation and differentiation hematopoietic lineage cells as well as stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Furthermore, administration of this pancreatic tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2445 NCT: https://clinicaltrials.gov/ct2/show/NCT00389610 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5340 100137216 5340 cancer vaccine Gene name: GM-CSF Sargramostim Plasmid DNA Pancreatic Tumor Cell Vaccine VO:0007141 A peptide vaccine containing an HLA-A*2402-restricted epitope of vascular endothelial growth factor receptor 1 (VEGFR1 or Flt-1) with potential immunostimulating, antiangiogenic, and antineoplastic activities. Upon vaccination, VEGFR1-1084 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against VEGFR1-expressing endothelial cells of the tumor microvasculature, which may inhibit tumor angiogenesis and tumor cell proliferation. VEGFR1, a receptor tyrosine kinase, may be overexpressed on endothelial cells of the tumor microvasculature and is associated with tumor cell proliferation, invasion and tumor angiogenesis. HLA-A*2402 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*2402 may improve antigenicity. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C77895 NCT: https://clinicaltrials.gov/ct2/show/NCT00655785 PMID:26190488 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5214 2321 5214 cancer vaccine Gene name: FLT1 VEGFR1-1084 Peptide Vaccine VO:0007142 A peptide vaccine containing an HLA-A*2402-restricted epitope of vascular endothelial growth factor receptor (VEGFR) 2 with potential immunostimulatory and antineoplastic activities. Upon administration, VEGFR2-169 peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against VEGFR2-expressing tumor cells. VEGFR2, a receptor tyrosine kinase, is overexpressed by a variety of tumor types; overexpression is associated with tumor cell proliferation and tumor angiogenesis. HLA-A*2402 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*2402 may improve antigenic peptide immunogenicity. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74090 NCT: https://clinicaltrials.gov/ct2/show/NCT00639925 PMID:15930316 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5419 16542 5419 cancer vaccine Gene name: Kdr VEGFR2-169 Peptide Vaccine VO:0007143 A cancer vaccine containing HLA class I- and II-binding peptides derived from the NY-ESO-1/LAGE-1 cancer/testis antigen with potential immunostimulatory and antineoplastic activities. Upon administration, NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine may induce a cytotoxic immune response against tumor cells that over-express NY-ESO-1/LAGE-1. Rarely expressed by normal cells, the NY-ESO-1/LAGE-1 cancer/testis antigen has been shown to be preferentially expressed on the surface of some cancer cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C74066 NCT: https://clinicaltrials.gov/ct2/show/NCT00616291 PMID:21131422 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5379 https://github.com/vaccineontology/VO/issues/111 1485 30848 5379 cancer vaccine Gene name: CTAG1B Gene name: CTAG2 NY-ESO-1/LAGE-1 peptide vaccine VO:0007144 An autologous dendritic cell (DCs) vaccine targeting prostate cancer with immunostimulating activity. The autologous DC vaccine is prepared via transfecting DCs with mRNAs extracted from primary prostate cancer tissue, and mRNAs of human telomerase reverse transcriptase (hTERT) and survivin. Upon administration, this DC vaccine may elicit a potent cytotoxic T-cell (CTL) response against prostate cancer cells, resulting in tumor cell death. Both hTERT and survivin are essential in neoplastic growth, and are considered to be universal tumor antigens. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C95771 NCT: https://clinicaltrials.gov/ct2/show/NCT00345293 PMID:30505813 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5205 7015 5205 cancer vaccine Gene name: TERT Primary Prostate Cancer Tissue/hTERT/Survivin mRNA-loaded Autologous Dendritic Cell Vaccine VO:0007145 This DNA vaccine expressed prostate-specific membrane antigen (PSMA) Jie Zheng Jimmy Guo Oliver He Virginia He PMID:22729556 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3710 3710 cancer vaccine Prostate cancer DNA vaccine pDOM-PSMA27 encoding PSMA VO:0007146 A cell-based vaccine derived from prostate cancer with potential immunopotentiating and antineoplastic activities. Prostate cancer vaccine ONY-P1 is derived from three irradiated allogeneic prostate cancer cell lines that represent different stages of prostate cancer and express a broad range of prostate and prostate cancer antigens. Upon administration, this vaccine may stimulate a host immune response against prostate cancer cells; in the vaccination schedule, the first two vaccinations are co-administered with bacillus Calmette-Guerin (BCG) as an adjuvant. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C71723 NCT: https://clinicaltrials.gov/ct2/show/NCT00514072 PMID:22932804 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5351 https://github.com/vaccineontology/VO/issues/141 959 5351 cancer vaccine Gene name: CD40 Prostate Cancer Vaccine ONY-P1 VO:0007147 A dendritic cell (DC)-based cancer vaccine composed of autologous dendritic cells (DCs) activated with a prostate tumor cell lysate containing tumor-associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, the prostate tumor antigen-activated autologous DC vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against prostate cancer cells expressing prostate tumor cell-specific antigens, which may result in prostate tumor cell lysis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C115106 NCT: https://clinicaltrials.gov/ct2/show/NCT02111577 PMID:27683469 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5132 354 5132 cancer vaccine Gene name: KLK3 Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine VO:0007148 A vaccinia virus carrying a copy of the human gene encoding prostate-specific antigen (PSA), contaminated with bovine viral diarrhea virus (BVDV). Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29334 PMID:27683469 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5260 https://github.com/vaccineontology/VO/issues/142 354 5260 cancer vaccine Gene name: KLK3 PROSTVAC-Contaminated W/ BVDV vaccine VO:0007149 A peptide vaccine containing the prostate specific antigen (PSA) with potential antineoplastic activity. PSA, a glycoprotein secreted by prostatic epithelial and ductal cells, is overexpressed in prostate cancer cells and is used as a tumor marker for both diagnosis and treatment evaluation. Vaccination with PSA peptide vaccine may produce anti-PSA antibodies as well as elicit a cytotoxic T-cell (CTL) response against prostate cancer cells expressing this antigen, thereby decreasing tumor cell growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2497 NCT: https://clinicaltrials.gov/ct2/show/NCT00015977 PMID:27683469 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5087 https://github.com/vaccineontology/VO/issues/143 354 5087 cancer vaccine Gene name: KLK3 PSA Prostate Cancer Vaccine VO:0007150 An autologous dendritic cell vaccine with potential immunostimulatory activity. Dendritic cells harvested from a prostate cancer patient are transfected with the mRNA encoding for prostate specific antigen (PSA), a tumor marker secreted by prostatic epithelial and ductal cells. When reintroduced back to the patient, these PSA RNA pulsed autologous dendritic cells may elicit a cytotoxic T-cell (CTL) response against PSA-positive prostate cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2236 NCT: https://clinicaltrials.gov/ct2/show/NCT00004211 PMID:14711334 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5022 https://github.com/vaccineontology/VO/issues/144 354 5022 cancer vaccine Gene name: KLK3 PSA RNA-Pulsed Dendritic Cell Vaccine VO:0007151 A 30-residue prostate specific antigen (PSA) oligoepitope peptide (OP) vaccine with potential antineoplastic activity. PSA-OP peptide vaccine contains the PSA-1 and PSA-3 HLA-A2 epitopes and the PSA-9 HLA-class I-A3 epitope joined by peptide linker sequences. In an animal model, vaccination with this agent has been shown to elicit a cytotoxic T-lymphocyte immune response. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29337 PMID:9743387 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5234 https://github.com/vaccineontology/VO/issues/179 354 5234 cancer vaccine Gene name: KLK3 PSA-OP Peptide Vaccine VO:0007152 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with the prostate-specific tumor associated antigens (TAAs) prostate specific antigen (PSA) and prostate acid phosphatase (PAP), and conjugated to the immunostimulant keyhole limpet hemocyanin (KLH), with potential immunostimulatory and antineoplastic activities. Upon administration, prostate cancer antigen/KLH-pulsed autologous dendritic cell vaccine may stimulate the immune system to mount anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against prostate cancer cells expressing PSA and PAP, which may result in prostate cancer cell lysis. KLH is an immunogenic carrier and serves as an immunostimulant to improve antigenic immune recognition and T-cell responses and can be used to evaluate vaccine efficacy. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C92573 NCT: https://clinicaltrials.gov/ct2/show/NCT01171729 PMID:12487060 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5353 56318 5353 cancer vaccine Gene name: Acpp PSA-PAP/KLH-pulsed Autologous Dendritic Cell Vaccine VO:0007153 A prostate cancer vaccine containing prostate specific antigen (PSA) combined with the cytokines, interleukin-2 (IL-2) and granulocyte macrophage-colony-stimulating factor (GM-CSF), with potential antineoplastic activity. Upon intradermal vaccination, PSA/IL-2/GM-CSF vaccine may activate the immune system to induce a cytotoxic T-cell (CTL) response against prostate cancer cells expressing this antigen, thereby decreasing tumor cell growth. PSA, a glycoprotein secreted by prostatic epithelial and ductal cells, is overexpressed by prostate cancer cells. IL-2 stimulates natural killer (NK) cells and cytotoxic T-cells against the PSA-expressing tumor cells. GM-CSF promotes antigen presentation to dendritic cells and further stimulates a tumor-specific cytotoxic T-lymphocyte (CTL) response. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C114289 NCT: https://clinicaltrials.gov/ct2/show/NCT02058680 PMID:12487060 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5109 https://github.com/vaccineontology/VO/issues/180 1437 3558 5109 cancer vaccine Gene name: GM-CSF Gene name: IL-2 PSA/IL-2/GM-CSF Vaccine VO:0007154 A plasmid DNA vaccine encoding the tumor-associated antigens (TAAs) prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA), with potential immunoactivating and antineoplastic activities. Upon intramuscular delivery and electroporation of the PSA/PSMA DNA plasmid INO-5150, both PSA and PSMA are translated in cells which then activate the immune system. This induces cytotoxic T-lymphocyte (CTL) responses against tumor cells expressing PSA and PSMA. This may result in both immune-mediated tumor cell death and the inhibition of tumor cell proliferation. PSA and PSMA are overexpressed on a variety of cancer cell types. The DNA encoding the TAAs in INO-5150 is based on both human and other primate antigen gene sequences. As the plasmid genes differ from the human gene sequences encoding these antigens, INO-5150 may overcome immune tolerance to human TAAs. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C123283 NCT: https://clinicaltrials.gov/ct2/show/NCT02514213 PMID:32208168 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5252 https://github.com/vaccineontology/VO/issues/181 2346 5252 cancer vaccine Gene name: FOLH1 PSA/PSMA DNA Plasmid INO-5150 vaccine VO:0007155 A synthetic peptide based on sequence corresponding to positions 154-163 of the amino acids of prostate-specific antigen (PSA), VISNDVCAQV. Upon administration, PSA:154-163 peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2798 NCT: https://clinicaltrials.gov/ct2/show/NCT00004156 PMID:19483644 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5106 https://github.com/vaccineontology/VO/issues/182 4582 5106 cancer vaccine Gene name: MUC1 PSA:154-163 Peptide vaccine VO:0007156 A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163(155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29338 NCT: https://clinicaltrials.gov/ct2/show/NCT00109811 PMID:19483644 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5155 https://github.com/vaccineontology/VO/issues/183 354 5155 cancer vaccine Gene name: KLK3 PSA:154-163(155L) Peptide Vaccine VO:0007157 A peptide-based cancer vaccine containing epitopes of T cell receptor gamma-chain alternate reading frame protein (TARP) and prostate-specific membrane antigen (PSMA) in combination with a Poly IC-LC immunoadjuvant, with potential antineoplastic activity. Upon administration, PSMA/TARP peptide vaccine may stimulate a host cytotoxic T-cell (CTL) response against TARP- and PSMA-expressing tumor cells, resulting in tumor cell cytotoxicity. The nuclear protein TARP and PSMA are commonly expressed in prostate cancer cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C78819 NCT: https://clinicaltrials.gov/ct2/show/NCT00694551 PMID:34494382 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5052 https://github.com/vaccineontology/VO/issues/184 354 5052 cancer vaccine Gene name: KLK3 PSMA/TARP Peptide Vaccine VO:0007158 A cancer vaccine containing plasmid DNA encoding human prostatic acid phosphatase (PAP) (pTVG-HP) with potential immunostimulatory and antineoplastic activities. Upon administration, pTVG-HP plasmid DNA vaccine may stimulate the host immune system to generate a cytotoxic T lymphocyte (CTL) response against PAP-expressing prostate cancer cells. PAP or prostatic specific acid phosphatase (PSAP) is a tumor associated antigen (TAA) that may be overexpressed in prostate cancer. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C82407 NCT: https://clinicaltrials.gov/ct2/show/NCT02499835 PMID:17102977 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5535 https://github.com/vaccineontology/VO/issues/185 55 5535 cancer vaccine Gene name: ACP3 pTVG-HP Plasmid DNA Vaccine VO:0007159 A cancer vaccine containing xenogenic DNA from rhesus macaque (Macaca mulatta) that encodes prostate specific antigen (PSA) with potential immunostimulating and antineoplastic activities. Upon repeated intradermal administration via electroporation, pVAXrcPSAv53l vaccine may induce a cytotoxic T-lymphocyte (CTL) response against PSA-expressing prostate cancer cells. Rhesus PSA is 89% homologous to human PSA. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82352 NCT: https://clinicaltrials.gov/ct2/show/NCT00859729 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5092 https://github.com/vaccineontology/VO/issues/187 354 5092 cancer vaccine Gene name: KLK3 pVAXrcPSAv53l DNA Vaccine VO:0007160 A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2675 NCT: https://clinicaltrials.gov/ct2/show/NCT00005039 PMID:17707059 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4988 https://github.com/vaccineontology/VO/issues/333 354 4988 cancer vaccine Gene name: KLK3 Recombinant Fowlpox-Prostate Specific Antigen Vaccine VO:0007161 A cancer vaccine consisting of a recombinant fowlpox virus encoding fragment of human prostate-specific antigen (PSA), PSA:154-163 (155L), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Administration of this agent may induce a cytotoxic T cell response against PSA-expressing tumor cells. Dendritic cells infected with TRICOM vectors greatly enhance naive T-cell activation and peptide-specific T-cell stimulation. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38708 NCT: https://clinicaltrials.gov/ct2/show/NCT00108732 PMID:16390546 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5434 https://github.com/vaccineontology/VO/issues/333 12519 3383 354 965 5434 cancer vaccine Gene name: CD58 Gene name: Cd80 Gene name: ICAM1 Gene name: KLK3 Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine VO:0007162 A cancer vaccine comprised of a recombinant fowlpox virus vector encoding TRICOM. TRICOM is comprised of three co-stimulatory molecule transgenes (B7-1, ICAM-1 and LFA-3) that may enhance antigen presentation and activate cytotoxic T-cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2667 NCT: https://clinicaltrials.gov/ct2/show/NCT00450619 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5253 https://github.com/vaccineontology/VO/issues/132 12519 3383 965 5253 cancer vaccine Gene name: CD58 Gene name: Cd80 Gene name: ICAM1 Recombinant Fowlpox-TRICOM Vaccine VO:0007163 A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific antigen vaccine stimulates the host immune system to mount a cytotoxic T-cell response against tumor cells expressing PSA. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2433 NCT: https://clinicaltrials.gov/ct2/show/NCT02649439 PMID:12242725 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5154 https://github.com/vaccineontology/VO/issues/339 354 5154 cancer vaccine Gene name: KLK3 Recombinant Vaccinia PSA Vaccine VO:0007164 A recombinant vaccinia virus encoding prostate-specific antigen (PSA). Vaccination with recombinant vaccinia-PSA may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for PSA, which may decrease tumor growth. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29945 NCT: https://clinicaltrials.gov/ct2/show/NCT00005039 PMID:12242725 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5302 https://github.com/vaccineontology/VO/issues/350 354 5302 cancer vaccine Gene name: KLK3 Recombinant Vaccinia-Prostate Specific Antigen Vaccine VO:0007165 A recombinant vaccinia virus encoding prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) with potential use in cancer immunotherapy. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29563 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5307 https://github.com/vaccineontology/VO/issues/351 2346 354 5307 cancer vaccine Gene name: KLK3 Gene name: Prostate-specific membrane antigen Recombinant Vaccinia-PSA/PSMA Vaccine VO:0007166 A synthetic fowlpox viral vaccine containing the tumor-associated antigens prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3; TRICOM). Vaccination with this viral vaccine may enhance antigen presentation and activate cytotoxic T-cells against PSA- or PSMA-expressing tumor cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29559 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5005 https://github.com/vaccineontology/VO/issues/358 354 5005 cancer vaccine Gene name: KLK3 rF-PSA/PSMA/TRICOM Vaccine VO:0007167 A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38681 NCT: https://clinicaltrials.gov/ct2/show/NCT02772562 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5183 https://github.com/vaccineontology/VO/issues/359 12519 3383 354 965 5183 cancer vaccine Gene name: CD58 Gene name: Cd80 Gene name: ICAM1 Gene name: KLK3 Rilimogene-galvacirepvec Vaccine VO:0007168 A cell-based vaccine composed of autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1985 NCT: https://clinicaltrials.gov/ct2/show/NCT02159950 PMID:20818862 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5216 https://github.com/vaccineontology/VO/issues/362 55 5216 cancer vaccine Gene name: ACP3 Sipuleucel-T Vaccine VO:0007169 A synthetic peptide vaccine, containing 16 amino acid residues (611-626) of the human telomerase reverse transcriptase catalytic subunit (hTERT), with potential antineoplastic activity. Telomerase, a reverse transcriptase normally repressed in healthy cells, is overexpressed in most cancer cells and plays a key role in cellular proliferation. Vaccination with tertomotide may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against telomerase-expressing cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C62756 NCT: https://clinicaltrials.gov/ct2/show/NCT02855892 PMID:27941629 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5101 https://github.com/vaccineontology/VO/issues/416 22059 5101 cancer vaccine Gene name: Trp53 Telomerase Peptide Vaccine GV1001 VO:0007170 A synthetic, peptide cancer vaccine directed against the human telomerase reverse transcriptase catalytic subunit (hTERT) with potential immunomodulating activity. Vaccination with the UV1 telomerase peptide may stimulate cytotoxic T-cells to recognize and kill telomerase-expressing cells. Telomerase, a reverse transcriptase normally repressed in healthy cells, is overexpressed in most cancer cells and plays a key role in cellular proliferation. Jie Zheng Jimmy Guo Oliver He Virginia He NCT: https://clinicaltrials.gov/ct2/show/NCT01784913 PMID:28391357 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5478 7015 5478 cancer vaccine Gene name: TERT UV1 Telomerase Peptide Vaccine VO:0007171 An adenovirus type 5 (Ad5) encoding human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), with potential apoptosis-inducing and antineoplastic activities. Upon administration of recombinant Ad5 encoding TRAIL, the adenovirus selectively infects tumor cells and expresses TRAIL. The virally expressed TRAIL binds to and activates its receptors TRAIL receptor-1 (TRAIL-R1, death receptor 4, DR4) and TRAIL receptor-2 (TRAIL-R2, death receptor 5, DR5), which subsequently activate caspases and induce apoptosis in TRAIL-R1/R2-expressing tumor cells. The pro-apoptotic cell surface receptors TRAIL-R1 and -R2, members of the TNF receptor family, are overexpressed by a variety of cancer cell types. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C116879 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5397 8743 5397 cancer vaccine Gene name: TNFSF10 Recombinant Adenovirus 5 Encoding Tumor Necrosis Factor-related Apoptosis-Inducing Ligand Vaccine VO:0007172 A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901 consists of 10 different synthetic tumor-associated peptide (TUMAP) antigens (9 HLA-class I-binding and 1 HLA class II-binding); endogenously, these TUMAPs are expressed by the majority of renal cell carcinomas. Vaccination with this agent may significantly increase host cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing these peptide antigens. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C70968 NCT: https://clinicaltrials.gov/ct2/show/NCT00523159 PMID:23899354 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5013 https://github.com/vaccineontology/VO/issues/354 3105 3106 5013 cancer vaccine Gene name: HLA-A Gene name: HLA-B Renal Cell Carcinoma Peptides Vaccine IMA901 VO:0007173 A cell-based preparation in which autologous, mature dendritic cells (DCs) are electroporated with in vitro transcribed (IVT) RNAs encoding for a synthetic form of T-cell protein CD40 ligand (CD40L) and IVT RNA encoding for autologous tumor-associated antigens (TAAs) derived from patient-specific bladder cell carcinoma (BCC) cells, with potential immunostimulatory and antineoplastic activities. Upon electroporation into autologous DCs, the RNA is translated and processed. BCC-specific antigenic peptides are subsequently presented via major histocompatibility complex (MHC) Class I molecules on the DCs surface. When AGS-003-BLD is reintroduced to the patient, the MHC-presented peptides interact with and activate CD8-positive T cells, which elicits a highly specific cytotoxic T-cell (CTL) response against tumor cells expressing the patient-specific BCC TAAs. The signal cascade initiated by expression of the co-stimulatory molecule CD40L results in the secretion of the inflammatory cytokine IL-12, which further stimulates CTLs. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C129522 NCT: https://clinicaltrials.gov/ct2/show/NCT02170389 PMID:25901286 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5373 958 5373 cancer vaccine Gene name: CD40 Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003 VO:0007174 Peripheral blood lymphocytes (PBL) harvested from the blood of a renal cancer patient and exposed in vitro to renal tumor-associated antigens (TAA). Introducing these renal tumor-reactive autologous peripheral blood lymphocytes back to the same patient target tumor cells expressing these TAAs and could induce a cytotoxic T-cell-mediated immune response against renal cell cancer. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C48816 PMID:33408117 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5196 5196 cancer vaccine Renal Tumor-Reactive Autologous Peripheral Blood Lymphocyte Vaccine VO:0007175 A peptide vaccine consisting of amino acids 65 through 76 derived from the tumor suppressor protein Von Hippel-Lindau (VHL) with a glycine substitution at position 74. As a cancer vaccine, VHL-59: 65-76(V74G) may stimulate a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing this VHL mutant protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38122 PMID:20109232 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5097 7428 5097 cancer vaccine Gene name: VHL VHL-42: 65-76(V74G) Peptide Vaccine VO:0007176 A peptide vaccine consisting of amino acids 116 through 128 derived from the tumor suppressor protein Von Hippel-Lindau (VHL) with a frameshift mutation. As a cancer vaccine, VHL-59: 116-128(FrSh116-128) peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing this VHL mutant protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38123 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5172 7428 5172 cancer vaccine Gene name: VHL VHL-59: 116-128 Peptide Vaccine VO:0007177 A peptide vaccine derived from the von Hippel-Lindau (VHL) tumor suppressor protein, a general transcription factor. VHL14 peptide is a point mutation variant of the VHL protein; the mutation is in amino acid position 166. It might be used to elicit or boost cellular immunity to cancers that expressing the von Hippel-Lindau mutation. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2741 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5012 7428 5012 cancer vaccine Gene name: VHL VHL14 Peptide Vaccine VO:0007178 A peptide vaccine derived from the von Hippel-Lindau (VHL) tumor suppressor protein, a general transcription factor. VHL16 peptide, also known as S111I, is a point mutation variant of the VHL tumor suppressor protein; the mutation is in amino acid position 111. Vaccination with this agent may stimulate a cytotoxic T-cell response in patients with VHL-associated cancers that express this variant of the VHL tumor suppressor protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2740 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5333 7428 5333 cancer vaccine Gene name: VHL VHL16 Peptide Vaccine VO:0007179 A peptide vaccine derived from the von Hippel-Lindau (VHL) tumor suppressor protein, a general transcription factor. VHL2 (Y12M) peptide is a point mutation variant (from tyrosine to methionine at amino acid position 12) of the VHL protein. Vaccination with this peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing this VHL mutant protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2824 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5490 7428 5490 cancer vaccine Gene name: VHL VHL2 (Y12M) Peptide Vaccine VO:0007180 A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2492 NCT: https://clinicaltrials.gov/ct2/show/NCT00001703 PMID:20109232 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5127 7428 5127 cancer vaccine Gene name: VHL Von Hippel-Lindau Peptide Vaccine VO:0007181 A synthetic peptide vaccine based on the sequences of a translocation mutation of 2 transcriptional factor genes, PAX3 and FKHR. PAX3/FKHR fusion proteins are frequently found in patients with rhabdomyosarcomas. Vaccination with PAX3/FKHR peptide may stimulate the host immune response to elicit a cytotoxic T-cell response against tumor cells that express this PAX3/FKHR fusion protein. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C49023 NCT: https://clinicaltrials.gov/ct2/show/NCT00001564 PMID:15838707 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5484 https://github.com/vaccineontology/VO/issues/114 2308 5077 7422 5484 cancer vaccine Gene name: FOXO1 Gene name: PAX3 Gene name: VEGFA PAX3/FKHR Peptide Vaccine VO:0007182 A recombinant retroviral virus derived from SR-A strain of Rous sarcoma virus carrying a constitutively active form of the AKT Gene. The viral vector RCAS harbors a Replication Competent ALV Splice acceptor. This recombinant virus was use in animal model to study gliomagenesis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29908 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5044 https://github.com/vaccineontology/VO/issues/192 207 5044 cancer vaccine Gene name: AKT1 RCAS-Akt Vaccine VO:0007183 A recombinant retroviral virus derived from SR-A strain of Rous sarcoma virus carrying a human gene encoding the G12D mutant form of K-Ras. The viral vector, RCAS harbors a Replication Competent ALV Splice acceptor. This recombinant virus was use in animal model to study gliomagenesis. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29910 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5500 3845 5500 cancer vaccine Gene name: KRAS RCAS-Ras Vaccine VO:0007184 A recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT). Telomerase expression has been directly linked to tumor development; its catalytic subunit is expressed in the majority of human cancer cells, but infrequently in normal cells. Vaccination with telomerase:540-548 peptide may stimulate cytotoxic T cells to recognize and kill telomerase-expressing cells. Jie Zheng Jimmy Guo Oliver He Virginia He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2640 NCT: https://clinicaltrials.gov/ct2/show/NCT00069940 PMID:11536162 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5098 7015 5098 cancer vaccine Gene name: TERT telomerase: 540-548 peptide vaccine VO:0007185 A cancer vaccine that may stimulate an immune response against 4 different melanoma associated antigens. This may lead to a reduction in tumor cell proliferation of cancer cells expressing these antigens. The vaccine may contain 4 class I MHC-restricted synthetic melanoma peptides (1 each restricted by HLA-A1, -A3, and two restricted by HLA-A2) and a helper tetanus peptide. The peptides may include Melan-A, gp100, MAGE-3, and NA17. The vaccine can be used in combination Ontak, which may produce an immune response in patients with metastatic melanoma, and the Ontak may improve these immune responses and lead to tumor shrinkage. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C91722 NCT: https://clinicaltrials.gov/study/NCT00515528 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6370 2315 4102 6490 6370 cancer vaccine Gene name: MAGE-3 Gene name: Melan-A Gene name: NA17 Gene name: gp100 4-peptide melanoma vaccine VO:0007186 To obtain SOCS1-silenced DCs, DCs derived from mouse bone marrow cells ex vivo were induced to differentiation in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-4, and then transduced with Len-SOCS1-shRNA or control Len-GFP lentiviruses. The SOCS1-silenced DCs were loaded by TRP2 peptide to prepare the DC vaccine, which was induced to mature by LPS. The DCs were analyzed by flow cytometry (FCM) for surface expressions of MHCII and CD86 and by real-time PCR for the expressions of SOCS1, IL-10 as well as IL-12p40. B16 or IL-10-silenced B16 (IL-10(-/-);) cells were inoculated into C57BL/6 mice. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He 1(SOCS1)-silenced dendritic cell (DC) Vaccine PMID:23643168 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4071 https://github.com/vaccineontology/VO/issues/78 4071 cancer vaccine 1(SOCS1)-silenced dendritic cell vaccine VO:0007187 A fragment of fibroblast growth factor-5 (FGF-5). Originally isolated from a renal cell carcinoma cell line that overexpressed FGF-5, FGF-5:117-126 peptide is recognized by tumor infiltrating cytotoxic T lymphocytes. Overexpressed by several cancer cell types, this peptide is being tested as a potential target for antineoplastic immunotherapies. (NCI04) Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5414 https://github.com/vaccineontology/VO/issues/79 5414 cancer vaccine 117-126:FGF-5 Peptide Vaccine VO:0007188 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He obsolete 12 Melanoma Peptide Vaccine true VO:0007189 Melonoma vaccine that uses 12 class I major histocompatibility complex-restricted melanoma peptides (12MP) from cancer-testis antigens (CTAs) and melanocytic differentiation proteins (MDPs). Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He 12MP vaccine PMID:21690475 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3978 https://github.com/vaccineontology/VO/issues/81 3978 cancer vaccine 12 melanoma peptide vaccine VO:0007190 4 treatment groups, vaccinated with 12 MHC class I-restricted melanoma peptides to stimulate CTL (12 MP, group A), plus a tetanus peptide (group B), or a mixture of 6 melanoma helper peptides (6 MHP, group C) to stimulate helper T lymphocytes (HTL), or with 6 melanoma helper peptide (6 MHP) alone (group D), in incomplete Freund's adjuvant plus granulocyte macrophage colony-stimulating factor. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:23653149 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4070 https://github.com/vaccineontology/VO/issues/82 4070 cancer vaccine 12MP, 12MP/Tet, 12MP/6MHP, or 6MHP vaccine VO:0007191 A synthetic peptide consisting of amino acids 27 through 35 of the melanoma differentiation antigen MART-1. 27-35(27L) MART-1 has a leucine substitution at amino acid position 27 to improve binding to HLA-A*0201. Vaccination with this agent may stimulate the host immune response to mount a cytotoxic T-lymphocyte response against melanoma cells expressing MART-1. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:22495394 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5290 https://github.com/vaccineontology/VO/issues/83 2315 6490 7299 5290 cancer vaccine Gene name: MLANA Gene name: Tyrosinase Gene name: gp100 27-35(27L):MART-1 peptide vaccine VO:0007192 A topical gel containing a peptide derived from the human papillomavirus (HPV). Application of 851B gel may stimulate the host immune system to trigger a cytotoxic T-lymphocyte response to cells that express HPV. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4986 https://github.com/vaccineontology/VO/issues/84 4986 cancer vaccine 851B Gel vaccine VO:0007193 A murine IgG1 monoclonal anti-idiotype antibody, containing a variable antigen-binding region that functionally mimics the three-dimensional structure of a specific epitope on the ovarian cancer tumor-associated antigen CA-125, with potential antineoplastic activity. With a variable antigen-binding region that acts as a surrogate antigen for CA-125, abagovomab may stimulate the host immune system to elicit humoral and cellular immune responses against CA-125-positive tumor cells, resulting in inhibition of tumor cell proliferation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He Abagovomab PMID:17000686 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5244 https://github.com/vaccineontology/VO/issues/86 94025 5244 cancer vaccine Gene name: MUC16 Abagovomab vaccine VO:0007194 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:11860704 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5543 https://github.com/vaccineontology/VO/issues/87 2875 7124 5543 cancer vaccine Gene name: GPT Gene name: TNF Ad CMV I kappaB alpha vaccine VO:0007195 A cancer vaccine consisting of a recombinant adenoviral vector encoding the tumor-associated antigen (TAA) human MUC-1 (hMUC-1) linked to the extracellular domain (ecd) of the co-stimulatory molecule CD40 ligand (CD40L) and an adenovirus signal sequence that encodes a secretory signal peptide (Ad-sig) with potential immunostimulating and antineoplastic activities. Due to the presence of the secretory signal peptide expressed by Ad-sig in the vaccine construct, transfected cells may secrete a fusion protein composed of hMUC-1 and the CD40L ecd. The CD40L moiety part of the fusion protein binds to CD40 receptors on dendritic cells (DCs). Subsequently, DCs may be activated and migrate, T-cells may expand, and a cytotoxic T lymphocyte (CTL) response against tumor cells that overexpress hMUC-1 may follow. MUC-1 is a hypoglycosylated TAA overexpressed by epithelial cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5179 https://ascopubs.org/doi/10.1200/JCO.2018.36.15_suppl.3098 https://github.com/vaccineontology/VO/issues/88 4582 959 5179 cancer vaccine Gene name: CD40LG Gene name: MUC1 Ad-sig-hMUC-1/ecdCD40L vaccine VO:0007196 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He obsolete Ad5-yCD/mutTKSR39rep-hIL12 Vaccine true VO:0007197 A nonreplicating adenoviral vector (adenovector) encoding the melanoma differentiation-associated 7 gene (MDA7) with potential antineoplastic activity. After intratumoral injection and adenovector-mediated gene transfer of MDA7 into tumor cells, the expressed MDA7 transgene may inhibit tumor cell proliferation and induce tumor cell apoptosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15300212 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5523 https://github.com/vaccineontology/VO/issues/92 5523 cancer vaccine Adenovector Encoding MDA7 Vaccine VO:0007198 A genetically-modified, dendritic cell-based (DCs) vaccine in which the autologous cells are transduced with an adenoviral vector expressing the tumor antigen prostate-specific membrane antigen (PSMA) and a fusion protein composed of synthetic ligand inducible adjuvant iMC composed of a drug-inducible costimulatory CD40 receptor (iCD40) and the adaptor protein MyD88, with potential immunomodulating and antineoplastic activities. The iCD40 contains a membrane-localized cytoplasmic CD40 domain fused to the FK506 modified drug-binding protein 12 (FKBP12). Upon intradermal administration of BPX-201, these DCs accumulate in local draining lymph nodes. Twenty-four hours after vaccination, the dimerizing agent AP1903 is administered. AP1903 binds to the drug binding domain, leading to iMC oligomerization and activation of iCD40 and MyD88-mediated signaling in iMC-expressing DCs. This signaling pathway activates the DCs and stimulates a cytotoxic T-lymphocyte (CTL) response against host tumor cells that express PSMA. PSMA, a glycoprotein secreted by prostatic epithelial and ductal cells, is overexpressed in prostate cancer cells and is used as a tumor marker for both diagnosis and treatment evaluation. MyD88 is involved in interleukin 1 receptor (IL1R) and toll-like receptor (TLR) signaling. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4999 https://github.com/vaccineontology/VO/issues/93 2346 4999 cancer vaccine Gene name: Prostate-specific membrane antigen Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 VO:0007199 A replication-defective, E1- and E2b-deleted oncolytic adenoviral serotype 5 (Ad5) encoding an epitope of human carcinoembryonic antigen (CEA) with potential antineoplastic activity. Adenoviral vector Ad5-CEA(6D) vaccine expresses a highly immunogenic analogue of CEA [CAP1-(6D)]. Upon administration, this vaccine may induce both humoral and cellular immune responses against tumor cells expressing the CEA antigen, thereby resulting in the immune-mediated inhibition of tumor cell proliferation and tumor cell death. CEA, a tumor-associated antigen, is overexpressed in various tumor cell types. Deletion of early genes E1 and E2b in Ad5 potentially circumvent pre-existing anti-adenovirus immunity and is capable of inducing strong immune responses. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:25956394 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5137 https://github.com/vaccineontology/VO/issues/94 1048 5137 cancer vaccine Gene name: CEACAM5 Adenoviral Vector Ad5-CEA(6D) Vaccine VO:0007200 An adenovirus vector engineered to produce CD40 ligand. For use as a possible gene therapy agent. May induce apoptosis through the TNF pathway. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15153545 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5529 https://github.com/vaccineontology/VO/issues/95 5529 cancer vaccine Adenovirus 5-CD40 Ligand Vaccine VO:0007201 Fibroblast growth factor-2-retargeted adenoviral vectors may be used to increase the transduction of GBM-derived endothelial cells, enabling a new and efficient antiangiogenesis strategy for the treatment of malignant gliomas. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:16709032 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5489 https://github.com/vaccineontology/VO/issues/96 2247 5489 cancer vaccine Gene name: FGF2 Adenovirus 5-Fibroblast Growth Factor 2 Vaccine VO:0007202 A replication-defective, recombinant adenoviral serotype 5 (Ad5) encoding human guanylyl cyclase C (hGCC) and the synthetic Pan DR epitope (PADRE), with potential antineoplastic and immunomodulating activities. Upon intramuscular administration, the Ad5-hGCC-PADRE vaccine expresses hGCC, which may induce both humoral and cellular immune responses against tumor cells expressing the hGCC antigen. This results in the immune-mediated inhibition of tumor cell proliferation, and leads to tumor death. The hGCC protein is normally restricted to intestinal epithelial cells but is overexpressed by metastatic colorectal tumors. PADRE is a helper T-lymphocyte epitope that is able to augment the magnitude and duration of the cytotoxic T-lymphocyte (CTL) response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT04111172 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5147 https://github.com/vaccineontology/VO/issues/97 2984 5147 cancer vaccine Gene name: GUCY2C Adenovirus 5-Human Guanylyl Cyclase C-PADRE vaccine VO:0007203 A gene-viral vector complex comprised of an adenovirus vector and B7-1 gene targeting the CD80 antigen. Adenovirus B7-1 is used as a component in antineoplastic vaccines to elicit a cytotoxic T-cell response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5435 https://github.com/vaccineontology/VO/issues/98 941 5435 cancer vaccine Gene name: CD80 Adenovirus B7-1 vaccine VO:0007204 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) transduced with a recombinant adenoviral vector encoding HER-2/neu. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00307229 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5388 https://github.com/vaccineontology/VO/issues/99 24337 5388 cancer vaccine Gene name: Erbb2 Adenovirus Encoding Rat HER-2/neu Vaccine VO:0007205 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) transduced with a recombinant adenoviral vector encoding three full length human melanoma associated antigens (MAAs), tyrosinase, melan-A (MART-1) and the melanoma antigen A6 (MAGEA6), with potential antineoplastic activity. Upon intradermal administration, adenovirus encoding tyrosinase/MART-1/MAGEA6-transduced autologous DC vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tyrosinase/MART-1/MAGEA6-positive tumor cells, which may result in tumor cell death and decreased tumor growth. Tyrosinase, a melanoma-specific differentiation antigen, catalyzes the first step of melanin synthesis in melanocytes. Vaccination with multi-antigen modified DC may improve the efficacy of the DC immunotherapy. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:22737604 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5370 https://github.com/vaccineontology/VO/issues/100 2315 4105 7299 5370 cancer vaccine Gene name: MAGEA6 Gene name: MLANA Gene name: Tyrosinase Adenovirus Encoding Tyrosinase/MART-1/MAGEA6-transduced Autologous Dendritic Cell Vaccine VO:0007206 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) transduced with a replication-deficient adenovirus vector encoding HER-2 with potential antineoplastic activity. Upon administration, adenovirus HER2-transduced autologous dendritic cell vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against HER-2-positive tumor cells, which may result in tumor cell death and decreased tumor growth. HER-2, a tyrosine kinase receptor for epidermal growth factor (EGF) (also known as neu and ErbB2), is overexpressed by some breast, ovarian, and gastric cancers. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00197522 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5082 https://github.com/vaccineontology/VO/issues/101 2064 5082 cancer vaccine Gene name: ERBB2 Adenovirus HER2-Transduced Autologous Dendritic Cell Vaccine VO:0007207 A gene viral vector complex comprised of a replication-defective adenovirus and a herpes simplex virus thymidine kinase gene that activates ganciclovir, causing inhibition of DNA synthesis and apoptosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:/8985364 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5122 https://github.com/vaccineontology/VO/issues/102 5122 cancer vaccine Adenovirus RSV-TK vaccine VO:0007208 A replication incompetent adenovirus encoding human pro-inflammatory cytokine interleukin-12 (IL-12) (Ad.hIL-12), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration, the adenovirus selectively infects and replicates in tumor cells, which may result in tumor cell lysis. Synergistically, IL-12 expressed by the adenovirus may activate the immune system by promoting the activation of natural killer cells (NKs), inducing secretion of interferon-gamma and inducing cytotoxic T cell responses against tumor cells, which may result in immune-mediated tumor cell death and inhibition of tumor cell proliferation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:33575474 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5285 https://github.com/vaccineontology/VO/issues/103 2346 5285 cancer vaccine Gene name: Prostate-specific membrane antigen gene engineering Adenovirus-mediated Human Interleukin-12 Vaccine VO:0007209 A cancer vaccine consisting of autologous dendritic cells (DCs) transduced with a recombinant adenovirus encoding p53 peptide, with potential immunomodulating activity. Intradermal vaccination with adenoviral-p53 transduced dendritic cell vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing mutant p53, resulting in tumor cell lysis. p53, a tumor suppressor gene, is mutated in many tumor cells, resulting in the loss of apoptosis regulation and abnormal cell proliferation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:20420527 PMID:29515795 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5256 https://github.com/vaccineontology/VO/issues/104 7157 5256 cancer vaccine Gene name: TP53 (P53) Adenovirus-p53 transduced dendritic cell vaccine VO:0007210 A cancer vaccine composed of a genetically engineered, replication-deficient type 5 adenovirus carrying the human prostate-specific antigen (PSA), with potential immunostimulating and antineoplastic activities. Upon subcutaneous vaccination with the adenovirus-PSA prostate cancer vaccine, the adenovirus infects cells and expresses PSA. In turn, PSA may activate the immune system and may induce a cytotoxic T-lymphocyte response against PSA-expressing tumor cells. PSA, a tumor associated antigen, is expressed by prostate epithelial cells and is overexpressed in prostate cancer. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5010 https://github.com/vaccineontology/VO/issues/105 2346 5010 cancer vaccine Gene name: Prostate-specific membrane antigen gene engineering Adenovirus-PSA Prostate Cancer Vaccine VO:0007211 A cell-based vaccine comprised of prostate cancer cells transduced with an adenoviral vector encoding human RTVP-1 (AdRTVP-1), with potential antineoplastic and immunostimulating activities. RTVP-1, also referred to as glioma pathogenesis-related protein 1 (GLIP1), is down-regulated in prostate tumors. Regulated by tumor suppressor p53, the expression of RTVP-1 functions as a tumor suppressor, and is abundant in normal human prostate epithelial cells as well as in differentiated macrophages. Administration of this vaccine leads to an induction of apoptosis through the expression of RTVP-1 and results in a reduction in cellular proliferation in prostate cancer cells. In addition, this cancer-cell based vaccine may induce a cytotoxic T lymphocyte (CTL) response against prostate specific tumor associated antigens, resulting in an immune-mediated prostate cancer cell death. Furthermore, RTVP-1 stimulates CTL and natural killer (NK) cell activities. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5203 https://github.com/vaccineontology/VO/issues/106 11010 5203 cancer vaccine Gene name: GLIPR1 AdRTVP-1-Transduced Prostate Cancer Cell-Based Vaccine VO:0007212 A vaccine containing HER2/Neu-derived epitope (amino acids 776-790) linked to li-Key peptide (li-Key/HER2/neu hybrid peptide or AE37), and combined with granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential antineoplastic and immunoadjuvant activities. Upon vaccination, AE37 may activate the immune system and stimulate T-helper cells against HER2/Neu expressing cancer cells. GM-CSF may potentiate the immune response against cancer cells expressing the HER2/Neu antigen. The Ii-Key moiety, a 4-amino acid (LRMK) epitope from the MHC class II-associated invariant chain (Ii protein), increases T-helper cell stimulation against HER2/neu antigen when compared to unmodified class II epitopes. HER2/neu, a tumor associated antigen (TAA), is overexpressed in a variety of tumor cell types and is highly immunogenic. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:32323103 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5436 https://github.com/vaccineontology/VO/issues/107 1437 2064 5436 cancer vaccine Gene name: ERBB2 Gene name: GM-CSF AE37 Peptide/GM-CSF Vaccine VO:0007213 A cancer vaccine composed of naked plasmid DNA of the gene for the tumor-associated antigen alpha-fetoprotein (AFP), a macromolecule that acts as a specific immunologic target for hepatocellular carcinoma. This agent exerts an antitumor effect by inducing cytotoxic T-lymphocytes to attack AFP-expressing tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5275 https://github.com/vaccineontology/VO/issues/108 174 5275 cancer vaccine Gene name: AFP AFP Gene Hepatocellular Carcinoma Vaccine VO:0007214 A cancer vaccine made of a recombinant NY-ESO-1 protein with a TLR7 agonist Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:C5941317 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3991 https://github.com/vaccineontology/VO/issues/109 1485 3991 cancer vaccine Gene name: NY-ESO-1 Ag NY-ESO-1 vaccine VO:0007215 A cancer vaccine containing the three frame shift peptides (FSP) AIM2(-1), HT001(-1) and TAF1B(-1), with potential immunomodulating activity. Upon administration, the AIM2(-1)/HT001(-1)/TAF1B(-1) FSP vaccine may induce an immune response against microsatellite instability (MSI) colorectal cancer-associated antigens. Frame shift mutations of AIM2 (absent in melanoma 2, an interferon-inducible protein), HT001 (asteroid homolog 1 or ASTE1, with an unknown function) and TAF1B (TATA box-binding protein-associated RNA polymerase I B, a transcription factor) are seen in MSI-positive colorectal cancers and may be associated with malignant transformation, tumor progression and the presence of tumor-infiltrating lymphocytes. These FSPs all have one-base deletions. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01461148 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5402 https://github.com/vaccineontology/VO/issues/110 28990 9014 9447 5402 cancer vaccine Gene name: AIM2 Gene name: ASTE1 Gene name: TAF1B AIM2(-1)/HT001(-1)/TAF1B(-1) Frameshift Peptide Vaccine VO:0007216 A cancer vaccine comprised of irradiated allogeneic pancreatic cancer cells transfected to express murine alpha-1,3-galactosyltransferase with potential antitumor activity. Vaccination is associated with the expression of murine alpha-1,3-galactosyl (alpha-gal) carbohydrate residues on cell membrane glycoproteins and glycolipids of the vaccine pancreatic cancer cell allograft; murine alpha-gal epitopes, not present on human cells, then induce a hyperacute rejection of the vaccine pancreatic cancer cell allograft. The hyperacute rejection involves the binding of pre-existing human anti-alpha-gal antibodies (which naturally occur against gut flora) to murine alpha-gal epitopes, resulting in the rapid activation of antibody-dependent cell-mediated cytotoxicity (ADCC) towards allograft cells. The host immune system then attacks endogenous pancreatic cancer cells, resulting in ADCC towards endogenous pancreatic cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:26787078 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5422 https://github.com/vaccineontology/VO/issues/145 1048 111518 5422 cancer vaccine CEA Gene name: CEACAM5 Algenpantucel-L Vaccine VO:0007217 A cancer vaccine consisting of allogeneic, immortalized dendritic precursor cells derived from a patient with acute myelogenous leukemia (AML), with potential immunostimulatory and antineoplastic activities. Upon ex vivo stimulation and expansion of the precursor cells into mature, fully functional dendritic cells (DCs) and subsequent administration, the allogeneic AML antigen-expressing DC vaccine may elicit a potent cytotoxic T-cell (CTL) and antibody response against AML antigen-expressing cells, resulting in tumor cell death. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5020 https://github.com/vaccineontology/VO/issues/146 5788 945 5020 cancer vaccine Gene name: CD33 Gene name: PTPRC Allogeneic AML Antigen-expressing Dendritic Cell Vaccine VO:0007218 An allogeneic whole cell vaccine, derived from irradiated allogenic tumor cells manipulated to express human B7.1 (CD80 antigen) and human leukocyte antigen (HLA) A1, with potential antitumor activity. Vaccination with allogeneic B7.1/HLA-A1 transfected tumor cell vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor cell proliferation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15254047 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4998 https://github.com/vaccineontology/VO/issues/147 941 4998 cancer vaccine Gene name: CD80 Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine VO:0007219 A pluripotent, allogeneic, tumor cell vaccine composed of irradiated tumor cells from the non-small cell lung cancer (NSCLC) cell line 1650 and the immunoadjuvant recombinant granulocyte-macrophage colony stimulating factor (GM-CSF) (1650-G), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic cellular vaccine 1650-G may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against tumor-associated antigens (TAAs) expressed on NSCLC cells. GM-CSF potentiates the antitumor immune response. The 1650 cell line is used as a source for TAAs. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5257 https://github.com/vaccineontology/VO/issues/148 1048 4101 7490 5257 cancer vaccine Gene name: CEACAM5 Gene name: MAGEA2 Gene name: WT1 Allogeneic Cellular Vaccine 1650-G VO:0007220 A cancer vaccine consisting of allogeneic, immortalized dendritic cells (DCs) loaded with tumor specific antigens and activated, with potential immunostimulatory and antineoplastic activities. Upon intratumoral administration of the allogeneic dendritic cell vaccine COMBIG-DC, these activated DCs attract natural killer (NK) cells, induce an anti-inflammatory response leading to the induction of NK-cell-mediated tumor cell death. Upon release of tumor associated antigens (TAAs) from the lysed tumor cells, these antigens are taken up by antigen presenting cells which activate the immune system to elicit a potent cytotoxic T-cell (CTL) response against the TAAs, resulting in the death of TAAs-expressing tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01525017 NCT: https://clinicaltrials.gov/ct2/show/NCT01974661 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5446 https://github.com/vaccineontology/VO/issues/149 3458 7124 5446 cancer vaccine Gene name: IFNG Gene name: TNF allogeneic dendritic cell vaccine COMBIG-DC VO:0007221 A cell-based vaccine composed of allogeneic dendritic cells pulsed ex-vivo with an autologous myeloma idiotype with potential antineoplastic activity. Upon administration, allogeneic dendritic cell-myeloma idiotype vaccine may stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against myeloma cells, resulting in cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5102 https://github.com/vaccineontology/VO/issues/150 5102 cancer vaccine Allogeneic Dendritic Cell-Myeloma Idiotype Vaccine VO:0007222 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from an allogeneic glioblastoma (GBM) stem-like cell line, with potential immunostimulatory and antineoplastic activities. Upon administration allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine exposes the immune system to GBM stem cell antigens, which may result in cytotoxic T lymphocyte (CTL) and antibody responses against GBM cells. This leads to GBM cell lysis. GBM stem-like cells contain a specific range of antigens that are essential for the neoplastic growth and survival of GBM cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5023 https://github.com/vaccineontology/VO/issues/151 7070 5023 cancer vaccine Gene name: CD90 Allogeneic Glioblastoma Stem-like Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine VO:0007223 An allogeneic tumor cell vaccine containing myeloma cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene with potential antineoplastic activity. Upon vaccination, allogeneic GM-CSF-based myeloma cellular vaccine secretes GM-CSF, which may potentiate a tumor-specific cytotoxic T-lymphocyte (CTL) response against myeloma cancer cell-associated antigens. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5327 https://github.com/vaccineontology/VO/issues/152 1437 4102 7490 9947 5327 cancer vaccine Gene name: GM-SCF Gene name: MAGEA3 Gene name: MAGEC1 Gene name: WT1 Allogeneic GM-CSF-Based Myeloma Cell Vaccine VO:0007224 An allogenic vaccine consisting of irradiated breast cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene. Upon vaccination, the genetically modified cells secrete GM-CSF, thereby potentiating a tumor-specific T cell response against breast cancer cell-asociated antigens.A vaccine that is being studied as a way to help the body's immune system kill breast cancer cells. To make the vaccine, the GM-CSF gene is put into breast cancer cells in the laboratory. The cells are then treated with radiation to stop them from growing and injected into the same or a different patient. The GM-CSF protein made by the changed breast cancer cells may help the immune system kill breast cancer cells in the body. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5059 https://github.com/vaccineontology/VO/issues/153 2064 5059 cancer vaccine Gene name: ERBB2 Allogeneic GM-CSF-Secreting Breast Cancer Vaccine VO:0007225 An allogeneic cancer vaccine composed of lethally irradiated, whole pancreatic cancer cells transfected with a plasmid carrying the gene for cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Allogeneic GM-CSF-secreting tumor vaccine PANC 10.05 pcDNA-1/GM-Neo secretes GM-CSF thereby activating dendritic cells, promoting antigen presentation to B- and T-cells, and promoting a cytotoxic T-lymphocyte (CTL) response. This may eventually kill tumor cells. The pancreatic tumor cells are derived from the PANC 10.05 tumor cell line. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01088789 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5075 https://github.com/vaccineontology/VO/issues/154 5075 cancer vaccine Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo VO:0007226 An allogeneic cancer vaccine composed of lethally irradiated, whole pancreatic cancer cells transfected with a plasmid carrying the gene for cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Allogeneic GM-CSF-secreting tumor vaccine PANC 6.03 pcDNA-1/GM-Neo secretes GM-CSF thereby activating dendritic cells, promoting antigen presentation to B- and T-cells, and promoting a cytotoxic T-lymphocyte (CTL) response. This may eventually kill tumor cells. The pancreatic tumor cells are derived from the PANC 6.03 tumor cell line. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5515 https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2010-01868&r=1 https://github.com/vaccineontology/VO/issues/155 5515 cancer vaccine Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo VO:0007227 A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5269 https://github.com/vaccineontology/VO/issues/156 1493 5269 cancer vaccine Gene name: CTLA4 Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine VO:0007228 A cancer vaccine, containing human-specific large multivalent immunogen (LMI) isolated from plasma membrane fractions of the melanoma cell lines MSM-M1 and MSM-M2, with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen melanoma vaccine LP2307 may stimulate a CD8+ cytotoxic T lymphocyte (CTL) response against melanoma tumor cells that express melanoma-specific LMI. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00726739 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5423 https://github.com/vaccineontology/VO/issues/157 2315 6490 5423 cancer vaccine Gene name: MLANA Gene name: gp100 (PMEL) Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 VO:0007229 A cancer vaccine derived from two gentically modified human melanoma cell lines with potential antineoplastic activity. Allogeneic melanoma vaccine AGI-101H consists of a 1:1 mixture of cells from two genetically modified human melanoma cell lines, designated as Mich1H6 and Mich2H6, that have been gamma-irradiated to render the cells non-proliferative. Upon administration, this vaccine may stimulate a cytotoxic immune response against melanoma tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:32002306 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5376 https://github.com/vaccineontology/VO/issues/158 216 5376 cancer vaccine Gene name: ALDH1A1 Allogeneic Melanoma Vaccine AGI-101H VO:0007230 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with a mixture of lysates from five allogeneic mesothelioma tumor cell lines, with potential immunostimulatory and antineoplastic activities. Upon leukapheresis, DCs are loaded with allogeneic mesothelioma tumor cell lysates. Upon re-administration of the allogeneic mesothelioma tumor lysate-pulsed autologous DC vaccine, the immune system is exposed to an undefined amount of mesothelioma-associated antigens, which stimulates the induction of a specific cytotoxic T-lymphocyte (CTL) response against mesothelioma tumor cells and leads to tumor cell lysis Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5440 https://github.com/vaccineontology/VO/issues/159 10232 5440 cancer vaccine Gene name: MSLN Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine VO:0007231 A biologic product that consists of undifferentiated stem cells, obtained from adult bone marrow or other non-embryonic tissue sources, that are expanded in vitro and deposited in master cell banks for ""off-the-shelf"" use, with potential hematopoiesis-inducing and immunomodulating activities. Allogeneic multipotent adult progenitor cells (MAPCs) are non-immunogenic due to the lack of major histocompatibility (MHC) molecule expression, and so elicit no immune response upon administration. In vivo, bone marrow-derived adult stem cells are capable of maturing into a broad range of cell types and may help restore the immune system by producing multiple therapeutic molecules in response to inflammation and tissue damage. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5054 https://github.com/vaccineontology/VO/issues/160 5054 cancer vaccine allogeneic multipotent adult progenitor cells vaccine VO:0007232 A whole cell vaccine comprised of irradiated allogeneic renal cell carcinoma (RCC) with potential immunostimulating and antineoplastic activities. Allogeneic renal cell carcinoma vaccine MGN1601 contains two active ingredients: 1) genetically modified allogeneic RCC cells that are transiently transfected with four different MIDGE (Minimalistic Immunogenically Defined Gene Expression) vectors encoding IL-7, GM-CSF, CD80 and CD154 and 2) the synthetic DNA-based immunomodulator dSLIM-30L1, a TLR9 agonist.. Vaccination results in expression of IL-7, GM-CSF, CD80 and CD154, which all contribute to the activation or enhancement of immune responses. Furthermore, administration of this RCC vaccine may elicit a cytotoxic T lymphocyte (CTL) response against similar host tumor cells, resulting in decreased tumor growth. TLR9 is a member of the TLR family, which plays a fundamental role in pathogen recognition and activation of innate immunity. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5358 https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)36654-0 https://github.com/vaccineontology/VO/issues/161 941 959 5358 cancer vaccine Gene name: CD40LG Gene name: CD80 Allogeneic Renal Cell Carcinoma Vaccine MGN1601 VO:0007233 A vaccine composed of tumor cells isolated from the tumor of one patient, killed and processed, and administered to another patient to stimulate cytotoxic immune responses to a similar tumor cell type. The cells found in this type of whole-cell vaccine express many cell-surface tumor-associated antigens. This vaccine is frequently administered with an adjuvant immunostimulant. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5339 https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/allogeneic-tumor-cell-vaccine https://github.com/vaccineontology/VO/issues/162 5339 cancer vaccine allogeneic tumor cell vaccine VO:0007234 A vaccine composed of killed glioma cancer cells from another patient for use in immunotherapy Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:24829761 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5119 https://github.com/vaccineontology/VO/issues/163 5119 cancer vaccine Allogenic Glioma Cancer Vaccine VO:0007235 A vaccine consisting of a recombinant adenoviral vector encoding alpha fetoprotein. After vaccination, expressed alpha fetoprotein may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells that express alpha fetoprotein, resulting in tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:25041030 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5313 https://github.com/vaccineontology/VO/issues/164 149 5313 cancer vaccine Gene name: AFP Alpha Fetoprotein Adenoviral Vector Vaccine VO:0007236 An allogeneic renal cell cancer (RCC) vaccine composed of cell line-derived RCCs that are genetically engineered to express the murine alpha-1,3-galactosyltransferase (GalT), with potential immunostimulatory and antineoplastic activities. Not naturally occurring in humans, GalT catalyzes the expression of foreign alpha-1,3-galactosyl (alpha-gal) carbohydrate epitopes on the cell membranes of the allogeneic RCCs present in the vaccine. This induces a hyperacute rejection reaction involving pre-existing human anti-alpha-gal antibodies, which bind to the foreign alpha-gal epitopes expressed by the allogeneic RCCs. This results in complement-mediated cytotoxicity (CMC) and antibody-dependent cell-mediated cytotoxicity (ADCC) towards endogenous RCCs with unmodified carbohydrate epitopes. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5349 https://github.com/vaccineontology/VO/issues/165 11605 5349 cancer vaccine Gene name: Gla Alpha-1,3-galactosyltransferase-expressing Allogeneic Renal Cell Carcinoma Vaccine VO:0007237 A cell-based cancer vaccine comprised of autologous dendritic cells pulsed with four alpha-fetoprotein (AFP) peptides, with potential immunostimulatory and antineoplastic activities. Upon administration, AFP peptide-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against AFP-expressing cancer cells, resulting in tumor cell lysis. AFP is overexpressed in a variety of cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:16675576 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5315 https://github.com/vaccineontology/VO/issues/166 174 5315 cancer vaccine Gene name: AFP Alpha-fetoprotein Peptide-Pulsed Autologous Dendritic Cell Vaccine VO:0007238 A cancer vaccine comprised of autologous dendritic cells (DCs) pulsed with the marine sponge glycolipid alpha-galactosylceramide (alpha-GalCer) with potential immunostimulatory and antimetastatic activities. Upon administration, alpha-galactosylceramide-pulsed autologous dendritic cells may result in the activation and proliferation of a subset of endogenous natural killer T (NKT) cells, B cells, and CD4+ and CD8+ T cells, and the production of interferon-gamma and interleukin-12; these cascade events may result in a T helper-1 cell-biased proinflammatory antitumor immune response. The NKT cell ligand alpha-GalCer was originally isolated from the marine sponge Agelas mauritianusis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:32188702 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5288 https://github.com/vaccineontology/VO/issues/167 5288 cancer vaccine Alpha-Galactosylceramide-Pulsed Autologous Dendritic Cell Vaccine VO:0007239 A mature polarized dendritic cell with potent immunostimulating activity. Treating dendritic cells (DCs) with interferon-alpha (IFN-a) and polyinosinic:polycytidylic acid (p-I:C) in addition to a cytokine cocktail (tumor necrosis factor alpha/Interleukin-1beta/IFN-gamma) produces mature but not exhausted alpha type-1 polarized DCs (alphaDC1) that are capable of: 1) high responsiveness to other lymphoid chemokines, and 2) producing high level of interleukin-12p70 (IL-12p70). Therefore, alphaDC1 has a much more significant capability of inducing helper T cell (CD4+ T-cell) responses in comparison with the ""gold standard"" DCs. When pulsed with specific tumor associated antigens (TAAs), alphaDC1 is able to induce a potent cytotoxic T lymphocyte (CTL) response against TAAs; as a result it can be used as a cancer vaccine. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5198 https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/alpha-type-1-polarized-dendritic-cells https://github.com/vaccineontology/VO/issues/168 2315 6490 7299 5198 cancer vaccine Gene name: MLANA Gene name: Tyrosinase Gene name: gp100 (PMEL) Alpha-type-1 polarized dendritic cell vaccine VO:0007240 A derivative of the Canarypox Virus, ALVAC can infect mammalian cells but it can't replicate. Thus, it produces a self-limiting infection which does not produce symptoms or harm the host. When carrying foreign genes it will cause transient expression of protein. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:16061912 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5334 https://github.com/vaccineontology/VO/issues/169 3458 5334 cancer vaccine Gene name: IFNG -Obselete ALVAC vaccine VO:0007241 A cancer vaccine consisting of ALVAC, a highly attenuated poxvirus strain derived from the canarypox virus. ALVAC-B7-CEA expresses carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cells, and B7.1 (also known as CD80), the natural ligand for the T-cell antigen CD28, to augment the host immune response. This agent has been shown to stimulate a host immune response against tumor cells that express CEA. (NCI04) Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:12596363 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5444 https://github.com/vaccineontology/VO/issues/210 1048 941 5444 cancer vaccine Gene name: CD80 Gene name: CEACAM5 (CEA) ALVAC-B7-CEA vaccine VO:0007242 A replication-defective recombinant canarypox virus (ALVAC) that contains the entire human carcinoembryonic antigen (CEA) gene. Vaccination with ALVAC-CEA (VCP248) may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against CEA-positive tumor cells, thereby decreasing tumor growth. (NCI04) Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5003 https://github.com/vaccineontology/VO/issues/212 1048 5003 cancer vaccine Gene name: CEACAM5 (CEA) ALVAC-CEA (VCP248) vaccine VO:0007243 A cancer vaccine that uses a viral vector system derived from the canarypox virus engineered to target the carcinoembryonic antigen (CEA). It causes infected cells to temporarily display CEA and activates the immune system to attack the tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:18676757 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5125 https://github.com/vaccineontology/VO/issues/213 941 5125 cancer vaccine Gene name: CD80 ALVAC-CEA B7.1 Vaccine VO:0007244 A cancer vaccine consisting of ALVAC, a highly attenuated poxvirus strain derived from the canarypox virus, encoding for the tumor associated antigen (TAA) carcinoembryonic antigen (CEA), with potential antineoplastic activity. Upon administration, ALVAC-CEA vaccine expresses CEA and may stimulate a host immune response against tumor cells expressing CEA. This may result in the inhibition of tumor growth and/or metastasis. CEA is overexpressed in a variety of tumor cell types. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5051 https://github.com/vaccineontology/VO/issues/214 1048 5051 cancer vaccine Gene name: CEACAM5 (CEA) ALVAC-CEA vaccine VO:0007245 A cancer vaccine consisting of a replication-defective recombinant canarypox virus (ALVAC) encoding the cancer-testis antigen NY-ESO-1, with potential immunostimulatory and antineoplastic activities. Upon administration, ALVAC-ESO-1 vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against NY-ESO-1-expressing cancer cells, which may result in the inhibition of tumor cell proliferation. NY-ESO-1, a tumor associated antigen (TAA), is found in normal testis and on the surface of various tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01982487 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5332 https://github.com/vaccineontology/VO/issues/215 1485 5332 cancer vaccine Gene name: NY-ESO-1 ALVAC-ESO-1 vaccine VO:0007246 A vaccine comprise of a canarypox viral vector that carries the gene for human B7.1 (CD80 antigen) with potential use as an autologous therapeutic cancer vaccine. Tumor cells harvested from a patient are infected with ALVAC-hB7 1, thereby producing an autologous cell line that exhibits increased expression of HLA class I and class II, CD54 (ICAM), and CD80. Increased expression of these proteins by this autologous cell line may activate an antitumor T-cell response when the modified cells are administered to the patient. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00003556 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5181 https://github.com/vaccineontology/VO/issues/216 1493 5181 cancer vaccine Gene name: CTLA4 ALVAC-hB7.1 vaccine VO:0007247 A cancer vaccine containing a replication-defective recombinant canarypox virus (ALVAC), encoding an epitope of MART-1 (melanoma antigen recognized by T-cells), with potential immunostimulatory and antineoplastic activities. Upon administration, the MART-1 epitope is expressed by the ALVAC vector in ALVAC-MART-1 vaccine; a host cytotoxic T lymphocyte (CTL) response against MART-1-expressing tumor cells may follow, resulting in tumor cell lysis and decreased tumor cell proliferation Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00612222 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5124 https://github.com/vaccineontology/VO/issues/217 2315 5124 cancer vaccine Gene name: MLANA ALVAC-MART-1 vaccine VO:0007248 A cancer vaccine used to treat patients with malignant melanoma. It is made of a compatible melanoma cell line that has been engineered to express a molecule termed 4-1BBL, which enhances the chances of the cell line to be recognized by the patient's immune system, and to induce its stimulation, with an immune response to residual tumor in the body. It will be used in combination with intravenous low dose cyclophosphamide, 300 mg/m2. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01898039 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6260 8744 6260 cancer vaccine Gene name: 4-1BBL a2/4-1bbl melanoma vaccine VO:0007249 A therapeutic cancer vaccine, based on a replication-defective recombinant canarypox virus (ALVAC) encoding multiple melanoma antigens, with potential immunostimulatory and antineoplastic activities. Vaccination with ALVAC(2) melanoma multi-antigen therapeutic vaccine may stimulate the host immune system to mount an immune response against antigen-expressing melanoma cells, resulting in inhibition of tumor growth and/or metastasis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5394 https://github.com/vaccineontology/VO/issues/170 1485 6490 5394 cancer vaccine Gene name: CTAG1B Gene name: gp100 (PMEL) ALVAC(2) Melanoma multi-antigen vaccine VO:0007250 A cancer vaccine consisting of a replication-defective recombinant canarypox virus [ALVAC(2)] encoding the cancer-testis antigen NY-ESO and the TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3; also called TRICOM), with potential immunostimulatory and antineoplastic activities. Upon administration, ALVAC(2)/NY-ESO (M)/TRICOM vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against NY-ESO-expressing cancer cells, which may result in the inhibition of tumor cell proliferation. NY-ESO-1, a tumor associated antigen (TAA), is found in normal testis and on the surface of various tumor cells, including bladder, breast, hepatocellular, melanoma, and prostate tumor cells. TRICOM may enhance antigen presentation and activate cytotoxic T-cells. In addition, ALVAC(2) encodes the vaccinia virus (vv) E3L ad K3L genes, which may potentiate the translation of the NY-ESO and TRICOM genes. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01982487 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5268 https://github.com/vaccineontology/VO/issues/171 1485 3383 941 965 5268 cancer vaccine Gene name: CD58 Gene name: CD80 Gene name: ICAM1 Gene name: NY-ESO-1 ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine VO:0007251 A cancer vaccine consisting of autologous dendritic cells loaded with separate preparations of acute myelogenous leukemia (AML) cell lysate and AML-specific messenger RNA (mRNA) with potential immunostimulatory and antineoplastic activities. Upon administration, AML mRNA plus lysate loaded autologous dendritic cell vaccine may elicit a potent cytotoxic T-cell (CTL) response against AML cells, resulting in tumor cell death. Autologous dendritic cells doubly-loaded with AML cell lysate and AML-specific mRNA may elicit superior primary, recall, and effector lytic immune responses compared to autologous dendritic cells loaded with tumor lysate or tumor mRNA alone. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5533 https://github.com/vaccineontology/VO/issues/219 5533 cancer vaccine AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine VO:0007252 A plasmid DNA-based vaccine consisting of small biodegradable poly(lactide-co-glicolide) polymer microparticles encapsulating plasmid-DNA vector encoding a chimeric protein comprising epitopes derived from the E6 and E7 oncoproteins of the human papillomavirus (HPV) types 16 and 18, with potential antineoplastic activity. Upon intramuscular vaccination, amolimogene bepiplasmid may elicit the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 and -18 E6 and E7 and may result in a reduction in tumor cell growth. HPV types 16 and 18 oncoproteins E6 and E7 are most commonly involved in cervical cancer. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:19051140 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5243 https://github.com/vaccineontology/VO/issues/220 1489079 5243 cancer vaccine Gene name: E7 Amolimogene Bepiplasmid Vaccine VO:0007253 A cancer vaccine containing pTVG4 plasmid DNA encoding the human androgen receptor (AR) ligand-binding domain (LBD) (pTVG-AR), with potential immunostimulating and antineoplastic activities. Upon intradermal administration of AR LBD-encoding plasmid DNA vaccine MVI-118, the plasmid DNA vaccine expresses AR LBD and may stimulate the host immune system to generate a cytotoxic T-lymphocyte (CTL) response against AR LBD-expressing prostate cancer cells. This reduces proliferation of AR-expressing tumor cells. AR, a tumor-associated antigen (TAA) overexpressed in prostate cancer cells, plays a key role in the development and progression of prostate cancer; its expression is correlated with poor prognosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:32513836 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5331 https://github.com/vaccineontology/VO/issues/221 367 5331 cancer vaccine Gene name: AR Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118 VO:0007254 A modified vaccinia Ankara (MVA) encoding 7 melanoma tumor antigen cytotoxic T lymphocyte (CTL) epitopes. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15627214 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3994 https://github.com/vaccineontology/VO/issues/222 3994 cancer vaccine Ankara (MVA) vaccine VO:0007255 Recombinant MVA-gp100M and ALVAC(2)-5T4 were constructed to complement existing ALVAC(2)-gp100M and MVA-5T4 vectors. Recombinant TAA expression in chicken embryo fibroblast cells was confirmed by Western blot analysis. 5T4 expression was approximately equal for both viruses, whereas ALVAC-derived gp100 was quickly degraded, at a time point when MVA-derived gp100 was still stable and expressed at high levels Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15627214 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4073 https://github.com/vaccineontology/VO/issues/223 4073 cancer vaccine Ankara (MVA) and ALVAC(2) vaccine VO:0007256 An anti-CD19/anti-CD3 bispecific tetravalent antibody with potential immunostimulatory and antineoplastic activities. Anti-CD19/CD3 tetravalent antibody AFM11 possesses two antigen-recognition and binding sites, one for the CD3 complex, a group of T-cell surface glycoproteins that complex with the T-cell receptor (TCR), and one for CD19, a tumor-associated antigen (TAA) overexpressed on the surface of B-cells. Upon bolus infusion of AFM11, this bispecific antibody binds to CD3-expressing T-cells and CD19-expressing cancer cells, thereby crosslinking CD19-expressing tumor B-cells and cytotoxic T-lymphocytes (CTLs). This may result in a potent CTL-mediated cell lysis of CD19-expressing B-lymphocytes. CD19, a B-cell specific membrane antigen, is expressed during both B-cell development and B-cell malignant growth. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5199 https://github.com/vaccineontology/VO/issues/224 5199 cancer vaccine Anti-CD19/CD3 Tetravalent Antibody AFM11 Vaccine VO:0007257 Autologous activated T cells that have been coated with bispecific antibodies (BiAb), with potential antineoplastic and immunomodulating activities. In vitro, T cells are activated through exposure to the anti-CD3 murine monoclonal antibody OKT3 and low-dose interleukin 2 (Il-2) for 6-14 days and then armed with anti-CD3 x anti-CD20 bispecific antibody (CD20Bi). Upon administration, anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (AATC) attach to CD3-expressing T cells and CD20-expressing tumor cells, selectively cross-linking T cells and tumor cells. This may result in the recruitment and activation of cytotoxic T lymphocyte (CTLs), CTL-mediated specific tumor cell lysis, and the secretion of antitumor cytokines and chemokines. CD20, a cell surface phosphoprotein, is found on normal B cells and most B-cell tumors. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5411 https://www.targetedonc.com/view/cd20-cd3-bispecific-antibodies-can-revolutionize-b-cell-lymphoma-therapy https://github.com/vaccineontology/VO/issues/225 931 5411 cancer vaccine Gene name: MS4A1 Anti-CD3 x Anti-CD20 Bispecific Antibody-Armed Activated T Cells Cancer Vaccine VO:0007258 Autologous human peripheral blood lymphocytes (PBLs), transduced with a retroviral vector encoding both the alpha and beta chains of a T cell receptor (TCR) specific for the carcinoembryonic antigen (CEA), with potential immunostimulating and antineoplastic activities. After transduction, expansion in culture, and reintroduction into the patient, anti-CEA TCR retroviral vector-transduced autologous lymphocytes bind to tumor cells expressing CEA, which may result in cytokine expression, activation and proliferation of T-cells, and a specific cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells. The tumor-associated antigen (TAA) CEA is overexpressed by a variety of cancer cell types, including those of the gastrointestinal tract, lung, and breast. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He Anti-CEA TCR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5536 https://github.com/vaccineontology/VO/issues/226 1048 5536 cancer vaccine Gene name: CEACAM5 (CEA) anti-CEA TCR retroviral vector-transduced autologous peripheral blood lymphocyte vaccine VO:0007259 An autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. Anti-CTLA4 MoAb RNA-transfected autologous DC vaccine is prepared by transfecting DCs with RNAs encoding humanized heavy and light chains of the anti-CTLA4 (cytotoxic T-Lymphocyte-Associated Antigen 4); expression of anti-CTLA4 blocks the inhibitory effect of CTLA4 on the activation of T-lymphocytes. Co-vaccination of this vaccine with melanoma antigen specific vaccine may eliminate the adverse effects associated with systemic administration of immune modulators, while also enhancing vaccine-induced immune responses Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5375 https://github.com/vaccineontology/VO/issues/227 1493 5375 cancer vaccine Gene name: CTLA4 anti-CTLA4 MoAb RNA-transfected autologous dendritic cell vaccine VO:0007260 An autologous dendritic cell (DC) cancer vaccine with potential immunostimulatory activity. Anti-CTLA4 MoAb RNA/GITRL RNA-transfected DC vaccine is prepared by transfecting DCs with RNAs encoding humanized heavy and light chains of the anti-CTLA4 (cytotoxic T-Lymphocyte-Associated Antigen 4) monoclonal antibody and tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18 or GlTRL); expression of anti-CTLA4 blocks the inhibitory effect of CTLA4 on the activation of T-lymphocytes, while expression of GlTRL modulates T lymphocyte survival in peripheral tissues. Co-vaccination of this vaccine with melanoma antigen specific vaccine may eliminate the adverse effects associated with systemic administration of immune modulators, while also enhancing vaccine-induced immune responses. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5149 https://github.com/vaccineontology/VO/issues/228 1493 5149 cancer vaccine Gene name: CTLA4 anti-CTLA4 MoAb RNA/GITRL RNA-transfected autologous dendritic cell vaccine VO:0007261 A peptide vaccine derived from the synthetic peptide pyroEHWSYGLRPG, corresponding to amino acids 22-31 of mouse gonadotropin releasing hormone (GnRH), with potential immunocastration activity. PEP223 is dimerized and contains a D-lysine (k) substitution at position 6 (pyroEHWSYkLRPG) to increase its immunogenicity. Anti-GnRH vaccine PEP223 may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against GnRH, neutralizing its activity. In turn, testosterone production and tumor cell growth may be inhibited in testosterone-sensitive tumors. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00895466 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5405 https://github.com/vaccineontology/VO/issues/229 14714 5405 cancer vaccine Gene name: Gnhr1 Anti-GnRH Vaccine PEP223 VO:0007262 A monoclonal antibody that functionally mimics MUC-1 antigen, a tumor cell surface antigen. Administration of anti-idiotype MUC-1 monoclonal antibody may elicit an anti-idiotype antibody and corresponding T-cell response against MUC-1 expressing tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15550589 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5175 https://github.com/vaccineontology/VO/issues/230 4582 5175 cancer vaccine Gene name: MUC1 anti-idiotype MUC-1 monoclonal antibody vaccine VO:0007263 A synthetic antibody produced by a genetically homogenous population of hybrid cells (hybridoma) against determinant idiotypes (Id) which usually mimic human epitopes. Anti-Id vaccines may be effective in the treatment of B-cell lymphomas, resulting in tumor regression. Anti-idiotype vaccine therapy is less likely to induce autoimmunity if the target antigen is not normally expressed on normal tissues. Monoclonal antibodies have become powerful tools for tumor targeting, recognizing different protein markers on certain cancer cells and may be used alone or as delivery agents for drugs, toxins or radioactive material targeted to tumors. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5301 https://github.com/vaccineontology/VO/issues/231 5301 cancer vaccine anti-Idiotype specified monoclonal antibody vaccine VO:0007264 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He anti-idiotypic mAb MK2-23+BCG PMID:9816036 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4015 https://github.com/vaccineontology/VO/issues/232 4015 cancer vaccine anti-idiotypic mAb MK2-23+BCG vaccine VO:0007265 A murine anti-idiotypic monoclonal antibody (anti-Id MoAb) that is directed against an idiotype mimicking a disialoganglioside GD3. GD3 represents a major surface marker on most human melanoma cells. Due to poor immunogenicity of GD3, anti-Id MoAb BEC2 (Ab2) was raised against a mouse anti-GD3 MoAb, R24 (Ab1). This anti-Id MoAb was shown to be functionally mimicking GD3 in stimulating an immune response to produce Ab3 that may be used in combination with other adjuvants for treatment of melanomas. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5433 https://github.com/vaccineontology/VO/issues/233 5433 cancer vaccine anti-idiotypic monoclonal antibody BEC2 vaccine VO:0007266 An immunotherapeutic agent targeting the tumor-associated antigen (TAA), cancer/testis antigen NY-ESO-1, with potential antineoplastic activity. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5485 https://github.com/vaccineontology/VO/issues/234 1485 5485 cancer vaccine Gene name: NY-ESO-1 anti-NY-ESO-1 Immunotherapeutic GSK-2241658A vaccine VO:0007267 Human autologous CD62L-positive T-lymphocytes transduced with a retroviral vector encoding a T cell receptor (TCR) specific for the cancer-testis antigen NY-ESO-1, with potential antineoplastic activity. Following leukapheresis, isolation of lymphocytes, expansion ex vivo, transduction, and reintroduction into the patient, the anti-NY-ESO1 TCR-transduced autologous CD62L+-derived T-Lymphocytes bind to NY-ESO-1-overexpressing tumor cells. This may result in cytotoxic T-lymphocyte (CTL)-mediated elimination of NY-ESO-1-positive cancer cells. NY-ESO-1, a tumor associated antigen (TAA), is found in normal testis and on the surface of various tumor cell types. CD62L, also called L-selectin, is a lymphoid homing receptor and differentiation marker and is expressed on a subset of CD8-positive T-lymphocytes; it is involved in the migration of T-lymphocytes to lymph nodes and may improve the efficacy for ex vivo-expanded T-cells following adoptive cell therapy. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5081 https://github.com/vaccineontology/VO/issues/235 1485 30484 5081 cancer vaccine Gene name: CTAG2 Gene name: NY-ESO-1 anti-NY-ESO1 TCR-transduced Autologous CD62L+-derived T-Lymphocytes vaccine VO:0007268 Human autologous peripheral blood lymphocytes (PBLs) transduced with an anti-p53 T cell receptor gene with potential antineoplastic activity. PBLs are harvested from a patient and pulsed with a retroviral vector that encodes the T-cell receptor gene specific for a mutated form of p53. The transduced PBLs are then expanded in culture. When reintroduced to the patient, these modified PBLs express the anti-p53 T cell receptor which binds to mutant p53-overexpressing tumor cells; PBL-mediated tumor growth inhibition may follow. Many tumor cell types overexpress mutant p53 proteins, which are associated with the loss of apoptosis regulation and abnormal cell proliferation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00393029 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5447 https://github.com/vaccineontology/VO/issues/236 7157 5447 cancer vaccine Gene name: TP53 (P53) anti-p53 T-Cell Receptor-Transduced peripheral blood lymphocytes vaccine VO:0007269 An immunotherapeutic agent targeting the tumor-associated antigen (TAA), preferentially expressed antigen of melanoma (PRAME), with potential antineoplastic activity. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01853878 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5361 https://github.com/vaccineontology/VO/issues/237 23532 5361 cancer vaccine Gene name: PRAME anti-PRAME Immunotherapeutic GSK2302032A Vaccine VO:0007270 An individualized, therapeutic cancer vaccine (IVAC) composed of liposomes containing RNA encoding two or three tumor associated antigens (TAAs) that are specifically expressed in the patient's individual cancer selected from a warehouse (""off the shelf"") and p53 RNA, with potential immunostimulatory and antineoplastic activities. Upon administration, the antigen-targeted personalized breast cancer vaccines are translated by antigen presenting cells (APCs) and the expressed protein is presented via major histocompatibility complex (MHC) molecules on the surface of the APCs. This leads to an induction of both cytotoxic T-lymphocyte (CTL) and memory T-cell immune responses against the TAAs. The RNAs in the vaccine are specifically selected for an individual patient after RNA profiling of the patient's tumor. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5138 https://github.com/vaccineontology/VO/issues/238 6490 5138 cancer vaccine Gene name: gp100 (PMEL) antigen-targeted Personalized Breast Cancer Vaccine VO:0007271 A cell-based vaccine composed of previously frozen autologous antigen-presenting peripheral blood mononuclear cells (enriched for a dendritic cell fraction) that have been exposed to a recombinant protein consisting of granulocyte-macrophage colony-stimulating factor (GM-CSF) fused to prostatic-acid phosphatase (PAP), a protein expressed by prostate cancer cells. Upon administration, the vaccine may stimulate an antitumor T-cell response against tumor cells expressing PAP. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01133704 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5420 https://github.com/vaccineontology/VO/issues/239 2346 354 55 5420 cancer vaccine Gene name: ACPP Gene name: KLK3 Gene name: Prostate APC8015F vaccine VO:0007272 A cell based cancer vaccine composed of mature polarized dendritic cells (DCs) and pulsed with apoptotic autologous tumor cells that has potential immunostimulating and antineoplatic activities. Dendritic cells (DCs) were treated with interleukin-1beta, tumor necrosis factor alpha, interferon-alpha (IFN-a), IFN-gamma and polyinosinic:polycytidylic acid (p-I:C) to produce mature alpha type-1 polarized DCs (alphaDC1) that are capable of producing high levels of interleukin-12p70 (IL-12p70). The alphaDC1 are subsequently pulsed with apoptotic autologous tumor cells. Upon administration, these DCs are able to induce a potent cytotoxic T lymphocyte (CTL) response against tumor associated antigens (TAAs), resulting in tumor cell lysis and inhibition of tumor cell growth. Apoptotic tumor cells contain an array of TAAs Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:21509164 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5222 https://github.com/vaccineontology/VO/issues/240 5222 cancer vaccine Apoptotic Autologous Tumor Cells-pulsed Alpha-type-1 Polarized Dendritic Cells Vaccine VO:0007273 A cancer vaccine that uses adenovirus MUC1 and Survivin transfected autologous dendritic cells combined with cytokine-induced killer cells in cancer patients with Extensive-Stage Small- Cell Lung Cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01174082 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6261 332 4582 6261 cancer vaccine Gene name: MUC1 Gene name: Survivin adenovirus-transfected autologous dc vaccine plus cik cells VO:0007274 A vaccine comprised of autologous epithelial ovarian cells infected with ALVAC-hB7.1 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5319 https://www.clincosm.com/trial/recurrent-ovarian-epithelial-cancer-houston-alvac-hb71-recombinant https://github.com/vaccineontology/VO/issues/242 155971 5319 cancer vaccine Gene name: env AUT-OV-ALVAC-hB7.1 Vaccine VO:0007275 An autologous tumor cell vaccine containing chronic lymphocytic leukemia (CLL) B cells transduced with an adenoviral vector carrying chimeric CD154 (ad-CD154) with potential antineoplastic activity. Administration of autologous ad-CD154 transduced CLL B cells may result in increases in the numbers of leukemia-specific CD4+ T cells and high serum-levels of IL-12 and IFN-gamma. Due to ligation of CD154 to CD40 on CLL cells, this agent may induce CLL cells to express the proapoptotic molecule BID and death receptors CD95 (Fas) and DR5, rendering CLL B cells first resistant and then sensitive to Fas-mediated apoptosis. In addition, autologous ad-CD154 transduced CLL B cells may induce MHC class I-dependent cytotoxic T lymphocyte (CTL) responses against autologous leukemia cells. CD154 is a type II membrane glycoprotein and ligand for CD40; both molecules are important in cognate co-stimulatory cell-cell interactions. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00779883 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5053 https://github.com/vaccineontology/VO/issues/243 959 5053 cancer vaccine Gene name: CD40LG Autologous Ad-CD154-Transduced CLL B Cells Vaccine VO:0007276 Human autologous peripheral blood lymphocytes (PBLs) transduced with a glycoprotein 100 (gp100) epitope-determined T cell receptor (TCR) gene, with potential antineoplastic activity. PBLs are isolated from a melanoma patient and pulsed with a viral vector encoding the TCR specific for amino acid residues 154-162 of gp100 (KTWGQYWQV). After expansion ex vivo, the transduced autologous PBLs, expressing this specific TCR, are reintroduced into the patient and bind to melanoma cells expressing the gp100 protein, which may result in specific cytotoxic T-lymphocyte (CTL) killing of gp100-expressing melanoma cells. gp100 is a melanocyte lineage-specific antigen overexpressed in melanomas. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00509496 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5507 https://github.com/vaccineontology/VO/issues/244 6490 5507 cancer vaccine Gene name: gp100 (PMEL) autologous anti-gp100:154-162 T-cell receptor gene-engineered peripheral blood lymphocytes vaccine VO:0007277 Human autologous peripheral blood lymphocytes (PBLs) transduced with a melanoma antigen MART-1 epitope-determined T cell receptor (TCR) gene, with potential antineoplastic activity. PBLs are isolated from a melanoma patient and pulsed with a viral vector that encodes the TCR specific for an epitope of MART-1 (F5 TCR). After expansion ex vivo, the transduced autologous PBLs, expressing this specific TCR, are reintroduced into the patient, and bind to melanoma cells expressing the MART-1 antigen, which may result in specific cytotoxic T-lymphocyte (CTL) killing of MART-1-expressing melanoma cells. MART-1 (melanoma antigen recognized by T cells 1), also known as Melan-A, is a melanocyte lineage-specific transmembrane protein. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00509288 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5293 https://github.com/vaccineontology/VO/issues/245 2315 5293 cancer vaccine Gene name: MLANA autologous anti-mart-1 f5 T-cell receptor gene-engineered peripheral blood lymphocytes vaccine VO:0007278 A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with CD133-positive autologous brain tumor stem cells (BTSCs) -derived mRNA with potential immunostimulatory and antineoplastic activities. Upon intradermal administration, autologous CD133-positive BTSC mRNA-pulsed autologous dendritic cell vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against the CD133-positive BTSCs from which the autologous tumor mRNA is derived. CD133, a tumor-associated antigen (TAA) and neural stem cell marker, has been found on a specific subset of glioblastoma multiforme (GBM) stem cells; its presence has been correlated with resistance to conventional chemotherapy and radiotherapy. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5463 https://mhlw-grants.niph.go.jp/system/files/2013/134041/201328051A/201328051A0017.pdf https://github.com/vaccineontology/VO/issues/246 8842 5463 cancer vaccine Gene name: PROM1 Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine VO:0007279 A cancer vaccine consisting of autologous, B-chronic lymphocytic leukemia (B-CLL) cells harvested from a patient and transduced with an adenoviral vector encoding the gene for the human CD40 ligand (CD40L; TRAP; CD154), with potential immunostimulating and antineoplastic activities. Upon reintroduction into the patient, the autologous CD40L-expressing B-CLL vaccine expresses the co-stimulatory molecule CD40L, which binds to its cognate receptor, CD40, on antigen presenting cells (APC). This induces apoptosis, stimulates maturation and proliferation of APCs, and facilitates a cytotoxic T-lymphocyte (CTL) response against tumor cells. CD40L is a type II membrane protein that binds to CD40, which is a cell surface receptor that belongs to the tumor necrosis factor (TNF) receptor superfamily. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5174 https://github.com/vaccineontology/VO/issues/247 959 5174 cancer vaccine Gene name: CD40LG Autologous CD40L-expressing B-CLL Vaccine VO:0007280 A dendritic cell (DC)-based cancer vaccine composed of autologous DCs pulsed with tumor cell lysates from a colorectal cancer patient containing tumor-associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon administration, autologous colorectal tumor antigen-pulsed DC vaccine exposes the immune system to colorectal tumor cell antigens, which may result in cytotoxic T-lymphocyte (CTL)-mediated immune responses against the colorectal cancer cells. This leads to cancer cell lysis. The tumor cell lysate contains a range of antigens that are essential for the neoplastic growth and survival of the cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5150 https://github.com/vaccineontology/VO/issues/248 174 5150 cancer vaccine Gene name: AFP Autologous Colorectal Tumor Antigen-pulsed Dendritic Cell Vaccine VO:0007281 An autologous tumor cell vaccine containing CD34+ hematopoietic progenitor cell (HPC)-derived Langerhans-type dendritic cells (LCs) electroporated with mRNA encoding the full-length cancer-testis antigens, CT7 and melanoma-associated antigen 3 (MAGE-A3), and the self-differentiation tumor antigen, Wilms tumor 1 (WT1) with potential immunomodulating and antineoplastic activity. The autologous CT7/MAGE-A3/WT1 mRNA-electroporated Langerhans-type dendritic cells are prepared by drawing a blood sample containing the CD34+ HPCs from a cancer patient. The CD34+ HPCs are treated with a combination of cytokines which specifically support LC development, and the LC population is enriched and expanded ex vivo. The cultured LCs are allowed to mature for one day and then electroporated separately with CT7, MAGE-A3 or WT1 mRNA before final maturation. Upon intradermal administration into the patient, the mature LCs may activate cell-mediated immunity and induce both cytotoxic CD8+ T cells and CD4+ helper T cells against cancer cells expressing CT7, MAGE-A3 and WT1 tumor antigens. This may result in the immune-mediated inhibition of tumor cell proliferation, leading to tumor cell death. CT7 and MAGE-A3 are tumor-specific proteins overexpressed in a number of cancers but not in healthy tissues other than testis and placenta. WT1 is a transcription factor important in development and cancer pathogenesis, which is overexpressed in a variety of cancers, including multiple myeloma, leukemia, ovarian cancer, malignant mesothelioma, neural tumors and renal carcinoma. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01995708 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5128 https://github.com/vaccineontology/VO/issues/249 7490 5128 cancer vaccine Gene name: WT1 Autologous CT7/MAGE-A3/WT1 mRNA-Electroporated Langerhans-Type Dendritic Cells Vaccine VO:0007282 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He autologous DCV autologous dendritic cell vaccine (DCV) PMID:22774527 PMID:31771601 PMID:34862245 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3967 https://github.com/vaccineontology/VO/issues/250 3967 cancer vaccine autologous dendritic cell vaccine VO:0007283 A cell-based cancer vaccine composed of autologous, immature dendritic cells (DCs), with potential immunostimulating and antineoplastic activities. Upon leukapheresis, immature DCs are isolated and re-administered intra-tumorally. The immature DCs internalize and process the tumor-associated antigens (TAAs), migrate to the lymphatic system, and then expose the immune system to the TAAs. This induces a specific cytotoxic T-lymphocyte (CTL) response against the cancer cells leading to tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT02649829 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5085 https://github.com/vaccineontology/VO/issues/251 958 5085 cancer vaccine Gene name: CD40 Autologous Dendritic Cell Vaccine ACT2001 VO:0007284 A cancer vaccine comprised of autologous dendritic cells (DCs) that have been transduced ex vivo with an adenoviral vector containing the CCL21 gene with potential immunostimulatory and antineoplastic activities. Upon intratumoral administration, autologous dendritic cell-adenovirus CCL21 vaccine expresses the chemokine CCL21, which may induce an antitumoral cytotoxic immune response in the tumor microenvironment. CCL21 [chemokine (C-C motif) ligand 21] has been shown to attract antigen presenting cells (APCs), like leukocytes and DCs, and natural killer (NK) cells and their T-cell effectors to induce a cytotoxic immune response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT03546361 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5030 https://github.com/vaccineontology/VO/issues/252 6366 5030 cancer vaccine Gene name: CCL21 Autologous Dendritic Cell-Adenovirus CCL21 Vaccine VO:0007285 An autologous vaccine composed of dendritic cells (DC) that have been transduced with a p53 tumor suppressor gene-modified virus. When the autologous dendritic cell-adenovirus p53 vaccine is administered, the host cytotoxic T lymphocytes (CTL) are directed against p53-positive tumor cells, which may result in tumor cell death and decreased tumor growth. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:20420527 PMID:29515795 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5088 https://github.com/vaccineontology/VO/issues/253 7157 5088 cancer vaccine Gene name: TP53 (P53) autologous dendritic cell-Adenovirus P53 vaccine VO:0007286 A cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated allogeneic melanoma tumor cells. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T-cell and antibody responses to melanoma cells bearing shared melanoma antigens such as MelanA/MART-1, gp100, MAGE3, resulting in tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5495 https://github.com/vaccineontology/VO/issues/254 2315 4102 6490 5495 cancer vaccine Gene name: MAGEA3 Gene name: MLANA Gene name: gp100 (PMEL) autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine VO:0007287 cancer vaccine consisting of autologous dendritic cells transfected with autologous tumor mRNA and the human CD40 ligand (CD40L) gene with immunostimulatory and antitumor activities. Vaccination with autologous dendritic cell-autologous tumor mRNA-human CD40L vaccine may elicit a cytotoxic T cell response against tumor cells from which the autologous tumor mRNA was derived. When expressed by dendritic cells, tumor antigens and the co-stimulatory molecule CD40L, which binds to CD40 receptors on antigen presenting cells (APC), facilitate both humoral and cellular immune responses against tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:20884622 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5066 https://github.com/vaccineontology/VO/issues/255 6490 5066 cancer vaccine Gene name: gp100 (PMEL) Autologous Dendritic Cell-Autologous Tumor mRNA-Human CD40L Vaccine VO:0007288 A therapeutic interleukin-12 (IL-12)-expressing dendritic cell (DC)-based vaccine composed of autologous monocyte-derived DCs loaded with autologous tumor cell lysate and exposed to the microbial cell wall component lipopolysaccharide (LPS), with potential immunomodulating and antineoplastic activities. The monocyte-derived immature DCs are loaded with autologous tumor cell lysates and are subsequently exposed to LPS and interferon-gamma (IFN-gamma). Upon administration of autologous DC-based immunotherapeutic AV0113, the mature DCs migrate into the lymph nodes, express the immune stimulatory cytokine interleukin-12 (IL-12) and activate the immune system by promoting the activation of natural killer (NK) cells and induce a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells, which may result in immune-mediated tumor cell death and inhibition of tumor cell proliferation. Exposure to LPS and IFN-gamma allows the maturation of DCs and optimizes the presentation of tumor-associated antigens (TAAs) by DCs to T-lymphocytes. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5284 https://ascopubs.org/doi/10.1200/jco.2014.32.15_suppl.2052 https://github.com/vaccineontology/VO/issues/256 5284 cancer vaccine Autologous Dendritic Cell-based Immunotherapeutic AV0113 Vaccine VO:0007289 A therapeutic cancer vaccine consisting of autologous dendritic cells (DCs) fused with autologous tumor cells with potential immunostimulatory and antineoplastic activities. Autologous dendritic cell-tumor fusion vaccine is generated in vitro by mixing DCs and irradiated tumor cells harvested from individual patients and treating them with polyethylene glycol (PEG) to produce DC-tumor cell fusion hybrid cells. Upon administration, autologous dendritic cell-tumor fusion vaccine may elicit antitumor humoral and cellular immune responses. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:23685836 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5056 https://github.com/vaccineontology/VO/issues/257 4582 6382 952 5056 cancer vaccine Gene name: CD38 Gene name: MUC1 Gene name: SDC1 Autologous Dendritic Cell-Tumor Fusion Vaccine VO:0007290 A vaccine consisting of autologous cancer cells modified with the hapten, Dinitrophenyl. The treatment program consists of multiple intradermal injections of irradiated DNP-modified autologous tumor cells mixed with bacillus Calmette-Guerin. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:/9400626 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5537 https://github.com/vaccineontology/VO/issues/258 5537 cancer vaccine autologous dinitrophenyl vaccine VO:0007291 A cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of autologous dinitrophenyl-modified ovarian cancer vaccine may induce a cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5459 https://github.com/vaccineontology/VO/issues/259 5459 cancer vaccine Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine VO:0007292 A cell-based vaccine composed of autologous tumor cells with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5118 https://github.com/vaccineontology/VO/issues/260 5118 cancer vaccine Autologous EBV-Transformed B Lymphoblastoid-Tumor Fusion Cell Vaccine VO:0007293 A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5225 https://github.com/vaccineontology/VO/issues/261 1880 5225 cancer vaccine Gene name: GPR183 Autologous Epstein-Barr Virus-Transformed B-Lymphoblastoid Cell Vaccine VO:0007294 Multipotent self-renewing adherent non-hematopoietic stromal cells harvested from a patient's bone marrow and grown in vitro. When injected back into the patient, autologous expanded mesenchymal stem cells OTI-010 may differentiate into various mesenchyme-derived cell types and, in some instances, may augment bone marrow engraftment after whole-body irradiation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5491 https://github.com/vaccineontology/VO/issues/262 5491 cancer vaccine Autologous Expanded Mesenchymal Stem Cells OTI-010 Vaccine VO:0007295 An autologous tumor cell vaccine containing irradiated breast cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene with potential antineoplastic activity. Autologous breast cancer cells are transduced ex vivo with an adenovirus vector encoding the GM-CSF gene and irradiated and then reintroduced into the patient. Upon repeated subcutaneous administration of the vaccine, autologous GM-CSF-secreting breast cancer cells secrete GM-CSF, which may stimulate a tumor-specific cytotoxic T-lymphocyte (CTL) response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5250 https://github.com/vaccineontology/VO/issues/263 2064 5250 cancer vaccine Gene name: ERBB2 Autologous GM-CSF-Secreting Breast Cancer Vaccine VO:0007296 A lethally irradiated, autologous colorectal cancer vaccine consisting of patient-specific colorectal cancer cells genetically modified to secrete the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon vaccination, the autologous GM-CSF-secreting lethally irradiated colorectal cancer cell vaccine releases GM-CSF. In turn, GM-CSF may increase the body's immune response against tumor cells by promoting the maturation and activation of dendritic cells (DCs), and enhancing tumor-specific antigen presentation to both B- and T-cells, which leads to better recognition of tumors by the immune system. In addition, GM-CSF promotes antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5188 https://github.com/vaccineontology/VO/issues/264 10232 5188 cancer vaccine Gene name: MSLN Autologous GM-CSF-secreting Lethally Irradiated Colorectal Cancer Cell Vaccine VO:0007297 An autologous cancer vaccine composed of lethally irradiated leukemia cells that are genetically modified to secrete the immunostimulatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF), with potential immunostimulating and antineoplastic activities. Upon intradermal injection, the autologous GM-CSF-secreting lethally irradiated leukemia cell vaccine secretes GM-CSF. In turn, GM-CSF may stimulate the immune system to attack tumor cells by enhancing the activation of dendritic cells (DCs) and promoting antigen presentation to both B- and T-lymphocytes. In addition, GM-CSF promotes antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5240 https://github.com/vaccineontology/VO/issues/265 1437 7490 5240 cancer vaccine Gene name: GM-CSF Gene name: WT1 Autologous GM-CSF-Secreting Lethally Irradiated Leukemia Cell Vaccine VO:0007298 A recombinant cancer vaccine made with tumor-derived heat shock protein 70 (HSP70) peptide complexes. HSP70 associates with antigenic peptides, transporting them into antigen presenting cells (APC) for processing. Tumor-derived HSP70-peptide complexes used in vaccine preparations have been shown to prime tumor immunity and tumor-specific T cells in animal models. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5266 https://github.com/vaccineontology/VO/issues/266 3308 5266 cancer vaccine Gene name: HSPA4 Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858 VO:0007299 A vaccine consisting of lethally irradiated human fetal lung fibroblasts (Medical Research Council 5 or MRC-5) transfected with autologous tumor DNA derived from a head and neck squamous cell carcinoma (HNSCC), with potential immunostimulatory and antineoplastic activities. Upon intradermal administration, the autologous HNSCC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine expresses HNSCC tumor-associated antigens (TAAs), which may activate the immune system to induce a cytotoxic T-lymphocyte (CTL) response against HNSCC cells. The MRC-5 cell line, established in 1966, is a human diploid lung fibroblast cell line derived from the human lung tissue of a 14-week-old male fetus. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT02211027 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5043 https://github.com/vaccineontology/VO/issues/267 6375 5043 cancer vaccine Gene name: XLC1 autologous HNSCC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine VO:0007300 A cancer vaccine consisting of autologous, B-chronic lymphocytic leukemia (B-CLL) cells harvested from a patient and transduced ex vivo with an adenoviral vector encoding the gene for the human cytokine interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Upon reintroduction into the patient, the autologous IL-2-expressing B-CLL vaccine expresses IL-2, stimulates natural killer (NK) cells, and may enhance the cytotoxic T-lymphocyte (CTL) immune response against the patient's B-CLL cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00458679 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5228 https://github.com/vaccineontology/VO/issues/268 12519 3383 942 5228 cancer vaccine Gene name: CD86 Gene name: Cd80 Gene name: ICAM1 Autologous IL-2-expressing B-CLL Vaccine VO:0007301 A cancer vaccine composed of tumor-specific idiotype determinants derived from an individual's tumor cells which are conjugated to keyhole limpet hemocyanin, an immunostimulant carrier protein. When injected into the individual from whom the tumor cells were isolated, this vaccine may stimulate an antitumoral cytotoxic T-lymphocytic immune response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00104819 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5057 https://github.com/vaccineontology/VO/issues/269 3123 5057 cancer vaccine Gene name: HLA-DRB1 Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine VO:0007302 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysate from autologous lymphoma cells with potential immunostimulatory and antineoplastic activities. Upon intranodal administration, autologous lymphoma cell lysate-pulsed autologous DC vaccine may stimulate the immune system to mount anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against lymphoma cells, which may result in lymphoma cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5248 https://github.com/vaccineontology/VO/issues/270 5248 cancer vaccine Autologous Lymphoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine VO:0007303 A cell-based cancer vaccine consisting of hybrid cells created by electrofusing allogeneic dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5503 https://github.com/vaccineontology/VO/issues/272 1638 2315 6490 7299 5503 cancer vaccine Gene name: DCT Gene name: MLANA Gene name: Tyrosinase Gene name: gp100 (PMEL) Autologous Lymphoma Cell/Allogeneic Dendritic Cell Electrofusion Hybrid Vaccine VO:0007304 A cell-based cancer vaccine consisting of hybrid cells created by electrofusing autologous dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5431 https://github.com/vaccineontology/VO/issues/273 5431 cancer vaccine Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine VO:0007305 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysate from autologous melanoma cells containing tumor associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, autologous melanoma lysate-pulsed autologous DC vaccine may stimulate the immune system to mount anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against melanoma cells, which may result in melanoma cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5148 https://github.com/vaccineontology/VO/issues/274 1485 2315 5148 cancer vaccine Gene name: MLANA-Dupuli Gene name: NY-ESO-1 autologous melanoma lysate-pulsed autologous dendritic cell vaccine VO:0007306 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysate from autologous melanoma cells containing tumor associated antigens (TAAs) and conjugated to the immunostimulant Keyhole limpet hemocyanin (KLH), with potential immunostimulatory and antineoplastic activities. Upon administration, autologous melanoma lysate/KLH-pulsed autologous dendritic cell vaccine may stimulate the immune system to mount anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against melanoma cells, which may result in melanoma cell lysis. KLH is an immunogenic carrier and serves as an immunostimulant to improve antigenic immune recognition and T-cell responses and can be used to evaluate vaccine efficacy. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5213 https://github.com/vaccineontology/VO/issues/275 3123 5213 cancer vaccine Gene name: HLA-DRB1 autologous melanoma Lysate/KLH-pulsed autologous dendritic cell vaccine VO:0007307 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with both a lysate from autologous melanoma cells containing tumor associated antigens (TAAs) and a synthetic peptide derived from the tumor associated antigen human cancer-testis antigen NY-ESO-1, with potential immunostimulatory and antineoplastic activities. Upon administration, autologous melanoma lysate/NY-ESO-1-pulsed autologous DC vaccine may stimulate the immune system to mount anti-tumoral cytotoxic T lymphocyte (CTL) and antibody-mediated immune responses against melanoma cells, which may result in melanoma cell lysis. NY-ESO-1 is expressed in normal testes and on the surfaces of various tumor cells, and plays a key role in tumor cell proliferation and survival. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5158 https://github.com/vaccineontology/VO/issues/276 1485 5158 cancer vaccine Gene name: NY-ESO-1 autologous melanoma Lysate/NY-ESO-1-pulsed autologous dendritic cell vaccine VO:0007308 A vaccine consisting of irradiated human fetal lung fibroblasts (Medical Research Council 5 or MRC-5) transfected with autologous non-small cell lung cancer (NSCLC)-derived DNA with potential immunostimulatory and antineoplastic activities. Upon administration, autologous NSCLC DNA-transfected semi-allogeneic fibroblasts MRC-5 vaccine expresses NSCLC tumor-associated antigens (TAAs) in addition to MHC class I-determinants and the co-stimulatory molecule B7.1, which may induce a cytotoxic T-lymphocyte (CTL) response against NSCLC cells. The MRC-5 cell line is a human diploid lung fibroblast cell line extablished in 1966. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5377 https://github.com/vaccineontology/VO/issues/277 5377 cancer vaccine Autologous NSCLC DNA-Transfected Semi-Allogeneic Fibroblasts MRC-5 Vaccine VO:0007309 A personalized cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with immunogenic peptides derived from autologous non-small cell lung cancer (NSCLC) cells, with potential immunostimulating and antineoplastic activities. During leukapheresis, mature DCs are loaded with autologous NSCLC-derived peptides. Upon re-administration of the NSCLC peptide-specific DC vaccine, the immune system is exposed to NSCLC-associated antigens. This results in the induction of a specific cytotoxic T-lymphocyte (CTL) response against NSCLC cells and tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5311 https://github.com/vaccineontology/VO/issues/278 5311 cancer vaccine Autologous NSCLC Peptide-specific Dendritic Cell Vaccine VO:0007310 A cancer vaccine consisting of autologous, mature monocyte-derived dendritic cells (DCs) transfected with oncofetal antigen immature laminin receptor protein (OFA-iLRP) RNA, with potential antineoplastic activity. Upon administration, DCs in the OFA-iLRP RNA-transfected autologous dendritic cell vaccine express, process, and present OFA-iLRP to the host immune system, which may mount a potent cytotoxic T-cell (CTL) response against OFA-iLRP-expressing tumor cells. As a highly conserved protein, OFA-iLRP is preferentially expressed in fetal tissues and in many types of cancer, including hematopoietic malignancies, but is not detectable in normal differentiated adult cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00715832 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5368 https://github.com/vaccineontology/VO/issues/279 16785 5368 cancer vaccine Gene name: Rspa Autologous OFA-iLRP RNA-Transfected Dendritic Cell Vaccine VO:0007311 A cell-based cancer vaccine composed of autologous, irradiated dendritic cells (DCs) pulsed with ovarian tumor cell lysate containing tumor associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against ovarian tumor cells expressing the patients ovarian tumor cell-specific TAAs, which may result in ovarian tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5427 https://github.com/vaccineontology/VO/issues/280 5427 5427 cancer vaccine Gene name: ERBB2 Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine VO:0007312 A specific population of autologous, pluripotent bone marrow derived cells that express high levels of the cytosolic enzyme aldehyde dehydrogenase (ALDH) with potential protective and neuro-cognition improving activity. Expression of high levels of ALDH is an indicator of the biological activity in heterogenous early stage stem cells. Upon intravenous administration, these ALDH bright cells may protect normal cells and may repair damaged cells. These cells may also protect brain cells from damage and may improve neurocognition. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5220 https://discovery.lifemapsc.com/regenerative-medicine/cell-therapy-applications/brain-ald451-bone-marrow-derived-cells-for-malignant-glioma https://github.com/vaccineontology/VO/issues/281 216 217 5220 cancer vaccine Gene name: ALDH1A1 Gene name: ALDH2 Autologous Pluripotent ALDHbr Stem Cells ALD-451 Vaccine VO:0007313 A genetically-modified autologous dendritic cell-based vaccine expressing a drug-inducible costimulatory CD40 receptor (iCD40) with potential immunomodulating and antineoplastic activities. Autologous dendritic cells (DCs) are genetically modified to express the iCD40 receptor and are pulsed with the tumor antigen prostate-specific membrane antigen (PSMA). Upon intradermal administration, these DCs accumulate in local draining lymph nodes. Twenty-four hours after vaccination, the dimerizer agent AP1903 is administered; AP1903 binds to and activates iCD40 receptors presented on DC surfaces, thus activating the DCs and stimulating a cytotoxic T-lymphocyte (CTL) response against host tumor cells that express PSMA. This delayed activation strategy optimizes DC accumulation in local draining lymph nodes prior to DC activation. iCD40 contains a membrane-localized cytoplasmic CD40 domain fused to a drug-binding domain. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5282 https://github.com/vaccineontology/VO/issues/282 2346 928 5282 cancer vaccine Gene name: CD40 Gene name: Prostate Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101 VO:0007314 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with renal cell carcinoma (RCC) tumor cell lysate containing tumor associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, autologous renal cell carcinoma tumor lysate-dendritic cell vaccine may stimulate anti-tumoral cytotoxic T-lymphocyte (CTL) and antibody responses against RCC tumor cells expressing RCC TAAs, resulting in RCC tumor cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5018 https://github.com/vaccineontology/VO/issues/283 2315863 7015 5018 cancer vaccine Gene name: Survivin Gene name: TERT Autologous Renal Cell Carcinoma Tumor Lysate-Pulsed Dendritic Cell Vaccine VO:0007315 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from sarcoma cells with potential immunostimulatory and antineoplastic activities. Upon administration, the autologous sarcoma lysate-pulsed dendritic cell vaccine exposes the immune system to an undefined amount of sarcoma-type tumor associated antigens (TAA), which may result in the induction of both specific anti-tumoral cytotoxic T lymphocytes (CTL) and antibody-dependent responses against the sarcoma TAA-expressing cells, resulting in sarcoma cell lysis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5189 https://github.com/vaccineontology/VO/issues/284 5189 cancer vaccine Autologous Sarcoma Lysate-pulsed Dendritic Cell Vaccine VO:0007316 A cell-based cancer vaccine comprised of autologous dendritic cells pulsed with autologous T cell receptor gamma-chain alternate reading frame protein (TARP) peptide with potential immunostimulatory and antineoplastic activities. Upon intradermal administration, autologous TARP peptide-pulsed dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against TARP-expressing cancer cells, resulting in tumor cell lysis. The highly immunogenic nuclear protein TARP is commonly expressed in breast and prostate cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT02362451 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5024 https://github.com/vaccineontology/VO/issues/285 6862 5024 cancer vaccine Gene name: TBXT Autologous TARP Peptide-Pulsed Dendritic Cell Vaccine VO:0007317 A cancer vaccine composed of autologous, mature dendritic cells (DCs) are electroporated with in vitro transcribed (IVT) RNAs encoding for a synthetic form of T-cell protein CD40 ligand (CD40L) and IVT RNA encoding for autologous tumor-associated antigens (TAAs) derived from patient-specific bladder cell carcinoma (BCC) cells, with potential immunostimulatory and antineoplastic activities. The RNA is translated and processed, and BCC-specific antigenic peptides are subsequently presented via major histocompatibility complex (MHC) Class I molecules on the DCs surface. The MHC-presented peptides interact with and activate CD8-positive T-cells, which elicits a highly specific cytotoxic T-cell (CTL) response against tumor cells expressing the patient-specific BCC TAAs. The signal cascade initiated by expression of the co-stimulatory molecule CD40L results in the secretion of the inflammatory cytokine IL-12, which further stimulates CTLs. The vaccine can be used in combination with gemcitabine hydrochloride and cisplatin which stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading, while the vaccine helps the body build an effective immune response to kill tumor cells. In combination, they may make the tumor smaller and reduce the amount of tissue that needs to be removed by surgery in patients with bladder cancer. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C129522 NCT: https://clinicaltrials.gov/study/NCT02944357 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6363 959 6363 cancer vaccine Gene name: CD40LG ags-003-bld vaccine VO:0007318 An autologous chronic lymphocytic leukemia cancer vaccine consisting of patient-specific membrane proteins directly extracted from patient autologous tumor cells and incorporated into liposomes along with Interleukin 2 (IL-2) to produce membrane-patched proteoliposomes, with potential immunostimulating and antineoplastic activities. After subcutaneous injection of the autologous tumor cell proteoliposomes chronic lymphocytic leukemia vaccine, liposomes deliver the encapsulated tumor antigens into the cytosol of antigen presenting cells (APCs). Subsequently, the APCs process the antigens and present antigen-derived peptides to the immune system. This may enhance recognition of tumors by the immune system, and activate both cytotoxic CD8+ T cells and CD4+ helper T cells against tumor cells. IL-2 is incorporated into the vaccine to leverage its ability to expand activated T cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5108 https://github.com/vaccineontology/VO/issues/287 3558 5108 cancer vaccine Gene name: IL2 Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine VO:0007319 A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the vaccine is then administered to the individual from whom the tumor cells were isolated. Typically combined with an adjuvant immunostimulant, an autologous cell vaccine may elicit a cytotoxic T-lymphocytic immune response to cell surface-expressed tumor-associated antigens (TAAs), resulting in tumor cell death. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:22854664 PMID:32558897 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5396 https://github.com/vaccineontology/VO/issues/288 942 5396 cancer vaccine Gene name: CD86 autologous tumor cell vaccine VO:0007320 A dendritic cell (DC)-based cancer vaccine composed of autologous DCs pulsed with specific tumor-associated peptide antigens (TAPA), with potential immunostimulatory and antineoplastic activities. Upon administration, autologous TAPA-pulsed DC vaccine exposes the immune system to the specific TAPAs, which may result in cytotoxic T-lymphocyte (CTL)-mediated immune responses against the TAPA-expressing cancer cells. This leads to cancer cell lysis. This vaccine is specific towards peptides derived from the following proteins: sperm autoantigenic protein 17 (SP17), ropporin, A-kinase anchor protein 4 (AKAP4), pituitary tumor-transforming 1 (PTTG1) and SPANX family member B (SPANX-B). Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:18528294 PMID:23482679 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5035 https://github.com/vaccineontology/VO/issues/289 53340 54763 728695 8852 9232 5035 cancer vaccine Gene name: AKAP4 Gene name: PTTG1 Gene name: ROPN1 Gene name: SPA17 Gene name: SPANXB1 autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine VO:0007321 An autologous therapeutic vaccine for the treatment of acute myelogenous leukemia. This vaccine is prepared from blood samples of patients following their first relapse. Tumor cells extracted from blood sample are modified with hapten, a process that makes the cells appear foreign to the patient's body and results in stimulating immune response against the cancer. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5404 https://github.com/vaccineontology/VO/issues/290 2315 4102 5404 cancer vaccine Gene name: MAGEA3 Gene name: MLANA Autologous-Cell Leukemia Vaccine VO:0007322 An autologous-cell vaccine for melanoma. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5110 https://github.com/vaccineontology/VO/issues/291 5110 cancer vaccine autologous-cell melanoma vaccine VO:0007323 A cancer vaccine that restored priming of Anaplastic lymphoma kinase (ALK)-specific CD8+ T cells, eradicated lung tumors in combination with ALK tyrosine kinase inhibitors (TKIs) and prevented metastatic dissemination of tumors to the brain. Human ALK peptides are displayed by HLA-A*02:01 and HLA-B*07:02 molecules. The peptides are immunogenic and recognized by CD8+ T cells from individuals with non-small cell lung cancer (NSCLC). Hayleigh Kahn Jie Zheng PMID:37430060 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6382 6382 cancer vaccine alk peptide vaccine VO:0007324 A cancer vaccine made of allogeneic pancreatic tumor cells are transfected with a GM-CSF gene to treat ocally advanced, unresectable or metastatic pancreatic adenocarcinoma. It may be in combination with Ipilimumab (an antibody that blocks negative signals to T cells). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00836407 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6336 12981 6336 cancer vaccine Gene name: GM-CSF allogeneic GM-CSF-secreting lethally irradiated pancreatic tumor cell vaccine VO:0007325 A cancer vaccine that consists of an allogeneic cell line that has a high expression level of melanoma molecules (HLA A2/4-1BB Ligand), and has been genetically modified to induce a strong immune response. Stimulation of the immune response against the tumor can help destroy residual tumor in melanoma patients with very high risk for disease recurrence and in patients with relatively low tumor burden who already got first line treatment for their disease. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01861938 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6313 3105 8744 6313 cancer vaccine Gene name: 4-1BBL Gene name: HLA-A allogeneic HLA-A2/4-1BB ligand-expressing melanoma vaccine VO:0007326 A cancer vaccine that uses anti-HER2/HER3 dendritic cells in combination with Pembrolizumab in patients with Asymptomatic Brain Metastasis From Triple Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC). The dendritic cells boost the immune system, and the Pembrolizumab enhances cancer immune responses, in combination they may shrink the cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT04348747 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6263 2064 2065 6263 cancer vaccine Gene name: HER2 Gene name:HER3 anti-HER2/HER3 dendritic cell vaccine VO:0007327 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:21036724 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5230 https://github.com/vaccineontology/VO/issues/296 5230 cancer vaccine BCG, Cell Wall Skeleton Vaccine VO:0007328 A vaccine consisting of replication-defective recombinant adenovirus that encodes for Bcl-Xs with potential antineoplastic activity. Vaccination with Bcl-Xs adenovirus vaccine induces apoptosis in Bcl-2 and Bcl-XL positive cancer cells, resulting in decreased tumor growth while leaving normal cells unaffected. Bcl-Xs block the function of the protooncogenes Bcl-2 and Bcl-XL which are overexpressed in a variety of solid tumors and promote cancer cell survival by inhibiting apoptosis. (NCI04)A vaccine consisting of replication-defective recombinant adenovirus that encodes for Bcl-Xs with potential antineoplastic activity. Vaccination with Bcl-Xs adenovirus vaccine induces apoptosis in Bcl-2 and Bcl-XL positive cancer cells, resulting in decreased tumor growth while leaving normal cells unaffected. Bcl-Xs block the function of the protooncogenes Bcl-2 and Bcl-XL which are overexpressed in a variety of solid tumors and promote cancer cell survival by inhibiting apoptosis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:7479929 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5399 https://github.com/vaccineontology/VO/issues/297 598 7306 5399 cancer vaccine Gene name: BCL2L1 Gene name: TYRP1 Bcl-Xs adenovirus vaccine VO:0007329 A transforming growth factor beta2 (TGF-beta2) antisense gene-modified allogeneic tumor cell vaccine with potential immunostimulatory and antineoplastic activities. Belagenpumatucel-L is prepared by transfecting allogeneic non-small cell lung cancer (NSCLC) cells with a plasmid containing a TGF-beta2 antisense transgene, expanding the cells, and then irradiating and freezing them. Upon administration, this agent may elicit a cytotoxic T lymphocyte (CTL) response against host NSCLC cells, resulting in decreased tumor cell proliferation; vaccine immunogenicity may be potentiated by suppression of tumor TGF-beta2 production by antisense RNA expressed by the vaccine plasmid TGF-beta2 antisense transgene. Elevated levels of TGF-beta2 are frequently linked to immunosuppression in cancer patients and may be inversely correlated with prognosis in patients with NSCLC. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:26211534 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5374 https://github.com/vaccineontology/VO/issues/298 7042 5374 cancer vaccine Gene name: TGFB2 Belagenpumatucel-L Vaccine VO:0007330 A synthetic vaccine combining the peptide antigens of two proteins, ras oncoprotein and tumor suppressor p53 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15983396 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4992 https://github.com/vaccineontology/VO/issues/299 7157 4992 cancer vaccine Gene name: TP53 (P53) Berzofsky Ras/P53 peptide vaccine VO:0007331 A cancer vaccine composed of a replication-deficient, attenuated derivative of the vaccinia virus strain Ankara expressing both a CD8+ T-cell epitope from the brachyury protein and a triad of T-cell co-stimulatory molecules (MVA Brachyury-TRICOM), with potential immunomodulating and antineoplastic activities. Upon subcutaneous administration of the brachyury-expressing modified vaccinia Ankara (MVA)-TRICOM vaccine, the expressed brachyury protein induces specific CD8+ and CD4+ T-cell responses against brachyury-expressing tumor cells. This causes both tumor cell lysis and a decrease in the growth of brachyury-expressing tumor cells. Brachyury, a member of the T-box family of transcription factors that is overexpressed in numerous cancer cell types, is correlated with increased epithelial-mesenchymal transition (EMT), cancer resistance and cancer progression. TRICOM, a triad of three human T-cell co-stimulatory molecules, B7.1, ICAM-1 and LFA-3, enhances antigen-specific T-cell activation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5439 https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2022-05711&r=1 https://github.com/vaccineontology/VO/issues/310 925 5439 cancer vaccine Gene name: CD8A Brachyury-expressing Modified Vaccinia Ankara-TRICOM Vaccine VO:0007332 A cell-based cancer vaccine comprised of brain tumor initiating cells (BTICs), with potential immunostimulating and antineoplastic activity. BITCs are from the glioblastoma multiforme (GBM) cell line GBM-6 and contain glioma stem-like cell-associated antigens. Upon administration, the BITC vaccine may stimulate a specific anti-tumoral cytotoxic T-lymphocyte (CTL) response against brain tumor cancer cells and brain tumor stem like cells, resulting in tumor cell lysis. BITC have unique antigenicity and have the ability to self-renew; vaccination against BITC antigens may kill these cells and may prevent tumor recurrences. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5210 https://github.com/vaccineontology/VO/issues/311 3383 941 965 5210 cancer vaccine Gene name: CD58 Gene name: CD80 Gene name: ICAM1 Brain Tumor Initiating Cell Vaccine VO:0007333 A cancer vaccine consisting of recombinant modified vaccinia Ankara (rMVA) encoding the prostate specific antigen (PSA), the prostate-specific membrane antigen (PSMA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). Vaccination with PSA/PSMA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells over-expressing PSA or PSMA. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29561 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5309 https://github.com/vaccineontology/VO/issues/312 5309 cancer vaccine rMVA-PSA/PSMA/TRICOM vaccine VO:0007334 A vaccine consisting of a replication-defective recombinant canarypox virus (ALVAC) that encodes the gene for human interleukin-12 (hIL-12). Produced mainly by B-cells, IL-12 is an endogenous cytokine that activates natural killer (NK) cells, promotes cytotoxic T lymphocyte (CTL) responses, induces the release of interferon-gamma (IFN-gamma), and may exhibit antitumor and anti-angiogenic effects. Vaccination with canarypox-hIL-12 melanoma vaccine may stimulate the host immune system to mount an immune response against tumor cells, thereby inhibiting tumor growth and/or metastasis. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5544 https://github.com/vaccineontology/VO/issues/313 2521 5544 cancer vaccine Gene name: FUS Canarypox-hIL-12 melanoma vaccine VO:0007335 A cancer vaccine that uses dendritic cells pulsed with autologous tumor homogenate in combination With High Dose-IL2 and immunomodulating radiotherapy for patients with Metastatic RCC. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03226236 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6266 6266 cancer vaccine autolgous DC vaccine pulsed with autologous tumor homogenate for metastatic rcc VO:0007336 A cancer vaccine that consists of of irradiated autologous tumor cells admixed with GM-CSF-secreting bystander cells. The CD8+ T cells can react against CLL-associated antigens. Autologous tumor cell vaccination is an effective strategy to advance long-term leukemia control following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Hayleigh Kahn Jie Zheng PMID:23912587 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6379 6379 cancer vaccine autologous CLL tumor cell vaccine VO:0007337 A cancer vaccine that uses autologous cancer testis (CT) antigen specific dendritic cell (DC) preceded by decitabine as a demethylating chemotherapy for patients with high-risk neuroblastoma, Ewings sarcoma, osteogenic sarcoma, rhabdomyosarcoma or synovial sarcoma. The mature DC is pulsed with overlapping peptides mixes derived from full-length NY-ESO-1, MAGE-A1, and MAGE-A3. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01241162 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6268 1485 4100 4102 6268 cancer vaccine Gene name: MAGE-A1 Gene name: MAGE-A3 Gene name: NY-ESO-1 autologous cancer testis antigen specific dendritic cell vaccine VO:0007338 A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with mRNA encoding the human cytomegalovirus (CMV) matrix protein pp65 (65 kDa lower matrix phosphoprotein; UL83) as a fusion protein with the full-length lysosome-associated membrane protein (flLAMP), with potential immunostimulatory and antineoplastic activities. The vaccine exposes the immune system to the CMV pp65 peptide, which may elicit a cytotoxic T-lymphocyte (CTL) response against CMV pp65-expressing tumor cells. The incorporation of flLAMP may route CMV pp-65 antigens into the lysosomal compartment, resulting in enhanced MHC class II antigen presentation, thereby promoting CD4-positive T-cell responses. Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) is a powerful adjuvant capable of stimulating macrophage function, inducing proliferation and maturation of DCs, and is able to enhance T-lymphocyte stimulatory function. The vaccine can be used in combination with monoclonal antibodies, such as basiliximab, that can block tumor growth in different ways, as well as temozolomide, and radiation therpay. The combination of treatments may kill more tumor cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C156067 NCT: https://clinicaltrials.gov/study/NCT00626483 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6347 27074 6347 cancer vaccine Gene name: LAMP autologous CMV-pp65-flLAMP mRNA loaded dendritic cell vaccine VO:0007339 A cancer vaccine made of dendritic cells (DCs) loaded with personalized peptides (PEP) given in combination with low-dose cyclophosphamide for patients with advanced or recurrent metastatic NSCLC. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT05195619 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6267 6267 cancer vaccine autologous dendritic cell vaccine loaded with personalized peptide vaccine (pep-dc vaccine) VO:0007340 A cancer vaccine that encodes macrophage inflammatory protein 3 alpha (MIP3a)-fused lymphoma idiotype in single chain format for patients with atients with Asymptomatic Phase Lymphoplasmacytic Lymphoma. Hayleigh Kahn Jie Zheng VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6264 6364 6264 cancer vaccine Gene name: MIP3a autologous lymphoma immunoglobulin-derived scFv-chemokine DNA vaccine VO:0007341 A cancer vaccine that uses autologous neuroblastoma cells, irradiated and genetically modified by adenoviral vectors to secrete interleukin-2 (IL-2) for patients with high-risk neuroblastoma. The adenoviral vector are used to transduce the cells ex-vivo, patients are not treated with the viral vector. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00048386 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6269 3558 6269 cancer vaccine Gene name: IL-2 autologous neuroblastoma cell vaccine VO:0007342 A cancer vaccine that is composed of oxidized ovarian tumor cell lysate, with potential immunostimulatory and antineoplastic activities. The autologous oxidized ovarian tumor cell lysate vaccine exposes the immune system to an undefined amount of tumor-associated antigens (TAAs), which may result in the induction of both anti-tumor cytotoxic T-lymphocytes (CTLs) and antibody-dependent responses against TAA-expressing cells, leading to tumor cell lysis. Compared to non-oxidized tumor cell lysate vaccines, oxidized tumor cell lysate vaccines induce necrotic cell death, increase the immunogenicity of the TAAs and may enhance the anti-tumor immune response. Cyclophosphamide/Fludarabine Lymphodepletion and an immunomodulatory combination of Interferon-alpha Bevacizumab and Aspirin followed by adoptive transfer of vaccine-primed ex vivo CD3/CD28-costimulated peripheral blood autologous T cells and vaccination with whole tumor vaccine administered intradermally in combination with Bevacizumab in patients with recurrent ovarian cancer fallopian tube or primary peritoneal cancer may help treat their tumors. Patients will receive 5-10 million cells intradermally. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C122402 NCT: [https://clinicaltrials.gov/study/NCT01312376 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6330 6330 cancer vaccine autologous oxidized ovarian tumor cell lysate vaccine VO:0007343 A cancer vaccine consisting of total tumor RNA (TTRNA) derived and amplified from autologous tumor cells and mRNA encoding the human cytomegalovirus (CMV) matrix protein pp65 (65 kDa lower matrix phosphoprotein; UL83) as a fusion protein with the full-length lysosome-associated membrane protein (flLAMP), formulated in DOTAP lipid particles, with potential immunostimulatory and antineoplastic activities. he autologous total tumor mRNA and CMV-pp65-flLAMP mRNA loaded liposome vaccine, the mRNA is taken up, translated and presented by antigen presenting cells (APCs). This leads to an induction of both cytotoxic T-lymphocyte and memory T-cell dependent immune responses that specifically target and destroy the patient's cancer cells that express these tumor antigens. The incorporation of flLAMP may route CMV pp-65 antigens into the lysosomal compartment, resulting in enhanced MHC class II antigen presentation, thereby promoting CD4-positive T-cell responses. Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine is used to treat patients with Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM). The vaccine is also used for for the treatment of early melanoma recurrence following adjuvant Anti-PD-1 antibody therapy. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C178432 NCT: https://clinicaltrials.gov/study/NCT04573140 NCT: https://clinicaltrials.gov/study/NCT05264974 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6270 27074 6270 cancer vaccine Gene name: LAMP autologous total tumor mrna and CMV-pp65-flLAMP mRNA loaded liposome vaccine VO:0007344 A cancer vaccine made from the patient's cancer cells that may make the body build an immune response and kill their tumor cells. The autologous tumor cell vaccine will be given together with adjuvant interferon gamma or sargramostim (GM-CSF) in patients with advanced cancer (breast, lung, prostate, colorectal, sarcoma, renal, melanoma). The vaccine uses irradiated autologous tumor cells and tumor lysate. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00002505 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6364 6364 cancer vaccine autologous tumor cell lysate vaccine VO:0007345 A cancer vaccine made from the patient's own tumor tissue may stimulate an immune response against the patient's tumor cells. O-Vax nay induce a DTH response to autologous, DNP-modified ovarian cancer cells. The vaccine includes DNP-modified autologous ovarian tumor cells followed by cyclophosphamide then weekly doses of DNP-modified autologous ovarian tumor cells mixed with Bacillus of Calmette and Guérin (BCG). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00660101 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6334 6334 cancer vaccine autologous, dnp-modified ovarian cancer vaccine VO:0007346 A cancer vaccine containing human acute myeloid leukemic (AML) blasts that have been genetically engineered to express a B7.1/IIL-2 fusion protein. It uses B7.1 (CD80)/IL-2 immune gene therapy for high risk MDS RAEB-2 and acute myeloid leukaemia (AML) patients who are unsuitable for an allogeneic haematological stem cell transplant. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02493829 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6265 941 6265 cancer vaccine Gene name: B7.1 B7.1/​IL-2 leukaemia cell vaccine VO:0007347 A cancer vaccine made with BC-819 (also known as DTA-H19), which is a double-stranded DNA plasmid, 4,560 base pairs (bp) in length, carrying the gene for the Diphtheria toxin A (DT-A) chain under the regulation of the H19 promoter. The DT-A chain expression is triggered by the presence of H19 transcription factors that are only up-regulated in tumor cells. The selective initiation of toxin expression results in selective tumor cell destruction via inhibition of protein synthesis selectively in the tumor cell, enabling highly targeted cancer treatment. It is used in combination with intravenously administered gemcitabine for patients with Locally Advanced Pancreatic Adenocarcinoma. The activation of the H19 gene promoter-containing plasmids and DTA expression are limited to tumor cells, as high levels of H19 expression are only found in tumor cells. DTA disrupts protein synthesis. Tumor-cell selective expression of this toxin leads to the selective destruction of the tumor while sparing healthy, normal cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C107685 NCT: https://clinicaltrials.gov/study/NCT01413087 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6273 6273 cancer vaccine BC-819 vaccine VO:0007348 A cancer vaccine made up of Bcl-xl_42 and the adjuvant CAF09b for patients with hormone-sensitive Prostate Cancer (PC) and lymph node metastases. B-cell lymphoma extra large protein (Bcl-xl) protein plays a vital role in the cancer cell's ability to avoid programmed cell death (apoptosis) and is upregulated in a variety of cancerous diseases, Bcl-xl_42 is a peptide fragment of the full protein and can lead to the death of cancer cells. CAF09b improves the activation of the immune system. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03412786 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6272 6272 cancer vaccine Bcl-Xl_42-CAF09b vaccine VO:0007349 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:/7629885 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5329 https://github.com/vaccineontology/VO/issues/372 5329 cancer vaccine CAP-2 (CEA peptide 9-mer) vaccine VO:0007350 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5380 https://link.springer.com/article/10.1007/s11888-014-0250-5 https://github.com/vaccineontology/VO/issues/373 5380 cancer vaccine CAP-3 (CEA Peptide 9-mer) Vaccine VO:0007351 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00203892 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5356 https://github.com/vaccineontology/VO/issues/374 1048 5356 cancer vaccine Gene name: CEACAM5 (CEA) Carcinoembryonic Antigen Peptide 1-6D Vaccine VO:0007352 A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:22630596 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5129 https://github.com/vaccineontology/VO/issues/375 1048 5129 cancer vaccine Gene name: CEACAM5 (CEA) carcinoembryonic antigen peptide 1-6D virus-like replicon particles vaccine VO:0007353 A cancer vaccine comprised of an epitope from the Carcinoembryonic Antigen obtained from cancer cells that can stimulate an immune response against tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:22630596 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5209 https://github.com/vaccineontology/VO/issues/376 1048 5209 cancer vaccine Gene name: CEACAM5 (CEA) carcinoembryonic antigen peptide-1 vaccine VO:0007354 A vaccine comprised of autologous dendritic cells pulsed with mRNA-encoded Carcinoembryonic Antigen (CEA) targeting tumor cells expressing CEA. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:21187495 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5041 https://github.com/vaccineontology/VO/issues/377 1048 5041 cancer vaccine Gene name: CEACAM5 (CEA) Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine VO:0007355 A cancer vaccine consisting of the bcr-abl b2a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b2a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b2a2 fusion protein. (NCIT_C61309) The vaccine is made from made from the proteins that cause leukemia cells in CML to behave abnormally. Imatinib mesylate is the standard therapy for CML and blocks the function of this protein. In combination, these may decrease or eliminate all evidence of disease in patients who have CML that is in remission after treatment with imatinib mesylate, but who still have small amounts of detectable disease. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C61309 NCT: https://clinicaltrials.gov/study/NCT00267085 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6353 25 6353 cancer vaccine Gene name: bcr-abl Bcr-Abl (b2a2)-derived peptide vaccine VO:0007356 A plasmid DNA vaccine containing the mammalian expression vector pUMVC3 (pNGVL3) encoding epitopes of CD105 (Endoglin), Y-box binding protein 1 (Yb-1), SRY-box 2 (SOX2), cadherin 3 (CDH3), and murine double minute 2 (MDM2) proteins, with potential immunomodulating and antineoplastic activities. Upon intradermal administration of pUMVC3-CD105/Yb-1/SOX2/CDH3/MDM2-epitopes plasmid DNA vaccine, the plasmid transfects cells and the peptides are expressed. This generates a specific memory Th1 (T-helper) cell immune response, stimulates secretion of cytokines by the T cells and leads to a cytotoxic T-lymphocyte (CTL) response against CD105/Yb-1/SOX2/CDH3/MDM2-expressing tumor cells. CD105/Yb-1/SOX2/CDH3/MDM2 proteins are highly immunogenic tumor associated antigens that are overexpressed in breast cancer. Additionally, these antigens are associated with breast cancer stem cells and with epithelial to mesenchymal transformation (EMT). Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5193 https://github.com/vaccineontology/VO/issues/379 1001 2022 4193 4904 6657 5193 cancer vaccine Gene name: CDH3 Gene name: ENG Gene name: MDM2 Gene name: SOX2 Gene name: YBX1 CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine VO:0007357 A cell-based cancer vaccine comprised of autologous dendritic cells (DCs) pulsed with human leukocyte antigen (HLA)-A2-restricted peptides derived from the CD133 antigen, with potential antineoplastic activity. Upon intradermal administration, the CD133 antigen peptide-pulsed autologous DC vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against CD133-expressing tumor cells, resulting in tumor cell lysis. CD133, a cancer stem cell marker, is expressed on hematopoietic stem and progenitor cells and overexpressed on many types of cancer cells; it is associated with resistance to chemotherapy and increased cancer survival. HLA-A2 is an MHC class I molecule that presents antigenic peptides to CD8+ T-cells. Epitope design that is restricted to those epitopes that bind most efficiently to HLA-A2 may improve antigenic peptide immunogenicity. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT02049489 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5107 https://github.com/vaccineontology/VO/issues/380 8842 5107 cancer vaccine Gene name: PROM1 CD133 Antigen Peptide-pulsed Autologous Dendritic Cell Vaccine VO:0007358 A vaccine comprised of CD80-transfected allogenic breast cancer cells to induce T-cell response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5476 https://github.com/vaccineontology/VO/issues/381 2064 941 5476 cancer vaccine Gene name: CD80 Gene name: ERBB2 CD80 Breast Cancer Vaccine VO:0007359 Autologous human dendritic cells pulsed with RNA encoding the carcinoembryonic antigen (CEA) are being studied for possible use in the treatment of cancer expressing CEA. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:21187495 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5045 https://github.com/vaccineontology/VO/issues/382 1048 5045 cancer vaccine Gene name: CEACAM5 (CEA) CEA RNA-pulsed Autologous Human Cultured Dendritic Cells Vaccine VO:0007360 A plasmid vaccine encoding wild type human carcinoembryonic antigen (CEA) fused to a tetanus toxoid T helper epitope, with potential antineoplastic activity. Upon vaccination and subsequent intradermal electroporation, CEA/tetanus toxoid T helper epitope fusion protein-expressing DNA plasmid vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against CEA-expressing tumor cells. CEA, a tumor associated antigen, is overexpressed in a variety of cancer cell types. The tetanus toxoid helper peptide epitope, obtained from the bacterial Clostridium tetani toxoid, binds to class II MHC molecules and increases the helper T-cell response thereby inducing an increased and long-term immune response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5367 https://github.com/vaccineontology/VO/issues/383 1048 5367 cancer vaccine Gene name: CEACAM5 (CEA) CEA/Tetanus Toxoid T Helper Epitope Fusion Protein-Expressing DNA Plasmid Vaccine VO:0007361 A complex, replication-selective, E1B and partial E3 gene deleted, adenovirus type 11p (Ad11p)/Ad3 chimeric oncolytic virus with potential antineoplastic activity. Upon intralesional injection of enadenotucirev, the adenovirus selectively and rapidly replicates in cancer cells; however, it is unable to replicate in normal, healthy cells. This induces a selective adenovirus-mediated cytotoxicity in cancer cells, which leads to cancer cell lysis. Following the lysis of infected cells, the replicated virus is released and can infect adjacent cells, which both induces further tumor cell oncolysis and may activate the immune system to kill the infected tumor cells. The E1B protein causes p53 inactivation in host cells, which promotes viral replication. Deletion of E1B prevents replication in normal, healthy cells that express wild-type p53. The mutation and subsequent inactivation of p53 in cancer cells enables the E1B-deleted adenovirus to selectively replicate in cancer cells. Partial deletion of the E3 gene, which encodes the adenovirus death protein, enhances the safety profile of the administered adenovirus. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5316 https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(05)00564-2 https://github.com/vaccineontology/VO/issues/384 5316 cancer vaccine Chimeric Ad11p/Ad3 Oncolytic Virus Vaccine VO:0007362 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with the human cytomegalovirus (CMV) phosphoprotein pp65, with potential immunostimulatory and antineoplastic activities. Upon administration, the CMV pp65 peptide-pulsed autologous DC vaccine exposes the immune system to the CMV pp65 peptide, which may result in a cytotoxic T-lymphocyte (CTL) response against CMV pp65-expressing tumor cells leading to cell lysis. The CMV pp65 protein, also called the 65 kDa lower matrix phosphoprotein, is the primary component of the enveloped subviral particle of CMV and is expressed in certain tumor types, such as glioblastoma Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4985 https://academic.oup.com/neuro-oncology/article/22/Supplement_3/iii306/6018727 https://github.com/vaccineontology/VO/issues/385 3077579 4985 cancer vaccine Gene name: UL83 CMV pp65 Peptide-pulsed Autologous Dendritic Cell Vaccine VO:0007363 A poloxamer-formulated, bivalent DNA vaccine containing two plasmids encoding both the human cytomegaloviral (CMV) tegument phosphoprotein 65 (pp65), a major internal matrix protein, and glycoprotein B (gB), an important CMV component responsible for attachment and entry into cells, with potential immunostimulatory properties. Upon intramuscular injection of CMVpp65/gB plasmid vaccine ASP0113, the expressed proteins may activate the immune system to mount both cellular and humoral immune responses against CMV-positive cells. This results in cell lysis of CMV-infected cells and prevents both viral replication and the development of CMV disease. This vaccine also provides active immunization and protective immunity against CMV infection in CMV-negative patients exposed to infected donor cells or tissues in transplant recipients. CMV infection can cause serious complications in patients receiving either allogeneic hematopoietic cell transplants (HCT) or solid organ transplants. The poloxamer-based delivery system enhances DNA delivery. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5306 https://github.com/vaccineontology/VO/issues/386 3077579 5306 cancer vaccine Gene name: UL83 CMVpp65/gB plasmid vaccine ASP0113 VO:0007364 A cancer vaccine consisting of the bcr-abl b2a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b2a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b2a2 fusion protein. The vaccine is made from made from the proteins that cause leukemia cells in CML to behave abnormally. Imatinib mesylate is the standard therapy for CML and blocks the function of this protein. In combination, these may decrease or eliminate all evidence of disease in patients who have CML that is in remission after treatment with imatinib mesylate, but who still have small amounts of detectable disease. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C61310 NCT: https://clinicaltrials.gov/study/NCT00466726 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6274 25 6274 cancer vaccine Gene name: bcr-abl Bcr-Abl (b3a2)-derived peptide vaccine VO:0007365 A vaccine composed of synthetic peptides derived from beta-human chorionic gonadotropin (hCG) conjugated to diphtheria toxoid. Vaccination with this peptide may elicit the host immune response against hCG-producing cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:/9815634 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5372 https://github.com/vaccineontology/VO/issues/389 11716682 5372 cancer vaccine Gene name: tox1 CTP-37-DT vaccine VO:0007366 A cell-based cancer vaccine comprised of autologous dendritic cells (DCs) pulsed with cyclin B1 peptide, with potential immunostimulatory and antineoplastic activities. Upon administration, cyclin B1 peptide-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and anti-cyclin B1 antibody responses against cyclin B1-expressing cancer cells, resulting in tumor cell lysis. Cyclin B1, a key regulator of the cell cycle and cell division, is overexpressed in a variety of cancer cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT01398124 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5139 https://github.com/vaccineontology/VO/issues/390 931 5139 cancer vaccine Gene name: MS4A1 Cyclin B1 Peptide-pulsed Autologous Dendritic Cell Vaccine VO:0007367 A preparation of autologous lymphocytes with potential immunopotentiating and antineoplastic activities. Cytokine-induced killer (CIK) cells are CD3- and CD56-positive, non-major histocompatibility complex (MHC)-restricted, natural killer (NK)-like T lymphocytes, generated ex-vivo by incubation of peripheral blood lymphocytes (PBLs) with anti-CD3 monoclonal antibody, interleukin (IL)-2, IL-1, and interferon gamma (IFN-gamma) and then expanded. When reintroduced back to patients after autologous stem cell transplantation, CIK cells may recognize and kill tumor cells associated with minimal residual disease (MRD). CIK cells may have enhanced cytotoxic activity compared to lymphokine-activated killer (LAK) cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:23210562 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5070 https://github.com/vaccineontology/VO/issues/391 174 5070 cancer vaccine Gene name: AFP Cytokine-Induced Killer Cells Vaccine VO:0007368 A vaccine composed of dendritic cells pulsed with tumor cells lysates that stimulate a potent and specific cell mediated anti-tumor immune response. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:15256471 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5163 https://github.com/vaccineontology/VO/issues/392 5163 cancer vaccine Dendritic Cell Tumor Cell Lysate Vaccine VO:0007369 A cancer vaccine consisting of lymphocytes harvested from a patient with lung cancer and induced to become antigen-presenting cells (APCs) known as dendritic cells. The dendritic cells are transduced with the gene encoding an antigen specific to the patient's cancer and then returned to the patient. In the host, the altered cells stimulate the immune system to mount a primary T cell response against lung tumor cells expressing the target antigen. Dendritic cell-autologous lung tumor vaccines have been investigated for use in cancer immunotherapy. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5161 https://github.com/vaccineontology/VO/issues/393 5161 cancer vaccine Dendritic Cell-Autologous Lung Tumor Vaccine VO:0007370 A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of carcinoembryonic antigen (CEA), a tumor-associated antigen expressed by a wide range of cancers. When the altered dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing CEA. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:21187495 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5417 https://github.com/vaccineontology/VO/issues/394 1048 5417 cancer vaccine Gene name: CEACAM5 (CEA) Dendritic Cell-CEA Peptide Vaccine VO:0007371 An autologous dendritic cells vaccine with antineoplastic property. Dendritic cells harvested from cancer patients are pulsed with human gp100 melanoma antigen and MART-1 (melanoma antigen recognized by T-cells) antigen; both antigens are up-regulated in melanomas. Vaccination with this vaccine may elicit the host immune response against MART-1 or gp100 expressing cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5067 https://github.com/vaccineontology/VO/issues/395 2315 6490 5067 cancer vaccine Gene name: MLANA Gene name: gp100 (PMEL) dendritic cell-gp100-MART-1 Antigen vaccine VO:0007372 A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of MART-1 (melanoma antigen recognized by T-cells), an antigen expressed by melanoma cells. When the altered dendritic cells are returned to the patient, they stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing MART-1. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5524 https://github.com/vaccineontology/VO/issues/396 2315 5524 cancer vaccine Gene name: MLANA dendritic cell-MART-1 Peptide vaccine VO:0007373 A vaccine comprised of autologous dendritic cells pulsed with a recombinant prostate specific membrane antigen. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5000 https://github.com/vaccineontology/VO/issues/397 2346 5000 cancer vaccine Gene name: Prostate-specific membrane antigen gene engineering: Dendritic Cell-Recombinant Prostate-Specific Membrane Antigen Vaccine VO:0007374 An engineered lentiviral vector targeting dendritic cells (DCs) and containing nucleic acids encoding for the human tumor-associated cancer-testis antigen NY-ESO-1, with potential immunostimulatory and antineoplastic activities. Upon intradermal administration, the DC-targeting lentiviral vector ID-LV305 targets and binds to dermal DCs via the DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) receptor. Upon internalization of the vector, the NY-ESO-1 protein is expressed, stimulates DC maturation and activates the immune system to mount a cytotoxic T-lymphocyte (CTL) response against NY-ESO-1-expressing cells, which may result in tumor cell lysis. NY-ESO-1 is expressed in normal testes and on the surfaces of various tumor cells, and plays a key role in tumor cell proliferation and survival. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5493 https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2018-00926&r=1 https://github.com/vaccineontology/VO/issues/398 1485 5493 cancer vaccine Gene name: NY-ESO-1 Dendritic Cell-targeting Lentiviral Vector ID-LV305 Vaccine VO:0007375 A cancer vaccine consisting of autologous renal cell carcinoma (RCC) tumor cells modified with the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of DNP-modified autologous renal cell carcinoma tumor cell vaccine may induce a cytotoxic T-lymphocyte (CTL) response against renal cell carcinoma tumor cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5338 https://github.com/vaccineontology/VO/issues/400 5338 cancer vaccine Dinitrophenyl-Modified Autologous Renal Cell Carcinoma Tumor cell Vaccine VO:0007376 A plasmid DNA vaccine encoding the human pro-inflammatory cytokine interleukin-12 (IL-12) with potential immunoactivating activity. Upon intramuscular delivery by electroporation of DNA plasmid encoding interleukin-12 INO-9012, IL-12 is translated in cells and activates the immune system by promoting the activation of natural killer cells (NK cells), inducing secretion of interferon-gamma and promoting cytotoxic T-cell responses against tumor cells. This may result in both immune-mediated tumor cell death and the inhibition of tumor cell proliferation. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He DNA Plasmid Encoding Interleukin-12 INO-9012 Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5016 https://jitc.bmj.com/content/9/7/e003019 https://github.com/vaccineontology/VO/issues/401 2902 5016 cancer vaccine Gene name: GRIN1 DNA plasmid-encoding Interleukin-12 INO-9012 vaccine VO:0007377 A DNA-based combination immunotherapeutic, INO-3112, composed of VGX-3100, a preparation of DNA plasmids encoding the E6 and E7 genes of human papillomavirus (HPV) subtypes 16 and 18, combined with INO-9012, a DNA plasmid encoding the immune activator and pro-inflammatory cytokine human interleukin-12 (IL-12) with potential immunoactivating and antineoplastic activities. Upon intramuscular delivery by electroporation of VGX-3100, the HPV E6 and E7 proteins are translated in cells and elicit a cytotoxic T-lymphocyte (CTL) response against cancer cells expressing the E6 and E7 antigens, resulting in tumor cell lysis. HPV type 16 and HPV type 18 are associated with the development of certain types of cancer. Upon intramuscular delivery by electroporation of INO-9012, IL-12 is expressed and activates the immune system by promoting the activation of natural killer cells (NK cells), inducing secretion of interferon-gamma (IFN-g) and promoting CTL responses against tumor cells. This boosts the immune response and results in increased CTL-mediated tumor cell death as compared with the administration of VGX-3100 alone. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT03439085 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5136 https://github.com/vaccineontology/VO/issues/402 1489078 1489079 5136 cancer vaccine Gene name: E6 Gene name: E7 DNA plasmid-encoding Interleukin-12/HPV DNA plasmids therapeutic vaccine INO-3112 VO:0007378 A therapeutic DNA vaccine composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), the second is a dimerization entity and the third part encodes a protein that specifically binds to antigen presenting cells (APCs), with potential immunostimulating and antineoplastic activities. Upon intramuscular administration, the DNA vaccine VB10.16 expresses HPV16 E6/7 and a protein that targets receptors on APCs. Upon binding to APCs and subsequent internalization, the APCs mature and the HPV16 E6/7 antigenic protein is presented by the APCs. This attracts and stimulates B-lymphocytes, CD4-positive T-lymphocytes and elicits a cytotoxic T-lymphocyte (CTL) response against cancer cells expressing HPV16-associated E6 and E7 oncoproteins, which result in tumor cell lysis. HPV16 E6/7, a viral antigen, plays a key role in the development of certain types of cancer. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:36129459 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5207 https://github.com/vaccineontology/VO/issues/403 1489078 1489079 5207 cancer vaccine Gene name: E6 Gene name: E7 DNA Vaccine VB10.16 VO:0007379 A cancer vaccine consisting of a DNA plasmid encoding epitopes of the human preferential antigen of melanoma (PRAME) and the prostate specific membrane antigen (PSMA) with potential immunostimulating activity. Upon direct administration of this vaccine into lymph nodes, peptides expressed by DNA plasmid vector pPRA-PSM may activate the immune system, resulting in a cytotoxic T-lymphocyte (CTL) response against PRAME- and PSMA-expressing cells. PRAME and PSMA are tumor associated antigens upregulated in a number of cancer cell types. As part of the MKC1106-PP regimen exploiting the 'prime-boost strategy', this plasmid is responsible for priming the immune response and is used in conjunction with a peptide vaccine consisting of PRAME and PSMA that boosts the immune system against PRAME- and PSMA-expressing tumor cells. Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He NCT: https://clinicaltrials.gov/ct2/show/NCT00423254 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5407 https://github.com/vaccineontology/VO/issues/404 2346 5407 cancer vaccine Gene name: Prostate-specific membrane antigen DNA vector pPRA-PSM vaccine VO:0007380 A cancer vaccine comprised of a recombinant fowlpox viral vector encoding the carcinoembryonic antigen (CEA), MUC-1, a transmembrane glycoprotein secreted by glandular epithelial tissues, and TRICOM, comprised of three co-stimulatory molecule transgenes (B7-1, ICAM-1 and LFA-3). This agent may enhance CEA and MUC-1 presentation to antigen-presenting cells (APC) and may activate a cytotoxic T-cell response against CEA- and MUC-1-expressing tumor cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5378 https://github.com/vaccineontology/VO/issues/126 4582 1048 5378 cancer vaccine Gene name: CEACAM5 Gene name: MUC1 Falimarev vaccine VO:0007381 A therapeutic cancer vaccine containing a truncated, synthetic peptide mimic of the human angiogenic activator vascular endothelial growth factor (VEGF), consisting of 79 amino acids (amino acids 26-104 of VEGF), and emulsified in the immunoadjuvant RFASE, with potential immunostimulatory and antitumor activities. Upon intramuscular vaccination, the hVEGF26-104 moiety of hVEGF26-104/RFASE acts as an antigen and induces an immune response against VEGF, which results in anti-VEGF antibody binding to and neutralization of endogenous VEGF. This prevents the binding of endogenous VEGF to the VEGF receptor (VEGFR) and blocks VEGFR-mediated endothelial cell signaling, resulting in an inhibition of both angiogenesis and tumor cell proliferation. VEGF plays a key role in angiogenesis, tumor cell proliferation and invasion. RFASE, which belongs to the group of sulpholipopolysaccharides (SLPs), is a synthetic polysaccharide covalently coupled to lipid groups and sulphate groups, and is able to induce a strong humoral immune response upon antigen administration. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5090 https://github.com/vaccineontology/VO/issues/456 7422 5090 cancer vaccine Gene name: VEGFA hVEGF26-104/RFASE peptide vaccine VO:0007382 A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus subtype 6 (HPV-6), with potential immunostimulating and antineoplastic activities. Administered via intramuscular electroporation, HPV-6-targeting immunotherapeutic vaccine INO-3106 expresses the HPV-6 E6 and E7 proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells that are expressing those proteins, resulting in tumor cell lysis. HPV-6 infections are associated with aerodigestive malignancies. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5464 https://github.com/vaccineontology/VO/issues/438 2829163 5464 cancer vaccine Gene name: HPV6 E6 HPV-6-targeting immunotherapeutic vaccine INO-3106 VO:0007383 A liposome-encapsulated peptide vaccine consisting of a synthetic peptide derived from the mucin 1 (MUC-1) antigen with potential antineoplastic activity. Upon vaccination, MUC-1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against MUC-1-expressing tumor cells, resulting in growth inhibition. MUC-1 antigen is a high-molecular-weight transmembrane glycoprotein that is overexpressed on the cell surfaces of many epithelial tumor cells as well as on the cell surfaces of some B-cell lymphoma cells and multiple myeloma cells. (NCIT_C2195). Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5103 https://github.com/vaccineontology/VO/issues/65 4582 5103 cancer vaccine Gene name: MUC1 Emepepimut-S vaccine VO:0007384 An allogeneic urothelial bladder cancer cell vaccine expressing a recombinant secretory form of the immunoadjuvant heat shock protein gp96 fused with an immunoglobulin Fc domain (gp96-Ig) protein, with potential antineoplastic activity. Upon administration of the gp96-Ig-secreting allogeneic bladder cancer cell vaccine HS-410, the live, irradiated tumor cells continuously secrete gp96-Ig along with its chaperoned tumor associated antigens (TAAs). This enhances antigen cross presentation to cytotoxic T-lymphocytes (CTLs) and, upon expansion, leads to the induction of a potent CTL response against the TAAs on the endogenous bladder cancer cells. This vaccine also induces a memory T cell response that could fight recurring cancer cells. gp96-Ig is constructed by replacing the KDEL endoplasmic reticulum (ER) retention sequence of gp96 with the Fc portion of the IgG1 protein. This allows for gp96, normally an ER-resident chaperone peptide, to be released from cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5033 https://github.com/vaccineontology/VO/issues/209 7184 5033 cancer vaccine Gene name: HSP90B1 gp96-secreting Allogeneic Bladder Cancer Cell Vaccine HS-410 VO:0007385 A cancer vaccine consisting of a recombinant fowlpox virus vector encoding an immunogenic peptide derived from the cancer-testis antigen NY-ESO-1, an antigen found in normal testis and various tumors, including bladder, breast, hepatocellular, melanoma, and prostate cancers. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5300 https://github.com/vaccineontology/VO/issues/131 1485 5300 cancer vaccine Gene name: NY-ESO-1 fowlpox-NY-ESO-1 vaccine VO:0007386 A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5096 https://github.com/vaccineontology/VO/issues/137 2548 5096 cancer vaccine Gene name: GAA Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine VO:0007387 A cell-based cancer vaccine comprised of dendritic cells (DCs) pulsed with various, synthetic glioma-associated antigen (GAA) peptides, with potential antineoplastic activity. Upon subcutaneous administration, the glioma-associated peptide-loaded DC vaccine SL-701 exposes the immune system to various GAA peptides. This may stimulate both anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against the GAA-expressing glioma cells, which may result in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5073 https://github.com/vaccineontology/VO/issues/138 1956 5073 cancer vaccine Gene name: EGFR Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701 VO:0007388 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5202 https://github.com/vaccineontology/VO/issues/426 55553 5202 cancer vaccine Gene name: SOX6 HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine VO:0007389 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5298 https://github.com/vaccineontology/VO/issues/458 3417 5298 cancer vaccine Gene name: IDH1 IDH1R132H Mutation-targeting IDH1 Peptide Vaccine VO:0007390 A peptide vaccine consisting of a peptide derived from isocitrate dehydrogenase 1 (IDH1) containing the point mutation R132H (IDH1R132H), with potential antineoplastic activity. Intradermal vaccination with the IDH1R132H-specific peptide vaccine PEPIDH1M may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the IDH1R132H protein. The IDH1 point mutation of amino acid residue 132 is highly expressed in gliomas and is associated with increased production of the oncometabolite R-2-hydroxyglutarate Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5461 https://github.com/vaccineontology/VO/issues/459 3417 5461 cancer vaccine Gene name: IDH1 IDH1R132H-Specific Peptide Vaccine PEPIDH1M VO:0007391 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from malignant glioma cells with potential immunostimulatory and antineoplastic activities. Upon administration, malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine exposes the immune system to undefined malignant glioma tumor-associated antigens (TAAs), which may result in anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against glioma cells and glioma cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5215 https://github.com/vaccineontology/VO/issues/494 4100 6490 5215 cancer vaccine Gene name: MAGEA1 Gene name: gp100 Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine VO:0007392 An antineoplastic vaccine directed against a peptide found in the epidermal growth factor receptor class III variant (EGFRvIII), a constitutively activated mutant of the wild-type tyrosine kinase. This protein variant is present in a substantial proportion of malignant gliomas and other human cancers. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5531 https://github.com/vaccineontology/VO/issues/64 1100818972 5531 cancer vaccine Gene name: EGFR EGFRvIII Peptide Vaccine VO:0007393 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5151 https://github.com/vaccineontology/VO/issues/127 5151 cancer vaccine Fas-Chimera Transgene-expressing Endothelial Tumor Cell-targeting Adenovector VB-111 Vaccine VO:0007394 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with purified peptides derived from the tumor-associated antigen (TAA) CD133, with potential immunostimulatory and antineoplastic activities. Upon leukapheresis, monocytes are differentiated into DCs and are mixed with the CD133 peptides. Upon intradermal re-administration of the ICT-121 DC vaccine, the DCs present the CD133 peptides to the immune system, which stimulates the immune system to induce a specific cytotoxic T-lymphocyte (CTL) response against CD133-expressing tumor cells and leads to tumor cell lysis. CD133 is overexpressed on various types of cancer cells; its overexpression is correlated with increased resistance to chemotherapy. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5277 https://github.com/vaccineontology/VO/issues/457 8842 5277 cancer vaccine Gene name: PROM1 ICT-121 Dendritic Cell Vaccine VO:0007395 A multivalent vaccine againt breast cancer that comprised of the epitope antigens of Globo H hexasaccharide 1 (Globo H), GM2 ganglioside, Lewis-Y, MUC1-32(aa), TF(c), and Tn(c) conjugated with keyhole limpet hemocyanin, with potential antineoplastic activity. The antigens included in this vaccine are associated various cancer cells. Vaccination with this multivalent vaccine may induce production of IgG and IgM antibodies as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing these antigens. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5229 https://github.com/vaccineontology/VO/issues/174 4582 2760 5229 cancer vaccine Gene name: GM2A Gene name: MUC1 Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine VO:0007396 A dendritic cell (DC)-based cancer vaccine composed of autologous, type-1 polarized dendritic cells (DCs) pulsed with human leukocyte antigen (HLA)-A2-restricted HER-2-derived peptides, with potential immunomodulatory and antineoplastic activities. Autologous DCs were treated with GM-CSF, interleukin-4, interferon-gamma and bacterial lipopolysaccharide (LPS), a toll-like receptor type 4 agonist, to produce highly polarized DCs (alphaDC1) that are capable of producing high levels of interleukin-12p70 (IL-12p70). Upon administration, HER2-pulsed autologous DC vaccine may stimulate a potent cytotoxic T-lymphocyte (CTL) response against HER-2-positive tumor cells, which may result in tumor cell death and decreased tumor growth. HER-2, a tyrosine kinase receptor for epidermal growth factor (EGF) (also known as neu and ErbB2), is overexpressed by a variety of cancers. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5237 https://github.com/vaccineontology/VO/issues/306 2064 5237 cancer vaccine Gene name: ERBB2 HER2-pulsed Autologous Type-1 Polarized Dendritic Cell Vaccine VO:0007397 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4997 https://github.com/vaccineontology/VO/issues/447 1442 7494 4997 cancer vaccine Gene name: CSH1 Gene name: XBP1 hTERT/Survivin/CMV Multipeptide Vaccine VO:0007398 A cancer vaccine containing a plasmid encoding the mammaglobin-A gene with potential immunostimulating and antineoplastic activities. Upon administration, mammaglobin-A DNA vaccine may induce both humoral and cytotoxic T lymphocyte (CTL) immune responses against tumor cells that express mammaglobin-A, which may result in decreased tumor growth. The 10 kiloDalton (kD) glycoprotein mammglobin-A is expressed in over 80% of human breast cancers. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5166 https://github.com/vaccineontology/VO/issues/495 4582 634 5166 cancer vaccine Gene name: CEACAM1 Gene name: MUC1 Mammaglobin-A DNA Vaccine VO:0007399 A cancer vaccine consisting of a proprietary, recombinant modified vaccinia Ankara (MVA) viral vector encoding an epitope of human epidermal growth factor receptor 2 (HER2) with potential antineoplastic activity. Upon administration, modified vaccinia Ankara (Bavarian Nordic)-HER2 vaccine may stimulate the host immune system to mount humoral and cytotoxic T lymphocyte responses against HER2-expressing tumor cells, resulting in tumor cell lysis. HER2, also known as ErbB-2, is a tyrosine kinase growth factor receptor and a member of the epidermal growth factor receptor family; it plays a significant role in the pathogenesis of some breast cancers Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5036 https://github.com/vaccineontology/VO/issues/530 2064 2315 5036 cancer vaccine Gene name: ERBB2 Gene name: MLANA-Dupli Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine VO:0007400 A cancer vaccine consisting of the bcr-abl b3a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b3a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b3a2 fusion protein. The bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine is used in combination with GM-CSF. The peptides may help the body build an effective immune response to kill cancer cells, and the GM-CSF may increase the number of immune cells found in bone marrow or peripheral blood. This combination is used to treat patients with Philadelphia chromosome-positive chronic myelogenous leukemia. It can also be used in combination with imatinib mesylate to decrease or eliminate all evidence of disease in patients who have CML that is in remission after treatment with imatinib mesylate, but who still have small amounts of detectable disease Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C2205 NCT: https://clinicaltrials.gov/study/NCT00004052 NCT: https://clinicaltrials.gov/study/NCT00455221 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6372 25 6372 cancer vaccine Gene name: bcr-abl Bcr-Abl peptide vaccine VO:0007401 A proprietary lipid emulsion containing five vaccines: diphtheria, pertussis, tetanus (DPT), Bacille Calmette-Guerin (BCG), measles, Serratia marcescens and pneumococcal, with potential immunostimulating activity. Subcutaneous administration of the DPT/BCG/measles/Serratia/pneumococcus vaccine activates the immune system and may both abrogate tumor-induced immune tolerance and induce an antitumor immune response, which may eradicate the tumor. (NCIT_C62801). Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4987 https://github.com/vaccineontology/VO/issues/51 4987 cancer vaccine E1M(184V) peptide vaccine VO:0007402 A cancer vaccine containing autologous dendritic cells (DCs) that are pulsed with mRNA encoding human telomerase reverse transcriptase (hTERT) and survivin peptide, with potential immunostimulatory and antineoplastic activities. Upon administration, hTERT mRNA/survivin peptide-double-loaded autologous dendritic cell vaccine may elicit an immune response against cancer cells expressing hTERT and survivin by activating cytotoxic T-cells (CTLs), natural killer cells (NKs), and B-lymphocytes. The tumor associated antigens (TAAs) hTERT, the catalytic subunit of human telomerase, and survivin, a member of the inhibitor of apoptosis (IAP) family of proteins, may be upregulated in certain tumor cell types and play key roles in tumor cell growth and survival. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5121 https://github.com/vaccineontology/VO/issues/440 7015 5121 cancer vaccine Gene name: TERT hTERT mRNA/survivin peptide-double-loaded autologous dendritic cell vaccine VO:0007403 A therapeutic cancer vaccine consisting of four epitopes derived from the human telomerase reverse transcriptase (hTERT), the catalytic subunit of human telomerase, including hTERT (540-548) acetate, hTERT (611-626) acetate, hTERT (672-686) acetate and hTERT (766-780) acetate, emulsified individually in the adjuvant montanide ISA-51 VG and administered with the immune response modifier (IRM) imiquimod, with potential immunostimulating and antineoplastic activities. Each hTERT peptide emulsion is administered individually by intradermal injection. Subsequently, imiquimod is applied topically to the injection site(s). Vaccination with GX 301 may elicit a cytotoxic T-cell (CTL) response against telomerase-expressing tumor cells. Telomerase is expressed in the majority of human cancer cells, infrequently expressed in normal cells, and is directly linked to tumorigenesis. Imiquimod stimulates cytokine production through the activation of toll-like receptor 7 (TLR-7), and also exhibits antiproliferative effects. Montanide ISA-51, also known as incomplete Freund's adjuvant (IFA), is a stabilized water-in-oil emulsion containing mineral oil with mannide oleate, which contains vegetable-grade (VG) oleic acid derived from olive oil. ISA-51 non-specifically stimulates cell-mediated immune responses to antigens. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5516 https://github.com/vaccineontology/VO/issues/441 7015 5516 cancer vaccine Gene name: TERT hTERT multipeptide/montanide ISA-51 VG/Imiquimod vaccine GX 301 VO:0007404 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5065 https://github.com/vaccineontology/VO/issues/445 7015 5065 cancer vaccine Gene name: TERT hTERT vaccine V934/V935 VO:0007405 A poxvirus made non-infectious by ultraviolet light or other inactivation methods in order to reduce its pathogenicity. In cancer gene therapy, inactivated vaccinia virus may be used as a vector to express a protein that kills tumor cells or elicits specific anti-tumor immunity. In a cancer vaccine application, tumor cells taken from the host may be adsorbed with inactivated vaccinia virus and returned to the host, where the modified tumor cells may stimulate an anti-tumor immune response. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5130 https://github.com/vaccineontology/VO/issues/465 5130 cancer vaccine inactivated vaccinia virus vaccine VO:0007406 A cancer vaccine comprised of a recombinant vaccinia viral vector encoding the carcinoembryonic antigen (CEA), MUC-1 (mucin-1), a transmembrane glycoprotein secreted by glandular tissues, and TRICOM, comprised of the three co-stimulatory molecule transgenes B7-1, ICAM-1 and LFA-3. Upon administration, inalimarev may enhance CEA and MUC-1 presentation to antigen presenting cells (APC) and may activate a cytotoxic T lymphocyte (CTL) response against CEA- and MUC-1-expressing tumor cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5099 https://github.com/vaccineontology/VO/issues/466 1048 4582 5099 cancer vaccine Gene name: CEACAM5 Gene name: MUC1 inalimarev vaccine VO:0007407 A proprietary, live-attenuated, double-deleted (LADD) strain of the Gram-positive bacterium Listeria monocytogenes (Lm) encoding multiple, as of yet undisclosed, tumor-associated antigens (TAAs), with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, live-attenuated double-deleted Listeria monocytogenes bacteria JNJ-64041809 is taken up by antigen-presenting cells (APCs), including dendritic cells (DCs). The TAAs are subsequently expressed by the APCs and then processed and presented to the immune system by both major histocompatibility complex (MHC) class I and II molecules. This activates the immune system and leads to the recruitment and activation of cytotoxic T-lymphocytes (CTLs) against the TAA-expressing tumor cells, eventually resulting in tumor cell lysis. Two genes contributing to the virulence of Lm have been removed to minimize the risk of infection. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5258 https://github.com/vaccineontology/VO/issues/472 5258 cancer vaccine live-attenuated double-deleted listeria monocytogenes bacteria JNJ-64041809 vaccine VO:0007408 A conjugate consisting of keyhole-limpet hemocyanin (KLH) and fluorescein isothiocyanate (FITC) with potential immunostimulating activity. Vaccination with KLH-FITC may elicit an immune response against fluorescein and the production of anti-fluorescein IgG antibodies. KLH, a natural protein isolated from the marine mollusk keyhole limpet, is an immunostimulant carrier protein. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5146 https://github.com/vaccineontology/VO/issues/473 5146 cancer vaccine KLH-FITC vaccine VO:0007409 A cell-based vaccine targets tumors expressing the HER2/neu marker. HER-2/neu is a growth factor receptor, and its overexpression has been associated with a number of cancers including breast, ovarian, colon and lung cancers. APC8024 comprise of autologous antigen-presenting peripheral blood mononuclear cells (APCs) that have been exposed to HER2/neu protein and can be administered to the patient. These cells may stimulate an antitumor T-cell response to cancer cells expressing HER2/neu. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5538 https://github.com/vaccineontology/VO/issues/475 2064 5538 cancer vaccine Gene name: ERBB2 Lapuleucel-T vaccine VO:0007410 A cell-based cancer vaccine consisting of autologous dendritic cells (DCs) pulsed with mesothelioma tumor lysate with potential immunostimulating and antineoplastic activities. Upon administration, mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine may stimulate the host immune system to mount a specific cytotoxic T lymphocyte (CTL) response against mesothelioma tumor cells, resulting in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5187 https://github.com/vaccineontology/VO/issues/525 1234 5187 cancer vaccine Gene name: CCR5 mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine VO:0007411 A cell wall fraction of bacillus Calmette-Guerin (BCG) obtained by menthol extraction with immunomodulating properties and potential use in cancer immunotherapy. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5235 https://github.com/vaccineontology/VO/issues/526 5235 cancer vaccine methanol extraction residue of BCG VO:0007412 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5347 https://github.com/vaccineontology/VO/issues/529 5347 cancer vaccine Gene name: P10 Mimotope-P10s-PADRE peptide vaccine VO:0007413 A vaccine consisting of a monoclonal antibody (MoAb) directed against an idiotype that mimics a human milk fat globule (HMFG) membrane epitope. Vaccination with monoclonal antibody 11D10 anti-idiotype vaccine induces anti-anti-idiotype antibodies (Ab3) that may react with breast cancer cell lines expressing the HMFG membrane epitope. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5286 https://github.com/vaccineontology/VO/issues/533 4240 5286 cancer vaccine Gene name: MFGE8 monoclonal antibody 11D10 anti-idiotype vaccine VO:0007414 A recombinant monoclonal antibody in which the heavy and light chain variable domains mimic a specific epitope of the tumor-associated protein carcinoembryonic antigen (CEA). This agent is used as a cancer vaccine against tumors that express CEA. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5452 https://github.com/vaccineontology/VO/issues/534 1048 5452 cancer vaccine Gene name: CEACAM5 monoclonal antibody 3H1 anti-idiotype vaccine VO:0007415 An anti-idiotypic (anti-Id) rat monoclonal antibody (MoAb) that mimics the disialoganglioside GD2, a cancer-associated antigen present on melanoma, small cell lung cancer, sarcoma, neuroblastoma, and other malignancies. GD2 is a highly expressed glycosphingolipid by melanoma and other neuroectodermal tumors with only minimal expression on normal tissues. Vaccination with anti-Id A1G4 MoAb may elicit cellular and humoral immune responses against GD2 expression tumor cells Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5308 https://github.com/vaccineontology/VO/issues/536 2583 5308 cancer vaccine Gene name: B4GALNT1 monoclonal antibody A1G4 anti-idiotype vaccine VO:0007416 An anti-idiotypic (anti-Id) rat monoclonal antibody (MoAb) that mimics the disialoganglioside GD2, a cancer-associated antigen present on melanoma, small cell lung cancer, sarcoma, neuroblastoma, and other malignancies. GD2 is a highly expressed glycosphingolipid by melanoma and other neuroectodermal tumors with only minimal expression on normal tissues. Vaccination with anti-Id A1G4 MoAb may elicit cellular and humoral immune responses against GD2 expression tumor cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5469 https://github.com/vaccineontology/VO/issues/537 6489 5469 cancer vaccine Gene name: ST8SIA1 monoclonal antibody GD2 anti-idiotype vaccine VO:0007417 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5239 https://github.com/vaccineontology/VO/issues/538 5239 cancer vaccine Montanide ISA-51/survivin peptide vaccine VO:0007418 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5362 https://github.com/vaccineontology/VO/issues/544 4255 5362 cancer vaccine Gene name: MGMT MSCV-MGMT(P140K) vaccine VO:0007419 A cancer vaccine comprised of a synthetic peptide derived from the mucin 1 (MUC1) antigen with potential antineoplastic activity. Upon administration, MUC1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC1 antigen, resulting in decreased tumor growth. Overexpressed on many tumor cells, MUC1 antigen, a mammary-type apomucin, is a high-molecular-weight transmembrane glycoprotein. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5517 https://github.com/vaccineontology/VO/issues/545 4582 5517 cancer vaccine Gene name: MUC1 MUC-1 peptide vaccine VO:0007420 A peptide vaccine containing human mucin 2 (MUC2) protein conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. MUC2, a secretory or gel forming glycoprotein expressed predominantly in goblet cells of the gastrointestinal and respiratory tracts, is overexpressed as an aberrant or deglycosylated form in various tumors such as gastric carcinomas and some hormone-refractory prostate cancers. MUC2 protein is conjugated with KLH, an immunostimulant and a hapten carrier, to enhance immune recognition. Vaccination with MUC2-KLH may result in the production of antibodies as well as elicit a cytotoxic T- lymphocyte (CTL) response against tumor cells expressing MUC2 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5169 https://github.com/vaccineontology/VO/issues/547 4583 5169 cancer vaccine Gene name: MUC2 MUC-2-KLH vaccine VO:0007421 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5123 https://github.com/vaccineontology/VO/issues/548 4582 5123 cancer vaccine Gene name: MUC1 MUC1 antigen/SB AS-2 vaccine VO:0007422 A peptide vaccine, containing human tumor-associated epithelial mucin (MUC1) conjugated with keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. Vaccination with MUC1-KLH conjugate vaccine may stimulate humoral and cytotoxic T-lymphocyte (CTL) responses against tumor cells expressing the MUC1 antigen. In this vaccine, MUC1 antigen is conjugated with KLH, an immunostimulant and a hapten carrier, to enhance immune recognition. MUC1 antigen, a membrane-bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed in an aberrant or deglycosylated form in various cancers such as those of the breast, prostate, and ovary. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5251 https://github.com/vaccineontology/VO/issues/549 4582 5251 cancer vaccine Gene name: MUC1 MUC1-KLH conjugate vaccine VO:0007423 A peptide vaccine containing the human tumor-associated antigen epithelial mucin (MUC1 antigen) conjugated with keyhole limpet hemocyanin (KLH) and combined with the nonspecific immunoadjuvant QS21, with potential antineoplastic activity. MUC1 antigen is linked with KLH, an immunostimulant and a hapten carrier, in order to enhance immune recognition; the co-administration of saponin-derived QS21 potentially amplifies the total immune response to the MUC1 antigen. Administration of MUC1-KLH vaccine/QS21 may result in both the production of antitumor antibodies and the stimulation of a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the MUC1 antigen. MUC1 antigen, a membrane-bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed as an aberrant or deglycosylated form in various cancers such as breast, prostate and ovarian cancers. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5160 https://github.com/vaccineontology/VO/issues/550 4582 5160 cancer vaccine Gene name: MUC1 MUC1-KLH vaccine/QS21 VO:0007424 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5068 https://github.com/vaccineontology/VO/issues/551 4582 5068 cancer vaccine Gene name: MUC1 MUC1-targeted peptide GO-203-2C vaccine VO:0007425 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5522 https://github.com/vaccineontology/VO/issues/552 2348 5522 cancer vaccine Gene name: FOLR1 multi-epitope folate receptor alpha peptide vaccine VO:0007426 A cancer vaccine composed of a combination of the injectable formulations S-488210, which contains the three HLA-A*02:01-restricted peptides up-regulated lung cancer 10 (lymphocyte antigen 6K; LY6K; URLC10), cell division cycle-associated protein 1 (kinetochore protein Nuf2; NUF2; CDCA1) and insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3; KOC1) and S-488211, which contains the two HLA-A*02:01-restricted peptides DEP domain-containing protein 1A (DEPDC1) and M-phase phosphoprotein 1 (kinesin-like protein KIF20B; MPHOSPH1), with potential immunostimulatory and antitumor activities. Upon administration, multipeptide vaccine S-588210 may stimulate a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing KOC1, CDCA1, URLC10, DEPDC1 or MPHOSPH1 peptides, resulting in tumor cell lysis and decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5064 https://github.com/vaccineontology/VO/issues/556 10643 54742 5064 cancer vaccine Gene name: IGF2BP3 Gene name: LY6K multipeptide vaccine S-588210 VO:0007427 A cancer vaccine consisting of autologous dendritic cells which have been pulsed with a mutant p53 peptide. Vaccination with mutant p53 peptide pulsed dendritic cells may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing mutant p53, resulting in tumor cell lysis. Many tumor cells overexpress mutant p53 proteins, resulting in the loss of apoptosis regulation and abnormal cell proliferation. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5364 https://github.com/vaccineontology/VO/issues/559 5364 cancer vaccine mutant p53 peptide pulsed dendritic cell vaccine VO:0007428 A bivalent cancer vaccine comprised of a modified vaccinia virus Ankara (MVA) strain encoding human mucin 1 (MUC1) and interleukin-2 (IL-2) with potential immunostimulating and antineoplastic activities. Originally developed for the eradication of smallpox, MVA is a highly attenuated and replication-defective strain incapable of virion assembly and exerts potent immunostimulatory activity against antigens. Vaccination with MVA-MUC1-IL2 vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) responses against tumor cells expressing MUC1, a tumor associated antigen, resulting in tumor cell lysis. Expression of IL-2 augments the specific CTL response against MUC1 expressing cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5091 https://github.com/vaccineontology/VO/issues/564 4582 5091 cancer vaccine Gene name: MUC1 MVA-MUC1-IL2 vaccine VO:0007429 A combination peptide vaccine of 2 chimeric peptides of the promiscuous T cell epitope derived from measles virus fusion protein (MVF; amino acid residues 288-302) co-synthesized with B-cell epitopes derived from the HER-2/neu a.a. 597-626 and HER-2/neu a.a. 266-296, with potential antineoplastic activity. Vaccination with MVF-HER-2(597-626)/MVF-HER-2(266-296) peptide vaccine may be capable of inducing an active specific immune response, mounting a cytotoxic T-lymphocyte (CTL) response and an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells that overexpress the HER-2 protein. The oncogenic protein HER-2, a member of the human epidermal growth factor receptor (EGFR) family of tyrosine kinases, is overexpressed in a variety of cancers and is correlated with increased tumor growth, progression and a poor prognosis. HER-2(597-626) corresponds to the binding site of trastuzumab on the extracellular domain IV of HER-2; HER-2 (266-296) corresponds to the binding site of pertuzumab on the dimerization loop of domain II of HER-2 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5400 https://github.com/vaccineontology/VO/issues/566 2064 5400 cancer vaccine Gene name: ERBB2 MVF-HER-2(597-626)/MVF-HER-2 (266-296) peptide vaccine VO:0007430 A vaccine formulation consisting of several types of human papillomavirus (HPV)-derived noninfectious virus-like particles (VLPs) with potential immunoprophylactic activity. Upon administration, HPV L1 VLP vaccine V504 may generate humoral immunity against various HPV L. major capsid proteins, thereby preventing cervical infection upon exposure to the associated HPV types. VLPs are composed of self-assembling L. major capsid proteins or functional L. major capsid protein derivatives. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5449 https://github.com/vaccineontology/VO/issues/450 5449 cancer vaccine Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine VO:0007431 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5408 https://github.com/vaccineontology/VO/issues/478 1489079 2829163 5408 cancer vaccine Gene name: E7 Gene name: HPV6 E6 liposomal HPV-16 E6/E7 multipeptide vaccine PDS0101 VO:0007432 A cancer vaccine consisting of a humanized monoclonal antibody that mimics a tumor-associated antigen 791Tgp72 (also known as CD55). Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing CD55, resulting in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5195 https://github.com/vaccineontology/VO/issues/532 1604 5195 cancer vaccine Gene name: CD55 monoclonal antibody 105AD7 anti-idiotype vaccine VO:0007433 A multipeptide vaccine consisting of peptides derived from lymphocyte antigen 6 complex locus K (LY6K) and type I and II vascular endothelial growth factor receptors (VEGFRs) with potential antineoplastic activity. Upon administration, LY6K/VEGFR1/VEGFR2 multipeptide vaccine may elicit an antitumor cytotoxic T-lymphocyte (CTL) immune response against LY6K-expressing tumor cells and/or VEGFR-expressing vascular endothelial cells involved in tumor angiogenesis. LY6K is a tumor-associated antigen (TAA) that occurs singly in glycosylphosphatidyl-inositol (GPI)-linked cell-surface glycoproteins or as three-fold repeated domain in the urokinase-type plasminogen activator receptor; VEGFRs are cell surface receptors that stimulate endothelial cell proliferation, invasion, angiogenesis, and vasculogenesis upon ligand binding and receptor activation. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5164 https://github.com/vaccineontology/VO/issues/486 54742 7422 5164 cancer vaccine Gene name: LY6K Gene name: VEGFA LY6K/VEGFR1/VEGFR2 Multipeptide Vaccine VO:0007434 A carbohydrate-based vaccine comprised of the Globo H hexasaccharide 1 (Globo H) antigen conjugated to DT-CRM197, a non-toxic, mutated form of diphtheria toxin (DT), with potential immunostimulating and antineoplastic activities. Upon administration of Globo H-DT vaccine OBI-833, the carbohydrate antigen Globo H may stimulate a cytotoxic T-lymphocyte (CTL) response against Globo H-expressing tumor cells, thereby decreasing tumor cell proliferation. The hexasaccharide Globo H is a tumor-associated antigen (TAA) commonly found on a variety of tumor cells. DT-CRM197, also called diphtheria toxin cross-reacting material 197, is used to increase the immunogenicity of the Globo H carbohydrate antigen. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5055 https://github.com/vaccineontology/VO/issues/172 11716682 5055 cancer vaccine Gene name: tox1 Globo H-DT vaccine OBI-833 VO:0007435 A synthetic peptide derived from the protein ESW/FLI1 type 2 with potential use in cancer immunotherapy. EWS/FLI1 is a fusion protein frequently found in patients with Ewing's sarcoma or primitive neuroectodermal tumors (PNET). Vaccination with EF-2 peptide may stimulate the host immune response to elicit a cytotoxic T-cell response against tumor cells that express this EWS/FL1 type 2 fusion protein. (NCIT_C49064). Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan PMID:/2753158 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5432 https://github.com/vaccineontology/VO/issues/63 297374825 5432 cancer vaccine Gene name: CD22 EF-2 peptide vaccine VO:0007436 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with six synthetic glioblastoma (GBM) peptides: absent in melanoma 2 (AIM-2), melanoma-associated antigen 1 (MAGE-1), tyrosinase-related protein 2 (TRP-2), glycoprotein 100 (gp100), epidermal growth factor receptor 2 (HER-2), interleukin-13 receptor subunit alpha-2 (IL-13Ra2), with potential immunostimulatory and antineoplastic activities. Mononuclear cells obtained via leukapheresis are differentiated into DCs, and pulsed with the GBM-associated peptides. Upon administration, multi-glioblastoma-peptide-targeting autologous DC vaccine ICT-107 exposes the immune system to GBM-associated antigens, which activates a specific cytotoxic T-lymphocyte (CTL) response against GBM cells. This leads to GBM cell lysis. The six peptides are derived from tumor associated antigens (TAA) expressed on GBM cells and cancer stem cells (CSCs). GBM stem-like cells contain a specific range of antigens that are essential for the neoplastic growth and survival of GBM cells Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5421 https://github.com/vaccineontology/VO/issues/554 4100 6490 5421 cancer vaccine Gene name: MAGEA1 Gene name: gp100 multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ICT-107 VO:0007437 A preparation of allogeneic HLA-matched leukocytes treated with a derivative of placental protein 14 (PP14) with potential immunomodulating activity. PP14 derivative-treated HLA-matched donor mononuclear cell-enriched leukocytes contain at least fifty-five percent early-apoptotic T cells; after infusion and when processed by recipient dendritic cells, early-apoptotic T cells may help induce a decrease in the donor effector T-cell responses against the recipient of an allogeneic hematopoietic stem cell (HSC) transplant, thereby minimizing allogeneic HSC transplant-related graft-versus-host disease (GVHD). PP14, a 162 amino acid glycosylated protein secreted by the late secretory phase endometrium, binds to T cells in a carbohydrate fashion and has been shown to induce T-cell apoptosis; maternal immune tolerance to the fetus and pregnancy-related remissions of autoimmune disease may involve PP14-induced T cell apoptosis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5093 https://github.com/vaccineontology/VO/issues/427 5047 5093 cancer vaccine Gene name: PAEP HLA-Matched Donor Mononuclear Cell-Enriched Leukocytes Apocell vaccine VO:0007438 Human mesenchymal stem cells (MSCs) transduced with a retroviral vector encoding a modified form of the cytokine interleukin-12 (IL-12), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration, IL-12-expressing MSC vaccine GX-051 secretes IL-12. IL-12 activates the immune system by both promoting the secretion of interferon-gamma, which activates natural killer cells (NKs), and inducing cytotoxic T-cell responses, which may result in both decreased cell proliferation and increased cell death in tumor cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5168 https://github.com/vaccineontology/VO/issues/461 5168 cancer vaccine IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051 VO:0007439 A dendritic cell (DC)-based vaccine composed of program death ligands 1 and 2 (PDL1/L2)-silenced DCs and loaded with the recipient's minor histocompatibility antigens (MiHA), with potential use for graft-versus-tumor (GVT) induction following allogeneic stem cell transplantation (allo-SCT). Donor DCs are electroporated ex vivo with MiHA mRNA and small interfering RNAs (siRNAs) designed to silence the expression of PD L1/L2. After allo-SCT and upon intravenous administration of the MiHA-loaded PD-L1/L2-silenced DC vaccine, the DCs induce the expansion and activation of MiHA-specific CD8-positive T-cells. These tumor antigen-reactive T-cells exert their GVT effect by killing miHA-positive tumor cells. PD-L1/L2, co-inhibitory ligands expressed on DCs, play key roles in preventing MiHA-specific CD8-positive T-cell expansion; silencing enhances MiHA-specific CD8-positive T-cell expansion and activity and improves the GVT effect. The MiHA are human leukocyte antigen (HLA)-bound peptides and are exclusively expressed by the recipient's hematopoietic tumor cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5015 https://github.com/vaccineontology/VO/issues/528 5133 5015 cancer vaccine Gene name: PDCD1 MiHA-loaded PD-L1/L2-silenced dendritic cell vaccine VO:0007440 A multi-antigen DNA vaccine consisting of plasmids encoding the hepatitis C virus (HCV) nonstructural proteins 3 (NS3), 4A (NS4A), 4B (NS4B) and 5A (NS5A), with potential immunomodulating and cancer preventive activities. Administered via intramuscular injection followed by electroporation, cells transfected with the HCV DNA vaccine INO-8000 express the encoded HCV proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against HCV-infected liver cells expressing the NS3, NS4A, NS4B or NS5A proteins. This results in the eradication of HCV-infected cells. HCV, a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family, is associated with the development of hepatocellular carcinoma (HCC) Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5002 https://github.com/vaccineontology/VO/issues/304 3845 5002 cancer vaccine Gene name: KRAS HCV DNA Vaccine INO-8000 VO:0007441 A cancer vaccine comprised of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the suicide gene FCU1 with potential antineoplastic activity. FCU1 is a bifunctional yeast cytosine deaminase (CD) / uracil phosphoribosyltransferase (UPRT) fusion gene. Upon intratumoral administration, MVA-FCU1TG4023 enters tumor cells where FCU1 is expressed. Subsequently, the noncytotoxic prodrug 5-fluorocytosine (5-FC) is administered systemically and is deaminated by CD in FCU1- transduced tumor cells into 5-fluorouracil (5-FU), which is then directly metabolized to 5-fluoro-uridine monophosphate (5-FUMP) by UPRT; 5-FUMP may then be further transformed to 5-fluoro-deoxyuridine monophosphate (5-FdUMP), an irreversible inhibitor of thymidylate synthase and, so, DNA synthesis through deprivation of deoxythymidine triphosphate (dTTP). 5-FU and its active metabolites may then selectively kill tumor cells, avoiding toxicity in nonmalignant cells. The MVA viral vector, derived from the replication-competent strain Ankara, is a highly attenuated, replication-defective vaccinia strain incapable of virion assembly Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5312 https://github.com/vaccineontology/VO/issues/563 5312 cancer vaccine MVA-FCU1 TG4023 vaccine VO:0007442 A synthetic HIV vaccine based on a recombinant canary pox virus vector expressing the human immunodeficiency virus (HIV) glycoprotein gp160. HIVgP160 vaccine has been used to generate in vivo primary T lymphocyte response against HIV antigens. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan https://github.com/vaccineontology/VO/issues/308 155971 vaccine Gene name: env HIVgP160 vaccine VO:0007443 A peptide derived from the oncogenic human papillomavirus (HPV) early gene product E6. The HPV 16 transforming protein E6 is expressed in precancerous and malignant cervical lesions and has a high affinity for the most common human lymphocyte antigen (HLA), HLA-A2. Immunogenic peptides from the HPV 16 E6 may be used to trigger a T-cell-mediated immune response to HPV. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV 16 E6 (18-26) peptide vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5474 https://github.com/vaccineontology/VO/issues/429 1489078 5474 cancer vaccine Gene name: E6 human papillomavirus 16 E6 (18-26) peptide vaccine VO:0007444 A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV 16 E7:86-93 peptide vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5184 https://github.com/vaccineontology/VO/issues/431 1489079 5184 cancer vaccine Gene name: E7 human papillomavirus 16 E7:86-93 peptide vaccine VO:0007445 A vaccine consisting of human papillomavirus-derived noninfectious virus-like particles (VLPs), containing the L. major capsid protein. Vaccination with HPV 16 L1-VLP results in increases in T cell-proliferative response to HPV 16 L1-VLP, as well as significant increases in cytokine (interferon-gamma, interleukin-5 and -10) responses to L1 VLP. This agent may reduce the incidence of persistent HPV-16 infection, which may be responsible for half of all cases of cervical cancer including high-grade cervical intraepithelial neoplasia. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV 16 L1-VLP vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5520 https://github.com/vaccineontology/VO/issues/432 25479185 5520 cancer vaccine Gene name: L1 human papillomavirus 16 L1-VLP vaccine VO:0007446 A synthetic peptide vaccine consisting of amino acids 13 through 21 of the viral oncoprotein human papillomavirus (HPV) 18 E6. The HPV 18E6 peptide cross-reacts immunologically with both HPV type 16 and HPV type 18, the most common HPV types involved in cervical cancer. Vaccination with HPV-18 E6:13-21 peptide may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV 16 and 18. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV 18 E6:13-21 peptide vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5159 https://github.com/vaccineontology/VO/issues/433 5159 cancer vaccine human papillomavirus 18 E6:13-21 peptide vaccine VO:0007447 Noninfectious, synthetic, virus-like particles (VLP) containing the major viral capsid protein, L1, of the human papillomavirus type 18 with potential immunoprotective activity. Vaccination with HPV 18 L1-VLP may stimulate the host immune system to mount cytotoxic T lymphocyte (CTL) response against cells positive for HPV 18, thereby preventing cervical infection upon exposure to HPV type 18. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV 18 L1-VLP vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5247 https://github.com/vaccineontology/VO/issues/434 5247 cancer vaccine human papillomavirus 18 L1-VLP vaccine VO:0007448 A DNA vaccine consisting of plasmids encoding the E6 and E7 genes of human papilloma virus (HPV) subtypes 16 and 18, respectively, with potential immunostimulating and antineoplastic activities. Administered via intramuscular electroporation, HPV DNA plasmids therapeutic vaccine VGX-3100 expresses E6 and E7 proteins, which may elicit a cytotoxic T-lymphocyte (CTL) response against cervical cancer cells expressing E6 and E7 proteins, resulting in tumor cell lysis. HPV type 16 and HPV type 18 are the most common HPV types involved in cervical carcinogenesis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV DNA plasmids therapeutic vaccine VGX-3100 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5226 https://github.com/vaccineontology/VO/issues/435 1489078 1489079 5226 cancer vaccine Gene name: E6 Gene name: E7 human papillomavirus DNA plasmids therapeutic vaccine VGX-3100 VO:0007449 A vaccine directed against Human Papillomavirus Type 11 that causes majority of the genital warts and anogenital cancers. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HPV-11 Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5227 https://github.com/vaccineontology/VO/issues/437 5227 cancer vaccine human papillomavirus -11 vaccine VO:0007450 A synthetic agent derived from human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related neoplasms. HPV E7 oncogenic protein binds the retinoblastoma tumor suppressor protein, pRB, as well as a number of other cellular proteins, and serves as a transcriptional activator. This protein is important in the induction and maintenance of cellular transformation and is co-expressed in the majority of HPV-containing carcinomas. PADRE(R) is a proprietary family of molecules that enhances the immune systems response against an administered immunogen such as the HPV E7 nuclear protein. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5162 https://github.com/vaccineontology/VO/issues/451 1489079 5162 cancer vaccine Gene name: E7 human papillomavirus 16 E7 peptide/padre 965.10 vaccine VO:0007451 A recombinant, bivalent, human papillomavirus (HPV) vaccine, containing virus-like particles for HPV types 16 and 18 linked to the adjuvant ASO4, with potential immunoprotective and antineoplastic properties. Upon administration, HPV 16/18 L1 virus-like particle/ASO4 vaccine may generate humoral and cellular immunity against HPV types-16 and -18 antigens, thereby preventing cervical infection upon exposure to HPV types 16 and 18. In addition, this agent may stimulate an antitumoral cellular immune response against cervical cancer associated with HPV infection. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5233 https://github.com/vaccineontology/VO/issues/452 5233 cancer vaccine human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine VO:0007452 A vaccinia viral based vaccine, encoding epitopes of E6 and E7 proteins from human papillomavirus (HPV) types 16 and 18, with immunostimulatory and antineoplastic activities. HPV types 16 and 18 account for approximately 70% of cervical cancers. Vaccination with this HPV-TA (tumor antigen) vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for E6 and E7 from either type 16 or 18 HPV, resulting in decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5279 https://github.com/vaccineontology/VO/issues/453 1489078 1489079 5279 cancer vaccine Gene name: E6 Gene name: E7 human papillomavirus tumor antigen vaccine VO:0007453 A vaccine consisting of noninfectious, recombinant virus-like particles (VLP) containing the major viral capsid protein L1 of nine strains of human papillomavirus (HPV), with potential immunoprotective activity. Vaccination with HPV V503 may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells positive for any of these nine strains of HPV, thereby preventing cervical infection upon exposure to certain HPV subtypes. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5167 https://github.com/vaccineontology/VO/issues/454 5167 cancer vaccine Gene name: major capsid protein L1 human papillomavirus vaccine V503 VO:0007454 A peptide based vaccine consisting of amino acids 12 through 20 of the E7 gene of the Human Papilloma Virus type 16. HPV-16 E7 12-20 peptide vaccine may elicit a specific CD8 T-cell response to the E7 oncogene protein, thereby inhibiting the abrogation of p53 and pRb function and thus prevent tumorigenesis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5079 https://github.com/vaccineontology/VO/issues/430 1489079 5079 cancer vaccine Gene name: E7 human papillomavirus 16 E7:12-20 peptide vaccine VO:0007455 A therapeutic DNA vaccine encoding the E6/E7 fusion protein of human papillomavirus (HPV) subtypes 16 and 18, plus the immune-enhancer, Fms-like tyrosine kinase-3 ligand (FLT3L), with potential immunostimulating and antineoplastic activities. DNA vaccine GX-188E is administered using a proprietary delivery system that electroporates the vaccine into cervical cells. Expression of the E6/E7 fusion product may elicit a cytotoxic T-lymphocyte (CTL) response against cervical cancer cells expressing E6 and E7 oncoproteins, resulting in tumor cell lysis. FLT3L is a ligand for the FLT3 tyrosine kinase receptor, which upon activation stimulates the proliferation of hematopoietic progenitor cells. HPV type 16 and 18 are the most common HPV types involved in cervical carcinogenesis Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5083 https://github.com/vaccineontology/VO/issues/436 1489078 1489079 5083 cancer vaccine Gene name: E6 Gene name: E7 human papillomavirus E6/E7 DNA vaccine GX-188E VO:0007456 A vaccine consisting of a plasmid DNA encoding the human prostate-specific membrane antigen (PSMA). Upon administration, expressed PSMA may stimulate a cytotoxic T cell response against tumor cells that express this antigen, resulting in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5262 https://github.com/vaccineontology/VO/issues/455 2346 5262 cancer vaccine Gene name: Prostate-specific membrane antigen Human Prostate-Specific Membrane Antigen Plasmid DNA Vaccine VO:0007457 A vaccine consisting of a plasmid DNA encoding the murine prostate-specific membrane antigen (PSMA). Upon administration, expressed PSMA may stimulate a cytotoxic T cell response against tumor cells that express PSMA, resulting in tumor cell lysis Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5105 https://github.com/vaccineontology/VO/issues/540 5105 cancer vaccine Mouse Prostate-Specific Membrane Antigen Plasmid DNA Vaccine VO:0007458 Early-to late-stage myeloid progenitor cells derived from adult human stem cells with potential hematopoietic activity. Upon infusion, human myeloid progenitor cells CLT-008 proliferate into mature myeloid cells, including granulocytes, macrophages, platelets, and erythrocytes. These myeloid progenitor cells die within forty-five days after a burst of hematopoiesis. This agent cannot create lymphoid cells, including T cells associated with graft-versus-host disease Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5511 https://github.com/vaccineontology/VO/issues/449 5511 cancer vaccine Human Myeloid Progenitor Cells CLT-008 vaccine VO:0007459 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with corpses of apoptotic leukemic cells, with potential immunostimulatory and antineoplastic activities. Upon vaccination, autologous dendritic cells pulsed with leukemic apoptotic corpse may activate the immune system to mount an anti-tumoral cytotoxic T-lymphocyte (CTL) response against leukemic cells expressing leukemia-associated antigens, which may result in leukemic cell lysis and inhibition of tumor cell growth. Apoptotic tumor cell corpses contain an array of tumor associated antigens Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5004 https://github.com/vaccineontology/VO/issues/476 5004 cancer vaccine Leukemic Apoptotic Corpse-Pulsed Autologous Dendritic Cells Vaccine VO:0007460 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5200 https://github.com/vaccineontology/VO/issues/555 3077513 3077579 5200 cancer vaccine Gene name: UL123 Gene name: UL83 multi-peptide CMV-modified vaccinia ankara vaccine VO:0007461 This is an autologous lung cancer vaccine consisting of patient-specific lung cancer cells genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), an immunostimulatory cytokine (NCIT_C1979). GM-CSF modulates the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production and may reverse treatment-induced neutropenias. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5453 https://github.com/vaccineontology/VO/issues/302 1437 5453 cancer vaccine Gene name: GM-CSF GVAX Lung Cancer Vaccine VO:0007462 A cancer vaccine that is a bivalent vaccine with the antigens GD2L and GD3L for patients with High-Risk Neuroblastoma. The antigens are linked to KLH and mixed with OPT-821. It is given in combination with oral β-glucan, which can help white blood cells kill cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00911560 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6262 6262 cancer vaccine bivalent neuroblastoma vaccine with adjuvant OPT-821 VO:0007463 A peptide vaccine consisting of the amino acids 280 through 288 of the melanoma antigen glycoprotein 100 (gp100) with potential antineoplastic activity. gp100:280-288(288V) peptide has a valine substitution at amino acid position 288 to improve immunogenicity. Vaccination with gp100:280-288(288V) peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the gp100 antigen, resulting in decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5112 https://github.com/vaccineontology/VO/issues/419 3791 5112 cancer vaccine Gene name: KDR HLA-A*2402-Restricted VEGFR1 peptide vaccine VO:0007464 A cancer vaccine containing two HLA-A*0201-restricted peptide epitopes with potential immunostimulatory and antitumor activities. Peptide epitopes in this vaccine are derived from: vascular endothelial growth factor receptors (VEGFR) 1 and 2. Upon administration, HLA-A*0201-restricted VEGFR1-VEGFR2 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing VEGFR 1 and 2 peptides, resulting in tumor cell lysis and decreased tumor growth. HLA-A*0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5294 https://github.com/vaccineontology/VO/issues/420 3791 5294 cancer vaccine Gene name: KDR HLA-A2402-restricted VEGFR1/2 multipeptide vaccine VO:0007465 A cancer vaccine consisting of allogeneic neuroblastoma tumor cells have been genetically modified to secrete the human cytokine interleukin-2 (IL-2) and the human chemokine lymphotactin (Lptn) with potential immunostimulating and antineoplastic activities. Upon administration, IL-2 and Lptn are secreted by the IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine, potentially enhancing the cytotoxic T lymphocyte (CTL) response elicited by vaccine neuroblastoma tumor-associated antigens (TAAs) against host neuroblastoma tumor cells. Produced by activated progenitor T cells, Lptn belongs to the C chemokine subfamily and is a potent chemotactic factor for lymphocytes; IL-2 stimulates natural killer (NK) cells and may enhance a vaccine-elicited CTL immune response against tumor cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5173 https://github.com/vaccineontology/VO/issues/462 6375 5173 cancer vaccine Gene name: XCL1 IL-2/Lptn gene-modified allogeneic neuroblastoma tumor cell vaccine VO:0007466 An immunotherapeutic containing a proprietary adjuvant system combined with a melanoma-associated antigen peptide MAGE-A3 epitope with potential immunomodulating and antineoplastic activities. Intramuscular administration with GSK1572932A may stimulate the immune system to exert both humoral and cellular immune responses against MAGE-A3-expressing tumor cells. MAGE-A3, a tumor associated antigen (TAA), is overexpressed in a variety of tumor cell types, including non-small cell lung cancer (NSCLC), melanoma, head and neck cancer, and bladder cancer. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan Immunotherapeutic GSK1572932A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5343 https://github.com/vaccineontology/VO/issues/463 4102 5343 cancer vaccine Gene name: MAGEA3 immunotherapeutic GSK1572932A vaccine VO:0007467 GVAX cancer vaccines are autologous cell vaccines comprised of tumor cells which have been irradiated and genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), a hormone which plays a key role in stimulating the body's immune response to vaccines. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5211 https://github.com/vaccineontology/VO/issues/301 1493 354 5211 cancer vaccine Gene name: CTLA4 Gene name: KLK3 GVAX cancer vaccine VO:0007468 A replication-defective adenoviral serotype 5 vector encoding a recombinant form of the human cytokine interferon-gamma (IFN-g), with potential antineoplastic and immunoregulatory activities. Upon intratumoral administration, the sustained expression of IFN-g by IFN-g-expressing adenovirus vaccine ASN-002 promotes a T-helper type 1 (Th1) immune response and inhibits the Th2-mediated cytokine production observed in many cutaneous lymphomas. IFN-g also mediates interleukin-12 (IL-12) production by antigen-presenting cells (APCs); activates macrophages, cytotoxic T-cells, and natural killer (NK) cells; upregulates major histocompatibility complex (MHC) molecules; and stimulates antibody-dependent cellular cytotoxicity (ADCC). Altogether, these IFN-g-mediated effects may result in both an inhibition of tumor cell proliferation and tumor cell death. Compared to IFN-g injections, the prolonged local production of IFN-g at the tumor site allows for higher efficacy and a reduction of systemic toxicity Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5540 https://github.com/vaccineontology/VO/issues/470 2546420 5540 cancer vaccine Gene name: WHcAg Interferon-gamma-expressing Adenovirus Vaccine ASN-002 VO:0007469 A vaccine based on anti-idiotype (Id) monoclonal antibodies combined with interleukin-2 (IL-2). Anti-Id vaccines have been shown to be effective in treatment of B-cell lymphoma in animal models and in clinical trials, resulting in tumor regression; the addition of interleukin-2 (IL-2) may augment the therapeutic effect of anti-Id vaccines. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5352 https://github.com/vaccineontology/VO/issues/471 5176180 5352 cancer vaccine Gene name: gp72 Interleukin-2 Anti-Idiotype Vaccine VO:0007470 A chimeric lymphoma vaccine generated by combining the recipient's Ig idiotype (Id) protein with keyhole limpet hemocyanin (KLH), an immune stimulant, with potential antineoplastic activity. Vaccination with KLH-Lymphoma Ig Vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against lymphoma cells, resulting in decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5519 https://github.com/vaccineontology/VO/issues/474 5519 cancer vaccine KLH-Lymphoma Ig Vaccine VO:0007471 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan Gene name: Fragment C from tetanus toxin obsolete Lymphoma DNA vaccine V_V_V_-FrC true VO:0007472 A preparation of autologous peripheral blood mononuclear cells (PBMCs) radiolabeled with indium In 111 with radioisotopic activity. Autologous PBMCs are isolated, expanded ex vivo, radiolabeled with indium In 111, and then infused back into the patient. Gamma scintigraphy may then be used to image gamma ray-emitting indium In 111 PBMCs localized in lymphoma tissue. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5212 https://github.com/vaccineontology/VO/issues/467 1048 5212 cancer vaccine Gene name: CEACAM5 indium in 111-labeled autologous peripheral blood mononuclear cells vaccine VO:0007473 A preparation of autologous peripheral polymorphonuclear (PMNLs) radiolabeled with indium In 111 with radioisotopic activity. Autologous PMNLs are isolated, expanded ex vivo, radiolabeled with indium In 111, and then infused back into the patient. Gamma scintigraphy may then be used to image gamma ray-emitting indium In 111 PMNLs localized in lymphoma tissue. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5273 https://github.com/vaccineontology/VO/issues/468 5273 cancer vaccine indium in 111-labeled autologous polymorphonuclear leukocytes vaccine VO:0007474 Human peripheral blood lymphocytes (PBL) isolated from a patient, exposed to the tumor-associated protein ESO-1 in vitro, and then transferred back to the same patient to target tumor cells expressing ESO-1. ESO-1 is a human self-antigen expressed by melanomas. The ESO-1 gene encodes several MHC class I- and MHC class II-restricted epitopes that may activate cytotoxic T-cell-mediated tumor destruction Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5178 https://pubmed.ncbi.nlm.nih.gov/?term=ESO-1+Reactive+Autologous+Peripheral+Blood+Lymphocyte https://github.com/vaccineontology/VO/issues/67 1485 5178 cancer vaccine Gene name: NY-ESO-1 ESO-1 reactive autologous peripheral blood lymphocyte vaccine VO:0007475 A recombinant fowlpox virus-based vaccine vector designed to express various tumor-associated peptide antigens. Strong CD8 cytotoxic T cell responses may be induced after prolonged immunization with fowlpox virus vaccines and have been associated with tumor regression. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5042 https://github.com/vaccineontology/VO/issues/130 4582 1048 5042 cancer vaccine Gene name: CEACAM5 Gene name: MUC1 fowlpox virus vector vaccine VO:0007476 A cancer vaccine containing of a synthetic form of the renal cell carcinoma (RCC)-associated antigen G250 with potential antineoplastic activity. Vaccination with G250 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the G250 antigen, resulting in decreased tumor growth. Found in the majority of renal cell carcinomas, G250 is a cell surface tumor-associated antigen (TAA) that contains an HLA-A2.1-restricted epitope that is recognized by CTLs. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5249 https://github.com/vaccineontology/VO/issues/135 2315 5249 cancer vaccine Gene name: MLANA Gag:267-274 peptide vaccine VO:0007477 An autologous dendritic cell (DC) cancer vaccine with GITRL RNA-transfected that has potential immunostimulatory activity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5410 https://github.com/vaccineontology/VO/issues/136 1493 5410 cancer vaccine Gene name: CTLA4 GITRL RNA-transfected autologous dendritic cell vaccine VO:0007478 Used C57BL/6 mice and irradiated B16 tumor cells expressing granulocyte and macrophage colony-stimulating factor (GM-CSF), interleukin-12 (IL-12) or both. Tumor was transplanted by the injection of wild-type B16 cells. Tumor growth and survival were measured to evaluate the efficacy of vaccination. Specific humoral response and immunoglobulin G (IgG) switch were evaluated measuring total IgG and IgG1 and IgG2a subtypes against tumor membrane proteins of B16 cells Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4061 https://github.com/vaccineontology/VO/issues/176 4061 cancer vaccine GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccine VO:0007479 A recombinant, oncolytic serotype 5/3 capsid-modified adenovirus encoding the immunostimulatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) with potential antineoplastic activity. Upon administration, the oncolytic adenovirus selectively infects and replicates in tumor cells, which may result in tumor cell lysis. Synergistically, GM-CSF (sargramostim) expressed by the oncolytic adenovirus enhances antigen presentation, promotes natural killer (NK) cell-mediated killing and causes a cytotoxic T cell (CTL) response against tumor cells harboring the oncolytic adenovirus, resulting in an immune-mediated tumor cell death. CGTG-102 is designed to replicate only in cells with defects in the p16/Rb/E2F pathway, attributed to a mutation common in many solid tumors. Replacement of the Ad5 capsid protein knob with a knob domain from serotype 3 causes higher transduction in cancer cells as compared to normal cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5111 https://github.com/vaccineontology/VO/issues/177 5111 cancer vaccine GM-CSF-encoding Oncolytic Adenovirus CGTG-102 vaccine VO:0007480 A cancer vaccine made of peripheral blood and tumor specimen harvested from patients with metastatic adenocarcinoma of the pancreas to generate cancer stem cell (CSC)-loaded denritic cell (DC) vaccines. CSC-primed antibodies and T cells are capable of selective targeting CSCs and conferring antitumor immunity. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02074046 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6276 6276 cancer vaccine cancer stem cell-loaded dc vaccine VO:0007481 A vaccine that injected peptides of gp100, MART-1, MAGE-3 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3993 https://github.com/vaccineontology/VO/issues/196 6490 3993 cancer vaccine Gene name: gp100 gp100 + Mart-1 + Mart-3 vaccine VO:0007482 A vaccine consisting of a replication-defective recombinant adenovirus that encodes the melanoma antigen glycoprotein 100 (gp100) with potential antineoplastic activity. Vaccination with gp100 adenovirus vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the gp100 antigen, resulting in decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5133 https://github.com/vaccineontology/VO/issues/197 6490 5133 cancer vaccine Gene name: gp100 gp100 Adenovirus vaccine VO:0007483 A vaccine consisting of microscopic gold particles coated with plasmid DNA encoding the glycoprotein 100 (gp100) melanoma antigen and granulocyte-macrophage colony-stimulating factor (GM-CSF). Vaccination with gp100 and GM-CSF DNA/gold vaccine may stimulate the host immune system to direct cytotoxic T lymphocytes (CTL) against gp100 positive cells, resulting in decreased tumor growth. GM-CSF is thought to increase the induction and activation of antigen-presenting cells (APC), allowing for a reduction in the dose of gp100 administered. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5084 https://github.com/vaccineontology/VO/issues/198 6490 5084 cancer vaccine Gene name: gp100 gp100 and GM-CSF DNA/Gold vaccine VO:0007484 A recombinant peptide derived from the human melanoma antigen glycoprotein 100 (gp100) with potential use in cancer immunotherapy. gp100 protein(184V) has a valine substitution at position 184. Vaccination with this peptide may evoke a cytotoxic T lymphocyte (CTL) response against tumor cells expression the gp100 antigen. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5482 https://github.com/vaccineontology/VO/issues/199 6490 5482 cancer vaccine Gene name: gp100 gp100 Protein (184V) vaccine VO:0007485 A cancer vaccine consisting of a recombinant vaccinia virus encoding the gp100 melanoma-melanocyte antigen. gp100 human antigen is a wild-type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5153 https://github.com/vaccineontology/VO/issues/200 6490 5153 cancer vaccine Gene name: gp100 gp100 Vaccinia vaccine VO:0007486 A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the melanoma antigen glycoprotein 100 (gp 100) with potential antineoplastic activity. The expression of gp100 may generate a cellular immune response to melanoma cells; this effect is enhanced by the co-administration of interleukin 2 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5135 https://github.com/vaccineontology/VO/issues/201 6490 5135 cancer vaccine Gene name: gp100 gp100-Fowlpox vaccine VO:0007487 Peripheral blood lymphocytes (PBL) harvested from host blood and stimulated in vitro with tumor-specific gp 100 antigen. 'Pulsing' PBL with gp100, a tumor associated antigen (TAA) commonly expressed by melanoma cells, may increase melanoma-reactive cytotoxic lymphocytes (CTL) in the PBL cell population. Autologous gp100-pulsed PBL have been administered to melanoma patients in order to augment cytotoxic immune responses to melanoma. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5007 https://github.com/vaccineontology/VO/issues/202 6490 5007 cancer vaccine Gene name: gp100 gp100-Pulsed Peripheral Blood Mononuclear Cell vaccine VO:0007488 Human peripheral blood lymphocytes (PBL) isolated from a patient, exposed to the tumor-associated antigen gp100 in vitro, and then transferred back to the same patient to target tumor sites expressing gp100. gp100 human antigen is a wild-type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4990 https://github.com/vaccineontology/VO/issues/203 6490 4990 cancer vaccine Gene name: gp100 gp100-Reactive Autologous Peripheral Blood Lymphocyte vaccine VO:0007489 To understand why cancer vaccine-induced T cells often do not eradicate tumors, we studied immune responses in mice vaccinated with gp100 melanoma peptide in incomplete Freund's adjuvant (peptide/IFA), which is commonly used in clinical cancer vaccine trials (Hailemichael et al., 2013). Immunization Route: Intramuscular injection (i.m.) Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4078 https://github.com/vaccineontology/VO/issues/204 6490 4078 cancer vaccine Gene name: gp100 gp100/IFA vaccine VO:0007490 A synthetic peptide vaccine consisting of amino acids 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen with an endoplasmic reticulum signal sequence (ES) to increase binding activity. Vaccination with gp100:ES209-217(210M) may stimulate the host immune system to mount a cytotoxic T lymphocyte response against tumor cells positive for gp100, resulting in decreased tumor growth Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5095 https://github.com/vaccineontology/VO/issues/205 6490 5095 cancer vaccine Gene name: gp100 gp100: ES209-217(210M) Peptide vaccine VO:0007491 A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance tumor-specific T-cell immunity. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells, and most melanoma lesions and is recognized via class I and II HLA-restricted mechanisms. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5145 https://github.com/vaccineontology/VO/issues/206 6490 5145 cancer vaccine Gene name: gp100 gp100:154-162 peptide vaccine VO:0007492 A synthetic peptide vaccine consisting of amino acids 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen with an endoplasmic reticulum signal sequence (ES) to increase binding activity. Vaccination with gp100:ES209-217(210M) may stimulate the host immune system to mount a cytotoxic T lymphocyte response against tumor cells positive for gp100, resulting in decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5050 https://github.com/vaccineontology/VO/issues/207 6490 5050 cancer vaccine Gene name: gp100 gp100:209-217 Peptide vaccine VO:0007493 A vaccine consisting of the amino acids 280 through 288 of the melanoma antigen glycoprotein 100 (gp100) with potential antineoplastic activity. Vaccination with gp100:280-288 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the gp100 antigen, resulting in decreased tumor growth. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5526 https://github.com/vaccineontology/VO/issues/208 6490 5526 cancer vaccine Gene name: gp100 gp100:280-288 peptide vaccine VO:0007494 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3989 https://github.com/vaccineontology/VO/issues/307 6490 3989 cancer vaccine Gene name: gp100 Hexapeptide melanoma vaccine VO:0007495 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with human leukocyte antigen (HLA)-A1-binding melanoma-associated antigen peptides MAGE-1 and MAGE-3 with potential immunomodulating and antineoplastic activity. Upon vaccination, HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine may stimulate the host immune system to mount an anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against MAGE1- and MAGE-3-expressing cancer cells, resulting in tumor cell lysis. HLA-A1 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A1 may improve antigenic peptide immunogenicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5185 https://github.com/vaccineontology/VO/issues/423 4100 4102 5185 cancer vaccine Gene name: MAGEA1 Gene name: MAGEA3 HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine VO:0007496 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with human leukocyte antigen (HLA)-A2-restricted melanoma-associated antigen peptides tyrosinase (TYR), MART-1(melanoma antigen recognized by T-cells) and melanoma antigen glycoprotein 100 (gp100), with potential immunomodulating and antineoplastic activity. Upon vaccination, HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine may stimulate the host immune system to mount an anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against Tyr-, MART-1 and gp100-expressing cancer cells, resulting in tumor cell lysis. HLA-A2 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A2 may improve antigenic peptide immunogenicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5034 https://github.com/vaccineontology/VO/issues/425 2315 6490 5034 cancer vaccine Gene name: MLANA Gene name: gp100 HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine VO:0007497 A cancer vaccine containing dendritic cells (DCs) that are transfected with messenger RNA (mRNA) encoding human telomerase reverse transcriptase (hTERT) and survivin in addition to patient-specific melanoma-derived mRNA with potential immunostimulatory and antineoplastic activities. Upon administration, hTERT/survivin/melanoma tumor cell-derived mRNA-transfected dendritic cell vaccine may elicit a highly specific cytotoxic T-cell (CTL) response against melanoma cells expressing hTERT, survivin, and patient-specific melanoma-associated antigens. hTERT, the catalytic subunit of human telomerase, and survivin, a member of the inhibitor of apoptosis (IAP) family of proteins, may be upregulated in certain tumor cell types, playing key roles in tumor cell growth and survival. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5270 https://github.com/vaccineontology/VO/issues/448 7015 5270 cancer vaccine Gene name: TERT hTERT/survivin/melanoma tumor cell-derived mRNA-transfected dendritic cell vaccine VO:0007498 A peptide vaccine consisting of a combination of seven synthetic long peptides (SLPs), which are each about 30 amino acids in size, and derived from cancer-testis antigens (CTA) and melanocytic differentiation proteins (MDP), with potential immunostimulating and antitumor activities. Upon administration, long peptide vaccine 7 may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL) response against tumor cells expressing these peptides. CTA and MDP are overexpressed in a variety of cancer cell types. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5143 https://github.com/vaccineontology/VO/issues/484 3845 7157 5143 cancer vaccine Gene name: KRAS Gene name: TP53 long peptide vaccine 7 VO:0007499 A synthetic peptide cancer vaccine consisting of human leukocyte antigen HLA-A1-restricted peptide derived from human melanoma antigen 3 (MAGE-3) with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-3.A1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-3, resulting in tumor cell lysis. MAGE-3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5021 https://github.com/vaccineontology/VO/issues/489 4102 5021 cancer vaccine Gene name: MAGEA3 MAGE-3.A1 peptide vaccine VO:0007500 A cancer vaccine made with chimeric antigen receptor (CAR) T cells that can be used to treat solid tumors. These CAR-T cells are engineered to target carbonic anhydrase IX (CAIX) to secrete anti-PD-L1 monoclonal antibody (mAb), termed immune-restoring (IR) CAR G36-PDL1. The T cells can be used to treat clear cell renal cell carcinoma (ccRCC) with reconstituted human leukocyte antigen (HLA) partially matched human leukocytes derived from fetal CD34+ hematopoietic stem cells (HSCs) and bearing human ccRCC skrc-59 cells under the kidney capsule. The cells can restore active antitumor immunity by promoting tumor-killing cytotoxicity, reducing immunosuppressive cell components such as M2 macrophages and exhausted CD8+ T cells, and enhancing T follicular helper (Tfh)-B cell crosstalk. Hayleigh Kahn Jie Zheng PMID:38327771 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6380 3105 6380 cancer vaccine Gene name: HLA CAR G36-PDL1 vaccine VO:0007501 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4003 https://github.com/vaccineontology/VO/issues/497 6490 4003 cancer vaccine Gene name: gp100 MART-1 vaccine VO:0007502 A vaccine consisting of recombinant adenovirus vector encoding MART-1 (melanoma antigen recognized by T-cells 1), an immunogenic protein of unknown function that is expressed by certain types of melanoma. Vaccination with MART-1 adenovirus vaccine may stimulate the host immune system to direct cytotoxic T lymphocytes (CTL) against MART-1 positive melanoma cells, resulting in an antitumor effect. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5398 https://github.com/vaccineontology/VO/issues/498 2315 5398 cancer vaccine Gene name: MLANA-Dupli MART-1 Adenovirus vaccine VO:0007503 A synthetic cancer vaccine derived from a melanoma-associated antigen, MART-1. Antigenic peptides derived from MART-1 are recognized by CD8+ T lymphocytes and have been used to immunize patients with advanced melanomas; prolonged immunization may result in a reduction in tumor size. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5254 https://github.com/vaccineontology/VO/issues/502 2315 5254 cancer vaccine Gene name: MLANA-Dupli MART-1 Fowlpox vaccine VO:0007504 A cancer vaccine consisting of an attenuated recombinant vaccinia virus expressing the melanoma-associated antigen MART-1. Vaccination with this agent may stimulate cytotoxic host immune responses to melanoma cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5204 https://github.com/vaccineontology/VO/issues/503 2315 5204 cancer vaccine Gene name: MLANA-Dupli MART-1 Vaccinia vaccine VO:0007505 Irradiated allogeneic, HLA-A*0201 positive, plasmacytoid dendritic cells (pDCs) loaded with 4 melanoma peptides derived from the tumor associated antigens (TAAs) MelA/MART-1, gp100/pmel17, tyrosinase, and MAGE-A3, with potential immunostimulating and antineoplastic activities. Upon subcutaneous administration, the irradiated allogeneic pDCs may trigger functional multi-specific T cells from peripheral blood mononuclear cells and tumor-infiltrating lymphocytes, and activate the immune system to mount a cytotoxic T-lymphocyte response against HLA-A*0201 positive melanoma cancer cells expressing the TAAs MelA/MART-1, gp100/pmel17, tyrosinase, and MAGE-A3. These TAAs are upregulated in a variety of tumor cells. The pDCs are derived from a distinct subset of dendritic cells (DCs) with a plasma cell-like morphology and express a characteristic set of surface markers and may increase the anti-tumor immune responses. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5028 https://github.com/vaccineontology/VO/issues/504 4100 6490 5028 cancer vaccine Gene name: MAGEA3 Gene name: gp100 MART-1/gp100/Tyrosinase/MAGE-A3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells vaccine VO:0007506 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5141 https://github.com/vaccineontology/VO/issues/505 2315 6490 5141 cancer vaccine Gene name: MLANA Gene name: gp100 MART-1:26-35(27L) peptide vaccine VO:0007507 A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5450 https://github.com/vaccineontology/VO/issues/506 2315 5450 cancer vaccine Gene name: MLANA MART-1:27-35 peptide vaccine VO:0007508 A vaccine consisting of the melanocyte differentiation antigen Melan A (also called MART-1) encapsulated in noninfectious virus-like particles (VLP) with potential immunostimulating and antineoplastic activities. Upon administration, Melan-A VLP vaccine may activate the immune system to exert a specific cytotoxic T lymphocyte (CTL) response against cancer cells expressing the Melan A antigen, resulting in tumor cell lysis. Melan A is an antigen that is upregulated in most melanomas. VLP stimulates the immune system and promotes the CTL response. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5142 https://github.com/vaccineontology/VO/issues/507 2315 5142 cancer vaccine Gene name: MLANA Melan-A VLP vaccine VO:0007509 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5318 https://github.com/vaccineontology/VO/issues/508 2315 4102 5318 cancer vaccine Gene name: MAGEA3 Gene name: MLANA Melan-A/MAGE-3.DP4 peptide vaccine VO:0007510 A cancer vaccine for bladder cancer designed to generate an immune response against a protein called human chorionic gonadotropin-beta (hCG-β). hCG-β is made by several types of cancers, including bladder cancer, and has been shown to be associated with shorter times to development of metastases and reduced survival in bladder cancer. Administering the CDX-1307 vaccine will cause the body's immune system to attack bladder cancer cells in order to kill them or otherwise keep them from spreading or coming back. The human monoclonal antibody (B11) directed against the mannose receptor and linked to the beta-subunit of human chorionic gonadotropin (hCG beta) with potential immunostimulating and antineoplastic activities. The monoclonal antibody moiety of human monoclonal antibody B11-hCG beta fusion protein CDX-1307 binds to mannose receptors on antigen presenting cells (APCs), including human dendritic cells (DCs) and macrophages. APCs present the processed hCG beta antigen on their cell surfaces, which may initiate an antibody-dependent cell-mediated cytotoxicity (ADCC) response against hCG beta-expressing tumor cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C77858 NCT: https://clinicaltrials.gov/study/NCT01094496 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6277 1082 6277 cancer vaccine Gene name: hCG-β CDX-1307 vaccine VO:0007511 A cancer vaccine prepared as tumor cells are isolated from the lesion site of patients with recurrent or metastatic bladder cancer, and dendritic cells or macrophages are isolated from peripheral blood. The vaccine activates an immune response and the microenvironment of bladder cancer lesions, and improves the anti-recurrence treatment effect of bladder cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT05559177 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6278 6278 cancer vaccine chimeric exosomal tumor vaccine VO:0007512 A cancer vaccine that treats patients with Binet Stage A Chronic Lymphocytic Leukemia (CLL) by using a fragment of Deoxyribonucleic acid (DNA) containing the sequence of their own immunoglobulin gene. The vaccine is designed to generate an immune response and shrink or slow the CLL. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00038415 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6279 6279 cancer vaccine CLL idiotypic DNA vaccine VO:0007513 A cancer vaccine for patients with Locally Advanced, Triple-Negative Breast Cancer or ER-Positive, Her2-Negative Breast Cancer to receive ex vivo-generated tumor antigen-loaded dendritic cells (DCs), which can prime lymphocytes and regulate and maintain immune responses. The vaccine may boost T cell immunity targeted against breast cancer, enhance chemotherapy effectiveness and decrease tumor metastagenicity, and decrease the recurrence rates of LA TNBC and ER+/HER2- BC. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02018458 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6288 2064 7490 931 6288 cancer vaccine Gene name: CEF Gene name: WT-1 Gene name: cyclin B1 cyclin B1/WT-1/CEF-loaded DC vaccine VO:0007514 A cancer vaccine consisting of autologous dendritic cells (DCs) fused with autologous acute myeloid leukemia (AML) cells, with potential immunostimulatory and antineoplastic activities. It is generated in vitro by mixing DCs and irradiated AML cells harvested from individual patients, in the presence of polyethylene glycol (PEG), to produce hybrid DC-leukemia fusion cells. The vaccine may elicit a cytotoxic T-lymphocyte (CTL)-mediated antitumor immune response against a broad array of AML-associated antigens, which may lead to AML cell lysis. When dendritic cells and tumor cells are brought together, the dendritic cells can stimulate immune responses against the tumor and, in some cases, cause the tumor to shrink. GM-CSF is a drug that stimulates white blood cells and is given with the DC AML Vaccine in an effort to enhance the effect of the vaccine. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148214 NCT: https://clinicaltrials.gov/study/NCT01096602 NCT: https://clinicaltrials.gov/study/NCT03059485 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6374 6374 cancer vaccine DC/AML fusion vaccine VO:0007515 A cancer vaccine made using the participant's own blood cells. The vaccine will contain a virus called an adenovirus, similar the virus that causes the common cold. The dendritic cells contain survivin+, CD11c+, Human Leukocyte Antigen - antigen D Related (HLA-DR)+ by flow-cytometry. The vaccine is given in combination with G-CSF, T cells, and the CD34 progenitor cells. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02851056 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6351 3123 332 3684 6351 cancer vaccine Gene name: CD11 Gene name: HLA-DR Gene name: survivin dendritic cell survivin vaccine VO:0007516 A cancer vaccine composed of dendritic cells pulsed with peptide epitopes that stimulate cytotoxic T lymphocyte anti-tumor activity. This vaccine is used to treat diffuse hemispheric glioma with a H3 G34 mutation that has come back (recurrent) and/or is growing, spreading, or getting worse (progressive). It is made with the patient's own white blood cells and peptide-pulsed dendritic cells, which may help the body build an effective immune response to kill tumor cells. It is combined with immunotherapy monoclonal antibodies, such as nivolumab and ipilimumab, which also may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1987 NCT: https://clinicaltrials.gov/study/NCT05457959 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6282 6282 cancer vaccine dendritic cell tumor peptide vaccine VO:0007517 A cancer vaccine onsisting of autologous dendritic cells (DCs) fused with patient-derived plasma cell (multiple) myeloma cells with potential immunostimulatory and antineoplastic activities. Autologous DC/multiple myeloma fusions stimulate both helper and cytotoxic T-lymphocyte (CTL) responses through the presentation of internalized and newly synthesized tumor associated antigens (TAAs). This may promote cellular and humoral antitumor immune responses in patients with plasma cell myeloma. This vaccine uses Dendritic cell/myeloma fusions with granulocyte macrophage colony-stimulating factor (GM-CSF) adjuvant plus lenalidomide maintenance therapy. The dendritic cell myeloma vaccine may improve response in patients with multiple myeloma after autologous Hematopoietic Cell Transplant (HCT). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C158480 NCT: https://clinicaltrials.gov/study/NCT02728102 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6323 6323 cancer vaccine dendritic cell/​myeloma fusion vaccine VO:0007518 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan obsolete Melanoma DNA vaccine TA2M(TM) encoding tyrosinase peptides true VO:0007519 A cancer vaccine made of tumor cells and tumor stem cells that are isolated from a sample from a patient with glioblastoma multiforme. Dendritic cells are isolated from peripheral blood mononuclear cells and cultured. The tumor sample provides tumor specific antigens to prepare the dendritic vaccine. Cytotoxic lymphocytes are obtained from peripheral blood after dendritic vaccine administrations. Hematopoietic stem cells are harvested from closely related donor after granulocyte-colony-stimulating factor (G-CSF) administration. Allogeneic haploidentical hematopoietic stem cells are administered intrathecally, dendritic cells are administered subcutaneously, and cytotoxic lymphocytes are adminstered intrathecally. The combination of these treatments may control tumor cell quantity and target regulation of effector functions of tumor stem cells. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01759810 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6285 6285 cancer vaccine dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes VO:0007520 A cancer vaccine from tumor cells and tumor stem cells that are isolated from a sample from a patient with glioblastoma multiforme. Dendritic cells are isolated from peripheral blood mononuclear cells and cultured. The tumor sample provides tumor specific antigens to prepare the dendritic vaccine. Cytotoxic lymphocytes are obtained from peripheral blood after dendritic vaccine administrations. Hematopoietic stem cells are harvested from closely related donor after granulocyte-colony-stimulating factor (G-CSF) administration. Autologous haploidentical hematopoietic stem cells are administered intrathecally, dendritic cells are administered subcutaneously, and cytotoxic lymphocytes are adminstered intrathecally. The combination of these treatments may control tumor cell quantity and target regulation of effector functions of tumor stem cells. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01759810 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6286 6286 cancer vaccine dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes VO:0007521 A cancer vaccine based on ex vivo genetic modifications in combination with known tumor-specific antigens may substantially enhance the activation potential of tumor-specific T cells with improved benefit to patients. This DC vaccine is based on autologous DCs pulsed with genetically modified tumor cells or related antigens such as neoantigens to induce a strong anti-tumor immunity. The patient will receive intravenous cyclophosphamide (200 mg/m2) or oral (cytoxan) before the vaccine, followed by DC vaccine and intravenous bevacizumab (15 mg/kg). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03914768 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6301 6301 cancer vaccine DIPG and GMB Immunomodulatory DC vaccine VO:0007522 A cancer vaccine made with PEG fusions generated from allogeneic dendritic cells and autologous tumor-derived cells with GM-CSF and Il-4. The vaccine is irradiated, frozen, and thawed before being administered to patients with AJCC Stage IV Renal Cell Carcinoma. The vaccine could have and effect on the immune system and cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00625755 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6287 6287 cancer vaccine electrofusion DC vaccine VO:0007523 A synthetic allogeneic cancer vaccine. Melanoma theraccine typically consists of lysed melanoma cells obtained from several melanoma cell lines combined with an adjuvant (such as DETOX or RIBI). This agent may be combined with immunomodulatory cytokines such as interferon alpha. Melanoma theraccine may induce a rise in the level of cytotoxic T-lymphocyte precursors. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan Melanoma Theraccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4989 https://github.com/vaccineontology/VO/issues/522 282617 4989 cancer vaccine Gene name: IFNL3 melanoma Theraccine vaccine VO:0007524 A therapeutic melanoma vaccine consisting of autologous dendritic cells (DCs) pulsed with antigens from lethally irradiated autologous tumor cells derived from a patient-specific, continuously proliferating and melanoma-initiating cell line and suspended in a solution containing the cytokine granulocyte-macrophage colony stimulating factor (GM-CSF), with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration, melapuldencel-T may stimulate the immune system to exert a cytotoxic T-lymphocyte (CTL) immune response against the patient's repertoire of melanoma-associated antigens, particularly tumor stem cell antigens, found in the irradiated autologous cancer cells. As an immunostimulant, GM-CSF enhances the activation of dendritic cells (DCs) and promotes antigen presentation to both B- and T-lymphocytes. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5014 https://github.com/vaccineontology/VO/issues/523 5014 cancer vaccine Melapuldencel-T vaccine VO:0007525 A multipeptide cancer vaccine comprised of 12 melanoma peptides restricted by Class I MHC (12MP), plus a tetanus helper peptide Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5261 https://github.com/vaccineontology/VO/issues/524 22178 6490 5261 cancer vaccine Gene name: TRP-1 Gene name: gp100 MELITAC 12.1 peptide vaccine VO:0007526 A cancer vaccine comprised of estrogen receptor alpha (ERa; estrogen receptor 1; ESR1) mutant peptides, combined with the immunoadjuvants granulocyte-macrophage colony-stimulating factor (GM-CSF) and montanide ISA, with potential immunomodulating and antineoplastic activities. ESR1 mutant peptides in the ESR1 peptides/GM-CSF/montanide ISA vaccine may activate the immune system to induce an immune response against tumor cells expressing these ESR1 mutations. Cancer peptides used in this vaccine are derived from the estrogen receptor and are combined with the adjuvant Montanide ISA and GM-CSF to enhance their immune response. The vaccine may improve outcomes of patients with endocrine resistant breast cancer. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C175590 NCT: https://clinicaltrials.gov/study/NCT04270149 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6289 2099 6289 cancer vaccine Gene name: ESR1 ESR1 peptide vaccine VO:0007527 A humanized anti-idiotypic (anti-Id) monoclonal antibody (MoAb) that mimics the disialoganglioside GD2 with potential immunostimulating and antineoplastic activities. Upon administration, monoclonal antibody 4B5 anti-idiotype vaccine may elicit both cellular and humoral immune responses against GD2- expressing tumor cells. GD2 is a glycosphingolipid (ceramide and oligosaccharide) that may be highly expressed by melanomas and other neuroectodermal tumors, while only minimally expressed by normal tissues. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5039 https://github.com/vaccineontology/VO/issues/535 2064 5039 cancer vaccine Gene name: ERBB2 monoclonal antibody 4B5 anti-idiotype vaccine VO:0007528 A vaccine consisting of a plasmid DNA encoding the murine melanoma-associated antigen gp100. Upon administration, expressed gp100 antigen may stimulate a cytotoxic T cell HLA-A2.1-restricted immune response against tumor cells that express the gp100 antigen, resulting in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5386 https://github.com/vaccineontology/VO/issues/539 20431 5386 cancer vaccine Gene name: Pmel17 Mouse gp100 Plasmid DNA vaccine VO:0007529 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan obsolete mRNA-Electroporated Dendritic Cells Vaccine true VO:0007530 A cancer vaccine directed against the soluble protein idiotype of an individual follicular lymphoma with potential antineoplastic activity. The vaccine may induce an idiotype-specific cytotoxic T-lymphocyte (CTL) response against follicular lymphoma cells expressing the idiotype, resulting in tumor cell lysis. Idiotypic vaccinations have the capacity of inducing an idiotype- and tumor-specific immune response, inducing specific immune responses able to kill in vivo follicular lymphoma cells, and prolonging survival of responding patients. This vaccine may contribute to preventing relapse indefinitely in responding patients. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C71036 NCT: https://clinicaltrials.gov/study/NCT00530140 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6290 6290 cancer vaccine follicular lymphoma, patient-specific, soluble protein idiotype vaccine VO:0007531 A plasmid DNA vaccine encoding the mouse tumor associated antigen tyrosinase-related protein-2 (TYRP2) with potential immunostimulating and antineoplastic activities. Upon administration, murine TYRP2 plasmid DNA vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing TYRP2; this vaccine may also induce an immune response against tyrosinase-related protein-1 (TYRP1). TYRP2 and TYRP1, melanosomal membrane glycoproteins upregulated in melanoma cells, are involved in melanin synthesis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5310 https://github.com/vaccineontology/VO/issues/558 1638 5310 cancer vaccine Gene name: DCT Murine TYRP2 plasmid DNA vaccine VO:0007532 A cancer vaccine containing dendritic cells (DCs) that are transfected with messenger RNA (mRNA) encoding human telomerase reverse transcriptase (hTERT) and LAMP. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5276 https://github.com/vaccineontology/VO/issues/446 7015 5276 cancer vaccine Gene name: TERT hTERT-LAMP mRNA-loaded autologous dendritic cell vaccine GRNVAC1 VO:0007533 A recombinant 19-residue peptide vaccine consisting of amino acids 161 through 180 of the cancer/testis (CT) antigen. ESO-1 (161-180) peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for ESO-1, resulting in decreased tumor growth. ESO-1 is expressed in a variety of cancers, including melanoma, breast, bladder, prostate, and hepatocellular cancers. (NCI04) (NCIT_C28775). Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5264 https://github.com/vaccineontology/VO/issues/66 1485 5264 cancer vaccine Gene name: NY-ESO-1 ESO-1 (161-180) peptide vaccine VO:0007534 A 9-residued peptide vaccine consisting of amino acids 157 through 165 of the cancer/testis (CT) antigen ESO-1. Modified at position 165 (cysteine to valine) to improve immunogenicity, ESO-1:157-165(165v) peptide administered as a vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for ESO-1, resulting in decreased tumor growth. ESO-1 is expressed in a variety of cancers, including melanoma, breast, bladder, prostate, and hepatocellular cancers. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5473 https://pubmed.ncbi.nlm.nih.gov/?term=ESO-1%3A157-165%28165V%29+Peptide https://github.com/vaccineontology/VO/issues/68 1485 5473 cancer vaccine Gene name: NY-ESO-1 ESO-1:157-165(165V) peptide vaccine VO:0007535 A recombinant virus-based vaccine that contains various peptide antigens. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues. Strong CD8 T cell responses may be induced after prolonged immunization and have been associated with tumor regression. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan PMID:15757474 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5031 https://github.com/vaccineontology/VO/issues/129 354 634 5031 cancer vaccine Gene name: CEACAM1 Gene name: KLK3 fowlpox virus vaccine VO:0007536 A peptide vaccine against the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO), with potential immunomodulating and antineoplastic activities. Vaccination with indoleamine 2,3-dioxygenase peptide vaccine may activate the immune system to induce an immune response against IDO-expressing cells. This may increase and restore the proliferation and activation of various immune cells, including dendritic cells (DCs), natural killer (NK) cells, and T-lymphocytes, and may eradicate IDO-expressing tumor cells. IDO, a cytosolic enzyme responsible for tryptophan catabolism and conversion of tryptophan into kynurenine, is overexpressed by a variety of tumor cell types and antigen presenting cells (APCs) and plays an important role in immunosuppression; Tryptophan depletion inhibits T-lymphocyte proliferation and activation, and suppresses the immune system Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5144 https://github.com/vaccineontology/VO/issues/469 3620 5144 cancer vaccine Gene name: IDO1 Indoleamine 2,3-dioxygenase Peptide vaccine VO:0007537 A conjugate consisting of fluorescein isothiocyanate (FITC) conjugated with folate with potential antineoplastic activity. Folate-FITC binds to folate receptors, which are overexpressed on the surfaces of many cancer cells including kidney and ovarian cancer cells. Once bound to the cancer cell through the folate moiety of the conjugate, circulating anti-fluorescein antibodies may recognize and bind to the FITC moiety, resulting in antibody-dependent cellular cytotoxicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan PMID:22855837 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5317 https://github.com/vaccineontology/VO/issues/128 2348 5317 cancer vaccine Gene name: FOLR1 Folate-FITC vaccine VO:0007538 A cancer vaccine consisting of a recombinant vaccinia virus encoding the tumor-associated gene MAGE-1 that is contaminated with bovine viral diarrhea virus (BVDV). The MAGE-1 gene is a member of the melanoma antigen-encoding gene family which is expressed in various malignant tumors such as hepatocellular carcinoma and germ cell tumors in addition to melanoma. Vaccination with vaccinia virus expressing human MAGE-1 may generate antitumoral T-cell responses. BVDV is an RNA pestivirus that may contaminate vaccines due to its presence in the fetal calf serum used as a growth supplement in the tissue culture of mammalian cells used in vaccine production. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan MAGE-1 Vaccinia Contaminated with BVDV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5157 https://github.com/vaccineontology/VO/issues/488 4100 5157 cancer vaccine Gene name: MAGEA1 MAGE-1 Vaccinia contaminated with bovine viral diarrhea virus vaccine VO:0007539 A peptide cancer vaccine comprised of a peptide derived from the human melanoma antigen A3 (MAGE-A3), with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A3 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A3, resulting in tumor cell lysis. MAGE-A3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5395 https://github.com/vaccineontology/VO/issues/491 4102 5395 cancer vaccine Gene name: MAGEA3 MAGE-A3 peptide vaccine VO:0007540 An oncolytic adenoviral vaccine composed of a replication-defective, E1- and E3-deleted adenovirus serotype 5 (Ad5) with a transgene encoding the human melanoma antigen A3 (MAGE-A3), with potential antineoplastic activity. Upon administration, MAGE-A3-expressing adenovirus type 5 vaccine selectively replicates in cancer cells and expresses MAGE-A3. This induces an immune response against tumor cells expressing the MAGE-A3 antigen, which leads to tumor cell death. The tumor-associated antigen MAGE-A3 is overexpressed by a variety of cancer cell types. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5336 https://github.com/vaccineontology/VO/issues/492 4102 5336 cancer vaccine Gene name: MAGEA3 MAGE-A3-expressing Adenovirus Type 5 vaccine VO:0007541 A peptide vaccine consisting of multiple epitopes derived from the human telomerase reverse transcriptase (hTERT), the catalytic subunit of human telomerase, with potential immunostimulating and antineoplastic activities. hTERT I540/R572Y/D988Y multipeptide vaccine contains strongly antigenic peptide epitopes I540 (9-mer), R572Y (9-mer) and D988Y (10-mer). Vaccination with this agent may elicit a cytotoxic T cell (CTL) response against telomerase-expressing tumor cells. Directly linked to tumorigenesis, telomerase is expressed in the majority of human cancer cells but is infrequently expressed in normal cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5191 https://github.com/vaccineontology/VO/issues/439 7015 5191 cancer vaccine Gene name: TERT hTERT I540/R572Y/D988Y multipeptide vaccine VO:0007542 A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with tumor-derived clonal immunoglobulin (Ig) with potential immunostimulatory and antineoplastic activities. Upon administration, idiotype-pulsed autologous dendritic cell vaccine APC8020, containing idiotype (Id) protein structures that can be recognized by antibodies and by CD41 T lymphocytes and CD81 T lymphocytes, may stimulate antitumoral cytotoxic T lymphocyte (CTL) and antibody responses against Id-expressing tumor cells. The Id represents the unique antigenic determinants in the variable regions of the clonal Ig. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5344 https://github.com/vaccineontology/VO/issues/460 5344 cancer vaccine Idiotype-pulsed autologous dendritic cell vaccine APC8020 VO:0007543 A cancer vaccine made from tumor-specific neopeptides resulting from frameshift mutations in tumor cells, so-called Frames, present potentially potent targets for the immune system and can be utilized in therapeutic anti-cancer vaccination with the intention to synergize in their effect with immune checkpoint inhibitors. The personalized vaccine FRAME-001 based on a patient's Framome and selection of Frame peptides in advanced NSCLC cancer patients after standard first line treatment consisting of immune checkpoint inhibitor pembrolizumab as monotherapy or combined with chemotherapy (carboplatin/cisplatin and pemetrexed/paclitaxel) could help treat patients with non-small cell lung cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT04998474 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6291 6291 cancer vaccine FRAME-001 personalized vaccine VO:0007544 A cancer vaccine consisting of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the gene for the CD4 epitope-rich C-terminal domain of the Epstein Barr Virus (EBV) antigen EBNA1 and fused to the full-length of the EBV-associated antigen latent membrane protein 2 (LMP2), with potential immunostimulatory and antineoplastic activities. Upon administration, MVA EBNA1/LMP2 vaccine may elicit a cytotoxic T-cell immune response against cancer cells expressing EBNA1 and LMP2. Multi-antigen vaccine therapy may be more efficacious than single-antigen therapy vaccine therapy. EBNA1, a sequence-specific DNA binding protein, plays an important role in EBV episomal genome maintenance and gene transactivation. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5460 https://github.com/vaccineontology/VO/issues/565 354 55 5460 cancer vaccine Gene name: ACP3 Gene name: KLK3 MVA-PSA/PAP Prostate Cancer Vaccine VO:0007545 A cancer vaccine consisting of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the gene for the CD4 epitope-rich C-terminal domain of the Epstein Barr Virus (EBV) antigen EBNA1 and fused to the full-length of the EBV-associated antigen latent membrane protein 2 (LMP2), with potential immunostimulatory and antineoplastic activities. Upon administration, MVA EBNA1/LMP2 vaccine may elicit a cytotoxic T-cell immune response against cancer cells expressing EBNA1 and LMP2. Multi-antigen vaccine therapy may be more efficacious than single-antigen therapy vaccine therapy. EBNA1, a sequence-specific DNA binding protein, plays an important role in EBV episomal genome maintenance and gene transactivation. (NCIT_C91076). Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5314 https://github.com/vaccineontology/VO/issues/560 3783709 5698 5314 cancer vaccine Gene name: EBNA-1 Gene name: PSMB9 MVA-EBNA1/LMP2 Vaccine VO:0007546 A peptide vaccine containing amino acids residues from 340 through 349 of the latent membrane protein-2 (LMP-2) of the Epstein-Barr virus (EBV) with potential immunostimulating and antineoplastic activities. LMP-2, an EBV transmembrane protein, is expressed in various malignancies including nasopharyngeal cancer and EBV-positive Hodgkin's disease. Vaccination with the LMP-2:340-349 peptide may boost the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against LMP-2 producing cells, resulting in cell lysis and inhibition of cancer cell proliferation Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5466 https://github.com/vaccineontology/VO/issues/482 5689 5466 cancer vaccine Gene name: PSMB9 LMP-2:340-349 Peptide Vaccine VO:0007547 A peptide vaccine containing amino acids residues from 419 through 427 of the latent membrane protein-2 (LMP-2) of the Epstein-Barr virus (EBV) with potential immunostimulating and antineoplastic activities. LMP-2, an EBV transmembrane protein, is expressed in various malignancies including nasopharyngeal cancer and EBV-positive Hodgkin's disease. Vaccination with the LMP-2:49-427 peptide may boost the immune system to mount a specific cytotoxic T-lymphocyte response against LMP-2 producing cells, resulting in cell lysis and inhibition of cancer cell proliferation. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5479 https://github.com/vaccineontology/VO/issues/483 5689 5479 cancer vaccine Gene name: PSMB9 LMP-2:419-427 Peptide Vaccine VO:0007548 A cancer vaccine comprised of synthetic peptides derived from human melanoma antigen A1 (MAGE-A1), human melanoma antigen A3 (MAGE-A3) and cancer-testis antigen NY-ESO-1 with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A1/MAGE-A3/NY-ESO-1 peptides vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A1, MAGE-A3 and NY-ESO-1, resulting in tumor cell lysis. The MAGE-A1, MAGE-A3, and NY-ESO-1 tumor-associated antigens (TAAS) are overexpressed by a variety of cancer cell types. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5263 https://github.com/vaccineontology/VO/issues/490 4100 4102 5263 cancer vaccine Gene name: MAGEA1 Gene name: MAGEA3 MAGE-A1/MAGE-A3/NY-ESO-1 peptide vaccine VO:0007549 A trivalent cancer vaccine containing the ganglioside lactones GM2, GD2 and GD3 conjugated with the immunostimulant keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. Vaccination with GM2 lactone/GD2 lactone/GD3 lactone-KLH conjugate trivalent vaccine may elicit antibodies against tumor cells expressing any of these epitopes, resulting in an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing these gangliosides. GM2, GD2 and GD3 are tumor associated antigens (TAAs) that are overexpressed in a variety of tumor cell membranes. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5532 https://github.com/vaccineontology/VO/issues/178 117189 2760 5532 cancer vaccine Gene name: GM2A Gene name: GRDX GM2/GD2/GD3 Lactone-KLH conjugate trivalent vaccine VO:0007550 A cancer vaccine containing four HLA-A*2402-restricted peptide epitopes with potential immunostimulatory and antitumor activities. Peptide epitopes in this vaccine are derived from ring finger protein 43 (RNF43); translocase of outer mitochondrial membrane 34 (TOMM34); and vascular endothelial growth factor receptors (VEGFR) 1 and 2. Upon administration, HLA-A*2404-restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing RNF43, TOMM34, and VEGFR 1 and 2 peptides, resulting in tumor cell lysis and decreased tumor growth. HLA-A*2402 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*2402 may improve antigenic peptide immunogenicity Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5429 https://github.com/vaccineontology/VO/issues/421 10953 3791 5429 cancer vaccine Gene name: KDR Gene name: TOMM34 HLA-A*2404-Restricted RNF43-TOMM34-VEGFR1-VEGFR2 multipeptide vaccine VO:0007551 A peptide vaccine comprised of synthetic HLA-A1, -A2 and -B35 restricted survivin epitopes combined with the adjuvant Montanide ISA-51 with potential antineoplastic activity. Upon administration, HLA-A1, A2, B35-restricted survivin peptides/Montanide ISA-51 vaccine may stimulate a cytotoxic T cell response against tumor cells that overexpress survivin, resulting in tumor cell lysis. Montanide ISA-51, also known as incomplete Freund's adjuvant or IFA, is a stabilized water-in-oil emulsion adjuvant containing mineral oil with mannide oleate added as a surfactant that non-specifically stimulates cell-mediated immune responses to antigens. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5120 https://github.com/vaccineontology/VO/issues/422 5120 cancer vaccine Gene name: Survivin HLA-A1, A2, B35-restricted survivin peptide/montanide ISA-51 vaccine VO:0007552 A dendritic cell (DC) vaccine containing ex vivo expanded autologous DCs obtained from a patient with leukemia with potential immunostimulating activity. Upon reintroduction into the host, the host dendritic cell vaccine-001 MSSM/BIIR may stimulate the immune system to mount a leukemia-specific cytotoxic T lymphocyte (CTL) response. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5246 https://github.com/vaccineontology/VO/issues/428 1489078 5246 cancer vaccine Gene name: E6 host dendritic cell vaccine-001 MSSM/BIIR VO:0007553 A multi-peptide cancer vaccine with potential immunostimulating and antineoplastic activities. IMT-1012 immunotherapeutic vaccine contains twelve different synthetic peptides or tumor associated antigens (TAAs), including cyclin I (CCNI), cyclin-dependent kinase CDC2, EDDRI and TACE/ADAM17, each of which is involved in a different pathway associated with tumor growth, survival, and metastasis. Each antigen in the vaccine elicits a specific cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing that antigen. This multi-antigen/multi-pathway targeting strategy provides broad immunotherapeutic coverage with respect to tumor complexity and heterogeneity and may result in enhanced vaccine efficacy. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5048 https://github.com/vaccineontology/VO/issues/464 10983 983 5048 cancer vaccine Gene name: CCNI Gene name: CDK1 IMT-1012 Immunotherapeutic vaccine VO:0007554 A cancer vaccine containing four HLA-A0201-restricted peptide epitopes with potential immunostimulatory and antitumor activities. Vaccine peptide epitopes are derived from the tumor associated antigens (TAAs) tyrosinase-related protein 2 (TRP2), glycoprotein 100 (gp100), Ephrin receptor A2 (EphA2) and human epidermal growth factor receptor 2 (HER2). Upon administration, HLA-A0201-restricted TRp2-gp100-EphA2-HER2 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against TRP2-gp100-EphA2-HER2-expressing tumor cells, resulting in tumor cell lysis and decreased tumor cell proliferation. HLA-A0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5355 https://github.com/vaccineontology/VO/issues/309 2064 6490 5355 cancer vaccine Gene name: ERBB2 Gene name: PMEL HLA-A0201-Restricted TRP2-gp100-EphA2-HER2 multipeptide vaccine VO:0007555 A cancer vaccine containing three HLA-A0201-restricted peptide epitopes with potential immunostimulatory, antiangiogenic, and antitumor activities. Vaccine peptide epitopes are derived from the tumor associated antigen (TAA) URLC (up-regulated in lung cancer 10) and vascular endothelial growth factor receptors (VEGFR) 1 and 2. Upon administration, HLA-A0201-restricted URLC10-VEGFR1-VEGFR2 multipeptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against URLC10-expressing tumor cells and the tumor microvasculature expressing VEGFR 1 and 2 peptides; this may result in tumor cell lysis, the inhibition of tumor angiogenesis, and decreased tumor growth. HLA-A0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5017 https://github.com/vaccineontology/VO/issues/417 3791 54742 5017 cancer vaccine Gene name: KDR Gene name: LY6K HLA-A*0201-Restricted URLC10-VEGFR1-VEGFR2 multipeptide vaccine VO:0007556 A live-attenuated, double-deleted strain of the Gram-positive bacterium Listeria monocytogenes (Lm) encoding a mutant form of the tumor associated antigens, epidermal growth factor receptor (EGFRvIII) and the cancer/testis antigen NY-ESO-1, with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, live-attenuated Listeria monocytogenes encoding EGFRvIII-NY-ESO-1 vaccine targets dendritic cells and expresses EGFRvIII and NY-ESO-1. This promotes both a potent innate immune response and an adaptive immune response involving the recruitment and activation of T lymphocytes against EGFRvIII and NY-ESO-1-expressing tumor cells, which results in tumor cell lysis. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4991 https://github.com/vaccineontology/VO/issues/480 1485 1956 4991 cancer vaccine Gene name: CTAG1B Gene name: EGFR live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 vaccine ADU-623 VO:0007557 A multivalent vaccine comprised of the epitope antigens of Globo H hexasaccharide 1 (Globo H), GM2 ganglioside, Lewis-Y, MUC1-32-mer, TF(c), and Tn(c) conjugated with keyhole limpet hemocyanin, with potential antineoplastic activity. The antigens included in this vaccine are associated various cancer cells. Vaccination with this multivalent vaccine may induce production of IgG and IgM antibodies as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing these antigens. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5104 https://github.com/vaccineontology/VO/issues/173 4582 2760 5104 cancer vaccine Gene name: GM2A Gene name: MUC1 Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH conjugate vaccine VO:0007558 Peripheral blood lymphocytes (PBL) transfected to express MOv have been designed for possible use in autologous adoptive cellular immunotherapy of ovarian adenocarcinomas that overexpress folate-binding protein. MOv-PBLs express MOv-gamma (MOv), a chimeric receptor gene product derived from a recombinant gene encoding the variable region of murine monoclonal antibody MOv18 against folate-binding protein (FBP), often overexpressed in human ovarian cancer cells, and the human gene encoding the IgG and IgE Fc receptor gamma subunit. Autologous vaccination with these PBLs stimulates a host cytotoxic T lymphocyte response against ovarian cancer cells that overexpress FBP. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5335 https://github.com/vaccineontology/VO/issues/541 4343 5335 cancer vaccine Gene name: MOV10 MOv-PBL Vaccine VO:0007559 An attenuated oncolytic vaccinia virus encoding the light-emitting fusion protein Renilla luciferase-Aequorea green fluorescent protein (RUC-GFP) with potential bioluminescent and antineoplastic activities. Upon administration, light-emitting oncolytic vaccinia virus GL-ONC1 specifically enters tumor cells due to the permeable nature of the tumor vasculature. Once inside the cell, the virus replicates, resulting in tumor cell lysis and the release of mature viral particles into the tumor microenvironment. Released viral particles may then infect and destroy neighboring tumor cells. In addition, the release of tumor-associated antigens (TAAs) by lysed tumor cells into the bloodstream may activate the immune system to mount a cytotoxic T lymphocyte (CTL) response against the tumor. The expression of RUC-GFP by this agent allows for both detection and monitoring of virally infected tumor cells in vivo and vitro with luciferase-mediated bioluminescence imaging and fluorescence imaging techniques. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5385 https://github.com/vaccineontology/VO/issues/477 5385 cancer vaccine Gene name: Tumor Associated Antigen light-emitting Oncolytic Vaccinia virus GL-ONC1 vaccine VO:0007560 A cancer vaccine containing an HLA-A*0201-restricted vascular endothelial growth factor receptor 1 (VEGFR1) peptide (sequence: TLFWLLLTL) with potential immunostimulatory and antitumor activities. Upon administration, HLA-A*0201-restricted VEGFR1-derived peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing VEGFR1, resulting in tumor cell lysis and decreased tumor growth. HLA-A*0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5413 https://github.com/vaccineontology/VO/issues/418 3791 5413 cancer vaccine Gene name: KDR HLA-A*0201-Restricted VEGFR1 peptide vaccine VO:0007561 A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA) and TRICOM, a combination of three immunostimulants (i.e., B7.1, ICAM-1, and LFA-3). Administration of this agent may induce a cytotoxic T cell response against PSA-expressing tumor cells. Dendritic cells infected with TRICOM vectors greatly enhance naive T-cell activation and peptide-specific T-cell stimulation. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5038 https://github.com/vaccineontology/VO/issues/132 354 5038 cancer vaccine Gene name: KLK3 Fowlpox-PSA-TRICOM Vaccine VO:0007562 A prostate cancer vaccine containing mRNAs encoding prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), prostate stem cell antigen (PSCA) and six-transmembrane epithelial antigen of the prostate (STEAP), with potential antitumor activity. Upon administration, mRNA-derived prostate cancer vaccine CV9103 may stimulate the immune system to mount a cytotoxic T lymphocyte response (CTL) against PSA-, PSMA-, PSCA- and STEAP-expressing prostate tumor cells. The mRNA used in this vaccine is modified and formulated to have enhanced translational potency and adjuvant activities. PSA, PSMA, PSCA and STEAP may be upregulated in prostate cancer cells; their expression in prostate cancer has been correlated with disease progression. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5369 https://github.com/vaccineontology/VO/issues/542 26872 5369 cancer vaccine Gene name: STEAP1 mRNA-Derived Prostate Cancer Vaccine CV9103 VO:0007563 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5126 https://github.com/vaccineontology/VO/issues/546 4583 5126 cancer vaccine Gene name: MUC2 MUC-2-Globo H-KLH Conjugate Vaccine VO:0007564 A recombinant agent consisting of a genetically-modified adenovirus 5 vector encoding the protein cytokine tumor necrosis factor (TNF) alpha. TNF exhibits potent anti-tumor cytolytic properties; the adenovirus 5 vector efficiently infects tumor cells, delivering tumor-specific TNF. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5292 https://github.com/vaccineontology/VO/issues/194 7124 5292 cancer vaccine Gene name: TNF Golnerminogene Pradenovec vaccine VO:0007565 A peptide vaccine comprised of synthetic HLA-A2- and HLA-A3-binding peptides, derived from amino acid sequences of fibroblast growth factor-5 (FGF-5), combined with the adjuvant Montanide ISA-51 with potential antineoplastic activity. HLA-A2, A3-restricted FGF-5 peptides contain motifs recognized by the MHC class I molecules HLA-A2 and HLA-A3 and may stimulate a cytotoxic T-cell response against tumor cells that overexpress FGF-5. Montanide ISA-51, a stabilized water-in-oil emulsion adjuvant containing mineral oil with mannide oleate added as a surfactant, non-specifically stimulates cell-mediated immune responses to antigens Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5465 https://github.com/vaccineontology/VO/issues/424 2250 5465 cancer vaccine Gene name: FGF5 HLA-A2, A3-Restricted FGF-5 Peptides/Montanide ISA-51 Vaccine VO:0007566 A naturally occurring 9-residue peptide of fibroblast growth factor 5 (FGF-5). Recognized by tumor infiltrating cytotoxic T lymphocytes originally isolated from a renal cell carcinoma that overexpressed FGF-5, FGF-5:172-176/217-220 peptide activates various cytotoxic CD8 lymphocytes in an HLA-restricted manner. Overexpressed in several cancer cell lines, FGF-5 is a tumor-associated antigen that may be useful in cancer immunotherapy. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5498 https://github.com/vaccineontology/VO/issues/134 4108 5498 cancer vaccine Gene name: MAGEA9 G250 Peptide Vaccine VO:0007567 A synthetic peptide derived from the protein ESW/FLI1 type 1 with potential use in cancer immunotherapy. EWS/FLI1 is a fusion protein frequently found in patients with Ewing's sarcoma or primitive neuroectodermal tumors (PNET). Vaccination with EF-1 peptide may stimulate the host immune response to elicit a cytotoxic T-cell response against tumor cells that express this EWS/FL1 type 1 fusion protein. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5509 https://github.com/vaccineontology/VO/issues/52 253970502 100306940 5509 cancer vaccine Gene name: EWSR1 Gene name: FL1 EF-1 Peptide Vaccine VO:0007568 A cancer vaccine comprised of a 43 amino acid epitope from glycoprotein MUC1 (mucin 1) and the synthetic Toll-like receptor 4 (TLR-4) agonist PET lipid A encapsulated in cholesterol/dipalmitoylphosphatidylcholine (DPPC)/dimyristoylphosphatidylglycerol (DMPG) liposomes, with potential immunostimulatory and antineoplastic activities. The MUC1 epitope is composed of two 20 amino glycosylated VNTR (various number tandem repeats) from human MUC1A and including 6 glycosylated sites modified by Tn (alfa-N-acetyl-D-galactosamine). Immunization of liposomal MUC1/PET-lipid A vaccine results in an antibody as well as a cytotoxic T-lymphocyte (CTL) response against hypoglycosylated MUC1 expressing tumor cells. The tumor associated antigen MUC1, a type I transmembrane protein, is overexpressed and aberrantly glycosylated in a variety of tumor cells. As a vaccine adjuvant, PET lipid A, also known as penta erythritol lipid A, stimulates both cellular and humoral responses to the vaccine antigen. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5488 https://github.com/vaccineontology/VO/issues/479 4582 5488 cancer vaccine Gene name: MUC1 liposomal MUC1/PET-lipid A vaccine VO:0007569 Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5345 https://github.com/vaccineontology/VO/issues/493 4102 5345 cancer vaccine Gene name: MAGEA3 MAGE-A3/HPV 16 peptide vaccine VO:0007570 A peptide derived from the tumor suppressor protein Von Hippel-Lindau (VHL). This peptide, sequence: MEAGRPRPCCAR, was constructed based on a frameshift mutation of one of the VHL gene products; the more abundant protein VHLp18(MEA) (where MEA stands for three amino acids, Met-Glu-Ala). Vaccination with FrSh61(MEA)VHL33 peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing this VHL mutant protein. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5236 https://github.com/vaccineontology/VO/issues/133 7428 5236 cancer vaccine Gene name: VHL FrSh61 (MEA) VHL33 peptide vaccine VO:0007571 A cancer vaccine based on virus-like replicon particles (VRP) packaged with an alphaviral vector encoding the extracellular domain (ECD) and transmembrane (TM) regions of the human epidermal growth factor receptor 2 (EGFR2, NEU or HER2), with potential antineoplastic activity. After immunization with HER2 ECD+TM virus-like replicon particles vaccine AVX901, the VRPs infect cells and express HER2 ECD+TM protein that may activate the immune system to elicit a cytotoxic T-lymphocyte (CTL) response against HER2-expressing tumor cells. The alphaviral replicon of this vaccine is an attenuated strain of the Venezuelan equine encephalitis virus (VEEV) in which 3 of the 7 viral genes were substituted with a truncated HER2 gene to create a self-amplifying replicon RNA. HER2, a tyrosine kinase involved in several cell growth signaling pathways, is dysregulated or overexpressed in a wide variety of cancer cell types. Jie Zheng Justin Song Oliver He Yuanyi (Penny) Pan VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5442 https://github.com/vaccineontology/VO/issues/305 2064 5442 cancer vaccine Gene name: ERBB2 HER2 ECD+TM virus-like replicon particles vaccine AVX901 VO:0007572 A replication-competent oncolytic adenovirus encoding the murine pro-inflammatory cytokine interleukin-12 (IL-12) gene and two suicide fusion genes, a yeast cytosine deaminase (yCD) and a mutant form of herpes simplex virus type 1 thymidine kinase (HSV-1 TKSR39), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration of Ad5-yCD/mutTKSR39rep-hIL12, the adenovirus selectively infects and replicates in tumor cells, which results in direct tumor cell lysis. Synergistically, IL-12 expressed by the adenovirus may activate the immune system by promoting the activation of natural killer cells (NKs), inducing secretion of interferon-gamma (IFN-g) and inducing cytotoxic T-lymphocyte (CTL) responses against tumor cells, which may result in immune-mediated tumor cell death, inhibition of tumor cell proliferation and inhibition of tumor angiogenesis. In addition, Ad5-yCD/mutTKSR39rep-hIL12-infected cancer cells express yCD and TKSR39; upon administration of the prodrugs 5-fluorocytosine (5-FC) and valganciclovir (vGCV), the yCD and HSV-1 TKSR39 activate these prodrugs to form 5-fluorouracil (5-FU) and ganciclovir, respectively. 5-FU gets converted to 5-fluoro-uridine monophosphate (5-FUMP) and subsequently to 5-fluoro-deoxyuridine monophosphate (5-FdUMP); 5-FdUMP irreversible inhibits thymidylate synthase, inhibits deoxythymidine triphosphate (dTTP) formation and halts DNA synthesis. Once phosphorylated intracellularly, ganciclovir triphosphate competitively inhibits deoxyguanosine triphosphate (dGTP) incorporation into DNA and inhibits DNA synthesis. Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5303 https://github.com/vaccineontology/VO/issues/89 5303 cancer vaccine Gene name: IL12A Gene name: IL12B Ad5-yCD/mutTKSR39rep-hIL12 vaccine VO:0007573 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5324 5324 cancer vaccine Ad5F35-LMP1/LMP2-Transduced autologous dendritic cell vaccine VO:0007574 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5534 5534 cancer vaccine Alpha Fetoprotein Plasmid DNA vaccine VO:0007575 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4995 4995 cancer vaccine ALVAC-CEA (6D)-B7.1 vaccine VO:0007576 Jie Zheng Oliver He VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5085 obsolete Autologous Dendritic Cell Vaccine ACT2001 true VO:0007577 Jie Zheng Oliver He obsolete Autologous Dendritic Cell-Tumor Fusion Vaccine true VO:0007578 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4051 4051 cancer vaccine autologous dendritic cells (DCs) vaccine VO:0007579 Jie Zheng Oliver He obsolete Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine true VO:0007580 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3981 3981 cancer vaccine autologous monocyte-derived mature DCs pulsed with p53, survivin and telomerase-derived peptide vaccine VO:0007581 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4029 4029 cancer vaccine Bacille Calmette Guerin for melanoma of lower extremity vaccine VO:0007582 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4028 https://github.com/vaccineontology/VO/issues/776 4028 cancer vaccine Bacillus Calmette-Guerin (BCG) vaccine for melanoma VO:0007583 Jie Zheng Oliver He Bacillus Calmette-Guerin (BCG), C. parvum vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4036 4036 cancer vaccine Bacillus Calmette-Guerin (BCG), Corynebacterium parvum vaccine VO:0007584 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4035 4035 cancer vaccine Bacillus Calmette-Guerin (BCG), dinitrochlorobenzene (DNCB) vaccine VO:0007585 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4034 4034 cancer vaccine Bacillus Calmette-Guerin (MER) vaccine VO:0007586 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4021 4021 cancer vaccine BCG and chemotherapy for malignant melanoma vaccine VO:0007587 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4022 4022 cancer vaccine BCG and Corynebacterium parvum for malignant melanoma vaccine VO:0007588 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4033 4033 cancer vaccine BCG treatment after surgical tumor removal vaccine VO:0007589 Jie Zheng Oliver He VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5399 obsolete Bcl-Xs Adenovirus Vaccine true VO:0007590 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4017 4017 cancer vaccine Biolistic DNA vaccine VO:0007591 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3984 3984 cancer vaccine Canvaxin VO:0007592 Jie Zheng Oliver He VIOLIN: https://violinet.org/canvaxkb/vaccine_detail.php?c_vaccine_id=5476 obsolete CD80 Breast Cancer Vaccine true VO:0007593 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4072 4072 cancer vaccine class I HLA-A0201-restricted gp100209-2M peptide vaccine VO:0007594 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5456 5456 cancer vaccine Contusugene ladenovec vaccine VO:0007595 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3990 3990 cancer vaccine CpG 7909/PF3512676 vaccine VO:0007596 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4170 4170 Recorded as licensed cancer vaccine without reference. Based on the vaccine name, it is not correct, see term:VO:0004719. obsolete CVB4/p24(73(3)) vaccine true VO:0007597 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5494 5494 cancer vaccine dendritic cell-Idiotype-Keyhole Limpet Hemocyanin vaccine VO:0007598 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5346 5346 cancer vaccine DEPDC1/MPHOSH1 peptide vaccine VO:0007599 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5116 5116 cancer vaccine DLK1/EPHA2/HBB/NRP1/RGS5/TEM1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine VO:0007600 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4060 4060 cancer vaccine DNA vaccine encoding p42.3 VO:0007601 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3998 3998 cancer vaccine DNP-modified autologous vaccine VO:0007602 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4076 4076 cancer vaccine electroloading of mature dendritic cells with melanoma whole tumor cell lysate vaccine VO:0007603 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4067 4067 cancer vaccine ESAT-6-gpi DNA vaccine combined with B16F10-ESAT-6-gpi/IL-21 vaccine VO:0007604 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4081 4081 cancer vaccine Flagrp170 vaccine VO:0007605 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4018 4018 cancer vaccine FVAX vaccine VO:0007606 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4047 4047 cancer vaccine GM-CSF transfected cells vaccine VO:0007607 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4008 4008 cancer vaccine gp100 vaccine VO:0007608 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3974 3974 cancer vaccine gp100:209-217(210M) peptide vaccine VO:0007609 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5438 5438 cancer vaccine gp100:280-288(288V) peptide vaccine VO:0007610 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5062 5062 cancer vaccine GVAX pancreatic cancer vaccine VO:0007611 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4010 4010 cancer vaccine hapten dinitrophenyl vaccine VO:0007612 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3992 3992 cancer vaccine HCA587 protein vaccine VO:0007613 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4053 4053 cancer vaccine hMART-IT vaccine VO:0007614 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3986 3986 cancer vaccine HSP65-HER2 fusion peptide vaccine VO:0007615 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4058 4058 cancer vaccine Hsp70 chaperone-based gel composition vaccine VO:0007616 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3982 3982 cancer vaccine HSPPC-96 vaccine VO:0007617 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3980 3980 cancer vaccine human leukocyte antigen class I-modified peptide vaccine VO:0007618 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4077 4077 cancer vaccine HUVECs-OK432 vaccine VO:0007619 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3976 3976 cancer vaccine IDD-3 vaccine VO:0007620 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4009 4009 cancer vaccine IFN/tremem vaccine VO:0007621 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4062 4062 cancer vaccine IL-12p70 vaccine VO:0007622 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3977 3977 cancer vaccine IMM-101 vaccine VO:0007623 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4069 4069 cancer vaccine Incomplete Freund's adjuvant (IFA) alone, or a melanoma vaccine in IFA VO:0007624 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4037 4037 cancer vaccine intralesional bacile Calmette-Guerin (BCG) vaccine VO:0007625 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4038 4038 cancer vaccine intralesional bacile Calmette-Guerin (BCG), DTIC, vincristine vaccine VO:0007626 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3975 3975 cancer vaccine ipilimumab vaccine VO:0007627 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4045 4045 cancer vaccine ipilimumab, vemurafenib vaccine VO:0007628 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4012 4012 cancer vaccine irradiated autologous cell vaccine VO:0007629 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4050 4050 cancer vaccine irradiated melanoma cells plus BCG vaccine VO:0007630 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5472 5472 cancer vaccine KSA-KLH conjugate vaccine VO:0007631 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4000 4000 cancer vaccine L612 HuMAb vaccine VO:0007632 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3968 3968 cancer vaccine Large Multivalent Immunogen (LMI) vaccine VO:0007633 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4048 4048 cancer vaccine long-peptide vaccine and mAb VO:0007634 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4066 4066 cancer vaccine mAb PC61 and DC/tumor fusion vaccine VO:0007635 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4005 4005 cancer vaccine MAGE-A12:170-178 vaccine VO:0007636 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4059 4059 cancer vaccine MAGE-A3 + AS15 vaccine VO:0007637 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4039 4039 cancer vaccine MAGE-A3-genetically modified lymphocyte vaccine VO:0007638 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4065 4065 cancer vaccine MCMV-TRP2 vaccine VO:0007639 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4046 4046 cancer vaccine mCRT-vGPCR-coated whole-cell vaccine VO:0007640 Jie Zheng Oliver He Melacine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3996 3996 cancer vaccine Melacine vaccine VO:0007641 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3985 3985 cancer vaccine Melan-A/Mart-1 vaccine VO:0007642 Jie Zheng Oliver He Melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3979 3979 cancer vaccine melanoma-specific Melan-A/Mart-1 peptide + virus-like nanoparticles vaccine VO:0007643 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5412 5412 cancer vaccine modified Vaccinia virus ankara vaccine expressing p53 VO:0007644 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4068 4068 cancer vaccine mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs vaccine VO:0007645 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5224 5224 cancer vaccine multi-epitope folate receptor alpha-loaded dendritic cell vaccine VO:0007646 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4063 4063 cancer vaccine Multipeptide melanoma vaccine VO:0007647 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4030 4030 cancer vaccine Oral Bacille Calmette-Guerin for malignant melanoma vaccine VO:0007648 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3983 3983 cancer vaccine OVA-TEXO vaccine VO:0007649 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4032 4032 cancer vaccine procarbazine, dactinomycin, velba vaccine VO:0007650 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4031 4031 cancer vaccine Pulmonary BCG immunotherapy for malignant melanoma vaccine VO:0007651 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6075 6075 cancer vaccine RIPO(H3.3) vaccine VO:0007652 Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=4011 4011 cancer vaccine alpha-GalCer-loaded tumor-cell vaccine VO:0007653 A cancer that is caused by human papillomavirus (HPV) infection. HPV infection can lead to six types of cancer including anal, cervical, oropharyngeal, penile, vaginal, and vulvar cancer. placeholder, will send new term requst to DOID Anna Maria Masci Jie Zheng Xingxian Li https://github.com/vaccineontology/VO/issues/677 disposition HPV associated cancer VO:0007654 An infection that has as part organisms of the human papillomavirus (HPV). Jie Zheng https://github.com/vaccineontology/VO/issues/677 material entity HPV infection VO:0007655 Either a tumor-specific or a tumor-associated antigen. Anna Maria Masci Barry Smith Jie Zheng Oliver He https://github.com/vaccineontology/VO/issues/677 material entity tumor antigen VO:0007656 Cancer vaccine that prevents cancer formation and development. Anna Maria Masci Barry Smith Jie Zheng Oliver He https://github.com/vaccineontology/VO/issues/677 cancer vaccine preventive cancer vaccine VO:0007657 Cancer vaccine that aims to eliminate or control tumor cells. Anna Maria Masci Barry Smith Jie Zheng Oliver He https://github.com/vaccineontology/VO/issues/677 cancer vaccine therapeutic cancer vaccine VO:0007658 A cancer vaccine that uses whole cells to deliver cancer antigen(s). Oliver He PMID:22595050 https://github.com/vaccineontology/VO/issues/683 cancer vaccine whole cell cancer vaccine VO:0007659 A whole cell cancer vaccine that uses whole tumor cells to deliver cancer antigen(s). Jie Zheng Oliver He PMID:37355722 https://github.com/vaccineontology/VO/issues/683 cancer vaccine whole tumor cell cancer vaccine VO:0007660 A cancer vaccine that is composed of a plasmid vaccine vector (a circular double stranded DNA molecule) containing the whole of parts of genes encoding one or more vaccine antigen proteins. Jie Zheng cancer vaccine DNA cancer vaccine VO:0007661 A cancer vaccine made with T cells genetically engineered to express anti-GD2 Chimeric Antigen Receptor to treat patients with children and young adults with GD2+ solid tumors, including neuroblastoma. The T cells may have an antitumor effect. They can be used in combination with AP1903 and Cyclophosphamide. (NCT02107963) There are increased CXCR3- classical monocytes in patients as CAR-T numbers waned. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02107963 PMID:38134936 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6381 6381 cancer vaccine GD2-CAR vaccine VO:0007662 A cancer vaccine used to treat patients with small cell lung cancer by using several components (small cell lung cancer targets) that have been tested individually in patients with small cell lung cancer or other cancers (GD2, GD3, Globo H, Fucosyl GM1 and N-propionylated polysialic acid) so that the body will make antibodies to the vaccine which will also react against the cancer. Two other substances (KLH and OPT-821) are added which boost the immune system. Vaccination with the pentavalent KLH conjugate vaccine may induce production of IgG and IgM antibodies as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing any of these antigens. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C97034 NCT: https://clinicaltrials.gov/study/NCT01349647 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6275 2524 2583 6489 8705 6275 cancer vaccine Gene name: GD 2 Gene name: GD3 Gene name: Globo H Gene name: fucosyl GM1 GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH conjugate vaccine VO:0007663 A cancer vaccine made with HLA class I-matched allogeneic human prostate carcinoma cells that are genetically engineered to secrete interleukin-2 and interferon gamma for patients with prostate carcinoma. Interleukin-2 may stimulate a person's white blood cells including natural killer cells to kill prostate cancer cells. Interferon gamma may interfere with the growth of the cancer cells. Combining interferon gamma with interleukin-2 may be a more effective treatment for prostate cancer. Hayleigh Kahn Jie Zheng genetically engineered allogeneic prostate carinoma cells secreting interleukin-2 and interferon gamma NCT: https://clinicaltrials.gov/study/NCT00002637 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6292 3458 3558 6292 cancer vaccine Gene name: IL2 Gene name: Interferon gamma genetically engineered allogeneic prostate carinoma cells secreting interleukin-3 and interferon gamma vaccine VO:0007664 A cancer vaccine comprised of K562 cells transfected with the granulocyte macrophage-colony stimulating factor (GM-CSF) gene with potential immunopotentiating properties. This vaccine may stimulate the host immune system to produce an antitumoral T-lymphocyte response, thereby inhibiting tumor growth. A cultured cell line is genetically changed to secrete GM-CSF mixed with irradiated leukemia cells obtained from a patient. Vaccines made from gene-modified cancer cells may help the body build an effective immune response to kill cancer cells. Imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving vaccine therapy together with imatinib mesylate may be an effective treatment for chronic myelogenous leukemia. The vaccine can also be combined with stem cell transplantation. The vaccine may induce an immune response to common myeloid antigens (e.g., Wilms' tumor-1 [WT-1], survivin, or proteinase-3) in patients with Myelodysplastic Syndrome. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C52190 NCT: https://clinicaltrials.gov/study/NCT00301093 NCT: https://clinicaltrials.gov/study/NCT00361296 NCT: https://clinicaltrials.gov/study/NCT00442130 NCT: https://clinicaltrials.gov/study/NCT00809250 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6293 1437 6293 cancer vaccine Gene name: GM-CSF GM-K562 cell vaccine VO:0007665 A cancer vaccine composed of irradiated tumor cells transduced with granulocyte-macrophage colony-stimulating factor (GM-CSF) and CD40-ligand (CD40L) genes. The vaccine may stimulate an anti-tumoral dendritic cell-mediated host immune response. Universal GM-CSF-producing and CD40L-expressing bystander cell line is used to form an autologous tumor cell-based vaccine for patients with mantle cell lymphoma in order to make the body build an effective immune response to kill cancer cells. It can be used in combination with Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Dexamethasone, and IL-2. The vaccine can be done with bystander and autologous tumor cells for patients with malignant melanoma. It can also be combined with lenalidomide for patients with myelodysplastic syndrome (MDS). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00840931 NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C48391 NCT: https://clinicaltrials.gov/study/NCT00101101 NCT: https://clinicaltrials.gov/study/NCT00101166 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6271 959 6271 cancer vaccine Gene name: CD40LG GM.CD40L cell vaccine VO:0007666 A cancer vaccine using dendritic cells (a kind of white blood cell) as a vaccine could stimulate your own immune system to react to your melanoma cells. Autologous dendritic cells are pulsed with 2 gp100 melanoma peptides (G209-2M and G280-9V) plus up to an additional 10 unique melanoma tumor-specific peptides. Patients also receive cyclophosphamide 300mg/m2 IV in order to deplete regulatory T cells. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00683670 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6308 6490 6308 cancer vaccine Gene name: gp100 gp100 mature dendritic cell vaccine VO:0007667 A cancer vaccine that uses irradiated, adenovirus transduced autologous myeloblasts to secrete granulocyte-macrophage colony-stimulating factor (GVAX) early after allogeneic hematopoietic stem cell transplantation (HSCT) to induce potent immune responses. The vaccine may prevent advanced myelodysplastic syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), or acute myeloid leukemia (AML) from relapsing after stem cell transplant. The patients own cancer cells are engineered to produce a protein called GM-CSF, which can be effective in stimulating a powerful immune response specific to that cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01773395 PMID:34807983 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6385 1437 6385 cancer vaccine Gene name: GM-CSF GVAX leukemia vaccine VO:0007668 A cancer vaccine composed of a peptide derived from histone H3.3 containing the amino acid substitution mutation lysine (Lys) 27-to-methionine (H3.3K27M), with potential immunoactivating and antineoplastic activities. Following the administration of the vaccine, the immune system may exert a cytotoxic T-lymphocyte (CTL)-mediated immune response against H3.3K27M-expressing tumor cells. A lysine 27-to-methionine (K27M) somatic mutation at histone H3 variant (H3.3) is a feature mutation in diffuse intrinsic pontine gliomas (DIPGs). This vaccine contains an H3.3-K27M targeted neoantigen peptide that can be taken up by antigen-presenting cells (APCs). APCs can present the peptide with the major histocompatibility complex (MHC) molecules on cell surface, thereby activating neoantigen-specific T cells and triggering corresponding cytotoxic T cell immune responses to eliminate H3.3-K27M-expressing DIPG cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C132684 NCT: https://clinicaltrials.gov/study/NCT04749641 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6295 6295 cancer vaccine H3.3K27M-specific peptide vaccine VO:0007669 A cancer vaccine comprised of HER-2-neu and carcinoembryonic antigen synthetic (CEA) peptides, combined with the adjuvants granulocyte-macrophage colony stimulating factor (GM-CSF), and Montanide ISA-51 with potential antineoplastic activity. The vaccine may stimulate a cytotoxic T-cell response against HER-2-neu- and CEA-expressing tumor cells. Vaccines made from peptides may make the body build an immune response to kill tumor cells. This vaccine is compromised of HER-2-neu and carcinoembryonic antigen synthetic peptides, sargramostim (GM-CSF), and Montanide ISA-51, and aims to cause an immune response in patients with stage IIB, III, or IV colorectal cancer. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C48392 NCT: https://clinicaltrials.gov/study/NCT00091286 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6294 1048 2064 6294 cancer vaccine Gene name: HER-2-neu Gene name: carcinoembryonic antigen HER-2-neu, CEA peptides, GM-CSF, montanide ISA-51 vaccine VO:0007670 A cancer vaccine made from peptides that may help the body build an effective immune response to kill tumor cells. Patients with HER2 positive locally advanced breast cancer can be vaccinated with a HER2 Intracellular Domain (ICD) peptide-based vaccine administered concurrently with trastuzumab. The vaccine may lead to an immune response (HER2 specific T cell immunity and/or the development of intramolecular epitope spreading). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00343109 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6352 2064 6352 cancer vaccine Gene name: HER-2/neu HER2 ICD peptide vaccine VO:0007671 A cancer vaccine for vaccination with neoantigens that can both expand pre-existing neoantigen-specific T-cell populations and induce a broader repertoire of new T-cell specificities in cancer patients, tipping the intra-tumoural balance in favour of enhanced tumour control. The vaccine targets up to 20 predicted personal tumour neoantigens. The vaccine induced CD4+ and CD8+ T cells responses. These T cells discriminated mutated from wild-type antigens, and in some cases directly recognized autologous tumour. Hayleigh Kahn Jie Zheng PMID:28678778 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6377 3123 6377 cancer vaccine Gene name: HLA HLA neoantigen vaccine VO:0007672 A cancer vaccine made from a person's white blood cells mixed with tumor proteins (HLA-A1- and HLA-A2.1-restricted peptides derived from melanoma-associated tumor antigens) and CD40-ligand, and may make the body build an immune response to kill tumor cells. This is combined with denileukin diftitox, which Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00056134 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6283 3105 959 6283 cancer vaccine Gene name: CD40L Gene name: HLA-A HLA-A1, HLA-A2, and CD40-ligand pulsed dendritic cell vaccine VO:0007673 A cancer vaccine consisting of Hodgkin lymphoma cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene with potential antineoplastic activity. Hodgkin antigens-GM-CSF-expressing cell vaccine may stimulate a cytotoxic T-lymphocyte (CTL) immune response against Hodgkin lymphoma-associated antigens, which may result in the lysis of tumor cells expressing these antigens. Also, transfected Hodgkin lymphoma cells secrete GM-CSF, which may potentiate the CTL response against Hodgkin lymphoma-associated antigens. Vaccines made from a tumor antigen may help the body build an effective immune response to kill tumor cells. This vaccine contains cells expressing Hodgkin's antigens and GM-CSF, and could cause an immunological response in Hodgkin's lymphoma patients. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C61592 NCT: https://clinicaltrials.gov/study/NCT00478062 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6296 6296 cancer vaccine hodgkin's antigens-GM-CSF-expressing cell vaccine VO:0007674 A cancer vaccine consisting of a recombinant, attenuated, replication-incompetent form of the Semliki Forest Virus (SFV) vector encoding the viral oncoproteins E6 and E7 derived from the human papillomavirus (HPV), with potential immunomodulating and antineoplastic activities. The vaccine induces expression of the E6/E7 proteins and stimulates both the innate and the adaptive immune system, resulting in a potent cytotoxic T-lymphocyte (CTL) response against and lysis of tumor cells expressing HPV E6 and E7. The vaccine may help to treat patients with a history of (pre) malignant cervical lesions. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148539 NCT: https://clinicaltrials.gov/study/NCT03141463 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6369 1489078 1489079 6369 cancer vaccine Gene name: E6 Gene name: E7 HPV E6/E7-encoding semliki forest virus vaccine Vvax001 VO:0007675 A cancer vaccine composed of irradiated allogeneic breast cancer cell lines (HAB-1 and HAB-2) that have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine alpha (1,3) GT gene. The immune response to the foreign substance could stimulate the immune system to attack the patient's own cancer cells that have similar proteins without this sugar pattern, causing the tumor to remain stable or shrink. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00090480 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6297 14594 6297 cancer vaccine Gene name: Ggta1 hyperacute - breast cancer vaccine VO:0007676 A cancer vaccine composed of irradiated allogeneic melanoma cell lines (HAM-1, HAM-2 and HAM-3). These cell lines have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine alpha(1,3)GT gene, a mouse gene that causes the production of a foreign pattern of protein-sugars on the cell surface. The immune response to the foreign substance could stimulate the immune system to attack the patient's own cancer cells that have similar proteins without this sugar pattern, causing the tumor to remain stable or shrink. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00300612 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6298 14594 6298 cancer vaccine Gene name: Ggta1 hyperacute-melanoma vaccine VO:0007677 A cancer vaccine composed of irradiated allogeneic prostate cancer cell lines (HAP-1 and HAP-2) that have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine alpha (1,3) GT gene, a mouse gene that causes the production of a foreign pattern of protein-sugars on the cell surface. It is hoped that the immune response to the foreign substance will stimulate the immune system to attack the patient's own cancer cells that have similar proteins without this sugar pattern, causing the tumor to remain stable or shrink.. The expression of the murine alpha (1,3) galactosyltransferase [alpha (1,3) GT] gene results in the cell surface expression of alpha (1,3) galactosyl-epitopes (alpha-gal) on membrane glycoproteins and glycolipids. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00105053 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6299 14594 6299 cancer vaccine Gene name: Ggta1 hyperacute-prostate cancer vaccine VO:0007678 A cancer vaccine derived from the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO) with potential immunomodulating and antineoplastic activities. It may activate the immune system to induce an immune response against IDO-expressing tumor cells, which may restore the proliferation and activation of various immune cells including cytotoxic T-lymphocytes (CTLs), natural killer cells (NKs), and dendritic cells (DCs), and may eradicate IDO-expressing tumor cells through a CTL-mediated response. This vaccine, using a small fragment of IDO, can be used in combination with either Ipilimumab or Vemurafenib to treat malignant melanoma that has metastasized. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C159498 NCT: https://clinicaltrials.gov/study/NCT02077114 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6368 3620 6368 cancer vaccine Gene name: IDO IDO peptide vaccine VO:0007679 A cancer vaccine compromised of melanoma peptides plus GM-CSF-in-adjuvant. It is combined with low-dose IL-2 therapy, which could significantly enhance the immunologic efficacy. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00928902 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6312 6312 cancer vaccine IL-2 peptide and GM-CSF-in-adjuvant melanoma vaccine VO:0007680 A cancer vaccine made with autologous dendritic cells that are manufactured with GM-CSF, IL15 and loaded with melanoma/HIV peptides and KLH; then activated with LPS and CD40 Ligand.IL15 is a T cell growth factor that could have a very important role in cancer immunotherapy. IL15 DCs are particularly efficient at priming functional melanoma specific CD8+ T cells. The use of IL15 in the manufacture of the DC vaccine could result in an improved immunotherapy product for melanoma patients. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01189383 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6300 3600 6300 cancer vaccine Gene name: IL15 IL15-DC vaccine VO:0007681 A cancer vaccine that could teach T-cells to detect and kill cancer cells better. Intracel KLH is given without adjuvant subcutaneously and with Tetanus Toxoid 0.5 ml intramuscularly. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00000105 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6302 6302 cancer vaccine intracel KLH vaccine VO:0007682 A cancer vaccine made with dendritic cells pulsed with KLH and tumor lysate for patients with neuroblastoma. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02745756 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6303 6303 cancer vaccine KLH and tumor lysate pulsed DC vaccine VO:0007683 A cancer vaccine made of tumor protein taken from a cancer patient's plasma (liquid part of the blood) and KLH (a protein designed to increase the immune response of the vaccine). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01174082 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6259 6259 cancer vaccine KLH-id vaccine VO:0007684 A cancer vaccine made with autologous dendritic cells pulsed with KLH for this vaccination, combined with radiation or a gene therapy agent, TNFerade. TNFerade or radiation serves to generate cell death stimulating the immune response. The dendritic cell vaccine may direct a distant and lasting effective anti-tumor immune response to achieve a local and systemic clinical benefit. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00868114 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6304 6304 cancer vaccine KLH-pulsed autologous dendritic cell vaccine VO:0007685 A cancer vaccine used alone or in combination with PD-1 inhibitor in patients with advanced solid tumors with KRAS mutation (G12C, G12D, or G12V) and HLA type HLA-A11:01 or HLA C08:02. The vaccine is a lipid nanoparticle (LNP)-formulated mRNA-based cancer vaccine that targets the most commonly occurring KRAS mutations (G12D, G12V, and G12C). The mRNA-derived KRAS-targeted vaccine V941 (mRNA-5671) is taken up and translated by antigen presenting cells (APCs). Following translation, the epitopes are presented via major histocompatibility complex (MHC) molecules on the surface of the APCs. This leads to an induction of both cytotoxic T-lymphocyte (CTL)- and memory T-cell-dependent immune responses that specifically target and destroy tumor cells harboring these specific KRAS mutations. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C162186 NCT: https://clinicaltrials.gov/study/NCT05202561 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6348 3845 6348 cancer vaccine Gene name: KRAS KRAS-targeted mRNA vaccine VO:0007686 A cancer vaccine made with Epstein Barr Virus (EBV)-derived tumor antigen, Latent Membrane Protein-2 (LMP2)-loaded dendritic cell (DC) vaccines are administered alone or co-administered with the TLR9 ligand, DUK-CPG-001, in patients with EBV+ lymphoma in the setting of autologous stem cell transplant with infusion of mature T cells. It may induce EBV derived tumor antigen specific CD8+ T cell response in patients with EBV+ lymphoma in the setting of autologous stem cell transplant. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02115126 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6305 10376 5698 6305 cancer vaccine Gene name: EBV Gene name: LMP2 LMP2A-loaded conventional DC vaccine VO:0007687 A cancer vaccine comprised of multiple peptides derived from MAGE-1A, Her-2/neu, and folate binding protein (FBP), with potential immunostimulating and antineoplastic properties. The MAGE-A1, Her-2/neu, FBP peptides cancer vaccine includes the peptides MAGE-A1:161-169, FBP:191-199, Her-2/neu:369-377, MAGE-A1:96-104, and Her-2/neu:754-762. Vaccination with this cancer vaccine may activate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing the corresponding antigens, resulting in tumor cell lysis. The vaccine compromises synthetic ovarian cancer-associated peptides administered with a synthetic tetanus toxoid helper peptide emulsified in Montanide ISA-51 before or after paclitaxel and carboplatin in patients with stage III-IV ovarian epithelial, primary peritoneal cavity, or fallopian tube cancer undergoing optimal cytoreductive surgery. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving vaccine therapy and chemotherapy after surgery may kill any tumor cells that remain after surgery. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C62775 NCT: https://clinicaltrials.gov/study/NCT00373217 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6306 2064 2348 4100 6306 cancer vaccine Gene name: FBP Gene name: HER2-neu Gene name: MAGE-A1 MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine VO:0007688 A cancer vaccine made with autologous dendritic cells (DC) are transduced with the MART-1, tyrosinase and MAGE-A6 (melanoma associated antigens, MAA) genes for melanoma patients. Some patients also receive interferon-alfa 2b (IFN) intravenously. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01622933 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6280 2315 4105 7299 6280 cancer vaccine Gene name: MAGE-A6 Gene name: MART-1 Gene name: tyrosinase MART-1, tyrosinase and MAGE-A6 autologous DC vaccine VO:0007689 A cancer vaccine that may elicit a cytotoxic T-cell (CTL) response against cancer cells. Autologous dendritic cells are pulsed with melanoma tumor-specific peptides. The mature dendritic cell (mDC3/8) vaccine (primer and booster) in patients with stage III and stage IV melanoma is followed by treatment with pembrolizumab (anti-PD-1 therapy). Using dendritic cells (a kind of white blood cell) as a vaccine could stimulate your own immune system to react to your melanoma cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C162250 NCT: https://clinicaltrials.gov/study/NCT03092453 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6307 6307 cancer vaccine mature dendritic cell melanoma vaccine VO:0007690 A cancer vaccine made up of two peptides that are pieces of a bigger melanoma protein (gp100). These peptides bind to HLA-A2 which is then recognized by T cells. It could be given in combination with MDX-010 (ipilimumab, BMS-734016). MDX-010 (anti-CTLA4) antibodies are designed to keep the immune system running by blocking CTLA-4 from down-regulating T cell activation. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00094653 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6309 6490 6309 cancer vaccine Gene name: gp100 MDX-1379 (gp100) melanoma peptide vaccine VO:0007691 A cancer vaccine composed of CTLA-4 antibody; tyrosinase, gp100, and MART-1 peptides; and incomplete Freund's adjuvant (IFA) with or without interleukin-12 in patients with resected stage III or IV melanoma. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00028431 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6310 2315 6490 7299 6310 cancer vaccine Gene name: MART-1 Gene name: gp100 Gene name: tyrosinase MDX-CTLA4 antibody/tyrosinase/gp100/MART-1 melanoma vaccine VO:0007692 A cancer vaccine consisting of peptides derived from melanoma-associated antigens and an adjuvant peptide derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing melanoma-associated antigens, resulting in tumor cell lysis. Vaccines made from peptides may make the body build an immune response to kill tumor cells. Vaccines using melanoma peptides from cytotoxic T cells and helper T cells could work in treating patients with metastatic melanoma. This vaccine contains 12 melanoma peptides restricted by Human Leukocyte Antigen (HLA)-A1, -A2, or -A3 and 6 melanoma helper peptides restricted by HLA-DR molecules emulsified with sargramostim (Granulocyte-macrophage colony-stimulating factor, GM-CSF) and Montanide ISA-51 or Montanide ISA-51 VG (ISA-51). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38700 NCT: https://clinicaltrials.gov/ct2/show/NCT00071981 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6311 6311 cancer vaccine melanoma helper peptide vaccine VO:0007693 A cancer vaccine containing a mixture of killed bacteria with potential immunostimulatory and antineoplastic activities. Mixed bacteria vaccine (MBV or Coley's toxins) consists of a pyrogenic bacterial lysate derived from Serratia marcescens and Streptococcus pyogenes; the active components in the lysate may be lipopolysaccharide (LPS), a component of the Gram-negative bacterial cell wall of Serratia, and streptokinase, an enzyme produced by Streptococcus pyogenes. LPS has been shown to stimulate the host humoral immune response and induce the release of various antitumor cytokines such as tumor necrosis factor (TNF) and interleukin-12 (IL-12). The mixed bacteria vaccine (MBV) is administered at a starting dose of 250 EU (1 µL) and escalated in each patient to a dose inducing the desired pyrogenic effect, defined as a body temperature of 38°C to 39.5°C. It is given to patients with malignant tumors that expressed the NY-ESO-1 antigen. It is designed to induce immunological effects and tumor response following vaccination. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C74063 NCT: https://clinicaltrials.gov/study/NCT00623831 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6314 6314 cancer vaccine mixed bacterial cancer vaccine VO:0007694 A cancer vaccine with or without PD-1/L1 may help treat patients with advanced gastric cancer. A personalized mRNA tumor vaccine encoding neoantigen may also help treat patients with advanced esophageal squamous carcinoma, gastric adenocarcinoma, pancreatic adenocarcinoma and colorectal adenocarcinoma. The vaccine can also be used in combination with PD-1 for the treatment of advanced solid tumors. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03468244 NCT: https://clinicaltrials.gov/study/NCT05227378 NCT: https://clinicaltrials.gov/study/NCT05359354 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6328 6328 cancer vaccine mRNA neoantigen tumor vaccine VO:0007695 A cancer vaccine made with dendritic cells (DCs) pulsed with mRNA encoded tumor antigens. These personalized cell vaccines may lead to antitumor specific T cell responses. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02808416 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6339 6339 cancer vaccine mRNA tumor antigen DC vaccine VO:0007696 A cancer vaccine targeting up to fifteen tumor-associated antigens (TAAs) that are specifically expressed by a patient's cancer cells, with potential immunostimulatory and antineoplastic activities. Up to fifteen neoantigen epitopes are incorporated in a proprietary formulation designed to maximize mRNA delivery and minimize mRNA-triggered immune responses. The mRNA-based PCV NCI-4650 is taken up and the mRNAs are translated by antigen presenting cells (APCs). Then, the expressed epitopes are presented via major histocompatibility complex (MHC) molecules on the surface of the APCs. This induces both cytotoxic T-lymphocyte (CTL)- and memory T-cell-dependent immune responses that specifically target and destroy the patient's cancer cells that express these neoantigens. Exome sequencing can identify certain gene mutations in a person's tumor. This can then be used to create cancer treatments. This mRNA vaccine might cause certain tumors to shrink. Immunogenic neoantigens and can predict for neoantigens binding the patient human leukocyte antigen (HLA) molecules from melanoma or epithelial cancer patients and use these epitopes for a personalized therapeutic messenger ribonucleic acid (mRNA) vaccine. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148239 NCT: https://clinicaltrials.gov/study/NCT03480152 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6324 6324 cancer vaccine mRNA-based personalized cancer vaccine NCI-4650 VO:0007697 A cancer vaccine consisting of autologous monocytes loaded with mRNA encoding the human cytomegalovirus (CMV) matrix protein pp65 (65 kDa lower matrix phosphoprotein; UL83) as a fusion protein with the lysosome-associated membrane protein (LAMP), with potential immunostimulatory and antineoplastic activities. The autologous CMV-pp65-LAMP mRNA loaded monocyte vaccine MT-201-GBM exposes the immune system to the CMV pp65 peptide, which may elicit a cytotoxic T-lymphocyte (CTL) response against CMV pp65-expressing tumor cells. The incorporation of LAMP may route CMV pp-65 antigens into the lysosomal compartment, resulting in enhanced MHC class II antigen presentation, thereby promoting CD4-positive T-cell responses. MT-201-GBM (pp65CMV antigen monocytes) are administered to patients newly diagnosed with a type of brain tumor called glioblastoma (GBM) that has an unmethylated MGMT (O[6]-methylguanine-DNA methyltransferase) (MGMT) gene promoter. The vaccine is made from a type of immune cell called monocytes, which have been engineered to express a cytomegalovirus (CMV) protein. Patients also receive standard radiation therapy combined with temozolomide. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C179670 NCT: https://clinicaltrials.gov/study/NCT04741984 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6315 6315 cancer vaccine MT-201-GBM monocyte vaccine VO:0007698 A cancer vaccine containing mucus 1 (MUC1) peptide and the adjuvant poly-ICLC with potential immunostimulatory and antineoplastic activities. MUC1 peptide-poly-ICLC adjuvant vaccine may induce the host immune system to mount a cytotoxic T cell response against MUC1-expressing tumor cells. MUC1 peptide-poly-ICLC adjuvant vaccine in boosting systemic immunity to MUC1 in women with stage I-III 'triple-negative' [i.e., ER(-) PR(-) HER2/neu(-)] breast cancer. MUC1 peptide-Poly-ICLC vaccine could also work in preventing lung cancer in current and former smokers at high risk for lung cancer. Vaccines made from peptides may help the body build an effective immune response to kill cells. MUC1 peptide-Poly-ICLC vaccine may stimulate the body's immune system and slow or stop the changes from normal to pre-cancer to cancer. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C82417 NCT: https://clinicaltrials.gov/study/NCT00986609 NCT: https://clinicaltrials.gov/study/NCT03300817 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6316 4582 6316 cancer vaccine Gene name: MUC-1 MUC1 peptide-poly-ICLC vaccine VO:0007699 A cancer vaccine comprised of four peptides derived from the tumor-associated antigen (TAA) HER-2/neu (ErbB-2), with potential immunomodulating and antineoplastic activities. The four peptides may induce a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing the HER-2/neu antigen, which may result in the inhibition of proliferation in Her-2/neu-expressing tumor cells. TPIV100 is a type of vaccine made from HER2 peptide that may help the body build an effective immune response to kill tumor cells that express HER2. Sargramostim increases the number of white blood cells in the body following chemotherapy for certain types of cancer and is used to alert the immune system. TPIV100 and sargramostim could work in treating patients with HER2 positive, stage II-III breast cancer. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C173525 NCT: https://clinicaltrials.gov/study/NCT04197687 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6317 2064 6317 cancer vaccine Gene name: HER2 multi-epitope HER2 peptide vaccine TPIV100 VO:0007700 A cancer vaccine consisting of a combination of peptides derived form several melanoma epitopes. Vaccination with multi-epitope melanoma peptide vaccine stimulates the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing the corresponding antigens, resulting in tumor cell lysis. This vaccine may stimulate a broader CTL response compared to single-antigen vaccines. Vaccines made from melanoma peptides or antigens may help the body build an effective immune response to kill tumor cells in patients with stage IIC-IV melanoma. This vaccine is a tyrosinase/gp100/MAGE-3 class I peptide vaccine combined with Montanide ISA 51 or ISA 51 VG with CpG adjuvant 7909 in human leukocyte antigen (HLA) class I A1, A3 or A11 and B44 matched patients with surgically resected stages IIC, III and IV melanoma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38695 NCT: https://clinicaltrials.gov/study/NCT00085189 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6318 3105 3106 4102 6490 7299 6318 cancer vaccine Gene name: HLA-A Gene name: HLA-B Gene name: MAGE-A3 Gene name: gp100 Gene name: tyrosinase multi-epitope melanoma peptide vaccine VO:0007701 A cancer vaccine for which Advanced Renal Cell Carcinoma patients undergo total nephrectomy to harvest primary tumor for vaccine preparation. Dendritic cells are then pulsed with multiantigens or tumor cells. Some patients also receive vaccination with irradiated autologous tumor lysate. The vaccine may make the body build an immune response to kill tumor cells. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00004880 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6284 6284 cancer vaccine multiantigen liposome loaded dendritic cell vaccine VO:0007702 A cancer vaccine adjuvant and synthetic Toll-like receptor (TLR) type 1 and 2 ligand composed of a lipopeptide containing a water-soluble derivative of Pam3-Cys, the biologically active component of the mycobacterial 19 kDa lipoprotein of mycobacteria, that is covalently linked to a synthetic peptide (GDPKHPKSF), with potential immunostimulating activity. TLR1/2 agonist Pam3Cys-GDPKHPKSF targets, binds to and activates TLR1/2, which induces CD8- and T-helper 1 CD4-positive T-cell responses. This may enhance T-cell-mediated immune responses when administered together with peptide vaccine. A multi-peptide vaccine can be used in combination with the TLR1/2 ligand XS15 in CLL patients undergoing ibrutinib-based regimes. Applying several CLL-associated antigens simultaneously increases the likelihood that a multi-clonal, broad and at the same time highly specific T-cell response is mounted, thereby preventing potential tumor escape mechanisms. The novel TLR1/2 ligand (XS15, developed in Tübingen) that (i) is water-soluble and (ii) GMP-amenable, (iii) non-toxic and (iv) effective in inducing T cells specific for peptides in vivo. A personalized multi-peptide vaccination can also be used in combination with the TLR1/2 ligand XS15 for individual patients with advanced solid and hematological malignancies without any approved treatment options. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C179595 NCT: https://clinicaltrials.gov/study/NCT04688385 NCT: https://clinicaltrials.gov/study/NCT05014607 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6319 7096 7097 6319 cancer vaccine Gene name: TLR1 Gene name: TLR2 multipeptide XS15 vaccine VO:0007703 A cancer vaccine that can efficiently present T cells with antigens of HCC sensitize their antitumor properties meanwhile low dose cyclophosphamide (CY) can effectively improve the microenvironment of immunity. Multiple signals loaded dendritic cells vaccine combined low dose of cyclophosphamide combining with radical surgery or TACE or targeted agents for patients with hepatocellular carcinoma coul prolong their survival time. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT04317248 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6320 6320 cancer vaccine multiple signals loaded dendritic cells vaccine VO:0007704 A cancer vaccine with neopeptides designed with single amino acid mutations to enhance their immunogenicity and bind to HLA class I and II molecules. Exome and RNA sequencing as well as in silico HLA-binding predictions to autologous HLA molecules were used to identify candidate neopeptides. Subsequently, in silico HLA-anchor placements were used to deduce putative T-cell receptor (TCR) contacts of peptides. Single amino acids of TCR contacting residues were then mutated by amino acid replacements. TIL-derived CD4+ T-cell clones showed strong responses and tumor cell lysis not only against the designed neopeptide but also against the unmutated natural peptides of the tumor. Turning tumor self-peptides into foreign antigens by introduction of designed mutations is a promising strategy to induce strong intratumoral CD4+ T-cell responses in a cold tumor like glioblastoma. Hayleigh Kahn Jie Zheng PMID:36228153 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6383 3123 6383 cancer vaccine Gene name: HLA mutated neopeptide vaccine VO:0007705 A cancer vaccine consisting of a proprietary version of the recombinant vaccinia viral vector, modified vaccinia Ankara-Bavarian Nordic (MVA-BN), encoding both the two human tumor-associated antigens (TAAs) carcinoembryonic antigen (CEA) and mucin-1 (MUC-1), and TRICOM, which is comprised of the three human immune-enhancing co-stimulatory molecules B7-1, ICAM-1 and LFA-3, with potential immunostimulatory and antineoplastic activities. MVA-BN-CV301, followed by multiple boosting doses of the fowlpox virus (FPV) vaccine CV301 may lead to a cytotoxic T-lymphocyte (CTL) response against CEA- and MUC-1-expressing tumor cells is activated. In addition, the CV301-dependent anti-tumor CTL response upregulates the expression of programmed cell death ligand 1 (PD-L1); therefore, when CV301 is combined with a programmed cell death 1 (PD-1) immune checkpoint inhibitor, the antitumor effect may be increased. CV301 is a poxviral-based vaccine comprised of recombinant Modified vaccinia Ankara (MVA-BN-CV301, prime) and recombinant fowlpox (FPV-CV301, boost). CV301 contains transgenes encoding two (2) tumor-associated antigens (TAA), mucin 1 (MUC1) and carcinoembryonic antigen (CEA), as well as three costimulatory molecules (B7.1, intercellular adhesion molecule 1 (ICAM-1) and lymphocyte function-associated antigen 3 (LFA-3), designated TRICOM). It is given in combination with SX-682 and M7824 for patients with Triple Negative Breast Cancer (TNBC) and Human papilloma virus (HPV) negative head and neck squamous cell carcinoma (HNSCC). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C143059 NCT: https://clinicaltrials.gov/study/NCT04574583 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6321 1048 3383 4582 941 965 6321 cancer vaccine Gene name: B7.1 Gene name: CEA Gene name: ICAM-1 Gene name: LFA-3 Gene name: MUC1 MVA-BN-CV301 vaccine VO:0007706 A cancer vaccine of a chimeric peptide immunogen of human epidermal growth factor-2 (HER-2) with antineoplastic property. MVF-HER-2(628-647)-CRL 1005 vaccine, coated with poloxamer CRL-1005 to form microparticles, consists of a mutated HER-2 B-cell epitope, HER-2(628-647), and a promiscuous T cell epitope (amino acid sequence 288-302) of the measles virus fusion protein (MVF). The vaccine may stimulate the host immune response to mount a cytotoxic T-lymphocyte response against tumor cells that overexpress the HER2 protein, resulting in tumor cell lysis. MVF-HER-2(628-647)-CRL 1005 vaccine may induce anti-HER-2 antibody in patients with metastatic or recurrent cancer (Breast, Ovarian, Non-small cell lung cancer, Gastric adenocarcinoma). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C2637 NCT: https://clinicaltrials.gov/study/NCT00017537 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6322 2064 6322 cancer vaccine Gene name: HER2 MVF-HER-2(628-647)-CRL 1005 vaccine VO:0007707 A cancer vaccine consisting of patient-specific mutated peptide epitopes, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. The neoantigen-based anti-cancer vaccine NEO-PV-01 stimulates the host immune system to mount a specific and potent cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. Both metastatic squamous non-small cell lung cancer (NSCLC) and extensive stage small cell lung cancer (SCLC) are incurable with current therapies, but due to mutations induced by cigarette smoke, typically express a large number of altered proteins that can be recognized as foreign by the immune system. Targeting the immune system against tumor specific antigens using a peptide vaccine could lead to improved response rate and prolonged overall survival with no additional toxicity when combined with Pembrolizumab (monoclonal antibodies that block PD-1/PD-L1 interactions) and standard of care chemotherapy. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C129935 NCT: https://clinicaltrials.gov/study/NCT03166254 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6325 6325 cancer vaccine NEO-PV-01 vaccine VO:0007708 A cancer vaccine that may enhance anti-tumor immune response in Renal Cell Carcinoma in combination with checkpoint inhibitors ipilimumab (anti-CTLA-4 antibody) and nivolumab (anti-PD-1 antibody). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03598816 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6326 6326 cancer vaccine neoantigen DNA vaccine VO:0007709 A cancer vaccine consisting of patient-specific antigens, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. The neoantigen peptide vaccine, the peptides stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. Personalized neo-antigen peptide vaccine is a product combines multiple patient specific neo-antigens. Given personalized neo-antigen peptide vaccine together with Th1 polarizing adjuvant poly ICLC may induce a polyclonal, poly-epitope, cytolytic T cell immunity against the patient's tumor. Patients also receive nivolumab. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C165508 NCT: https://clinicaltrials.gov/study/NCT05098210 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6327 6327 cancer vaccine neoantigen peptide vaccine VO:0007710 A cancer vaccine consisting of synthetic long peptides (SLPs), ranging from 20-35 amino acids in size, that are derived from two or more of the patient's tumor-specific mutant antigens (TSMAs), with potential immunostimulatory and antitumor activities. SLP vaccine may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL)-mediated immune response against the TSMAs expressed by the tumor cells. This vaccine is a optimized neoantigen synthetic long peptide (SLP) vaccines for pancreatic cancer patients following neoadjuvant chemotherapy. The neoantigen SLP vaccines will incorporate prioritized neoantigens and will be co-administered with poly-ICLC. It can be used in combination with chemoradiation with temozolomide for patients with newly diagnosed glioblastoma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C150471 NCT: https://clinicaltrials.gov/study/NCT02510950 NCT: https://clinicaltrials.gov/study/NCT05111353 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6332 6332 cancer vaccine neoantigen synthetic long peptide vaccine VO:0007711 A cancer vaccine consisting of autologous DCs loaded with immunogenic peptides derived from autologous cancer cells, with potential immunomodulating and antineoplastic activities. Vaccination with the neoantigen-loaded autologous DC vaccine stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. Neoantigens arising from the mutations of the tumor genome expressed specifically on the tumor cell instead of normal cells, suggesting that vaccines targeting neoantigens should generate a highly tumor-specific response with minimal off-target effects. Neoantigens are identified from tumor tissues from a gastric cancer, hepatocellular carcinoma, lung cancer or colorectal cancer patient. Dendritic cells are then primed with synthesized peptides. The vaccine can be combined with microwave ablation ti treat patients with Hepatocellular Carcinoma (HCC). It can also be combined with Anti-PD1 (Nivolumab) as for patients with resected Hepatocellular Carcinoma (HCC) and Liver Metastases From Colorectal Cancer (CRLM). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03871205 NCT: https://clinicaltrials.gov/study/NCT04147078 NCT: https://clinicaltrials.gov/study/NCT04912765] NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C141422 NCT: https://clinicaltrials.gov/study/NCT03674073 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6281 6281 cancer vaccine neoantigen-loaded autologous dendritic cell vaccine VO:0007712 A cancer vaccine that is made from the subject's blood cells and is designed to interact in the patient's body with cells that are programmed to fight specific tumor proteins NY-ESO-1, Melanoma Antigen Gene-A1 (MAGE-A1) and Melanoma Antigen Gene-A3 (MAGE-A3). The vaccine can be given in combination with decitabine which may increase the amount and activity of these cancer proteins on the surface of tumor cells to increase the possibility that the vaccine will stimulate cells to act against the tumor cells. The dendritic cells may stimulate CD4 and CD8 antigen specific T cells in patients with relapsed or refractory pediatric high grade gliomas, medulloblastomas, and central nervous system primitive neuroectodermal tumors (CNS PNETs). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02332889 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6367 1485 4100 4102 6367 cancer vaccine Gene name: MAGE-A1 Gene name: MAGE-A3 Gene name: NY-ESO-1 NY-ESO-1, MAGE-A1, and MAGE-A3 dendritic cell vaccine VO:0007713 A cancer vaccine comprised of synthetic peptides derived from the cancer-testis antigen NY-ESO-1, preferentially expressed antigen in melanoma (PRAME), human melanoma antigen A3 (MAGE-A3) and the human Wilms tumor protein-1 (WT-1), with potential immunostimulating and antineoplastic activities. NY-ESO-1/PRAME/MAGE-A3/WT-1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing NY-ESO-1, PRAME, MAGE-A3 and WT-1, resulting in tumor cell lysis. As proteins are degraded in cells, peptides are presented on the surface of these cells as a complex with tissue type molecules (HLA molecules). T-cells may then recognize the peptide-HLA complexes, via its T-cell receptor, potentially resulting in tumor-cell killing, if sufficient priming takes place. Cancer testis antigens (CTA's) are known to be immunogenic and are only expressed at immunoprivileged sites, thus out of reach of immune responses, and on cancer cells, making them ideal targets for therapeutic cancer vaccination. The CTA's chosen were NY-ESO-1, MAGE-A3 and PRAME. WT-1 is additionally included as this protein has proven to be an important antigen in hematological malignancies. It is combined with azacitidine for treatment of patients with high-risk myelodysplastic syndrome or acute myeloid leukemia. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C127125 NCT: https://clinicaltrials.gov/study/NCT02750995 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6329 1485 23532 4102 7490 6329 cancer vaccine Gene name: MAGE-A3 Gene name: NY-ESO-1 Gene name: PRAME Gene name: WT-1 NY-ESO-1/PRAME/MAGE-A3/WT-1 peptide vaccine VO:0007714 A cancer vaccine made with autologous DCs that are pulsed with HOCl-oxidized autologous tumor lysate (OCDC) and administered in prime phase, along with a personal neoantigen-sensitized DC(NeoDC) vaccine administered in the boost phase for Esophageal Squamous Cell Carcinoma. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT05317325 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6331 6331 cancer vaccine OCDC and NeoDC vaccine VO:0007715 A cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. The ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells. Ovarian cancer patients can be given one pill a day for three months. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C159540 NCT: https://clinicaltrials.gov/study/NCT03556566 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6354 6354 cancer vaccine oral cancer vaccine V3-OVA VO:0007716 A cancer vaccine consisting of the tumor-associated antigen (TAA) oligosaccharide antigen sialyl Lewis A (CA19-9; sialylated Lewis A antigen; carbohydrate antigen 19-9; cancer antigen 19-9), with potential immunostimulating and antineoplastic activities. Oral therapeutic vaccine V3-X induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing CA19-9. Cholangiocarcinoma (CCA) is a malignant neoplasm originating from the epithelial cells lining the intra- or extrahepatic biliary ducts. This immunotherapeutic formulation is made from pooled heat- and chemically-inactivated blood from donors with CCA for a pill for cholangiocarcinoma patients. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148144 NCT: https://clinicaltrials.gov/study/NCT03042182 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6333 6333 cancer vaccine oral therapeutic vaccine V3-X VO:0007717 A cancer vaccine comprised of three immunogenic tetanus toxoid epitope P30-linked tumor-associated antigen (TAA) peptides, P30-linked Ephrin receptor A2 (EphA2), P30-linked cytomegalovirus (CMV) matrix protein pp65 (65 kDa lower matrix phosphoprotein; UL83) and P30-linked survivin, with potential immunostimulating and antineoplastic activities. The vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing EphA2, CMV pp65 and survivin. Hiltonol is used as an adjuvant to stimulate or enhance the activation of your immune system. The vaccine and adjuvant may help treat HLA-A*0201 positive patients with a newly diagnosed, unmethylated, and untreated World Health Organization (WHO) grade IV malignant glioma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C187131 NCT: https://clinicaltrials.gov/study/NCT05283109 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6362 1969 332 6362 cancer vaccine Gene name: EphA2 Gene name: survivin P30-linked EphA2/CMV pp65/survivin peptide vaccine P30-EPS VO:0007718 A cancer vaccine made up of CPC-P501 protein formulated with the adjuvant AS15. Patients with hormone-sensitive prostate cancer and rising PSA, after primary tumor treatment, can be treated with the P501-AS15 vaccine. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00148928 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6335 6335 cancer vaccine P501-AS15 vaccine VO:0007719 A cancer vaccine based on next-generation sequencing and major histocompatibility complex affinity prediction algorithm, which may help treat patients with pancreatic ductal adenocarcinoma. This vaccine may elicit measurable neoantigen-specific immunologic responses in patients. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03558945 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6341 6341 cancer vaccine pancreatic tumor personalized neoantigen vaccine VO:0007720 A cancer vaccine composed of a peptide derived from the tumor-associated antigen (TAA) and immune checkpoint molecule programmed cell death-1 ligand 1 (PD-L1) combined with the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Vaccination with PD-L1 peptide vaccine may activate the immune system to induce an immune response against PD-L1-expressing cells. This may increase and restore the proliferation and activation of various immune cells, including cytotoxic T-lymphocytes (CTLs), and may eradicate PD-L1-expressing tumor cells. The vaccines aims to stimulate PD-L1 specific T-cells, hence eliminating both PD-L1 positive tumor cells as well as PD-L1 positive immunosuppressive and antigen presenting cells in the tumor microenvironment. It has been used in clinical trials for patients with multiple melanoma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148146 NCT: https://clinicaltrials.gov/study/NCT03042793 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6338 29126 6338 cancer vaccine Gene name: PD-L1 PD-L1 peptide vaccine VO:0007721 A cancer vaccine composed of IO103, a peptide derived from the tumor-associated antigen (TAA) programmed cell death-1 ligand 1 (PD-L1), IO102, the 21-mer peptide vaccine derived from the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO), and the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Both IDO and PD-L1 reactive CD8 T cells are cytotoxic and can kill cancer cells and immune regulatory cells in vitro. Thus boosting specific T cells that recognize immune regulatory proteins such as IDO and PD-L1 may directly modulate immune regulation. The the programmed death 1 (PD-1) regulatory antibody Nivolumab may further help treat patients with metastatic melanoma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C148154 NCT: https://clinicaltrials.gov/study/NCT03047928 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6337 29126 3620 6337 cancer vaccine Gene name: IDO Gene name: PD-L1 PD-L1/IDO peptide vaccine IO102-103 VO:0007722 A cancer vaccine designed to target the unique immunogenic mutations arising in each patient's tumor. Peptide binding to MHC is a critical gateway to both the initiation of a T-cell immune response by the antigen presenting cell (APC), and to the detection and elimination of tumor cells presenting the particular peptide by the stimulated cytotoxic T lymphocyte (CTL). The attraction of neoantigens as cancer targets for the immune system results from the structural and geographical features of the mutation. Neoantigen peptides are only found in tumor cells, so CTLs should show exquisite specificity, reducing the opportunity for autoimmune disease. Hayleigh Kahn Jie Zheng PMID:25101225 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6387 6387 cancer vaccine personal neoantigen cancer vaccine VO:0007723 A cancer vaccine co-administered with poly-ICLC, nivolumab, and rituximab (or another monoclonal antibody against CD20) to treat Follicular Lymphoma. The peptides comprising the vaccine are reconstituted in up to 4 pools with 5 peptides per pool (A, B, C, and D). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT03121677 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6342 6342 cancer vaccine personalized follicular lymphoma vaccine VO:0007724 A cancer vaccine that may stimulate the immune system to react to lung cancer cells, in combination with Cyclophosphamide. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT02419170 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6340 6340 cancer vaccine personalized mature dendritic cell vaccine VO:0007725 A cancer vaccine for melanoma. Melanomas have mutations (changes in genetic material) that are specific to an individual patient and tumor. These mutations can cause the tumor cells to produce proteins that appear very different from the body's own cells. These proteins used in a vaccine may induce strong immune responses, which may help the participant's body fight any tumor cells that could cause the melanoma to come back in the future. NeoVax is a long-peptide vaccine targeting up to 20 personal neoantigens per patient for patients with surgically resected stage IIIB/C or IVM1a/b melanoma. There was long-term persistence of neoantigen-specific T cell responses following vaccination, with ex vivo detection of neoantigen-specific T cells exhibiting a memory phenotype, as well as diversification of neoantigen-specific T cell clones over time, with emergence of multiple T cell receptor clonotypes exhibiting distinct functional avidities. There was also tumor infiltration by neoantigen-specific T cell clones after vaccination and epitope spreading, suggesting on-target vaccine-induced tumor cell killing. Personal neoantigen peptide vaccines thus induce T cell responses that persist over years and broaden the spectrum of tumor-specific cytotoxicity in patients with melanoma. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT01970358 PMID:33479501 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6375 6375 cancer vaccine personalized neoantigen melanoma vaccine VO:0007726 A cancer vaccine that contains 6 synthetic peptides mixed with the adjuvant Montanide™. The peptides were selected to induce T cell responses against 12 dominant epitopes from 7 cancer testis antigens (CTAs), which are the most frequently expressed CTAs in colorectal cancer. The 6 peptides were optimized to induce long lasting CRC specific T cell responses. Colorectal cancer peptide vaccine PolyPEPI1018 potentially elicits a cytotoxic T-lymphocyte response against colorectal tumors expressing the CTAs associated with the vaccine, which may result in a reduction in tumor cell proliferation. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C154278 NCT: https://clinicaltrials.gov/study/NCT03391232 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6343 1485 6343 cancer vaccine Gene name: CTAG1B PolyPEPI1018 CRC vaccine VO:0007727 A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death. Vaccines may make the body build an immune response and kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells. Interferon alfa-2b may interfere with the growth of tumor cells. Treatment with this combination may help treat melanoma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1633 NCT: https://clinicaltrials.gov/study/NCT00004104 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6344 6344 cancer vaccine polyvalent melanoma vaccine VO:0007728 A cancer vaccine made with autologous dendritic cells targeting prostate cancer (PC)-specific antigen(s), with potential immunostimulatory and antineoplastic activities. Upon administration of prodencel, the DCs stimulate a specific cytotoxic T-lymphocyte (CTL)-mediated immune response against PC cells expressing the antigen(s), resulting in tumor cell lysis. (NCIT_C192174) The vaccine could help treat patients with metastatic castration-resistant prostate cancer (mCRPC) after novel androgen-deprived therapy and docetaxel chemotherapy failure. Hayleigh Kahn Jie Zheng prodencel NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C192174 NCT: https://clinicaltrials.gov/study/NCT05533203 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6345 6345 cancer vaccine prodencel vaccine VO:0007729 A cancer vaccine containing the mammalian expression vector pUMVC3 encoding epitopes derived from three tumor-associated antigens (TAAs): human insulin-like growth factor-binding protein 2 (IGFBP2), human epidermal growth factor receptor 2 (HER2; ERBB2) and insulin-like growth factor 1 receptor (IGF1R), with potential immunostimulating and antineoplastic activities. The vaccine This activates the immune system to mount a combined response from specific T helper type 1 (Th1) cells, memory T-cells and cytotoxic T-lymphocytes (CTL) against IGFBP2-, HER2-, and IGF1R-expressing tumor cells. This vaccine may prevent cancer from coming back in patients with non-metastatic, node positive, human epidermal growth factor receptor (HER)2 negative breast cancer in which all signs and symptoms have disappeared. Vaccines made from deoxyribonucleic acid (DNA) may help the body build an effective immune response to kill tumor cells. It is given in combination with sargramostim. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C127910 NCT: https://clinicaltrials.gov/study/NCT02780401 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6346 2064 3480 3485 6346 cancer vaccine Gene name: HER2 Gene name: IGF1R Gene name: IGFBP2 pUMVC3-IGFBP2-HER2-IGF1R plasmid DNA vaccine VO:0007730 A cancer vaccine containing seven 17 amino acids long synthetic RAS oncogene-encoded peptides representing the most common codon 12 and 13 oncogenic mutations in Kirsten rat sarcoma viral oncogene homolog (KRAS), with potential immunomodulating and antineoplastic activities. The vaccine may stimulate a specific CD4-positive helper T-lymphocyte- and cytotoxic T-lymphocyte (CTL)-mediated immune response against RAS mutant-specific-expressing cancer cells, resulting in an inhibition of tumor cell proliferation and tumor cell death. The vaccine can be given in combination with Balstilimab and QS-21 for patients with pancreatic cancer to increase efficacy. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C200465 NCT: https://clinicaltrials.gov/study/NCT05638698 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6356 6356 cancer vaccine RAS peptide cancer vaccine TG01 VO:0007731 A cancer vaccine that encodes a melanoma antigen tyrosinase-related protein 2 (TRP2) cytotoxic T-lymphocyte (CTL) epitope and a modified monoclonal antibody, a chimera of human IgG1/murine IgG2a with T cell mimotopes expressed within the complementarity-determining regions (CDR) of the antibodies, with potential immunostimulating and antineoplastic activities. The melanoma TRP2 CTL epitope vaccine SCIB1 expresses the modified antibody. Subsequently, the Fc component of the engineered antibody targets and binds to the CD64 receptor on the dendritic cells (DCs); upon processing by DCs, the cellular immune system may be activated to induce helper T-cell and CTL immune responses against tumor cells expressing the TRP2 antigen. SCIB1 can be used in combination with either nivolumab (Opdivo) with ipilimumab (Yervoy) or pembrolizumab (Keytruda), standard treatments approved for patients with advanced melanoma. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C91380 NCT: https://clinicaltrials.gov/study/NCT04079166 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6349 1638 6349 cancer vaccine Gene name: TRP-2 SCIB1 DNA vaccine VO:0007732 A cancer vaccine made with secPD-L1, a splice variant of PD-L1 (programmed death ligand-1, an immune checkpoint pathway) that does not splice into the transmembrane domain, but instead produces a secreted form of PD-L1 that has a unique 18 amino acid tail containing a cysteine that allows it to homodimerize and more effectively inhibit lymphocyte function than monomeric soluble PD-L1. Recombinant secPD-L1 can dimerize and inhibit T-cell proliferation and IFN-gamma production in vitro. SecPD-L1 may function as a paracrine negative immune regulator within the tumor, since secPD-L1 does not require a cell-to-cell interaction to mediate its inhibitory effect. This could lead to improved survival for patients with numerous types of cancers, including lung cancer, melanoma, renal cell carcinoma, and Hodgkin lymphoma. Hayleigh Kahn Jie Zheng PMID:30564891 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6376 29126 6376 cancer vaccine Gene name: PD-L1 secPD-L1 vaccine VO:0007733 A cancer vaccine that consists of the oligosaccharide antigen sialyl Lewis (CA19-9) conjugated to the nonspecific immunomodulator keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. The sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine may induce production of IgG and IgM antibodies as well as trigger an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing the sialyl Lewis antigen. The vaccine therapy together with QS21 may cause a stronger immune response and kill more tumor cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C69000 NCT: https://clinicaltrials.gov/study/NCT00470574 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6350 6350 cancer vaccine sialyl lewis-keyhole limpet hemocyanin conjugate vaccine VO:0007734 A cancer vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth. This vaccine is compromised of multi-epitope melanoma peptide vaccine (12MP) and 1 tetanus peptide melanoma vaccine emulsified with GM-CSF and ISA-51 (incomplete Freund's adjuvant). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C2468 NCT: https://clinicaltrials.gov/study/NCT00071981 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6355 6355 cancer vaccine tetanus peptide melanoma vaccine VO:0007735 A cancer vaccine made with GMCSF transgene that directly stimulates increased expression of tumor antigen(s) and enhances dendritic cell migration to the vaccination site. TGFβ2 blockade following intracellular TGFβ2 antisense gene expression reduces production of immune inhibiting activity at the vaccine site. This vaccine integrates enhancement of an anticancer immune response concurrently with a reduction in cancer-induced immune suppression. Autologous cancer cells are harvested from patients with advanced refractory cancer, and a TGFβ2 antisense / GMCSF expression vector plasmid is constructed. The autologous cancer tissue is irradiated and electrocorporated with the vector. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00684294 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6357 6357 cancer vaccine TGFβ2 antisense-GMCSF gene modified autologous tumor cell vaccine VO:0007736 A cancer vaccine containing autologous dendritic cells (DCs) that are loaded with total tumor RNA (TTRNA) from a specific tumor, with potential immunostimulatory and antineoplastic activities. The vaccine may elicit a highly specific cytotoxic T-cell (CTL) response against the tumor-associated antigens (TAAs) encoded by the TTRNA. The vaccine can be given in combination with Temozolomide (TMZ) and Autologous Hematopoietic Stem Cells (HSC). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C116913 NCT: https://clinicaltrials.gov/study/NCT03396575 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6360 6360 cancer vaccine total tumor RNA-loaded dendritic cell vaccine VO:0007737 A cancer vaccine made as patient's lymphocytes are rendered transgenic for a gene coding for selected portion of telomerase an enzyme expressed in the vast majority of cancer cells. Transgenic cells are then returned to the patient to produce an immune response targeted at cancer cells expressing telomerase. The transgenic cells serve as antigen- presenting cells (APCs) with the dual function of antigen synthesis and presentation. Vaccination produces an immune response targeting cancer cells expressing telomerase. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38720 NCT: https://clinicaltrials.gov/study/NCT00061035 PMID:12653092 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6358 7015 6358 cancer vaccine Gene name: telomerase transgenic lymphocyte immunization vaccine VO:0007738 A cancer vaccine of 3 adenoviral vaccines (ETBX-011, ETBX-051 & ETBX-061). ETBX-011 uses a replication-defective, E1- and E2b-deleted oncolytic adenoviral serotype 5 (Ad5) encoding an epitope of human carcinoembryonic antigen (CEA). ETBX-051 is composed of a replication-defective, serotype 5 adenovirus (Ad5) with the viral genes early 1 (E1), early 2b (E2b), and early 3 (E3) deleted, and the human transcription factor brachyury encoded. ETBX-061 composed of a replication-defective, serotype 5 adenovirus (Ad5) with the viral genes early 1 (E1), early 2b (E2b), and early 3 (E3) deleted, and the human glycoprotein mucin 1 (MUC1) encoded. The three of these vaccines act against tumor associated antigens and have potential immunostimulating and antineoplastic activities. The TriAd vaccine can be used in combination with Anti-PD-L1/TGF-beta trap (M7824) and Anktiva (N-803) to shrink previously untreated head and neck tumors before surgery or stop the tumors from coming back after all treatment. Hayleigh Kahn Jie Zheng NCI: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C91373 NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C143034 NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C143035 NCT: https://clinicaltrials.gov/study/NCT04247282 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6359 1048 4582 6862 6359 cancer vaccine Gene name: CEA Gene name: MUC1 Gene name: brachyury TriAd cancer vaccine VO:0007739 A cancer vaccine that can be used in combination with Neo-antigen DC vaccine and their sensitized T cells for the treatment of esophageal cancer, advanced malignant melanoma, bladder cancer and colorectal cancer. Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT05023928 NCT: https://clinicaltrials.gov/study/NCT05235607 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6361 6361 cancer vaccine tumor antigen-sensitized DC vaccine VO:0007740 A cancer vaccine that is composed of dendritic cells pulsed with tumor cells lysates that stimulate a potent and specific cell mediated anti-tumor immune response. It can be used in combination with high-dose chemotherapy and hematopoietic stem cell transplantation (HSCT). The combination may increase overall survival and progression-free survival for patients with high-risk pediatric and young adult tumors (localized solid tumors such as, sarcoma, neuroblastoma, and Wilms' tumor). Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1988 NCT: https://clinicaltrials.gov/study/NCT00405327 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6366 6366 cancer vaccine tumor lysate-pulsed dendritic cell vaccine VO:0007741 A cancer vaccine made from proteins from the patient's tumor cells may boost the body's immune response against the tumor. The effects of chemotherapy on the immune system can potentially make immunotherapy more effective if administered soon after completion of chemotherapy. The addition of recombinant human IL-7 (interleukin 7) (rhIL-7 (recombinant human interleukin 7)) may make the immunotherapy more effective. Alpha cluster of differentiation 25 (CD25) and 8H9 depleted autologous lymphocytes plus tumor lysate/keyhole limpet hemocyanin (KLH) pulsed dendritic cell vaccines plus or minus r-hIL7 (CYT107) may induce immune responses to tumor lysate in patients (with Ewing's sarcoma, rhabdomyosarcoma or neuroblastoma). Hayleigh Kahn Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00923351 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6365 6365 cancer vaccine tumor lysate/KLH pulsed dendritic cell vaccine VO:0007742 A cancer vaccine made as the patient's cancer will be surgically removed to provide cells for the vaccine, then the patient will be vaccinated twice with those cells and GM-CSF. After, the patient's blood will be filtered for white cells which will then be cultured and stimulated to reach a higher (killer) activity level. Next, the activated white blood cells will be infused into the patient's bloodstream so that they will be able to attack the cancer. Lastly, the entire process starting with vaccination will be repeated, for a total of two rounds of therapy. The autologous vaccine-enhanced ex vivo activated cancer neoantigens-specific T-cells TVI-Brain-1 recognize and bind to tumor cells expressing the cancer neoantigens, resulting in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the patient's tumor cells. Hayleigh Kahn Jie Zheng NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C199632 NCT: https://clinicaltrials.gov/study/NCT01081223 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6373 6373 cancer vaccine TVI-Brain-1 vaccine VO:0007743 A cancer vaccine administered within the first 2 to 3 months after allogeneic stem cell transplantation may enhance graft-vs.-leukemia responses. Irradiated autologous cancer cells provide a source of tumor antigens at the vaccination site. Granulocyte macrophage colony-stimulating factor (GM-CSF) secreted by irradiated bystander cells stimulates the recruitment, maturation and immunostimulatory activity of dendritic cells (DCs) at the vaccination site. Autologous whole tumor cell-based vaccination may tip the balance between leukemia-specific and alloreactive T cell responses in favor of a graft-vs.-leukemia (GvL) effect. Hayleigh Kahn Jie Zheng PMID:24482749 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6388 6388 cancer vaccine whole tumor cell-based leukemia vaccine VO:0007747 Vaccine role that indicates a vaccine has received emergency use authorization (EUA) from regulatory authorities for distribution and administration to the public. Jie Zheng role authorized vaccine role VO:0007748 USA licensed vaccine for veterinary uses approved by USDA. Jie Zheng USDA licensed vaccine vaccine USA licensed veterinary vaccine VO:0007749 Jie Zheng vaccine licensed duck vaccine VO:0010000 A Cp12 protein that is part of Crptosporidium parvum Anthony Huffman protein Cp12 from Crptosporidium parvum VO:0010001 A Cp21 protein that is part of Crptosporidium parvum Anthony Huffman protein Cp21 from Crptosporidium parvum VO:0010002 A Cp15 protein that is part of Crptosporidium parvum Anthony Huffman protein Cp15 from Crptosporidium parvum VO:0010003 A CP60 protein that is part of Crptosporidium parvum Anthony Huffman protein Cp60 from Crptosporidium parvum VO:0010004 A Cp23 protein that is part of Crptosporidium parvum Anthony Huffman obsolete Crptosporidium parvum Cp23 true VO:0010005 A CpP2 protein that is part of Crptosporidium parvum Anthony Huffman protein CpP2 from Crptosporidium parvum VO:0010006 A 3-1E protein that is part of Eimeria acervulina Anthony Huffman protein Eimeria acervulina 3-1E VO:0010007 A gam56 protein that is part of Eimeria maxima Anthony Huffman protein Eimeria maxima gam56 VO:0010008 Vaccine role that is characteristic of an inactivated vaccine. Jie Zheng role inactivated vaccine role VO:0010009 A a1-giardin protein that is part of Giardia duodenalis Anthony Huffman protein Giardia duodenalis a1-giardin NCBI Gene ID 5697168 VO:0010010 A a1-giardin protein that is part of Giardia lamblia Anthony Huffman protein Giardia lamblia a1-giardin NCBI Gene ID 5697168 VO:0010011 A alpha-enolase protein that is part of Giardia lamblia Anthony Huffman protein Giardia lamblia alpha-enolase NCBI Gene ID 2023 VO:0010012 A CWP2 protein that is part of Giardia lamblia Anthony Huffman protein Giardia lamblia CWP2 NCBI Gene ID 5703171 VO:0010013 A Acen1 protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani Acen1 VO:0010014 A Beta-tubulin protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani Beta-tubulin NCBI Gene ID 13392307 VO:0010015 A FML protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani FML VO:0010016 A Gp63 protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani Gp63 NCBI Gene ID 13389283 VO:0010017 A HASPB1 protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani HASPB1 VO:0010018 A KH protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani KH VO:0010019 A LdyGCS protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani LdyGCS VO:0010020 A NH36 protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani NH36 VO:0010021 A P1 protein that is part of Leishmania donovani Anthony Huffman protein Leishmania donovani P1 NCBI Gene ID 13388831 VO:0010022 A A2 protein that is part of Leishmania infantum Anthony Huffman protein Leishmania infantum A2 NCBI Gene ID 13387764 VO:0010023 A HSP70 II protein that is part of Leishmania infantum Anthony Huffman protein Leishmania infantum HSP70 II NCBI Gene ID 5073319 VO:0010024 A KMP-11 protein that is part of Leishmania major Anthony Huffman protein Leishmania major KMP-11 NCBI Gene ID 13387683 VO:0010025 A LmSTI1 protein that is part of Leishmania major Anthony Huffman protein Leishmania major LmSTI1 VO:0010026 A LIPO-A protein that is part of Leishmania major Anthony Huffman protein Leishmania major LIPO-A VO:0010027 A P36 protein that is part of Leishmania major Anthony Huffman protein Leishmania major P36 VO:0010028 A PEPCK protein that is part of Leishmania major Anthony Huffman protein Leishmania major PEPCK NCBI Gene ID 5649768 VO:0010029 A LeIF protein that is part of Leishmania major Anthony Huffman protein Leishmania major LeIF NCBI Gene ID 12981542 VO:0010030 A MIC3 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum MIC3 VO:0010031 A GRA2 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum GRA2 VO:0010032 A GRA6 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum GRA6 VO:0010033 A SRS2 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum SRS2 VO:0010034 A MIC10 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum MIC10 VO:0010035 A p24 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum p24 VO:0010036 A PDI protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum PDI VO:0010037 A SAG1 protein that is part of Neospora caninum Anthony Huffman protein Neospora caninum SAG1 VO:0010038 Vaccine role that is characteristic of a live attenuated vaccine. Jie Zheng role live attenuated vaccine role VO:0010039 A P36p protein that is part of Plasmodium berghei Anthony Huffman protein Plasmodium berghei P36p VO:0010040 A ABRA protein that is part of Plasmodium falciparum|An ABRA protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum ABRA VO:0010041 A EBA-175 RII protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum EBA-175 RII VO:0010042 A Hsp90 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Hsp90 VO:0010043 A MSP1 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum MSP1 VO:0010044 A RESA protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum RESA VO:0010045 A MSP2 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum MSP2 VO:0010046 A MSP4 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum MSP4 VO:0010047 A Pf ribosomal protein P0 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Pf ribosomal protein P0 VO:0010048 A PfCelTOS protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum PfCelTOS VO:0010049 A PfSSP2 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum PfSSP2 VO:0010050 A LSA1 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum LSA1 VO:0010051 A Pfen protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Pfen VO:0010052 A Pfs230 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Pfs230 VO:0010053 A Pfs25 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Pfs25 VO:0010054 A Pfs48 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Pfs48 VO:0010055 A RH5 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum RH5 VO:0010056 A TRAP protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum TRAP VO:0010057 A Pfs45 protein that is part of Plasmodium falciparum Anthony Huffman protein Plasmodium falciparum Pfs45 VO:0010058 A PkCSP protein that is part of Plasmodium knowlesi Anthony Huffman protein Plasmodium knowlesi PkCSP VO:0010059 A PkSSP2 protein that is part of Plasmodium knowlesi|A SSP2 protein that is part of Plasmodium knowlesi Anthony Huffman Plasmodium vivax Thrombospondin-related apical merozoite protein protein Plasmodium knowlesi SSP2 VO:0010060 A PkAMA1 protein that is part of Plasmodium knowlesi Anthony Huffman protein Plasmodium knowlesi PkAMA1 VO:0010061 A PkMSP1 protein that is part of Plasmodium knowlesi|A PkMSP1p42 protein that is part of Plasmodium knowlesi Anthony Huffman protein Plasmodium knowlesi PkMSP1p42 VO:0010062 A CelTOS protein that is part of Plasmodium vivax|A PvCelTOS protein that is part of Plasmodium vivax Anthony Huffman protein Plasmodium vivax CelTOS VO:0010063 A CS protein that is part of Plasmodium vivax|A PvCS protein that is part of Plasmodium vivax Anthony Huffman protein Plasmodium vivax CS VO:0010064 A DBPII protein that is part of Plasmodium vivax|A PvDBPII protein that is part of Plasmodium vivax Anthony Huffman protein Plasmodium vivax PvDBPII VO:0010065 A TRAP protein that is part of Plasmodium vivax Anthony Huffman protein Plasmodium vivax TRAP VO:0010066 A HEP17 protein that is part of Plasmodium yoelii Anthony Huffman protein Plasmodium yoelii HEP17 VO:0010067 A HSP60 protein that is part of Plasmodium yoelii Anthony Huffman protein PMC98419 citation for occurance in all lifestages Plasmodium yoelii HSP60 VO:0010068 A SSP2 protein that is part of Plasmodium yoelii Anthony Huffman protein Plasmodium yoelii SSP2 VO:0010069 A ASP-1 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi ASP-1 VO:0010070 A CRP protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi CRP NCBI Gene ID 947867 VO:0010071 A G1 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi G1 VO:0010072 A PAR3 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi PAR3 NCBI Gene ID 3540497 VO:0010073 A PFR Ag protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi PFR Ag VO:0010074 A rTcENO from H8 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi rTcENO from H8 VO:0010075 A Tc24 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi Tc24 VO:0010076 A Tc80 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi Tc80 VO:0010077 A TcENO protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TcENO VO:0010078 A TcSSP4 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TcSSP4 VO:0010079 A TcTASV-C protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TcTASV-C VO:0010080 A TCTS-154 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TCTS-154 VO:0010081 A Trans-salidase protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi Trans-salidase NCBI Gene ID 3537653 VO:0010082 A TSA-1 protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TSA-1 NCBI Gene ID 3544076 VO:0010083 A TsF protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TsF NCBI Gene ID 3537653 VO:0010084 A TSSA protein that is part of Trypanosoma cruzi Anthony Huffman protein Trypanosoma cruzi TSSA VO:0010085 A CDPK1 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii CDPK1 VO:0010086 A CDPK6 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii CDPK6 VO:0010087 A ROP18 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ROP18 VO:0010088 A CST2 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii CST2 VO:0010089 A CyP protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii CyP VO:0010091 A GRA1 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA1 VO:0010092 A GRA16 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA16 VO:0010093 A GRA17 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA17 VO:0010094 A GRA24 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA24 VO:0010095 A GRA23 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA23 VO:0010096 A GRA25 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA25 VO:0010097 A GRA41 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA41 VO:0010098 A GRA6 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA6 VO:0010099 A GRA7 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA7 VO:0010100 A GRA8 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii GRA8 VO:0010101 A hsp70 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii hsp70 VO:0010102 A ISP3 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ISP3 VO:0010103 A MIC1 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii MIC1 VO:0010104 A MIC11 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii MIC11 VO:0010105 A MIC13 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii MIC13 VO:0010106 A MIC4 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii MIC4 VO:0010107 A MIC6 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii MIC6 VO:0010108 A MIC8 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii MIC8 VO:0010109 A PGAM2 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii PGAM2 VO:0010110 A RACK1 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii RACK1 VO:0010111 A ROP16 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ROP16 VO:0010112 A ROP17 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ROP17 VO:0010114 A PLP1 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii PLP1 VO:0010115 A ROP38 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ROP38 VO:0010116 A ROP8 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ROP8 VO:0010118 A ROP2 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii ROP2 VO:0010119 A SAG2 protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii SAG2 VO:0010120 A SAG5B protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii SAG5B VO:0010121 A SAG5C protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii SAG5C VO:0010122 A TgADF protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii TgADF VO:0010123 A TgNTPase-II protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii TgNTPase-II VO:0010124 A TgPF protein that is part of Toxoplasma gondii Anthony Huffman protein Toxoplasma gondii TgPF VO:0010125 Yuanyi Pan 76 40213225 Staphylococcus bacteriophage lysate vaccine Staphylococcus bacteriophage lysate VO:0010126 A variable representing the species of the host used for a study. Anthony Huffman PMID:29485622 information content entity host species variable VO:0010127 Yuanyi Pan obsolete Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. true VO:0010128 Yuanyi Pan influenza, live, intranasal, quadrivalent vaccine influenza, live, intranasal, quadrivalent vaccine VO:0010129 A variable representing the host's participation in a disease state (i.e. healthy, or diabetic). Anthony Huffman PMID:32516066 information content entity host disease state variable VO:0010130 A variable representing the biological sex of the host Anthony Huffman PMID:29485622 information content entity host sex variable VO:0010131 A variable representing the age of the host Anthony Huffman PMID:32347787 information content entity host age variable VO:0010132 A variable representing the presence of another developing organism in an animal host Anthony Huffman PMID:34082643 information content entity host pregnancy variable VO:0010133 Yuanyi Pan vaccine influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free VO:0010134 A variable representing host quality's that leads to a wore outcome to vaccination or pathogen disease state. Anthony Huffman PMID:32516066 information content entity host comorbidity variable VO:0010135 Yuanyi Pan 303 Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF vaccine Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free VO:0010136 Yuanyi Pan 305 Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF vaccine Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free VO:0010137 Yuanyi Pan 306 Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months vaccine Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months VO:0010138 Yuanyi Pan 307 Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months vaccine Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months VO:0010139 Yuanyi Pan 308 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL vaccine SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose VO:0010140 Yuanyi Pan 309 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL vaccine SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose VO:0010141 Yuanyi Pan 310 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL vaccine SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose VO:0010142 Yuanyi Pan 311 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL vaccine SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose VO:0010143 Yuanyi Pan 312 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL vaccine SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose VO:0010144 Yuanyi Pan 313 SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL vaccine SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose VO:0010145 A variable representing the prior immungenic memory a host has against a specific pathogen Anthony Huffman PMID:32668444 information content entity host pathogen exposure variable VO:0010146 Yuanyi Pan 316 Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF vaccine Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free VO:0010147 Yuanyi Pan 317 Chikungunya, live attenuated vaccine, 0.5 mL, preservative free Chikungunya live attenuated vaccine, 0.5 mL, PF vaccine Chikungunya, live attenuated vaccine, 0.5 mL, preservative free VO:0010148 Yuanyi Pan 318 Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis Anthrax, post-exposure prophylaxis vaccine Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis VO:0010149 An information content entity that specify no vaccine adminstered. Jie Zheng https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx 998 no vaccine administered no vaccine administered information content entity no vaccine administered VO:0010150 A record of missing knowledge indicating that vaccine or immune globulin is unknown. Jie Zheng unknown vaccine or immune globulin https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx 999 40213263 unknown vaccine or immune globulin unknown information content entity record of unknown vaccine or immune globulin VO:0010153 Yuanyi Pan 521 716026 SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK vaccine SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK VO:0010154 Yuanyi Pan 43 40213306 hepatitis B vaccine, adult dosage Hep B, adult vaccine hepatitis B vaccine, adult dosage VO:0010155 Yuanyi Pan 44 40213307 hepatitis B vaccine, dialysis patient dosage Hep B, dialysis vaccine hepatitis B vaccine, dialysis patient dosage VO:0010156 Yuanyi Pan 24 40213268 Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis vaccine Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis VO:0010157 Yuanyi Pan 195 724894 Diphtheria, Tetanus, Poliomyelitis adsorbed DT, IPV adsorbed vaccine Diphtheria, Tetanus, Poliomyelitis adsorbed VO:0010158 Yuanyi Pan 28 40213280 diphtheria and tetanus toxoids, adsorbed for pediatric use DT (pediatric) vaccine diphtheria and tetanus toxoids, adsorbed for pediatric use VO:0010159 Yuanyi Pan 113 40213227 tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed vaccine tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) VO:0010160 Yuanyi Pan 106 40213282 diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens DTaP, 5 pertussis antigens vaccine diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens VO:0010161 Yuanyi Pan 130 40213289 Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated DTaP-IPV vaccine diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated VO:0010162 Yuanyi Pan 132 40213290 Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. DTaP-IPV-HIB-HEP B, historical vaccine historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. VO:0010163 Yuanyi Pan 120 40213288 diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) DTaP-Hib-IPV vaccine diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) VO:0010164 Yuanyi Pan 170 40213285 non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) DTAP/IPV/HIB - non-US vaccine non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) VO:0010165 Yuanyi Pan 51 40213317 Haemophilus influenzae type b conjugate and Hepatitis B vaccine Hib-Hep B vaccine Haemophilus influenzae type b conjugate and Hepatitis B vaccine VO:0010166 Yuanyi Pan 47 40213312 Haemophilus influenzae type b vaccine, HbOC conjugate Hib (HbOC) vaccine Haemophilus influenzae type b vaccine, HbOC conjugate VO:0010167 Yuanyi Pan 48 Haemophilus influenzae type b vaccine, PRP-T conjugate Hib (PRP-T) vaccine Haemophilus influenzae type b vaccine, PRP-T conjugate VO:0010168 Yuanyi Pan 49 40213314 Haemophilus influenzae type b vaccine, PRP-OMP conjugate Hib (PRP-OMP) vaccine Haemophilus influenzae type b vaccine, PRP-OMP conjugate VO:0010169 Yuanyi Pan 83 40213299 hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule Hep A, ped/adol, 2 dose vaccine hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule VO:0010170 Yuanyi Pan 193 706109 hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) Hep A-Hep B, pediatric/adolescent vaccine hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) VO:0010171 Yuanyi Pan 08 40213304 hepatitis B vaccine, pediatric or pediatric/adolescent dosage Hep B, adolescent or pediatric vaccine hepatitis B vaccine, pediatric or pediatric/adolescent dosage VO:0010172 Yuanyi Pan 189 706105 Hepatitis B vaccine (recombinant), CpG adjuvanted HepB-CpG vaccine hepatitis B vaccine (recombinant), CpG adjuvanted VO:0010173 Yuanyi Pan 62 40213320 human papilloma virus vaccine, quadrivalent HPV, quadrivalent vaccine human papilloma virus vaccine, quadrivalent VO:0010174 Yuanyi Pan 118 40213319 human papilloma virus vaccine, bivalent HPV, bivalent vaccine human papilloma virus vaccine, bivalent VO:0010175 Yuanyi Pan 165 40213322 Human Papillomavirus 9-valent vaccine HPV9 vaccine human papillomavirus 9-valent vaccine VO:0010176 Yuanyi Pan 111 40213149 Influenza, live, trivalent, intranasal Influenza, live, trivalent, intranasal vaccine influenza, live, trivalent, intranasal VO:0010177 Yuanyi Pan 123 40213140 influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) influenza, H5N1-1203 vaccine influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) VO:0010178 Yuanyi Pan 135 40213141 Influenza, high-dose, split virus, trivalent, injectable, preservative free Influenza, high-dose, trivalent, PF vaccine influenza, high-dose, split virus, trivalent, injectable, preservative free VO:0010179 Yuanyi Pan 140 40213154 Influenza, split virus, trivalent, injectable, preservative free Influenza, split virus, trivalent, PF vaccine influenza, split virus, trivalent, injectable, preservative free VO:0010180 Yuanyi Pan 141 40213153 Influenza, split virus, trivalent, injectable, contains preservative Influenza, split virus, trivalent, preservative vaccine influenza, split virus, trivalent, injectable, contains preservative VO:0010181 Yuanyi Pan 144 40213155 seasonal influenza, intradermal, preservative free influenza, seasonal, intradermal, preservative free vaccine seasonal influenza, intradermal, preservative free VO:0010182 Yuanyi Pan 149 40213150 Influenza, live, quadrivalent, intranasal Influenza, live, quadrivalent, intranasal vaccine influenza, live, quadrivalent, intranasal VO:0010183 Yuanyi Pan 150 40213146 Influenza, split virus, quadrivalent, injectable, preservative free Influenza, split virus, quadrivalent, PF vaccine influenza, split virus, quadrivalent, injectable, preservative free VO:0010184 Yuanyi Pan 153 40213142 Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free Influenza, MDCK, trivalent, PF vaccine influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free VO:0010185 Yuanyi Pan 155 40213151 Influenza, recombinant, trivalent, injectable, preservative free Influenza, recombinant, trivalent, PF vaccine influenza, recombinant, trivalent, injectable, preservative free VO:0010186 Yuanyi Pan 158 40213145 Influenza, split virus, quadrivalent, injectable, contains preservative Influenza, split virus, quadrivalent, preservative vaccine influenza, split virus, quadrivalent, injectable, contains preservative VO:0010187 Yuanyi Pan 160 40213326 Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 Influenza A monovalent (H5N1), ADJUVANTED-2013 vaccine influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 VO:0010188 Yuanyi Pan 168 40213157 Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free Influenza, adjuvanted, trivalent, PF vaccine influenza, adjuvanted, inactivated, trivalent, injectable, preservative free VO:0010189 Yuanyi Pan 171 40213143 Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free Influenza, MDCK, quadrivalent, PF vaccine influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free VO:0010190 Yuanyi Pan 185 40213152 Influenza, recombinant, quadrivalent, injectable, preservative free Influenza, recombinant, quadrivalent, PF vaccine influenza, recombinant, quadrivalent, injectable, preservative free VO:0010191 Yuanyi Pan 194 724893 influenza, Southern Hemisphere, unspecified formulation Influenza, Southern Hemisphere vaccine influenza, Southern Hemisphere, unspecified formulation VO:0010192 Yuanyi Pan 197 724896 Influenza, high-dose, split virus, quadrivalent, injectable, preservative free Influenza, high-dose, quadrivalent, PF vaccine influenza, high-dose, split virus, quadrivalent, injectable, preservative free VO:0010193 Yuanyi Pan 200 724897 influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free influenza, Southern Hemisphere, pediatric, preservative free vaccine influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free VO:0010194 Yuanyi Pan 201 724898 influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative influenza, Southern Hemisphere, preservative free vaccine influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative VO:0010195 Yuanyi Pan 202 724899 influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative influenza, Southern Hemisphere, quadrivalent, with preservative vaccine influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative VO:0010196 Yuanyi Pan 205 724902 Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free Influenza, adjuvanted, quadrivalent, PF vaccine Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free VO:0010197 Yuanyi Pan 231 716027 influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free influenza, Southern Hemisphere, high-dose, quadrivalent vaccine influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free VO:0010198 Yuanyi Pan 320 Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative Influenza, MDCK, trivalent, preservative vaccine influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative VO:0010199 Yuanyi Pan 39 40213162 Japanese Encephalitis Vaccine SC Japanese encephalitis SC vaccine Japanese Encephalitis vaccine SC VO:0010200 Yuanyi Pan 134 40213161 Japanese Encephalitis vaccine for intramuscular administration Japanese Encephalitis IM vaccine Japanese Encephalitis vaccine for intramuscular administration VO:0010201 Yuanyi Pan 32 40213181 meningococcal polysaccharide vaccine (MPSV4) meningococcal MPSV4 vaccine meningococcal polysaccharide vaccine (MPSV4) VO:0010202 Yuanyi Pan 114 40213180 meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) meningococcal MCV4P vaccine meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) VO:0010203 Yuanyi Pan 136 40213179 meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) Meningococcal MCV4O vaccine meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) VO:0010204 Yuanyi Pan 148 40213177 Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine Meningococcal C/Y-HIB PRP vaccine meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine VO:0010205 Yuanyi Pan 162 40213174 meningococcal B vaccine, fully recombinant meningococcal B, recombinant vaccine meningococcal B vaccine, fully recombinant VO:0010206 Yuanyi Pan 163 40213173 meningococcal B vaccine, recombinant, OMV, adjuvanted meningococcal B, OMV vaccine meningococcal B vaccine, recombinant, OMV, adjuvanted VO:0010207 Yuanyi Pan 33 40213201 pneumococcal polysaccharide vaccine, 23 valent pneumococcal polysaccharide PPV23 vaccine pneumococcal polysaccharide vaccine, 23 valent VO:0010208 Yuanyi Pan 89 40213203 poliovirus vaccine, unspecified formulation polio, unspecified formulation vaccine poliovirus vaccine, unspecified formulation VO:0010209 Yuanyi Pan 182 40213193 Oral Polio Vaccine, Unspecified formulation OPV, Unspecified vaccine Oral Polio Vaccine, Unspecified formulation VO:0010210 Yuanyi Pan 100 40213199 pneumococcal conjugate vaccine, 7 valent pneumococcal conjugate PCV 7 vaccine pneumococcal conjugate vaccine, 7 valent VO:0010211 Yuanyi Pan 133 40213198 pneumococcal conjugate vaccine, 13 valent Pneumococcal conjugate PCV 13 vaccine pneumococcal conjugate vaccine, 13 valent VO:0010212 Yuanyi Pan 18 40213208 rabies vaccine, for intramuscular injection RETIRED CODE rabies, intramuscular injection vaccine rabies vaccine, for intramuscular injection RETIRED CODE VO:0010213 Yuanyi Pan 176 40213206 Human rabies vaccine from Chicken fibroblast culture Rabies - IM fibroblast culture vaccine human rabies vaccine from Chicken fibroblast culture VO:0010214 Yuanyi Pan 304 Respiratory syncytial virus (RSV), unspecified Respiratory syncytial virus (RSV), unspecified vaccine Respiratory syncytial virus (RSV), unspecified VO:0010215 Yuanyi Pan 314 Respiratory syncytial virus (RSV) vaccine, unspecified Respiratory syncytial virus (RSV) vaccine, unspecified vaccine Respiratory syncytial virus (RSV) vaccine, unspecified VO:0010216 Yuanyi Pan 315 Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified Respiratory syncytial virus (RSV) MAB, unspecified vaccine Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified VO:0010217 Yuanyi Pan 116 40213217 rotavirus, live, pentavalent vaccine rotavirus, pentavalent vaccine rotavirus, live, pentavalent vaccine VO:0010218 Yuanyi Pan 119 40213216 rotavirus, live, monovalent vaccine rotavirus, monovalent vaccine rotavirus, live, monovalent vaccine VO:0010219 Yuanyi Pan 109 40213202 pneumococcal vaccine, unspecified formulation pneumococcal, unspecified formulation vaccine pneumococcal vaccine, unspecified formulation VO:0010220 Yuanyi Pan 35 40213232 tetanus toxoid, adsorbed tetanus toxoid, adsorbed vaccine tetanus toxoid, adsorbed VO:0010221 Yuanyi Pan 139 40213229 Td(adult) unspecified formulation Td(adult) unspecified formulation vaccine Td(adult) unspecified formulation VO:0010222 Yuanyi Pan 101 40213246 typhoid Vi capsular polysaccharide vaccine typhoid, ViCPs vaccine typhoid Vi capsular polysaccharide vaccine VO:0010223 Yuanyi Pan 187 706103 zoster vaccine recombinant zoster recombinant vaccine zoster vaccine recombinant VO:0010224 Yuanyi Pan 188 706104 zoster vaccine, unspecified formulation zoster, unspecified formulation vaccine zoster vaccine, unspecified formulation VO:0010225 Yuanyi Pan 172 40213276 cholera, WC-rBS cholera, WC-rBS vaccine cholera, WC-rBS VO:0010226 Yuanyi Pan 37 40213257 yellow fever vaccine live yellow fever live vaccine yellow fever vaccine live VO:0010227 Yuanyi Pan 183 40213258 Yellow fever vaccine live - alternative formulation for vaccine shortage Yellow fever vaccine live - alt vaccine yellow fever vaccine live - alternative formulation for vaccine shortage VO:0010228 Yuanyi Pan 184 40213259 Yellow fever vaccine, unspecified formulation Yellow fever, unspecified vaccine yellow fever vaccine, unspecified formulation VO:0010229 An information content entity that specifies the CVX code that will not be used to avoid confusion with code 999. Jie Zheng RESERVED - do not use https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx 99 RESERVED - do not use RESERVED - do not use information content entity reserved cvx code for not using VO:0010230 Jie Zheng TST-OT tine test 95 40213238 tuberculin skin test; old tuberculin, multipuncture device TST-OT tine test assay tuberculin skin test; old tuberculin, multipuncture device VO:0010231 Jie Zheng TST-PPD intradermal 96 40213239 tuberculin skin test; purified protein derivative solution, intradermal TST-PPD intradermal assay tuberculin skin test; purified protein derivative solution, intradermal VO:0010232 Jie Zheng TST-PPD tine test 97 40213240 tuberculin skin test; purified protein derivative, multipuncture device TST-PPD tine test assay tuberculin skin test; purified protein derivative, multipuncture device VO:0010233 Jie Zheng TST, unspecified formulation 98 tuberculin skin test; unspecified formulation TST, unspecified formulation assay tuberculin skin test; unspecified formulation VO:0010234 A variable representing the lineage (breed, ethnicity) of the animal host Anthony Huffman PMID:35469999 information content entity host lineage variable VO:0010235 A variable representing the interval between vaccination and pathogen challenge Anthony Huffman PMID:34328699 information content entity vaccination-challenge interval variable VO:0010236 A variable representing the interval between the vaccination and pathogen challenge start Anthony Huffman PMID:34328699 information content entity intevention interval variable VO:0010237 A variable representing the interval between the pathogen challenge start and end Anthony Huffman PMID:34328699 information content entity challenge-killing interval variable VO:0010238 A variable representing the administration route of the pathogen challenge Anthony Huffman PMID:34328699 information content entity challenge admistration route VO:0010239 A variable representing the planned process used for the sacrifice Anthony Huffman PMID:34328699 information content entity sacrifice process variable VO:0010240 A variable representing the presence of host adverse events from the vaccination process. Anthony Huffman PMID:34153517 information content entity host adverse event variable VO:0010241 A variable representing the measurement used for an assay Anthony Huffman PMID:29485622 information content entity assay mesurement variable VO:0010242 A variable representing the timepoint a biological sample was taken after vaccination Anthony Huffman PMID:29485622 information content entity assay sample endpoint variable VO:0010243 A variable representing the assay type (ELISA, microarray) etc. Anthony Huffman PMID:29485622 information content entity assay type variable VO:0010244 A variable representing the programs used to analyze an assay Anthony Huffman PMID:29485622 information content entity assay analysis tool version variable VO:0010245 A variable representing the tissue or source of sample used for an assay. Anthony Huffman PMID:29485622 information content entity assay sample source variable VO:0010246 A variable representing the assay platform used (Nanopore,) etc. Anthony Huffman PMID:29485622 information content entity assay platform variable VO:0010247 A variable representing the species or type of the pathogen Anthony Huffman PMID:29485622 information content entity pathogen variable VO:0010248 A variable representing the lineage of pathogen strain (incljuding presence or absence of virulence factors) Anthony Huffman PMID:24259431 information content entity pathogen strain variable VO:0010249 A variable representing the presence of an attenuation process (killed microbe) on a pathogen challenge Anthony Huffman PMID:29485622 information content entity pathogen attenuation variable VO:0010250 A variable representing the host vaccination frequency etc. Anthony Huffman PMID:29485622 information content entity host vaccination frequency variable VO:0010251 A variable representing the vaccination route etc. Anthony Huffman PMID:24259431 information content entity vaccination route variable VO:0010252 A variable representing dose representing the vaccination Anthony Huffman PMID:34328699 information content entity vaccination dose variable VO:0010253 A variable represting the number of occurences a vaccination was administered Anthony Huffman PMID:24259431 information content entity vaccination frequency variable VO:0010254 A variable representing the interval between multiple vaccinations. Anthony Huffman PMID:24259431 information content entity vaccination interval variable VO:0010255 A variable representing the vaccine target (pathogen, disease) etc. Anthony Huffman PMID:24259431 information content entity vaccine target variable VO:0010256 A variable representing the vaccine antigen (SARS-CoV-2 protein, whole organism) etc. Anthony Huffman PMID:24259431 information content entity vaccine antigen variable VO:0010257 A variable representing the vaccine adjuvant (silver) etc. Anthony Huffman PMID:24259431 information content entity vaccine adjuvant variable VO:0010258 A variable representing the vaccine vector (DNA plasmid, viral vector) etc. Anthony Huffman PMID:24259431 information content entity vaccine vector variable VO:0010259 A variable representing the vaccine preservative Anthony Huffman PMID:24259431 information content entity vaccine preservative variable VO:0010260 A study design variable that is used in a vaccine study. Anthony Huffman information content entity vaccine study design variable VO:0010261 A study design that is about a vaccine study. Anthony Huffman information content entity vaccine study design VO:0010262 A vaccine study design that is about the host response to a vaccine. Anthony Huffman information content entity host response to vaccine study design VO:0010263 A vaccine study design that is about the vaccine challenge to a host. Anthony Huffman information content entity vaccine challenge study design VO:0010264 A measurement datum that records the presence of a disease process in a host during the implementation of a vaccine study. Anthony Huffman data item host disease state datum VO:0010265 A biological sex datum that records the biological sex of the target of a vaccine. Anthony Huffman data item host sex datum VO:0010266 A measurment datum that records the age of thost. Anthony Huffman data item host age datum VO:0010267 A measurement datum that records to involvement of the host of the pregnancy process. Anthony Huffman data item host pregnancy datum VO:0010268 A measurment datum that records the quality of the host to have a comorbidity. Anthony Huffman data item host comorbidity datum VO:0010269 A measurment datum that records the presence of a prior infection or immune memory to a pathogen. Anthony Huffman data item host pathogen exposure datum VO:0010270 A measurment datum that records the interval between the vaccine challenge and the sacrifice of the organism during a vaccine challenge. Anthony Huffman data item challenge-killing interval datum VO:0010271 A measurment datum that records the route of a pathogen challenge occurs in. Anthony Huffman data item challenge admistration route datum VO:0010272 A measurment datum that records the method of sacrifice (i.e. killing). Anthony Huffman data item sacrifice process datum VO:0010273 A measurment datum that records the presence or abasence of adverse event in a host in response of some vaccine. Anthony Huffman data item host adverse event to vaccine datum VO:0010274 A measurment datum that records the measurement of an assay. Anthony Huffman data item assay mesurement datum VO:0010275 A measurment datum that records the time point between the start of a first intervention in a planned process and the measurment of a sample. Anthony Huffman data item assay measurement sample interval VO:0010276 A measurment datum that records the type of assay used. Anthony Huffman data item assay type datum VO:0010277 A measurment datum that records the version of an analysis tool (software) used for an assay. Anthony Huffman data item assay analysis tool version datum VO:0010278 A measurment datum that records the type of platform used for an assay. Anthony Huffman data item assay platform datum VO:0010279 A measurment datum that records the utilization of an attenaution process on a pathogen. Anthony Huffman data item pathogen attenuation datum VO:0010280 A measurment datum that records the number of occurences the host was vaccinated as part of the vaccination process. Anthony Huffman data item vaccination frequency datum VO:0010281 A measurment datum that records the interval between vaccinations of a host. Anthony Huffman data item vaccination interval datum VO:0010282 A measurment datum that records the intended target of a vaccine. Anthony Huffman data item vaccine target datum VO:0010283 A measurment datum that records the vaccine vector of a vaccine. Anthony Huffman data item vaccine vector datum VO:0010284 A measurment datum that records the vaccine preservative of a vaccine. Anthony Huffman data item vaccine preservative datum VO:0010285 An assay that measures the survival rate of organisms exposed to a pathogen. Anthony Huffman assay vaccine challenge survival assay VO:0010286 An assay that measures the gut adhesion of a pathogen within an organism. Anthony Huffman assay pathogen gut adhesion assay VO:0010287 An assay that measures the titer of antibodies that neturalize a pathogen within an organism. Anthony Huffman assay viral neutralization titer assay VO:0010288 A directive information entity that is part of a study design. It can be eithor independent variables whose values are selected to determine its relationship to an observed phenomenon (the dependent variable) or dependent variables that are studied and expected to change when the independent variable varies. Jie Zheng information content entity study design variable VO:0010289 Jie Zheng Xingxian Li vaccine meningococcal group A polysaccharide vaccine VO:0010290 Jie Zheng Xingxian Li vaccine meningococcal group C polysaccharide vaccine VO:0010291 Jie Zheng Xingxian Li vaccine Bacillus anthracis strain V770-NP1-R antigen vaccine VO:0010292 Jie Zheng Xingxian Li vaccine Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen vaccine VO:0010293 Jie Zheng Xingxian Li vaccine Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen vaccine VO:0010294 Jie Zheng Xingxian Li vaccine Neisseria meningitidis serogroup B recombinant NADA fusion protein antigen vaccine VO:0010295 Jie Zheng Xingxian Li vaccine Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen vaccine VO:0010296 Jie Zheng Xingxian Li vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen vaccine VO:0010297 Jie Zheng Xingxian Li vaccine Influenza A virus (H1N1) antigen vaccine VO:0010298 Jie Zheng Xingxian Li vaccine influenza A virus A/South Australia/55/2014 (H3N2) antigen vaccine VO:0010299 Jie Zheng Xingxian Li vaccine influenza A virus (H3N2) antigen vaccine VO:0010300 Jie Zheng Xingxian Li vaccine influenza B virus B/Utah/9/2014 antigen vaccine VO:0010301 Jie Zheng Xingxian Li vaccine influenza B virus antigen vaccine VO:0010302 Jie Zheng Xingxian Li vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen vaccine VO:0010303 Jie Zheng Xingxian Li vaccine influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen vaccine VO:0010304 Jie Zheng Xingxian Li vaccine influenza B virus B/Brisbane/60/2008 antigen vaccine VO:0010305 Jie Zheng Xingxian Li vaccine influenza B virus B/Phuket/3073/2013 antigen vaccine VO:0010306 Jie Zheng Xingxian Li vaccine influenza A virus A/California/7/2009 (H1N1) antigen vaccine VO:0010307 Jie Zheng Xingxian Li vaccine influenza A virus A/Bolivia/559/2013 (H1N1) antigen vaccine VO:0010308 Jie Zheng Xingxian Li vaccine influenza B virus B/Brisbane/9/2014 antigen vaccine VO:0010309 Jie Zheng Xingxian Li vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen vaccine VO:0010310 Jie Zheng Xingxian Li vaccine influenza B virus B/Hong Kong/259/2010 antigen vaccine VO:0010311 Jie Zheng Xingxian Li vaccine influenza A virus A/New Caledonia/71/2014 (H3N2) antigen vaccine VO:0010312 Jie Zheng Xingxian Li vaccine Vibrio cholerae CVD 103-HGR strain live antigen vaccine VO:0010313 Jie Zheng Xingxian Li vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen vaccine VO:0010314 Jie Zheng Xingxian Li vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen vaccine VO:0010315 Jie Zheng Xingxian Li vaccine influenza A virus A/Slovenia/2903/2015 (H1N1) antigen vaccine VO:0010316 Jie Zheng Xingxian Li vaccine influenza B virus B/Maryland/15/2016 antigen vaccine VO:0010317 Jie Zheng Xingxian Li vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen vaccine VO:0010318 Jie Zheng Xingxian Li vaccine influenza B virus B/Colorado/06/2017 antigen vaccine VO:0010319 Jie Zheng Xingxian Li vaccine Neisseria meningitidis Group B Membrane vesicles External Omv vaccine VO:0010320 Jie Zheng Xingxian Li vaccine Neisseria meningitidis Recombinant Fusion Protein Fhbp Group B vaccine VO:0010321 Jie Zheng Xingxian Li vaccine Bordetella Pertussis Filamentous Haemagglutinin Antigen vaccine VO:0010322 Jie Zheng Xingxian Li vaccine Bordetella Pertussis Fimbriae Serotype 2 And 3 Antigen vaccine VO:0010323 Jie Zheng Xingxian Li vaccine Haemophilus capsular oligosaccharide vaccine VO:0010324 Jie Zheng Xingxian Li vaccine influenza A virus (H5N1) antigen vaccine VO:0010325 Jie Zheng Xingxian Li vaccine hepatitis A virus strain CR 326F antigen, inactivated vaccine VO:0010326 Jie Zheng Xingxian Li vaccine Varicella zoster virus glycoprotein E vaccine VO:0010327 Jie Zheng Xingxian Li vaccine hepatitis B virus subtype ADW2 HBsAg surface protein antigen vaccine VO:0010328 Jie Zheng Xingxian Li vaccine Varicella zoster virus glycoprotein E, recombinant vaccine VO:0010329 Jie Zheng Xingxian Li vaccine influenza A virus A/Victoria/361/2011 (H3N2) antigen vaccine VO:0010330 A route of administration that inject the material (such as vaccines, allergens) directly into a tumor. Jie Zheng site intratumoral route VO:0010331 A route of administration that inject the material (such as vaccines, allergens) directly into a lesion or into the skin. Jie Zheng site intralesional route VO:0010332 Antigen that is only expressed by tumor cells. Anna Maria Masci Barry Smith Jie Zheng Oliver He material entity tumor-specific antigen VO:0010333 Antigen that is overexpressed by tumor cells. Anna Maria Masci Barry Smith Jie Zheng Oliver He material entity tumor-associated antigen VO:0010334 Jie Zheng Xingxian Li Respiratory Syncytial Virus Vaccine ABRYSVO Active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age. https://www.fda.gov/media/171482/download?attachment 125768 vaccine ABRYSVO (STN 125768) vaccine VO:0010335 Jie Zheng Xingxian Li Respiratory Syncytial Virus Vaccine ABRYSVO Active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. https://www.fda.gov/media/168889/download?attachment 125769 vaccine ABRYSVO (STN 125769) vaccine VO:0010336 Jie Zheng Xingxian Li Influenza Vaccine Afluria Quadrivalent Southern Hemisphere Active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Afluria Quadrivalent is approved for use in persons 6 months of age and older. https://www.fda.gov/media/145736/download?attachment BL 125254 vaccine AFLURIA QUADRIVALENT SOUTHERN HEMISPHERE vaccine VO:0010337 Jie Zheng Xingxian Li Influenza Virus Vaccine (Trivalent, Types A and B) Afluria Southern Hemisphere Active immunization against influenza disease cause by influenza virus subtypes A and type B present in the vaccine. Afluria is approved for use in persons 6 months of age and older. https://www.fda.gov/media/145737/download?attachment BL 125254 vaccine AFLURIA SOUTHERN HEMISPHERE vaccine VO:0010338 Jie Zheng Xingxian Li Respiratory Syncytial Virus Vaccine, Adjuvanted AREXVY AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in: individuals 60 years of age and older; individuals 50 through 59 years of age who are at increased risk for LRTD caused by RSV https://www.fda.gov/media/167805/download?attachment 125775 vaccine AREXVY vaccine VO:0010339 Jie Zheng Xingxian Li Influenza A (H5N1) Monovalent Vaccine, Adjuvanted AUDENZ AUDENZ is an inactivated vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. AUDENZ is approved for use in persons 6 months of age and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine. https://www.fda.gov/media/135020/download?attachment 125692 vaccine AUDENZ vaccine VO:0010340 Jie Zheng Xingxian Li Pneumococcal 21-valent Conjugate Vaccine CAPVAXIVE CAPVAXIVE is indicated for: Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A,15B, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B inindividuals 18 years of age and older. Active immunization for the prevention of pneumonia caused by S. pneumoniaeserotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F,23A, 23B, 24F, 31, 33F, and 35B in individuals 18 years of age and older. The indication for the prevention of pneumonia caused by S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, and 35B is approved under accelerated approval based on immune responses as measured by opsonophagocytic activity (OPA) [see Clinical Studies (14.1)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. https://www.fda.gov/media/179426/download?attachment 125814 vaccine CAPVAXIVE vaccine VO:0010341 Jie Zheng Xingxian Li Anthrax Vaccine Adsorbed, Adjuvanted CYFENDUS For post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs https://www.fda.gov/media/170445/download?attachment 125761 vaccine CYFENDUS vaccine VO:0010342 Jie Zheng Xingxian Li Dengue Tetravalent Vaccine, Live VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5954 5954 DENGVAXIA For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 6 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas. https://www.fda.gov/media/124379/download?attachment 125682 vaccine DENGVAXIA vaccine VO:0010343 Jie Zheng Xingxian Li Ebola Zaire Vaccine, Live ERVEBO ERVEBO is a vaccine indicated for For the prevention of disease caused by Zaire ebolavirus in individuals 12 months of age and older. https://www.fda.gov/media/133748/download?attachment https://www.fda.gov/vaccines-blood-biologics/ervebo 125690 vaccine ERVEBO vaccine VO:0010344 Jie Zheng Xingxian Li Influenza Vaccine, Adjuvanted FLUAD QUADRIVALENT For active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine https://www.fda.gov/media/135432/download?attachment 125510 vaccine FLUAD QUADRIVALENT vaccine VO:0010345 Jie Zheng Xingxian Li Influenza Virus Vaccine (Quadrivalent, Types A and Types B) Fluzone High-Dose Quadrivalent Fluzone High-Dose Quadrivalent: For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. https://www.fda.gov/media/139731/download?attachment 103914 vaccine Fluzone High-Dose Quadrivalent vaccine VO:0010346 Jie Zheng Xingxian Li Influenza Virus Vaccine (Trivalent, Types A and B) Fluzone Intradermal Fluzone Intradermal Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone Intradermal Quadrivalent is approved for use in persons 18 through 64 years of age. https://www.fda.gov/media/106170/download?attachment BL 103914 vaccine Fluzone Intradermal vaccine VO:0010347 Jie Zheng Xingxian Li Measles, Mumps and Rubella Vaccine, Live ProQuad ProQuad(HSA) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age. https://www.fda.gov/media/75203/download?attachment 125108 vaccine Frozen Formulation - Human SerumAlbumin (HSA) - ProQuad vaccine VO:0010348 Jie Zheng Xingxian Li Chikungunya Vaccine, Live IXCHIQ For the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. https://www.fda.gov/media/173758/download?attachment 125777 vaccine IXCHIQ vaccine VO:0010349 Jie Zheng Xingxian Li Influenza A (H1N1) 2009 Monovalent Vaccine Active immunization of persons ages 18 years of age older against influenza disease caused by pandemic (H1N1) 2009 virus. https://www.fda.gov/media/77835/download?attachment 125163 vaccine Influenza A (H1N1) 2009 Monovalent Vaccine (ID Biomedical Corporation of Quebec) VO:0010350 Jie Zheng Xingxian Li Influenza Virus Vaccine, H5N1 (for National Stockpile) For active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine https://www.fda.gov/media/74534/download?attachment 125244 vaccine Influenza Virus Vaccine, H5N1 (for National Stockpile) VO:0010351 Jie Zheng Xingxian Li Smallpox and Monkeypox Vaccine, Live, Non-Replicating JYNNEOS For prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. https://www.fda.gov/media/131078/download?attachment 125678 vaccine JYNNEOS vaccine VO:0010352 Jie Zheng Xingxian Li Respiratory Syncytial Virus Vaccine MRESVIA MRESVIA is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. https://www.fda.gov/media/179005/download?attachment 125796 vaccine MRESVIA vaccine VO:0010353 Jie Zheng Xingxian Li Meningococcal (Groups A, C, Y, and W-135) Vaccine MenQuadfi MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older.MenQuadfi does not prevent N. meningitidis serogroup B disease. https://www.fda.gov/media/137306/download?attachment 125701 vaccine MenQuadfi vaccine VO:0010354 Jie Zheng Xingxian Li Meningococcal Groups A, B, C, W and Y Vaccine PENBRAYA PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. PENBRAYA is approved for use in individuals 10 through 25 years of age. https://www.fda.gov/media/173223/download?attachment 125770 vaccine PENBRAYA vaccine VO:0010355 Jie Zheng Xingxian Li Hepatitis B Vaccine (Recombinant) PREHEVBRIO For prevention of infection caused by all known subtypes of the hepatitis B virus in adults 18 years and older. https://www.fda.gov/media/154561/download?attachment 125737 vaccine PREHEVBRIO vaccine VO:0010356 Jie Zheng Xingxian Li Pneumococcal 20-valent Conjugate Vaccine PREVNAR 20 Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in individuals 6 weeks of age and older. Active immunization for the prevention of otitis media caused by S. pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F in individuals 6 weeks through 5 years of age. Active immunization for the prevention of pneumonia caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F in individuals 18 years of age and older. https://www.fda.gov/media/149987/download?attachment 125731 vaccine PREVNAR 20 vaccine VO:0010357 Jie Zheng Xingxian Li Measles, Mumps and Rubella Vaccine, Live ProQuad ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age. https://www.fda.gov/media/147563/download?attachment 125108 vaccine Proquad (Frozen) vaccine VO:0010358 Jie Zheng Xingxian Li Measles, Mumps and Rubella Vaccine, Live ProQuad ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age. https://www.fda.gov/media/75195/download?attachment 125108 vaccine Refrigerator-Stable Formulation - ProQuad vaccine VO:0010359 Jie Zheng Xingxian Li COVID-19 Vaccine, mRNA SPIKEVAX Active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. https://www.fda.gov/media/155675/download?attachment 125752 vaccine SPIKEVAX vaccine VO:0010360 Jie Zheng Xingxian Li Tetanus & Diphtheria Toxoids, Adsorbed TDVAX For active immunization for the prevention of tetanus and diptheria for use in persons 7 years of age or older. https://www.fda.gov/media/76430/download?attachment 101322 vaccine TDVAX (NDC 14362-0111) vaccine VO:0010361 Jie Zheng Xingxian Li Tick-Borne Encephalitis Vaccine TICOVAC For active immunization to prevent tick-borne encephalitis (TBE) in individuals 1 year of age and older. https://www.fda.gov/media/151502/download?attachment 125740 vaccine TICOVAC vaccine VO:0010362 Jie Zheng Xingxian Li Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine VAXELIS Active immunization against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib) in children 6 weeks through 4 years of age (prior to fifth birthday). https://www.fda.gov/media/119465/download?attachment 125563 vaccine VAXELIS vaccine VO:0010363 Jie Zheng Xingxian Li Varicella Virus Vaccine Live VARIVAX VARIVAX is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. https://www.fda.gov/media/76008/download?attachment BL 103552 vaccine Varivax (Frozen) vaccine VO:0010364 Jie Zheng Xingxian Li Varicella Virus Vaccine Live VARIVAX VARIVAX is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. https://www.fda.gov/media/76000/download?attachment BL 103552 vaccine Varivax (Refrigerator) vaccine VO:0010365 Jie Zheng Xingxian Li Zoster Vaccine, Live, (Oka/Merck) Zostavax For prevention of herpes zoster (shingles) in individuals 50 years of age and older. https://www.fda.gov/media/119879/download?attachment 125123 vaccine Zostavax (Frozen) vaccine VO:0010366 Jie Zheng Xingxian Li Zoster Vaccine, Live, (Oka/Merck) Zostavax For prevention of herpes zoster (shingles) in individuals 50 years of age and older. https://www.fda.gov/media/82524/download?attachment 125123 vaccine Zostavax (Refrigerator Stable) vaccine VO:0010367 Jie Zheng Xingxian Li Rotavirus Vaccine, Live, Oral ROTARIX For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9), for use in infants 6 weeks to 24 weeks of age. https://www.fda.gov/media/163010/download?attachment BL 125265 vaccine (Squeezable Tube Presentation) - ROTARIX vaccine VO:0010368 Jie Zheng Xingxian Li Influenza Virus Vaccine (Quadrivalent, Types A and Types B) Fluzone High-Dose Quadrivalent Southern Hemisphere Fluzone High-Dose Quadrivalent Southern Hemisphere is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. https://www.fda.gov/media/165357/download?attachment 103914 vaccine Fluzone High-Dose Quadrivalent Southern Hemisphere vaccine VO:0010369 Jie Zheng Xingxian Li Influenza Virus Vaccine (Quadrivalent, Types A and Types B) Fluzone Quadrivalent Fluzone Quadrivalent : For active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. It is approved for use in persons 6 months of age and older. https://www.fda.gov/media/119856/download?attachment 103914 vaccine Fluzone Quadrivalent 2022-2023 formula vaccine VO:0010370 Jie Zheng Xingxian Li Tetanus & Diphtheria Toxoids Adsorbed for Adult Use TDVAX For active immunization for the prevention of tetanus and diptheria for use in persons 7 years of age or older. https://www.fda.gov/media/117947/download?attachment 101322 vaccine TDVAX (NDC 13533) vaccine VO:0010371 Jie Zheng Xingxian Li Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine Pentacel For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel is approved for use as a four dose series in children 6 weeks through 4 years of age (prior to 5thbirthday). https://www.fda.gov/media/74385/download?attachment 125145 vaccine Pentacel MRC-5 vaccine VO:0010372 Jie Zheng Xingxian Li Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine Pentacel For active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel is approved for use as a four dose series in children 6 weeks through 4 years of age (prior to 5thbirthday). https://www.fda.gov/media/146048/download?attachment 125145 vaccine Pentacel - (inactivated poliovirus component grown in Vero cells) vaccine VO:0010373 Jie Zheng Xingxian Li Measles, Mumps and Rubella Vaccine, Live ProQuad ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age. https://www.fda.gov/media/147562/download?attachment 125108 vaccine (Refrigerated) - ProQuad vaccine VO:0010374 Jie Zheng Xingxian Li Measles, Mumps and Rubella Vaccine, Live ProQuad ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age. https://www.fda.gov/media/119880/download?attachment 125108 vaccine Frozen Formulation - Recombinant Human Albumin (RHA) - ProQuad vaccine VO:0010375 Patient information for M-M-R II vaccine Jie Zheng Xingxian Li Measles, Mumps, and Rubella Virus Vaccine, Live M-M-R II M-M-R II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.For active immunization against invasive meningococcal disease caused by Neisseria meningiditis serogroups A, C, Y, and W-135. Menomune – A/C/Y/W-135 vaccine is approved for use in persons 2 years of age and older. https://www.fda.gov/media/87361/download?attachment BL 101069 vaccine M-M-R II vaccine - patient VO:0010390 Jie Zheng Xingxian Li Quadracel Active immunization against diphtheria, tetanus, pertussis and poliomyelitis. A single dose of Quadracel is approved as a fifth dose in the diphtheria, tetanus, pertussis (DTaP) vaccination series, and as a fourth or fifth dose in the inactivated poliovirus (IPV) vaccination series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with Pentacel, DAPTACEL, and/or VAXELIS. https://www.fda.gov/media/91640/download?attachment BL 125525 vaccine Quadracel (inactivated poliovirus component grown in MRC-5 cells) vaccine VO:0010391 Jie Zheng Xingxian Li Quadracel Active immunization against diphtheria, tetanus, pertussis and poliomyelitis. A single dose of Quadracel is approved as a fifth dose in the diphtheria, tetanus, pertussis (DTaP) vaccination series, and as a fourth or fifth dose in the inactivated poliovirus (IPV) vaccination series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with Pentacel, DAPTACEL, and/or VAXELIS. https://www.fda.gov/media/146047/download?attachment BL 125525 vaccine Quadracel (inactivated poliovirus component grown in Vero cells) vaccine VO:0010393 A vaccine that is designed to immunize against a single antigen or single strain of a pathogen. Jie Zheng Xingxian Li role vaccine monovalent role VO:0010394 A vaccine that is designed to immunize against multiple antigen or multiple strain of a pathogen. Jie Zheng Xingxian Li role vaccine multivalent role VO:0010395 A period typically associated with a higher incidence of influenza virus infections, characterized by the increased circulation of flu viruses in a population. Flu viruses circulate year-round, but most cases are typically reported during the fall and winter months, a period known as flu season (CDC, 2022). The seasonality of flu varies globally, influenced by the distinct seasonal patterns of each hemisphere. Therefore, the flu season in the Northern Hemisphere often spans two calendar years, while in the Southern Hemisphere, it generally occurs within a single year. In temperate climate zones, peak flu activity typically occurs from October to April in the Northern Hemisphere and from April to October in the Southern Hemisphere (CDC, 2023; Kakoullis et al., 2023). In the United States, the flu season typically peaks between December and February, according to the CDC (2022). Ellen Zhang Jie Zheng Xingxian Li PMID: 37535890 https://www.cdc.gov/flu/about/season/index.html#:~:text=While%20influenza%20viruses%20spread%20year,varies%20from%20season%20to%20season https://www.cdc.gov/ncird/whats-new/flu-southern-hemisphere.html information content entity flu season VO:0010415 Jie Zheng Xingxian Li vaccine licensed human influenza virus vaccine VO:0010416 Jie Zheng Xingxian Li human influenza virus vaccine 2013-2014 VO:0010417 Jie Zheng Xingxian Li human influenza virus vaccine 2014-2015 VO:0010418 Jie Zheng Xingxian Li human influenza virus vaccine 2012-2013 VO:0010419 Jie Zheng Xingxian Li human influenza virus vaccine 2011-2012 VO:0010420 Jie Zheng Xingxian Li human influenza virus vaccine 2019-2020 VO:0010421 Jie Zheng Xingxian Li human influenza virus vaccine 2020 VO:0010422 Jie Zheng Xingxian Li human influenza virus vaccine 2016 VO:0010423 Jie Zheng Xingxian Li human influenza virus vaccine 2021-2022 VO:0010424 Jie Zheng Xingxian Li human influenza virus vaccine 2020-2021 VO:0010425 Jie Zheng Xingxian Li human influenza virus vaccine 2021 VO:0010426 Jie Zheng Xingxian Li human influenza virus vaccine 2010-2011 VO:0010427 Jie Zheng Xingxian Li human influenza virus vaccine 2015-2016 VO:0010428 Jie Zheng Xingxian Li human influenza virus vaccine 2022-2023 VO:0010429 Jie Zheng Xingxian Li human influenza virus vaccine 2023 VO:0010430 Jie Zheng Xingxian Li human influenza virus vaccine 2022 VO:0010431 Jie Zheng Xingxian Li human influenza virus vaccine 2018-2019 VO:0010432 Jie Zheng Xingxian Li human influenza virus vaccine 2016-2017 VO:0010433 Jie Zheng Xingxian Li human influenza virus vaccine 2017-2018 VO:0010434 Bacillus anthracis vaccine with license for human use. Jie Zheng 319 Anthrax vaccine, unspecified Anthrax vaccine, unspecified vaccine licensed human bacillus anthracis vaccine VO:0010435 Bordetella pertussis vaccine with license for human use. Jie Zheng 11 19033193 pertussis vaccine pertussis vaccine licensed human bordetella pertussis vaccine VO:0010436 Clostridium tetani vaccine with license for human use. Jie Zheng vaccine licensed human clostridium tetani vaccine VO:0010437 Haemophilus influenzae serotype b vaccine with license for human use. Jie Zheng vaccine licensed human haemophilus influenzae serotype b vaccine VO:0010438 Hepatitis A virus vaccine with license for human use. Jie Zheng vaccine licensed human hepatitis A virus vaccine VO:0010439 Hepatitis B virus vaccine with license for human use. Jie Zheng vaccine licensed human hepatitis B virus vaccine VO:0010440 Japanese encephalitis virus vaccine with license for human use. Jie Zheng vaccine licensed human Japanese encephalitis virus vaccine VO:0010441 Measles virus vaccine with license for human use. Jie Zheng 05 40213170 measles virus vaccine measles vaccine licensed human measles virus vaccine VO:0010442 Mumps virus vaccine with license for human use. Jie Zheng 07 40213185 mumps virus vaccine mumps vaccine licensed human mumps virus vaccine VO:0010443 Mycobacterium tuberculosis vaccine with license for human use. Jie Zheng vaccine licensed human mycobacterium tuberculosis vaccine VO:0010444 Neisseria meningitidis vaccine with license for human use. Jie Zheng vaccine licensed human neisseria meningitidis vaccine VO:0010445 Corynebacterium diphtheriae vaccine with license for human use. Jie Zheng vaccine licensed human orynebacterium diphtheriae vaccine VO:0010446 human papillomavirus vaccine with license for human use. Jie Zheng 137 40213321 HPV, unspecified formulation HPV, unspecified formulation vaccine licensed human papillomavirus vaccine VO:0010447 Poliovirus vaccine with license for human use. Jie Zheng vaccine licensed human poliovirus vaccine VO:0010448 Rabies virus vaccine with license for human use. Jie Zheng vaccine licensed human rabies virus vaccine VO:0010449 Rotavirus vaccine with license for human use. Jie Zheng vaccine licensed human rotavirus vaccine VO:0010450 Rubella virus vaccine with license for human use. Jie Zheng 06 40213223 rubella virus vaccine rubella vaccine licensed human rubella virus vaccine VO:0010451 Salmonella typhi vaccine with license for human use. Jie Zheng vaccine licensed human salmonella typhi vaccine VO:0010452 Smallpox virus vaccine with license for human use. Jie Zheng vaccine licensed human smallpox virus vaccine VO:0010453 Streptococcus pneumoniae vaccine with license for human use. Jie Zheng vaccine licensed human streptococcus pneumoniae vaccine VO:0010454 Tick-borne Encephalitis Virus (TBEV) vaccine with license for human use. Jie Zheng vaccine licensed human tick-borne encephalitis virus vaccine VO:0010455 Vibrio cholerae vaccine with license for human use. Jie Zheng vaccine licensed human vibrio cholerae vaccine VO:0010456 yellow fever virus vaccine with license for human use. Jie Zheng vaccine licensed human yellow fever virus vaccine VO:0010457 Jie Zheng Xingxian Li vaccine seasonal licensed human influenza virus vaccine VO:0010460 Jie Zheng organism SARS Coronavirus 2 XBB.1.5 VO:0010461 Oliver He vaccine-induced response vaccine-induced innate immune response VO:0010462 Oliver He vaccine-induced response vaccine-induced cell-mediated immune response VO:0010463 An immune biomarker that indicates a humoral immune response. Oliver He material entity humoral immune marker VO:0010464 An immune biomarker that indicates a cell-mediated immune response. Oliver He material entity cell-mediated immune marker VO:0010465 Oliver He PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile correlated profile of immune protection based on population coverage VO:0010466 Jie Zheng Lindsey N Anderson Oliver He specific correlate of protection PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile specific correlate of immune protection VO:0010467 Correlated profile of immune protection that reliably predicts vaccine efficacy across settings different from those studied in an efficacy trial. Jeremy Zucker Oliver He bCoP bridging correlate of protection PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile general correlate of immune protection VO:0010468 Oliver He PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile correlated profile of immune protection based on statistical level VO:0010469 Jie Zheng Lindsey N Anderson Oliver He cocorrelate PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile cocorrelate of immune protection VO:0010470 Jie Zheng Lindsey N Anderson Oliver He relative correlate PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile relative correlate of immune protection VO:0010471 Jie Zheng Lindsey N Anderson Oliver He absolute correlate PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile absolute correlate of immune protection VO:0010472 Jie Zheng Lindsey N Anderson Oliver He surrogate of protection PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile correlated profile of immune protection based on causality VO:0010473 Correlated profile of immune protection that is not a mechanistic causal agent of protection, but is still predictive of vaccine efficacy. Jeremy Zucker Jie Zheng Lindsey N Anderson Oliver He nCoP nonmechanistic correlate of immune protection PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile nonmechanistic correlate of immune protection VO:0010474 Correlated profile of immune protection that is mechanistically and causally responsible for protection. Jeremy Zucker Jie Zheng Lindsey N Anderson Oliver He mCoP mechanistic correlate of protection PMID:22437237 https://github.com/vaccineontology/VO/issues/603 process profile mechanistic correlate of immune protection VO:0010475 Jie Zheng vaccine licensed mink vaccine VO:0010476 Jie Zheng DTaP vaccine 20 40213291 diphtheria, tetanus toxoids and acellular pertussis vaccine vaccine Diphtheria, Tetanus, and acellular Pertussis vaccine VO:0010477 Coxiella burnetii vaccine that is licensed for use in humans. Jie Zheng 70 40213204 Q fever vaccine Q fever vaccine licensed human coxiella burnetii vaccine VO:0010478 Francisella tularensis vaccine that is licensed for use in humans. Jie Zheng 78 40213241 tularemia vaccine tularemia vaccine vaccine licensed human francisella tularensis vaccine VO:0010479 Borrelia burgdorferi vaccine that is licensed for use in humans preventing Lyme disease. Jie Zheng 66 40213167 Lyme disease vaccine Lyme disease vaccine licensed human Lyme disease vaccine VO:0010480 Rheumatic fever vaccine that is licensed for use in humans. Jie Zheng 72 40213210 rheumatic fever vaccine rheumatic fever vaccine licensed human rheumatic fever vaccine VO:0010481 Leprosy vaccine that is licensed for use in humans. Jie Zheng 65 40213166 leprosy vaccine leprosy vaccine licensed human leprosy vaccine VO:0010482 23 40213197 plague vaccine plague vaccine licensed human Yersinia pestis vaccine VO:0010483 Hantavirus vaccine that is licensed for use in humans. Jie Zheng 57 40213294 hantavirus vaccine hantavirus vaccine licensed human Hantavirus vaccine VO:0010484 Human immunodeficiency virus vaccine that is licensed for use in humans. Jie Zheng 61 40213318 human immunodeficiency virus vaccine HIV vaccine licensed human immunodeficiency virus vaccine VO:0010485 Junin virus vaccine that is licensed for use in humans. Jie Zheng 63 40213164 Junin virus vaccine Junin virus vaccine licensed human Junin virus vaccine VO:0010486 Rift Valley Fever virus vaccine that is licensed for use in humans. Jie Zheng 73 40213214 Rift Valley fever vaccine Rift Valley fever vaccine licensed human Rift Valley Fever virus vaccine VO:0010487 Licensed human smallpox virus vaccine that uses vaccinia virus. Jie Zheng 75 40213248 vaccinia (smallpox) vaccine vaccinia (smallpox) vaccine licensed human vaccinia virus vaccine VO:0010488 Leishmania vaccine is licensed for use in humans. Jie Zheng 64 40213165 leishmaniasis vaccine leishmaniasis vaccine licensed human Leishmania vaccine VO:0010489 malaria vaccine is licensed for use in humans. Jie Zheng 67 40213169 malaria vaccine malaria vaccine licensed human malaria vaccine VO:0010490 Melanoma vaccine that is licensed for use in humans. Jie Zheng 68 40213171 melanoma vaccine melanoma cancer vaccine licensed human melanoma vaccine VO:0010491 Parainfluenza 3 virus vaccine is licensed for use in humans. Jie Zheng 69 40213194 parainfluenza-3 virus vaccine parainfluenza-3 licensed human Parainfluenza 3 virus vaccine VO:0010632 Oliver He site country VO:0010633 USA is a country that exists in north America. Oliver He site USA VO:0010637 A viral vaccine that protects against infection with Rubella virus. Oliver He rubella vaccine vaccine Rubella virus vaccine VO:0010702 A vaccine regulation for vaccine safety. Oliver He process vaccine saftey regulation VO:0010704 A vaccine regulatory process that is for vaccine regulatory agent to review vaccine license application from vaccine producer. Oliver He process review of vaccine license application VO:0010705 Allen Xiang Oliver He Actacel VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=554 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=555 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=557 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=761 554 555 557 761 Actacel vaccine Actacel vaccine VO:0010706 Allen Xiang Oliver He Avaxim VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=559 559 Avaxim vaccine Avaxim vaccine VO:0010707 Allen Xiang Oliver He Avaxim - Pediatric VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=560 560 Avaxim - Pediatric vaccine Avaxim - Pediatric vaccine VO:0010708 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=3231 3231 BCG Vaccine (Freeze-Dried) vaccine BCG vaccine (Freeze-Dried) (by Sanofi Pasteur) VO:0010709 Allen Xiang Oliver He DT Polio Adsorbed VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=563 563 DT Polio Adsorbed vaccine DT Polio Adsorbed vaccine VO:0010710 Allen Xiang Oliver He Dukoral VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=567 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=759 567 759 Dukoral vaccine Dukoral vaccine VO:0010711 Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=323 https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm110102.htm 323 ENGERIX-B ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM224503.pdf 103239 vaccine Engerix-B vaccine VO:0010712 A Measles-Rubella vaccine that is live attenuated and manufactured by GlaxoSmithKline Biologicals. Allen Xiang Oliver He Eolarix VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=568 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=569 568 569 Eolarix vaccine Eolarix vaccine VO:0010713 Allen Xiang Oliver He Epaxal VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=570 570 vaccine Epaxal vaccine VO:0010714 todo: assign parent immunogen: TBE Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=742 742 FSME - IMMUN vaccine FSME - IMMUN VO:0010715 Allen Xiang Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=572 http://purl.bioontology.org/ontology/RXNORM/683648 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179527.htm 572 HIBERIX For active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b. HIBERIX is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday). https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM179530.pdf 125347 vaccine Hiberix vaccine VO:0010716 Allen Xiang Oliver He Imovax Polio VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=573 573 Imovax Polio vaccine Imovax Polio vaccine VO:0010717 Allen Xiang Oliver He Imovax Rabies (Canada) Imovax Rabies vaccine Imovax Rabies (Canada) vaccine VO:0010718 A poliovirus vaccine that contains inactivtated Poliomyelitis to prevent disease caused from the vaccine. Allen Xiang Hector Guzman-Orozco Oliver He Inactived Poliomyelitis Vaccine - IPV vaccine Inactivated Poliomyelitis vaccine - IPV VO:0010719 A combination vaccine that protects infants from diphtheria, tetanus, pertussis (whooping cough), polio, hepatitis B and Haemophilus influenzae type b (Hib). Allen Xiang Oliver He Infanrix-hexa VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=578 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=579 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=581 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=582 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=583 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=763 http://www.immune.org.nz/vaccines/available-vaccines/infanrix-hexa 578 579 581 582 583 763 Infanrix-hexa vaccine Infanrix-hexa vaccine VO:0010720 Allen Xiang Oliver He Infanrix/Hib VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=584 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=585 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=587 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=762 584 585 587 762 Infanrix/Hib vaccine Infanrix/Hib vaccine VO:0010721 Allen Xiang Oliver He Infanrix-IPV VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=588 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=589 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=591 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=767 588 589 591 767 Infanrix-IPV vaccine Infanrix-IPV vaccine VO:0010722 Allen Xiang Oliver He Infanrix -IPV/Hib VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=592 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=593 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=595 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=596 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=764 592 593 595 596 764 Infanrix -IPV/Hib vaccine Infanrix -IPV/Hib vaccine VO:0010723 Allen Xiang Oliver He Liquid Pedvax HIB vaccine Liquid Pedvax HIB vaccine VO:0010724 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=598 598 Meningitec vaccine Meningitec vaccine VO:0010725 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=599 599 Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C vaccine meningococcal polysaccharide vaccine, Groups A & C, Menomune A/C VO:0010726 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=600 600 Menjugate vaccine Menjugate vaccine VO:0010727 Menomune A/C/Y/W-135 Allen Xiang Oliver He Trade Name: Menomune A/C/Y/W-135 obsolete Menomune A/C/Y/W-135 vaccine true VO:0010728 A live attenuated V. cholerae vaccine that is manufactured by Berna Biotech, Ltd. This vaccine uses the V. Cholera strain CVD 103-HGR. Allen Xiang Oliver He Mutacol VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=780 780 Mutacol vaccine Trade Name: Mutacol Mutacol vaccine VO:0010729 Allen Xiang Oliver He Neisvac-C VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=603 603 Neisvac-C vaccine Neisvac-C vaccine VO:0010730 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=604 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=605 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=607 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=608 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=766 604 605 607 608 766 Pediacel vaccine Pediacel vaccine VO:0010731 A polyvalent pneumococcal vaccine used to protectsagainst serious infection (e.g., meningitis, bacteria in the blood) due to Streptococcus pneumoniae, and it is manufactured by Sanofi Pasteur. Allen Xiang Oliver He PNEUMO (PNU-IMUNE) Pnu-Imune Pnu-Imune 23 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=615 https://www.webmd.com/drugs/2/drug-5547/pnu-imune-injection/details 615 Pneumo 23 vaccine Generic Name: pneumococcal vaccine polyvalent (Intramuscular route, Subcutaneous route) Pneumo 23 VO:0010732 Allen Xiang Oliver He Trade Name: Pneumovax 23 obsolete Pneumovax 23 (Canada) true VO:0010733 Allen Xiang Oliver He https://www.prevnar13.com/ Trade Name: Prevnar obsolete Prevnar (Canada) true VO:0010734 A MMR vaccine that is manufactured by GlaxoSmithKline Biologicals. Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6143 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=616 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=617 6143 616 617 Priorix For active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. https://www.fda.gov/media/158941/download?attachment 125748 vaccine Priorix vaccine VO:0010735 A Measles-Mumps-Rubella-Vericella vaccine that is live attenuated and manufactured by GlaxoSmithKline Biologicals. Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=619 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=620 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=621 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=622 619 620 621 622 Priorix-Tetra vaccine Priorix-Tetra vaccine VO:0010736 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=623 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=624 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=626 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=770 http://purl.bioontology.org/ontology/RXNORM/1607804 623 624 626 770 Quadracel Active immunization against diphtheria, tetanus, pertussis and poliomyelitis. A single dose of Quadracel is approved as a fifth dose in the diphtheria, tetanus, pertussis (DTaP) vaccination series, and as a fourth or fifth dose in the inactivated poliovirus (IPV) vaccination series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with Pentacel, DAPTACEL, and/or VAXELIS. https://www.fda.gov/vaccines-blood-biologics/vaccines/quadracel BL 125525 vaccine Quadracel vaccine VO:0010737 Kallan Roan Oliver He Recombivax HB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=322 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm110098.htm 322 RECOMBIVAX HB RECOMBIVAX HB is indicated for vaccination against infection caused by all known subtypes of hepatitis B virus. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM110114.pdf BL 101066 vaccine Recombivax HB vaccine VO:0010738 todo: assign parent immunogen: ROT Allen Xiang Kallan Roan Oliver He ROTARIX VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=343 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm133920.htm 343 Rotarix For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9), for use in infants 6 weeks to 24 weeks of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM133539.pdf BL 125265 vaccine Rotarix vaccine VO:0010739 Allen Xiang Oliver He Td Adsorbed VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=627 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=771 627 771 Td Adsorbed vaccine Td Adsorbed vaccine VO:0010742 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=632 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=633 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=778 632 633 778 Tripacel vaccine Tripacel vaccine VO:0010743 Allen Xiang Oliver He Twinrix Junior VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=637 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=638 637 638 Twinrix Junior vaccine Twinrix Junior vaccine VO:0010744 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=639 639 Typherix vaccine Typherix vaccine VO:0010745 Allen Xiang Kallan Roan Oliver He Vaqta VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=321 321 VAQTA For the prevention of disease cause by hepatitis A virus (HAV) in persons 12 months of age and older. https://www.fda.gov/media/74519/download?attachment BL 103606 vaccine Vaqta vaccine VO:0010746 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=640 640 vaccine Trade Name: Varilrix Varilrix vaccine VO:0010747 Allen Xiang Oliver He Varivax III VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=641 641 vaccine Trade Name: Varivax III Varivax III vaccine VO:0010748 Allen Xiang Oliver He Vivaxim VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=643 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=644 643 644 vaccine Vivaxim vaccine VO:0010749 Allen Xiang Oliver He Vivotif (Canada) Vivotif vaccine Vivotif vaccine (Canada) VO:0010751 a protein from a bacterium Allen Xiang Oliver He protein bacterium protein VO:0010752 Allen Xiang Oliver He protein G+ bacterium protein VO:0010753 Allen Xiang Oliver He protein G- bacterium protein VO:0010754 a protein from a virus Allen Xiang Oliver He protein virus protein VO:0010755 a protein from a parasite Allen Xiang Oliver He protein parasite protein VO:0010756 a protein from fungus Allen Xiang Oliver He protein fungus protein VO:0010757 Allen Xiang Oliver He protein Bacillus anthracis protein VO:0010758 Allen Xiang Oliver He protein Brucella protein VO:0010759 Allen Xiang Oliver He protein Yersinia pestis protein VO:0010760 Allen Xiang Oliver He protein Francisella tularensis protein VO:0010761 Allen Xiang Oliver He protein Ebola virus protein VO:0010762 Allen Xiang Oliver He protein Clostridium botulinum protein VO:0010763 Allen Xiang Oliver He protein Lassa Fever Virus protein VO:0010764 Allen Xiang Oliver He protein Variola virus protein VO:0010765 Allen Xiang Oliver He protein Campylobacter jejuni protein VO:0010766 Allen Xiang Oliver He protein Escherichia coli protein VO:0010767 Allen Xiang Oliver He protein Human Immunodeficiency Virus protein VO:0010768 Allen Xiang Oliver He protein Hantavirus protein VO:0010769 Allen Xiang Oliver He protein Marburg Virus protein VO:0010770 Allen Xiang Oliver He protein Mycobacterium tuberculosis protein VO:0010771 Allen Xiang Oliver He protein Plasmodium spp. protein VO:0010772 Allen Xiang Oliver He protein Haemophilus influenzae protein VO:0010773 Allen Xiang Oliver He protein Coxiella burnetii protein VO:0010774 Allen Xiang Oliver He protein VEE Virus protein VO:0010775 Allen Xiang Oliver He protein Clostridium tetani protein VO:0010776 Allen Xiang Oliver He protein Salmonella spp. protein VO:0010777 Allen Xiang Oliver He protein Shigella protein VO:0010778 Allen Xiang Oliver He protein Neisseria meningitidis protein VO:0010779 Allen Xiang Oliver He protein Streptococcus pneumoniae protein VO:0010780 Allen Xiang Oliver He protein Hepatitis A virus protein VO:0010781 Allen Xiang Oliver He protein Hepatitis B virus protein VO:0010782 Allen Xiang Oliver He protein Influenza virus protein VO:0010783 Allen Xiang Oliver He protein Japanese encephalitis virus protein VO:0010784 Allen Xiang Oliver He protein Measles virus protein VO:0010785 Allen Xiang Oliver He protein Mumps virus protein VO:0010786 Allen Xiang Oliver He protein Human papillomavirus protein VO:0010787 Allen Xiang Oliver He protein Poliovirus protein VO:0010788 Allen Xiang Oliver He protein Rabies virus protein VO:0010789 Allen Xiang Oliver He protein Rotavirus protein VO:0010790 Allen Xiang Oliver He protein Rubella virus protein VO:0010791 Allen Xiang Oliver He protein Yellow fever virus protein VO:0010792 Allen Xiang Oliver He protein Varicella-zoster virus protein VO:0010793 Allen Xiang Oliver He protein Tick-borne Encephalitis Virus (TBEV) protein VO:0010794 Allen Xiang Oliver He protein Chlamydophila pneumoniae protein VO:0010795 Allen Xiang Oliver He protein Chlamydia muridarum protein VO:0010796 Allen Xiang Oliver He protein Yersinia pseudotuberculosis protein VO:0010797 Allen Xiang Oliver He protein Bovine Leukemia virus protein VO:0010798 Allen Xiang Oliver He protein Corynebacterium diphtheriae protein VO:0010799 Allen Xiang Oliver He protein Porcine circovirus 2 protein VO:0010800 Allen Xiang Oliver He protein Pseudorabies virus protein VO:0010801 Allen Xiang Oliver He protein Classical swine fever virus protein VO:0010802 Allen Xiang Oliver He protein Bovine herpesvirus 1 protein VO:0010803 Allen Xiang Oliver He protein West Nile virus protein VO:0010804 Allen Xiang Oliver He protein Marek's disease virus protein VO:0010805 Allen Xiang Oliver He protein Newcastle disease virus protein VO:0010806 Allen Xiang Oliver He protein Feline leukemia virus protein VO:0010807 Allen Xiang Oliver He protein Canine parvovirus protein VO:0010808 Allen Xiang Oliver He protein Canine coronavirus protein VO:0010809 Allen Xiang Oliver He protein Canine distemper virus protein VO:0010810 Allen Xiang Oliver He protein Infectious Hematopoietic Necrosis Virus protein VO:0010811 Allen Xiang Oliver He protein Lawsonia intracellularis protein VO:0010812 Allen Xiang Oliver He protein Porphyromonas gulae protein VO:0010813 Allen Xiang Oliver He protein Yersinia ruckeri protein VO:0010814 Allen Xiang Oliver He protein Aeromonas salmonicida protein VO:0010815 Allen Xiang Oliver He protein Vibrio anguillarum (Listonella anguillarum) protein VO:0010816 Allen Xiang Oliver He protein Streptococcus equi protein VO:0010817 Allen Xiang Oliver He protein Chlamydophila abortus protein VO:0010818 Allen Xiang Oliver He protein Mycoplasma synoviae protein VO:0010819 Allen Xiang Oliver He protein Mycoplasma gallisepticum protein VO:0010820 Allen Xiang Oliver He protein Bordetella avium protein VO:0010821 Allen Xiang Oliver He protein Actinobacillus pleuropneumoniae protein VO:0010822 Allen Xiang Oliver He protein Eimeria spp. protein VO:0010823 Allen Xiang Oliver He protein Eimeria tenella protein VO:0010824 Allen Xiang Oliver He protein Theileria parva protein VO:0010825 Allen Xiang Oliver He protein Theileria annulata protein VO:0010826 Allen Xiang Oliver He protein Toxoplasma gondii protein VO:0010827 Allen Xiang Oliver He protein Babesia bovis protein VO:0010828 Allen Xiang Oliver He protein Neospora caninum protein VO:0010829 Allen Xiang Oliver He protein Giardia duodenalis protein VO:0010830 Allen Xiang Oliver He protein Sarcocystis neurona protein VO:0010831 Allen Xiang Oliver He protein Babesia canis protein VO:0010832 Allen Xiang Oliver He protein Leishmania donovani protein VO:0010833 Allen Xiang Oliver He protein Eimeria maxima protein VO:0010834 Allen Xiang Oliver He protein Herpes simplex virus type 1 and 2 protein VO:0010835 Allen Xiang Oliver He protein Leishmania major protein VO:0010836 Allen Xiang Oliver He protein Leishmania infantum protein VO:0010837 Allen Xiang Oliver He protein Leishmania amazonensis protein VO:0010838 Allen Xiang Oliver He protein Trypanosoma cruzi protein VO:0010839 Allen Xiang Oliver He protein Chlamydophila psittaci protein VO:0010840 Allen Xiang Oliver He protein Burkholderia pseudomallei protein VO:0010841 Allen Xiang Oliver He protein Western equine encephalomyelitis virus protein VO:0010842 Allen Xiang Oliver He protein Cryptosporidium parvum protein VO:0010843 Allen Xiang Oliver He protein Hendra virus protein VO:0010844 Allen Xiang Oliver He protein Dengue Virus protein VO:0010845 Allen Xiang Oliver He protein Nipah virus protein VO:0010846 Allen Xiang Oliver He protein Rickettsia spp protein VO:0010847 Allen Xiang Oliver He protein Bordetella pertussis protein VO:0010848 Allen Xiang Oliver He protein Vibrio cholerae protein VO:0010849 Allen Xiang Oliver He protein Rift Valley Fever virus protein VO:0010850 Allen Xiang Oliver He protein SARS-CoV protein VO:0010851 Allen Xiang Oliver He protein Yersinia enterocolitica protein VO:0010852 Allen Xiang Oliver He protein Entamoeba histolytica protein VO:0010853 Allen Xiang Oliver He protein Coccidioides spp. protein VO:0010854 Allen Xiang Oliver He protein Trypanosoma brucei protein VO:0010855 Allen Xiang Oliver He protein Helicobacter pylori protein VO:0010856 Allen Xiang Oliver He protein IMMUNOGENICITY: Induces antigen-specific Th1 immune response, as indicated by the specific induction of serum IgG2a, but not IgG1, antibodies and by the secretion of IFN-alpha but not IL-4, by the Cu/Zn SOD-stimulated splenocytes. Has been used for vaccine development [PubMed: 10816475][PubMed: 11953393][PubMed: 12933826]. MUTATION: An isogenic sodC mutant constructed from B abortus 2308 by gene replacement exhibited much greater susceptibility to killing by exogenous O(2)(-) than the parental 2308 strain, supporting a role for SodC in protecting this bacterium from O(2)(-) stress. The B abortus sodC mutant was much more sensitive to killing by cultured resident peritoneal macrophages from C57BL6J mice than 2308, and its attenuation in cultured murine macrophages was enhanced when these phagocytes were treated with gamma interferon. The attenuation of the B abortus sodC mutant in both resting and IFN-gamma-activated macrophages was alleviated in the presence of the NADPH oxidase inhibitor apocynin. Consistently, the B abortus sodC mutant also displayed significant attenuation in infected C57BL6J mice compared to the parental strain. These findings suggest that SodC protects B abortus 2308 from the respiratory burst of host macrophages [PubMed: 15845493]. SodC from B. abortus strain 2308 VIOLILN Protegen ID: 3; NCBI Protein GI: 83269434; NCBI Protein Accession: YP_418725.1; NCBITaxon: 234 VO:0010857 Allen Xiang Oliver He protein Lef from B. anthracis str. A2012 Protegen ID: 5; NCBI Gene GI: 1158731; NCBI Protein GI: 40646957; NCBI Protein Accession: AAR88323.1; NCBITaxon: 32630 VO:0010858 Allen Xiang Oliver He protein EBOV GP Protegen ID: 10; NCBI Gene GI: 955190 VO:0010859 Allen Xiang Oliver He protein EBOV NP Protegen ID: 11; NCBI Gene GI: 955194; NCBI Protein GI: 22789223; NCBI Protein Accession: NP_690580; NCBITaxon: 186539 VO:0010860 Allen Xiang Oliver He protein VP24 from Reston ebolavirus Protegen ID: 12; NCBI Gene GI: 955193; NCBI Protein GI: 22789228; NCBI Protein Accession: NP_690586; NCBITaxon: 186539 VO:0010861 Allen Xiang Oliver He protein VP40 from Reston ebolavirus Protegen ID: 13; NCBI Gene GI: 955192; NCBI Protein GI: 22789225; NCBI Protein Accession: NP_690582; NCBITaxon: 186539 VO:0010862 Allen Xiang Oliver He protein VP30 from Reston ebolavirus Protegen ID: 14; NCBI Gene GI: 955196; NCBI Protein GI: 22789227; NCBI Protein Accession: NP_690585; NCBITaxon: 186539 VO:0010863 Allen Xiang Oliver He protein VP35 from Reston ebolavirus Protegen ID: 15; NCBI Gene GI: 955189; NCBI Protein GI: 22789224; NCBI Protein Accession: NP_690581; NCBITaxon: 186539 VO:0010864 Allen Xiang Oliver He protein VP35 expressed from alphavirus replicons induced a protective immune response in C57BL/6 mice when challenged with Ebola virus Zaire [PubMed: 11485406]. VP35 from Zaire ebolavirus Protegen ID: 16; NCBI Gene GI: 911827; NCBI Protein GI: 10313992; NCBI Protein Accession: NP_066244; NCBITaxon: 186538 VO:0010865 Allen Xiang Oliver He protein Recombinant Tbp1 and Tbp2 proteins were expressed from Escherichia coli and antisera were raised to the purified proteins. In a passive model of bacteraemia, infant rats were protected from challenge with Hib after transfer of anti-rTbp2 antiserum, but not after anti-rTbp1 antiserum [PubMed: 8830248]. Tbp2 Protegen ID: 277; NCBI Gene GI: 3430457; NCBI Protein GI: 68249580; NCBI Protein Accession: YP_248692; NCBITaxon: 281310 VO:0010866 Allen Xiang Oliver He protein VP24 expressed from alphavirus replicons induced a protective immune response in BALB/c mice when challenged with Ebola virus Zaire [PubMed: 11485406]. VP24 from Zaire ebolavirus Protegen ID: 17; NCBI Gene GI: 911828; NCBI Protein GI: 10313998; NCBI Protein Accession: NP_066250; NCBITaxon: 186538 VO:0010867 Allen Xiang Oliver He protein VP30 expressed from alphavirus replicons induced a protective immune response in BALB/c mice when challenged with Ebola virus Zaire [PubMed: 11485406]. VP30 from Zaire ebolavirus Protegen ID: 18; NCBI Gene GI: 911826; NCBI Protein GI: 10313997; NCBI Protein Accession: NP_066249; NCBITaxon: 186538 VO:0010868 Allen Xiang Oliver He protein Vaccination of BALB/c or C57BL/6 mice with eVLPs, composed of the EBOV glycoprotein and matrix viral protein (VP)40 with a lipid membrane, in conjunction with QS-21 adjuvant resulted in mixed IgG subclass responses, a Th1-like memory cytokine response, and protection from lethal EBOV challenge [PubMed: 16002721]. VP40 expressed from alphavirus replicons induced a protective immune response in BALB/c mice when challenged with Ebola virus Zaire [PubMed: 11485406]. VP40 from Zaire ebolavirus Protegen ID: 19; NCBI Gene GI: 911825; NCBI Protein GI: 10313993; NCBI Protein Accession: NP_066245; NCBITaxon: 186538 VO:0010869 Allen Xiang Oliver He protein HLA-A*0201 mice immunized with either GPC(42-50) from LASVsSgp2 glycoprotein or GPC(60-68) were protected against challenge with a recombinant vaccinia virus that expressed LASV GPC [PubMed: 16912286]. LASVsSgp2 glycoprotein Protegen ID: 20; NCBI Gene GI: 956585; NCBI Protein GI: 23343511; NCBI Protein Accession: NP_694870; NCBITaxon: 11620 VO:0010870 Allen Xiang Oliver He protein Caf1 from Y. pestis biovar Microtus str. 91001 Protegen ID: 23; NCBI Gene GI: 2767670; NCBI Protein GI: 45478667; NCBI Protein Accession: NP_995523; NCBITaxon: 229193 VO:0010871 Allen Xiang Oliver He protein It has previously been shown that a DNA subunit vaccine (4pox) based on four orthopoxvirus immunogens (L1R, B5R, A27L and A33R) can produce protective immunity against lethal orthopoxvirus challenges in mice and nonhuman primates. the immunogenicity of an L1R construct to which a tissue plasminogen activator signal sequence was placed in frame with the full-length L1R gene was tested. When the tPA-L1R construct was substituted for the unmodified L1R gene in the 4pox vaccine, given as a prime and single boost, animals were better protected from lethal challenge with vaccinia virus (VACV) [PubMed: 18485547]. L1R from Monkeypox virus Zaire-96-I-16 Protegen ID: 28; NCBI Gene GI: 928938; NCBI Protein GI: 17974998; NCBI Protein Accession: NP_536512; NCBITaxon: 619591 VO:0010872 Allen Xiang Oliver He protein PagA from B. anthracis str. Ames Ancestor Protegen ID: 32; NCBI Gene GI: 2820165; NCBI Protein GI: 47566476; NCBI Protein Accession: NC_007322.2 VO:0010873 Allen Xiang Oliver He protein Lef from B. anthracis str. Ames Ancestor Protegen ID: 38; NCBI Gene GI: 2820148; NCBI Protein GI: 47566484; NCBI Protein Accession: NC_007322.2 VO:0010874 Allen Xiang Oliver He protein MAb BA5 protected animals against plague, neutralized the Y. pestis type III secretion pathway and promoted opsonophagocytic clearance of bacteria in blood. LcrV residues 196-225 were necessary and sufficient for MAb BA5 binding. These results identify LcrV residues 196-225 as a linear epitope that is recognized by the murine immune system to confer plague protection [PubMed: 20005318]. LcrV from y. pestis CO92 Protegen ID: 44; NCBI Gene GI: 1172676; NCBI Protein GI: 16082719; NCBI Protein Accession: NP_395165; NCBITaxon: 214092 VO:0010875 Allen Xiang Oliver He protein An LcrV variant lacking amino acid residues 271 to 300 (rV10) elicited immune responses that protected mice against a lethal challenge with Y. pestis [PubMed: 16041032]. LcrV from Y. pestis KIM 10 Protegen ID: 45; NCBI Gene GI: 1149310; NCBI Protein GI: 31795491; NCBI Protein Accession: NP_857946; NCBITaxon: 187410 VO:0010876 Allen Xiang Oliver He protein V antigen Protegen ID: 46; NCBI Gene GI: 4118094 VO:0010877 Allen Xiang Oliver He protein Study evaluated the humoral immune response of mice that survived lethal Y. pestis aerosol challenge after antibiotic treatment. Results indicated that one of the predominant antibody response of mice surviving pneumonic plague after treatment with antibiotics was to pla [PubMed: 10085037]. Pla Protegen ID: 48; NCBI Gene GI: 1172643; NCBI Protein GI: 16082686; NCBI Protein Accession: NP_395233; NCBITaxon: 214092 VO:0010878 Allen Xiang Oliver He protein The type III secretion apparatus encoded on the low-calcium response (LCR) virulence plasmid, pCD1 in strain KIM5, of Y. pestis is a conserved virulence mechanism that is absolutely required for virulence of Y. pestis. YscF is a surface localized protein required both to secrete Yops and to translocate toxins into eukaryotic cells. YscF polymerization is possibly required for a YscF needle to puncture eukaryotic cell membranes. It is also likely that YscF and its homologs function to provide a base that a translocon complex is built upon, or that YscF builds a conduit from the bacterium to the eukaryotic membrane - this suggestion seems more likely given that other proteins such as YopB, YopD, and LcrV are also required for translocation into eukaryotic cells. YscF is thought to be a surface-expressed protein in Y. pestis and is required for virulence. YscF has been found to function as a protective antigen against experimental plague infection [PubMed: 15978133]. YopD from Y. pestis CO92 Protegen ID: 49; NCBI Gene GI: 1172673; NCBI Protein GI: 16082716; NCBI Protein Accession: NP_395162; NCBITaxon: 214092 VO:0010879 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. Glu-tRNA Gln Amidotransferase (CP #3, gatA) was found to be protective. Three of the clones (CP #1) elicited protection that was statistically higher than the unvaccinated control, which has high variance [PubMed: 15811648]. Note: Part of CP #3 also belongs to gatB GatA Protegen ID: 422; NCBI Protein GI: 62184918; NCBITaxon: 218497 VO:0010880 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. Glu-tRNA Gln Amidotransferase (CP #3, gatB) was found to be protective. Three of the clones (CP #1) elicited protection that was statistically higher than the unvaccinated control, which has high variance [PubMed: 15811648]. Note: Part of CP #3 also belongs to gatA GatB Protegen ID: 424; NCBI Protein GI: 62147986; NCBITaxon: 218497 VO:0010881 Allen Xiang Oliver He protein The MOMP (omp1) DNA immunization induced a non-specific and partial protection in OF1 outbred mice fetuses against challenge with C. abortus [PubMed: 12488563]. Omp1 Protegen ID: 425; NCBI Protein GI: 40601; NCBITaxon: 83555 VO:0010882 Allen Xiang Oliver He protein In pregnant mice, the dnaK vaccine induced a non-specific partial protection from abortion after challenge with Chlamydophila abortus [PubMed: 12056482]. DnaK from Chlamydophila abortus Protegen ID: 426; NCBI Protein GI: 26006347; NCBITaxon: 83555 VO:0010883 Allen Xiang Oliver He protein The immunogenicity and protective effect of recombinant LcrE protein combined either with Freund's or Alum adjuvant were investigated in mice. The immunization with both protocols resulted in a significant reduction of the number of viable C. pneumoniae in the lungs after challenge. Results confirm that LcrE induces protective immunity in mice [PubMed: 19451031]. LcrE Protegen ID: 428; NCBI Gene GI: 895078; NCBI Protein GI: 15618244; NCBI Protein Accession: NP_224529; NCBITaxon: 115713 VO:0010884 Allen Xiang Oliver He protein Results of this study showed that intranasal immunization of BALB/c mice with heat-aggregated CopN protein and an Escherichia coli heat-labile toxin (LT) induced a strong immune response. The immunization induced statistically significant protection against intranasal C. pneumoniae challenge, the level of which correlated with the magnitude of CopN-specific lymphocyte proliferation [PubMed: 16949182]. CopN Protegen ID: 429; NCBI Protein GI: 33241669; NCBITaxon: 182082 VO:0010885 Allen Xiang Oliver He protein Following vaginal challenge with live Chlamydia, the groups of female BALB/c mice immunized intra-abdominally with TC0512 showed significant levels of protection when compared to negative control animals. At 9 days following challenge TC0512 showed a 73% reduction in the number of recoverable Chlamydia compared with vector only immunized controls [PubMed: 17239501]. TC0512 outer membrane protein, putative Protegen ID: 430; NCBI Gene GI: 1245872; NCBI Protein GI: 15835130; NCBI Protein Accession: NP_296889; NCBITaxon: 243161 VO:0010886 Allen Xiang Oliver He protein Following vaginal challenge with live Chlamydia, the groups of female BALB/c mice immunized intra-abdominally with TC0757 showed significant levels of protection when compared to negative control animals [PubMed: 17239501]. TC0757 hypothetical protein Protegen ID: 431; NCBI Gene GI: 1246122; NCBI Protein GI: 15835371; NCBI Protein Accession: NP_297130; NCBITaxon: 243161 VO:0010887 Allen Xiang Oliver He protein Following vaginal challenge with live Chlamydia, the groups of female BALB/c mice immunized intra-abdominally with TC0439 showed significant levels of protection when compared to negative control animals [PubMed: 17239501]. TC0439 adherence factor Protegen ID: 432; NCBI Gene GI: 1245792; NCBI Protein GI: 15835057; NCBI Protein Accession: NP_296816; NCBITaxon: 243161 VO:0010888 Allen Xiang Oliver He protein Following vaginal challenge with live Chlamydia, the groups of female BALB/c mice immunized intra-abdominally with TC0767/768 showed significant levels of protection when compared to negative control animals [PubMed: 17239501]. TC0767 hypothetical protein Protegen ID: 433; NCBI Gene GI: 1246132; NCBI Protein GI: 15835381; NCBI Protein Accession: NP_297140; NCBITaxon: 243161 VO:0010889 Allen Xiang Oliver He protein Following vaginal challenge with live Chlamydia, the groups of female BALB/c mice immunized intra-abdominally with TC0767/768 showed significant levels of protection when compared to negative control animals [PubMed: 17239501]. TC0768 hypothetical protein Protegen ID: 434; NCBI Gene GI: 1246133; NCBI Protein GI: 15835382; NCBI Protein Accession: NP_297141; NCBITaxon: 243161 VO:0010890 Allen Xiang Oliver He protein Female BALB/c mice were immunized with chlamydial major outer membrane protein (MOMP) mixed with cholera toxin and CpG oligodeoxynucleotide adjuvants by either the IN or TCI routes. Both intranasal and transcutaneous immunization protected mice against respiratory challenge with Chlamydia [PubMed: 16153755]. MOMP Protegen ID: 435; NCBI Protein GI: 1518659; NCBITaxon: 83560 VO:0010891 Allen Xiang Oliver He protein Mice vaccinated with DCs transfected with individual Chlamydia protein PmpG-1(25-500), RplF, or PmpE/F-2(25-575) exhibited significant resistance to challenge infection. Overall, vaccination with DCs transfected with PmpG-1(25-500) exhibited the greatest degree of protective immunity among the four Chlamydia Ags tested [PubMed: 19155509]. PmpG-1 Protegen ID: 436; NCBI Gene GI: 1246433; NCBI Protein GI: 15834883; NCBI Protein Accession: NP_296642; NCBITaxon: 243161 VO:0010892 Allen Xiang Oliver He protein Mice vaccinated with DCs transfected with individual Chlamydia protein PmpG-1(25-500), RplF, or PmpE/F-2(25-575) exhibited significant resistance to challenge infection. In addition, RplF was able to engender protective immunity against challenge with C. muridarum [PubMed: 19155509]. RplF Protegen ID: 437; NCBI Gene GI: 1246168; NCBI Protein GI: 15835415; NCBI Protein Accession: NP_297174; NCBITaxon: 243161 VO:0010893 Allen Xiang Oliver He protein Mice vaccinated with DCs transfected with individual Chlamydia protein PmpG-1(25-500), RplF, or PmpE/F-2(25-575) exhibited significant resistance to challenge infection. In addition, pmpE/F-2 was able to engender protective immunity against challenge with C. muridarum [PubMed: 19155509]. PmpE/F-2 Protegen ID: 438; NCBI Gene GI: 1246432; NCBI Protein GI: 15834882; NCBI Protein Accession: NP_296641; NCBITaxon: 243161 VO:0010894 Allen Xiang Oliver He protein IM-ID vaccination with CPn0095 (pknD) generated a response that resulted in moderately, but significantly reduced total C. pneumoniae lung loads as compared to control mice vaccinated with a plasmid expressing a non-Chlamydia ORF (p0.019). This resulted in the ability of CPN0095 to mediate a moderate, but statistically significant level of protection in an inbred A/J mouse respiratory challenge model [PubMed: 16434129]. PknD Protegen ID: 439; NCBI Gene GI: 895704; NCBI Protein GI: 161353778; NCBI Protein Accession: NP_224303; NCBITaxon: 115713 VO:0010895 Allen Xiang Oliver He protein M-ID vaccination with fabD generated a response that resulted in moderately, but significantly reduced total C. pneumoniae lung loads as compared to control mice vaccinated with a plasmid expressing a non-Chlamydia ORF (p 0.019). This resulted in the ability of fabD to mediate a moderate, but statistically significant level of protection in an inbred A/J mouse respiratory challenge model [PubMed: 16434129]. FabD Protegen ID: 440; NCBI Gene GI: 894994; NCBI Protein GI: 15618217; NCBI Protein Accession: NP_224502; NCBITaxon: 115713 VO:0010896 Allen Xiang Oliver He protein Mice vaccinated with candidate gene ssb showed significant reduction of spleen chlamydial loads as compared to nave, non-protected control mice (p 0.048). This resulted in the ability of ssb to mediate a modest, but significant level of protection in an inbred A/J mouse respiratory challenge model [PubMed: 16434129]. Ssb Protegen ID: 441; NCBI Gene GI: 894901; NCBI Protein GI: 15618301; NCBI Protein Accession: NP_224586; NCBITaxon: 115713 VO:0010897 Allen Xiang Oliver He protein Pigs were subjected to challenge infection with a dose of 1x10(5)TCID(50) (50% tissue culture infective dose) virulent CSFV strain. At 1 week post challenge infection, all of the yE2-immunized pigs were alive and without symptoms or signs of CSF. The yeast-expressed E2 protein retains correct immunogenicity and is able to induce a protective immune response against CSFV infection [PubMed: 19625145]. In a seperate study, swine vaccinated with VVR expressing E0 and/or E2 resisted a lethal challenge infection with CSFV. Glycoprotein E0 represents a second determinant for the induction of protective immunity against classical swine fever [PubMed: 7666549]. E2 from Classical swine fever virus Protegen ID: 442; NCBI Gene GI: 920146; NCBI Protein GI: 12657942; NCBI Protein Accession: NP_075354; NCBITaxon: 11096 VO:0010898 Allen Xiang Oliver He protein Swine vaccinated with VVR expressing E0 and/or E2 resisted a lethal challenge infection with CSFV. Glycoprotein E0 represents a second determinant for the induction of protective immunity against classical swine fever [PubMed: 7666549]. E0 Protegen ID: 443; NCBI Protein GI: 115343287; NCBITaxon: 11096 VO:0010899 Allen Xiang Oliver He protein Intramuscular vaccination of pigs with immunoaffinity-purified E1 (gp55) in a double water-oil emulsion elicited high titers of neutralizing antibodies between 2 and 4 weeks after vaccination at the lowest dose tested (20 micrograms). The vaccinated pigs were completely protected against intranasal challenge with 100 50% lethal doses of HCV (Classical swine fever virus) strain Brescia [PubMed: 8350404]. Gp55 Protegen ID: 444; NCBI Protein GI: 1763691; NCBITaxon: 11096 VO:0010900 Allen Xiang Oliver He protein A single dose of ciBoNT/A1 HP provided equivalent or greater protective immunity, not only against the homologous toxin, but also against two distinct toxin subtypes with significant amino acid divergence in mice when challenged with BoNT/A subtypes /A1, /A2, and /A3 from Clostridium botulinum [PubMed: 19450643]. BoNT/A1 from C. botulinum Protegen ID: 445; NCBI Protein GI: 241183337; NCBITaxon: 1491 VO:0010901 Allen Xiang Oliver He protein Purified FHc was used to vaccinate mice and evaluate their survival against challenge with active botulinum neurotoxin serotype F (BoNT/F). Mice that received one injection of 5 microg or two injections of >or=0.04 microg of FHc were completely protected [PubMed: 18845829]. FHc Protegen ID: 446; NCBI Protein GI: 166236883; NCBITaxon: 32630 VO:0010902 Allen Xiang Oliver He protein A completely synthetic gene encoding fragment C, a approximately 50-kDa fragment, of botulinum neurotoxin serotype A was constructed from oligonucleotides. Mice given three subcutaneous vaccinations were protected against an intraperitoneal administration of 10^6 50% lethal doses (ID50) of serotype A toxin [PubMed: 7790092]. BotA Protegen ID: 447; NCBI Protein GI: 733429; NCBITaxon: 32630 VO:0010903 Allen Xiang Oliver He protein Mice and rabbits were immunized with recombinant HCR/A1 (rHCR/A1) from the classical type A-Hall strain (ATCC 3502) (BoNT/A1) and rHCR/E from BoNT serotype E Beluga (BoNT/E(B)). The protection elicited by rHCR/A1 to BoNT/A1 and BoNT/A2 and by rHCR/E(B) to BoNT/E(A) indicate that immunization with receptor binding domains elicit protection within sub-serotypes of BoNT [PubMed: 16177380]. BoNT/A1 from C. botulinum A str. Hall Protegen ID: 448; NCBI Gene GI: 5398487; NCBI Protein GI: 153936924; NCBI Protein Accession: YP_001386738; NCBITaxon: 441771 VO:0010904 Allen Xiang Oliver He protein The DNA replicon vaccine (pSCARSBHc) encoding the Hc domain of BoNT/B (BHc) induced better responses and protection against BoNT/B mouse challenge than conventional DNA vaccine. Recombinant SFV particle VRP-BHc protected mice from high-dose BoNT/B challenge [PubMed: 19712769]. BoNT/B Protegen ID: 449; NCBI Gene GI: 6030102; NCBI Protein GI: 169834607; NCBI Protein Accession: YP_001693307; NCBITaxon: 498213 VO:0010905 Allen Xiang Oliver He protein Researchers constructed a replication-incompetent adenovirus encoding a synthesized codon-optimized gene for expression of the heavy chain C-fragment (H(C)50) of botulinum neurotoxin type C (BoNT/C). After a single dose of 2 x 10^7pfu adenoviral vectors in a mouse model, the animals were completely protected against intraperitoneal challenge with 100 x MLD(50) of active BoNT/C [PubMed: 17897756]. BoNT/C(Hc50) Protegen ID: 450; NCBI Protein GI: 217781; NCBI Protein Accession: BAA14235.1; NCBITaxon: 12336 VO:0010906 Allen Xiang Oliver He protein A recombinant vaccinia virus containing most of the P1 region of hepatitis A virus (HAV) was constructed bearing epitopes from structural polypeptides VP4, -3 and -2, and the N terminus of VP. Inoculation of tamarin monkeys with the recombinant virus resulted in the development of a specific anti-HAV immune response which was protective against challenge with a virulent strain of HAV [PubMed: 1654376]. HAVgp2 Protegen ID: 680; NCBI Gene GI: 1493919; NCBI Protein GI: 9626734; NCBI Protein Accession: NP_041008; NCBITaxon: 12092 VO:0010907 Allen Xiang Oliver He protein Following two intragastric immunizations in BALB/c mice, the Yersinia vectors harboring a DNA vaccine encoding BFR (P39) induced antigen-specific serum immunoglobulin and Th1-type responses among splenocytes. The best protection was conferred by a serotype O:9 strain carrying pCIP39, confirming the importance of the P39 T-cell antigen in this mechanism [PubMed: 11895955]. Bfr from B. abortus S19 Protegen ID: 681; NCBI Gene GI: 6326162; NCBI Protein GI: 189022832; NCBI Protein Accession: YP_001932573; NCBITaxon: 430066 VO:0010908 Allen Xiang Oliver He protein Study was designed to evaluate the immunogenicity and the protective efficacy of a divalent fusion DNA vaccine encoding both the Brucella abortus L7/L12 protein (ribosomal protein, rplL) and Omp16 protein (outer membrane lipoprotein). This divalent DNA vaccine induced a significant level of protection against challenge with the virulent B. abortus in BALB/c mice [PubMed: 16622210]. RplL Protegen ID: 682; NCBI Gene GI: 3788918; NCBI Protein GI: 82700077; NCBI Protein Accession: YP_414651; NCBITaxon: 359391 VO:0010909 Allen Xiang Oliver He protein The fragment C of tetanus toxin was amplified from Clostridium tetani DNA by PCR. Immunization of mice with rTTC resulted in the production of antibodies that were able to protect mice against a challenge with tetanus toxin furthermore, rTTC in vivo appeared to be able to undergo retrograde axonal transport [PubMed: 12075415]. TTC Protegen ID: 451; NCBI Protein GI: 157829735; NCBITaxon: 1513 VO:0010910 Allen Xiang Oliver He protein Cynomolgus macaques were immunized with DNA/rAd5 vaccines expressing ZEBOV (GP) and SEBOV glycoprotein (GP) prior to lethal challenge with BEBOV. Vaccinated subjects developed robust, antigen-specific humoral and cellular immune responses against the GP from ZEBOV as well as cellular immunity against BEBOV GP, and immunized macaques were uniformly protected against lethal challenge with BEBOV [PubMed: 20502688]. GP from Zaire ebolavirus Protegen ID: 452; NCBI Gene GI: 911829; NCBI Protein GI: 10313995; NCBI Protein Accession: NP_066246; NCBITaxon: 186538 VO:0010911 Allen Xiang Oliver He protein Cynomolgus macaques were immunized with DNA/rAd5 vaccines expressing ZEBOV (GP) and SEBOV glycoprotein (GP) prior to lethal challenge with BEBOV. Vaccinated subjects developed robust, antigen-specific humoral and cellular immune responses against the GP from ZEBOV as well as cellular immunity against BEBOV GP, and immunized macaques were uniformly protected against lethal challenge with BEBOV [PubMed: 20502688]. GP from Sudan ebolavirus Protegen ID: 453; NCBI Gene GI: 3160774; NCBI Protein GI: 55770812; NCBI Protein Accession: YP_138523; NCBITaxon: 186540 VO:0010912 Allen Xiang Oliver He protein Guinea pigs infected with a single intranasal inoculation of HPIV3/EboGP-NP showed no apparent signs of disease yet developed a strong humoral response specific to the EV proteins. When these animals were challenged with an intraperitoneal injection of 10(3) PFU of EV, there were no outward signs of disease, no viremia or detectable EV antigen in the blood, and no evidence of infection in the spleen, liver, and lungs. In contrast, all of the control animals died or developed severe EV disease following challenge [PubMed: 16474134]. NP Protegen ID: 454; NCBI Gene GI: 911830; NCBI Protein GI: 10314000; NCBI Protein Accession: NP_066243; NCBITaxon: 186538 VO:0010913 Allen Xiang Oliver He protein Ten mice were inoculated subcutaneously, administered booster injections after one month, and challenged with 130 LD(50) of wild type Y. pestis CO92. The vaccinated animals produced high levels of specific antibodies against YscF as determined by Western blot. The data were statistically significant (P = 0.053 by two-tailed Fisher's test), suggesting that the YscF protein can provide a protective immune response against lethal plague challenge during subcutaneous plague infection [PubMed: 15939303]. YscF from Y. pestis CO92 Protegen ID: 54; NCBI Gene GI: 1172700; NCBI Protein GI: 16082743; NCBI Protein Accession: NP_395189; NCBITaxon: 214092 VO:0010914 Allen Xiang Oliver He protein The P4 protein is an integral outer membrane protein that has a role in acquiring hemin and nucleosides [PubMed: 1715322 ]. P4 from Haemophilus influenzae Protegen ID: 100; NCBITaxon: 727 VO:0010915 Allen Xiang Oliver He protein Recombinant P6 (pal) was capable of eliciting a protective antibody response against live H. influenzae type b challenge in a modified infant rat model of bacteremia [PubMed: 9261944]. Pal Protegen ID: 101; NCBI Gene GI: 3429820; NCBI Protein GI: 68248984; NCBI Protein Accession: YP_248096; NCBITaxon: 281310 VO:0010916 Allen Xiang Oliver He protein When mice immunized intranasally with recombinant protein corresponding to the C-terminal region of Hap(S) from H. influenzae strains N187, P860295, and TN106 plus mutant cholera toxin CT-E29H were challenged with strain TN106, they were protected against nasopharyngeal colonization [PubMed: 15557618]. Hap from H. influenzae Protegen ID: 103; Protegen ID: 102; NCBI Protein GI: 21686508; NCBITaxon: 727 VO:0010917 Allen Xiang Oliver He obsolete Hap from H. influenzae Protegen ID: 103; NCBITaxon: 727 true VO:0010918 Allen Xiang Oliver He protein OMP26 was used to immunize rats via intestinal Peyer's patches, followed by an intratracheal boost. Immunization was found to significantly enhance bacterial clearance following pulmonary challenge with both the homologous NTHI strain and a different NTHI strain [PubMed: 9573117]. Omp26 Protegen ID: 276; NCBI Nucleotide GI: 4574245; NCBI Protein GI: 4574246; NCBI Protein Accession: AAD23967.1; NCBITaxon: 727 VO:0010919 Allen Xiang Oliver He protein The heterologous prime-boost strategy of live Salmonella vaccine expressing Mycobacterium tuberculosis fusion antigen Age5B-ESAT6 (esxA) from the chromosome followed by a systemic boost of antigen and adjuvant reduced the levels of M. tuberculosis bacteria in the lungs and spleen to the same extent as BCG. Additionally, this vaccination regimen was observed to be statistically equivalent in terms of protection to immunisation with BCG [PubMed: 19755145]. EsxA Protegen ID: 104; NCBI Gene GI: 886209; NCBI Protein GI: 57117165; NCBI Protein Accession: NC_000962.2; NCBITaxon: 1773 VO:0010920 Allen Xiang Oliver He protein TRAP from P. falciparum Protegen ID: 138; NCBI Gene GI: 814170; NCBI Protein GI: 124513464; NCBI Protein Accession: XP_001350088; NCBITaxon: 36329 VO:0010921 Allen Xiang Oliver He protein LolC was evaluated as an antigen for a vaccine candidate against B. pseudomallei infection. Nonmembrane regions of the B. pseudomallei protein was expressed and purified from Escherichia coli and then evaluated as a vaccine candidate in an established mouse model of B. pseudomallei infection. When delivered with the monophosphoryl lipid A-trehalose dicorynomycolate adjuvant, the protein stimulated antigen-specific humoral and cellular immune responses. Immunization with the LolC protein domain afforded significant protection against a subsequent challenge with B. pseudomallei. LolC provided a greater level of protection when it was administered with immune-stimulating complexes complexed with CpG oligodeoxynucleotide 10103. Immunization with LolC also protected against a subsequent challenge with a heterologous strain of B. pseudomallei, demonstrating the potential utility of this protein as a vaccine antigen for melioidosis [PubMed: 17517877]. LolC/E Protegen ID: 768; NCBI Gene GI: 3093214; NCBI Protein GI: 53719887; NCBI Protein Accession: YP_108873; NCBITaxon: 272560 VO:0010922 Allen Xiang Oliver He protein PotF was evaluated as an antigen for a vaccine candidate against B. pseudomallei infection. Nonmembrane regions of the B. pseudomallei protein was expressed and purified from Escherichia coli and then evaluated as a vaccine candidate in an established mouse model of B. pseudomallei infection. When delivered with the monophosphoryl lipid A-trehalose dicorynomycolate adjuvant, the protein stimulated antigen-specific humoral and cellular immune responses. Immunization with the PotF protein domain afforded significant protection against a subsequent challenge with B. pseudomallei [PubMed: 17517877]. PotF Protegen ID: 769; NCBI Gene GI: 3095748; NCBI Protein GI: 53721504; NCBI Protein Accession: YP_110489; NCBITaxon: 272560 VO:0010923 Allen Xiang Oliver He protein AMA1 from P. falciparum 3D7 Protegen ID: 139; NCBI Gene GI: 810891; NCBI Protein GI: 124804478; NCBI Protein Accession: XP_001348015; NCBITaxon: 36329 VO:0010924 Allen Xiang Oliver He protein The ompA codon was adapted to the codon usage in birds, resulting in pcDNA1/MOMP(opt). Researchers examined the capacity of nebulised or intramuscularly (IM) administered brPEI-pcDNA1/MOMP(opt) to induce a significant protective immune response in SPF turkeys experimentally infected with 10^8 TCID(50) of a virulent Cp. psittaci strain. Vaccinated groups were significantly protected against Cp. psittaci challenge [PubMed: 20199760]. OmpA from C. psittaci Protegen ID: 766; NCBI Protein GI: 94467392; NCBITaxon: 83554 VO:0010925 Allen Xiang Oliver He protein Plasmid DNA (pcDNA1::MOMP A) expressing the major outer membrane protein (MOMP) of Chlamydophila psittaci genotype A strain 89/1051 has been tested for its ability to induce protective immunity against Cp. psittaci challenge in budgerigars. DNA immunisation significantly reduced clinical signs, macroscopic lesions, pharyngeal and cloacal excretion as well as chlamydial replication, even in the presence of pre-existing serum antibodies, as compared to the placebo-vaccinated controls [PubMed: 19640395]. MOMP from C. psittaci Protegen ID: 767; NCBI Nucleotide GI: 144544; NCBI Protein GI: 144545; NCBI Protein Accession: AAA17396.1; NCBITaxon: 83554 VO:0010926 Allen Xiang Oliver He protein Protective antigen [PubMed: 11489167] ABRA Protegen ID: 137; NCBITaxon: 5835 VO:0010927 Allen Xiang Oliver He protein This gene was originally isolated from a lambda gt11 expression library probed with sera from Brucella-infected sheep. Sequence analysis of the cloned gene revealed the presence of an open reading frame of 158 amino acids encoding a protein of 17.3 kDa [PubMed: 7664168 ]. It was later identified as a cytoplasmic protein lumazine synthase [PubMed: 10482294 ]. This gene can be used for diagnosis [PubMed: 7664168 ] [PubMed: 10482294 ] and vaccine development [PubMed: 11953389 ]. ORF Protegen ID: 113; NCBI Nucleotide GI: 599653; NCBI Protein GI: 599654; NCBI Protein Accession: CAA86936.1; NCBITaxon: 235 VO:0010928 Allen Xiang Oliver He protein B. abortus strain 19 L7/L12 Protegen ID: 114; NCBI Protein GI: 304271 VO:0010929 Allen Xiang Oliver He protein Guinea pigs were vaccinated with recombinant VEE replicons (packaged into VEE-like particles), inoculated with MBGV, and evaluated for viremia and survival after challenge with typical MGBV disease. Results indicated that VP35 afforded incomplete protection [PubMed: 9813200 ]. VP35 from Marburg Virus Protegen ID: 167; NCBI Gene GI: 920948; NCBI Protein GI: 13489277; NCBI Protein Accession: NP_042026.1; NCBITaxon: 11269 VO:0010930 Allen Xiang Oliver He protein The purified recombinant proteins, P1, HspB, and P1-HspB, and whole-cell antigen (WCA) of C. burnetii were used to immunize BALB/c mice. Protective immunity against Q fever was induced with a recombinant P1 antigen fused with HspB after Coxiella burnetii challenge [PubMed: 16481504 ]. P1 from Coxiella burnetii Protegen ID: 171; NCBI Protein GI: 30025845; NCBITaxon: 777 VO:0010931 Allen Xiang Oliver He protein NP from Zaire ebolavirus Protegen ID: 172; NCBI Gene GI: 911830; NCBI Protein GI: 10314000; NCBI Protein Accession: NP_066243; NCBITaxon: 186538 VO:0010932 Allen Xiang Oliver He protein GP from Marburg Virus Protegen ID: 173; NCBI Protein GI: 21702651; NCBITaxon: 186538 VO:0010933 Allen Xiang Oliver He protein NP Marburgvirus - Ravn Protegen ID: 174; NCBI Protein GI: 91177744; NCBITaxon: 378809 VO:0010934 Allen Xiang Oliver He protein The purified recombinant proteins, P1, HspB, and P1-HspB, and whole-cell antigen (WCA) of C. burnetii were used to immunize BALB/c mice. Protective immunity against Q fever was induced with a recombinant P1 antigen fused with HspB after Coxiella burnetii challenge [PubMed: 16481504 ]. HspB from Coxiella burnetii Protegen ID: 175; NCBI Protein GI: 197253489; NCBITaxon: 777 VO:0010935 Allen Xiang Oliver He protein Mice were immunized with recombinant H3L protein to examine H3L-specific antibody responses in greater detail. H3L-immunized mice developed high-titer vaccinia virus-neutralizing antibodies (mean PRNT50 = 1:3,760). Importantly, H3L-immunized mice were subsequently protected against lethal intranasal challenges with 1 or 5 50% lethal doses (LD50) of pathogenic vaccinia virus strain WR, demonstrating the in vivo value of an anti-H3L response. To formally demonstrate that neutralizing anti-H3L antibodies are protective in vivo, we performed anti-H3L serum passive-transfer experiments. Mice receiving H3L-neutralizing antiserum were protected from a lethal challenge with 3 LD50 of vaccinia virus strain WR (5/10 versus 0/10; P < 0.02) [PubMed: 16140750]. H3L Protegen ID: 62; NCBI Gene GI: 3707557; NCBI Protein GI: 66275898; NCBI Protein Accession: YP_232983; NCBITaxon: 10245 VO:0010936 Allen Xiang Oliver He protein Ag85A Protegen ID: 154; NCBITaxon: 1773 VO:0010937 Allen Xiang Oliver He protein Env Gp160 Protegen ID: 153; NCBITaxon: 11676 VO:0010938 Allen Xiang Oliver He protein StxB2 Protegen ID: 225; NCBI Gene GI: 1262010; NCBI Protein GI: 9632507; NCBI Protein Accession: NP_049501; NCBITaxon: 10730 VO:0010939 Allen Xiang Oliver He protein Omp31 Protegen ID: 231; NCBI Gene GI: 3788834; NCBI Protein GI: 82700421; NCBI Protein Accession: YP_414995; NCBITaxon: 359391 VO:0010940 Allen Xiang Oliver He protein Tir Protegen ID: 199; NCBI Gene GI: 960860; NCBI Protein GI: 15804222; NCBI Protein Accession: NP_290261.1; NCBITaxon: 562 VO:0010941 Allen Xiang Oliver He protein ETEC also expresses a range of colonisation factor antigens (CFAs), which allow adherence to the mucosal surface and therefore colonisation of the intestine. Some CFAs are sub-divided into coli surface (CS) antigens [PubMed: 17566016]. CS1 Protegen ID: 79; NCBI Gene GI: 4188469; NCBI Protein GI: 110643341; NCBI Protein Accession: YP_671071; NCBITaxon: 362663 VO:0010942 Allen Xiang Oliver He protein FlaA from C. jejuni NCTC 11168 Protegen ID: 87; NCBI Gene GI: 905631; NCBI Protein GI: 15792662; NCBI Protein Accession: NP_282485.1; NCBITaxon: 197 VO:0010943 Allen Xiang Oliver He protein LT is a hetero-oligomeric AB5 type enterotoxin composed of a 27 kDa A subunit with toxic ADP ribosyl transferase activity and a stable noncovalent-linked pentamer of 11.6 kDa B subunits. ETEC infection and colonization of the small intestine, and the production of LT, causes acute diarrhea that can be fatal without intervention [PubMed: 17188785]. EltB Protegen ID: 92; NCBI Protein GI: 157021162; NCBITaxon: 562 VO:0010944 Allen Xiang Oliver He protein EHEC strains produce intimin, an outer membrane adhesin encoded by the eae gene located in a chromosomal pathogenicity island termed the locus of enterocyte effacement [PubMed: 17258324]. Eae Protegen ID: 93; NCBI Gene GI: 960862; NCBI Protein GI: 15804220; NCBI Protein Accession: NP_290259; NCBITaxon: 155864 VO:0010945 Allen Xiang Oliver He protein FimH is a protective antigen [PubMed: 9110982] FimH from E. coli UTI89 Protegen ID: 263; NCBI Gene GI: 3992235; NCBI Protein GI: 91213965; NCBI Protein Accession: YP_543951; NCBITaxon: 364106 VO:0010946 Allen Xiang Oliver He protein Protective antigen [PubMed: 10710308]. GNA2132 Protegen ID: 264; NCBI Gene GI: 903357; NCBI Protein GI: 15677945; NCBI Protein Accession: NP_275117; NCBITaxon: 122586 VO:0010947 Allen Xiang Oliver He protein Protective antigen [PubMed: 10710308] GNA2001 Protegen ID: 265; NCBI Gene GI: 904124; NCBI Protein GI: 15677829; NCBI Protein Accession: NP_274993; NCBITaxon: 122586 VO:0010948 Allen Xiang Oliver He protein The 39-kDa protein is immunogenic. B. melitensis M5 P39 Protegen ID: 110; NCBI Protein GI: 122892474; NCBI Protein Accession: ABM67295 VO:0010949 Allen Xiang Oliver He protein A novel primate lentivirus was identified in Mandrillus sphinx. One of the newly isolated SIV strains was intravenously inoculated into two rhesus macaques and resulted in chronic infection. These SIVs do not cluster with SIVmndGB1, the former representative strain of SIVmnd, but form a new, independent lineage. These results indicate that these SIVmnds are a novel type of SIVmnd and have infected Cameroonian mandrills for a long time. To date, M. sphinx is the only primate species other than humans that is naturally infected with two different types of SIV [PubMed: 11522184]. Gag protein from SIV-mnd 2 Protegen ID: 98; NCBI Gene GI: 956108; NCBITaxon: 159122 VO:0010950 Allen Xiang Oliver He protein Vaccination of mice and guinea pigs with a secA2 mutant significantly increased resistance to M. tuberculosis challenge compared with standard M. bovis bacille Calmette-Gurin vaccination [PubMed: 17671656]. SecA2 Protegen ID: 117; NCBI Gene GI: 885594; NCBI Protein GI: 15608958; NCBI Protein Accession: NP_216337; NCBITaxon: 83332 VO:0010951 Allen Xiang Oliver He protein The 10-kDa culture filtrate protein (CFP-10, esxB) and 6-kDa early secretory antigen of T cells (ESAT-6) are secreted in abundance by Mycobacterium tuberculosis. Study demonstrated that protective immunity is induced by CFP-10 DNA vaccination in C3H mice as measured by a CFU reduction in the lung and spleen 4 and 8 weeks after challenge with M. tuberculosis [PubMed: 18332205]. EsxB Protegen ID: 121; NCBI Gene GI: 886194; NCBI Protein GI: 15611010; NCBI Protein Accession: NP_218391; NCBITaxon: 83332 VO:0010952 Allen Xiang Oliver He protein Researchers have developed DNA vaccines expressing M. tuberculosis antigen 85A (Ag85A, fbpA) and cytokine granulocyte macrophage colony stimulating factor (GM-CSF). The immune strategy of BCG-prime and DNA vaccine boost induced mice to generate efficient immune protection against M. tuberculosis challenge [PubMed: 19450898]. FbpA Protegen ID: 122; NCBI Gene GI: 886132; NCBI Protein GI: 15610940; NCBI Protein Accession: NC_000962.2; NCBITaxon: 1773 VO:0010953 Allen Xiang Oliver He protein PepA Protegen ID: 123; NCBI Gene GI: 886924; NCBI Protein GI: 15607267; NCBI Protein Accession: NC_000962.2; NCBITaxon: 1773 VO:0010954 Allen Xiang Oliver He protein PPE18 Protegen ID: 124; NCBI Gene GI: 886073; NCBI Protein GI: 57116841; NCBI Protein Accession: NC_000962.2; NCBITaxon: 1773 VO:0010955 Allen Xiang Oliver He protein CjaA from C. jejuni RM 1221 Protegen ID: 133; NCBI Gene GI: 3231573; NCBI Protein GI: 57237809; NCBI Protein Accession: YP_179057.1; NCBITaxon: 197 VO:0010956 Allen Xiang Oliver He protein A total of 840 Light Sussex chickens were used to evaluate a Salmonella enterica serovar Typhimurium DeltaaroA vaccine expressing the C. jejuni amino acid binding protein CjaA. Chickens were given the vaccine at 1-day-old and two weeks later by oral gavage, then challenged after a further two weeks with C. jejuni. Across six biological replicates, statistically significant reductions in caecal C. jejuni of c. 1.4log(10) colony-forming units/g were observed at three and four weeks post-challenge relative to age-matched unvaccinated birds. Protection was associated with the induction of CjaA-specific serum IgY and biliary IgA [PubMed: 19853682]. CjaA from C. jejuni Protegen ID: 134; NCBI Protein GI: 1813949; NCBITaxon: 197 VO:0010957 Allen Xiang Oliver He protein Pvs25 Protegen ID: 141; NCBITaxon: 5855 VO:0010958 Allen Xiang Oliver He protein Aotus monkeys were challenged with the virulent Vietnam Oak Knoll (FVO) strain of P. falciparum. Vaccination of A. nancymai with yMSP1(19) induced protective immune responses. Both of the A. nancymai vaccinated with yMSP1(19) self-resolved an otherwise lethal infection [PubMed: 8529111]. MSP1 from P. falciparum Protegen ID: 143; NCBI Protein GI: 94420988; NCBITaxon: 5833 VO:0010959 Allen Xiang Oliver He protein RESA Protegen ID: 144 VO:0010960 Allen Xiang Oliver He protein Study compared the immunogenicity and protective efficacy of recombinant DOBV nucleocapsid protein (rDOBV N, S) given with Alum or Freund's as adjuvant, or PBS, in C57/BL6 mice. Mice receiving rDOBV N with Freund's adjuvant were protected from challenge (75% protected) [PubMed: 15364453]. S nucleocapsid protein from Dobrava-Belgrade virus Protegen ID: 146; NCBI Gene GI: 2656266; NCBI Protein GI: 38505524; NCBI Protein Accession: NP_942553; NCBITaxon: 12506 VO:0010961 Allen Xiang Oliver He protein Study developed replication-competent vaccines against EBOV and MARV based on attenuated recombinant vesicular stomatitis virus vectors expressing either the EBOV glycoprotein or MARV glycoprotein from Lake Victoria marburgvirus - Musoke. A single intramuscular injection of the EBOV or MARV vaccine elicited completely protective immune responses in nonhuman primates against lethal EBOV or MARV challenges [PubMed: 15937495]. GP from Lake Victoria marburgvirus Protegen ID: 150; NCBI Protein GI: 77543430; NCBITaxon: 33727 VO:0010962 Allen Xiang Oliver He protein This is a protective antigen [PubMed: 17239499]. Bp26 Protegen ID: 232; NCBI Gene GI: 1196247; NCBI Protein GI: 17986819; NCBI Protein Accession: NP_539453; NCBITaxon: 224914 VO:0010963 Allen Xiang Oliver He protein RpsL Protegen ID: 236; NCBI Gene GI: 1196463; NCBI Protein GI: 161511151; NCBI Protein Accession: NP_539669; NCBITaxon: 224914 VO:0010964 Allen Xiang Oliver He protein Iss Protegen ID: 240; NCBI Gene GI: 5616654; NCBI Protein GI: 157418230; NCBI Protein Accession: YP_001481302; NCBITaxon: 405955 VO:0010965 Allen Xiang Oliver He protein FyuA Protegen ID: 247; NCBI Gene GI: 4492541; NCBI Protein GI: 117624167; NCBI Protein Accession: YP_853080; NCBITaxon: 405955 VO:0010966 Allen Xiang Oliver He protein Brucella Omp25 is a protective antigen [PubMed: 17049676]. Omp25 Protegen ID: 253; NCBI Gene GI: 1196960; NCBI Protein GI: 17987532; NCBI Protein Accession: NP_540166; NCBITaxon: 224914 VO:0010967 Allen Xiang Oliver He protein Brucella IalB is a protective antigen [PubMed: 17049676]. IalB Protegen ID: 254; NCBI Gene GI: 1197295; NCBI Protein GI: 17987867; NCBI Protein Accession: NP_540501; NCBITaxon: 224914 VO:0010968 Allen Xiang Oliver He protein Brucella bacterioferritin is a protective antigen [PubMed: 11447155 ] Bfr from B. melitensis biovar Abortus 2308 Protegen ID: 255; NCBI Gene GI: 3828133; NCBI Protein GI: 83269559; NCBI Protein Accession: YP_418850; NCBITaxon: 359391 VO:0010969 Allen Xiang Oliver He protein protective antigen [PubMed: 17239499] Tig Protegen ID: 256; NCBI Gene GI: 1196780; NCBI Protein GI: 17987352; NCBI Protein Accession: NP_539986; NCBITaxon: 224914 VO:0010970 Allen Xiang Oliver He protein Brucella DnaK is a protective antigen [PubMed: 17686554]. DnaK from Brucella Protegen ID: 257; NCBI Gene GI: 3341115; NCBI Protein GI: 62290965; NCBI Protein Accession: YP_222758; NCBITaxon: 262698 VO:0010971 Allen Xiang Oliver He protein Brucella SurA is a protective antigen [PubMed: 17686554]. SurA Protegen ID: 258; NCBI Gene GI: 3787419; NCBI Protein GI: 82699574; NCBI Protein Accession: YP_414148; NCBITaxon: 359391 VO:0010972 Allen Xiang Oliver He protein Brucella Omp19 is a protective antigen [PubMed: 18981242]. Omp19 Protegen ID: 259; NCBI Gene GI: 3788831; NCBI Protein GI: 82700695; NCBI Protein Accession: YP_415269; NCBITaxon: 359391 VO:0010973 Allen Xiang Oliver He protein Brucella Omp16 is a protective antigen [PubMed: 18981242]. Omp16 Protegen ID: 260; NCBI Gene GI: 3788229; NCBI Protein GI: 82700483; NCBI Protein Accession: YP_415057; NCBITaxon: 359391 VO:0010974 Allen Xiang Oliver He protein Protective antigen [PubMed: 10710308] GNA1946 Protegen ID: 266; NCBI Gene GI: 904205; NCBI Protein GI: 15677776; NCBI Protein Accession: NP_274940; NCBITaxon: 122586 VO:0010975 Allen Xiang Oliver He protein Protective antigen [PubMed: 10710308] GNA1220 Protegen ID: 267; NCBI Gene GI: 903642; NCBI Protein GI: 15677093; NCBI Protein Accession: NP_274245; NCBITaxon: 122586 VO:0010976 Allen Xiang Oliver He protein Protective antigen[PubMed: 10710308] GNA1162 Protegen ID: 268; NCBI Gene GI: 903582; NCBI Protein GI: 15677037; NCBI Protein Accession: NP_274189; NCBITaxon: 122586 VO:0010977 Allen Xiang Oliver He protein Protective antigen [PubMed: 10710308] GNA992 (hsf) Protegen ID: 269; NCBI Gene GI: 903112; NCBI Protein GI: 15676883; NCBI Protein Accession: NP_274028; NCBITaxon: 122586 VO:0010978 Allen Xiang Oliver He protein Protective antigen [PubMed: 10710308] GNA33 Protegen ID: 270; NCBI Gene GI: 902136; NCBI Protein GI: 15675973; NCBI Protein Accession: NP_273099; NCBITaxon: 122586 VO:0010979 Allen Xiang Oliver He protein Protective antigen [PubMed: 9104804] NspA from N. meningitidis MC58 Protegen ID: 271; NCBI Gene GI: 902774; NCBI Protein GI: 15676561; NCBI Protein Accession: NP_273705; NCBITaxon: 122586 VO:0010980 Allen Xiang Oliver He protein Protective antigen [PubMed: 16825336][PubMed: 12045242] with GeneID: 902509. However, according to sequence analysis, this nadA is not the same NadA that was found to be protective antigen [PubMed: 16825336][PubMed: 12045242]. NadA Protegen ID: 272; NCBI Gene GI: 904134; NCBI Protein GI: 15677822; NCBI Protein Accession: NP_274986; NCBITaxon: 122586 VO:0010981 Allen Xiang Oliver He protein Protective antigen [PubMed: 16825336] GNA1870 Protegen ID: 273; NCBI Gene GI: 904318; NCBI Protein GI: 15677705; NCBI Protein Accession: NP_274866; NCBITaxon: 122586 VO:0010982 Allen Xiang Oliver He protein Protective antigen as shown in some assays [PubMed: 16825336] GNA2091 Protegen ID: 274; NCBI Gene GI: 903958; NCBI Protein GI: 15677911; NCBI Protein Accession: NP_275079; NCBITaxon: 122586 VO:0010983 Allen Xiang Oliver He protein Protective antigen as shown in some assays [PubMed: 16825336] GNA1030 Protegen ID: 275; NCBI Gene GI: 903167; NCBI Protein GI: 15676917; NCBI Protein Accession: NP_274064; NCBITaxon: 122586 VO:0010984 Allen Xiang Oliver He protein A vaccine made by Hma from E. coli strain CFT073 and 536 induced protection to the infection of virulent strain CFT073 and 536, respectively, in the bladder in the CBA/J mice. [PubMed: 19806177]. Hma Protegen ID: 278; NCBI Gene GI: 1037732; NCBI Protein GI: 26248334; NCBI Protein Accession: NP_754374; NCBITaxon: 199310 VO:0010985 Allen Xiang Oliver He protein Immunization with IreA protects against urinary tract colinization by E.coli CFT073 and reduces colinization by E.coli 536 in the bladder of CBA/J mice [PubMed: 19806177]. IreA Protegen ID: 279; NCBI Gene GI: 1037614; NCBI Protein GI: 26250982; NCBI Protein Accession: NP_757022; NCBITaxon: 199310 VO:0010986 Allen Xiang Oliver He protein Immunization with IutA protects against urinary tract colinization by E.coli CFT073 in the bladders of CBA/J mice [PubMed: 19806177]. IutA Protegen ID: 280; NCBI Gene GI: 1039578; NCBI Protein GI: 26249458; NCBI Protein Accession: NP_755498; NCBITaxon: 199310 VO:0010987 Allen Xiang Oliver He protein Antibodies directed at the putative binding region of FimH (anti- s-FimH1-25) significantly reduced E. coli bladder infections in the experimental mouse model of urinary tract infections [PubMed: 9276729]. FimH Protegen ID: 281; NCBI Gene GI: 948847; NCBI Protein GI: 16132141; NCBI Protein Accession: NP_418740; NCBITaxon: 511145 VO:0010988 Allen Xiang Oliver He protein Active immunization of BALB/c mice with IroN antigen in Freund's adjuvant protects mice from lethal challenge with ExPEC strain S26 [PubMed: 17145948 ]. IroN from Escherichia coli Protegen ID: 282; NCBI Gene GI: 7379404; NCBI Protein GI: 222104801; NCBI Protein Accession: YP_002539290; NCBITaxon: 562 VO:0010989 Allen Xiang Oliver He protein Active immunization of BALB/c mice with C0393 antigen in Freund's adjuvant protects mice from lethal challenge with ExPEC strain S26 [PubMed: 17145948]. C0393 Protegen ID: 283; NCBI Gene GI: 1034958; NCBI Protein GI: 26246291; NCBI Protein Accession: NP_752330; NCBITaxon: 199310 VO:0010990 Allen Xiang Oliver He protein Active immunization of BALB/c mice with C4424 antigen in Freund's adjuvant protects mice from lethal challenge with ExPEC strain S26 [PubMed: 17145948]. C4424 Protegen ID: 284; NCBI Gene GI: 1038067; NCBI Protein GI: 26250246; NCBI Protein Accession: NP_756286; NCBITaxon: 199310 VO:0010991 Allen Xiang Oliver He protein Active immunization of BALB/c mice with recombinant E. coli protein C3389 antigen in Freund's adjuvant protects mice from lethal challenge with ExPEC strain S26 [PubMed: 17145948]. C3389 Protegen ID: 285; NCBI Gene GI: 1039252; NCBI Protein GI: 26249224; NCBI Protein Accession: NP_755264; NCBITaxon: 199310 VO:0010992 Allen Xiang Oliver He protein S. flexneri M90T is a colonisation-defective mutant with a transposon in fnr, which encodes a regulator of anaerobic metabolism. To establish whether FNR-mediated repression of spa32 and spa33 contributes to increased Shigella entry into cells in an anaerobic cabinet, recombinant M90T strains were constructed which contain spa32 and spa33 under the control of either their native promoters (M90Tp32/33) or promoters with disrupted FNR boxes (M90Tp#32/#33).The presence in M90T of spa32 and spa33 alleles that are not repressed by FNR led to IpaB secretion during anaerobic growth, and loss of the increased entry of Shigella into cells in an anaerobic cabinet [PubMed: 20436458]. Spa32 Protegen ID: 288; NCBI Gene GI: 876502; NCBI Protein GI: 13449098; NCBI Protein Accession: NP_085314; NCBITaxon: 424718 VO:0010993 Allen Xiang Oliver He protein Oral immunization of FaeG-expressing L. lactis exhibits a protective response against ETEC infection in mice [PubMed: 19277476]. ECSE_P3-0034 Protegen ID: 289; NCBI Gene GI: 7003192; NCBI Protein GI: 209921909; NCBI Protein Accession: YP_002295988; NCBITaxon: 409438 VO:0010994 Allen Xiang Oliver He protein The invasiveness and virulence of Shigella spp. are largely due to the expression of plasmid-encoded virulence factors, among which are the invasion plasmid antigens (IpaB, IpaC, and IpaD). Recent observations have indicated that the Ipa proteins (IpaB, IpaC, and possibly IpaD) form a multiprotein complex capable of inducing the phagocytic event which internalizes the bacterium. Researchers isolated a complex of invasins and LPS from water-extractable antigens of virulent shigellae. Western blot analysis of the complex indicates that all of the major virulence antigens of Shigella, including IpaB, IpaC, and IpaD, and LPS are components of this macromolecular complex. Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model) immunized intranasally with purivied invasin complex (invaplex) on days 0, 14, and 28 and challenged 3 weeks later with virulent shigellae were protected from disease (P<0.01 for both animal models) [PubMed: 11083774]. IpaB Protegen ID: 307; NCBI Protein GI: 22036246; NCBITaxon: 42897 VO:0010995 Allen Xiang Oliver He protein The invasiveness and virulence of Shigella spp. are largely due to the expression of plasmid-encoded virulence factors, among which are the invasion plasmid antigens (IpaB, IpaC, and IpaD). Recent observations have indicated that the Ipa proteins (IpaB, IpaC, and possibly IpaD) form a multiprotein complex capable of inducing the phagocytic event which internalizes the bacterium. Researchers isolated a complex of invasins and LPS from water-extractable antigens of virulent shigellae. Western blot analysis of the complex indicates that all of the major virulence antigens of Shigella, including IpaB, IpaC, and IpaD, and LPS are components of this macromolecular complex. Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model) immunized intranasally with purivied invasin complex (invaplex) on days 0, 14, and 28 and challenged 3 weeks later with virulent shigellae were protected from disease (P<0.01 for both animal models) [PubMed: 11083774]. IpaC Protegen ID: 308; NCBI Protein GI: 47056; NCBITaxon: 42897 VO:0010996 Allen Xiang Oliver He protein The invasiveness and virulence of Shigella spp. are largely due to the expression of plasmid-encoded virulence factors, among which are the invasion plasmid antigens (IpaB, IpaC, and IpaD). Recent observations have indicated that the Ipa proteins (IpaB, IpaC, and possibly IpaD) form a multiprotein complex capable of inducing the phagocytic event which internalizes the bacterium. Researchers isolated a complex of invasins and LPS from water-extractable antigens of virulent shigellae. Western blot analysis of the complex indicates that all of the major virulence antigens of Shigella, including IpaB, IpaC, and IpaD, and LPS are components of this macromolecular complex. Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model) immunized intranasally with purivied invasin complex (invaplex) on days 0, 14, and 28 and challenged 3 weeks later with virulent shigellae were protected from disease (P<0.01 for both animal models) [PubMed: 11083774]. IpaD Protegen ID: 309; NCBI Protein GI: 22036352; NCBITaxon: 42897 VO:0010997 Allen Xiang Oliver He protein Thirty-day-old chickens were immunized intramuscularly with purified IroN from Salmonella Typhimurium mixed with Freund's incomplete adjuvant; the chickens were then challenged intravenously with Salmonella Enteritidis. The mortality rate of immunized chickens was 10%. On the other hand, that of control chickens was 80% [PubMed: 20095157]. IroN from Salmonella spp. Protegen ID: 318; NCBI Protein GI: 259475459; NCBITaxon: 90371 VO:0010998 Allen Xiang Oliver He protein Researchers evaluated the immunogenicity and protective efficacy of GroEL of Salmonella enterica serovar Typhi against lethal infection by S. typhi Ty2 in mice with or without adjuvants. Immunization of mice with GroEL-alone, GroEL + alum, and GroEL + CFA provided 70, 50 and 80% protection, respectively, against lethal challenge by S. typhi in mice. The present study shows that GroEL forms an ideal candidate molecule to develop a recombinant protein based vaccine against human typhoid [PubMed: 19851830]. GroEL from Salmonella spp. Protegen ID: 320; NCBI Gene GI: 1068458; NCBI Protein GI: 29144631; NCBI Protein Accession: NP_807973; NCBITaxon: 209261 VO:0010999 Allen Xiang Oliver He protein The entire SopB and SifB genes were cloned into DNA vaccine vectors and were administered along with live attenuated Salmonella. It was found that SopB vaccination reduced the bacterial burden of organs by about 5-fold on day 4 and day 8 after challenge with virulent Salmonella and proved to be a more efficient vaccination strategy than live attenuated bacteria alone [PubMed: 19428891]. SopB Protegen ID: 321; NCBI Protein GI: 54036439; NCBITaxon: 90371 VO:0011000 Allen Xiang Oliver He protein Oral immunization of mice with ZJ111/pcDNA3-SAG1 elicited specific humoral responses and stimulated proliferation of splenocytes (P<0.05). Mice immunized with ZJ111/pcDNA3-SAG1 displayed significant protection against an intraperitoneally challenge with 500 tachyzoite forms of T. gondii RH strain. Vaccination at 10(7) and 10(8)CFU per mice provided a 20% and 10% survival rate comparing 100% mortality of the non-immunized mice, exhibiting longer living time and better survival rate [PubMed: 18590785]. SAG1 from Toxoplasma gondii Protegen ID: 326; NCBI Gene GI: 7900172; NCBI Protein GI: 237839159; NCBI Protein Accession: XP_002368877; NCBITaxon: 508771 VO:0011001 Allen Xiang Oliver He protein Modified YscF antigens were able to partially protect immunized mice at various levels against lethal challenge with Y. pestis KIM 1001 strain [PubMed: 18291562]. YscF from Y. pestis KIM 10 Protegen ID: 338; NCBI Gene GI: 1149286; NCBI Protein GI: 31795470; NCBI Protein Accession: NP_857922; NCBITaxon: 187410 VO:0011002 Allen Xiang Oliver He protein Modified yopD antigens were able to partially protect immunized mice at various levels against lethal challenge with Y. pestis KIM 1001 strain [PubMed: 18291562]. YopD from Y. pestis KIM 10 Protegen ID: 339; NCBI Gene GI: 1149313; NCBI Protein GI: 31795494; NCBI Protein Accession: NP_857949; NCBITaxon: 187410 VO:0011003 Allen Xiang Oliver He protein Modified yopO antigens were able to partially protect immunized mice at various levels against lethal challenge with Y. pestis KIM 1001 strain [PubMed: 18291562]. YopO Protegen ID: 340; NCBI Gene GI: 5798322; NCBI Protein GI: 162417777; NCBI Protein Accession: YP_001604502; NCBITaxon: 349746 VO:0011004 Allen Xiang Oliver He protein Intranasal immunization with flagellin and the F1 antigen was protective against intranasal challenge with virulent Y. pestis CO92, with 93 to 100% survival of immunized mice. Lastly, vaccination of cynomolgus monkeys with flagellin and a fusion of the F1 and V antigens of Y. pestis induced a robust antigen-specific IgG antibody response [PubMed: 16428759]. YPMT1.84 (F1 capsule antigen) Protegen ID: 341; NCBI Gene GI: 1172839; NCBI Protein GI: 16082876; NCBI Protein Accession: NP_395430; NCBITaxon: 214092 VO:0011005 Allen Xiang Oliver He protein Using a mouse model, YPO0606 (yapF) partially protected mice from infection with Y. pestis at a high challenge dosage (200x LD(50)) [PubMed: 19651863]. YapF Protegen ID: 342; NCBI Gene GI: 1173449; NCBI Protein GI: 218927800; NCBI Protein Accession: YP_002345675; NCBITaxon: 214092 VO:0011006 Allen Xiang Oliver He protein Using a mouse plague model, YPO1914 (irp7) may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. Irp7 Protegen ID: 343; NCBI Gene GI: 1174753; NCBI Protein GI: 218929030; NCBI Protein Accession: YP_002346905; NCBITaxon: 214092 VO:0011007 Allen Xiang Oliver He protein Using a mouse plague model, YPO0612 may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. YPO0612 Protegen ID: 344; NCBI Gene GI: 1173455; NCBI Protein GI: 218927806; NCBI Protein Accession: YP_002345681; NCBITaxon: 214092 VO:0011008 Allen Xiang Oliver He protein Using a mouse plague model, YPO3119 (htpG) may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. HtpG Protegen ID: 345; NCBI Gene GI: 1175934; NCBI Protein GI: 218930152; NCBI Protein Accession: YP_002348027; NCBITaxon: 214092 VO:0011009 Allen Xiang Oliver He protein Using a mouse plague model, YPO3047 (ydeN) may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. YdeN Protegen ID: 346; NCBI Gene GI: 1175868; NCBI Protein GI: 218930092; NCBI Protein Accession: YP_002347967; NCBITaxon: 214092 VO:0011010 Allen Xiang Oliver He protein Using a mouse plague model, YPO1377 (lolA) may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. LolA Protegen ID: 347; NCBI Gene GI: 1174218; NCBI Protein GI: 218928525; NCBI Protein Accession: YP_002346400; NCBITaxon: 214092 VO:0011011 Allen Xiang Oliver He protein Using a mouse plague model, YPCD1.05c (yerA) may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. YerA Protegen ID: 348; NCBI Gene GI: 1172650; NCBI Protein GI: 16082696; NCBI Protein Accession: NP_395142; NCBITaxon: 214092 VO:0011012 Allen Xiang Oliver He protein Using a mouse plague model, YPO0420 may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. YPO0420 Protegen ID: 349; NCBI Gene GI: 1173265; NCBI Protein GI: 218927621; NCBI Protein Accession: YP_002345496; NCBITaxon: 214092 VO:0011013 Allen Xiang Oliver He protein Using a mouse plague model, YPO3720 (hpmB) may provide partial protection against challenge with a low dose (20 times the 50% lethal dose [20x LD(50)]) of Y. pestis [PubMed: 19651863]. HpmB Protegen ID: 350; NCBI Gene GI: 1176539; NCBI Protein GI: 218930726; NCBI Protein Accession: YP_002348601; NCBITaxon: 214092 VO:0011014 Allen Xiang Oliver He protein Study tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. Results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system [PubMed: 17966435]. Psn Protegen ID: 351; NCBI Gene GI: 1147351; NCBI Protein GI: 22126288; NCBI Protein Accession: NP_669711; NCBITaxon: 187410 VO:0011015 Allen Xiang Oliver He protein Study evaluated the humoral immune response of mice that survived lethal Y. pestis aerosol challenge after antibiotic treatment. Results indicated that one of the predominant antibody response of mice surviving pneumonic plague after treatment with antibiotics was to yopH [PubMed: 10085037]. YopH from Y. pestis CO92 Protegen ID: 352; NCBI Gene GI: 1172712; NCBI Protein GI: 16082755; NCBI Protein Accession: NP_395201; NCBITaxon: 214092 VO:0011016 Allen Xiang Oliver He protein Complexes of YopB (pYV0055), YopD, and YopE (BDE) secreted by Yersinia pseudotuberculosis were purified by affinity chromatography and used as immunogens to determine if antibodies to the translocon could provide protection against Y. pestis in mice. The YopB protein or a complex of YopB and YopD (BD) was purified and determined by vaccination to be immunogenic in mice. Mice actively vaccinated with BD or passively vaccinated with anti-BD serum were protected against lethal challenge with F1(-) Y. pestis [PubMed: 18765742]. pYV0055 Protegen ID: 354; NCBI Gene GI: 2952948; NCBI Protein GI: 51593897; NCBI Protein Accession: YP_068464; NCBITaxon: 273123 VO:0011017 Allen Xiang Oliver He protein Vaccination of mice with deF1 DNA conferred protection against subcutaneous infection with the virulent Y. pestis Kimberley53 strain, even at challenge amounts as high as 4,000 50% lethal doses [PubMed: 12496187 ]. Caf1 from Y. pestis Protegen ID: 355; NCBI Protein GI: 48621; NCBITaxon: 632 VO:0011018 Allen Xiang Oliver He protein Following passive immunization, antisera partially protected infant rats from bacteremia resulting from intraperitoneal challenge with bacteria. As assessed by immunoblotting, pooled adult human sera contained antibodies reactive with P145. Following passive immunization, these antisera partially protected infant rats from bacteremia resulting from intraperitoneal challenge with bacteria. Antibody to P145 may contribute to protection against Brazilian purpuric fever [PubMed: 1937817]. P145 Protegen ID: 356 VO:0011019 Allen Xiang Oliver He protein The ApxI antigen is an important factor in the protection against Actinobacillus pleuropneumoniae serotype 5 infection; therefore, the protective immunity in mice following oral immunization with Saccharomyces cerevisiae expressing either ApxIA (group C) or ApxIIA (group D) alone or both (group E) was compared with that in two control groups (group A and B). The immunogenicity of the rApxIA antigen derived from the yeast was confirmed by a high survival rate and an ApxIA-specific IgG antibody response (p < 0.01) [PubMed: 17993753]. ApxIA Protegen ID: 358; NCBI Protein GI: 312899; NCBITaxon: 715 VO:0011020 Allen Xiang Oliver He protein The levels of local and systemic antibodies specific to the Apx antigens were investigated in mice orally immunized with Apx antigen-expressing yeast. Specific IgA responses to ApxIA or ApxIIA in the intestines and lungs from mice immunized with yeast expressing Apx antigens were significantly higher than those in the control groups after the second and third immunizations, respectively (p < 0.05). All mice were monitored for up to 72 h after challenge with the MLD of an A. pleuropneumoniae field isolate. Overall, the final survival rates of the vaccinated groups were higher than those of the control groups at each time point [PubMed: 17993753]. ApxIIA Protegen ID: 360; NCBI Protein GI: 52630374; NCBITaxon: 715 VO:0011021 Allen Xiang Oliver He protein Following a booster vaccination, a significant (P < 0.05) IgG antibody response to the CP (cps5C), LPS, and HP was detected in the vaccinated pigs. The pigs vaccinated with the CP-HP and LPS-HP conjugates exhibited significantly less mortality (P < 0.05) and significantly greater weight gain (P < 0.001) than unvaccinated pigs. Vaccinated pigs exhibited significantly fewer and less extensive gross pulmonary lesions (P < 0.001) when compared with unvaccinated pigs [PubMed: 1455686]. CP Protegen ID: 361 VO:0011022 Allen Xiang Oliver He protein Following a booster vaccination, a significant (P < 0.05) IgG antibody response to the CP, LPS, and HP (APP7_1016) was detected in the vaccinated pigs. The pigs vaccinated with the CP-HP and LPS-HP conjugates exhibited significantly less mortality (P < 0.05) and significantly greater weight gain (P < 0.001) than unvaccinated pigs. Vaccinated pigs exhibited significantly fewer and less extensive gross pulmonary lesions (P < 0.001) when compared with unvaccinated pigs [PubMed: 1455686]. APP7_1016 Protegen ID: 362; NCBI Gene GI: 6398034; NCBI Protein GI: 190150285; NCBI Protein Accession: YP_001968810; NCBITaxon: 537457 VO:0011024 Allen Xiang Oliver He protein The aroA gene of A. salmonicida was cloned in Escherichia coli, and the nucleotide sequence was determined. Vaccination of brown trout with 10(7) CFU of A. salmonicida 644Rb aroA by intraperitoneal injection resulted in a 253-fold increase in the 50% lethal dose (LD50) compared with unvaccinated controls challenged with a virulent clinical isolate 9 weeks later [PubMed: 8478107]. AroA Protegen ID: 366; NCBI Protein GI: 512545; NCBITaxon: 645 VO:0011025 Allen Xiang Oliver He protein Passive immunisation of Atlantic salmon with rainbow trout or rabbit anti-AsaP1 antisera conferred significant protection against challenge with a virulent A. salmonicida [Ref1011:Gudmundsdottir et al., 1997] AsaP1 Protegen ID: 367; NCBI Gene GI: 4998702; NCBITaxon: 382245 VO:0011026 Allen Xiang Oliver He protein RAP-1 (21B4) is a candidate for inclusion in a B. bovis vaccine based on its ability to induce partial protection in vaccinates, defined as a significant reduction in parasitemia upon challenge [PubMed: 1441189]. RAP-1 Protegen ID: 368; NCBI Gene GI: 5479143; NCBI Protein GI: 156087004; NCBI Protein Accession: XP_001610909; NCBITaxon: 484906 VO:0011027 Allen Xiang Oliver He protein Crude extracts of Babesia bovis parasites were systematically fractionated and tested in numerous sequential vaccination/challenge experiments in adult cattle. Two of these, GST-12D3 and GST-11C5, when used in combination were almost as protective as has been previously shown for the commercially available live attenuated vaccine [PubMed: 1441189]. 12D3 Protegen ID: 371; NCBI Gene GI: 5478971; NCBI Protein GI: 156086656; NCBI Protein Accession: XP_001610737; NCBITaxon: 484906 VO:0011028 Allen Xiang Oliver He protein Crude extracts of Babesia bovis parasites were systematically fractionated and tested in numerous sequential vaccination/challenge experiments in adult cattle. A short fragment of the third antigen (21B4) has been shown to be protective [PubMed: 1441189]. 21B4 Protegen ID: 373; NCBI Protein GI: 1246924; NCBITaxon: 5865 VO:0011029 Allen Xiang Oliver He protein Study described the construction and evaluation of an adenovirus vaccine expressing domain 4 of Bacillus anthracis protective antigen, Ad.D4. Ad.D4 elicited antibodies to protective antigen 14 days after a single intramuscular injection, which were further increased upon boosting. Furthermore, two doses of Ad.D4 4 weeks apart were sufficient to protect 67% of mice from toxin challenge [PubMed: 16428747]. PagA from B. anthracis Protegen ID: 374; NCBI Protein GI: 9280533; NCBITaxon: 1392 VO:0011030 Allen Xiang Oliver He protein A combination of the 69-kDa outer membrane protein and filamentous hemagglutinin (fhaB), both isolated from lymphocytosis promoting factor (LPF; pertussis toxin) minus mutants of Bordetella pertussis, is protective in the mouse intracerebral challenge potency (Kendrick) test [PubMed: 2056199]. FhaB Protegen ID: 375; NCBI Protein GI: 3980256; NCBITaxon: 520 VO:0011031 Allen Xiang Oliver He protein A study demonstrated that passive immunization with specific anti-B. pertussis adenylate cyclase antibodies or active immunization with purified B. pertussis secreted adenylate cyclase (cyaA) protect mice against a lethal respiratory challenge with B. pertussis or B. parapertussis. Results suggest that adenylate cyclase might be the primary cytotoxin responsible for mouse pulmonary lesions during respiratory tract infection with B. pertussis or with the related species B. parapertussis and is a protective antigen of B. pertussis [PubMed: 2622329]. CyaA Protegen ID: 376; NCBI Protein GI: 580668; NCBITaxon: 520 VO:0011032 Allen Xiang Oliver He protein BALB/c mice were immunized with PTx vaccine on day 6 of life and then challenged with B. pertussis using the aerosol challenge model. These primed mice were significantly better protected against leukocytosis, weight loss, and proliferation of B. pertussis in the lungs following aerosol challenge than the nonprimed group. This protection correlated with levels of anti-PT antibody in serum present on the day of aerosol challenge [PubMed: 12117973]. PtxD Protegen ID: 377; NCBI Protein GI: 225311181; NCBITaxon: 520 VO:0011033 Allen Xiang Oliver He protein Researchers constructed isogenic mutants of B. pertussis Tohama expressing the alleles ptxA1 or ptxA2 and prn1 or prn2 and compared the efficacies of an acellular pertussis vaccine against the mutants in a mouse model. While the vaccine was effective against all of the B. pertussis strains regardless of the allele expression pattern, the strain expressing ptxA1 and prn2 displayed a survival advantage over the other strains [PubMed: 20357056]. Prn Protegen ID: 378; NCBI Gene GI: 2664290; NCBI Protein GI: 33592195; NCBI Protein Accession: NP_879839; NCBITaxon: 257313 VO:0011034 Allen Xiang Oliver He protein BALB/c mice were immunized with PTx vaccine on day 6 of life and then challenged with B. pertussis using the aerosol challenge model. These primed mice were significantly better protected against leukocytosis, weight loss, and proliferation of B. pertussis in the lungs following aerosol challenge than the nonprimed group. This protection correlated with levels of anti-PT antibody in serum present on the day of aerosol challenge [PubMed: 12117973]. PtxA Protegen ID: 379; NCBI Gene GI: 2665068; NCBI Protein GI: 33594638; NCBI Protein Accession: NP_882282; NCBITaxon: 257313 VO:0011035 Allen Xiang Oliver He protein A soluble fraction obtained from Bordetella pertussis was evaluated as adjuvant for the pertussis component of the Diphtheria-Pertussis-Tetanus (DPT) vaccine. High levels of antibodies were induced, and a 78% protection rate of mice challenged with live B. pertussis was observed. Two proteins were identified as the 73 kDa N-terminal alpha-domain of BrkA autotransporter protein and the Cpn60/60 kDa chaperonin. Both stimulated antibodies against pertussis and induced a 42% protection rate against the challenge [PubMed: 17011680]. Cpn60 Protegen ID: 382; NCBI Protein GI: 968920; NCBITaxon: 520 VO:0011036 Allen Xiang Oliver He protein A soluble fraction obtained from Bordetella pertussis was evaluated as adjuvant for the pertussis component of the Diphtheria-Pertussis-Tetanus (DPT) vaccine. High levels of antibodies were induced, and a 78% protection rate of mice challenged with live B. pertussis was observed. Two proteins were identified as the 73 kDa N-terminal alpha-domain of BrkA autotransporter protein and the Cpn60/60 kDa chaperonin. Both stimulated antibodies against pertussis and induced a 42% protection rate against the challenge [PubMed: 17011680]. BrkA Protegen ID: 383; NCBI Protein GI: 562026; NCBITaxon: 520 VO:0011037 Allen Xiang Oliver He protein BALB/c mice were immunized with PTx vaccine on day 6 of life and then challenged with B. pertussis using the aerosol challenge model. These primed mice were significantly better protected against leukocytosis, weight loss, and proliferation of B. pertussis in the lungs following aerosol challenge than the nonprimed group. This protection correlated with levels of anti-PT antibody in serum present on the day of aerosol challenge [PubMed: 12117973]. PtxB Protegen ID: 384; NCBI Protein GI: 225311180; NCBITaxon: 520 VO:0011038 Allen Xiang Oliver He protein BALB/c mice were immunized with PTx vaccine on day 6 of life and then challenged with B. pertussis using the aerosol challenge model. These primed mice were significantly better protected against leukocytosis, weight loss, and proliferation of B. pertussis in the lungs following aerosol challenge than the nonprimed group. This protection correlated with levels of anti-PT antibody in serum present on the day of aerosol challenge [PubMed: 12117973]. PtxC Protegen ID: 385; NCBI Protein GI: 225311183; NCBITaxon: 520 VO:0011039 Allen Xiang Oliver He protein BALB/c mice were immunized with PTx vaccine on day 6 of life and then challenged with B. pertussis using the aerosol challenge model. These primed mice were significantly better protected against leukocytosis, weight loss, and proliferation of B. pertussis in the lungs following aerosol challenge than the nonprimed group. This protection correlated with levels of anti-PT antibody in serum present on the day of aerosol challenge [PubMed: 12117973]. PtxE Protegen ID: 386; NCBI Protein GI: 225311182; NCBITaxon: 520 VO:0011040 Allen Xiang Oliver He protein Protection against a BHV-1 challenge was obtained in calves immunized with the plasmid encoding tgD-VP22 (UL49), as shown by significant reductions in viral excretion [PubMed: 15650221]. UL49 from Bovine herpesvirus 1 Protegen ID: 389; NCBI Gene GI: 1487397; NCBI Protein GI: 9629826; NCBI Protein Accession: NP_045310; NCBITaxon: 10320 VO:0011041 Allen Xiang Oliver He protein Calves were injected intranasally with either AdCMVgC or AdCMVgD (US6) or a combination of these two recombinants or a commercially available live vaccine for comparison. The highest BHV-1 neutralizing antibody titres were obtained with AdCMVgD (US6) followed by the live vaccine and to a lower extent with the combination of the two recombinants. Calves were protected against intranasal BHV-1 challenge performed 3 weeks after the second immunization [PubMed: 11818166]. US6 from Bovine herpesvirus 1 Protegen ID: 390; NCBI Gene GI: 1487406; NCBI Protein GI: 9629886; NCBI Protein Accession: NP_045370; NCBITaxon: 10320 VO:0011042 Allen Xiang Oliver He protein Immunization of calves with truncated gpI (US7) protein induced gpI-specific nasal IgA, IgG1, serum neutralizing antibodies and gpI-specific peripheral lymphocyte proliferation. All immunized calves were protected from clinical disease after BHV-1 challenge. Further, nine of ten immunized calves had no intranasal viral shedding [PubMed: 8147097]. US7 Protegen ID: 392; NCBI Gene GI: 4783432; NCBI Protein GI: 9629887; NCBI Protein Accession: NP_045371; NCBITaxon: 10320 VO:0011043 Allen Xiang Oliver He protein A DNA vaccine expressing glycoprotein C (gC, UL44) of bovine herpesvirus-1 (BHV-1) was evaluated for inducing immunity in bovines. Results indicate that DNA immunization with gC could induce neutralizing antibody and lymphoproliferative responses with BHV-1 responsive memory B cells in bovines. However, the immunity developed sufficient for only partial protection against BHV-1 challenge [PubMed: 11182496]. UL44 from Bovine herpesvirus 1 Protegen ID: 393; NCBI Gene GI: 4783424; NCBI Protein GI: 9629830; NCBI Protein Accession: NP_045314; NCBITaxon: 10320 VO:0011044 Allen Xiang Oliver He protein Chitosan-DNA vaccines were prepared by embedding pcDNA3.1(+)-cadF and pcDNA3.1(+)-peblA with chitosan respectively. The mice immunized with chitosan-DNA vaccines have generated high levels of IgA and IgG from the sera and IgA from the intestinal secretions and the P/N value went up to 20.58, 30.13 and 6.87 respectively. The chitosan-DNA vaccines induced strongest level of protection in BALB/c mice against challenge with C. jejuni HS:19 strain and the protective efficacies was 93.70 [PubMed: 18206008]. CadF Protegen ID: 396; NCBI Protein GI: 4704601; NCBITaxon: 197 VO:0011045 Allen Xiang Oliver He protein Chitosan-DNA vaccines were prepared by embedding pcDNA3.1(+)-cadF and pcDNA3.1(+)-peblA with chitosan respectively. The mice immunized with chitosan-DNA vaccines have generated high levels of IgA and IgG from the sera and IgA from the intestinal secretions and the P/N value went up to 20.58, 30.13 and 6.87 respectively. The chitosan-DNA vaccines induced strongest level of protection in BALB/c mice against challenge with C. jejuni HS:19 strain and the protective efficacies was 93.70 [PubMed: 18206008]. Peb1A Protegen ID: 397; NCBI Protein GI: 112360246; NCBITaxon: 192222 VO:0011046 Allen Xiang Oliver He protein Mice were immunized intranasally with two doses of 3 to 50 microgram of MBP-FlaA. The protective efficacies of a 50 microgram of MBP-FlaA plus LT(R192G) dose against disease symptoms and intestinal colonization were 81.1 and 84%, respectively. When mice which had been immunized with 50 microgram of MBP-FlaA plus LT(R192G) intranasally were challenged orally with 8 x 10(10), 8 x 10(9), or 8 x 10(8) cells of strain 81-176, the protective efficacies against intestinal colonization at 7 days postinfection were 71.4, 71.4, and 100%, respectively [PubMed: 10531231]. FlaA from C. jejuni 81-176 Protegen ID: 398; NCBI Gene GI: 4682159; NCBI Protein GI: 121612545; NCBI Protein Accession: YP_001000997; NCBITaxon: 354242 VO:0011047 Allen Xiang Oliver He protein Immunogenicity and protective efficacy of three Campylobacter jejuni flagellum-secreted proteins, FlaC, FspA1, and FspA2, were compared by use of a mouse model. Immunization with FspA1 resulted in 57.8% protection without adjuvant or 63.8% protection with adjuvant against homologous challenge with 81-176 [PubMed: 18426878]. FspA1 Protegen ID: 399; NCBI Protein GI: 116292649; NCBITaxon: 197 VO:0011048 Allen Xiang Oliver He protein Immunogenicity and protective efficacy of three Campylobacter jejuni flagellum-secreted proteins, FlaC, FspA1, and FspA2, were compared by use of a mouse model. All three proteins were immunogenic, FlaC provided an 18% protection against disease from C. jejuni 81-176 [PubMed: 18426878]. FlaC Protegen ID: 400; NCBI Gene GI: 4682885; NCBI Protein GI: 121612344; NCBI Protein Accession: YP_001000416; NCBITaxon: 354242 VO:0011049 Allen Xiang Oliver He protein Immunogenicity and protective efficacy of three Campylobacter jejuni flagellum-secreted proteins, FlaC, FspA1, and FspA2, were compared by use of a mouse model. Immunization with FspA2 provided 38.4% (without adjuvant) or 47.2% (with adjuvant) protection against disease from homologous challenge with CG8486 [PubMed: 18426878]. FspA2 Protegen ID: 409; NCBI Protein GI: 116292677; NCBITaxon: 197 VO:0011050 Allen Xiang Oliver He protein A DNA vaccination trial was performed on sheep to determine whether vaccination with bovine leukemia virus (BLV) transactivator Tax DNA is effective against BLV infection. Results showed higher levels of virus titers in control sheep than those in Tax-vaccinated sheep. Higher levels of IFN-gamma mRNA expression have been demonstrated in vaccinated sheep after the challenge. These results suggested that Th1 type immune response induced by Tax DNA vaccine inhibited BLV propagation in vaccinated sheep at the early phase of infection [PubMed: 14665749]. Tax Protegen ID: 410; NCBI Gene GI: 2760848; NCBI Protein GI: 9626228; NCBI Protein Accession: NP_056895; NCBITaxon: 11901 VO:0011051 Allen Xiang Oliver He protein The bovine leukemia virus (BLV) envelope gene encoding extracellular glycoprotein gp51 (encoded by env gene) and transmembrane glycoprotein gp30 was cloned into a vehicle expression vector under the human cytomegalovirus (CMV) intermediate early promoter. The intramuscular injection of this plasmid vector generated a cellular immune response. Seven out of ten cows vaccinated with the DNA construct resisted a drastic challenge [PubMed: 10824867]. Env/Rex/Tax Protegen ID: 411; NCBI Gene GI: 2760849; NCBI Protein GI: 9626230; NCBI Protein Accession: NP_056898; NCBITaxon: 11901 VO:0011052 Allen Xiang Oliver He protein Young mink kits (n=8) were vaccinated with DNA plasmids encoding the viral haemagglutinin protein (H) of a vaccine strain of Canine distemper virus (CDV). The mink were protected against viraemia, lymphopenia, clinical disease and changes in the percentage of IFN-gamma producing peripheral blood leucocytes after challenge inoculation with a recent wild type strain of CDV. Essentially, these results demonstrate that early life DNA vaccination with the H gene of a CDV vaccine strain induced robust protective immunity against a recent wild type CDV [PubMed: 19596418]. CDVgp6 haemagglutinin protein H Protegen ID: 412; NCBI Gene GI: 1489792; NCBI Protein GI: 9630651; NCBI Protein Accession: NP_047206; NCBITaxon: 11232 VO:0011053 Allen Xiang Oliver He protein Study reports the engineering and the characterization of two replication-competent canine adenovirus type 2 (CAV2)-based vaccines expressing, respectively, the CDV hemagglutinin (HA) and fusion (F) antigens (CDVgp5). We first demonstrated that the intranasal vaccination with a mixture of both recombinant CAV2s provides an excellent level of protection in seronegative puppies, confirming the value of replication-competent adenovirus-based vectors for mucosal vaccination [PubMed: 12297394]. CDVgp5 Protegen ID: 413; NCBI Gene GI: 1489793; NCBI Protein GI: 9630650; NCBI Protein Accession: NP_047205; NCBITaxon: 11232 VO:0011054 Allen Xiang Oliver He protein A vaccine based upon a recombinant plant virus (CPMV-PARVO1), displaying a peptide derived from the VP2 capsid protein of canine parvovirus (CPV), has previously been described. To date, studies with the vaccine have utilized viable plant chimaeric particles (CVPs). Results show that the inactivated CVP is able to protect dogs from a lethal challenge with CPV following parenteral immunization with the vaccine. Dogs immunized with the inactivated CPMV-PARVO1 in adjuvant displayed no clinical signs of disease and shedding of CPV in faeces was limited following CPV challenge. [PubMed: 11395200]. VP2 from Canine parvovirus Protegen ID: 414; NCBI Gene GI: 1489588; NCBITaxon: 10788 VO:0011055 Allen Xiang Oliver He protein This study shows that a plasmid DNA (pGT36VP1) encoding the full length VP1 region of canine parvovirus (CPV) induces immunity that protects dogs against challenge with virulent virus [PubMed: 9569471]. VP1 from Canine parvovirus Protegen ID: 415; NCBI Gene GI: 1489587; NCBITaxon: 10788 VO:0011056 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. DNA pol III Gamma and Tau (CP #1, dnaX) was found to be protective. CP #1 (dnaX) was more protective than the live-vaccine, positive control. [PubMed: 15811648]. DnaX Protegen ID: 416; NCBI Protein GI: 62148024; NCBITaxon: 218497 VO:0011057 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. Glu-tRNA Gln Amidotransferase (CP #2, gatC) was found to be protective. Three of the clones (CP #1) elicited protection that was statistically higher than the unvaccinated control, which has high variance [PubMed: 15811648]. GatC Protegen ID: 417; NCBI Protein GI: 62184917; NCBITaxon: 218497 VO:0011058 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. Protective clone CP #4 (OMP90A, pomp90A) was diluted 1/2000 in a non-protective sublibrary pool of clones. This CP #4-spiked sublibrary conferred protection. Five clones were significantly more protective than the genes encoding fewer than 50 amino acids (CP #1 and 7, p-value of less than 0.05 when comparing lung weights). [PubMed: 15811648]. Pomp90A Protegen ID: 418; NCBI Protein GI: 187438939; NCBITaxon: 83555 VO:0011059 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. CP #5 (Transglycolase/transpeptidase, CAB049 putative penicillin-binding protein) was significantly more protective than the genes encoding fewer than 50 amino acids (p-value of less than 0.05 when comparing lung weights). The chlamydial loads generally tracked with protection and the most protective genes were significantly lower than in unvaccinated controls (p < 0.05 in the Mannhitney U-test for genes CP #1, 2, 4, 9, 10) [PubMed: 15811648]. CAB049 putative penicillin-binding protein Protegen ID: 419; NCBI Protein GI: 62184696; NCBITaxon: 218497 VO:0011060 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. CP #7 (omlA) was significantly more protective than the genes encoding fewer than 50 amino acids (p-value of less than 0.05 when comparing lung weights). The chlamydial loads generally tracked with protection and the most protective genes were significantly lower than in unvaccinated controls (p < 0.05 in the Mannhitney U-test for genes CP #1, 2, 4, 9, 10) [PubMed: 15811648]. OmlA Protegen ID: 420; NCBI Protein GI: 62184824; NCBITaxon: 218497 VO:0011061 Allen Xiang Oliver He protein Genetic immunization was used to functionally test the genes of C. abortus as vaccines in a mouse challenge system. Of the 14 individually tested clones, CP #1 through CP #9 had positive relative protection scores. CP #8 (CAB613, Oligopeptidase) was found to confer protection [PubMed: 15811648]. CAB613 putative peptidase Protegen ID: 421; NCBI Protein GI: 62185225; NCBITaxon: 218497 VO:0011062 Allen Xiang Oliver He protein Animals vaccinated with Gam82 and challenged with E. maxima showed lower oocyst shedding and reduced intestinal pathology compared with non-vaccinated and parasite-challenged animals. Gam82 vaccination also stimulated the production of antigen-specific serum antibodies and induced greater levels of IL-2 and IL-15 mRNAs compared with non-vaccinated controls. These results demonstrate that the Gam82 recombinant protein protects against E. maxima and augments humoral and cell-mediated immunity [PubMed: 20178868]. Gam82 Protegen ID: 457; NCBI Protein GI: 38565038; NCBITaxon: 5804 VO:0011063 Allen Xiang Oliver He protein Birds vaccinated with Eimeria tenella microneme recombinant gene (EtMIC2) and encoded protein developed protective immunity against infection by E. tenella as assessed by significantly increased body weight gain and decreased fecal oocyst shedding compared with non-vaccinated controls. Vaccination with the EtMIC2 gene also led to protective immunity against infection by E. acervulina, but not E. maxima [PubMed: 15882535]. MIC2 Protegen ID: 459; NCBI Protein GI: 225579627; NCBITaxon: 5802 VO:0011064 Allen Xiang Oliver He protein Two recombinant Mycobacterium bovis BCG (rBCG) strains carrying the Eimeria tenella rhomboid gene (Rho) delivered by extrachromosomal vector pMV261 and integrative vector pMV361 were evaluated for their ability to protect chickens against E. tenella challenge. Chickens were immunized intranasal with BCG, rBCG pMV261-Rho, or rBCG pMV361-Rho twice at a 2-week interval. All the recombinant BCG immunized chickens developed specific immune responses, and there was a significant increases of the percentages of CD4(+) and CD8(+) cells compared to the control (P<0.05). Challenge experiments demonstrated that the two rBCG strains could provide significant protection against E. tenella challenge [PubMed: 19117681]. Rho Protegen ID: 460; NCBI Protein GI: 84043169; NCBITaxon: 5802 VO:0011065 Allen Xiang Oliver He protein The immunization procedure of DNA vaccine pcDNA-TA4-IL-2 of Eimeria tenella, including route, dose, time of immunization and age of primary immunization of chicken, was optimized. results illustrated that 25 microg was the optimal dose and intramuscular injection was the most effective route to induce protective immunity in Chinese Yellow chickens [PubMed: 19019543]. TA4 Protegen ID: 461; NCBI Protein GI: 84783094; NCBITaxon: 5802 VO:0011066 Allen Xiang Oliver He protein The Eimeria tenella antigen gene (3-1E) and chicken interferon gamma gene (ChIFN-gamma) were subcloned into the mammalian expression vector proVAX forming the plasmids proE and prol. After challenge the proIE-vaccinated chickens showed protective immunity as demonstrated by significantly reduced oocyst shedding [PubMed: 17274297]. 3-1E Protegen ID: 463; NCBI Protein GI: 126362934; NCBITaxon: 5802 VO:0011067 Allen Xiang Oliver He protein A cDNA clone derived from sporulated oocysts of Eimeria tenella and encoding the expression product GX3262 was identified using a monoclonal antibody raised against Eimeria acervulina sporozoites. After challenge with an experimental E. tenella infection, the greatest degree of protection in immunized broiler chickens was seen after only a single immunization of 2-day-old birds with a live recombinant E. coli preparation [PubMed: 2659532]. GX3262 Protegen ID: 464; NCBI Protein GI: 102304; NCBITaxon: 5802 VO:0011068 Allen Xiang Oliver He protein Study describes experiments which demonstrate that the vaccine, (EURIFEL FeLV; Merial) that expresses the FeLV env and gag protective genes, is effective against any oronasal FeLV challenge. The protection was shown to be solid against an oronasal challenge one year after the initial vaccination, and was effective against a very severe 'in-contact' challenge [PubMed: 12934796]. Env Protegen ID: 465; NCBI Gene GI: 1491868; NCBI Protein GI: 9630709; NCBI Protein Accession: NP_047256; NCBITaxon: 11768 VO:0011069 Allen Xiang Oliver He protein The vaccine, (EURIFEL FeLV; Merial) that expresses the FeLV env and gag protective genes, is effective against any oronasal FeLV challenge. The protection was shown to be solid against an oronasal challenge one year after the initial vaccination, and was effective against a very severe 'in-contact' challenge [PubMed: 12934796]. Gag Protegen ID: 466; NCBI Protein GI: 323916; NCBITaxon: 11768 VO:0011070 Allen Xiang Oliver He protein Intranasal immunization of HLA-DR4 tg mice with the single antigen FopB from F. tularensis subsp. novicida conferred significant protection against lethal pulmonary challenge with an F. tularensis subsp. holarctica live vaccine strain. FopB Protegen ID: 468; NCBI Gene GI: 4547777; NCBI Protein GI: 118496734; NCBI Protein Accession: YP_897784; NCBITaxon: 401614 VO:0011071 Allen Xiang Oliver He protein Intranasal vaccination with KKF235 (F. tularensis subsp. novicida mutant (DeltaiglB) ) protected mice from subsequent homotypic challenge with U112 as well as heterotypic challenge with F. tularensis subsp. holarctica (LVS). Most significantly, oral immunization with KKF235 protected mice from a highly lethal subsp. tularensis (SCHU S4) pulmonary challenge [PubMed: 20016043]. IglB Protegen ID: 469; NCBI Gene GI: 4548125; NCBI Protein GI: 118497903; NCBI Protein Accession: YP_898953; NCBITaxon: 401614 VO:0011072 Allen Xiang Oliver He protein Mice immunized with rLm/iglC were protected against lethal challenge with F. tularensis LVS administered by the intranasal route, a route chosen to mimic airborne infection, and, most importantly, against aerosol challenge with the highly virulent Type A F. tularensis SchuS4 strain [PubMed: 19126421]. IglC1 Protegen ID: 470; NCBI Gene GI: 3191591; NCBI Protein GI: 56708413; NCBI Protein Accession: YP_170309; NCBITaxon: 177416 VO:0011073 Allen Xiang Oliver He protein Mice immunized with rLm/iglC were protected against lethal challenge with F. tularensis LVS administered by the intranasal route, a route chosen to mimic airborne infection, and, most importantly, against aerosol challenge with the highly virulent Type A F. tularensis SchuS4 strain [PubMed: 19126421]. IglC2 Protegen ID: 471; NCBI Gene GI: 3191814; NCBI Protein GI: 56708721; NCBI Protein Accession: YP_170617; NCBITaxon: 177416 VO:0011074 Allen Xiang Oliver He protein Immunization with WbtI(G191V) protected mice against a relatively low-dose intraperitoneal challenge with LVS (F. tularensis subspecies holarctica live vaccine strain), but was less protective against a high-dose challenge [PubMed: 17768257]. WbtI Protegen ID: 472; NCBI Gene GI: 5522688; NCBI Protein GI: 156502002; NCBI Protein Accession: YP_001428067; NCBITaxon: 458234 VO:0011075 Allen Xiang Oliver He protein Researchers have shown that mice that had been immunized with purified heat shock protein 60 (Hsp60, groEL) isolated from Francisella tularensis were protected against a subsequent challenge with some strains of the bacterium [PubMed: 15213156]. GroEL from Francisella tularensis Protegen ID: 473; NCBI Protein GI: 282159959; NCBITaxon: 510831 VO:0011076 Allen Xiang Oliver He protein A 17-kDa lipoprotein, TUL4, of the facultative intracellular bacterium Francisella tularensis is one of several membrane proteins that induce an in vitro response in T cells from F. tularensis-primed humans. When mice were immunized with S. typhimurium chi 4072(pTUL4-15), some animals showed an antibody response and a T-cell response to TUL4. The present study demonstrated that the 17-kDa lipoprotein TUL4 of F. tularensis is involved in a protective immunity to tularemia [PubMed: 1612751]. TUL4 Protegen ID: 474; NCBI Protein GI: 148688; NCBITaxon: 263 VO:0011077 Allen Xiang Oliver He protein C57BL/6 mice were vaccinated intranasally (i.n.) with the sodB(Ft) mutant and challenged i.n. with lethal doses of F. tularensis SchuS4. SodB(Ft) vaccinated mice following SchuS4 challenge exhibited significantly reduced bacterial burden in lungs, liver and spleen, regulated production of pro-inflammatory cytokines and less severe histopathological lesions compared to the LVS vaccinated mice. The sodB(Ft) vaccination induced a potent humoral immune response and protection against SchuS4 required both CD4 and CD8 T cells in the vaccinated mice [PubMed: 18692537]. SodB from F. tularensis SCHU S4 Protegen ID: 475; NCBI Gene GI: 3190713; NCBI Protein GI: 56707247; NCBI Protein Accession: YP_169143; NCBITaxon: 177416 VO:0011078 Allen Xiang Oliver He protein Anti-FopA MAbs protected 90% of nave C3H/HeN mice from lethal challenge with F. tularensis LVS when administered prophylactically as well as therapeutically [PubMed: 19176692]. FopA Protegen ID: 476; NCBI Gene GI: 4306351; NCBI Protein GI: 115315051; NCBI Protein Accession: YP_763774; NCBITaxon: 393011 VO:0011079 Allen Xiang Oliver He protein Anti-lpnA MAbs conferred significant, although not complete, protection of nave C3H/HeN mice from lethal challenge with F. tularensis LVS when administered therapeutically [PubMed: 19176692]. LpnA Protegen ID: 477; NCBI Gene GI: 3191792; NCBI Protein GI: 56708002; NCBI Protein Accession: YP_169898; NCBITaxon: 177416 VO:0011080 Allen Xiang Oliver He protein The gene encoding the full length cyst wall protein-2 (CWP2) from Giardia lamblia was subcloned into the pCDNA3 mammalian expression vector and stably introduced into S. typhimurium STM1. Challenge infection with live Giardia muris cysts revealed that mice receiving the CWP2-encoding DNA vaccine were able to reduce cyst shedding by approximately 60% compared to control mice [PubMed: 17996337]. CWP2 Protegen ID: 479; NCBI Gene GI: 5703171; NCBI Protein GI: 159120052; NCBI Protein Accession: XP_001710242; NCBITaxon: 50803 VO:0011081 Allen Xiang Oliver He protein Rats vaccinated with PD (hpd) cleared NT H. influenzae better after middle ear and pulmonary bacterial challenge, and chinchillas vaccinated with PD showed significant protection against NT H. influenzae-dependent acute otitis media. In a clinical trial involving children, PD was used as an antigenically active carrier protein in an 11-valent pneumococcal conjugate investigational vaccine; significant protection was achieved against acute otitis media not only caused by pneumococci but also caused by NT H. influenzae [PubMed: 18230042]. Hpd Protegen ID: 480; NCBI Protein GI: 148971; NCBITaxon: 727 VO:0011082 Allen Xiang Oliver He protein In a chinchilla model of otitis media, initial screening of P5-fimbrin, delivered singly or in combination with either Freund's adjuvant or alum, indicated that augmented bacterial clearance from the nasopharynx, the middle ears, or both anatomical sites could be induced by parenteral immunization with P5-fimbrin combined with lipoprotein D, lipoprotein D alone, or the synthetic chimeric peptide LB1 (derived from P5-fimbrin), respectively [PubMed: 10338477]. OmpP5 Protegen ID: 482; NCBI Gene GI: 3430592; NCBI Protein GI: 68249712; NCBI Protein Accession: YP_248824; NCBITaxon: 281310 VO:0011083 Allen Xiang Oliver He protein Purified rD15 was found to be highly immunogenic in mice, guinea pigs, and rabbits, and passive transfer of anti-rD15 antibodies protected infant rats from challenge with H. influenzae type b or type a in infant rat models of bacteremia [PubMed: 9284140]. D15 Protegen ID: 483; NCBI Gene GI: 3430379; NCBI Protein GI: 68249503; NCBI Protein Accession: YP_248615; NCBITaxon: 281310 VO:0011084 Allen Xiang Oliver He protein Rabbit antibody prepared against P2 from one strain was cross-reactive with P2 isolated from the other two heterologous strains by Western blot. This antibody passively protected infant rats against type b Haemophilus infection caused by the homologous organism, but not against challenge by a strain with the heterologous 36,500 mol wt P2 protein [PubMed: 6603479]. OmpP2 Protegen ID: 485; NCBI Gene GI: 3429565; NCBI Protein GI: 68248747; NCBI Protein Accession: YP_247859; NCBITaxon: 281310 VO:0011085 Allen Xiang Oliver He protein Seoul virus (SEOV) is one of the four known hantaviruses causing hemorrhagic fever with renal syndrome (HFRS). A replication-competent recombinant canine adenovirus type 2 expressing the Gc protein of SEOV (rCAV-2-Gc) in BALB/c mice induced complete protection against a intensive infectious challenge with ~1,000 50% infective doses (ID50) for SEOV strain CC-2 [PubMed: 20181748]. Gc Protegen ID: 486; NCBI Protein GI: 284157806; NCBITaxon: 11608 VO:0011086 Allen Xiang Oliver He protein Study used a deer mouse infection model to test the protective efficacy of genetic vaccine candidates for Sin Nombre (SN) virus that were known to provoke immunological responses in BALB/c mice. Protective epitopes were localized in each of four overlapping cDNA fragments that encoded portions of the SN virus G1 glycoprotein antigen; the nucleocapsid gene also was protective [PubMed: 12075094]. G1 Protegen ID: 487; NCBI Protein GI: 1113859; NCBITaxon: 37705 VO:0011087 Allen Xiang Oliver He protein Study used a deer mouse infection model to test the protective efficacy of genetic vaccine candidates for Sin Nombre (SN) virus that were known to provoke immunological responses in BALB/c mice. Protective epitopes were localized in each of four overlapping cDNA fragments that encoded portions of the SN virus G1 glycoprotein antigen; the nucleocapsid gene (SNVsSgp1) also was protective [PubMed: 12075094]. SNVsSgp1 Protegen ID: 489; NCBI Gene GI: 2943142; NCBI Protein GI: 38371726; NCBI Protein Accession: NP_941975; NCBITaxon: 37705 VO:0011088 Allen Xiang Oliver He protein To investigate the ability of recombinant N (rN, nucleocapsid proteins) from different hantaviruses to elicit cross-protection, we immunized bank voles with rN from Puumala (PUUV), Topografov (TOPV), Andes (ANDV), and Dobrava (DOBV) viruses and subsequently challenged them with PUUV. All animals immunized with PUUV (PUUVsSgp1) and TOPV rN were completely protected [PubMed: 12050380]. PUUVsSgp1 Protegen ID: 490; NCBI Gene GI: 2943083; NCBI Protein GI: 38371721; NCBI Protein Accession: NP_941984; NCBITaxon: 11604 VO:0011089 Allen Xiang Oliver He protein To investigate the ability of recombinant N (rN, nucleocapsid proteins) from different hantaviruses to elicit cross-protection, we immunized bank voles with rN from Puumala (PUUV), Topografov (TOPV), Andes (ANDV), and Dobrava (DOBV) viruses and subsequently challenged them with PUUV. All animals immunized with PUUV and TOPV rN were completely protected [PubMed: 12050380]. N protein [Topografov virus] Protegen ID: 491; NCBI Protein GI: 4757106; NCBITaxon: 83192 VO:0011090 Allen Xiang Oliver He protein Researchers vaccinated hamsters with a vaccinia virus-vectored vaccine expressing the M and the S segments of Hantaan (HTN) virus and challenged them with HTN, Seoul (SEO), or Puumala (PUU) virus. Study found that vaccinated hamsters, challenged with HTN or SEO virus, were neither viremic nor had evidence of virus in their lungs or kidneys [PubMed: 7666542]. M Segment Protegen ID: 492; NCBI Protein GI: 1389703; NCBITaxon: 11599 VO:0011091 Allen Xiang Oliver He protein Passive transfer of spleen cells from mice immunized with rNP (HTNVsSgp1) conferred partial protection or prolongation of time to death from fatal Hantaan virus infection in suckling mice which were challenged with Hantaan virus at 40 LD50 (survival rate: 43%) or 4 LD50 (survival rate: 43%) [PubMed: 8517793]. HTNVsSgp1 Protegen ID: 493; NCBI Gene GI: 2943078; NCBI Protein GI: 38371711; NCBI Protein Accession: NP_941977; NCBITaxon: 11599 VO:0011092 Allen Xiang Oliver He protein Nonreplicating adenovirus (Ad) vectors that express Andes hantavirus (ANDV) nucleocapsid protein (AdN, ANDVsSgp1) or glycoproteins (AdG(N) and AdG(C)) were constructed . When administered once, all three Ad vectors, individually or in combination, elicited a robust immune response that protected Syrian hamsters from a lethal ANDV infection that mimics the pulmonary disease seen in humans. No vaccinated animal died, and there were no obvious clinical signs of disease [PubMed: 19403663]. ANDVsSgp1 Protegen ID: 494; NCBI Gene GI: 991232; NCBI Protein GI: 19744950; NCBI Protein Accession: NP_604471; NCBITaxon: 46607 VO:0011093 Allen Xiang Oliver He protein Study compared a current HBV vaccine that contains recombinant hepatitis B surface antigen HBsAg) adsorbed to alum in chimpanzees, with two novel vaccine strategies that have proven superior to the current vaccine in mice. All animals receiving either control or CpG-containing subunit vaccines at 0 and 4 weeks attained titers of HBsAg-specific antibody (anti-HBs) considered protective (> or =10 mIU/ml) and were indeed protected from challenge at 8 weeks with 10(3.5) 50% chimp infectious doses (CID(50)) of intravenous HBV [PubMed: 16428890]. Hepatitis B surface antigen Protegen ID: 495; NCBI Protein GI: 128168861; NCBITaxon: 10407 VO:0011094 Allen Xiang Oliver He protein The immunological protection of pVAX-PS, a DNA vaccine, was assessed in the tree shrews model. pVAX-PS was constructed by inserting the gene encoding the middle (pre-S2 plus S) envelope protein of HBV into a plasmid vector pVAX1. Results indicated that pVAX-PS immunization could induce remarkable humoral immune response and prevent the experimental tree shrews from infection of HBV [PubMed: 12932306]. PreS2 middle surface protein Protegen ID: 496; NCBI Protein GI: 113207330; NCBITaxon: 10407 VO:0011095 Allen Xiang Oliver He protein Immunisation with a plasmid encoding the DHBV large (L) envelope protein (HBVgp2 pre-S1/pre-S2/S) induced a strong, specific, highly neutralising and long-lasting anti-preS humoral response in uninfected ducks. Importantly, maternal antibodies elicited by such DNA immunisation were vertically transmitted and protected progeny against viral challenge [PubMed: 12531335]. HBVgp2 pre-S1/pre-S2/S Protegen ID: 497; NCBI Gene GI: 944569; NCBI Protein GI: 77680739; NCBI Protein Accession: YP_355333; NCBITaxon: 10407 VO:0011096 Allen Xiang Oliver He protein The herpes simplex virus type 2 (HSV-2) glycoprotein D (gD2) gene was inserted into an intergenic site in the unique short region of the Oka VZV genome. Expression of gD2 in cells infected with the recombinant Oka strain VZV (ROka-gD2) was confirmed by antibody staining of fixed cells and by immunoblot analysis. Forty days after the third inoculation, guinea pigs were challenged intravaginally with HSV-2. Inoculation of guinea pigs with ROka-gD2 significantly reduced the severity of primary HSV-2 infection (P < 0.001) [PubMed: 7494331]. US6 from Herpes simplex virus type 1 and 2 Protegen ID: 499; NCBI Gene GI: 1487358; NCBI Protein GI: 9629336; NCBI Protein Accession: NP_044536; NCBITaxon: 10310 VO:0011097 Allen Xiang Oliver He protein The present study evaluated the modulatory functions of salbutamol co-administered with DNA vaccine expressing gB (UL27) of herpes simplex virus (HSV) via intranasal (i.n.) route. The enhanced immune responses caused by co-administration of salbutamol provided effective and rapid responses to HSV mucosal challenge, thereby conferring prolonged survival and reduced inflammation against viral infection [PubMed: 19641376]. UL27 from Herpes simplex virus type 2 Protegen ID: 500; NCBI Protein GI: 1869850; NCBITaxon: 10310 VO:0011098 Allen Xiang Oliver He protein BALB/c mice receiving a glycoprotein D1 (gD1, US5) DNA vaccine alone were 80% protected against a subsequent HSV-1 challenge. Results also indicate that the administration of NLX as an adjuvant improved protective immunity against HSV-1 [PubMed: 19174474]. US5 Protegen ID: 501; NCBI Gene GI: 2703406; NCBI Protein GI: 9629447; NCBI Protein Accession: NP_044668; NCBITaxon: 10298 VO:0011099 Allen Xiang Oliver He protein Study demonstrated that recombinant Listeria monocytogenes (Lm) expressing the H-2K(b) glycoprotein B (gB, UL27)(498-505) peptide from HSV-1 triggers a robust CD8 T cell response to this Ag resulting in protective immunity to HSV infection in mice [PubMed: 17404252]. UL27 from Herpes simplex virus type 1 Protegen ID: 502; NCBI Gene GI: 2703455; NCBI Protein GI: 9629408; NCBI Protein Accession: NP_044629; NCBITaxon: 10298 VO:0011100 Allen Xiang Oliver He protein Particle-mediated DNA vaccination of mice with a DNA plasmid-encoding ICP27 resulted in the induction of ICP27-specific IFN-gamma and TNF-alpha production in Balb/c mice. When the DNA vaccine was supplemented with as little as 50ng of a vector encoding the A and B subunits of the Escherichia coli heat labile enterotoxin (LT), animals were profoundly protected from morbidity and mortality [PubMed: 16621198]. ICP27 from Herpes simplex virus type 2 Protegen ID: 503; NCBI Protein GI: 124181; NCBITaxon: 10315 VO:0011101 Allen Xiang Oliver He protein Epitopes from the ICP27 (H1, H2), glycoprotein B (gB) and glycoprotein D (gD) proteins of HSV-1 were attached to either the J TCBL/ICBL or the G TCBL/ICBL. The JH1, JH2, JgB and JgD vaccines elicited DTH responses without antibody but conferred protection upon lethal challenge with HSV [PubMed: 15569635]. ICP27 from Herpes simplex virus type 1 Protegen ID: 504; NCBI Protein GI: 75812153; NCBITaxon: 10298 VO:0011102 Allen Xiang Oliver He protein In two experiments, mice immunised with phage displaying a single epitope of gG2 (US4) were protected against challenge with a lethal dose of whole HSV-2 [PubMed: 10725197]. US4 Protegen ID: 505; NCBI Gene GI: 1487356; NCBI Protein GI: 9629334; NCBI Protein Accession: NP_044534; NCBITaxon: 10310 VO:0011103 Allen Xiang Oliver He protein Protection against a lethal intraperitoneal challenge of HSV-1 (5 x 10(4) pfu) with gC (UL44) or gE plasmid vaccination could be demonstrated if the inoculating dose of DNA was 250 microg. All mice immunized with vaccinia recombinants expressing either gC or gE survived HSV-1 challenge [PubMed: 9728527]. UL44 from Herpes simplex virus type 1 and 2 Protegen ID: 506; NCBI Gene GI: 2703410; NCBI Protein GI: 9629425; NCBI Protein Accession: NP_044646; NCBITaxon: 10298 VO:0011104 Allen Xiang Oliver He protein Protection against a lethal intraperitoneal challenge of HSV-1 (5 x 10(4) pfu) with gC or gE (US8) plasmid vaccination could be demonstrated if the inoculating dose of DNA was 250 microg. All mice immunized with vaccinia recombinants expressing either gC or gE survived HSV-1 challenge [PubMed: 9728527]. US8 Protegen ID: 507; NCBI Gene GI: 2703448; NCBI Protein GI: 9629449; NCBI Protein Accession: NP_044670; NCBITaxon: 10298 VO:0011105 Allen Xiang Oliver He E7 protein Researchers combined the HPV16 E7 peptide(38-61) with a murine IgG heavy chain constant region to construct a chimeric protein compound. The chimeric vaccine candidate was able to effectively protect mice against the challenge of HPV16-positive tumor cells, and to eradicate HPV16-expressing tumors in mice [PubMed: 15661238]. HPV E7 Protegen ID: 509; NCBI Gene GI: 1489079; NCBI Protein GI: 9627105; NCBI Protein Accession: NP_041326; NCBITaxon: 333760 VO:0011106 Allen Xiang Oliver He L2 protein Antibody responses of mice (n = 120) and rabbits (n = 23) to vaccination with HPV-16 amino-terminal L2 polypeptides or multitype L2 fusion proteins were compared. 11-200 x 3 formulated in GPI-0100 adjuvant or alum with 1018 ISS protected mice against HPV-16 challenge (reduction in HPV-16 infection vs phosphate-buffered saline control, P < .001) 4 months after vaccination as well as HPV-16 L1 VLPs [PubMed: 19470949]. HPV L2 Protegen ID: 510; NCBI Gene GI: 1489081; NCBI Protein GI: 9627107; NCBI Protein Accession: NP_041331; NCBITaxon: 333760 VO:0011107 Allen Xiang Oliver He E6 protein C57BL/6 mice vaccinated with pNGVL4a-E6/opt are able to generate potent protective and therapeutic antitumor effects against challenge with E6-expressing tumor cell line, TC-1 of HPV [PubMed: 16649071]. HPV E6 Protegen ID: 511; NCBI Gene GI: 1489078; NCBI Protein GI: 9627104; NCBI Protein Accession: NP_041325; NCBITaxon: 333760 VO:0011108 Allen Xiang Oliver He L1 protein rAAV5, -8 and -9 vectors expressing an HPV16 L1/E7 fusion gene were generated and applied intranasally for combined prophylactic and therapeutic vaccination of mice. Vaccination with the rAAV vectors led to a significant protection of animals against a challenge with different HPV tumour cell lines [PubMed: 20032542]. HPV L1 Protegen ID: 512; NCBI Gene GI: 1489082; NCBI Protein GI: 9627108; NCBI Protein Accession: NP_041332; NCBITaxon: 333760 VO:0011109 Allen Xiang Oliver He protein The DNA vaccine pIHNw-G encodes the glycoprotein of the fish rhabdovirus infectious hematopoietic necrosis virus (IHNV). Vaccine performance in rainbow trout was measured 3, 6, 13, 24, and 25 months after vaccination. At three months all fish vaccinated with 0.1 microg pIHNw-G had detectable neutralizing antibody (NAb) and they were completely protected from lethal IHNV challenge with a relative percent survival (RPS) of 100% compared to control fish [PubMed: 16154239]. G glycoprotein from Infectious Hematopoietic Necrosis Virus Protegen ID: 513; NCBI Gene GI: 1489848; NCBI Protein GI: 9628086; NCBI Protein Accession: NP_042679; NCBITaxon: 11290 VO:0011110 Allen Xiang Oliver He protein BALB/c mice were immunized intranasally with an adjuvant (cholera toxin B subunit containing 0.2% of the whole toxin)-combined with A or B virus recombinant NP. The NP-immune mice, when challenged intranasally with a sublethal dose of the virus 3 wk after immunization, had accelerated virus clearance from the nasal site in both an influenza type-specific and a nonspecific manner, as shown by the protection from high morbidity from the second day after challenge [PubMed: 8621928]. NP from Influenza B virus Protegen ID: 514; NCBI Gene GI: 956539; NCBI Protein GI: 8486155; NCBI Protein Accession: NP_056661; NCBITaxon: 11520 VO:0011111 Allen Xiang Oliver He protein BALB/c mice were immunized intranasally with an adjuvant (cholera toxin B subunit containing 0.2% of the whole toxin)-combined with A or B virus recombinant NP. The NP-immune mice, when challenged intranasally with a sublethal dose of the virus 3 wk after immunization, had accelerated virus clearance from the nasal site in both an influenza type-specific and a nonspecific manner, as shown by the protection from high morbidity from the second day after challenge [PubMed: 8621928]. NP from Influenza A virus H3N2 Protegen ID: 515; NCBI Protein GI: 3722159; NCBITaxon: 41857 VO:0011112 Allen Xiang Oliver He protein Skin and mucosal vaccination provided complete protection from clinical signs of infection with ponies subjected to a challenge infection of Equine influenza virus, while skin vaccination provided partial protection; DNA vaccination provided partial protection from viral shedding [PubMed: 10403592]. HA from Equine influenza virus H3N8 Protegen ID: 516; NCBI Protein GI: 404517; NCBITaxon: 31660 VO:0011113 Allen Xiang Oliver He protein A nonpathogenic vector of the cytoplasmic domain of the VSV G protein and expressing influenza virus HA (derived from Influenza A virus (A/WSN/1933(H1N1))) provides complete protection from lethal influenza virus challenge after intranasal administration. A second vector with VSV G deleted and expressing HA (DeltaG-HA) is also protective and nonpathogenic and has the advantage of not inducing neutralizing antibodies to the vector itself [PubMed: 10196265]. HA from Influenza A virus (A/WSN/1933(H1N1)) Protegen ID: 518; NCBI Protein GI: 324200; NCBITaxon: 382835 VO:0011114 Allen Xiang Oliver He protein A recombinant baculovirus expressing the hemagglutinin gene of the influenza virus, A/PR/8/34 (H1N1), under the control of the chicken beta-actin promoter, was constructed. Protection from a lethal challenge of the influenza virus was achieved by intranasal immunization of the recombinant baculovirus [PubMed: 12874198]. HA from Influenza A virus (A/Puerto Rico/8/1934(H1N1)) Protegen ID: 519; NCBI Protein GI: 126599271; NCBITaxon: 211044 VO:0011115 Allen Xiang Oliver He protein Two cyclic peptide analogues corresponding to residues 139-146 (site A) of influenza A virus haemagglutinin (strain X31) were synthesized. When OF1 mice were immunized with cyclic peptides, approximately 80% of the animals were protected against an intranasal challenge with influenza virus [PubMed: 2396470]. HA from Influenza A virus (A/Aichi/2/1968(H3N2)), (X31) Protegen ID: 520; NCBI Protein GI: 324132; NCBITaxon: 387139 VO:0011116 Allen Xiang Oliver He protein Mice and ferrets were immunised with two doses of the split virus vaccine (12-24 microg haemagglutinin derived from Influenza A virus (A/chicken/Italy/13474/99(H7N1))) with or without aluminium hydroxide adjuvant and challenged 3 weeks after second dose with the highly pathogenic A/chicken/Italy/13474/99 (H7N1) virus. The vaccine induced significant protection from disease after challenge with the wild-type virus. In the murine lethal challenge model, vaccination effectively prevented death and, furthermore, formulation with adjuvant reduced excessive weight loss and viral shedding [PubMed: 19453487]. HA from Influenza A virus (A/chicken/Italy/13474/99(H7N1)) Protegen ID: 521; NCBI Protein GI: 32261025; NCBITaxon: 199442 VO:0011117 Allen Xiang Oliver He protein Immunization and challenge experiments in mice indicated that even though vaccination with the recombinant HA vaccinia viruses derived from Influenza B virus (Strain B/England/222/82) induced different levels of cross-reactive neutralizing antibodies, mice vaccinated with either recombinant vaccinia virus were protected from infection with either subpopulation of influenza virus [PubMed: 3318092]. HA from Influenza B virus (Strain B/England/222/82) Protegen ID: 522; NCBI Protein GI: 122955; NCBITaxon: 11527 VO:0011118 Allen Xiang Oliver He protein Mice vaccinated with a recombinant VLP vaccine from both influenza A H5N1 clade 1 and clade 2 isolates (Influenza A virus (A/duck/Badung-Bali/05/2005(H5N1))) with pandemic potential were protected against challenge with lethal reassortant viruses expressing the H5N1 HA and NA, regardless if the H5N1 clade was homologous or heterologous to the vaccine [PubMed: 18231588]. HA from Influenza A virus (A/duck/Badung-Bali/05/2005(H5N1)) Protegen ID: 523; NCBI Protein GI: 190344179; NCBITaxon: 389226 VO:0011119 Allen Xiang Oliver He protein A targeted fusion protein based on the CTA1-DD adjuvant and containing tandem repeats of the matrix protein 2 (M2e) ectodomain epitope derived from Influenza A virus (A/Puerto Rico/8/34(H1N1)), CTA1-3M2e-DD, confers strong protective immunity against a potentially lethal challenge infection with influenza virus in mice. The formulation was highly effective for mucosal immunizations and promoted high M2e-specific serum IgG and mucosal IgA antibody titers and an hitherto unknown anti-M2e CD4 T cell immunity [PubMed: 18243429]. M2 from Influenza A virus (A/Puerto Rico/8/34(H1N1)) Protegen ID: 524; NCBI Gene GI: 956528; NCBI Protein GI: 56583270; NCBI Protein Accession: NP_040979; NCBITaxon: 211044 VO:0011120 Allen Xiang Oliver He protein Vaccination with HA-VRP derived from Influenza A virus (A/Hong Kong/1/68(H3N2)) did not strongly stimulate either neutralizing or IgG1 antibodies but did induce IgG2a antibodies. Expression of IgG2a antibodies in this context correlated with clearance of virus and increased protection against lethal influenza challenge [PubMed: 16960108]. HA from Influenza A virus (A/Hong Kong/1/68(H3N2)) Protegen ID: 525; NCBI Protein GI: 16960108; NCBITaxon: 10090 VO:0011121 Allen Xiang Oliver He protein Researchers report that a DNA vaccine encoding hemagglutinin from the index human influenza isolate A/HK/156/97 provides immunity against H5N1 infection of mice [PubMed: 9971791]. HA from Influenza A virus (A/environment/Hong Kong/156/1997(H5N1)) Protegen ID: 527; NCBI Protein GI: 269826115; NCBITaxon: 680785 VO:0011122 Allen Xiang Oliver He protein A simian adenovirus 24 (AdC7) vector expressing the influenza A/Puerto Rico/8/34 NP was tested for its efficacy in protecting BALB/c mice against two H5N1 strains. When tested in a mouse challenge model, there was a significantly improved survival rate following challenge with the Vietnam/1203/04 strain of H5N1 that has caused human outbreaks [PubMed: 17728024]. NP from Influenza A virus (A/Puerto Rico/8/34(H1N1)) Protegen ID: 528; NCBI Gene GI: 956531; NCBI Protein GI: 8486130; NCBI Protein Accession: NP_040982; NCBITaxon: 211044 VO:0011123 Allen Xiang Oliver He protein The protective effect of neuraminidase (NA) was studied in a mouse protection test using isolated neuraminidase of A2/Aichi/68(H3N2) virus and the complete recombinant virus A/eq(Heq-1)-HK(N2) as antigens. Immunized mice were protected against A2/Aichi(H3N2) challenge virus; however, the protection rate was low in comparison to animals immunized with comparable amounts of the complete A2/68(H3N2) virus9 [PubMed: 1126575]. NA from Influenza A virus (A/Aichi/2/1968(H3N2)) Protegen ID: 530; NCBI Protein GI: 46401580; NCBITaxon: 387139 VO:0011124 Allen Xiang Oliver He protein In mouse models of influenza infection, the vaccines derived from Influenza A virus (A/Solomon Islands/3/2006(H1N1)) hemagglutinin elicit robust antibody responses that mitigate disease and protect mice from lethal challenge [PubMed: 18493310]. HA from Influenza A virus (A/Solomon Islands/3/2006(H1N1)) Protegen ID: 531; NCBI Protein GI: 156123416; NCBITaxon: 464623 VO:0011125 Allen Xiang Oliver He protein Results indicated that two doses of 10 microg of pCAGGoptiHA derived from Influenza A virus (A/Goose/Guangdong/1/96(H5N1)) could induce complete protection in chickens against H5 lethal virus challenge [PubMed: 17451817]. HA from Influenza A virus (A/Goose/Guangdong/1/96(H5N1)) Protegen ID: 532; NCBI Gene GI: 3654620; NCBI Protein GI: 73852955; NCBI Protein Accession: YP_308669; NCBITaxon: 93838 VO:0011126 Allen Xiang Oliver He protein The inoculation of HA vaccine prepared from influenza viruses A/Yamagata/120/86 (H1N1) or A/Fukuoka/C29/85 (H3N2) together with CTB provided partial protection against PR-8 infection in Balb/c mice [PubMed: 2781859]. HA from Influenza A virus (A/Yamagata/120/1986(H1N1)) Protegen ID: 533; NCBI Protein GI: 221344; NCBITaxon: 379740 VO:0011127 Allen Xiang Oliver He protein The inoculation of HA vaccine prepared from influenza viruses A/Yamagata/120/86 (H1N1) or A/Fukuoka/C29/85 (H3N2) together with CTB provided partial protection against PR-8 infection in Balb/c mice [PubMed: 2781859]. HA from Influenza A virus (A/Fukuoka/C29/85(H3N2)) Protegen ID: 534; NCBI Protein GI: 221306; NCBITaxon: 62549 VO:0011128 Allen Xiang Oliver He protein Protection against a lethal influenza B virus infection was examined in BALB/c mice immunized with plasmid DNAs encoding hemagglutinin (HA), neuraminidase (NA and NB) and nucleoprotein (NP) from the B/Ibaraki/2/85 virus. Both HA and NA DNAs conferred complete protection against the lethal challenge in all the tested mouse strains [PubMed: 11163667]. HA from Influenza B virus (B/Ibaraki/2/85) Protegen ID: 535; NCBI Protein GI: 122959; NCBITaxon: 107411 VO:0011129 Allen Xiang Oliver He protein Protection against a lethal influenza B virus infection was examined in BALB/c mice immunized with plasmid DNAs encoding hemagglutinin (HA), neuraminidase (NA and NB) and nucleoprotein (NP) from the B/Ibaraki/2/85 virus. Both HA and NA DNAs conferred complete protection against the lethal challenge in all the tested mouse strains [PubMed: 11163667]. NA from Influenza B virus (B/Ibaraki/2/85) Protegen ID: 536; NCBI Protein GI: 53829726; NCBITaxon: 107411 VO:0011130 Allen Xiang Oliver He protein Viral challenge studies showed that live BacHA derived from Influenza A virus (A/Indonesia/CDC669/2006(H5N1)) was able to provide 100% protection against 5 50% mouse lethal doses (MLD(50)) of homologous (clade 2.1) and heterologous (clade 1) H5N1 [PubMed: 20071572]. HA from Influenza A virus (A/Indonesia/CDC669/2006(H5N1)) Protegen ID: 537; NCBI Protein GI: 113497156; NCBITaxon: 400828 VO:0011131 Allen Xiang Oliver He protein Viral challenge studies showed that live BacHA derived from Influenza A virus (A/Indonesia/CDC594/2006(H5N1)) was able to provide 100% protection against 5 50% mouse lethal doses (MLD(50)) of homologous (clade 2.1) and heterologous (clade 1) H5N1 [PubMed: 20071572]. HA from Influenza A virus (A/Indonesia/CDC594/2006(H5N1)) Protegen ID: 538; NCBI Protein GI: 113495780; NCBITaxon: 400810 VO:0011132 Allen Xiang Oliver He protein A DNA vaccine encoding HA (from Influenza A virus (A/Hawaii/01/1991(H3N2))), NP and M1 (from a 1989 strain) protected ferrets better against challenge with the antigenic drift variant A/Georgia/03/93 than did the inactivated vaccine from the 1992-93 influenza season. Researchers report that the same DNA vaccine protected ferrets against a second, further divergent, drift variant (A/Johannesburg/33/94) [PubMed: 9234535]. HA from Influenza A virus (A/Hawaii/01/1991(H3N2)) Protegen ID: 539; NCBI Protein GI: 110313990; NCBITaxon: 387158 VO:0011133 Allen Xiang Oliver He protein Plasmids carrying the HA, NA, NP, M1, and M2 genes, respectively, of the avian influenza virus (AIV) A/Chicken/Henan/12/2004(H5N1) strain were administered to mice, and the mice were challenged with the homologous virus later. The mice immunized with HA plasmid once and the NA plasmid twice survived 100% [PubMed: 19067149]. HA from Influenza A virus (A/chicken/Henan/12/2004(H5N1)) Protegen ID: 540; NCBI Protein GI: 61698018; NCBITaxon: 319102 VO:0011134 Allen Xiang Oliver He protein Plasmids carrying the HA, NA, NP, M1, and M2 genes, respectively, of the avian influenza virus (AIV) A/Chicken/Henan/12/2004(H5N1) strain were administered to mice, and the mice were challenged with the homologous virus later. The mice immunized with NP plasmid showed 60-80% survival rate with at least three immunizations. The mixture of M1 and NP plasmids protected 95% of the mice against the homologous virus, and 80% of the mice against a challenge with heterologous H1N1 (PR8) virus [PubMed: 19067149]. NP from Influenza A virus (A/chicken/Henan/12/2004(H5N1)) Protegen ID: 541; NCBI Protein GI: 61698066; NCBITaxon: 319102 VO:0011135 Allen Xiang Oliver He protein Plasmids carrying the HA, NA, NP, M1, and M2 genes, respectively, of the avian influenza virus (AIV) A/Chicken/Henan/12/2004(H5N1) strain were administered to mice, and the mice were challenged with the homologous virus later. The mice immunized with HA plasmid once and the NA plasmid twice survived 100% [PubMed: 19067149]. NA from Influenza A virus (A/chicken/Henan/12/2004(H5N1)) Protegen ID: 542; NCBI Protein GI: 61698053; NCBITaxon: 319102 VO:0011136 Allen Xiang Oliver He protein Plasmids carrying the HA, NA, NP, M1, and M2 genes, respectively, of the avian influenza virus (AIV) A/Chicken/Henan/12/2004(H5N1) strain were administered to mice, and the mice were challenged with the homologous virus later. The mice immunized with M1 plasmid survived 25% with five immunizations. The mixture of M1 and NP plasmids protected 95% of the mice against the homologous virus, and 80% of the mice against a challenge with heterologous H1N1 (PR8) virus [PubMed: 19067149]. M1 from Influenza A virus (A/chicken/Henan/12/2004(H5N1)) Protegen ID: 543; NCBI Protein GI: 61698034; NCBITaxon: 319102 VO:0011137 Allen Xiang Oliver He protein Vaccination with ptPAs/NP derived from Influenza A virus (A/chicken/Hubei/489/2004(H5N1)) efficiently cleared the homologous H5N1 influenza virus in the infected lungs and induced partial cross-protection against heterologous, highly pathogenic H5N1 strains in mice [PubMed: 18789973]. NP from Influenza A virus (A/chicken/Hubei/489/2004(H5N1)) Protegen ID: 544; NCBI Protein GI: 55233233; NCBITaxon: 298603 VO:0011138 Allen Xiang Oliver He protein Researchers evaluated the immunogenicity and efficacy of a panel of flagellin-based hemagglutinin (HA) globular head fusion vaccines in inbred mice. The HA globular head of these vaccines was derived from the A/Vietnam/1203/04 (VN04; H5N1) HA molecule. Results show that replacement of domain D3 of flagellin with the VN04 HA globular head creates a highly effective vaccine that elicits protective HAI titers which protect mice against disease and death in a lethal challenge model with H5 VN virus [PubMed: 19654064]. HA from Influenza A virus (A/Viet Nam/1203/2004(H5N1)) Protegen ID: 545; NCBI Protein GI: 159144921; NCBITaxon: 284218 VO:0011139 Allen Xiang Oliver He protein Using reverse genetics, we constructed a recombinant NDV expressing an H9 AIV hemagglutinin (HA) from an H9N2 field isolate, A/Chicken/ Shandong/2/2007. When tested, 90% of chickens were protected from clinical disease, mortality, and virus shedding against challenge with homologous H9N2 AIV [PubMed: 20521648]. HA from Influenza A virus (A/chicken/Guangdong/02/2007(H9N2)) Protegen ID: 546; NCBI Protein GI: 206812650; NCBITaxon: 563925 VO:0011140 Allen Xiang Oliver He protein Immunization with DNA/rAd5 vaccines encoding HA derived from Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) conferred protection in ferrets against a stringent virus challenge [PubMed: 20352112]. HA from Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) Protegen ID: 547; NCBI Nucleotide GI: 46578137; NCBI Protein GI: 46578138; NCBI Protein Accession: AAS65615.2; NCBITaxon: 266827 VO:0011141 Allen Xiang Oliver He protein All specific-pathogen-free chickens immunized with (vFP89) expressing the native hemagglutinin (HA) gene from H5N8 A/turkey/ Ireland/1378/83 were clinically protected from HPAI challenge [PubMed: 20521642]. HA from Influenza A virus (A/turkey/Ireland/1378/1983(H5N8)) Protegen ID: 549; NCBI Protein GI: 115279333; NCBITaxon: 380285 VO:0011142 Allen Xiang Oliver He protein All specific-pathogen-free chickens immunized with (vFP2211) expressing a modified synthetic HA gene from H5N1 A/chicken/Indonesia/7/2003 were clinically protected from HPAI challenge [PubMed: 20521642]. HA from Influenza A virus (A/chicken/Indonesia/7/2003(H5N1)) Protegen ID: 550; NCBI Protein GI: 129282887; NCBITaxon: 430432 VO:0011143 Allen Xiang Oliver He protein A neutralizing monoclonal antibody (mAb) 9F4 against the hemagglutinin (HA) of the influenza A/chicken/hatay/2004 H5N1 virus was generated. MAb 9F4 was found to be protective, both prophylactically and therapeutically, against lethal viral challenge of mice [PubMed: 20519402]. HA from Influenza A virus (A/Hatay/2004/(H5N1)) Protegen ID: 551; NCBI Protein GI: 56311402; NCBITaxon: 303316 VO:0011144 Allen Xiang Oliver He protein Chickens immunized with attenuated Salmonella strains expressing the hemagglutinin (HA1) gene from a highly pathogenic avian influenza (HPAI) H5N1 (A/whooper swan/Mongolia/3/2005) demonstrated a statistically significant increase in survival compared to control groups [PubMed: 20406663]. HA from Influenza A virus (A/whooper swan/Mongolia/3/05(H5N1)) Protegen ID: 553; NCBI Protein GI: 81687119; NCBITaxon: 344596 VO:0011145 Allen Xiang Oliver He protein Researchers constructed a recombinant pseudotype baculovirus encoding the JEV envelope (E) protein and demonstrated that it could elicit high protective immunity in mice. Intramuscular injections of BV-G-E at various doses into mice produced higher levels of JEV-specific neutralizing antibodies, IFN-gamma and better protective efficacy against a lethal challenge with JEV than that of pc-E. Furthermore, BV-G-E could elicit a higher level of cellular immunity response and provide equal protective efficacy against JEV challenge compared to inactivated vaccine [PubMed: 19006097]. Envelope protein Protegen ID: 554; NCBI Protein GI: 16445023; NCBITaxon: 11072 VO:0011146 Allen Xiang Oliver He protein Researchers established a simple and effective method for DNA immunization against Japanese encephalitis virus (JEV) infection with plasmids encoding the viral PrM and E proteins and colloidal gold. After being inoculated twice, BALB/c mice were found to resist challenge with 100,000 times the 50% lethal dose (LD(50)) of JEV (Beijing-1 strain) even when immunized with a relatively small dose of 0.5 micro g of plasmid DNA [PubMed: 12634382]. PrM from Japanese encephalitis virus Protegen ID: 555; NCBI Protein GI: 90019439; NCBITaxon: 11072 VO:0011147 Allen Xiang Oliver He protein Balb/c mice and swine vaccinated with TK(-)/gG(-)/NS1(+) expressing NS1 protein of JEV could confer protective immunity against lethal challenge of the virulent PRV Ea strain and develop a good humoral and cellular immune response against JEV [PubMed: 15121294]. NS1 from Japanese encephalitis virus Protegen ID: 556; NCBI Protein GI: 18418672; NCBITaxon: 11072 VO:0011148 Allen Xiang Oliver He protein Researchers constructed plasmid DNAs encoding JE virus proteins. Cytotoxic T lymphocytes (CTLs) were induced by NS3 in a mouse model. Three immunizations with pUJENS3 provided a 50% partial protection from a lethal dose of JE virus [PubMed: 12922097]. NS3 Protegen ID: 557; NCBI Protein GI: 27696332; NCBITaxon: 11072 VO:0011149 Allen Xiang Oliver He protein Researchers constructed plasmid DNAs encoding JE virus proteins. Cytotoxic T lymphocytes (CTLs) were induced by NS5 in a mouse model. Three immunizations with pUJENS5 provided a 57% partial protection from a lethal dose of JE virus [PubMed: 12922097]. NS5 Protegen ID: 558; NCBI Protein GI: 158702649; NCBITaxon: 11072 VO:0011150 Allen Xiang Oliver He protein A cDNA clone representing the genome of structural proteins of Japanese encephalitis virus (JEV) was inserted into the thymidine kinase gene of vaccinia virus strains LC16mO and WR. Inoculation of rabbits with the infectious recombinant vaccinia virus resulted in rapid production of antiserum specific for the PreM and E glycoproteins of JEV. Mice vaccinated with the recombinant produced JEV-neutralizing antibodies and were resistant to challenge with JEV [PubMed: 2159544]. PreM Protegen ID: 559; NCBI Protein GI: 14600066; NCBITaxon: 11072 VO:0011151 Allen Xiang Oliver He protein Vaccine efficacy trials in guinea pigs indicated that the nucleoprotein is capable of eliciting a protective immune response against a lethal dose of Lassa virus. Ninety-four percent of the animals vaccinated with V-LSN survived a Lassa virus challenge in which only 14% of unvaccinated animals and 39% of animals vaccinated with the New York Board of Health (NYBH) strain of vaccinia virus survived [PubMed: 2741340]. LASVsSgp1 nucleoprotein Protegen ID: 560; NCBI Gene GI: 956584; NCBI Protein GI: 23343510; NCBI Protein Accession: NP_694869; NCBITaxon: 11620 VO:0011152 Allen Xiang Oliver He protein BALB/c mice were immunized with a vaccine expressing the 78kDa (GRP-78) antigen of Leishmania donovani. Challenge infection was given intracardially after 2 weeks of second booster. A significant decrease in parasite burden was seen in vaccinees over the infected controls on all post challenge days and was found that maximum protection was provided by 78kDa+rIL-12 vaccine. It was highly immunogenic as depicted by the reduction in parasite load (71-94.8%) [PubMed: 20093205]. GRP-78 Protegen ID: 561; NCBI Protein GI: 16797868; NCBITaxon: 5661 VO:0011153 Allen Xiang Oliver He protein Study results show that a single intraperitoneal administration of the A2-recombinant L. tarentolae strain expressing the Leishmania donovani A2 antigen protects BALB/c mice against L. infantum challenge and that protective immunity is associated with high levels of IFN-gamma production prior and after challenge [PubMed: 19818721]. A2 Protegen ID: 563; NCBI Protein GI: 30385439; NCBITaxon: 5671 VO:0011154 Allen Xiang Oliver He protein Study compared the vaccine efficacy of various L. donovani antigens encapsulated in cationic liposomes in BALB/c mice against challenge infection with L. donovani. Results demonstrated that liposomal LD31 (ATP synthase alpha chain) reduced parasite burden by 74%-77% [PubMed: 19503834]. F1-ATPase Protegen ID: 564; NCBI Protein GI: 722242; NCBITaxon: 5661 VO:0011155 Allen Xiang Oliver He protein Study compared the vaccine efficacy of various L. donovani antigens encapsulated in cationic liposomes in BALB/c mice against challenge infection with L. donovani. Results demonstrated that liposomal LD51 (beta-tubulin) reduced parasite burden by 72%-75% [PubMed: 19503834]. Beta-tubulin Protegen ID: 565; NCBI Protein GI: 262233287; NCBITaxon: 5661 VO:0011156 Allen Xiang Oliver He protein Study compared the vaccine efficacy of various L. donovani antigens encapsulated in cationic liposomes in BALB/c mice against challenge infection with L. donovani. Results demonstrated that liposomal LD72 (Hsp70) reduced parasite burden by 65%-67% [PubMed: 19503834]. Hsp70 Protegen ID: 566; NCBI Protein GI: 281426606; NCBITaxon: 5661 VO:0011157 Allen Xiang Oliver He protein KMP-11 DNA vaccination alone in an experimental BALB/c mice model showed significant potential in terms of resolution of splenic and hepatic parasite burden against virulent LD challenge. KMP-11 DNA immunization significantly protects against L. donovani infection [PubMed: 19162111]. KMP-11 Protegen ID: 567; NCBI Protein GI: 7579896; NCBITaxon: 5661 VO:0011158 Allen Xiang Oliver He protein Study showed that cationic distearoyl phosphatidylcholine (DSPC) liposomes, when used as vaccine adjuvant with the immunodominant 63-kDa glycoprotein (gp63, mspC) of Leishmania donovani promastigotes, induced significant protection against progressive visceral leishmaniasis in susceptible BALB/c mice. gp63 used without adjuvant elicited partial protection but in association with liposomes exhibited marked resistance in both the livers and spleens of the mice challenged 10 days after the last vaccination [PubMed: 18195029]. MspC Protegen ID: 568; NCBI Protein GI: 21954466; NCBITaxon: 5661 VO:0011159 Allen Xiang Oliver He protein An expression plasmid encoding both p35 and p40 subunits of IL-12 when co-administered with a recombinant open-reading frame (rORFF) gene from the LD1 locus of Leishmania donovani induces significant protection with around 82% protection in both liver and spleen of BALB/c mice when challenged with L. donovani [PubMed: 16413950]. ORFF Protegen ID: 569; NCBI Protein GI: 703122; NCBITaxon: 5661 VO:0011160 Allen Xiang Oliver He protein Immunization of mice with recombinant BT1 proteins (a biopterin transporter) from multigenic LD1 locus on chromosome 35 of L. donovani conferred partial protection against challenge with Leishmania donovani in a BALB/c mice [PubMed: 15357215]. BT1 Protegen ID: 570; NCBI Protein GI: 703123; NCBITaxon: 5661 VO:0011161 Allen Xiang Oliver He protein Experimental infection of immunized BALB/c mice demonstrated that the VR1012-NH36 DNA vaccine derived from the nucleoside hydrolase gene (NH) of L. donovani induced an 88% reduction in L. chagasi parasite load and a 65% reduction in L. mexicana lesion size [PubMed: 15664920]. NH Protegen ID: 571; NCBI Protein GI: 19697561; NCBITaxon: 5661 VO:0011162 Allen Xiang Oliver He protein Study demonstrated for the first time that a recombinant stage-specific hydrophilic surface protein of Leishmania donovani, recombinant hydrophilic acylated surface protein B1 (HASPB1), is able to confer protection against experimental challenge with L. donovani in BALB/c mice [PubMed: 11120835]. L. donovani HASPB1 Protegen ID: 572; NCBI Protein GI: 51847753; NCBITaxon: 5661 VO:0011163 Allen Xiang Oliver He protein Nonhuman primates (cynomolgus macaques) were inoculated with VEE replicons expressing MBGV GP and/or NP and challenged with MGBV. MBGV NP afforded incomplete (partial) protection, sufficient to prevent death but not disease in two of three macaques [PubMed: 9813200 ]. NP from Lake Victoria marburgvirus Protegen ID: 573; NCBI Protein GI: 332181; NCBITaxon: 11269 VO:0011164 Allen Xiang Oliver He protein Recombinant fowl poxviruses (rFPVs) were constructed to express genes from serotype 1 Marek's disease virus (MDV, Gallid herpesvirus 2). rFPV/gB1 expressing MDV040 conferred 42% protection in maternal antibody-positive chickens when challenged with highly virulent MDV isolates [PubMed: 14562881]. MDV040 Protegen ID: 574; NCBI Gene GI: 4811501; NCBI Protein GI: 125745079; NCBI Protein Accession: YP_001033956; NCBITaxon: 10390 VO:0011165 Allen Xiang Oliver He protein Recombinant fowl poxviruses (rFPVs) were constructed to express genes from serotype 1 Marek's disease virus (MDV, Gallid herpesvirus 2). rFPV/gI expressing MDV095 conferred 43% protection in maternal antibody-positive chickens when challenged with highly virulent MDV isolates [PubMed: 14562881]. MDV095 Protegen ID: 575; NCBI Gene GI: 4811454; NCBI Protein GI: 125745128; NCBI Protein Accession: YP_001034012; NCBITaxon: 10390 VO:0011166 Allen Xiang Oliver He protein Chimeric Venezuelan equine encephalitis/Sindbis virus (VEE/SIN) replicon particles were used to express the hemagglutinin (H) and fusion (F) proteins of measles virus (MV). When challenged with wild-type MV 12 to 17 months after vaccination, all vaccinated juvenile and infant monkeys vaccinated with VEE/SIN-H, VEE/SIN-H+F, and LAV were protected from rash and viremia [PubMed: 20130066]. H hemagglutinin protein Protegen ID: 577; NCBI Gene GI: 1489801; NCBI Protein GI: 9626951; NCBI Protein Accession: NP_056923; NCBITaxon: 11234 VO:0011167 Allen Xiang Oliver He protein Mice vaccinated with a vaccinia virus recombinant encoding the fusion protein of Measles virus developed measles neutralizing antibodies. The mice also resisted a normally lethal intracerebral inoculation of a cell-associated measles virus subacute sclerosing panencephalitis strain [PubMed: 3422488]. F fusion protein from Measles virus Protegen ID: 578; NCBI Gene GI: 1489800; NCBI Protein GI: 9626950; NCBI Protein Accession: NP_056922; NCBITaxon: 11234 VO:0011168 Allen Xiang Oliver He protein Lewis rats were immunized with recombinant vaccinia virus (VV) expressing various proteins of measles virus (MV). VVN (Nucleocapsid Protein) -immunized rats survived a MV challenge infection [PubMed: 1833505]. N nucleocapsid protein Protegen ID: 579; NCBI Gene GI: 1489804; NCBI Protein GI: 9626946; NCBI Protein Accession: NP_056918; NCBITaxon: 11234 VO:0011169 Allen Xiang Oliver He protein Lewis rats were immunized with recombinant vaccinia virus (VV) expressing various proteins of measles virus (MV). VVP (Phosphoprotein) -immunized rats were partially protected from MV challenge [PubMed: 1833505]. P phosphoprotein Protegen ID: 580; NCBI Gene GI: 1489805; NCBI Protein GI: 9626947; NCBI Protein Accession: NP_056919; NCBITaxon: 11234 VO:0011170 Allen Xiang Oliver He protein Lewis rats were immunized with recombinant vaccinia virus (VV) expressing various proteins of measles virus (MV). VVM (Matrix Protein) -immunized rats were partially protected from MV challenge [PubMed: 1833505]. M matrix protein Protegen ID: 581; NCBI Gene GI: 1489803; NCBI Protein GI: 9626949; NCBI Protein Accession: NP_056921; NCBITaxon: 11234 VO:0011171 Allen Xiang Oliver He protein A novel mumps vaccine with good immunity and safety was developed by selecting an antigen (HN) component of the mumps virus. The clinical and pathological observations after challenge of vaccinated rhesus monkeys indicated further that the immune response induced by this vaccine provided complete protection from wild-type virus infection [PubMed: 18597904]. HN Protegen ID: 582; NCBI Gene GI: 1489765; NCBI Protein GI: 9695422; NCBI Protein Accession: NP_054713; NCBITaxon: 11161 VO:0011172 Allen Xiang Oliver He protein Immunization with DNA encoding Ag85B (fbpB), a candidate vaccine antigen of Mycobacterium tuberculosis, elicited in mice a low but protective CD4(+) T cell-mediated IFN-gamma response [PubMed: 20544034]. FbpB from M. tuberculosis Protegen ID: 583; NCBI Gene GI: 885785; NCBI Protein GI: 15609023; NCBI Protein Accession: NP_216402; NCBITaxon: 83332 VO:0011173 Allen Xiang Oliver He protein Our lead construct, Mtb72F, codes for a 72-kDa polyprotein genetically linked in tandem in the linear order Mtb32(C)-Mtb39-Mtb32(N). All forms of Mtb72F immunization tested resulted in the protection of C57BL/6 mice against aerosol challenge with a virulent strain of M. tuberculosis [PubMed: 15187142]. Mtb72F Protegen ID: 584; NCBI Protein GI: 283801990; NCBITaxon: 32630 VO:0011174 Allen Xiang Oliver He protein Protective experiments of DNA vaccine pcDNA3-MIC3 (pMIC3i) in Kumming mice showed that the vaccine could significantly prolong the survival time of the mice challenged by virulent RH strains of T. gondii [PubMed: 19800170]. MIC3 Protegen ID: 587; NCBI Gene GI: 7901253; NCBI Protein GI: 237841071; NCBI Protein Accession: XP_002369833; NCBITaxon: 508771 VO:0011175 Allen Xiang Oliver He protein We show that the 50- to 55-kDa Apa protein, specified by the Rv1860 gene of M. tuberculosis, can elicit both lymphoproliferative response and gamma interferon (IFN-gamma) production. A poxvirus recombinant expressing the Apa protein conferred a significant level of protective immunity in guinea pigs against a challenge dose of virulent M. tuberculosis [PubMed: 12654810]. Apa Protegen ID: 588; NCBI Gene GI: 885896; NCBI Protein GI: 57116926; NCBI Protein Accession: YP_177849; NCBITaxon: 83332 VO:0011176 Allen Xiang Oliver He protein MPT63 (Rv1926c), a major secreted protein of Mycobacterium tuberculosis, is immunoreactive in antibody assays in humans and animals and provides protection as a combined DNA vaccine in mice [PubMed: 19281533]. Mpt63 Protegen ID: 589; NCBI Gene GI: 885334; NCBI Protein GI: 15609063; NCBI Protein Accession: NP_216442; NCBITaxon: 83332 VO:0011177 Allen Xiang Oliver He protein The immunogenicity and protective efficacy of a recombinant subunit West Nile virus (WNV) vaccine was evaluated in rhesus macaques (Macaca mulatta). The vaccine consisted of a recombinant envelope (E) protein truncated at the C-terminal end, resulting in a polypeptide containing 80% of the N-terminal amino acids of the native WNV protein (WN-80E), mixed with an adjuvant (GPI-0100). Groups of monkeys were immunized with the WN-80E/GPI-0100 vaccine or an adjuvant-only control formulation. Animals were then challenged by inoculation of wild-type WNV, and the level of viremia in each animal was monitored daily for 10 days. The results showed that whereas all animals in the control group had detectable viremia for at least 3 days after challenge, all of the vaccinated animals were negative on all days after challenge. Thus, the WN-80E vaccine was 100% efficacious in protecting monkeys against infection with WNV [PubMed: 19641099]. E protein from West Nile virus Protegen ID: 590; NCBI Protein GI: 111145461; NCBITaxon: 11082 VO:0011178 Allen Xiang Oliver He protein An antiserum raised in chicken against the TM-1 polypeptide, which was produced by recombinant Escherichia coli cells and purified by column chromatography, inhibited growth of M.g. cells in vitro. Moreover, chickens immunized with this 29 kDa polypeptide (TM-1) were partially protected from a challenge with virulent M.g [PubMed: 8212828]. TM-1 Protegen ID: 591; NCBI Protein GI: 7249262; NCBITaxon: 2096 VO:0011179 Allen Xiang Oliver He protein Starting with a previously designed eukaryotic expression vector, a recombinant plasmid (pCBWN) that expressed the WN virus prM and E proteins was constructed. A single intramuscular injection of pCBWN DNA induced protective immunity, preventing WN virus infection in mice and horses when subjected to challenge with the NY99-6480 strain of WNV [PubMed: 11287553]. PrM from West Nile virus Protegen ID: 592; NCBI Gene GI: 5714902; NCBI Protein GI: 158516888; NCBI Protein Accession: YP_001527877; NCBITaxon: 11082 VO:0011180 Allen Xiang Oliver He protein Seventeen monoclonal antibodies to one of three main cell surface antigens of Neisseria meningitidis group B were tested for protective efficacy in the infant rat using as challenge seven strains of different class 2/3 protein serotypes. Survival of the animals was regularly obtained with antibodies to the P1 protein and to LPS [PubMed: 2510417]. P1 from Neisseria meningitidis Protegen ID: 594; NCBI Gene GI: 902192; NCBI Protein GI: 15676020; NCBI Protein Accession: NP_273150; NCBITaxon: 122586 VO:0011181 Allen Xiang Oliver He protein Sera of the challenge group immunized with CCPS-P64kR showed a three-fold higher bactericidal response than the sera of the group immunized with the plain CCPS and they were able to protect against challenge with Neisseria meningococci in the infant rat protection model [PubMed: 15039094]. LpdA Protegen ID: 596; NCBI Protein GI: 1017430; NCBITaxon: 487 VO:0011182 Allen Xiang Oliver He protein Mice immunized with purified Tbp2 survived a lethal challenge to a similar degree as animals immunized with the Tbp1-Tbp2 complex, demonstrating that Tbp2 played an important role in the protective activity observed with the complex, eliciting antibodies that are not only bactericidal but also inhibitory for meningococcal growth [PubMed: 7868259]. TBP2 Protegen ID: 597; NCBI Protein GI: 1017433; NCBITaxon: 487 VO:0011183 Allen Xiang Oliver He protein Immunization with recombinant forms of a sporozoite surface antigen (r-p67), derived from either bacterial or insect cells, induces high levels of sporozoite neutralizing antibodies in cattle.In vivo immunization studies have shown that approximately 30% of immunized cattle are nonreactors to a needle LD70 sporozoite challenge, 40% experience a mild disease reaction from which they recover, and the remaining 30% suffer severe disease and are clinically indistinguishable from controls. Transient parasitosis and mild clinical reactions are also observed in challenge of cattle immunized by infection and treatment and such responses constitute immunity to ECF. Hence, p67 is able to routinely induce immunity at a level of about 70% [PubMed: 11193661]. P67 Protegen ID: 598; NCBI Protein GI: 4106806; NCBITaxon: 5875 VO:0011184 Allen Xiang Oliver He protein NspA-containing outer membrane vesicles conferred protection against otherwise lethal intraperitoneal challenge of mice with N. meningitidis serogroup B, and sera raised against them mediated opsonophagocytosis of meningococcal strains expressing this antigen [PubMed: 15501782]. NspA from N. meningitidis Protegen ID: 599; NCBI Protein GI: 5825543; NCBITaxon: 487 VO:0011185 Allen Xiang Oliver He protein A total of 11 meningococcal proteins that are necessary for establishing systemic infection were expressed as recombinant antigens and assessed for their ability to protect mice against live bacterial challenge against N. meningitidis; the lactate permease (LctP) elicited protective immunity [PubMed: 15964482]. LctP Protegen ID: 600; NCBI Protein GI: 254667969; NCBITaxon: 662598 VO:0011186 Allen Xiang Oliver He protein A total of 11 meningococcal proteins that are necessary for establishing systemic infection were expressed as recombinant antigens and assessed for their ability to protect mice against live bacterial challenge against N. meningitidis; ExbB, which is required for iron acquisition, elicited protective immunity [PubMed: 15964482]. ExbB Protegen ID: 601; NCBI Gene GI: 903370; NCBI Protein GI: 15677575; NCBI Protein Accession: NP_274732; NCBITaxon: 122586 VO:0011187 Allen Xiang Oliver He protein The trial vaccination of cattle against T. annulata using recombinant sporozoite antigens (SPAG-1 and p67) and/or merozoite antigens (TAMS 1-1 and 1-2). The aim of these trials was to try and enhance the levels of protection induced compared with previous trials. Different approaches were tried. SPAG-1 was expressed as a fusion protein with a His6 tag and then either incorporated into ISCOMs, with or without TAMS 1-1 and 1-2, or administered with RWL, a proprietary saponin-based adjuvant. Cross-protection studies were also performed by immunizing cattle with the T. parva sporozoite antigen, p67, and then challenging with a T. annulata sporozoite stabilate.All the data collected from these two trials indicate that SPAG-1 administered with RWL is better at inducing an effective immune response than SPAG-1 incorporated into ISCOMs, with or without the presence of merozoite antigens [PubMed: 9668470]. Spag-1 Protegen ID: 602; NCBI Protein GI: 161885; NCBITaxon: 5874 VO:0011188 Allen Xiang Oliver He protein To test the potential of subunit vaccines against T. annulata infection, we immunized four groups of three calves with either recombinant (re-) (Tams1-1 and Tams1-2) proteins or naked DNA encoding these antigens. All calves vaccinated with ISCOMs proved to be protected from T. annulata infection and had generated antibodies against both re-(Tams1-1 and Tams1-2) at the time of challenge [PubMed: 9364686]. TA17050 merozoite-piroplasm surface antigen Tams1 Protegen ID: 603; NCBI Gene GI: 3864438; NCBI Protein GI: 84997996; NCBI Protein Accession: XP_953719; NCBITaxon: 353154 VO:0011189 Allen Xiang Oliver He protein Intraperitoneal application of NcMAG1 suspended in saponin adjuvants lead to protection against disease in 50% of animals vaccinated in a C57Bl/6 mouse cerebral infection model [PubMed: 19835644]. NcMAG1 Protegen ID: 604; NCBI Protein GI: 147886433; NCBITaxon: 29176 VO:0011190 Allen Xiang Oliver He protein Vaccination with an RASV synthesizing full-length PsaA induced high titers of anti-PsaA antibodies in both systemic (IgG in serum) and mucosal (IgA in vaginal washes, nasal washes, and lung homogenates) sites. BALB/c (haplotype H2(d)) or C57BL/6 (haplotype H2(b)) mice vaccinated either orally or intranasally exhibited a significant reduction in colonization of nasopharyngeal tissues after intranasal challenge with S. pneumoniae strains compared to controls, although protection was not observed with all challenge strains. None of the vaccine constructs provided protection against intraperitoneal challenge with S. pneumoniae strain WU2 (serotype 3) [PubMed: 20479086]. PsaA Protegen ID: 605; NCBI Protein GI: 209867628; NCBITaxon: 1313 VO:0011191 Allen Xiang Oliver He protein A 90% protection rate was achieved following intra-nasal vaccination with recNcPDI emulsified in cholera toxin employing the C57Bl/6 mouse cerebral infection model when challenged with Neospora caninum tachyzoites [PubMed: 19835644]. NcPDI Protegen ID: 606; NCBI Protein GI: 82568727; NCBITaxon: 29176 VO:0011192 Allen Xiang Oliver He protein The protective effects a pneumolysin mutant (DeltaA146 Ply) against pneumococcal infections in mice was evaluated. Vaccinated mice were challenged with pneumococcal strain D39 at 1,500 times the LD50 (1.5 x 105 CFU) and the vaccinated mice survived significantly longer than control mice after challenge [PubMed: 20038538]. Ply Protegen ID: 607; NCBI Gene GI: 4441611; NCBI Protein GI: 116515376; NCBI Protein Accession: YP_817150; NCBITaxon: 373153 VO:0011193 Allen Xiang Oliver He protein The protective effects of ATP-dependent caseinolytic protease (ClpP) was evaluated. Vaccinated mice were intraperitoneally and/or intranasally challenged with different pneumococcal strains. In intraperitoneal challenge models with pneumococcal strain D39 (serotype 2), clpP elicited some protection in mice [PubMed: 20038538]. ClpP Protegen ID: 608; NCBI Gene GI: 4441476; NCBI Protein GI: 116516216; NCBI Protein Accession: YP_816144; NCBITaxon: 373153 VO:0011194 Allen Xiang Oliver He protein The production of a recombinant vaccine was achieved following PCR amplification of putative lipoate protein ligase (Lpl), with subsequent cloning and expression of the genes in E. coli. The putative lipoate protein ligase (Lpl) , resulted in a reduced CFU titre and a trend towards reduced mortality in an animal sepsis model [PubMed: 18034862]. LplA Protegen ID: 609; NCBI Gene GI: 934072; NCBI Protein GI: 15903091; NCBI Protein Accession: NP_358641; NCBITaxon: 171101 VO:0011195 Allen Xiang Oliver He protein NcSAG1 and NcSRS2, the two major immunodominant tachyzoite surface antigens of the apicomplexan parasite Neospora caninum, were investigated for their potential as vaccine candidates in mice. Results suggest that a combined DNA/recombinant antigen-vaccine, based on NcSAG1 and NcSRS2, respectively, exhibited a highly significant protective effect against experimentally induced cerebral neosporosis in mice [PubMed: 12741509]. NcSRS2 Protegen ID: 610; NCBI Protein GI: 5579384; NCBITaxon: 29176 VO:0011196 Allen Xiang Oliver He protein NcSAG1 and NcSRS2, the two major immunodominant tachyzoite surface antigens of the apicomplexan parasite Neospora caninum, were investigated for their potential as vaccine candidates in mice. Results suggest that a combined DNA/recombinant antigen-vaccine, based on NcSAG1 and NcSRS2, respectively, exhibited a highly significant protective effect against experimentally induced cerebral neosporosis in mice [PubMed: 12741509]. NcSAG1 Protegen ID: 611; NCBI Protein GI: 4583447; NCBITaxon: 29176 VO:0011197 Allen Xiang Oliver He protein Mice immunized with recombinant (r)PsrP(BR) had significantly less bacteria in their blood and improved survival versus controls following intranasal challenge [PubMed: 19627498]. PsrP Protegen ID: 613; NCBI Gene GI: 7329552; NCBI Protein GI: 221232510; NCBI Protein Accession: YP_002511663; NCBITaxon: 561276 VO:0011198 Allen Xiang Oliver He protein This study used an immunisation/challenge model of transplacental transmission, based on the Qs mouse with an Nc-Liverpool challenge to investigate the vaccine potential of a number of formulations based on four recombinant proteins of N. caninum. A mixture of MIC10 and p24B produced partial protection against transplacental transmission of N. caninum in this mouse model [PubMed: 18789996]. Note: MIC10 must be used in conjunction with p24B in order to confer protection against N. caninum. MIC10 Protegen ID: 614; NCBI Protein GI: 11141617; NCBITaxon: 29176 VO:0011199 Allen Xiang Oliver He protein Intraperitoneal immunization with recombinant SrtA was found to have conferred to mice protection against S. pneumoniae intraperitoneal challenge and the passive transfer of immune serum before intraperitoneal challenge was also protective. Moreover, by using the intranasal challenge model, significant reduction of bacteremia when mice were intraperitoneally immunized with SrtA was observed, while a moderate decrease of lung infection was achieved by intranasal immunization, even though no influence on nasopharynx colonization was seen [PubMed: 19433540]. SrtA Protegen ID: 615; NCBI Gene GI: 4442999; NCBI Protein GI: 116515518; NCBI Protein Accession: YP_816547; NCBITaxon: 373153 VO:0011200 Allen Xiang Oliver He protein Study assessed the potential protectivity of NcMIC1-based vaccination against experimental N. caninum infection in mice. Quantitative real-time PCR revealed that the infection intensity was significantly reduced in the group vaccinated with recNcMIC1 antigen. Serological analysis showed that only recNcMIC1-immunized animals generated detectable antibody levels recognizing native NcMIC1. Thus, of all protocols applied, only recNcMIC1 vaccination appears to be suited to reduce cerebral infection in mice challenged with N. caninum tachyzoites [PubMed: 16108562]. NcMIC1 Protegen ID: 616; NCBI Protein GI: 17226315; NCBITaxon: 29176 VO:0011201 Allen Xiang Oliver He protein Glutamyl tRNA synthetase (GtS) has been found to be among the Streptococcus pneumoniae cell wall-derived proteins that have age-dependent immunogenicity in children. Here, GtS was cloned, expressed, and purified and then was used to immunize 7-week-old BALB/c OlaHsd mice. Thirty-nine percent of rGtS-immunized mice survived a lethal bacterial challenge, whereas no control mice survived [PubMed: 17703427]. GltX Protegen ID: 617; NCBI Gene GI: 931970; NCBI Protein GI: 15901888; NCBI Protein Accession: NP_346492; NCBITaxon: 170187 VO:0011202 Allen Xiang Oliver He protein Separate groups of gerbils were immunized with purified recombinant proteins singly or in combinations and animals were then challenged with N. caninum. The protective efficacy of each vaccination was determined by assessing animal survival rate. The highest protection efficacy was observed for combined vaccination with NcSRS2 and NcDG1 (67.5% survival) compared to control (17.4% survival). Vaccination with NcDG1 alone elicited 62.5% survival in the challenge model [PubMed: 15793355]. NcDG1 Protegen ID: 618; NCBI Protein GI: 2149142; NCBITaxon: 29176 VO:0011203 Allen Xiang Oliver He protein Mice were actively immunized with a fragment of choline binding protein A (CbpA; also known as PspC, Hic, and SpsA). CbpA was able to protect mice from intraperitoneal challenge with medium to very high doses of a highly virulent capsular type 2 pneumococcal strain, D39 [PubMed: 11553536]. CbpA Protegen ID: 619; NCBI Gene GI: 4441159; NCBI Protein GI: 116515359; NCBI Protein Accession: YP_817402; NCBITaxon: 373153 VO:0011204 Allen Xiang Oliver He protein Groups of BALB/c mice immunized with choline binding protein PspA were challenged with either D39 or WCH16. PspA elicited protection by using moderate challenge doses of S. pneumoniae [PubMed: 17088353]. PspA Protegen ID: 620; NCBI Gene GI: 4441373; NCBI Protein GI: 116515876; NCBI Protein Accession: YP_815641; NCBITaxon: 373153 VO:0011205 Allen Xiang Oliver He protein Separate groups of gerbils were immunized with purified recombinant proteins singly or in combinations and animals were then challenged with N. caninum. The protective efficacy of each vaccination was determined by assessing animal survival rate. All experimental groups showed protective effects. Vaccination with NcDG2 alone elicited 50% survival rate compared to a control survival rate of 17.4% [PubMed: 15793355]. NcDG2 Protegen ID: 621; NCBI Protein GI: 3237325; NCBITaxon: 29176 VO:0011206 Allen Xiang Oliver He protein BALB/c mice were immunized with recombinant 6-Phosphogluconate dehydrogenase (r6PGD) and boosted after 3 weeks. Immunized mice were challenged intranasally with a lethal dose of S. pneumoniae. Immunization of mice with r6PGD protected 60% (P < 0.001) of mice for 5 days and 40% (P < 0.05) of the mice for 21 days following intranasal lethal challenge [PubMed: 16634799]. Gnd Protegen ID: 622; NCBI Gene GI: 4441177; NCBI Protein GI: 116515453; NCBI Protein Accession: YP_815856; NCBITaxon: 373153 VO:0011207 Allen Xiang Oliver He protein Mice immunized with recombinant PiaA were protected against systemic challenge to a degree similar to those immunized with an existing protein vaccine candidate, PdB (a genetically modified pneumolysin toxoid). Immunization with a combination of both PiuA and PiaA resulted in additive protection and was highly protective against systemic infection with S. pneumoniae [PubMed: 11598041]. PiaA Protegen ID: 623; NCBI Gene GI: 4442863; NCBI Protein GI: 116515816; NCBI Protein Accession: YP_815744; NCBITaxon: 373153 VO:0011208 Allen Xiang Oliver He protein A recombinant fowlpox virus expressing the fusion protein of Newcastle disease virus strain F48E8 protected chickens against virulent NDV challenge. The protective rate was 96.7% [PubMed: 11191764]. F fusion protein from Newcastle disease virus Protegen ID: 624; NCBI Gene GI: 912271; NCBI Protein GI: 11545723; NCBI Protein Accession: NP_071469; NCBITaxon: 11176 VO:0011209 Allen Xiang Oliver He protein Recombinant baculoviruses containing the fusion (F) and hemagglutinin-neuraminidase (HN) glycoprotein gene of the viscerotropic velogenic (vv) Newcastle disease virus (NDV) isolate, Kr-005/00, and a lentogenic La Sota strain of the NDV were constructed. A single dose of rNDHN(V) had a protective effect against mortality (p <0.01) in chickens [PubMed: 18716451]. HN hemagglutinin-neuraminidase Protegen ID: 625; NCBI Gene GI: 912270; NCBI Protein GI: 11545724; NCBI Protein Accession: NP_071470; NCBITaxon: 11176 VO:0011210 Allen Xiang Oliver He protein Researchers constructed a new recombinant molecule of SERA5, namely SE36. Vaccination of Squirrel monkeys with SE36 protein and aluminium hydroxyl gel (SE36/AHG) conferred protection against high parasitemia and boosted serum anti-SE36 IgG after P. falciparum parasite challenge [PubMed: 20493274]. SERA-5 Protegen ID: 626; NCBI Protein GI: 238629807; NCBITaxon: 5833 VO:0011211 Allen Xiang Oliver He protein Vaccination of mice with EAG (2-macroglobulin, albumin, and immunoglobulin G [IgG] binding protein) as a single antigen with EtxB (as an adjuvant) induced protection in mice against bacterial challenge, but was less protective than at affording protection than immunization with FNZ, SFS, EAG, and EtxB [PubMed: 15155624]. binding protein Eag Protegen ID: 627; NCBI Gene GI: 7696154; NCBI Protein GI: 225870123; NCBI Protein Accession: YP_002746070; NCBITaxon: 553482 VO:0011212 Allen Xiang Oliver He protein Researchers found that the cysteine-rich, carboxyl-terminal region of the MSP-1 protein from the rodent malarial parasite Plasmodium yoelii yoelii can be expressed in a native configuration as a fusion protein in Escherichia coli. This recombinant polypeptide elicits antibodies in mice which recognize the native parasite MSP-1. Most significantly, both inbred and outbred mice immunized with the fusion protein in Ribi adjuvant are partially and in some cases completely protected against challenge infection with an otherwise lethal parasite strain [PubMed: 8363656]. MSP1 from P. yoelii str. 17XNL Protegen ID: 628; NCBI Gene GI: 3791597; NCBI Protein GI: 82596427; NCBI Protein Accession: XP_726257; NCBITaxon: 352914 VO:0011213 Allen Xiang Oliver He protein Mice were immunised i.n. with collagen-binding protein (CNE) and were subsequently subjected to infection with S. equi subsp. equi. A control group of mice was given only adjuvant. The CNE vaccinated group had a delayed onset of infection compared to the control group. Immunization with CNE led to significant protection from infection [PubMed: 16580099]. collagen binding, ancillary pilus subunit Cne Protegen ID: 629; NCBI Gene GI: 7695900; NCBI Protein GI: 225870316; NCBI Protein Accession: YP_002746263; NCBITaxon: 553482 VO:0011214 Allen Xiang Oliver He protein Parts of the three recombinant proteins (FNZ (cell surface-bound fibronectin binding protein), SFS (secreted fibronectin binding protein), and EAG (alpha2-macroglobulin, albumin, and immunoglobulin G [IgG] binding protein)) were used to immunize mice, either subcutaneously or intranasally, prior to nasal challenge with S. equi subsp. equi. The adjuvant used was EtxB, a recombinant form of the B subunit of Escherichia coli heat-labile enterotoxin. It was shown that nasal colonization of S. equi subsp. equi and weight loss due to infection were significantly reduced after vaccination compared with a mock-vaccinated control group. This effect was more pronounced after intranasal vaccination than after subcutaneous vaccination; nearly complete eradication of nasal colonization was obtained after intranasal vaccination (P < 0.001) [PubMed: 15155624]. Fnz Protegen ID: 630; NCBI Gene GI: 7695217; NCBI Protein GI: 225869227; NCBI Protein Accession: YP_002745175; NCBITaxon: 40041 VO:0011215 Allen Xiang Oliver He protein Parts of the three recombinant proteins (FNZ (cell surface-bound fibronectin binding protein), SFS (secreted fibronectin binding protein), and EAG (alpha2-macroglobulin, albumin, and immunoglobulin G [IgG] binding protein)) were used to immunize mice, either subcutaneously or intranasally, prior to nasal challenge with S. equi subsp. equi. The adjuvant used was EtxB, a recombinant form of the B subunit of Escherichia coli heat-labile enterotoxin. It was shown that nasal colonization of S. equi subsp. equi and weight loss due to infection were significantly reduced after vaccination compared with a mock-vaccinated control group. This effect was more pronounced after intranasal vaccination than after subcutaneous vaccination; nearly complete eradication of nasal colonization was obtained after intranasal vaccination (P < 0.001) [PubMed: 15155624]. Sfs Protegen ID: 631; NCBI Gene GI: 7696331; NCBI Protein GI: 225869898; NCBI Protein Accession: YP_002745845; NCBITaxon: 553482 VO:0011216 Allen Xiang Oliver He protein The fibrinogen-binding protein (FgBP) reacted with serum taken from horses recovering from strangles and protected mice against lethal challenge from S. equi subsp. equi [PubMed: 9579073]. Fbp Protegen ID: 632; NCBI Gene GI: 7697172; NCBI Protein GI: 225871286; NCBI Protein Accession: YP_002747233; NCBITaxon: 553482 VO:0011217 Allen Xiang Oliver He protein Researchers produced a prototypic malaria vaccine based on a highly versatile self-assembling polypeptide nanoparticle (SAPN) platform that can repetitively display antigenic epitopes. Researchers used this platform to display a tandem repeat of the B cell immunodominant repeat epitope (DPPPPNPN)(2)D of the malaria parasite Plasmodium berghei circumsporozoite (CS) protein. Administered in saline, without the need for a heterologous adjuvant, the SAPN construct P4c-Mal conferred a long-lived, protective immune response to mice with a broad range of genetically distinct immune backgrounds including the H-2(b), H-2(d), and H-2(k) alleles. Mice were protected against an initial challenge of parasites up to 6 mo after the last immunization or for up to 15 mo against a second challenge after an initial challenge of parasites had successfully been cleared. [PubMed: 19915055]. CS from P. berghei str. ANKA Protegen ID: 633; NCBI Gene GI: 3428738; NCBI Protein GI: 68076353; NCBI Protein Accession: XP_680096; NCBITaxon: 5823 VO:0011218 Allen Xiang Oliver He CS from P. falciparum P. falciparum circumsporozoite protein https://www.ncbi.nlm.nih.gov/pubmed/18159254 protein A P. berghei parasite line was used to expresses a heterologous circumsporozoite protein (CSP) from P. falciparum. A sterile immunity was obtained by vaccination with the radiation-attenuated P. berghei parasite [PubMed: 18159254]. P. falciparum CSP Protegen ID: 634; NCBI Protein GI: 552191; NCBITaxon: 5833 VO:0011219 Allen Xiang Oliver He protein Study showed that immunization with irradiated sporozoites (IrrSpz) of a P. berghei line whose endogenous CS was replaced by that of P. yoelii conferred sterile protection against challenge with wild type P. berghei sporozoites [PubMed: 19890387]. CS from P. yoelii str. 17XNL Protegen ID: 635; NCBI Gene GI: 3830374; NCBI Protein GI: 83317409; NCBI Protein Accession: XP_731149; NCBITaxon: 352914 VO:0011220 Allen Xiang Oliver He protein Immunization with a recombinant yeast-expressed Plasmodium falciparum merozoite surface protein 3 (MSP3) protected Aotus nancymai monkeys against a virulent challenge infection [PubMed: 19073223]. MSP3 Protegen ID: 636; NCBI Protein GI: 113207288; NCBITaxon: 5833 VO:0011221 Allen Xiang Oliver He protein Immunization with Plasmodium yoelii merozoite surface protein (PyMSP)-8 protects mice from lethal malaria but does not prevent infection [PubMed: 18097046]. MSP8 Protegen ID: 637; NCBI Protein GI: 58197887; NCBITaxon: 5861 VO:0011222 Allen Xiang Oliver He protein Intranasal or oral delivery of the chimeric rotavirus VP6 protein MBP::VP6 to mice elicited >90% reductions in fecal rotavirus shedding after murine rotavirus challenge [PubMed: 17629371]. VP6 from Murine rotavirus Protegen ID: 638; NCBI Protein GI: 268080815; NCBITaxon: 28327 VO:0011223 Allen Xiang Oliver He protein Mice immunized with r-Pfen (recombinant P. falciparum enolase protein) showed protection against a challenge with the 17XL lethal strain of the mouse malarial parasite Plasmodium yoelii [PubMed: 17785475]. PF10_0155 enolase Protegen ID: 639; NCBI Gene GI: 810313; NCBI Protein GI: 124802328; NCBI Protein Accession: XP_001347440; NCBITaxon: 36329 VO:0011224 Allen Xiang Oliver He protein Mice immunized with recombinant PbAMA-1 were partially protected from the challenge of P. berghei [PubMed: 17639690]. AMA-1 from P. berghei Protegen ID: 640; NCBI Protein GI: 1438889; NCBITaxon: 5821 VO:0011225 Allen Xiang Oliver He protein Mice vaccinated with recombinant rMSP1 (rPbMSP1), which was generated from Plasmodium berghei, in alum mounted significant protective immunity against challenge infection (P < 0.01). On day 121 after the booster, three out of ten mice immunized with rPbMSP1 in PBS survived parasite infection (P < 0.05) and eight out of ten mice vaccinated with r MSP1 in alum did (P < 0.01). Hence, immunization with MSP1 in alum obviously has conferred protective effects, which prevented death from P. berghei lethal infection in mice (P < 0.01) [PubMed: 17568385]. MSP1 from P. berghei Protegen ID: 641; NCBI Protein GI: 1762646; NCBITaxon: 5821 VO:0011226 Allen Xiang Oliver He protein Rotavirus structural proteins VP4, VP6 and VP7 from Bovine Rotavirus Strain C486 were cloned and expressed in a baculovirus expression system. Neonates of animals immunized with virus-like particles composed of VP7 assembled on VP6 spherical particles were protected against challenge with the homotypic virus and significantly protected from a heterotypic challenge. Unassembled VP7 protein provided partial protection against challenge [PubMed: 8382422]. VP7 from Bovine rotavirus Protegen ID: 642; NCBI Protein GI: 195661008; NCBITaxon: 10927 VO:0011227 Allen Xiang Oliver He protein Rotavirus structural proteins VP4, VP6 and VP7 from Bovine Rotavirus Strain C486 were cloned and expressed in a baculovirus expression system. Challenge of neonates born to animals immunized with VP4 protein on assembled particles or in cell lysates showed protection against challenge with both homologous (bovine C486) and heterologous (SA-11) strains of rotavirus [PubMed: 8382422]. VP4 from Bovine rotavirus Protegen ID: 643; NCBI Protein GI: 172054621; NCBITaxon: 10927 VO:0011228 Allen Xiang Oliver He protein Immunization of mice with subunit vaccines based on the Plasmodium yoelii 17kDa hepatocyte erythrocyte protein (PyHEP17), orthologue of Plasmodium falciparum exported protein 1 (PfExp1), induces antigen-specific immune responses and protects against sporozoite challenge [PubMed: 17303242]. HEP17 Protegen ID: 644; NCBI Protein GI: 1399353; NCBITaxon: 5861 VO:0011229 Allen Xiang Oliver He protein Immunized animals were challenged in vivo with various parasite strains or clones of malaria. Immunization with the PfEMP1-DBL1 alpha domain abolished the PfEMP1-dependent sequestration of the homologous strain in immunized rats and substantially inhibited parasite adhesion in immunized monkeys. Protection against sequestration of heterologous parasite strains was also confirmed by direct or indirect challenge in the rat model [PubMed: 17074852]. EMP1 Protegen ID: 645; NCBI Protein GI: 2961468; NCBITaxon: 5833 VO:0011230 Allen Xiang Oliver He protein Immunization of BALB/c mice and Aotus monkeys with PvMSP-1 induced IgG antibodies (titer > 10(6)) that cross-reacted with P. vivax parasites. Immunized monkeys displayed partial protection against a challenge with P. vivax blood stages [PubMed: 16291762]. MSP1 from P. vivax Protegen ID: 646; NCBI Protein GI: 26985160; NCBITaxon: 5855 VO:0011231 Allen Xiang Oliver He protein A DNA vaccine based on lysosome-targeted glycoprotein of the rabies virus was evaluated in BALB/c mice. It imparted partial protection (60%) against challenge with 20 LD(50) of the challenge virus standard (CVS) strain of rabies virus [PubMed: 19741168]. Glycoprotein Protegen ID: 647; NCBI Protein GI: 56384945; NCBITaxon: 11292 VO:0011232 Allen Xiang Oliver He protein Mice vaccinated intraperitoneally (i.p.) with 10^7 p.f.u. of a vaccinia virus recombinant expressing either the glycoprotein (rVac-G) or nucleoprotein (rVac-N) of rabies virus 3 weeks before challenge were protected against peripheral lethal infection [PubMed: 8207400]. RABVgp1 nucleoprotein N Protegen ID: 648; NCBI Gene GI: 1489853; NCBI Protein GI: 9627198; NCBI Protein Accession: NP_056793; NCBITaxon: 11292 VO:0011233 Allen Xiang Oliver He protein Two large fragments of PfKbeta representing the N- and C-terminal halves were expressed in E. coli. The recombinant proteins were highly immunogenic in mice, and also found to be the target for immune response in natural infections of Plasmodium spp. Immunization with recombinant PfKbeta fragments was partially protective against a heterologous challenge infection in mice [PubMed: 15987343]. Kbeta Protegen ID: 649; NCBI Gene GI: 813054; NCBI Protein GI: 124506397; NCBI Protein Accession: XP_001351796; NCBITaxon: 36329 VO:0011234 Allen Xiang Oliver He protein Immunization with one of the constructs of M. vaccae expressing OmpA in combination with booster immunization with the homologous recombinant protein protected a significant portion of mice from lethal challenge [PubMed: 11738766]. OmpA Protegen ID: 650; NCBI Protein GI: 112710; NCBITaxon: 783 VO:0011235 Allen Xiang Oliver He protein R. rickettsii OmpB contain B and T lymphocyte epitopes. Immunizations with each of two fragments from OmpB (rompB1550-2738 and rompB2459-4123) conferred protection against challenge with a lethal dose of R. conorii. Protection appeared to be better achieved among the groups that received both DNA and recombinant protein immunizations, although recombinant protein immunizations alone provided some protection [PubMed: 11693887]. OmpB Protegen ID: 651; NCBI Protein GI: 6685726; NCBITaxon: 783 VO:0011236 Allen Xiang Oliver He protein Oral immunization of mice with Escherichia coli-expressed Plasmodium yoelii merozoite surface protein 4/5 or the C-terminal 19-kDa fragment of merozoite surface protein 1 induced systemic antibody responses and protected mice against lethal malaria infection [PubMed: 15385527]. MSP4/5 Protegen ID: 652; NCBI Protein GI: 49798469; NCBITaxon: 73239 VO:0011237 Allen Xiang Oliver He protein Mice immunized with a refolded, recombinant, Plasmodium chabaudi AMA1 fragment (AMA1B) can withstand subsequent challenge with P. chabaudi adami [PubMed: 10861076]. AMA-1 from P. chabaudi Protegen ID: 653; NCBI Protein GI: 1469500; NCBITaxon: 5825 VO:0011238 Allen Xiang Oliver He protein Recombinant adenovirus expressing gB (rAd-gB) was found to induce effective protective immunity against a virulent viral infection, regardless of whether it was administered via the muscular or systemic route [PubMed: 19116444]. GB Protegen ID: 654; NCBI Protein GI: 4138504; NCBITaxon: 10345 VO:0011239 Allen Xiang Oliver He protein A trial vaccine containing pseudorabies virus (PRV) glycoprotein gC as the main component showed excellent protection against virulent virus infection in pigs [PubMed: 9300361]. UL44 from Pseudorabies virus Protegen ID: 655; NCBI Gene GI: 2952505; NCBI Protein GI: 51557513; NCBI Protein Accession: YP_068347; NCBITaxon: 10345 VO:0011240 Allen Xiang Oliver He protein The pseudorabies virus (PrV) DNA vaccine carrying the glycoprotein D (gD) gene delivered by E. coli was able to induce protective immune responses in mice against a lethal PrV challenge [PubMed: 11312026]. Immunization of mice with affinity-purified gD of Aujeszky's disease virus (ADV, Suid herpesvirus 1) induced a strong humoral immune response and protected mice against lethal ADV challenge [PubMed: 17601050]. US6 from Pseudorabies virus Protegen ID: 656; NCBI Gene GI: 2952521; NCBI Protein GI: 51557553; NCBI Protein Accession: YP_068387; NCBITaxon: 10345 VO:0011241 Allen Xiang Oliver He protein A monkey vaccination trial using a Plasmodium falciparum protein fraction containing antigens of 90-110 kDa is reported. Three monkeys out of five resisted a heavy challenge dose of highly virulent parasites. Hsp90 was found in the immunoprecipitates obtained with SERP antisera. Interestingly, the response to hsp90 correlated with protection, high antibody titres being found only in the protected monkeys [PubMed: 8303938]. Hsp90 Protegen ID: 657; NCBI Protein GI: 1093612; NCBITaxon: 5833 VO:0011242 Allen Xiang Oliver He protein To examine the response by IE180 more closely, a vaccine trial in mice with a vector DNA construct that contains the gene encoding for IE180, designated pcDNAIE180 was conducted. Seven months after immunization with pcDNAIE180, an overall 25% of BALB/c, C3H/HeJ, and C57BL/6 mice receiving a lethal PrV challenge were protected [PubMed: 9586695]. IE180 Protegen ID: 658; NCBI Gene GI: 2952540; NCBI Protein GI: 51557548; NCBI Protein Accession: YP_068382; NCBITaxon: 10345 VO:0011243 Allen Xiang Oliver He protein An open reading frame 2 plasmid (pORF2) and the capsid protein (Cap) of PCV2 were used as DNA and subunit vaccines, respectively. In FCM analysis, although pORF2 and Cap alone showed comparable efficacy in eliciting lymphoproliferative responses and Cap-specific CD4(+) T cells, pORF2 was superior to the Cap protein in triggering CD8(+) T cells. Following virus challenge, real-time PCR and histopathological analysis confirmed that only low viral DNA loads and mild microscopic lesions appeared in pORF2-immunized mice [PubMed: 18632956]. ORF2 Protegen ID: 659; NCBI Protein GI: 78217439; NCBITaxon: 85708 VO:0011244 Allen Xiang Oliver He protein To examine the mechanism of immunity in vivo, researchers used poliovirus receptor-transgenic mice on a BALB/c (H-2d) background. Mice immunized with the vaccine strain were protected against a subsequent challenge with wild-type virus. Protection was observed when mice received primed B cells in the presence of a VP4-specific Th1 clone. Findings demonstrate that CD4+ T cells, specific for the internal poliovirus capsid protein, VP4, can provide effective help for a protective antibody response directed against surface capsid proteins [PubMed: 7699320]. VP4 from Poliovirus Protegen ID: 660; NCBI Protein GI: 68532656; NCBITaxon: 12080 VO:0011245 Allen Xiang Oliver He protein Series of plasmid constructs encoding different forms of the envelope glycoprotein E of the flavivirus tick-borne encephalitis virus were constructed. These included a secreted recombinant subviral particle, a secreted carboxyl-terminally truncated soluble homodimer, a nonsecreted full-length form, and an inefficiently secreted truncated form. Mice were immunized using both i.m. injection and Gene Gun-mediated application of plasmids. The functional immune response was evaluated by determining specific neutralizing and hemagglutination-inhibiting Ab activities and by challenging the mice with a lethal dose of the virus.The plasmid construct encoding a secreted subviral particle, which carries multiple copies of the protective Ag on its surface, was superior to the other constructs in terms of extent and functionality of the Ab response as well as protection against virus challenge [PubMed: 10586074]. TBEVgp1 polyprotein Protegen ID: 661; NCBI Gene GI: 1489719; NCBI Protein GI: 9628432; NCBI Protein Accession: NP_043135; NCBITaxon: 11084 VO:0011246 Allen Xiang Oliver He protein Monoclonal antibodies to gE neutralize VZV in vitro in a complement- dependent manner [PubMed: 9125048]. Guinea pigs immunized with recombinant varicella-zoster virus (VZV) glycoproteins E (gE) and I (gI) developed antigen-specific antibodies in the sera, vitreous, and conjunctival washes. Sera from immunized animals neutralized both cell-free and cell-associated VZV, and peripheral blood lymphocytes proliferated in vitro in response to recombinant gE and gI and to antigens from VZV-infected cells. Immunized guinea pigs were inoculated intravitreally with VZV, which induces chronic uveitis. VZV DNA was more rapidly cleared and infectious VZV was isolated less frequently from the retinas of animals immunized with gE and gI compared with that in controls receiving adjuvant alone [PubMed: 9697709]. ORF68 Protegen ID: 662; NCBI Gene GI: 1487709; NCBI Protein GI: 9625942; NCBI Protein Accession: NP_040190; NCBITaxon: 10335 VO:0011247 Allen Xiang Oliver He protein Monoclonal antibodies to gI neutralize VZV in vitro in a complement- dependent manner [PubMed: 3021804]. Guinea pigs immunized with recombinant varicella-zoster virus (VZV) glycoproteins E (gE) and I (gI) developed antigen-specific antibodies in the sera, vitreous, and conjunctival washes. Sera from immunized animals neutralized both cell-free and cell-associated VZV, and peripheral blood lymphocytes proliferated in vitro in response to recombinant gE and gI and to antigens from VZV-infected cells. Immunized guinea pigs were inoculated intravitreally with VZV, which induces chronic uveitis. VZV DNA was more rapidly cleared and infectious VZV was isolated less frequently from the retinas of animals immunized with gE and gI compared with that in controls receiving adjuvant alone [PubMed: 9697709]. ORF67 Protegen ID: 663; NCBI Gene GI: 1487689; NCBI Protein GI: 9625941; NCBI Protein Accession: NP_040189; NCBITaxon: 10335 VO:0011248 Allen Xiang Oliver He protein A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 was administered to pigs to determine if it would have a greater protective effect than a vector containing the gene for gp50 alone. Both NYVAC vectors protected pigs similarly from virulent pseudorabies virus challenge [PubMed: 8904669]. Gp50 Protegen ID: 664; NCBI Protein GI: 2440155; NCBITaxon: 10345 VO:0011249 Allen Xiang Oliver He protein A NYVAC vaccinia vector containing genes for pseudorables virus glycoproteins gII and gp50 was administered to pigs to determine if it would have a greater protective effect than a vector containing the gene for gp50 alone. Both NYVAC vectors protected pigs similarly from virulent pseudorabies virus challenge [PubMed: 8904669]. GII Protegen ID: 665; NCBI Protein GI: 1335775; NCBITaxon: 10345 VO:0011250 Allen Xiang Oliver He protein Mice immunized with either gII, gIII, gVI antigen or a mixture of them were challenged intraperitoneally with 8.5 x 10(3) plaque forming units of PRV. All the mice immunized with 1.5 and 4.5 micrograms of the mixture and 4.5 micrograms of the gIII antigen survived [PubMed: 1322712]. GIII Protegen ID: 667; NCBI Protein GI: 334050; NCBITaxon: 10345 VO:0011251 Allen Xiang Oliver He protein Vaccination of mice with fusion proteins containing the N terminus of gI from Suid herpesvirus 1 are able to confer protection to mice against a lethal challenge of PRV [PubMed: 1693164]. GI Protegen ID: 668; NCBI Protein GI: 255957222; NCBITaxon: 10345 VO:0011252 Allen Xiang Oliver He protein A recombinant, vP869, expressing prM and E induced high titers of neutralizing and hemagglutination inhibiting antibodies in mice and was protective against intracranial challenge with the French neurotropic strain of YFV [PubMed: 1736531]. E (envelope glycoprotein) Protegen ID: 669; NCBI Protein GI: 262283879; NCBITaxon: 11089 VO:0011253 Allen Xiang Oliver He protein Horses were vaccinated with adjuvanted recombinant SnSAG1 (rSnSAG1)and 5 control (sham vaccinated) horses were vaccinated with adjuvant only. The effect of vaccination with rSnSAG1 on in vivo infection by S. neurona was evaluated by challenging all the horses with S. neurona merozoites. The study showed that vaccination with rSnSAG-1 produced antibodies in horses that neutralized merozoites when tested by in vitro culture and significantly reduced clinical signs demonstrated by in vivo challenge [PubMed: 19794889]. SAG1 from Sarcocystis neurona Protegen ID: 672; NCBI Protein GI: 295682690; NCBITaxon: 42890 VO:0011254 Allen Xiang Oliver He protein Both inbred BALB/c and outbred CD-1 mice were immunized with rotavirus VP2/6-rVLPs (2/6-VLPs) combined with CT-E29H, orally or intranasally (i.n.), and the comparative efficacy of different formulations was then determined. Two immunizations with 2-6VLPs and CT-E29H were sufficient to protect BALB/c mice, regardless of the route of administration [PubMed: 11270595]. VP2 from Rotavirus Protegen ID: 673; NCBI Protein GI: 431460; NCBITaxon: 10970 VO:0011255 Allen Xiang Oliver He protein Plasmid DNA vaccines encoding for murine rotaviral proteins VP4, VP6, and VP7 were tested in adult BALB/c mice for their ability to induce immune responses and provide protection against rotavirus challenge. Vaccines encoding VP4 were effective in protecting mice against infection after rotavirus (100 ID50) challenge [PubMed: 9015117]. VP4 from Murine rotavirus Protegen ID: 675; NCBI Protein GI: 475695; NCBITaxon: 28327 VO:0011256 Allen Xiang Oliver He protein Plasmid DNA vaccines encoding for murine rotaviral proteins VP4, VP6, and VP7 were tested in adult BALB/c mice for their ability to induce immune responses and provide protection against rotavirus challenge. Vaccines encoding VP7 were effective in protecting mice against infection after rotavirus (100 ID50) challenge [PubMed: 9015117]. VP7 from Murine rotavirus Protegen ID: 676; NCBI Protein GI: 475697; NCBITaxon: 28327 VO:0011257 Allen Xiang Oliver He protein VP6 derived from Group A rotavirus conferred in vivo partial protection against rotavirus challenge in a neonatal mouse model [PubMed: 18632867]. VP6 from Rotavirus A Protegen ID: 677; NCBI Gene GI: 7011372; NCBI Protein GI: 210136699; NCBI Protein Accession: YP_002302229; NCBITaxon: 28875 VO:0011258 Allen Xiang Oliver He protein Rotavirus structural proteins VP4, VP6 and VP7 from Bovine Rotavirus Strain C486 were cloned and expressed in a baculovirus expression system. Challenge of neonates born to animals immunized with VP6 protein showed partial protection [PubMed: 8382422]. VP6 from Bovine rotavirus Protegen ID: 678; NCBI Protein GI: 195661002; NCBITaxon: 10927 VO:0011259 Allen Xiang Oliver He protein Protection from lethal viral infection has been achieved with passively administered monoclonal antibody specific for flavivirus glycoprotein NS1 [PubMed: 1736531]. Immunization of monkeys with yellow fever virus-specified nonstructural protein NS1 resulted in protection against fatal hepatitis as well as marked reduction in the magnitude of viremia after subcutaneous challenge with yellow fever virus [PubMed: 3783816]. NS1 (non-structural protein 1) Protegen ID: 684; NCBITaxon: 11089 VO:0011260 Allen Xiang Oliver He protein Researchers evaluated the potency of different DNA vaccine candidates in BALB/c mice using high dose footpad parasite challenge. A truncated portion of the LACK antigen (LACKp24) was able to induce the highest protective effect compared to other constructs. The DNA vaccine encoding LACK was able to induce partial protection in mice [PubMed: 18951941]. LACK Protegen ID: 734; NCBI Nucleotide GI: 1276476; NCBI Protein GI: 1276477; NCBI Protein Accession: AAA97577.1; NCBITaxon: 5664 VO:0011261 Allen Xiang Oliver He protein Study compared the handling of overlapping 24-mer peptides from HIV Nef either mixed or covalently linked in tandem in one protein. With adjuvant, overlapping peptides were capable of protecting Balb/c mice against lethal viral challenge with 3 108 plaque forming units of vv-nef, whereas the intact protein was less protective [PubMed: 19193636]. Nef Protegen ID: 707; NCBI Gene GI: 156110; NCBI Protein GI: 28872818; NCBI Protein Accession: NP_057857; NCBITaxon: 11676 VO:0011262 Allen Xiang Oliver He protein HIV-1 DNA plasmids expressing Env, Gag and Tat, either alone or combined with the corresponding protein immunogens formulated in the MF59 adjuvant, resulted in protection against an experimental HIV-1 infection in C57Bl/6 mice [PubMed: 17707956]. Tat Protegen ID: 711; NCBI Gene GI: 155871; NCBI Protein GI: 9629358; NCBI Protein Accession: NP_057853; NCBITaxon: 11676 VO:0011263 Allen Xiang Oliver He protein HIV-1 DNA plasmids expressing Env, Gag and Tat, either alone or combined with the corresponding protein immunogens formulated in the MF59 adjuvant, resulted in protection against an experimental HIV-1 infection in C57Bl/6 mice [PubMed: 17707956]. Gag from HIV 1 Protegen ID: 713; NCBI Gene GI: 155030; NCBI Protein GI: 9629360; NCBI Protein Accession: NP_057850; NCBITaxon: 11676 VO:0011264 Allen Xiang Oliver He protein Mice immunized with Recombinant-derived nucleoprotein (rNP) from S. typhimurium expressing the cloned NP gene from A/NT/60/68 (Jones & Brownlee, 1985) were protected against a lethal challenge with Influenza A/Puerto Rico/8/34 (A/PR8) virus but showed considerable morbidity before recovery [PubMed: 2172156]. NP from Influenza A virus (A/nt/60/1968(H3N2)) Protegen ID: 718; NCBI Protein GI: 324704; NCBITaxon: 384505 VO:0011265 Allen Xiang Oliver He protein Since the E2 amino-terminal sequence for all VEE subtype viruses is conserved, we tested the protective capacity in mice of passively transferred mAb 1A2B-10 and found it to protect from both epizootic and enzootic VEE virus challenge. Since horses are an important natural host for VEE virus, pep1-19 was used to immunize horses and was found to be immunogenic and to elicit virus-reactive antibody [PubMed: 7543231]. E2 envelope protein Protegen ID: 725; NCBI Protein GI: 25140296; NCBITaxon: 11036 VO:0011266 Allen Xiang Oliver He protein Study demonstrated that a recombinant construction of heat-shock protein (hslU) with lypopolysaccharide (rcHSP-LPS) administered 24 hours before inoculation induced resistance to S. typhimurium infection. Protection formed after 3 injections of rcHSP-LPS with 10 mcg in each or single injection with 100 mcg/mouse. Forty to eighty percent of immunized mice survived after challenge while 90% of control animals died. Destruction of the HSP by boiling of the construction led to loss of protective effect [PubMed: 19621817]. HslU Protegen ID: 726; NCBI Protein GI: 9650897; NCBITaxon: 90371 VO:0011267 Allen Xiang Oliver He protein The monoclonal antibody against E1 glycoprotein protect outbred albino mice from lethal infection caused by the virulent strain Trd of the VEE virus [PubMed: 7529989]. E1 glycoprotein Protegen ID: 727; NCBI Protein GI: 798795; NCBITaxon: 11036 VO:0011268 Allen Xiang Oliver He protein Immunisation of mice with DnaJ derived from Salmonella enterica subsp. enterica serovar Typhi str. CT18 was found to provide 70% protection against lethal challenge by S. Typhimurium indicating the possible use of DnaJ as vaccine candidate against typhoid [PubMed: 16887241]. DnaJ Protegen ID: 728; NCBI Gene GI: 1246524; NCBI Protein GI: 16759006; NCBI Protein Accession: NP_454623; NCBITaxon: 220341 VO:0011269 Allen Xiang Oliver He protein The viaB (tviB) gene coding for the Vi antigen of Salmonella typhi Ty2 was subcloned into expression vector pYA248. The recombinant plasmid was termed SMM202 and transformed into Salmonella typhimurium 4072, an attenuated crp mutant. Immunization of mice with Vi4072 afforded complete protection against fatal infection with virulent S. typhi Ty2 [PubMed: 1612747]. TviB Protegen ID: 729; NCBI Gene GI: 1067316; NCBI Protein GI: 29144603; NCBI Protein Accession: NP_807945; NCBITaxon: 209261 VO:0011270 Allen Xiang Oliver He protein The immune sera elicited by CTB DNA vaccine were functional and protective against V. cholerae O1 infection in mice [PubMed: 19443090]. CtxB Protegen ID: 731; NCBI Protein GI: 110264635; NCBITaxon: 127906 VO:0011271 Allen Xiang Oliver He protein Antibodies against TCP were able to protect baby mice against challenge with V. cholerae O1 of the classical but not of the El Tor biotype [PubMed: 7911787]. TcpA Protegen ID: 732; NCBI Protein GI: 21616882; NCBITaxon: 127906 VO:0011272 Allen Xiang Oliver He protein Antibodies generated against TcpF are protective against experimental V. cholerae infection in the infant mouse cholera model [PubMed: 16040956]. TcpF Protegen ID: 733; NCBI Gene GI: 2614504; NCBI Protein GI: 15640854; NCBI Protein Accession: NP_230485; NCBITaxon: 243277 VO:0011273 Allen Xiang Oliver He protein Researchers evaluated the potency of different DNA vaccine candidates in BALB/c mice using high dose footpad parasite challenge with L. major. Mice inoculated pCMV3ISS-TSA developed significantly smaller lesions in their footpads after challenge with the parasite. The vaccine was able to induce a partially protective effect [PubMed: 18951941]. TSA from Leishmania major Protegen ID: 735; NCBI Nucleotide GI: 3411093; NCBI Protein GI: 3411094; NCBI Protein Accession: AAC31146.1; NCBITaxon: 5664 VO:0011274 Allen Xiang Oliver He protein Researchers evaluated the potency of different DNA vaccine candidates in BALB/c mice using high dose footpad parasite challenge with L. major. Mice inoculated pCMV3ISS-LmSTI1 developed significantly smaller lesions in their footpads after challenge with the parasite. The vaccine was able to induce a partially protective effect [PubMed: 18951941]. LmSTI1 Protegen ID: 736; NCBI Nucleotide GI: 1698879; NCBI Protein GI: 1698880; NCBI Protein Accession: AAB37318.1; NCBITaxon: 5664 VO:0011275 Allen Xiang Oliver He protein Researchers evaluated the potency of different DNA vaccine candidates in BALB/c mice using high dose footpad parasite challenge with L. major. Mice inoculated pCMV3ISS-CPa developed significantly smaller lesions in their footpads after challenge with the parasite. The vaccine was able to induce a partially protective effect [PubMed: 18951941]. Cpa Protegen ID: 737; NCBI Nucleotide GI: 71084305; NCBI Protein GI: 71084306; NCBI Protein Accession: AAZ23598.1; NCBITaxon: 5664 VO:0011276 Allen Xiang Oliver He protein The potential protection of Lmjsp (Leishmania major signal peptidase) was evaluated in three different vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein), against L. major infection. We demonstrated that vaccination with SPase through all three mentioned strategies induced a parasite specific Th1 response and conferred partial protection against parasite challenge. However, our results indicated that DNA/DNA strategy developed more effective protective responses than the other two approaches and induced 81% reduction in L. major parasite load [PubMed: 16481076]. SP Protegen ID: 738; NCBI Protein GI: 23168331; NCBITaxon: 5664 VO:0011277 Allen Xiang Oliver He protein Researchers tested the ability of the entire H2B protein of L. major, its divergent or conserved regions to provide protection against virulent L. major challenge. The divergent amino-terminal region of H2B is able to confer potent protection against a virulent challenge in BALB/c mice [PubMed: 16417957]. H2B Protegen ID: 739; NCBI Protein GI: 13384083; NCBITaxon: 5664 VO:0011278 Allen Xiang Oliver He protein Cell-mediated immunity to Leishmania major (L. major) was induced by injecting BALB/c mice intradermally with plasmid DNA expressing the conserved L. major cell surface glycoprotein gp63 (gp63-pcDNA-3). Challenge studies revealed that gp63-pcDNA-3 vaccination protected 30% of susceptible mice (21 of 70) from Leishmania infection [PubMed: 9741428]. Gp63 Protegen ID: 741; NCBI Protein GI: 259011719; NCBITaxon: 5664 VO:0011279 Allen Xiang Oliver He protein Intraperitoneal vaccination of C3H/He mice with PSA-2 with Corynebacterium parvum as an adjuvant resulted in complete protection from lesion development after challenge infection with virulent L. major. Significant protection was also obtained in the genetically susceptible BALB/cH-2k and BALB/c mice [PubMed: 7591056]. PSA-2 Protegen ID: 742; NCBI Protein GI: 1129058; NCBITaxon: 5664 VO:0011280 Allen Xiang Oliver He protein In a murine model of experimental cutaneous leishmaniasis, researchers investigated the protection elicited by injection of histone H1 (SW3.1) isolated from parasites by perchloric extraction, of a H1 recombinant protein produced in E. coli, and of H1 long and short synthetic peptides, against infection by L. major. Partial protection was achieved in most of the animals as shown by reduction in lesion size, upon immunization with histone H1 or its peptides, provided that the region 1-60 was present in the molecule [PubMed: 10580198]. SW3.1 Protegen ID: 743; NCBI Protein GI: 4008565; NCBITaxon: 5664 VO:0011281 Allen Xiang Oliver He protein Together with poloxamer 407 as adjuvant the recombinant type I (rCPB) cysteine proteinase of Leishmania major was screened as a potential vaccines against L. major in a mouse model. Using the footpad thickness increase to monitor the clinical outcome/cutaneous lesion at site of L. major delivery, it was possible to document that rCPB allowed BALB/c mice to mount a partial protective response [PubMed: 12057598]. Cpb Protegen ID: 744; NCBI Protein GI: 54287314; NCBITaxon: 5664 VO:0011282 Allen Xiang Oliver He protein Upon challenge with L. infantum, C57BL/6 mice immunized with SMT formulated in MPL-SE adjuvant showed significantly lower parasite burdens in both spleens and livers compared with non-immunized mice or mice injected with adjuvant alone [PubMed: 17804125]. SMT Protegen ID: 745; NCBI Protein GI: 146104463; NCBITaxon: 435258 VO:0011283 Allen Xiang Oliver He protein Study examined the immunogenic properties of the Leishmania infantum acidic ribosomal protein P0 (LiP0) in the BALB/c mouse model. When mice were immunized with pcDNA3-LiP0, noticeable protection against L. major infection was achieved [PubMed: 14573678]. LIPO-A Protegen ID: 746; NCBI Protein GI: 730579; NCBITaxon: 5671 VO:0011284 Allen Xiang Oliver He protein BALB/c mice immunized with a DNA vector expressing p36/LACK of Leishmania infantum followed by a booster with VVp36/LACK induced significant protection against Leishmania major infection [PubMed: 11489418]. P36/LACK Protegen ID: 747; NCBI Protein GI: 134085114; NCBITaxon: 5671 VO:0011285 Allen Xiang Oliver He protein Following infection with L. infantum promastigotes, five out of eight beagle dogs immunized with H1 Montanide remained free of clinical signs, compared to two out of eight dogs in the control group. The results demonstrate that H1 antigens with Montanide were able to induce partial protection against canine leishmaniasis, even under extreme experimental challenge conditions [PubMed: 17576026]. H1 Protegen ID: 748; NCBI Nucleotide GI: 78146499; NCBI Protein GI: 78146500; NCBI Protein Accession: ABB22792.1; NCBITaxon: 5671 VO:0011286 Allen Xiang Oliver He protein Following infection with L. infantum promastigotes, four out of eight beagle dogs immunized with HASPB1 Montanide remained free of clinical signs, compared to two out of eight dogs in the control group. The results demonstrate that HASPB1 antigens with Montanide were able to induce partial protection against canine leishmaniasis, even under extreme experimental challenge conditions [PubMed: 17576026]. HASPB1 Protegen ID: 749; NCBI Nucleotide GI: 3724133; NCBI Protein GI: 3724134; NCBI Protein Accession: CAA09789.1; NCBITaxon: 5661 VO:0011287 Allen Xiang Oliver He protein In 1923, it was discovered that treatment with formalin eliminated the toxicity of diphtheria toxin (DT) without destroying its immunogenicity. Formalinreated DT, now called diphtheria toxoid, rapidly became the preferred vaccine against diphtheria, and diphtheria toxoid (usually in combined vaccines, such as diphtheriaetanus toxoidsertussis vaccine [DTP] or diphtheriaetanus toxoidscellular pertussis vaccine [DTaP] for children and tetanusiphtheria toxoids vaccine for adults [Td]) is still used throughout the world for active immunization against diphtheria [PubMed: 10657208]. Tox Protegen ID: 750; NCBI Protein GI: 38199106; NCBITaxon: 1717 VO:0011288 Allen Xiang Oliver He protein Susceptible BALB/c mice were immunized with the DNA encoding P4 alone, P4/IL-12, or P4/HSP70 prior to challenge with L. amazonensis promastigotes. Mice immunized with P4 alone had a delayed onset of lesion development and significantly smaller lesions than the infection control group at 11 weeks postinfection (P < 0.05). P4/IL-12 immunized animals showed no sign of lesion development in three independent experiments (P < 0.01). Our results indicate that different vaccine combinations, including DNA encoding P4, HSP70, or IL-12, can provide significant protection against both Old World and New World cutaneous leishmaniasis [PubMed: 14573646]. P4 from Leishmania amazonensis Protegen ID: 751; NCBI Nucleotide GI: 29165286; NCBI Protein GI: 29165287; NCBI Protein Accession: AAO65599.1; NCBITaxon: 5659 VO:0011289 Allen Xiang Oliver He protein To examine the efficacy of a new mode of recombinant viral vaccine, a vaccine was constructed of two non-transmissible Sendai viruses (rSeV/dF) encoding the full-length parasite antigen amastigote surface protein-2 (ASP2) or ASP2 fused with a mono-ubiquitin on its N-terminus (UASP2). C57BL/6 mice immunized intranasally with rSeV/dF expressing either ASP2 or UASP2 showed significantly suppressed parasitemia and could be protected from lethal T. cruzi challenge [PubMed: 19712768]. T. cruzi amastigote surface protein-2 Protegen ID: 752; NCBI Protein GI: 284180153; NCBITaxon: 5693 VO:0011290 Allen Xiang Oliver He protein DNA vaccination in BALB/c mice with the LAWD (for Leishmania antigenic WD protein) and IL-12 genes significantly delayed lesion development from challenge with Leishmania amazonensis, which correlated with a dramatic reduction in parasite burdens [PubMed: 15039343]. WD Protegen ID: 753; NCBI Nucleotide GI: 38455440; NCBI Protein GI: 38455441; NCBI Protein Accession: AAR20840.1; NCBITaxon: 5659 VO:0011291 Allen Xiang Oliver He protein Immunization of CBA mice with the M-2 glycoprotein of L. amazonensis and C. parvum adjuvant resulted in complete protection against a challenge infection of 10^4 and 10^6 late log-phase promastigotes of L. amazonensis. In the BALB/c strain, complete protection was observed in some of the immunized animals (28 to 50%); in the rest of the mice the onset of infection was significantly delayed. Protective immunity for C57BL/6 mice was observed only at the low infecting dose (10(4) L. amazonensis organisms) [PubMed: 3182080]. M2 Protegen ID: 754; NCBI Nucleotide GI: 2828562; NCBI Protein GI: 2828563; NCBI Protein Accession: AAC08302.1; NCBITaxon: 5659 VO:0011292 Allen Xiang Oliver He protein cDNAs encoding L. m. amazonensis gp46 antigen were subcloned into the VR1012 plasmid, and susceptible BALB/c mice were immunised with two i.m. injections of 100 microg of plasmid DNA. Mice were challenged by the injection of 4 x 10^6 L. m. mexicana parasites in the foot pad to evaluate protection. Measurement of lesion size indicated that mice immunised with VR012-GP46 were partially protected against infection [PubMed: 11713811]. Gp46 Protegen ID: 755; NCBI Nucleotide GI: 159320; NCBI Protein GI: 159321; NCBI Protein Accession: AAA29234.1; NCBITaxon: 5659 VO:0011293 Allen Xiang Oliver He protein To study the protective effects in vivo of cruzipain-specific Th1 responses against systemic T. cruzi challenges, mice were immunized with recombinant cruzipain plus interleukin 12 (IL-12) and a neutralizing anti-IL-4 MAb. These immunized mice developed potent cruzipain-specific memory Th1 cell responses and were significantly protected against normally lethal systemic T. cruzi challenges. To study whether cruzipain could induce mucosal immune responses relevant for vaccine development, recombinant attenuated Salmonella enterica serovar Typhimurium vaccines expressing cruzipain were prepared. BALB/c mice immunized with salmonella expressing cruzipain were significantly protected against T. cruzi mucosal infection [PubMed: 12183554]. T. cruzi Cruzipain Protegen ID: 756; NCBI Protein GI: 1136308; NCBITaxon: 5693 VO:0011294 Allen Xiang Oliver He protein To develop a vaccine strategy taking advantage of activated CD8(+)T cells,a DNA vaccine, designated pGFP-TSA1, encoding a fusion protein linking GFP to a single CTL epitope of TSA1(TS), a leading candidate for vaccine against T. cruzi was constructed. C57BL/6 mice vaccinated with this plasmid showed suppressed parasitemia and prolonged survival. Vaccination with pGFP-TSA1 enhanced epitope-specific cytotoxicity and IFN-gamma secretion by CD8(+)T cells [PubMed: 18321749]. T. cruzi TS Protegen ID: 757; NCBI Protein GI: 258547365; NCBITaxon: 5693 VO:0011295 Allen Xiang Oliver He protein A 500 bp fragment encoding an isoform of cysteine proteinase (CP) from Leishmania (Leishmania) amazonensis was subcloned and expressed in the pHis vector, resulting in a recombinant protein of 24 kDa, rLacys24. Immunization of BALB/c mice with rLacys24 plus CFA adjuvant resulted in a low but significant decrease of foot lesions after challenge with L. (L.) amazonensis compared to those exhibited by control mice [PubMed: 19735658]. CP cysteine proteinase Protegen ID: 758; NCBI Nucleotide GI: 30142041; NCBI Protein GI: 30142042; NCBI Protein Accession: AAN34826.1; NCBITaxon: 5659 VO:0011296 Allen Xiang Oliver He protein Following the intramuscular immunization of H-2(b) and H-2(d) mice with a plasmid DNA encoding an N-terminally truncated TSA-1 lacking or containing the C-terminal nonapeptide tandem repeats, the antibody level, CTL response, and protection against challenge with T. cruzi were assessed. In H-2(b) mice, antiparasite antibodies were induced only by immunization with the DNA construct encoding TSA-1 containing the C-terminal repeats. However, both DNA constructs were efficient in eliciting long-lasting CTL responses against the protective H-2Kb-restricted TSA-1515-522 epitope. In H-2(d) mice, inoculation with either of the two TSA-1-expressing vectors effectively generated antiparasite antibodies and primed CTLs that lysed T. cruzi-infected cells in an antigen-specific, MHC class I-restricted, and CD8(+)-T-cell-dependent manner. When TSA-1 DNA-vaccinated animals were challenged with T. cruzi, 14 of 22 (64%) H-2(b) and 16 of 18 (89%) H-2(d) mice survived the infection [PubMed: 9784506]. T. cruzi TSA-1 Protegen ID: 759; NCBI Protein GI: 162315; NCBITaxon: 5693 VO:0011297 Allen Xiang Oliver He protein A complement regulatory protein (CRP) of Trypanosoma cruzi was evaluated as a vaccine candidate in a murine model of experimental T. cruzi infection. Recombinant CRP derived from an Escherichia coli expression system and a plasmid encoding the full-length crp structural gene under the control of a eukaryotic promoter were used to immunize BALB/c mice. Immunization with both protein and DNA vaccines resulted in a Th1-type T-cell response, comparable antibody titers, and similar immunoglobulin G isotype profiles. Only mice immunized with the crp DNA plasmid produced antibodies capable of lysing the parasites in the presence of complement and were protected against a lethal challenge with T. cruzi trypomastigotes [PubMed: 10948115]. T. cruzi CRP-10 Protegen ID: 760; NCBI Protein GI: 1389837; NCBITaxon: 5693 VO:0011298 Allen Xiang Oliver He protein The vaccine efficacy of a putative candidate antigen against T. cruzi infection and disease in a mouse model. C57BL/6 mice vaccinated with a T. cruzi G4-encoding plasmid and cytokine (interleukin-12 and granulocyte-macrophage colony-stimulating factor) expression plasmids elicited a strong Th1-type antibody response dominated by immunoglobulin G2b (IgG2b)/IgG1 isotypes. The dominant IgG2b/IgG1 antibody response was maintained after a challenge infection and was associated with 90% control of the acute-phase tissue parasite burden and an almost undetectable level of tissue parasites during the chronic phase, as determined by a sensitive T. cruzi 18S rRNA gene-specific real-time PCR approach [PubMed: 18550728]. T. cruzi G4 Protegen ID: 761; NCBI Protein GI: 52424038; NCBITaxon: 5693 VO:0011299 Allen Xiang Oliver He protein The vaccine efficacy of a putative candidate antigen against T. cruzi infection and disease in a mouse model. C57BL/6 mice vaccinated with a T. cruzi G2-encoding plasmid and cytokine (interleukin-12 and granulocyte-macrophage colony-stimulating factor) expression plasmids elicited a strong Th1-type antibody response dominated by immunoglobulin G2b (IgG2b)/IgG1 isotypes. The dominant IgG2b/IgG1 antibody response was maintained after a challenge infection and was associated with 50% control of the acute-phase tissue parasite burden and an almost undetectable level of tissue parasites during the chronic phase, as determined by a sensitive T. cruzi 18S rRNA gene-specific real-time PCR approach [PubMed: 18550728]. T. cruzi G2 Protegen ID: 762; NCBI Protein GI: 205278890; NCBITaxon: 5693 VO:0011300 Allen Xiang Oliver He Tc00.1047053434931.10 protein C57BL/6 mice were immunized s.c. with recombinant PFR-2 (PAR2) protein co-adsorbed to alum with rIL-12. rPFR-2 immunized animals were able to successfully resolve parasitemia by day 30 p.i., with the peak parasitemia occurring between days 17 and 21 p.i. [PubMed: 12798650]. T. cruzi PAR2 Protegen ID: 763; NCBI Gene GI: 3532027; NCBI Protein GI: 71398801; NCBI Protein Accession: XP_802646; NCBITaxon: 353153 VO:0011301 Allen Xiang Oliver He protein C57BL/6 mice were immunized s.c. with recombinant PFR-1 (PAR1) protein co-adsorbed to alum with rIL-12. rPFR-1 immunized animals were able to successfully resolve parasitemia by day 30 p.i., with the peak parasitemia occurring between days 17 and 21 p.i. [PubMed: 12798650]. T. cruzi PAR1 Protegen ID: 764; NCBI Protein GI: 2209137; NCBITaxon: 5693 VO:0011302 Allen Xiang Oliver He protein Skin and mucosal vaccination of ponies with HA from influenza virus A/equine/Ky/1/81 provided complete protection from clinical signs of infection after challenge, while skin vaccination provided partial protection; DNA vaccination provided partial protection from viral shedding [PubMed: 10403592]. HA from Influenza A virus (A/equine/Kentucky/1/1981(H3N8)) Protegen ID: 765; NCBI Nucleotide GI: 166079523; NCBI Protein GI: 166079524; NCBI Protein Accession: ABY81481.1; NCBITaxon: 475467 VO:0011303 Allen Xiang Oliver He protein Flagellin encoding plasmid DNA was injected into Balb/c mice intramuscularly and this elicited both a humoral and a cellular immune response. Subsequent intravenous challenge of the vaccinated Balb/c mice with 10^5CFU of B. pseudomallei resulted in the number of bacterial cells detected in liver and/or spleen being significantly reduced in the flagellin plasmid DNA vaccinated mice. At 7 days subsequent to infection of B. pseudomallei, 5/6 (83%) of flagellin plasmid DNA vaccinated mice had survived [PubMed: 16169637]. FliC Protegen ID: 770; NCBI Protein GI: 1929918; NCBITaxon: 28450 VO:0011304 Allen Xiang Oliver He protein Transgenic rice immunization expressing the Chlamydophila psittaci (Cp. psittaci) antigen (MOMP) fused to the B subunit of Escherichia coli heat-labile enterotoxin (LTB) induced partial protection (53.3%) against a lethal challenge with the highly virulent Cp. psittaci 6BC strain in a BALB/c mouse model [PubMed: 19146896]. MOMP from C. psittaci 6BC Protegen ID: 771; NCBI Nucleotide GI: 40568; NCBI Protein GI: 40569; NCBI Protein Accession: CAA40300.1; NCBITaxon: 331636 VO:0011305 Allen Xiang Oliver He protein This report describes the successful cloning of the E2 gene of WEEV and expression in Escherichia coli as inclusion bodies. The immunogenicity of the refolded rE2 protein was demonstrated by strong humoral and cell mediated immune (CMI) responses in rE2-immunized BALB/c mice. The current study also demonstrated that rE2-immunized mice could be partially protected from lethal challenge of WEEV [PubMed: 17499379]. E2 from Western equine encephalomyelitis virus Protegen ID: 773; NCBI Protein GI: 29611992; NCBITaxon: 11039 VO:0011306 Allen Xiang Oliver He protein DNA vaccines encoding different portions of the structural proteins of western equine encephalitis virus were tested for the efficacy of their protection in a 100% lethal mouse model of the virus. The 6K-E1 structural protein encoded by the DNA vaccine conferred complete protection against challenge with the homologous strain and limited protection against challenge with a heterologous strain [PubMed: 19923571]. Note: The E1 glycoprotein is part of the 6K-E1 structural protein E1 Protegen ID: 774; NCBI Nucleotide GI: 17148716; NCBI Protein GI: 17148717; NCBI Protein Accession: AAL35792.1; NCBITaxon: 11039 VO:0011307 Allen Xiang Oliver He protein DNA vaccines encoding different portions of the structural proteins of western equine encephalitis virus were tested for the efficacy of their protection in a 100% lethal mouse model of the virus. The 6K-E1 structural protein encoded by the DNA vaccine conferred complete protection against challenge with the homologous strain and limited protection against challenge with a heterologous strain [PubMed: 19923571]. Note: The 6K protein is part of the 6K-E1 structural protein 6K Protegen ID: 775; NCBI Protein GI: 29611993; NCBITaxon: 11039 VO:0011308 A Cp23 protein that is part of Crptosporidium parvum Allen Xiang Anthony Huffman Oliver He protein In this study, Cp23 antigen was investigated as a vaccine candidate using the DNA vaccine model in adult interleukin-12 (IL-12) knockout (KO) mice, which are susceptible to C. parvum infection. Cp23-DNA vaccination induced a 50-60% reduction in oocysts shedding, indicating a partial protection against C. parvum infection in IL-12 KO mice [PubMed: 17487508]. Cp23 from Crptosporidium parvum Protegen ID: 776; NCBI Protein GI: 88659549; NCBITaxon: 5807 VO:0011309 Allen Xiang Oliver He protein Preparturient cows were immunized three times over a six-week period with recombinant plasmid DNA encoding the Cryptosporidium parvum CP15/60 antigen by injecting the DNA in the mammary gland. Colostrum from these cows contained Ab specific for C. parvum sporozoites and oocysts as indicated by immunofluorescence Ab (IFA) staining. Mice receiving immune colostrum showed partial protection (about 50% reduction) against intestinal C. parvum development compared to mice receiving control colostrum. This protection was evident at a challenge dose of 10^3 C. parvum oocysts per mouse [PubMed: 10392628]. CP15/60 Protegen ID: 777; NCBI Nucleotide GI: 170676501; NCBI Protein GI: 170676502; NCBI Protein Accession: ACB30404.1; NCBITaxon: 5807 VO:0011310 Allen Xiang Oliver He protein A subunit vaccine formulation containing only recombinant, soluble, attachment glycoprotein G from HeV (sG(HeV)) and CpG adjuvant was evaluated as a potential NiV vaccine in the cat model. Upon oronasal challenge with NiV (50,000TCID50), all vaccinated cats were protected from disease although virus was detected on day 21 post-challenge in one animal [PubMed: 18556094]. G glycoprotein from Hendra virus Protegen ID: 779; NCBI Gene GI: 1446471; NCBI Protein GI: 29468607; NCBI Protein Accession: NP_047112; NCBITaxon: 63330 VO:0011311 Allen Xiang Oliver He protein A recombinant baculovirus encoding a dengue (DEN)-2 virus envelope glycoprotein truncated of 102 amino acids (aa) at its C-terminus (D2EA102) was constructed. Both intracellular and extracellular D2EA102 induced neutralizing antibodies in mice and were thus immunogenic. Sixty eight percent (P < 0.001) of mice vaccinated with 5 gg of extracellular D2EA102 protein were protected against lethal challenge [PubMed: 7826210]. E protein from Dengue virus Protegen ID: 780; NCBI Protein GI: 202078796; NCBITaxon: 11060 VO:0011312 Allen Xiang Oliver He protein The protective efficacy and immune responses of mice intramuscularly injected with plasmid encoding DEN-2 non-structural protein 1 (NS1) was evaluated. Intravenously challenged by lethal DEN-2, mice vaccinated with NS1-DNA exhibited a delay onset of paralysis, a marked decrease of morbidity, and a significant enhancement of survival [PubMed: 12922127]. NS1 from Dengue virus Protegen ID: 781; NCBI Protein GI: 288848; NCBITaxon: 11060 VO:0011313 Allen Xiang Oliver He protein Hamsters were immunized subcutaneously with either 107 PFU of VV-NiV.G or VV-NiV.F expressing the G and F glycoproteins, respectively, or with the two combined. When the VV-NiV.G-vaccinated animals were challenged with Nipah virus 3 months after the last immunization (1,000 PFU/animal intraperitoneally), there was complete protection against mortality [PubMed: 14694115]. G glycoprotein from Nipah virus Protegen ID: 782; NCBI Gene GI: 920955; NCBI Protein GI: 13559814; NCBI Protein Accession: NP_112027; NCBITaxon: 121791 VO:0011314 Allen Xiang Oliver He protein Hamsters were immunized subcutaneously with either 10^7 PFU of VV-NiV.G or VV-NiV.F expressing the G and F glycoproteins, respectively, or with the two combined. When the VV-NiV.F-vaccinated animals were challenged with Nipah virus 3 months after the last immunization (1,000 PFU/animal intraperitoneally), there was complete protection against mortality [PubMed: 14694115]. F fusion protein from Nipah virus Protegen ID: 783; NCBI Nucleotide GI: 8164021; NCBI Protein GI: 8164022; NCBI Protein Accession: AAF73956.1; NCBITaxon: 121791 VO:0011315 Allen Xiang Oliver He protein A recombinant vaccinia virus that expressed the pre-M protein of Dengue 4 virus was constructed. Mice immunized with the recombinant virus were protected against subsequent dengue 4 encephalitis challenge [PubMed: 1926792]. PrM from Dengue Virus Protegen ID: 784; NCBI Protein GI: 18308086; NCBITaxon: 11070 VO:0011316 Allen Xiang Oliver He protein A recombinant vaccinia virus that expressed the M protein of Dengue 4 virus was constructed. Mice immunized with the recombinant virus were protected against subsequent dengue 4 encephalitis challenge [PubMed: 1926792]. M protein Protegen ID: 785; NCBI Protein GI: 73671170; NCBITaxon: 11070 VO:0011317 Allen Xiang Oliver He protein Guinea pigs immunized with different doses of the SPA appear to be protected against challenge with live organisms as compared with nonimmunized controls [PubMed: 2122457]. SpaP Protegen ID: 786; NCBI Protein GI: 152498; NCBITaxon: 782 VO:0011318 Allen Xiang Oliver He protein The glycoprotein (GP) and nucleocapsid (NC) genes of Rift Valley fever virus (RVFV) were expressed in different expression systems and were evaluated for their ability to protect mice from virulent challenge using a prime-boost regime. Mice vaccinated with a lumpy skin disease virus-vectored recombinant vaccine (rLSDV-RVFV) expressing the two RVFV glycoproteins (G1 and G2, expressed by the RVFV M Segment) developed neutralising antibodies and were fully protected when challenged, as were those vaccinated with a crude extract of truncated G2 glycoprotein (tG2) [PubMed: 16870311]. RVFVsMgp1 M protein Protegen ID: 787; NCBI Gene GI: 956559; NCBI Protein GI: 27881464; NCBI Protein Accession: NP_777376; NCBITaxon: 11588 VO:0011319 Allen Xiang Oliver He protein Immunisation of mice with cDNA encoding the nucleocapsid protein induced strong humoral and lymphocyte proliferative immune responses. Even though complete protection was not achieved by genetic immunisation, four out of eight mice vaccinated with cDNA encoding the nucleocapsid protein displayed no clinical signs of infection after challenge. In contrast, all fourteen control animals displayed clinical manifestations of Rift Valley Fever after challenge [PubMed: 19149901]. RVFVsSgp2 N protein Protegen ID: 788; NCBI Gene GI: 956562; NCBI Protein GI: 9632367; NCBI Protein Accession: NP_049344; NCBITaxon: 11588 VO:0011320 Allen Xiang Oliver He protein The receptor-binding domain (RBD) of SARS-CoV spike (S) protein is an important target in developing safe and effective SARS vaccines. A previous study has demonstrated that vaccination with adeno-associated virus encoding RBD (RBD-rAAV) induces high titer of neutralizing antibodies. The immune responses and protective effect of the immunization with RBD-rAAV prime/RBD-specific T cell peptide boost were assessed. Compared with the RBD-rAAV prime/boost vaccination, RBD-rAAV prime/RBD-peptide (RBD-Pep) boost induced similar levels of Th1 and neutralizing antibody responses that protected the vaccinated mice from subsequent SARS-CoV challenge, but stronger Th2 and CTL responses. No significant immune responses and protective effects were detected in mice vaccinated with RBD-Pep or blank AAV alone [PubMed: 18289745]. S protein of SARS-CoV Protegen ID: 789; NCBI Gene GI: 1489668; NCBI Protein GI: 29836496; NCBI Protein Accession: NP_828851; NCBITaxon: 694009 VO:0011321 Allen Xiang Oliver He protein Mice actively immunized using a recombinant V antigen (rVagHis, encoded by lcrV gene) of Y. enterocolitica were completely protected against challenge with both, Y. enterocolitica 0:8 and Y. pseudotuberculosis serotype III [PubMed: 10089162]. LcrV Protegen ID: 790; NCBI Gene GI: 1449458; NCBI Protein GI: 32470278; NCBI Protein Accession: NP_863514; NCBITaxon: 630 VO:0011322 Allen Xiang Oliver He protein 80% of C3H/HeJ mice immunized with Eh29 administered in combination with a subclinical dose of whole cholera toxin, but not as an Eh29-CTxB fusion, showed no evidence of infection in tissue sections harvested following intracecal challenge with virulent E. histolytica trophozoites. These results suggest that Eh29 is capable of inducing protective anti-amoebic immune responses in mice following oral immunization and could be used in the development of oral vaccines against amoebiasis [PubMed: 20303954]. GEh29 Protegen ID: 791; NCBI Nucleotide GI: 399673; NCBI Protein GI: 399674; NCBI Protein Accession: CAA50324.1; NCBITaxon: 5759 VO:0011323 Allen Xiang Oliver He protein Study tested if vaccination with the E. histolytica Gal/GalNAc lectin could prevent cecal infection in a C3H mouse model of amebic colitis. Vaccination prevented intestinal infection with efficacies of 84 and 100% in the two native lectin trials and 91 and 34% in the two LecA trials. Results show for the first time that immunization with the Gal/GalNAc lectin can prevent intestinal amebiasis in mice [PubMed: 14741152]. Gal/GalNAc lectin Protegen ID: 792; NCBI Gene GI: 3404842; NCBI Protein GI: 67469085; NCBI Protein Accession: XP_650534; NCBITaxon: 294381 VO:0011324 Allen Xiang Oliver He protein Report describes a recombinant fusion protein containing the serine-rich Entamoeba histolytica protein (SREHP), a protective antigen derived from virulent amebae, and a bacterially derived maltose-binding protein (MBP) from an attenuated strain of Salmonella typhimurium. Gerbils vaccinated with S typhimurium SREHP-MBP were protected against amebic liver abscess after challenge with E. histolytica, the most common extraintestinal complication of amebiasis [PubMed: 8613356]. SREHP Protegen ID: 793; NCBI Gene GI: 3402462; NCBI Protein GI: 67463194; NCBI Protein Accession: XP_648254; NCBITaxon: 294381 VO:0011325 Allen Xiang Oliver He protein Groups of C57BL/6 mice (20 per group) vaccinated with rPep1 (1 mug per dose) plus adjuvant and challenged with an intranasal inoculum began to die at about 14 to 16 days but then showed significantly greater survival than the control mice [PubMed: 16369008]. PEP1 Protegen ID: 794; NCBI Protein GI: 73915320; NCBITaxon: 199306 VO:0011326 Allen Xiang Oliver He protein Researcherse tested the ability of the galactose-specific adherence lectin of E. histolytica to elicit a protective immune response in conjunction with Freund's incomplete and complete adjuvants. Four independent trials demonstrated complete protection from amebic liver abscess formation in 67% of lectin-immunized gerbils. The gerbil antilectin antibodies were shown by Western immunoblotting to be directed to the heavy subunit (CEL-170/4) but not the light subunit of the lectin [PubMed: 1987067]. CEL-170/4 Protegen ID: 795; NCBI Protein GI: 401088; NCBITaxon: 5759 VO:0011327 Allen Xiang Oliver He protein C57BL/6 mice immunized with rPlb showed a significant reduction of the fungal burden in their lungs at 90 days postchallenge compared to the control mice at 15 days [PubMed: 16369008]. PLB Protegen ID: 796; NCBI Protein GI: 74486661; NCBITaxon: 199306 VO:0011328 Allen Xiang Oliver He protein C57BL/6 mice immunized with rAMN1 showed a significant reduction of the fungal burden in their lungs at 90 days postchallenge compared to the control mice at 15 days [PubMed: 16369008]. AMN1 Protegen ID: 797; NCBI Protein GI: 76786276; NCBITaxon: 199306 VO:0011329 Allen Xiang Oliver He protein ELI-Antigen 1 (ELI-Ag1) was tested for its protective capacity in BALB/c mice against intraperitoneal challenge with 2500 arthroconidia of this dimorphic fungus and was found to be highly protective [PubMed: 14505918]. ELI-Ag1 Protegen ID: 798; NCBI Protein GI: 37779128; NCBITaxon: 5501 VO:0011330 Allen Xiang Oliver He protein The GEL1 mRNA of C. posadasii was detected at the highest level during the endosporulation stage of the parasitic cycle, and the mature protein was immunolocalized to the surface of endospores. BALB/c or C57BL/6 mice were immunized subcutaneously with the bacterium-expressed recombinant protein (rGel1p) to evaluate its protective efficacy against a lethal challenge of C. posadasii by either the intraperitoneal or intranasal route. In both cases, rGel1p-immune mice infected with the pathogen showed a significant reduction in fungal burden and increased survival compared to nonimmune mice [PubMed: 12761077]. GEL1.00 Protegen ID: 799; NCBI Protein GI: 14582416; NCBITaxon: 199306 VO:0011331 Allen Xiang Oliver He protein Recombinant urease (rURE) of C. immitis was expressed in Escherichia coli and tested asa vaccine candidate in BALB/c mice. BALB/c mice immunized subcutaneously with rURE and subsequently challenged by the intraperitoneal (i.p.) route with a lethal inoculum of C. immitis arthroconidia demonstrated a significant reduction in the level of C. immitis infection compared to control animals [PubMed: 11292702]. URE Protegen ID: 800; NCBI Protein GI: 73808050; NCBITaxon: 5501 VO:0011332 Allen Xiang Oliver He protein Recombinant Pmp1 was reactive with serum from individuals with both acute and protracted disease, and evoked protection in two murine models of infection with C. posadasii [PubMed: 16495561]. Pmp1 Protegen ID: 801; NCBI Protein GI: 78364922; NCBITaxon: 199306 VO:0011333 Allen Xiang Oliver He protein C57BL6 mice were immunized with syngeneic, bone marrow-derived DCs (JAWS II cells) transfected with a cDNA encoding the protective Coccidioides-Ag2/proline-rich Ag (pra). The immunized mice were lethally challenged with C. posadasii through either an i.p. or intranasal route. Upon necropsy after 10 days of infection, fungal burden in lung and spleen of immunized mice was significantly reduced as compared with the control animals. The lung tissue homogenates of immunized animals showed higher levels of IFN-gamma. Histologically, lung tissues of immunized mice were in better condition than the control mice [PubMed: 16148136]. Pra Protegen ID: 802; NCBI Protein GI: 42742528; NCBITaxon: 5501 VO:0011334 Allen Xiang Oliver He protein The microtubule-associate protein (MAP p15) was tested as a vaccine in mice, and tests showed that p15 (native or recombinant) generated up to 100% protection from an otherwise lethal challenge of a heterologous strain of Trypanosoma brucei [PubMed: 15161078]. MAPP15 Protegen ID: 803; NCBI Protein GI: 777767; NCBITaxon: 5691 VO:0011335 Allen Xiang Oliver He protein Vaccination with poliovirus vector containing the gene for the B subunit of H. pylori urease provides significant prophylactic and strong therapeutic protection against H. pylori in mice [PubMed: 15603891]. UreB Protegen ID: 804; NCBI Protein GI: 40737733; NCBITaxon: 210 VO:0011336 Allen Xiang Oliver He protein Researchers prepared an oral liposome-encapsulated recombinant Helicobacter pylori (Hp) heat shock protein 60 (Hsp60) vaccine and investigate its effect against Hp infection in mice. rHsp60 plus CT (choleratoxin), liposome-encapsulated rHsp60 and liposome-encapsulated rHsp60 plus CT had protective rates against Hp infection of 73.3%, 66.7% and 86.7%, respectively [PubMed: 15897126]. Hsp60 Protegen ID: 805; NCBI Protein GI: 397869; NCBITaxon: 210 VO:0011337 Allen Xiang Oliver He protein A study shows that vaccination of mice with HP-NAP (H. pylori NAP) induces protection against H. pylori challenge, and that the majority of infected patients produce antibodies specific for HP-NAP, suggesting an important role of this factor in immunity [PubMed: 10790422]. NAP Protegen ID: 806; NCBI Protein GI: 8777456; NCBITaxon: 210 VO:0011338 Allen Xiang Oliver He protein BALB-c mice immunized intramuscularly with a single dose (100 microg) of a plasmid DNA encoding the 5'-terminal region of the trans-sialidase (nTSA) gene of T. brucei brucei are able to produce IgG antibodies that bind to the bloodstream form of T. brucei-protein extract and recognize the recombinant nTSA protein, expressed in Escherichia coli. Furthermore, this DNA vaccination process was able to protect 60% of mice submitted to a challenge assay with the infective form of T. brucei brucei parasites [PubMed: 19582478]. TSA from Trypanosoma brucei Protegen ID: 807; NCBI Protein GI: 62175539; NCBITaxon: 5691 VO:0011339 Allen Xiang Oliver He protein Recombinant H. pylori catalase plus CT was used for immunization, and groups of mice were challenged with the Sydney strain of H. pylori. Immunization with recombinant catalase protected a significant proportion (9 of 10) of the mice from H. pylori challenge, indicating that this enzyme should be considered as a candidate for a future vaccine [PubMed: 9353048]. Catalase Protegen ID: 808; NCBI Protein GI: 3128145; NCBITaxon: 210 VO:0011340 Allen Xiang Oliver He protein A study to examine the immunostimulatory properties of Leishmania infantum Hsp83 (83) to elicit humoral and cellular response against the Toxoplasma gondii Rop2 protein in an adjuvant-free vaccination system was conducted. Mice immunized with fusion Rop2-83 elicited a stronger humoral and cellular response in comparison to mice immunized with Rop2 alone, or a mix of LiHsp83 and Rop2. The fusion protein induced a Th1 type response, with predominance of specific IgG2a/IgG2c isotype and IFN-gamma secretions, whereas Rop2 alone or mixed with LiHsp83 produced a Th1/Th2 mixed response. Vaccination with fusion protein conferred a remarkable resistance against oral infection with ME49 cysts in C57BL/6 and C3H mice, in comparison to mice immunized with Rop2 alone or the protein mixture. Following lethal challenge, a significant survival rate was observed in Rop2-83 immunized Balb/c and C57BL/6 mice in comparison to control groups [PubMed: 16545504]. Rop2 Protegen ID: 809; NCBI Protein GI: 115299638; NCBITaxon: 5811 VO:0011341 Allen Xiang Oliver He protein Treatment of the Helicobacter pylori vacuolating cytotoxin with very low concentrations of formaldehyde resulted in abrogation of toxic activity in both a HeLa cell vacuolation assay and an in vivo assay of gastric epithelial damage. Detoxification had only a minimal effect on the integrity of the oligomeric or monomeric structure. The toxoid retained the ability to bind to target cells and to induce high-titer neutralizing antibodies after immunization of rabbits. Furthermore, oral immunization of mice with the toxoid resulted in protection against infective challenge with mouse-adapted strains of H. pylori [PubMed: 9353041]. VacA Protegen ID: 810; NCBI Protein GI: 50313203; NCBITaxon: 210 VO:0011342 Allen Xiang Oliver He protein The immunogenicity of a 48-kDa T-cell-reactive protein (TCRP) was investigated. Immunization of BALB/c and C3H/HeN mice with the rTCRP affords a modest but significant level of protection against an intraperitoneal challenge with C. immitis. It is suggested that the rTCRP may be able to contribute to a multicomponent vaccine designed to stimulate CMI response against the parasitic cycle of C. immitis. TcrP Protegen ID: 811; NCBI Protein GI: 13508695; NCBITaxon: 5501 VO:0011343 Allen Xiang Oliver He protein Some of the S. sciureus monkeys immunized with MSP-3(212-380)-AS02 or GLURP(27-500)-alum were able to fully or partially control parasitaemia upon an experimental P. falciparum [Falciparum Uganda Palo Alto (FUP-SP) strain] blood-stage infection, and this protection was related to the prechallenge antibody titres induced. The data are indicative that MSP-3 and GLURP can induce protective immunity against an experimental P. falciparum infection using adjuvants that are acceptable for human use and this should trigger further studies with those new antigens [PubMed: 15049780]. GLURP Protegen ID: 812; NCBI Gene GI: 810501; NCBI Protein GI: 124802897; NCBI Protein Accession: XP_001347628; NCBITaxon: 36329 VO:0011344 Allen Xiang Oliver He protein Asian seabass vaccinated with the OMP38 (OmpU) DNA vaccine was challenged with pathogenic V. anguillarum by intramuscular injection. A relative percent survival (RPS) rate of 55.6% was recorded [PubMed: 17337208]. OmpU Protegen ID: 813; NCBI Protein GI: 26513901; NCBITaxon: 55601 VO:0011345 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1067 1067 vaccine Japanese encephalitis virus DNA vaccine encoding PrM VO:0011346 Allen Xiang Oliver He DeltaFTT0918 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=439 439 vaccine DeltaFTT0918 vaccine VO:0011347 Allen Xiang Oliver He obsolete rLm/iglC VIOLIN Vaccine ID: 440 true VO:0011348 Allen Xiang Oliver He 5CVMB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=438 438 vaccine 5CVMB vaccine VO:0011349 Allen Xiang Oliver He L. amazonensis DNA vaccine encoding WD protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1041 1041 vaccine Leishmania amazonensis DNA vaccine encoding WD protein VO:0011350 Allen Xiang Oliver He L. infantum H1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1042 1042 vaccine Leishmania infantum H2 protein vaccine VO:0011351 Allen Xiang Oliver He L. infantum HASPB1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1043 1043 vaccine Leishmania infantum HASPB2 protein vaccine VO:0011352 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1036 1036 vaccine Japanese encephalitis virus DNA vaccine pUJENS5 VO:0011353 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1037 1037 vaccine Japanese encephalitis virus DNA vaccine encoding E protein VO:0011354 Allen Xiang Oliver He L. amazonensis DNA vaccine encoding GP46 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1038 1038 vaccine Leishmania amazonensis DNA vaccine encoding GP47 VO:0011355 Allen Xiang Oliver He L. amazonensis M2 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1039 1039 vaccine Leishmania amazonensis M3 protein vaccine VO:0011356 Allen Xiang Oliver He A. pleuropneumoniae ApxIA protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=782 782 vaccine Actinobacillus pleuropneumoniae ApxIA protein vaccine VO:0011357 Allen Xiang Oliver He B. pertussis Cpn60 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=797 797 vaccine Bordetella pertussis Cpn60 protein vaccine VO:0011359 Allen Xiang Oliver He B. pertussis CyaA protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=799 799 vaccine Bordetella pertussis CyaA protein vaccine VO:0011360 Allen Xiang Oliver He V. cholerae CTB DNA Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=800 800 vaccine Vibrio cholerae CTB DNA vaccine VO:0011361 Allen Xiang Oliver He B. pertussis PTx protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=801 801 vaccine Bordetella pertussis PTx protein vaccine VO:0011362 Allen Xiang Oliver He C. parvum DNA vaccine encoding CP23 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1050 1050 vaccine Cryptosporidium. parvum DNA vaccine encoding CP24 VO:0011363 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:C7828795 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1051 https://github.com/vaccineontology/VO/issues/343 2064 1051 cancer vaccine Gene name: ERBB2 Cancer Her-2/neu Protein Subunit Vaccine VO:0011364 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:17266027 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1052 https://github.com/vaccineontology/VO/issues/315 6528 1052 cancer vaccine Gene name: SLC5A5 cancer DNA vaccine MIDGE/hNIS encoding hNIS protein VO:0011365 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:19526360 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1053 https://github.com/vaccineontology/VO/issues/318 2315863 1053 cancer vaccine Gene name: Survivin cancer DNA vaccine pSURV encoding Survivin VO:0011366 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:21448901 PMID:31980914 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1047 https://github.com/vaccineontology/VO/issues/368 1485 1047 cancer vaccine Gene name: CTAG1B cancer subunit NY-ESO-1 protein vaccine VO:0011367 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1048 https://github.com/vaccineontology/VO/issues/314 13805 1048 cancer vaccine Gene name: Eng cancer DNA vaccine encoding Endoglin Boosted with recombinant Endoglin Protein VO:0011368 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:10678354 PMID:8363286 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1049 https://github.com/vaccineontology/VO/issues/345 14972 1049 cancer vaccine Gene name: H2-K1 Cancer recombinant vector vaccine encoding H-2Kb VO:0011369 An xenogenic DNA vaccine encoding human TEM8 carried by attenuated Salmonella typhimurium to help reduce tumor growth and suppress angiogenesis in the tumors. Allen Xiang Oliver He PMID:19609240 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1046 1046 cancer vaccine cancer DNA vaccine encoding TEM8 VO:0011370 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:10881691 PMID:19188665 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1064 https://github.com/vaccineontology/VO/issues/319 4072 1064 cancer vaccine Gene name: EPCAM Cancer EPCAM protein vaccine VO:0011371 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:19034678 PMID:32164575 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1066 https://github.com/vaccineontology/VO/issues/371 7422 1066 cancer vaccine Gene name: VEGFA Cancer VEGFA protein vaccine VO:0011372 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1058 1058 cancer vaccine cancer retroviral vector vaccine encoding Cd40lg VO:0011373 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:/7533183 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1059 https://github.com/vaccineontology/VO/issues/317 12524 1059 cancer vaccine Gene name: Cd86 Cancer DNA Vaccine pLXSHDmB7-2 encoding Cd86 VO:0011374 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1054 1054 vaccine Phleum pratense allergy Phl p 12 subunit vaccine VO:0011375 Allen Xiang Oliver He B. bovis GST-12D3 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=791 791 vaccine Babesia bovis GST-12D3 vaccine VO:0011377 Allen Xiang Oliver He B. pertussis BrkA protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=796 796 vaccine Bordetella pertussis BrkA protein vaccine VO:0011378 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=825 825 vaccine Bovine leukemia virus DNA vaccine encoding Env VO:0011379 Allen Xiang Oliver He vaccine Bovine leukemia virus DNA vaccine encoding Tax VO:0011380 Allen Xiang Oliver He B. abortus DNA vaccine encoding RplL and Omp16 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=831 831 vaccine Brucella abortus DNA vaccine encoding RplL and Omp16 VO:0011381 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=821 821 vaccine Bovine herpesvirus 1 DNA vaccine AdCMVgD VO:0011382 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=823 823 vaccine Bovine herpesvirus 1 DNA vaccine AdCMVgC VO:0011383 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=824 824 vaccine Bovine herpesvirus 1 GPI protein vaccine VO:0011384 Allen Xiang Oliver He A. pleuropneumoniae ApxIa and ApxIIa protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=784 784 vaccine Actinobacillus pleuropneumoniae ApxIa and ApxIIa protein vaccine VO:0011385 Allen Xiang Oliver He Rebecca Racz A. pleuropneumoniae HS93C-Ampr VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=786 786 vaccine In the present study, the gene encoding the ApxII-activating protein, apxIIC, was insertionally inactivated on the chromosome of a serovar 7 strain, HS93. Pigs vaccinated with live HS93C-Ampr via the intranasal route were protected against a cross-serovar challenge with a virulent serovar 1 strain of A. pleuropneumoniae Actinobacillus pleuropneumoniae HS93C-Ampr VO:0011386 Allen Xiang Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=788 788 vaccine The aroA gene was inactivated by inserting a fragment expressing kanamycin resistance within the coding sequence and challenged in fish. The LD50 for unvaccinated fish was 71. In contrast, the LD50 was 1.8 x 104 in fish vaccinated once and 3 x 105 in fish vaccinated twice A. salmonicida live-attenuated vaccine encoding AroA VO:0011387 An Ebola virus vaccine that is composed of VEE replicon particle (VRP) encoding Ebola virus NP protein. Allen Xiang Oliver He NP-VRP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=443 443 vaccine NP-VRP vaccine VO:0011388 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1044 1044 vaccine Rickettsia rickettsii vaccine using M. vaccae expressing R. rickettsii OmpA Protein VO:0011389 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1045 1045 vaccine Rickettsia DNA vaccine encoding OmpB Protein boosted with recombinant OmpB VO:0011391 Allen Xiang Oliver He B. pertussis DNA vaccine encoding Prn VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=808 808 vaccine Bordetella pertussis DNA vaccine encoding Prn VO:0011392 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=993 993 vaccine Marek's Disease Virus Vaccine rFPV/gI VO:0011393 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=994 994 vaccine Marek's Disease Virus Vaccine rFPV/gB1 VO:0011394 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=997 997 vaccine Marburg Virus Nucleoprotein Vaccine VO:0011395 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=986 986 vaccine Human papillomavirus E7 protein vaccine VO:0011396 Allen Xiang Oliver He P. falciparum Hsp90 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=987 987 vaccine Plasmodium falciparum Hsp90 protein subunit vaccine VO:0011397 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=988 988 vaccine Human papillomavirus L2 protein vaccine VO:0011398 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=989 989 vaccine IHNV DNA vaccine pIHNw-G VO:0011399 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=990 990 vaccine Rift Valley Fever Virus DNA Vaccine encoding N Protein VO:0011400 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=949 949 vaccine Puumala virus PUUVsSgp1 (NP) protein vaccine VO:0011401 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=950 950 vaccine Sin Nombre virus DNA vaccine encoding G1 VO:0011402 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=951 951 vaccine Seoul virus vaccine rCAV-2-Gc VO:0011403 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=952 952 vaccine Topografov virus N protein vaccine VO:0011404 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=968 968 vaccine Hepatitis B virus DNA vaccine pVAX-PS VO:0011405 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=969 969 vaccine Herpes simplex virus type 2 DNA vaccine encoding ICP27 VO:0011406 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=970 970 vaccine Herpes simplex virus type 2 DNA vaccine encoding GB VO:0011407 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=971 971 vaccine NIpah Virus G and F Proteins subunit vaccine VO:0011408 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=972 972 vaccine Herpes simplex virus type 1 DNA vaccine encoding GC VO:0011409 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=963 963 vaccine Hendra virus G protein vaccine VO:0011410 Allen Xiang Oliver He M. tuberculosis DNA Vaccine encoding Ag85B Protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=964 964 vaccine Mycobacterium tuberculosis DNA vaccine encoding Ag85B protein VO:0011411 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=965 965 vaccine Hepatitis B virus DNA vaccine encoding HBVgp2 pre-S1/pre-S2/S VO:0011412 Allen Xiang Oliver He M. tuberculosis Mtb72F protein subunit vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=967 967 vaccine Mycobacterium tuberculosis Mtb72F protein subunit vaccine VO:0011413 Allen Xiang Oliver He B. pertussis DNA vaccine encoding TcfA vaccine Bordetella pertussis DNA vaccine encoding TcfA VO:0011414 Allen Xiang Oliver He E. histolytica CEL-170/4 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=918 918 vaccine Entamoeba histolytica CEL-170/4 protein vaccine VO:0011415 Allen Xiang Oliver He P. falciparum Subunit SE36 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=919 919 vaccine Plasmodium falciparum subunit SE36 protein vaccine VO:0011416 Allen Xiang Oliver He E. histolytica SREHP protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=920 920 vaccine Entamoeba histolytica SREHP protein vaccine VO:0011417 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=921 921 vaccine E. coli C3389 protein vaccine VO:0011418 Allen Xiang Oliver He P. falciparum Pfen Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=922 922 vaccine Plasmodium falciparum Pfen protein subunit vaccine VO:0011419 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=973 973 vaccine Mumps HN protein subunit vaccine VO:0011420 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=974 974 vaccine Herpes simplex virus type 2 vaccine using phage displaying GG protein VO:0011421 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=975 975 vaccine Herpes simplex virus type 1 DNA vaccine encoding GD VO:0011422 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=976 976 vaccine Measles Virus vaccine VEE/SIN-H+F VO:0011423 Allen Xiang Oliver He Rebecca Racz VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=977 977 vaccine An HSV-1 gE (Us8) deletion strain, NS-gEnull, was used as a live attenuated vaccine. After HSV-1 challenge, latent virus was recovered by DRG explant cocultures from <10% of vaccinated mice compared with 100% of mock-vaccinated mice Herpes simplex virus type 1 DNA vaccine encoding GE VO:0011424 Allen Xiang Oliver He C. pneumoniae DNA vaccine encoding PknD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=887 887 vaccine Chlamydophila pneumoniae DNA vaccine encoding PknD VO:0011425 Allen Xiang Oliver He C. pneumoniae DNA vaccine encoding Ssb VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=888 888 vaccine Chlamydophila pneumoniae DNA vaccine encoding Ssb VO:0011426 Allen Xiang Oliver He C. psittaci DNA vaccine pcDNA1/MOMP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=889 889 vaccine Chlamydophila psittaci DNA vaccine pcDNA2/MOMP VO:0011427 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=890 890 vaccine Classical swine fever virus vaccine VAC-E0 VO:0011428 Allen Xiang Oliver He C. abortus DNA vaccine encoding GatC VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=878 878 vaccine Chlamydophila abortus DNA vaccine encoding GatC VO:0011429 Allen Xiang Oliver He C. abortus DNA vaccine encoding OmlA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=879 879 vaccine Chlamydophila abortus DNA vaccine encoding OmlA VO:0011430 Allen Xiang Oliver He C. abortus DNA vaccine encoding MOMP VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=880 880 vaccine Chlamydophila abortus DNA vaccine encoding MOMP VO:0011431 Allen Xiang Oliver He C. abortus DNA vaccine Pomp90A VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=881 881 vaccine Chlamydophila abortus DNA vaccine Pomp90A VO:0011432 Allen Xiang Oliver He C. pneumoniae CopN protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=882 882 vaccine Chlamydophila pneumoniae CopN protein vaccine VO:0011433 Allen Xiang Oliver He cancer vaccine prostate cancer DNA vaccine encoding prostatic acid phosphatase (PAP) VO:0011434 Allen Xiang Oliver He C. pneumoniae DNA vaccine encoding FabD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=884 884 vaccine Chlamydophila pneumoniae DNA vaccine encoding FabD VO:0011435 Allen Xiang Oliver He C. pneumoniae LcrE protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=885 885 vaccine Chlamydophila pneumoniae LcrE protein vaccine VO:0011436 Allen Xiang Oliver He B. pseudomallei Subunit LolC Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=860 860 vaccine Burkholderia pseudomallei subunit LolC protein vaccine VO:0011437 Allen Xiang Oliver He C. muridarum RplF protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=861 861 vaccine Chlamydia muridarum RplF protein vaccine VO:0011438 Allen Xiang Oliver He B. pseudomallei Subunit PotF Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=862 862 vaccine Burkholderia pseudomallei subunit PotF protein vaccine VO:0011439 Allen Xiang Oliver He P. yoelii MSP1 and MSP4/5 Proteins Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=984 984 vaccine Plasmodium yoelii MSP1 and MSP4/5 proteins subunit vaccine VO:0011440 Allen Xiang Oliver He P. falciparum MSP3 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=985 985 vaccine Plasmodium falciparum MSP3 protein subunit vaccine VO:0011441 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1035 1035 vaccine Lassa Virus Nucleoprotein subunit vaccine VO:0011442 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=923 923 vaccine E. coli C4424 protein vaccine VO:0011443 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=924 924 vaccine E. coli Hma protein vaccine VO:0011444 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=925 925 vaccine E. coli IreA protein vaccine VO:0011445 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=926 926 vaccine E. coli IutA protein vaccine VO:0011446 Allen Xiang Oliver He F. tularensis GroEL protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=928 928 vaccine Francisella tularensis GroEL protein vaccine VO:0011447 Allen Xiang Oliver He F. tularensis DNA vaccine rLm/iglC obsolete Francisella tularensis DNA vaccine rLm/iglC true VO:0011448 Allen Xiang Oliver He E. tenella vaccine rBCG pMV361-Rho VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=912 912 vaccine Eimeria tenella vaccine rBCG pMV361-Rho VO:0011449 Allen Xiang Oliver He E. tenella DNA vaccine pcDNA-TA4-IL-2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=913 913 vaccine Eimeria tenella DNA vaccine pcDNA-TA4-IL-2 VO:0011450 Allen Xiang Oliver He E. histolytica Eh29 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=915 915 vaccine Entamoeba histolytica Eh29 protein vaccine VO:0011451 Allen Xiang Oliver He E. histolytica Gal/GalNAc lectin protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=916 916 vaccine Entamoeba histolytica Gal/GalNAc lectin protein vaccine VO:0011452 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=853 853 vaccine Dengue vaccine using Vaccinia virus expressing prM protein VO:0011453 Allen Xiang Oliver He C. muridarum MOMP protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=854 854 vaccine Chlamydia muridarum MOMP protein vaccine VO:0011454 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=855 855 vaccine Dengue DNA vaccine encoding NS1 protein VO:0011455 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=856 856 vaccine Dengue vaccine using Vaccinia virus expressing M protein VO:0011456 Allen Xiang Oliver He C. muridarum PmpE/F-2 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=857 857 vaccine Chlamydia muridarum PmpE/F-2 protein vaccine VO:0011457 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=858 858 vaccine Dengue subunit E protein vaccine VO:0011458 Allen Xiang Oliver He C. muridarum PmpG-1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=859 859 vaccine Chlamydia muridarum PmpG-1 protein vaccine VO:0011459 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=847 847 vaccine Canine distemper virus DNA vaccine encoding HA VO:0011460 a Coccidioides vaccine that contains C. posadasii PMP1 protein Allen Xiang Oliver He C. posadasii subunit PMP1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=848 848 vaccine Coccidioides posadasii subunit PMP1 protein vaccine VO:0011461 a Coccidioides vaccine that contains C. posadasii DNA vaccine encoding PRA protein Allen Xiang Oliver He C. posadasii DNA Vaccine encoding PRA protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=849 849 vaccine Coccidioides posadasii DNA vaccine encoding PRA protein VO:0011462 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=850 850 vaccine Canine parvovirus DNA vaccine pGT36VP1 VO:0011463 a Coccidioides vaccine that contains C. immitis subunit URE protein Allen Xiang Oliver He C. immitis subunit URE protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=851 851 vaccine Coccidioides immitis subunit URE protein vaccine VO:0011464 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=852 852 vaccine Canine parvovirus CPMV-PARVO1 protein vaccine VO:0011465 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=901 901 vaccine Ebola virus DNA vaccine encoding ZEBOV GP and SEBOV GP VO:0011466 Allen Xiang Oliver He S. flexneri Invaplex 24 Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=902 902 vaccine Shigella flexneri Invaplex 24 subunit vaccine VO:0011467 Allen Xiang Oliver He E. maxima Gam82 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=903 903 vaccine Eimeria maxima Gam82 protein vaccine VO:0011468 Allen Xiang Oliver He S. flexneri Invaplex 50 Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=904 904 vaccine Shigella flexneri Invaplex 50 subunit vaccine VO:0011469 Allen Xiang Oliver He E. tenella DNA vaccine proIE VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=905 905 vaccine Eimeria tenella DNA vaccine proIE VO:0011470 Allen Xiang Oliver He E. tenella GX3262 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=907 907 vaccine Eimeria tenella GX3262 protein vaccine VO:0011471 Allen Xiang Oliver He E. tenella DNA vaccine EtMIC2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=909 909 vaccine Eimeria tenella DNA vaccine EtMIC2 VO:0011472 Allen Xiang Oliver He E. tenella DNA vaccine rBCG pMV261-Rho VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=910 910 vaccine Eimeria tenella DNA vaccine rBCG pMV261-Rho VO:0011473 Allen Xiang Oliver He Vaxxitek HVT+IBD VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=397 397 vaccine Vaxxitek HVT+IBD vaccine VO:0011474 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=398 398 vaccine Newcastle disease virus vaccine by Dow AgroSciences VO:0011475 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=427 427 vaccine Theileria parva vaccine by Centre for Ticks and Tickborne Disease, Malawi VO:0011476 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=428 428 vaccine Theileria annulata vaccine by Local veterinary institutes VO:0011477 Allen Xiang Oliver He H. pylori DNA vaccine encoding UreB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=960 960 vaccine Helicobacter pylori DNA vaccine encoding UreB VO:0011478 Allen Xiang Oliver He M. tuberculosis DNA Vaccine APADNA priming and APAMVA boosting VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=961 961 vaccine Mycobacterium tuberculosis DNA vaccine APADNA priming and APAMVA boosting VO:0011479 Allen Xiang Oliver He H. pylori VacA protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=962 962 vaccine Helicobacter pylori VacA protein vaccine VO:0011480 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=981 981 vaccine Human papillomavirus DNA vaccine pNGVL4a-E6/opt VO:0011481 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=982 982 vaccine PCV2 DNA vaccine encoding ORF2 protein VO:0011482 A multivalent vaccine against tetanus, diphtheria, and poliomyelitis. Allen Xiang Ningxian Fan Oliver He Td Polio Adsorbed Tetanus and Diphtheria Toxoids Adsorbed and Inactivated Poliomyelitis Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=628 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=629 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=630 WEB: https://www.vaccineshoppecanada.com/document.cfm?file=td_polio_adsorbed_e.pdf 628 629 630 vaccine Td Polio Adsorbed vaccine VO:0011483 Allen Xiang Oliver He This term is obsolete since there is another term with the same name. obsolete Td Polio Adsorbed true VO:0011484 Allen Xiang Oliver He This term is obsolete since there is another term with the same name. obsolete Td Polio Adsorbed true VO:0011485 Allen Xiang Oliver He C. jejuni FspA1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=841 841 vaccine Campylobacter jejuni FspA1 protein vaccine VO:0011486 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=842 842 vaccine SARS subunit spike protein vaccine VO:0011487 Allen Xiang Oliver He C. jejuni FspA2 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=843 843 vaccine Campylobacter jejuni FspA2 protein vaccine VO:0011488 Allen Xiang Oliver He C. jejuni DNA vaccine pcDNA3.1(+)-peblA VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=844 844 vaccine Campylobacter jejuni DNA vaccine pcDNA3.1(+)-peblA VO:0011489 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=845 845 vaccine Canine distemper virus DNA vaccine encoding F and HA VO:0011490 a Coccidioides vaccine that contains C. posadasii subunit GEL1 protein Allen Xiang Oliver He C. posadasii subunit GEL1 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=846 846 vaccine Coccidioides posadasii subunit GEL1 protein vaccine VO:0011491 Allen Xiang Oliver He T. brucei DNA Vaccine encoding TSA protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=836 836 vaccine Trypanosoma brucei DNA vaccine encoding TSA protein VO:0011492 Allen Xiang Oliver He T. brucei Subunit p15 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=837 837 vaccine Trypanosoma brucei subunit p15 Protein vaccine VO:0011493 Allen Xiang Oliver He C. jejuni MBP-FlaA protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=838 838 vaccine Campylobacter jejuni MBP-FlaA protein vaccine VO:0011494 Allen Xiang Oliver He T. parva Subunit p67 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=839 839 vaccine Theileria parva Subunit p67 protein vaccine VO:0011495 Allen Xiang Oliver He C. jejuni FlaC protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=840 840 vaccine Campylobacter jejuni FlaC protein vaccine VO:0011498 Allen Xiang Oliver He B. pertussis FhaB and 69 kDa OMP protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=805 805 vaccine Bordetella pertussis FhaB and 69 kDa OMP protein vaccine VO:0011499 Allen Xiang Oliver He H. influenzae Hap protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=936 936 vaccine Haemophilus influenzae Hap protein vaccine VO:0011500 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1033 1033 vaccine Japanese encephalitis virus DNA vaccine encoding NS1 (pUSK-NS1) VO:0011501 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1034 1034 vaccine Japanese encephalitis virus DNA vaccine pUJENS3 VO:0011502 Allen Xiang Oliver He C. parvum DNA vaccine encoding CP15/60 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=900 900 vaccine Cryptosporidium. parvum DNA vaccine encoding CP15/61 VO:0011503 Allen Xiang Oliver He Y. enterocolititica Subunit V Antigen Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=896 896 vaccine Yersinia enterocolititica Subunit V Antigen Protein vaccine VO:0011504 Allen Xiang Oliver He C. botulinum FHc protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=897 897 vaccine Clostridium botulinum FHc protein vaccine VO:0011505 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=898 898 vaccine WEEV DNA vaccine encoding 6K-E1 protein VO:0011506 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=899 899 vaccine WEEV Subunit E2 protein vaccine VO:0011507 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:C5187854 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=891 https://github.com/vaccineontology/VO/issues/367 7015 891 cancer vaccine Gene name: TERT Cancer Subunit GV1001 Protein Vaccine VO:0011508 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=892 892 vaccine Classical swine fever virus vaccine VAC-E2 VO:0011509 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=893 893 vaccine Classical swine fever virus E1 protein vaccine VO:0011510 Eliyas Asfaw Ibrahim Seleznev Jie Zheng Oliver He PMID:wler=tru VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=894 https://github.com/vaccineontology/VO/issues/366 1084 894 cancer vaccine Gene name: CEACAM3 Cancer Subunit DC (Tat-CEA) vaccine VO:0011511 Allen Xiang Oliver He C. botulinum DNA vaccine pSCARSBHc vaccine Clostridium botulinum DNA vaccine pSCARSBHc VO:0011512 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=954 954 vaccine Dobrava-Belgrade virus S nucleocapsid protein vaccine VO:0011513 Allen Xiang Oliver He H. pylori catalase protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=955 955 vaccine Helicobacter pylori catalase protein vaccine VO:0011514 Allen Xiang Oliver He H. pylori NAP protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=958 958 vaccine Helicobacter pylori NAP protein vaccine VO:0011515 Allen Xiang Oliver He M. gallisepticum TM-1 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=959 959 vaccine Mycoplasma gallisepticum TM-1 protein subunit vaccine VO:0011516 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1027 1027 vaccine Japanese encephalitis virus vaccine BV-G-E VO:0011517 Allen Xiang Oliver He T. annulata Subunit SPAG-1 Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=873 873 vaccine Theileria annulata Subunit SPAG-1 protein vaccine VO:0011518 Allen Xiang Oliver He C. abortus DNA vaccine encoding DnaK VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=874 874 vaccine Chlamydophila abortus DNA vaccine encoding DnaK VO:0011519 Allen Xiang Oliver He C. abortus DNA vaccine encoding DnaX VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=875 875 vaccine Chlamydophila abortus DNA vaccine encoding DnaX VO:0011520 Allen Xiang Oliver He C. abortus DNA vaccine encoding GatA/GatB VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=876 876 vaccine Chlamydophila abortus DNA vaccine encoding GatA/GatB VO:0011521 Allen Xiang Oliver He T. gondii Subunit Rop2-Hsp83 Fusion Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=866 866 vaccine Toxoplasma gondii Subunit Rop2-Hsp83 fusion protein vaccine VO:0011522 Allen Xiang Oliver He C. muridarum DNA vaccine encoding TC0757 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=867 867 vaccine Chlamydia muridarum DNA vaccine encoding TC0757 VO:0011523 Allen Xiang Oliver He T. gondii DNA vaccine pcDNA3-MIC3 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=868 868 vaccine Toxoplasma gondii DNA vaccine pcDNA3-MIC3 VO:0011524 Allen Xiang Oliver He C. muridarum DNA vaccine encoding TC0767/768 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=869 869 vaccine Chlamydia muridarum DNA vaccine encoding TC0767/768 VO:0011525 Allen Xiang Oliver He T. gondii DNA Vaccine encoding SAG1 Protein vaccine Toxoplasma gondii DNA vaccine encoding SAG1 protein VO:0011526 Allen Xiang Oliver He C. abortus DNA vaccine encoding CAB049 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=871 871 vaccine Chlamydophila abortus DNA vaccine encoding CAB049 VO:0011527 Allen Xiang Oliver He C. abortus DNA vaccine encoding CAB613 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=872 872 vaccine Chlamydophila abortus DNA vaccine encoding CAB613 VO:0011528 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1023 1023 vaccine infleunza virus DNA vaccine encoding NP from Influenza A virus (A/chicken/Henan/12/2004(H5N1)) VO:0011529 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1024 1024 vaccine influenza virus DNA vaccine encoding NP from influenza A virus (A/chicken/Hubei/489/2004(H5N1)) VO:0011530 Allen Xiang Oliver He L. donovani DNA vaccine encoding KMP-11 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1025 1025 vaccine Leishmania donovani DNA vaccine encoding KMP-11 VO:0011531 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1026 1026 vaccine influenza virus NP protein vaccine (influenza A virus (A/nt/60/1968(H3N2))) VO:0011532 Allen Xiang Oliver He L. donovani gp63 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1022 1022 vaccine Leishmania donovani gp63 protein subunit vaccine VO:0011533 Allen Xiang Oliver He C. muridarum DNA vaccine encoding TC0439 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=864 864 vaccine Chlamydia muridarum DNA vaccine encoding TC0439 VO:0011534 Allen Xiang Oliver He C. muridarum DNA vaccine encoding TC0512 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=865 865 vaccine Chlamydia muridarum DNA vaccine encoding TC0512 VO:0011535 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=978 978 vaccine Measles Virus vaccine VVN VO:0011536 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=979 979 vaccine Measles Virus vaccine VVP VO:0011537 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=980 980 vaccine Measles Virus vaccine VVM VO:0011538 Allen Xiang Oliver He B. pseudomallei DNA vaccine encoding Flagellin Protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=863 863 vaccine Burkholderia pseudomallei DNA vaccine encoding Flagellin protein VO:0011539 Allen Xiang Oliver He L. donovani ORFF Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1017 1017 vaccine Leishmania donovani ORFF protein subunit vaccine VO:0011540 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1018 1018 vaccine influenza virus DNA vaccine encoding NA from influenza B virus (B/Ibaraki/2/85) VO:0011541 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1019 1019 vaccine influenza virus DNA vaccine encoding NA from influenza A virus (A/chicken/Henan/12/2004(H5N1)) VO:0011542 Allen Xiang Oliver He L. donovani DNA Vaccine encoding NH36 Protein VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=1020 1020 vaccine Leishmania donovani DNA vaccine encoding NH36 Protein VO:0011543 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=945 945 vaccine Sin Nombre virus DNA vaccine encoding SNVsSgp1 (NP) VO:0011544 Allen Xiang Oliver He S. equi Subunit EAG, FNZ and SFS Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=832 832 vaccine Streptococcus equi Subunit EAG, FNZ and SFS protein vaccine VO:0011545 Allen Xiang Oliver He C. jejuni DNA vaccine pcDNA3.1(+)-cadF VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=833 833 vaccine Campylobacter jejuni DNA vaccine pcDNA3.1(+)-cadF VO:0011546 Allen Xiang Oliver He S. equi Subunit CNE Protein Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=834 834 vaccine Streptococcus equi Subunit CNE protein vaccine VO:0011548 Allen Xiang Oliver He F. tularensis DNA vaccine pTUL4-15 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=930 930 vaccine Francisella tularensis DNA vaccine pTUL4-15 VO:0011549 Allen Xiang Oliver He P. berghei CS protein subunit vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=931 931 vaccine Plasmodium berghei CS protein subunit vaccine VO:0011550 Allen Xiang Oliver He G. duodenalis DNA vaccine encoding CWP2 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=932 932 vaccine Giardia duodenalis DNA vaccine encoding CWP2 VO:0011551 Allen Xiang Oliver He H. influenzae D15 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=933 933 vaccine Haemophilus influenzae D15 protein vaccine VO:0011552 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=934 934 vaccine Newcastle Disease Virus HN glycoprotein subunit vaccine VO:0011553 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=816 816 vaccine Rabies DNA vaccine encoding Rabies virus Glycoprotein VO:0011554 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=817 817 vaccine Bovine herpesvirus 1 DNA vaccine tgD-VP22 VO:0011555 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=818 818 vaccine Rabies vaccine rVac-N VO:0011556 Allen Xiang Oliver He Vivotif L VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=645 645 vaccine Vivotif L vaccine VO:0011557 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=815 815 vaccine Bovine herpesvirus 1 DNA vaccine pRSV-gC VO:0011558 Allen Xiang Kallan Roan Oliver He Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=741 http://purl.bioontology.org/ontology/RXNORM/845529 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm179132.htm 741 IXIARO For the prevention of disease caused by Japanese encephalitis virus in persons 2 months of age and older. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142569.pdf BL 125280 vaccine Ixiaro vaccine VO:0011559 Allen Xiang Kallan Roan Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=740 http://purl.bioontology.org/ontology/RXNORM/661026 https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186957.htm 740 Cervarix Prevention of cervical cancer, cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and cervical intraepithelial neoplasia (CIN) grade 1, caused by oncogenic human papillomavirus (HPV) types 16 and 18, in females9 through 25 years of age. https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM186981.pdf BL 125259 vaccine Cervarix vaccine VO:0011561 Allen Xiang Oliver He VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=943 943 vaccine Andes virus vaccine using adenovirus viral vector expressing ANDV NP VO:0011562 Allen Xiang Oliver He H. influenzae Omp26 protein vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=938 938 vaccine Haemophilus influenzae Omp26 protein vaccine VO:0011563 Allen Xiang Oliver He N. caninum NcMIC1 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=939 939 vaccine Neospora caninum NcMIC1 protein subunit vaccine VO:0011564 Allen Xiang Oliver He N. caninum NcMAG1 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=941 941 vaccine Neospora caninum NcMAG1 protein subunit vaccine VO:0011565 Allen Xiang Oliver He N. caninum NcDG2 Protein Subunit Vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=942 942 vaccine Neospora caninum NcDG2 protein subunit vaccine VO:0012158 A vaccine that protects against Leishmania amazonensis. Allen Xiang Oliver He Leishmania amazonensis vaccine Leishmania amazonensis vaccine VO:0012159 A vaccine that protects against Leishmania infantum. Allen Xiang Oliver He Leishmania infantum vaccine Leishmania infantum vaccine VO:0012160 A vaccine that protects against Cryptosporidium parvum. Allen Xiang Oliver He Cryptosporidium parvum vaccine Cryptosporidium parvum vaccine VO:0012161 A vaccine that protects against Bovine Leukemia virus. Allen Xiang Oliver He bovine leukemia virus vaccine bovine leukemia virus vaccine VO:0012162 A vaccine that protects against Marek's disease virus. Allen Xiang Oliver He Marek's; disease virus vaccine Marek's disease virus vaccine VO:0012163 A vaccine that protects against Marburg Virus. Allen Xiang Oliver He Marburg Virus vaccine Marburg Virus vaccine VO:0012165 A vaccine that protects against Infectious Hematopoietic Necrosis Virus. Allen Xiang Oliver He Infectious Hematopoietic Necrosis Virus vaccine Infectious Hematopoietic Necrosis Virus vaccine VO:0012166 A vaccine that protects against Rift Valley Fever virus. Allen Xiang Oliver He Rift Valley Fever virus vaccine Rift Valley Fever virus vaccine VO:0012167 Viral vaccine that protects against Hantavirus. Allen Xiang Oliver He Hantavirus vaccine Hantavirus vaccine VO:0012168 A vaccine that protects against Herpes simplex virus type 1 and 2. Allen Xiang Oliver He Herpes simplex virus type 1 and 2 vaccine Herpes simplex virus type 1 and 2 vaccine VO:0012169 A vaccine that protects against Nipah virus. Allen Xiang Oliver He vaccine Nipah virus vaccine VO:0012170 A vaccine that protects against Hendra virus. Allen Xiang Oliver He Hendra virus vaccine Hendra virus vaccine VO:0012171 A vaccine that protects against Entamoeba histolytica. Allen Xiang Oliver He Entamoeba histolytica vaccine Entamoeba histolytica vaccine VO:0012173 A Chlamydia vaccine that protects against Chlamydophila pneumoniae. Allen Xiang Oliver He vaccine Chlamydophila pneumoniae vaccine VO:0012174 A Chlamydia bacterial vaccine against Chlamydophila psittaci infection Allen Xiang Oliver He vaccine Chlamydophila psittaci vaccine VO:0012175 A vaccine that protects against Burkholderia pseudomallei. Allen Xiang Oliver He Burkholderia pseudomallei vaccine Burkholderia pseudomallei vaccine VO:0012176 A Chlamydia vaccine that protects against Chlamydia muridarum. Allen Xiang Oliver He Chlamydia muridarum vaccine Chlamydia muridarum vaccine VO:0012177 A vaccine that protects against Lassa Fever Virus. Allen Xiang Oliver He Lassa Fever Virus vaccine Lassa Fever Virus vaccine VO:0012178 A vaccine that protects against Canine distemper virus. Allen Xiang Oliver He vaccine canine distemper virus vaccine VO:0012179 A vaccine that protects against Coccidioides spp. Allen Xiang Oliver He Coccidioides spp. vaccine vaccine Coccidioides vaccine VO:0012180 A vaccine that protects against Canine parvovirus. Allen Xiang Oliver He Canine parvovirus vaccine canine parvovirus vaccine VO:0012181 Vaccine that protects against Helicobacter pylori infection. Allen Xiang Oliver He Helicobacter pylori vaccine Helicobacter pylori vaccine VO:0012182 A Campylobacter vaccine that protects against Campylobacter jejuni. Allen Xiang Oliver He vaccine Campylobacter jejuni vaccine VO:0012183 A vaccine that protects against SARS-CoV. Allen Xiang Oliver He SARS-CoV vaccine vaccine SARS vaccine VO:0012184 A vaccine that protects against Trypanosoma brucei. Allen Xiang Oliver He Trypanosoma brucei vaccine Trypanosoma brucei vaccine VO:0012185 A vaccine that protects against Haemophilus influenzae. Allen Xiang Oliver He vaccine Haemophilus influenzae vaccine VO:0012186 A vaccine that protects against Yersinia enterocolitica. Allen Xiang Oliver He Yersinia enterocolitica vaccine Yersinia enterocolitica vaccine VO:0012187 A vaccine that protects against Clostridium botulinum . Allen Xiang Oliver He Clostridium botulinum vaccine Clostridium botulinum vaccine VO:0012188 A vaccine that protects against Western equine encephalomyelitis virus. Allen Xiang Oliver He Western equine encephalomyelitis virus vaccine Western equine encephalomyelitis virus vaccine VO:0012190 A vaccine that protects against Tick-borne Encephalitis Virus (TBEV). Allen Xiang Oliver He tick-borne encephalitis vaccine vaccine Tick-borne Encephalitis Virus (TBEV) vaccine VO:0012212 A vaccine preparation that results in the generation of a Cancer vaccine Allen Xiang Oliver He VO:0001236 vaccine preparation cancer vaccine preparation VIOLIN Pathogen ID: 99 VO:0012213 A vaccine preparation that results in the generation of a Allergy vaccine Allen Xiang Oliver He vaccine preparation allergy vaccine preparation VIOLIN Pathogen ID: 114 VO:0012355 Allen Xiang Oliver He protein Staphylococcus aureus protein VO:0012356 Allen Xiang Oliver He protein Streptococcus agalactiae protein VO:0012357 Allen Xiang Oliver He protein Streptococcus pyogenes protein VO:0012358 Allen Xiang Oliver He protein Treponema pallidum protein VO:0012359 Allen Xiang Oliver He protein YopH from Y. pestis strain: CO92, biovar: Orientalis Protegen ID: 51; NCBI Gene GI: 1172712; NCBI Protein GI: 16082755; NCBI Protein Accession: NP_395201; NCBITaxon: 214092 VO:0012360 Allen Xiang Oliver He protein The oprF gene was cloned into plasmid vector pVR1020, and the plasmid vaccines were delivered to mice by biolistic (gene gun) intradermal inoculation. Following the initial immunization and two consecutive boosts, each at 2-week intervals, protection was demonstrated in a mouse model of chronic pulmonary infection by P. aeruginosa. Eight days postchallenge, both lungs were removed and examined. A significant reduction in the presence of severe macroscopic lesions, as well as in the number of bacteria present in the lungs, was seen [PubMed: 11292786]. OprF Protegen ID: 843; NCBI Gene GI: 878442; NCBI Protein GI: 15596974; NCBI Protein Accession: NP_250468; NCBITaxon: 208964 VO:0012361 Allen Xiang Oliver He protein Burned Pseudomonas aeruginosa-infected mice immunized against PcrV, a type III virulence system translocating protein, showed significantly enhanced survival compared to controls [PubMed: 11500471]. PcrV Protegen ID: 844; NCBI Gene GI: 882997; NCBI Protein GI: 15596903; NCBI Protein Accession: NP_250397; NCBITaxon: 208964 VO:0012362 Allen Xiang Oliver He protein Recombinant OprI protein was used to immunize mice, and was found to be protective against a challenge with a four- to fivefold 50% lethal dose of P. aeruginosa [PubMed: 2114360]. OprI Protegen ID: 845; NCBI Gene GI: 879851; NCBI Protein GI: 15598049; NCBI Protein Accession: NP_251543; NCBITaxon: 208964 VO:0012363 Allen Xiang Oliver He protein AY243312 Protegen ID: 68; NCBI Nucleotide GI: 29692106 VO:0012364 Allen Xiang Oliver He protein In mice, a primary vaccination with Ag85B-encoding plasmid DNA (DNA-85B) was protective against Mycobacterium tuberculosis (MTB) infection and associated with Ag85B-specific CD4+ T cells producing IFN-gamma and controlling intramacrophagic MTB growth [PubMed: 17250590]. Ag85B from M. tuberculosis H37Rv Protegen ID: 118; NCBI Gene GI: 885785; NCBI Protein GI: 15609023; NCBI Protein Accession: NC_000962.2; NCBITaxon: 1773 VO:0012365 Allen Xiang Oliver He protein znuA Protegen ID: 228; NCBI Gene GI: 3341411; NCBI Protein GI: 62317941; NCBI Protein Accession: YP_223794; NCBITaxon: 262698 VO:0012366 Allen Xiang Oliver He protein Intravenous vaccination with recombinant bacteria carrying expression plasmid for MPB/MPT51 in BALB/c mice elicited significant protective responses, comparable to those evoked by a live Mycobacterium bovis BCG vaccine [PubMed: 15039321]. FbpD Protegen ID: 814; NCBI Gene GI: 7562680; NCBI Protein GI: 224992215; NCBI Protein Accession: YP_002646905; NCBITaxon: 561275 VO:0012367 Allen Xiang Oliver He protein DNA vaccines encoding secreted proteins Ag85B and MPT64 protect mice from the tuberculosis H37Rv strain [PubMed: 15498274]. *Note* MPT64 in combination with Ag85B was protective, DNA vaccine of just MPT64 was mildly protective in mice. MPT64 Protegen ID: 815; NCBI Gene GI: 885925; NCBI Protein GI: 15609117; NCBI Protein Accession: NP_216496; NCBITaxon: 83332 VO:0012368 Allen Xiang Oliver He protein In a prophylactic vaccine model, immunization with the Mycobacterium tuberculosis protein ESAT-6 with LANAC adjuvant elicited significant protective immunity against aerosol challenge with virulent M. tuberculosis [PubMed: 16751377]. ESAT-6 Protegen ID: 816; NCBI Gene GI: 886209; NCBI Protein GI: 57117165; NCBI Protein Accession: YP_178023; NCBITaxon: 83332 VO:0012369 Allen Xiang Oliver He protein DNA vaccines encoding KatG antigen fused to TPA signal sequences evoked a significant protective response in mice aerogenically challenged with low doses of Mycobacterium tuberculosis Erdman 17 to 21 days after the final immunization [PubMed: 10456931]. KatG Protegen ID: 817; NCBI Gene GI: 885638; NCBI Protein GI: 15609045; NCBI Protein Accession: NP_216424; NCBITaxon: 83332 VO:0012370 Allen Xiang Oliver He protein Mice vaccinated with PstS-3 DNA demonstrated significant and sustained reduction in bacterial CFU numbers in spleen and lungs for 3 mo after M. tuberculosis challenge, as compared with CFU counts in mice vaccinated with control DNA [PubMed: 9916741]. PstS3 Protegen ID: 818; NCBI Gene GI: 885366; NCBI Protein GI: 57116798; NCBI Protein Accession: YP_177768; NCBITaxon: 83332 VO:0012371 Allen Xiang Oliver He protein A selection of previously identified protective Mycobacterium tuberculosis DNA vaccines were re-formulated as proteins and administered with a Th1-inducing adjuvant to help stimulate the relevant immune responses necessary for protection. One candidate (Rv1806-1807) induced protection in the guinea pig aerosol infection model 30 days post-challenge on the basis of reducing the bacterial burden of M. tuberculosis in the lungs [PubMed: 16520093]. PE20 Protegen ID: 819; NCBI Gene GI: 885537; NCBI Protein GI: 57116919; NCBI Protein Accession: YP_177843; NCBITaxon: 83332 VO:0012372 Allen Xiang Oliver He protein A selection of previously identified protective Mycobacterium tuberculosis DNA vaccines were re-formulated as proteins and administered with a Th1-inducing adjuvant to help stimulate the relevant immune responses necessary for protection. One candidate (Rv1806-1807) induced protection in the guinea pig aerosol infection model 30 days post-challenge on the basis of reducing the bacterial burden of M. tuberculosis in the lungs [PubMed: 16520093]. PPE31 Protegen ID: 820; NCBI Gene GI: 885072; NCBI Protein GI: 57116920; NCBI Protein Accession: YP_177653; NCBITaxon: 83332 VO:0012373 Allen Xiang Oliver He protein Purified preparations of HBHA were emulsified in a dimethyldioctadecylammonium bromide-monophosphoryl lipid A adjuvant and tested for the ability to reduce M. tuberculosis infection in the mouse aerosol challenge model for tuberculosis. The HBHA-containing vaccine gave a approximately 0.7-log reduction in CFU in both mouse lungs and spleens compared to adjuvant controls 28 days following challenge [PubMed: 15557600]. HBHA Protegen ID: 821; NCBI Gene GI: 5211814; NCBI Protein GI: 148660242; NCBI Protein Accession: YP_001281765; NCBITaxon: 25177 VO:0012374 Allen Xiang Oliver He protein immunization with the soluble recombinant rMTB41 protein plus adjuvant, a regimen known to generate primarily CD4+ T cells, resulted in induction of protection comparable to BCG in two well-established animal models of tuberculosis (mice and guinea pigs) [PubMed: 15917115]. PPE14 Protegen ID: 822; NCBI Gene GI: 885069; NCBI Protein GI: 57116795; NCBI Protein Accession: YP_177765; NCBITaxon: 83332 VO:0012375 Allen Xiang Oliver He protein GAPDH (Gap) associated with murine IL-12 gene in a DNA vaccine formulation partially protected mice against experimental infection [PubMed: 12171297]. Gap Protegen ID: 823; NCBI Gene GI: 3340207; NCBI Protein GI: 62290600; NCBI Protein Accession: YP_222393; NCBITaxon: 262698 VO:0012376 Allen Xiang Oliver He protein rHtrA was found to be very immunogenic and partially protective in both the passive infant rat model of bacteremia and the active chinchilla model of otitis media [PubMed: 9488373]. HtrA Protegen ID: 824; NCBI Protein GI: 2935168; NCBITaxon: 727 VO:0012377 Allen Xiang Oliver He protein Orogastric immunization of mice with recombinant H. pylori HspA proteins protected 80% of animals from a challenge dose of 10^4 Helicobacter felis bacteria [PubMed: 7604021]. HspA Protegen ID: 825; NCBI Protein GI: 712830; NCBITaxon: 210 VO:0012378 Allen Xiang Oliver He protein Orogastric immunization of mice with recombinant H. pylori HspB proteins protected 70% of animals from a challenge dose of 10^4 Helicobacter felis bacteria [PubMed: 7604021]. HspB from Helicobacter pylori Protegen ID: 826; NCBI Protein GI: 712831; NCBITaxon: 210 VO:0012379 Allen Xiang Oliver He protein Mice were immunised with the citrate synthase protein by intra-Peyer's patch immunisation. Pre-immunisation with the citrate synthase protein led to a 84-91% reduction in H. pylori infection compared to unimmunised controls [PubMed: 10378424]. GltA Protegen ID: 827; NCBI Protein GI: 2493711; NCBITaxon: 210 VO:0012380 Allen Xiang Oliver He protein Recombinant TbpA protein was used in a mouse intraperitoneal-infection model to determine their ability to protect against meningococcal infection and to induce cross-reactive and bactericidal antibodies. TbpA was found to afford protection against meningococcal challenge when administered as the sole immunogen [PubMed: 11179327]. TbpA Protegen ID: 833; NCBI Protein GI: 8926211; NCBITaxon: 487 VO:0012381 Allen Xiang Oliver He protein In chimpanzees (Pan troglodytes), the primates most closely related to humans and that share a similar susceptibility to P. falciparum liver-stage infection, immunization with LSA-3 induced protection against successive heterologous challenges with large numbers of P. falciparum sporozoites [PubMed: 11062538]. LSA-3 Protegen ID: 834; NCBI Gene GI: 812783; NCBI Protein GI: 124801463; NCBI Protein Accession: XP_001349701; NCBITaxon: 36329 VO:0012382 Allen Xiang Oliver He protein 1 of 3 Monkeys vaccinated with EBA-175 was protected from challenge of parasitized erythrocytes [PubMed: 11471569]. eba-175 Protegen ID: 835; NCBI Gene GI: 2654998; NCBI Protein GI: 296004911; NCBI Protein Accession: XP_001349207; NCBITaxon: 36329 VO:0012383 Allen Xiang Oliver He protein Immunization with rPhpA-79 protein adjuvanted with monophosphoryl lipid A (for subcutaneous immunization) or a mutant cholera toxin, CT-E29H (for intranasal immunization), protected CBA/N mice against death and bacteremia, as well as reduced nasopharyngeal colonization, following intranasal challenge with a heterologous pneumococcal strain [PubMed: 11349048]. phpA-79 Protegen ID: 836; NCBI Protein GI: 13447096; NCBITaxon: 32630 VO:0012384 Allen Xiang Oliver He protein Mice immunized with recombinant OspA protein were protected from challenge with Borrelia burgdorferi [PubMed: 8168958]. OspA Protegen ID: 838; NCBI Gene GI: 1194357; NCBI Protein GI: 11496927; NCBI Protein Accession: NP_045688; NCBITaxon: 224326 VO:0012385 Allen Xiang Oliver He protein Mice immunized with recombinant OspB protein were protected from challenge with Borrelia burgdorferi [PubMed: 8168958]. OspB Protegen ID: 839; NCBI Gene GI: 1194340; NCBI Protein GI: 11496910; NCBI Protein Accession: NP_045689; NCBITaxon: 224326 VO:0012386 Allen Xiang Oliver He protein Mice immunized with recombinant OspC protein were protected from challenge with Borrelia burgdorferi [PubMed: 8168958]. OspC Protegen ID: 840; NCBI Gene GI: 1194415; NCBI Protein GI: 11497024; NCBI Protein Accession: NP_047005; NCBITaxon: 224326 VO:0012387 Allen Xiang Oliver He protein Mice immunized with recombinant DbpA protein are protected against challenge with Borrelia burgdorferi [PubMed: 11035759]. DbpA Protegen ID: 841; NCBI Gene GI: 8319341; NCBI Protein GI: 256041910; NCBI Protein Accession: YP_003110629; NCBITaxon: 521009 VO:0012388 Allen Xiang Oliver He protein In an attempt to generate a subunit vaccine in this experimental disease model, eukaryotic plasmid DNA expression vectors containing genes encoding either the wild-type or modified forms of recombinant listeriolysin O (hly) were generated and used for genetic vaccination of naive mice. Results of these studies indicate that the intramuscular immunization of mice with specifically designed plasmid DNA constructs encoding recombinant forms of listeriolysin O (hly) stimulates peptide-specific CD8+ immune T cells that exhibit in vitro cytotoxic activity. More importantly, such immunization can provide protective immunity against a subsequent challenge with viable L. monocytogenes [PubMed: 10384131]. Hly Protegen ID: 842; NCBI Gene GI: 987033; NCBI Protein GI: 16802248; NCBI Protein Accession: NP_463733; NCBITaxon: 169963 VO:0012389 Allen Xiang Oliver He protein Mice were immunized with a recombinant fragment of CNA protein, and were then challenged with the S. aureus clinical isolate strain Phillips. At 14 d after inoculation, mortality in the collagen adhesin-vaccinated group was only 13%, compared with 87% in the control antigen immunized group [PubMed: 9637697]. CNA Protegen ID: 846; NCBI Nucleotide GI: 387879; NCBI Protein GI: 387880; NCBI Protein Accession: AAA20874.1; NCBITaxon: 1280 VO:0012390 Allen Xiang Oliver He protein Mice immunized with recombinant ClfA and challenged with S. aureus developed less-severe arthritis than did mice immunized with a control antigen [PubMed: 11740733]. ClfA Protegen ID: 847; NCBI Gene GI: 5330438; NCBI Protein GI: 151220968; NCBI Protein Accession: YP_001331790; NCBITaxon: 426430 VO:0012391 Allen Xiang Oliver He protein An internal region from the transpeptidase domain from the PBP2a (encoded by mecA) was cloned into a mammalian expression vector, to be used as DNA vaccine in a Murine model. After three sets of DNA vaccination, the immune response represented by antibodies against a fragment of PBP2a was evaluated by enzyme linked immunosorbent assay (ELISA), showing a significant antibody response. The antibacterial effect of the DNA vaccine was evaluated by intraperitoneal immunization and challenge with a sublethal dose of MRSA for 7 days in mice. After the challenge, the number of bacteria from kidneys from immunized and non-immunized mice were determined. Kidneys from immunized mice had 1000 times less on bacteria than the positive controls (non-immunized mice) [PubMed: 12744903]. MecA Protegen ID: 848; NCBI Gene GI: 2861157; NCBI Protein GI: 49482291; NCBI Protein Accession: YP_039515; NCBITaxon: 282458 VO:0012392 Allen Xiang Oliver He protein Mice were immunized with fusion proteins encompassing the fibronectin-binding domain of a staphylococcal fibronectin-binding protein (FnBP-A). Vaccination of mice with recombinant FnBP resulted in significant protection against challenge with S. aureus [PubMed: 7975852]. FnbA Protegen ID: 849; NCBI Protein GI: 120457; NCBITaxon: 93061 VO:0012393 Allen Xiang Oliver He protein Immunization of mice with recombinant BPS protein by the subcutaneous route produced an efficient antigen-specific response, and immunized animals survived challenge with a lethal dose of a virulent strain [PubMed: 11796614]. BPS Protegen ID: 850; NCBI Protein GI: 5327234; NCBITaxon: 1311 VO:0012394 Allen Xiang Oliver He protein Intranasal immunization of mice with either SfbI alone or coupled to cholera toxin B subunit (CTB) triggered efficient SfbI-specific humoral (mainly IgG) and lung mucosal (14% of total IgA) responses. SfbI-vaccinated animals showed 80% and 90% protection against homologous and heterologous challenge, respectively [PubMed: 10068585]. SfbI Protegen ID: 851; NCBI Nucleotide GI: 511149; NCBI Protein GI: 511150; NCBI Protein Accession: CAA48133.1; NCBITaxon: 1314 VO:0012395 Allen Xiang Oliver He protein Mice subcutaneously or orally immunized with FBP54 survived significantly longer following the challenge with S. pyogenes than did nonimmunized mice [PubMed: 11159987]. FBP54 Protegen ID: 852; NCBI Nucleotide GI: 496254; NCBITaxon: 1314 VO:0012396 Allen Xiang Oliver He protein Mice immunized with FbpA were protected from challenge with group A streptococcus [PubMed: 19254483]. FbaA Protegen ID: 853; NCBI Protein GI: 14915682; NCBITaxon: 1314 VO:0012397 Allen Xiang Oliver He protein Mice were intranasally immunized with diphtheria toxoid (DT) conjugated polypeptides encompassing a conformational-constrained B cell epitope of the M1 protein (J8). Vaccinated mice were challenged 10 days after the last boost by the intranasal route. Animals had 60% protection against challenge [PubMed: 16828529]. Emm1 Protegen ID: 854; NCBI Nucleotide GI: 311757; NCBI Protein GI: 311758; NCBI Protein Accession: CAA44062.1; NCBITaxon: 1314 VO:0012398 Allen Xiang Oliver He protein Immunization with Sib 35 enhanced survival rates in mice challenged with a GAS strain, while exhibiting no toxicity in hosts [PubMed: 15990202]. Sib35 Protegen ID: 855; NCBI Protein GI: 90567992; NCBITaxon: 342023 VO:0012399 Allen Xiang Oliver He protein Immunization with the recombinant GlpQ significantly protected rabbits from subsequent T. pallidum challenge, altering lesion development at the sites of challenge [PubMed: 9826352]. GlpQ Protegen ID: 856; NCBI Gene GI: 2611763; NCBI Protein GI: 15639249; NCBI Protein Accession: NP_218698; NCBITaxon: 243276 VO:0012400 Allen Xiang Oliver He protein Treponema pallidum-susceptible guinea pigs of strain C4D were immunized with recombinant T. pallidum antigen TmpB. Guinea pigs receiving TmpB antigen demonstrated protection expressed by the development of significantly (P less than 0.01) smaller, atypical lesions of significantly (P less than 0.01) shorter duration and devoid of or containing fewer T. pallidum organisms than lesions in the remaining immunized and control animals [PubMed: 1937794]. TmpB Protegen ID: 857; NCBI Gene GI: 2611387; NCBI Protein GI: 15639756; NCBI Protein Accession: NP_219206; NCBITaxon: 243276 VO:0012401 Allen Xiang Oliver He protein Immunization with recombinant Tp92 partially protected rabbits from subsequent T. pallidum challenge [PubMed: 10762571]. Tp92 Protegen ID: 858; NCBI Protein GI: 159158965; NCBITaxon: 243276 VO:0012402 Allen Xiang Oliver He protein Immunization with the recombinant Sip protein efficiently protected CD-1 mice against deadly challenges with six GBS strains of serotypes Ia/c, Ib, II/R, III, V, and VI [PubMed: 10992461]. Sip Protegen ID: 859; NCBI Gene GI: 3685788; NCBI Protein GI: 76788047; NCBI Protein Accession: YP_328758; NCBITaxon: 205921 VO:0012403 Allen Xiang Oliver He protein Vaccination of mice with the Rib protein protected against two strains of capsular type III and two strains of type II, and vaccination with the alpha protein protected against one strain of type II and one strain of type Ib [PubMed: 8751893]. Rib Protegen ID: 860; NCBI Protein GI: 1620648; NCBITaxon: 1311 VO:0012404 Allen Xiang Oliver He protein Mice immunized with p60 encapsulated in liposomes launched a strong CTL response and were protected against a subsequent challenge with L. monocytogenes [PubMed: 18433404]. p60 Protegen ID: 862; NCBI Protein GI: 215422507; NCBITaxon: 1639 VO:0012405 Allen Xiang Oliver He protein Mouse antiserum directed against the recombinant NucA protein was reactive on Western immunoblots and whole-cell ELISA with all H. influenzae strains tested including Eagan and was bactericidal for two heterologous strains tested. The antiserum also resulted in a log reduction in bacteremia, in an infant-rat protection study with H. influenzae type b as the challenge strain [PubMed: 10768940]. NucA Protegen ID: 863; NCBI Protein GI: 4929317; NCBITaxon: 727 VO:0012406 Allen Xiang Oliver He protein When chinchillas were immunized with recombinant P1 (rP1) obtained from one of these isolates (BCH-3), all animals developed antibodies specific for rP1. Immunized animals were protected against disease when challenged with BCH-3, but not with an ompP1 mutant of BCH-3 or a strain (BCH-2) possessing a heterologous P1 (91% identity). We conclude that (i) while P1 induces protection against NTHI-mediated otitis media, development of a polyvalent vaccine reflecting the variability of P1 would be necessary to construct an efficacious vaccine [PubMed: 10899849]. OmpP1 Protegen ID: 864; NCBI Protein GI: 9716645; NCBITaxon: 727 VO:0012407 Allen Xiang Oliver He protein Vaccination with the recombinant PstS-1 antigen and cholera toxin significantly protected against the challenge given 10 days later, but only marginally after 12 weeks [PubMed: 10869767]. PstS1 Protegen ID: 865; NCBI Gene GI: 885724; NCBI Protein GI: 57116801; NCBI Protein Accession: YP_177770; NCBITaxon: 83332 VO:0012408 Allen Xiang Oliver He protein In an ex vivo transfection approach with a retroviral vector a single antigen (hsp70) could evoke strong protection in mice [PubMed: 9234527]. DnaK from Mycobacterium tuberculosis Protegen ID: 866; NCBI Gene GI: 885946; NCBI Protein GI: 15607491; NCBI Protein Accession: NP_214864; NCBITaxon: 83332 VO:0012409 Allen Xiang Oliver He protein A single DNA vaccine encoding the MPT-83 tuberculosis antigens evoked partial protection against an aerogenic challenge with M. tuberculosis Erdman in the mouse model of pulmonary tuberculosis [PubMed: 10715531]. MPT83 Protegen ID: 867; NCBI Gene GI: 887155; NCBI Protein GI: 15610010; NCBI Protein Accession: NP_217389; NCBITaxon: 83332 VO:0015001 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/803365 803365 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML [Twinrix] 19131619 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Twinrix] VO:0015003 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/803371 803371 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Twinrix Hepatitis A Inactivated and Hepatitis B (Recombinant) Vaccine 1 ML Prefilled Syringe 19131622 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] VO:0015004 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/803367 803367 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Injection [Twinrix] Twinrix Hepatitis A inactivated and Hepatitis B (recombinant) Vaccine 1 ML Injection 19131620 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] VO:0015005 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657671 1657671 hepatitis A vaccine (inactivated) strain HM175 / hepatitis B surface antigen vaccine Injection [Twinrix] 46276305 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injection [Twinrix] VO:0015006 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/803370 803370 hepatitis A vaccine (inactivated) strain HM175 / hepatitis B surface antigen vaccine Prefilled Syringe [Twinrix] 40153071 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix] VO:0015008 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300468 1300468 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] ActHIB (purified capsular polysaccharide 10 MCG conjugated to inactivated tetanus toxoid 24 MCG) per 0.5 ML Injection 42800807 vaccine 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] VO:0015009 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300467 1300467 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML [ActHIB] 42800808 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML [ActHIB] VO:0015010 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658093 1658093 Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injection [ActHIB] 46275192 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injection [ActHIB] VO:0015011 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1169156 vaccine ActHIB Injectable Product VO:0015012 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300465 1300465 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML 42800805 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML VO:0015013 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300464 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine VO:0015014 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798279 798279 Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 529118 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine VO:0015015 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1300466 1300466 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection purified capsular polysaccharide 10 MCG conjugated to inactivated tetanus toxoid 24 MCG per 0.5 ML Injection 42800806 vaccine 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection VO:0015016 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658069 1658069 Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injection 46275176 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injection VO:0015017 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1160291 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Product VO:0015019 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1166419 vaccine Engerix-B Injectable Product VO:0015020 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658143 1658143 hepatitis B surface antigen vaccine Injection [Engerix-B] 46275230 vaccine Hepatitis B Surface Antigen Vaccine Injection [Engerix-B] VO:0015022 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1190916 1190916 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Tenivac] Tenivac (Diphtheria Toxoid Vaccine 2 UNT / Tetanus Toxoid Vaccine 5 UNT) per 0.5 ML Injection 40243772 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Tenivac] VO:0015023 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1190919 1190919 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Tenivac] Tenivac (Diphtheria and Tetanus Toxoid Vaccines) 0.5 ML Prefilled Syringe 40243219 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Tenivac] VO:0015024 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1190918 1190918 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Tenivac] 40243771 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Tenivac] VO:0015025 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657592 1657592 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tenivac] 46276278 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tenivac] VO:0015026 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1190914 vaccine Tenivac Injectable Product VO:0015027 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1190912 1190912 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Tenivac] 40243773 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Tenivac] VO:0015028 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1292427 1292427 varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML [Varivax] 42800032 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML [Varivax] VO:0015029 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1292459 1292459 0.5 ML varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] Varivax 1350 PFU per 0.5 ML Injection 42800031 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] VO:0015030 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1187569 vaccine Varivax Injectable Product VO:0015031 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658008 1658008 varicella-zoster virus vaccine live (Oka-Merck) strain Injection [Varivax] 46275139 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection [Varivax] VO:0015032 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798267 798267 L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML 529115 vaccine L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML VO:0015033 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597084 1597084 L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML 45892498 vaccine L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML VO:0015034 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597099 1597099 0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Injection [Gardasil 9] Gardasil 9, Human Papillomavirus 9-valent (Types 6,11,16,18,31,33,45,52,58) Vaccine, Recombinant 0.5 ML Injection 45892510 vaccine 0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Injection [Gardasil 9] VO:0015035 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597096 1597096 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML [Gardasil 9] 45892508 vaccine L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML [Gardasil 9] VO:0015036 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597103 1597103 0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9] Gardasil 9, human Papillomavirus 9-valent (types 6,11,16,18,31,33,45,52,58) vaccine, recombinant 0.5 ML Prefilled Syringe 45892514 vaccine 0.5 ML L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.08 MG/ML / L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9] VO:0015037 Khadeejah Khan Oliver He L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 31 Vaccine / L1 protein, Human papillomavirus type 33 Vaccine / L1 protein, Human papillomavirus type 45 Vaccine / L1 protein, Human papillomavirus type 52 Vaccine / L1 protein, Human papillomavirus type 58 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Injection [Gardasil 9] http://purl.bioontology.org/ontology/RXNORM/1656976 1656976 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine Injection [Gardasil 9] 46275947 vaccine Gardasil 9 injection VO:0015038 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597098 vaccine Gardasil 9 Injectable Product VO:0015039 Khadeejah Khan Oliver He L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 31 Vaccine / L1 protein, Human papillomavirus type 33 Vaccine / L1 protein, Human papillomavirus type 45 Vaccine / L1 protein, Human papillomavirus type 52 Vaccine / L1 protein, Human papillomavirus type 58 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Prefilled Syringe [Gardasil 9] http://purl.bioontology.org/ontology/RXNORM/1597102 1597102 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine Prefilled Syringe [Gardasil 9] 45892513 vaccine Gardasil 9 prefilled syringe VO:0015040 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798263 798263 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML 529077 vaccine L1 protein, Human papillomavirus type 11 Vaccine 0.08 MG/ML VO:0015041 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597083 1597083 L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML 45892497 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.12 MG/ML VO:0015042 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597085 1597085 L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML 45892499 vaccine L1 protein, Human papillomavirus type 31 Vaccine 0.04 MG/ML VO:0015043 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597086 1597086 L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML 45892500 vaccine L1 protein, Human papillomavirus type 33 Vaccine 0.04 MG/ML VO:0015044 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597087 1597087 L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML 45892501 vaccine L1 protein, Human papillomavirus type 45 Vaccine 0.04 MG/ML VO:0015045 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597088 1597088 L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML 45892502 vaccine L1 protein, Human papillomavirus type 52 Vaccine 0.04 MG/ML VO:0015046 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597089 1597089 L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML 45892503 vaccine L1 protein, Human papillomavirus type 58 Vaccine 0.04 MG/ML VO:0015047 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1597090 1597090 L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML 45892504 vaccine L1 protein, Human papillomavirus type 6 Vaccine 0.06 MG/ML VO:0015048 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804184 804184 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML [M-M-R II] 19131657 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML [M-M-R II] VO:0015049 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804186 804186 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection [M-M-R II] M-M-R II, Measles, Mumps, and Rubella Virus Vaccine Live 0.5 ML Injection 19131658 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injection [M-M-R II] VO:0015050 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658025 1658025 measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [M-M-R II] 46275150 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection [M-M-R II] VO:0015051 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1184336 vaccine M-M-R II Injectable Product VO:0015052 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804179 804179 measles virus vaccine live, Enders' attenuated Edmonston strain 532272 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain VO:0015053 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804180 804180 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML 19131654 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 UNT/ML VO:0015054 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762817 762817 rubella virus vaccine live (Wistar RA 27-3 strain) 523212 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) VO:0015055 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/762818 762818 rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML 523213 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML VO:0015056 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798372 798372 mumps virus vaccine live, Jeryl Lynn strain 529713 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain VO:0015057 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798373 798373 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML 529714 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML VO:0015058 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1156380 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain Injectable Product VO:0015059 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/798375 798375 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML Injectable Solution 529715 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 40000 UNT/ML Injectable Solution VO:0015060 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/804181 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 UNT/ML VO:0015061 A material entity of a drug based on their general physical form and how they are administered. Jie Zheng dose form group https://www.nlm.nih.gov/research/umls/rxnorm/docs/appendix3.html material entity drug dose form VO:0015062 Jie Zheng material entity injectable product VO:0015063 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797629 797629 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 528271 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine VO:0015064 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797630 797630 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML 19130326 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML VO:0015065 Jie Zheng material entity prefilled syringe VO:0015066 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797632 797632 Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML 528296 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML VO:0015067 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797631 797631 Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 528295 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine VO:0015068 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797636 797636 Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML 528322 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML VO:0015069 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797633 797633 Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 528297 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine VO:0015070 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797635 797635 Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 528301 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine VO:0015071 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/797634 797634 Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML 528298 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML VO:0015072 Jie Zheng material entity injectable suspension VO:0015073 Jie Zheng material entity injectable solution VO:0015074 Jie Zheng injection material entity injection form VO:0015075 Jie Zheng material entity intramuscular solution VO:0015076 Jie Zheng material entity drug package VO:0015077 An information content entity that specifies a family of drug products containing a specific active ingredient. Jie Zheng https://www.nlm.nih.gov/research/umls/rxnorm/docs/appendix5.html information content entity drug brand name VO:0015080 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658702 vaccine Fluzone 2015-2016 vaccine VO:0015081 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1658705 vaccine Fluzone 2015-2016 Injectable Product VO:0015084 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657128 1657128 influenza A virus (H1N1) antigen 46275993 vaccine component Influenza A virus (H1N1) antigen VO:0015085 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657131 1657131 influenza A virus (H3N2) antigen 46275996 vaccine component influenza A virus (H3N2) antigen VO:0015086 Khadeejah Khan Oliver He http://purl.bioontology.org/ontology/RXNORM/1657134 1657134 influenza B virus antigen 46275999 vaccine component influenza B virus antigen VO:0015087 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe 41409674 OMOP2607636 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe VO:0015088 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] 41409380 OMOP2607342 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] VO:0015089 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 41408038 OMOP2606000 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 VO:0015090 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Eurim-Pharm 41410014 OMOP2607976 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Eurim-Pharm VO:0015091 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Merck 44197058 OMOP3073781 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Merck VO:0015092 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Sanofi 41410199 OMOP2608161 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Sanofi VO:0015093 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe Box of 1 41408941 OMOP2606903 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe Box of 1 VO:0015094 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe 41408584 OMOP2606546 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe VO:0015095 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] 41408037 OMOP2605999 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] VO:0015096 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 1 41409188 OMOP2607150 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 1 VO:0015097 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 1 by Stada 41408331 OMOP2606293 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 1 by Stada VO:0015098 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 10 41407843 OMOP2605805 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 10 VO:0015099 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] 41407250 OMOP2605212 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] VO:0015100 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 1 41407433 OMOP2605395 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 1 VO:0015101 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 1 by Novartis 41407721 OMOP2605683 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 1 by Novartis VO:0015102 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 10 41409719 OMOP2607681 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 10 VO:0015103 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 1 41407988 OMOP2605950 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 1 VO:0015104 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 10 41408400 OMOP2606362 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 10 VO:0015105 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension 36896209 OMOP993468 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension VO:0015106 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] 43186889 OMOP506638 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] VO:0015107 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 43175985 OMOP506639 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 VO:0015108 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 by Glaxosmithkline 43164968 OMOP506640 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 by Glaxosmithkline VO:0015109 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension Box of 1 43197928 OMOP506637 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension Box of 1 VO:0015110 OHDSI Vaccine WG obsolete 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe true VO:0015111 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 41409720 OMOP2607682 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 VO:0015112 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Aca Mueller 41409056 OMOP2607018 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Aca Mueller VO:0015113 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Axicorp 41407720 OMOP2605682 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Axicorp VO:0015114 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Cc 41407719 OMOP2605681 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Cc VO:0015115 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Emra-Med 41408516 OMOP2606478 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Emra-Med VO:0015116 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Eurim-Pharm 41407514 OMOP2605476 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Eurim-Pharm VO:0015117 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by European 44197023 OMOP3073746 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by European VO:0015118 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Gerke 41410013 OMOP2607975 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Gerke VO:0015119 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Kohlpharma 41410198 OMOP2608160 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Kohlpharma VO:0015120 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Orifarm Leverkus 41409809 OMOP2607771 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Orifarm Leverkus VO:0015121 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 1 41407378 OMOP2605340 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 1 VO:0015122 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution 41409328 OMOP2607290 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution VO:0015123 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] 41407249 OMOP2605211 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] VO:0015124 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] Box of 1 41407842 OMOP2605804 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] Box of 1 VO:0015125 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution Box of 1 41408583 OMOP2606545 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution Box of 1 VO:0015126 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe 41407171 OMOP2605133 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe VO:0015127 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] 41408259 OMOP2606221 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] VO:0015128 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 1 41408982 OMOP2606944 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 1 VO:0015129 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 1 by Kohlpharma 41408872 OMOP2606834 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 1 by Kohlpharma VO:0015130 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 10 41408258 OMOP2606220 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 10 VO:0015131 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 1 41407590 OMOP2605552 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 1 VO:0015132 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 10 41407379 OMOP2605341 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 10 VO:0015133 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution 41408401 OMOP2606363 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution VO:0015134 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] 41409539 OMOP2607501 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] VO:0015135 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 41408614 OMOP2606576 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 VO:0015136 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Merck 44197151 OMOP3073874 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Merck VO:0015137 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Sanofi 41407722 OMOP2605684 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Sanofi VO:0015138 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 1 41409673 OMOP2607635 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 1 VO:0015139 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe 41409329 OMOP2607291 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe VO:0015140 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] 41409934 OMOP2607896 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] VO:0015141 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 41407633 OMOP2605595 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 VO:0015142 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Merck 44197097 OMOP3073820 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Merck VO:0015143 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Sanofi 41409443 OMOP2607405 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Sanofi VO:0015144 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 1 41408940 OMOP2606902 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 1 VO:0015145 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution 44132744 OMOP1127375 vaccine 0.5 ML Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution VO:0015146 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Vivaxim] 44132582 OMOP1127213 vaccine 0.5 ML Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Vivaxim] VO:0015147 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Vivaxim] by Sanofi 44132768 OMOP1127399 vaccine 0.5 ML Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Vivaxim] by Sanofi VO:0015148 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe 41328809 OMOP2526771 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe VO:0015149 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] 41328994 OMOP2526956 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] VO:0015150 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 41335037 OMOP2532999 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 VO:0015151 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Aca Mueller 41329315 OMOP2527277 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Aca Mueller VO:0015152 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Cc 41327395 OMOP2525357 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Cc VO:0015153 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Emra-Med 41330622 OMOP2528584 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Emra-Med VO:0015154 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Eurim-Pharm 41330621 OMOP2528583 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Eurim-Pharm VO:0015155 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by European 44189948 OMOP3066671 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by European VO:0015156 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Gerke 41335374 OMOP2533336 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Gerke VO:0015157 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Haematogmbh 41336045 OMOP2534007 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Haematogmbh VO:0015158 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Kohlpharma 41329314 OMOP2527276 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Kohlpharma VO:0015159 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Mevita 41331956 OMOP2529918 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Mevita VO:0015160 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Mtk 41328658 OMOP2526620 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Mtk VO:0015161 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by MZG 41336716 OMOP2534678 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by MZG VO:0015162 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Orifarm Leverkus 41331286 OMOP2529248 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Orifarm Leverkus VO:0015163 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Veron 41328657 OMOP2526619 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Veron VO:0015164 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 41328363 OMOP2526325 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 VO:0015165 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Cc 41328656 OMOP2526618 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Cc VO:0015166 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Emra-Med 41337974 OMOP2535936 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Emra-Med VO:0015167 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Eurim-Pharm 41329996 OMOP2527958 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Eurim-Pharm VO:0015168 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Gerke 41337348 OMOP2535310 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Gerke VO:0015169 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Kohlpharma 41334687 OMOP2532649 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Kohlpharma VO:0015170 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Mevita 41330620 OMOP2528582 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Mevita VO:0015171 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by MZG 41330619 OMOP2528581 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by MZG VO:0015172 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Orifarm Leverkus 41327469 OMOP2525431 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Orifarm Leverkus VO:0015173 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Veron 41334686 OMOP2532648 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Veron VO:0015174 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 1 41337516 OMOP2535478 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 1 VO:0015175 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 10 41327509 OMOP2525471 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 10 VO:0015176 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension 43806383 OMOP740525 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension VO:0015177 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] 43842623 OMOP740526 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] VO:0015178 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] by Glaxosmithkline 43590563 OMOP740527 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] by Glaxosmithkline VO:0015179 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension 43626501 OMOP740542 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension VO:0015180 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] 43608544 OMOP740546 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] VO:0015181 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 10 43842625 OMOP740548 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 10 VO:0015182 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 10 by Glaxosmithkline 43716436 OMOP740549 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 10 by Glaxosmithkline VO:0015183 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 20 43842626 OMOP740550 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 20 VO:0015184 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 20 by Glaxosmithkline 43644718 OMOP740552 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 20 by Glaxosmithkline VO:0015185 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 50 43824551 OMOP740553 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 50 VO:0015186 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 50 by Glaxosmithkline 43824552 OMOP740554 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 50 by Glaxosmithkline VO:0015187 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] by Glaxosmithkline 43590565 OMOP740547 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] by Glaxosmithkline VO:0015188 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 10 43752452 OMOP740543 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 10 VO:0015189 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 20 43734588 OMOP740544 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 20 VO:0015190 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 50 43698682 OMOP740545 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 50 VO:0015191 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension 36895104 OMOP1003501 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension VO:0015192 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] 36895114 OMOP1005714 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] VO:0015193 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 43207318 OMOP507724 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 VO:0015194 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 by Glaxosmithkline 43163567 OMOP507725 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 by Glaxosmithkline VO:0015195 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension Box of 1 43141360 OMOP507723 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension Box of 1 VO:0015196 OHDSI Vaccine WG obsolete 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe true VO:0015197 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 41333720 OMOP2531682 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 VO:0015198 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Axicorp 41333335 OMOP2531297 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Axicorp VO:0015199 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Mtk 41335373 OMOP2533335 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 by Mtk VO:0015200 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 41335736 OMOP2533698 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 VO:0015201 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Aca Mueller 41329994 OMOP2527956 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Aca Mueller VO:0015202 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Axicorp 41334018 OMOP2531980 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Axicorp VO:0015203 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Haematogmbh 41327455 OMOP2525417 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 by Haematogmbh VO:0015204 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 1 41337515 OMOP2535477 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 1 VO:0015205 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 10 41337514 OMOP2535476 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 10 VO:0015206 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution 41332122 OMOP2530084 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution VO:0015207 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] 41332317 OMOP2530279 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] VO:0015208 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 41336410 OMOP2534372 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 VO:0015209 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Merck 44190062 OMOP3066785 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Merck VO:0015210 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Sanofi 41336714 OMOP2534676 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 by Sanofi VO:0015211 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 41327699 OMOP2525661 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 VO:0015212 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 by Merck 44189841 OMOP3066564 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 by Merck VO:0015213 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 by Sanofi 41334685 OMOP2532647 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 by Sanofi VO:0015214 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 1 41334866 OMOP2532828 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 1 VO:0015215 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 10 41336199 OMOP2534161 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 10 VO:0015216 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe 41332123 OMOP2530085 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe VO:0015217 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] 41329692 OMOP2527654 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] VO:0015218 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 41336411 OMOP2534373 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 VO:0015219 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Emra-Med 41331285 OMOP2529247 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Emra-Med VO:0015220 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Eurim-Pharm 41332650 OMOP2530612 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Eurim-Pharm VO:0015221 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Kohlpharma 41329995 OMOP2527957 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Kohlpharma VO:0015222 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Merck 44189756 OMOP3066479 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Merck VO:0015223 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Sanofi 41333336 OMOP2531298 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 by Sanofi VO:0015224 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 41331656 OMOP2529618 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 VO:0015225 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 by Merck 44189364 OMOP3066087 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 by Merck VO:0015226 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 by Sanofi 41336715 OMOP2534677 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 by Sanofi VO:0015227 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 1 41328808 OMOP2526770 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 1 VO:0015228 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 10 41336200 OMOP2534162 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 10 VO:0015229 OHDSI Vaccine WG 1 ML Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection 43269673 OMOP560886 vaccine 1 ML Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection VO:0015230 OHDSI Vaccine WG 1 ML Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection [Vivaxim] 43264199 OMOP560887 vaccine 1 ML Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection [Vivaxim] VO:0015231 Jie Zheng Xingxian Li vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain VO:0015232 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension 43768855 OMOP707745 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension VO:0015233 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension [Hepatyrix] 43624842 OMOP707746 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension [Hepatyrix] VO:0015234 OHDSI Vaccine WG hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM] 36950482 OMOP5204511 vaccine hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM] VO:0015235 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML 40857357 OMOP2055319 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML VO:0015236 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML [Havrix] 40827674 OMOP2025636 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML [Havrix] VO:0015237 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe 40864917 OMOP2062879 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe VO:0015238 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] 40963890 OMOP2161852 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] VO:0015239 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 41120165 OMOP2318127 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 1 VO:0015240 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 41214131 OMOP2412093 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe [Havrix] Box of 10 VO:0015241 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 1 41239597 OMOP2437559 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 1 VO:0015242 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 10 40989652 OMOP2187614 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1.44 UNT/ML Prefilled Syringe Box of 10 VO:0015243 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML 41262913 OMOP2460875 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML VO:0015244 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML [Vaqta] 41264522 OMOP2462484 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML [Vaqta] VO:0015245 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe 41083410 OMOP2281372 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe VO:0015246 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] 41245068 OMOP2443030 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] VO:0015247 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 40995169 OMOP2193131 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe [Vaqta] Box of 1 VO:0015248 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe Box of 1 41208656 OMOP2406618 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 100 UNT/ML Prefilled Syringe Box of 1 VO:0015249 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML 41201115 OMOP2399077 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML VO:0015250 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML [Epaxal] 40890269 OMOP2088231 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML [Epaxal] VO:0015251 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML [Havpur] 41264521 OMOP2462483 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML [Havpur] VO:0015252 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe 40958366 OMOP2156328 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe VO:0015253 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] 40963889 OMOP2161851 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] VO:0015254 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 1 41307116 OMOP2505078 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 1 VO:0015255 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 10 41276028 OMOP2473990 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Epaxal] Box of 10 VO:0015256 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] 41214129 OMOP2412091 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] VO:0015257 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 1 40932646 OMOP2130608 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 1 VO:0015258 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 10 41245067 OMOP2443029 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe [Havpur] Box of 10 VO:0015259 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 1 41146207 OMOP2344169 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 1 VO:0015260 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 10 41301537 OMOP2499499 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1000 UNT/ML Prefilled Syringe Box of 10 VO:0015261 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML 43841039 OMOP707842 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML VO:0015262 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML [Hepatyrix] 43841040 OMOP707843 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML [Hepatyrix] VO:0015263 Jie Zheng Xingxian Li vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML VO:0015264 Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML [Hepatyrix] 43661216 OMOP707747 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML [Hepatyrix] VO:0015265 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension 43786823 OMOP707748 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension VO:0015266 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] 43859161 OMOP707749 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] VO:0015267 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension 43643097 OMOP707844 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension VO:0015268 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] 43624848 OMOP707848 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] VO:0015269 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 10 43643098 OMOP707849 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 10 VO:0015270 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 20 43696997 OMOP707850 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 20 VO:0015271 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 50 43822934 OMOP707852 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension [Hepatyrix] Box of 50 VO:0015272 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 10 43732941 OMOP707845 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 10 VO:0015273 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 20 43714920 OMOP707846 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 20 VO:0015274 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 50 43768860 OMOP707847 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 CELLS/ML Injectable Suspension Box of 50 VO:0015275 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension 36892618 OMOP992628 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension VO:0015276 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] 36889945 OMOP990694 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] VO:0015277 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 43133965 OMOP432651 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension [Havrix] Box of 1 VO:0015278 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension Box of 1 43156100 OMOP432650 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Injectable Suspension Box of 1 VO:0015279 OHDSI Vaccine WG vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe VO:0015280 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 41182815 OMOP2380777 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 1 VO:0015281 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 41214130 OMOP2412092 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] Box of 10 VO:0015282 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 1 41301539 OMOP2499501 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 1 VO:0015283 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 10 41301538 OMOP2499500 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML Prefilled Syringe Box of 10 VO:0015284 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML 41138603 OMOP2336565 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML VO:0015285 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML [Vaqta] 41014781 OMOP2212743 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML [Vaqta] VO:0015286 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution 41208655 OMOP2406617 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution VO:0015287 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] 41151744 OMOP2349706 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] VO:0015288 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] Box of 1 41214128 OMOP2412090 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution [Vaqta] Box of 1 VO:0015289 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution Box of 1 41301536 OMOP2499498 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 25000 UNT/ML Injectable Solution Box of 1 VO:0015290 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML 41232175 OMOP2430137 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML VO:0015291 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML [Epaxal] 41014782 OMOP2212744 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML [Epaxal] VO:0015292 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe 40927098 OMOP2125060 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe VO:0015293 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] 40870458 OMOP2068420 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] VO:0015294 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 1 40995168 OMOP2193130 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 1 VO:0015295 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 10 40932647 OMOP2130609 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe [Epaxal] Box of 10 VO:0015296 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 1 40864915 OMOP2062877 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 1 VO:0015297 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 10 40833778 OMOP2031740 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 48 UNT/ML Prefilled Syringe Box of 10 VO:0015298 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML 41201116 OMOP2399078 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML VO:0015299 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML [Vaqta] 40827673 OMOP2025635 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML [Vaqta] VO:0015300 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution 41051818 OMOP2249780 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution VO:0015301 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] 41057408 OMOP2255370 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] VO:0015302 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 41276029 OMOP2473991 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 1 VO:0015303 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 41088927 OMOP2286889 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution [Vaqta] Box of 10 VO:0015304 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 1 40927099 OMOP2125061 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 1 VO:0015305 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 10 41083408 OMOP2281370 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Injectable Solution Box of 10 VO:0015306 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe 41301540 OMOP2499502 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe VO:0015307 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] 41307117 OMOP2505079 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] VO:0015308 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 40870459 OMOP2068421 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 1 VO:0015309 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 41182816 OMOP2380778 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe [Vaqta] Box of 10 VO:0015310 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 1 40864916 OMOP2062878 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 1 VO:0015311 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 10 41083409 OMOP2281371 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 50 UNT/ML Prefilled Syringe Box of 10 VO:0015312 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Solution 41173771 OMOP2371733 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Solution VO:0015313 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Solution [Hav Sorbat Ssw] 40862428 OMOP2060390 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Solution [Hav Sorbat Ssw] VO:0015314 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Solution [Vaqta] 40862427 OMOP2060389 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Solution [Vaqta] VO:0015315 OHDSI Vaccine WG 798363 hepatitis A vaccine (inactivated) strain HM175 Injectable Suspension 40150661 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension VO:0015316 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension [Hav Sorbat Ssw] 40831214 OMOP2029176 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension [Hav Sorbat Ssw] VO:0015317 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension [Havrix] 36886628 OMOP993889 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension [Havrix] VO:0015318 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension [Hepatyrix] 43786831 OMOP707841 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Injectable Suspension [Hepatyrix] VO:0015319 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe [Epaxal] 40893624 OMOP2091586 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe [Epaxal] VO:0015320 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe [Havpur] 40955887 OMOP2153849 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe [Havpur] VO:0015321 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe [Vaqta] 40987117 OMOP2185079 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 Prefilled Syringe [Vaqta] VO:0015322 Jie Zheng Xingxian Li vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain VO:0015323 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension 40749995 OMOP4707291 vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension VO:0015324 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM] 40749994 OMOP4707292 vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM] VO:0015325 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution 44068849 OMOP1063480 vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution VO:0015326 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution [Vivaxim] 44025224 OMOP1019855 vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution [Vivaxim] VO:0015327 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Prefilled Syringe 36421621 OMOP4763902 vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Prefilled Syringe VO:0015328 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Prefilled Syringe [ViATIM] 36421620 OMOP4763901 vaccine Hepatitis A Vaccine, Inactivated / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Prefilled Syringe [ViATIM] VO:0015329 Jie Zheng Xingxian Li vaccine Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML VO:0015330 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Vivaxim] 44093231 OMOP1087862 vaccine Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Vivaxim] VO:0015331 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution 44110125 OMOP1104756 vaccine Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution VO:0015332 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Vivaxim] 44060599 OMOP1055230 vaccine Hepatitis A Vaccine, Inactivated 320 UNT/ML / Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Vivaxim] VO:0015333 OHDSI Vaccine WG Hepatitis A Virus / Salmonella Typhi Inactivated Antigen Injection 43275040 OMOP558176 vaccine Hepatitis A Virus / Salmonella Typhi Inactivated Antigen Injection VO:0015334 OHDSI Vaccine WG Hepatitis A Virus / Salmonella Typhi Inactivated Antigen Injection [Vivaxim] 43275041 OMOP558177 vaccine Hepatitis A Virus / Salmonella Typhi Inactivated Antigen Injection [Vivaxim] VO:0015335 OHDSI Vaccine WG hepatitis A virus / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension 36065570 OMOP4991908 vaccine hepatitis A virus / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension VO:0015336 OHDSI Vaccine WG hepatitis A virus / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM] 36065569 OMOP4991907 vaccine hepatitis A virus / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM] VO:0015337 Jie Zheng Xingxian Li vaccine Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML VO:0015338 OHDSI Vaccine WG Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML [Vivaxim] 43258581 OMOP558178 vaccine Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML [Vivaxim] VO:0015339 OHDSI Vaccine WG Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection 43264016 OMOP558179 vaccine Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection VO:0015340 OHDSI Vaccine WG Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection [Vivaxim] 43285829 OMOP558180 vaccine Hepatitis A Virus 160 UNT/ML / Salmonella Typhi Inactivated Antigen 0.025 MG/ML Injection [Vivaxim] VO:0015471 protein Plasmodium falciparum protein VO:0015472 protein Plasmodium knowlesi protein VO:0015473 protein Plasmodium vivax protein VO:0015474 protein Plasmodium yoelii protein VO:0015475 protein Plasmodium berghei protein VO:0015476 protein Plasmodium chabaudi protein VO:0015478 protein Leishmania protein VO:0015483 Anthony Huffman protein Giardia lamblia protein VO:0015484 OHDSI Vaccine WG Neisseria meningitidis Group B Membrane vesicles External Omv 36878723 OMOP990054 vaccine component Neisseria meningitidis Group B Membrane vesicles External Omv VO:0015485 OHDSI Vaccine WG 830258 0.5 ML hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe 0.5 ML hepatitis B surface antigen vaccine 0.0005 % Prefilled Syringe 19133383 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe VO:0015486 OHDSI Vaccine WG 2050057 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe hepatitis B surface antigen vaccine 0.04 MG/ML per 0.5 ML Prefilled Syringe 35201908 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe VO:0015487 Xingxian Li vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe VO:0015488 OHDSI Vaccine WG Neisseria meningitidis Recombinant Fusion Protein Fhbp Group B 36878793 OMOP999022 vaccine component Neisseria meningitidis Recombinant Fusion Protein Fhbp Group B VO:0015489 OHDSI Vaccine WG 1359950 hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe 42902837 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe VO:0015490 OHDSI Vaccine WG 1658151 hepatitis B surface antigen vaccine 0.01 MG/ML Injection 46275238 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection VO:0015491 OHDSI Vaccine WG 1360366 hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe 42903253 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe VO:0015492 OHDSI Vaccine WG 562127 hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Solution 568231 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution VO:0015493 OHDSI Vaccine WG 798421 hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension 528325 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension VO:0015494 OHDSI Vaccine WG 1658145 hepatitis B surface antigen vaccine 0.02 MG/ML Injection 46275232 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection VO:0015495 OHDSI Vaccine WG 1658146 hepatitis B surface antigen vaccine 0.02 MG/ML Injection [Engerix-B] Engerix-B 0.02 MG/ML Injection 46275233 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] VO:0015496 OHDSI Vaccine WG 1359874 hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe 42902761 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe VO:0015497 OHDSI Vaccine WG 1360290 hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] 42903177 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] VO:0015498 OHDSI Vaccine WG 1657685 hepatitis B surface antigen vaccine 0.04 MG/ML Injection 46276310 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection VO:0015499 OHDSI Vaccine WG 2050060 hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe 35200004 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe VO:0015500 OHDSI Vaccine WG 372385 hepatitis B surface antigen vaccine Injectable Solution 40047709 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution VO:0015501 OHDSI Vaccine WG 2588234 hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML 1758555 vaccine hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML VO:0015502 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.001 MG/ML [HBvaxPRO] 41295612 OMOP2493574 vaccine Hepatitis B Surface Antigen Vaccine 0.001 MG/ML [HBvaxPRO] VO:0015503 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML [H B Vax] 40827671 OMOP2025633 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML [H B Vax] VO:0015504 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML [HBvaxPRO] 41014780 OMOP2212742 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML [HBvaxPRO] VO:0015505 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML [Hevac B] 41264520 OMOP2462482 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML [Hevac B] VO:0015506 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [Gen Vax] 40827672 OMOP2025634 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [Gen Vax] VO:0015507 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [H B Vax] 40824153 OMOP2022115 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [H B Vax] VO:0015508 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [H-B-Vax II] 43275042 OMOP558190 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [H-B-Vax II] VO:0015509 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [HBvaxPRO] 21169357 OMOP345331 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML [HBvaxPRO] VO:0015510 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Engerix B] 21051479 OMOP345312 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Engerix B] VO:0015511 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Gemvites] 40983561 OMOP2181523 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Gemvites] VO:0015512 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [H B Vax] 41295613 OMOP2493575 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [H B Vax] VO:0015513 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Hepasorbat] 44168181 OMOP3044904 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Hepasorbat] VO:0015514 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Lt Grk] 41140111 OMOP2338073 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Lt Grk] VO:0015515 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Fendrix] 21022028 OMOP345322 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Fendrix] VO:0015516 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Gen Vax] 41295614 OMOP2493576 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Gen Vax] VO:0015517 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [H-B-Vax II] 43296589 OMOP558182 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [H-B-Vax II] VO:0015518 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [HBvaxPRO] 21061267 OMOP345321 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [HBvaxPRO] VO:0015519 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [VACCIN GENHEVAC B] 43172255 OMOP486134 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [VACCIN GENHEVAC B] VO:0015520 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML [Engerix B] 43606937 OMOP707800 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML [Engerix B] VO:0015521 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Intramuscular Solution [Recombivax] 44044125 OMOP1038756 vaccine Hepatitis B Surface Antigen Vaccine Intramuscular Solution [Recombivax] VO:0015522 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Injectable Suspension [Engerix B] 43588889 OMOP707797 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Injectable Suspension [Engerix B] VO:0015523 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.001 MG/ML 40919653 OMOP2117615 vaccine Hepatitis B Surface Antigen Vaccine 0.001 MG/ML VO:0015524 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML 43768858 OMOP707798 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML VO:0015525 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Intramuscular Solution 44055862 OMOP1050493 vaccine Hepatitis B Surface Antigen Vaccine Intramuscular Solution VO:0015526 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Injectable Suspension 43786829 OMOP707795 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN Injectable Suspension VO:0015527 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Intramuscular Solution [Recombivax] 44125210 OMOP1119841 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Intramuscular Solution [Recombivax] VO:0015528 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] 43588891 OMOP707810 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] VO:0015529 OHDSI Vaccine WG Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injectable Solution [Procomvax] 40831215 OMOP2029177 vaccine Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injectable Solution [Procomvax] VO:0015530 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Bimmugen] 35130652 OMOP4787901 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Bimmugen] VO:0015531 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Engerix B] 41206223 OMOP2404185 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Engerix B] VO:0015532 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Fendrix] 35774853 OMOP2776314 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Fendrix] VO:0015533 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Gemvites] 41174633 OMOP2372595 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Gemvites] VO:0015534 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Gen Vax] 41143678 OMOP2341640 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Gen Vax] VO:0015535 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [H B Vax] 41112118 OMOP2310080 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [H B Vax] VO:0015536 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [HBvaxPRO] 41174632 OMOP2372594 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [HBvaxPRO] VO:0015537 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Hepasorbat] 41112117 OMOP2310079 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Hepasorbat] VO:0015538 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Solution [Heptavax] 35159779 OMOP4816762 vaccine Hepatitis B Surface Antigen Vaccine Injectable Solution [Heptavax] VO:0015539 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Suspension [Engerix B] 41080815 OMOP2278777 vaccine Hepatitis B Surface Antigen Vaccine Injectable Suspension [Engerix B] VO:0015540 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Suspension [Engerix-B] 36885649 OMOP991609 vaccine Hepatitis B Surface Antigen Vaccine Injectable Suspension [Engerix-B] VO:0015541 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Suspension [Fendrix] 36264542 OMOP3115417 vaccine Hepatitis B Surface Antigen Vaccine Injectable Suspension [Fendrix] VO:0015542 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Suspension [HBvaxPRO] 36891548 OMOP1004210 vaccine Hepatitis B Surface Antigen Vaccine Injectable Suspension [HBvaxPRO] VO:0015543 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injectable Suspension [VACCIN GENHEVAC B] 43205170 OMOP486133 vaccine Hepatitis B Surface Antigen Vaccine Injectable Suspension [VACCIN GENHEVAC B] VO:0015544 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Injection [H-B-Vax II] 43291185 OMOP558181 vaccine Hepatitis B Surface Antigen Vaccine Injection [H-B-Vax II] VO:0015545 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix B] 21080893 OMOP345308 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix B] VO:0015546 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Fendrix] 21100587 OMOP345310 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Fendrix] VO:0015547 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Gen Vax] 41206224 OMOP2404186 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Gen Vax] VO:0015548 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [H B Vax] 40831213 OMOP2029175 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [H B Vax] VO:0015549 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [HBvaxPRO] 21071201 OMOP345309 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [HBvaxPRO] VO:0015550 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Hepasorbat] 40831212 OMOP2029174 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Hepasorbat] VO:0015551 OHDSI Vaccine WG hepatitis B surface antigen vaccine Prefilled Syringe [Heptavax] 35830517 OMOP5038158 vaccine hepatitis B surface antigen vaccine Prefilled Syringe [Heptavax] VO:0015552 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Hevac B] 40955886 OMOP2153848 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Hevac B] VO:0015553 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Lt Grk] 40831211 OMOP2029173 vaccine Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Lt Grk] VO:0015554 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Intramuscular Solution 44123292 OMOP1117923 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Intramuscular Solution VO:0015555 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension 43661224 OMOP707802 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension VO:0015556 OHDSI Vaccine WG Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injectable Solution 41142747 OMOP2340709 vaccine Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injectable Solution VO:0015557 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] 43791869 OMOP719101 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] VO:0015558 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] 43698681 OMOP740533 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] VO:0015559 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension 43612078 OMOP719096 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension VO:0015560 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension 43662811 OMOP740528 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension VO:0015561 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] 41276025 OMOP2473987 vaccine Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015562 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] 40839335 OMOP2037297 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] VO:0015563 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] 41088923 OMOP2286885 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] VO:0015564 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] 40995166 OMOP2193128 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] VO:0015565 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] 41088926 OMOP2286888 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] VO:0015566 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] 41026225 OMOP2224187 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] VO:0015567 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] 36890932 OMOP995062 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] VO:0015568 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] 43296591 OMOP558192 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] VO:0015569 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] 40963888 OMOP2161850 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] VO:0015570 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] 41182814 OMOP2380776 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] VO:0015571 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] 21031763 OMOP345336 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015572 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] 41088921 OMOP2286883 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] VO:0015573 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] 41182809 OMOP2380771 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] VO:0015574 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] 40963885 OMOP2161847 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] VO:0015575 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] 44172899 OMOP3049622 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] VO:0015576 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] 41088920 OMOP2286882 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] VO:0015577 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] 36893891 OMOP997914 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] VO:0015578 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] 21022026 OMOP345317 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] VO:0015579 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] 40995163 OMOP2193125 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] VO:0015580 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] 35754700 OMOP2756161 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] VO:0015581 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] 41214124 OMOP2412086 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] VO:0015582 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] 40870453 OMOP2068415 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] VO:0015583 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] 36257850 OMOP3108725 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] VO:0015584 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] 36894832 OMOP996363 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] VO:0015585 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] 43161319 OMOP486136 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] VO:0015586 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [H-B-Vax II] 43280341 OMOP558184 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [H-B-Vax II] VO:0015587 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] 21169356 OMOP345328 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] VO:0015588 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] 21022029 OMOP345326 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015589 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 43606938 OMOP707813 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 VO:0015590 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 43786830 OMOP707814 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 VO:0015591 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 43679180 OMOP707811 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 VO:0015592 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 50 43679181 OMOP707815 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 50 VO:0015593 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe 40989650 OMOP2187612 vaccine Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe VO:0015594 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution 41177148 OMOP2375110 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution VO:0015595 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution 41020607 OMOP2218569 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution VO:0015596 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension 36887647 OMOP994581 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension VO:0015597 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution 40896130 OMOP2094092 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution VO:0015598 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension 36883802 OMOP1006583 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension VO:0015599 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 10 43643094 OMOP707804 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 10 VO:0015600 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 25 43804820 OMOP707805 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 25 VO:0015601 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 3 43859162 OMOP707803 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 3 VO:0015602 OHDSI Vaccine WG HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 50 43588890 OMOP707806 vaccine HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 50 VO:0015603 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline 43702260 OMOP719102 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline VO:0015604 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline 43842624 OMOP740534 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline VO:0015605 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Intramuscular Solution [Recombivax] by Merck 44037315 OMOP1031946 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Intramuscular Solution [Recombivax] by Merck VO:0015606 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 43756057 OMOP719106 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 VO:0015607 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 43684258 OMOP719108 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 VO:0015608 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 43630191 OMOP719103 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 VO:0015609 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 50 43719976 OMOP719110 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 50 VO:0015610 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 43806384 OMOP740535 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 VO:0015611 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 43860794 OMOP740537 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 VO:0015612 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] 41409718 OMOP2607680 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] VO:0015613 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] 41408036 OMOP2605998 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] VO:0015614 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] 41408027 OMOP2605989 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] VO:0015615 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] 36896187 OMOP1002121 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] VO:0015616 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] 43292061 OMOP559834 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] VO:0015617 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] 41409378 OMOP2607340 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] VO:0015618 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] 41408035 OMOP2605997 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] VO:0015619 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] 21039542 OMOP286592 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015620 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] 41407429 OMOP2605391 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] VO:0015621 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] 41407838 OMOP2605800 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] VO:0015622 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] 41408253 OMOP2606215 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] VO:0015623 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] 36896201 OMOP989536 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] VO:0015624 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] 21176995 OMOP286577 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] VO:0015625 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] 35785563 OMOP2787024 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] VO:0015626 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] 36281161 OMOP3132036 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] VO:0015627 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] 43153999 OMOP507046 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] VO:0015628 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] 21098435 OMOP286584 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] VO:0015629 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] 41334369 OMOP2532331 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] VO:0015630 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] 41335034 OMOP2532996 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] VO:0015631 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] 41329690 OMOP2527652 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] VO:0015632 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] 41330334 OMOP2528296 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] VO:0015633 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] 36895171 OMOP998444 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] VO:0015634 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] 43269674 OMOP560894 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] VO:0015635 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] 41333717 OMOP2531679 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] VO:0015636 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] 41331655 OMOP2529617 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] VO:0015637 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] 21135958 OMOP290989 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015638 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] 41336404 OMOP2534366 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] VO:0015639 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] 41333716 OMOP2531678 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] VO:0015640 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] 41336407 OMOP2534369 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] VO:0015641 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] 44189514 OMOP3066237 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] VO:0015642 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] 41329688 OMOP2527650 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] VO:0015643 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] 36895156 OMOP1003703 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] VO:0015644 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] 21067349 OMOP290969 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] VO:0015645 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] 41328987 OMOP2526949 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] VO:0015646 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] 41330973 OMOP2528935 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] VO:0015647 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] 41335029 OMOP2532991 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] VO:0015648 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] 36895115 OMOP992059 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] VO:0015649 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [H-B-Vax II] 43280537 OMOP560888 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [H-B-Vax II] VO:0015650 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] 21037876 OMOP290982 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015651 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] 41365245 OMOP2563207 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015652 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] 41365246 OMOP2563208 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] VO:0015653 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 10 43630190 OMOP719098 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 10 VO:0015654 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 25 43702259 OMOP719099 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 25 VO:0015655 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 3 43828109 OMOP719097 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 3 VO:0015656 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 50 43791868 OMOP719100 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 50 VO:0015657 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 10 43590564 OMOP740531 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 10 VO:0015658 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 25 43662812 OMOP740532 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension Box of 25 VO:0015659 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution 41409499 OMOP2607461 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution VO:0015660 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension 36896210 OMOP1002738 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension VO:0015661 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution 41407985 OMOP2605947 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution VO:0015662 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension 36896171 OMOP999489 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension VO:0015663 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution 35785520 OMOP2786981 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution VO:0015664 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension 36896204 OMOP990705 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension VO:0015665 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution 41334183 OMOP2532145 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution VO:0015666 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe 41332120 OMOP2530082 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe VO:0015667 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution 41327508 OMOP2525470 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution VO:0015668 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension 36895143 OMOP1002820 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension VO:0015669 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution 41337511 OMOP2535473 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution VO:0015670 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension 36895078 OMOP1006413 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension VO:0015671 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution 41336198 OMOP2534160 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution VO:0015672 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension 36895009 OMOP1006864 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension VO:0015673 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe 41364999 OMOP2562961 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe VO:0015674 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe 41365000 OMOP2562962 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe VO:0015675 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 41214119 OMOP2412081 vaccine Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015676 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 1 40839334 OMOP2037296 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015677 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 10 41245065 OMOP2443027 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 10 VO:0015678 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 1 41151742 OMOP2349704 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 1 VO:0015679 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 10 41182810 OMOP2380772 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 10 VO:0015680 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 25 41307114 OMOP2505076 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 25 VO:0015681 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 50 41307113 OMOP2505075 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 50 VO:0015682 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] Box of 1 41088922 OMOP2286884 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] Box of 1 VO:0015683 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 41120162 OMOP2318124 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 VO:0015684 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 41276027 OMOP2473989 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 VO:0015685 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 2 40839338 OMOP2037300 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 2 VO:0015686 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 20 40932645 OMOP2130607 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 20 VO:0015687 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 25 41214123 OMOP2412085 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 25 VO:0015688 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 41120161 OMOP2318123 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 VO:0015689 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 50 41307115 OMOP2505077 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 50 VO:0015690 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 40839330 OMOP2037292 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015691 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 40901539 OMOP2099501 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 VO:0015692 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 41182803 OMOP2380765 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 VO:0015693 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 50 40932637 OMOP2130599 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 50 VO:0015694 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 36893892 OMOP1003081 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 VO:0015695 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 41307110 OMOP2505072 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 VO:0015696 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 41182802 OMOP2380764 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 VO:0015697 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 50 41120154 OMOP2318116 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 50 VO:0015698 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] Box of 10 43269468 OMOP558193 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] Box of 10 VO:0015699 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 41120160 OMOP2318122 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 VO:0015700 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 40870457 OMOP2068419 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 VO:0015701 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 20 41245066 OMOP2443028 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 20 VO:0015702 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 41088925 OMOP2286887 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 VO:0015703 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 41276026 OMOP2473988 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 VO:0015704 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 41214122 OMOP2412084 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 VO:0015705 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 41182813 OMOP2380775 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 VO:0015706 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 41026228 OMOP2224190 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 VO:0015707 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 20 41214121 OMOP2412083 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 20 VO:0015708 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 25 40963887 OMOP2161849 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 25 VO:0015709 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 41182812 OMOP2380774 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 VO:0015710 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 40839337 OMOP2037299 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 VO:0015711 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 21051482 OMOP345337 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015712 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 21149648 OMOP345338 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 VO:0015713 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 40932639 OMOP2130601 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 VO:0015714 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 50 40932638 OMOP2130600 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 50 VO:0015715 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 40901542 OMOP2099504 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 VO:0015716 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 40839331 OMOP2037293 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 VO:0015717 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 100 41120156 OMOP2318118 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 100 VO:0015718 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 41182805 OMOP2380767 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 VO:0015719 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 250 41182804 OMOP2380766 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 250 VO:0015720 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 40839332 OMOP2037294 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 VO:0015721 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 1 40932644 OMOP2130606 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 1 VO:0015722 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 10 41182808 OMOP2380770 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 10 VO:0015723 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 3 41026227 OMOP2224189 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 3 VO:0015724 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 40995165 OMOP2193127 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 VO:0015725 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 10 40870455 OMOP2068417 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 10 VO:0015726 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 1 44172898 OMOP3049621 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 1 VO:0015727 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 10 44180351 OMOP3057074 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 10 VO:0015728 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 3 44161548 OMOP3038271 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 3 VO:0015729 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 40870454 OMOP2068416 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 VO:0015730 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 41307112 OMOP2505074 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 VO:0015731 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 100 40901540 OMOP2099502 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 100 VO:0015732 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 41151740 OMOP2349702 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 VO:0015733 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 250 40932640 OMOP2130602 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 250 VO:0015734 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 41151741 OMOP2349703 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 VO:0015735 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 43196224 OMOP504189 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 VO:0015736 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 40995164 OMOP2193126 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 VO:0015737 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 100 41120155 OMOP2318117 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 100 VO:0015738 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 41026226 OMOP2224188 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 VO:0015739 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 250 40932641 OMOP2130603 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 250 VO:0015740 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 40901541 OMOP2099503 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 VO:0015741 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 40901543 OMOP2099505 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 VO:0015742 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 10 43291187 OMOP558188 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 10 VO:0015743 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 100 41307111 OMOP2505073 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 100 VO:0015744 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 43258582 OMOP558189 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 VO:0015745 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 250 41057405 OMOP2255367 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 250 VO:0015746 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 40932642 OMOP2130604 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 VO:0015747 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 21051480 OMOP345318 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 VO:0015748 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 21090623 OMOP345320 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 VO:0015749 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 41182806 OMOP2380768 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 VO:0015750 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 21022027 OMOP345319 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 VO:0015751 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 41057406 OMOP2255368 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 VO:0015752 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 41182807 OMOP2380769 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 VO:0015753 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 41120159 OMOP2318121 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 VO:0015754 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 41120158 OMOP2318120 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 VO:0015755 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 40932643 OMOP2130605 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 VO:0015756 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 41245064 OMOP2443026 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 VO:0015757 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] Box of 25 41026224 OMOP2224186 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] Box of 25 VO:0015758 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 1 35758803 OMOP2760264 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 1 VO:0015759 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 10 35754699 OMOP2756160 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 10 VO:0015760 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 41026229 OMOP2224191 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 VO:0015761 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 40839329 OMOP2037291 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015762 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 40753449 OMOP4703821 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 VO:0015763 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 10 40753448 OMOP4703822 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 10 VO:0015764 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 36888969 OMOP1006454 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 VO:0015765 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] Box of 1 43150113 OMOP486137 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] Box of 1 VO:0015766 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 1 21061268 OMOP345329 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 1 VO:0015767 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 10 21090625 OMOP345330 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 10 VO:0015768 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 21090624 OMOP345327 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015769 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe Box of 1 41020603 OMOP2218565 vaccine Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe Box of 1 VO:0015770 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 1 41051816 OMOP2249778 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 1 VO:0015771 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 10 41239594 OMOP2437556 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 10 VO:0015772 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 1 41270454 OMOP2468416 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 1 VO:0015773 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 10 41208654 OMOP2406616 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 10 VO:0015774 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 25 40896128 OMOP2094090 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 25 VO:0015775 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 50 41083406 OMOP2281368 vaccine Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 50 VO:0015776 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 41114620 OMOP2312582 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 VO:0015777 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 41239595 OMOP2437557 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 VO:0015778 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 2 41270456 OMOP2468418 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 2 VO:0015779 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 41114619 OMOP2312581 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 VO:0015780 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 25 41020606 OMOP2218568 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 25 VO:0015781 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 3 41146206 OMOP2344168 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 3 VO:0015782 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 50 41301534 OMOP2499496 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 50 VO:0015783 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 1 36883803 OMOP1004140 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 1 VO:0015784 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 10 41177147 OMOP2375109 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 10 VO:0015785 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 20 41270452 OMOP2468414 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 20 VO:0015786 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 50 40896127 OMOP2094089 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 50 VO:0015787 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection Box of 10 43285830 OMOP558191 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection Box of 10 VO:0015788 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 21169358 OMOP345334 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 VO:0015789 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 21061269 OMOP345335 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 VO:0015790 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 40958364 OMOP2156326 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 VO:0015791 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 25 40989651 OMOP2187613 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 25 VO:0015792 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 3 41270455 OMOP2468417 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 3 VO:0015793 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 50 40896129 OMOP2094091 vaccine Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 50 VO:0015794 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 41270453 OMOP2468415 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 VO:0015795 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 40864913 OMOP2062875 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 VO:0015796 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 100 40958361 OMOP2156323 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 100 VO:0015797 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 25 40833777 OMOP2031739 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 25 VO:0015798 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 250 41239593 OMOP2437555 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 250 VO:0015799 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 3 41020605 OMOP2218567 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 3 VO:0015800 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 36891632 OMOP1000770 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0015801 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 10 40864912 OMOP2062874 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 10 VO:0015802 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 100 41020604 OMOP2218566 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 100 VO:0015803 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 25 40958362 OMOP2156324 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 25 VO:0015804 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 250 40864911 OMOP2062873 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 250 VO:0015805 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 3 41208653 OMOP2406615 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 3 VO:0015806 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 589739 OMOP3138499 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 VO:0015807 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 43291186 OMOP558185 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 VO:0015808 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 100 588993 OMOP3135394 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 100 VO:0015809 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 25 43296590 OMOP558186 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 25 VO:0015810 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 250 589956 OMOP3135376 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 250 VO:0015811 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 3 589091 OMOP3138338 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 3 VO:0015812 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 21169355 OMOP345314 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0015813 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 21159585 OMOP345316 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 VO:0015814 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 25 40958363 OMOP2156325 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 25 VO:0015815 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 3 21031762 OMOP345315 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 3 VO:0015816 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 50 41114618 OMOP2312580 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 50 VO:0015817 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 40927096 OMOP2125058 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 VO:0015818 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 10 35762444 OMOP2763905 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 10 VO:0015819 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 1 36885720 OMOP993359 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 1 VO:0015820 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 10 40753450 OMOP4703820 vaccine Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 10 VO:0015821 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] by Sanofi 35785774 OMOP2787235 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] by Sanofi VO:0015822 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Merck 40719403 OMOP4737826 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Merck VO:0015823 OHDSI Vaccine WG 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Organon 36952508 OMOP5207848 vaccine 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Organon VO:0015824 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] by Sanofi 21069053 OMOP286593 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] by Sanofi VO:0015825 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] by Glaxosmithkline 35785475 OMOP2786936 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] by Glaxosmithkline VO:0015826 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline 40719401 OMOP4737828 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline VO:0015827 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Glaxosmithkline 44132818 OMOP1127449 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Glaxosmithkline VO:0015828 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by GSK 36281233 OMOP3132108 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by GSK VO:0015829 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] by Glaxosmithkline 21069051 OMOP286578 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] by Glaxosmithkline VO:0015830 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] by Glaxosmithkline 35785640 OMOP2787101 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] by Glaxosmithkline VO:0015831 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] by Glaxosmithkline 40719408 OMOP4737821 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] by Glaxosmithkline VO:0015832 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] by GSK 36281179 OMOP3132054 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] by GSK VO:0015833 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] by Glaxosmithkline 21167207 OMOP286585 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] by Glaxosmithkline VO:0015834 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 by Glaxosmithkline 43612079 OMOP719107 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 by Glaxosmithkline VO:0015835 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Glaxosmithkline 43719975 OMOP719109 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Glaxosmithkline VO:0015836 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Glaxosmithkline 43864417 OMOP719105 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Glaxosmithkline VO:0015837 OHDSI Vaccine WG 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 50 by Glaxosmithkline 43594113 OMOP719111 vaccine 0.5 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 50 by Glaxosmithkline VO:0015838 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] by Sanofi 35776431 OMOP2777892 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] by Sanofi VO:0015839 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Merck 40719442 OMOP4738259 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Merck VO:0015840 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by MSD 36277870 OMOP3128745 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by MSD VO:0015841 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Organon 36963575 OMOP5208422 vaccine 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] by Organon VO:0015842 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] by Sanofi 21028078 OMOP290990 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] by Sanofi VO:0015843 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] by Glaxosmithkline 35777855 OMOP2779316 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] by Glaxosmithkline VO:0015844 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] by Waymade 35776712 OMOP2778173 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] by Waymade VO:0015845 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline 40719438 OMOP4738263 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] by Glaxosmithkline VO:0015846 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] by Waymade 40719439 OMOP4738262 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] by Waymade VO:0015847 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Glaxosmithkline 36054373 OMOP4979614 vaccine 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Glaxosmithkline VO:0015848 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by GSK 36277760 OMOP3128635 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by GSK VO:0015849 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Waymade 36054374 OMOP4979615 vaccine 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Waymade VO:0015850 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] by Glaxosmithkline 21096747 OMOP290971 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] by Glaxosmithkline VO:0015851 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] by Waymade 21116368 OMOP290970 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] by Waymade VO:0015852 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] by Merck 40719446 OMOP4738255 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] by Merck VO:0015853 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] by Sanofi 35776154 OMOP2777615 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] by Sanofi VO:0015854 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] by Merck 40719444 OMOP4738257 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] by Merck VO:0015855 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] by MSD 36277806 OMOP3128681 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] by MSD VO:0015856 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] by Sanofi 21135957 OMOP290983 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] by Sanofi VO:0015857 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 by Glaxosmithkline 43644717 OMOP740536 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 by Glaxosmithkline VO:0015858 OHDSI Vaccine WG 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Glaxosmithkline 43680748 OMOP740538 vaccine 1 ML HEPATITIS B VIRUS SUBTYPE ADW2 HBSAG SURFACE PROTEIN ANTIGEN 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Glaxosmithkline VO:0015859 OHDSI Vaccine WG Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Glaxosmithkline 44063500 OMOP1058131 vaccine Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] by Glaxosmithkline VO:0015860 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 1 41408255 OMOP2606217 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 1 VO:0015861 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 10 41409536 OMOP2607498 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 10 VO:0015862 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 25 41407839 OMOP2605801 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 25 VO:0015863 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 50 41408033 OMOP2605995 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 50 VO:0015864 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 41407841 OMOP2605803 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 VO:0015865 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 41407840 OMOP2605802 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 VO:0015866 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 25 41407432 OMOP2605394 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 25 VO:0015867 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 50 41408452 OMOP2606414 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 50 VO:0015868 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 41407630 OMOP2605592 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015869 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 41408451 OMOP2606413 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 VO:0015870 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 41408450 OMOP2606412 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 VO:0015871 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 50 41408792 OMOP2606754 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 50 VO:0015872 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 43165027 OMOP507189 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 VO:0015873 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 41407243 OMOP2605205 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 VO:0015874 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 41407836 OMOP2605798 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 VO:0015875 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 50 41408026 OMOP2605988 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 50 VO:0015876 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] Box of 10 43297445 OMOP559835 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] Box of 10 VO:0015877 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 41409933 OMOP2607895 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 VO:0015878 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 41407431 OMOP2605393 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 VO:0015879 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 41408257 OMOP2606219 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 VO:0015880 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 41409537 OMOP2607499 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 VO:0015881 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 41407247 OMOP2605209 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 VO:0015882 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 41409187 OMOP2607149 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 VO:0015883 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 25 41409186 OMOP2607148 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 25 VO:0015884 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 41407632 OMOP2605594 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 VO:0015885 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 21049374 OMOP286594 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015886 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 41407244 OMOP2605206 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 VO:0015887 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 41408028 OMOP2605990 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 VO:0015888 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 50 41409534 OMOP2607496 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 50 VO:0015889 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 41409376 OMOP2607338 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 VO:0015890 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 41409717 OMOP2607679 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 VO:0015891 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 41409535 OMOP2607497 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 VO:0015892 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 41408030 OMOP2605992 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 VO:0015893 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 41408793 OMOP2606755 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 VO:0015894 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 43154020 OMOP507187 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 VO:0015895 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 41407631 OMOP2605593 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 VO:0015896 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 43519241 OMOP2806356 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 VO:0015897 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 41407837 OMOP2605799 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 VO:0015898 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 10 43270324 OMOP559831 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 10 VO:0015899 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 43264848 OMOP559832 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 VO:0015900 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 21108259 OMOP286579 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 VO:0015901 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 41407245 OMOP2605207 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 VO:0015902 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 41408254 OMOP2606216 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 VO:0015903 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 41407430 OMOP2605392 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 VO:0015904 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 41408032 OMOP2605994 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 VO:0015905 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 41407181 OMOP2605143 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 VO:0015906 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 41408613 OMOP2606575 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 VO:0015907 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 41408794 OMOP2606756 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 VO:0015908 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 1 35785451 OMOP2786912 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 1 VO:0015909 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 10 35785611 OMOP2787072 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 10 VO:0015910 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 40719407 OMOP4737822 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 VO:0015911 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 10 40719405 OMOP4737824 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 10 VO:0015912 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] Box of 1 43142857 OMOP507047 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] Box of 1 VO:0015913 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 1 21137645 OMOP286586 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 1 VO:0015914 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 10 21059130 OMOP286588 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 10 VO:0015915 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 1 41335033 OMOP2532995 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015916 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 10 41333715 OMOP2531677 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 10 VO:0015917 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] Box of 1 41330338 OMOP2528300 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] Box of 1 VO:0015918 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 41335734 OMOP2533696 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 VO:0015919 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 41328992 OMOP2526954 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 VO:0015920 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 2 41337039 OMOP2535001 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 2 VO:0015921 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 20 41333718 OMOP2531680 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 20 VO:0015922 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 41333719 OMOP2531681 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 VO:0015923 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 41331648 OMOP2529610 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015924 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 41337033 OMOP2534995 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 VO:0015925 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 41328359 OMOP2526321 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 VO:0015926 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 43141460 OMOP508827 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 VO:0015927 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 41328360 OMOP2526322 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 VO:0015928 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 41333714 OMOP2531676 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 VO:0015929 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] Box of 10 43258757 OMOP560896 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection [H-B-Vax II] Box of 10 VO:0015930 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 41335036 OMOP2532998 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 VO:0015931 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 41333002 OMOP2530964 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 VO:0015932 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 20 41330340 OMOP2528302 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 20 VO:0015933 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 41333003 OMOP2530965 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 VO:0015934 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 41328991 OMOP2526953 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 VO:0015935 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 41336409 OMOP2534371 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 VO:0015936 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 20 41328990 OMOP2526952 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 20 VO:0015937 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 41337038 OMOP2535000 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 VO:0015938 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 21067351 OMOP290991 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015939 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 21155783 OMOP290993 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 VO:0015940 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 41329684 OMOP2527646 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 VO:0015941 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 41329687 OMOP2527649 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 VO:0015942 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 41331650 OMOP2529612 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 VO:0015943 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 100 41330970 OMOP2528932 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 100 VO:0015944 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 41330336 OMOP2528298 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 VO:0015945 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 250 41334368 OMOP2532330 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 250 VO:0015946 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 41335031 OMOP2532993 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 VO:0015947 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 1 41331654 OMOP2529616 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 1 VO:0015948 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 10 41329689 OMOP2527651 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 10 VO:0015949 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 3 41336408 OMOP2534370 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 3 VO:0015950 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 41336406 OMOP2534368 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 VO:0015951 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 10 41331653 OMOP2529615 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 10 VO:0015952 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 1 44189726 OMOP3066449 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 1 VO:0015953 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 10 44189424 OMOP3066147 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 10 VO:0015954 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 3 44189513 OMOP3066236 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 3 VO:0015955 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 41335032 OMOP2532994 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 VO:0015956 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 41331649 OMOP2529611 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 VO:0015957 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 100 41329685 OMOP2527647 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 100 VO:0015958 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 41327698 OMOP2525660 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 VO:0015959 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 250 41337034 OMOP2534996 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 250 VO:0015960 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 41328989 OMOP2526951 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 VO:0015961 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 43141459 OMOP508824 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 VO:0015962 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 41337696 OMOP2535658 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 VO:0015963 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 100 41330335 OMOP2528297 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 100 VO:0015964 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 41330972 OMOP2528934 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 VO:0015965 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 250 41336403 OMOP2534365 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 250 VO:0015966 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 41332999 OMOP2530961 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 VO:0015967 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 41331651 OMOP2529613 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 VO:0015968 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 10 43275214 OMOP560891 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 10 VO:0015969 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 100 41330971 OMOP2528933 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 100 VO:0015970 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 43286012 OMOP560892 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 VO:0015971 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 250 41337035 OMOP2534997 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 250 VO:0015972 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 41337036 OMOP2534998 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 VO:0015973 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 21106590 OMOP290972 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 VO:0015974 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 21096749 OMOP290977 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 VO:0015975 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 41330337 OMOP2528299 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 VO:0015976 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 21135956 OMOP290975 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 VO:0015977 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 41336405 OMOP2534367 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 VO:0015978 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 41335733 OMOP2533695 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 VO:0015979 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 41331652 OMOP2529614 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 VO:0015980 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 41333000 OMOP2530962 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 VO:0015981 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] Box of 25 41328358 OMOP2526320 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] Box of 25 VO:0015982 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 41328993 OMOP2526955 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 VO:0015983 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 41328988 OMOP2526950 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 VO:0015984 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 43196509 OMOP508822 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 VO:0015985 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 21067350 OMOP290984 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015986 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 41366794 OMOP2564756 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015987 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 41370588 OMOP2568550 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 VO:0015988 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 1 41407793 OMOP2605755 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 1 VO:0015989 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 10 41407196 OMOP2605158 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 10 VO:0015990 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 25 41409878 OMOP2607840 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 25 VO:0015991 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 50 41408582 OMOP2606544 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 50 VO:0015992 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 41407794 OMOP2605756 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 VO:0015993 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 41407197 OMOP2605159 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 VO:0015994 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 41409877 OMOP2607839 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 VO:0015995 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 25 41410074 OMOP2608036 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 25 VO:0015996 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 50 41408749 OMOP2606711 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 50 VO:0015997 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 1 36896190 OMOP1004754 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 1 VO:0015998 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 10 41407589 OMOP2605551 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 10 VO:0015999 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 20 41410072 OMOP2608034 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 20 VO:0016000 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 50 41407792 OMOP2605754 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 50 VO:0016001 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection Box of 10 43264849 OMOP559833 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection Box of 10 VO:0016002 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 21049373 OMOP286591 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 VO:0016003 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 41407377 OMOP2605339 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 VO:0016004 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 41407195 OMOP2605157 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 VO:0016005 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 25 41407986 OMOP2605948 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 25 VO:0016006 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 50 41407180 OMOP2605142 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 50 VO:0016007 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 41409136 OMOP2607098 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 VO:0016008 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 41410073 OMOP2608035 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 VO:0016009 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 36896203 OMOP1004291 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0016010 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 10 41409135 OMOP2607097 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 10 VO:0016011 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 25 43519193 OMOP2806308 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 25 VO:0016012 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 587570 OMOP3136329 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 VO:0016013 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 43264847 OMOP559830 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 VO:0016014 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 25 43297444 OMOP559829 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 25 VO:0016015 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 21108258 OMOP286576 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0016016 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 41407190 OMOP2605152 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 VO:0016017 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 25 41408748 OMOP2606710 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 25 VO:0016018 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 50 41407984 OMOP2605946 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 50 VO:0016019 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 35785519 OMOP2786980 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 VO:0016020 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 10 35785483 OMOP2786944 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 10 VO:0016021 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 1 36896214 OMOP990500 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 1 VO:0016022 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 10 40719409 OMOP4737820 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 10 VO:0016023 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 1 41328807 OMOP2526769 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 1 VO:0016024 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 10 41332119 OMOP2530081 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 10 VO:0016025 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 1 41334185 OMOP2532147 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe Box of 1 VO:0016026 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 41331448 OMOP2529410 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 VO:0016027 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 41336861 OMOP2534823 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 VO:0016028 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 2 41334865 OMOP2532827 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 2 VO:0016029 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 41327507 OMOP2525469 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 VO:0016030 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 3 41332809 OMOP2530771 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 3 VO:0016031 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 1 36895105 OMOP988071 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 1 VO:0016032 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 10 41330786 OMOP2528748 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 10 VO:0016033 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 20 41328160 OMOP2526122 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension Box of 20 VO:0016034 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection Box of 10 43264200 OMOP560893 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection Box of 10 VO:0016035 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 21057504 OMOP290986 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 VO:0016036 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 21145824 OMOP290987 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 VO:0016037 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 41336860 OMOP2534822 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 VO:0016038 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 3 41330161 OMOP2528123 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 3 VO:0016039 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 41334184 OMOP2532146 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 VO:0016040 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 41335536 OMOP2533498 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 VO:0016041 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 100 41334864 OMOP2532826 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 100 VO:0016042 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 25 41336197 OMOP2534159 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 25 VO:0016043 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 250 41332118 OMOP2530080 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 250 VO:0016044 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 3 41336859 OMOP2534821 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 3 VO:0016045 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 36895142 OMOP1005055 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0016046 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 10 41330160 OMOP2528122 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 10 VO:0016047 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 100 41331447 OMOP2529409 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 100 VO:0016048 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 25 41335535 OMOP2533497 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 25 VO:0016049 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 250 41336196 OMOP2534158 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 250 VO:0016050 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 3 41336858 OMOP2534820 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 3 VO:0016051 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 589758 OMOP3138102 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 VO:0016052 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 43280538 OMOP560890 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 VO:0016053 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 100 588474 OMOP3137481 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 100 VO:0016054 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 25 43296787 OMOP560889 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 25 VO:0016055 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 250 588771 OMOP3135819 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 250 VO:0016056 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 3 589211 OMOP3136264 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 3 VO:0016057 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 21028076 OMOP290965 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0016058 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 21077245 OMOP290968 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 VO:0016059 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 25 41328161 OMOP2526123 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 25 VO:0016060 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 3 21037874 OMOP290966 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 3 VO:0016061 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 41336862 OMOP2534824 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 VO:0016062 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 1 36895052 OMOP999769 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension Box of 1 VO:0016063 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe Box of 1 41363538 OMOP2561500 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe Box of 1 VO:0016064 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 41363539 OMOP2561501 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 VO:0016065 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Kohlpharma 41410008 OMOP2607970 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Kohlpharma VO:0016066 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Boehringer Ingelheim 41407925 OMOP2605887 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Boehringer Ingelheim VO:0016067 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Sanofi 41408870 OMOP2606832 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Sanofi VO:0016068 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Sanofi 41407166 OMOP2605128 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Sanofi VO:0016069 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 25 by Sanofi 41409055 OMOP2607017 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 25 by Sanofi VO:0016070 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 50 by Sanofi 41410011 OMOP2607973 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 50 by Sanofi VO:0016071 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Aca Mueller 41408866 OMOP2606828 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Aca Mueller VO:0016072 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Axicorp 41407314 OMOP2605276 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Axicorp VO:0016073 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Cc 41409803 OMOP2607765 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Cc VO:0016074 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Emra-Med 41409801 OMOP2607763 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Emra-Med VO:0016075 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Eurim-Pharm 41410195 OMOP2608157 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Eurim-Pharm VO:0016076 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Gerke 41408327 OMOP2606289 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Gerke VO:0016077 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Mtk 41409439 OMOP2607401 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Mtk VO:0016078 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Sanofi 41407715 OMOP2605677 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Sanofi VO:0016079 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Aca Mueller 41409048 OMOP2607010 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Aca Mueller VO:0016080 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Cc 41408514 OMOP2606476 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Cc VO:0016081 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Emra-Med 41410005 OMOP2607967 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Emra-Med VO:0016082 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Eurim-Pharm 41409263 OMOP2607225 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Eurim-Pharm VO:0016083 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Mtk 41410194 OMOP2608156 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Mtk VO:0016084 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Sanofi 41408118 OMOP2606080 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Sanofi VO:0016085 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Emra-Med 41407713 OMOP2605675 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Emra-Med VO:0016086 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Eurim-Pharm 41407919 OMOP2605881 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Eurim-Pharm VO:0016087 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Mtk 41409261 OMOP2607223 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Mtk VO:0016088 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Sanofi 41407712 OMOP2605674 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Sanofi VO:0016089 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 50 by Sanofi 41408326 OMOP2606288 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 50 by Sanofi VO:0016090 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Aca Mueller 44197130 OMOP3073853 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Aca Mueller VO:0016091 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Axicorp 44197178 OMOP3073901 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Axicorp VO:0016092 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Cc 44197149 OMOP3073872 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Cc VO:0016093 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Emra-Med 44197054 OMOP3073777 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Emra-Med VO:0016094 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Eurim-Pharm 44197095 OMOP3073818 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Eurim-Pharm VO:0016095 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Gerke 44197096 OMOP3073819 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Gerke VO:0016096 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Merck 44197057 OMOP3073780 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Merck VO:0016097 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Mtk 44197056 OMOP3073779 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Mtk VO:0016098 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Aca Mueller 44197053 OMOP3073776 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Aca Mueller VO:0016099 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Cc 44197127 OMOP3073850 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Cc VO:0016100 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Emra-Med 44197207 OMOP3073930 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Emra-Med VO:0016101 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Eurim-Pharm 44197177 OMOP3073900 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Eurim-Pharm VO:0016102 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Merck 44197129 OMOP3073852 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Merck VO:0016103 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Mtk 44197017 OMOP3073740 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Mtk VO:0016104 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Emra-Med 44197174 OMOP3073897 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Emra-Med VO:0016105 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Eurim-Pharm 44197094 OMOP3073817 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Eurim-Pharm VO:0016106 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Merck 44197091 OMOP3073814 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Merck VO:0016107 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Mtk 44197146 OMOP3073869 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Mtk VO:0016108 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 50 by Merck 44197231 OMOP3073954 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 50 by Merck VO:0016109 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Aca Mueller 41408680 OMOP2606642 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Aca Mueller VO:0016110 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Axicorp 41408120 OMOP2606082 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Axicorp VO:0016111 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Cc 41410196 OMOP2608158 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Cc VO:0016112 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Eurim-Pharm 41408679 OMOP2606641 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Eurim-Pharm VO:0016113 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Gerke 41409440 OMOP2607402 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Gerke VO:0016114 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Merck 40719402 OMOP4737827 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Merck VO:0016115 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Mtk 41408119 OMOP2606081 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Mtk VO:0016116 OHDSI Vaccine WG 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Organon 36921262 OMOP5207849 vaccine 0.5 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Organon VO:0016117 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Sanofi 41407506 OMOP2605468 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Sanofi VO:0016118 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Eurim-Pharm 41408678 OMOP2606640 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Eurim-Pharm VO:0016119 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Sanofi 41409262 OMOP2607224 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Sanofi VO:0016120 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 by Eurim-Pharm 41407313 OMOP2605275 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 20 by Eurim-Pharm VO:0016121 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Eurim-Pharm 41407512 OMOP2605474 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Eurim-Pharm VO:0016122 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Sanofi 41408869 OMOP2606831 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Sanofi VO:0016123 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 by Eurim-Pharm 41408868 OMOP2606830 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 by Eurim-Pharm VO:0016124 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 by Sanofi 41410010 OMOP2607972 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 by Sanofi VO:0016125 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 by Eurim-Pharm 41409054 OMOP2607016 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 by Eurim-Pharm VO:0016126 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 by Sanofi 41410197 OMOP2608159 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 25 by Sanofi VO:0016127 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 by Eurim-Pharm 41409807 OMOP2607769 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 by Eurim-Pharm VO:0016128 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 by Sanofi 41408681 OMOP2606643 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 50 by Sanofi VO:0016129 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Eurim-Pharm 41410009 OMOP2607971 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Eurim-Pharm VO:0016130 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Kohlpharma 41407718 OMOP2605680 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Kohlpharma VO:0016131 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Mtk 41408515 OMOP2606477 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Mtk VO:0016132 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 by Kohlpharma 41408867 OMOP2606829 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 by Kohlpharma VO:0016133 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 by Eurim-Pharm 41409607 OMOP2607569 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 by Eurim-Pharm VO:0016134 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 by Kohlpharma 41407717 OMOP2605679 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 50 by Kohlpharma VO:0016135 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Aca Mueller 41409049 OMOP2607011 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Aca Mueller VO:0016136 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Axicorp 41407505 OMOP2605467 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Axicorp VO:0016137 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Cc 41409050 OMOP2607012 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Cc VO:0016138 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Emra-Med 41409438 OMOP2607400 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Emra-Med VO:0016139 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Eurim-Pharm 41409437 OMOP2607399 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Eurim-Pharm VO:0016140 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Europharma 41409051 OMOP2607013 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Europharma VO:0016141 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Gerke 41407508 OMOP2605470 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Gerke VO:0016142 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Kohlpharma 41408121 OMOP2606083 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Kohlpharma VO:0016143 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Orifarm Leverkus 41409802 OMOP2607764 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016144 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Sanofi 41408677 OMOP2606639 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Sanofi VO:0016145 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Cc 41408676 OMOP2606638 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Cc VO:0016146 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Emra-Med 41408675 OMOP2606637 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Emra-Med VO:0016147 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Eurim-Pharm 41409436 OMOP2607398 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Eurim-Pharm VO:0016148 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Europharma 41409441 OMOP2607403 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Europharma VO:0016149 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Kohlpharma 41407315 OMOP2605277 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Kohlpharma VO:0016150 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Sanofi 41407312 OMOP2605274 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Sanofi VO:0016151 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Kohlpharma 41407507 OMOP2605469 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Kohlpharma VO:0016152 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Sanofi 41407714 OMOP2605676 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Sanofi VO:0016153 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Aca Mueller 44197018 OMOP3073741 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Aca Mueller VO:0016154 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Axicorp 44197209 OMOP3073932 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Axicorp VO:0016155 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Cc 44197179 OMOP3073902 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Cc VO:0016156 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Emra-Med 44197055 OMOP3073778 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Emra-Med VO:0016157 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Eurim-Pharm 44197093 OMOP3073816 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Eurim-Pharm VO:0016158 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Europharma 44197022 OMOP3073745 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Europharma VO:0016159 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Gerke 44197021 OMOP3073744 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Gerke VO:0016160 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Kohlpharma 44197131 OMOP3073854 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Kohlpharma VO:0016161 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Merck 44197148 OMOP3073871 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Merck VO:0016162 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Orifarm Leverkus 44197092 OMOP3073815 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Orifarm Leverkus VO:0016163 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Cc 44197147 OMOP3073870 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Cc VO:0016164 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Emra-Med 44197128 OMOP3073851 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Emra-Med VO:0016165 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Eurim-Pharm 44197176 OMOP3073899 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Eurim-Pharm VO:0016166 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Europharma 44197020 OMOP3073743 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Europharma VO:0016167 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Kohlpharma 44197210 OMOP3073933 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Kohlpharma VO:0016168 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Merck 44197208 OMOP3073931 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Merck VO:0016169 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Kohlpharma 44197019 OMOP3073742 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Kohlpharma VO:0016170 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Merck 44197175 OMOP3073898 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Merck VO:0016171 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Glaxosmithkline 35785474 OMOP2786935 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Glaxosmithkline VO:0016172 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Glaxosmithkline 40719400 OMOP4737829 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Glaxosmithkline VO:0016173 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Glaxosmithkline 43186938 OMOP507188 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Glaxosmithkline VO:0016174 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by GSK 36781842 OMOP4770128 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by GSK VO:0016175 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Aca Mueller 41409805 OMOP2607767 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Aca Mueller VO:0016176 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Axicorp 41408329 OMOP2606291 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Axicorp VO:0016177 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Cc 41407924 OMOP2605886 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Cc VO:0016178 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Emra-Med 41407711 OMOP2605673 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Emra-Med VO:0016179 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Eurim-Pharm 41410193 OMOP2608155 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Eurim-Pharm VO:0016180 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Gerke 41409053 OMOP2607015 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Gerke VO:0016181 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Glaxosmithkline 21108260 OMOP286580 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Glaxosmithkline VO:0016182 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Kohlpharma 41409260 OMOP2607222 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Kohlpharma VO:0016183 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mevita 41408328 OMOP2606290 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mevita VO:0016184 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mtk 41409259 OMOP2607221 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mtk VO:0016185 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Orifarm Leverkus 41409265 OMOP2607227 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Orifarm Leverkus VO:0016186 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Aca Mueller 41410003 OMOP2607965 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Aca Mueller VO:0016187 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Axicorp 41407923 OMOP2605885 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Axicorp VO:0016188 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Cc 41409804 OMOP2607766 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Cc VO:0016189 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Emra-Med 41409434 OMOP2607396 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Emra-Med VO:0016190 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Eurim-Pharm 41407918 OMOP2605880 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Eurim-Pharm VO:0016191 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Gerke 41407509 OMOP2605471 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Gerke VO:0016192 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Kohlpharma 41407311 OMOP2605273 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Kohlpharma VO:0016193 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mevita 41409606 OMOP2607568 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mevita VO:0016194 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mtk 41409800 OMOP2607762 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mtk VO:0016195 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Orifarm Leverkus 41407922 OMOP2605884 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Orifarm Leverkus VO:0016196 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Aca Mueller 41408513 OMOP2606475 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Aca Mueller VO:0016197 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Emra-Med 41410191 OMOP2608153 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Emra-Med VO:0016198 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Eurim-Pharm 41409798 OMOP2607760 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Eurim-Pharm VO:0016199 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Gerke 41407921 OMOP2605883 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Gerke VO:0016200 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Kohlpharma 41407310 OMOP2605272 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Kohlpharma VO:0016201 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Mtk 41410190 OMOP2608152 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Mtk VO:0016202 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Orifarm Leverkus 41410002 OMOP2607964 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Orifarm Leverkus VO:0016203 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Emra-Med 41408325 OMOP2606287 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Emra-Med VO:0016204 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Kohlpharma 41407708 OMOP2605670 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Kohlpharma VO:0016205 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Mtk 41408117 OMOP2606079 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Mtk VO:0016206 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Orifarm Leverkus 41409258 OMOP2607220 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 50 by Orifarm Leverkus VO:0016207 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Aca Mueller 41408124 OMOP2606086 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Aca Mueller VO:0016208 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Axicorp 41410007 OMOP2607969 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Axicorp VO:0016209 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Cc 41407511 OMOP2605473 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Cc VO:0016210 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Emra-Med 41409047 OMOP2607009 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Emra-Med VO:0016211 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Eurim-Pharm 41408865 OMOP2606827 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Eurim-Pharm VO:0016212 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Gerke 41407510 OMOP2605472 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Gerke VO:0016213 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Kohlpharma 41409435 OMOP2607397 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Kohlpharma VO:0016214 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mevita 41408123 OMOP2606085 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mevita VO:0016215 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mtk 41410004 OMOP2607966 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mtk VO:0016216 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Orifarm Leverkus 41409264 OMOP2607226 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Orifarm Leverkus VO:0016217 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Aca Mueller 41409046 OMOP2607008 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Aca Mueller VO:0016218 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Axicorp 41410006 OMOP2607968 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Axicorp VO:0016219 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Cc 41408122 OMOP2606084 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Cc VO:0016220 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Emra-Med 41407710 OMOP2605672 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Emra-Med VO:0016221 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Eurim-Pharm 41408674 OMOP2606636 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Eurim-Pharm VO:0016222 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Gerke 41409052 OMOP2607014 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Gerke VO:0016223 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Kohlpharma 41410192 OMOP2608154 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Kohlpharma VO:0016224 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mevita 41409605 OMOP2607567 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mevita VO:0016225 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mtk 41409045 OMOP2607007 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mtk VO:0016226 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Orifarm Leverkus 41407716 OMOP2605678 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Orifarm Leverkus VO:0016227 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Aca Mueller 41409799 OMOP2607761 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Aca Mueller VO:0016228 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Emra-Med 41407709 OMOP2605671 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Emra-Med VO:0016229 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Eurim-Pharm 41409044 OMOP2607006 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Eurim-Pharm VO:0016230 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Gerke 41407920 OMOP2605882 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Gerke VO:0016231 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Kohlpharma 41408512 OMOP2606474 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Kohlpharma VO:0016232 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Mtk 41409604 OMOP2607566 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Mtk VO:0016233 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Orifarm Leverkus 41407504 OMOP2605466 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Orifarm Leverkus VO:0016234 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Emra-Med 41410001 OMOP2607963 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Emra-Med VO:0016235 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Kohlpharma 41409603 OMOP2607565 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Kohlpharma VO:0016236 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Mtk 41407175 OMOP2605137 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Mtk VO:0016237 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Orifarm Leverkus 41409433 OMOP2607395 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 50 by Orifarm Leverkus VO:0016238 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 by European 44197150 OMOP3073873 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 by European VO:0016239 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 1 by Glaxosmithkline 35785639 OMOP2787100 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 1 by Glaxosmithkline VO:0016240 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 10 by Glaxosmithkline 35785588 OMOP2787049 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Fendrix] Box of 10 by Glaxosmithkline VO:0016241 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 by Glaxosmithkline 40719406 OMOP4737823 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 by Glaxosmithkline VO:0016242 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 by GSK 36781843 OMOP4770129 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 1 by GSK VO:0016243 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 10 by Glaxosmithkline 40719404 OMOP4737825 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [Fendrix] Box of 10 by Glaxosmithkline VO:0016244 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] Box of 1 by Sanofi 43142858 OMOP507049 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [VACCIN GENHEVAC B] Box of 1 by Sanofi VO:0016245 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 1 by Glaxosmithkline 21176997 OMOP286587 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 1 by Glaxosmithkline VO:0016246 OHDSI Vaccine WG 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 10 by Glaxosmithkline 21167208 OMOP286589 vaccine 0.5 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Fendrix] Box of 10 by Glaxosmithkline VO:0016247 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Orifarm Leverkus 41337970 OMOP2535932 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016248 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Orifarm Leverkus 41332647 OMOP2530609 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Orifarm Leverkus VO:0016249 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 1 by Orifarm Leverkus 44189637 OMOP3066360 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 1 by Orifarm Leverkus VO:0016250 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 10 by Orifarm Leverkus 44189755 OMOP3066478 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Injectable Solution Box of 10 by Orifarm Leverkus VO:0016251 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] Box of 1 by Merieux 41328649 OMOP2526611 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.005 MG/ML Prefilled Syringe [Hevac B] Box of 1 by Merieux VO:0016252 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Boehringer Ingelheim 41334015 OMOP2531977 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Boehringer Ingelheim VO:0016253 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Eurim-Pharm 41334684 OMOP2532646 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Eurim-Pharm VO:0016254 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Kohlpharma 41329990 OMOP2527952 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Kohlpharma VO:0016255 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Mtk 41330618 OMOP2528580 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Mtk VO:0016256 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Sanofi 41334683 OMOP2532645 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 1 by Sanofi VO:0016257 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Eurim-Pharm 41333333 OMOP2531295 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Eurim-Pharm VO:0016258 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Kohlpharma 41337972 OMOP2535934 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Kohlpharma VO:0016259 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Sanofi 41335370 OMOP2533332 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 10 by Sanofi VO:0016260 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 2 by Boehringer Ingelheim 41337346 OMOP2535308 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 2 by Boehringer Ingelheim VO:0016261 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 20 by Sanofi 41327997 OMOP2525959 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 20 by Sanofi VO:0016262 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Boehringer Ingelheim 41331284 OMOP2529246 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Boehringer Ingelheim VO:0016263 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Eurim-Pharm 41328651 OMOP2526613 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Eurim-Pharm VO:0016264 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Kohlpharma 41328650 OMOP2526612 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Kohlpharma VO:0016265 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Sanofi 41334682 OMOP2532644 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [Gen Vax] Box of 3 by Sanofi VO:0016266 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Aca Mueller 41328645 OMOP2526607 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Aca Mueller VO:0016267 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Axicorp 41337339 OMOP2535301 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Axicorp VO:0016268 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Cc 41329987 OMOP2527949 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Cc VO:0016269 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Emra-Med 41330612 OMOP2528574 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Emra-Med VO:0016270 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Eurim-Pharm 41335364 OMOP2533326 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Eurim-Pharm VO:0016271 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Mtk 41333320 OMOP2531282 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Mtk VO:0016272 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Orifarm Leverkus 41337965 OMOP2535927 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016273 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Sanofi 41329985 OMOP2527947 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Sanofi VO:0016274 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Veron 41335363 OMOP2533325 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Veron VO:0016275 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Aca Mueller 41329301 OMOP2527263 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Aca Mueller VO:0016276 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Emra-Med 41335367 OMOP2533329 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Emra-Med VO:0016277 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Eurim-Pharm 41331942 OMOP2529904 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Eurim-Pharm VO:0016278 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Mtk 41333319 OMOP2531281 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Mtk VO:0016279 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Orifarm Leverkus 41335366 OMOP2533328 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Orifarm Leverkus VO:0016280 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Sanofi 41331275 OMOP2529237 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Sanofi VO:0016281 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Veron 41331941 OMOP2529903 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 10 by Veron VO:0016282 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Sanofi 41336030 OMOP2533992 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Sanofi VO:0016283 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Veron 41330608 OMOP2528570 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution [HBvaxPRO] Box of 20 by Veron VO:0016284 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Aca Mueller 44189536 OMOP3066259 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Aca Mueller VO:0016285 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Axicorp 44189362 OMOP3066085 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Axicorp VO:0016286 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Cc 44189947 OMOP3066670 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Cc VO:0016287 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Emra-Med 44189634 OMOP3066357 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Emra-Med VO:0016288 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Eurim-Pharm 44189359 OMOP3066082 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Eurim-Pharm VO:0016289 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Merck 44189358 OMOP3066081 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Merck VO:0016290 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Mtk 44189944 OMOP3066667 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Mtk VO:0016291 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Orifarm Leverkus 44189946 OMOP3066669 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Orifarm Leverkus VO:0016292 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Veron 44189357 OMOP3066080 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 1 by Veron VO:0016293 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Aca Mueller 44190059 OMOP3066782 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Aca Mueller VO:0016294 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Emra-Med 44189361 OMOP3066084 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Emra-Med VO:0016295 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Eurim-Pharm 44189943 OMOP3066666 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Eurim-Pharm VO:0016296 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Merck 44190058 OMOP3066781 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Merck VO:0016297 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Mtk 44189831 OMOP3066554 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Mtk VO:0016298 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Orifarm Leverkus 44189753 OMOP3066476 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Orifarm Leverkus VO:0016299 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Veron 44189747 OMOP3066470 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 10 by Veron VO:0016300 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Merck 44189535 OMOP3066258 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Merck VO:0016301 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Veron 44189942 OMOP3066665 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Solution Box of 20 by Veron VO:0016302 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Axicorp 41329304 OMOP2527266 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Axicorp VO:0016303 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Cc 41336033 OMOP2533995 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Cc VO:0016304 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Emra-Med 41329303 OMOP2527265 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Emra-Med VO:0016305 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Merck 40719441 OMOP4738260 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Merck VO:0016306 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by MSD 36781742 OMOP4770027 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by MSD VO:0016307 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Organon 36935840 OMOP5208423 vaccine 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Organon VO:0016308 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Orifarm Leverkus 41337964 OMOP2535926 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016309 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Sanofi 43141461 OMOP508828 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Sanofi VO:0016310 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Emra-Med 41329986 OMOP2527948 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Emra-Med VO:0016311 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Merck 40719440 OMOP4738261 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Merck VO:0016312 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Organon 36966738 OMOP5208424 vaccine 1 ML hepatitis B surface antigen vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Organon VO:0016313 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Orifarm Leverkus 41333324 OMOP2531286 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injectable Suspension [HBvaxPRO] Box of 10 by Orifarm Leverkus VO:0016314 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Eurim-Pharm 41334014 OMOP2531976 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Eurim-Pharm VO:0016315 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Sanofi 41333332 OMOP2531294 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 1 by Sanofi VO:0016316 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 by Sanofi 41337345 OMOP2535307 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 10 by Sanofi VO:0016317 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 20 by Sanofi 41327996 OMOP2525958 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 20 by Sanofi VO:0016318 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 by Eurim-Pharm 41331954 OMOP2529916 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 by Eurim-Pharm VO:0016319 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 by Sanofi 41331283 OMOP2529245 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Gen Vax] Box of 3 by Sanofi VO:0016320 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Eurim-Pharm 41327995 OMOP2525957 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Eurim-Pharm VO:0016321 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Kohlpharma 41334013 OMOP2531975 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Kohlpharma VO:0016322 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Mtk 41327994 OMOP2525956 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 1 by Mtk VO:0016323 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 by Kohlpharma 41334681 OMOP2532643 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 10 by Kohlpharma VO:0016324 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 20 by Mtk 41336710 OMOP2534672 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 20 by Mtk VO:0016325 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 by Eurim-Pharm 41331953 OMOP2529915 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 by Eurim-Pharm VO:0016326 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 by Kohlpharma 41336042 OMOP2534004 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 by Kohlpharma VO:0016327 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 by Mtk 41329989 OMOP2527951 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [H B Vax] Box of 3 by Mtk VO:0016328 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Aca Mueller 41334669 OMOP2532631 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Aca Mueller VO:0016329 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Axicorp 41331279 OMOP2529241 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Axicorp VO:0016330 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Cc 41329306 OMOP2527268 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Cc VO:0016331 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Emra-Med 41330610 OMOP2528572 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Emra-Med VO:0016332 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Eurim-Pharm 41333322 OMOP2531284 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Eurim-Pharm VO:0016333 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Europharma 41334671 OMOP2532633 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Europharma VO:0016334 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Gerke 41330613 OMOP2528575 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Gerke VO:0016335 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Kohlpharma 41329305 OMOP2527267 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Kohlpharma VO:0016336 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Orifarm Leverkus 41331944 OMOP2529906 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016337 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Sanofi 41330609 OMOP2528571 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Sanofi VO:0016338 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Veron 41336031 OMOP2533993 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Veron VO:0016339 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Aca Mueller 41331278 OMOP2529240 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Aca Mueller VO:0016340 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Axicorp 41331277 OMOP2529239 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Axicorp VO:0016341 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Cc 41331276 OMOP2529238 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Cc VO:0016342 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Emra-Med 41335365 OMOP2533327 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Emra-Med VO:0016343 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Eurim-Pharm 41328647 OMOP2526609 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Eurim-Pharm VO:0016344 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Europharma 41334008 OMOP2531970 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Europharma VO:0016345 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Gerke 41336034 OMOP2533996 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Gerke VO:0016346 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Kohlpharma 41337340 OMOP2535302 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Kohlpharma VO:0016347 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Orifarm Leverkus 41331943 OMOP2529905 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Orifarm Leverkus VO:0016348 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Sanofi 41337337 OMOP2535299 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 10 by Sanofi VO:0016349 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Sanofi 41328646 OMOP2526608 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Sanofi VO:0016350 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Veron 41333321 OMOP2531283 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [HBvaxPRO] Box of 20 by Veron VO:0016351 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Aca Mueller 44189540 OMOP3066263 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Aca Mueller VO:0016352 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Axicorp 44189834 OMOP3066557 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Axicorp VO:0016353 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Cc 44189363 OMOP3066086 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Cc VO:0016354 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Emra-Med 44189751 OMOP3066474 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Emra-Med VO:0016355 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Eurim-Pharm 44189539 OMOP3066262 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Eurim-Pharm VO:0016356 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Europharma 44189636 OMOP3066359 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Europharma VO:0016357 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Gerke 44189543 OMOP3066266 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Gerke VO:0016358 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Kohlpharma 44189635 OMOP3066358 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Kohlpharma VO:0016359 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Merck 44190060 OMOP3066783 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Merck VO:0016360 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Orifarm Leverkus 44189750 OMOP3066473 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Orifarm Leverkus VO:0016361 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Veron 44189749 OMOP3066472 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 1 by Veron VO:0016362 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Aca Mueller 44189833 OMOP3066556 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Aca Mueller VO:0016363 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Axicorp 44189832 OMOP3066555 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Axicorp VO:0016364 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Cc 44189945 OMOP3066668 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Cc VO:0016365 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Emra-Med 44189290 OMOP3066013 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Emra-Med VO:0016366 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Eurim-Pharm 44189538 OMOP3066261 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Eurim-Pharm VO:0016367 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Europharma 44189754 OMOP3066477 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Europharma VO:0016368 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Gerke 44189542 OMOP3066265 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Gerke VO:0016369 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Kohlpharma 44189448 OMOP3066171 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Kohlpharma VO:0016370 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Merck 44189631 OMOP3066354 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Merck VO:0016371 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Orifarm Leverkus 44189630 OMOP3066353 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 10 by Orifarm Leverkus VO:0016372 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Merck 44189748 OMOP3066471 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Merck VO:0016373 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Veron 44189537 OMOP3066260 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe Box of 20 by Veron VO:0016374 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Emra-Med 41334675 OMOP2532637 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Emra-Med VO:0016375 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Eurim-Pharm 41334673 OMOP2532635 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Eurim-Pharm VO:0016376 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Glaxosmithkline 35776711 OMOP2778172 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Glaxosmithkline VO:0016377 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Kohlpharma 41327988 OMOP2525950 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Kohlpharma VO:0016378 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Mtk 41333327 OMOP2531289 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Mtk VO:0016379 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Waymade 35777265 OMOP2778726 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 1 by Waymade VO:0016380 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 by Glaxosmithkline 35777854 OMOP2779315 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 10 by Glaxosmithkline VO:0016381 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 by Emra-Med 41335358 OMOP2533320 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 by Emra-Med VO:0016382 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 by Mtk 41329984 OMOP2527946 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 25 by Mtk VO:0016383 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Emra-Med 41333326 OMOP2531288 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Emra-Med VO:0016384 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Glaxosmithkline 35776155 OMOP2777616 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Glaxosmithkline VO:0016385 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Kohlpharma 41331946 OMOP2529908 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Kohlpharma VO:0016386 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Mtk 41333325 OMOP2531287 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Engerix B] Box of 3 by Mtk VO:0016387 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 1 by Glaxosmithkline 41327993 OMOP2525955 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 1 by Glaxosmithkline VO:0016388 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 3 by Glaxosmithkline 41337344 OMOP2535306 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Gemvites] Box of 3 by Glaxosmithkline VO:0016389 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 by Boehringer Ingelheim 41337971 OMOP2535933 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [H B Vax] Box of 1 by Boehringer Ingelheim VO:0016390 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 1 by Glaxosmithkline 44189639 OMOP3066362 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 1 by Glaxosmithkline VO:0016391 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 3 by Glaxosmithkline 44189638 OMOP3066361 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution [Hepasorbat] Box of 3 by Glaxosmithkline VO:0016392 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Emra-Med 41330615 OMOP2528577 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Emra-Med VO:0016393 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Eurim-Pharm 41331947 OMOP2529909 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Eurim-Pharm VO:0016394 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Glaxosmithkline 40719436 OMOP4738265 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Glaxosmithkline VO:0016395 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Kohlpharma 41337967 OMOP2535929 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Kohlpharma VO:0016396 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Mtk 41333328 OMOP2531290 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Mtk VO:0016397 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Waymade 40719437 OMOP4738264 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 1 by Waymade VO:0016398 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 by Glaxosmithkline 40719433 OMOP4738267 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 10 by Glaxosmithkline VO:0016399 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Emra-Med 41336702 OMOP2534664 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Emra-Med VO:0016400 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Mtk 41337334 OMOP2535296 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 25 by Mtk VO:0016401 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Emra-Med 41336037 OMOP2533999 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Emra-Med VO:0016402 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Glaxosmithkline 40719435 OMOP4738266 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Glaxosmithkline VO:0016403 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Kohlpharma 41328648 OMOP2526610 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Kohlpharma VO:0016404 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Mtk 41337966 OMOP2535928 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix B] Box of 3 by Mtk VO:0016405 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Emra-Med 41337341 OMOP2535303 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Emra-Med VO:0016406 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Eurim-Pharm 41331281 OMOP2529243 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Eurim-Pharm VO:0016407 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Glaxosmithkline 43185528 OMOP508825 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Glaxosmithkline VO:0016408 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by GSK 36781741 OMOP4770026 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by GSK VO:0016409 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Kohlpharma 41336708 OMOP2534670 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Kohlpharma VO:0016410 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Mtk 41327987 OMOP2525949 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Mtk VO:0016411 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Waymade 36054372 OMOP4979613 vaccine 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 1 by Waymade VO:0016412 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 by Glaxosmithkline 36054370 OMOP4979611 vaccine 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 10 by Glaxosmithkline VO:0016413 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 by Emra-Med 41332639 OMOP2530601 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 by Emra-Med VO:0016414 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 by Mtk 41336025 OMOP2533987 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 25 by Mtk VO:0016415 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Emra-Med 41330614 OMOP2528576 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Emra-Med VO:0016416 OHDSI Vaccine WG 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Glaxosmithkline 36054371 OMOP4979612 vaccine 1 ML hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Glaxosmithkline VO:0016417 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Kohlpharma 41332644 OMOP2530606 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Kohlpharma VO:0016418 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Mtk 41336035 OMOP2533997 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Engerix-B] Box of 3 by Mtk VO:0016419 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Emra-Med 41334674 OMOP2532636 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Emra-Med VO:0016420 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Eurim-Pharm 41327989 OMOP2525951 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Eurim-Pharm VO:0016421 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Kohlpharma 41333329 OMOP2531291 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Kohlpharma VO:0016422 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Mtk 41334672 OMOP2532634 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 1 by Mtk VO:0016423 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 by Emra-Med 41331939 OMOP2529901 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 by Emra-Med VO:0016424 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 by Mtk 41334004 OMOP2531966 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 25 by Mtk VO:0016425 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 by Emra-Med 41336036 OMOP2533998 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 by Emra-Med VO:0016426 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 by Kohlpharma 41335368 OMOP2533330 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 by Kohlpharma VO:0016427 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 by Mtk 41331945 OMOP2529907 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Engerix-B] Box of 3 by Mtk VO:0016428 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Aca Mueller 41336705 OMOP2534667 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Aca Mueller VO:0016429 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Axicorp 41334680 OMOP2532642 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Axicorp VO:0016430 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Cc 41329309 OMOP2527271 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Cc VO:0016431 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Emra-Med 41331274 OMOP2529236 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Emra-Med VO:0016432 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Eurim-Pharm 41331273 OMOP2529235 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Eurim-Pharm VO:0016433 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Gerke 41337969 OMOP2535931 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Gerke VO:0016434 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Glaxosmithkline 21096748 OMOP290974 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Glaxosmithkline VO:0016435 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Haematogmbh 41331951 OMOP2529913 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Haematogmbh VO:0016436 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by HVD 41327992 OMOP2525954 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by HVD VO:0016437 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Kohlpharma 41335361 OMOP2533323 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Kohlpharma VO:0016438 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mevita 41336040 OMOP2534002 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mevita VO:0016439 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mtk 41328644 OMOP2526606 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Mtk VO:0016440 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Orifarm Leverkus 41330617 OMOP2528579 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Orifarm Leverkus VO:0016441 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Veron 41337343 OMOP2535305 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Veron VO:0016442 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Waymade 21135955 OMOP290973 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 1 by Waymade VO:0016443 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Aca Mueller 41331272 OMOP2529234 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Aca Mueller VO:0016444 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Axicorp 41331949 OMOP2529911 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Axicorp VO:0016445 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Cc 41331948 OMOP2529910 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Cc VO:0016446 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Emra-Med 41327985 OMOP2525947 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Emra-Med VO:0016447 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Eurim-Pharm 41336027 OMOP2533989 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Eurim-Pharm VO:0016448 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Gerke 41334677 OMOP2532639 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Gerke VO:0016449 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Glaxosmithkline 21126095 OMOP290979 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Glaxosmithkline VO:0016450 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Haematogmbh 41327984 OMOP2525946 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Haematogmbh VO:0016451 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Kohlpharma 41334666 OMOP2532628 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Kohlpharma VO:0016452 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mevita 41334009 OMOP2531971 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mevita VO:0016453 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mtk 41334665 OMOP2532627 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Mtk VO:0016454 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Orifarm Leverkus 41327983 OMOP2525945 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Orifarm Leverkus VO:0016455 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Veron 41327990 OMOP2525952 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 10 by Veron VO:0016456 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Aca Mueller 41334664 OMOP2532626 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Aca Mueller VO:0016457 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Emra-Med 41337335 OMOP2535297 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Emra-Med VO:0016458 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Kohlpharma 41328642 OMOP2526604 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Kohlpharma VO:0016459 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Mtk 41332640 OMOP2530602 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 25 by Mtk VO:0016460 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Aca Mueller 41328643 OMOP2526605 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Aca Mueller VO:0016461 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Axicorp 41331950 OMOP2529912 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Axicorp VO:0016462 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Emra-Med 41329300 OMOP2527262 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Emra-Med VO:0016463 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Eurim-Pharm 41337959 OMOP2535921 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Eurim-Pharm VO:0016464 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Gerke 41329988 OMOP2527950 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Gerke VO:0016465 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Glaxosmithkline 21116369 OMOP290976 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Glaxosmithkline VO:0016466 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Kohlpharma 41332642 OMOP2530604 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Kohlpharma VO:0016467 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Mevita 41337968 OMOP2535930 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Mevita VO:0016468 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Mtk 41334667 OMOP2532629 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Mtk VO:0016469 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Orifarm Leverkus 41334679 OMOP2532641 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Orifarm Leverkus VO:0016470 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Veron 41329308 OMOP2527270 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix B] Box of 3 by Veron VO:0016471 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Aca Mueller 41337960 OMOP2535922 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Aca Mueller VO:0016472 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Axicorp 41333331 OMOP2531293 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Axicorp VO:0016473 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Cc 41336709 OMOP2534671 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Cc VO:0016474 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Emra-Med 41337336 OMOP2535298 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Emra-Med VO:0016475 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Eurim-Pharm 41335362 OMOP2533324 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Eurim-Pharm VO:0016476 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Gerke 41331952 OMOP2529914 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Gerke VO:0016477 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Haematogmbh 41336041 OMOP2534003 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Haematogmbh VO:0016478 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Kohlpharma 41336029 OMOP2533991 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Kohlpharma VO:0016479 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mevita 41331282 OMOP2529244 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mevita VO:0016480 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mtk 41334668 OMOP2532630 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Mtk VO:0016481 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Orifarm Leverkus 41333330 OMOP2531292 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Orifarm Leverkus VO:0016482 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Veron 41335369 OMOP2533331 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 1 by Veron VO:0016483 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Aca Mueller 41331940 OMOP2529902 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Aca Mueller VO:0016484 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Axicorp 41334678 OMOP2532640 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Axicorp VO:0016485 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Cc 41336039 OMOP2534001 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Cc VO:0016486 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Emra-Med 41334006 OMOP2531968 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Emra-Med VO:0016487 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Eurim-Pharm 41332641 OMOP2530603 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Eurim-Pharm VO:0016488 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Gerke 41336038 OMOP2534000 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Gerke VO:0016489 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Haematogmbh 41330607 OMOP2528569 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Haematogmbh VO:0016490 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Kohlpharma 41329298 OMOP2527260 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Kohlpharma VO:0016491 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mevita 41334676 OMOP2532638 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mevita VO:0016492 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mtk 41336703 OMOP2534665 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Mtk VO:0016493 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Orifarm Leverkus 41329297 OMOP2527259 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Orifarm Leverkus VO:0016494 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Veron 41332645 OMOP2530607 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 10 by Veron VO:0016495 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Aca Mueller 41327982 OMOP2525944 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Aca Mueller VO:0016496 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Emra-Med 41334005 OMOP2531967 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Emra-Med VO:0016497 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Kohlpharma 41329296 OMOP2527258 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Kohlpharma VO:0016498 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Mtk 41336026 OMOP2533988 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 25 by Mtk VO:0016499 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Aca Mueller 41335360 OMOP2533322 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Aca Mueller VO:0016500 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Axicorp 41332646 OMOP2530608 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Axicorp VO:0016501 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Emra-Med 41336028 OMOP2533990 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Emra-Med VO:0016502 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Eurim-Pharm 41335359 OMOP2533321 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Eurim-Pharm VO:0016503 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Gerke 41337342 OMOP2535304 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Gerke VO:0016504 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Kohlpharma 41336704 OMOP2534666 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Kohlpharma VO:0016505 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Mevita 41330616 OMOP2528578 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Mevita VO:0016506 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Mtk 41329299 OMOP2527261 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Mtk VO:0016507 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Orifarm Leverkus 41327991 OMOP2525953 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Orifarm Leverkus VO:0016508 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Veron 41329307 OMOP2527269 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Box of 3 by Veron VO:0016509 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] Box of 25 by Gerke 41333318 OMOP2531280 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Lt Grk] Box of 25 by Gerke VO:0016510 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 by European 41334010 44189839 OMOP2531972 OMOP3066562 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 by European VO:0016511 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 3 by European 44189838 OMOP3066561 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 3 by European VO:0016512 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 by Boehringer Ingelheim 41327482 OMOP2525444 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 by Boehringer Ingelheim VO:0016513 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 by Sanofi 41337347 OMOP2535309 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [Gen Vax] Box of 1 by Sanofi VO:0016514 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Aca Mueller 41333323 OMOP2531285 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Aca Mueller VO:0016515 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Axicorp 41337963 OMOP2535925 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Axicorp VO:0016516 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Cc 41331280 OMOP2529242 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Cc VO:0016517 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Emra-Med 41337962 OMOP2535924 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Emra-Med VO:0016518 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Eurim-Pharm 41334670 OMOP2532632 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Eurim-Pharm VO:0016519 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Europharma 41329302 OMOP2527264 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Europharma VO:0016520 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Gerke 41336701 OMOP2534663 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Gerke VO:0016521 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by HVD 41334003 OMOP2531965 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by HVD VO:0016522 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Kohlpharma 41327986 OMOP2525948 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Kohlpharma VO:0016523 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Merck 40719445 OMOP4738256 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Merck VO:0016524 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Mtk 41336707 OMOP2534669 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Mtk VO:0016525 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Orifarm Leverkus 41336706 OMOP2534668 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016526 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Sanofi 41337338 OMOP2535300 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Sanofi VO:0016527 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Veron 41330611 OMOP2528573 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution [HBvaxPRO] Box of 1 by Veron VO:0016528 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Aca Mueller 44189836 OMOP3066559 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Aca Mueller VO:0016529 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Axicorp 44189447 OMOP3066170 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Axicorp VO:0016530 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Cc 44189837 OMOP3066560 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Cc VO:0016531 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Emra-Med 44189541 OMOP3066264 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Emra-Med VO:0016532 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Eurim-Pharm 44190061 OMOP3066784 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Eurim-Pharm VO:0016533 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Europharma 44189360 OMOP3066083 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Europharma VO:0016534 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Gerke 44189446 OMOP3066169 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Gerke VO:0016535 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by HVD 44189830 OMOP3066553 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by HVD VO:0016536 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Kohlpharma 44189752 OMOP3066475 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Kohlpharma VO:0016537 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Merck 44189632 OMOP3066355 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Merck VO:0016538 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Mtk 44189835 OMOP3066558 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Mtk VO:0016539 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Orifarm Leverkus 44189296 OMOP3066019 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Orifarm Leverkus VO:0016540 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Veron 44189633 OMOP3066356 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Solution Box of 1 by Veron VO:0016541 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Axicorp 41332643 OMOP2530605 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Axicorp VO:0016542 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Cc 41334007 OMOP2531969 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Cc VO:0016543 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Emra-Med 41336032 OMOP2533994 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Emra-Med VO:0016544 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Gerke 41330606 OMOP2528568 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Gerke VO:0016545 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by HVD 41330605 OMOP2528567 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by HVD VO:0016546 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Merck 40719443 OMOP4738258 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Merck VO:0016547 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by MSD 36781743 OMOP4770028 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by MSD VO:0016548 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Sanofi 43185527 OMOP508823 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Sanofi VO:0016549 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Veron 41337961 OMOP2535923 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injectable Suspension [HBvaxPRO] Box of 1 by Veron VO:0016550 OHDSI Vaccine WG 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Sanofi 21057503 OMOP290985 vaccine 1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Sanofi VO:0016551 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Orifarm Leverkus 41372442 OMOP2570404 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe [HBvaxPRO] Box of 1 by Orifarm Leverkus VO:0016552 OHDSI Vaccine WG 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe Box of 1 by Orifarm Leverkus 44192698 OMOP3069421 vaccine 10 ML Hepatitis B Surface Antigen Vaccine 0.001 MG/ML Prefilled Syringe Box of 1 by Orifarm Leverkus VO:0016554 OHDSI Vaccine WG 1657669 hepatitis A vaccine (inactivated) strain HM175 / hepatitis B surface antigen vaccine Injection 46276304 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injection VO:0016556 Xingxian Li vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML VO:0016557 Xingxian Li vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML VO:0016558 OHDSI Vaccine WG 1657673 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Injection 46276306 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection VO:0016559 OHDSI Vaccine WG 1360088 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe 42902975 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe VO:0016560 OHDSI Vaccine WG 803368 hepatitis A vaccine (inactivated) strain HM175 / hepatitis B surface antigen vaccine Prefilled Syringe 40153070 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Prefilled Syringe VO:0016561 OHDSI Vaccine WG 1657674 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Injection [Twinrix] 46276307 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] VO:0016562 OHDSI Vaccine WG 1359682 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] 42902569 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] VO:0016563 OHDSI Vaccine WG 803364 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Injection hepatitis A inactivated and hepatitis B (recombinant) vaccine per 1 ML Injection 19131618 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection VO:0016564 OHDSI Vaccine WG 803369 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe hepatitis A vaccine (inactivated) strain HM175 720 UNT / hepatitis B surface antigen vaccine 20 MCG per 1 ML Prefilled Syringe 19131621 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe VO:0016565 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Twinrix] 41045946 OMOP2243908 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML [Twinrix] VO:0016566 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Twinrix Adult] 43156102 OMOP432657 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Twinrix Adult] VO:0016567 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Twinrix Paediatric] 43144907 OMOP432658 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML [Twinrix Paediatric] VO:0016568 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Suspension [Twinrix Adult] 43133966 OMOP432654 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Suspension [Twinrix Adult] VO:0016569 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Suspension [Twinrix Paediatric] 43167026 OMOP432656 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Suspension [Twinrix Paediatric] VO:0016570 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution [Ambirix] 36409658 OMOP3101700 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution [Ambirix] VO:0016571 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution [Twinrix Adult] 36405796 OMOP3097838 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution [Twinrix Adult] VO:0016572 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution [Twinrix Paediatric] 36408083 OMOP3100125 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution [Twinrix Paediatric] VO:0016573 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Ambirix] 21158544 OMOP378260 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Ambirix] VO:0016574 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix Adult] 21168343 OMOP378279 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix Adult] VO:0016575 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix Paediatric] 21099525 OMOP378271 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix Paediatric] VO:0016576 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix] 36421777 OMOP4764055 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Twinrix] VO:0016577 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Solution 41298124 OMOP2496086 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Solution VO:0016578 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Suspension 36883661 OMOP1003998 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Injectable Suspension VO:0016579 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution 36404961 OMOP3097003 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Injectable Solution VO:0016580 OHDSI Vaccine WG Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe 36889539 OMOP997277 vaccine Hepatitis A Vaccine, Inactivated / Hepatitis B Surface Antigen Vaccine Prefilled Syringe VO:0016581 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] 43178094 OMOP432661 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] VO:0016582 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] 43200051 OMOP432663 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] VO:0016583 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Ambirix] 40893623 OMOP2091585 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 / Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Ambirix] VO:0016584 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution 41083407 OMOP2281369 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution VO:0016585 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension 43133967 OMOP432659 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension VO:0016586 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] 43208778 OMOP506643 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] VO:0016587 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] 43174560 OMOP507728 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] VO:0016588 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension 43142819 OMOP506641 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension VO:0016589 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution 41335537 OMOP2533499 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution VO:0016590 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension 43185419 OMOP507726 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension VO:0016591 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] 41120163 OMOP2318125 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] VO:0016592 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] Box of 1 43156103 OMOP432662 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] Box of 1 VO:0016593 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] Box of 1 43200052 OMOP432664 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] Box of 1 VO:0016594 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe 40927097 OMOP2125059 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe VO:0016595 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 41239596 OMOP2437558 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 VO:0016596 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 41114621 OMOP2312583 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 VO:0016597 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 43189017 OMOP432660 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0016598 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] Box of 1 43186890 OMOP506645 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] Box of 1 VO:0016599 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] Box of 1 43174561 OMOP507729 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] Box of 1 VO:0016600 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] 41409379 OMOP2607341 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] VO:0016601 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] 41408981 OMOP2606943 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] VO:0016602 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 43175986 OMOP506642 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0016603 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 41330162 OMOP2528124 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 1 VO:0016604 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 41328162 OMOP2526124 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Solution Box of 10 VO:0016605 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 43218317 OMOP507727 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0016606 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe 41408939 OMOP2606901 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe VO:0016607 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe 41410075 OMOP2608037 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe VO:0016608 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] Box of 1 41214125 OMOP2412087 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] Box of 1 VO:0016609 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 1 41120164 OMOP2318126 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 1 VO:0016610 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 10 41214127 OMOP2412089 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 10 VO:0016611 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 41026231 OMOP2224193 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 VO:0016612 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 41214126 OMOP2412088 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 VO:0016613 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe Box of 1 40958365 OMOP2156327 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe Box of 1 VO:0016614 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 587981 OMOP3138587 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 VO:0016615 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 589069 OMOP3135025 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 VO:0016616 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 41270457 OMOP2468419 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0016617 OHDSI Vaccine WG Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 40864914 OMOP2062876 vaccine Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 VO:0016618 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] Box of 1 by Glaxosmithkline 43153959 OMOP506646 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Paediatric] Box of 1 by Glaxosmithkline VO:0016619 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] Box of 1 by Glaxosmithkline 43185420 OMOP507731 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injectable Suspension [Twinrix Adult] Box of 1 by Glaxosmithkline VO:0016620 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] Box of 1 41409538 OMOP2607500 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] Box of 1 VO:0016621 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 41410115 OMOP2608077 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 VO:0016622 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 41407248 OMOP2605210 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 VO:0016623 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 1 41332316 OMOP2530278 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 1 VO:0016624 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 10 41332315 OMOP2530277 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection [Twinrix] Box of 10 VO:0016625 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 41335735 OMOP2533697 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 VO:0016626 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 41329691 OMOP2527653 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 VO:0016627 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe Box of 1 41409137 OMOP2607099 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe Box of 1 VO:0016628 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 41407987 OMOP2605949 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0016629 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 41407795 OMOP2605757 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 VO:0016630 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 587625 OMOP3134989 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 1 VO:0016631 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 589356 OMOP3135089 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection Box of 10 VO:0016632 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 41337513 OMOP2535475 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0016633 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 41337512 OMOP2535474 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe Box of 10 VO:0016634 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Aca Mueller 41408682 OMOP2606644 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 1440 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Aca Mueller VO:0016635 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by A+S Unicare 41408683 OMOP2606645 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by A+S Unicare VO:0016636 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Cc 41407926 OMOP2605888 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Cc VO:0016637 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Emra-Med 41408871 OMOP2606833 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Emra-Med VO:0016638 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Eurim-Pharm 41409266 OMOP2607228 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Eurim-Pharm VO:0016639 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Gerke 41408330 OMOP2606292 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Gerke VO:0016640 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Veron 41410012 OMOP2607974 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Veron VO:0016641 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by A+S Unicare 41407178 OMOP2605140 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by A+S Unicare VO:0016642 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Aca Mueller 41409808 OMOP2607770 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Aca Mueller VO:0016643 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Emra-Med 41407513 OMOP2605475 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Emra-Med VO:0016644 OHDSI Vaccine WG 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Eurim-Pharm 41409442 OMOP2607404 vaccine 0.5 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Eurim-Pharm VO:0016645 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by A+S Unicare 41329993 OMOP2527955 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by A+S Unicare VO:0016646 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Aca Mueller 41335372 OMOP2533334 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Aca Mueller VO:0016647 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by ADL 41337973 OMOP2535935 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by ADL VO:0016648 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Axicorp 41336713 OMOP2534675 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Axicorp VO:0016649 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Bb Farma 41336712 OMOP2534674 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Bb Farma VO:0016650 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Europharma 41331955 OMOP2529917 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Europharma VO:0016651 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Gerke 41329313 OMOP2527275 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Gerke VO:0016652 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by HVD 41329312 OMOP2527274 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by HVD VO:0016653 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Kohlpharma 41335371 OMOP2533333 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Kohlpharma VO:0016654 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Medicopharm 41328655 OMOP2526617 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Medicopharm VO:0016655 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Mevita 41329992 OMOP2527954 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Mevita VO:0016656 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Milinda Am 41336711 OMOP2534673 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Milinda Am VO:0016657 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Mtk 41328654 OMOP2526616 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Mtk VO:0016658 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Opti 41334017 OMOP2531979 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Opti VO:0016659 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Orifarm Leverkus 41329311 OMOP2527273 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Orifarm Leverkus VO:0016660 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Tisida 41332649 OMOP2530611 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Tisida VO:0016661 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Veron 41332648 OMOP2530610 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 1 by Veron VO:0016662 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by A+S Unicare 41328653 OMOP2526615 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by A+S Unicare VO:0016663 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Abacus Medicine 41334016 44189840 OMOP2531978 OMOP3066563 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Abacus Medicine VO:0016664 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by ADL 41336044 OMOP2534006 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by ADL VO:0016665 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Cc 41329991 OMOP2527953 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Cc VO:0016666 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Europharma 41333334 OMOP2531296 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Europharma VO:0016667 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Gerke 41336043 OMOP2534005 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Gerke VO:0016668 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Kohlpharma 41328652 OMOP2526614 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Kohlpharma VO:0016669 OHDSI Vaccine WG 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Orifarm Leverkus 41327998 OMOP2525960 vaccine 1 ML Hepatitis A Vaccine (Inactivated) Strain HM175 720 UNT/ML / Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Prefilled Syringe [Twinrix] Box of 10 by Orifarm Leverkus VO:0016670 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Boostrix] 43696923 OMOP706554 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Boostrix] VO:0016671 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Covaxis] 43697097 OMOP709499 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Covaxis] VO:0016672 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Diphtherie-Adsorbat-Impfstoff Behring] 43661160 OMOP706557 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Diphtherie-Adsorbat-Impfstoff Behring] VO:0016673 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Repevax] 43697098 OMOP709501 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Repevax] VO:0016674 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Revaxis] 43643199 OMOP709500 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Revaxis] VO:0016675 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Td-Impfstoff Merieux] 43643007 OMOP706555 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Td-Impfstoff Merieux] VO:0016676 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML [Td-Pur] 43588832 OMOP706553 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML [Td-Pur] VO:0016677 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML [Tetravac] 43823026 OMOP709516 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML [Tetravac] VO:0016678 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML [Infanrix] 43696921 OMOP706538 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML [Infanrix] VO:0016679 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML [Pediacel] 43643198 OMOP709492 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML [Pediacel] VO:0016680 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Boostrix] 43679112 OMOP706527 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Boostrix] VO:0016681 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Covaxis] 43661307 OMOP709489 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Covaxis] VO:0016682 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Dipht Toxoid Asid] 41174640 OMOP2372602 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Dipht Toxoid Asid] VO:0016683 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] 43696920 OMOP706536 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] VO:0016684 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Infanrix] 43804760 OMOP706533 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Infanrix] VO:0016685 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Pediacel] 43823024 OMOP709488 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Pediacel] VO:0016686 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Repevax] 43643005 OMOP706534 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Repevax] VO:0016687 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Revaxis] 43624948 OMOP709490 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Revaxis] VO:0016688 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Td-Impfstoff Merieux] 43624762 OMOP706528 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Td-Impfstoff Merieux] VO:0016689 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Td-Pur] 43624761 OMOP706526 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Td-Pur] VO:0016690 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension [Tetravac] 43661306 OMOP709485 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension [Tetravac] VO:0016691 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.2 LFU/ML 44104861 OMOP1099492 vaccine diphtheria toxoid vaccine, inactivated 0.2 LFU/ML VO:0016692 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.5 UNT/ML 41044311 OMOP2242273 vaccine diphtheria toxoid vaccine, inactivated 0.5 UNT/ML VO:0016693 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 10 UNT/ML 41232176 OMOP2430138 vaccine diphtheria toxoid vaccine, inactivated 10 UNT/ML VO:0016694 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 12.5 LFU/ML 36885209 OMOP996298 vaccine diphtheria toxoid vaccine, inactivated 12.5 LFU/ML VO:0016695 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 150 UNT/ML 40857358 OMOP2055320 vaccine diphtheria toxoid vaccine, inactivated 150 UNT/ML VO:0016696 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT 43280285 OMOP557492 vaccine diphtheria toxoid vaccine, inactivated 2 UNT VO:0016697 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML 36892073 OMOP995705 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML VO:0016698 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 20 UNT 43859273 OMOP709491 vaccine diphtheria toxoid vaccine, inactivated 20 UNT VO:0016699 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 30 LFU/ML 44040139 OMOP1034770 vaccine diphtheria toxoid vaccine, inactivated 30 LFU/ML VO:0016700 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 30 UNT 43285749 OMOP557494 vaccine diphtheria toxoid vaccine, inactivated 30 UNT VO:0016701 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 40 UNT/ML 35410277 OMOP1143862 vaccine diphtheria toxoid vaccine, inactivated 40 UNT/ML VO:0016702 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 5 LFU/ML 44053198 OMOP1047829 vaccine diphtheria toxoid vaccine, inactivated 5 LFU/ML VO:0016703 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 50 LFU/ML 44078928 OMOP1073559 vaccine diphtheria toxoid vaccine, inactivated 50 LFU/ML VO:0016704 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML 36892074 OMOP1003447 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML VO:0016705 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML 44117739 OMOP1112370 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML VO:0016706 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Suspension 43732866 OMOP706535 vaccine diphtheria toxoid vaccine, inactivated Injectable Suspension VO:0016707 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] 43661162 OMOP706566 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] VO:0016708 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] 43624950 OMOP709508 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] VO:0016709 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] 43679113 OMOP706585 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] VO:0016710 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] 43714850 OMOP706581 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] VO:0016711 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] 43697099 OMOP709510 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] VO:0016712 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] 43606880 OMOP706568 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] VO:0016713 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] 43822863 OMOP706563 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] VO:0016714 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] 43768963 OMOP709522 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] VO:0016715 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] 43714849 OMOP706542 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] VO:0016716 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] 43768961 OMOP709495 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] VO:0016717 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated Injectable Solution [Dipht Toxoid Asid] 41299078 OMOP2497040 vaccine diphtheria toxoid vaccine, inactivated Injectable Solution [Dipht Toxoid Asid] VO:0016718 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension 43696922 OMOP706545 vaccine diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension VO:0016719 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension 43745624 OMOP921873 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension VO:0016720 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension 43607027 OMOP709517 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension VO:0016721 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension 43624763 OMOP706540 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension VO:0016722 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] 43666348 OMOP718558 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] VO:0016723 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] 43774104 OMOP719324 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] VO:0016724 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] 43756028 OMOP718597 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] VO:0016725 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] 43774057 OMOP718591 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] VO:0016726 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] 43864427 OMOP719329 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] VO:0016727 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] 43684224 OMOP718562 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] VO:0016728 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] 43719940 OMOP718551 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] VO:0016729 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] 43612101 OMOP719343 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] VO:0016730 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] 43738088 OMOP718528 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] VO:0016731 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] 43828121 OMOP719308 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] VO:0016732 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension 43719938 OMOP718532 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension VO:0016733 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension 43666347 OMOP718546 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension VO:0016734 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension 43612100 OMOP719339 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension VO:0016735 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension 43684222 OMOP718526 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension VO:0016736 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 10 43786764 OMOP706567 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 10 VO:0016737 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 20 43588834 OMOP706573 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 20 VO:0016738 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 25 43606881 OMOP706574 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 25 VO:0016739 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 50 43696925 OMOP706575 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 50 VO:0016740 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] Box of 10 43607024 OMOP709509 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] Box of 10 VO:0016741 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] Box of 10 43822864 OMOP706586 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] Box of 10 VO:0016742 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 10 43697100 OMOP709514 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 10 VO:0016743 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 20 43607026 OMOP709515 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 20 VO:0016744 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 5 43750801 OMOP706582 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 5 VO:0016745 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 10 43661310 OMOP709512 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 10 VO:0016746 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 20 43607025 OMOP709513 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 20 VO:0016747 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 43643008 OMOP706569 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 VO:0016748 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 43859077 OMOP706570 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 VO:0016749 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 10 43661161 OMOP706565 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 10 VO:0016750 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 2 43786763 OMOP706564 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 2 VO:0016751 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 10 43750993 OMOP709523 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 10 VO:0016752 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 25 43643201 OMOP709524 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 25 VO:0016753 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 50 43733031 OMOP709525 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 50 VO:0016754 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] Box of 25 43786760 OMOP706543 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] Box of 25 VO:0016755 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 10 43804918 OMOP709496 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 10 VO:0016756 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 20 43624949 OMOP709497 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 20 VO:0016757 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution 44058801 OMOP1053432 vaccine diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution VO:0016758 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution 40833780 OMOP2031742 vaccine diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution VO:0016759 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 40864922 OMOP2062884 vaccine diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0016760 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution 41083412 OMOP2281374 vaccine diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution VO:0016761 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML Injectable Solution 44032803 OMOP1027434 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML Injectable Solution VO:0016762 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution 40864921 OMOP2062883 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution VO:0016763 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 50 LFU/ML Injectable Solution 44084499 OMOP1079130 vaccine diphtheria toxoid vaccine, inactivated 50 LFU/ML Injectable Solution VO:0016764 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 43822862 OMOP706547 vaccine diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 VO:0016765 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 43786761 OMOP706548 vaccine diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 VO:0016766 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 43624764 OMOP706546 vaccine diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 VO:0016767 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 1 41301542 OMOP2499504 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 1 VO:0016768 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 43674011 OMOP921874 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 VO:0016769 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 2 43804761 OMOP706559 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 2 VO:0016770 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 43588833 OMOP706560 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 VO:0016771 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 25 43696924 OMOP706561 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 25 VO:0016772 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 43661308 OMOP709503 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 VO:0016773 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 50 43732868 OMOP706562 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 50 VO:0016774 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 10 43841131 OMOP709518 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 10 VO:0016775 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 25 43841132 OMOP709519 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 25 VO:0016776 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 50 43786926 OMOP709521 vaccine diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 50 VO:0016777 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 10 43750991 OMOP709493 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 10 VO:0016778 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 20 43715006 OMOP709494 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 20 VO:0016779 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 25 43661159 OMOP706541 vaccine diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 25 VO:0016780 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension by Statens Serum Institut 43809998 OMOP718538 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension by Statens Serum Institut VO:0016781 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] by Glaxosmithkline 43774054 OMOP718559 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] by Glaxosmithkline VO:0016782 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] by Sanofi 43594127 OMOP719325 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] by Sanofi VO:0016783 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] by Novartis 43648232 OMOP718598 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] by Novartis VO:0016784 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] by Sanofi 43702230 OMOP718592 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] by Sanofi VO:0016785 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] by Sanofi 43719993 OMOP719330 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] by Sanofi VO:0016786 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] by Sanofi 43774055 OMOP718563 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] by Sanofi VO:0016787 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] by Novartis 43791839 OMOP718552 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] by Novartis VO:0016788 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension by Glaxosmithkline 43702174 OMOP717407 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension by Glaxosmithkline VO:0016789 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension by Sanofi 43864315 OMOP717411 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension by Sanofi VO:0016790 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension by Statens Serum Institut 43774103 OMOP719317 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension by Statens Serum Institut VO:0016791 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] by Sanofi 43719995 OMOP719344 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] by Sanofi VO:0016792 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] by Glaxosmithkline 43594079 OMOP718529 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] by Glaxosmithkline VO:0016793 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] by Sanofi 43756066 OMOP719309 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] by Sanofi VO:0016794 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 10 43648230 OMOP718560 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 10 VO:0016795 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 20 43594081 OMOP718573 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 20 VO:0016796 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 25 43630166 OMOP718575 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 25 VO:0016797 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 50 43612043 OMOP718578 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 50 VO:0016798 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] Box of 10 43612099 OMOP719327 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] Box of 10 VO:0016799 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] Box of 10 43828079 OMOP718599 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] Box of 10 VO:0016800 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 10 43774107 OMOP719336 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 10 VO:0016801 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 20 43774108 OMOP719338 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 20 VO:0016802 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 5 43810001 OMOP718593 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 5 VO:0016803 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 10 43648265 OMOP719331 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 10 VO:0016804 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 20 43828124 OMOP719333 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 20 VO:0016805 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 43719942 OMOP718564 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 VO:0016806 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 43828078 OMOP718567 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 VO:0016807 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 10 43791840 OMOP718556 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 10 VO:0016808 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 2 43719941 OMOP718553 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 2 VO:0016809 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 10 43594128 OMOP719346 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 10 VO:0016810 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 25 43846158 OMOP719348 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 25 VO:0016811 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 50 43810045 OMOP719350 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 50 VO:0016812 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] Box of 25 43648226 OMOP718530 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] Box of 25 VO:0016813 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 10 43864426 OMOP719310 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 10 VO:0016814 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 20 43738131 OMOP719312 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 20 VO:0016815 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 43846124 OMOP718535 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 VO:0016816 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 43594080 OMOP718536 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 VO:0016817 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 43774051 OMOP718533 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 VO:0016818 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 1 41409330 OMOP2607292 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 1 VO:0016819 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 43719886 OMOP717405 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 VO:0016820 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 2 43648228 OMOP718547 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 2 VO:0016821 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 43846125 OMOP718548 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 VO:0016822 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 25 43630165 OMOP718549 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 25 VO:0016823 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 43828122 OMOP719314 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 VO:0016824 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 50 43648229 OMOP718550 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 50 VO:0016825 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 10 43719994 OMOP719340 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 10 VO:0016826 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 25 43864429 OMOP719341 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 25 VO:0016827 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 50 43828125 OMOP719342 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension Box of 50 VO:0016828 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 10 43666385 OMOP719306 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 10 VO:0016829 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 20 43594124 OMOP719307 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 20 VO:0016830 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 25 43702228 OMOP718527 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension Box of 25 VO:0016831 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 41408750 OMOP2606712 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0016832 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution 41407156 OMOP2605118 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution VO:0016833 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution 41407797 OMOP2605759 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution VO:0016834 OHDSI Vaccine WG 10 ML diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution 41361286 OMOP2559248 vaccine 10 ML diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution VO:0016835 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution Box of 5 44097418 OMOP1092049 vaccine diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution Box of 5 VO:0016836 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution Box of 1 40864920 OMOP2062882 vaccine diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution Box of 1 VO:0016837 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 41270459 OMOP2468421 vaccine diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 VO:0016838 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 41051819 OMOP2249781 vaccine diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 VO:0016839 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 40958367 OMOP2156329 vaccine diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 VO:0016840 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML Injectable Solution Box of 5 44045779 OMOP1040410 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML Injectable Solution Box of 5 VO:0016841 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 41270458 OMOP2468420 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 VO:0016842 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 41114623 OMOP2312585 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 VO:0016843 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 by Statens Serum Institut 43756024 OMOP718542 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 by Statens Serum Institut VO:0016844 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 by Statens Serum Institut 43719939 OMOP718544 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 by Statens Serum Institut VO:0016845 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 by Statens Serum Institut 43774052 OMOP718540 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 by Statens Serum Institut VO:0016846 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 10 by Glaxosmithkline 43791841 OMOP718561 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 10 by Glaxosmithkline VO:0016847 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 20 by Glaxosmithkline 43738091 OMOP718574 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 20 by Glaxosmithkline VO:0016848 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 25 by Glaxosmithkline 43774056 OMOP718577 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 25 by Glaxosmithkline VO:0016849 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 50 by Glaxosmithkline 43684225 OMOP718579 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Boostrix] Box of 50 by Glaxosmithkline VO:0016850 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] Box of 10 by Sanofi 43774105 OMOP719328 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Covaxis] Box of 10 by Sanofi VO:0016851 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] Box of 10 by Novartis 43846126 OMOP718600 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Diphtherie-Adsorbat-Impfstoff Behring] Box of 10 by Novartis VO:0016852 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 10 by Sanofi 43810044 OMOP719337 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 10 by Sanofi VO:0016853 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 20 by Sanofi 43612044 OMOP718596 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 20 by Sanofi VO:0016854 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 5 by Sanofi 43756027 OMOP718594 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Repevax] Box of 5 by Sanofi VO:0016855 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 10 by Sanofi 43864428 OMOP719332 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 10 by Sanofi VO:0016856 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 20 by Sanofi 43774106 OMOP719334 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Revaxis] Box of 20 by Sanofi VO:0016857 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 by Sanofi 43828077 OMOP718566 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 by Sanofi VO:0016858 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 by Sanofi 43719943 OMOP718568 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 by Sanofi VO:0016859 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 10 by Novartis 43738089 OMOP718557 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 10 by Novartis VO:0016860 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 2 by Novartis 43828076 OMOP718555 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Td-Pur] Box of 2 by Novartis VO:0016861 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 1 by Novartis 41409444 OMOP2607406 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 1 by Novartis VO:0016862 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 by Glaxosmithkline 43773994 OMOP717409 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 by Glaxosmithkline VO:0016863 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 by Novartis 41408684 OMOP2606646 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 by Novartis VO:0016864 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 by Statens Serum Institut 43828123 OMOP719321 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 by Statens Serum Institut VO:0016865 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 by Sanofi 43809941 OMOP717416 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 by Sanofi VO:0016866 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 by Statens Serum Institut 43612098 OMOP719323 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 20 by Statens Serum Institut VO:0016867 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 by Sanofi 43828013 OMOP717414 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 by Sanofi VO:0016868 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 by Statens Serum Institut 43684268 OMOP719319 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 5 by Statens Serum Institut VO:0016869 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 10 by Sanofi 43684269 OMOP719347 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 10 by Sanofi VO:0016870 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 25 by Sanofi 43702273 OMOP719349 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 25 by Sanofi VO:0016871 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 50 by Sanofi 43719996 OMOP719351 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 LFU/ML Injectable Suspension [Tetravac] Box of 50 by Sanofi VO:0016872 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] Box of 25 by Glaxosmithkline 43828075 OMOP718531 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Infanrix] Box of 25 by Glaxosmithkline VO:0016873 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 10 by Sanofi 43666386 OMOP719311 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 10 by Sanofi VO:0016874 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 20 by Sanofi 43630204 OMOP719313 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 60 UNT/ML Injectable Suspension [Pediacel] Box of 20 by Sanofi VO:0016875 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution by Connaught 44089491 OMOP1084122 vaccine diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution by Connaught VO:0016876 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 50 LFU/ML Injectable Solution by Aventis 44102505 OMOP1097136 vaccine diphtheria toxoid vaccine, inactivated 50 LFU/ML Injectable Solution by Aventis VO:0016877 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 41407592 OMOP2605554 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 VO:0016878 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 41408942 OMOP2606904 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 VO:0016879 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 41409880 OMOP2607842 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 VO:0016880 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 41409138 OMOP2607100 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 VO:0016881 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 41407591 OMOP2605553 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 VO:0016882 OHDSI Vaccine WG 10 ML diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution Box of 1 41371837 OMOP2569799 vaccine 10 ML diphtheria toxoid vaccine, inactivated 0.5 UNT/ML Injectable Solution Box of 1 VO:0016883 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 by Boehringer Ingelheim 41409445 OMOP2607407 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 by Boehringer Ingelheim VO:0016884 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 by Novartis 41409058 OMOP2607020 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 by Novartis VO:0016885 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 by Boehringer Ingelheim 41410200 OMOP2608162 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 by Boehringer Ingelheim VO:0016886 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 by Novartis 41408126 OMOP2606088 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 10 by Novartis VO:0016887 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 by Boehringer Ingelheim 41407316 OMOP2605278 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 by Boehringer Ingelheim VO:0016888 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 by Novartis 41408685 OMOP2606647 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 by Novartis VO:0016889 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 by Novartis 41407927 OMOP2605889 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 by Novartis VO:0016890 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution Box of 5 by Aventis 44037757 OMOP1032388 vaccine diphtheria toxoid vaccine, inactivated 0.2 LFU/ML Injectable Solution Box of 5 by Aventis VO:0016891 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML Injectable Solution Box of 5 by Aventis 44037758 OMOP1032389 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML Injectable Solution Box of 5 by Aventis VO:0016892 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 43286675 OMOP559761 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0016893 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] 43292053 OMOP559763 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] VO:0016894 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] Box of 5 43270320 OMOP559764 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] Box of 5 VO:0016895 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 43286676 OMOP559762 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 VO:0016896 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43666346 OMOP718519 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0016897 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] 43864385 OMOP718520 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] VO:0016898 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] by Sanofi 43684221 OMOP718521 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] by Sanofi VO:0016899 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 43292054 OMOP559773 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0016900 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] 43275889 OMOP559775 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] VO:0016901 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] Box of 10 43264838 OMOP559776 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] Box of 10 VO:0016902 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 10 43275888 OMOP559774 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 10 VO:0016903 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection 43281218 OMOP559757 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection VO:0016904 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] 43270319 OMOP559759 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] VO:0016905 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] Box of 5 43281219 OMOP559760 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] Box of 5 VO:0016906 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 43264835 OMOP559758 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 VO:0016907 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 43630163 OMOP718509 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0016908 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] 43684220 OMOP718510 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] VO:0016909 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] by Glaxosmithkline 43630164 OMOP718511 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] by Glaxosmithkline VO:0016910 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 36281241 OMOP3132116 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0016911 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 36281193 OMOP3132068 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0016912 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] by GSK 36281117 OMOP3131992 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] by GSK VO:0016913 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 36281153 OMOP3132028 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0016914 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetravac] 36281053 OMOP3131928 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetravac] VO:0016915 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetravac] by Sanofi 36281138 OMOP3132013 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetravac] by Sanofi VO:0016916 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 36281240 OMOP3132115 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0016917 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] 36281220 OMOP3132095 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] VO:0016918 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] by GSK 36281175 OMOP3132050 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] by GSK VO:0016919 OHDSI Vaccine WG 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 44132573 OMOP1127204 vaccine 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0016920 OHDSI Vaccine WG 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Tripacel] 44132508 OMOP1127139 vaccine 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Tripacel] VO:0016921 OHDSI Vaccine WG 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 44132527 OMOP1127158 vaccine 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0016922 OHDSI Vaccine WG 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Adacel] 44132587 OMOP1127218 vaccine 0.5 ML Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Adacel] VO:0016923 OHDSI Vaccine WG 0.5 ML Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43774059 OMOP718612 vaccine 0.5 ML Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0016924 OHDSI Vaccine WG 0.5 ML Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 43630169 OMOP718613 vaccine 0.5 ML Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0016925 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.05 MG/ML Injectable Solution 44132659 OMOP1127290 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.05 MG/ML Injectable Solution VO:0016926 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.05 MG/ML Injectable Solution by Aventis 44132772 OMOP1127403 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.05 MG/ML Injectable Solution by Aventis VO:0016927 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML / tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension 43612045 OMOP718606 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML / tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension VO:0016928 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML / tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension by Statens Serum Institut 43828080 OMOP718608 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 12.5 LFU/ML / tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension by Statens Serum Institut VO:0016929 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection 43519139 OMOP2806254 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection VO:0016930 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection Box of 10 43519222 OMOP2806337 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection Box of 10 VO:0016931 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection Box of 10 by Massbiologics 43519191 OMOP2806306 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection Box of 10 by Massbiologics VO:0016932 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection by Massbiologics 43519171 OMOP2806286 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection by Massbiologics VO:0016933 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 43519269 OMOP2806384 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0016934 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] 43519278 OMOP2806393 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] VO:0016935 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] Box of 5 43519215 OMOP2806330 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] Box of 5 VO:0016936 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Vaccine] 43519170 OMOP2806285 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Vaccine] VO:0016937 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 43519238 OMOP2806353 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 VO:0016938 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution 44132785 OMOP1127416 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution VO:0016939 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution [Tri-Immunol Im] 44132543 OMOP1127174 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution [Tri-Immunol Im] VO:0016940 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution [Tri-Immunol Im] by Lederle Products 44132826 OMOP1127457 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution [Tri-Immunol Im] by Lederle Products VO:0016941 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension 44132614 OMOP1127245 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension VO:0016942 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension Box of 5 44132656 OMOP1127287 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension Box of 5 VO:0016943 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension Box of 5 by Sanofi 44132689 OMOP1127320 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension Box of 5 by Sanofi VO:0016944 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 44132657 OMOP1127288 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0016945 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension by Iaf Biovac 44132771 OMOP1127402 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension by Iaf Biovac VO:0016946 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension by Lederle Products 44132690 OMOP1127321 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension by Lederle Products VO:0016947 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection 43286678 OMOP559783 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection VO:0016948 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection Box of 10 43259416 OMOP559784 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection Box of 10 VO:0016949 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection Box of 10 by Massbiologics 43275890 OMOP559786 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection Box of 10 by Massbiologics VO:0016950 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection by Massbiologics 43264839 OMOP559785 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection by Massbiologics VO:0016951 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 36281184 OMOP3132059 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0016952 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] 36281077 OMOP3131952 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] VO:0016953 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] by Sanofi 36281178 OMOP3132053 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] by Sanofi VO:0016954 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 44132702 OMOP1127333 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0016955 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 44132586 OMOP1127217 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0016956 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43594023 OMOP717417 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0016957 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] 43648233 OMOP718604 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] VO:0016958 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] by Sanofi 43810002 OMOP718605 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] by Sanofi VO:0016959 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] 43666351 OMOP718601 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] VO:0016960 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] by Novartis 43666352 OMOP718602 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] by Novartis VO:0016961 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Glaxosmithkline 43666287 OMOP717419 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Glaxosmithkline VO:0016962 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Sanofi 43738032 OMOP717421 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Sanofi VO:0016963 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection 43281222 OMOP559777 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection VO:0016964 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] 43297433 OMOP559780 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] VO:0016965 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] Box of 5 43292055 OMOP559781 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] Box of 5 VO:0016966 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Vaccine] 43297434 OMOP559782 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Vaccine] VO:0016967 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 43286677 OMOP559779 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 VO:0016968 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution 44132524 OMOP1127155 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution VO:0016969 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution by Aventis 44132641 OMOP1127272 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution by Aventis VO:0016970 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution 44132523 OMOP1127154 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution VO:0016971 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution by Aventis 44132733 OMOP1127364 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution by Aventis VO:0016972 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / tetanus toxin 10 LFU/ML Injectable Solution 44132747 OMOP1127378 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / tetanus toxin 10 LFU/ML Injectable Solution VO:0016973 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / tetanus toxin 10 LFU/ML Injectable Solution by Aventis 44132884 OMOP1127515 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 LFU/ML / tetanus toxin 10 LFU/ML Injectable Solution by Aventis VO:0016974 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injectable Solution 44132844 OMOP1127475 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injectable Solution VO:0016975 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection 589430 OMOP3136316 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection VO:0016976 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection [Hiberix] 44132624 OMOP1127255 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection [Hiberix] VO:0016977 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection [Hiberix] by Glaxosmithkline 44132551 OMOP1127182 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection [Hiberix] by Glaxosmithkline VO:0016978 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injectable Solution 44132780 OMOP1127411 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injectable Solution VO:0016979 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection 588673 OMOP3135813 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection VO:0016980 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection [ActHIB] 44132757 OMOP1127388 vaccine 0.5 ML Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection [ActHIB] VO:0016981 OHDSI Vaccine WG 0.5 ML meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension 44132838 OMOP1127469 vaccine 0.5 ML meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension VO:0016982 OHDSI Vaccine WG 0.5 ML meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension [Neisvac C] 44132620 OMOP1127251 vaccine 0.5 ML meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension [Neisvac C] VO:0016983 OHDSI Vaccine WG 0.5 ML meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension [Neisvac C] by Pfizer 44132688 OMOP1127319 vaccine 0.5 ML meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension [Neisvac C] by Pfizer VO:0016984 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 44132567 OMOP1127198 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0016985 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [T Polio Adsorbed] 44132752 OMOP1127383 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [T Polio Adsorbed] VO:0016986 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [T Polio Adsorbed] by Aventis 44132724 OMOP1127355 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [T Polio Adsorbed] by Aventis VO:0016987 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension 43828087 OMOP718701 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension VO:0016988 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 43594084 OMOP718703 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 VO:0016989 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 by Statens Serum Institut 43684233 OMOP718711 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 by Statens Serum Institut VO:0016990 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 43828088 OMOP718704 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 VO:0016991 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 by Statens Serum Institut 43864389 OMOP718713 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 by Statens Serum Institut VO:0016992 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 43684232 OMOP718702 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 VO:0016993 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 by Statens Serum Institut 43648238 OMOP718709 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 by Statens Serum Institut VO:0016994 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension by Statens Serum Institut 43738101 OMOP718706 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension by Statens Serum Institut VO:0016995 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution 41407982 OMOP2605944 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution VO:0016996 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] 41407237 OMOP2605199 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] VO:0016997 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 1 41410114 OMOP2608076 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 1 VO:0016998 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 1 by Baxter 41407914 OMOP2605876 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 1 by Baxter VO:0016999 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 10 41410113 OMOP2608075 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 10 VO:0017000 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 10 by Baxter 41408861 OMOP2606823 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 10 by Baxter VO:0017001 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] 41408787 OMOP2606749 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] VO:0017002 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] Box of 100 41409530 OMOP2607492 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] Box of 100 VO:0017003 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] 41408250 OMOP2606212 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] VO:0017004 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 41407236 OMOP2605198 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017005 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 by Boehringer Ingelheim 41407307 OMOP2605269 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 by Boehringer Ingelheim VO:0017006 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 by Novartis 41408324 OMOP2606286 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 by Novartis VO:0017007 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 41407234 OMOP2605196 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 VO:0017008 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 by Boehringer Ingelheim 41407502 OMOP2605464 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 by Boehringer Ingelheim VO:0017009 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 by Novartis 41408858 OMOP2606820 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 by Novartis VO:0017010 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 100 41409712 OMOP2607674 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 100 VO:0017011 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 41407235 OMOP2605197 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 VO:0017012 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 by Boehringer Ingelheim 41408860 OMOP2606822 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 by Boehringer Ingelheim VO:0017013 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 by Novartis 41407913 OMOP2605875 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 by Novartis VO:0017014 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 41409529 OMOP2607491 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 VO:0017015 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 by Boehringer Ingelheim 41408114 OMOP2606076 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 by Boehringer Ingelheim VO:0017016 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 by Novartis 41409037 OMOP2606999 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 by Novartis VO:0017017 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 50 41409713 OMOP2607675 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 50 VO:0017018 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 50 by Boehringer Ingelheim 41409793 OMOP2607755 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 50 by Boehringer Ingelheim VO:0017019 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 41408579 OMOP2606541 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 VO:0017020 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 10 41408935 OMOP2606897 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 10 VO:0017021 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 100 41408399 OMOP2606361 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 100 VO:0017022 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 2 41408936 OMOP2606898 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 2 VO:0017023 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 20 41408578 OMOP2606540 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 20 VO:0017024 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 50 41409874 OMOP2607836 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 50 VO:0017025 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension 43738033 OMOP717422 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension VO:0017026 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] 43666288 OMOP717425 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] VO:0017027 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] Box of 10 43755955 OMOP717427 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] Box of 10 VO:0017028 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] Box of 10 by Baxter 43666290 OMOP717428 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] Box of 10 by Baxter VO:0017029 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] by Baxter 43666289 OMOP717426 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] by Baxter VO:0017030 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension Box of 10 43809942 OMOP717424 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension Box of 10 VO:0017031 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe 41408398 OMOP2606360 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe VO:0017032 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] 41409711 OMOP2607673 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] VO:0017033 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 41409927 OMOP2607889 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 VO:0017034 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 by Boehringer Ingelheim 41408113 OMOP2606075 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 by Boehringer Ingelheim VO:0017035 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 by Novartis 41409255 OMOP2607217 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 by Novartis VO:0017036 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 41408249 OMOP2606211 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 VO:0017037 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 by Boehringer Ingelheim 41408859 OMOP2606821 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 by Boehringer Ingelheim VO:0017038 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 by Novartis 41407501 OMOP2605463 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 by Novartis VO:0017039 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 100 41407233 OMOP2605195 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 100 VO:0017040 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 20 41407426 OMOP2605388 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 20 VO:0017041 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 20 by Novartis 41407306 OMOP2605268 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 20 by Novartis VO:0017042 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 50 41407425 OMOP2605387 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 50 VO:0017043 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 50 by Boehringer Ingelheim 41408672 OMOP2606634 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 50 by Boehringer Ingelheim VO:0017044 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 1 41408934 OMOP2606896 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 1 VO:0017045 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 10 41410069 OMOP2608031 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 10 VO:0017046 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 100 41408747 OMOP2606709 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 100 VO:0017047 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 20 41408397 OMOP2606359 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 20 VO:0017048 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 50 41407588 OMOP2605550 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 50 VO:0017049 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension 43612102 OMOP719352 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension VO:0017050 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] 43810046 OMOP719357 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] VO:0017051 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 10 43630205 OMOP719359 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 10 VO:0017052 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 10 by Sanofi 43630206 OMOP719360 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 10 by Sanofi VO:0017053 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 25 43864431 OMOP719361 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 25 VO:0017054 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 25 by Sanofi 43648267 OMOP719362 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 25 by Sanofi VO:0017055 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 50 43684270 OMOP719363 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 50 VO:0017056 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 50 by Sanofi 43702274 OMOP719364 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 50 by Sanofi VO:0017057 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] by Sanofi 43648266 OMOP719358 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] by Sanofi VO:0017058 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 10 43864430 OMOP719353 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 10 VO:0017059 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 25 43756068 OMOP719354 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 25 VO:0017060 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 50 43666387 OMOP719355 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 50 VO:0017061 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution 41409133 OMOP2607095 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution VO:0017062 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] 41410112 OMOP2608074 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] VO:0017063 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 1 41407424 OMOP2605386 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 1 VO:0017064 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 10 41409179 OMOP2607141 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 10 VO:0017065 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 41410068 OMOP2608030 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 VO:0017066 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 41408933 OMOP2606895 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 VO:0017067 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension 43630210 OMOP719397 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension VO:0017068 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] 43864435 OMOP719399 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] VO:0017069 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] Box of 10 43791890 OMOP719401 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] Box of 10 VO:0017070 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] Box of 10 by Glaxosmithkline 43864436 OMOP719402 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] Box of 10 by Glaxosmithkline VO:0017071 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] by Glaxosmithkline 43791889 OMOP719400 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] by Glaxosmithkline VO:0017072 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 43719997 OMOP719398 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 VO:0017073 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43702176 OMOP717429 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017074 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 43846127 OMOP718631 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0017075 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 10 43612049 OMOP718633 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 10 VO:0017076 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 10 by Glaxosmithkline 43756030 OMOP718634 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 10 by Glaxosmithkline VO:0017077 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 20 43630172 OMOP718647 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 20 VO:0017078 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 20 by Glaxosmithkline 43719949 OMOP718648 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 20 by Glaxosmithkline VO:0017079 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 25 43810004 OMOP718649 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 25 VO:0017080 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 25 by Glaxosmithkline 43738097 OMOP718650 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 25 by Glaxosmithkline VO:0017081 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 50 43810005 OMOP718651 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 50 VO:0017082 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 50 by Glaxosmithkline 43774060 OMOP718652 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 50 by Glaxosmithkline VO:0017083 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] by Glaxosmithkline 43719948 OMOP718632 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] by Glaxosmithkline VO:0017084 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] 43702276 OMOP719382 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] VO:0017085 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] Box of 10 43846161 OMOP719385 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] Box of 10 VO:0017086 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] Box of 10 by Sanofi 43810047 OMOP719386 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] Box of 10 by Sanofi VO:0017087 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] by Sanofi 43864434 OMOP719384 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] by Sanofi VO:0017088 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] 43828082 OMOP718664 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] VO:0017089 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 10 43810007 OMOP718668 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 10 VO:0017090 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 10 by Sanofi 43702277 OMOP719395 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 10 by Sanofi VO:0017091 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 20 43756070 OMOP719396 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 20 VO:0017092 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 20 by Sanofi 43756034 OMOP718669 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 20 by Sanofi VO:0017093 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 5 43810006 OMOP718665 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 5 VO:0017094 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 5 by Sanofi 43846129 OMOP718666 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 5 by Sanofi VO:0017095 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] by Sanofi 43738134 OMOP719394 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] by Sanofi VO:0017096 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] 43756069 OMOP719387 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] VO:0017097 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 10 43791887 OMOP719389 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 10 VO:0017098 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 10 by Sanofi 43810048 OMOP719390 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 10 by Sanofi VO:0017099 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 20 43738133 OMOP719391 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 20 VO:0017100 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 20 by Sanofi 43791888 OMOP719392 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 20 by Sanofi VO:0017101 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] by Sanofi 43630209 OMOP719388 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] by Sanofi VO:0017102 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] 43648235 OMOP718636 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] VO:0017103 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 43756031 OMOP718638 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 VO:0017104 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 by Sanofi 43684227 OMOP718639 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 by Sanofi VO:0017105 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 43630171 OMOP718640 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 VO:0017106 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 by Sanofi 43756032 OMOP718641 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 by Sanofi VO:0017107 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] by Sanofi 43738096 OMOP718637 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] by Sanofi VO:0017108 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] 43630170 OMOP718625 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] VO:0017109 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 10 43738095 OMOP718629 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 10 VO:0017110 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 10 by Novartis 43719947 OMOP718630 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 10 by Novartis VO:0017111 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 2 43666353 OMOP718627 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 2 VO:0017112 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 2 by Novartis 43738094 OMOP718628 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 2 by Novartis VO:0017113 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] by Novartis 43612048 OMOP718626 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] by Novartis VO:0017114 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 43612047 OMOP718621 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 VO:0017115 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 by Glaxosmithkline 43738034 OMOP717435 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 by Glaxosmithkline VO:0017116 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 by Statens Serum Institut 43648268 OMOP719379 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 by Statens Serum Institut VO:0017117 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 2 43828081 OMOP718619 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 2 VO:0017118 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 43755956 OMOP717430 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 VO:0017119 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 by Sanofi 43828015 OMOP717441 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 by Sanofi VO:0017120 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 by Statens Serum Institut 43702275 OMOP719381 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 by Statens Serum Institut VO:0017121 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 25 43864386 OMOP718622 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 25 VO:0017122 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 43738093 OMOP718620 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 VO:0017123 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 by Sanofi 43684171 OMOP717439 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 by Sanofi VO:0017124 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 by Statens Serum Institut 43666389 OMOP719377 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 by Statens Serum Institut VO:0017125 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 50 43756029 OMOP718623 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 50 VO:0017126 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Glaxosmithkline 43828014 OMOP717433 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Glaxosmithkline VO:0017127 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Sanofi 43773995 OMOP717437 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Sanofi VO:0017128 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Statens Serum Institut 43630208 OMOP719375 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension by Statens Serum Institut VO:0017129 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution 41408577 OMOP2606539 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution VO:0017130 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] 41408248 OMOP2606210 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] VO:0017131 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] Box of 1 41409926 OMOP2607888 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] Box of 1 VO:0017132 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] Box of 1 by Ribosepharm 41407706 OMOP2605668 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] Box of 1 by Ribosepharm VO:0017133 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] 41410111 OMOP2608073 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] VO:0017134 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 1 41409924 OMOP2607886 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017135 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 10 41409370 OMOP2607332 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 10 VO:0017136 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 2 41409371 OMOP2607333 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 2 VO:0017137 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 2 by Novartis 41407705 OMOP2605667 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 2 by Novartis VO:0017138 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 20 41409925 OMOP2607887 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 20 VO:0017139 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 20 by Novartis 41409599 OMOP2607561 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 20 by Novartis VO:0017140 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 80 41410110 OMOP2608072 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 80 VO:0017141 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 1 41408576 OMOP2606538 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 1 VO:0017142 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 1 by Sanofi 41407707 OMOP2605669 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 1 by Sanofi VO:0017143 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 10 41408932 OMOP2606894 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 10 VO:0017144 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 10 by Sanofi 41407912 OMOP2605874 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 10 by Sanofi VO:0017145 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 100 41409498 OMOP2607460 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 100 VO:0017146 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 2 41409132 OMOP2607094 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 2 VO:0017147 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 20 41407164 OMOP2605126 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 20 VO:0017148 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 20 by Sanofi 41407305 OMOP2605267 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 20 by Sanofi VO:0017149 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 50 41408396 OMOP2606358 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 50 VO:0017150 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 50 by Sanofi 41409036 OMOP2606998 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 50 by Sanofi VO:0017151 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 80 41407375 OMOP2605337 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 80 VO:0017152 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 43864432 OMOP719365 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0017153 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] 43612055 OMOP718688 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] VO:0017154 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] Box of 25 43774062 OMOP718690 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] Box of 25 VO:0017155 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] Box of 25 by Glaxosmithkline 43864388 OMOP718691 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] Box of 25 by Glaxosmithkline VO:0017156 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] by Glaxosmithkline 43630175 OMOP718689 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] by Glaxosmithkline VO:0017157 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] 43846159 OMOP719367 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] VO:0017158 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 10 43666388 OMOP719369 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 10 VO:0017159 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 10 by Sanofi 43791886 OMOP719370 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 10 by Sanofi VO:0017160 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 20 43594129 OMOP719371 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 20 VO:0017161 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 20 by Sanofi 43738132 OMOP719372 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 20 by Sanofi VO:0017162 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] by Sanofi 43630207 OMOP719368 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] by Sanofi VO:0017163 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] 43666354 OMOP718692 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] VO:0017164 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 10 43684231 OMOP718697 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 10 VO:0017165 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 10 by Novartis 43612056 OMOP718698 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 10 by Novartis VO:0017166 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 2 43684230 OMOP718694 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 2 VO:0017167 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 2 by Novartis 43702233 OMOP718695 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 2 by Novartis VO:0017168 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 20 43719951 OMOP718699 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 20 VO:0017169 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 20 by Novartis 43791845 OMOP718700 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 20 by Novartis VO:0017170 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] by Novartis 43828086 OMOP718693 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] by Novartis VO:0017171 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] 43738100 OMOP718679 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] VO:0017172 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 10 43684228 OMOP718681 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 10 VO:0017173 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 10 by Sanofi 43630174 OMOP718682 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 10 by Sanofi VO:0017174 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 20 43684229 OMOP718683 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 20 VO:0017175 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 20 by Sanofi 43828084 OMOP718684 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 20 by Sanofi VO:0017176 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 50 43864387 OMOP718686 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 50 VO:0017177 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 50 by Sanofi 43828085 OMOP718687 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 50 by Sanofi VO:0017178 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] by Sanofi 43774061 OMOP718680 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] by Sanofi VO:0017179 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] 43828083 OMOP718675 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] VO:0017180 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] Box of 10 43594083 OMOP718677 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] Box of 10 VO:0017181 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] Box of 10 by Glaxosmithkline 43702232 OMOP718678 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] Box of 10 by Glaxosmithkline VO:0017182 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] by Glaxosmithkline 43612054 OMOP718676 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] by Glaxosmithkline VO:0017183 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 10 43774109 OMOP719366 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 10 VO:0017184 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 2 43738099 OMOP718670 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 2 VO:0017185 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 20 43756035 OMOP718671 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 20 VO:0017186 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 25 43756036 OMOP718672 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 25 VO:0017187 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 50 43612053 OMOP718673 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 50 VO:0017188 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe 41408931 OMOP2606893 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe VO:0017189 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] 41407831 OMOP2605793 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] VO:0017190 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 1 41407830 OMOP2605792 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 1 VO:0017191 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 1 by Novartis 41408857 OMOP2606819 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 1 by Novartis VO:0017192 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 10 41408247 OMOP2606209 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 10 VO:0017193 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 10 by Novartis 41409997 OMOP2607959 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 10 by Novartis VO:0017194 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 20 41408023 OMOP2605985 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 20 VO:0017195 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 20 by Novartis 41408856 OMOP2606818 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 20 by Novartis VO:0017196 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 1 41409131 OMOP2607093 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 1 VO:0017197 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 1 by Sanofi 41409428 OMOP2607390 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 1 by Sanofi VO:0017198 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 10 41409873 OMOP2607835 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 10 VO:0017199 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 10 by Sanofi 41408323 OMOP2606285 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 10 by Sanofi VO:0017200 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 100 41408930 OMOP2606892 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 100 VO:0017201 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 20 41409672 OMOP2607634 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 20 VO:0017202 OHDSI Vaccine WG 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 20 by Sanofi 41409998 OMOP2607960 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 20 by Sanofi VO:0017203 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 2000 IU/ML Injectable Solution 2031037 OMOP4929831 vaccine 1 ML tetanus toxoid vaccine, inactivated 2000 IU/ML Injectable Solution VO:0017204 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 2000 IU/ML Injectable Solution by SK Chemical 2031038 OMOP4929832 vaccine 1 ML tetanus toxoid vaccine, inactivated 2000 IU/ML Injectable Solution by SK Chemical VO:0017205 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution 40719061 OMOP4738203 vaccine 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution VO:0017206 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] 40719059 OMOP4738205 vaccine 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] VO:0017207 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] Box of 1 40719057 OMOP4738207 vaccine 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] Box of 1 VO:0017208 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] Box of 1 by Baxter 40719056 OMOP4738208 vaccine 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] Box of 1 by Baxter VO:0017209 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] by Baxter 40719058 OMOP4738206 vaccine 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] by Baxter VO:0017210 OHDSI Vaccine WG 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution Box of 1 40719060 OMOP4738204 vaccine 1 ML tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution Box of 1 VO:0017211 OHDSI Vaccine WG 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution 41369548 OMOP2567510 vaccine 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution VO:0017212 OHDSI Vaccine WG 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] 41370587 OMOP2568549 vaccine 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] VO:0017213 OHDSI Vaccine WG 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] Box of 1 41365244 OMOP2563206 vaccine 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017214 OHDSI Vaccine WG 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution Box of 1 41362046 OMOP2560008 vaccine 10 ML tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution Box of 1 VO:0017215 OHDSI Vaccine WG 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution 41392734 OMOP2590696 vaccine 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution VO:0017216 OHDSI Vaccine WG 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] 41392996 OMOP2590958 vaccine 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] VO:0017217 OHDSI Vaccine WG 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] Box of 1 41399795 OMOP2597757 vaccine 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017218 OHDSI Vaccine WG 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution Box of 1 41400192 OMOP2598154 vaccine 50 ML tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution Box of 1 VO:0017219 OHDSI Vaccine WG 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 41444730 OMOP2642692 vaccine 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0017220 OHDSI Vaccine WG 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] 41444795 OMOP2642757 vaccine 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] VO:0017221 OHDSI Vaccine WG 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] Box of 1 41444770 OMOP2642732 vaccine 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017222 OHDSI Vaccine WG 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 41444722 OMOP2642684 vaccine 7.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 VO:0017223 OHDSI Vaccine WG 7.5 ML tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution 41444762 OMOP2642724 vaccine 7.5 ML tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution VO:0017224 OHDSI Vaccine WG 7.5 ML tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution Box of 1 41444731 OMOP2642693 vaccine 7.5 ML tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution Box of 1 VO:0017225 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution 43642953 OMOP705778 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017226 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] 43804721 OMOP705779 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] VO:0017227 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension 43661108 OMOP705776 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017228 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Covaxis] 43606831 OMOP705797 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Covaxis] VO:0017229 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] 43588787 OMOP705777 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] VO:0017230 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection 43263934 OMOP557555 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection VO:0017231 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adacel] 43269407 OMOP557524 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adacel] VO:0017232 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Boostrix] 43258521 OMOP557556 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Boostrix] VO:0017233 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tripacel] 43296519 OMOP557525 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tripacel] VO:0017234 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella Pertussis Filamentous Haemagglutinin Antigen / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / tetanus toxoid vaccine, inactivated Injection 43516274 OMOP2803389 vaccine acellular pertussis vaccine, inactivated / Bordetella Pertussis Filamentous Haemagglutinin Antigen / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / tetanus toxoid vaccine, inactivated Injection VO:0017235 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella Pertussis Filamentous Haemagglutinin Antigen / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / tetanus toxoid vaccine, inactivated Injection [Boostrix] 43515491 OMOP2802606 vaccine acellular pertussis vaccine, inactivated / Bordetella Pertussis Filamentous Haemagglutinin Antigen / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / tetanus toxoid vaccine, inactivated Injection [Boostrix] VO:0017236 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella Pertussis Filamentous Haemagglutinin Antigen / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / tetanus toxoid vaccine, inactivated Injection [Infanrix] 43515093 OMOP2802208 vaccine acellular pertussis vaccine, inactivated / Bordetella Pertussis Filamentous Haemagglutinin Antigen / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / tetanus toxoid vaccine, inactivated Injection [Infanrix] VO:0017237 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension 36274599 OMOP3125474 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017238 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [HEXYON] 36277369 OMOP3128244 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [HEXYON] VO:0017239 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Solution 36266934 OMOP3117809 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017240 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix Hexa] 36259461 OMOP3110336 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix Hexa] VO:0017241 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution 41111269 OMOP2309231 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017242 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hibdt] 40924669 OMOP2122631 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hibdt] VO:0017243 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe 40923787 OMOP2121749 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0017244 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Anrix] 41299076 OMOP2497038 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Anrix] VO:0017245 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Eurim Pharm] 41174639 OMOP2372601 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Hepatitis B Surface Antigen Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Eurim Pharm] VO:0017246 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension 36277137 OMOP3128012 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017247 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] 36267158 OMOP3118033 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] VO:0017248 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] 36259460 OMOP3110335 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] VO:0017249 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Tetravac] 36272252 OMOP3123127 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Tetravac] VO:0017250 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution 41173773 OMOP2371735 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017251 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Repevax] 40862432 OMOP2060394 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Repevax] VO:0017252 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe 40861507 OMOP2059469 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0017253 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] 41174638 OMOP2372600 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] VO:0017254 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Repevax] 41143680 OMOP2341642 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Repevax] VO:0017255 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Tetravac] 41237095 OMOP2435057 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Tetravac] VO:0017256 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Covaxis] 41174637 OMOP2372599 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Covaxis] VO:0017257 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] 36421995 OMOP4764271 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] VO:0017258 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] 36790363 OMOP4778603 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] VO:0017259 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Triaxis] 36790365 OMOP4778604 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Triaxis] VO:0017260 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Covaxis] 36421994 OMOP4764270 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Covaxis] VO:0017261 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Triaxis] 36790362 OMOP4778602 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Triaxis] VO:0017262 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.0055 MG / Bordetella pertussis 0.01 MG / diphtheria toxoid vaccine, inactivated 2 UNT / tetanus toxoid vaccine, inactivated 20 UNT Injection 43285755 OMOP557527 vaccine acellular pertussis vaccine, inactivated 0.0055 MG / Bordetella pertussis 0.01 MG / diphtheria toxoid vaccine, inactivated 2 UNT / tetanus toxoid vaccine, inactivated 20 UNT Injection VO:0017263 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Adacel] 43291124 OMOP557534 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Adacel] VO:0017264 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 43280287 OMOP557535 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0017265 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] 43280288 OMOP557537 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] VO:0017266 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] Box of 5 43269409 OMOP557538 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adacel] Box of 5 VO:0017267 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 43269408 OMOP557536 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 VO:0017268 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Covaxis] 43859031 OMOP705798 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Covaxis] VO:0017269 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43642955 OMOP705799 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017270 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] 43750754 OMOP705800 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] VO:0017271 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT [Infanrix] 43859030 OMOP705783 vaccine acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT [Infanrix] VO:0017272 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injectable Solution 43822830 OMOP705785 vaccine acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injectable Solution VO:0017273 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injectable Solution [Infanrix] 43661109 OMOP705786 vaccine acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injectable Solution [Infanrix] VO:0017274 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injectable Solution [Infanrix] by Glaxosmithkline 43588788 OMOP705787 vaccine acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injectable Solution [Infanrix] by Glaxosmithkline VO:0017275 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Boostrix] 43258522 OMOP557557 vaccine acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Boostrix] VO:0017276 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 43280291 OMOP557558 vaccine acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0017277 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] 43291128 OMOP557560 vaccine acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] VO:0017278 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] Box of 10 43291129 OMOP557562 vaccine acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Boostrix] Box of 10 VO:0017279 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 10 43291127 OMOP557559 vaccine acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 10 VO:0017280 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.0105 MG / Bordetella pertussis 0.008 MG / diphtheria toxoid vaccine, inactivated 2 UNT / tetanus toxoid vaccine, inactivated 20 UNT Injection 43274967 OMOP557563 vaccine acellular pertussis vaccine, inactivated 0.0105 MG / Bordetella pertussis 0.008 MG / diphtheria toxoid vaccine, inactivated 2 UNT / tetanus toxoid vaccine, inactivated 20 UNT Injection VO:0017281 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.013 MG / Bordetella pertussis 0.01 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injection 43258518 OMOP557526 vaccine acellular pertussis vaccine, inactivated 0.013 MG / Bordetella pertussis 0.01 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT Injection VO:0017282 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Tripacel] 43291123 OMOP557528 vaccine acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Tripacel] VO:0017283 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection 43258519 OMOP557529 vaccine acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection VO:0017284 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] 43274965 OMOP557532 vaccine acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] VO:0017285 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] Box of 5 43285756 OMOP557533 vaccine acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Tripacel] Box of 5 VO:0017286 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 43263931 OMOP557530 vaccine acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 VO:0017287 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML [Infanrix] 43679064 OMOP705780 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML [Infanrix] VO:0017288 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 43714811 OMOP705781 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0017289 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] 43859029 OMOP705782 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] VO:0017290 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] 36277063 OMOP3127938 vaccine acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] VO:0017291 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 36275112 OMOP3125987 vaccine acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017292 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 36265801 OMOP3116676 vaccine acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0017293 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetravac] 36261714 OMOP3112589 vaccine acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetravac] VO:0017294 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 36264922 OMOP3115797 vaccine acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0017295 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetravac] 36268394 OMOP3119269 vaccine acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetravac] VO:0017296 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML [Infanrix] 36274501 OMOP3125376 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML [Infanrix] VO:0017297 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 36264923 OMOP3115798 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0017298 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] 36258139 OMOP3109014 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] VO:0017299 OHDSI Vaccine WG Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution 44029894 OMOP1024525 vaccine Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017300 OHDSI Vaccine WG Bordetella pertussis / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension 43661165 OMOP706607 vaccine Bordetella pertussis / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017301 OHDSI Vaccine WG Bordetella pertussis / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] 43588836 OMOP706608 vaccine Bordetella pertussis / diphtheria toxoid vaccine, inactivated / pertactin adsorbed / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] VO:0017302 OHDSI Vaccine WG Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension 44107526 OMOP1102157 vaccine Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017303 OHDSI Vaccine WG Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Adacel] 44083028 OMOP1077659 vaccine Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Adacel] VO:0017304 OHDSI Vaccine WG Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Tripacel] 44108834 OMOP1103465 vaccine Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Tripacel] VO:0017305 OHDSI Vaccine WG Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML [Tripacel] 44054802 OMOP1049433 vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML [Tripacel] VO:0017306 OHDSI Vaccine WG Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 44071614 OMOP1066245 vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0017307 OHDSI Vaccine WG Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Tripacel] 44047817 OMOP1042448 vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Tripacel] VO:0017308 OHDSI Vaccine WG Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML [Adacel] 44041725 OMOP1036356 vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML [Adacel] VO:0017309 OHDSI Vaccine WG Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 44097416 OMOP1092047 vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0017310 OHDSI Vaccine WG Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Adacel] 44073649 OMOP1068280 vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension [Adacel] VO:0017311 OHDSI Vaccine WG Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] 43679114 OMOP706611 vaccine Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] VO:0017312 OHDSI Vaccine WG Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43732870 OMOP706613 vaccine Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017313 OHDSI Vaccine WG Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 43679115 OMOP706614 vaccine Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0017314 OHDSI Vaccine WG Candida albicans extract / diphtheria toxoid vaccine, inactivated / Glycerin / Proteus mirabilis / Purified Protein Derivative of Tuberculin / tetanus toxin Injectable Solution 44107649 OMOP1102280 vaccine Candida albicans extract / diphtheria toxoid vaccine, inactivated / Glycerin / Proteus mirabilis / Purified Protein Derivative of Tuberculin / tetanus toxin Injectable Solution VO:0017315 OHDSI Vaccine WG Candida albicans extract / diphtheria toxoid vaccine, inactivated / Glycerin / Proteus mirabilis / Purified Protein Derivative of Tuberculin / tetanus toxin Injectable Solution [Multitest Cmi] 44083294 OMOP1077925 vaccine Candida albicans extract / diphtheria toxoid vaccine, inactivated / Glycerin / Proteus mirabilis / Purified Protein Derivative of Tuberculin / tetanus toxin Injectable Solution [Multitest Cmi] VO:0017316 OHDSI Vaccine WG Diphtheria Antitoxin / diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension 21158543 OMOP378051 vaccine Diphtheria Antitoxin / diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017317 OHDSI Vaccine WG Diphtheria Antitoxin / diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] 21148593 OMOP378062 vaccine Diphtheria Antitoxin / diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] VO:0017318 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution 41048532 OMOP2246494 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017319 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hibdt] 41049417 OMOP2247379 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hibdt] VO:0017320 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution 40755188 OMOP4701741 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017321 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Act-HIB DTP] 40755187 OMOP4701742 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Act-HIB DTP] VO:0017322 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix-Hib] 40755189 OMOP4701740 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix-Hib] VO:0017323 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension 36810981 OMOP4825016 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017324 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Act-HIB DTP] 36811692 OMOP4825726 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Act-HIB DTP] VO:0017325 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix-Hib] 36813338 OMOP4827372 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix-Hib] VO:0017326 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution 44120573 OMOP1115204 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution VO:0017327 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension 36264378 OMOP3115253 vaccine diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017328 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Revaxis] 36274763 OMOP3125638 vaccine diphtheria toxoid vaccine, inactivated / Human poliovirus / tetanus toxoid vaccine, inactivated Injectable Suspension [Revaxis] VO:0017329 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution 36405734 OMOP3097776 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017330 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Act-HIB DTP] 36405030 OMOP3097072 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Act-HIB DTP] VO:0017331 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] 36404259 OMOP3096301 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] VO:0017332 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injection 21099524 OMOP378218 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injection VO:0017333 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injection [Act-HIB DTP] 21070185 OMOP378229 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injection [Act-HIB DTP] VO:0017334 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injection [Infanrix] 21079897 OMOP378240 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injection [Infanrix] VO:0017335 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution 36408030 OMOP3100072 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017336 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Pediacel] 36408849 OMOP3100891 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Pediacel] VO:0017337 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension 35770408 OMOP2771869 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017338 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension [Pediacel] 35770617 OMOP2772078 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Suspension [Pediacel] VO:0017339 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe 21079894 OMOP378007 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0017340 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Pediacel] 21148592 OMOP378018 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen, Hong Kong 330-2001 / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Pediacel] VO:0017341 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution 44120572 OMOP1115203 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017342 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] 35770619 OMOP2772080 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] VO:0017343 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Repevax] 35770618 OMOP2772079 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Repevax] VO:0017344 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe 21119060 OMOP377977 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0017345 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] 40893627 OMOP2091589 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] VO:0017346 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Infanrix] 21099522 OMOP377988 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Infanrix] VO:0017347 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Quatro Virelon No] 41143679 OMOP2341641 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Quatro Virelon No] VO:0017348 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Repevax] 21089624 OMOP377998 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Repevax] VO:0017349 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution 44042944 OMOP1037575 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017350 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Acel Imune] 41080816 OMOP2278778 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Acel Imune] VO:0017351 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Di Te Tuss Asid] 40955889 OMOP2153851 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Di Te Tuss Asid] VO:0017352 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Dpt Merieux] 40987119 OMOP2185081 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Dpt Merieux] VO:0017353 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Dpt Vaccinol] 40893625 OMOP2091587 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Dpt Vaccinol] VO:0017354 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hib Dpt Merieux] 40862430 OMOP2060392 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hib Dpt Merieux] VO:0017355 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hibdpt Vaccinol] 41268094 OMOP2466056 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Hibdpt Vaccinol] VO:0017356 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] 35762217 OMOP2763678 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Infanrix] VO:0017357 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Tri-Immunol Im] 44095966 OMOP1090597 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Solution [Tri-Immunol Im] VO:0017358 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension 44120574 OMOP1115205 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017359 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] 44070166 OMOP1064797 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] VO:0017360 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] 40755183 OMOP4701746 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] VO:0017361 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe 21128853 OMOP378340 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0017362 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Dtp Rix] 40987118 OMOP2185080 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Dtp Rix] VO:0017363 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Infanrix] 21148598 OMOP378349 vaccine diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / tetanus toxoid vaccine, inactivated Prefilled Syringe [Infanrix] VO:0017364 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxin Injectable Suspension 43134665 OMOP445897 vaccine diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxin Injectable Suspension VO:0017365 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxin Injectable Suspension [Revaxis] 43167739 OMOP445898 vaccine diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxin Injectable Suspension [Revaxis] VO:0017366 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution 35745313 OMOP2746774 vaccine diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017367 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Revaxis] 35766310 OMOP2767771 vaccine diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [Revaxis] VO:0017368 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe 21050395 OMOP378029 vaccine diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0017369 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Revaxis] 21119061 OMOP378040 vaccine diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Revaxis] VO:0017370 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxin Injectable Solution 44107525 OMOP1102156 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxin Injectable Solution VO:0017371 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxin Injectable Suspension 44107524 OMOP1102155 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxin Injectable Suspension VO:0017372 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Boostrix] 35745500 OMOP2746961 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Boostrix] VO:0017373 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Di Tetasorbat] 41018107 OMOP2216069 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Di Tetasorbat] VO:0017374 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Diftavax] 35753886 OMOP2755347 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Diftavax] VO:0017375 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Dt Impfstoff] 40831216 OMOP2029178 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Dt Impfstoff] VO:0017376 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Dt Vaccinol] 40862431 OMOP2060393 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Dt Vaccinol] VO:0017377 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Dt Wellcovax] 40987120 OMOP2185082 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Dt Wellcovax] VO:0017378 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Repevax] 35758018 OMOP2759479 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Repevax] VO:0017379 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Td Impfstoff] 40893626 OMOP2091588 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution [Td Impfstoff] VO:0017380 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Diftavax] 40755182 OMOP4701747 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Diftavax] VO:0017381 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Impfstoff Merieux] 43804762 OMOP706588 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Impfstoff Merieux] VO:0017382 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Pur] 43822865 OMOP706587 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Pur] VO:0017383 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adt Booster] 43263935 OMOP557564 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adt Booster] VO:0017384 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adt Vaccine] 43291130 OMOP557565 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Adt Vaccine] VO:0017385 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] 42481199 OMOP416654 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Boostrix] VO:0017386 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Diftavax] 21031164 OMOP287053 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Diftavax] VO:0017387 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Dt Rix] 40955890 OMOP2153852 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Dt Rix] VO:0017388 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Repevax] 21060638 OMOP287032 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Repevax] VO:0017389 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.05 MG/ML Injectable Solution 44097415 OMOP1092046 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.05 MG/ML Injectable Solution VO:0017390 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 12.5 LFU/ML / tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension 36882829 OMOP1007021 vaccine diphtheria toxoid vaccine, inactivated 12.5 LFU/ML / tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension VO:0017391 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection 43515984 OMOP2803099 vaccine diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection VO:0017392 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection Box of 10 43517621 OMOP2804736 vaccine diphtheria toxoid vaccine, inactivated 2 LFU/ML / tetanus toxoid vaccine, inactivated 2 LFU/ML Injection Box of 10 VO:0017393 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Adt Booster] 43515871 OMOP2802986 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Adt Booster] VO:0017394 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Adt Vaccine] 43515044 OMOP2802159 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Adt Vaccine] VO:0017395 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 43517201 OMOP2804316 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0017396 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] 43516500 OMOP2803615 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] VO:0017397 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] Box of 5 43516925 OMOP2804040 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Booster] Box of 5 VO:0017398 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Vaccine] 43516499 OMOP2803614 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Adt Vaccine] VO:0017399 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 43517622 OMOP2804737 vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection Box of 5 VO:0017400 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML [Tri-Immunol Im] 44119406 OMOP1114037 vaccine diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML [Tri-Immunol Im] VO:0017401 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution 44032799 OMOP1027430 vaccine diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution VO:0017402 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution [Tri-Immunol Im] 44125477 OMOP1120108 vaccine diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution [Tri-Immunol Im] VO:0017403 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension 44032798 OMOP1027429 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension VO:0017404 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension Box of 5 44071612 OMOP1066243 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxin 10 LFU/ML Injectable Suspension Box of 5 VO:0017405 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection 43296524 OMOP557573 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection VO:0017406 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection Box of 10 43296523 OMOP557572 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 4 LFU/ML Injection Box of 10 VO:0017407 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Revaxis] 36269372 OMOP3120247 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Revaxis] VO:0017408 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 36262273 OMOP3113148 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017409 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] 36260541 OMOP3111416 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] VO:0017410 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] 44093466 OMOP1088097 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] VO:0017411 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 44058800 OMOP1053431 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017412 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 44073648 OMOP1068279 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0017413 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Adt Booster] 43274968 OMOP557566 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Adt Booster] VO:0017414 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Adt Vaccine] 43263936 OMOP557567 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Adt Vaccine] VO:0017415 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Impfstoff Merieux] 43696927 OMOP706591 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Impfstoff Merieux] VO:0017416 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Pur] 43859078 OMOP706590 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Pur] VO:0017417 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43859079 OMOP706592 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017418 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] 43804763 OMOP706594 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] VO:0017419 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] 43696928 OMOP706593 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] VO:0017420 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection 36894543 OMOP1002207 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection VO:0017421 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] 43269410 OMOP557569 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] VO:0017422 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] Box of 5 43280292 OMOP557570 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Booster] Box of 5 VO:0017423 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Vaccine] 43274969 OMOP557571 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection [Adt Vaccine] VO:0017424 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 43263937 OMOP557568 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML Injection Box of 5 VO:0017425 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution 44084496 OMOP1079127 vaccine diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution VO:0017426 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution 44058799 OMOP1053430 vaccine diphtheria toxoid vaccine, inactivated 50 LFU/ML / Pertussis Vaccine 24 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Solution VO:0017427 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 50 LFU/ML / tetanus toxin 10 LFU/ML Injectable Solution 44032797 OMOP1027428 vaccine diphtheria toxoid vaccine, inactivated 50 LFU/ML / tetanus toxin 10 LFU/ML Injectable Solution VO:0017428 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide Injectable Solution 36066375 OMOP4992799 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide Injectable Solution VO:0017429 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide Injectable Solution [Menitorix] 36066373 OMOP4992798 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide Injectable Solution [Menitorix] VO:0017430 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Solution 44055873 OMOP1050504 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Solution VO:0017431 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Solution [PedvaxHIB] 44121770 OMOP1116401 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Solution [PedvaxHIB] VO:0017432 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Suspension 44068858 OMOP1063489 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Suspension VO:0017433 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.015 MG / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG [PedvaxHIB] 44119179 OMOP1113810 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.015 MG / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG [PedvaxHIB] VO:0017434 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.015 MG / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG Injectable Solution 44110141 OMOP1104772 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.015 MG / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG Injectable Solution VO:0017435 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML 44066066 OMOP1060697 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML VO:0017436 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML [Hiberix] 44119178 OMOP1113809 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML [Hiberix] VO:0017437 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injectable Solution 44032644 OMOP1027275 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injectable Solution VO:0017438 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection 587658 OMOP3136157 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection VO:0017439 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection [Hiberix] 44086291 OMOP1080922 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.02 MG/ML Injection [Hiberix] VO:0017440 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML 42725397 OMOP2728756 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML VO:0017441 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML [ActHIB] 44067586 OMOP1062217 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML [ActHIB] VO:0017442 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injectable Solution 44097268 OMOP1091899 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injectable Solution VO:0017443 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection 589493 OMOP3138277 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection VO:0017444 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection [ActHIB] 44060611 OMOP1055242 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.08 MG/ML Injection [ActHIB] VO:0017445 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution 44042880 OMOP1037511 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution VO:0017446 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution [Hiberix] 40753560 OMOP4703707 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution [Hiberix] VO:0017447 OHDSI Vaccine WG Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution [HibTITER] 36059716 OMOP4985476 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injectable Solution [HibTITER] VO:0017448 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y / tetanus toxoid vaccine, inactivated Injectable Solution 44055806 OMOP1050437 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017449 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y / tetanus toxoid vaccine, inactivated Injectable Solution [Nimenrix] 44056941 OMOP1051572 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y / tetanus toxoid vaccine, inactivated Injectable Solution [Nimenrix] VO:0017450 OHDSI Vaccine WG meningococcal group C polysaccharide / tetanus toxoid vaccine, inactivated Injectable Suspension 44055805 OMOP1050436 vaccine meningococcal group C polysaccharide / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0017451 OHDSI Vaccine WG meningococcal group C polysaccharide / tetanus toxoid vaccine, inactivated Injectable Suspension [Neisvac C] 44056939 OMOP1051570 vaccine meningococcal group C polysaccharide / tetanus toxoid vaccine, inactivated Injectable Suspension [Neisvac C] VO:0017452 OHDSI Vaccine WG meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML [Neisvac C] 44067356 OMOP1061987 vaccine meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML [Neisvac C] VO:0017453 OHDSI Vaccine WG meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension 44025498 OMOP1020129 vaccine meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension VO:0017454 OHDSI Vaccine WG meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension [Neisvac C] 44086041 OMOP1080672 vaccine meningococcal group C polysaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.04 MG/ML Injectable Suspension [Neisvac C] VO:0017455 OHDSI Vaccine WG Neisseria meningitidis polysaccharide group Y tetanus toxoid conjugate 36878795 OMOP1002805 vaccine Neisseria meningitidis polysaccharide group Y tetanus toxoid conjugate VO:0017456 OHDSI Vaccine WG Neisseria meningitidis polysaccharide group Y tetanus toxoid conjugate 0.01 MG/ML 43168450 OMOP452262 vaccine Neisseria meningitidis polysaccharide group Y tetanus toxoid conjugate 0.01 MG/ML VO:0017457 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution 44081441 OMOP1076072 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution VO:0017458 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [T Polio Adsorbed] 44121379 OMOP1116010 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / tetanus toxoid vaccine, inactivated Injectable Solution [T Polio Adsorbed] VO:0017459 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [T Polio Adsorbed] 44041033 OMOP1035664 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [T Polio Adsorbed] VO:0017460 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 44123008 OMOP1117639 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0017461 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [T Polio Adsorbed] 44124723 OMOP1119354 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 160 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [T Polio Adsorbed] VO:0017462 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 0.04 MG/ML 44052446 OMOP1047077 vaccine tetanus toxoid vaccine, inactivated 0.04 MG/ML VO:0017463 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 0.088 MG/ML 44052447 OMOP1047078 vaccine tetanus toxoid vaccine, inactivated 0.088 MG/ML VO:0017464 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 1.5 UNT/ML 41201114 OMOP2399076 vaccine tetanus toxoid vaccine, inactivated 1.5 UNT/ML VO:0017465 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 1.5 UNT/ML [Tetanol] 41045944 OMOP2243906 vaccine tetanus toxoid vaccine, inactivated 1.5 UNT/ML [Tetanol] VO:0017466 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution 41208651 OMOP2406613 vaccine tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution VO:0017467 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] 41307106 OMOP2505068 vaccine tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] VO:0017468 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] Box of 1 40995158 OMOP2193120 vaccine tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017469 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution Box of 1 40864909 OMOP2062871 vaccine tetanus toxoid vaccine, inactivated 1.5 UNT/ML Injectable Solution Box of 1 VO:0017470 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 10 UNT/ML [Tetanol] 41108764 OMOP2306726 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML [Tetanol] VO:0017471 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 40822025 OMOP2019987 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0017472 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] 41151736 OMOP2349698 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] VO:0017473 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] Box of 1 41120147 OMOP2318109 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017474 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 41270449 OMOP2468411 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution Box of 1 VO:0017475 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 12.5 LFU/ML 36892072 OMOP999502 vaccine tetanus toxoid vaccine, inactivated 12.5 LFU/ML VO:0017476 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension 43822871 OMOP706681 vaccine tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension VO:0017477 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 43768796 OMOP706683 vaccine tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 10 VO:0017478 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 43786772 OMOP706684 vaccine tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 20 VO:0017479 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 43840962 OMOP706682 vaccine tetanus toxoid vaccine, inactivated 12.5 LFU/ML Injectable Suspension Box of 5 VO:0017480 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML [T Immun] 40952397 OMOP2150359 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML [T Immun] VO:0017481 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML [Tet Aktiv] 40983558 OMOP2181520 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML [Tet Aktiv] VO:0017482 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML [Tetanol] 41171277 OMOP2369239 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML [Tetanol] VO:0017483 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML [T-Immun Immuno] 43817655 OMOP921892 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML [T-Immun Immuno] VO:0017484 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] 40963878 OMOP2161840 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] VO:0017485 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 1 41276015 OMOP2473977 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 1 VO:0017486 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 10 40901533 OMOP2099495 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [T Immun] Box of 10 VO:0017487 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] 40839327 OMOP2037289 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] VO:0017488 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] Box of 100 41276014 OMOP2473976 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tet Aktiv] Box of 100 VO:0017489 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] 41245056 OMOP2443018 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] VO:0017490 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 41182800 OMOP2380762 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017491 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 40932632 OMOP2130594 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 10 VO:0017492 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 100 40995160 OMOP2193122 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 100 VO:0017493 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 40824578 OMOP2022540 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 2 VO:0017494 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 41057402 OMOP2255364 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 20 VO:0017495 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 50 40932631 OMOP2130593 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution [Tetanol] Box of 50 VO:0017496 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 40823587 OMOP2021549 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 1 VO:0017497 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 10 41083404 OMOP2281366 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 10 VO:0017498 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 100 40989647 OMOP2187609 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 100 VO:0017499 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 2 41301531 OMOP2499493 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 2 VO:0017500 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 20 41177145 OMOP2375107 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 20 VO:0017501 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 50 41301530 OMOP2499492 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution Box of 50 VO:0017502 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension 43655881 OMOP921893 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension VO:0017503 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] 43745625 OMOP921896 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] VO:0017504 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] Box of 10 43781640 OMOP921897 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension [T-Immun Immuno] Box of 10 VO:0017505 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension Box of 10 43691797 OMOP921894 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Suspension Box of 10 VO:0017506 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe 41083403 OMOP2281365 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe VO:0017507 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] 40932630 OMOP2130592 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] VO:0017508 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 41120148 OMOP2318110 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 1 VO:0017509 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 41245055 OMOP2443017 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 10 VO:0017510 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 100 41182799 OMOP2380761 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 100 VO:0017511 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 20 41057401 OMOP2255363 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 20 VO:0017512 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 50 41245054 OMOP2443016 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe [Tetanol] Box of 50 VO:0017513 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 1 40896125 OMOP2094087 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 1 VO:0017514 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 10 41208652 OMOP2406614 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 10 VO:0017515 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 100 40864910 OMOP2062872 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 100 VO:0017516 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 20 41301529 OMOP2499491 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 20 VO:0017517 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 50 41301528 OMOP2499490 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Prefilled Syringe Box of 50 VO:0017518 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 2 LFU/ML 43517470 OMOP2804585 vaccine tetanus toxoid vaccine, inactivated 2 LFU/ML VO:0017519 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML 36879462 OMOP1000612 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML VO:0017520 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML [Tetravac] 43823028 OMOP709535 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML [Tetravac] VO:0017521 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension 43733033 OMOP709536 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension VO:0017522 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] 43697101 OMOP709540 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] VO:0017523 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 10 43588995 OMOP709542 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 10 VO:0017524 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 25 43823029 OMOP709543 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 25 VO:0017525 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 50 43643203 OMOP709544 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension [Tetravac] Box of 50 VO:0017526 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 10 43607028 OMOP709537 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 10 VO:0017527 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 25 43661311 OMOP709538 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 25 VO:0017528 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 50 43750994 OMOP709539 vaccine tetanus toxoid vaccine, inactivated 20 LFU/ML Injectable Suspension Box of 50 VO:0017529 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 2000 IU/ML 2040754 OMOP4940419 vaccine tetanus toxoid vaccine, inactivated 2000 IU/ML VO:0017530 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 2000 IU/ML Injectable Solution 2040753 OMOP4940418 vaccine tetanus toxoid vaccine, inactivated 2000 IU/ML Injectable Solution VO:0017531 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 250 UNT/ML 40755199 OMOP4701730 vaccine tetanus toxoid vaccine, inactivated 250 UNT/ML VO:0017532 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 250 UNT/ML [Tetabulin] 40755198 OMOP4701731 vaccine tetanus toxoid vaccine, inactivated 250 UNT/ML [Tetabulin] VO:0017533 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution 40755197 OMOP4701732 vaccine tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution VO:0017534 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] 40755195 OMOP4701734 vaccine tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] VO:0017535 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] Box of 1 40755194 OMOP4701735 vaccine tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution [Tetabulin] Box of 1 VO:0017536 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution Box of 1 40755196 OMOP4701733 vaccine tetanus toxoid vaccine, inactivated 250 UNT/ML Injectable Solution Box of 1 VO:0017537 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 LFU/ML 43285780 OMOP557686 vaccine tetanus toxoid vaccine, inactivated 4 LFU/ML VO:0017538 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML [Tetamun] 41233749 OMOP2431711 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML [Tetamun] VO:0017539 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] 41245053 OMOP2443015 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] VO:0017540 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 1 41057400 OMOP2255362 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 1 VO:0017541 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 10 41088916 OMOP2286878 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution [Tetamun] Box of 10 VO:0017542 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 40989646 OMOP2187608 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 1 VO:0017543 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 41177144 OMOP2375106 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution Box of 10 VO:0017544 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension 43786931 OMOP709571 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension VO:0017545 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] 43750995 OMOP709573 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] VO:0017546 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] Box of 10 43859276 OMOP709574 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension [Tetamun] Box of 10 VO:0017547 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 43588997 OMOP709572 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Suspension Box of 10 VO:0017548 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML 44065424 OMOP1060055 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0017549 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] 43840959 OMOP706627 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML [Boostrix] VO:0017550 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML [Covaxis] 43823030 OMOP709553 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML [Covaxis] VO:0017551 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML [Repevax] 43624770 OMOP706631 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML [Repevax] VO:0017552 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML [Revaxis] 43643204 OMOP709554 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML [Revaxis] VO:0017553 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Impfstoff Merieux] 43750804 OMOP706628 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Impfstoff Merieux] VO:0017554 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Pur] 43732873 OMOP706626 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML [Td-Pur] VO:0017555 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension 43661166 OMOP706632 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension VO:0017556 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] 43643011 OMOP706640 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] VO:0017557 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 10 43588838 OMOP706641 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 10 VO:0017558 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 20 43606885 OMOP706648 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 20 VO:0017559 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 25 43714852 OMOP706649 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 25 VO:0017560 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 50 43822868 OMOP706650 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Boostrix] Box of 50 VO:0017561 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] 43715008 OMOP709561 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] VO:0017562 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] Box of 10 43786928 OMOP709562 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Covaxis] Box of 10 VO:0017563 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] 43715009 OMOP709567 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] VO:0017564 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 10 43804922 OMOP709568 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 10 VO:0017565 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 20 43661168 OMOP706657 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 20 VO:0017566 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 5 43714853 OMOP706656 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Repevax] Box of 5 VO:0017567 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] 43624954 OMOP709563 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] VO:0017568 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 10 43804921 OMOP709564 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 10 VO:0017569 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 20 43786929 OMOP709565 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Revaxis] Box of 20 VO:0017570 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] 43643012 OMOP706642 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] VO:0017571 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 43624771 OMOP706643 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 10 VO:0017572 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 43859082 OMOP706645 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Impfstoff Merieux] Box of 20 VO:0017573 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] 43588837 OMOP706637 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] VO:0017574 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 10 43679119 OMOP706639 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 10 VO:0017575 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 2 43679118 OMOP706638 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension [Td-Pur] Box of 2 VO:0017576 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 43601697 OMOP921900 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 10 VO:0017577 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 2 43606884 OMOP706633 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 2 VO:0017578 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 43804920 OMOP709556 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 20 VO:0017579 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 25 43804766 OMOP706635 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 25 VO:0017580 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 43679117 OMOP706634 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 5 VO:0017581 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 50 43661167 OMOP706636 vaccine tetanus toxoid vaccine, inactivated 40 UNT/ML Injectable Suspension Box of 50 VO:0017582 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 5.33 UNT/ML 40981930 OMOP2179892 vaccine tetanus toxoid vaccine, inactivated 5.33 UNT/ML VO:0017583 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution 41270450 OMOP2468412 vaccine tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution VO:0017584 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution Box of 1 41146204 OMOP2344166 vaccine tetanus toxoid vaccine, inactivated 5.33 UNT/ML Injectable Solution Box of 1 VO:0017585 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 8 UNT/ML [Tetanol] 40983557 OMOP2181519 vaccine tetanus toxoid vaccine, inactivated 8 UNT/ML [Tetanol] VO:0017586 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] 41088913 OMOP2286875 vaccine tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] VO:0017587 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] Box of 1 40870447 OMOP2068409 vaccine tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017588 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution Box of 1 40896123 OMOP2094085 vaccine tetanus toxoid vaccine, inactivated 8 UNT/ML Injectable Solution Box of 1 VO:0017589 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML [Infanrix] 43588839 OMOP706661 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML [Infanrix] VO:0017590 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML [Pediacel] 43859274 OMOP709545 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML [Pediacel] VO:0017591 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML [T Wellcovax] 40890267 OMOP2088229 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML [T Wellcovax] VO:0017592 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetanol] 40921230 OMOP2119192 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetanol] VO:0017593 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetanus-Impfstoff Merieux] 43786770 OMOP706660 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetanus-Impfstoff Merieux] VO:0017594 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetasorbat] 43786769 OMOP706659 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML [Tetasorbat] VO:0017595 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] 41276013 OMOP2473975 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] VO:0017596 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] Box of 1 41026221 OMOP2224183 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [T Wellcovax] Box of 1 VO:0017597 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] 40932629 OMOP2130591 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] VO:0017598 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 1 41088915 OMOP2286877 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 1 VO:0017599 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 10 41276011 OMOP2473973 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 10 VO:0017600 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 2 40995159 OMOP2193121 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 2 VO:0017601 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 20 41120146 OMOP2318108 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 20 VO:0017602 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 80 41276012 OMOP2473974 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution [Tetanol] Box of 80 VO:0017603 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 1 40958357 OMOP2156319 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 1 VO:0017604 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 10 41083402 OMOP2281364 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 10 VO:0017605 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 100 41270448 OMOP2468410 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 100 VO:0017606 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 2 41020602 OMOP2218564 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 2 VO:0017607 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 20 40896124 OMOP2094086 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 20 VO:0017608 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 50 40989645 OMOP2187607 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 50 VO:0017609 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 80 40989644 OMOP2187606 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution Box of 80 VO:0017610 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension 43732875 OMOP706663 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension VO:0017611 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] 43679120 OMOP706673 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] VO:0017612 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] Box of 25 43679121 OMOP706674 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Infanrix] Box of 25 VO:0017613 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] 43841135 OMOP709548 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] VO:0017614 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 10 43768964 OMOP709549 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 10 VO:0017615 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 20 43624952 OMOP709550 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Pediacel] Box of 20 VO:0017616 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] 43822870 OMOP706675 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] VO:0017617 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 10 43750808 OMOP706677 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 10 VO:0017618 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 2 43859083 OMOP706676 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 2 VO:0017619 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 20 43624773 OMOP706678 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanol] Box of 20 VO:0017620 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] 43750807 OMOP706669 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] VO:0017621 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 10 43643013 OMOP706670 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 10 VO:0017622 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 20 43786771 OMOP706671 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 20 VO:0017623 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 50 43822869 OMOP706672 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetanus-Impfstoff Merieux] Box of 50 VO:0017624 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] 43606887 OMOP706667 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] VO:0017625 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] Box of 10 43840961 OMOP706668 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension [Tetasorbat] Box of 10 VO:0017626 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 10 43859275 OMOP709546 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 10 VO:0017627 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 2 43588840 OMOP706664 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 2 VO:0017628 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 20 43841134 OMOP709547 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 20 VO:0017629 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 25 43732876 OMOP706665 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 25 VO:0017630 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 50 43732877 OMOP706666 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Suspension Box of 50 VO:0017631 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe 41020601 OMOP2218563 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe VO:0017632 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] 40839326 OMOP2037288 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] VO:0017633 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 1 41088914 OMOP2286876 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 1 VO:0017634 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 10 40870448 OMOP2068410 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 10 VO:0017635 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 20 40932628 OMOP2130590 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe [Tetanol] Box of 20 VO:0017636 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 1 40958356 OMOP2156318 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 1 VO:0017637 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 10 41270447 OMOP2468409 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 10 VO:0017638 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 100 41239592 OMOP2437554 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 100 VO:0017639 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 20 41020600 OMOP2218562 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Prefilled Syringe Box of 20 VO:0017640 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Clostet] 35762178 OMOP2763639 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Clostet] VO:0017641 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [T Immun] 41143665 OMOP2341627 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [T Immun] VO:0017642 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [T Medevax] 40893614 OMOP2091576 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [T Medevax] VO:0017643 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [T Vaccinol] 41206209 OMOP2404171 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [T Vaccinol] VO:0017644 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [T Wellcovax] 41143664 OMOP2341626 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [T Wellcovax] VO:0017645 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Tet Aktiv] 41268087 OMOP2466049 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Tet Aktiv] VO:0017646 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Tetabulin] 40755200 OMOP4701729 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Tetabulin] VO:0017647 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Tetamun] 41174625 OMOP2372587 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Tetamun] VO:0017648 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Tetanol] 41268086 OMOP2466048 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Tetanol] VO:0017649 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Tetasorbat] 40955880 OMOP2153842 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Tetasorbat] VO:0017650 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Solution [Tetatoxoid] 40831202 OMOP2029164 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [Tetatoxoid] VO:0017651 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] 43732871 OMOP706617 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Boostrix] VO:0017652 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Clostet] 35770580 OMOP2772041 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Clostet] VO:0017653 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Covaxis] 43733032 OMOP709529 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Covaxis] VO:0017654 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] 43822867 OMOP706624 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Infanrix] VO:0017655 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Pediacel] 43624951 OMOP709528 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Pediacel] VO:0017656 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Repevax] 43643202 OMOP709533 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Repevax] VO:0017657 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Revaxis] 43715007 OMOP709532 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Revaxis] VO:0017658 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Impfstoff Merieux] 43804764 OMOP706618 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Impfstoff Merieux] VO:0017659 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Pur] 43768794 OMOP706616 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Td-Pur] VO:0017660 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Tetamun] 43786927 OMOP709534 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Tetamun] VO:0017661 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Tetanol] 43696930 OMOP706625 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Tetanol] VO:0017662 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Tetanus-Impfstoff Merieux] 43732872 OMOP706622 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Tetanus-Impfstoff Merieux] VO:0017663 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Tetasorbat] 43786767 OMOP706621 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Tetasorbat] VO:0017664 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [Tetravac] 43823027 OMOP709526 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [Tetravac] VO:0017665 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Injectable Suspension [T-Immun Immuno] 43763558 OMOP921888 vaccine tetanus toxoid vaccine, inactivated Injectable Suspension [T-Immun Immuno] VO:0017666 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Prefilled Syringe [Clostet] 21022024 OMOP345290 vaccine tetanus toxoid vaccine, inactivated Prefilled Syringe [Clostet] VO:0017667 OHDSI Vaccine WG tetanus toxoid vaccine, inactivated Prefilled Syringe [Tetanol] 41174626 OMOP2372588 vaccine tetanus toxoid vaccine, inactivated Prefilled Syringe [Tetanol] VO:0017668 Xingxian Li vaccine Diphtheria-Tetanus-Poliovirus-Influenza B vaccine VO:0017669 Xingxian Li vaccine Diphtheria-Tetanus-Haemophilus b vaccine VO:0017670 OHDSI Vaccine WG 1657590 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection 46276277 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection VO:0017671 OHDSI Vaccine WG 2588235 hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML 1758556 vaccine hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML VO:0017672 Xingxian Li vaccine Meningococcal-Haemophilis B-Tetanus Vaccine VO:0017673 Xingxian Li vaccine Meningococcal-Tetanus Vaccine VO:0017674 Xingxian Li vaccine poliovirus vaccine inactivated, type 1 (Mahoney) and tetanus toxoid conjugate vaccine VO:0017675 OHDSI Vaccine WG 2588236 hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML 1758557 vaccine hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML VO:0017676 OHDSI Vaccine WG 251908 tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution 19064695 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML Injectable Solution VO:0017677 OHDSI Vaccine WG http://purl.bioontology.org/ontology/RXNORM/1427171 1427171 hepatitis B virus subtype ADW2 HBsAg surface protein antigen 43532382 protein hepatitis B virus subtype ADW2 HBsAg surface protein antigen VO:0017678 OHDSI Vaccine WG 412992 tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution 19104174 vaccine tetanus toxoid vaccine, inactivated 4 UNT/ML Injectable Solution VO:0017679 OHDSI Vaccine WG 76469 BCG, live, Connaught strain 19023835 vaccine BCG, live, Connaught strain VO:0017680 OHDSI Vaccine WG http://purl.bioontology.org/ontology/RXNORM/221105 221105 Haemophilus capsular oligosaccharide 586306 vaccine component Haemophilus capsular oligosaccharide VO:0017681 OHDSI Vaccine WG 314513 BCG, live, Montreal strain 19013730 vaccine BCG, live, Montreal strain VO:0017682 OHDSI Vaccine WG 452027 tetanus toxoid vaccine, inactivated 80 UNT/ML 19112113 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML VO:0017683 OHDSI Vaccine WG 412908 tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution 19104170 vaccine tetanus toxoid vaccine, inactivated 80 UNT/ML Injectable Solution VO:0017684 OHDSI Vaccine WG 336990 tetanus toxoid vaccine, inactivated 150 UNT/ML 19093066 vaccine tetanus toxoid vaccine, inactivated 150 UNT/ML VO:0017685 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension 43810013 OMOP718747 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension VO:0017686 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] 43774066 OMOP718758 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] VO:0017687 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] Box of 10 43846131 OMOP718760 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] Box of 10 VO:0017688 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] Box of 10 by Sanofi 43702236 OMOP718761 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] Box of 10 by Sanofi VO:0017689 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] by Sanofi 43738105 OMOP718759 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] by Sanofi VO:0017690 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] 43828091 OMOP718751 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] VO:0017691 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 10 43810015 OMOP718754 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 10 VO:0017692 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 10 by Sanofi 43791850 OMOP718755 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 10 by Sanofi VO:0017693 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 20 43756039 OMOP718756 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 20 VO:0017694 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 20 by Sanofi 43719952 OMOP718757 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 20 by Sanofi VO:0017695 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] by Sanofi 43774065 OMOP718753 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] by Sanofi VO:0017696 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] 43738106 OMOP718762 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] VO:0017697 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 10 43774067 OMOP718767 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 10 VO:0017698 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 10 by Sanofi 43864392 OMOP718768 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 10 by Sanofi VO:0017699 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 20 43648241 OMOP718769 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 20 VO:0017700 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 20 by Sanofi 43719953 OMOP718770 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 20 by Sanofi VO:0017701 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 5 43702237 OMOP718765 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 5 VO:0017702 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 5 by Sanofi 43738107 OMOP718766 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 5 by Sanofi VO:0017703 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] by Sanofi 43594086 OMOP718764 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] by Sanofi VO:0017704 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 10 43810014 OMOP718749 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 10 VO:0017705 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 20 43774064 OMOP718750 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 20 VO:0017706 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 5 43738104 OMOP718748 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 5 VO:0017707 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension 43846132 OMOP718771 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension VO:0017708 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] 43630177 OMOP718773 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] VO:0017709 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] Box of 25 43810017 OMOP718776 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] Box of 25 VO:0017710 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] Box of 25 by Glaxosmithkline 43702238 OMOP718777 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] Box of 25 by Glaxosmithkline VO:0017711 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] by Glaxosmithkline 43719954 OMOP718775 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] by Glaxosmithkline VO:0017712 OHDSI Vaccine WG 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension Box of 25 43810016 OMOP718772 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension Box of 25 VO:0017713 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension 43810009 OMOP718714 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension VO:0017714 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] 43612057 OMOP718721 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] VO:0017715 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 10 43738102 OMOP718723 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 10 VO:0017716 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 10 by Glaxosmithkline 43702234 OMOP718724 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 10 by Glaxosmithkline VO:0017717 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 20 43738103 OMOP718729 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 20 VO:0017718 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 20 by Glaxosmithkline 43594085 OMOP718731 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 20 by Glaxosmithkline VO:0017719 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 25 43846130 OMOP718732 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 25 VO:0017720 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 25 by Glaxosmithkline 43666358 OMOP718733 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 25 by Glaxosmithkline VO:0017721 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 50 43756038 OMOP718734 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 50 VO:0017722 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 50 by Glaxosmithkline 43791847 OMOP718735 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 50 by Glaxosmithkline VO:0017723 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] by Glaxosmithkline 43791846 OMOP718722 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] by Glaxosmithkline VO:0017724 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 10 43684234 OMOP718715 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 10 VO:0017725 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 20 43666357 OMOP718716 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 20 VO:0017726 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 25 43684235 OMOP718717 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 25 VO:0017727 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 50 43864390 OMOP718720 vaccine 0.5 ML Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 50 VO:0017728 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 600 UNT/ML Injectable Suspension 44132707 OMOP1127338 vaccine 0.5 ML Pertussis Vaccine 600 UNT/ML Injectable Suspension VO:0017729 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 600 UNT/ML Injectable Suspension [Acel-P] 44132810 OMOP1127441 vaccine 0.5 ML Pertussis Vaccine 600 UNT/ML Injectable Suspension [Acel-P] VO:0017730 OHDSI Vaccine WG 0.5 ML Pertussis Vaccine 600 UNT/ML Injectable Suspension [Acel-P] by Lederle Products 44132645 OMOP1127276 vaccine 0.5 ML Pertussis Vaccine 600 UNT/ML Injectable Suspension [Acel-P] by Lederle Products VO:0017731 OHDSI Vaccine WG 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution 41341006 OMOP2538968 vaccine 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution VO:0017732 OHDSI Vaccine WG 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] 41341725 OMOP2539687 vaccine 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] VO:0017733 OHDSI Vaccine WG 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] Box of 1 41343323 OMOP2541285 vaccine 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] Box of 1 VO:0017734 OHDSI Vaccine WG 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 1 41343622 OMOP2541584 vaccine 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 1 VO:0017735 OHDSI Vaccine WG 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 5 41342007 OMOP2539969 vaccine 2 ML acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 5 VO:0017736 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injection 36887570 OMOP1006452 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injection VO:0017737 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injection [Infanrix Hexa] 43287202 OMOP546031 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Haemophilus B Conjugate Vaccine / Hepatitis B Surface Antigen Vaccine Injection [Infanrix Hexa] VO:0017738 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML [Covaxis] 43768801 OMOP706721 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML [Covaxis] VO:0017739 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML [Pediacel] 43696937 OMOP706720 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML [Pediacel] VO:0017740 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML [Repevax] 43661170 OMOP706722 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML [Repevax] VO:0017741 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension 43714855 OMOP706723 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension VO:0017742 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] 43859085 OMOP706731 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] VO:0017743 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] Box of 10 43661172 OMOP706732 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Covaxis] Box of 10 VO:0017744 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] 43661171 OMOP706727 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] VO:0017745 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 10 43714857 OMOP706728 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 10 VO:0017746 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 20 43679123 OMOP706730 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Pediacel] Box of 20 VO:0017747 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] 43732880 OMOP706733 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] VO:0017748 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 10 43588842 OMOP706735 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 10 VO:0017749 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 20 43859086 OMOP706736 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 20 VO:0017750 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 5 43624778 OMOP706734 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension [Repevax] Box of 5 VO:0017751 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 10 43732879 OMOP706725 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 10 VO:0017752 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 20 43822874 OMOP706726 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 20 VO:0017753 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 5 43714856 OMOP706724 vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML Injectable Suspension Box of 5 VO:0017754 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.008 MG 43291142 OMOP557654 vaccine acellular pertussis vaccine, inactivated 0.008 MG VO:0017755 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML [Infanrix] 43661173 OMOP706737 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML [Infanrix] VO:0017756 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension 43714858 OMOP706738 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension VO:0017757 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] 43624780 OMOP706741 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] VO:0017758 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] Box of 25 43643017 OMOP706742 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension [Infanrix] Box of 25 VO:0017759 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension Box of 25 43624779 OMOP706740 vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML Injectable Suspension Box of 25 VO:0017760 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML 41232898 OMOP2430860 vaccine acellular pertussis vaccine, inactivated 160 MG/ML VO:0017761 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML [Tussoglobin] 41141204 OMOP2339166 vaccine acellular pertussis vaccine, inactivated 160 MG/ML [Tussoglobin] VO:0017762 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution 40929108 OMOP2127070 vaccine acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution VO:0017763 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] 41031759 OMOP2229721 vaccine acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] VO:0017764 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] Box of 1 40906974 OMOP2104936 vaccine acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution [Tussoglobin] Box of 1 VO:0017765 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 1 41303553 OMOP2501515 vaccine acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 1 VO:0017766 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 5 41241568 OMOP2439530 vaccine acellular pertussis vaccine, inactivated 160 MG/ML Injectable Solution Box of 5 VO:0017767 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Solution [Acel P Lederle] 41143670 OMOP2341632 vaccine acellular pertussis vaccine, inactivated Injectable Solution [Acel P Lederle] VO:0017768 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Solution [Pac Merieux] 41206217 OMOP2404179 vaccine acellular pertussis vaccine, inactivated Injectable Solution [Pac Merieux] VO:0017769 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Solution [Tussoglobin] 40863333 OMOP2061295 vaccine acellular pertussis vaccine, inactivated Injectable Solution [Tussoglobin] VO:0017770 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Suspension 36887521 OMOP1004473 vaccine acellular pertussis vaccine, inactivated Injectable Suspension VO:0017771 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Suspension [Covaxis] 43750811 OMOP706716 vaccine acellular pertussis vaccine, inactivated Injectable Suspension [Covaxis] VO:0017772 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Suspension [Infanrix] 43786774 OMOP706717 vaccine acellular pertussis vaccine, inactivated Injectable Suspension [Infanrix] VO:0017773 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Suspension [Pediacel] 43786773 OMOP706715 vaccine acellular pertussis vaccine, inactivated Injectable Suspension [Pediacel] VO:0017774 OHDSI Vaccine WG acellular pertussis vaccine, inactivated Injectable Suspension [Repevax] 43822873 OMOP706718 vaccine acellular pertussis vaccine, inactivated Injectable Suspension [Repevax] VO:0017775 OHDSI Vaccine WG Bordetella Pertussis Filamentous Haemagglutinin Antigen 43514466 OMOP2810051 vaccine component Bordetella Pertussis Filamentous Haemagglutinin Antigen VO:0017776 OHDSI Vaccine WG Bordetella Pertussis Fimbriae Serotype 2 And 3 Antigen 43514467 OMOP2810052 vaccine component Bordetella Pertussis Fimbriae Serotype 2 And 3 Antigen VO:0017777 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML 43213868 OMOP466544 vaccine Pertussis Vaccine 0.016 MG/ML VO:0017778 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML [Boostrix] 43804768 OMOP706694 vaccine Pertussis Vaccine 0.016 MG/ML [Boostrix] VO:0017779 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension 43624774 OMOP706697 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension VO:0017780 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] 43696935 OMOP706703 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] VO:0017781 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 10 43696936 OMOP706704 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 10 VO:0017782 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 20 43624775 OMOP706707 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 20 VO:0017783 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 25 43859084 OMOP706708 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 25 VO:0017784 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 50 43732878 OMOP706709 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension [Boostrix] Box of 50 VO:0017785 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 10 43768799 OMOP706698 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 10 VO:0017786 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 20 43643015 OMOP706699 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 20 VO:0017787 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 25 43750809 OMOP706701 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 25 VO:0017788 OHDSI Vaccine WG Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 50 43696934 OMOP706702 vaccine Pertussis Vaccine 0.016 MG/ML Injectable Suspension Box of 50 VO:0017789 OHDSI Vaccine WG Pertussis Vaccine 0.025 MG 43696933 OMOP706693 vaccine Pertussis Vaccine 0.025 MG VO:0017790 OHDSI Vaccine WG Pertussis Vaccine 15000000000 UNT/ML 44078447 OMOP1073078 vaccine Pertussis Vaccine 15000000000 UNT/ML VO:0017791 OHDSI Vaccine WG Pertussis Vaccine 15000000000 UNT/ML Injectable Suspension 44123042 OMOP1117673 vaccine Pertussis Vaccine 15000000000 UNT/ML Injectable Suspension VO:0017792 OHDSI Vaccine WG Pertussis Vaccine 15000000000 UNT/ML Injectable Suspension Box of 5 44058340 OMOP1052971 vaccine Pertussis Vaccine 15000000000 UNT/ML Injectable Suspension Box of 5 VO:0017793 OHDSI Vaccine WG Pertussis Vaccine 15000000000 UNT/ML Injectable Suspension Box of 5 by Aventis 44088328 OMOP1082959 vaccine Pertussis Vaccine 15000000000 UNT/ML Injectable Suspension Box of 5 by Aventis VO:0017794 OHDSI Vaccine WG Pertussis Vaccine 600 UNT/ML [Acel-P] 44081323 OMOP1075954 vaccine Pertussis Vaccine 600 UNT/ML [Acel-P] VO:0017795 OHDSI Vaccine WG Pertussis Vaccine 600 UNT/ML Injectable Suspension 44111022 OMOP1105653 vaccine Pertussis Vaccine 600 UNT/ML Injectable Suspension VO:0017796 OHDSI Vaccine WG Pertussis Vaccine 600 UNT/ML Injectable Suspension [Acel-P] 44035664 OMOP1030295 vaccine Pertussis Vaccine 600 UNT/ML Injectable Suspension [Acel-P] VO:0017797 OHDSI Vaccine WG Pertussis Vaccine Injectable Solution [Pa Vaccinol] 40862415 OMOP2060377 vaccine Pertussis Vaccine Injectable Solution [Pa Vaccinol] VO:0017798 OHDSI Vaccine WG Pertussis Vaccine Injectable Solution [Pertuvac] 41049407 OMOP2247369 vaccine Pertussis Vaccine Injectable Solution [Pertuvac] VO:0017799 OHDSI Vaccine WG Pertussis Vaccine Injectable Suspension 36889505 OMOP995235 vaccine Pertussis Vaccine Injectable Suspension VO:0017800 OHDSI Vaccine WG Pertussis Vaccine Injectable Suspension [Acel-P] 44032027 OMOP1026658 vaccine Pertussis Vaccine Injectable Suspension [Acel-P] VO:0017801 OHDSI Vaccine WG Pertussis Vaccine Injectable Suspension [Boostrix] 43714854 OMOP706689 vaccine Pertussis Vaccine Injectable Suspension [Boostrix] VO:0017802 Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML VO:0017803 Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML VO:0017804 OHDSI Vaccine WG 452809 pertussis vaccine 600 UNT/ML 19112496 vaccine Pertussis Vaccine 600 UNT/ML VO:0017805 Xingxian Li vaccine Diphtheria Toxoid-Pertussis-Haemophilus B-Hepatitis B vaccine VO:0017806 OHDSI Vaccine WG 380957 acellular pertussis vaccine, inactivated Injectable Solution 40069051 vaccine acellular pertussis vaccine, inactivated Injectable Solution VO:0017807 OHDSI Vaccine WG 331446 Neisseria meningitidis 0.5 MG/ML 19087335 vaccine Neisseria meningitidis 0.5 MG/ML VO:0017808 OHDSI Vaccine WG 450547 pertussis vaccine Injectable Solution 40068748 vaccine Pertussis Vaccine Injectable Solution VO:0017810 Xingxian Li vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide VO:0017811 Xingxian Li vaccine influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide VO:0017812 Xingxian Li vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y VO:0017813 Xingxian Li vaccine Meningococcal Polysaccharide Vaccine, Groups A & C VO:0017814 Xingxian Li vaccine Haemophilus B Conjugate Vaccine / meningococcal group C polysaccharide VO:0017815 Xingxian Li vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y / tetanus toxoid vaccine, inactivated VO:0017816 Xingxian Li vaccine meningococcal group C polysaccharide / tetanus toxoid vaccine, inactivated VO:0017817 Xingxian Li vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine VO:0017818 OHDSI Vaccine WG 375536 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine Injectable Solution 40045078 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution VO:0017819 OHDSI Vaccine WG 378898 meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injectable Solution 40055280 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution VO:0017820 OHDSI Vaccine WG 1658225 meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injection 46275260 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection VO:0017821 OHDSI Vaccine WG 378654 meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution 40055282 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution VO:0017822 OHDSI Vaccine WG 343255 Haemophilus capsular oligosaccharide 0.015 MG/ML 586322 vaccine Haemophilus capsular oligosaccharide 0.015 MG/ML VO:0017823 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Meningitec] 44106517 OMOP1101148 vaccine diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Meningitec] VO:0017824 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Menjugate] 44054945 OMOP1049576 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Menjugate] VO:0017825 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML [ActHIB] 43194097 OMOP485102 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML [ActHIB] VO:0017826 OHDSI Vaccine WG meningococcal group A polysaccharide 0.008 MG/ML / meningococcal group C polysaccharide 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.008 MG/ML [Menactra] 44028291 OMOP1022922 vaccine meningococcal group A polysaccharide 0.008 MG/ML / meningococcal group C polysaccharide 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.008 MG/ML [Menactra] VO:0017827 OHDSI Vaccine WG meningococcal group B vaccine 0.3 MG/ML [Bexsero] 36271732 OMOP3122607 vaccine meningococcal group B vaccine 0.3 MG/ML [Bexsero] VO:0017828 OHDSI Vaccine WG meningococcal group B vaccine 0.3 MG/ML [Boostrix] 36274314 OMOP3125189 vaccine meningococcal group B vaccine 0.3 MG/ML [Boostrix] VO:0017829 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Meningitec] 43163523 OMOP505646 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Meningitec] VO:0017830 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Menjugate] 43174520 OMOP505647 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML [Menjugate] VO:0017831 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [ActHIB] 43215973 OMOP485101 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [ActHIB] VO:0017832 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Begrivac] 21124768 OMOP266495 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Begrivac] VO:0017833 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Enzira] 21105351 OMOP266494 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Enzira] VO:0017834 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Imuvac] 21105352 OMOP266500 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Imuvac] VO:0017835 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Invivac] 21026825 OMOP266504 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Invivac] VO:0017836 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Mastaflu] 21026826 OMOP266508 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe [Mastaflu] VO:0017837 OHDSI Vaccine WG influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injectable Solution [Menitorix] 36407337 OMOP3099379 vaccine influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injectable Solution [Menitorix] VO:0017838 OHDSI Vaccine WG influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injection [Menitorix] 21129872 OMOP345296 vaccine influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injection [Menitorix] VO:0017839 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Intramuscular Solution [Menactra] 44030928 OMOP1025559 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Intramuscular Solution [Menactra] VO:0017840 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Prefilled Syringe [Mencevax Acwy] 36788305 OMOP4776562 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Prefilled Syringe [Mencevax Acwy] VO:0017841 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide Injection [AC Vax] 21050925 OMOP301556 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injection [AC Vax] VO:0017842 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide Injection [Mengivac A + C] 21100029 OMOP301545 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injection [Mengivac A + C] VO:0017843 OHDSI Vaccine WG meningococcal group B vaccine Injectable Solution [Bexsero] 36405016 OMOP3097058 vaccine meningococcal group B vaccine Injectable Solution [Bexsero] VO:0017844 OHDSI Vaccine WG meningococcal group B vaccine Injectable Suspension [Bexsero] 36277147 OMOP3128022 vaccine meningococcal group B vaccine Injectable Suspension [Bexsero] VO:0017845 OHDSI Vaccine WG meningococcal group B vaccine Injectable Suspension [Boostrix] 36274617 OMOP3125492 vaccine meningococcal group B vaccine Injectable Suspension [Boostrix] VO:0017846 OHDSI Vaccine WG meningococcal group B vaccine Injectable Suspension [Trumenba] 36810838 OMOP4824874 vaccine meningococcal group B vaccine Injectable Suspension [Trumenba] VO:0017847 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Meningitec] 43174519 OMOP505643 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Meningitec] VO:0017848 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Menjugate] 43185375 OMOP505644 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Menjugate] VO:0017849 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection [Meningitec] 43514649 OMOP2801764 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection [Meningitec] VO:0017850 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML 36886207 OMOP991005 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML VO:0017851 OHDSI Vaccine WG meningococcal group A polysaccharide 0.008 MG/ML 44026807 OMOP1021438 vaccine meningococcal group A polysaccharide 0.008 MG/ML VO:0017852 OHDSI Vaccine WG meningococcal group A polysaccharide 0.5 MG 44052885 OMOP1047516 vaccine meningococcal group A polysaccharide 0.5 MG VO:0017853 OHDSI Vaccine WG meningococcal group A polysaccharide 2.5 MG 44026808 OMOP1021439 vaccine meningococcal group A polysaccharide 2.5 MG VO:0017854 OHDSI Vaccine WG meningococcal group B vaccine 0.3 MG/ML 36264077 OMOP3114952 vaccine meningococcal group B vaccine 0.3 MG/ML VO:0017855 OHDSI Vaccine WG meningococcal group C polysaccharide 0.008 MG/ML 44117395 OMOP1112026 vaccine meningococcal group C polysaccharide 0.008 MG/ML VO:0017856 OHDSI Vaccine WG meningococcal group C polysaccharide 0.5 MG 44091506 OMOP1086137 vaccine meningococcal group C polysaccharide 0.5 MG VO:0017857 OHDSI Vaccine WG meningococcal group C polysaccharide 2.5 MG 44065872 OMOP1060503 vaccine meningococcal group C polysaccharide 2.5 MG VO:0017858 OHDSI Vaccine WG MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.008 MG/ML 44104539 OMOP1099170 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.008 MG/ML VO:0017859 OHDSI Vaccine WG MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.5 MG 44091504 OMOP1086135 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.5 MG VO:0017860 OHDSI Vaccine WG MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 2.5 MG 44091505 OMOP1086136 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 2.5 MG VO:0017861 OHDSI Vaccine WG MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.008 MG/ML 44117394 OMOP1112025 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.008 MG/ML VO:0017862 OHDSI Vaccine WG MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.5 MG 44078574 OMOP1073205 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.5 MG VO:0017863 OHDSI Vaccine WG MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 2.5 MG 44025573 OMOP1020204 vaccine MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 2.5 MG VO:0017864 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG 43285831 OMOP558205 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG VO:0017865 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML 43285833 OMOP558211 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML VO:0017866 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG 43280344 OMOP558210 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG VO:0017867 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG 43280342 OMOP558206 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG VO:0017868 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG/ML 43147645 OMOP463515 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG/ML VO:0017869 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG 43269498 OMOP558407 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG VO:0017870 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG 44026749 OMOP1021380 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG VO:0017871 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG/ML 44117344 OMOP1111975 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.25 MG/ML VO:0017872 OHDSI Vaccine WG Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG 43280346 OMOP558230 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG VO:0017873 OHDSI Vaccine WG Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML 43264020 OMOP558223 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML VO:0017874 OHDSI Vaccine WG Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG 590078 OMOP3136508 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG VO:0017875 OHDSI Vaccine WG Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG/ML 43172058 OMOP484428 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG/ML VO:0017876 OHDSI Vaccine WG Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG 43269497 OMOP558393 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG VO:0017877 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML 36884243 OMOP1002210 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML VO:0017878 OHDSI Vaccine WG Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG 43296595 OMOP558237 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG VO:0017879 OHDSI Vaccine WG Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML 43258587 OMOP558239 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML VO:0017880 OHDSI Vaccine WG Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG 43258586 OMOP558238 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG VO:0017881 OHDSI Vaccine WG Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG/ML 43217154 OMOP495975 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG/ML VO:0017882 OHDSI Vaccine WG Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG 43280374 OMOP558408 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG VO:0017883 OHDSI Vaccine WG Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG 43285839 OMOP558241 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG VO:0017884 OHDSI Vaccine WG Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML 43264024 OMOP558240 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.004 MG/ML VO:0017885 OHDSI Vaccine WG Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG 43285840 OMOP558242 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.005 MG VO:0017886 OHDSI Vaccine WG Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG 43269499 OMOP558409 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.05 MG VO:0017887 OHDSI Vaccine WG COVID-19 vaccine Injectable Solution 35897994 OMOP5042233 vaccine COVID-19 vaccine Injectable Solution VO:0017888 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe 586946 OMOP3138668 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Prefilled Syringe VO:0017889 OHDSI Vaccine WG influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injectable Solution 36407283 OMOP3099325 vaccine influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injectable Solution VO:0017890 OHDSI Vaccine WG influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injection 21041706 OMOP345295 vaccine influenza B virus antigen, Hong Kong 330-2001 / meningococcal group C polysaccharide Injection VO:0017891 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Intramuscular Solution 44055804 OMOP1050435 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Intramuscular Solution VO:0017892 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Prefilled Syringe 36788306 OMOP4776563 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Prefilled Syringe VO:0017893 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide Injection 36887548 OMOP991052 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injection VO:0017894 OHDSI Vaccine WG meningococcal group B vaccine Injectable Solution 36405729 OMOP3097771 vaccine meningococcal group B vaccine Injectable Solution VO:0017895 OHDSI Vaccine WG meningococcal group B vaccine Injectable Suspension 36272005 OMOP3122880 vaccine meningococcal group B vaccine Injectable Suspension VO:0017896 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Suspension 43138345 OMOP478593 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injectable Suspension VO:0017897 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injection 43258583 OMOP558202 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injection VO:0017898 OHDSI Vaccine WG Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension 43141318 OMOP505642 vaccine Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension VO:0017899 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension 36884609 OMOP996060 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension VO:0017900 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection 43515059 OMOP2802174 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection VO:0017901 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] 43161207 OMOP485104 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] VO:0017902 OHDSI Vaccine WG meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Bexsero] 36275190 OMOP3126065 vaccine meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Bexsero] VO:0017903 OHDSI Vaccine WG meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Boostrix] 36267567 OMOP3118442 vaccine meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Boostrix] VO:0017904 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] 43207270 OMOP505650 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] VO:0017905 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] 43218281 OMOP505652 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] VO:0017906 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] 43516402 OMOP2803517 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] VO:0017907 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Meningitec] 44108948 OMOP1103579 vaccine diphtheria toxoid vaccine, inactivated / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Meningitec] VO:0017908 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Menjugate] 44096073 OMOP1090704 vaccine diphtheria toxoid vaccine, inactivated / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Menjugate] VO:0017909 OHDSI Vaccine WG Haemophilus B Conjugate Vaccine / meningococcal group C polysaccharide Injectable Solution [Menitorix] 40731786 OMOP4725436 vaccine Haemophilus B Conjugate Vaccine / meningococcal group C polysaccharide Injectable Solution [Menitorix] VO:0017910 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Begrivac] 35749520 OMOP2750981 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Begrivac] VO:0017911 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Enzira] 35774724 OMOP2776185 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Enzira] VO:0017912 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Imuvac] 35766144 OMOP2767605 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Imuvac] VO:0017913 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Invivac] 35753726 OMOP2755187 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Invivac] VO:0017914 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Mastaflu] 35766143 OMOP2767604 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine Injectable Solution [Mastaflu] VO:0017915 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [ACWY Vax] 35766294 OMOP2767755 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [ACWY Vax] VO:0017916 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Menactra] 35146370 OMOP4803450 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Menactra] VO:0017917 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Mencevax Acwy] 36788307 OMOP4776564 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Mencevax Acwy] VO:0017918 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injectable Solution [Menquadfi] 36923646 OMOP5186787 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injectable Solution [Menquadfi] VO:0017919 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Menveo] 35766293 OMOP2767754 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Menveo] VO:0017920 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Nimenrix] 35753882 OMOP2755343 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injectable Solution [Nimenrix] VO:0017921 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection [ACWY Vax] 21031231 OMOP301502 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection [ACWY Vax] VO:0017922 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection [Menveo] 21100028 OMOP301513 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection [Menveo] VO:0017923 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection [Nimenrix] 21021512 OMOP301524 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y Injection [Nimenrix] VO:0017924 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [AC Vax] 35762196 OMOP2763657 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [AC Vax] VO:0017925 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [Mengivac A + C] 35770591 OMOP2772052 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [Mengivac A + C] VO:0017926 OHDSI Vaccine WG meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [Mengivac] 40734162 OMOP4723522 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [Mengivac] VO:0017927 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe 36881901 OMOP1005669 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe VO:0017928 OHDSI Vaccine WG meningococcal group A polysaccharide 0.008 MG/ML / meningococcal group C polysaccharide 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.008 MG/ML Intramuscular Solution 44071335 OMOP1065966 vaccine meningococcal group A polysaccharide 0.008 MG/ML / meningococcal group C polysaccharide 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.008 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.008 MG/ML Intramuscular Solution VO:0017929 OHDSI Vaccine WG meningococcal group B vaccine 0.3 MG/ML Injectable Suspension 36277400 OMOP3128275 vaccine meningococcal group B vaccine 0.3 MG/ML Injectable Suspension VO:0017930 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG Injection 43280343 OMOP558208 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.01 MG Injection VO:0017931 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 43141319 OMOP505648 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017932 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection 43515932 OMOP2803047 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection VO:0017933 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension 44042986 OMOP1037617 vaccine diphtheria toxoid vaccine, inactivated / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine Injectable Suspension VO:0017934 OHDSI Vaccine WG Haemophilus B Conjugate Vaccine / meningococcal group C polysaccharide Injectable Solution 40731787 OMOP4725435 vaccine Haemophilus B Conjugate Vaccine / meningococcal group C polysaccharide Injectable Solution VO:0017935 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] 43208816 OMOP506995 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] VO:0017936 OHDSI Vaccine WG 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Bexsero] 36281212 OMOP3132087 vaccine 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Bexsero] VO:0017937 OHDSI Vaccine WG 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Boostrix] 36281011 OMOP3131886 vaccine 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Boostrix] VO:0017938 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] 43186944 OMOP507209 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] VO:0017939 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] 43519258 OMOP2806373 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] VO:0017940 OHDSI Vaccine WG 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] 43219844 OMOP507326 vaccine 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] VO:0017941 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe 43219815 OMOP506992 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe VO:0017942 OHDSI Vaccine WG 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension 36281092 OMOP3131967 vaccine 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension VO:0017943 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 43208844 OMOP507207 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017944 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection 43519172 OMOP2806287 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection VO:0017945 OHDSI Vaccine WG 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 43186963 OMOP507322 vaccine 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017946 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] 44086674 OMOP1081305 vaccine diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] VO:0017947 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] 44073786 OMOP1068417 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] VO:0017948 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] Box of 1 43139076 OMOP485105 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] Box of 1 VO:0017949 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 1 43141320 OMOP505651 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 1 VO:0017950 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 10 43515191 OMOP2802306 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 10 VO:0017951 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] Box of 1 43174522 OMOP505653 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] Box of 1 VO:0017952 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] Box of 10 43516825 OMOP2803940 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] Box of 10 VO:0017953 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 44045862 OMOP1040493 vaccine diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017954 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 44084575 OMOP1079206 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017955 OHDSI Vaccine WG meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.5 MG Injectable Solution 44032490 OMOP1027121 vaccine meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.5 MG Injectable Solution VO:0017956 OHDSI Vaccine WG meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG Injectable Solution 44045486 OMOP1040117 vaccine meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG Injectable Solution VO:0017957 OHDSI Vaccine WG meningococcal group A polysaccharide 2.5 MG / meningococcal group C polysaccharide 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 2.5 MG Injectable Solution 44058469 OMOP1053100 vaccine meningococcal group A polysaccharide 2.5 MG / meningococcal group C polysaccharide 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 2.5 MG Injectable Solution VO:0017958 OHDSI Vaccine WG Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 43172134 OMOP485103 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0017959 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 1 43174521 OMOP505649 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0017960 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 10 43514698 OMOP2801813 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 10 VO:0017961 OHDSI Vaccine WG Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection Box of 10 43515111 OMOP2802226 vaccine Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection Box of 10 VO:0017962 OHDSI Vaccine WG 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Bexsero] by GSK 36281177 OMOP3132052 vaccine 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Bexsero] by GSK VO:0017963 OHDSI Vaccine WG 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Boostrix] by GSK 36281200 OMOP3132075 vaccine 0.5 ML meningococcal group B vaccine 0.3 MG/ML Injectable Suspension [Boostrix] by GSK VO:0017964 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] Box of 1 43165007 OMOP506996 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] Box of 1 VO:0017965 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 1 43186945 OMOP507211 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 1 VO:0017966 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 10 43519158 OMOP2806273 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 10 VO:0017967 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] Box of 10 43519157 OMOP2806272 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection [Meningitec] Box of 10 VO:0017968 OHDSI Vaccine WG 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] Box of 1 43208856 OMOP507327 vaccine 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] Box of 1 VO:0017969 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] 44132864 OMOP1127495 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] VO:0017970 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] 44132807 OMOP1127438 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] VO:0017971 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 43186921 OMOP506994 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe Box of 1 VO:0017972 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 1 43208845 OMOP507208 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0017973 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 10 43519132 OMOP2806247 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 10 VO:0017974 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection Box of 10 43519216 OMOP2806331 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injection Box of 10 VO:0017975 OHDSI Vaccine WG 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 1 43154033 OMOP507325 vaccine 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension Box of 1 VO:0017976 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 44132704 OMOP1127335 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017977 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension 44132529 OMOP1127160 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension VO:0017978 OHDSI Vaccine WG 0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injectable Solution 44132517 OMOP1127148 vaccine 0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML Injectable Solution VO:0017979 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] by Nuron Biotech 44132885 OMOP1127516 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] by Nuron Biotech VO:0017980 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] by Glaxosmithkline 44132738 OMOP1127369 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] by Glaxosmithkline VO:0017981 OHDSI Vaccine WG 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] Box of 1 by Sanofi 43176027 OMOP506997 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine 0.02 MG/ML Prefilled Syringe [ActHIB] Box of 1 by Sanofi VO:0017982 OHDSI Vaccine WG 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 1 by Nuron Biotech 43165028 OMOP507212 vaccine 0.5 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Meningitec] Box of 1 by Nuron Biotech VO:0017983 OHDSI Vaccine WG 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] Box of 1 by Glaxosmithkline 43186964 OMOP507328 vaccine 0.6 ML Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML Injectable Suspension [Menjugate] Box of 1 by Glaxosmithkline VO:0017984 OHDSI Vaccine WG meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.5 MG Injectable Solution by Sanofi 44050095 OMOP1044726 vaccine meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.5 MG Injectable Solution by Sanofi VO:0017985 OHDSI Vaccine WG meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG Injectable Solution by Aventis 44088674 OMOP1083305 vaccine meningococcal group A polysaccharide 0.5 MG / meningococcal group C polysaccharide 0.5 MG Injectable Solution by Aventis VO:0017986 OHDSI Vaccine WG meningococcal group A polysaccharide 2.5 MG / meningococcal group C polysaccharide 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 2.5 MG Injectable Solution by Aventis 44036973 OMOP1031604 vaccine meningococcal group A polysaccharide 2.5 MG / meningococcal group C polysaccharide 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 2.5 MG / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 2.5 MG Injectable Solution by Aventis VO:0017987 OHDSI Vaccine WG 0.5 ML poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution 43828097 OMOP718903 vaccine 0.5 ML poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution VO:0017988 OHDSI Vaccine WG 0.5 ML poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Poliovaccine Ssi] 43738110 OMOP718904 vaccine 0.5 ML poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Poliovaccine Ssi] VO:0017989 OHDSI Vaccine WG 0.5 ML poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Poliovaccine Ssi] by Statens Serum Institut 43666365 OMOP718905 vaccine 0.5 ML poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Poliovaccine Ssi] by Statens Serum Institut VO:0017990 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension 43612108 OMOP719493 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension VO:0017991 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension [Polio Sabin-S] 43630214 OMOP719494 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension [Polio Sabin-S] VO:0017992 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution 589165 OMOP3135649 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution VO:0017993 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] 43281223 OMOP559791 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] VO:0017994 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] Box of 10 43297436 OMOP559792 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] Box of 10 VO:0017995 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution Box of 10 586586 OMOP3136352 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution Box of 10 VO:0017996 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection 43264840 OMOP559787 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection VO:0017997 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection Box of 10 43270321 OMOP559790 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection Box of 10 VO:0017998 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection Box of 10 by Saudi 43297435 OMOP559789 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection Box of 10 by Saudi VO:0017999 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection by Saudi 43292056 OMOP559788 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection by Saudi VO:0018000 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution 44132743 OMOP1127374 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution VO:0018001 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution Box of 5 44132842 OMOP1127473 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution Box of 5 VO:0018002 OHDSI Vaccine WG 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution Box of 5 by Sanofi 44132635 OMOP1127266 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution Box of 5 by Sanofi VO:0018003 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection 36884659 OMOP997398 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / Pertussis Vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection VO:0018004 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection 36882751 OMOP1000731 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection VO:0018005 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection [Adacel] 43258514 OMOP557508 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection [Adacel] VO:0018006 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection [Boostrix] 43296520 OMOP557541 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection [Boostrix] VO:0018007 OHDSI Vaccine WG acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection [Quadracel] 43291121 OMOP557509 vaccine acellular pertussis vaccine, inactivated / Bordetella pertussis / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) Injection [Quadracel] VO:0018008 OHDSI Vaccine WG Human poliovirus 160 BAU/ML 36261502 OMOP3112377 vaccine Human poliovirus 160 BAU/ML VO:0018009 OHDSI Vaccine WG Poliomyelitis Virus Type 1 (Sabin Strain (Ls-C, 2ab)) Live Attenuated Oral Vaccine 36879031 OMOP998167 vaccine Poliomyelitis Virus Type 1 (Sabin Strain (Ls-C, 2ab)) Live Attenuated Oral Vaccine VO:0018010 OHDSI Vaccine WG Poliomyelitis Virus Type 1 (Sabin Strain (Ls-C, 2ab)) Live Attenuated Oral Vaccine 1000000 UNT 43285776 OMOP557673 vaccine Poliomyelitis Virus Type 1 (Sabin Strain (Ls-C, 2ab)) Live Attenuated Oral Vaccine 1000000 UNT VO:0018011 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde 36879187 OMOP1004381 vaccine poliomyelitis virus type 1 brunhilde VO:0018012 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Solution 43840989 OMOP707046 vaccine poliomyelitis virus type 1 brunhilde / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Solution VO:0018013 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Solution [Poliovaccine Ssi] 43588861 OMOP707047 vaccine poliomyelitis virus type 1 brunhilde / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Solution [Poliovaccine Ssi] VO:0018014 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde 80 UNT/ML 43804917 OMOP709436 vaccine poliomyelitis virus type 1 brunhilde 80 UNT/ML VO:0018015 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML [Poliovaccine Ssi] 43859108 OMOP707048 vaccine poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML [Poliovaccine Ssi] VO:0018016 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution 43859109 OMOP707049 vaccine poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution VO:0018017 OHDSI Vaccine WG poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Poliovaccine Ssi] 43624799 OMOP707050 vaccine poliomyelitis virus type 1 brunhilde 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution [Poliovaccine Ssi] VO:0018018 OHDSI Vaccine WG Poliomyelitis Virus Type 2 (Sabin Strain (P712, Ch, 2ab)) Live Attenuated Oral Vaccine 36878872 OMOP1004329 vaccine Poliomyelitis Virus Type 2 (Sabin Strain (P712, Ch, 2ab)) Live Attenuated Oral Vaccine VO:0018019 OHDSI Vaccine WG Poliomyelitis Virus Type 2 (Sabin Strain (P712, Ch, 2ab)) Live Attenuated Oral Vaccine 100000 UNT 43258539 OMOP557681 vaccine Poliomyelitis Virus Type 2 (Sabin Strain (P712, Ch, 2ab)) Live Attenuated Oral Vaccine 100000 UNT VO:0018020 OHDSI Vaccine WG Poliomyelitis Virus Type 3 (Sabin Strain (Leon 12a1b)) Live Attenuated Oral Vaccine 36878873 OMOP1004287 vaccine Poliomyelitis Virus Type 3 (Sabin Strain (Leon 12a1b)) Live Attenuated Oral Vaccine VO:0018021 OHDSI Vaccine WG Poliomyelitis Virus Type 3 (Sabin Strain (Leon 12a1b)) Live Attenuated Oral Vaccine 600000 UNT 43274982 OMOP557684 vaccine Poliomyelitis Virus Type 3 (Sabin Strain (Leon 12a1b)) Live Attenuated Oral Vaccine 600000 UNT VO:0018022 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injection 36889507 OMOP992748 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injection VO:0018023 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS 43697113 OMOP709700 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS VO:0018024 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS / poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS / poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS [Polio Sabin-Rit Multi] 43679266 OMOP709708 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS / poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS / poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS [Polio Sabin-Rit Multi] VO:0018025 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS / poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS / poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS Injectable Suspension 43751008 OMOP709709 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS / poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS / poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS Injectable Suspension VO:0018026 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS / poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS / poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS Injectable Suspension [Polio Sabin-Rit Multi] 43661321 OMOP709710 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 1000000 CELLS / poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS / poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS Injectable Suspension [Polio Sabin-Rit Multi] VO:0018027 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML 43841146 OMOP709689 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML VO:0018028 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML [Polio Sabin-S] 43643211 OMOP709705 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML [Polio Sabin-S] VO:0018029 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension 43679265 OMOP709706 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension VO:0018030 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension [Polio Sabin-S] 43768971 OMOP709707 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 2000000 CELLS/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML / poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML Injectable Suspension [Polio Sabin-S] VO:0018031 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML 43269418 OMOP557667 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML VO:0018032 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML [Ipol] 43258537 OMOP557668 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML [Ipol] VO:0018033 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution 587995 OMOP3136749 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution VO:0018034 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] 43258538 OMOP557671 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] VO:0018035 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] Box of 10 43285775 OMOP557672 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution [Ipol] Box of 10 VO:0018036 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution Box of 10 587297 OMOP3135031 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injectable Solution Box of 10 VO:0018037 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection 43280300 OMOP557669 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection VO:0018038 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection Box of 10 43274980 OMOP557670 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML Injection Box of 10 VO:0018039 OHDSI Vaccine WG poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution Box of 5 44110095 OMOP1104726 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Solution Box of 5 VO:0018040 OHDSI Vaccine WG poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS 43607038 OMOP709714 vaccine poliovirus vaccine inactivated, type 2 (MEF-1) 100000 CELLS VO:0018041 OHDSI Vaccine WG poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML 43589007 OMOP709715 vaccine poliovirus vaccine inactivated, type 2 (MEF-1) 200000 CELLS/ML VO:0018042 OHDSI Vaccine WG poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML 43285778 OMOP557680 vaccine poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML VO:0018043 OHDSI Vaccine WG poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS 43841150 OMOP709727 vaccine poliovirus vaccine inactivated, type 3 (Saukett) 300000 CELLS VO:0018044 OHDSI Vaccine WG poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML 43291145 OMOP557683 vaccine poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML VO:0018045 OHDSI Vaccine WG poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML 43607039 OMOP709728 vaccine poliovirus vaccine inactivated, type 3 (Saukett) 600000 CELLS/ML VO:0018046 Xingxian Li vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) VO:0018047 Xingxian Li vaccine poliomyelitis virus type 1 brunhilde / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) VO:0018048 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution 43684195 OMOP717900 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution VO:0018049 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Priorix-Tetra] 43828038 OMOP717901 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Priorix-Tetra] VO:0018050 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension 43219807 OMOP506910 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension VO:0018051 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension Box of 1 43208806 OMOP506911 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension Box of 1 VO:0018052 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution 36896194 OMOP991334 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution VO:0018053 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] 43630196 OMOP719167 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] VO:0018054 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 10 43612084 OMOP719170 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 10 VO:0018055 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 10 by Glaxosmithkline 43702265 OMOP719171 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 10 by Glaxosmithkline VO:0018056 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 100 43612085 OMOP719178 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 100 VO:0018057 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 100 by Glaxosmithkline 43791877 OMOP719180 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 100 by Glaxosmithkline VO:0018058 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 20 43719979 OMOP719172 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 20 VO:0018059 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 20 by Glaxosmithkline 43594116 OMOP719173 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 20 by Glaxosmithkline VO:0018060 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 25 43594117 OMOP719174 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 25 VO:0018061 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 25 by Glaxosmithkline 43846149 OMOP719175 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 25 by Glaxosmithkline VO:0018062 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 40 43630198 OMOP719176 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 40 VO:0018063 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 40 by Glaxosmithkline 43846150 OMOP719177 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 40 by Glaxosmithkline VO:0018064 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] by Glaxosmithkline 43630197 OMOP719169 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] by Glaxosmithkline VO:0018065 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] 43612086 OMOP719181 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] VO:0018066 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 10 43648260 OMOP719183 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 10 VO:0018067 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 10 by Glaxosmithkline 43828119 OMOP719184 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 10 by Glaxosmithkline VO:0018068 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 100 43774094 OMOP719189 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 100 VO:0018069 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 100 by Glaxosmithkline 43594118 OMOP719191 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 100 by Glaxosmithkline VO:0018070 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 20 43810038 OMOP719185 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 20 VO:0018071 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 20 by Glaxosmithkline 43810039 OMOP719186 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 20 by Glaxosmithkline VO:0018072 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 50 43666379 OMOP719187 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 50 VO:0018073 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 50 by Glaxosmithkline 43648261 OMOP719188 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 50 by Glaxosmithkline VO:0018074 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] by Glaxosmithkline 43666378 OMOP719182 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] by Glaxosmithkline VO:0018075 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 10 43702264 OMOP719161 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 10 VO:0018076 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 100 43810037 OMOP719166 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 100 VO:0018077 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 20 43828118 OMOP719162 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 20 VO:0018078 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 25 43791876 OMOP719163 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 25 VO:0018079 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 40 43864419 OMOP719164 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 40 VO:0018080 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 50 43630195 OMOP719165 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 50 VO:0018081 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension 35414596 OMOP1148181 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension VO:0018082 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension Box of 1 35414666 OMOP1148251 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension Box of 1 VO:0018083 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension Box of 1 by Sanofi 35414588 OMOP1148173 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension Box of 1 by Sanofi VO:0018084 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution 43738120 OMOP719192 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution VO:0018085 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] 43756059 OMOP719195 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] VO:0018086 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 10 43864420 OMOP719197 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 10 VO:0018087 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 10 by Glaxosmithkline 43774095 OMOP719198 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 10 by Glaxosmithkline VO:0018088 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 20 43648262 OMOP719199 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 20 VO:0018089 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 20 by Glaxosmithkline 43774096 OMOP719200 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 20 by Glaxosmithkline VO:0018090 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] by Glaxosmithkline 43846151 OMOP719196 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] by Glaxosmithkline VO:0018091 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 10 43791878 OMOP719193 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 10 VO:0018092 OHDSI Vaccine WG 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 20 43702266 OMOP719194 vaccine 0.5 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 20 VO:0018093 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe 43197968 OMOP507065 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe VO:0018094 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] 43165018 OMOP507067 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] VO:0018095 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] Box of 1 43176036 OMOP507068 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] Box of 1 VO:0018096 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] Box of 1 by Glaxosmithkline 43176037 OMOP507069 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] Box of 1 by Glaxosmithkline VO:0018097 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe Box of 1 43154002 OMOP507066 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe Box of 1 VO:0018098 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe 35414574 OMOP1148159 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe VO:0018099 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] 35414639 OMOP1148224 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] VO:0018100 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] Box of 1 35414565 OMOP1148150 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] Box of 1 VO:0018101 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] Box of 1 by Glaxosmithkline 35414614 OMOP1148199 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] Box of 1 by Glaxosmithkline VO:0018102 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe Box of 1 35414635 OMOP1148220 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe Box of 1 VO:0018103 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution 44132778 OMOP1127409 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution VO:0018104 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution Box of 10 44132694 OMOP1127325 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution Box of 10 VO:0018105 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution Box of 10 by Merck 44132767 OMOP1127398 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution Box of 10 by Merck VO:0018106 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution 44132840 OMOP1127471 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution VO:0018107 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution [Priorix] 44132796 OMOP1127427 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution [Priorix] VO:0018108 OHDSI Vaccine WG 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution [Priorix] by Glaxosmithkline 44132633 OMOP1127264 vaccine 0.5 ML MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution [Priorix] by Glaxosmithkline VO:0018109 OHDSI Vaccine WG 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution 43698683 OMOP740569 vaccine 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution VO:0018110 OHDSI Vaccine WG 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] 43806387 OMOP740572 vaccine 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] VO:0018111 OHDSI Vaccine WG 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] Box of 100 43608546 OMOP740574 vaccine 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] Box of 100 VO:0018112 OHDSI Vaccine WG 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] Box of 100 by Glaxosmithkline 43626502 OMOP740575 vaccine 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] Box of 100 by Glaxosmithkline VO:0018113 OHDSI Vaccine WG 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] by Glaxosmithkline 43662814 OMOP740573 vaccine 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] by Glaxosmithkline VO:0018114 OHDSI Vaccine WG 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution Box of 100 43770505 OMOP740570 vaccine 1 ML Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution Box of 100 VO:0018115 OHDSI Vaccine WG Measles Vaccine / Mumps Vaccine / Rubella virus vaccine / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution 40892713 OMOP2090675 vaccine Measles Vaccine / Mumps Vaccine / Rubella virus vaccine / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution VO:0018116 OHDSI Vaccine WG Measles Vaccine / Mumps Vaccine / Rubella virus vaccine / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix] 41049414 OMOP2247376 vaccine Measles Vaccine / Mumps Vaccine / Rubella virus vaccine / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix] VO:0018117 OHDSI Vaccine WG Measles Vaccine / Mumps Vaccine / Rubella virus vaccine / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [ProQuad] 44164545 OMOP3041268 vaccine Measles Vaccine / Mumps Vaccine / Rubella virus vaccine / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [ProQuad] VO:0018118 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution 36407293 OMOP3099335 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution VO:0018119 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution [M-M-R II] 36403478 OMOP3095520 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution [M-M-R II] VO:0018120 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution [M-M-RVAXPRO] 36407367 OMOP3099409 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution [M-M-RVAXPRO] VO:0018121 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution [Priorix] 36406599 OMOP3098641 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injectable Solution [Priorix] VO:0018122 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection 21158545 OMOP378320 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection VO:0018123 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection [M-M-R II] 21021052 OMOP378308 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection [M-M-R II] VO:0018124 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection [M-M-RVAXPRO] 36404258 OMOP3096300 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection [M-M-RVAXPRO] VO:0018125 OHDSI Vaccine WG Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection [Priorix] 21070186 OMOP378297 vaccine Measles Vaccine / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella virus vaccine Injection [Priorix] VO:0018126 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Vaccine / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution 43855698 OMOP955950 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Vaccine / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution VO:0018127 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Vaccine / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix-Tetra] 43783606 OMOP955951 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Vaccine / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix-Tetra] VO:0018128 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution 44094493 OMOP1089124 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution VO:0018129 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution 40753443 OMOP4703827 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution VO:0018130 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [M-M-R II] 40753442 OMOP4703828 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [M-M-R II] VO:0018131 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [M-M-RVAXPRO] 40753441 OMOP4703829 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [M-M-RVAXPRO] VO:0018132 OHDSI Vaccine WG measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution [Priorix] 36062569 OMOP4988598 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution [Priorix] VO:0018133 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension 36883664 OMOP995185 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension VO:0018134 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension [M-M-RVAXPRO] 40753440 OMOP4703830 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension [M-M-RVAXPRO] VO:0018135 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML 43138012 OMOP475662 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML VO:0018136 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML [Priorix-Tetra] 43855699 OMOP955952 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML [Priorix-Tetra] VO:0018137 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution 43585548 OMOP955954 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution VO:0018138 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Priorix-Tetra] 43675951 OMOP955955 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Priorix-Tetra] VO:0018139 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension 43171064 OMOP475665 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension VO:0018140 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension Box of 1 43182058 OMOP475666 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Injectable Suspension Box of 1 VO:0018141 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML [Mmr Priorix] 43643101 OMOP707901 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML [Mmr Priorix] VO:0018142 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML [Priorix-Tetra] 43768866 OMOP707902 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML [Priorix-Tetra] VO:0018143 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution 36891631 OMOP989935 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution VO:0018144 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] 43841042 OMOP707910 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] VO:0018145 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 10 43750903 OMOP707911 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 10 VO:0018146 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 100 43606945 OMOP707916 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 100 VO:0018147 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 20 43588898 OMOP707912 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 20 VO:0018148 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 25 43714924 OMOP707913 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 25 VO:0018149 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 40 43606944 OMOP707915 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Mmr Priorix] Box of 40 VO:0018150 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] 43822936 OMOP707917 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] VO:0018151 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 10 43822937 OMOP707918 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 10 VO:0018152 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 100 43714925 OMOP707921 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 100 VO:0018153 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 20 43588899 OMOP707919 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 20 VO:0018154 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 50 43643102 OMOP707920 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution [Priorix-Tetra] Box of 50 VO:0018155 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 10 43750902 OMOP707904 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 10 VO:0018156 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 100 43859169 OMOP707909 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 100 VO:0018157 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 20 43606942 OMOP707905 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 20 VO:0018158 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 25 43606943 OMOP707906 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 25 VO:0018159 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 40 43732944 OMOP707907 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 40 VO:0018160 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 50 43661230 OMOP707908 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML Injectable Solution Box of 50 VO:0018161 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML 35408789 OMOP1142374 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML VO:0018162 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension 35408217 OMOP1141802 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension VO:0018163 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension Box of 1 35409771 OMOP1143356 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Injectable Suspension Box of 1 VO:0018164 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML 43859170 OMOP707929 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML VO:0018165 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML [Priorix] 43661231 OMOP707930 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML [Priorix] VO:0018166 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution 43768867 OMOP707931 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution VO:0018167 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] 43841043 OMOP707934 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] VO:0018168 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 10 43661232 OMOP707935 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 10 VO:0018169 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 20 43697003 OMOP707938 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution [Priorix] Box of 20 VO:0018170 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 10 43859171 OMOP707932 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 10 VO:0018171 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 20 43768868 OMOP707933 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 TCID/ML Injectable Solution Box of 20 VO:0018172 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 6 CELLS/ML 44104541 OMOP1099172 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 6 CELLS/ML VO:0018173 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML 43697002 OMOP707922 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML VO:0018174 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML [Priorix] 43804825 OMOP707923 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML [Priorix] VO:0018175 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution 43624852 OMOP707924 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution VO:0018176 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] 43679184 OMOP707927 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] VO:0018177 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] Box of 100 43624853 OMOP707928 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution [Priorix] Box of 100 VO:0018178 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution Box of 100 43804826 OMOP707926 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 700 PFU/ML Injectable Solution Box of 100 VO:0018179 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution 36894420 OMOP992661 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution VO:0018180 OHDSI Vaccine WG measles virus vaccine live, Enders' attenuated Edmonston strain Injectable Solution [Attenuvax] 36058798 OMOP4984454 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain Injectable Solution [Attenuvax] VO:0018181 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution [Mmr Priorix] 43661229 OMOP707899 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution [Mmr Priorix] VO:0018182 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution [Priorix] 43643100 OMOP707898 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution [Priorix] VO:0018183 OHDSI Vaccine WG Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution [Priorix-Tetra] 43697001 OMOP707900 vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain Injectable Solution [Priorix-Tetra] VO:0018184 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection 43258601 OMOP558369 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection VO:0018185 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection [Priorix] 43264037 OMOP558371 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection [Priorix] VO:0018186 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus Injection 43264036 OMOP558360 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus Injection VO:0018187 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus Injection [M-M-R II] 43296608 OMOP558361 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus Injection [M-M-R II] VO:0018188 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus Injection [Priorix] 43296609 OMOP558362 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus Injection [Priorix] VO:0018189 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine / Varicella Virus Vaccine Live (Oka-Merck) strain Injectable Solution 36259257 OMOP3110132 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine / Varicella Virus Vaccine Live (Oka-Merck) strain Injectable Solution VO:0018190 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine / Varicella Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix-Tetra] 36274804 OMOP3125679 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine / Varicella Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix-Tetra] VO:0018191 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Solution 36261795 OMOP3112670 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Solution VO:0018192 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Solution [Priorix] 36277370 OMOP3128245 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Solution [Priorix] VO:0018193 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Suspension 36269510 OMOP3120385 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Suspension VO:0018194 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Suspension [M.M.R. VaxPro] 36274805 OMOP3125680 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Injectable Suspension [M.M.R. VaxPro] VO:0018195 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Prefilled Syringe 36789582 OMOP4777828 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Prefilled Syringe VO:0018196 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Prefilled Syringe [Priorix] 36789581 OMOP4777827 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps virus / Rubella virus vaccine Prefilled Syringe [Priorix] VO:0018197 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution 44029759 OMOP1024390 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution VO:0018198 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix-Tetra] 44121581 OMOP1116212 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Priorix-Tetra] VO:0018199 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution 44120423 OMOP1115054 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution VO:0018200 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [Priorix] 44095640 OMOP1090271 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [Priorix] VO:0018201 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection 40753445 OMOP4703825 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection VO:0018202 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection [Priorix] 40753444 OMOP4703826 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection [Priorix] VO:0018203 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Prefilled Syringe 43205643 OMOP490338 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Prefilled Syringe VO:0018204 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Prefilled Syringe [Priorix] 43205644 OMOP490339 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Mumps Virus Vaccine Live, Jeryl Lynn Strain / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Prefilled Syringe [Priorix] VO:0018205 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution 44081509 OMOP1076140 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution VO:0018206 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID [M-M-R II] 43280364 OMOP558366 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID [M-M-R II] VO:0018207 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID Injection 43296610 OMOP558367 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID Injection VO:0018208 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID Injection [M-M-R II] 43280365 OMOP558368 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID Injection [M-M-R II] VO:0018209 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT [M.M.R. VaxPro] 36274503 OMOP3125378 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT [M.M.R. VaxPro] VO:0018210 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT Injectable Suspension 36257253 OMOP3108128 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT Injectable Suspension VO:0018211 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT Injectable Suspension [M.M.R. VaxPro] 36276047 OMOP3126922 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT Injectable Suspension [M.M.R. VaxPro] VO:0018212 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT Injectable Suspension [M.M.R. VaxPro] by MSD 36263433 OMOP3114308 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT Injectable Suspension [M.M.R. VaxPro] by MSD VO:0018213 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU [Priorix] 43258602 OMOP558372 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU [Priorix] VO:0018214 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection 43280366 OMOP558373 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection VO:0018215 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection [Priorix] 43258603 OMOP558374 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection [Priorix] VO:0018216 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT [Priorix-Tetra] 36271960 OMOP3122835 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT [Priorix-Tetra] VO:0018217 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT Injectable Solution 36272539 OMOP3123414 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT Injectable Solution VO:0018218 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT Injectable Solution [Priorix-Tetra] 36276046 OMOP3126921 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT Injectable Solution [Priorix-Tetra] VO:0018219 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT Injectable Solution [Priorix-Tetra] by GSK 36273690 OMOP3124565 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT Injectable Solution [Priorix-Tetra] by GSK VO:0018220 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT [Priorix] 36264311 OMOP3115186 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT [Priorix] VO:0018221 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT Injectable Solution 36264924 OMOP3115799 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT Injectable Solution VO:0018222 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT Injectable Solution [Priorix] 36273455 OMOP3124330 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT Injectable Solution [Priorix] VO:0018223 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT Injectable Solution [Priorix] by GSK 36274051 OMOP3124926 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT Injectable Solution [Priorix] by GSK VO:0018224 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT [Priorix] 43258599 OMOP558363 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT [Priorix] VO:0018225 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT Injection 43258600 OMOP558364 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT Injection VO:0018226 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT Injection [Priorix] 43269491 OMOP558365 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT Injection [Priorix] VO:0018227 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML [Priorix] 43139653 OMOP490340 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML [Priorix] VO:0018228 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe 43194685 OMOP490341 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe VO:0018229 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] 43194686 OMOP490343 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] VO:0018230 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] Box of 1 43205645 OMOP490344 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe [Priorix] Box of 1 VO:0018231 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe Box of 1 43161777 OMOP490342 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML Prefilled Syringe Box of 1 VO:0018232 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML [Priorix] 35411928 OMOP1145513 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML [Priorix] VO:0018233 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe 35410511 OMOP1144096 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe VO:0018234 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] 35409147 OMOP1142732 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] VO:0018235 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] Box of 1 35412248 OMOP1145833 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe [Priorix] Box of 1 VO:0018236 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe Box of 1 35412089 OMOP1145674 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML Prefilled Syringe Box of 1 VO:0018237 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution 44045490 OMOP1040121 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution VO:0018238 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution Box of 10 44071341 OMOP1065972 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution Box of 10 VO:0018239 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML [Priorix] 44067367 OMOP1061998 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML [Priorix] VO:0018240 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution 44109994 OMOP1104625 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution VO:0018241 OHDSI Vaccine WG MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution [Priorix] 44111801 OMOP1106432 vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution [Priorix] VO:0018242 Xingxian Li vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Vaccine 35000 PFU/ML / Rubella virus 1400 PFU/ML / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML VO:0018243 Xingxian Li vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 17500 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML VO:0018244 Xingxian Li vaccine Measles Virus Vaccine Live, Enders' attenuated Edmonston strain 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 25000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML VO:0018245 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 TCID / Mumps virus 12500 TCID / Rubella virus 1000 TCID VO:0018246 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 12500 UNT / Rubella virus vaccine 1000 UNT VO:0018247 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus 1000 UNT / Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU VO:0018248 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT / Varicella Virus Vaccine Live (Oka-Merck) strain 1000 UNT VO:0018249 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 25100 UNT / Rubella virus vaccine 1000 UNT VO:0018250 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1000 UNT / Mumps virus 5000 UNT / Rubella virus 1000 UNT VO:0018251 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 1400 PFU/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 7000 PFU/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1400 PFU/ML VO:0018252 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 /ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 /ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 /ML VO:0018253 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML VO:0018254 Xingxian Li vaccine MEASLES VIRUS VACCINE,LIVE ATTENUATED 2000 UNT/ML / Mumps Virus Vaccine Live, Jeryl Lynn Strain 20000 UNT/ML / Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML VO:0018255 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT [RabAvert] 44079671 OMOP1074302 vaccine rabies virus vaccine flury-lep strain 2.5 UNT [RabAvert] VO:0018256 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML [Rabipur] 43167474 OMOP443770 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML [Rabipur] VO:0018257 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML [Rabivac] 40858955 OMOP2056917 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML [Rabivac] VO:0018258 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT [Imovax] 44040931 OMOP1035562 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT [Imovax] VO:0018259 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML [Tollwut-Impfstoff] 43804821 OMOP707866 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML [Tollwut-Impfstoff] VO:0018260 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML [VACCIN RABIQUE INACTIVE MERIEUX] 43183263 OMOP486548 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML [VACCIN RABIQUE INACTIVE MERIEUX] VO:0018261 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injectable Solution [Rabipur] 43679183 OMOP707870 vaccine rabies virus vaccine flury-lep strain Injectable Solution [Rabipur] VO:0018262 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injectable Solution [Rabivac] 41080810 OMOP2278772 vaccine rabies virus vaccine flury-lep strain Injectable Solution [Rabivac] VO:0018263 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injectable Solution [Verorab] 35745478 OMOP2746939 vaccine rabies virus vaccine flury-lep strain Injectable Solution [Verorab] VO:0018264 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injectable Suspension [Rabipur] 40753244 OMOP4703886 vaccine rabies virus vaccine flury-lep strain Injectable Suspension [Rabipur] VO:0018265 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Prefilled Syringe [Rabipur] 36888557 OMOP1000408 vaccine rabies virus vaccine flury-lep strain Prefilled Syringe [Rabipur] VO:0018266 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Injectable Suspension [Tollwut-Impfstoff] 43750900 OMOP707864 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Injectable Suspension [Tollwut-Impfstoff] VO:0018267 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] 43161361 OMOP486544 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] VO:0018268 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT 44104295 OMOP1098926 vaccine rabies virus vaccine flury-lep strain 2.5 UNT VO:0018269 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT 44117108 OMOP1111739 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT VO:0018270 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injectable Solution 36887520 OMOP994373 vaccine rabies virus vaccine flury-lep strain Injectable Solution VO:0018271 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injectable Suspension 40753245 OMOP4703885 vaccine rabies virus vaccine flury-lep strain Injectable Suspension VO:0018272 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Prefilled Syringe 43589318 OMOP901149 vaccine rabies virus vaccine flury-lep strain Prefilled Syringe VO:0018273 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Injectable Solution 44042731 OMOP1037362 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Injectable Solution VO:0018274 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Injectable Suspension 36886560 OMOP992050 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Injectable Suspension VO:0018275 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Prefilled Syringe 36890528 OMOP1006576 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated Prefilled Syringe VO:0018276 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] 43768862 OMOP707874 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] VO:0018277 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] 41307107 OMOP2505069 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] VO:0018278 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] 43156545 OMOP443772 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] VO:0018279 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension [Tollwut-Impfstoff] 43679182 OMOP707868 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension [Tollwut-Impfstoff] VO:0018280 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] 43150159 OMOP486549 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] VO:0018281 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injection [Rabipur] 21110381 OMOP345287 vaccine rabies virus vaccine flury-lep strain Injection [Rabipur] VO:0018282 OHDSI Vaccine WG rabies virus vaccine flury-lep strain Injection [Verorab] 21090622 OMOP345288 vaccine rabies virus vaccine flury-lep strain Injection [Verorab] VO:0018283 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT Injectable Solution 44084005 OMOP1078636 vaccine rabies virus vaccine flury-lep strain 2.5 UNT Injectable Solution VO:0018284 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution 43822935 OMOP707873 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution VO:0018285 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe 43732942 OMOP707872 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe VO:0018286 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injectable Solution 44071142 OMOP1065773 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injectable Solution VO:0018287 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Solution 44122950 OMOP1117581 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Solution VO:0018288 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension 43661228 OMOP707867 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension VO:0018289 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe 36880938 OMOP1001066 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe VO:0018290 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] 43734590 OMOP740567 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] VO:0018291 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] 41336401 OMOP2534363 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] VO:0018292 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] 43185426 OMOP507802 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] VO:0018293 OHDSI Vaccine WG 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension [Tollwut-Impfstoff] 43608545 OMOP740563 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension [Tollwut-Impfstoff] VO:0018294 OHDSI Vaccine WG 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] 43174649 OMOP508540 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] VO:0018295 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution 43734589 OMOP740566 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution VO:0018296 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe 43218327 OMOP507799 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe VO:0018297 OHDSI Vaccine WG 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension 43752455 OMOP740561 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension VO:0018298 OHDSI Vaccine WG 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe 43163646 OMOP508539 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe VO:0018299 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT Injection [RabAvert] 44085669 OMOP1080300 vaccine rabies virus vaccine flury-lep strain 2.5 UNT Injection [RabAvert] VO:0018300 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injection [Imovax] 44033934 OMOP1028565 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injection [Imovax] VO:0018301 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 40963879 OMOP2161841 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 VO:0018302 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 5 41151737 OMOP2349699 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 5 VO:0018303 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 41245057 OMOP2443019 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 VO:0018304 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 5 41276016 OMOP2473978 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 5 VO:0018305 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] Box of 1 43156546 OMOP443773 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] Box of 1 VO:0018306 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT Injection 590559 OMOP3137574 vaccine rabies virus vaccine flury-lep strain 2.5 UNT Injection VO:0018307 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injection 587650 OMOP3135277 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injection VO:0018308 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT Injectable Solution Box of 1 41114616 OMOP2312578 vaccine rabies virus vaccine flury-lep strain 2.5 UNT Injectable Solution Box of 1 VO:0018309 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT Injectable Solution Box of 5 41146205 OMOP2344167 vaccine rabies virus vaccine flury-lep strain 2.5 UNT Injectable Solution Box of 5 VO:0018310 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 1 40833773 OMOP2031735 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 1 VO:0018311 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 5 40896126 OMOP2094088 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 5 VO:0018312 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe Box of 1 43178538 OMOP443771 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe Box of 1 VO:0018313 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] by Novartis 43788320 OMOP740568 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] by Novartis VO:0018314 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] by Novartis 43644719 OMOP740565 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] by Novartis VO:0018315 OHDSI Vaccine WG 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension [Tollwut-Impfstoff] by Sanofi 43716437 OMOP740564 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Suspension [Tollwut-Impfstoff] by Sanofi VO:0018316 OHDSI Vaccine WG 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] by Sanofi 43207396 OMOP508541 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Prefilled Syringe [VACCIN RABIQUE INACTIVE MERIEUX] by Sanofi VO:0018317 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Solution by Aventis 44101105 OMOP1095736 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT/ML Injectable Solution by Aventis VO:0018318 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 41331647 OMOP2529609 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 VO:0018319 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 5 41336402 OMOP2534364 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 5 VO:0018320 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 41332998 OMOP2530960 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 VO:0018321 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 5 41332997 OMOP2530959 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 5 VO:0018322 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] Box of 1 43196407 OMOP507803 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] Box of 1 VO:0018323 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 1 41332808 OMOP2530770 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 1 VO:0018324 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 5 41336195 OMOP2534157 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 5 VO:0018325 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe Box of 1 43152460 OMOP507801 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe Box of 1 VO:0018326 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Boehringer Ingelheim 41331938 OMOP2529900 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Boehringer Ingelheim VO:0018327 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Emra-Med 41336700 OMOP2534662 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Emra-Med VO:0018328 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Eurim-Pharm 41328641 OMOP2526603 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Eurim-Pharm VO:0018329 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Kohlpharma 41336699 OMOP2534661 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Kohlpharma VO:0018330 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Novartis 41335357 OMOP2533319 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Novartis VO:0018331 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Orifarm Leverkus 41337333 OMOP2535295 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 1 by Orifarm Leverkus VO:0018332 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 5 by Boehringer Ingelheim 41327981 OMOP2525943 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabipur] Box of 5 by Boehringer Ingelheim VO:0018333 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 by Boehringer Ingelheim 41331271 OMOP2529233 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 by Boehringer Ingelheim VO:0018334 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 by Novartis 41332638 OMOP2530600 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 1 by Novartis VO:0018335 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 5 by Boehringer Ingelheim 41334002 OMOP2531964 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution [Rabivac] Box of 5 by Boehringer Ingelheim VO:0018336 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 1 by Sanofi 41335356 OMOP2533318 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injectable Solution Box of 1 by Sanofi VO:0018337 OHDSI Vaccine WG 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] Box of 1 by Glaxosmithkline 43152461 OMOP507804 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Prefilled Syringe [Rabipur] Box of 1 by Glaxosmithkline VO:0018338 OHDSI Vaccine WG rabies virus vaccine flury-lep strain 2.5 UNT Injection [RabAvert] by Glaxosmithkline 44025539 OMOP1020170 vaccine rabies virus vaccine flury-lep strain 2.5 UNT Injection [RabAvert] by Glaxosmithkline VO:0018339 OHDSI Vaccine WG rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injection [Imovax] by Sanofi 44113949 OMOP1108580 vaccine rabies virus vaccine wistar strain PM-1503-3M (Human), Inactivated 2.5 UNT Injection [Imovax] by Sanofi VO:0018340 OHDSI Vaccine WG Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43280358 OMOP558330 vaccine Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018341 OHDSI Vaccine WG Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43280357 OMOP558329 vaccine Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018342 OHDSI Vaccine WG Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG 43296602 OMOP558299 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG VO:0018343 OHDSI Vaccine WG Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML 43269481 OMOP558301 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML VO:0018344 OHDSI Vaccine WG Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43296601 OMOP558298 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018345 OHDSI Vaccine WG Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43258595 OMOP558302 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018346 OHDSI Vaccine WG Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG 43296600 OMOP558295 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG VO:0018347 OHDSI Vaccine WG Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML 43291196 OMOP558293 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML VO:0018348 OHDSI Vaccine WG Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43275051 OMOP558291 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018349 OHDSI Vaccine WG Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43269479 OMOP558292 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018350 OHDSI Vaccine WG Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43258588 OMOP558244 vaccine Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018351 OHDSI Vaccine WG Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43291193 OMOP558243 vaccine Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018352 OHDSI Vaccine WG Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG 43258594 OMOP558287 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG VO:0018353 OHDSI Vaccine WG Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML 43291195 OMOP558290 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML VO:0018354 OHDSI Vaccine WG Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43269477 OMOP558284 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018355 OHDSI Vaccine WG Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43264030 OMOP558285 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018356 OHDSI Vaccine WG Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG 43296597 OMOP558263 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG VO:0018357 OHDSI Vaccine WG Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML 43280349 OMOP558266 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML VO:0018358 OHDSI Vaccine WG Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43280347 OMOP558264 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018359 OHDSI Vaccine WG Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43280348 OMOP558265 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018360 OHDSI Vaccine WG Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43264033 OMOP558333 vaccine Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018361 OHDSI Vaccine WG Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43269486 OMOP558334 vaccine Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018362 OHDSI Vaccine WG Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG 43291204 OMOP558324 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG VO:0018363 OHDSI Vaccine WG Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML 43280355 OMOP558325 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML VO:0018364 OHDSI Vaccine WG Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43285849 OMOP558323 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018365 OHDSI Vaccine WG Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43285850 OMOP558327 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018366 OHDSI Vaccine WG Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43291202 OMOP558318 vaccine Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018367 OHDSI Vaccine WG Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43291203 OMOP558319 vaccine Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018368 OHDSI Vaccine WG Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43285848 OMOP558317 vaccine Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018369 OHDSI Vaccine WG Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43296604 OMOP558316 vaccine Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018370 OHDSI Vaccine WG Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG 43280354 OMOP558310 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG VO:0018371 OHDSI Vaccine WG Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 43296603 OMOP558315 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0018372 OHDSI Vaccine WG Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG 43285846 OMOP558311 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG VO:0018373 OHDSI Vaccine WG Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML 43258597 OMOP558313 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML VO:0018374 OHDSI Vaccine WG Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43285851 OMOP558335 vaccine Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018375 OHDSI Vaccine WG Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43296605 OMOP558336 vaccine Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018376 OHDSI Vaccine WG Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG 43291198 OMOP558304 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG VO:0018377 OHDSI Vaccine WG Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML 43291199 OMOP558306 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG/ML VO:0018378 OHDSI Vaccine WG Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG 43269482 OMOP558307 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG VO:0018379 OHDSI Vaccine WG Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML 43275052 OMOP558305 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0022 MG/ML VO:0018380 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML [Pneumovax 23] 44105716 OMOP1100347 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML [Pneumovax 23] VO:0018381 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML [Pnu-Imune] 44041036 OMOP1035667 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML [Pnu-Imune] VO:0018382 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML [Pneumopur] 40921231 OMOP2119193 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML [Pneumopur] VO:0018383 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML [Pneumovax 23] 40890268 OMOP2088230 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML [Pneumovax 23] VO:0018384 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML [Pneumovax II] 40952398 OMOP2150360 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML [Pneumovax II] VO:0018385 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pneumopur] 41049412 OMOP2247374 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pneumopur] VO:0018386 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pneumovax 23] 44082483 OMOP1077114 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pneumovax 23] VO:0018387 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pneumovax II] 41299069 OMOP2497031 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pneumovax II] VO:0018388 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pnu-Imune] 44082484 OMOP1077115 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Pnu-Imune] VO:0018389 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Prevnar] 35770581 OMOP2772042 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Prevnar] VO:0018390 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Synflorix] 35774856 OMOP2776317 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution [Synflorix] VO:0018391 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Moniarix] 41049413 OMOP2247375 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Moniarix] VO:0018392 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pneumopur] 41206216 OMOP2404178 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pneumopur] VO:0018393 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pneumorix] 40831206 OMOP2029168 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pneumorix] VO:0018394 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pneumovax II] 21100583 OMOP345282 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pneumovax II] VO:0018395 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pnu-Imune] 21051477 OMOP345283 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Pnu-Imune] VO:0018396 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Prevnar] 42481173 OMOP421053 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Prevnar] VO:0018397 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Synflorix] 21139788 OMOP345286 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe [Synflorix] VO:0018398 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.001 MG 36789344 OMOP4777592 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.001 MG VO:0018399 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.002 MG/ML 44065681 OMOP1060312 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.002 MG/ML VO:0018400 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML 40950807 OMOP2148769 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML VO:0018401 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 14 vaccine 0.001 MG 36789410 OMOP4777658 vaccine pneumococcal capsular polysaccharide type 14 vaccine 0.001 MG VO:0018402 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 14 vaccine 0.002 MG/ML 44078408 OMOP1073039 vaccine pneumococcal capsular polysaccharide type 14 vaccine 0.002 MG/ML VO:0018403 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 18C vaccine 0.004 MG 36789409 OMOP4777657 vaccine pneumococcal capsular polysaccharide type 18C vaccine 0.004 MG VO:0018404 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 18C vaccine 0.006 MG/ML 44065682 OMOP1060313 vaccine pneumococcal capsular polysaccharide type 18C vaccine 0.006 MG/ML VO:0018405 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 19F vaccine 0.004 MG 36789420 OMOP4777668 vaccine pneumococcal capsular polysaccharide type 19F vaccine 0.004 MG VO:0018406 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 19F vaccine 0.006 MG/ML 44078409 OMOP1073040 vaccine pneumococcal capsular polysaccharide type 19F vaccine 0.006 MG/ML VO:0018407 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 23F vaccine 0.001 MG 36789342 OMOP4777591 vaccine pneumococcal capsular polysaccharide type 23F vaccine 0.001 MG VO:0018408 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 23F vaccine 0.002 MG/ML 44065680 OMOP1060311 vaccine pneumococcal capsular polysaccharide type 23F vaccine 0.002 MG/ML VO:0018409 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 4 vaccine 0.004 MG 36789415 OMOP4777663 vaccine pneumococcal capsular polysaccharide type 4 vaccine 0.004 MG VO:0018410 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 4 vaccine 0.006 MG/ML 44091340 OMOP1085971 vaccine pneumococcal capsular polysaccharide type 4 vaccine 0.006 MG/ML VO:0018411 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 5 vaccine 0.001 MG 36789414 OMOP4777662 vaccine pneumococcal capsular polysaccharide type 5 vaccine 0.001 MG VO:0018412 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 5 vaccine 0.002 MG/ML 44117191 OMOP1111822 vaccine pneumococcal capsular polysaccharide type 5 vaccine 0.002 MG/ML VO:0018413 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 6B vaccine 0.001 MG 36789413 OMOP4777661 vaccine pneumococcal capsular polysaccharide type 6B vaccine 0.001 MG VO:0018414 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 6B vaccine 0.002 MG/ML 44104371 OMOP1099002 vaccine pneumococcal capsular polysaccharide type 6B vaccine 0.002 MG/ML VO:0018415 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 7F vaccine 0.001 MG 36789412 OMOP4777660 vaccine pneumococcal capsular polysaccharide type 7F vaccine 0.001 MG VO:0018416 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 7F vaccine 0.002 MG/ML 44091339 OMOP1085970 vaccine pneumococcal capsular polysaccharide type 7F vaccine 0.002 MG/ML VO:0018417 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 9V vaccine 0.001 MG 36789411 OMOP4777659 vaccine pneumococcal capsular polysaccharide type 9V vaccine 0.001 MG VO:0018418 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 9V vaccine 0.002 MG/ML 44078407 OMOP1073038 vaccine pneumococcal capsular polysaccharide type 9V vaccine 0.002 MG/ML VO:0018419 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23] 44072872 OMOP1067503 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23] VO:0018420 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pnu-Imune] 44098714 OMOP1093345 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pnu-Imune] VO:0018421 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] 41214118 OMOP2412080 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] VO:0018422 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] 40901536 OMOP2099498 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] VO:0018423 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] 40963882 OMOP2161844 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] VO:0018424 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] 40870451 OMOP2068413 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] VO:0018425 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] 40963883 OMOP2161845 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] VO:0018426 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution 44084058 OMOP1078689 vaccine pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution VO:0018427 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution 41301532 OMOP2499494 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution VO:0018428 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe 41051815 OMOP2249777 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe VO:0018429 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23] 44132577 OMOP1127208 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23] VO:0018430 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pnu-Imune] 44132853 OMOP1127484 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pnu-Imune] VO:0018431 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] 41407628 OMOP2605590 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] VO:0018432 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] 41409931 OMOP2607893 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] VO:0018433 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] 41407834 OMOP2605796 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] VO:0018434 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] 41407240 OMOP2605202 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] VO:0018435 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] 41407427 OMOP2605389 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] VO:0018436 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 10 40995161 OMOP2193123 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 10 VO:0018437 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 20 41276021 OMOP2473983 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 20 VO:0018438 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 40824891 OMOP2022853 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 VO:0018439 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 41151739 OMOP2349701 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 VO:0018440 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 41120150 OMOP2318112 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 VO:0018441 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 40932636 OMOP2130598 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 VO:0018442 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 41276020 OMOP2473982 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 VO:0018443 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 40963881 OMOP2161843 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 VO:0018444 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 1 41057403 OMOP2255365 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 1 VO:0018445 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 10 41120153 OMOP2318115 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 10 VO:0018446 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 20 40839328 OMOP2037290 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 20 VO:0018447 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 41245059 OMOP2443021 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 VO:0018448 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 41307109 OMOP2505071 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 VO:0018449 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 41088917 OMOP2286879 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 VO:0018450 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23] by Merck 44132593 OMOP1127224 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pneumovax 23] by Merck VO:0018451 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pnu-Imune] by Lederle Products 44132811 OMOP1127442 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution [Pnu-Imune] by Lederle Products VO:0018452 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 10 41409181 OMOP2607143 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 10 VO:0018453 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 20 41407627 OMOP2605589 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumopur] Box of 20 VO:0018454 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 41408790 OMOP2606752 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 VO:0018455 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 41408251 OMOP2606213 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 VO:0018456 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 41407833 OMOP2605795 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 VO:0018457 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 41407626 OMOP2605588 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 VO:0018458 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 41408447 OMOP2606409 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 VO:0018459 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 41409374 OMOP2607336 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 VO:0018460 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 1 41408979 OMOP2606941 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 1 VO:0018461 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 10 41409183 OMOP2607145 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 10 VO:0018462 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 20 41408252 OMOP2606214 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumopur] Box of 20 VO:0018463 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 41409716 OMOP2607678 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 VO:0018464 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 41408025 OMOP2605987 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 VO:0018465 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 41409182 OMOP2607144 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 VO:0018466 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Axicorp 41409041 OMOP2607003 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Axicorp VO:0018467 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Cc 41409600 OMOP2607562 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Cc VO:0018468 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Eurim-Pharm 41409039 OMOP2607001 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Eurim-Pharm VO:0018469 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Gerke 41409038 OMOP2607000 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Gerke VO:0018470 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Kohlpharma 41409429 OMOP2607391 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Kohlpharma VO:0018471 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Orifarm Leverkus 41408510 OMOP2606472 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 1 by Orifarm Leverkus VO:0018472 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Abacus Medicine 41407309 44197230 OMOP2605271 OMOP3073953 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Abacus Medicine VO:0018473 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Axicorp 41408511 OMOP2606473 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Axicorp VO:0018474 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Cc 41409040 OMOP2607002 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Cc VO:0018475 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Gerke 41407308 OMOP2605270 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Gerke VO:0018476 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Kohlpharma 41408862 OMOP2606824 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 10 by Kohlpharma VO:0018477 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 by Cc 41410000 OMOP2607962 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 by Cc VO:0018478 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 by Gerke 41409999 OMOP2607961 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 by Gerke VO:0018479 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 by Kohlpharma 41409794 OMOP2607756 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax 23] Box of 20 by Kohlpharma VO:0018480 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Emra-Med 41409796 OMOP2607758 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Emra-Med VO:0018481 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Merck 44197089 OMOP3073812 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Merck VO:0018482 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Novartis 41408863 OMOP2606825 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Novartis VO:0018483 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Sanofi 41409431 OMOP2607393 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 1 by Sanofi VO:0018484 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Emra-Med 41407916 OMOP2605878 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Emra-Med VO:0018485 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Eurim-Pharm 41409042 OMOP2607004 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Eurim-Pharm VO:0018486 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Merck 44197052 OMOP3073775 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Merck VO:0018487 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Orifarm Leverkus 41409795 OMOP2607757 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Orifarm Leverkus VO:0018488 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Sanofi 41409602 OMOP2607564 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 10 by Sanofi VO:0018489 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Axicorp 41409601 OMOP2607563 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Axicorp VO:0018490 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Emra-Med 41407503 OMOP2605465 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Emra-Med VO:0018491 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Eurim-Pharm 41409256 OMOP2607218 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Eurim-Pharm VO:0018492 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Merck 44197143 OMOP3073866 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Merck VO:0018493 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Orifarm Leverkus 41409430 OMOP2607392 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Orifarm Leverkus VO:0018494 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Sanofi 41407915 OMOP2605877 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution [Pneumovax II] Box of 20 by Sanofi VO:0018495 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 by Merck 44197206 OMOP3073929 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 by Merck VO:0018496 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 by Sanofi 41410189 OMOP2608151 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 1 by Sanofi VO:0018497 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 by Merck 44197016 OMOP3073739 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 by Merck VO:0018498 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 by Sanofi 41409043 OMOP2607005 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 10 by Sanofi VO:0018499 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 by Merck 44197145 OMOP3073868 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 by Merck VO:0018500 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 by Sanofi 41408673 OMOP2606635 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe [Pneumovax II] Box of 20 by Sanofi VO:0018501 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution 44132691 OMOP1127322 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 0.05 MG/ML Injectable Solution VO:0018502 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution 41410070 OMOP2608032 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution VO:0018503 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe 41408581 OMOP2606543 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe VO:0018504 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 41409875 OMOP2607837 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 VO:0018505 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 41407193 OMOP2605155 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 VO:0018506 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 41408937 OMOP2606899 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 VO:0018507 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 1 41407983 OMOP2605945 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 1 VO:0018508 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 10 41409327 OMOP2607289 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 10 VO:0018509 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 20 41408580 OMOP2606542 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 20 VO:0018510 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 by Emra-Med 41408864 OMOP2606826 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 by Emra-Med VO:0018511 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 by European 41409432 44197090 OMOP2607394 OMOP3073813 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 by European VO:0018512 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 by Emra-Med 41407917 OMOP2605879 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 by Emra-Med VO:0018513 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 by European 41409257 44197144 OMOP2607219 OMOP3073867 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 by European VO:0018514 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 by Emra-Med 44197173 OMOP3073896 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 by Emra-Med VO:0018515 OHDSI Vaccine WG 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 by European 41408115 44197205 OMOP2606077 OMOP3073928 vaccine 0.5 ML pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 by European VO:0018516 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution 44094440 OMOP1089071 vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Solution VO:0018517 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe 21100584 OMOP345284 vaccine pneumococcal capsular polysaccharide type 1 vaccine Prefilled Syringe VO:0018518 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 40958358 OMOP2156320 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 1 VO:0018519 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 40833774 OMOP2031736 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 10 VO:0018520 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 41083405 OMOP2281367 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Injectable Solution Box of 20 VO:0018521 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 1 41301533 OMOP2499495 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 1 VO:0018522 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 10 41177146 OMOP2375108 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 10 VO:0018523 OHDSI Vaccine WG pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 20 41270451 OMOP2468413 vaccine pneumococcal capsular polysaccharide type 1 vaccine 1.15 MG/ML Prefilled Syringe Box of 20 VO:0018524 Joy Hu vaccine pneumococcal capsular polysaccharide type 1 vaccine Injectable Product VO:0018525 OHDSI Vaccine WG 0.5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension 43738156 OMOP719855 vaccine 0.5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension VO:0018526 OHDSI Vaccine WG 0.5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] 43594159 OMOP719856 vaccine 0.5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] VO:0018527 OHDSI Vaccine WG 0.5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] by Emergent Sales And Marketing 43702300 OMOP719857 vaccine 0.5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] by Emergent Sales And Marketing VO:0018528 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension 36896182 OMOP992409 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension VO:0018529 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] 36896219 OMOP1005136 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] VO:0018530 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] Box of 1 43165008 OMOP507004 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] Box of 1 VO:0018531 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] Box of 1 by Valneva 43142853 OMOP507005 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] Box of 1 by Valneva VO:0018532 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] by Valneva 44132817 OMOP1127448 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] by Valneva VO:0018533 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension Box of 1 43197964 OMOP507003 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension Box of 1 VO:0018534 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection 43281224 OMOP559802 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection VO:0018535 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection [Jespect] 43275892 OMOP559803 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection [Jespect] VO:0018536 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension 36281035 OMOP3131910 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension VO:0018537 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension [Ixiaro] 36281130 OMOP3132005 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension [Ixiaro] VO:0018538 OHDSI Vaccine WG 0.5 ML Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension [Ixiaro] by Eco.Pharma.Supply 36281090 OMOP3131965 vaccine 0.5 ML Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension [Ixiaro] by Eco.Pharma.Supply VO:0018539 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection 43270323 OMOP559813 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection VO:0018540 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] 43281227 OMOP559816 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] VO:0018541 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 10 43292059 OMOP559817 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 10 VO:0018542 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 20 43297443 OMOP559818 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 20 VO:0018543 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 10 43297442 OMOP559814 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 10 VO:0018544 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 20 43259418 OMOP559815 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 20 VO:0018545 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension 36896175 OMOP1003019 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension VO:0018546 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] 36896217 OMOP996911 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] VO:0018547 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Box of 1 43208813 OMOP506970 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Box of 1 VO:0018548 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Box of 1 by Glaxosmithkline 43219812 OMOP506972 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Box of 1 by Glaxosmithkline VO:0018549 OHDSI Vaccine WG 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension Box of 1 43186919 OMOP506969 vaccine 0.5 ML L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension Box of 1 VO:0018550 OHDSI Vaccine WG 0.5 ML Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution 44132692 OMOP1127323 vaccine 0.5 ML Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution VO:0018551 OHDSI Vaccine WG 0.5 ML Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution [Mumpsvax] 44132795 OMOP1127426 vaccine 0.5 ML Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution [Mumpsvax] VO:0018552 OHDSI Vaccine WG 0.5 ML Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution [Mumpsvax] by Merck 44132874 OMOP1127505 vaccine 0.5 ML Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution [Mumpsvax] by Merck VO:0018553 OHDSI Vaccine WG 0.5 ML Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution 44132512 OMOP1127143 vaccine 0.5 ML Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution VO:0018554 OHDSI Vaccine WG 0.5 ML Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution by Aventis 44132683 OMOP1127314 vaccine 0.5 ML Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 2000 UNT/ML Injectable Solution by Aventis VO:0018555 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution 36281236 OMOP3132111 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution VO:0018556 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] 36281041 OMOP3131916 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] VO:0018557 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 36781828 OMOP4770114 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 VO:0018558 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Sanofi 36781827 OMOP4770113 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Sanofi VO:0018559 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] by Sanofi 36281089 OMOP3131964 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] by Sanofi VO:0018560 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution Box of 1 36781829 OMOP4770115 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution Box of 1 VO:0018561 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection 43292065 OMOP559856 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection VO:0018562 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] 43259425 OMOP559860 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] VO:0018563 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] Box of 10 43259426 OMOP559862 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] Box of 10 VO:0018564 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] 43286682 OMOP559858 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] VO:0018565 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] Box of 10 43275897 OMOP559859 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] Box of 10 VO:0018566 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection Box of 10 43286681 OMOP559857 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection Box of 10 VO:0018567 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution 36281033 OMOP3131908 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution VO:0018568 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution [Typherix] 36281215 OMOP3132090 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution [Typherix] VO:0018569 OHDSI Vaccine WG 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution [Typherix] by GSK 36281139 OMOP3132014 vaccine 0.5 ML Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution [Typherix] by GSK VO:0018570 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension 43186930 OMOP507103 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension VO:0018571 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] 43208827 OMOP507106 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] VO:0018572 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 1 43186931 OMOP507108 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 1 VO:0018573 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 1 by Sanofi 43142865 OMOP507109 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 1 by Sanofi VO:0018574 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 10 43208828 OMOP507110 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 10 VO:0018575 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 10 by Sanofi 43176039 OMOP507111 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 10 by Sanofi VO:0018576 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 1 43219827 OMOP507104 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 1 VO:0018577 OHDSI Vaccine WG 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 10 43197970 OMOP507105 vaccine 0.5 ML Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 10 VO:0018578 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension 43186999 OMOP509137 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension VO:0018579 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] 43219886 OMOP509139 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] VO:0018580 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] Box of 1 43142919 OMOP509140 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] Box of 1 VO:0018581 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline 43219887 OMOP509141 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline VO:0018582 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension Box of 1 43154072 OMOP509138 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension Box of 1 VO:0018583 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension 35414764 OMOP1148349 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension VO:0018584 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] 35414795 OMOP1148380 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] VO:0018585 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] Box of 1 35414743 OMOP1148328 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] Box of 1 VO:0018586 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline 35414804 OMOP1148389 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline VO:0018587 OHDSI Vaccine WG 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension Box of 1 35414739 OMOP1148324 vaccine 1.5 ML Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension Box of 1 VO:0018588 OHDSI Vaccine WG 5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension 43807480 OMOP773096 vaccine 5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension VO:0018589 OHDSI Vaccine WG 5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] 43789378 OMOP773097 vaccine 5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] VO:0018590 OHDSI Vaccine WG 5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] by Emergent Sales And Marketing 43681729 OMOP773098 vaccine 5 ML Anthrax Vaccine Adsorbed 0.1 MG/ML Injectable Suspension [Biothrax] by Emergent Sales And Marketing VO:0018591 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.0075 MG/ML 43269437 OMOP557843 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.0075 MG/ML VO:0018592 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.00752 MG/ML 42713316 OMOP2731437 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.00752 MG/ML VO:0018593 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.015 MG/ML 43258555 OMOP557842 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.015 MG/ML VO:0018594 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML 35411046 OMOP1144631 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML VO:0018595 OHDSI Vaccine WG Bacillus anthracis Injectable Suspension 36065062 OMOP4991332 vaccine Bacillus anthracis Injectable Suspension VO:0018596 OHDSI Vaccine WG Bacillus anthracis Injectable Suspension [Biothrax] 36065061 OMOP4991331 vaccine Bacillus anthracis Injectable Suspension [Biothrax] VO:0018597 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 2210000 UNT 44039976 OMOP1034607 vaccine Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 2210000 UNT VO:0018598 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 770000 PFU/ML 43296580 OMOP558085 vaccine Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 770000 PFU/ML VO:0018599 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 772000 PFU/ML 588735 OMOP3137149 vaccine Human-Bovine Reassortant Rotavirus Strain G1 Vaccine 772000 PFU/ML VO:0018600 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 2840000 UNT 44039975 OMOP1034606 vaccine Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 2840000 UNT VO:0018601 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 980000 PFU/ML 43275027 OMOP558092 vaccine Human-Bovine Reassortant Rotavirus Strain G2 Vaccine 980000 PFU/ML VO:0018602 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 2220000 UNT 44104696 OMOP1099327 vaccine Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 2220000 UNT VO:0018603 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 770000 PFU/ML 43280332 OMOP558093 vaccine Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 770000 PFU/ML VO:0018604 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 772000 PFU/ML 587998 OMOP3138212 vaccine Human-Bovine Reassortant Rotavirus Strain G3 Vaccine 772000 PFU/ML VO:0018605 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 2040000 UNT 44026999 OMOP1021630 vaccine Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 2040000 UNT VO:0018606 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 698000 PFU/ML 588444 OMOP3138214 vaccine Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 698000 PFU/ML VO:0018607 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 700000 PFU/ML 43285821 OMOP558094 vaccine Human-Bovine Reassortant Rotavirus Strain G4 Vaccine 700000 PFU/ML VO:0018608 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 2290000 UNT 44026998 OMOP1021629 vaccine Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 2290000 UNT VO:0018609 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 805000 PFU/ML 43269458 OMOP558095 vaccine Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 805000 PFU/ML VO:0018610 OHDSI Vaccine WG Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 807000 PFU/ML 588939 OMOP3134981 vaccine Human-Bovine Reassortant Rotavirus Strain P1A[8] Vaccine 807000 PFU/ML VO:0018611 OHDSI Vaccine WG Japanese encephalitis virus Injectable Solution 40750631 OMOP4706628 vaccine Japanese encephalitis virus Injectable Solution VO:0018612 OHDSI Vaccine WG Japanese encephalitis virus Injectable Suspension 40750630 OMOP4706629 vaccine Japanese encephalitis virus Injectable Suspension VO:0018613 OHDSI Vaccine WG Japanese encephalitis virus Injectable Suspension [Ixiaro] 40750629 OMOP4706630 vaccine Japanese encephalitis virus Injectable Suspension [Ixiaro] VO:0018614 OHDSI Vaccine WG Japanese encephalitis virus Injection 43296576 OMOP558070 vaccine Japanese encephalitis virus Injection VO:0018615 OHDSI Vaccine WG Japanese encephalitis virus Injection [Imojev] 43296577 OMOP558071 vaccine Japanese encephalitis virus Injection [Imojev] VO:0018616 OHDSI Vaccine WG Japanese encephalitis virus Injection [Ixiaro] 40750628 OMOP4706631 vaccine Japanese encephalitis virus Injection [Ixiaro] VO:0018617 OHDSI Vaccine WG Japanese encephalitis virus Prefilled Syringe 40892714 OMOP2090676 vaccine Japanese encephalitis virus Prefilled Syringe VO:0018618 OHDSI Vaccine WG Japanese encephalitis virus Prefilled Syringe [Ixiaro] 41080814 OMOP2278776 vaccine Japanese encephalitis virus Prefilled Syringe [Ixiaro] VO:0018619 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML [Jespect] 43263998 OMOP558074 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML [Jespect] VO:0018620 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension 36889651 OMOP998792 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension VO:0018621 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] 36880290 OMOP988593 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] VO:0018622 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] Box of 1 43161232 OMOP485272 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension [Ixiaro] Box of 1 VO:0018623 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension Box of 1 43205074 OMOP485271 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injectable Suspension Box of 1 VO:0018624 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection 36892614 OMOP1000069 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection VO:0018625 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection [Jespect] 43269457 OMOP558075 vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML Injection [Jespect] VO:0018626 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 1 UNT 44052985 OMOP1047616 vaccine Japanese encephalitis virus vaccine, inactivated 1 UNT VO:0018627 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 1 UNT [Je-Vax] 44041385 OMOP1036016 vaccine Japanese encephalitis virus vaccine, inactivated 1 UNT [Je-Vax] VO:0018628 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 1 UNT Injectable Suspension 44110067 OMOP1104698 vaccine Japanese encephalitis virus vaccine, inactivated 1 UNT Injectable Suspension VO:0018629 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 1 UNT Injectable Suspension [Je-Vax] 44099142 OMOP1093773 vaccine Japanese encephalitis virus vaccine, inactivated 1 UNT Injectable Suspension [Je-Vax] VO:0018630 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 1 UNT Injectable Suspension [Je-Vax] by The Res.Found.For Microb.Dis.Osaka University 44088876 OMOP1083507 vaccine Japanese encephalitis virus vaccine, inactivated 1 UNT Injectable Suspension [Je-Vax] by The Res.Found.For Microb.Dis.Osaka University VO:0018631 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 12 BAU/ML 36269208 OMOP3120083 vaccine Japanese encephalitis virus vaccine, inactivated 12 BAU/ML VO:0018632 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 12 BAU/ML [Ixiaro] 36266773 OMOP3117648 vaccine Japanese encephalitis virus vaccine, inactivated 12 BAU/ML [Ixiaro] VO:0018633 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension 36264784 OMOP3115659 vaccine Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension VO:0018634 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension [Ixiaro] 36260315 OMOP3111190 vaccine Japanese encephalitis virus vaccine, inactivated 12 BAU/ML Injectable Suspension [Ixiaro] VO:0018635 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injectable Solution 36409578 OMOP3101620 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Solution VO:0018636 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injectable Solution [Ixiaro] 36408840 OMOP3100882 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Solution [Ixiaro] VO:0018637 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injectable Solution [Japanese encephalitis GCVC] 36409650 OMOP3101692 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Solution [Japanese encephalitis GCVC] VO:0018638 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injectable Suspension [Ixiaro] 36891545 OMOP990350 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Suspension [Ixiaro] VO:0018639 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injectable Suspension [Japanese encephalitis GCVC] 35770599 OMOP2772060 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Suspension [Japanese encephalitis GCVC] VO:0018640 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injection 43296695 OMOP572698 vaccine Japanese encephalitis virus vaccine, inactivated Injection VO:0018641 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injection [Jespect] 43280330 OMOP558073 vaccine Japanese encephalitis virus vaccine, inactivated Injection [Jespect] VO:0018642 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Injection [Je-Vax] 43515898 OMOP2803013 vaccine Japanese encephalitis virus vaccine, inactivated Injection [Je-Vax] VO:0018643 OHDSI Vaccine WG Japanese encephalitis virus vaccine, inactivated Prefilled Syringe [Japanese encephalitis GCVC] 21119475 OMOP281370 vaccine Japanese encephalitis virus vaccine, inactivated Prefilled Syringe [Japanese encephalitis GCVC] VO:0018644 OHDSI Vaccine WG L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Injectable Suspension 36789911 OMOP4778156 vaccine L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Injectable Suspension VO:0018645 OHDSI Vaccine WG L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Injectable Suspension [Gardasil] 36789910 OMOP4778155 vaccine L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Injectable Suspension [Gardasil] VO:0018646 OHDSI Vaccine WG L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Prefilled Syringe [Silgard] 41144528 OMOP2342490 vaccine L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Prefilled Syringe [Silgard] VO:0018647 OHDSI Vaccine WG L1 protein, Human papillomavirus type 11 Vaccine 0.04 MG/ML 43264003 OMOP558116 vaccine L1 protein, Human papillomavirus type 11 Vaccine 0.04 MG/ML VO:0018648 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Injection 36893469 OMOP991852 vaccine L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Injection VO:0018649 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Injection [Cervarix] 36882767 OMOP995487 vaccine L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Injection [Cervarix] VO:0018650 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Prefilled Syringe [Cervarix Grk] 40832060 OMOP2030022 vaccine L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Prefilled Syringe [Cervarix Grk] VO:0018651 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML 43264004 OMOP558117 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML VO:0018652 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML [Cervarix] 43269462 OMOP558119 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML [Cervarix] VO:0018653 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection 43275030 OMOP558122 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection VO:0018654 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] 43280334 OMOP558123 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] VO:0018655 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 10 43258573 OMOP558124 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 10 VO:0018656 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 20 43269464 OMOP558125 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection [Cervarix] Box of 20 VO:0018657 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 10 43269463 OMOP558120 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 10 VO:0018658 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 20 43275029 OMOP558121 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.02 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML Injection Box of 20 VO:0018659 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Box of 1 43161166 OMOP484785 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Box of 1 VO:0018660 OHDSI Vaccine WG L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension Box of 1 43139030 OMOP484784 vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension Box of 1 VO:0018661 OHDSI Vaccine WG L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML 43258574 OMOP558126 vaccine L1 protein, Human papillomavirus type 18 Vaccine 0.02 MG/ML VO:0018662 OHDSI Vaccine WG L1 protein, Human papillomavirus type 6 Vaccine 0.02 MG/ML 43291182 OMOP558109 vaccine L1 protein, Human papillomavirus type 6 Vaccine 0.02 MG/ML VO:0018663 OHDSI Vaccine WG Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML 44065831 OMOP1060462 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML VO:0018664 OHDSI Vaccine WG Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML [Mumpsvax] 44054289 OMOP1048920 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML [Mumpsvax] VO:0018665 OHDSI Vaccine WG Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution 44058422 OMOP1053053 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution VO:0018666 OHDSI Vaccine WG Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution [Mumpsvax] 44124902 OMOP1119533 vaccine Mumps Virus Vaccine Live, Jeryl Lynn Strain 10000 UNT/ML Injectable Solution [Mumpsvax] VO:0018667 OHDSI Vaccine WG rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG 36074315 OMOP4986341 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG VO:0018668 OHDSI Vaccine WG rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG [Rotarix] 36074314 OMOP4986340 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG [Rotarix] VO:0018669 OHDSI Vaccine WG rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG Oral Suspension 36074313 OMOP4986339 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG Oral Suspension VO:0018670 OHDSI Vaccine WG rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG Oral Suspension [Rotarix] 36074312 OMOP4986338 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG Oral Suspension [Rotarix] VO:0018671 OHDSI Vaccine WG rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG Oral Suspension [Rotarix] by Glaxosmithkline 36074311 OMOP4986337 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000 MG Oral Suspension [Rotarix] by Glaxosmithkline VO:0018672 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 35408000 OMOP1141585 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 VO:0018673 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 [Rotarix] 35406820 OMOP1140405 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 [Rotarix] VO:0018674 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension 35410483 OMOP1144068 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension VO:0018675 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension [Rotarix] 35410606 OMOP1144191 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension [Rotarix] VO:0018676 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension [Rotarix] Box of 1 35412968 OMOP1146553 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension [Rotarix] Box of 1 VO:0018677 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline 35412519 OMOP1146104 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline VO:0018678 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension Box of 1 35407383 OMOP1140968 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 1000000 Powder for Oral Suspension Box of 1 VO:0018679 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML 43152382 OMOP505444 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML VO:0018680 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML [Rotarix] 43152383 OMOP505445 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML [Rotarix] VO:0018681 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension 43218260 OMOP505446 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension VO:0018682 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] 43152384 OMOP505450 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] VO:0018683 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] Box of 1 43141294 OMOP505451 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension [Rotarix] Box of 1 VO:0018684 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension Box of 1 43207250 OMOP505449 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 467000 PFU/ML Oral Suspension Box of 1 VO:0018685 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML 35412643 OMOP1146228 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML VO:0018686 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML [Rotarix] 35410295 OMOP1143880 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML [Rotarix] VO:0018687 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension 35406764 OMOP1140349 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension VO:0018688 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] 35409842 OMOP1143427 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] VO:0018689 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] Box of 1 35410605 OMOP1144190 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension [Rotarix] Box of 1 VO:0018690 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension Box of 1 35412859 OMOP1146444 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 667000 /ML Oral Suspension Box of 1 VO:0018691 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU 43185350 OMOP505437 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU VO:0018692 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU [Rotarix] 43141293 OMOP505438 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU [Rotarix] VO:0018693 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension 43163500 OMOP505439 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension VO:0018694 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension [Rotarix] 43185351 OMOP505441 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension [Rotarix] VO:0018695 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension [Rotarix] Box of 1 43163501 OMOP505442 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension [Rotarix] Box of 1 VO:0018696 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline 43174506 OMOP505443 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension [Rotarix] Box of 1 by Glaxosmithkline VO:0018697 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension Box of 1 43174505 OMOP505440 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain 700000 PFU Powder for Oral Suspension Box of 1 VO:0018698 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain Powder for Oral Suspension 43163499 OMOP505434 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain Powder for Oral Suspension VO:0018699 OHDSI Vaccine WG Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain Powder for Oral Suspension [Rotarix] 43185349 OMOP505435 vaccine Rotavirus Vaccine, Live Attenuated, G1P[8] Human 89-12 strain Powder for Oral Suspension [Rotarix] VO:0018700 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID 43185265 OMOP504787 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID VO:0018701 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID [RUDIVAX] 43218196 OMOP504788 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID [RUDIVAX] VO:0018702 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension 43174434 OMOP504789 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension VO:0018703 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension [RUDIVAX] 43218197 OMOP504791 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension [RUDIVAX] VO:0018704 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension [RUDIVAX] Box of 1 43185267 OMOP504792 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension [RUDIVAX] Box of 1 VO:0018705 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension [RUDIVAX] Box of 1 by Sanofi 43185268 OMOP504793 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension [RUDIVAX] Box of 1 by Sanofi VO:0018706 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension Box of 1 43185266 OMOP504790 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 TCID Injectable Suspension Box of 1 VO:0018707 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 UNT 44078295 OMOP1072926 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 UNT VO:0018708 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 UNT Injectable Solution 44071125 OMOP1065756 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 UNT Injectable Solution VO:0018709 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 UNT Injectable Solution by Iaf Biovac 44088007 OMOP1082638 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) 1000 UNT Injectable Solution by Iaf Biovac VO:0018710 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [Ervevax] 40720032 OMOP4737261 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution [Ervevax] VO:0018711 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension 36882711 OMOP993471 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension VO:0018712 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension [RUDIVAX] 43207181 OMOP504786 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Suspension [RUDIVAX] VO:0018713 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection 40720031 OMOP4737262 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection VO:0018714 OHDSI Vaccine WG Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection [Ervevax] 40720030 OMOP4737263 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injection [Ervevax] VO:0018715 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 36879164 OMOP990305 vaccine Salmonella Typhi Inactivated Antigen VO:0018716 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.025 MG/ML 43269487 OMOP558342 vaccine Salmonella Typhi Inactivated Antigen 0.025 MG/ML VO:0018717 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML 43291206 OMOP558343 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML VO:0018718 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML [Typherix] 43269488 OMOP558345 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML [Typherix] VO:0018719 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML [Typhim VI] 43280360 OMOP558344 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML [Typhim VI] VO:0018720 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution 36269780 OMOP3120655 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution VO:0018721 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] 36257453 OMOP3108328 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] VO:0018722 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 36787630 OMOP4775896 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 VO:0018723 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution Box of 1 36787631 OMOP4775897 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injectable Solution Box of 1 VO:0018724 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection 43269489 OMOP558346 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection VO:0018725 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] 43280361 OMOP558351 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] VO:0018726 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] Box of 10 43280362 OMOP558352 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typherix] Box of 10 VO:0018727 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] 43296606 OMOP558349 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] VO:0018728 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] Box of 10 43275053 OMOP558350 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection [Typhim VI] Box of 10 VO:0018729 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection Box of 10 43291207 OMOP558348 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Injection Box of 10 VO:0018730 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution 36264702 OMOP3115577 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution VO:0018731 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution [Typherix] 36270208 OMOP3121083 vaccine Salmonella Typhi Inactivated Antigen 0.05 MG/ML Intramuscular Solution [Typherix] VO:0018732 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS 36261496 OMOP3112371 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS VO:0018733 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS [Vivotif Berna] 36271765 OMOP3122640 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS [Vivotif Berna] VO:0018734 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule 36274883 OMOP3125758 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule VO:0018735 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule [Vivotif Berna] 36267698 OMOP3118573 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule [Vivotif Berna] VO:0018736 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule [Vivotif Berna] Box of 3 36259961 OMOP3110836 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule [Vivotif Berna] Box of 3 VO:0018737 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule [Vivotif Berna] Box of 3 by Paxvax Berna 36271090 OMOP3121965 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule [Vivotif Berna] Box of 3 by Paxvax Berna VO:0018738 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule Box of 3 36274882 OMOP3125757 vaccine Salmonella Typhi Inactivated Antigen 2000000000 ORGANISMS Delayed Release Oral Capsule Box of 3 VO:0018739 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 8 X 40919902 OMOP2117864 vaccine Salmonella Typhi Inactivated Antigen 8 X VO:0018740 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 8 X Oral Tablet 41270972 OMOP2468934 vaccine Salmonella Typhi Inactivated Antigen 8 X Oral Tablet VO:0018741 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 8 X Oral Tablet Box of 1 40865416 OMOP2063378 vaccine Salmonella Typhi Inactivated Antigen 8 X Oral Tablet Box of 1 VO:0018742 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen 8 X Oral Tablet Box of 1 by Staufen 41132959 OMOP2330921 vaccine Salmonella Typhi Inactivated Antigen 8 X Oral Tablet Box of 1 by Staufen VO:0018743 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Delayed Release Oral Capsule 36277106 OMOP3127981 vaccine Salmonella Typhi Inactivated Antigen Delayed Release Oral Capsule VO:0018744 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Delayed Release Oral Capsule [Vivotif Berna] 36274651 OMOP3125526 vaccine Salmonella Typhi Inactivated Antigen Delayed Release Oral Capsule [Vivotif Berna] VO:0018745 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Injectable Solution 41236298 OMOP2434260 vaccine Salmonella Typhi Inactivated Antigen Injectable Solution VO:0018746 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Injectable Solution [Typhim VI] 36269546 OMOP3120421 vaccine Salmonella Typhi Inactivated Antigen Injectable Solution [Typhim VI] VO:0018747 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Injection 43280359 OMOP558339 vaccine Salmonella Typhi Inactivated Antigen Injection VO:0018748 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Injection [Typherix] 43285853 OMOP558341 vaccine Salmonella Typhi Inactivated Antigen Injection [Typherix] VO:0018749 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Injection [Typhim VI] 43264034 OMOP558340 vaccine Salmonella Typhi Inactivated Antigen Injection [Typhim VI] VO:0018750 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Intramuscular Solution 36272010 OMOP3122885 vaccine Salmonella Typhi Inactivated Antigen Intramuscular Solution VO:0018751 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Intramuscular Solution [Typherix] 36259304 OMOP3110179 vaccine Salmonella Typhi Inactivated Antigen Intramuscular Solution [Typherix] VO:0018752 OHDSI Vaccine WG Salmonella Typhi Inactivated Antigen Oral Tablet 41267212 OMOP2465174 vaccine Salmonella Typhi Inactivated Antigen Oral Tablet VO:0018753 OHDSI Vaccine WG Tick-borne encephalitis virus inactivated 36086760 OMOP4997511 vaccine Tick-borne encephalitis virus inactivated VO:0018754 OHDSI Vaccine WG Tick-borne encephalitis virus inactivated Injectable Suspension 36064700 OMOP4990935 vaccine Tick-borne encephalitis virus inactivated Injectable Suspension VO:0018755 OHDSI Vaccine WG Tick-borne encephalitis virus inactivated Injectable Suspension [Fsme Immun] 36064698 OMOP4990933 vaccine Tick-borne encephalitis virus inactivated Injectable Suspension [Fsme Immun] VO:0018756 OHDSI Vaccine WG Tick-borne encephalitis virus inactivated Injectable Suspension [Ticovac] 36964542 OMOP5206883 vaccine Tick-borne encephalitis virus inactivated Injectable Suspension [Ticovac] VO:0018757 OHDSI Vaccine WG Vaccine, Typh.-Paratyph.A & B 40799176 OMOP2721523 vaccine Vaccine, Typh.-Paratyph.A & B VO:0018758 OHDSI Vaccine WG Vaccine, Typh.-Paratyph.A & B Injectable Solution 40861505 OMOP2059467 vaccine Vaccine, Typh.-Paratyph.A & B Injectable Solution VO:0018759 OHDSI Vaccine WG Vaccine, Typh.-Paratyph.A & B Injectable Solution [Tab Impfstoff] 41237084 OMOP2435046 vaccine Vaccine, Typh.-Paratyph.A & B Injectable Solution [Tab Impfstoff] VO:0018760 OHDSI Vaccine WG yellow fever virus strain 17D-204 live antigen Injectable Suspension [Arilvax] 36074157 OMOP4984439 vaccine yellow fever virus strain 17D-204 live antigen Injectable Suspension [Arilvax] VO:0018761 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension 43217001 OMOP494497 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension VO:0018762 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] 43173284 OMOP494500 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] VO:0018763 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 1 43173285 OMOP494501 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 1 VO:0018764 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 10 43217002 OMOP494502 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension [Stamaril] Box of 10 VO:0018765 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 1 43195158 OMOP494498 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 1 VO:0018766 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 10 43162247 OMOP494499 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain 2000 UNT/ML Injectable Suspension Box of 10 VO:0018767 OHDSI Vaccine WG Yellow-Fever Virus Vaccine, 17D-204 strain Injectable Suspension [Stamaril] 43216999 OMOP494494 vaccine Yellow-Fever Virus Vaccine, 17D-204 strain Injectable Suspension [Stamaril] VO:0018768 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 36878800 OMOP1000965 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus vaccine VO:0018769 OHDSI Vaccine WG 379163 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution 40034292 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution VO:0018770 OHDSI Vaccine WG 798308 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension 40150352 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0018771 OHDSI Vaccine WG 806592 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe 40153532 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0018772 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML VO:0018773 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.006 MG/ML / Bordetella pertussis 0.025 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018774 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.008 MG / Bordetella pertussis 0.05 MG / diphtheria toxoid vaccine, inactivated 30 UNT / tetanus toxoid vaccine, inactivated 40 UNT VO:0018775 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.01 MG/ML / Bordetella pertussis 0.008 MG/ML / diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML VO:0018776 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.013 MG/ML / Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018777 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.016 MG/ML / Bordetella pertussis 0.1 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML VO:0018778 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018779 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.0936 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML VO:0018780 Jie Zheng Xingxian Li vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 60 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 80 UNT/ML VO:0018781 OHDSI Vaccine WG 358497 Haemophilus capsular oligosaccharide 0.03 MG/ML 19099054 vaccine Haemophilus capsular oligosaccharide 0.03 MG/ML VO:0018782 OHDSI Vaccine WG 384561 Neisseria meningitidis 0.25 MG/ML 515692 vaccine Neisseria meningitidis 0.25 MG/ML VO:0018783 Jie Zheng Xingxian Li vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 30 LFU/ML / Pertussis Vaccine 0.0468 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML VO:0018784 Jie Zheng Xingxian Li vaccine Bordetella pertussis 0.01 MG/ML / diphtheria toxoid vaccine, inactivated 4 LFU/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML VO:0018785 Jie Zheng Xingxian Li vaccine Bordetella pertussis 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / pertactin adsorbed 0.005 MG/ML / Pertussis Vaccine 0.016 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018786 OHDSI Vaccine WG 375806 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution 40034293 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Solution VO:0018787 OHDSI Vaccine WG 802048 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension 40152821 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0018788 OHDSI Vaccine WG 807272 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe 40153466 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0018789 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 0.03 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML VO:0018790 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML VO:0018791 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 2 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML VO:0018792 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 25 LFU/ML / Pertussis Vaccine 8 UNT/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML VO:0018793 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Human poliovirus 160 BAU/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018794 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / Pertussis Vaccine 0.021 MG/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018795 Jie Zheng Xingxian Li vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 40 UNT/ML VO:0018796 OHDSI Vaccine WG 371915 diphtheria toxoid vaccine, inactivated Injectable Solution 40034345 vaccine diphtheria toxoid vaccine, inactivated Injectable Solution VO:0018797 Jie Zheng Xingxian Li vaccine Human Papillomavirus 16/18 L1 virus vaccine VO:0018798 Jie Zheng Xingxian Li vaccine Human Papillomavirus 6/11/16/18 L1 virus vaccine VO:0018799 Jie Zheng Xingxian Li vaccine Japanese encephalitis virus vaccine, inactivated 0.012 MG/ML VO:0018800 OHDSI Vaccine WG 845535 Japanese encephalitis virus vaccine, inactivated Injectable Suspension 40159356 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Suspension VO:0018801 OHDSI Vaccine WG 845527 Japanese encephalitis virus vaccine, inactivated Prefilled Syringe 40159358 vaccine Japanese encephalitis virus vaccine, inactivated Prefilled Syringe VO:0018802 OHDSI Vaccine WG 798275 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 6 vaccine Prefilled Syringe 40150715 vaccine L1 protein, Human papillomavirus type 11 Vaccine / L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine / L1 protein, Human papillomavirus type 6 Vaccine Prefilled Syringe VO:0018803 OHDSI Vaccine WG 867485 L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine Prefilled Syringe 40167171 vaccine L1 protein, Human papillomavirus type 16 Vaccine / L1 protein, Human papillomavirus type 18 Vaccine Prefilled Syringe VO:0018804 Jie Zheng Xingxian Li vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension VO:0018805 Jie Zheng Xingxian Li vaccine L1 protein, Human papillomavirus type 16 Vaccine 0.04 MG/ML / L1 protein, Human papillomavirus type 18 Vaccine 0.04 MG/ML Injectable Suspension [Cervarix] VO:0018806 OHDSI Vaccine WG 1658029 rabies virus vaccine flury-lep strain Injection 46275153 vaccine rabies virus vaccine flury-lep strain Injection VO:0018807 OHDSI Vaccine WG 762819 rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution 40148731 vaccine Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution VO:0018808 OHDSI Vaccine WG 1292825 yellow fever virus strain 17D-204 live antigen Injectable Suspension 42800063 vaccine yellow fever virus strain 17D-204 live antigen Injectable Suspension VO:0018809 Jie Zheng Xingxian Li vaccine Yellow-Fever Virus Vaccine, 17D-204 strain Injectable Suspension VO:0018843 Jie Zheng material entity oral VO:0018844 Jie Zheng material entity oral suspension VO:0018845 Jie Zheng material entity powder for oral suspension VO:0018846 Jie Zheng material entity oral capsule VO:0018847 Jie Zheng material entity oral tablet VO:0018848 OHDSI Vaccine WG 1653577 BCG, live, Tice strain 50 MG 46234106 vaccine BCG, live, Tice strain 50 MG VO:0018849 OHDSI Vaccine WG http://purl.bioontology.org/ontology/RXNORM/1804260 1804260 influenza A virus (H5N1) antigen 40220901 vaccine component influenza A virus (H5N1) antigen VO:0018850 OHDSI Vaccine WG 1869639 influenza A virus A/Indonesia/05/2005 (H5N1) antigen 0.0075 MG/ML 1594218 vaccine influenza A virus A/Indonesia/05/2005 (H5N1) antigen 0.0075 MG/ML VO:0018851 OHDSI Vaccine WG 1876707 yellow fever virus strain 17D-204 live antigen 2000 UNT/ML [Stamaril] 1593655 vaccine yellow fever virus strain 17D-204 live antigen 2000 UNT/ML [Stamaril] VO:0018852 OHDSI Vaccine WG 1928530 influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML 1593541 vaccine influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML VO:0018853 OHDSI Vaccine WG 1942126 influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML 793950 vaccine influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML VO:0018854 OHDSI Vaccine WG 2050799 influenza B virus antigen 0.03 MG/ML 35200075 vaccine influenza B virus antigen 0.03 MG/ML VO:0018855 OHDSI Vaccine WG 2056522 influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML 35200566 vaccine influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML VO:0018856 OHDSI Vaccine WG 2056524 influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML 35200568 vaccine influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML VO:0018857 OHDSI Vaccine WG 2056526 influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML 35200570 vaccine influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML VO:0018858 OHDSI Vaccine WG 2177390 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML 1361075 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML VO:0018859 OHDSI Vaccine WG 2177391 influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML 1361076 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML VO:0018860 OHDSI Vaccine WG 2177690 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML 1361095 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML VO:0018861 OHDSI Vaccine WG 2177691 influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML 1361096 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML VO:0018862 OHDSI Vaccine WG 2178089 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML 1361151 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML VO:0018863 OHDSI Vaccine WG 2178090 influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML 1361152 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML VO:0018864 OHDSI Vaccine WG 2180398 influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML 1361315 vaccine influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML VO:0018865 OHDSI Vaccine WG 2180399 influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML 1361316 vaccine influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML VO:0018866 OHDSI Vaccine WG 2198897 influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML 37496498 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML VO:0018867 OHDSI Vaccine WG 2198898 influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML 37496499 vaccine influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML VO:0018868 OHDSI Vaccine WG http://purl.bioontology.org/ontology/RXNORM/2274413 2274413 hepatitis A virus strain CR 326F antigen, inactivated 37498625 vaccine component hepatitis A virus strain CR 326F antigen, inactivated VO:0018869 OHDSI Vaccine WG 2275271 hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML 37498652 vaccine hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML VO:0018870 OHDSI Vaccine WG 2275275 hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML [Vaqta] 37498655 vaccine hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML [Vaqta] VO:0018871 OHDSI Vaccine WG 2280739 influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML 37498843 vaccine influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML VO:0018872 OHDSI Vaccine WG 2280740 influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML 37498844 vaccine influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML VO:0018873 OHDSI Vaccine WG 2280748 influenza A virus (H3N2) antigen 0.03 MG/ML 37498851 vaccine influenza A virus (H3N2) antigen 0.03 MG/ML VO:0018874 OHDSI Vaccine WG 2379630 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML 1146353 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML VO:0018875 OHDSI Vaccine WG 2379631 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML 1146354 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML VO:0018876 OHDSI Vaccine WG 2380592 influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML 1146456 vaccine influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML VO:0018877 OHDSI Vaccine WG 2380593 influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML 1146457 vaccine influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML VO:0018878 OHDSI Vaccine WG 2380839 influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML 1146488 vaccine influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML VO:0018879 OHDSI Vaccine WG 2380840 influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML 1146489 vaccine influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML VO:0018880 OHDSI Vaccine WG 2380841 influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML 1146490 vaccine influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML VO:0018881 OHDSI Vaccine WG 2380854 influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML 1146500 vaccine influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML VO:0018882 OHDSI Vaccine WG 2380855 influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML 1146501 vaccine influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML VO:0018883 OHDSI Vaccine WG 2380856 influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML 1146502 vaccine influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML VO:0018884 OHDSI Vaccine WG 2383542 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML 1146552 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML VO:0018885 OHDSI Vaccine WG 2383543 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML 1146553 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML VO:0018886 OHDSI Vaccine WG 2383544 influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML 1146606 vaccine influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML VO:0018887 OHDSI Vaccine WG 2383545 influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML 1146607 vaccine influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML VO:0018888 OHDSI Vaccine WG 2388149 influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML 37002437 vaccine influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML VO:0018889 OHDSI Vaccine WG 2388150 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML 37002438 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML VO:0018890 OHDSI Vaccine WG 2388151 influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML 37002439 vaccine influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML VO:0018891 OHDSI Vaccine WG 2479042 influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML 739848 vaccine influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML VO:0018892 OHDSI Vaccine WG 2561272 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML 1537382 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML VO:0018893 OHDSI Vaccine WG 2562993 influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML 1537469 vaccine influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML VO:0018894 OHDSI Vaccine WG 2563001 influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML 1537474 vaccine influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML VO:0018895 OHDSI Vaccine WG 2563010 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML 1537480 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML VO:0018896 OHDSI Vaccine WG 2563011 influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML 1537481 vaccine influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML VO:0018897 OHDSI Vaccine WG 2563023 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML 1537492 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML VO:0018898 OHDSI Vaccine WG 2563036 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML 1537503 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML VO:0018899 OHDSI Vaccine WG 2564394 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML 701447 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML VO:0018900 OHDSI Vaccine WG 2564396 influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML 701449 vaccine influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML VO:0018901 OHDSI Vaccine WG 2588239 hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML [Prehevbrio] 1758559 vaccine hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML [Prehevbrio] VO:0018902 OHDSI Vaccine WG 2593855 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML 1759211 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML VO:0018903 OHDSI Vaccine WG 2593856 influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML 1759212 vaccine influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML VO:0018904 OHDSI Vaccine WG 2605044 influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML 780052 vaccine influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML VO:0018905 OHDSI Vaccine WG 2605089 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML 780067 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML VO:0018906 OHDSI Vaccine WG 2605098 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML 780074 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML VO:0018907 OHDSI Vaccine WG 2605099 influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML 780075 vaccine influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML VO:0018908 OHDSI Vaccine WG 2605562 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML 780103 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML VO:0018909 OHDSI Vaccine WG 2605563 influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML 780104 vaccine influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML VO:0018910 OHDSI Vaccine WG 2605726 influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML 780122 vaccine influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML VO:0018911 OHDSI Vaccine WG 2605727 influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML 780123 vaccine influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML VO:0018912 OHDSI Vaccine WG 2605728 influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML 780124 vaccine influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML VO:0018913 OHDSI Vaccine WG 2607742 influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML 1525409 vaccine influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML VO:0018914 OHDSI Vaccine WG 2607743 influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML 1525410 vaccine influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML VO:0018915 OHDSI Vaccine WG 2630222 influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML 1301743 vaccine influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML VO:0018916 OHDSI Vaccine WG 2630656 influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML 1301766 vaccine influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML VO:0018917 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Brisbane/02/2018 (H1N1) antigen VO:0018918 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Darwin/6/2021 (H3N2) antigen VO:0018919 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Darwin/9/2021 (H3N2) antigen VO:0018920 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen VO:0018921 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen VO:0018922 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Kansas/14/2017 (H3N2) antigen VO:0018923 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Sydney/5/2021 (H1N1) antigen VO:0018924 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Tasmania/503/2020 (H3N2) antigen VO:0018925 Jie Zheng Xumeng Zhang vaccine component influenza A virus A/Victoria/2570/2019 (H1N1) antigen VO:0018926 Jie Zheng Xumeng Zhang vaccine component influenza B virus B/Austria/1359417/2021 antigen VO:0018927 Jie Zheng Xumeng Zhang vaccine component influenza B virus B/Michigan/01/2021 antigen VO:0018928 Jie Zheng Xumeng Zhang vaccine component influenza B virus B/Washington/02/2019 antigen VO:0018929 Jie Zheng Xumeng Zhang vaccine component yellow fever virus strain 17D-204 live antigen VO:0019097 Jie Zheng material entity oral product VO:0019098 Jie Zheng material entity pill VO:0019099 Jie Zheng material entity delayed release oral capsule VO:0019100 Jie Zheng material entity nasal spray VO:0019101 Jie Zheng material entity oral liquid product VO:0019102 Jie Zheng material entity delayed release oral tablet VO:0019103 OHDSI Vaccine WG 1801070 0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2016-2017 (quadrivalent - California/Hong Kong/Brisbane/Phuket) 0.1 ML Prefilled Syringe 36249399 vaccine 0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019104 OHDSI Vaccine WG 1661111 0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe 46276043 vaccine 0.1 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019105 OHDSI Vaccine WG 1928468 0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (quadrivalent - Hong Kong/Michigan/Brisbane/Phuket) 0.1 ML Prefilled Syringe 1593533 vaccine 0.1 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019106 OHDSI Vaccine WG 1598359 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe 45892706 vaccine 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe VO:0019107 OHDSI Vaccine WG 1429577 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2014-2015 trivalent intradermal 0.1 ML Prefilled Syringe 43532866 vaccine 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe VO:0019108 OHDSI Vaccine WG 1429582 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2013-2014 Formula] Fluzone Intradermal 2013-2014 Formula Influenza Virus Vaccine 0.1 ML Prefilled Syringe 43532867 vaccine 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2013-2014 Formula] VO:0019109 OHDSI Vaccine WG 1537551 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula] Fluzone Intradermal 2014-2015 Formula Influenza Virus Vaccine 0.1 ML Prefilled Syringe 44818425 vaccine 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula] VO:0019110 OHDSI Vaccine WG 1304311 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.09 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML 0.1 ML Prefilled Syringe 42873640 vaccine 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe VO:0019111 OHDSI Vaccine WG 1304316 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2012-2013 Formula] Fluzone Intradermal 2012-2013 Formula Influenza Virus Vaccine 0.1 ML Prefilled Syringe 42873641 vaccine 0.1 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2012-2013 Formula] VO:0019112 OHDSI Vaccine WG 1111370 0.1 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe 40239559 vaccine 0.1 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe VO:0019113 OHDSI Vaccine WG 1111372 0.1 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] Fluzone Intradermal 2011-2012 Formula Influenza Virus Vaccine 0.1 ML Prefilled Syringe 40239560 vaccine 0.1 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0019114 OHDSI Vaccine WG 2280750 0.25 ML influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 37499808 vaccine 0.25 ML influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019115 OHDSI Vaccine WG influenza virus vaccine 2019-2020 (quadrivalent - Brisbane/Kansas/Maryland/Phuket) 0.25 mL Prefilled Syringe 2177503 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2019-2020 (quadrivalent - Brisbane/Kansas/Maryland/Phuket) 0.25 ML Prefilled Syringe 1361658 vaccine 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019116 OHDSI Vaccine WG Fluzone Quadrivalent 2019-2020 vaccine 0.25 ML Prefilled Syringe 2177504 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] Fluzone Quadrivalent 2019-2020 vaccine 0.25 ML Prefilled Syringe 1361659 vaccine 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] VO:0019117 OHDSI Vaccine WG 2178787 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] Afluria Quadrivalent 2019-2020 vaccine 0.25 ML Prefilled Syringe 1361672 vaccine 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] VO:0019118 OHDSI Vaccine WG 2280752 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 ML Prefilled Syringe 37499809 vaccine 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019119 OHDSI Vaccine WG 2281817 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 37499814 vaccine 0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019120 OHDSI Vaccine WG 1794451 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 36249569 vaccine 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019121 OHDSI Vaccine WG 1794452 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] Fluzone Quadrivalent 2016 Southern Hemisphere vaccine 0.25 ML Prefilled Syringe 36249570 vaccine 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019122 OHDSI Vaccine WG 1659754 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46275736 vaccine 0.25 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019123 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe 2564023 0.25 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe 702586 vaccine 0.25 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0019124 OHDSI Vaccine WG 2564024 0.25 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] Afluria Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe 702587 vaccine 0.25 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] VO:0019125 OHDSI Vaccine WG 2380582 0.25 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.25 ML Prefilled Syringe 1146785 vaccine 0.25 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019126 OHDSI Vaccine WG 2380584 0.25 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] Fluzone Quadrivalent 2020-2021 vaccine 0.25 ML Prefilled Syringe 1146786 vaccine 0.25 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] VO:0019127 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe 2380603 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe 1146792 vaccine 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0019128 OHDSI Vaccine WG afluria Quadrivalent 2020-2021 vaccine 0.25 ML Prefilled Syringe 2380604 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] Afluria Quadrivalent 2020-2021 vaccine 0.25 ML Prefilled Syringe 1146793 vaccine 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] VO:0019129 OHDSI Vaccine WG 2479034 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.25 ML Prefilled Syringe 740252 vaccine 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019130 OHDSI Vaccine WG 2479038 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.25 ML Prefilled Syringe 740253 vaccine 0.25 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0019131 OHDSI Vaccine WG 1928330 0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (quadrivalent - Hong Kong/Michigan/Brisbane/Phuket) 0.25 ML Prefilled Syringe 1593343 vaccine 0.25 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019132 OHDSI Vaccine WG 2050788 0.25 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2018-2019 (quadrivalent - Michigan/Singapore/Maryland/Phuket) 0.25 ML Prefilled Syringe 35201920 vaccine 0.25 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019133 OHDSI Vaccine WG 2563038 0.25 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] Fluzone Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe 1537649 vaccine 0.25 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] VO:0019134 OHDSI Vaccine WG 2563048 0.25 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.25 ML Prefilled Syringe 1537652 vaccine 0.25 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019135 OHDSI Vaccine WG 1427051 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2014-2015 pediatric quadrivalent 0.25 ML Prefilled Syringe 43531874 vaccine 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019136 OHDSI Vaccine WG 1429603 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2013-2014 trivalent 0.25 ML Prefilled Syringe 43532875 vaccine 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019137 OHDSI Vaccine WG 1429605 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2013-2014 Formula] Fluzone 2013-2014 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe 43532876 vaccine 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2013-2014 Formula] VO:0019138 OHDSI Vaccine WG 1537556 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula] Fluzone Quadrivalent Pediatric 2014-2015 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe 44818429 vaccine 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula] VO:0019139 OHDSI Vaccine WG 1304296 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML 0.25 ML Prefilled Syringe 42873643 vaccine 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe VO:0019140 OHDSI Vaccine WG 1304297 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2012-2013 Formula] Fluzone Pediatric 2012-2013 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe 42873644 vaccine 0.25 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2012-2013 Formula] VO:0019141 OHDSI Vaccine WG 1005944 0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe 40224118 vaccine 0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe VO:0019142 OHDSI Vaccine WG 1005946 0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] Fluzone 2010-2011 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe 40224119 vaccine 0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] VO:0019143 OHDSI Vaccine WG 1111361 0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] Fluzone Pediatric 2011-2012 Formula Influenza Virus Vaccine 0.25 ML Prefilled Syringe 40239561 vaccine 0.25 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0019144 OHDSI Vaccine WG acellular pertussis vaccine 0.058 MG / diphtheria toxoid vaccine 25 UNT / hepatitis B surface antigen vaccine 0.01 MG / poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT / tetanus toxoid vaccine 10 UNT per 0.5 ML Prefilled Syringe 829987 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe 523289 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0019145 OHDSI Vaccine WG acellular pertussis vaccine 0.058 MG / diphtheria toxoid vaccine 25 UNT / poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT / tetanus toxoid vaccine 10 UNT per 0.5 ML Prefilled Syringe 830555 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe DTaP-IPV 0.5 ML Prefilled Syringe 19133451 vaccine 0.5 ML acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0019146 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus (mIPV) and Haemophilus influenzae type b conjugate vaccine (DTaP-IPV/Hib) 0.5 ML Injection 805375 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 19131877 vaccine 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0019147 OHDSI Vaccine WG DTaP-IPV/Hib (diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus (vIPV) and Haemophilus b conjugate (tetanus toxoid conjugate)) 0.5 ML Injection 2585714 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 702639 vaccine 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0019148 OHDSI Vaccine WG Pentacel DTaP-IPV/Hib (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus (vIPV) and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)) 0.5 ML Injection 2585717 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] 702640 vaccine 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] VO:0019149 OHDSI Vaccine WG tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Prefilled Syringe 1300189 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 5 MCG / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 5 MCG / Bordetella pertussis pertactin vaccine, inactivated 3 MCG / Bordetella pertussis toxoid vaccine, inactivated 2.5 MCG / diphtheria toxoid vaccine, inactivated 2 UNT / tetanus toxoid vaccine, inactivated 5 UNT per 0.5 ML Prefilled Syringe 42800264 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019150 OHDSI Vaccine WG Tdap (tetanus toxoid vaccine, inactivated 5 UNT / diphtheria toxoid vaccine, inactivated 2 UNT / acellular pertussis vaccine, inactivated 15.5 MCG) per 0.5 ML Injection 1300205 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection Tdap (tetanus toxoid vaccine, inactivated 5 UNT / diphtheria toxoid vaccine, inactivated 2 UNT / acellular pertussis vaccine, inactivated 15.5 MCG) per 0.5 ML Injection 42800463 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019151 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Daptacel) 0.5 ML Injection 1300308 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection DTaP (diphtheria toxoid vaccine, inactivated 15 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 23 MCG) per 0.5 ML Injection 42800465 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019152 OHDSI Vaccine WG Tdap (tetanus toxoid vaccine, inactivated 5 UNT / diphtheria toxoid vaccine, inactivated 2.5 UNT / acellular pertussis vaccine, inactivated 18.5 MCG) per 0.5 ML Prefilled Syringe 1300368 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 42800266 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019153 OHDSI Vaccine WG Tdap (tetanus toxoid vaccine, inactivated 5 UNT / diphtheria toxoid vaccine, inactivated 2.5 UNT / acellular pertussis vaccine, inactivated 18.5 MCG) per 0.5 ML Injection 1300377 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 8 MCG / Bordetella pertussis pertactin vaccine, inactivated 2.5 MCG / Bordetella pertussis toxoid vaccine, inactivated 8 MCG / diphtheria toxoid vaccine, inactivated 2.5 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injection 42800473 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019154 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (mIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Injection 1607803 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 46221246 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019155 OHDSI Vaccine WG DTap-IPV-Hib-HepB 0.5 ML Injection 2109615 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection DTap-IPV-Hib-HepB 0.5 ML Injection 1366739 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019156 OHDSI Vaccine WG Vaxelis 0.5 ML Injection 2109620 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Vaxelis] Vaxelis (Diphtheria and Tetanus Toxoids and Acelluar Pertussis Absorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine) 0.5 ML Injection 1366740 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Vaxelis] VO:0019157 OHDSI Vaccine WG DTap-IPV-Hib-HepB 0.5 ML Prefilled Syringe 2468237 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe DTap-IPV-Hib-HepB 0.5 ML Prefilled Syringe 37003648 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019158 OHDSI Vaccine WG Vaxelis 0.5 ML Prefilled Syringe 2468239 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis] 37003649 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis] VO:0019159 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (vIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Injection 2587054 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 702645 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019160 OHDSI Vaccine WG Quadracel (with vIPV) vaccine 0.5 ML Injection 2587057 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] 702646 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] VO:0019161 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus (vIPV) vaccine (DTaP-IPV generic for Quadracel) 0.5 ML Prefilled Syringe 2593118 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 1759261 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019162 OHDSI Vaccine WG Quadracel (with vIPV) vaccine 0.5 ML Prefilled Syringe 2593121 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel] Quadracel (with vIPV) vaccine 0.5 ML Prefilled Syringe 1759262 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel] VO:0019163 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (DTaP-IPV generic for Kinrix) 0.5 ML Injection 830549 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 19133448 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0019164 OHDSI Vaccine WG diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Prefilled Syringe 1300382 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe 42800270 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0019165 OHDSI Vaccine WG DTaP (diphtheria toxoid vaccine, inactivated 25 UNT / tetanus toxoid vaccine, inactivated 10 UNT / acellular pertussis vaccine, inactivated 58 MCG) per 0.5 ML Injection 1300385 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection DTaP (diphtheria toxoid vaccine, inactivated 25 UNT / tetanus toxoid vaccine, inactivated 10 UNT / acellular pertussis vaccine, inactivated 58 MCG) per 0.5 ML Injection 42800481 vaccine 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0019166 OHDSI Vaccine WG 807277 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection diphtheria toxoid vaccine, inactivated 2 UNT / tetanus toxoid vaccine, inactivated 5 UNT per 0.5 ML Injection 19132301 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019167 OHDSI Vaccine WG 807273 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe diphtheria toxoid vaccine 2 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Prefilled Syringe 19132298 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019168 OHDSI Vaccine WG 807276 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Decavac] Decavac, Tetanus and Diphtheria Toxoids Adsorbed Prefilled Syringe 19132300 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Decavac] VO:0019169 OHDSI Vaccine WG 205259 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection tetanus toxoid vaccine, inactivated 2 UNT / diphtheria toxoid vaccine, inactivated 2 UNT per 0.5 ML Injection 19028828 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection VO:0019170 OHDSI Vaccine WG 2106334 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection [Tdvax] Tdvax (tetanus toxoid vaccine, inactivated 2 UNT / diphtheria toxoid vaccine, inactivated 2 UNT) per 0.5 ML Injection 1356449 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection [Tdvax] VO:0019171 OHDSI Vaccine WG 1244205 0.5 ML diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection diphtheria toxoid vaccine 25 UNT/ML / tetanus toxoid vaccine 5 UNT per 0.5 ML Injection 42708198 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019172 OHDSI Vaccine WG 798440 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection Haemophilus influenzae type b conjugate (meningococcal protein conjugate) 7.5 MCG vaccine / hepatitis B surface antigen recombinant vaccine 5 MCG per 0.5 ML Injection 19130427 vaccine 0.5 ML Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection VO:0019173 OHDSI Vaccine WG 1437911 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection meningococcal groups C and Y and Haemophilus b tetanus toxoid conjugate vaccine 0.5 ML Injection 43560547 vaccine 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection VO:0019174 OHDSI Vaccine WG 1300808 0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection Haemophilus influenzae type b strain 20,752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 35 MCG per 0.5 ML Injection 42873448 vaccine 0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection VO:0019175 OHDSI Vaccine WG 798481 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe hepatitis A vaccine (inactivated) strain HM175 720 UNT per 0.5 ML Prefilled Syringe 529686 vaccine 0.5 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe VO:0019176 OHDSI Vaccine WG 1658105 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection hepatitis A virus strain CR 326F antigen, inactivated 25 UNT per 0.5 ML Injection 46275201 vaccine 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection VO:0019177 OHDSI Vaccine WG 836635 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe hepatitis A virus strain CR 326F antigen, inactivated 25 UNT per 0.5 ML Prefilled Syringe 596899 vaccine 0.5 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe VO:0019178 OHDSI Vaccine WG 830259 0.5 ML hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe [Recombivax] Recombivax HB, hepatitis B vaccine (recombinant) 0.5 ML Prefilled Syringe 19133384 vaccine 0.5 ML hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe [Recombivax] VO:0019179 OHDSI Vaccine WG 1994347 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection hepatitis B vaccine (recombinant) pediatric/adolescent 20 MCG in 0.5 ML Injection 793515 vaccine 0.5 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection VO:0019180 OHDSI Vaccine WG 1301889 0.5 ML human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.02 MG / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.02 MG per 0.5 ML Prefilled Syringe 42873513 vaccine 0.5 ML human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe VO:0019181 OHDSI Vaccine WG 2177498 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 1361656 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019182 OHDSI Vaccine WG 2177500 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2019-2020] Fluzone Quadrivalent 2019-2020 vaccine 0.5 ML Injection 1361657 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2019-2020] VO:0019183 OHDSI Vaccine WG 2177393 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2019-2020 (quadrivalent - Brisbane/Kansas/Maryland/Phuket) 0.5 ML Prefilled Syringe 1361653 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019184 OHDSI Vaccine WG 2177398 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2019-2020] Fluarix Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe 1361654 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2019-2020] VO:0019185 OHDSI Vaccine WG 2177495 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] Fluzone Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe 1361655 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] VO:0019186 OHDSI Vaccine WG 2177797 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2019-2020] Flulaval Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe 1361662 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2019-2020] VO:0019187 OHDSI Vaccine WG 2178785 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] Afluria Quadrivalent 2019-2020 vaccine 0.5 ML Prefilled Syringe 1361671 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] VO:0019188 OHDSI Vaccine WG 2178357 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2019-2020 (generic for Fluad- Brisbane/Kansas/Maryland) 0.5 ML Prefilled Syringe 1361667 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019189 OHDSI Vaccine WG 2178362 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2019-2020] Fluad 2019-2020 vaccine 0.5 mL Injection 1361668 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2019-2020] VO:0019190 OHDSI Vaccine WG influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) 0.5 ML Prefilled Syringe 2280755 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 37499810 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019191 OHDSI Vaccine WG Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe 2280756 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] 37499811 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019192 OHDSI Vaccine WG 2178091 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2019-2020 (quadrivalent generic for Flublok - Brisbane/Kansas/Maryland/Phuket) 0.5 ML Prefilled Syringe 1361663 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019193 OHDSI Vaccine WG 2178093 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2019-2020] 1361664 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2019-2020] VO:0019194 OHDSI Vaccine WG 2177692 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe influenza virus vaccine 2019-2020 high-dose (trivalent - Brisbane/Kansas/Maryland) 0.5 ML Prefilled Syringe 1361660 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe VO:0019195 OHDSI Vaccine WG 2177697 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020] Fluzone 2019-2020 high-dose vaccine 0.5 ML Prefilled Syringe 1361661 vaccine 0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020] VO:0019196 OHDSI Vaccine WG 1801606 0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2016-2017 (quadrivalent - Brisbane/Hong Kong/Utah/Hong Kong) 0.5 ML Prefilled Syringe 40220716 vaccine 0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe VO:0019197 OHDSI Vaccine WG 1657139 0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe 46276002 vaccine 0.5 ML influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe VO:0019198 OHDSI Vaccine WG 1724010 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe influenza virus vaccine 2015-2016 (trivalent - California/Switzerland/Brisbane) 0.5 ML Prefilled Syringe 35606414 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe VO:0019199 OHDSI Vaccine WG 1794440 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2016-2017 (quadrivalent - California/Hong Kong/Brisbane/Phuket) 0.5 ML Prefilled Syringe 36249495 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019200 OHDSI Vaccine WG 1794445 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] Fluzone Quadrivalent 2016 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe 36249563 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019201 OHDSI Vaccine WG 1801187 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection influenza virus vaccine 2016-2017 (quadrivalent - California/Hong Kong/Brisbane/Phuket) 0.5 ML Injection 36249514 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019202 OHDSI Vaccine WG 1661802 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2015-2016 (trivalent - California/South Australia/Phuket) 0.5 ML Prefilled Syringe 46276261 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019203 OHDSI Vaccine WG 1657844 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46275064 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019204 OHDSI Vaccine WG 1657846 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [FluLaval Quadrivalent 2015-2016] 46275066 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [FluLaval Quadrivalent 2015-2016] VO:0019205 OHDSI Vaccine WG 1659746 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 46275654 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019206 OHDSI Vaccine WG 1803019 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection influenza virus vaccine 2016-2017 (trivalent - California/Hong Kong/Brisbane) 0.5 ML Injection 40220827 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection VO:0019207 OHDSI Vaccine WG 1660924 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection 46276014 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection VO:0019208 OHDSI Vaccine WG 1801178 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe influenza virus vaccine 2016-2017 high-dose (trivalent - California/Hong Kong/Brisbane) 0.5 ML Prefilled Syringe 36249505 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe VO:0019209 OHDSI Vaccine WG 1658711 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe 46275394 vaccine 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe VO:0019210 OHDSI Vaccine WG Fluad Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 2562996 0.5 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2021-2022] Fluad Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 1537641 vaccine 0.5 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2021-2022] VO:0019211 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.5 ML Prefilled Syringe 2562998 0.5 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe 1537642 vaccine 0.5 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0019212 OHDSI Vaccine WG Afluria Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 2564021 0.5 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] Afluria Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 702585 vaccine 0.5 ML influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] VO:0019213 OHDSI Vaccine WG 1799109 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 36249175 vaccine 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019214 OHDSI Vaccine WG 1801161 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2015-2016 (trivalent - Christchurch/Hong Kong/Brisbane) 0.5 ML Prefilled Syringe 36249432 vaccine 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe VO:0019215 OHDSI Vaccine WG 1657231 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46276104 vaccine 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019216 OHDSI Vaccine WG 1659981 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46275886 vaccine 0.5 ML influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019217 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe 2605729 0.5 ML influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) 0.5 ML Prefilled Syringe 780307 vaccine 0.5 ML influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe VO:0019218 OHDSI Vaccine WG Flucevax Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 2605735 0.5 ML influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] Flucelvax Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 780308 vaccine 0.5 ML influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] VO:0019219 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe 2605090 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-6/Phuket/Victoria) 0.5 ML Prefilled Syringe 780294 vaccine 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019220 OHDSI Vaccine WG Fluarix Quadrivalent 2022-2023 vaccine 0.5 mL Prefilled Syringe 2605096 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2022-2023] Fluarix Quadrivalent 2022-2023 vaccine 0.5 mL Prefilled Syringe 780295 vaccine 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2022-2023] VO:0019221 OHDSI Vaccine WG Fluad Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 2605540 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2022-2023] Fluad Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 780299 vaccine 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2022-2023] VO:0019222 OHDSI Vaccine WG Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 2605557 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2022-2023] Afluria Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 780303 vaccine 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2022-2023] VO:0019223 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe 2605564 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) 0.5 ML Prefilled Syringe 780304 vaccine 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019224 OHDSI Vaccine WG Flublok Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 2605570 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2022-2023] Flublok Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 780305 vaccine 0.5 ML influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2022-2023] VO:0019225 OHDSI Vaccine WG influenza virus vaccine 2023 (quadrivalent - Darwin/Sydney/Michigan/Phuket) 0.5 ML Prefilled Syringe, southern hemisphere 2630657 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1302359 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019226 OHDSI Vaccine WG Fluzone Quadrivalent 2023 Southern Hemisphere vaccine 0.5 mL Prefilled Syringe 2630660 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] 1302360 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019227 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe 2605045 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin-9/Phuket/Victoria) 0.5 ML Prefilled Syringe 780291 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019228 OHDSI Vaccine WG Flulaval Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 2605051 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2022-2023] Flulaval Quadrivalent 2022-2023 vaccine 0.5 ML Prefilled Syringe 780293 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2022-2023] VO:0019229 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection 2605546 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Injection 780301 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019230 OHDSI Vaccine WG Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection 2605549 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2022-2023] Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Injection 780302 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2022-2023] VO:0019231 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Prefilled Syringe 2593857 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) 0.5 ML Prefilled Syringe 1759265 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019232 OHDSI Vaccine WG 2593863 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] Fluzone Quadrivalent 2022 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe 1759266 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] VO:0019233 OHDSI Vaccine WG Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe 2605543 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine 0.5 ML Prefilled Syringe 780300 vaccine 0.5 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] VO:0019234 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) 0.5 ML Prefilled Syringe 2380849 0.5 ML influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) 0.5 ML Prefilled Syringe 1146796 vaccine 0.5 ML influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019235 OHDSI Vaccine WG Flucelvax Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 2380851 0.5 ML influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] Flucelvax Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146797 vaccine 0.5 ML influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] VO:0019236 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 ML Prefilled Syringe 2379633 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 1146773 vaccine 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019237 OHDSI Vaccine WG Fluarix Quadrivalent 2020-2021 vaccine 0.5 mL Prefilled Syringe 2379638 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2020-2021] Fluarix Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146774 vaccine 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2020-2021] VO:0019238 OHDSI Vaccine WG Flulaval Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 2379736 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2020-2021] Flulaval Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146775 vaccine 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2020-2021] VO:0019239 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 mL Injection 2380586 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.5 ML Injection 1146787 vaccine 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection VO:0019240 OHDSI Vaccine WG Fluzone Quadrivalent 2020-2021 vaccine 0.5 mL Injection 2380588 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2020-2021] Fluzone Quadrivalent 2020-2021 vaccine 0.5 ML Injection 1146788 vaccine 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2020-2021] VO:0019241 OHDSI Vaccine WG Fluzone Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 2380591 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] Fluzone Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146789 vaccine 0.5 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] VO:0019242 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent generic for Flublok - Hawaii/Minnesota/Phuket/Washington) 0.5 ML Prefilled Syringe 2380858 0.5 ML influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 (quadrivalent generic for Flublok - Hawaii/Minnesota/Phuket/Washington) 0.5 ML Prefilled Syringe 1146798 vaccine 0.5 ML influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe VO:0019243 OHDSI Vaccine WG Flublok Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 2380863 0.5 ML influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2020-2021] Flublok Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146799 vaccine 0.5 ML influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2020-2021] VO:0019244 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.5 ML Prefilled Syringe 2380595 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) 0.5 ML Prefilled Syringe 1146790 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0019245 OHDSI Vaccine WG Afluria Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 2380600 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] Afluria Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146791 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] VO:0019246 OHDSI Vaccine WG FLUAD Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 2382439 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2020-2021] Fluad Quadrivalent 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146802 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2020-2021] VO:0019247 OHDSI Vaccine WG 2381145 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 (Hong Kong/Victoria/Victoria) 0.5 ML Prefilled Syringe 1146800 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0019248 OHDSI Vaccine WG 2381150 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2020-2021] Fluad 2020-2021 vaccine 0.5 ML Prefilled Syringe 1146801 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2020-2021] VO:0019249 OHDSI Vaccine WG Fluzone Quadrivalent 2021 Southern Hemisphere vaccine 0.5 ML Prefilled Syringe 2479041 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] 740254 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0019250 OHDSI Vaccine WG influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 mL Prefilled Syringe 2479045 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe 740255 vaccine 0.5 ML influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019251 OHDSI Vaccine WG 1928312 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 1593194 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019252 OHDSI Vaccine WG 1928358 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1593518 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019253 OHDSI Vaccine WG 1942161 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 793962 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019254 OHDSI Vaccine WG 1942127 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong, Singapore, Brisbane) 0.5 ML Prefilled Syringe 793951 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe VO:0019255 OHDSI Vaccine WG 1928302 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (quadrivalent generic for Fluarix, Flulaval - Hong Kong/Singapore/Brisbane/Phuket) 0.5 ML Prefilled Syringe 1593185 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019256 OHDSI Vaccine WG 1928960 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (trivalent generic for Fluad, Fluvirin - Hong Kong, Singapore, Brisbane) 0.5 ML Prefilled Syringe 1593896 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe VO:0019257 OHDSI Vaccine WG 1928360 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (quadrivalent generic for Flublok - Hong Kong/Michigan/Brisbane/Phuket) 0.5 ML Prefilled Syringe 1593520 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019258 OHDSI Vaccine WG 1928472 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection influenza virus vaccine 2017-2018 (trivalent - Hong Kong/Michigan/Brisbane) 0.5 ML Injection 1593537 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection VO:0019259 OHDSI Vaccine WG 1928339 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 high-dose (trivalent - Michigan/Hong Kong/Brisbane) 0.5 ML Prefilled Syringe 1593352 vaccine 0.5 ML influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe VO:0019260 OHDSI Vaccine WG 2180401 0.5 ML influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2019-2020 (quadrivalent - Idaho/Indiana/Iowa/Singapore) 0.5 ML Prefilled Syringe 1361677 vaccine 0.5 ML influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019261 OHDSI Vaccine WG 2180406 0.5 ML influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] 1361678 vaccine 0.5 ML influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] VO:0019262 OHDSI Vaccine WG 2050772 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 35201916 vaccine 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019263 OHDSI Vaccine WG 2050780 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 35201918 vaccine 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019264 OHDSI Vaccine WG 2050377 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2018-2019 (quadrivalent generic for Flublok - Michigan/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe 35201910 vaccine 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019265 OHDSI Vaccine WG 2050418 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe influenza virus vaccine 2018-2019 (trivalent - Michigan/Singapore/Maryland) 0.5 ML Prefilled Syringe 35201912 vaccine 0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe VO:0019266 OHDSI Vaccine WG 2055031 0.5 ML influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] Flucelvax Quadrivalent 2018-2019 vaccine 0.5 ML Prefilled Syringe 35201950 vaccine 0.5 ML influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] VO:0019267 OHDSI Vaccine WG 2056528 0.5 ML influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) 0.5 ML Prefilled Syringe 35201961 vaccine 0.5 ML influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019268 OHDSI Vaccine WG 1928538 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2017-2018 (quadrivalent - Singapore/Singapore/Hong Kong/Utah) 0.5 ML Prefilled Syringe 1593687 vaccine 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe VO:0019269 OHDSI Vaccine WG 2048961 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2018-2019 (quadrivalent - Singapore/Singapore/Maryland/Phuket) 0.5 ML Prefilled Syringe 1560161 vaccine 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019270 OHDSI Vaccine WG 2050758 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) 0.5 ML Prefilled Syringe 35201914 vaccine 0.5 ML influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019271 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent - Tasmania/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe 2561266 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2021-2022 (quadrivalent - Tasmania/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe 1537636 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019272 OHDSI Vaccine WG Flulaval Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 2561270 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2021-2022] Flulaval Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 1537637 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2021-2022] VO:0019273 OHDSI Vaccine WG Fluarix Quadrivalent 2021-2022 vaccine 0.5 mL Prefilled Syringe 2561275 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2021-2022] Fluarix Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 1537638 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2021-2022] VO:0019274 OHDSI Vaccine WG Fluzone Quadrivalent 2021-2022 vaccine 0.5 ML Injection 2563032 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2021-2022] 1537648 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2021-2022] VO:0019275 OHDSI Vaccine WG Fluzone Quadrivalent 2021-2022 vaccine 0.5 Prefilled Syringe 2563039 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] 1537650 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] VO:0019276 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.5 mL Injection 2563047 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.5 mL Injection 1537651 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection VO:0019277 OHDSI Vaccine WG Flucelvax Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 2562995 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] 1537640 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] VO:0019278 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Prefilled Syringe 2563007 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe 1537645 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019279 OHDSI Vaccine WG Flublok Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe 2563002 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2021-2022] 1537643 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2021-2022] VO:0019280 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent generic for Flublok - Phuket/Tasmania/Washington/Wisconsin) 0.5 ML Prefilled Syringe 2563024 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe 1537647 vaccine 0.5 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe VO:0019281 OHDSI Vaccine WG 1541622 0.5 ML influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 45776079 vaccine 0.5 ML influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019282 OHDSI Vaccine WG 1541627 0.5 ML influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] 45776083 vaccine 0.5 ML influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] VO:0019283 OHDSI Vaccine WG 1546093 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 45775135 vaccine 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019284 OHDSI Vaccine WG 1546095 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] 45775137 vaccine 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] VO:0019285 OHDSI Vaccine WG 1544626 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe Influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / Influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), Inactivated 0.03 MG/ML / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML 0.5 ML Prefilled Syringe 45774414 vaccine 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019286 OHDSI Vaccine WG 1544628 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] Flulaval 2014-2015 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 45774416 vaccine 0.5 ML influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] VO:0019287 OHDSI Vaccine WG 1427037 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza B virus vaccine, B-Brisbane-60-2008-like virus 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML 0.5 ML Prefilled Syringe 43531882 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019288 OHDSI Vaccine WG 1427039 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula] Fluzone Quadrivalent 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43531883 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula] VO:0019289 OHDSI Vaccine WG 1537561 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] Fluzone Quadrivalent 2014-2015 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 44818430 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] VO:0019290 OHDSI Vaccine WG 1428988 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML 0.5 ML Prefilled Syringe 43532840 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019291 OHDSI Vaccine WG 1431432 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2013-2014 Formula] Afluria 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43532957 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2013-2014 Formula] VO:0019292 OHDSI Vaccine WG 1537485 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2014-2015 Formula] Afluria 2014-2015 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 44818411 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2014-2015 Formula] VO:0019293 OHDSI Vaccine WG 1428993 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2013-2014 Formula] Fluarix 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43532841 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2013-2014 Formula] VO:0019294 OHDSI Vaccine WG 1543407 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] Fluarix 2014-2015 Formula 45 mcg (15 mcg x 3) per 0.5 ML Prefilled 45776653 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] VO:0019295 OHDSI Vaccine WG 1433776 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2013-2014 Formula] Flucelvax 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43559981 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2013-2014 Formula] VO:0019296 OHDSI Vaccine WG 1537526 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2014-2015 Formula] Flucelvax 2014-2015 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 44818417 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2014-2015 Formula] VO:0019297 OHDSI Vaccine WG 1433758 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2013-2014 Formula] Fluvirin 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43559980 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2013-2014 Formula] VO:0019298 OHDSI Vaccine WG 1537534 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2014-2015 Formula] Fluvirin 2014-2015 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 44818420 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2014-2015 Formula] VO:0019299 OHDSI Vaccine WG 1429607 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2013-2014 Formula] Fluzone 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43532878 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2013-2014 Formula] VO:0019300 OHDSI Vaccine WG 1537554 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula] Fluzone 2014-2015 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 44818427 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula] VO:0019301 OHDSI Vaccine WG 1304128 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.03 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML 0.5 ML Prefilled Syringe 42873646 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe VO:0019302 OHDSI Vaccine WG 1304131 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2012-2013 Formula] Afluria 2012-2013 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 42873647 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2012-2013 Formula] VO:0019303 OHDSI Vaccine WG 1304370 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Agriflu 2012-2013 Formula] Agriflu 2012-2013 Formula 0.5 ML Prefilled Syringe 42873648 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Agriflu 2012-2013 Formula] VO:0019304 OHDSI Vaccine WG 1304196 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2012-2013 Formula] Fluarix 2012-2013 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 42873649 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2012-2013 Formula] VO:0019305 OHDSI Vaccine WG 1361803 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] Flucelvax 2012-2013 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43011866 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] VO:0019306 OHDSI Vaccine WG 1304212 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2012-2013 Formula] Fluvirin 2012-2013 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 42873650 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2012-2013 Formula] VO:0019307 OHDSI Vaccine WG 1304291 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2012-2013 Formula] Fluzone 2012-2013 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 42873651 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2012-2013 Formula] VO:0019308 OHDSI Vaccine WG 1429590 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe influenza virus vaccine 2014-2015 trivalent, high-dose 0.5 ML Prefilled Syringe 43532870 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe VO:0019309 OHDSI Vaccine WG 1429595 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2013-2014 Formula] Fluzone High-Dose 2013-2014 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 43532871 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2013-2014 Formula] VO:0019310 OHDSI Vaccine WG 1537545 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula] Fluzone High-Dose 2014-2015 Formula 0.5 ML Prefilled Syringe 44818423 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula] VO:0019311 OHDSI Vaccine WG 1304302 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe influenza A virus vaccine, A-California-7-2009 (H1N1)-like virus 0.12 MG/ML / influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML 0.5 ML Prefilled Syringe 42873652 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe VO:0019312 OHDSI Vaccine WG 1304307 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2012-2013 Formula] Fluzone High-Dose 2012-2013 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 42873653 vaccine 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2012-2013 Formula] VO:0019313 OHDSI Vaccine WG 1005948 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] 40224121 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] VO:0019314 OHDSI Vaccine WG 1006276 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2010-2011 Formula] Fluarix 2010-2011 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 40224125 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2010-2011 Formula] VO:0019315 OHDSI Vaccine WG 1006279 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2010-2011 Formula] Fluvirin 2010-2011 Formula 0.5 ML Prefilled Syringe 40224126 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2010-2011 Formula] VO:0019316 OHDSI Vaccine WG 1006309 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2010-2011 Formula] Afluria 2010-2011 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 40224127 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2010-2011 Formula] VO:0019317 OHDSI Vaccine WG 1012197 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Agriflu 2010-2011 Formula] 40225815 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Agriflu 2010-2011 Formula] VO:0019318 OHDSI Vaccine WG 1111362 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] Fluzone 2011-2012 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 40239565 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0019319 OHDSI Vaccine WG 1114639 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2011-2012 Formula] Fluarix 2011-2012 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 40240354 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2011-2012 Formula] VO:0019320 OHDSI Vaccine WG 1116693 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2011-2012 Formula] 40240355 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2011-2012 Formula] VO:0019321 OHDSI Vaccine WG 1116742 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe 40240356 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe VO:0019322 OHDSI Vaccine WG 1116746 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2011-2012 Formula] Fluvirin 2011-2012 Formula Influenza Virus Vaccine 0.5 ML Prefilled Syringe 40240357 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2011-2012 Formula] VO:0019323 OHDSI Vaccine WG 1005951 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe 40224122 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe VO:0019324 OHDSI Vaccine WG 1005953 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] 40224123 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] VO:0019325 OHDSI Vaccine WG 1111366 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] 40239566 vaccine 0.5 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0019326 OHDSI Vaccine WG 1300781 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 6 MCG per 0.5 ML Prefilled Syringe 42873438 vaccine 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe VO:0019327 OHDSI Vaccine WG 798271 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection human papillomavirus quadrivalent (types 6,11,16,18) vaccine, recombinant 0.5 ML Injection 529078 vaccine 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection VO:0019328 OHDSI Vaccine WG human papillomavirus quadrivalent (types 6,11,16,18) vaccine, recombinant 0.5 ML Prefilled Syringe 798276 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe human papillomavirus quadrivalent (types 6,11,16,18) vaccine, recombinant 0.5 ML Prefilled Syringe 529080 vaccine 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe VO:0019329 OHDSI Vaccine WG human papillomavirus 9-valent (types 6,11,16,18,31,33,45,52,58) vaccine, recombinant 0.5 mL Injection 1597094 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection human papillomavirus 9-valent (types 6,11,16,18,31,33,45,52,58) vaccine, recombinant 0.5 ML Injection 45892506 vaccine 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection VO:0019330 OHDSI Vaccine WG human papillomavirus 9-valent (types 6,11,16,18,31,33,45,52,58) vaccine, recombinant 0.5 ML Prefilled Syringe 1597101 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe human papillomavirus 9-valent (types 6,11,16,18,31,33,45,52,58) vaccine, recombinant 0.5 ML Prefilled Syringe 45892512 vaccine 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe VO:0019331 OHDSI Vaccine WG 804183 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection measles, mumps, and rubella virus vaccine live (generic for M-M-R II) 0.5 ML Injection 19131656 vaccine 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection VO:0019332 OHDSI Vaccine WG measles, mumps, rubella and varicella virus vaccine live 0.5 ML Injection 1292440 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection measles, mumps, rubella and varicella virus vaccine live 0.5 ML Injection 42799831 vaccine 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection VO:0019333 OHDSI Vaccine WG 2122273 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection 1511432 vaccine 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection VO:0019334 OHDSI Vaccine WG 547243 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection [Attenuvax] 0.5 ML Attenuvax 2000 UNT/ML Injection 594272 vaccine 0.5 ML measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection [Attenuvax] VO:0019335 OHDSI Vaccine WG 1658226 0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection meningococcal group A polysaccharide 50 MCG / meningococcal group C polysaccharide 50 MCG / meningococcal polysaccharide vaccine group W-135 50 MCG / meningococcal polysaccharide vaccine group Y 50 MCG per 0.5 ML Injection 46275261 vaccine 0.5 ML meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection VO:0019336 OHDSI Vaccine WG meningococcal group B vaccine 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG per 0.5 ML Prefilled Syringe 1601402 meningococcal group B vaccine 50 MCG / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 50 MCG / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 25 MCG per 0.5 ML Prefilled Syringe 45892095 vaccine 0.5 ML meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe VO:0019337 OHDSI Vaccine WG meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV4 generic for Menactra) 0.5 ML Injection 797638 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection 528293 vaccine 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection VO:0019338 OHDSI Vaccine WG Menactra Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine 0.5 ML Injection 797641 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection [Menactra] Menactra Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine 0.5 ML Injection 528299 vaccine 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection [Menactra] VO:0019339 OHDSI Vaccine WG Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG per 0.5 ML Prefilled Syringe 797643 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.052 MG per 0.5 ML Prefilled Syringe 528294 vaccine 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe VO:0019340 OHDSI Vaccine WG Menactra Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Prefilled Syringe 797645 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe [Menactra] Menactra Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine Prefilled Syringe 528300 vaccine 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe [Menactra] VO:0019341 OHDSI Vaccine WG meningococcal (groups A, C, Y and W-135) polysaccharide tetanus toxoid conjugate vaccine 0.5 ML Injection 2360583 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection meningococcal (groups A, C, Y and W-135) polysaccharide tetanus toxoid conjugate vaccine 0.5 ML Injection 1146728 vaccine 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection VO:0019342 OHDSI Vaccine WG MenQuadfi vaccine 0.5 ML Injection 2360588 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi] 1146729 vaccine 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi] VO:0019343 OHDSI Vaccine WG meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine 0.5 ML Injection 901514 0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine 0.5 ML Injection 40173203 vaccine 0.5 ML Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection VO:0019344 OHDSI Vaccine WG 1593135 0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 60 MCG / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 60 MCG per 0.5 ML Prefilled Syringe 45775640 vaccine 0.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe VO:0019345 OHDSI Vaccine WG 866820 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML 0.5 ML Prefilled Syringe 40166836 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe VO:0019346 OHDSI Vaccine WG 1596461 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe [Ipol] Ipol (poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML) 0.5 ML Prefilled Syringe 45892427 vaccine 0.5 ML poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe [Ipol] VO:0019347 OHDSI Vaccine WG pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 Protein) 0.5 ML Prefilled Syringe 901640 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe 40173507 vaccine 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe VO:0019348 OHDSI Vaccine WG 798242 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.002 MG per 0.5 ML Prefilled Syringe 0.5 ML Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein) 0.5 ML Prefilled Syringe 529050 vaccine 0.5 ML Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe VO:0019349 OHDSI Vaccine WG 798244 0.5 ML Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe [Prevnar] Prevnar (Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria CRM197 Protein)) 0.5 ML Prefilled Syringe 529051 vaccine 0.5 ML Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe [Prevnar] VO:0019350 OHDSI Vaccine WG 792157 0.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe tetanus toxoid vaccine 5 UNT per 0.5 ML Prefilled Syringe 529657 vaccine 0.5 ML tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019351 OHDSI Vaccine WG 807239 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 25 MCG per 0.5 ML Prefilled Syringe 19132282 vaccine 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe VO:0019352 OHDSI Vaccine WG 1986825 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection 0.5 ML zoster vaccine, recombinant 0.1 MG/ML 792781 vaccine 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection VO:0019353 OHDSI Vaccine WG influenza virus vaccine 2023 southern hemisphere (quadrivalent - Darwin/Michigan/Phuket/Sydney) 0.7 mL Prefilled Syringe 2630223 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe 1302357 vaccine 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe VO:0019354 OHDSI Vaccine WG Fluzone Quadrivalent 2023 Southern Hemisphere vaccine 0.7 mL Prefilled Syringe 2630229 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] 1302358 vaccine 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019355 OHDSI Vaccine WG influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe 2605100 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 high-dose (quadrivalent - Darwin/Michigan/Phuket/Victoria) 0.7 mL Prefilled Syringe 780296 vaccine 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe VO:0019356 OHDSI Vaccine WG Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe 2605106 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] Fluzone Quadrivalent 2022-2023 high dose vaccine 0.7 ML Prefilled Syringe 780297 vaccine 0.7 ML influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] VO:0019357 OHDSI Vaccine WG influenza virus vaccine 2020-2021 high-dose (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.7 ML Prefilled Syringe 2383546 0.7 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe influenza virus vaccine 2020-2021 high-dose (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) 0.7 ML Prefilled Syringe 1146807 vaccine 0.7 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe VO:0019358 OHDSI Vaccine WG Fluzone Quadrivalent 2020-2021 high-dose vaccine 0.7 ML Prefilled Syringe 2383548 0.7 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] Fluzone Quadrivalent 2020-2021 high-dose vaccine 0.7 ML Prefilled Syringe 1146808 vaccine 0.7 ML influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] VO:0019359 OHDSI Vaccine WG Fluzone Quadrivalent 2021-2022 high dose vaccine 0.7 ML Prefilled Syringe 2563004 0.7 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] Fluzone Quadrivalent 2021-2022 high dose vaccine 0.7 ML Prefilled Syringe 1537644 vaccine 0.7 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] VO:0019360 OHDSI Vaccine WG acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension [Pediarix] 2563017 0.7 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe influenza virus vaccine 2021-2022 high-dose (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.7 ML Prefilled Syringe 1537646 vaccine 0.7 ML influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe VO:0019361 OHDSI Vaccine WG 1361668 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe 43011853 vaccine 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe VO:0019362 OHDSI Vaccine WG 798477 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe hepatitis A vaccine (inactivated) strain HM175 1440 UNT per 1 ML Prefilled Syringe 529684 vaccine 1 ML hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe VO:0019363 OHDSI Vaccine WG 1658100 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection 46275196 vaccine 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection VO:0019364 OHDSI Vaccine WG 727782 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe hepatitis A virus strain CR 326F antigen, inactivated 50 UNT per 1 ML Prefilled Syringe 596894 vaccine 1 ML hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe VO:0019365 OHDSI Vaccine WG 2588237 1 ML hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection 1759238 vaccine 1 ML hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection VO:0019366 OHDSI Vaccine WG 2588240 1 ML hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection [Prehevbrio] Prehevbrio vaccine 1 ML Injection 1759239 vaccine 1 ML hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection [Prehevbrio] VO:0019367 OHDSI Vaccine WG 995161 1 ML hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe 40221830 vaccine 1 ML hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe VO:0019368 OHDSI Vaccine WG 995163 1 ML hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe [Recombivax] 1 ML Recombivax HB 0.0025 MG/ML Prefilled Syringe 40221831 vaccine 1 ML hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe [Recombivax] VO:0019369 OHDSI Vaccine WG 830261 1 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection hepatitis B surface antigen vaccine 40 MCG in 1 ML Injection 19133386 vaccine 1 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection VO:0019370 OHDSI Vaccine WG 830263 1 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Recombivax] Recombivax HB, Hepatitis B vaccine (recombinant) Dialysis Formulation 40 MCG per 1 ML Injection 19133388 vaccine 1 ML hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Recombivax] VO:0019371 OHDSI Vaccine WG 830460 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection rabies virus vaccine flury-lep strain 2.5 UNT per 1 ML Injection 19133402 vaccine 1 ML rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection VO:0019372 OHDSI Vaccine WG 830467 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT per 1 ML Injection 19133406 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection VO:0019373 OHDSI Vaccine WG 830470 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection [Imovax] Imovax Rabies, Wistar Rabies Virus Strain PM-1503-3M (Human) 2.5 UNT per 1 ML Injection 19133408 vaccine 1 ML rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection [Imovax] VO:0019374 OHDSI Vaccine WG 798431 1.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe 528331 vaccine 1.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe VO:0019375 OHDSI Vaccine WG 798432 1.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] Engerix-B, Hepatitis B Surface Antigen Vaccine, Adsorbed (Pediatric Dose) 1.5 ML Prefilled Syringe 528352 vaccine 1.5 ML hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe [Engerix-B] VO:0019376 OHDSI Vaccine WG 2109613 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection 1366348 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection VO:0019377 OHDSI Vaccine WG 2109618 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Vaxelis] 1366351 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Vaxelis] VO:0019378 OHDSI Vaccine WG 2468236 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe 37003437 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0019379 OHDSI Vaccine WG 2468238 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Vaxelis] 37003438 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Vaxelis] VO:0019380 OHDSI Vaccine WG 1657394 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection 46276200 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection VO:0019381 OHDSI Vaccine WG 829970 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injectable Suspension 40156519 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injectable Suspension VO:0019382 OHDSI Vaccine WG 829973 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injectable Suspension [PEDIARIX] 40156522 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injectable Suspension [Pediarix] VO:0019383 OHDSI Vaccine WG 829986 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe 40156525 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0019384 OHDSI Vaccine WG 830554 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe 40156658 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe VO:0019385 OHDSI Vaccine WG 1657429 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection 46276202 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection VO:0019386 OHDSI Vaccine WG 1657432 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Quadracel] 46276203 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection [Quadracel] VO:0019387 OHDSI Vaccine WG 2593120 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Quadracel] 1759162 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe [Quadracel] VO:0019388 OHDSI Vaccine WG 365627 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [ACEL-IMUNE] 40001983 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [ACEL-IMUNE] VO:0019389 OHDSI Vaccine WG 365683 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Certiva] 40021647 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Certiva] VO:0019390 OHDSI Vaccine WG 798311 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Tripedia] 40150353 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injectable Suspension [Tripedia] VO:0019391 OHDSI Vaccine WG 1657463 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection 46276206 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection VO:0019392 OHDSI Vaccine WG 1657871 acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Daptacel] 46275084 vaccine acellular pertussis vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Daptacel] VO:0019393 OHDSI Vaccine WG 795938 acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 15 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension 551974 vaccine acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 15 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019394 OHDSI Vaccine WG 830518 acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension 19133426 vaccine acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019395 OHDSI Vaccine WG 359455 acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Solution 551949 vaccine acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Solution VO:0019396 OHDSI Vaccine WG 795930 acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension 19130194 vaccine acellular pertussis vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension VO:0019397 OHDSI Vaccine WG 829971 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension DTaP-HepB-IPV (diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined) Injectable Suspension 523287 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension VO:0019398 OHDSI Vaccine WG 829974 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension [PEDIARIX] 523288 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension [Pediarix] VO:0019399 OHDSI Vaccine WG 1359438 acellular pertussis vaccine, inactivated 0.936 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension 42902325 vaccine acellular pertussis vaccine, inactivated 0.936 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019400 OHDSI Vaccine WG 798309 acellular pertussis vaccine, inactivated 0.936 UNT/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension DTaP (Diphtheria Toxoid Vaccine 6.7 UNT / Tetanus Toxoid Vaccine 5 UNT / Acellular Pertussis Vaccine 46.8 MCG) per 0.5 ML Injectable Suspension 19130408 vaccine acellular pertussis vaccine, inactivated 0.936 UNT/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019401 OHDSI Vaccine WG 380956 acellular pertussis vaccine, inactivated 600 UNT/ML 19100619 vaccine acellular pertussis vaccine, inactivated 600 UNT/ML VO:0019402 OHDSI Vaccine WG 251653 acellular pertussis vaccine, inactivated 600 UNT/ML Injectable Solution 551945 vaccine acellular pertussis vaccine, inactivated 600 UNT/ML Injectable Solution VO:0019403 OHDSI Vaccine WG 795939 acellular pertussis vaccine, inactivated 8 UNT/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension 529377 vaccine acellular pertussis vaccine, inactivated 8 UNT/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019404 OHDSI Vaccine WG 807415 acellular pertussis vaccine, inactivated 8 UNT/ML / diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension 19132353 vaccine acellular pertussis vaccine, inactivated 8 UNT/ML / diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019405 OHDSI Vaccine WG 2585716 acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Pentacel] 702273 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Pentacel] VO:0019406 OHDSI Vaccine WG 2273309 Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML 37498567 vaccine Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML VO:0019407 OHDSI Vaccine WG 2273313 Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML [Biothrax] 37498570 vaccine Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML [Biothrax] VO:0019408 OHDSI Vaccine WG 832679 Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML Injectable Suspension 19045674 vaccine Bacillus anthracis strain V770-NP1-R antigens 0.1 MG/ML Injectable Suspension VO:0019409 OHDSI Vaccine WG 2273311 Bacillus anthracis strain V770-NP1-R antigens Injectable Suspension 37498569 vaccine Bacillus anthracis strain V770-NP1-R antigens Injectable Suspension VO:0019410 OHDSI Vaccine WG 2273314 Bacillus anthracis strain V770-NP1-R antigens Injectable Suspension [Biothrax] 37498571 vaccine Bacillus anthracis strain V770-NP1-R antigens Injectable Suspension [Biothrax] VO:0019411 OHDSI Vaccine WG 1653579 BCG, live, Tice strain 50 MG Injection BCG vaccine 50 MG Injection 46234108 vaccine BCG, live, Tice strain 50 MG Injection VO:0019412 Jie Zheng Xingxian Li 1653578 BCG, live, Tice strain Injection 46234107 vaccine BCG, Live, Tice Strain Injection VO:0019413 OHDSI Vaccine WG 2109617 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Vaxelis] 1366350 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Vaxelis] VO:0019414 OHDSI Vaccine WG 2587056 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Quadracel] 702405 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Quadracel] VO:0019415 OHDSI Vaccine WG 1300391 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Tripedia] 42800478 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Tripedia] VO:0019416 OHDSI Vaccine WG 1300390 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension DTaP (diphtheria toxoid vaccine, inactivated 13.4 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 46.8 MCG) per 0.5 ML Injectable Suspension 42800476 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019417 OHDSI Vaccine WG 1300392 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [Tripedia] Tripedia DTaP (diphtheria toxoid vaccine, inactivated 6.7 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 46.8 MCG) per 0.5 ML Injectable Suspension 42800477 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [Tripedia] VO:0019419 OHDSI Vaccine WG 1300401 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension 42800485 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019420 OHDSI Vaccine WG 1300402 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [ACEL-IMUNE] 42800484 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [ACEL-IMUNE] VO:0019421 OHDSI Vaccine WG 1300403 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE] 42800486 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE] VO:0019422 OHDSI Vaccine WG 1300395 Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML [Certiva] 42800502 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML [Certiva] VO:0019423 OHDSI Vaccine WG 1300394 Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension 42800500 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension VO:0019424 OHDSI Vaccine WG 1300396 Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension [Certiva] Certiva (Bordetella pertussis toxoid vaccine, inactivated 40 MCG / diphtheria toxoid vaccine, inactivated 15 UNT / tetanus toxoid vaccine, inactivated 6 UNT) per 0.5 ML Injectable Suspension 42800501 vaccine Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension [Certiva] VO:0019425 OHDSI Vaccine WG 378439 diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Solution 40034290 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Solution VO:0019426 OHDSI Vaccine WG 363455 diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Solution [Prohibit] 40034291 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Solution [Prohibit] VO:0019427 OHDSI Vaccine WG 795941 diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Suspension 40150267 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Suspension VO:0019428 OHDSI Vaccine WG 795944 diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Suspension [HibTITER] 40150268 vaccine diphtheria toxoid vaccine, inactivated / Haemophilus capsular oligosaccharide Injectable Suspension [HibTITER] VO:0019429 OHDSI Vaccine WG 1657596 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Decavac] 46276281 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Decavac] VO:0019430 OHDSI Vaccine WG 2106332 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax] 1355885 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax] VO:0019431 OHDSI Vaccine WG 807275 diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Decavac] 40153467 vaccine diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Prefilled Syringe [Decavac] VO:0019432 OHDSI Vaccine WG 574101 diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML [Prohibit] 19120570 vaccine diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML [Prohibit] VO:0019433 OHDSI Vaccine WG 260122 diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution 19067185 vaccine diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution VO:0019434 OHDSI Vaccine WG 260299 diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution [Prohibit] 19067404 vaccine diphtheria toxoid vaccine, inactivated 0.036 MG/ML / Haemophilus capsular oligosaccharide 0.05 MG/ML Injectable Solution [Prohibit] VO:0019435 OHDSI Vaccine WG 795943 diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus capsular oligosaccharide 0.02 MG/ML [HibTITER] 19063339 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus capsular oligosaccharide 0.02 MG/ML [HibTITER] VO:0019436 OHDSI Vaccine WG 795942 diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus capsular oligosaccharide 0.02 MG/ML Injectable Suspension 586324 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus capsular oligosaccharide 0.02 MG/ML Injectable Suspension VO:0019437 OHDSI Vaccine WG 795945 diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus capsular oligosaccharide 0.02 MG/ML Injectable Suspension [HibTITER] HibTITER Diphtheria Toxoid Vaccine Injectable Suspension 586325 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / Haemophilus capsular oligosaccharide 0.02 MG/ML Injectable Suspension [HibTITER] VO:0019438 OHDSI Vaccine WG 342864 diphtheria toxoid vaccine, inactivated 0.2 UNT/ML 529347 vaccine diphtheria toxoid vaccine, inactivated 0.2 UNT/ML VO:0019439 OHDSI Vaccine WG 247766 diphtheria toxoid vaccine, inactivated 0.2 UNT/ML Injectable Solution 529343 vaccine diphtheria toxoid vaccine, inactivated 0.2 UNT/ML Injectable Solution VO:0019440 OHDSI Vaccine WG 802049 diphtheria toxoid vaccine, inactivated 13.2 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension diphtheria toxoid vaccine 6.6 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension 19131460 vaccine diphtheria toxoid vaccine, inactivated 13.2 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019441 OHDSI Vaccine WG 795926 diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution 529374 vaccine diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Solution VO:0019442 OHDSI Vaccine WG 805379 diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension diphtheria toxoid vaccine, inactivated 6.7 UNT / tetanus toxoid vaccine, inactivated 5 UNT per 0.5 ML vaccine Injectable Suspension 19131880 vaccine diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019443 OHDSI Vaccine WG 795937 diphtheria toxoid vaccine, inactivated 15 UNT/ML 529376 vaccine diphtheria toxoid vaccine, inactivated 15 UNT/ML VO:0019444 OHDSI Vaccine WG 795935 diphtheria toxoid vaccine, inactivated 18 UNT/ML 19130195 vaccine diphtheria toxoid vaccine, inactivated 18 UNT/ML VO:0019445 OHDSI Vaccine WG 200288 diphtheria toxoid vaccine, inactivated 20 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 19023455 vaccine diphtheria toxoid vaccine, inactivated 20 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0019446 OHDSI Vaccine WG 205256 diphtheria toxoid vaccine, inactivated 20 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension diphtheria toxoid vaccine 10 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension 19028826 vaccine diphtheria toxoid vaccine, inactivated 20 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019447 OHDSI Vaccine WG 402457 diphtheria toxoid vaccine, inactivated 25 LFU/ML 19102282 vaccine diphtheria toxoid vaccine, inactivated 25 LFU/ML VO:0019448 OHDSI Vaccine WG 200260 diphtheria toxoid vaccine, inactivated 25 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 19023428 vaccine diphtheria toxoid vaccine, inactivated 25 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0019449 OHDSI Vaccine WG 205255 diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension diphtheria toxoid vaccine 12.5 UNT / tetanus toxoid vaccine 5 UNT per 0.5 ML Injectable Suspension 19028825 vaccine diphtheria toxoid vaccine, inactivated 25 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension VO:0019450 OHDSI Vaccine WG 204525 diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension 19027664 vaccine diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension VO:0019451 OHDSI Vaccine WG 402455 diphtheria toxoid vaccine, inactivated 4 LFU/ML 19102280 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML VO:0019452 OHDSI Vaccine WG 200259 diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension 19023427 vaccine diphtheria toxoid vaccine, inactivated 4 LFU/ML / tetanus toxoid vaccine, inactivated 10 LFU/ML Injectable Suspension VO:0019453 OHDSI Vaccine WG 807274 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Decavac] 19132299 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Decavac] VO:0019454 OHDSI Vaccine WG 1657594 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 46276279 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019455 OHDSI Vaccine WG 1657598 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Decavac] 46276282 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Decavac] VO:0019456 OHDSI Vaccine WG 1657595 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Tenivac] 46276280 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Tenivac] VO:0019457 OHDSI Vaccine WG 1360484 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 42903371 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0019458 OHDSI Vaccine WG 1360433 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Decavac] 42903320 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Decavac] VO:0019459 OHDSI Vaccine WG 1359524 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Tenivac] 42902411 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Tenivac] VO:0019460 OHDSI Vaccine WG 205257 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension 19028827 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Suspension VO:0019461 OHDSI Vaccine WG 2106331 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML [Tdvax] 1355884 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML [Tdvax] VO:0019462 OHDSI Vaccine WG 1866066 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection 1593421 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection VO:0019463 OHDSI Vaccine WG 2106335 diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection [Tdvax] 1355887 vaccine diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 4 UNT/ML Injection [Tdvax] VO:0019464 OHDSI Vaccine WG 583410 diphtheria toxoid vaccine, inactivated 5 MG/ML / tetanus toxoid vaccine, inactivated 10 MG/ML Injectable Suspension 19122006 vaccine diphtheria toxoid vaccine, inactivated 5 MG/ML / tetanus toxoid vaccine, inactivated 10 MG/ML Injectable Suspension VO:0019465 OHDSI Vaccine WG 221050 BCG, live, Tice strain 19086176 vaccine BCG, live, Tice strain VO:0019466 OHDSI Vaccine WG 1866068 diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 1593422 vaccine diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0019467 OHDSI Vaccine WG 247765 diphtheria toxoid vaccine, inactivated 50 UNT/ML Injectable Solution 529342 vaccine diphtheria toxoid vaccine, inactivated 50 UNT/ML Injectable Solution VO:0019468 OHDSI Vaccine WG 374588 Haemophilus capsular oligosaccharide / Neisseria meningitidis Injectable Solution 40046016 vaccine Haemophilus capsular oligosaccharide / Neisseria meningitidis Injectable Solution VO:0019469 OHDSI Vaccine WG 606316 Haemophilus capsular oligosaccharide / Neisseria meningitidis Injectable Suspension 40129825 vaccine Haemophilus capsular oligosaccharide / Neisseria meningitidis Injectable Suspension VO:0019470 OHDSI Vaccine WG 606319 Haemophilus capsular oligosaccharide / Neisseria meningitidis Injectable Suspension [Liquid PedvaxHIB] 40129826 vaccine Haemophilus capsular oligosaccharide / Neisseria meningitidis Injectable Suspension [Liquid PedvaxHIB] VO:0019471 OHDSI Vaccine WG 379116 Haemophilus capsular oligosaccharide / tetanus toxoid vaccine, inactivated Injectable Solution 40046017 vaccine Haemophilus capsular oligosaccharide / tetanus toxoid vaccine, inactivated Injectable Solution VO:0019472 OHDSI Vaccine WG 363454 Haemophilus capsular oligosaccharide / tetanus toxoid vaccine, inactivated Injectable Solution [OmniHIB] 40046018 vaccine Haemophilus capsular oligosaccharide / tetanus toxoid vaccine, inactivated Injectable Solution [OmniHIB] VO:0019473 OHDSI Vaccine WG 606318 Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML [Liquid PedvaxHIB] 19123083 vaccine Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML [Liquid PedvaxHIB] VO:0019474 OHDSI Vaccine WG 260209 Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Solution 19067229 vaccine Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Solution VO:0019475 OHDSI Vaccine WG 606317 Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Suspension 19123082 vaccine Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Suspension VO:0019476 OHDSI Vaccine WG 606320 Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Suspension [Liquid PedvaxHIB] 19123084 vaccine Haemophilus capsular oligosaccharide 0.015 MG/ML / Neisseria meningitidis 0.25 MG/ML Injectable Suspension [Liquid PedvaxHIB] VO:0019477 OHDSI Vaccine WG 574102 Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML [OmniHIB] 19120571 vaccine Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML [OmniHIB] VO:0019478 OHDSI Vaccine WG 260123 Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution 19067186 vaccine Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution VO:0019479 OHDSI Vaccine WG 260301 Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution [OmniHIB] 19067405 vaccine Haemophilus capsular oligosaccharide 0.02 MG/ML / tetanus toxoid vaccine, inactivated 0.048 MG/ML Injectable Solution [OmniHIB] VO:0019480 OHDSI Vaccine WG 260208 Haemophilus capsular oligosaccharide 0.03 MG/ML / Neisseria meningitidis 0.5 MG/ML Injectable Solution 19067228 vaccine Haemophilus capsular oligosaccharide 0.03 MG/ML / Neisseria meningitidis 0.5 MG/ML Injectable Solution VO:0019481 OHDSI Vaccine WG 1657693 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine Injection 46276312 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine Injection VO:0019482 OHDSI Vaccine WG 1657695 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine Injection [COMVAX] 46276383 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine Injection [COMVAX] VO:0019483 OHDSI Vaccine WG 336250 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.015 MG/ML 19092518 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.015 MG/ML VO:0019484 OHDSI Vaccine WG 242233 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.015 MG/ML Injectable Solution 19058439 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.015 MG/ML Injectable Solution VO:0019485 OHDSI Vaccine WG 1657697 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection 46276384 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection VO:0019486 OHDSI Vaccine WG 1657698 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection [COMVAX] 46276385 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML / hepatitis B surface antigen vaccine 0.01 MG/ML Injection [COMVAX] VO:0019487 OHDSI Vaccine WG 1657735 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML Injection 46276401 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML Injection VO:0019488 OHDSI Vaccine WG 1657736 Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML Injection [PedvaxHIB] PedvaxHIB 0.265 MG/ML Injection 46276402 vaccine Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.265 MG/ML Injection [PedvaxHIB] VO:0019489 OHDSI Vaccine WG 1657742 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection 46276405 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection VO:0019490 OHDSI Vaccine WG 1657743 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection [MenHibrix] 46276406 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.005 MG/ML / meningococcal group C polysaccharide 0.01 MG/ML / meningococcal polysaccharide vaccine group Y 0.01 MG/ML Injection [MenHibrix] VO:0019491 OHDSI Vaccine WG 1658095 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection 46275193 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection VO:0019492 OHDSI Vaccine WG 1658096 Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] ActHIB 0.068 MG/ML Injection 46275194 vaccine Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection [ActHIB] VO:0019493 OHDSI Vaccine WG 1658073 Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection 46275178 vaccine Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection VO:0019494 OHDSI Vaccine WG 1658074 Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix] Hiberix 0.07 MG/ML Injection 46275179 vaccine Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix] VO:0019495 OHDSI Vaccine WG 1657738 Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group Y Injection 46276403 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group Y Injection VO:0019496 OHDSI Vaccine WG 1657740 Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group Y Injection [MenHibrix] 46276404 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group Y Injection [MenHibrix] VO:0019497 OHDSI Vaccine WG 1658071 Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injection [Hiberix] 46275177 vaccine Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine Injection [Hiberix] VO:0019498 OHDSI Vaccine WG 1361666 hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe 43011518 vaccine hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe VO:0019499 OHDSI Vaccine WG 1361669 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe 43011854 vaccine hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe VO:0019500 OHDSI Vaccine WG 1658061 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection 46275172 vaccine hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection VO:0019501 OHDSI Vaccine WG 1658062 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection [Havrix] Havrix 1440 UNT/ML Injection 46275173 vaccine hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection [Havrix] VO:0019502 OHDSI Vaccine WG 1359766 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe 42902653 vaccine hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe VO:0019503 OHDSI Vaccine WG 1360146 hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] 42903033 vaccine hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix] VO:0019504 OHDSI Vaccine WG 995112 hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML Injectable Suspension 40222717 vaccine hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML Injectable Suspension VO:0019505 OHDSI Vaccine WG obsolete hepatitis A vaccine (inactivated) strain HM175 Injectable Suspension true VO:0019506 OHDSI Vaccine WG 1658103 hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection 46275199 vaccine hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection VO:0019507 OHDSI Vaccine WG 1658104 hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta] Vaqta 50 UNT/ML Injection 46275200 vaccine hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta] VO:0019508 OHDSI Vaccine WG 1360145 hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe 42903032 vaccine hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe VO:0019509 OHDSI Vaccine WG 1360094 hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] Vaqta 50 UNT/ML Prefilled Syringe 42902981 vaccine hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta] VO:0019510 OHDSI Vaccine WG 2275273 hepatitis A virus strain CR 326F antigen, inactivated Injection 37498654 vaccine hepatitis A virus strain CR 326F antigen, inactivated Injection VO:0019511 OHDSI Vaccine WG 2275276 hepatitis A virus strain CR 326F antigen, inactivated Injection [Vaqta] 37498656 vaccine hepatitis A virus strain CR 326F antigen, inactivated Injection [Vaqta] VO:0019512 OHDSI Vaccine WG 2275282 hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe 37498657 vaccine hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe VO:0019513 OHDSI Vaccine WG 2275284 hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe [Vaqta] 37498658 vaccine hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe [Vaqta] VO:0019514 OHDSI Vaccine WG 2588238 hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection 1758558 vaccine hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection VO:0019515 OHDSI Vaccine WG 2588241 hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection [Prehevbrio] Prehevbrio vaccine Injection 1758560 vaccine hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection [Prehevbrio] VO:0019516 OHDSI Vaccine WG 995160 hepatitis B surface antigen vaccine 0.0025 MG/ML 40222723 vaccine hepatitis B surface antigen vaccine 0.0025 MG/ML VO:0019517 OHDSI Vaccine WG 995162 hepatitis B surface antigen vaccine 0.0025 MG/ML [Recombivax] 40222724 vaccine hepatitis B surface antigen vaccine 0.0025 MG/ML [Recombivax] VO:0019518 OHDSI Vaccine WG 1360098 hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe 42902985 vaccine hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe VO:0019519 OHDSI Vaccine WG 1359554 hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe [Recombivax] 42902441 vaccine hepatitis B surface antigen vaccine 0.0025 MG/ML Prefilled Syringe [Recombivax] VO:0019520 OHDSI Vaccine WG 336710 hepatitis B surface antigen vaccine 0.003 MG/ML 19092916 vaccine hepatitis B surface antigen vaccine 0.003 MG/ML VO:0019521 OHDSI Vaccine WG 250071 hepatitis B surface antigen vaccine 0.003 MG/ML Injectable Solution 19062035 vaccine hepatitis B surface antigen vaccine 0.003 MG/ML Injectable Solution VO:0019522 OHDSI Vaccine WG 830238 hepatitis B surface antigen vaccine 0.005 MG/ML [Recombivax] 19133375 vaccine hepatitis B surface antigen vaccine 0.005 MG/ML [Recombivax] VO:0019523 OHDSI Vaccine WG 830239 hepatitis B surface antigen vaccine 0.005 MG/ML Injectable Suspension [Recombivax] Recombivax HB, Hepatitis B Vaccine (Recombinant) Pediatric/Adolescent Formulation Injectable Suspension 19133376 vaccine hepatitis B surface antigen vaccine 0.005 MG/ML Injectable Suspension [Recombivax] VO:0019524 OHDSI Vaccine WG 1360057 hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe [Recombivax] 42902944 vaccine hepatitis B surface antigen vaccine 0.005 MG/ML Prefilled Syringe [Recombivax] VO:0019525 OHDSI Vaccine WG 1658152 hepatitis B surface antigen vaccine 0.01 MG/ML Injection [Recombivax] Recombivax 0.01 MG/ML Injection 46275239 vaccine hepatitis B surface antigen vaccine 0.01 MG/ML Injection [Recombivax] VO:0019526 OHDSI Vaccine WG 1360035 hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] 42902922 vaccine hepatitis B surface antigen vaccine 0.01 MG/ML Prefilled Syringe [Recombivax] VO:0019527 OHDSI Vaccine WG 798453 hepatitis B surface antigen vaccine 0.02 MG/ML [HB-VAX] 19030113 vaccine hepatitis B surface antigen vaccine 0.02 MG/ML [HB-VAX] VO:0019528 OHDSI Vaccine WG 798455 hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [HB-VAX] HB-VAX 0.02 MG/ML Injectable Suspension 528354 vaccine hepatitis B surface antigen vaccine 0.02 MG/ML Injectable Suspension [HB-VAX] VO:0019529 OHDSI Vaccine WG obsolete hepatitis B surface antigen vaccine 0.04 MG/ML true VO:0019530 OHDSI Vaccine WG 830262 hepatitis B surface antigen vaccine 0.04 MG/ML [Recombivax] 19133387 vaccine hepatitis B surface antigen vaccine 0.04 MG/ML [Recombivax] VO:0019531 OHDSI Vaccine WG 1994353 hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Heplisav-B] Heplisav-B 0.04 MG/ML Injection 793521 vaccine hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Heplisav-B] VO:0019532 OHDSI Vaccine WG 1657686 hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Recombivax] Recombivax 0.04 MG/ML Injection 46276311 vaccine hepatitis B surface antigen vaccine 0.04 MG/ML Injection [Recombivax] VO:0019533 OHDSI Vaccine WG 2050061 hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] Heplisav-B 0.04 MG/ML Prefilled Syringe 35200005 vaccine hepatitis B surface antigen vaccine 0.04 MG/ML Prefilled Syringe [Heplisav-B] VO:0019534 OHDSI Vaccine WG 798454 hepatitis B surface antigen vaccine Injectable Suspension [HB-VAX] 40150693 vaccine hepatitis B surface antigen vaccine Injectable Suspension [HB-VAX] VO:0019535 OHDSI Vaccine WG 830213 hepatitis B surface antigen vaccine Injectable Suspension [Recombivax] 40156555 vaccine hepatitis B surface antigen vaccine Injectable Suspension [Recombivax] VO:0019536 OHDSI Vaccine WG 2588231 hepatitis B surface antigen vaccine Injection [Prehevbrio] 1758554 vaccine hepatitis B surface antigen vaccine Injection [Prehevbrio] VO:0019537 OHDSI Vaccine WG 1301894 human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.02 MG / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.02 MG per 0.5 ML Injectable Suspension 42873515 vaccine human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension VO:0019538 OHDSI Vaccine WG 1301895 human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix] Cervarix (Human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.02 MG / Human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.02 MG) per 0.5 ML Injectable Suspension 42873516 vaccine human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix] VO:0019539 OHDSI Vaccine WG 1360385 human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe 42903272 vaccine human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe VO:0019540 OHDSI Vaccine WG 1359982 human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix] 42902869 vaccine human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix] VO:0019541 OHDSI Vaccine WG 798296 human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension 40150604 vaccine human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension VO:0019542 OHDSI Vaccine WG 798299 human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq] 40150605 vaccine human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq] VO:0019543 OHDSI Vaccine WG rotavirus, live pentavalent (RV5) Oral Vaccine 798297 human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML / human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML / human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML Oral Suspension rotavirus, live pentavalent (RV5) Oral Vaccine 529178 vaccine human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML / human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML / human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML Oral Suspension VO:0019544 OHDSI Vaccine WG 1657324 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension 46276177 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension VO:0019545 OHDSI Vaccine WG 1661811 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2015-2016] 46276314 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2015-2016] VO:0019546 OHDSI Vaccine WG 1799412 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2016-2017] 36249271 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2016-2017] VO:0019547 OHDSI Vaccine WG 1942157 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2017-2018] 793960 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2017-2018] VO:0019548 OHDSI Vaccine WG 2050769 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2018-2019] 35200052 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2018-2019] VO:0019549 OHDSI Vaccine WG 1858965 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2016-2017 Formula] 1718586 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2016-2017 Formula] VO:0019550 OHDSI Vaccine WG 1942172 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2017-2018] 793971 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2017-2018] VO:0019551 OHDSI Vaccine WG 2050793 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2018-2019] 35200070 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2018-2019] VO:0019552 OHDSI Vaccine WG 2178788 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2019-2020] 1361224 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2019-2020] VO:0019553 OHDSI Vaccine WG 2380606 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2020-2021] 1146465 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2020-2021] VO:0019554 OHDSI Vaccine WG 2588638 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2021-2022] 1758620 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2021-2022] VO:0019555 OHDSI Vaccine WG 2605560 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2022-2023] 780101 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2022-2023] VO:0019556 OHDSI Vaccine WG 1928535 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2017-2018] 1593545 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2017-2018] VO:0019557 OHDSI Vaccine WG 2055033 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2018-2019] 35200347 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2018-2019] VO:0019558 OHDSI Vaccine WG 2180410 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2019-2020] 1361325 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2019-2020] VO:0019559 OHDSI Vaccine WG 2380846 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2020-2021] 1146494 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2020-2021] VO:0019560 OHDSI Vaccine WG 2588641 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2021-2022] 1758623 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2021-2022] VO:0019561 OHDSI Vaccine WG 2605738 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023] 780132 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flucelvax Quadrivalent 2022-2023] VO:0019562 OHDSI Vaccine WG 1657337 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [FluLaval Quadrivalent 2015-2016] 46276188 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [FluLaval Quadrivalent 2015-2016] VO:0019563 OHDSI Vaccine WG 1799204 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2016-2017] 36249202 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2016-2017] VO:0019564 OHDSI Vaccine WG 1928327 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2017-2018] 1593340 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2017-2018] VO:0019565 OHDSI Vaccine WG 2048972 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2018-2019] 1559899 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2018-2019] VO:0019566 OHDSI Vaccine WG 2177792 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2019-2020] 1361105 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Flulaval Quadrivalent 2019-2020] VO:0019567 OHDSI Vaccine WG 1657328 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluvirin 2015-2016] 46276181 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluvirin 2015-2016] VO:0019568 OHDSI Vaccine WG 1801155 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluvirin 2016-2017] 36249429 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluvirin 2016-2017] VO:0019569 OHDSI Vaccine WG 1928972 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluvirin 2017-2018] 1593907 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluvirin 2017-2018] VO:0019570 OHDSI Vaccine WG 1658704 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone 2015-2016] 46275384 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone 2015-2016] VO:0019571 OHDSI Vaccine WG 1659727 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2015-2016] 46275641 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2015-2016] VO:0019572 OHDSI Vaccine WG 1794449 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2016 Southern Hemisphere] 36249567 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019573 OHDSI Vaccine WG 1801192 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2016-2017] 36249519 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2016-2017] VO:0019574 OHDSI Vaccine WG 1928355 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2017-2018] 1593516 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2017-2018] VO:0019575 OHDSI Vaccine WG 2050786 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2018-2019] 35200066 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2018-2019] VO:0019576 OHDSI Vaccine WG 2177591 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2019-2020] 1361093 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2019-2020] VO:0019577 OHDSI Vaccine WG 2281589 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498875 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019578 OHDSI Vaccine WG 2380579 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020-2021] 1146448 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2020-2021] VO:0019579 OHDSI Vaccine WG 2479035 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere] 739843 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0019580 OHDSI Vaccine WG 2588642 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2021-2022] 1758624 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2021-2022] VO:0019581 OHDSI Vaccine WG 2593866 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022 Southern Hemisphere] 1759220 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022 Southern Hemisphere] VO:0019582 OHDSI Vaccine WG 2605551 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022-2023] 780093 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2022-2023] VO:0019583 OHDSI Vaccine WG 2630663 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2023 Southern Hemisphere] 1301771 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019584 OHDSI Vaccine WG 1659745 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection 46275653 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection VO:0019585 OHDSI Vaccine WG 1660927 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Flublok 2015-2016] 46276017 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Flublok 2015-2016] VO:0019586 OHDSI Vaccine WG 1803022 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Flublok 2016-2017] 40220830 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Flublok 2016-2017] VO:0019587 OHDSI Vaccine WG 1928878 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Flublok 2017-2018] 1593874 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Flublok 2017-2018] VO:0019588 OHDSI Vaccine WG 2177499 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2019-2020] 1361088 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2019-2020] VO:0019589 OHDSI Vaccine WG 2380587 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2020-2021] 1146453 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2020-2021] VO:0019590 OHDSI Vaccine WG 2588632 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2021-2022] 1758614 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2021-2022] VO:0019591 OHDSI Vaccine WG 2605548 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2022-2023] 780091 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2022-2023] VO:0019592 OHDSI Vaccine WG 1664473 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray 46287745 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray VO:0019593 OHDSI Vaccine WG 1664641 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist 2015-2016] 46287292 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist 2015-2016] VO:0019594 OHDSI Vaccine WG 1801827 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2016-2017] 40220776 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2016-2017] VO:0019595 OHDSI Vaccine WG 1946972 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2017-2018] 792412 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2017-2018] VO:0019596 OHDSI Vaccine WG 2054184 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2018-2019] 35200258 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2018-2019] VO:0019597 OHDSI Vaccine WG 2198903 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2019-2020] 37496503 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2019-2020] VO:0019598 OHDSI Vaccine WG 2389316 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2020-2021] 37002464 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2020-2021] VO:0019599 OHDSI Vaccine WG 2588643 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2021-2022] 1758625 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2021-2022] VO:0019600 OHDSI Vaccine WG 2607749 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2022-2023] 1525416 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist Quadrivalent 2022-2023] VO:0019601 OHDSI Vaccine WG 1657137 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe 46276001 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe VO:0019602 OHDSI Vaccine WG 2178783 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2019-2020] 1361221 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2019-2020] VO:0019603 OHDSI Vaccine WG 2380598 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2020-2021] 1146460 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2020-2021] VO:0019604 OHDSI Vaccine WG 2588637 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2021-2022] 1758619 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2021-2022] VO:0019605 OHDSI Vaccine WG 2605556 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2022-2023] 780098 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2022-2023] VO:0019606 OHDSI Vaccine WG 2178360 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2019-2020] 1361188 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2019-2020] VO:0019607 OHDSI Vaccine WG 2381148 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2020-2021] 1146532 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2020-2021] VO:0019608 OHDSI Vaccine WG 2382437 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2020-2021] 1146555 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2020-2021] VO:0019609 OHDSI Vaccine WG 2588640 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2021-2022] 1758622 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2021-2022] VO:0019610 OHDSI Vaccine WG 2605539 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2022-2023] 780085 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad Quadrivalent 2022-2023] VO:0019611 OHDSI Vaccine WG 2177396 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2019-2020] 1361079 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2019-2020] VO:0019612 OHDSI Vaccine WG 2379636 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2020-2021] 1146357 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2020-2021] VO:0019613 OHDSI Vaccine WG 2588639 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2021-2022] 1758621 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2021-2022] VO:0019614 OHDSI Vaccine WG 2605095 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2022-2023] 780072 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix Quadrivalent 2022-2023] VO:0019615 OHDSI Vaccine WG 2178084 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2019-2020] 1361148 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2019-2020] VO:0019616 OHDSI Vaccine WG 2380861 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2020-2021] 1146505 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2020-2021] VO:0019617 OHDSI Vaccine WG 2588635 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2021-2022] 1758617 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2021-2022] VO:0019618 OHDSI Vaccine WG 2605569 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2022-2023] 780109 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok Quadrivalent 2022-2023] VO:0019619 OHDSI Vaccine WG 2055029 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] 35200344 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] VO:0019620 OHDSI Vaccine WG 2180404 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] 1361320 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] VO:0019621 OHDSI Vaccine WG 2380850 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] 1146497 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] VO:0019622 OHDSI Vaccine WG 2588636 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] 1758618 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] VO:0019623 OHDSI Vaccine WG 2605734 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] 780129 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] VO:0019624 OHDSI Vaccine WG 1657845 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [FluLaval Quadrivalent 2015-2016] 46275065 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [FluLaval Quadrivalent 2015-2016] VO:0019625 OHDSI Vaccine WG 2177796 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2019-2020] 1361108 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2019-2020] VO:0019626 OHDSI Vaccine WG 2379734 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2020-2021] 1146364 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2020-2021] VO:0019627 OHDSI Vaccine WG 2588634 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2021-2022] 1758616 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2021-2022] VO:0019628 OHDSI Vaccine WG 2605050 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2022-2023] 780058 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval Quadrivalent 2022-2023] VO:0019629 OHDSI Vaccine WG 2177695 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2019-2020] 1361099 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2019-2020] VO:0019630 OHDSI Vaccine WG 1794443 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] 36249498 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019631 OHDSI Vaccine WG 2177493 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2019-2020] 1361085 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2019-2020] VO:0019632 OHDSI Vaccine WG 2280745 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498848 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019633 OHDSI Vaccine WG 2380583 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020-2021] 1146451 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2020-2021] VO:0019634 OHDSI Vaccine WG 2479032 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] 739841 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0019635 OHDSI Vaccine WG 2588633 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2021-2022] 1758615 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2021-2022] VO:0019636 OHDSI Vaccine WG 2593862 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] 1759217 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] VO:0019637 OHDSI Vaccine WG 2605105 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022-2023] 780080 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2022-2023] VO:0019638 OHDSI Vaccine WG 2630228 influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] 1301748 vaccine influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019639 OHDSI Vaccine WG 2280751 influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498853 vaccine influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019640 OHDSI Vaccine WG 2280753 influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 37498854 vaccine influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019641 OHDSI Vaccine WG 2280754 influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498855 vaccine influenza A virus (H3N2) antigen 0.03 MG/ML / influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019642 OHDSI Vaccine WG 1869637 influenza A virus (H5N1) antigen Injectable Suspension 1594217 vaccine influenza A virus (H5N1) antigen Injectable Suspension VO:0019643 OHDSI Vaccine WG 1801824 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray influenza virus vaccine, live attenuated, 2016-2017 Quadrivalent Nasal Spray 40220743 vaccine influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray VO:0019644 OHDSI Vaccine WG 1664475 influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray influenza virus vaccine 2015-2016 Quadrivalent Nasal Spray 46287746 vaccine influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray VO:0019645 OHDSI Vaccine WG 2179839 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Fluad 2019-2020] 1361278 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML [Fluad 2019-2020] VO:0019646 OHDSI Vaccine WG 2178782 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2019-2020] 1361220 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2019-2020] VO:0019647 OHDSI Vaccine WG 2177395 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2019-2020] 1361078 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2019-2020] VO:0019648 OHDSI Vaccine WG 2177791 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2019-2020] 1361104 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2019-2020] VO:0019649 OHDSI Vaccine WG 2177492 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2019-2020] 1361084 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2019-2020] VO:0019650 OHDSI Vaccine WG influenza virus vaccine 2019-2020 (quadrivalent - Brisbane/Kansas/Maryland/Phuket) Injectable Suspension 2177590 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2019-2020 (quadrivalent - Brisbane/Kansas/Maryland/Phuket) Injectable Suspension 1361092 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019651 OHDSI Vaccine WG 2177592 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2019-2020] Fluzone Quadrivalent 2019-2020 vaccine Injectable Suspension 1361094 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2019-2020] VO:0019652 OHDSI Vaccine WG 2177794 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2019-2020] 1361107 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Flulaval Quadrivalent 2019-2020] VO:0019653 OHDSI Vaccine WG 2178789 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2019-2020] Afluria Quadrivalent 2019-2020 vaccine Injectable Suspension 1361225 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2019-2020] VO:0019654 OHDSI Vaccine WG 2177501 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 1361090 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019655 OHDSI Vaccine WG 2177502 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2019-2020] 1361091 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2019-2020] VO:0019656 OHDSI Vaccine WG 2177400 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2019-2020] 1361082 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2019-2020] VO:0019657 OHDSI Vaccine WG 2177798 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2019-2020] 1361109 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2019-2020] VO:0019658 OHDSI Vaccine WG 2178786 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] 1361223 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2019-2020] VO:0019659 OHDSI Vaccine WG 2179841 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe 1361279 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019660 OHDSI Vaccine WG 2179842 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2019-2020] 1361280 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2019-2020] VO:0019661 OHDSI Vaccine WG 2280744 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498847 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019662 OHDSI Vaccine WG influenza virus vaccine 2020 (quadrivalent - Brisbane/South Australia/Phuket/Washington) Injectable Suspension, southern hemisphere 2281668 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension 37498876 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension VO:0019663 OHDSI Vaccine WG 2281669 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498877 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019664 OHDSI Vaccine WG 2280742 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 37498845 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0019665 OHDSI Vaccine WG 2280747 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] 37498850 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] VO:0019666 OHDSI Vaccine WG 2178092 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2019-2020] 1361153 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2019-2020] VO:0019667 OHDSI Vaccine WG 2178094 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe 1361154 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019668 OHDSI Vaccine WG 2178095 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2019-2020] 1361155 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2019-2020] VO:0019669 OHDSI Vaccine WG 2177694 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML [Fluzone 2019-2020] 1361098 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML [Fluzone 2019-2020] VO:0019670 OHDSI Vaccine WG 2177698 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe 1361101 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe VO:0019671 OHDSI Vaccine WG 2177699 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020] 1361102 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020] VO:0019672 OHDSI Vaccine WG 1595882 Bacillus anthracis 45892384 vaccine component Bacillus anthracis as vaccine component VO:0019673 OHDSI Vaccine WG 1801612 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe 40220722 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe VO:0019674 OHDSI Vaccine WG 1801613 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2016-2017] 40220723 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2016-2017] VO:0019675 OHDSI Vaccine WG 1657145 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe 46276054 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe VO:0019676 OHDSI Vaccine WG 1657146 influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2015-2016] 46276055 vaccine influenza A virus A/Brisbane/10/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax 2015-2016] VO:0019677 OHDSI Vaccine WG 1724013 influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe 35606417 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe VO:0019678 OHDSI Vaccine WG 1724014 influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe [FLUAD 2015-2016] FLUAD 2015-2016 Formula Influenza Virus Vaccine ML Prefilled Syringe 35606418 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.015 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.015 MG/ML / influenza B virus B/Brisbane/9/2014 antigen 0.015 MG/ML Prefilled Syringe [FLUAD 2015-2016] VO:0019679 OHDSI Vaccine WG 1608803 Bordetella pertussis 46221326 vaccine component Bordetella pertussis as vaccine component VO:0019680 OHDSI Vaccine WG 1794442 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2016 Southern Hemisphere] 36249497 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019681 OHDSI Vaccine WG 1794448 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension 36249566 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019682 OHDSI Vaccine WG 1794450 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2016 Southern Hemisphere] Fluzone Quadrivalent 2016 Southern Hemisphere Injectable Suspension 36249568 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019683 OHDSI Vaccine WG 1801190 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 36249517 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019684 OHDSI Vaccine WG 1801191 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2016-2017] 36249518 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2016-2017] VO:0019685 OHDSI Vaccine WG 1794446 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 36249564 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019686 OHDSI Vaccine WG 1794447 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] 36249565 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016 Southern Hemisphere] VO:0019687 OHDSI Vaccine WG 1799107 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2016-2017] 36249174 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2016-2017] VO:0019688 OHDSI Vaccine WG 1801175 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] 36249502 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] VO:0019689 OHDSI Vaccine WG 1858964 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2016-2017 Formula] 1718585 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2016-2017 Formula] VO:0019690 OHDSI Vaccine WG 1799411 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2016-2017 (trivalent - California/Hong Kong/Brisbane) Injectable Suspension 36249270 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension VO:0019691 OHDSI Vaccine WG 1799404 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe 36249265 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe VO:0019692 OHDSI Vaccine WG 1799405 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2016-2017] 36249266 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2016-2017] VO:0019693 OHDSI Vaccine WG 1801083 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2016-2017] 36249412 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2016-2017] VO:0019694 OHDSI Vaccine WG 1661810 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2015-2016 (trivalent - California/South Australia/Phuket) Injectable Suspension 46276313 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019695 OHDSI Vaccine WG 1661808 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46276266 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019696 OHDSI Vaccine WG 1661809 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2015-2016] 46276267 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2015-2016] VO:0019697 OHDSI Vaccine WG 1657334 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension 46276185 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019698 OHDSI Vaccine WG 1659749 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 46275657 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019699 OHDSI Vaccine WG 1659750 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2015-2016] 46275658 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2015-2016] VO:0019700 OHDSI Vaccine WG 1657847 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46275067 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019701 OHDSI Vaccine WG 1657848 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [FluLaval Quadrivalent 2015-2016] 46275068 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [FluLaval Quadrivalent 2015-2016] VO:0019702 OHDSI Vaccine WG 1659738 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] 46275648 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] VO:0019703 OHDSI Vaccine WG 1658701 influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2015-2016 (trivalent - California/Switzerland/Phuket) Injectable Suspension 46275381 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019704 OHDSI Vaccine WG 1801076 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe 36249405 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019705 OHDSI Vaccine WG 1801077 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] 36249406 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2016-2017] VO:0019706 OHDSI Vaccine WG 1803025 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection 40220833 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection VO:0019707 OHDSI Vaccine WG 1803026 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2016-2017] 40220834 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2016-2017] VO:0019708 OHDSI Vaccine WG 1661114 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe 46276046 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019709 OHDSI Vaccine WG 1661115 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] 46276047 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2015-2016] VO:0019710 OHDSI Vaccine WG 1660930 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection 46276019 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection VO:0019711 OHDSI Vaccine WG 1660931 influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection [Flublok 2015-2016] 46276020 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Injection [Flublok 2015-2016] VO:0019712 OHDSI Vaccine WG 1801184 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe 36249511 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe VO:0019713 OHDSI Vaccine WG 1801185 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2016-2017] 36249512 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2016-2017] VO:0019714 OHDSI Vaccine WG 1658715 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe 46275398 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe VO:0019715 OHDSI Vaccine WG 1658716 influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2015-2016] 46275399 vaccine influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2015-2016] VO:0019716 OHDSI Vaccine WG 2564018 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2021-2022] 701419 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2021-2022] VO:0019717 OHDSI Vaccine WG 2563005 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2021-2022] 1537476 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2021-2022] VO:0019718 OHDSI Vaccine WG afluria Quadrivalent 2021-2022 vaccine Injectable Suspension 2564038 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2021-2022] Afluria Quadrivalent 2021-2022 vaccine Injectable Suspension 701436 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2021-2022] VO:0019719 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) Injectable Suspension 2564040 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) Injectable Suspension 701438 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension VO:0019720 OHDSI Vaccine WG 1799115 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 36249176 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019721 OHDSI Vaccine WG 1799124 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2016-2017] 36249182 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2016-2017] VO:0019722 OHDSI Vaccine WG 1801152 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2016-2017 (trivalent - Christchurch/Hong Kong/Brisbane) Injectable Suspension 36249426 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension VO:0019723 OHDSI Vaccine WG 1801164 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe 36249435 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe VO:0019724 OHDSI Vaccine WG 1801166 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2016-2017] 36249436 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2016-2017] VO:0019725 OHDSI Vaccine WG 1657237 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46276175 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019726 OHDSI Vaccine WG 1657238 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2015-2016] 46276176 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2015-2016] VO:0019727 OHDSI Vaccine WG 1657325 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension 46276178 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019728 OHDSI Vaccine WG 1659984 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 46275889 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019729 OHDSI Vaccine WG 1659985 influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2015-2016] 46275890 vaccine influenza A virus A/Christchurch/16/2010 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2015-2016] VO:0019730 OHDSI Vaccine WG 2605732 influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2022-2023] 780127 vaccine influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2022-2023] VO:0019731 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension 2605737 influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Delaware/Singapore INFTT-16-0610/Singapore WUH4618) Injectable Suspension 780131 vaccine influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension VO:0019732 OHDSI Vaccine WG FLUCELVAX Quadrivalent 2022-2023 vaccine Injectable Suspension 2605739 influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2022-2023] 780133 vaccine influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2022-2023] VO:0019733 OHDSI Vaccine WG 2605554 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2022-2023] 780096 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2022-2023] VO:0019734 OHDSI Vaccine WG 2605537 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluad Quadrivalent 2022-2023] 780083 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluad Quadrivalent 2022-2023] VO:0019735 OHDSI Vaccine WG 2605093 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2022-2023] 780070 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluarix Quadrivalent 2022-2023] VO:0019736 OHDSI Vaccine WG influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension 2605559 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Injectable Suspension 780100 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019737 OHDSI Vaccine WG Afluria Quadrivalent 2022-2023 vaccine Injectable Suspension 2605561 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2022-2023] 780102 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2022-2023] VO:0019738 OHDSI Vaccine WG 2605567 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2022-2023] 780107 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML [Flublok Quadrivalent 2022-2023] VO:0019739 OHDSI Vaccine WG 2630659 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2023 Southern Hemisphere] 1301768 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019740 OHDSI Vaccine WG influenza virus vaccine 2023 (quadrivalent - Darwin/Sydney/Michigan/Phuket) Injectable Suspension, southern hemisphere 2630662 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension 1301770 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019741 OHDSI Vaccine WG Fluzone Quadrivalent 2023 Southern Hemisphere vaccine Injectable Suspension 2630664 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2023 Southern Hemisphere] Fluzone Quadrivalent 2023 Southern Hemisphere vaccine Injectable Suspension 1301772 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019742 OHDSI Vaccine WG 2630658 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1301767 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019743 OHDSI Vaccine WG 2630661 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] Fluzone Quadrivalent 2023 Southern Hemisphere vaccine Prefilled Syringe 1301769 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019744 OHDSI Vaccine WG 2605048 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2022-2023] 780056 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Flulaval Quadrivalent 2022-2023] VO:0019745 OHDSI Vaccine WG 2593860 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022 Southern Hemisphere] 1759215 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022 Southern Hemisphere] VO:0019746 OHDSI Vaccine WG 2605542 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022-2023] 780088 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Fluzone Quadrivalent 2022-2023] VO:0019747 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) Injectable Suspension 2593865 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injectable Suspension 1759219 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019748 OHDSI Vaccine WG 2593867 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2022 Southern Hemisphere] 1759221 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2022 Southern Hemisphere] VO:0019749 OHDSI Vaccine WG Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injectable Suspension 2605552 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2022-2023] 780094 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2022-2023] VO:0019750 OHDSI Vaccine WG 2605547 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Michigan/Phuket) Injection 780090 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019751 OHDSI Vaccine WG 2593864 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] 1759218 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022 Southern Hemisphere] VO:0019752 OHDSI Vaccine WG 2630226 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2023 Southern Hemisphere] 1301746 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019753 OHDSI Vaccine WG 2630224 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe 1301744 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe VO:0019754 OHDSI Vaccine WG 2630230 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] 1301749 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2023 Southern Hemisphere] VO:0019755 OHDSI Vaccine WG 2605103 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2022-2023] 780078 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2022-2023] VO:0019756 OHDSI Vaccine WG 2380845 influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2020-2021] 1146493 vaccine influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2020-2021] VO:0019757 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) Injectable Suspension 2380843 influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2020-2021 (quadrivalent - Delaware/Nebraska/Darwin/Singapore) Injectable Suspension 1146491 vaccine influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension VO:0019758 OHDSI Vaccine WG Flucelvax Quadrivalent 2020-2021 vaccine Injectable Suspension 2380848 influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2020-2021] 1146496 vaccine influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2020-2021] VO:0019759 OHDSI Vaccine WG 2379635 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2020-2021] 1146356 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2020-2021] VO:0019760 OHDSI Vaccine WG 2379733 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2020-2021] 1146363 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2020-2021] VO:0019761 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) Injectable Suspension 2380576 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2020-2021 (quadrivalent - Guangdong-Maonan/Hong Kong/Phuket/Washington) Injectable Suspension 1146445 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension VO:0019762 OHDSI Vaccine WG 2380578 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020-2021] 1146447 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2020-2021] VO:0019763 OHDSI Vaccine WG Fluzone Quadrivalent 2020-2021 vaccine Injectable Suspension 2380581 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2020-2021] 1146450 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2020-2021] VO:0019764 OHDSI Vaccine WG 2383547 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2020-2021] 1146608 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2020-2021] VO:0019765 OHDSI Vaccine WG FluMist Quadrivalent, 2020-2021 Formula Nasal Spray 2389313 influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray [Flumist Quadrivalent 2020-2021] 37002461 vaccine influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray [Flumist Quadrivalent 2020-2021] VO:0019766 OHDSI Vaccine WG influenza virus vaccine, 2020-2021 Quadrivalent Nasal Spray 2389317 influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray influenza virus vaccine, 2020-2021 Quadrivalent Nasal Spray 37002465 vaccine influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray VO:0019767 OHDSI Vaccine WG 2389318 influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [Flumist Quadrivalent 2020-2021] 37002466 vaccine influenza A virus A/Hawaii/66/2019 (H1N1) antigen 158000000 UNT/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [Flumist Quadrivalent 2020-2021] VO:0019768 OHDSI Vaccine WG 2380860 influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2020-2021] 1146504 vaccine influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2020-2021] VO:0019769 OHDSI Vaccine WG 2380597 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2020-2021] 1146459 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2020-2021] VO:0019770 OHDSI Vaccine WG 2382436 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2020-2021] 1146554 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2020-2021] VO:0019771 OHDSI Vaccine WG influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) Injectable Suspension 2380605 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2020-2021 (quadrivalent - Hong Kong/Victoria/Phuket/Victoria) Injectable Suspension 1146464 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension VO:0019772 OHDSI Vaccine WG Afluria Quadrivalent 2020-2021 vaccine Injectable Suspension 2380607 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2020-2021] 1146467 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Injectable Suspension [Afluria Quadrivalent 2020-2021] VO:0019773 OHDSI Vaccine WG 2381147 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad 2020-2021] 1146531 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad 2020-2021] VO:0019774 OHDSI Vaccine WG 2381151 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe 1146534 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0019775 OHDSI Vaccine WG 2381152 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2020-2021] 1146535 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2020-2021] VO:0019776 OHDSI Vaccine WG 2479036 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021 Southern Hemisphere] 739844 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0019777 OHDSI Vaccine WG Fluzone Quadrivalent 2021 Southern Hemisphere vaccine Injectable Suspension 2479030 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere] 739839 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0019778 OHDSI Vaccine WG influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) Injectable Suspension 2479043 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2021 (quadrivalent - Hong Kong/Victoria/Phuket/Washington) Injectable Suspension 739849 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension VO:0019779 OHDSI Vaccine WG 1928354 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2017-2018 (quadrivalent - Hong Kong/Michigan/Brisbane/Phuket) Injectable Suspension 1593515 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019780 OHDSI Vaccine WG 1928318 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 1593335 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019781 OHDSI Vaccine WG 1928319 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2017-2018] 1593336 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2017-2018] VO:0019782 OHDSI Vaccine WG 1928333 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1593346 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019783 OHDSI Vaccine WG 1928334 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] 1593347 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] VO:0019784 OHDSI Vaccine WG 1942171 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) Injectable Suspension 793970 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019785 OHDSI Vaccine WG 1942167 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 793968 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019786 OHDSI Vaccine WG 1942168 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2017-2018] 793969 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2017-2018] VO:0019787 OHDSI Vaccine WG 1942153 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong/Singapore/Brisbane) Injectable Suspension 793959 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Injectable Suspension VO:0019788 OHDSI Vaccine WG 1942133 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe 793957 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe VO:0019789 OHDSI Vaccine WG 1942134 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2017-2018] 793958 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2017-2018] VO:0019790 OHDSI Vaccine WG 1928324 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension 1593337 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019791 OHDSI Vaccine WG 1928308 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1593191 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019792 OHDSI Vaccine WG 1928309 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2017-2018] 1593192 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2017-2018] VO:0019793 OHDSI Vaccine WG 1928337 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2017-2018] 1593350 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2017-2018] VO:0019794 OHDSI Vaccine WG 1928969 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2017-2018 (trivalent generic for Fluvirin - Hong Kong/Singapore/Brisbane) Injectable Suspension 1593904 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Injectable Suspension VO:0019795 OHDSI Vaccine WG 1928966 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe 1593902 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe VO:0019796 OHDSI Vaccine WG 1928967 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2017-2018] 1593903 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2017-2018] VO:0019797 OHDSI Vaccine WG 1928983 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2017-2018] 1593912 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe [Fluvirin 2017-2018] VO:0019798 OHDSI Vaccine WG 1928363 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe 1593523 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019799 OHDSI Vaccine WG 1928364 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2017-2018] 1593524 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2017-2018] VO:0019800 OHDSI Vaccine WG 1928471 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] 1593536 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2017-2018] VO:0019801 OHDSI Vaccine WG 1928478 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection 1593538 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection VO:0019802 OHDSI Vaccine WG 1928881 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2017-2018] 1593877 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.09 MG/ML Injection [Flublok 2017-2018] VO:0019803 OHDSI Vaccine WG 1928345 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe 1593358 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe VO:0019804 OHDSI Vaccine WG 1928346 influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2017-2018] 1593359 vaccine influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2017-2018] VO:0019805 OHDSI Vaccine WG 2180403 influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2019-2020] 1361319 vaccine influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2019-2020] VO:0019806 OHDSI Vaccine WG 2180409 influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension 1361324 vaccine influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension VO:0019807 OHDSI Vaccine WG 2180411 influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2019-2020] 1361326 vaccine influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2019-2020] VO:0019808 OHDSI Vaccine WG 2180407 influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe 1361322 vaccine influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019809 OHDSI Vaccine WG 2180408 influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] 1361323 vaccine influenza A virus A/Idaho/07/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Indiana/08/2018 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2019-2020] VO:0019810 OHDSI Vaccine WG 1869640 influenza A virus A/Indonesia/05/2005 (H5N1) antigen 0.0075 MG/ML Injectable Suspension influenza A (H5N1) virus vaccine (monovalent - Indonesia/05/2005) Injectable Suspension 1594219 vaccine influenza A virus A/Indonesia/05/2005 (H5N1) antigen 0.0075 MG/ML Injectable Suspension VO:0019811 OHDSI Vaccine WG 2198900 influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray 37496500 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray VO:0019812 OHDSI Vaccine WG 2198902 influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [FluMist Quadrivalent 2019-2020] 37496502 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [FluMist Quadrivalent 2019-2020] VO:0019813 OHDSI Vaccine WG 2198906 influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2019-2020] FluMist Quadrivalent, 2019-2020 Formula Nasal Spray 37496506 vaccine influenza A virus A/Kansas/14/2017 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2019-2020] VO:0019814 OHDSI Vaccine WG 2050778 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 35200059 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019815 OHDSI Vaccine WG 2050779 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2018-2019] 35200060 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2018-2019] VO:0019816 OHDSI Vaccine WG 2050783 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection 35200062 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection VO:0019817 OHDSI Vaccine WG 2050784 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2018-2019] 35200063 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2018-2019] VO:0019818 OHDSI Vaccine WG 2050785 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension 35200065 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019819 OHDSI Vaccine WG 2050383 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe 35200027 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe VO:0019820 OHDSI Vaccine WG 2050384 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2018-2019] 35200028 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2018-2019] VO:0019821 OHDSI Vaccine WG 2050424 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe 35200036 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe VO:0019822 OHDSI Vaccine WG 2050425 influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019] 35200038 vaccine influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019] VO:0019823 OHDSI Vaccine WG 1946984 influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray influenza virus vaccine, live attenuated, 2017-2018 Quadrivalent Nasal Spray 792420 vaccine influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray VO:0019824 OHDSI Vaccine WG 2055032 influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] 35200346 vaccine influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2018-2019] VO:0019825 OHDSI Vaccine WG 2055034 influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2018-2019] Flucelvax Quadrivalent 2018-2019 vaccine Injectable Suspension 35200348 vaccine influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2018-2019] VO:0019826 OHDSI Vaccine WG 2056529 influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2018-2019] 35200571 vaccine influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2018-2019] VO:0019827 OHDSI Vaccine WG 2056531 influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe 35200572 vaccine influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019828 OHDSI Vaccine WG 2056533 influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2018-2019 (quadrivalent - Singapore/North Carolina/Iowa/Singapore) Injectable Suspension 35200574 vaccine influenza A virus A/North Carolina/04/2016 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Iowa/06/2017 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension VO:0019829 OHDSI Vaccine WG influenza virus vaccine 2022-2023 Quadrivalent Nasal Spray 2607744 influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray influenza virus vaccine 2022-2023 Quadrivalent Nasal Spray 1525411 vaccine influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray VO:0019830 OHDSI Vaccine WG 2607746 influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [FluMist Quadrivalent 2022-2023] 1525413 vaccine influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [FluMist Quadrivalent 2022-2023] VO:0019831 OHDSI Vaccine WG FluMist Quadrivalent, 2022-2023 Formula Nasal Spray 2607750 influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2022-2023] 1525417 vaccine influenza A virus A/Norway/16606/2021 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Austria/1359417/2021 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2022-2023] VO:0019832 OHDSI Vaccine WG 1928532 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2017-2018 (quadrivalent - Singapore/Singapore/Hong Kong/Utah) Injectable Suspension 1593542 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Injectable Suspension VO:0019833 OHDSI Vaccine WG 1928541 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe 1593690 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe VO:0019834 OHDSI Vaccine WG 1928542 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2017-2018] 1593691 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP2050/2015 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Hong Kong/259/2010 antigen 0.03 MG/ML / influenza B virus B/Utah/9/2014 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2017-2018] VO:0019835 OHDSI Vaccine WG 2050801 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML [Afluria 2018-2019] 35200076 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML [Afluria 2018-2019] VO:0019836 OHDSI Vaccine WG 2050804 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML Prefilled Syringe 35200078 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML Prefilled Syringe VO:0019837 OHDSI Vaccine WG 2050805 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] 35200079 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] VO:0019838 OHDSI Vaccine WG 2048967 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1559894 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0019839 OHDSI Vaccine WG 2048968 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2018-2019] 1559895 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2018-2019] VO:0019840 OHDSI Vaccine WG 2048969 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2018-2019 (quadrivalent - Singapore/Singapore/Maryland/Phuket) Injectable Suspension 1559896 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension VO:0019841 OHDSI Vaccine WG 2048977 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2018-2019] 1559903 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2018-2019] VO:0019842 OHDSI Vaccine WG 2050798 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2018-2019] 35200074 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2018-2019] VO:0019843 OHDSI Vaccine WG 2050766 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2018-2019 (trivalent - Singapore/Singapore/Maryland) Injectable Suspension 35200049 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Injectable Suspension VO:0019844 OHDSI Vaccine WG 2050764 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe 35200047 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0019845 OHDSI Vaccine WG 2050944 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] 35200084 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2018-2019] VO:0019846 OHDSI Vaccine WG 2050765 influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2018-2019] 35200048 vaccine influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML Prefilled Syringe [Fluad 2018-2019] VO:0019847 OHDSI Vaccine WG 2054272 influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray influenza virus vaccine, live attenuated, 2018-2019 Quadrivalent Nasal Spray 35200283 vaccine influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Colorado/06/2017 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML Nasal Spray VO:0019848 OHDSI Vaccine WG 2561264 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2021-2022] 1537376 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2021-2022] VO:0019849 OHDSI Vaccine WG 2561280 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2021-2022] 1537388 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2021-2022] VO:0019850 OHDSI Vaccine WG 2563000 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021-2022] 1537473 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021-2022] VO:0019851 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension 2563009 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension 1537479 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension VO:0019852 OHDSI Vaccine WG Fluzone Quadrivalent 2021-2022 vaccine Injectable Suspension 2563031 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2021-2022] 1537499 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2021-2022] VO:0019853 OHDSI Vaccine WG influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 ML Injectable Suspension 2562997 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension 1537471 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension VO:0019854 OHDSI Vaccine WG Flucelvax Quadrivalent 2021-2022 vaccine Injectable Suspension 2563020 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2021-2022] 1537489 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Injectable Suspension [Flucelvax Quadrivalent 2021-2022] VO:0019855 OHDSI Vaccine WG 2563022 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2021-2022] 1537491 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2021-2022] VO:0019856 OHDSI Vaccine WG 2563046 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2021-2022] 1537511 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2021-2022] VO:0019857 OHDSI Vaccine WG 2563044 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2021-2022] 1537509 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2021-2022] VO:0019858 OHDSI Vaccine WG 2564400 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray 701453 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray VO:0019859 OHDSI Vaccine WG 2564402 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [FluMist Quadrivalent 2021-2022] 701455 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [FluMist Quadrivalent 2021-2022] VO:0019860 OHDSI Vaccine WG Flumist Quadrivalent, 2021-2022 Formula Nasal Spray 2564406 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2021-2022] 701459 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray [FluMist Quadrivalent 2021-2022] VO:0019861 OHDSI Vaccine WG 1541620 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe 45776078 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe VO:0019862 OHDSI Vaccine WG 1541625 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix Quad 2014-2015 Formula] 45776082 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix Quad 2014-2015 Formula] VO:0019863 OHDSI Vaccine WG 1541624 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix Quad 2014-2015 Formula] 45776081 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix Quad 2014-2015 Formula] VO:0019864 OHDSI Vaccine WG 1541628 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 45776084 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019865 OHDSI Vaccine WG 1541629 influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] 45776085 vaccine influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix Quad 2014-2015 Formula] VO:0019866 OHDSI Vaccine WG 1544622 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML 45774410 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML VO:0019867 OHDSI Vaccine WG 1544631 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension 45774419 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension VO:0019868 OHDSI Vaccine WG 1544632 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval Quad 2014-2015 Formula] 45774420 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval Quad 2014-2015 Formula] VO:0019869 OHDSI Vaccine WG 1544633 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2014-2015 Formula] Flulaval Quad 2014-2015 Formula Influenza Virus Injectable Suspension 45774421 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2014-2015 Formula] VO:0019870 OHDSI Vaccine WG 1546096 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 45775138 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019871 OHDSI Vaccine WG 1546097 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] 45775139 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval Quad 2014-2015 Formula] VO:0019872 OHDSI Vaccine WG 1544624 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval 2014-2015 Formula] 45774412 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval 2014-2015 Formula] VO:0019873 OHDSI Vaccine WG 1544623 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension 45774411 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension VO:0019874 OHDSI Vaccine WG 1544625 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2014-2015 Formula] Flulaval 2014-2015 Formula Influenza Virus Vaccine Injectable Suspension 45774413 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2014-2015 Formula] VO:0019875 OHDSI Vaccine WG 1544629 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 45774417 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019876 OHDSI Vaccine WG 1544630 influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] 45774418 vaccine influenza A virus vaccine, A-Texas-50-2012 X-223A (H3N2), inactivated 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flulaval 2014-2015 Formula] VO:0019877 OHDSI Vaccine WG 1427025 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension 43531924 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension VO:0019878 OHDSI Vaccine WG 1427030 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone Quadrivalent 2013-2014 Formula] 43531925 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone Quadrivalent 2013-2014 Formula] VO:0019879 OHDSI Vaccine WG 1483332 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval Quad 2013-2014 Formula] 44784848 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval Quad 2013-2014 Formula] VO:0019880 OHDSI Vaccine WG 1537512 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval Quad 2014-2015 Formula] 44818103 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval Quad 2014-2015 Formula] VO:0019881 OHDSI Vaccine WG 1537563 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone Quadrivalent 2014-2015 Formula] 44818127 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone Quadrivalent 2014-2015 Formula] VO:0019882 OHDSI Vaccine WG 1543764 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Spray 45776789 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Spray VO:0019883 OHDSI Vaccine WG 1543769 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Spray [Flumist 2014-2015 Formula] 45776793 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Nasal Spray [Flumist 2014-2015 Formula] VO:0019884 OHDSI Vaccine WG 1427036 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe 43531926 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe VO:0019885 OHDSI Vaccine WG 1546094 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flulaval Quad 2014-2015 Formula] 45775136 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flulaval Quad 2014-2015 Formula] VO:0019886 OHDSI Vaccine WG 1442204 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution 44507842 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution VO:0019887 OHDSI Vaccine WG 1442208 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution [Flublok 2013-2014 Formula] 44507843 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution [Flublok 2013-2014 Formula] VO:0019888 OHDSI Vaccine WG 1537519 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution [Flublok 2014-2015 Formula] 44818106 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Solution [Flublok 2014-2015 Formula] VO:0019889 OHDSI Vaccine WG 1429569 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension 43532648 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension VO:0019890 OHDSI Vaccine WG 1431802 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Afluria 2013-2014 Formula] 43532775 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Afluria 2013-2014 Formula] VO:0019891 OHDSI Vaccine WG 1537493 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Afluria 2014-2015 Formula] 44818097 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Afluria 2014-2015 Formula] VO:0019892 OHDSI Vaccine WG 1429573 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval 2013-2014 Formula] 43532651 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval 2013-2014 Formula] VO:0019893 OHDSI Vaccine WG 1537502 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval 2014-2015 Formula] 44818100 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Flulaval 2014-2015 Formula] VO:0019894 OHDSI Vaccine WG 1433739 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluvirin 2013-2014 Formula] 43560213 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluvirin 2013-2014 Formula] VO:0019895 OHDSI Vaccine WG 1537530 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluvirin 2014-2015 Formula] 44818112 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluvirin 2014-2015 Formula] VO:0019896 OHDSI Vaccine WG 1429600 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone 2013-2014 Formula] 43532662 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone 2013-2014 Formula] VO:0019897 OHDSI Vaccine WG 1537538 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone 2014-2015 Formula] 44818116 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Injectable Suspension [Fluzone 2014-2015 Formula] VO:0019898 OHDSI Vaccine WG 1428986 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe 43532607 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe VO:0019899 OHDSI Vaccine WG 1431430 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Afluria 2013-2014 Formula] 43532766 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Afluria 2013-2014 Formula] VO:0019900 OHDSI Vaccine WG 1537483 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Afluria 2014-2015 Formula] 44818094 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Afluria 2014-2015 Formula] VO:0019901 OHDSI Vaccine WG 1428991 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix 2013-2014 Formula] 43532610 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix 2013-2014 Formula] VO:0019902 OHDSI Vaccine WG 1543405 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix 2014-2015 Formula] 45776652 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluarix 2014-2015 Formula] VO:0019903 OHDSI Vaccine WG 1433774 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flucelvax 2013-2014 Formula] 43560214 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flucelvax 2013-2014 Formula] VO:0019904 OHDSI Vaccine WG 1537524 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flucelvax 2014-2015 Formula] 44818109 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flucelvax 2014-2015 Formula] VO:0019905 OHDSI Vaccine WG 1544627 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flulaval 2014-2015 Formula] 45774415 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Flulaval 2014-2015 Formula] VO:0019906 OHDSI Vaccine WG 1433757 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluvirin 2013-2014 Formula] 43560215 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluvirin 2013-2014 Formula] VO:0019907 OHDSI Vaccine WG 1537533 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluvirin 2014-2015 Formula] 44818113 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluvirin 2014-2015 Formula] VO:0019908 OHDSI Vaccine WG 1429604 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone 2013-2014 Formula] 43532663 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone 2013-2014 Formula] VO:0019909 OHDSI Vaccine WG 1537553 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone 2014-2015 Formula] 44818123 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone 2014-2015 Formula] VO:0019910 OHDSI Vaccine WG 1429593 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone High-Dose 2013-2014 Formula] 43532659 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone High-Dose 2013-2014 Formula] VO:0019911 OHDSI Vaccine WG 1537543 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula] 44818119 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula] VO:0019912 OHDSI Vaccine WG 1429580 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone Intradermal 2013-2014 Formula] 43532655 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone Intradermal 2013-2014 Formula] VO:0019913 OHDSI Vaccine WG 1537549 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula] 44818122 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Massachusetts-2-2012-like virus Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula] VO:0019914 OHDSI Vaccine WG 1366999 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Solution 43012763 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Solution VO:0019915 OHDSI Vaccine WG 1367003 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Solution [Flublok 2012-2013 Formula] 43012764 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Solution [Flublok 2012-2013 Formula] VO:0019916 OHDSI Vaccine WG 1304181 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension 42873919 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension VO:0019917 OHDSI Vaccine WG 1304360 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Afluria 2012-2013 Formula] 42873920 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Afluria 2012-2013 Formula] VO:0019918 OHDSI Vaccine WG 1304185 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Flulaval 2012-2013 Formula] 42873921 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Flulaval 2012-2013 Formula] VO:0019919 OHDSI Vaccine WG 1304208 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Fluvirin 2012-2013 Formula] 42873922 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Fluvirin 2012-2013 Formula] VO:0019920 OHDSI Vaccine WG 1304281 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Fluzone 2012-2013 Formula] 42873923 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Injectable Suspension [Fluzone 2012-2013 Formula] VO:0019921 OHDSI Vaccine WG 1304260 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Nasal Spray 42873924 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Nasal Spray VO:0019922 OHDSI Vaccine WG 1304264 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Nasal Spray [Flumist 2012-2013 Formula] 42873925 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Nasal Spray [Flumist 2012-2013 Formula] VO:0019923 OHDSI Vaccine WG 1304126 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe 42873926 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe VO:0019924 OHDSI Vaccine WG 1304130 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Afluria 2012-2013 Formula] 42873927 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Afluria 2012-2013 Formula] VO:0019925 OHDSI Vaccine WG 1304367 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Agriflu 2012-2013 Formula] 42873928 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Agriflu 2012-2013 Formula] VO:0019926 OHDSI Vaccine WG 1304194 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluarix 2012-2013 Formula] 42873929 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluarix 2012-2013 Formula] VO:0019927 OHDSI Vaccine WG 1361801 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Flucelvax 2012-2013 Formula] 43011540 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Flucelvax 2012-2013 Formula] VO:0019928 OHDSI Vaccine WG 1304211 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluvirin 2012-2013 Formula] 42873930 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluvirin 2012-2013 Formula] VO:0019929 OHDSI Vaccine WG 1304290 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluzone 2012-2013 Formula] 42873931 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluzone 2012-2013 Formula] VO:0019930 OHDSI Vaccine WG 1304305 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluzone High-Dose 2012-2013 Formula] 42873932 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluzone High-Dose 2012-2013 Formula] VO:0019931 OHDSI Vaccine WG 1304314 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluzone Intradermal 2012-2013 Formula] 42873933 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine, B-Wisconsin-1-2010-like virus Prefilled Syringe [Fluzone Intradermal 2012-2013 Formula] VO:0019932 OHDSI Vaccine WG 1427027 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension 43531929 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension VO:0019933 OHDSI Vaccine WG 1427032 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2013-2014 Formula] Fluzone Quadrivalent 2013-2014 Formula Influenza Virus Vaccine Injectable Suspension 43531930 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2013-2014 Formula] VO:0019934 OHDSI Vaccine WG 1427040 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 43531931 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019935 OHDSI Vaccine WG 1427041 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula] 43531932 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2013-2014 Formula] VO:0019936 OHDSI Vaccine WG 1483331 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval Quad 2013-2014 Formula] 44784849 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval Quad 2013-2014 Formula] VO:0019937 OHDSI Vaccine WG 1483334 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2013-2014 Formula] Flulaval Quad 2013-2014 Formula Influenza Virus Injectable Suspension 44784850 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval Quad 2013-2014 Formula] VO:0019938 OHDSI Vaccine WG 1537558 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone Quadrivalent 2014-2015 Formula] 44818125 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone Quadrivalent 2014-2015 Formula] VO:0019939 OHDSI Vaccine WG 1537562 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] 44818431 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] VO:0019940 OHDSI Vaccine WG 1537564 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2014-2015 Formula] 44818432 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2014-2015 Formula] VO:0019941 OHDSI Vaccine WG 1431429 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Afluria 2013-2014 Formula] 43532765 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Afluria 2013-2014 Formula] VO:0019942 OHDSI Vaccine WG 1537482 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Afluria 2014-2015 Formula] 44818093 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Afluria 2014-2015 Formula] VO:0019943 OHDSI Vaccine WG 1428990 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix 2013-2014 Formula] 43532609 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix 2013-2014 Formula] VO:0019944 OHDSI Vaccine WG 1543404 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix 2014-2015 Formula] 45776651 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluarix 2014-2015 Formula] VO:0019945 OHDSI Vaccine WG 1433773 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flucelvax 2013-2014 Formula] 43560219 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flucelvax 2013-2014 Formula] VO:0019946 OHDSI Vaccine WG 1537523 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flucelvax 2014-2015 Formula] 44818108 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flucelvax 2014-2015 Formula] VO:0019947 OHDSI Vaccine WG 1429572 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval 2013-2014 Formula] 43532650 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Flulaval 2013-2014 Formula] VO:0019948 OHDSI Vaccine WG 1433738 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluvirin 2013-2014 Formula] 43560220 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluvirin 2013-2014 Formula] VO:0019949 OHDSI Vaccine WG 1537529 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluvirin 2014-2015 Formula] 44818111 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluvirin 2014-2015 Formula] VO:0019950 OHDSI Vaccine WG 1429599 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone 2013-2014 Formula] 43532661 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone 2013-2014 Formula] VO:0019951 OHDSI Vaccine WG 1537537 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone 2014-2015 Formula] 44818115 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML [Fluzone 2014-2015 Formula] VO:0019952 OHDSI Vaccine WG 1429570 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension influenza virus vaccine 2013-2014 trivalent Injectable Suspension 43532864 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension VO:0019953 OHDSI Vaccine WG 1431803 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Afluria 2013-2014 Formula] 43532964 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Afluria 2013-2014 Formula] VO:0019954 OHDSI Vaccine WG 1537494 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Afluria 2014-2015 Formula] 44818413 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Afluria 2014-2015 Formula] VO:0019955 OHDSI Vaccine WG 1429575 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2013-2014 Formula] 43532865 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2013-2014 Formula] VO:0019956 OHDSI Vaccine WG 1433741 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2013-2014 Formula] 43560216 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2013-2014 Formula] VO:0019957 OHDSI Vaccine WG 1537532 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2014-2015 Formula] 44818419 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2014-2015 Formula] VO:0019958 OHDSI Vaccine WG 1429602 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2013-2014 Formula] 43532874 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2013-2014 Formula] VO:0019959 OHDSI Vaccine WG 1537540 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2014-2015 Formula] 44818422 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2014-2015 Formula] VO:0019960 OHDSI Vaccine WG 1428994 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe 43532842 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe VO:0019961 OHDSI Vaccine WG 1431433 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2013-2014 Formula] 43532958 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2013-2014 Formula] VO:0019962 OHDSI Vaccine WG 1537486 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2014-2015 Formula] 44818412 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2014-2015 Formula] VO:0019963 OHDSI Vaccine WG 1428995 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2013-2014 Formula] 43532843 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2013-2014 Formula] VO:0019964 OHDSI Vaccine WG 1543408 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] 45776654 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2014-2015 Formula] VO:0019965 OHDSI Vaccine WG 1433777 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2013-2014 Formula] 43560217 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2013-2014 Formula] VO:0019966 OHDSI Vaccine WG 1537527 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2014-2015 Formula] 44818418 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2014-2015 Formula] VO:0019967 OHDSI Vaccine WG 1433759 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2013-2014 Formula] 43560218 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2013-2014 Formula] VO:0019968 OHDSI Vaccine WG 1537535 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2014-2015 Formula] 44818421 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2014-2015 Formula] VO:0019969 OHDSI Vaccine WG 1429606 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2013-2014 Formula] 43532877 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2013-2014 Formula] VO:0019970 OHDSI Vaccine WG 1537555 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula] 44818428 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2014-2015 Formula] VO:0019971 OHDSI Vaccine WG 1304129 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Afluria 2012-2013 Formula] 42873942 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Afluria 2012-2013 Formula] VO:0019972 OHDSI Vaccine WG 1304366 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Agriflu 2012-2013 Formula] 42873943 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Agriflu 2012-2013 Formula] VO:0019973 OHDSI Vaccine WG 1304193 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Fluarix 2012-2013 Formula] 42873944 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Fluarix 2012-2013 Formula] VO:0019974 OHDSI Vaccine WG 1361800 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Flucelvax 2012-2013 Formula] 43011539 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Flucelvax 2012-2013 Formula] VO:0019975 OHDSI Vaccine WG 1304184 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Flulaval 2012-2013 Formula] 42873945 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Flulaval 2012-2013 Formula] VO:0019976 OHDSI Vaccine WG 1304207 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Fluvirin 2012-2013 Formula] 42873946 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Fluvirin 2012-2013 Formula] VO:0019977 OHDSI Vaccine WG 1304280 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Fluzone 2012-2013 Formula] 42873947 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML [Fluzone 2012-2013 Formula] VO:0019978 OHDSI Vaccine WG 1304182 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension 42873937 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension VO:0019979 OHDSI Vaccine WG 1304361 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Afluria 2012-2013 Formula] 42873938 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Afluria 2012-2013 Formula] VO:0019980 OHDSI Vaccine WG 1304187 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2012-2013 Formula] 42873939 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Flulaval 2012-2013 Formula] VO:0019981 OHDSI Vaccine WG 1304210 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2012-2013 Formula] 42873940 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Fluvirin 2012-2013 Formula] VO:0019982 OHDSI Vaccine WG 1304283 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2012-2013 Formula] 42873941 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Injectable Suspension [Fluzone 2012-2013 Formula] VO:0019983 OHDSI Vaccine WG 1360225 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe 42903112 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe VO:0019984 OHDSI Vaccine WG 1359550 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2012-2013 Formula] 42902437 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Afluria 2012-2013 Formula] VO:0019985 OHDSI Vaccine WG 1364147 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Agriflu 2012-2013 Formula] 43012150 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Agriflu 2012-2013 Formula] VO:0019986 OHDSI Vaccine WG 1360243 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2012-2013 Formula] 42903130 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluarix 2012-2013 Formula] VO:0019987 OHDSI Vaccine WG 1361804 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] 43011867 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Flucelvax 2012-2013 Formula] VO:0019988 OHDSI Vaccine WG 1359760 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2012-2013 Formula] 42902647 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluvirin 2012-2013 Formula] VO:0019989 OHDSI Vaccine WG 1359912 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2012-2013 Formula] 42902799 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML Prefilled Syringe [Fluzone 2012-2013 Formula] VO:0019990 OHDSI Vaccine WG 1598362 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe 45892709 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe VO:0019991 OHDSI Vaccine WG 1598363 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] 45892710 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2014-2015 Formula] VO:0019992 OHDSI Vaccine WG 1429579 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Fluzone Intradermal 2013-2014 Formula] 43532654 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Fluzone Intradermal 2013-2014 Formula] VO:0019993 OHDSI Vaccine WG 1537548 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Fluzone Intradermal 2014-2015 Formula] 44818121 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML [Fluzone Intradermal 2014-2015 Formula] VO:0019994 OHDSI Vaccine WG 1442205 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution influenza virus vaccine 2014-2015 trivalent recombinant Injectable Solution 44507887 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Injectable Solution VO:0019995 OHDSI Vaccine WG 1429583 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe 43532868 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe VO:0019996 OHDSI Vaccine WG 1429584 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2013-2014 Formula] 43532869 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2013-2014 Formula] VO:0019997 OHDSI Vaccine WG 1537552 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula] 44818426 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2014-2015 Formula] VO:0019998 OHDSI Vaccine WG 1304313 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML [Fluzone Intradermal 2012-2013 Formula] 42873949 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML [Fluzone Intradermal 2012-2013 Formula] VO:0019999 OHDSI Vaccine WG 1367000 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Injectable Solution 43012767 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Injectable Solution VO:0020000 OHDSI Vaccine WG 1360099 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe 42902986 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe VO:0020001 OHDSI Vaccine WG 1359656 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2012-2013 Formula] 42902543 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.09 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.09 MG/ML Prefilled Syringe [Fluzone Intradermal 2012-2013 Formula] VO:0020002 OHDSI Vaccine WG 1429592 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML [Fluzone High-Dose 2013-2014 Formula] 43532658 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML [Fluzone High-Dose 2013-2014 Formula] VO:0020003 OHDSI Vaccine WG 1537542 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML [Fluzone High-Dose 2014-2015 Formula] 44818118 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML [Fluzone High-Dose 2014-2015 Formula] VO:0020004 OHDSI Vaccine WG 1429596 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe 43532872 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe VO:0020005 OHDSI Vaccine WG 1429597 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2013-2014 Formula] 43532873 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2013-2014 Formula] VO:0020006 OHDSI Vaccine WG 1537546 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula] 44818424 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2014-2015 Formula] VO:0020007 OHDSI Vaccine WG 1304304 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML [Fluzone High-Dose 2012-2013 Formula] 42873951 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML [Fluzone High-Dose 2012-2013 Formula] VO:0020008 OHDSI Vaccine WG 1359687 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe 42902574 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe VO:0020009 OHDSI Vaccine WG 1359686 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2012-2013 Formula] 42902573 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.12 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML Prefilled Syringe [Fluzone High-Dose 2012-2013 Formula] VO:0020010 OHDSI Vaccine WG 1304256 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML 42873960 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML VO:0020011 OHDSI Vaccine WG 1304263 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML [Flumist 2012-2013 Formula] 42873955 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML [Flumist 2012-2013 Formula] VO:0020012 OHDSI Vaccine WG 1304261 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML Nasal Spray 42873953 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML Nasal Spray VO:0020013 OHDSI Vaccine WG 1304267 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML Nasal Spray [Flumist 2012-2013 Formula] 42873954 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 158000000 UNT/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML Nasal Spray [Flumist 2012-2013 Formula] VO:0020014 OHDSI Vaccine WG 1543759 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML 45776786 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML VO:0020015 OHDSI Vaccine WG 1543766 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML Nasal Spray influenza virus vaccine 2014-2015 quadrivalent Nasal Spray 45776790 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML Nasal Spray VO:0020016 OHDSI Vaccine WG 1543768 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML [Flumist 2014-2015 Formula] 45776792 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML [Flumist 2014-2015 Formula] VO:0020017 OHDSI Vaccine WG 1543772 influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML Nasal Spray [Flumist 2014-2015 Formula] 45776794 vaccine influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 50000000 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 50000000 MG/ML Nasal Spray [Flumist 2014-2015 Formula] VO:0020018 OHDSI Vaccine WG 864701 influenza A-California-7-2009-(H1N1)v-like virus vaccine 40166605 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine VO:0020019 OHDSI Vaccine WG 1116749 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension 40240925 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension VO:0020020 OHDSI Vaccine WG 1006314 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Afluria 2010-2011 Formula] 40225015 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Afluria 2010-2011 Formula] VO:0020021 OHDSI Vaccine WG 1116727 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Afluria 2011-2012 Formula] 40240914 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Afluria 2011-2012 Formula] VO:0020022 OHDSI Vaccine WG 1006140 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [FluLaval 2010-2011 Formula] 40225000 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [FluLaval 2010-2011 Formula] VO:0020023 OHDSI Vaccine WG 1114607 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Flulaval 2011-2012 Formula] 40240913 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Flulaval 2011-2012 Formula] VO:0020024 OHDSI Vaccine WG 1006285 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluvirin 2010-2011 Formula] 40225014 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluvirin 2010-2011 Formula] VO:0020025 OHDSI Vaccine WG 1116751 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluvirin 2011-2012 Formula] 40240926 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluvirin 2011-2012 Formula] VO:0020026 OHDSI Vaccine WG 1005941 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluzone 2010-2011 Formula] 40224999 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluzone 2010-2011 Formula] VO:0020027 OHDSI Vaccine WG 1111363 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluzone 2011-2012 Formula] 40240131 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injectable Suspension [Fluzone 2011-2012 Formula] VO:0020028 OHDSI Vaccine WG 1116740 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe 40240923 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe VO:0020029 OHDSI Vaccine WG 1006308 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Afluria 2010-2011 Formula] 40225019 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Afluria 2010-2011 Formula] VO:0020030 OHDSI Vaccine WG 1116692 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Afluria 2011-2012 Formula] 40240916 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Afluria 2011-2012 Formula] VO:0020031 OHDSI Vaccine WG 1012196 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Agriflu 2010-2011 Formula] 40226922 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Agriflu 2010-2011 Formula] VO:0020032 OHDSI Vaccine WG 1006275 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluarix 2010-2011 Formula] 40225017 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluarix 2010-2011 Formula] VO:0020033 OHDSI Vaccine WG 1114638 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluarix 2011-2012 Formula] 40240915 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluarix 2011-2012 Formula] VO:0020034 OHDSI Vaccine WG 1006278 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluvirin 2010-2011 Formula] 40225018 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluvirin 2010-2011 Formula] VO:0020035 OHDSI Vaccine WG 1116745 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluvirin 2011-2012 Formula] 40240924 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluvirin 2011-2012 Formula] VO:0020036 OHDSI Vaccine WG 1005945 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluzone 2010-2011 Formula] 40225002 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluzone 2010-2011 Formula] VO:0020037 OHDSI Vaccine WG 1111360 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluzone 2011-2012 Formula] 40240132 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0020038 OHDSI Vaccine WG 1005913 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain Nasal Spray 40225032 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain Nasal Spray VO:0020039 OHDSI Vaccine WG 1005917 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain Nasal Spray [FluMist 2010-2011 Formula] 40225033 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain Nasal Spray [FluMist 2010-2011 Formula] VO:0020040 OHDSI Vaccine WG 1114124 influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain Nasal Spray [Flumist 2011-2012 Formula] 40240931 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus vaccine B/Brisbane/60/2008 antigen / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain Nasal Spray [Flumist 2011-2012 Formula] VO:0020041 OHDSI Vaccine WG 864702 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML 40166606 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML VO:0020042 OHDSI Vaccine WG 1006307 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Afluria 2010-2011 Formula] 40225024 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Afluria 2010-2011 Formula] VO:0020043 OHDSI Vaccine WG 1116691 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Afluria 2011-2012 Formula] 40240919 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Afluria 2011-2012 Formula] VO:0020044 OHDSI Vaccine WG 1012195 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Agriflu 2010-2011 Formula] 40226923 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Agriflu 2010-2011 Formula] VO:0020045 OHDSI Vaccine WG 1006274 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluarix 2010-2011 Formula] 40225021 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluarix 2010-2011 Formula] VO:0020046 OHDSI Vaccine WG 1114637 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluarix 2011-2012 Formula] 40240918 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluarix 2011-2012 Formula] VO:0020047 OHDSI Vaccine WG 1006139 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [FluLaval 2010-2011 Formula] 40225005 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [FluLaval 2010-2011 Formula] VO:0020048 OHDSI Vaccine WG 1114606 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Flulaval 2011-2012 Formula] 40240917 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Flulaval 2011-2012 Formula] VO:0020049 OHDSI Vaccine WG 1006277 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluvirin 2010-2011 Formula] 40225023 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluvirin 2010-2011 Formula] VO:0020050 OHDSI Vaccine WG 1116744 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluvirin 2011-2012 Formula] 40240928 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluvirin 2011-2012 Formula] VO:0020051 OHDSI Vaccine WG 1005940 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluzone 2010-2011 Formula] 40225004 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluzone 2010-2011 Formula] VO:0020052 OHDSI Vaccine WG 1111359 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluzone 2011-2012 Formula] 40240133 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML [Fluzone 2011-2012 Formula] VO:0020053 OHDSI Vaccine WG 1005942 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluzone 2010-2011 Formula] Fluzone 2010-2011 Formula Influenza Virus Vaccine Injectable Suspension 40225007 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluzone 2010-2011 Formula] VO:0020054 OHDSI Vaccine WG 1006141 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [FluLaval 2010-2011 Formula] FluLaval 2010-2011 Formula Influenza Virus Vaccine Injectable Suspension 40225008 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [FluLaval 2010-2011 Formula] VO:0020055 OHDSI Vaccine WG 1006286 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluvirin 2010-2011 Formula] Fluvirin 2010-2011 Formula Influenza Virus Vaccine Injectable Suspension 40225026 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluvirin 2010-2011 Formula] VO:0020056 OHDSI Vaccine WG 1006315 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Afluria 2010-2011 Formula] Afluria 2010-2011 Formula Influenza Virus Vaccine Injectable Suspension 40225027 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Afluria 2010-2011 Formula] VO:0020057 OHDSI Vaccine WG 1111364 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluzone 2011-2012 Formula] 40240134 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluzone 2011-2012 Formula] VO:0020058 OHDSI Vaccine WG 1114608 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Flulaval 2011-2012 Formula] Flulaval 2011-2012 Formula Influenza Virus Vaccine Injectable Suspension 40240920 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Flulaval 2011-2012 Formula] VO:0020059 OHDSI Vaccine WG 1116728 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Afluria 2011-2012 Formula] Afluria 2011-2012 Formula Influenza Virus Vaccine Injectable Suspension 40240921 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Afluria 2011-2012 Formula] VO:0020060 OHDSI Vaccine WG 1116750 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension 40240929 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension VO:0020061 OHDSI Vaccine WG 1116752 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluvirin 2011-2012 Formula] Fluvirin 2011-2012 Formula Influenza Virus Vaccine Injectable Suspension 40240930 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Injectable Suspension [Fluvirin 2011-2012 Formula] VO:0020062 OHDSI Vaccine WG 1359598 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Agriflu 2010-2011 Formula] 42902485 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Agriflu 2010-2011 Formula] VO:0020063 OHDSI Vaccine WG 1359621 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2011-2012 Formula] 42902508 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2011-2012 Formula] VO:0020064 OHDSI Vaccine WG 1359998 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2010-2011 Formula] 42902885 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluarix 2010-2011 Formula] VO:0020065 OHDSI Vaccine WG 1359999 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2010-2011 Formula] 42902886 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2010-2011 Formula] VO:0020066 OHDSI Vaccine WG 1360060 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe 42902947 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe VO:0020067 OHDSI Vaccine WG 1360092 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2011-2012 Formula] 42902979 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2011-2012 Formula] VO:0020068 OHDSI Vaccine WG 1360166 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2011-2012 Formula] 42903053 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Afluria 2011-2012 Formula] VO:0020069 OHDSI Vaccine WG 1360173 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2010-2011 Formula] 42903060 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluvirin 2010-2011 Formula] VO:0020070 OHDSI Vaccine WG 1360228 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] 42903115 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] VO:0020071 OHDSI Vaccine WG 1360260 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] 42903147 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.03 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.03 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0020072 OHDSI Vaccine WG 1111371 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML [Fluzone 2011-2012 Formula] 40240136 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML [Fluzone 2011-2012 Formula] VO:0020073 OHDSI Vaccine WG 1359809 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] 42902696 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0020074 OHDSI Vaccine WG 1360288 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe 42903175 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.09 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.09 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.09 MG/ML Prefilled Syringe VO:0020075 OHDSI Vaccine WG 1005949 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML 40225009 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML VO:0020076 OHDSI Vaccine WG 1005952 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML [Fluzone 2010-2011 Formula] 40225010 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML [Fluzone 2010-2011 Formula] VO:0020077 OHDSI Vaccine WG 1111365 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML [Fluzone 2011-2012 Formula] 40240137 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML [Fluzone 2011-2012 Formula] VO:0020078 OHDSI Vaccine WG 1360279 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe 42903166 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe VO:0020079 OHDSI Vaccine WG 1360324 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] 42903211 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2011-2012 Formula] VO:0020080 OHDSI Vaccine WG 1360409 influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] 42903296 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.12 MG/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML / influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML Prefilled Syringe [Fluzone 2010-2011 Formula] VO:0020081 OHDSI Vaccine WG 864812 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML 40166608 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML VO:0020082 OHDSI Vaccine WG 1005916 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML [FluMist 2010-2011 Formula] 40225035 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML [FluMist 2010-2011 Formula] VO:0020083 OHDSI Vaccine WG 1114123 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML [Flumist 2011-2012 Formula] 40240932 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML [Flumist 2011-2012 Formula] VO:0020084 OHDSI Vaccine WG 1005914 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML Nasal Spray influenza virus vaccine, live attenuated, trivalent, 2011-2012 formula Nasal Spray 40225036 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML Nasal Spray VO:0020085 OHDSI Vaccine WG 1005918 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML Nasal Spray [FluMist 2010-2011 Formula] 40225037 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML Nasal Spray [FluMist 2010-2011 Formula] VO:0020086 OHDSI Vaccine WG 1298792 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML Nasal Spray [Flumist 2011-2012 Formula] 42800823 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML / influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML Nasal Spray [Flumist 2011-2012 Formula] VO:0020087 OHDSI Vaccine WG 1298819 influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML Nasal Spray influenza-A (H1N1) virus vaccine, monvalent, live attentuated, 2009 Formula Nasal Spray 42801283 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 158000000 UNT/ML Nasal Spray VO:0020088 OHDSI Vaccine WG 1543758 influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML 45776785 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 MG/ML VO:0020089 OHDSI Vaccine WG 864813 influenza A-California-7-2009-(H1N1)v-like virus vaccine Nasal Spray 40166610 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine Nasal Spray VO:0020090 OHDSI Vaccine WG 890947 influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML 40168754 vaccine influenza B virus vaccine B/Brisbane/60/2008 antigen 0.12 MG/ML VO:0020091 OHDSI Vaccine WG 857954 influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML 40164834 vaccine influenza B virus vaccine B/Brisbane/60/2008 antigen 158000000 UNT/ML VO:0020092 OHDSI Vaccine WG 1543761 influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML 45776788 vaccine influenza B virus vaccine B/Brisbane/60/2008 antigen 50000000 MG/ML VO:0020093 OHDSI Vaccine WG 1303856 influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML 42873962 vaccine influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.03 MG/ML VO:0020094 OHDSI Vaccine WG 1304301 influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML 42873964 vaccine influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.12 MG/ML VO:0020095 OHDSI Vaccine WG 1304257 influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML 42873965 vaccine influenza B virus vaccine, B-Wisconsin-1-2010-like virus 158000000 UNT/ML VO:0020096 OHDSI Vaccine WG 1005950 influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML 40225030 vaccine influenza virus vaccine, inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.12 MG/ML VO:0020097 OHDSI Vaccine WG 1005911 influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 40225038 vaccine influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain VO:0020098 OHDSI Vaccine WG 1005912 influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML 40225039 vaccine influenza virus vaccine, live attenuated, A-Perth-16-2009 (H3N2) strain 158000000 UNT/ML VO:0020099 OHDSI Vaccine WG 1307268 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML 42899469 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML VO:0020100 OHDSI Vaccine WG 1307270 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML [Je-Vax] 42899472 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML [Je-Vax] VO:0020101 OHDSI Vaccine WG 1307269 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension 42899470 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension VO:0020102 OHDSI Vaccine WG 1307271 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension [Je-Vax] Je-Vax Japanese Encephalitis Virus vaccine, inactivated Injectable Suspension 42899471 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension [Je-Vax] VO:0020103 OHDSI Vaccine WG 1359542 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe 42902429 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe VO:0020104 OHDSI Vaccine WG 1360313 Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro] 42903200 vaccine Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe [Ixiaro] VO:0020105 OHDSI Vaccine WG 845538 Japanese encephalitis virus vaccine, inactivated Injectable Suspension [Je-Vax] 40159357 vaccine Japanese encephalitis virus vaccine, inactivated Injectable Suspension [Je-Vax] VO:0020106 OHDSI Vaccine WG 1597100 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine Prefilled Syringe 45892511 vaccine L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine Prefilled Syringe VO:0020107 OHDSI Vaccine WG 1656973 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine Injection 46275946 vaccine L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 31 vaccine / L1 protein, human papillomavirus type 33 vaccine / L1 protein, human papillomavirus type 45 vaccine / L1 protein, human papillomavirus type 52 vaccine / L1 protein, human papillomavirus type 58 vaccine / L1 protein, human papillomavirus type 6 vaccine Injection VO:0020108 OHDSI Vaccine WG 1656958 L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 6 vaccine Injection 46275944 vaccine L1 protein, human papillomavirus type 11 vaccine / L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine / L1 protein, human papillomavirus type 6 vaccine Injection VO:0020109 OHDSI Vaccine WG 1657893 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection 46275095 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection VO:0020110 OHDSI Vaccine WG 1657894 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection [Gardasil] 46275096 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Injection [Gardasil] VO:0020111 OHDSI Vaccine WG 867490 L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine Injectable Suspension 40167169 vaccine L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine Injectable Suspension VO:0020112 OHDSI Vaccine WG 867492 L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine Injectable Suspension [Cervarix] 40167170 vaccine L1 protein, human papillomavirus type 16 vaccine / L1 protein, human papillomavirus type 18 vaccine Injectable Suspension [Cervarix] VO:0020113 OHDSI Vaccine WG 1657998 measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection 46275134 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection VO:0020114 OHDSI Vaccine WG 1658023 measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection 46275149 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection VO:0020115 OHDSI Vaccine WG 2122274 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML [Attenuvax] 1511038 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML [Attenuvax] VO:0020116 OHDSI Vaccine WG 1658027 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection 46275151 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection VO:0020117 OHDSI Vaccine WG 1658028 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection [M-M-R II] 46275152 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 25000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injection [M-M-R II] VO:0020118 OHDSI Vaccine WG 2122277 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection 1511040 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection VO:0020119 OHDSI Vaccine WG 2122278 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection [Attenuvax] Attenuvax 2000 UNT/ML Injection 1511041 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML Injection [Attenuvax] VO:0020120 OHDSI Vaccine WG 2122272 measles virus vaccine live, Enders' attenuated Edmonston strain Injection 1511037 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain Injection VO:0020121 OHDSI Vaccine WG 2122275 measles virus vaccine live, Enders' attenuated Edmonston strain Injection [Attenuvax] 1511039 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain Injection [Attenuvax] VO:0020122 OHDSI Vaccine WG 363592 meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injectable Solution [Menomune A/C/Y/W-135] 40055281 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide / meningococcal polysaccharide vaccine group W-135 / meningococcal polysaccharide vaccine group Y Injectable Solution [Menomune A/C/Y/W-135] VO:0020123 OHDSI Vaccine WG 545641 meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [Meningovax-AC] 40124278 vaccine meningococcal group A polysaccharide / meningococcal group C polysaccharide Injectable Solution [Meningovax-AC] VO:0020124 OHDSI Vaccine WG 545640 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML [Meningovax-AC] 19114777 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML [Meningovax-AC] VO:0020125 OHDSI Vaccine WG 347699 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injectable Solution 509104 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injectable Solution VO:0020126 OHDSI Vaccine WG 1658229 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection 46275264 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection VO:0020127 OHDSI Vaccine WG 1658230 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection [Menomune A/C/Y/W-135] 46275265 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / meningococcal polysaccharide vaccine group W-135 0.1 MG/ML / meningococcal polysaccharide vaccine group Y 0.1 MG/ML Injection [Menomune A/C/Y/W-135] VO:0020128 OHDSI Vaccine WG 251817 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML Injectable Solution 509103 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML Injectable Solution VO:0020129 OHDSI Vaccine WG 545642 meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML Injectable Solution [Meningovax-AC] Meningovax-AC Injectable Solution 509106 vaccine meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML Injectable Solution [Meningovax-AC] VO:0020130 OHDSI Vaccine WG 204459 meningococcal group A polysaccharide 0.1 MG/ML Injectable Solution 19027528 vaccine meningococcal group A polysaccharide 0.1 MG/ML Injectable Solution VO:0020131 OHDSI Vaccine WG 374403 meningococcal group A polysaccharide Injectable Solution 40055545 vaccine meningococcal group A polysaccharide Injectable Solution VO:0020132 OHDSI Vaccine WG 805076 mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution 40153160 vaccine mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution VO:0020133 OHDSI Vaccine WG 805079 mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution [Biavax II] 40153161 vaccine mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution [Biavax II] VO:0020134 OHDSI Vaccine WG 798376 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML [Mumpsvax] 19062680 vaccine mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML [Mumpsvax] VO:0020135 OHDSI Vaccine WG 805078 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML [Biavax II] 19131819 vaccine mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML [Biavax II] VO:0020136 OHDSI Vaccine WG 805077 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution 19131818 vaccine mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution VO:0020137 OHDSI Vaccine WG 805080 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution [Biavax II] Biavax II, Rubella and Mumps Virus Vaccine Live Injectable Solution 19131820 vaccine mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution [Biavax II] VO:0020138 OHDSI Vaccine WG 798378 mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML Injectable Solution [Mumpsvax] Mumpsvax, Mumps Virus Vaccine Live, (Jeryl Lynn Strain) Injectable Solution 529716 vaccine mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML Injectable Solution [Mumpsvax] VO:0020139 OHDSI Vaccine WG 798374 mumps virus vaccine live, Jeryl Lynn strain Injectable Solution 40150800 vaccine mumps virus vaccine live, Jeryl Lynn strain Injectable Solution VO:0020140 OHDSI Vaccine WG 798377 mumps virus vaccine live, Jeryl Lynn strain Injectable Solution [Mumpsvax] 40150801 vaccine mumps virus vaccine live, Jeryl Lynn strain Injectable Solution [Mumpsvax] VO:0020141 OHDSI Vaccine WG 797642 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Prefilled Syringe 40150781 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Prefilled Syringe VO:0020142 OHDSI Vaccine WG 797644 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Prefilled Syringe [Menactra] 40150782 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Prefilled Syringe [Menactra] VO:0020143 OHDSI Vaccine WG 1657443 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injection 46276204 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injection VO:0020144 OHDSI Vaccine WG 1657446 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injection [Menactra] 46276205 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Injection [Menactra] VO:0020145 OHDSI Vaccine WG 797639 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML [Menactra] 19081261 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML [Menactra] VO:0020146 OHDSI Vaccine WG 2360571 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 1145513 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine VO:0020147 OHDSI Vaccine WG 2360581 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection 1145522 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection VO:0020148 OHDSI Vaccine WG 2360586 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection [Menquadfi] 1145525 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection [Menquadfi] VO:0020149 OHDSI Vaccine WG 2360576 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML 1145517 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML VO:0020150 OHDSI Vaccine WG 2360585 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML [Menquadfi] 1145524 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML [Menquadfi] VO:0020151 OHDSI Vaccine WG 1657353 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection 46276196 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection VO:0020152 OHDSI Vaccine WG 1657356 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection [Menveo] 46276197 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine Injection [Menveo] VO:0020153 OHDSI Vaccine WG 1593141 Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe 45775645 vaccine Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe VO:0020154 OHDSI Vaccine WG 1593142 Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba] 45775646 vaccine Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba] VO:0020155 OHDSI Vaccine WG 2360572 Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 1145514 vaccine Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine VO:0020156 OHDSI Vaccine WG 2360577 Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML 1145518 vaccine Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML VO:0020157 OHDSI Vaccine WG 2360573 Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 1145515 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine VO:0020158 OHDSI Vaccine WG 2360578 Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML 1145519 vaccine Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML VO:0020159 OHDSI Vaccine WG 1540822 Brucella abortus 45775684 vaccine component Brucella abortus as vaccine component VO:0020160 OHDSI Vaccine WG 1318470 Brucella melitensis 42903954 vaccine component Brucella melitensis as vaccine component VO:0020161 OHDSI Vaccine WG 2360574 Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 1145516 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine VO:0020162 OHDSI Vaccine WG 2360579 Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML 1145520 vaccine Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML VO:0020163 OHDSI Vaccine WG 452810 pertussis vaccine 0.0468 MG/ML 19112497 vaccine pertussis vaccine 0.0468 MG/ML VO:0020164 OHDSI Vaccine WG 415373 pertussis vaccine 0.0468 MG/ML Injectable Solution 19033195 vaccine pertussis vaccine 0.0468 MG/ML Injectable Solution VO:0020165 OHDSI Vaccine WG 415374 pertussis vaccine 600 UNT/ML Injectable Solution 19033196 vaccine pertussis vaccine 600 UNT/ML Injectable Solution VO:0020166 OHDSI Vaccine WG 450546 pertussis vaccine 8 UNT/ML 19111283 vaccine pertussis vaccine 8 UNT/ML VO:0020167 OHDSI Vaccine WG 413786 pertussis vaccine 8 UNT/ML Injectable Solution 19033194 vaccine pertussis vaccine 8 UNT/ML Injectable Solution VO:0020168 OHDSI Vaccine WG 2282756 poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Suspension 37499035 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Suspension VO:0020169 OHDSI Vaccine WG 2282758 poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Suspension [Ipol] 37499036 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Injectable Suspension [Ipol] VO:0020170 OHDSI Vaccine WG 866819 poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Prefilled Syringe 40167299 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Prefilled Syringe VO:0020171 OHDSI Vaccine WG 1596432 poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Prefilled Syringe [Ipol] 45892416 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) Prefilled Syringe [Ipol] VO:0020172 OHDSI Vaccine WG 763103 poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Suspension poliovirus vaccine inactivated, type 1 (Mahoney) 40 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 8 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 32 UNT/ML per 0.5 ML Injectable Suspension 19129482 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Injectable Suspension VO:0020173 OHDSI Vaccine WG 1360431 poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe poliovirus vaccine inactivated Prefilled Syringe 42903318 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe VO:0020174 OHDSI Vaccine WG 1596462 poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe [Ipol] Ipol (poliovirus vaccine inactivated) Prefilled Syringe 45892428 vaccine poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML Prefilled Syringe [Ipol] VO:0020175 OHDSI Vaccine WG 1658033 rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection 46275155 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection VO:0020176 OHDSI Vaccine WG 1658034 rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert] RabAvert 2.5 UNT/ML Injection 46275156 vaccine rabies virus vaccine flury-lep strain 2.5 UNT/ML Injection [RabAvert] VO:0020177 OHDSI Vaccine WG 1658031 rabies virus vaccine flury-lep strain Injection [RabAvert] 46275154 vaccine rabies virus vaccine flury-lep strain Injection [RabAvert] VO:0020178 OHDSI Vaccine WG 1658039 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection 46275158 vaccine rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection VO:0020179 OHDSI Vaccine WG 1658040 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection [Imovax] Imovax 2.5 UNT/ML Injection 46275159 vaccine rabies virus vaccine wistar strain PM-1503-3M (human), inactivated 2.5 UNT/ML Injection [Imovax] VO:0020180 OHDSI Vaccine WG 1658035 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated Injection 46275157 vaccine rabies virus vaccine wistar strain PM-1503-3M (human), inactivated Injection VO:0020181 OHDSI Vaccine WG 1659732 rabies virus vaccine wistar strain PM-1503-3M (human), inactivated Injection [Imovax] 46275645 vaccine rabies virus vaccine wistar strain PM-1503-3M (human), inactivated Injection [Imovax] VO:0020182 OHDSI Vaccine WG 805576 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000000 UNT/ML Oral Suspension rotavirus, live attenuated (RV1) G1P[8] Oral Vaccine 1 ML Lyophilized Powder for Oral Suspension 19131938 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 1000000 UNT/ML Oral Suspension VO:0020183 OHDSI Vaccine WG 2627822 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML 1301593 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML VO:0020184 OHDSI Vaccine WG 2627824 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML [Rotarix] 1301595 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML [Rotarix] VO:0020185 OHDSI Vaccine WG 2627823 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML Oral Suspension rotavirus, live attenuated (RV1) G1P[8] Oral Vaccine 1.5 ML Oral Suspension 1301594 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML Oral Suspension VO:0020186 OHDSI Vaccine WG 2627825 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML Oral Suspension [Rotarix] Rotarix 667000 UNT/ML Oral Suspension 1301596 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain 667000 UNT/ML Oral Suspension [Rotarix] VO:0020187 OHDSI Vaccine WG 805575 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain Oral Suspension 40153981 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain Oral Suspension VO:0020188 OHDSI Vaccine WG 805578 rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain Oral Suspension [Rotarix] 40153982 vaccine rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain Oral Suspension [Rotarix] VO:0020189 OHDSI Vaccine WG 762821 rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML [Meruvax II] 19062674 vaccine rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML [Meruvax II] VO:0020190 OHDSI Vaccine WG 762820 rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution rubella virus vaccine live (Wistar RA 27-3 Strain) 1000 UNT per 0.5 ML Injectable Solution 19129406 vaccine rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution VO:0020191 OHDSI Vaccine WG 762823 rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution [Meruvax II] Meruvax II, Rubella Virus Vaccine Live (Wistar RA 27-3 Strain) Injectable Solution 523215 vaccine rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML Injectable Solution [Meruvax II] VO:0020192 OHDSI Vaccine WG 762822 rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution [Meruvax II] 40148732 vaccine rubella virus vaccine live (Wistar RA 27-3 strain) Injectable Solution [Meruvax II] VO:0020193 OHDSI Vaccine WG 2468231 SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein 37003432 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein VO:0020194 OHDSI Vaccine WG 2468234 SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension 37003435 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension VO:0020195 OHDSI Vaccine WG 2593846 SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Comirnaty] 1759205 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Comirnaty] VO:0020196 OHDSI Vaccine WG 2601551 SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Spikevax] 779678 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Suspension [Spikevax] VO:0020197 OHDSI Vaccine WG 2623376 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML 742036 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML VO:0020198 OHDSI Vaccine WG 2623378 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML Injectable Suspension SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 5y (EUA) 742038 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.025 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML Injectable Suspension VO:0020199 OHDSI Vaccine WG 2610324 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML 1525540 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML VO:0020200 OHDSI Vaccine WG 2610328 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension SARS-CoV-2 vaccine, mRNA 1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA) 1525543 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension VO:0020201 OHDSI Vaccine WG 2598699 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML 779413 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML VO:0020202 OHDSI Vaccine WG 2598700 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 25 MCG/0.25 ML Injectable Suspension, 6m through 5y 779414 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.1 MG/ML Injectable Suspension VO:0020203 OHDSI Vaccine WG 2470233 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML 37003517 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML VO:0020204 OHDSI Vaccine WG 2601549 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML [Spikevax] 779676 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML [Spikevax] VO:0020205 OHDSI Vaccine WG 2470234 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 100 MCG/0.5 ML Injectable Suspension 37003518 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension VO:0020206 OHDSI Vaccine WG 2601552 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension [Spikevax] Spikevax 0.2 MG/ML Injectable Suspension 779679 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.2 MG/ML Injectable Suspension [Spikevax] VO:0020207 OHDSI Vaccine WG 2623377 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML 742037 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.025 MG/ML VO:0020208 OHDSI Vaccine WG 2610327 SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML 1525542 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML VO:0020209 OHDSI Vaccine WG 2623380 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML 742039 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML VO:0020210 OHDSI Vaccine WG 2623382 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML Injectable Suspension SARS-CoV-2 vaccine, mRNA-BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6m through 4y (EUA) 742041 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.0075 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML Injectable Suspension VO:0020211 OHDSI Vaccine WG 2603832 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML 779947 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML VO:0020212 OHDSI Vaccine WG 2603833 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML Injectable Suspension SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 3 MCG/0.2 ML Injectable Suspension, 6m through 4y (EUA) 779948 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.015 MG/ML Injectable Suspension VO:0020213 OHDSI Vaccine WG 2621899 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML 742008 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML VO:0020214 OHDSI Vaccine WG 2621900 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML Injectable Suspension SARS-CoV-2 vaccine, mRNA BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 5y through 11y (EUA) 742009 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.025 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML Injectable Suspension VO:0020215 OHDSI Vaccine WG 2583742 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML 702117 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML VO:0020216 OHDSI Vaccine WG 2610319 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension SARS-CoV-2 vaccine, mRNA BNT162b2 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 12y+ (EUA) 1525538 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension VO:0020217 OHDSI Vaccine WG 2583743 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML Injectable Suspension SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 10 MCG/0.2 ML Injectable Suspension, 5y through 11y 702118 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.05 MG/ML Injectable Suspension VO:0020218 OHDSI Vaccine WG 2468232 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML 37003433 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML VO:0020219 OHDSI Vaccine WG 2593844 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML [Comirnaty] 1759203 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML [Comirnaty] VO:0020220 OHDSI Vaccine WG 2468235 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 30 MCG/0.3 ML Injectable Suspension 37003436 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension VO:0020221 OHDSI Vaccine WG 2593847 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension [Comirnaty] Comirnaty 30 MCG/0.3 ML Injectable Suspension 1759206 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 0.1 MG/ML Injectable Suspension [Comirnaty] VO:0020222 OHDSI Vaccine WG 2623381 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML 742040 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.0075 MG/ML VO:0020223 OHDSI Vaccine WG 2621898 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML 742007 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.025 MG/ML VO:0020224 OHDSI Vaccine WG 2610346 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.05 MG/ML 1525544 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5) 0.05 MG/ML VO:0020225 OHDSI Vaccine WG 2479832 SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML 739903 vaccine SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML VO:0020226 OHDSI Vaccine WG 2479835 SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension SARS-COV-2 (COVID-19) vaccine, vector - Ad26 0.5 ML Injectable Suspension (EUA) 739906 vaccine SARS-COV-2 (COVID-19) vaccine, vector - Ad26 100000000000 UNT/ML Injectable Suspension VO:0020227 OHDSI Vaccine WG 2479831 SARS-COV-2 (COVID-19) vaccine, vector non-replicating 739902 vaccine SARS-COV-2 (COVID-19) vaccine, vector non-replicating VO:0020228 OHDSI Vaccine WG 2479834 SARS-COV-2 (COVID-19) vaccine, vector non-replicating Injectable Suspension 739905 vaccine SARS-COV-2 (COVID-19) vaccine, vector non-replicating Injectable Suspension VO:0020229 OHDSI Vaccine WG 798467 smallpox vaccine live, New York City Board of Health vaccinia strain 19030120 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain VO:0020230 OHDSI Vaccine WG 798468 smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML 19030171 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML VO:0020231 OHDSI Vaccine WG 798471 smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML [Dryvax] 19032691 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML [Dryvax] VO:0020232 OHDSI Vaccine WG 798470 smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML Injectable Suspension 19130428 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML Injectable Suspension VO:0020233 OHDSI Vaccine WG 798473 smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML Injectable Suspension [Dryvax] Dryvax, Dried Smallpox Vaccine Injectable Suspension 19030173 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 100000000 UNT/ML Injectable Suspension [Dryvax] VO:0020234 OHDSI Vaccine WG 2170514 smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML 1396491 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML VO:0020235 OHDSI Vaccine WG 2170517 smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML [ACAM2000] 1396493 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML [ACAM2000] VO:0020236 OHDSI Vaccine WG 833082 smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML Injectable Solution 19133775 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain 500000000 UNT/ML Injectable Solution VO:0020237 OHDSI Vaccine WG 2170515 smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution 1396492 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution VO:0020238 OHDSI Vaccine WG 2170518 smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000] 1396494 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000] VO:0020239 OHDSI Vaccine WG 798469 smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Suspension 40150914 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Suspension VO:0020240 OHDSI Vaccine WG 798472 smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Suspension [Dryvax] 40150915 vaccine smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Suspension [Dryvax] VO:0020241 OHDSI Vaccine WG 901639 Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe 40174005 vaccine Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe VO:0020242 OHDSI Vaccine WG 798234 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Suspension 40150933 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Suspension VO:0020243 OHDSI Vaccine WG 798238 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Prevnar] 40150934 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Suspension [Prevnar] VO:0020244 OHDSI Vaccine WG 798241 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe 40150936 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe VO:0020245 OHDSI Vaccine WG 798243 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe [Prevnar] 40150937 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe [Prevnar] VO:0020246 OHDSI Vaccine WG 798221 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 528987 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0020247 OHDSI Vaccine WG 798235 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Injectable Suspension 529048 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Injectable Suspension VO:0020248 OHDSI Vaccine WG 798237 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML [Prevnar] 19029084 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML [Prevnar] VO:0020249 OHDSI Vaccine WG 798239 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Injectable Suspension [Prevnar] 529049 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Injectable Suspension [Prevnar] VO:0020250 OHDSI Vaccine WG 1359589 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe 42902476 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe VO:0020251 OHDSI Vaccine WG 1359785 Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe [Prevnar] 42902672 vaccine Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe [Prevnar] VO:0020252 OHDSI Vaccine WG 798223 Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 528989 vaccine Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0020253 OHDSI Vaccine WG 798225 Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 528991 vaccine Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0020254 OHDSI Vaccine WG 798227 Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 529043 vaccine Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0020255 OHDSI Vaccine WG 798229 Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 529045 vaccine Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0020256 OHDSI Vaccine WG 798231 Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML 529047 vaccine Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML VO:0020257 OHDSI Vaccine WG 798233 Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML 529073 vaccine Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML VO:0020258 OHDSI Vaccine WG 343382 tetanus toxoid vaccine, inactivated 0.048 MG/ML 529652 vaccine tetanus toxoid vaccine, inactivated 0.048 MG/ML VO:0020259 OHDSI Vaccine WG 359119 tetanus toxoid vaccine, inactivated 0.5 ML 19099513 vaccine tetanus toxoid vaccine, inactivated 0.5 ML VO:0020260 OHDSI Vaccine WG 318243 tetanus toxoid vaccine, inactivated 0.5 ML Injectable Solution 19082708 vaccine tetanus toxoid vaccine, inactivated 0.5 ML Injectable Solution VO:0020261 OHDSI Vaccine WG 402456 tetanus toxoid vaccine, inactivated 10 LFU/ML 19102281 vaccine tetanus toxoid vaccine, inactivated 10 LFU/ML VO:0020262 OHDSI Vaccine WG 583409 tetanus toxoid vaccine, inactivated 10 MG/ML 19122005 vaccine tetanus toxoid vaccine, inactivated 10 MG/ML VO:0020263 OHDSI Vaccine WG 1359520 tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 42902407 vaccine tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0020264 OHDSI Vaccine WG 350758 tetanus toxoid vaccine, inactivated 1000 UNT 19097917 vaccine tetanus toxoid vaccine, inactivated 1000 UNT VO:0020265 OHDSI Vaccine WG 347145 tetanus toxoid vaccine, inactivated 1000 UNT Injectable Suspension 19096253 vaccine tetanus toxoid vaccine, inactivated 1000 UNT Injectable Suspension VO:0020266 OHDSI Vaccine WG 316781 tetanus toxoid vaccine, inactivated 2 UNT/ML 529461 vaccine tetanus toxoid vaccine, inactivated 2 UNT/ML VO:0020267 OHDSI Vaccine WG 318241 tetanus toxoid vaccine, inactivated 2 UNT/ML Injectable Solution 529483 vaccine tetanus toxoid vaccine, inactivated 2 UNT/ML Injectable Solution VO:0020268 OHDSI Vaccine WG 967042 tetanus toxoid vaccine, inactivated 20 UNT/ML [TE Anatoxal Berna] 40173989 vaccine tetanus toxoid vaccine, inactivated 20 UNT/ML [TE Anatoxal Berna] VO:0020269 OHDSI Vaccine WG 967039 tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Solution 40173953 vaccine tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Solution VO:0020270 OHDSI Vaccine WG 967043 tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Solution [TE Anatoxal Berna] TE Anatoxal Berna 20 UNT/ML Injectable Solution 40173988 vaccine tetanus toxoid vaccine, inactivated 20 UNT/ML Injectable Solution [TE Anatoxal Berna] VO:0020271 OHDSI Vaccine WG 1360308 tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe 42903195 vaccine tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0020272 OHDSI Vaccine WG 335677 tetanus toxoid vaccine, inactivated 5 LFU 529490 vaccine tetanus toxoid vaccine, inactivated 5 LFU VO:0020273 OHDSI Vaccine WG 242857 tetanus toxoid vaccine, inactivated 5 LFU Injectable Solution 529455 vaccine tetanus toxoid vaccine, inactivated 5 LFU Injectable Solution VO:0020274 OHDSI Vaccine WG 632467 tetanus toxoid vaccine, inactivated Injectable Solution [TE Anatoxal Berna] 40134143 vaccine tetanus toxoid vaccine, inactivated Injectable Solution [TE Anatoxal Berna] VO:0020275 OHDSI Vaccine WG obsolete typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution true VO:0020276 OHDSI Vaccine WG obsolete typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe true VO:0020277 OHDSI Vaccine WG obsolete typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] true VO:0020278 OHDSI Vaccine WG 807221 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Solution 40154085 vaccine typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Solution VO:0020279 OHDSI Vaccine WG 807224 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Solution [Typhim VI] 40154086 vaccine typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Solution [Typhim VI] VO:0020280 OHDSI Vaccine WG 807238 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe 40154087 vaccine typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe VO:0020281 OHDSI Vaccine WG 1986824 varicella zoster virus glycoprotein E Injection 792780 vaccine varicella zoster virus glycoprotein E Injection VO:0020282 OHDSI Vaccine WG 1986828 varicella zoster virus glycoprotein E Injection [Shingrix] 792784 vaccine varicella zoster virus glycoprotein E Injection [Shingrix] VO:0020283 OHDSI Vaccine WG 1986831 varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection 792787 vaccine varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection VO:0020284 OHDSI Vaccine WG 1986832 varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix] Shingrix 0.1 MG/ML Injection 792788 vaccine varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection [Shingrix] VO:0020285 OHDSI Vaccine WG 1658010 varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection 46275140 vaccine varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection VO:0020286 OHDSI Vaccine WG 1658011 varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] Varivax 2700 UNT/ML Injection 46275141 vaccine varicella-zoster virus vaccine live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] VO:0020287 OHDSI Vaccine WG 1658015 varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection 46275143 vaccine varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection VO:0020288 OHDSI Vaccine WG 1658016 varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection [Zostavax] Zostavax 29800 UNT/ML Injection 46275144 vaccine varicella-zoster virus vaccine live (Oka-Merck) strain 29800 UNT/ML Injection [Zostavax] VO:0020289 OHDSI Vaccine WG 2270604 Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML 37498444 vaccine Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML VO:0020290 OHDSI Vaccine WG 2272202 Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML [Vaxchora] 37498488 vaccine Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML [Vaxchora] VO:0020291 OHDSI Vaccine WG 1812945 Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension 1718159 vaccine Vibrio cholerae CVD 103-HGR strain live antigen 12000000 UNT/ML Oral Suspension VO:0020292 OHDSI Vaccine WG 2270607 Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension 37498447 vaccine Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension VO:0020293 OHDSI Vaccine WG 2272203 Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora] 37498489 vaccine Vibrio cholerae CVD 103-HGR strain live antigen Oral Suspension [Vaxchora] VO:0020294 OHDSI Vaccine WG 1876711 yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection 1593659 vaccine yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection VO:0020295 OHDSI Vaccine WG 1876712 yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection [Stamaril] Stamaril 2000 UNT/ML Injection 1593660 vaccine yellow fever virus strain 17D-204 live antigen 2000 UNT/ML Injection [Stamaril] VO:0020296 OHDSI Vaccine WG 1658242 yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection 46275271 vaccine yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection VO:0020297 OHDSI Vaccine WG 1658243 yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection [YF-Vax] YF-Vax 4000 UNT/ML Injection 46275272 vaccine yellow fever virus strain 17D-204 live antigen 4000 UNT/ML Injection [YF-Vax] VO:0020298 Xingxian Li vaccine Afluria 2010-2011 Formula vaccine VO:0020299 Xingxian Li vaccine Afluria 2011-2012 Formula vaccine VO:0020300 Xingxian Li vaccine Afluria 2012-2013 Formula vaccine VO:0020301 Xingxian Li vaccine Afluria 2013-2014 Formula vaccine VO:0020302 Xingxian Li vaccine Afluria 2014-2015 Formula vaccine VO:0020303 Xingxian Li vaccine Afluria Quadrivalent 2019-2020 vaccine VO:0020304 Xingxian Li vaccine Afluria Quadrivalent 2020-2021 vaccine VO:0020305 Xingxian Li vaccine Afluria Quadrivalent 2021-2022 vaccine VO:0020306 Xingxian Li vaccine Afluria Quadrivalent 2022-2023 vaccine VO:0020307 Xingxian Li vaccine Agriflu 2010-2011 Formula vaccine VO:0020308 Xingxian Li vaccine Agriflu 2012-2013 Formula vaccine VO:0020309 Xingxian Li vaccine Fluad 2019-2020 vaccine VO:0020310 Xingxian Li vaccine Fluad 2020-2021 vaccine VO:0020311 Xingxian Li vaccine Fluad Quadrivalent 2020-2021 vaccine VO:0020312 Xingxian Li vaccine Fluad Quadrivalent 2021-2022 vaccine VO:0020313 Xingxian Li vaccine Fluad Quadrivalent 2022-2023 vaccine VO:0020314 Xingxian Li vaccine Fluarix 2010-2011 Formula vaccine VO:0020315 Xingxian Li vaccine Fluarix 2011-2012 Formula vaccine VO:0020316 Xingxian Li vaccine Fluarix 2012-2013 Formula vaccine VO:0020317 Xingxian Li vaccine Fluarix 2013-2014 Formula vaccine VO:0020318 Xingxian Li vaccine Fluarix 2014-2015 Formula vaccine VO:0020319 Xingxian Li vaccine Fluarix Quad 2014-2015 Formula vaccine VO:0020320 Xingxian Li vaccine Fluarix Quadrivalent 2019-2020 vaccine VO:0020321 Xingxian Li vaccine Fluarix Quadrivalent 2020-2021 vaccine VO:0020322 Xingxian Li vaccine Fluarix Quadrivalent 2021-2022 vaccine VO:0020323 Xingxian Li vaccine Fluarix Quadrivalent 2022-2023 vaccine VO:0020324 Xingxian Li vaccine Flublok Quadrivalent 2019-2020 vaccine VO:0020325 Xingxian Li vaccine Flublok Quadrivalent 2020-2021 vaccine VO:0020326 Xingxian Li vaccine Flublok Quadrivalent 2021-2022 vaccine VO:0020327 Xingxian Li vaccine Flublok Quadrivalent 2022-2023 vaccine VO:0020328 Xingxian Li vaccine Flucelvax 2012-2013 Formula vaccine VO:0020329 Xingxian Li vaccine Flucelvax 2013-2014 Formula vaccine VO:0020330 Xingxian Li vaccine Flucelvax 2014-2015 Formula vaccine VO:0020331 Xingxian Li vaccine Flucelvax Quadrivalent 2018-2019 vaccine VO:0020332 Xingxian Li vaccine Flucelvax Quadrivalent 2019-2020 vaccine VO:0020333 Xingxian Li vaccine Flucelvax Quadrivalent 2020-2021 vaccine VO:0020334 Xingxian Li vaccine Flucelvax Quadrivalent 2021-2022 vaccine VO:0020335 Xingxian Li vaccine Flucelvax Quadrivalent 2022-2023 vaccine VO:0020336 Xingxian Li vaccine FluLaval 2010-2011 Formula vaccine VO:0020337 Xingxian Li vaccine Flulaval 2011-2012 Formula vaccine VO:0020338 Xingxian Li vaccine Flulaval 2012-2013 Formula vaccine VO:0020339 Xingxian Li vaccine Flulaval 2013-2014 Formula vaccine VO:0020340 Xingxian Li vaccine Flulaval 2014-2015 Formula vaccine VO:0020341 Xingxian Li vaccine Flulaval Quad 2013-2014 Formula vaccine VO:0020342 Xingxian Li vaccine Flulaval Quad 2014-2015 Formula vaccine VO:0020343 Xingxian Li vaccine Flulaval Quadrivalent 2019-2020 vaccine VO:0020344 Xingxian Li vaccine Flulaval Quadrivalent 2020-2021 vaccine VO:0020345 Xingxian Li vaccine Flulaval Quadrivalent 2021-2022 vaccine VO:0020346 Xingxian Li vaccine Flulaval Quadrivalent 2022-2023 vaccine VO:0020347 Xingxian Li vaccine FluMist 2010-2011 Formula vaccine VO:0020348 Xingxian Li vaccine Flumist 2011-2012 Formula vaccine VO:0020349 Xingxian Li vaccine Flumist 2012-2013 Formula vaccine VO:0020350 Xingxian Li vaccine Flumist 2014-2015 Formula vaccine VO:0020351 Xingxian Li vaccine FluMist Quadrivalent 2019-2020 vaccine VO:0020352 Xingxian Li vaccine Flumist Quadrivalent 2020-2021 vaccine VO:0020353 Xingxian Li vaccine FluMist Quadrivalent 2021-2022 vaccine VO:0020354 Xingxian Li vaccine FluMist Quadrivalent 2022-2023 vaccine VO:0020355 Xingxian Li vaccine Fluvirin 2010-2011 Formula vaccine VO:0020358 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT [Vivotif] 44040649 OMOP1035280 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT [Vivotif] VO:0020359 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML [Hepatyrix] 43606932 OMOP707726 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML [Hepatyrix] VO:0020360 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Typherix] 43171355 OMOP478115 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Typherix] VO:0020361 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Typhim V] 44066909 OMOP1061540 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML [Typhim V] VO:0020362 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Extended Release Oral Capsule [Vivotif] 44175816 OMOP3052539 vaccine Typhoid Vaccine Live Ty21a Extended Release Oral Capsule [Vivotif] VO:0020363 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Oral Capsule [Typhoral L] 40862416 OMOP2060378 vaccine Typhoid Vaccine Live Ty21a Oral Capsule [Typhoral L] VO:0020364 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Oral Capsule [Vivotif Berna] 41268085 OMOP2466047 vaccine Typhoid Vaccine Live Ty21a Oral Capsule [Vivotif Berna] VO:0020365 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Oral Capsule [Vivotif] 41237083 OMOP2435045 vaccine Typhoid Vaccine Live Ty21a Oral Capsule [Vivotif] VO:0020366 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Oral Powder [Vivotif] 44082203 OMOP1076834 vaccine Typhoid Vaccine Live Ty21a Oral Powder [Vivotif] VO:0020367 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension [Hepatyrix] 43732932 OMOP707722 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension [Hepatyrix] VO:0020368 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution [Typhim V] 44095349 OMOP1089980 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution [Typhim V] VO:0020369 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT 44091053 OMOP1085684 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT VO:0020370 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 1000000000 UNT/ML 44091054 OMOP1085685 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 1000000000 UNT/ML VO:0020371 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Extended Release Oral Capsule 44168273 OMOP3044996 vaccine Typhoid Vaccine Live Ty21a Extended Release Oral Capsule VO:0020372 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Oral Capsule 41048530 OMOP2246492 vaccine Typhoid Vaccine Live Ty21a Oral Capsule VO:0020373 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Oral Powder 44055664 OMOP1050295 vaccine Typhoid Vaccine Live Ty21a Oral Powder VO:0020374 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension 36879843 OMOP994401 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Suspension VO:0020375 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution 44094393 OMOP1089024 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Intramuscular Solution VO:0020376 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT Oral Powder [Vivotif] 44111135 OMOP1105766 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT Oral Powder [Vivotif] VO:0020377 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] 43841035 OMOP707731 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] VO:0020378 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Typhim V] 44098497 OMOP1093128 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Typhim V] VO:0020379 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a Delayed Release Oral Capsule [Vivotif Berna] 782625 OMOP4830457 vaccine Typhoid Vaccine Live Ty21a Delayed Release Oral Capsule [Vivotif Berna] VO:0020380 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Solution [Typherix] 43643089 OMOP707725 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Injectable Solution [Typherix] VO:0020381 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Prefilled Syringe [Typherix] 43149217 OMOP478112 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain Prefilled Syringe [Typherix] VO:0020382 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT Oral Powder 44032101 OMOP1026732 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT Oral Powder VO:0020383 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension 43841034 OMOP707727 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension VO:0020384 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution 44109776 OMOP1104407 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution VO:0020385 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 1000000000 UNT/ML Injectable Suspension 44070978 OMOP1065609 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 1000000000 UNT/ML Injectable Suspension VO:0020386 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Typhim V] 44132616 OMOP1127247 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Typhim V] VO:0020387 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] 43698679 OMOP740517 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] VO:0020388 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution 44132775 OMOP1127406 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution VO:0020389 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension 43608543 OMOP740513 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension VO:0020390 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT Delayed Release Oral Capsule [Vivotif] 44124353 OMOP1118984 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT Delayed Release Oral Capsule [Vivotif] VO:0020391 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] 43624841 OMOP707741 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] VO:0020392 OHDSI Vaccine WG typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] 36937289 OMOP5206733 vaccine typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] VO:0020393 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] 43193301 OMOP478117 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] VO:0020394 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 10 43696992 OMOP707732 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 10 VO:0020395 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 20 43750892 OMOP707733 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 20 VO:0020396 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 50 43859160 OMOP707734 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 50 VO:0020397 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT Delayed Release Oral Capsule 44109650 OMOP1104281 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT Delayed Release Oral Capsule VO:0020398 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 10 43679176 OMOP707728 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 10 VO:0020399 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 20 43750891 OMOP707729 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 20 VO:0020400 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 50 43768854 OMOP707730 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 50 VO:0020401 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Typhim V] by Sanofi 44132546 OMOP1127177 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Intramuscular Solution [Typhim V] by Sanofi VO:0020402 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] by Glaxosmithkline 43770503 OMOP740518 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] by Glaxosmithkline VO:0020403 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT Oral Powder [Vivotif] by Berna Biotech 44113473 OMOP1108104 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT Oral Powder [Vivotif] by Berna Biotech VO:0020404 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 1000000000 UNT/ML Injectable Suspension by Aventis 44035884 OMOP1030515 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 1000000000 UNT/ML Injectable Suspension by Aventis VO:0020405 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 10 43626500 OMOP740519 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 10 VO:0020406 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 20 43806382 OMOP740521 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 20 VO:0020407 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 50 43770504 OMOP740523 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 50 VO:0020408 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] 43684255 OMOP719053 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] VO:0020409 OHDSI Vaccine WG obsolete 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] true VO:0020410 OHDSI Vaccine WG 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] 36938486 43791865 OMOP5207894 OMOP719050 vaccine 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] VO:0020411 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] 43142846 OMOP506919 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] VO:0020412 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 10 43734585 OMOP740514 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 10 VO:0020413 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 20 43770501 OMOP740515 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 20 VO:0020414 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 50 43770502 OMOP740516 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension Box of 50 VO:0020415 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution 43774087 OMOP719046 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution VO:0020416 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 1 35410733 OMOP1144318 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 1 VO:0020417 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 10 43606935 OMOP707742 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 10 VO:0020418 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 100 43804816 OMOP707744 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 100 VO:0020419 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 50 43643090 OMOP707743 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 50 VO:0020420 OHDSI Vaccine WG obsolete Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 true VO:0020421 OHDSI Vaccine WG typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 36921202 40749997 OMOP4707289 OMOP5206734 vaccine typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 VO:0020422 OHDSI Vaccine WG obsolete Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 true VO:0020423 OHDSI Vaccine WG typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 36947181 40749996 OMOP4707290 OMOP5206735 vaccine typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 VO:0020424 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] Box of 1 43171357 OMOP478118 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] Box of 1 VO:0020425 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Box of 1 43204309 OMOP478114 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Box of 1 VO:0020426 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 1 35412892 OMOP1146477 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 1 VO:0020427 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 10 43732933 OMOP707738 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 10 VO:0020428 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 100 43732934 OMOP707740 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 100 VO:0020429 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 50 43606934 OMOP707739 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 50 VO:0020430 OHDSI Vaccine WG Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe Box of 1 43171356 OMOP478116 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe Box of 1 VO:0020431 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] by Glaxosmithkline 43738118 OMOP719054 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] by Glaxosmithkline VO:0020432 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] by Sanofi true VO:0020433 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] by Sanofi 36934225 43594110 OMOP5207895 OMOP719052 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] by Sanofi VO:0020434 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] by Waymade true VO:0020435 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] by Waymade 36952652 40719395 OMOP4737834 OMOP5207896 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] by Waymade VO:0020436 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 10 by Glaxosmithkline 43698680 OMOP740520 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 10 by Glaxosmithkline VO:0020437 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 20 by Glaxosmithkline 43734586 OMOP740522 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 20 by Glaxosmithkline VO:0020438 OHDSI Vaccine WG 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 50 by Glaxosmithkline 43734587 OMOP740524 vaccine 1 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.025 MG/ML Injectable Suspension [Hepatyrix] Box of 50 by Glaxosmithkline VO:0020439 OHDSI Vaccine WG Typhoid Vaccine Live Ty21a 10000000000 UNT Delayed Release Oral Capsule [Vivotif] by Paxvax Berna 44035883 OMOP1030514 vaccine Typhoid Vaccine Live Ty21a 10000000000 UNT Delayed Release Oral Capsule [Vivotif] by Paxvax Berna VO:0020440 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 1 35414655 OMOP1148240 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 1 VO:0020441 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 10 43756055 OMOP719055 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 10 VO:0020442 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 100 43666373 OMOP719059 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 100 VO:0020443 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 50 43594111 OMOP719057 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 50 VO:0020444 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 36934151 40719394 OMOP4737835 OMOP5207897 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 VO:0020445 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 true VO:0020446 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 true VO:0020447 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 36929118 40719391 OMOP4737838 OMOP5207900 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 VO:0020448 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] Box of 1 43208808 OMOP506920 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] Box of 1 VO:0020449 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Box of 1 43219808 OMOP506916 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Box of 1 VO:0020450 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 1 35414617 OMOP1148202 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 1 VO:0020451 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 10 43756054 OMOP719047 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 10 VO:0020452 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 100 43594109 OMOP719049 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 100 VO:0020453 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 50 43738117 OMOP719048 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution Box of 50 VO:0020454 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe Box of 1 43142845 OMOP506915 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe Box of 1 VO:0020455 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 1 by Glaxosmithkline 35414647 OMOP1148232 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 1 by Glaxosmithkline VO:0020456 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 10 by Glaxosmithkline 43666372 OMOP719056 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 10 by Glaxosmithkline VO:0020457 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 100 by Glaxosmithkline 43810029 OMOP719060 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 100 by Glaxosmithkline VO:0020458 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 50 by Glaxosmithkline 43612076 OMOP719058 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typherix] Box of 50 by Glaxosmithkline VO:0020459 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Sanofi true VO:0020460 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Sanofi 36932240 40719393 OMOP4737836 OMOP5207898 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Sanofi VO:0020461 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Waymade true VO:0020462 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Waymade 36941731 40719392 OMOP4737837 OMOP5207899 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 1 by Waymade VO:0020463 OHDSI Vaccine WG obsolete 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 by Sanofi true VO:0020464 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 by Sanofi 36963560 40719390 OMOP4737839 OMOP5207901 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 by Sanofi VO:0020465 OHDSI Vaccine WG obsolete 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 by Waymade true VO:0020466 OHDSI Vaccine WG 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 by Waymade 36967490 40719389 OMOP4737840 OMOP5207902 vaccine 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution [Typhim VI] Box of 10 by Waymade VO:0020467 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] Box of 1 by Glaxosmithkline 43186914 OMOP506921 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typherix] Box of 1 by Glaxosmithkline VO:0020468 OHDSI Vaccine WG 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Box of 1 by Sanofi 43153982 OMOP506917 vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Box of 1 by Sanofi VO:0020469 OHDSI Vaccine WG 807222 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 25 MCG per 0.5 ML Injectable Solution 19132273 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution VO:0020470 OHDSI Vaccine WG 1486497 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] Typhim VI 0.05 MG/ML Prefilled Syringe 44785329 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] VO:0020471 Xingxian Li vaccine Fluvirin 2011-2012 Formula vaccine VO:0020472 OHDSI Vaccine WG 1359739 typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe 42902626 vaccine Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe VO:0020473 Xingxian Li vaccine Fluvirin 2012-2013 Formula vaccine VO:0020474 OHDSI Vaccine WG vaccine 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe [Typhim VI] VO:0020475 OHDSI Vaccine WG obsolete 0.5 ML Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe true VO:0020476 Xingxian Li vaccine Fluvirin 2013-2014 Formula vaccine VO:0020477 Xingxian Li vaccine Fluvirin 2014-2015 Formula vaccine VO:0020478 Xingxian Li vaccine Fluzone 2010-2011 Formula vaccine VO:0020479 Xingxian Li vaccine Fluzone 2011-2012 Formula vaccine VO:0020480 Xingxian Li vaccine Fluzone 2012-2013 Formula vaccine VO:0020481 Xingxian Li vaccine Fluzone 2013-2014 Formula vaccine VO:0020482 Xingxian Li vaccine Fluzone 2014-2015 Formula vaccine VO:0020483 Xingxian Li vaccine Fluzone 2019-2020 vaccine VO:0020484 Xingxian Li vaccine Fluzone High-Dose 2013-2014 Formula vaccine VO:0020485 Xingxian Li vaccine Fluzone High-Dose 2014-2015 Formula vaccine VO:0020486 Xingxian Li vaccine Fluzone Intradermal 2013-2014 Formula vaccine VO:0020487 Xingxian Li vaccine Fluzone Intradermal 2014-2015 Formula vaccine VO:0020488 Xingxian Li vaccine Fluzone Quadrivalent 2016 Southern Hemisphere vaccine VO:0020489 Xingxian Li vaccine Fluzone Quadrivalent 2019-2020 vaccine VO:0020490 Xingxian Li vaccine Fluzone Quadrivalent 2020 Southern Hemisphere vaccine VO:0020491 Xingxian Li vaccine Fluzone Quadrivalent 2020-2021 vaccine VO:0020492 Xingxian Li vaccine Fluzone Quadrivalent 2021 Southern Hemisphere vaccine VO:0020493 Xingxian Li vaccine Fluzone Quadrivalent 2021-2022 vaccine VO:0020494 Xingxian Li vaccine Fluzone Quadrivalent 2022 Southern Hemisphere vaccine VO:0020495 Xingxian Li vaccine Fluzone Quadrivalent 2022-2023 vaccine VO:0020496 Xingxian Li vaccine Fluzone Quadrivalent 2023 Southern Hemisphere vaccine VO:0020497 Xingxian Li vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 VO:0020498 Xingxian Li vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 VO:0020499 OHDSI Vaccine WG 1364467 Haemophilus influenzae 43012721 vaccine component Haemophilus influenzae as vaccine component VO:0020500 OHDSI Vaccine WG 1491863 hepatitis C virus 44814323 vaccine component hepatitis C virus as vaccine component VO:0020501 OHDSI Vaccine WG 1312375 influenza A virus 42903441 vaccine component influenza A virus as vaccine component VO:0020502 OHDSI Vaccine WG 1312376 influenza B virus influenza B virus whole 42903442 vaccine component influenza B virus as vaccine component VO:0020503 OHDSI Vaccine WG 1439114 Japanese encephalitis virus 44506749 vaccine component Japanese encephalitis virus as vaccine component VO:0020504 OHDSI Vaccine WG 7288 Neisseria meningitidis 515671 vaccine component Neisseria meningitidis as vaccine component VO:0020505 OHDSI Vaccine WG 1648419 rabies virus 46234308 vaccine component rabies virus as vaccine component VO:0020506 OHDSI Vaccine WG 1744460 Rickettsia prowazekii 35603526 vaccine component Rickettsia prowazekii as vaccine component VO:0020507 OHDSI Vaccine WG 1365969 rubella virus 43012953 vaccine component rubella virus as vaccine component VO:0020508 OHDSI Vaccine WG 1432993 Yersinia pestis 43560347 vaccine component Yersinia pestis as vaccine component VO:0020509 OHDSI Vaccine WG 50937 Haemophilus influenzae type b 19113026 vaccine component Haemophilus influenzae type b as vaccine component VO:0020510 OHDSI Vaccine WG 1491862 hepatitis A virus 44814322 vaccine component hepatitis A virus as vaccine component VO:0020511 OHDSI Vaccine WG 1427211 hepatitis B virus 43532406 vaccine component hepatitis B virus as vaccine component VO:0020512 OHDSI Vaccine WG 1427212 poliovirus 43532418 vaccine component poliovirus as vaccine component VO:0020513 OHDSI Vaccine WG 1432992 Vibrio cholerae 43560345 vaccine component Vibrio cholerae as vaccine component VO:0020514 OHDSI Vaccine WG 0.1 ML BCG, Live, Connaught Strain 1 MG/ML Injectable Solution 44132415 OMOP1127046 vaccine 0.1 ML BCG, Live, Connaught Strain 1 MG/ML Injectable Solution VO:0020515 OHDSI Vaccine WG 0.1 ML BCG, Live, Connaught Strain 1 MG/ML Injectable Solution by Sanofi 44132431 OMOP1127062 vaccine 0.1 ML BCG, Live, Connaught Strain 1 MG/ML Injectable Solution by Sanofi VO:0020516 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray 44132442 OMOP1127073 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray VO:0020517 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray [FluMist Quadrivalent] 44132460 OMOP1127091 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray [FluMist Quadrivalent] VO:0020518 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray [FluMist Quadrivalent] by Astrazeneca 44132450 OMOP1127081 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray [FluMist Quadrivalent] by Astrazeneca VO:0020519 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray 44132438 OMOP1127069 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray VO:0020520 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] 44132447 OMOP1127078 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] VO:0020521 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] Box of 5 44132443 OMOP1127074 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] Box of 5 VO:0020522 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] Box of 5 by Astrazeneca 44132441 OMOP1127072 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] Box of 5 by Astrazeneca VO:0020523 OHDSI Vaccine WG 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray Box of 5 44132454 OMOP1127085 vaccine 0.2 ML influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray Box of 5 VO:0020524 OHDSI Vaccine WG 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension 43633809 OMOP715582 vaccine 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension VO:0020525 OHDSI Vaccine WG 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] 43723554 OMOP715584 vaccine 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] VO:0020526 OHDSI Vaccine WG 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 43795508 OMOP715587 vaccine 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 VO:0020527 OHDSI Vaccine WG 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 by Mylan 43813623 OMOP715588 vaccine 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 by Mylan VO:0020528 OHDSI Vaccine WG 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] by Mylan 43633810 OMOP715585 vaccine 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] by Mylan VO:0020529 OHDSI Vaccine WG 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 43597637 OMOP715583 vaccine 0.25 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 VO:0020530 OHDSI Vaccine WG 0.5 ML A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension 35414652 OMOP1148237 vaccine 0.5 ML A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension VO:0020531 OHDSI Vaccine WG 0.5 ML A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension [INFLUVAC] 35414599 OMOP1148184 vaccine 0.5 ML A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension [INFLUVAC] VO:0020532 OHDSI Vaccine WG 0.5 ML A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension Box of 1 35414575 OMOP1148160 vaccine 0.5 ML A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension Box of 1 VO:0020533 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution 44132576 OMOP1127207 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution VO:0020534 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] 44132722 OMOP1127353 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] VO:0020535 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] Box of 5 44132681 OMOP1127312 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] Box of 5 VO:0020536 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] Box of 5 by Praxis Biologics 44132644 OMOP1127275 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] Box of 5 by Praxis Biologics VO:0020537 OHDSI Vaccine WG 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution Box of 5 44132748 OMOP1127379 vaccine 0.5 ML diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution Box of 5 VO:0020538 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension 43720029 OMOP719840 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension VO:0020539 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] 43594165 OMOP719905 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] VO:0020540 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] Box of 10 43720036 OMOP719907 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] Box of 10 VO:0020541 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] Box of 10 by bioCSL 43864462 OMOP719908 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] Box of 10 by bioCSL VO:0020542 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] by bioCSL 43612139 OMOP719906 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] by bioCSL VO:0020543 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] 43684295 OMOP719921 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] VO:0020544 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] Box of 10 43756092 OMOP719923 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] Box of 10 VO:0020545 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] Box of 10 by Novartis 43720038 OMOP719925 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] Box of 10 by Novartis VO:0020546 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] by Novartis 43774140 OMOP719922 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] by Novartis VO:0020547 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] 43630232 OMOP719896 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] VO:0020548 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] Box of 10 43828152 OMOP719898 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] Box of 10 VO:0020549 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] Box of 10 by Novartis 43648299 OMOP719899 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] Box of 10 by Novartis VO:0020550 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] by Novartis 43720035 OMOP719897 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] by Novartis VO:0020551 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] 43774141 OMOP719926 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] VO:0020552 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 10 43810075 OMOP719928 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 10 VO:0020553 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 10 by Glaxosmithkline 43828153 OMOP719929 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 10 by Glaxosmithkline VO:0020554 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 20 43666424 OMOP719930 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 20 VO:0020555 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 20 by Glaxosmithkline 43756093 OMOP719931 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 20 by Glaxosmithkline VO:0020556 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] by Glaxosmithkline 43648300 OMOP719927 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] by Glaxosmithkline VO:0020557 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] 43791924 OMOP719900 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] VO:0020558 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] Box of 10 43612138 OMOP719903 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] Box of 10 VO:0020559 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] Box of 10 by bioCSL 43630233 OMOP719904 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] Box of 10 by bioCSL VO:0020560 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] by bioCSL 43684294 OMOP719902 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] by bioCSL VO:0020561 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] 43594163 OMOP719892 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] VO:0020562 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] Box of 10 43594164 OMOP719894 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] Box of 10 VO:0020563 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] Box of 10 by Mylan 43612137 OMOP719895 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] Box of 10 by Mylan VO:0020564 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] by Mylan 43791923 OMOP719893 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] by Mylan VO:0020565 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] 43666423 OMOP719909 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] VO:0020566 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] Box of 10 43720037 OMOP719911 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] Box of 10 VO:0020567 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] Box of 10 by Mylan 43612140 OMOP719914 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] Box of 10 by Mylan VO:0020568 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] by Mylan 43738158 OMOP719910 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] by Mylan VO:0020569 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] 43846189 OMOP719851 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] VO:0020570 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] Box of 10 43738155 OMOP719853 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] Box of 10 VO:0020571 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] Box of 10 by Crucell 43864459 OMOP719854 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] Box of 10 by Crucell VO:0020572 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] by Crucell 43594158 OMOP719852 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] by Crucell VO:0020573 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] 43846191 OMOP719915 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] VO:0020574 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 10 43594166 OMOP719917 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 10 VO:0020575 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 10 by Glaxosmithkline 43810073 OMOP719918 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 10 by Glaxosmithkline VO:0020576 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 20 43810074 OMOP719919 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 20 VO:0020577 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 20 by Glaxosmithkline 43846192 OMOP719920 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 20 by Glaxosmithkline VO:0020578 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] by Glaxosmithkline 43756091 OMOP719916 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] by Glaxosmithkline VO:0020579 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] 43684292 OMOP719874 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] VO:0020580 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 43594161 OMOP719876 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 VO:0020581 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 by Mylan 43720033 OMOP719877 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 by Mylan VO:0020582 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] by Mylan 43594160 OMOP719875 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] by Mylan VO:0020583 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] 43774137 OMOP719842 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] VO:0020584 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] Box of 10 43648297 OMOP719844 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] Box of 10 VO:0020585 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] Box of 10 by Baxter 43666421 OMOP719845 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] Box of 10 by Baxter VO:0020586 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] by Baxter 43810066 OMOP719843 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] by Baxter VO:0020587 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] 43864461 OMOP719883 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] VO:0020588 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 10 43774138 OMOP719885 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 10 VO:0020589 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 10 by Sanofi 43684293 OMOP719886 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 10 by Sanofi VO:0020590 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 20 43594162 OMOP719887 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 20 VO:0020591 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 20 by Sanofi 43774139 OMOP719888 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 20 by Sanofi VO:0020592 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 50 43846190 OMOP719889 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 50 VO:0020593 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 50 by Sanofi 43791922 OMOP719891 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 50 by Sanofi VO:0020594 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] by Sanofi 43810072 OMOP719884 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] by Sanofi VO:0020595 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] 43612136 OMOP719846 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] VO:0020596 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] Box of 10 43630227 OMOP719848 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] Box of 10 VO:0020597 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] Box of 10 by Crucell 43810067 OMOP719849 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] Box of 10 by Crucell VO:0020598 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] by Crucell 43846188 OMOP719847 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] by Crucell VO:0020599 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] 43791921 OMOP719870 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] VO:0020600 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] Box of 10 43720032 OMOP719872 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] Box of 10 VO:0020601 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] Box of 10 by Mylan 43630230 OMOP719873 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] Box of 10 by Mylan VO:0020602 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] by Mylan 43666422 OMOP719871 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] by Mylan VO:0020603 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 43864415 OMOP719083 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 VO:0020604 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 by Evans Vaccines 43864416 OMOP719090 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 by Evans Vaccines VO:0020605 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 by Sanofi 43810060 OMOP719696 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 by Sanofi VO:0020606 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 20 43684257 OMOP719091 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 20 VO:0020607 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 20 by Evans Vaccines 43719974 OMOP719092 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 20 by Evans Vaccines VO:0020608 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 50 43612077 OMOP719084 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 50 VO:0020609 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 50 by Evans Vaccines 43810032 OMOP719085 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 50 by Evans Vaccines VO:0020610 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension by Evans Vaccines 43702257 OMOP719082 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension by Evans Vaccines VO:0020611 OHDSI Vaccine WG 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension by Sanofi 43702258 OMOP719089 vaccine 0.5 ML influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension by Sanofi VO:0020612 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injectable Solution 43612081 OMOP719137 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injectable Solution VO:0020613 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] by Merck 44132591 OMOP1127222 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] by Merck VO:0020614 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] by Sanofi 43828113 OMOP719139 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injection [Varivax] by Sanofi VO:0020615 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution 44132563 OMOP1127194 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution VO:0020616 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] 44132667 OMOP1127298 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] VO:0020617 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 41407827 OMOP2605789 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 VO:0020618 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Cc 41408319 OMOP2606281 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Cc VO:0020619 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Emra-Med 41408667 OMOP2606629 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Emra-Med VO:0020620 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Eurim-Pharm 41409033 OMOP2606995 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Eurim-Pharm VO:0020621 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Kohlpharma 41410175 OMOP2608137 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Kohlpharma VO:0020622 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Orifarm Leverkus 41409032 OMOP2606994 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 by Orifarm Leverkus VO:0020623 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 43612083 OMOP719148 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 VO:0020624 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Cc 41408853 OMOP2606815 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Cc VO:0020625 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Emra-Med 41409992 OMOP2607954 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Emra-Med VO:0020626 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Eurim-Pharm 41408107 OMOP2606069 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Eurim-Pharm VO:0020627 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Glaxosmithkline 43719978 OMOP719149 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Glaxosmithkline VO:0020628 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Kohlpharma 41408666 OMOP2606628 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Kohlpharma VO:0020629 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Orifarm Leverkus 41409247 OMOP2607209 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 by Orifarm Leverkus VO:0020630 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] by Glaxosmithkline 44132628 OMOP1127259 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] by Glaxosmithkline VO:0020631 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 1 41408395 OMOP2606357 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 1 VO:0020632 OHDSI Vaccine WG 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 10 43684260 OMOP719141 vaccine 0.5 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 10 VO:0020633 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension 44135579 OMOP1130210 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension VO:0020634 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension [Zostavax] 44135577 OMOP1130208 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension [Zostavax] VO:0020635 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension [Zostavax] by Merck 44135578 OMOP1130209 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension [Zostavax] by Merck VO:0020636 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe 41446175 OMOP2644137 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe VO:0020637 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] 41446202 OMOP2644164 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] VO:0020638 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 41446176 OMOP2644138 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 VO:0020639 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 by Merck 44201226 OMOP3077949 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 by Merck VO:0020640 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 by Sanofi 41446197 OMOP2644159 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 by Sanofi VO:0020641 OHDSI Vaccine WG 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe Box of 1 41446180 OMOP2644142 vaccine 0.65 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe Box of 1 VO:0020642 OHDSI Vaccine WG 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution 36073732 OMOP4979609 vaccine 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution VO:0020643 OHDSI Vaccine WG 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution Box of 10 36073730 OMOP4979607 vaccine 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution Box of 10 VO:0020644 OHDSI Vaccine WG 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution Box of 10 by AJ Vaccines 36073731 OMOP4979608 vaccine 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution Box of 10 by AJ Vaccines VO:0020645 OHDSI Vaccine WG 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution by AJ Vaccines 36073733 OMOP4979610 vaccine 1 ML BCG, live, Connaught strain 20000 UNT/ML Injectable Solution by AJ Vaccines VO:0020646 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution 41332117 OMOP2530079 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution VO:0020647 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] 41335731 OMOP2533693 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] VO:0020648 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 1 41327697 OMOP2525659 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 1 VO:0020649 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 1 by European 41327980 44189356 OMOP2525942 OMOP3066079 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 1 by European VO:0020651 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 10 41333713 OMOP2531675 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 10 VO:0020652 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 10 by European 41331270 44189941 OMOP2529232 OMOP3066664 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 10 by European VO:0020654 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 1 41330785 OMOP2528747 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 1 VO:0020655 OHDSI Vaccine WG 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 10 41327506 OMOP2525468 vaccine 1 ML Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 10 VO:0020656 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution 43611712 OMOP817111 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution VO:0020657 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] 43666052 OMOP817115 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] VO:0020658 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 3 43647940 OMOP817117 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 3 VO:0020659 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 3 by Sanofi 43845820 OMOP817118 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 3 by Sanofi VO:0020660 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 5 43827736 OMOP817119 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 5 VO:0020661 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 5 by Sanofi 43773741 OMOP817121 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 5 by Sanofi VO:0020662 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 6 43827737 OMOP817122 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 6 VO:0020663 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 6 by Sanofi 43864045 OMOP817123 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 6 by Sanofi VO:0020664 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] by Sanofi 43827735 OMOP817116 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] by Sanofi VO:0020665 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 3 43719615 OMOP817112 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 3 VO:0020666 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 5 43864044 OMOP817113 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 5 VO:0020667 OHDSI Vaccine WG 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 6 43737754 OMOP817114 vaccine 50 ML BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 6 VO:0020668 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension 784848 OMOP4832667 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension VO:0020669 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] 784850 OMOP4832669 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] VO:0020670 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] Box of 1 784851 OMOP4832670 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] Box of 1 VO:0020671 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] Box of 1 by Lamepro 784852 OMOP4832671 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] Box of 1 by Lamepro VO:0020672 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] by Lamepro 42658551 OMOP4870114 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] by Lamepro VO:0020673 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension Box of 1 784849 OMOP4832668 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension Box of 1 VO:0020674 OHDSI Vaccine WG 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension by Lamepro 42683741 OMOP4912798 vaccine 50 ML BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension by Lamepro VO:0020675 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension 35411181 OMOP1144766 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension VO:0020676 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [INFLUVAC] 35408151 OMOP1141736 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / influenza A-California-7-2009-(H1N1)v-like virus vaccine / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [INFLUVAC] VO:0020677 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension 35411183 OMOP1144768 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension VO:0020678 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [IMMUGRIP] 35408945 OMOP1142530 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [IMMUGRIP] VO:0020679 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [VAXIGRIP] 35410458 OMOP1144043 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [VAXIGRIP] VO:0020680 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension 35410393 OMOP1143978 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension VO:0020681 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [Fluarix] 35412834 OMOP1146419 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus / Influenza Virus Vaccine, Inactivated A-Christchurch-16-2010 NIB-74 (H1N1) (A-California-7-2009) strain / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain Injectable Suspension [Fluarix] VO:0020682 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML [INFLUVAC] 35408057 OMOP1141642 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML [INFLUVAC] VO:0020683 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension 35412909 OMOP1146494 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension VO:0020684 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension [INFLUVAC] 35412351 OMOP1145936 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension [INFLUVAC] VO:0020685 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 1 35409237 OMOP1142822 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 1 VO:0020686 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension Box of 1 35410544 OMOP1144129 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension Box of 1 VO:0020687 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML [IMMUGRIP] 35410361 OMOP1143946 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML [IMMUGRIP] VO:0020688 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML [VAXIGRIP] 35408075 OMOP1141660 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML [VAXIGRIP] VO:0020689 OHDSI Vaccine WG A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension 35409039 OMOP1142624 vaccine A/Hong Kong/4801/2014 (H3n2) - Like Virus 0.03 MG/ML / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain 0.03 MG/ML / Influenza Virus Vaccine, Inactivated B-Brisbane-60-2008 strain 0.03 MG/ML Injectable Suspension VO:0020690 OHDSI Vaccine WG Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Injectable Solution 44187045 OMOP3063768 vaccine Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Injectable Solution VO:0020691 OHDSI Vaccine WG Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Injectable Solution [Metavirulent] 44175999 OMOP3052722 vaccine Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Injectable Solution [Metavirulent] VO:0020692 OHDSI Vaccine WG Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Oral Solution 44183300 OMOP3060023 vaccine Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Oral Solution VO:0020693 OHDSI Vaccine WG Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Oral Solution [Metavirulent] 44168558 OMOP3045281 vaccine Aconitum napellus extract / ferrous cation / Gelsemium Sempervirens Preparation / Gentiana lutea root extract / Influenza A virus / Lactate / Luffa operculata whole extract / VERATRUM ALBUM Preparation Oral Solution [Metavirulent] VO:0020694 OHDSI Vaccine WG Antigens Surface Of Virus Influenza, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 36879013 OMOP1004394 vaccine Antigens Surface Of Virus Influenza, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 VO:0020695 OHDSI Vaccine WG Antigens Surface Of Virus Influenza, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 0.03 MG/ML 43167156 OMOP441055 vaccine Antigens Surface Of Virus Influenza, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 0.03 MG/ML VO:0020696 OHDSI Vaccine WG Antigens Surface Of Virus Influenza, strain B / Brisbane / 9/2014 Wild Type 36879093 OMOP995333 vaccine Antigens Surface Of Virus Influenza, strain B / Brisbane / 9/2014 Wild Type VO:0020697 OHDSI Vaccine WG Antigens Surface Of Virus Influenza, strain B / Brisbane / 9/2014 Wild Type 0.03 MG/ML 43201435 OMOP452068 vaccine Antigens Surface Of Virus Influenza, strain B / Brisbane / 9/2014 Wild Type 0.03 MG/ML VO:0020698 OHDSI Vaccine WG BCG, Live, Connaught Strain 1 MG/ML 44118056 OMOP1112687 vaccine BCG, Live, Connaught Strain 1 MG/ML VO:0020699 OHDSI Vaccine WG BCG, Live, Connaught Strain 1 MG/ML Injectable Solution 44124002 OMOP1118633 vaccine BCG, Live, Connaught Strain 1 MG/ML Injectable Solution VO:0020700 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML 43624938 OMOP709363 vaccine BCG, Live, Connaught Strain 1.62 MG/ML VO:0020701 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML [ImmuCyst] 43859262 OMOP709364 vaccine BCG, Live, Connaught Strain 1.62 MG/ML [ImmuCyst] VO:0020702 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution 43823018 OMOP709365 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution VO:0020703 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] 43768951 OMOP709369 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] VO:0020704 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 3 43643190 OMOP709370 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 3 VO:0020705 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 5 43786917 OMOP709371 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 5 VO:0020706 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 6 43715003 OMOP709372 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution [ImmuCyst] Box of 6 VO:0020707 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 3 43624939 OMOP709366 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 3 VO:0020708 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 5 43859263 OMOP709367 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 5 VO:0020709 OHDSI Vaccine WG BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 6 43643189 OMOP709368 vaccine BCG, Live, Connaught Strain 1.62 MG/ML Injectable Solution Box of 6 VO:0020710 OHDSI Vaccine WG BCG, Live, Connaught Strain 1920000000 CFU 43274425 OMOP552675 vaccine BCG, Live, Connaught Strain 1920000000 CFU VO:0020711 OHDSI Vaccine WG BCG, Live, Connaught Strain 1920000000 CFU [ImmuCyst] 43268890 OMOP552676 vaccine BCG, Live, Connaught Strain 1920000000 CFU [ImmuCyst] VO:0020712 OHDSI Vaccine WG BCG, Live, Connaught Strain 1920000000 CFU Injection 43279769 OMOP552677 vaccine BCG, Live, Connaught Strain 1920000000 CFU Injection VO:0020713 OHDSI Vaccine WG BCG, Live, Connaught Strain 1920000000 CFU Injection [ImmuCyst] 43279770 OMOP552678 vaccine BCG, Live, Connaught Strain 1920000000 CFU Injection [ImmuCyst] VO:0020714 OHDSI Vaccine WG BCG, live, Connaught strain 20000 UNT/ML 36074334 OMOP4986504 vaccine BCG, live, Connaught strain 20000 UNT/ML VO:0020715 OHDSI Vaccine WG BCG, live, Connaught strain 20000 UNT/ML Injectable Solution 36074333 OMOP4986503 vaccine BCG, live, Connaught strain 20000 UNT/ML Injectable Solution VO:0020716 OHDSI Vaccine WG BCG, live, Connaught strain 20000 UNT/ML Injectable Solution Box of 10 36060659 OMOP4986501 vaccine BCG, live, Connaught strain 20000 UNT/ML Injectable Solution Box of 10 VO:0020717 OHDSI Vaccine WG BCG, Live, Connaught Strain 660000000 CFU 43257999 OMOP552671 vaccine BCG, Live, Connaught Strain 660000000 CFU VO:0020718 OHDSI Vaccine WG BCG, Live, Connaught Strain 660000000 CFU [ImmuCyst] 43258000 OMOP552672 vaccine BCG, Live, Connaught Strain 660000000 CFU [ImmuCyst] VO:0020719 OHDSI Vaccine WG BCG, Live, Connaught Strain 660000000 CFU Injection 43290604 OMOP552673 vaccine BCG, Live, Connaught Strain 660000000 CFU Injection VO:0020720 OHDSI Vaccine WG BCG, Live, Connaught Strain 660000000 CFU Injection [ImmuCyst] 43290605 OMOP552674 vaccine BCG, Live, Connaught Strain 660000000 CFU Injection [ImmuCyst] VO:0020721 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG 21047191 OMOP278739 vaccine BCG, Live, Connaught Strain 81 MG VO:0020722 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG [ImmuCyst] 21056922 OMOP278740 vaccine BCG, Live, Connaught Strain 81 MG [ImmuCyst] VO:0020723 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Solution 21027513 OMOP278741 vaccine BCG, Live, Connaught Strain 81 MG Injectable Solution VO:0020724 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] 21056923 OMOP278744 vaccine BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] VO:0020725 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] Box of 1 21155208 OMOP278746 vaccine BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] Box of 1 VO:0020726 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] Box of 1 by Alliance 21115828 OMOP278747 vaccine BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] Box of 1 by Alliance VO:0020727 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] by Alliance 21086417 OMOP278745 vaccine BCG, Live, Connaught Strain 81 MG Injectable Solution [ImmuCyst] by Alliance VO:0020728 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Solution Box of 1 21106049 OMOP278743 vaccine BCG, Live, Connaught Strain 81 MG Injectable Solution Box of 1 VO:0020729 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Suspension 36889667 OMOP998768 vaccine BCG, Live, Connaught Strain 81 MG Injectable Suspension VO:0020730 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] 36887961 OMOP1003184 vaccine BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] VO:0020731 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] Box of 1 36887960 OMOP1002041 vaccine BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] Box of 1 VO:0020732 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] Box of 1 by Sanofi 43201177 OMOP449758 vaccine BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] Box of 1 by Sanofi VO:0020733 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] by Sanofi 44129412 OMOP1124043 vaccine BCG, Live, Connaught Strain 81 MG Injectable Suspension [ImmuCyst] by Sanofi VO:0020734 OHDSI Vaccine WG BCG, Live, Connaught Strain 81 MG Injectable Suspension Box of 1 36894551 OMOP997929 vaccine BCG, Live, Connaught Strain 81 MG Injectable Suspension Box of 1 VO:0020735 OHDSI Vaccine WG BCG, Live, Connaught Strain Injectable Solution 21165020 OMOP278737 vaccine BCG, Live, Connaught Strain Injectable Solution VO:0020736 OHDSI Vaccine WG BCG, Live, Connaught Strain Injectable Solution [ImmuCyst] 21076673 OMOP278738 vaccine BCG, Live, Connaught Strain Injectable Solution [ImmuCyst] VO:0020737 OHDSI Vaccine WG BCG, Live, Connaught Strain Injectable Suspension 36888502 OMOP1004994 vaccine BCG, Live, Connaught Strain Injectable Suspension VO:0020738 OHDSI Vaccine WG BCG, Live, Connaught Strain Injectable Suspension [ImmuCyst] 36882769 OMOP993796 vaccine BCG, Live, Connaught Strain Injectable Suspension [ImmuCyst] VO:0020739 OHDSI Vaccine WG BCG, live, Connaught strain Injectable Suspension [InterVax] 36074335 OMOP4986505 vaccine BCG, live, Connaught strain Injectable Suspension [InterVax] VO:0020740 OHDSI Vaccine WG BCG, Live, Connaught Strain Injection 36881781 OMOP1005550 vaccine BCG, Live, Connaught Strain Injection VO:0020741 OHDSI Vaccine WG BCG, Live, Connaught Strain Injection [ImmuCyst] 36890586 OMOP998050 vaccine BCG, Live, Connaught Strain Injection [ImmuCyst] VO:0020742 OHDSI Vaccine WG BCG, Live, Montreal Strain 120 MG 44079224 OMOP1073855 vaccine BCG, Live, Montreal Strain 120 MG VO:0020743 OHDSI Vaccine WG BCG, Live, Montreal Strain 120 MG [Pacis] 44119958 OMOP1114589 vaccine BCG, Live, Montreal Strain 120 MG [Pacis] VO:0020744 OHDSI Vaccine WG BCG, Live, Montreal Strain 120 MG Injectable Solution 44110806 OMOP1105437 vaccine BCG, Live, Montreal Strain 120 MG Injectable Solution VO:0020745 OHDSI Vaccine WG BCG, Live, Montreal Strain 120 MG Injectable Solution [Pacis] 44061481 OMOP1056112 vaccine BCG, Live, Montreal Strain 120 MG Injectable Solution [Pacis] VO:0020746 OHDSI Vaccine WG BCG, Live, Montreal Strain 120 MG Injectable Solution [Pacis] by ID bio 44103451 OMOP1098082 vaccine BCG, Live, Montreal Strain 120 MG Injectable Solution [Pacis] by ID bio VO:0020747 OHDSI Vaccine WG BCG, Live, Montreal Strain 4000000 ORGANISMS/ML 783985 OMOP4831813 vaccine BCG, Live, Montreal Strain 4000000 ORGANISMS/ML VO:0020748 OHDSI Vaccine WG BCG, Live, Montreal Strain 4000000 ORGANISMS/ML [Bcg Medac] 783986 OMOP4831814 vaccine BCG, Live, Montreal Strain 4000000 ORGANISMS/ML [Bcg Medac] VO:0020749 OHDSI Vaccine WG BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension 783987 OMOP4831815 vaccine BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension VO:0020750 OHDSI Vaccine WG BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] 783989 OMOP4831817 vaccine BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] VO:0020751 OHDSI Vaccine WG BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] Box of 1 783991 OMOP4831818 vaccine BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension [Bcg Medac] Box of 1 VO:0020752 OHDSI Vaccine WG BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension Box of 1 783988 OMOP4831816 vaccine BCG, Live, Montreal Strain 4000000 ORGANISMS/ML Injectable Suspension Box of 1 VO:0020753 OHDSI Vaccine WG BCG, Live, Montreal Strain Injectable Solution 44107859 OMOP1102490 vaccine BCG, Live, Montreal Strain Injectable Solution VO:0020754 OHDSI Vaccine WG BCG, Live, Montreal Strain Injectable Solution [Pacis] 44031776 OMOP1026407 vaccine BCG, Live, Montreal Strain Injectable Solution [Pacis] VO:0020755 OHDSI Vaccine WG BCG, Live, Montreal Strain Injectable Suspension 783983 OMOP4831811 vaccine BCG, Live, Montreal Strain Injectable Suspension VO:0020756 OHDSI Vaccine WG BCG, Live, Montreal Strain Injectable Suspension [Bcg Medac] 783984 OMOP4831812 vaccine BCG, Live, Montreal Strain Injectable Suspension [Bcg Medac] VO:0020757 OHDSI Vaccine WG BCG, Live, Montreal Strain Injection 35766103 OMOP2767564 vaccine BCG, Live, Montreal Strain Injection VO:0020758 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG 21135385 OMOP278749 vaccine BCG, Live, Tice Strain 12.5 MG VO:0020759 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG [OncoTICE] 21115829 OMOP278750 vaccine BCG, Live, Tice Strain 12.5 MG [OncoTICE] VO:0020760 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Solution 21165021 OMOP278751 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Solution VO:0020761 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] 21076675 OMOP278754 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] VO:0020762 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] Box of 1 21155209 OMOP278756 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] Box of 1 VO:0020763 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] Box of 1 by Merck 21145269 OMOP278757 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] Box of 1 by Merck VO:0020764 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] by Merck 21096181 OMOP278755 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Solution [OncoTICE] by Merck VO:0020765 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Solution Box of 1 21047192 OMOP278753 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Solution Box of 1 VO:0020766 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Suspension 42948920 OMOP4675509 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Suspension VO:0020767 OHDSI Vaccine WG BCG, Live, Tice Strain 12.5 MG Injectable Suspension [OncoTICE] 42948919 OMOP4675508 vaccine BCG, Live, Tice Strain 12.5 MG Injectable Suspension [OncoTICE] VO:0020768 OHDSI Vaccine WG BCG, live, Tice strain 12.5 MG Injection 2042152 OMOP4941876 vaccine BCG, live, Tice strain 12.5 MG Injection VO:0020769 OHDSI Vaccine WG BCG, live, Tice strain 12.5 MG Injection [OncoTICE] 2042151 OMOP4941875 vaccine BCG, live, Tice strain 12.5 MG Injection [OncoTICE] VO:0020770 OHDSI Vaccine WG BCG, live, Tice strain 12.5 MG Injection [OncoTICE] by MSD 2042149 OMOP4941872 vaccine BCG, live, Tice strain 12.5 MG Injection [OncoTICE] by MSD VO:0020771 OHDSI Vaccine WG BCG, live, Tice strain 12.5 MG Injection [OncoTICE] by Organon 2042150 OMOP4941874 vaccine BCG, live, Tice strain 12.5 MG Injection [OncoTICE] by Organon VO:0020772 OHDSI Vaccine WG BCG, live, Tice strain 12.5 MG Injection [OncoTICE] by Schering-Plough 2010866 OMOP4941873 vaccine BCG, live, Tice strain 12.5 MG Injection [OncoTICE] by Schering-Plough VO:0020773 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS 36786282 OMOP4774554 vaccine BCG, Live, Tice Strain 200000000 CELLS VO:0020774 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS [OncoTICE] 36786281 OMOP4774553 vaccine BCG, Live, Tice Strain 200000000 CELLS [OncoTICE] VO:0020775 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension 36786280 OMOP4774552 vaccine BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension VO:0020776 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension [OncoTICE] 36786278 OMOP4774550 vaccine BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension [OncoTICE] VO:0020777 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension [OncoTICE] Box of 1 36786277 OMOP4774549 vaccine BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension [OncoTICE] Box of 1 VO:0020778 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension [OncoTICE] Box of 1 by MSD 36786276 OMOP4774548 vaccine BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension [OncoTICE] Box of 1 by MSD VO:0020779 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension Box of 1 36786279 OMOP4774551 vaccine BCG, Live, Tice Strain 200000000 CELLS Injectable Suspension Box of 1 VO:0020780 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS 36271728 OMOP3122603 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS VO:0020781 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS [OncoTICE] 36271974 OMOP3122849 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS [OncoTICE] VO:0020782 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension 36275136 OMOP3126011 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension VO:0020783 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] 36260714 OMOP3111589 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] VO:0020784 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] Box of 1 783289 OMOP4831120 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] Box of 1 VO:0020785 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] Box of 1 by MSD 783290 OMOP4831121 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] Box of 1 by MSD VO:0020786 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] by MSD 36273968 OMOP3124843 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension [OncoTICE] by MSD VO:0020787 OHDSI Vaccine WG BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension Box of 1 783288 OMOP4831119 vaccine BCG, Live, Tice Strain 200000000 ORGANISMS Injectable Suspension Box of 1 VO:0020788 OHDSI Vaccine WG BCG, Live, Tice Strain 500000000 CFU 43279771 OMOP552680 vaccine BCG, Live, Tice Strain 500000000 CFU VO:0020789 OHDSI Vaccine WG BCG, Live, Tice Strain 500000000 CFU [Oncotice Bcg] 43285188 OMOP552681 vaccine BCG, Live, Tice Strain 500000000 CFU [Oncotice Bcg] VO:0020790 OHDSI Vaccine WG BCG, Live, Tice Strain 500000000 CFU Injection 43279772 OMOP552682 vaccine BCG, Live, Tice Strain 500000000 CFU Injection VO:0020791 OHDSI Vaccine WG BCG, Live, Tice Strain 500000000 CFU Injection [Oncotice Bcg] 43285189 OMOP552683 vaccine BCG, Live, Tice Strain 500000000 CFU Injection [Oncotice Bcg] VO:0020792 OHDSI Vaccine WG BCG, Live, Tice Strain 500000000 CFU Injection [Oncotice Bcg] Box of 3 43515219 OMOP2802334 vaccine BCG, Live, Tice Strain 500000000 CFU Injection [Oncotice Bcg] Box of 3 VO:0020793 OHDSI Vaccine WG BCG, Live, Tice Strain 500000000 CFU Injection Box of 3 43515949 OMOP2803064 vaccine BCG, Live, Tice Strain 500000000 CFU Injection Box of 3 VO:0020794 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 CELLS 43607019 OMOP709375 vaccine BCG, Live, Tice Strain 800000000 CELLS VO:0020795 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 CELLS [OncoTICE] 43697092 OMOP709376 vaccine BCG, Live, Tice Strain 800000000 CELLS [OncoTICE] VO:0020796 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 CELLS Injectable Suspension 43768952 OMOP709377 vaccine BCG, Live, Tice Strain 800000000 CELLS Injectable Suspension VO:0020797 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 CELLS Injectable Suspension [OncoTICE] 43750986 OMOP709378 vaccine BCG, Live, Tice Strain 800000000 CELLS Injectable Suspension [OncoTICE] VO:0020798 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 CELLS Injectable Suspension [OncoTICE] by Organon 43823019 OMOP709379 vaccine BCG, Live, Tice Strain 800000000 CELLS Injectable Suspension [OncoTICE] by Organon VO:0020799 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 UNT 44053534 OMOP1048165 vaccine BCG, Live, Tice Strain 800000000 UNT VO:0020800 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 UNT [OncoTICE] 44042314 OMOP1036945 vaccine BCG, Live, Tice Strain 800000000 UNT [OncoTICE] VO:0020801 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 UNT Injectable Solution 44097982 OMOP1092613 vaccine BCG, Live, Tice Strain 800000000 UNT Injectable Solution VO:0020802 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 UNT Injectable Solution [OncoTICE] 44061480 OMOP1056111 vaccine BCG, Live, Tice Strain 800000000 UNT Injectable Solution [OncoTICE] VO:0020803 OHDSI Vaccine WG BCG, Live, Tice Strain 800000000 UNT Injectable Solution [OncoTICE] by Merck 44038684 OMOP1033315 vaccine BCG, Live, Tice Strain 800000000 UNT Injectable Solution [OncoTICE] by Merck VO:0020804 OHDSI Vaccine WG BCG, Live, Tice Strain Injectable Solution 42479084 OMOP419174 vaccine BCG, Live, Tice Strain Injectable Solution VO:0020805 OHDSI Vaccine WG BCG, Live, Tice Strain Injectable Solution [OncoTICE] 44109323 OMOP1103954 vaccine BCG, Live, Tice Strain Injectable Solution [OncoTICE] VO:0020806 OHDSI Vaccine WG BCG, Live, Tice Strain Injectable Suspension 36886597 OMOP999217 vaccine BCG, Live, Tice Strain Injectable Suspension VO:0020807 OHDSI Vaccine WG BCG, Live, Tice Strain Injectable Suspension [OncoTICE] 43661297 OMOP709374 vaccine BCG, Live, Tice Strain Injectable Suspension [OncoTICE] VO:0020808 OHDSI Vaccine WG BCG, Live, Tice Strain Injection [Oncotice Bcg] 43274426 OMOP552679 vaccine BCG, Live, Tice Strain Injection [Oncotice Bcg] VO:0020809 OHDSI Vaccine WG BCG, live, Tice strain Injection [OncoTICE] 2042153 OMOP4941877 vaccine BCG, live, Tice strain Injection [OncoTICE] VO:0020810 OHDSI Vaccine WG 1359638 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX] 42902525 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [PEDIARIX] VO:0020811 OHDSI Vaccine WG 1360312 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe 42903199 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0020812 OHDSI Vaccine WG 1359511 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Kinrix] 42902398 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Kinrix] VO:0020813 OHDSI Vaccine WG 1360171 acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe 42903058 vaccine acellular pertussis vaccine, inactivated 0.116 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0020814 OHDSI Vaccine WG 2585718 acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] 702274 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] VO:0020815 OHDSI Vaccine WG 1657758 acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] 46276419 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] VO:0020816 OHDSI Vaccine WG 2585715 acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 702272 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0020817 OHDSI Vaccine WG 1657757 acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 46276418 vaccine acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0020818 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen Injectable Solution 44107572 OMOP1102203 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen Injectable Solution VO:0020819 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated / influenza B virus antigen Injectable Solution [HibTITER] 44044438 OMOP1039069 vaccine diphtheria toxoid vaccine, inactivated / influenza B virus antigen Injectable Solution [HibTITER] VO:0020820 OHDSI Vaccine WG 1657874 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Daptacel] 46275086 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Daptacel] VO:0020821 OHDSI Vaccine WG 1360356 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel] 42903243 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Adacel] VO:0020822 OHDSI Vaccine WG 1657771 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Adacel] 46276423 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Adacel] VO:0020823 OHDSI Vaccine WG 1657769 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 46276422 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0020824 OHDSI Vaccine WG 1657873 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 46275085 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0020825 OHDSI Vaccine WG 1359594 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 42902481 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0020826 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML [HibTITER] 44041847 OMOP1036478 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML [HibTITER] VO:0020827 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution 44058882 OMOP1053513 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution VO:0020828 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] 44047990 OMOP1042621 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] VO:0020829 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] Box of 5 44060988 OMOP1055619 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution [HibTITER] Box of 5 VO:0020830 OHDSI Vaccine WG diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution Box of 5 44071698 OMOP1066329 vaccine diphtheria toxoid vaccine, inactivated 0.05 MG/ML / influenza B virus antigen 0.02 MG/ML Injectable Solution Box of 5 VO:0020831 OHDSI Vaccine WG Haemophilus influenzae 0.01 MG Injection 43269495 OMOP558384 vaccine Haemophilus influenzae 0.01 MG Injection VO:0020832 OHDSI Vaccine WG Haemophilus influenzae Injection 43269500 OMOP558410 vaccine Haemophilus influenzae Injection VO:0020833 OHDSI Vaccine WG Haemophilus influenzae type b 0.035 MG Injectable Solution 36269905 OMOP3120780 vaccine Haemophilus influenzae type b 0.035 MG Injectable Solution VO:0020834 OHDSI Vaccine WG Haemophilus influenzae type b 0.04 MG Injectable Solution 43643086 OMOP707641 vaccine Haemophilus influenzae type b 0.04 MG Injectable Solution VO:0020835 OHDSI Vaccine WG Haemophilus influenzae type b 0.05 MG Injectable Solution 43750879 OMOP707627 vaccine Haemophilus influenzae type b 0.05 MG Injectable Solution VO:0020836 OHDSI Vaccine WG Haemophilus influenzae type b Injectable Solution 43859153 OMOP707620 vaccine Haemophilus influenzae type b Injectable Solution VO:0020837 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Afluria] 43733277 OMOP713856 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Afluria] VO:0020838 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Begripal] 43643462 OMOP713859 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Begripal] VO:0020839 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Fluad] 43589233 OMOP713854 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Fluad] VO:0020840 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Fluarix] 43769218 OMOP713861 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Fluarix] VO:0020841 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Grippe-Impfstoff Csl] 43661571 OMOP713855 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Grippe-Impfstoff Csl] VO:0020842 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Grippe-Impfstoff Stada] 43751224 OMOP713851 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Grippe-Impfstoff Stada] VO:0020843 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Grippeimpfstoff Ratiopharm] 43661572 OMOP713857 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Grippeimpfstoff Ratiopharm] VO:0020844 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Inflexal] 43733275 OMOP713773 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Inflexal] VO:0020845 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Influsplit] 43859534 OMOP713858 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Influsplit] VO:0020846 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [INFLUVAC] 43643461 OMOP713848 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [INFLUVAC] VO:0020847 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Preflucel] 43715227 OMOP713766 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Preflucel] VO:0020848 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [VAXIGRIP] 43751223 OMOP713850 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [VAXIGRIP] VO:0020849 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Viroflu] 43859528 OMOP713772 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Viroflu] VO:0020850 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML [Xanaflu] 43697369 OMOP713847 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML [Xanaflu] VO:0020851 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension 43732937 OMOP707792 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension VO:0020852 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] 43643464 OMOP713881 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] VO:0020853 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] Box of 10 43607294 OMOP713882 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Afluria] Box of 10 VO:0020854 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] 43643465 OMOP713889 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] VO:0020855 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] Box of 10 43841387 OMOP713890 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Begripal] Box of 10 VO:0020856 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] 43769219 OMOP713877 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] VO:0020857 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] Box of 10 43841386 OMOP713878 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluad] Box of 10 VO:0020858 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] 43841389 OMOP713893 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] VO:0020859 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 10 43643466 OMOP713895 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 10 VO:0020860 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 20 43643467 OMOP713896 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Fluarix] Box of 20 VO:0020861 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] 43733281 OMOP713879 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] VO:0020862 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] Box of 10 43751225 OMOP713880 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Csl] Box of 10 VO:0020863 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] 43679500 OMOP713875 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] VO:0020864 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] Box of 10 43643463 OMOP713876 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippe-Impfstoff Stada] Box of 10 VO:0020865 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] 43805152 OMOP713884 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] VO:0020866 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] Box of 10 43607295 OMOP713885 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Grippeimpfstoff Ratiopharm] Box of 10 VO:0020867 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] 43661565 OMOP713776 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] VO:0020868 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] Box of 10 43589230 OMOP713777 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Inflexal] Box of 10 VO:0020869 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] 43679501 OMOP713886 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] VO:0020870 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 10 43607296 OMOP713887 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 10 VO:0020871 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 20 43751226 OMOP713888 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Influsplit] Box of 20 VO:0020872 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] 43589235 OMOP713866 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] VO:0020873 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 43805151 OMOP713867 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [INFLUVAC] Box of 10 VO:0020874 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] 43805145 OMOP713768 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] VO:0020875 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] Box of 10 43607284 OMOP713769 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Preflucel] Box of 10 VO:0020876 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] 43733279 OMOP713870 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] VO:0020877 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 10 43625199 OMOP713871 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 10 VO:0020878 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 20 43679499 OMOP713873 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 20 VO:0020879 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 50 43733280 OMOP713874 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [VAXIGRIP] Box of 50 VO:0020880 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] 43841379 OMOP713774 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] VO:0020881 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] Box of 10 43769213 OMOP713775 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Viroflu] Box of 10 VO:0020882 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] 43733278 OMOP713864 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] VO:0020883 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] Box of 10 43805150 OMOP713865 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension [Xanaflu] Box of 10 VO:0020884 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 43823257 OMOP713767 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 10 VO:0020885 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 20 43589234 OMOP713863 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 20 VO:0020886 OHDSI Vaccine WG influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 50 43661223 OMOP707794 vaccine influenza A virus (H1N1) antigen 0.03 MG/ML Injectable Suspension Box of 50 VO:0020887 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension 43607290 OMOP713832 vaccine influenza A virus (H1N1) antigen Injectable Suspension VO:0020888 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Afluria] 43823263 OMOP713840 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Afluria] VO:0020889 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Begripal] 43841384 OMOP713844 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Begripal] VO:0020890 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Fluad] 43787158 OMOP713838 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Fluad] VO:0020891 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Fluarix] 43805149 OMOP713846 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Fluarix] VO:0020892 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Grippe-Impfstoff Csl] 43751222 OMOP713839 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Grippe-Impfstoff Csl] VO:0020893 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Grippe-Impfstoff Stada] 43607292 OMOP713837 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Grippe-Impfstoff Stada] VO:0020894 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Grippeimpfstoff Ratiopharm] 43661570 OMOP713841 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Grippeimpfstoff Ratiopharm] VO:0020895 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Inflexal] 43607285 OMOP713771 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Inflexal] VO:0020896 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Influsplit] 43607293 OMOP713843 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Influsplit] VO:0020897 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [INFLUVAC] 43661569 OMOP713834 vaccine influenza A virus (H1N1) antigen Injectable Suspension [INFLUVAC] VO:0020898 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Pandemrix] 40745078 OMOP4712094 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Pandemrix] VO:0020899 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Preflucel] 43823256 OMOP713765 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Preflucel] VO:0020900 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [VAXIGRIP] 43751221 OMOP713836 vaccine influenza A virus (H1N1) antigen Injectable Suspension [VAXIGRIP] VO:0020901 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Viroflu] 43661564 OMOP713770 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Viroflu] VO:0020902 OHDSI Vaccine WG influenza A virus (H1N1) antigen Injectable Suspension [Xanaflu] 43697368 OMOP713833 vaccine influenza A virus (H1N1) antigen Injectable Suspension [Xanaflu] VO:0020903 OHDSI Vaccine WG Influenza A virus / Influenza B virus Injectable Suspension 36782737 OMOP4771017 vaccine Influenza A virus / Influenza B virus Injectable Suspension VO:0020904 OHDSI Vaccine WG Influenza A virus / Influenza B virus Injectable Suspension [Alpha RIX Tetra] 36782736 OMOP4771016 vaccine Influenza A virus / Influenza B virus Injectable Suspension [Alpha RIX Tetra] VO:0020905 OHDSI Vaccine WG Influenza A virus / Influenza B virus Injectable Suspension [INFLUVAC] 36782734 OMOP4771014 vaccine Influenza A virus / Influenza B virus Injectable Suspension [INFLUVAC] VO:0020906 OHDSI Vaccine WG Influenza A virus / Influenza B virus Injectable Suspension [VAXIGRIP] 36782735 OMOP4771015 vaccine Influenza A virus / Influenza B virus Injectable Suspension [VAXIGRIP] VO:0020907 OHDSI Vaccine WG Influenza A virus Injectable Suspension 36272024 OMOP3122899 vaccine Influenza A virus Injectable Suspension VO:0020908 OHDSI Vaccine WG Influenza A virus Injectable Suspension [Alpha RIX Tetra] 36259274 OMOP3110149 vaccine Influenza A virus Injectable Suspension [Alpha RIX Tetra] VO:0020909 OHDSI Vaccine WG Influenza A virus Injectable Suspension [INFLUVAC] 36272156 OMOP3123031 vaccine Influenza A virus Injectable Suspension [INFLUVAC] VO:0020910 OHDSI Vaccine WG Influenza A virus Injectable Suspension [VAXIGRIP] 36264405 OMOP3115280 vaccine Influenza A virus Injectable Suspension [VAXIGRIP] VO:0020911 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain Injectable Suspension 43172138 OMOP485123 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain Injectable Suspension VO:0020912 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain Injectable Suspension [Intanza] 43150002 OMOP485124 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-179A (H1N1) strain Injectable Suspension [Intanza] VO:0020913 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection 43254642 OMOP569769 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection VO:0020914 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Agrippal] 43276374 OMOP570704 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Agrippal] VO:0020915 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluarix] 43259942 OMOP570485 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluarix] VO:0020916 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluvax] 43281747 OMOP570162 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluvax] VO:0020917 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [INFLUVAC] 43276373 OMOP570380 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [INFLUVAC] VO:0020918 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Intanza] 43292575 OMOP570271 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Intanza] VO:0020919 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Vaxigrip Junior] 43270868 OMOP570056 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Vaxigrip Junior] VO:0020920 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [VAXIGRIP] 43265388 OMOP569950 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [VAXIGRIP] VO:0020921 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain Nasal Spray 43214537 OMOP472230 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain Nasal Spray VO:0020922 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain Nasal Spray [Fluenz] 43148570 OMOP472231 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus / Influenza B virus vaccine, B-Massachusetts-2-2012-like virus / Influenza Virus Vaccine, Live Attenuated, A-California-7-2009 (H1N1) strain Nasal Spray [Fluenz] VO:0020923 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.0075 MG/ML 43265392 OMOP573606 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.0075 MG/ML VO:0020924 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.00752 MG/ML 42712031 OMOP2743427 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.00752 MG/ML VO:0020925 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.009 MG/ML 43292582 OMOP573607 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.009 MG/ML VO:0020926 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.015 MG/ML 43259949 OMOP573602 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.015 MG/ML VO:0020927 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.09 MG/ML 44066068 OMOP1060699 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 0.09 MG/ML VO:0020928 OHDSI Vaccine WG Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 50000000 UNT/ML 43184688 OMOP499373 vaccine Influenza A virus vaccine, A-Texas-50-2012 (H3N2)-like virus 50000000 UNT/ML VO:0020929 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection 43516683 OMOP2803798 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection VO:0020930 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Agrippal] 43515468 OMOP2802583 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Agrippal] VO:0020931 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluarix] 43514647 OMOP2801762 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluarix] VO:0020932 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluvax] 43517512 OMOP2804627 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Fluvax] VO:0020933 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [INFLUVAC] 43517511 OMOP2804626 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [INFLUVAC] VO:0020934 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Intanza] 43514648 OMOP2801763 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Intanza] VO:0020935 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Vaxigrip Junior] 43516686 OMOP2803801 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [Vaxigrip Junior] VO:0020936 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [VAXIGRIP] 43516279 OMOP2803394 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus / Influenza B virus vaccine, B-Wisconsin-1-2010-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain Injection [VAXIGRIP] VO:0020937 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.0075 MG/ML 43514582 OMOP2801697 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.0075 MG/ML VO:0020938 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.00752 MG/ML 587387 OMOP3135604 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.00752 MG/ML VO:0020939 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.009 MG/ML 43514583 OMOP2801698 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.009 MG/ML VO:0020940 OHDSI Vaccine WG Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.015 MG/ML 43514581 OMOP2801696 vaccine Influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.015 MG/ML VO:0020941 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus antigen Nasal Spray 44029794 OMOP1024425 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus antigen Nasal Spray VO:0020942 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus antigen Nasal Spray [FluMist Quadrivalent] 44095754 OMOP1090385 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus antigen Nasal Spray [FluMist Quadrivalent] VO:0020943 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus antigen Nasal Spray [Flumist] 44069929 OMOP1064560 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine / influenza B virus antigen Nasal Spray [Flumist] VO:0020944 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML 44091681 OMOP1086312 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML VO:0020945 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML [FluMist Quadrivalent] 44028427 OMOP1023058 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML [FluMist Quadrivalent] VO:0020946 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray 44110093 OMOP1104724 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray VO:0020947 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray [FluMist Quadrivalent] 44086193 OMOP1080824 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 160000000 /ML / influenza B virus antigen 160000000 /ML Nasal Spray [FluMist Quadrivalent] VO:0020948 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML 44026970 OMOP1021601 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML VO:0020949 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML [Flumist] 44041414 OMOP1036045 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML [Flumist] VO:0020950 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray 44123243 OMOP1117874 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray VO:0020951 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] 44086192 OMOP1080823 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] VO:0020952 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] Box of 5 44125127 OMOP1119758 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray [Flumist] Box of 5 VO:0020953 OHDSI Vaccine WG influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray Box of 5 44032595 OMOP1027226 vaccine influenza A-California-7-2009-(H1N1)v-like virus vaccine 50000000 /ML / influenza B virus antigen 50000000 /ML Nasal Spray Box of 5 VO:0020954 OHDSI Vaccine WG influenza B virus antigen 160000000 /ML 44104673 OMOP1099304 vaccine influenza B virus antigen 160000000 /ML VO:0020955 OHDSI Vaccine WG influenza B virus antigen 50000000 /ML 44066028 OMOP1060659 vaccine influenza B virus antigen 50000000 /ML VO:0020956 OHDSI Vaccine WG 1359491 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Boostrix] 42902378 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Boostrix] VO:0020957 OHDSI Vaccine WG 1359625 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 42902512 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0020958 OHDSI Vaccine WG 1657469 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Boostrix] 46276269 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Boostrix] VO:0020959 OHDSI Vaccine WG 1657468 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 46276268 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0020960 OHDSI Vaccine WG Influenza B virus vaccine, B-Brisbane-60-2008-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain / Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injection 43269509 OMOP558514 vaccine Influenza B virus vaccine, B-Brisbane-60-2008-like virus / Influenza Virus Vaccine, Inactivated A-California-07-2009 X-181 (H1N1) strain / Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain Injection VO:0020961 OHDSI Vaccine WG Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.0075 MG/ML 43270876 OMOP573613 vaccine Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.0075 MG/ML VO:0020962 OHDSI Vaccine WG Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.00752 MG/ML 42724203 OMOP2724006 vaccine Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.00752 MG/ML VO:0020963 OHDSI Vaccine WG Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.009 MG/ML 43270875 OMOP573609 vaccine Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.009 MG/ML VO:0020964 OHDSI Vaccine WG Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.015 MG/ML 43254645 OMOP573611 vaccine Influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.015 MG/ML VO:0020965 OHDSI Vaccine WG Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.0075 MG/ML 43258661 OMOP558926 vaccine Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.0075 MG/ML VO:0020966 OHDSI Vaccine WG Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.00752 MG/ML 42721609 OMOP2741208 vaccine Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.00752 MG/ML VO:0020967 OHDSI Vaccine WG Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.009 MG/ML 43280430 OMOP558927 vaccine Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.009 MG/ML VO:0020968 OHDSI Vaccine WG Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.015 MG/ML 43275129 OMOP558928 vaccine Influenza B virus vaccine, B-Wisconsin-1-2010-like virus 0.015 MG/ML VO:0020969 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Ivr-175 36878617 OMOP999126 vaccine Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Ivr-175 VO:0020970 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Ivr-175 0.03 MG/ML 43195410 OMOP496890 vaccine Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Ivr-175 0.03 MG/ML VO:0020971 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 36879023 OMOP998063 vaccine Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 VO:0020972 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 0.03 MG/ML 43162393 OMOP495687 vaccine Influenza Virus Fragmented, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / Switzerland / 9715293/2013, Nib-88 0.03 MG/ML VO:0020973 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 36878713 OMOP989577 vaccine Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 VO:0020974 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.0075 MG/ML 43280264 OMOP557346 vaccine Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.0075 MG/ML VO:0020975 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.00752 MG/ML 42725347 OMOP2726942 vaccine Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.00752 MG/ML VO:0020976 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.015 MG/ML 43263916 OMOP557345 vaccine Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.015 MG/ML VO:0020977 OHDSI Vaccine WG Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.03 MG/ML 43141286 OMOP505361 vaccine Influenza Virus Fragmented, Inactivated, Strain B / Phuket / 3073/2013 0.03 MG/ML VO:0020978 OHDSI Vaccine WG Influenza Virus Surface Antigen, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Type Wild 36879091 OMOP993272 vaccine Influenza Virus Surface Antigen, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Type Wild VO:0020979 OHDSI Vaccine WG Influenza Virus Surface Antigen, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Type Wild 0.03 MG/ML 43172142 OMOP485149 vaccine Influenza Virus Surface Antigen, Inactivated, Strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain A / South Australia / 55/2014 Type Wild 0.03 MG/ML VO:0020980 OHDSI Vaccine WG Influenza Virus Surface Antigen, Inactivated, Strain B / Phuket / 3073/2013 & ndash; Analogue strain B / Utah / 9/2014, Wild Type 36878953 OMOP997977 vaccine Influenza Virus Surface Antigen, Inactivated, Strain B / Phuket / 3073/2013 & ndash; Analogue strain B / Utah / 9/2014, Wild Type VO:0020981 OHDSI Vaccine WG Influenza Virus Surface Antigen, Inactivated, Strain B / Phuket / 3073/2013 & ndash; Analogue strain B / Utah / 9/2014, Wild Type 0.03 MG/ML 43150023 OMOP485273 vaccine Influenza Virus Surface Antigen, Inactivated, Strain B / Phuket / 3073/2013 & ndash; Analogue strain B / Utah / 9/2014, Wild Type 0.03 MG/ML VO:0020982 OHDSI Vaccine WG Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 36878619 OMOP1003334 vaccine Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 VO:0020983 OHDSI Vaccine WG Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.0075 MG/ML 43269559 OMOP558924 vaccine Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.0075 MG/ML VO:0020984 OHDSI Vaccine WG Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.00752 MG/ML 42712051 OMOP2734246 vaccine Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.00752 MG/ML VO:0020985 OHDSI Vaccine WG Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.009 MG/ML 43285912 OMOP558923 vaccine Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.009 MG/ML VO:0020986 OHDSI Vaccine WG Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.015 MG/ML 43285913 OMOP558925 vaccine Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.015 MG/ML VO:0020987 OHDSI Vaccine WG Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.03 MG/ML 43151706 OMOP499811 vaccine Influenza Virus Surface Antigen, strain A / Victoria / 361/2011 H3N2 - Derived Strain Used Ivr-165 0.03 MG/ML VO:0020988 OHDSI Vaccine WG Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 36879025 OMOP991645 vaccine Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 VO:0020989 OHDSI Vaccine WG Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.0075 MG/ML 43258495 OMOP557344 vaccine Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.0075 MG/ML VO:0020990 OHDSI Vaccine WG Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.00752 MG/ML 42718694 OMOP2732839 vaccine Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.00752 MG/ML VO:0020991 OHDSI Vaccine WG Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.015 MG/ML 43274944 OMOP557343 vaccine Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.015 MG/ML VO:0020992 OHDSI Vaccine WG Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.03 MG/ML 43140034 OMOP493571 vaccine Influenza Virus Surface Antigens, strain A / Switzerland / 9715293/2013 H3N2 - Analogue Strain Nib-88 0.03 MG/ML VO:0020993 OHDSI Vaccine WG Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.0075 MG/ML 43285904 OMOP558872 vaccine Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.0075 MG/ML VO:0020994 OHDSI Vaccine WG Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.00752 MG/ML 42724280 OMOP2723218 vaccine Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.00752 MG/ML VO:0020995 OHDSI Vaccine WG Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.009 MG/ML 43275119 OMOP558873 vaccine Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.009 MG/ML VO:0020996 OHDSI Vaccine WG Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.015 MG/ML 43291274 OMOP558875 vaccine Influenza Virus Vaccine, Inactivated A-Victoria-210-2009 X-187 (H3N2) (A-Perth-16-2009) strain 0.015 MG/ML VO:0020997 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU 43285855 OMOP558424 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU VO:0020998 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU [Varivax] 43285856 OMOP558425 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU [Varivax] VO:0020999 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU Injection 43275062 OMOP558426 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU Injection VO:0021000 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU Injection [Varivax] 43275063 OMOP558427 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 PFU Injection [Varivax] VO:0021001 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT 44104046 OMOP1098677 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT VO:0021002 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT [Varivax] 44027667 OMOP1022298 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT [Varivax] VO:0021003 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injectable Solution 44070963 OMOP1065594 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injectable Solution VO:0021004 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injection 587889 OMOP3135821 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injection VO:0021005 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injection [Varivax] 44111111 OMOP1105742 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injection [Varivax] VO:0021006 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injection [Varivax] by Merck 44026047 OMOP1020678 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 1350 UNT Injection [Varivax] by Merck VO:0021007 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU 43280378 OMOP558428 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU VO:0021008 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU [Zostavax] 43291211 OMOP558429 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU [Zostavax] VO:0021009 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU Injection 43285857 OMOP558430 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU Injection VO:0021010 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU Injection [Zostavax] 43285858 OMOP558431 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 19400 PFU Injection [Zostavax] VO:0021011 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML 41013226 OMOP2211188 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML VO:0021012 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML [Varilrix] 41171275 OMOP2369237 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML [Varilrix] VO:0021013 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution 41020598 OMOP2218560 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution VO:0021014 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] 40901529 OMOP2099491 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] VO:0021015 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 1 41120142 OMOP2318104 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 1 VO:0021016 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 10 41057398 OMOP2255360 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution [Varilrix] Box of 10 VO:0021017 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 1 41301524 OMOP2499486 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 1 VO:0021018 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 10 40864904 OMOP2062866 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 200 UNT/ML Injectable Solution Box of 10 VO:0021019 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU 43285859 OMOP558432 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU VO:0021020 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU [Varilrix] 43264043 OMOP558433 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU [Varilrix] VO:0021021 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection 43291212 OMOP558434 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection VO:0021022 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection [Varilrix] 43264044 OMOP558435 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2000 PFU Injection [Varilrix] VO:0021023 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injectable Solution 43786832 OMOP707879 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 2700 UNT/ML Injectable Solution VO:0021024 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML 44104045 OMOP1098676 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML VO:0021025 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML [Zostavax] 44053688 OMOP1048319 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML [Zostavax] VO:0021026 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension 44058055 OMOP1052686 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension VO:0021027 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension [Zostavax] 44046628 OMOP1041259 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 PFU/ML Injectable Suspension [Zostavax] VO:0021028 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe 41146202 OMOP2344164 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe VO:0021029 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] 41276010 OMOP2473972 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] VO:0021030 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 41151733 OMOP2349695 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe [Zostavax] Box of 1 VO:0021031 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe Box of 1 41051813 OMOP2249775 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 29800 UNT/ML Prefilled Syringe Box of 1 VO:0021032 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML 44026330 OMOP1020961 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML VO:0021033 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML [Varilrix] 44079373 OMOP1074004 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML [Varilrix] VO:0021034 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution 44096748 OMOP1091379 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution VO:0021035 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] 44111110 OMOP1105741 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] VO:0021036 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 41057397 OMOP2255359 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 1 VO:0021037 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 43786834 OMOP707891 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution [Varilrix] Box of 10 VO:0021038 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 1 40896119 OMOP2094081 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 1 VO:0021039 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 10 43732943 OMOP707886 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain 4000 UNT/ML Injectable Solution Box of 10 VO:0021040 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution 36889564 OMOP1001914 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution VO:0021041 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Varilrix] 36881854 OMOP1007424 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Varilrix] VO:0021042 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Varivax] 36421490 OMOP4763773 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Varivax] VO:0021043 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Zostavax] 40748062 OMOP4709180 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Solution [Zostavax] VO:0021044 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Suspension 44042651 OMOP1037282 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Suspension VO:0021045 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Suspension [Zostavax] 44121109 OMOP1115740 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injectable Suspension [Zostavax] VO:0021046 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection [Varilrix] 21079816 OMOP362082 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Injection [Varilrix] VO:0021047 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Prefilled Syringe 41205313 OMOP2403275 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Prefilled Syringe VO:0021048 OHDSI Vaccine WG Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Prefilled Syringe [Zostavax] 40955879 OMOP2153841 vaccine Varicella-Zoster Virus Vaccine Live (Oka-Merck) strain Prefilled Syringe [Zostavax] VO:0021080 OHDSI Vaccine WG 2109622 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Vaxelis] 1366354 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Vaxelis] VO:0021081 OHDSI Vaccine WG 1657656 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] 46276295 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] VO:0021082 OHDSI Vaccine WG 2593122 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel] 1759163 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel] VO:0021083 OHDSI Vaccine WG 2468241 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis] 37003440 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Vaxelis] VO:0021084 OHDSI Vaccine WG 2593119 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 1759161 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0021085 OHDSI Vaccine WG 1657653 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 46276292 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0021086 OHDSI Vaccine WG 2587055 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 702404 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0021087 OHDSI Vaccine WG 2468240 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe 37003439 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe VO:0021088 OHDSI Vaccine WG 2109621 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection 1366353 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine 0.006 MG/ML / hepatitis B surface antigen vaccine 0.02 MG/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection VO:0021089 OHDSI Vaccine WG 1657881 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Infanrix] 46275090 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Infanrix] VO:0021090 OHDSI Vaccine WG 1657890 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Kinrix] 46275094 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Kinrix] VO:0021091 OHDSI Vaccine WG 1359595 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Infanrix] 42902482 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe [Infanrix] VO:0021092 OHDSI Vaccine WG 1657880 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 46275089 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0021093 OHDSI Vaccine WG 1359677 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe 42902564 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Prefilled Syringe VO:0021094 OHDSI Vaccine WG 1657889 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection 46275093 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 80 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 16 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 64 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection VO:0021095 OHDSI Vaccine WG 2605550 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2022-2023] Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection 780092 vaccine Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Injection VO:0021096 OHDSI Vaccine WG 2177399 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1361081 vaccine Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe VO:0021097 OHDSI Vaccine WG 2605544 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] Fluzone Quadrivalent 2022-2023 Northern Hemisphere vaccine Prefilled Syringe 780089 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] VO:0021098 OHDSI Vaccine WG 2177496 influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] 1361087 vaccine influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020] VO:0021099 OHDSI Vaccine WG 2563006 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2021-2022] 1537477 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2021-2022] VO:0021100 OHDSI Vaccine WG 2564022 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] 701422 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] VO:0021101 OHDSI Vaccine WG 2563015 influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe 1537485 vaccine influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0021102 OHDSI Vaccine WG 2605736 influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] 780130 vaccine influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2022-2023] VO:0021103 OHDSI Vaccine WG 2605730 influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe 780125 vaccine influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Prefilled Syringe VO:0021104 OHDSI Vaccine WG 2605541 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2022-2023] 780087 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2022-2023] VO:0021105 OHDSI Vaccine WG 2605558 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2022-2023] influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2022-2023] 780099 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2022-2023] VO:0021106 OHDSI Vaccine WG 2605097 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2022-2023] 780073 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2022-2023] VO:0021107 OHDSI Vaccine WG 2605571 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2022-2023] 780110 vaccine influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2022-2023] VO:0021108 OHDSI Vaccine WG 2605052 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2022-2023] 780059 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2022-2023] VO:0021109 OHDSI Vaccine WG 2593858 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe 1759213 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe VO:0021110 OHDSI Vaccine WG 2605107 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] 780081 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2022-2023] VO:0021111 OHDSI Vaccine WG 2605101 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe 780076 vaccine influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe VO:0021112 OHDSI Vaccine WG 2380853 influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] 1146499 vaccine influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2020-2021] VO:0021113 OHDSI Vaccine WG 2380852 influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe 1146498 vaccine influenza A virus A/Delaware/39/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Nebraska/14/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0021114 OHDSI Vaccine WG 2379737 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2020-2021] 1146366 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2020-2021] VO:0021115 OHDSI Vaccine WG 2379640 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2020-2021] 1146360 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2020-2021] VO:0021116 OHDSI Vaccine WG 2380590 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2020-2021] 1146455 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2020-2021] VO:0021117 OHDSI Vaccine WG 2380585 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] 1146452 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] VO:0021118 OHDSI Vaccine WG 2379639 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 1146359 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0021119 OHDSI Vaccine WG 2380589 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection 1146454 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection VO:0021120 OHDSI Vaccine WG 2383550 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] 1146610 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2020-2021] VO:0021121 OHDSI Vaccine WG 2383549 influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe 1146609 vaccine influenza A virus A/Guangdong-Maonan/SWL1536/2019 (H1N1) antigen 0.0857 MG/ML / influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe VO:0021122 OHDSI Vaccine WG 2380865 influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2020-2021] 1146508 vaccine influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2020-2021] VO:0021123 OHDSI Vaccine WG 2380864 influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe 1146507 vaccine influenza A virus A/Hawaii/70/2019 (H1N1) antigen 0.09 MG/ML / influenza A virus A/Minnesota/41/2019 (H3N2) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe VO:0021124 OHDSI Vaccine WG 2380602 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] 1146463 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2020-2021] VO:0021125 OHDSI Vaccine WG 2382440 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2020-2021] 1146557 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2020-2021] VO:0021126 OHDSI Vaccine WG 2380601 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe 1146462 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2454/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe VO:0021127 OHDSI Vaccine WG 2479037 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] 739845 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021 Southern Hemisphere] VO:0021128 OHDSI Vaccine WG 2479033 influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 739842 vaccine influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0021129 OHDSI Vaccine WG 2563014 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2021-2022] 1537484 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2021-2022] VO:0021130 OHDSI Vaccine WG 2563028 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection 1537496 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection VO:0021131 OHDSI Vaccine WG 2561278 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2021-2022] 1537386 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2021-2022] VO:0021132 OHDSI Vaccine WG 2561267 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2021-2022] 1537378 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2021-2022] VO:0021133 OHDSI Vaccine WG 2563035 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] 1537502 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] VO:0021134 OHDSI Vaccine WG 2561276 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe 1537384 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe VO:0021135 OHDSI Vaccine WG 2563029 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] 1537497 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] VO:0021136 OHDSI Vaccine WG 2563016 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe 1537486 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe VO:0021137 OHDSI Vaccine WG 2563013 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] 1537483 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] VO:0021138 OHDSI Vaccine WG 2563018 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe 1537487 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe VO:0021139 OHDSI Vaccine WG 2563043 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2021-2022] 1537508 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2021-2022] VO:0021140 OHDSI Vaccine WG 2563012 influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe 1537482 vaccine influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe VO:0021141 OHDSI Vaccine WG 1799398 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2016-2017 (trivalent - California/Hong Kong/Brisbane) 0.5 ML Prefilled Syringe 36249259 vaccine influenza virus vaccine 2016-2017 (trivalent - California/Hong Kong/Brisbane) 0.5 ML Prefilled Syringe VO:0021142 OHDSI Vaccine WG 2605091 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe 780068 vaccine influenza virus vaccine 2022-2023 (quadrivalent - Austria/Darwin/Phuket/Victoria) Prefilled Syringe VO:0021143 OHDSI Vaccine WG 2605046 influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe 780053 vaccine influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Victoria/Austria/Phuket) Prefilled Syringe VO:0021144 OHDSI Vaccine WG 2605565 influenza A virus A/Darwin/6/2021 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Austria/1359417/2021 antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML Prefilled Syringe influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe 780105 vaccine influenza virus vaccine 2022-2023 (quadrivalent - Darwin/Wisconsin/Austria/Phuket) Prefilled Syringe VO:0021145 OHDSI Vaccine WG 1360354 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe [Gardasil] 42903241 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe [Gardasil] VO:0021146 OHDSI Vaccine WG 1360401 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe 42903288 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.04 MG/ML Prefilled Syringe VO:0021147 OHDSI Vaccine WG 1597105 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9] 45892516 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9] VO:0021148 OHDSI Vaccine WG 1657898 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9] 46275098 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9] VO:0021149 OHDSI Vaccine WG 1657897 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection 46275097 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection VO:0021150 OHDSI Vaccine WG 1597104 L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe 45892515 vaccine L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe VO:0021151 OHDSI Vaccine WG 1658003 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection [ProQuad] 46275137 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection [ProQuad] VO:0021152 OHDSI Vaccine WG 1658002 measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection 46275136 vaccine measles virus vaccine live, Enders' attenuated Edmonston strain 2000 UNT/ML / mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 2000 UNT/ML / varicella-zoster virus vaccine live (Oka-Merck) strain 20000 UNT/ML Injection VO:0021153 OHDSI Vaccine WG 1601409 meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero] 45892101 vaccine meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe [Bexsero] VO:0021154 OHDSI Vaccine WG 1601408 meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe 45892100 vaccine meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML Prefilled Syringe VO:0021155 OHDSI Vaccine WG 1359783 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe [Menactra] 42902670 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe [Menactra] VO:0021156 OHDSI Vaccine WG 1657655 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection [Menactra] 46276294 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection [Menactra] VO:0021157 OHDSI Vaccine WG 1657654 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection 46276293 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Injection VO:0021158 OHDSI Vaccine WG 1359795 Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe 42902682 vaccine Neisseria meningitidis serogroup A capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine 0.104 MG/ML Prefilled Syringe VO:0021159 OHDSI Vaccine WG 2360590 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi] 1145528 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi] VO:0021160 OHDSI Vaccine WG 2360589 Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection 1145527 vaccine Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection VO:0021161 OHDSI Vaccine WG 1657643 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection [Menveo] 46276291 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection [Menveo] VO:0021162 OHDSI Vaccine WG 1657642 Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection 46276290 vaccine Neisseria meningitidis serogroup A oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y oligosaccharide diphtheria CRM197 protein conjugate vaccine 0.01 MG/ML Injection VO:0021163 OHDSI Vaccine WG 2587058 Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] 702406 vaccine Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel] VO:0021164 A varicella-zoster virus live vaccine designed to prevent shingles (herpes zoster). Jie Zheng 121 40213260 zoster vaccine, live vaccine zoster vaccine, live VO:0021165 A varicella-zoster virus vaccine, also known as the chickenpox vaccine, that protects against the varicella-zoster virus (VZV) causes chickenpox. Jie Zheng 21 40213251 varicella virus vaccine vaccine varicella virus vaccine VO:0021166 A DTP-Haemophilus influenzae type b conjugate and hepatitis B vaccine that is used outside USA. Jie Zheng 102 40213293 DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine (non-US) vaccine DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine (non-US) VO:0021167 Jie Zheng Yuanyi Pan 2664832 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.0333 MG/ML Injection 747828 vaccine 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.0333 MG/ML Injection VO:0021168 Jie Zheng Yuanyi Pan 2664829 SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.01 MG/ML Injectable Suspension 746555 vaccine SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.01 MG/ML Injectable Suspension VO:0021169 Jie Zheng Yuanyi Pan 2664729 0.25 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection 747823 vaccine 0.25 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection VO:0021170 Jie Zheng Yuanyi Pan vaccine 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML VO:0021171 Jie Zheng Yuanyi Pan 2664837 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe 747829 vaccine 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe VO:0021172 Jie Zheng Yuanyi Pan 2664843 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection 747831 vaccine 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection VO:0021173 Jie Zheng Yuanyi Pan 2664841 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Comirnaty 2023-2024] 747830 vaccine 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Comirnaty 2023-2024] VO:0021174 Jie Zheng Yuanyi Pan 2664846 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection [Comirnaty 2023-2024] 747832 vaccine 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (XBB.1.5) 0.1 MG/ML Injection [Comirnaty 2023-2024] VO:0021175 Jie Zheng Yuanyi Pan vaccine 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML VO:0021176 Jie Zheng Yuanyi Pan 2664819 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection 747826 vaccine 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection VO:0021177 Jie Zheng Yuanyi Pan 2664811 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe 747824 vaccine 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe VO:0021178 Jie Zheng Yuanyi Pan 2664822 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection [Spikevax 2023-2024] 747827 vaccine 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Injection [Spikevax 2023-2024] VO:0021179 Jie Zheng Yuanyi Pan 2664817 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Spikevax 2023-2024] 747825 vaccine 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (XBB.1.5) 0.1 MG/ML Prefilled Syringe [Spikevax 2023-2024] VO:0021180 Jie Zheng https://github.com/vaccineontology/VO/issues/766 vaccine Fluzone High-Dose 2010-2011 vaccine owl:Thing example to be eventually removed example to be eventually removed failed exploratory term The term was used in an attempt to structure part of the ontology but in retrospect failed to do a good job Person:Alan Ruttenberg failed exploratory term metadata complete Class has all its metadata, but is either not guaranteed to be in its final location in the asserted IS_A hierarchy or refers to another class that is not complete. metadata complete organizational term Term created to ease viewing/sort terms for development purpose, and will not be included in a release organizational term ready for release Class has undergone final review, is ready for use, and will be included in the next release. Any class lacking "ready_for_release" should be considered likely to change place in hierarchy, have its definition refined, or be obsoleted in the next release. Those classes deemed "ready_for_release" will also derived from a chain of ancestor classes that are also "ready_for_release." ready for release metadata incomplete Class is being worked on; however, the metadata (including definition) are not complete or sufficiently clear to the branch editors. metadata incomplete uncurated Nothing done yet beyond assigning a unique class ID and proposing a preferred term. uncurated pending final vetting All definitions, placement in the asserted IS_A hierarchy and required minimal metadata are complete. The class is awaiting a final review by someone other than the term editor. pending final vetting Core is an instance of a grouping of terms from an ontology or ontologies. It is used by the ontology to identify main classes. PERSON: Alan Ruttenberg PERSON: Melanie Courtot obsolete_core true placeholder removed placeholder removed terms merged An editor note should explain what were the merged terms and the reason for the merge. terms merged term imported This is to be used when the original term has been replaced by a term imported from an other ontology. An editor note should indicate what is the URI of the new term to use. term imported term split This is to be used when a term has been split in two or more new terms. An editor note should indicate the reason for the split and indicate the URIs of the new terms created. term split universal Hard to give a definition for. Intuitively a "natural kind" rather than a collection of any old things, which a class is able to be, formally. At the meta level, universals are defined as positives, are disjoint with their siblings, have single asserted parents. Alan Ruttenberg A Formal Theory of Substances, Qualities, and Universals, http://ontology.buffalo.edu/bfo/SQU.pdf universal defined class A defined class is a class that is defined by a set of logically necessary and sufficient conditions but is not a universal "definitions", in some readings, always are given by necessary and sufficient conditions. So one must be careful (and this is difficult sometimes) to distinguish between defined classes and universal. Alan Ruttenberg defined class named class expression A named class expression is a logical expression that is given a name. The name can be used in place of the expression. named class expressions are used in order to have more concise logical definition but their extensions may not be interesting classes on their own. In languages such as OWL, with no provisions for macros, these show up as actuall classes. Tools may with to not show them as such, and to replace uses of the macros with their expansions Alan Ruttenberg named class expression to be replaced with external ontology term Terms with this status should eventually replaced with a term from another ontology. Alan Ruttenberg group:OBI to be replaced with external ontology term requires discussion A term that is metadata complete, has been reviewed, and problems have been identified that require discussion before release. Such a term requires editor note(s) to identify the outstanding issues. Alan Ruttenberg group:OBI requires discussion The term was added to the ontology on the assumption it was in scope, but it turned out later that it was not. This obsolesence reason should be used conservatively. Typical valid examples are: un-necessary grouping classes in disease ontologies, a phenotype term added on the assumption it was a disease. https://github.com/information-artifact-ontology/ontology-metadata/issues/77 https://orcid.org/0000-0001-5208-3432 out of scope The term was added to the ontology on the assumption it was a valid domain entity, but it turns out the entity does not exist in reality. This obsolesence reason should be used conservatively. For example: Obsoleting class that describes a breed of cow based on a record in an existing database, that was later retracted as faulty (breed does not exist). Do not use this term to obsolete a historic concept (that was once valid, but not anymore). https://github.com/information-artifact-ontology/ontology-metadata/issues/136 https://orcid.org/0000-0002-4142-7153 domain entity does not exist Allen Xiang Oliver He Invitrogen United Vaccines, Inc Heska Corporation Texas Vet lab, Inc SolidTech Animal Health, Inc MVP Laboratories, Inc Addison Biological Laboratory, Inc neotechvaccines.com Neotech, LLC Aceto Pharma Corp Intervet has merged with Schering-Plough Animal Health and become Intervet/Schering-Plough Animal Health™ (YL.) Oliver He Intervet Oliver He Fort Dodge www.protatek.com ProtaTek International, Inc www.arkolabs.com Arko Laboratories Ltd www.newportlabs.com Newport Laboratories, Inc Texas Agricultural Experiment Station Brinton Laboratories Inc Asiyah Yu Lin Novartis Animal Health US, Inc. Intercell Biomedical Oliver He Acambis, Inc Oliver He Berna Biotech, Ltd Oliver He BioPort Corp Oliver He CSL Limited A British multinational pharmaceutical company headquartered in Brentford, England Oliver He Philip Huang GSK https://en.wikipedia.org/wiki/GlaxoSmithKline GlaxoSmithKline plc Oliver He Greer Laboratories Inc Oliver He Massachusetts Public Health Biologic Lab Oliver He MedImmune Vaccines, Inc Oliver He Merck Sharp & Dohme Corp. Merck & Co., Inc. Oliver He Novartis Vaccines and Diagnostics 100 Rodolphe Street Building 1300 Durham, NC 27712 Oliver He Organon Teknika Corp LLC Oliver He Research Foundation for Microbial Diseases of Osaka University Oliver He Sanofi Pasteur Limited Oliver He Sanofi Pasteur, Inc Oliver He Wyeth Pharmaceuticals Inc Oliver He Sanofi Pasteur, SA Oliver He Vetech Labs Oliver He Pfizer Animal Health Oliver He BIOPHARM Oliver He Cutter Biological Oliver He Bioproperties Oliver He Solvay Pharmaceuticals Oliver He Websters Animal Health Oliver He Colorado Serum Company CZ Veterinaria Allen Xiang Oliver He Biken Oliver He Schering-Plough Allen Xiang Oliver He Baxter Healthcare Corporation Allen Xiang Oliver He Merck Frosst Oliver He Boehringer-Ingelheim Vetmedica, Inc Allen Xiang Oliver He SBL Vaccine Allen Xiang Oliver He Wyeth Canada Oliver He Virbac Oliver He Embrex Oliver He Novartis Animal Health Oliver He Aqua Health Novartis Oliver He Novus International Oliver He Biomune Vical, Inc. Promega Oliver He Lohman Animal Health International Oliver He Centre for Ticks and Tickborne Disease, Malawi Oliver He ImmunoVaccine Technologies, Canada Oliver He Local veterinary institutes Oliver He United States Department of Agriculture USDA Oliver He Merial, Inc Intervet has merged with Schering-Plough Animal Health and become Intervet/Schering-Plough Animal Health‚Ñ¢ (YL.) Oliver He Schering-Plough Animal Health Oliver He Bayer Leverkusen Oliver He Coopers Animal Health Oliver He Dow AgroSciences Asiyah Yu Lin http://www.duckhealth.com/idrc.html International Duck Research Cooperative, Inc. Asiyah Yu Lin Vaccicel, Inc. has a location in Belton, TX. Active officers include Andre Menchu, Andres Menchu, Kathryn M Baker, Katheryn Becker and Andres Menches. Vaccicel, Inc. filed as a Domestic For-Profit Corporation on Tuesday, August 22, 1995 in the state of Texas and is currently active. Andres Menchu serves as the registered agent for this organization.The company's line of business includes Mfg Research & Development Veterinary Bacterial Vaccines. (http://www.corporationwiki.com/Texas/Belton/vaccicel-inc/34296230.aspx) VacciCel, Inc. Asiyah Yu Lin GSK Acquires Influenza Vaccine Manufacturer ID Biomedical Corporation http://www.medicalnewstoday.com/releases/34803.php GlaxoSmithKline plc (NYSE:GSK) announced the completion of the acquisition of ID Biomedical. This follows regulatory clearances of the transaction and adoption of the acquisition agreement by ID Biomedical's shareholders (which occurred on the 16th of November). ID Biomedical becomes a wholly-owned subsidiary of GSK. ... ID Biomedical Corporation of Quebec http://www.proteinsciences.com/ Protein Sciences Corporation Valneva SE An Israeli research and development laboratory Philip Huang https://en.wikipedia.org/wiki/Israel_Institute_for_Biological_Research Israel Institute for Biological Research PaxVax, Inc. Out of buisness Lederle Laboratories Division Abbot Laboratories Parke, Davis, Company Max Planck Institute for Infection Biology Bio-Manguinhos Mylan Products Limited French National Agency for Research on AIDS and Viral Hepatitis (ANRS) A company trhat is located at Berkeley, CA, USA. Its website is: http://www.dynavax.com. Kallan Roan Oliver He Randi Vita http://www.dynavax.com/ Dynavax Technologies Corporation Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. http://novavax.com/ Novavax, Inc. Kallan Roan Oliver He Teva Pharmaceuticals USA, Inc. Kallan Roan Oliver He Seqirus, Inc. Located in Swiftwater, Pennsylvania, this company is now known as Sanofi Pasteur Limited. Kallan Roan Oliver He Connaught Laboratories, Inc. Chiron Behring Vaccines Private Ltd https://www.advent-gmp.com/about-us/ ADVENT SRL VIA CRESCENZIO 9 ROMA, ROMA, 00193 Italy +39-0691093692 Company Type: Corporation Subsidiary http://www.hoovers.com/company-information/cs/company-profile.advent_srl.aebb99e74ae57b09.html?aka_re=1 Advent Srl., Italy A pharmaceutical company that was founded in 1953 by Paul Janssen, is headquartered in Beerse, Belgium, and owned by Johnson & Johnson. Oliver He Philip Huang https://en.wikipedia.org/wiki/Janssen_Pharmaceutica https://www.janssen.com/us/ Janssen Pharmaceutica Oliver He Philip Huang 康希诺生物 http://www.cansinotech.com/ https://en.wikipedia.org/wiki/CanSino_Biologics CanSino Biologics A German biotechnology company that is dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases. Oliver He Philip Huang https://en.wikipedia.org/wiki/BioNTech BioNTech An American multinational pharmaceutical corporation headquartered in New York City. Oliver He Philip Huang https://en.wikipedia.org/wiki/Pfizer https://www.pfizer.com/ Pfizer Inc. A British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Sodertalje, Sweden. AstraZeneca makes products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Oliver He Philip Huang https://en.wikipedia.org/wiki/AstraZeneca AstraZeneca Oliver He Philip Huang https://www.cnbg.com.cn/ https://www.trialsitenews.com/chinas-beijing-institute-of-biological-products-covid-19-vaccine-reportedly-ready-for-phase-iii/ Beijing Institute of Biological Products Oliver He Philip Huang Sinopharm Sinopharm Group 国药控股股份有限公司 http://www.sinopharm.com/1156.html https://en.wikipedia.org/wiki/Sinopharm_Group Sinopharm Group Co., Ltd. Oliver He Philip Huang http://www.wibp.com.cn Wuhan Institute of Biological Products Oliver He Philip Huang https://en.wikipedia.org/wiki/Gamaleya_Research_Institute_of_Epidemiology_and_Microbiology https://gamaleya.org/en/ Gamaleya Research Institute Oliver He Philip Huang https://en.wikipedia.org/wiki/Moderna https://www.modernatx.com/ Moderna A biopharmaceutical company headquartered in Beijing, China Sinovac http://www.sinovac.com/ Sinovac Biotech Ltd Philip Huang AnGes, Inc. An American biotech company focused on the discovery, development and commercialization of therapeutics for rare diseases with focus on RNA Philip Huang https://en.wikipedia.org/wiki/Arcturus_Therapeutics Arcturus Therapeutics Philip Huang Beijing Minhai Biotechnology Co., Ltd. Oliver He Philip Huang Vaxxinity Philip Huang Beijing Wantai Biological Pharmacy Philip Huang FBRI SRC VB VECTOR Federal Budgetary Research Institution State Research Center of Virology and Biotechnology Vector Institute State Research Center of Virology and Biotechnology VECTOR Philip Huang Genexine, Inc. An American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases Philip Huang https://en.wikipedia.org/wiki/Inovio_Pharmaceuticals Inovio Pharmaceuticals, Inc. Philip Huang Kentucky Bioprocessing, Inc. Philip Huang Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. A manufacturer of immunobiological drugs including vaccines in India Philip Huang https://en.wikipedia.org/wiki/Serum_Institute_of_India Serum Institute of India Philip Huang Zydus Cadila Philip Huang Adimmune Corporation A China-based company principally engaged in the research, development, production and distribution of vaccines, monoclonal antibodies and blood products Philip Huang https://www.reuters.com/companies/300142.SZ Walvax Biotechnology Co., Ltd. Philip Huang Symvivo Philip Huang Chulalongkorn University A public research university in London Philip Huang https://en.wikipedia.org/wiki/Imperial_College_London Imperial College London A Canadian biotechnology company focused on the discovery, development, and commercialization of virus-like particles using plants as "bioreactors" to produce proteins as candidate vaccines and medications Philip Huang https://en.wikipedia.org/wiki/Medicago_Inc. Medicago Inc. Philip Huang Entos Pharmaceuticals Philip Huang ReiThera Srl Philip Huang ImmunityBio, Inc. Philip Huang NantKwest, Inc. The teaching hospital of the University of Hamburg and one of the largest hospitals in Hamburg, Germany Philip Huang https://en.wikipedia.org/wiki/University_Medical_Center_Hamburg-Eppendorf University Medical Center Hamburg-Eppendorf Philip Huang Medigen, Inc. A public research university in Chengdu, Sichuan, China Philip Huang 四川大学 https://en.wikipedia.org/wiki/Sichuan_University Sichuan University Philip Huang Vaxine Pty Ltd. Philip Huang Instituto Finlay de Vacunas Philip Huang Clover Biopharmaceuticals, Inc. A French non-profit private foundation dedicated to the study of biology, micro-organisms, diseases, and vaccines Philip Huang Pasteur Institute https://en.wikipedia.org/wiki/Pasteur_Institute Institut Pasteur Philip Huang COVAXX A public research university located primarily in Brisbane, Queensland, Australia Philip Huang https://en.wikipedia.org/wiki/University_of_Queensland University of Queensland An American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines Philip Huang https://en.wikipedia.org/wiki/Vaxart Vaxart, Inc. Philip Huang Cellid Co., Ltd. Philip Huang University Medical Center Groningen Philip Huang AIVITA Biomedical, Inc. Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France. Philip Huang https://en.wikipedia.org/wiki/Sanofi Sanofi S.A. Philip Huang https://www.curevac.com/en/ CureVac AG Philip Huang Research Institute for Biological Safety Problems Philip Huang Bharat Biotech International Limited Philip Huang University of Munich (Ludwig-Maximilians) Philip Huang West China Hospital Philip Huang University Hospital Tuebingen Philip Huang Shenzhen Geno-Immune Medical Institute Philip Huang Providence Health & Services Philip Huang City of Hope Medical Center Philip Huang https://codagenix.com/ Codagenix, Inc. Philip Huang Center for Genetic Engineering and Biotechnology Philip Huang Biological E. Ltd Philip Huang GeneOne Life Science, Inc. Philip Huang Nanogen Pharmaceutical Biotechnology Philip Huang Shionogi Philip Huang Altimmune, Inc. Philip Huang Erciyes University Philip Huang Vaccine and Infectious Disease Organization An NIAID compendium repository that stores vaccine adjuvants derived from their research studies. Amogh Madireddi Oliver He Wolfgang Leitner VAC https://vac.niaid.nih.gov/ Vaccine Adjuvant Compendium Jie Zheng https://www.dnb.com/business-directory/company-profiles.barr_laboratories_inc.5fc4bde57c6b28b4257534a1c35fe57e.html Barr Laboratories, Inc. Jie Zheng https://www.daiichisankyo.com Daiichi Sankyo Co., Ltd. A company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Jie Zheng https://elixirgentx.com Elixirgen Therapeutics, Inc. A company offers pharmaceutical and specialized products to healthcare providers located in United States. Jie Zheng https://www.bloomberg.com/profile/company/49277Z:US Emergent BioDefense Operations Lansing LLC A company located in Gaithersburg, Maryland. Jie Zheng https://taggs.hhs.gov/Detail/RecipDetail?arg_EntityId=%2FLjAxy73AkKHW18%2FTlCD%2Fw%3D%3D Emergent Product Development Gaithersburg, Inc. A company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Jie Zheng https://sanaria.com Sanaria Inc., Rockville, MD Jie Zheng https://www.dnb.com/business-directory/company-profiles.seqirus_(australia)_pty_ltd.a3a1cc9f0ea41e8031a3b20bec6d9097.html Seqirus Pty. Ltd Jie Zheng https://find-and-update.company-information.service.gov.uk/company/03970089 Seqirus Vaccines Limited Jie Zheng https://www.syneoshealth.com Syneos Health Jie Zheng Xingxian Li Organon Teknika Corp., LLC Jie Zheng Xingxian Li Merck Sharp & Dohme LLC Jie Zheng Xingxian Li Emergent Product Development Gaithersburg Inc. Jie Zheng Xingxian Li Valneva Austria GmbH Jie Zheng Xingxian Li Bavarian Nordic Jie Zheng Xingxian Li ModernaTX, Inc. Jie Zheng Xingxian Li Pfizer Ireland Pharmaceuticals Jie Zheng Xingxian Li VBI Vaccines (Delaware) Inc. Jie Zheng Xingxian Li Moderna Tx Inc. Jie Zheng Xingxian Li MassBiologics Jie Zheng Xingxian Li MSP Vaccine Company Jie Zheng Xingxian Li BioNTech Manufacturing GmbH Ellen Zhang Jie Zheng Xingxian Li flu season 2013-2014 Ellen Zhang Jie Zheng Xingxian Li flu season 2014-2015 Ellen Zhang Jie Zheng Xingxian Li flu season 2012-2013 Ellen Zhang Jie Zheng Xingxian Li flu season 2011-2012 Ellen Zhang Jie Zheng Xingxian Li flu season 2019-2020 Ellen Zhang Jie Zheng Xingxian Li flu season 2020 Ellen Zhang Jie Zheng Xingxian Li flu season 2016 Ellen Zhang Jie Zheng Xingxian Li flu season 2021-2022 Ellen Zhang Jie Zheng Xingxian Li flu season 2020-2021 Ellen Zhang Jie Zheng Xingxian Li flu season 2021 Ellen Zhang Jie Zheng Xingxian Li flu season 2010-2011 Ellen Zhang Jie Zheng Xingxian Li flu season 2015-2016 Ellen Zhang Jie Zheng Xingxian Li flu season 2022-2023 Ellen Zhang Jie Zheng Xingxian Li flu season 2023 Ellen Zhang Jie Zheng Xingxian Li flu season 2022 Ellen Zhang Jie Zheng Xingxian Li flu season 2018-2019 Ellen Zhang Jie Zheng Xingxian Li flu season 2016-2017 Ellen Zhang Jie Zheng Xingxian Li flu season 2017-2018 Jie Zheng Comirnaty 2023-2024 Jie Zheng Spikevax 2023-2024 Jie Zheng Box of 1 Jie Zheng Box of 10 Jie Zheng Box of 20 Jie Zheng Box of 50 Jie Zheng Vaqta Jie Zheng Epaxal Jie Zheng Havpur Jie Zheng Havrix Jie Zheng Vivaxim Jie Zheng Hepatyrix Jie Zheng ViATIM Jie Zheng Hav Sorbat Ssw Jie Zheng Box of 2 Jie Zheng Box of 3 Jie Zheng Box of 5 Jie Zheng Box of 25 Jie Zheng Box of 40 Jie Zheng Box of 80 Jie Zheng Box of 100 Jie Zheng Box of 250 Jie Zheng AC Vax Jie Zheng Acel Imune Jie Zheng Acel P Lederle Jie Zheng Acel-P Jie Zheng Act-HIB DTP Jie Zheng ActHIB Jie Zheng ACWY Vax Jie Zheng Adacel Jie Zheng Adt Booster Jie Zheng Adt Vaccine Adt Jie Zheng Ambirix Jie Zheng Anrix Jie Zheng Arilvax Jie Zheng Attenuvax Jie Zheng Begrivac Jie Zheng Bexsero Jie Zheng Bimmugen Jie Zheng Biothrax Jie Zheng Boostrix Jie Zheng Cervarix Jie Zheng Cervarix Grk Jie Zheng Clostet Jie Zheng Covaxis Jie Zheng Di Te Tuss Asid Jie Zheng Di Tetasorbat Jie Zheng Diftavax Jie Zheng Dipht Toxoid Asid Jie Zheng Diphtherie-Adsorbat-Impfstoff Behring Jie Zheng Dpt Merieux Jie Zheng Dpt Vaccinol Jie Zheng Dt Impfstoff Jie Zheng Dt Rix Jie Zheng Dt Vaccinol Jie Zheng Dt Wellcovax Jie Zheng Dtp Rix Jie Zheng Engerix-B Jie Zheng Enzira Jie Zheng Ervevax Jie Zheng Eurim Pharm Jie Zheng Fendrix Jie Zheng Fsme Immun Jie Zheng Gardasil Jie Zheng Gemvites Jie Zheng Gen Vax Jie Zheng H B Vax Jie Zheng H-B-Vax II Jie Zheng HBvaxPRO Jie Zheng Hepasorbat Jie Zheng Heptavax Jie Zheng Hevac B Jie Zheng HEXYON Jie Zheng Hib Dpt Merieux Jie Zheng Hibdpt Vaccinol Jie Zheng Hibdt Jie Zheng Hiberix Jie Zheng HibTITER Jie Zheng Imojev Jie Zheng Imovax Jie Zheng Imuvac Jie Zheng Infanrix Jie Zheng Infanrix Hexa Jie Zheng Infanrix-Hib Jie Zheng Invivac Jie Zheng Ipol Jie Zheng Ixiaro Jie Zheng Japanese encephalitis GCVC Jie Zheng Je-Vax Jie Zheng Jespect Jie Zheng Lt Grk Jie Zheng M-M-R II Jie Zheng M-M-RVAXPRO Jie Zheng Mastaflu Jie Zheng Menactra Jie Zheng Mencevax Acwy Jie Zheng Mengivac Jie Zheng Mengivac A + C Jie Zheng Meningitec Jie Zheng Menitorix Jie Zheng Menjugate Jie Zheng Menquadfi Jie Zheng Menveo Jie Zheng Mmr Priorix Jie Zheng Moniarix Jie Zheng Multitest Cmi Jie Zheng Mumpsvax Jie Zheng Neisvac C Jie Zheng Nimenrix Jie Zheng Pa Vaccinol Jie Zheng Pac Merieux Jie Zheng Pediacel Jie Zheng PedvaxHIB Jie Zheng Pertuvac Jie Zheng Pneumopur Jie Zheng Pneumorix Jie Zheng Pneumovax 23 Jie Zheng Pneumovax II Jie Zheng Pnu-Imune Jie Zheng Polio Sabin-Rit Multi Jie Zheng Polio Sabin-S Jie Zheng Poliovaccine Ssi Jie Zheng Prevnar Jie Zheng Priorix Jie Zheng Priorix-Tetra Jie Zheng Procomvax Jie Zheng ProQuad Jie Zheng Quadracel Jie Zheng Quatro Virelon No Jie Zheng RabAvert Jie Zheng Rabipur Jie Zheng Rabivac Jie Zheng Recombivax Jie Zheng Repevax Jie Zheng Revaxis Jie Zheng Rotarix Jie Zheng RUDIVAX Jie Zheng Silgard Jie Zheng Stamaril Jie Zheng Synflorix Jie Zheng T Immun Jie Zheng T Medevax Jie Zheng T Polio Adsorbed Jie Zheng T Vaccinol Jie Zheng T Wellcovax Jie Zheng T-Immun Immuno Jie Zheng Tab Impfstoff Jie Zheng Td Impfstoff Jie Zheng Td-Impfstoff Merieux Jie Zheng Td-Pur Jie Zheng Tet Aktiv Jie Zheng Tetabulin Jie Zheng Tetamun Jie Zheng Tetanol Jie Zheng Tetanus-Impfstoff Merieux Jie Zheng Tetasorbat Jie Zheng Tetatoxoid Jie Zheng Tetravac Jie Zheng TicoVac Jie Zheng Tollwut-Impfstoff Jie Zheng Tri-Immunol Im Jie Zheng Triaxis Jie Zheng Tripacel Jie Zheng Trumenba Jie Zheng Tussoglobin Jie Zheng Twinrix Jie Zheng Twinrix Adult Jie Zheng Twinrix Paediatric Jie Zheng Typherix Jie Zheng Typhim VI Jie Zheng VACCIN GENHEVAC B Jie Zheng VACCIN RABIQUE INACTIVE MERIEUX Jie Zheng Verorab Jie Zheng Vivotif Berna Jie Zheng ACAM2000 Jie Zheng ACEL-IMUNE Jie Zheng Afluria 2010-2011 Formula Jie Zheng Afluria 2011-2012 Formula Jie Zheng Afluria 2012-2013 Formula Jie Zheng Afluria 2013-2014 Formula Jie Zheng Afluria 2014-2015 Formula Jie Zheng Afluria 2015-2016 Jie Zheng Afluria 2016-2017 Jie Zheng Afluria 2017-2018 Jie Zheng Afluria 2018-2019 Jie Zheng Afluria Quadrivalent 2016-2017 Formula Jie Zheng Afluria Quadrivalent 2017-2018 Jie Zheng Afluria Quadrivalent 2018-2019 Jie Zheng Afluria Quadrivalent 2019-2020 Jie Zheng Afluria Quadrivalent 2020-2021 Jie Zheng Afluria Quadrivalent 2021-2022 Jie Zheng Afluria Quadrivalent 2022-2023 Jie Zheng Agriflu 2010-2011 Formula Jie Zheng Agriflu 2012-2013 Formula Jie Zheng Biavax II Jie Zheng Certiva Jie Zheng Comirnaty Jie Zheng COMVAX Jie Zheng Daptacel Jie Zheng Decavac Jie Zheng Dryvax Jie Zheng FLUAD 2015-2016 Jie Zheng Fluad 2016-2017 Jie Zheng Fluad 2017-2018 Jie Zheng Fluad 2018-2019 Jie Zheng Fluad 2019-2020 Jie Zheng Fluad 2020-2021 Jie Zheng Fluad Quadrivalent 2020-2021 Jie Zheng Fluad Quadrivalent 2021-2022 Jie Zheng Fluad Quadrivalent 2022-2023 Jie Zheng Fluarix 2010-2011 Formula Jie Zheng Fluarix 2011-2012 Formula Jie Zheng Fluarix 2012-2013 Formula Jie Zheng Fluarix 2013-2014 Formula Jie Zheng Fluarix 2014-2015 Formula Jie Zheng Fluarix Quad 2014-2015 Formula Jie Zheng Fluarix Quadrivalent 2015-2016 Jie Zheng Fluarix Quadrivalent 2016-2017 Jie Zheng Fluarix Quadrivalent 2017-2018 Jie Zheng Fluarix Quadrivalent 2018-2019 Jie Zheng Fluarix Quadrivalent 2019-2020 Jie Zheng Fluarix Quadrivalent 2020-2021 Jie Zheng Fluarix Quadrivalent 2021-2022 Jie Zheng Fluarix Quadrivalent 2022-2023 Jie Zheng Flublok 2012-2013 Formula Jie Zheng Flublok 2013-2014 Formula Jie Zheng Flublok 2014-2015 Formula Jie Zheng Flublok 2015-2016 Jie Zheng Flublok 2016-2017 Jie Zheng Flublok 2017-2018 Jie Zheng Flublok Quadrivalent 2017-2018 Jie Zheng Flublok Quadrivalent 2018-2019 Jie Zheng Flublok Quadrivalent 2019-2020 Jie Zheng Flublok Quadrivalent 2020-2021 Jie Zheng Flublok Quadrivalent 2021-2022 Jie Zheng Flublok Quadrivalent 2022-2023 Jie Zheng Flucelvax 2012-2013 Formula Jie Zheng Flucelvax 2013-2014 Formula Jie Zheng Flucelvax 2014-2015 Formula Jie Zheng Flucelvax 2015-2016 Jie Zheng Flucelvax Quadrivalent 2016-2017 Jie Zheng Flucelvax Quadrivalent 2017-2018 Jie Zheng Flucelvax Quadrivalent 2018-2019 Jie Zheng Flucelvax Quadrivalent 2019-2020 Jie Zheng Flucelvax Quadrivalent 2020-2021 Jie Zheng Flucelvax Quadrivalent 2021-2022 Jie Zheng Flucelvax Quadrivalent 2022-2023 Jie Zheng FluLaval 2010-2011 Formula Jie Zheng Flulaval 2011-2012 Formula Jie Zheng Flulaval 2012-2013 Formula Jie Zheng Flulaval 2013-2014 Formula Jie Zheng Flulaval 2014-2015 Formula Jie Zheng Flulaval Quad 2013-2014 Formula Jie Zheng Flulaval Quad 2014-2015 Formula Jie Zheng FluLaval Quadrivalent 2015-2016 Jie Zheng Flulaval Quadrivalent 2016-2017 Jie Zheng Flulaval Quadrivalent 2017-2018 Jie Zheng Flulaval Quadrivalent 2018-2019 Jie Zheng Flulaval Quadrivalent 2019-2020 Jie Zheng Flulaval Quadrivalent 2020-2021 Jie Zheng Flulaval Quadrivalent 2021-2022 Jie Zheng Flulaval Quadrivalent 2022-2023 Jie Zheng FluMist 2010-2011 Formula Jie Zheng Flumist 2011-2012 Formula Jie Zheng Flumist 2012-2013 Formula Jie Zheng Flumist 2014-2015 Formula Jie Zheng Flumist 2015-2016 Jie Zheng Flumist Quadrivalent 2016-2017 Jie Zheng Flumist Quadrivalent 2017-2018 Jie Zheng Flumist Quadrivalent 2018-2019 Jie Zheng FluMist Quadrivalent 2019-2020 Jie Zheng Flumist Quadrivalent 2020-2021 Jie Zheng FluMist Quadrivalent 2021-2022 Jie Zheng FluMist Quadrivalent 2022-2023 Jie Zheng Fluvirin 2010-2011 Formula Jie Zheng Fluvirin 2011-2012 Formula Jie Zheng Fluvirin 2012-2013 Formula Jie Zheng Fluvirin 2013-2014 Formula Jie Zheng Fluvirin 2014-2015 Formula Jie Zheng Fluvirin 2015-2016 Jie Zheng Fluvirin 2016-2017 Jie Zheng Fluvirin 2017-2018 Jie Zheng Fluzone 2010-2011 Formula Jie Zheng Fluzone 2011-2012 Formula Jie Zheng Fluzone 2012-2013 Formula Jie Zheng Fluzone 2013-2014 Formula Jie Zheng Fluzone 2014-2015 Formula Jie Zheng Fluzone 2015-2016 Jie Zheng Fluzone 2016-2017 Jie Zheng Fluzone 2017-2018 Jie Zheng Fluzone 2018-2019 Jie Zheng Fluzone 2019-2020 Jie Zheng Fluzone High-Dose 2012-2013 Formula Jie Zheng Fluzone High-Dose 2013-2014 Formula Jie Zheng Fluzone High-Dose 2014-2015 Formula Jie Zheng Fluzone Intradermal 2012-2013 Formula Jie Zheng Fluzone Intradermal 2013-2014 Formula Jie Zheng Fluzone Intradermal 2014-2015 Formula Jie Zheng Fluzone Quadrivalent 2013-2014 Formula Jie Zheng Fluzone Quadrivalent 2014-2015 Formula Jie Zheng Fluzone Quadrivalent 2015-2016 Jie Zheng Fluzone Quadrivalent 2016 Southern Hemisphere Jie Zheng Fluzone Quadrivalent 2016-2017 Jie Zheng Fluzone Quadrivalent 2017-2018 Jie Zheng Fluzone Quadrivalent 2018-2019 Jie Zheng Fluzone Quadrivalent 2019-2020 Jie Zheng Fluzone Quadrivalent 2020 Southern Hemisphere Jie Zheng Fluzone Quadrivalent 2020-2021 Jie Zheng Fluzone Quadrivalent 2021 Southern Hemisphere Jie Zheng Fluzone Quadrivalent 2021-2022 Jie Zheng Fluzone Quadrivalent 2022 Southern Hemisphere Jie Zheng Fluzone Quadrivalent 2022-2023 Jie Zheng Fluzone Quadrivalent 2023 Southern Hemisphere Jie Zheng Gardasil 9 Jie Zheng HB-VAX Jie Zheng Heplisav-B Jie Zheng Kinrix Jie Zheng Liquid PedvaxHIB Jie Zheng MenHibrix Jie Zheng Meningovax-AC Jie Zheng Menomune A/C/Y/W-135 Jie Zheng Meruvax II Jie Zheng OmniHIB Jie Zheng Pediarix Jie Zheng Pentacel Jie Zheng Prehevbrio Jie Zheng Prevnar 13 Jie Zheng Prohibit Jie Zheng RotaTeq Jie Zheng Shingrix Jie Zheng Spikevax Jie Zheng Tdvax Jie Zheng TE Anatoxal Berna Jie Zheng Tenivac Jie Zheng Tripedia Jie Zheng Varivax Jie Zheng Vaxchora Jie Zheng Vaxelis Jie Zheng Vivotif Jie Zheng YF-Vax Jie Zheng Zostavax Jie Zheng Liquid Pedvax HIB Jie Zheng Typhim V Jie Zheng Typhoral L Jie Zheng Afluria Jie Zheng Agrippal Jie Zheng Alpha RIX Tetra Jie Zheng Bcg Medac Jie Zheng Begripal Jie Zheng Fluad Jie Zheng Fluarix Jie Zheng Fluenz Jie Zheng Flumist Jie Zheng FluMist Quadrivalent Jie Zheng Fluvax Jie Zheng Grippe-Impfstoff Csl Jie Zheng Grippe-Impfstoff Stada Jie Zheng Grippeimpfstoff Ratiopharm Jie Zheng ImmuCyst Jie Zheng IMMUGRIP Jie Zheng Inflexal Jie Zheng Influsplit Jie Zheng INFLUVAC Jie Zheng Intanza Jie Zheng InterVax Jie Zheng Metavirulent Jie Zheng OncoTICE Jie Zheng Oncotice Bcg Jie Zheng Pacis Jie Zheng Pandemrix Jie Zheng Preflucel Jie Zheng Varilrix Jie Zheng VAXIGRIP Jie Zheng Vaxigrip Junior Jie Zheng Viroflu Jie Zheng Xanaflu Jie Zheng Box of 6 2025-05-24 has part my body has part my brain (continuant parthood, two material entities) my stomach has part my stomach cavity (continuant parthood, material entity has part immaterial entity) this year has part this day (occurrent parthood) a core relation that holds between a whole and its part Everything has itself as a part. Any part of any part of a thing is itself part of that thing. Two distinct things cannot have each other as a part. Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See http://purl.obolibrary.org/obo/ro/docs/temporal-semantics/ Parthood requires the part and the whole to have compatible classes: only an occurrent have an occurrent as part; only a process can have a process as part; only a continuant can have a continuant as part; only an independent continuant can have an independent continuant as part; only a specifically dependent continuant can have a specifically dependent continuant as part; only a generically dependent continuant can have a generically dependent continuant as part. (This list is not exhaustive.) A continuant cannot have an occurrent as part: use 'participates in'. An occurrent cannot have a continuant as part: use 'has participant'. An immaterial entity cannot have a material entity as part: use 'location of'. An independent continuant cannot have a specifically dependent continuant as part: use 'bearer of'. A specifically dependent continuant cannot have an independent continuant as part: use 'inheres in'. has_part has part realized in this disease is realized in this disease course this fragility is realized in this shattering this investigator role is realized in this investigation is realized by realized_in [copied from inverse property 'realizes'] to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003]) Paraphrase of elucidation: a relation between a realizable entity and a process, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process realized in realizes this disease course realizes this disease this investigation realizes this investigator role this shattering realizes this fragility to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003]) Paraphrase of elucidation: a relation between a process and a realizable entity, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process realizes preceded by x is preceded by y if and only if the time point at which y ends is before or equivalent to the time point at which x starts. Formally: x preceded by y iff ω(y) <= α(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point. An example is: translation preceded_by transcription; aging preceded_by development (not however death preceded_by aging). Where derives_from links classes of continuants, preceded_by links classes of processes. Clearly, however, these two relations are not independent of each other. Thus if cells of type C1 derive_from cells of type C, then any cell division involving an instance of C1 in a given lineage is preceded_by cellular processes involving an instance of C. The assertion P preceded_by P1 tells us something about Ps in general: that is, it tells us something about what happened earlier, given what we know about what happened later. Thus it does not provide information pointing in the opposite direction, concerning instances of P1 in general; that is, that each is such as to be succeeded by some instance of P. Note that an assertion to the effect that P preceded_by P1 is rather weak; it tells us little about the relations between the underlying instances in virtue of which the preceded_by relation obtains. Typically we will be interested in stronger relations, for example in the relation immediately_preceded_by, or in relations which combine preceded_by with a condition to the effect that the corresponding instances of P and P1 share participants, or that their participants are connected by relations of derivation, or (as a first step along the road to a treatment of causality) that the one process in some way affects (for example, initiates or regulates) the other. is preceded by preceded_by http://www.obofoundry.org/ro/#OBO_REL:preceded_by preceded by occurs in b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t occurs_in unfolds in unfolds_in Paraphrase of definition: a relation between a process and an independent continuant, in which the process takes place entirely within the independent continuant occurs in This document is about information artifacts and their representations A (currently) primitive relation that relates an information artifact to an entity. 7/6/2009 Alan Ruttenberg. Following discussion with Jonathan Rees, and introduction of "mentions" relation. Weaken the is_about relationship to be primitive. We will try to build it back up by elaborating the various subproperties that are more precisely defined. Some currently missing phenomena that should be considered "about" are predications - "The only person who knows the answer is sitting beside me" , Allegory, Satire, and other literary forms that can be topical without explicitly mentioning the topic. person:Alan Ruttenberg Smith, Ceusters, Ruttenberg, 2000 years of philosophy is about An information artifact IA mentions an entity E exactly when it has a component/part that denotes E 7/6/2009 Alan Ruttenberg. P4 RC1 munges our GCI so remove it for now: mentions some entity equivalentTo has_part some ('generically denotes' some entity) 7/6/2009 Alan Ruttenberg: Add this relation following conversation with Jonathan Rees that N&S GCI for is_about was too strong. Really it was simply sufficient. To effect this change we introduce this relation, which is subproperty of is_about, and have previous GCI use this relation "mentions" in it's (logical) definition PERSON: Jonathan Rees Person: Alan Ruttenberg mentions has_specified_input see is_input_of example_of_usage The inverse property of is_specified_input_of 8/17/09: specified inputs of one process are not necessarily specified inputs of a larger process that it is part of. This is in contrast to how 'has participant' works. PERSON: Alan Ruttenberg PERSON: Bjoern Peters PERSON: Larry Hunter PERSON: Melanie Coutot has_specified_input is_specified_input_of some Autologous EBV(Epstein-Barr virus)-transformed B-LCL (B lymphocyte cell line) is_input_for instance of Chromum Release Assay described at https://wiki.cbil.upenn.edu/obiwiki/index.php/Chromium_Release_assay A relation between a planned process and a continuant participating in that process that is not created during the process. The presence of the continuant during the process is explicitly specified in the plan specification which the process realizes the concretization of. Alan Ruttenberg PERSON:Bjoern Peters is_specified_input_of has_specified_output The inverse property of is_specified_output_of PERSON: Alan Ruttenberg PERSON: Bjoern Peters PERSON: Larry Hunter PERSON: Melanie Courtot has_specified_output is_specified_output_of A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of. Alan Ruttenberg PERSON:Bjoern Peters is_specified_output_of achieves_planned_objective A cell sorting process achieves the objective specification 'material separation objective' This relation obtains between a planned process and a objective specification when the criteria specified in the objective specification are met at the end of the planned process. BP, AR, PPPB branch PPPB branch derived modified according to email thread from 1/23/09 in accordince with DT and PPPB branch achieves_planned_objective has grain the relation of the cells in the finger of the skin to the finger, in which an indeterminate number of grains are parts of the whole by virtue of being grains in a collective that is part of the whole, and in which removing one granular part does not nec- essarily damage or diminish the whole. Ontological Whether there is a fixed, or nearly fixed number of parts - e.g. fingers of the hand, chambers of the heart, or wheels of a car - such that there can be a notion of a single one being missing, or whether, by contrast, the number of parts is indeterminate - e.g., cells in the skin of the hand, red cells in blood, or rubber molecules in the tread of the tire of the wheel of the car. Discussion in Karslruhe with, among others, Alan Rector, Stefan Schulz, Marijke Keet, Melanie Courtot, and Alan Ruttenberg. Definition take from the definition of granular parthood in the cited paper. Needs work to put into standard form PERSON: Alan Ruttenberg PAPER: Granularity, scale and collectivity: When size does and does not matter, Alan Rector, Jeremy Rogers, Thomas Bittner, Journal of Biomedical Informatics 39 (2006) 333-349 has grain has value specification A relation between an information content entity and a value specification that specifies its value. PERSON: James A. Overton OBI has value specification inheres in this fragility is a characteristic of this vase this red color is a characteristic of this apple a relation between a specifically dependent continuant (the characteristic) and any other entity (the bearer), in which the characteristic depends on the bearer for its existence. inheres_in Note that this relation was previously called "inheres in", but was changed to be called "characteristic of" because BFO2 uses "inheres in" in a more restricted fashion. This relation differs from BFO2:inheres_in in two respects: (1) it does not impose a range constraint, and thus it allows qualities of processes, as well as of information entities, whereas BFO2 restricts inheres_in to only apply to independent continuants (2) it is declared functional, i.e. something can only be a characteristic of one thing. characteristic of participates in this blood clot participates in this blood coagulation this input material (or this output material) participates in this process this investigator participates in this investigation a relation between a continuant and a process, in which the continuant is somehow involved in the process participates_in participates in has participant this blood coagulation has participant this blood clot this investigation has participant this investigator this process has participant this input material (or this output material) a relation between a process and a continuant, in which the continuant is somehow involved in the process Has_participant is a primitive instance-level relation between a process, a continuant, and a time at which the continuant participates in some way in the process. The relation obtains, for example, when this particular process of oxygen exchange across this particular alveolar membrane has_participant this particular sample of hemoglobin at this particular time. has_participant http://www.obofoundry.org/ro/#OBO_REL:has_participant has participant this enzyme has function this catalysis function (more colloquially: this enzyme has this catalysis function) a relation between an independent continuant (the bearer) and a function, in which the function specifically depends on the bearer for its existence A bearer can have many functions, and its functions can exist for different periods of time, but none of its functions can exist when the bearer does not exist. A function need not be realized at all the times that the function exists. has_function has function this apple has quality this red color a relation between an independent continuant (the bearer) and a quality, in which the quality specifically depends on the bearer for its existence A bearer can have many qualities, and its qualities can exist for different periods of time, but none of its qualities can exist when the bearer does not exist. has_quality has quality this person has role this investigator role (more colloquially: this person has this role of investigator) a relation between an independent continuant (the bearer) and a role, in which the role specifically depends on the bearer for its existence A bearer can have many roles, and its roles can exist for different periods of time, but none of its roles can exist when the bearer does not exist. A role need not be realized at all the times that the role exists. has_role has role a relation between an independent continuant (the bearer) and a disposition, in which the disposition specifically depends on the bearer for its existence has disposition this cell derives from this parent cell (cell division) this nucleus derives from this parent nucleus (nuclear division) a relation between two distinct material entities, the new entity and the old entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops from'. derives_from derives from located in my brain is located in my head this rat is located in this cage a relation between two independent continuants, the target and the location, in which the target is entirely within the location Location as a relation between instances: The primitive instance-level relation c located_in r at t reflects the fact that each continuant is at any given time associated with exactly one spatial region, namely its exact location. Following we can use this relation to define a further instance-level location relation - not between a continuant and the region which it exactly occupies, but rather between one continuant and another. c is located in c1, in this sense, whenever the spatial region occupied by c is part_of the spatial region occupied by c1. Note that this relation comprehends both the relation of exact location between one continuant and another which obtains when r and r1 are identical (for example, when a portion of fluid exactly fills a cavity), as well as those sorts of inexact location relations which obtain, for example, between brain and head or between ovum and uterus Most location relations will only hold at certain times, but this is difficult to specify in OWL. See http://purl.obolibrary.org/obo/ro/docs/temporal-semantics/ located_in http://www.obofoundry.org/ro/#OBO_REL:located_in located in x is in taxon y if an only if y is an organism, and the relationship between x and y is one of: part of (reflexive), developmentally preceded by, derives from, secreted by, expressed. Connects a biological entity to its taxon of origin. in taxon w 'has component' p if w 'has part' p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type. The definition of 'has component' is still under discussion. The challenge is in providing a definition that does not imply transitivity. For use in recording has_part with a cardinality constraint, because OWL does not permit cardinality constraints to be used in combination with transitive object properties. In situations where you would want to say something like 'has part exactly 5 digit, you would instead use has_component exactly 5 digit. has component y expresses x if and only if there is a gene expression process (GO:0010467) that occurs in y, and one of the following holds: (i) x is a gene, and x is transcribed into a transcript as part of the gene expression process (ii) x is a transcript, and x was transcribed from a gene as part of the gene expression process (iii) x is a mature gene product (protein or RNA), and x was translated or otherwise processed from a transcript that was transcribed as part of the gene expression process. expresses has member is a mereological relation between a collection and an item. SIO has member 2017-11-05T03:26:47Z disease has basis in An object property that specifies a relation between a vaccine and a vaccine allergen Oliver He has vaccine allergen An object property that specifies a relation between a vaccine and a vaccinate route vaccinated in route A shortcut relation that is equivalent to: 'processed material' and (is_specified_output_of some 'vaccine preparation') and ('has function' some ('vaccine function' and ('is realized by' only ('vaccine immunization' and (realizes some ('vaccine host role' and (role_of some 'organism' and has_disposition some disease)))))))). The domain of this relation is a vaccine. The range of this relation is a disease. Asiyah Yu Lin Oliver He immunization against disease vaccine immunization against disease immunizes against disease An object property that represents an organism has a mutation of a specific gene from the organism genome. Oliver He has gene mutation A shortcut relation that is equivalent to: 'processed material' and (is_specified_output_of some 'vaccine preparation') and ('has function' some ('vaccine function' and ('is realized by' only ('vaccine immunization' and (realizes some ('vaccine recipient role' and (role_of some 'organism')))))))). The domain of this relation is a vaccine. The range of this relation is a organism. Anna Maria Masci Asiyah Yu Lin Barry Smith Jie Zheng Oliver He immunization for host immunization for recipient immunizes host vaccine immunization for host vaccine immunization for recipient immunizes recipient A shortcut relation that is equivalent to: processed material and (is_specified_output_of some vaccine preparation) and (has function some (vaccine function and (is realized by only (vaccine immunization and (realizes some ('immunization target role' and (role_of some 'pathogen')))))))) The domain of this relation is a vaccine. The range of this relation is a pathogen (a bacterium, a virus, a fungus, and a parasite) Ranges: organism and 'has role' some 'pathogen role' Oliver He immunization against pathogen immunizes against microbe vaccine immunization against pathogen https://github.com/vaccineontology/VO/issues/675 immunizes against pathogen A shortcut relation that is equivalent to: ('vaccine' and 'has function' some ('vaccine function' and ('is realized by' some ('vaccine immunization' and 'has participant' some ('organism' and 'has role' some 'laboratory animal model role'))))). The domain of this relation is a vaccine. The range of this relation is a organism. Jie Zheng Oliver He test in lab animal model An object property that represents a relation between a material entity (such as vaccine or vaccine adjuvant) and an immune profile where the material entity can induce the immune profile in a host. Amogh Madireddi Oliver He induces immune profile A vaccine adjuvant T-vant has molecular receptor of TLR4. Reference: https://vac.niaid.nih.gov/view?id=61. An object property that represents a relation between a material entity and a molecular entitiy that serves as the molecular receptor to the material entity. Oliver He has molecular receptor A relation between a vaccine and a parasite where the vaccine immunizes against some parasite such that the parasite is blocked transmitting to additional hosts or vectors. https://github.com/vaccineontology/VO/issues/675 blocks transmission of pathogen via vaccine A relation between a vaccine X and organism Y where the vaccine X generates an immune response in a vaccinated organism and the immune product (e.g., antibody) can be transferred to the organism Y vaccine immunity response transferrable to organism Jie Zheng drug form has drug dose form en Chris mungall Erica Marcos Ningxian Fan Paul Fabry Randi Vita Ryan R. Brinkman Shunzhou Deng Alan Ruttenburg Alexander D. Diehl Amogh Madireddi Anna Maria Masci Anthony Huffman Barry Smith Bjoern Peters Edison Ong Ellen Zhang Hong Yu Jason Hu Jie Zheng Kallan Roan Khadeejah Khan Lindsay Cowell Melanie Courtot Ningxian Fan Omar Tibi Philip Huang Randi Vita Rebecca Racz Richard H. Scheuermann Rohit Goru Ronak Sutariya Samantha G. Sayers (SGS) Taiyu Lin Thomas Todd Xingxian Li Yongqun "Oliver" He (YH) Yu Lin (YL) Yuanyi (Penny) Pan Yuping Zheng Zuoshuang "Allen" Xiang The Vaccine Ontology (VO) is a community-based biomedical ontology in the domain of vaccine and vaccination. VO aims to standardize vaccine types and annotations, integrate various vaccine data, and support computer-assisted reasoning. The VO supports basic vaccine R&D and clinical vaccine usage. VO is being developed as a community-based ontology with support and collaborations from the vaccine and bio-ontology communities. OWL-DL An ontology in the domain of vaccine and vaccination Vaccine Ontology 2025-05-24